Mitch Report

date generated: 2024-12-13

Background

Mitch performs unidimensional and multidimensional gene set enrichment analysis. The concept behind this dates to work by Cox and Mann (https://doi.org/10.1186/1471-2105-13-S16-S12). This implementation is suited to R based workflows of multi-omics datasets. This software was developed by Antony Kaspi and Mark Ziemann. Learn more about Mitch at the website: https://github.com/markziemann/Mitch

Input profiles

Here is the first few lines of the input profile.

The profiling data being passed to mitch

	cancer	incidence
A1BG	0.5004944	0.0006228
A1BG-AS1	0.6143223	0.0006301
A1CF	-1.8473972	-0.0013322
A2M	1.5320527	-0.0010101
A2M-AS1	-1.3189297	-0.0000065
A2ML1	1.1002124	-0.0008100

Here are some metrics about the input data profile:

Profiling data metrics

	Profile metrics
num_genes_in_profile	21922
duplicated_genes_present	0
num_profile_genes_in_sets	17585
num_profile_genes_not_in_sets	4337
profile_pearson_correl	0.20738
profile_spearman_correl	0.21406

Here is a plot of the input profiles. Note the dynamic ranges.

Here is the contour plot of the profile including all detected genes.

Input genesets

Here are some metrics about the gene sets used:

GMT file of genesets:

Gene set metrics

	Gene sets metrics
num_genesets	13188
num_genesets_excluded	4273
num_genesets_included	8915

Gene sets by quadrant

Number of significant gene sets (FDR<0.05)= 1922

Interactive enrichment scatterplot

All sets with FDR<0.05. Try hovering over the points.

Top N sets irrespective of FDR. Try hovering over the points.

A heatmap of S values for top results

A plot of effect size versus significance

Significance is the -log2(p.adjustMANOVA) and effect size is the s.dist which is the hypotenuse of the s scores.

Results table

Top N= 50 gene sets

set	setSize	pMANOVA	p.adjustMANOVA	s.dist	s.cancer	s.incidence	p.cancer	p.incidence
GOMF CCR6 CHEMOKINE RECEPTOR BINDING	5	1.32e-03	1.29e-02	1.030	-0.79400	-0.6620	2.11e-03	1.03e-02
GOMF INHIBITORY MHC CLASS I RECEPTOR ACTIVITY	9	8.64e-06	1.90e-04	0.998	-0.89000	-0.4510	3.74e-06	1.90e-02
GOMF ODORANT BINDING	99	2.31e-54	1.29e-51	0.962	-0.89800	-0.3450	4.68e-54	2.81e-09
GOMF HEMOGLOBIN ALPHA BINDING	5	1.66e-03	1.52e-02	0.955	-0.92200	-0.2490	3.55e-04	3.34e-01
GOBP REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY	6	1.10e-03	1.13e-02	0.951	0.77700	0.5480	9.73e-04	2.01e-02
GOBP MATURE CONVENTIONAL DENDRITIC CELL DIFFERENTIATION	5	2.05e-04	2.82e-03	0.944	-0.68300	0.6510	8.14e-03	1.17e-02
Organic anion transport	5	3.19e-03	2.52e-02	0.923	-0.32400	-0.8640	2.10e-01	8.22e-04
GOBP ANTIGEN PROCESSING AND PRESENTATION ENDOGENOUS LIPID ANTIGEN VIA MHC CLASS IB	5	1.96e-03	1.73e-02	0.906	-0.90300	-0.0709	4.69e-04	7.84e-01
GOMF LIPID ANTIGEN BINDING	5	1.96e-03	1.73e-02	0.906	-0.90300	-0.0709	4.69e-04	7.84e-01
GOBP CARDIAC SEPTUM CELL DIFFERENTIATION	5	4.84e-03	3.44e-02	0.891	0.82900	0.3270	1.32e-03	2.05e-01
GOMF PROTEIN ARGININE DEIMINASE ACTIVITY	5	6.82e-03	4.49e-02	0.889	-0.48800	-0.7430	5.87e-02	4.02e-03
GOMF OLFACTORY RECEPTOR ACTIVITY	338	0.00e+00	0.00e+00	0.875	-0.79600	-0.3630	0.00e+00	1.53e-30
Expression and translocation of olfactory receptors	339	0.00e+00	0.00e+00	0.857	-0.78000	-0.3560	0.00e+00	1.60e-29
Olfactory Signaling Pathway	346	0.00e+00	0.00e+00	0.844	-0.76500	-0.3560	0.00e+00	4.93e-30
NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake	5	1.29e-02	7.20e-02	0.839	0.57500	0.6110	2.59e-02	1.79e-02
H139Hfs13* PPM1K causes a mild variant of MSUD	5	1.10e-02	6.43e-02	0.837	0.73500	0.4000	4.44e-03	1.21e-01
Maple Syrup Urine Disease	5	1.10e-02	6.43e-02	0.837	0.73500	0.4000	4.44e-03	1.21e-01
GOBP REGULATION OF AMACRINE CELL DIFFERENTIATION	6	1.37e-03	1.32e-02	0.833	-0.01630	0.8330	9.45e-01	4.12e-04
Conjugation of salicylate with glycine	8	1.08e-03	1.12e-02	0.824	-0.67800	-0.4690	9.00e-04	2.16e-02
GOBP SENSORY PERCEPTION OF SMELL	364	0.00e+00	0.00e+00	0.823	-0.74500	-0.3500	0.00e+00	1.79e-30
Digestion of dietary carbohydrate	6	6.50e-03	4.34e-02	0.821	-0.64400	-0.5100	6.32e-03	3.05e-02
GOBP PROTEIN POLYUFMYLATION	5	1.57e-02	8.37e-02	0.812	0.67300	0.4550	9.20e-03	7.78e-02
GOBP MESENCHYME MIGRATION	5	6.36e-03	4.27e-02	0.811	0.81000	0.0418	1.71e-03	8.72e-01
Branched-chain ketoacid dehydrogenase kinase deficiency	5	1.61e-02	8.51e-02	0.811	0.66500	0.4640	1.00e-02	7.23e-02
GOMF TRACE AMINE RECEPTOR ACTIVITY	7	2.74e-03	2.25e-02	0.805	-0.71900	-0.3620	9.88e-04	9.75e-02
GOBP NEGATIVE REGULATION OF INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY	8	5.93e-05	1.01e-03	0.803	0.66000	-0.4570	1.22e-03	2.51e-02
Prostanoid ligand receptors	9	3.44e-04	4.38e-03	0.803	0.24600	0.7640	2.01e-01	7.21e-05
GOBP REGULATION OF BINDING OF SPERM TO ZONA PELLUCIDA	5	1.22e-02	6.89e-02	0.797	-0.22600	-0.7640	3.80e-01	3.08e-03
GOMF ESTROGEN 2 HYDROXYLASE ACTIVITY	5	2.66e-03	2.20e-02	0.795	0.42100	-0.6750	1.03e-01	8.98e-03
GOCC INTRACELLULAR CYCLIC NUCLEOTIDE ACTIVATED CATION CHANNEL COMPLEX	5	1.63e-02	8.60e-02	0.786	-0.30200	-0.7260	2.43e-01	4.96e-03
GOBP NEGATIVE REGULATION OF MHC CLASS II BIOSYNTHETIC PROCESS	5	4.08e-03	3.04e-02	0.785	-0.26200	0.7410	3.11e-01	4.13e-03
GOBP XENOBIOTIC GLUCURONIDATION	6	9.47e-03	5.75e-02	0.785	-0.44100	-0.6500	6.11e-02	5.85e-03
GOBP CARDIAC PACEMAKER CELL DEVELOPMENT	8	2.08e-03	1.82e-02	0.779	0.66300	0.4090	1.16e-03	4.50e-02
Activation of C3 and C5	6	1.03e-02	6.10e-02	0.773	-0.39300	-0.6660	9.54e-02	4.75e-03
Ficolins bind to repetitive carbohydrate structures on the target cell surface	5	2.66e-02	1.22e-01	0.766	-0.55100	-0.5320	3.27e-02	3.94e-02
GOBP POSITIVE REGULATION OF KERATINOCYTE APOPTOTIC PROCESS	5	2.69e-02	1.22e-01	0.765	0.53400	0.5480	3.87e-02	3.39e-02
GOBP SPERM MITOCHONDRIAL SHEATH ASSEMBLY	6	1.32e-02	7.35e-02	0.764	-0.55100	-0.5290	1.93e-02	2.49e-02
GOCC RADIAL SPOKE HEAD	5	1.03e-02	6.11e-02	0.764	0.00255	0.7640	9.92e-01	3.10e-03
Conjugation of benzoate with glycine	6	1.37e-02	7.57e-02	0.752	-0.40600	-0.6330	8.49e-02	7.29e-03
Regulation of gene expression in early pancreatic precursor cells	8	3.19e-03	2.52e-02	0.749	0.64800	0.3760	1.50e-03	6.53e-02
Sensory perception of salty taste	6	1.57e-02	8.38e-02	0.748	-0.56300	-0.4920	1.69e-02	3.70e-02
GOBP FC RECEPTOR MEDIATED INHIBITORY SIGNALING PATHWAY	5	3.00e-02	1.32e-01	0.746	-0.62000	-0.4150	1.64e-02	1.08e-01
GOMF MHC CLASS IB RECEPTOR ACTIVITY	7	2.51e-03	2.11e-02	0.742	-0.74100	-0.0185	6.81e-04	9.32e-01
GOMF COENZYME A DIPHOSPHATASE ACTIVITY	5	6.76e-03	4.47e-02	0.736	-0.33600	0.6550	1.94e-01	1.12e-02
GOBP NEGATIVE REGULATION OF MIRNA PROCESSING	9	2.51e-03	2.11e-02	0.733	0.49300	0.5430	1.04e-02	4.77e-03
GOBP SENSORY PERCEPTION OF CHEMICAL STIMULUS	439	0.00e+00	0.00e+00	0.733	-0.65600	-0.3280	0.00e+00	3.10e-32
GOBP ASCENDING AORTA DEVELOPMENT	5	3.68e-02	1.52e-01	0.730	0.47100	0.5580	6.81e-02	3.08e-02
GOBP POSITIVE REGULATION OF ENAMEL MINERALIZATION	5	1.53e-02	8.21e-02	0.730	-0.00052	-0.7300	9.98e-01	4.72e-03
GOBP EMBRYONIC HEART TUBE LEFT RIGHT PATTERN FORMATION	6	1.80e-02	9.20e-02	0.729	0.60400	0.4080	1.04e-02	8.34e-02
GOBP NEGATIVE REGULATION OF CERAMIDE BIOSYNTHETIC PROCESS	5	3.61e-02	1.50e-01	0.727	0.41600	0.5970	1.07e-01	2.08e-02

---

Results (complete table)

Click HERE to show results for all gene sets

Complete results

set	setSize	pMANOVA	p.adjustMANOVA	s.dist	s.cancer	s.incidence	p.cancer	p.incidence
GOMF CCR6 CHEMOKINE RECEPTOR BINDING	5	1.32e-03	1.29e-02	1.03000	-7.94e-01	-6.62e-01	2.11e-03	1.03e-02
GOMF INHIBITORY MHC CLASS I RECEPTOR ACTIVITY	9	8.64e-06	1.90e-04	0.99800	-8.90e-01	-4.51e-01	3.74e-06	1.90e-02
GOMF ODORANT BINDING	99	2.31e-54	1.29e-51	0.96200	-8.98e-01	-3.45e-01	4.68e-54	2.81e-09
GOMF HEMOGLOBIN ALPHA BINDING	5	1.66e-03	1.52e-02	0.95500	-9.22e-01	-2.49e-01	3.55e-04	3.34e-01
GOBP REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY	6	1.10e-03	1.13e-02	0.95100	7.77e-01	5.48e-01	9.73e-04	2.01e-02
GOBP MATURE CONVENTIONAL DENDRITIC CELL DIFFERENTIATION	5	2.05e-04	2.82e-03	0.94400	-6.83e-01	6.51e-01	8.14e-03	1.17e-02
Organic anion transport	5	3.19e-03	2.52e-02	0.92300	-3.24e-01	-8.64e-01	2.10e-01	8.22e-04
GOBP ANTIGEN PROCESSING AND PRESENTATION ENDOGENOUS LIPID ANTIGEN VIA MHC CLASS IB	5	1.96e-03	1.73e-02	0.90600	-9.03e-01	-7.09e-02	4.69e-04	7.84e-01
GOMF LIPID ANTIGEN BINDING	5	1.96e-03	1.73e-02	0.90600	-9.03e-01	-7.09e-02	4.69e-04	7.84e-01
GOBP CARDIAC SEPTUM CELL DIFFERENTIATION	5	4.84e-03	3.44e-02	0.89100	8.29e-01	3.27e-01	1.32e-03	2.05e-01
GOMF PROTEIN ARGININE DEIMINASE ACTIVITY	5	6.82e-03	4.49e-02	0.88900	-4.88e-01	-7.43e-01	5.87e-02	4.02e-03
GOMF OLFACTORY RECEPTOR ACTIVITY	338	1.17e-148	1.43e-144	0.87500	-7.96e-01	-3.63e-01	1.80e-141	1.53e-30
Expression and translocation of olfactory receptors	339	4.07e-143	2.50e-139	0.85700	-7.80e-01	-3.56e-01	3.21e-136	1.60e-29
Olfactory Signaling Pathway	346	3.22e-141	1.32e-137	0.84400	-7.65e-01	-3.56e-01	6.68e-134	4.93e-30
NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake	5	1.29e-02	7.20e-02	0.83900	5.75e-01	6.11e-01	2.59e-02	1.79e-02
H139Hfs13* PPM1K causes a mild variant of MSUD	5	1.10e-02	6.43e-02	0.83700	7.35e-01	4.00e-01	4.44e-03	1.21e-01
Maple Syrup Urine Disease	5	1.10e-02	6.43e-02	0.83700	7.35e-01	4.00e-01	4.44e-03	1.21e-01
GOBP REGULATION OF AMACRINE CELL DIFFERENTIATION	6	1.37e-03	1.32e-02	0.83300	-1.63e-02	8.33e-01	9.45e-01	4.12e-04
Conjugation of salicylate with glycine	8	1.08e-03	1.12e-02	0.82400	-6.78e-01	-4.69e-01	9.00e-04	2.16e-02
GOBP SENSORY PERCEPTION OF SMELL	364	7.14e-141	2.19e-137	0.82300	-7.45e-01	-3.50e-01	2.89e-133	1.79e-30
Digestion of dietary carbohydrate	6	6.50e-03	4.34e-02	0.82100	-6.44e-01	-5.10e-01	6.32e-03	3.05e-02
GOBP PROTEIN POLYUFMYLATION	5	1.57e-02	8.37e-02	0.81200	6.73e-01	4.55e-01	9.20e-03	7.78e-02
GOBP MESENCHYME MIGRATION	5	6.36e-03	4.27e-02	0.81100	8.10e-01	4.18e-02	1.71e-03	8.72e-01
Branched-chain ketoacid dehydrogenase kinase deficiency	5	1.61e-02	8.51e-02	0.81100	6.65e-01	4.64e-01	1.00e-02	7.23e-02
GOMF TRACE AMINE RECEPTOR ACTIVITY	7	2.74e-03	2.25e-02	0.80500	-7.19e-01	-3.62e-01	9.88e-04	9.75e-02
GOBP NEGATIVE REGULATION OF INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY	8	5.93e-05	1.01e-03	0.80300	6.60e-01	-4.57e-01	1.22e-03	2.51e-02
Prostanoid ligand receptors	9	3.44e-04	4.38e-03	0.80300	2.46e-01	7.64e-01	2.01e-01	7.21e-05
GOBP REGULATION OF BINDING OF SPERM TO ZONA PELLUCIDA	5	1.22e-02	6.89e-02	0.79700	-2.26e-01	-7.64e-01	3.80e-01	3.08e-03
GOMF ESTROGEN 2 HYDROXYLASE ACTIVITY	5	2.66e-03	2.20e-02	0.79500	4.21e-01	-6.75e-01	1.03e-01	8.98e-03
GOCC INTRACELLULAR CYCLIC NUCLEOTIDE ACTIVATED CATION CHANNEL COMPLEX	5	1.63e-02	8.60e-02	0.78600	-3.02e-01	-7.26e-01	2.43e-01	4.96e-03
GOBP NEGATIVE REGULATION OF MHC CLASS II BIOSYNTHETIC PROCESS	5	4.08e-03	3.04e-02	0.78500	-2.62e-01	7.41e-01	3.11e-01	4.13e-03
GOBP XENOBIOTIC GLUCURONIDATION	6	9.47e-03	5.75e-02	0.78500	-4.41e-01	-6.50e-01	6.11e-02	5.85e-03
GOBP CARDIAC PACEMAKER CELL DEVELOPMENT	8	2.08e-03	1.82e-02	0.77900	6.63e-01	4.09e-01	1.16e-03	4.50e-02
Activation of C3 and C5	6	1.03e-02	6.10e-02	0.77300	-3.93e-01	-6.66e-01	9.54e-02	4.75e-03
Ficolins bind to repetitive carbohydrate structures on the target cell surface	5	2.66e-02	1.22e-01	0.76600	-5.51e-01	-5.32e-01	3.27e-02	3.94e-02
GOBP POSITIVE REGULATION OF KERATINOCYTE APOPTOTIC PROCESS	5	2.69e-02	1.22e-01	0.76500	5.34e-01	5.48e-01	3.87e-02	3.39e-02
GOBP SPERM MITOCHONDRIAL SHEATH ASSEMBLY	6	1.32e-02	7.35e-02	0.76400	-5.51e-01	-5.29e-01	1.93e-02	2.49e-02
GOCC RADIAL SPOKE HEAD	5	1.03e-02	6.11e-02	0.76400	2.55e-03	7.64e-01	9.92e-01	3.10e-03
Conjugation of benzoate with glycine	6	1.37e-02	7.57e-02	0.75200	-4.06e-01	-6.33e-01	8.49e-02	7.29e-03
Regulation of gene expression in early pancreatic precursor cells	8	3.19e-03	2.52e-02	0.74900	6.48e-01	3.76e-01	1.50e-03	6.53e-02
Sensory perception of salty taste	6	1.57e-02	8.38e-02	0.74800	-5.63e-01	-4.92e-01	1.69e-02	3.70e-02
GOBP FC RECEPTOR MEDIATED INHIBITORY SIGNALING PATHWAY	5	3.00e-02	1.32e-01	0.74600	-6.20e-01	-4.15e-01	1.64e-02	1.08e-01
GOMF MHC CLASS IB RECEPTOR ACTIVITY	7	2.51e-03	2.11e-02	0.74200	-7.41e-01	-1.85e-02	6.81e-04	9.32e-01
GOMF COENZYME A DIPHOSPHATASE ACTIVITY	5	6.76e-03	4.47e-02	0.73600	-3.36e-01	6.55e-01	1.94e-01	1.12e-02
GOBP NEGATIVE REGULATION OF MIRNA PROCESSING	9	2.51e-03	2.11e-02	0.73300	4.93e-01	5.43e-01	1.04e-02	4.77e-03
GOBP SENSORY PERCEPTION OF CHEMICAL STIMULUS	439	2.12e-133	5.21e-130	0.73300	-6.56e-01	-3.28e-01	3.38e-124	3.10e-32
GOBP ASCENDING AORTA DEVELOPMENT	5	3.68e-02	1.52e-01	0.73000	4.71e-01	5.58e-01	6.81e-02	3.08e-02
GOBP POSITIVE REGULATION OF ENAMEL MINERALIZATION	5	1.53e-02	8.21e-02	0.73000	-5.20e-04	-7.30e-01	9.98e-01	4.72e-03
GOBP EMBRYONIC HEART TUBE LEFT RIGHT PATTERN FORMATION	6	1.80e-02	9.20e-02	0.72900	6.04e-01	4.08e-01	1.04e-02	8.34e-02
GOBP NEGATIVE REGULATION OF CERAMIDE BIOSYNTHETIC PROCESS	5	3.61e-02	1.50e-01	0.72700	4.16e-01	5.97e-01	1.07e-01	2.08e-02
GOBP REGULATION OF MYELOID DENDRITIC CELL ACTIVATION	5	6.51e-03	4.34e-02	0.72600	-5.10e-01	5.17e-01	4.84e-02	4.51e-02
GOCC PREFOLDIN COMPLEX	6	2.04e-02	1.01e-01	0.72400	5.33e-01	4.90e-01	2.37e-02	3.76e-02
Amino Acid conjugation	9	2.93e-03	2.36e-02	0.72300	-5.45e-01	-4.75e-01	4.60e-03	1.35e-02
Conjugation of carboxylic acids	9	2.93e-03	2.36e-02	0.72300	-5.45e-01	-4.75e-01	4.60e-03	1.35e-02
GOMF GUANYLATE CYCLASE REGULATOR ACTIVITY	8	5.45e-04	6.45e-03	0.71900	2.87e-01	-6.59e-01	1.60e-01	1.24e-03
GOMF MHC CLASS I RECEPTOR ACTIVITY	13	1.79e-04	2.51e-03	0.71900	-6.28e-01	-3.50e-01	8.90e-05	2.90e-02
GOCC FC RECEPTOR COMPLEX	5	2.26e-02	1.08e-01	0.71600	-7.09e-01	-9.85e-02	6.04e-03	7.03e-01
GOCC MLL3 4 COMPLEX	10	2.68e-04	3.57e-03	0.71600	7.15e-01	-3.63e-02	9.07e-05	8.43e-01
GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OSMOTIC STRESS	5	3.22e-02	1.39e-01	0.71500	6.67e-01	2.58e-01	9.84e-03	3.18e-01
GOBP POSITIVE REGULATION OF ACROSOME REACTION	11	8.41e-04	9.20e-03	0.71500	-5.94e-01	-3.97e-01	6.47e-04	2.25e-02
GOBP DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION	456	9.05e-131	1.85e-127	0.71400	-6.35e-01	-3.25e-01	4.51e-121	1.04e-32
GOBP RESPONSE TO ACTINOMYCIN D	5	3.23e-02	1.39e-01	0.71100	6.69e-01	2.41e-01	9.57e-03	3.51e-01
GOBP TELENCEPHALON REGIONALIZATION	13	2.14e-04	2.92e-03	0.71100	3.46e-01	6.21e-01	3.06e-02	1.05e-04
GOBP REGULATION OF LENS FIBER CELL DIFFERENTIATION	8	5.61e-03	3.86e-02	0.71100	6.17e-01	3.53e-01	2.50e-03	8.39e-02
GOBP REGULATION OF TERMINATION OF DNA TEMPLATED TRANSCRIPTION	5	4.36e-02	1.72e-01	0.71000	5.54e-01	4.44e-01	3.20e-02	8.55e-02
GOBP PROTEIN UFMYLATION	6	2.42e-02	1.14e-01	0.70800	5.03e-01	4.99e-01	3.29e-02	3.42e-02
GOBP FLAVONOID GLUCURONIDATION	5	4.02e-02	1.63e-01	0.70700	-3.43e-01	-6.18e-01	1.84e-01	1.67e-02
Digestion of dietary lipid	7	1.30e-02	7.29e-02	0.70600	-4.42e-01	-5.51e-01	4.28e-02	1.16e-02
GOCC INSULIN LIKE GROWTH FACTOR BINDING PROTEIN COMPLEX	5	2.97e-02	1.31e-01	0.70500	6.84e-01	1.70e-01	8.03e-03	5.10e-01
Classical antibody-mediated complement activation	6	2.14e-02	1.05e-01	0.70500	-3.35e-01	-6.20e-01	1.55e-01	8.54e-03
GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 2B COMPLEX	5	4.30e-02	1.70e-01	0.70300	5.99e-01	3.69e-01	2.03e-02	1.53e-01
GOBP CENTROMERIC SISTER CHROMATID COHESION	10	9.25e-04	9.84e-03	0.70300	6.82e-01	1.72e-01	1.88e-04	3.47e-01
GOCC SPERM FIBROUS SHEATH	6	2.22e-02	1.07e-01	0.70100	-3.32e-01	-6.18e-01	1.59e-01	8.78e-03
GOBP NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY	5	4.83e-02	1.84e-01	0.69900	4.59e-01	5.28e-01	7.58e-02	4.08e-02
Formation of lateral plate mesoderm	5	3.26e-02	1.40e-01	0.69900	1.82e-01	6.74e-01	4.80e-01	9.01e-03
GOBP SPLICEOSOMAL CONFORMATIONAL CHANGES TO GENERATE CATALYTIC CONFORMATION	5	3.45e-02	1.45e-01	0.69900	6.67e-01	2.09e-01	9.82e-03	4.19e-01
GOBP CARDIAC FIBROBLAST CELL DIFFERENTIATION	5	2.65e-02	1.21e-01	0.69800	6.93e-01	8.64e-02	7.29e-03	7.38e-01
GOCC EARLY ENDOSOME LUMEN	5	1.44e-02	7.82e-02	0.69700	-1.90e-01	6.70e-01	4.62e-01	9.43e-03
GOMF PROSTANOID RECEPTOR ACTIVITY	11	4.67e-04	5.70e-03	0.69500	1.37e-01	6.82e-01	4.32e-01	9.00e-05
Developmental Cell Lineages	5	1.41e-02	7.73e-02	0.69500	6.61e-01	-2.12e-01	1.04e-02	4.11e-01
Developmental Lineage of Pancreatic Acinar Cells	5	1.41e-02	7.73e-02	0.69500	6.61e-01	-2.12e-01	1.04e-02	4.11e-01
GOBP FORMATION OF ANATOMICAL BOUNDARY	7	1.54e-02	8.25e-02	0.69400	4.68e-01	5.13e-01	3.21e-02	1.87e-02
GOCC ANNULATE LAMELLAE	5	5.07e-02	1.90e-01	0.69300	5.34e-01	4.42e-01	3.86e-02	8.72e-02
GOMF L LEUCINE BINDING	6	2.77e-02	1.25e-01	0.69100	5.61e-01	4.03e-01	1.73e-02	8.73e-02
GOMF U6 SNRNA BINDING	14	1.29e-04	1.91e-03	0.69100	6.42e-01	2.54e-01	3.18e-05	9.93e-02
ATF6 (ATF6-alpha) activates chaperone genes	10	2.87e-03	2.33e-02	0.68600	4.31e-01	5.34e-01	1.82e-02	3.46e-03
GOBP LATERAL MESODERM MORPHOGENESIS	5	4.65e-02	1.79e-01	0.68600	6.15e-01	3.02e-01	1.72e-02	2.42e-01
GOMF CENTROMERIC DNA BINDING	6	3.09e-02	1.34e-01	0.68500	5.01e-01	4.67e-01	3.37e-02	4.75e-02
GOBP REGULATION OF ARTERY MORPHOGENESIS	13	5.38e-04	6.38e-03	0.68400	-5.21e-01	-4.43e-01	1.15e-03	5.70e-03
Digestion	17	5.15e-05	8.90e-04	0.68300	-4.18e-01	-5.40e-01	2.84e-03	1.16e-04
GOBP CARDIAC PACEMAKER CELL DIFFERENTIATION	10	3.01e-03	2.41e-02	0.68200	5.43e-01	4.13e-01	2.92e-03	2.39e-02
GOBP UMP CATABOLIC PROCESS	5	1.50e-02	8.08e-02	0.68200	-6.31e-01	2.59e-01	1.46e-02	3.17e-01
GOBP CEREBRAL CORTEX REGIONALIZATION	7	1.88e-02	9.52e-02	0.67800	4.84e-01	4.74e-01	2.65e-02	2.97e-02
GOBP CHONDROBLAST DIFFERENTIATION	5	5.66e-02	2.02e-01	0.67700	5.51e-01	3.94e-01	3.29e-02	1.27e-01
GOBP IMMUNE RESPONSE INHIBITING CELL SURFACE RECEPTOR SIGNALING PATHWAY	9	5.33e-03	3.71e-02	0.67700	-5.74e-01	-3.59e-01	2.87e-03	6.22e-02
GOMF INSULIN BINDING	5	5.75e-02	2.04e-01	0.67700	5.37e-01	4.12e-01	3.75e-02	1.11e-01
Creation of C4 and C2 activators	14	3.70e-04	4.65e-03	0.67500	-4.37e-01	-5.14e-01	4.60e-03	8.69e-04
Initial triggering of complement	21	7.34e-06	1.66e-04	0.67500	-4.53e-01	-5.00e-01	3.22e-04	7.33e-05
GOCC ENDOPLASMIC RETICULUM PALMITOYLTRANSFERASE COMPLEX	8	1.11e-02	6.48e-02	0.67400	5.09e-01	4.41e-01	1.26e-02	3.07e-02
Lectin pathway of complement activation	8	1.12e-02	6.52e-02	0.67300	-5.14e-01	-4.34e-01	1.18e-02	3.35e-02
GOCC MUSCLE MYOSIN COMPLEX	15	1.28e-04	1.90e-03	0.67200	-2.71e-01	-6.15e-01	6.90e-02	3.72e-05
GOBP PERICENTRIC HETEROCHROMATIN FORMATION	5	5.12e-02	1.91e-01	0.67200	2.80e-01	6.11e-01	2.78e-01	1.80e-02
GOBP CITRATE METABOLIC PROCESS	5	2.37e-02	1.12e-01	0.67000	6.63e-01	-9.63e-02	1.02e-02	7.09e-01
GOBP REGULATION OF CYTOPLASMIC MRNA PROCESSING BODY ASSEMBLY	7	2.07e-02	1.02e-01	0.66900	4.86e-01	4.60e-01	2.59e-02	3.50e-02
GOBP DTMP METABOLIC PROCESS	6	6.37e-03	4.27e-02	0.66900	-5.56e-01	3.72e-01	1.83e-02	1.15e-01
GOMF INTRACILIARY TRANSPORT PARTICLE B BINDING	5	6.32e-02	2.17e-01	0.66800	5.00e-01	4.43e-01	5.28e-02	8.64e-02
GOBP REGULATION OF ENAMEL MINERALIZATION	8	3.66e-03	2.80e-02	0.66700	5.08e-03	-6.67e-01	9.80e-01	1.09e-03
GOMF TYPE I INTERFERON RECEPTOR BINDING	14	4.37e-04	5.38e-03	0.66600	-4.08e-01	-5.26e-01	8.18e-03	6.49e-04
GOMF CARNITINE O ACYLTRANSFERASE ACTIVITY	6	3.66e-02	1.52e-01	0.66500	5.28e-01	4.04e-01	2.51e-02	8.62e-02
GOCC TRANSCRIPTION FACTOR AP 1 COMPLEX	5	4.20e-02	1.68e-01	0.66300	1.32e-01	6.50e-01	6.09e-01	1.18e-02
GOCC EPSILON DNA POLYMERASE COMPLEX	5	3.32e-02	1.42e-01	0.66300	2.06e-02	6.62e-01	9.36e-01	1.03e-02
GOBP REGULATION OF CARDIOBLAST DIFFERENTIATION	5	6.78e-02	2.27e-01	0.66000	4.58e-01	4.75e-01	7.59e-02	6.59e-02
GOMF AP 1 ADAPTOR COMPLEX BINDING	5	2.43e-02	1.14e-01	0.65800	-1.47e-01	6.41e-01	5.68e-01	1.31e-02
GOMF AMMONIA LYASE ACTIVITY	5	2.69e-02	1.22e-01	0.65700	1.00e-01	-6.50e-01	6.98e-01	1.19e-02
GOMF CORTICOTROPIN RELEASING HORMONE RECEPTOR BINDING	6	8.66e-03	5.40e-02	0.65600	-5.88e-01	2.90e-01	1.25e-02	2.18e-01
GOBP NEGATIVE REGULATION OF LENS FIBER CELL DIFFERENTIATION	6	3.70e-02	1.53e-01	0.65500	5.67e-01	3.28e-01	1.62e-02	1.64e-01
GOMF U2 SNRNA BINDING	6	4.13e-02	1.66e-01	0.65200	3.89e-01	5.23e-01	9.92e-02	2.64e-02
GOBP SEQUESTERING OF BMP IN EXTRACELLULAR MATRIX	5	6.72e-02	2.26e-01	0.65100	5.56e-01	3.39e-01	3.13e-02	1.89e-01
ATF6 (ATF6-alpha) activates chaperones	11	3.14e-03	2.48e-02	0.65100	4.48e-01	4.73e-01	1.01e-02	6.65e-03
GOCC PTW PP1 PHOSPHATASE COMPLEX	7	2.43e-02	1.14e-01	0.65000	5.32e-01	3.74e-01	1.48e-02	8.67e-02
GOMF RETINOIC ACID RESPONSIVE ELEMENT BINDING	6	4.37e-02	1.72e-01	0.65000	4.72e-01	4.46e-01	4.51e-02	5.83e-02
GOBP THYMOCYTE MIGRATION	7	2.54e-02	1.18e-01	0.64900	-5.09e-01	-4.03e-01	1.96e-02	6.49e-02
Prednisone ADME	10	4.20e-03	3.11e-02	0.64900	-2.94e-01	-5.78e-01	1.07e-01	1.54e-03
GOBP FLAVONE METABOLIC PROCESS	6	4.36e-02	1.72e-01	0.64600	-3.85e-01	-5.19e-01	1.02e-01	2.77e-02
GOMF PROSTAGLANDIN E RECEPTOR ACTIVITY	5	3.83e-02	1.57e-01	0.64600	9.68e-03	6.46e-01	9.70e-01	1.23e-02
GOBP STEM CELL FATE SPECIFICATION	6	1.11e-02	6.46e-02	0.64600	-2.34e-01	6.02e-01	3.21e-01	1.06e-02
GOMF NADPLUS PROTEIN LYSINE ADP RIBOSYLTRANSFERASE ACTIVITY	5	1.92e-02	9.69e-02	0.64600	-3.88e-01	5.16e-01	1.33e-01	4.57e-02
GOCC CATALYTIC STEP 1 SPLICEOSOME	12	1.29e-03	1.27e-02	0.64600	5.95e-01	2.52e-01	3.60e-04	1.31e-01
GOBP INTERNAL PEPTIDYL LYSINE ACETYLATION	8	4.83e-03	3.44e-02	0.64400	6.43e-01	-3.58e-02	1.65e-03	8.61e-01
GOMF INTEGRIN BINDING INVOLVED IN CELL MATRIX ADHESION	5	5.59e-02	2.01e-01	0.64300	6.19e-01	1.76e-01	1.66e-02	4.96e-01
GOMF CALCIUM SENSITIVE GUANYLATE CYCLASE ACTIVATOR ACTIVITY	5	2.23e-02	1.08e-01	0.64300	2.85e-01	-5.77e-01	2.70e-01	2.56e-02
GOBP MITOCHONDRIAL ELECTRON TRANSPORT SUCCINATE TO UBIQUINONE	5	7.62e-02	2.45e-01	0.64200	5.11e-01	3.89e-01	4.76e-02	1.32e-01
GOBP HINDBRAIN MATURATION	5	7.44e-02	2.41e-01	0.64200	3.60e-01	5.32e-01	1.64e-01	3.93e-02
GOBP RESPONSE TO ERYTHROPOIETIN	7	4.12e-03	3.07e-02	0.64100	-4.43e-01	4.64e-01	4.24e-02	3.37e-02
GOBP POSITIVE REGULATION OF INTERLEUKIN 18 PRODUCTION	8	9.71e-03	5.85e-02	0.64100	-6.21e-01	-1.59e-01	2.35e-03	4.37e-01
GOBP KERATINIZATION	77	3.92e-18	4.97e-16	0.64100	-5.44e-01	-3.38e-01	1.40e-16	2.96e-07
GOMF INTRACELLULARLY CAMP ACTIVATED CATION CHANNEL ACTIVITY	8	1.72e-02	8.91e-02	0.64000	-4.09e-01	-4.92e-01	4.52e-02	1.59e-02
Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus	7	2.52e-02	1.17e-01	0.63900	-3.10e-01	-5.59e-01	1.56e-01	1.04e-02
Metal sequestration by antimicrobial proteins	6	1.18e-02	6.76e-02	0.63900	-5.91e-01	2.45e-01	1.22e-02	2.99e-01
GOBP POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN	7	2.37e-02	1.13e-01	0.63900	-5.75e-01	-2.78e-01	8.37e-03	2.02e-01
GOBP CELL SUBSTRATE JUNCTION DISASSEMBLY	8	1.58e-02	8.40e-02	0.63800	3.31e-01	5.46e-01	1.05e-01	7.50e-03
GOBP INTERLEUKIN 11 MEDIATED SIGNALING PATHWAY	6	4.53e-02	1.76e-01	0.63800	3.42e-01	5.39e-01	1.47e-01	2.23e-02
GOBP B 1 B CELL DIFFERENTIATION	5	2.06e-02	1.02e-01	0.63800	-4.56e-01	4.46e-01	7.73e-02	8.42e-02
GOBP EXOCRINE PANCREAS DEVELOPMENT	7	2.15e-02	1.05e-01	0.63800	5.97e-01	2.25e-01	6.26e-03	3.02e-01
GOMF TRAIL BINDING	5	2.08e-02	1.02e-01	0.63700	-4.53e-01	4.47e-01	7.91e-02	8.32e-02
GOMF FIBROBLAST GROWTH FACTOR RECEPTOR ACTIVITY	5	8.18e-02	2.56e-01	0.63600	-4.35e-01	-4.65e-01	9.20e-02	7.20e-02
GOBP REGULATION OF PANCREATIC JUICE SECRETION	7	2.22e-02	1.07e-01	0.63600	5.93e-01	2.29e-01	6.57e-03	2.95e-01
Tachykinin receptors bind tachykinins	5	4.30e-02	1.70e-01	0.63600	6.35e-01	1.24e-02	1.39e-02	9.62e-01
GOBP ESTABLISHMENT OR MAINTENANCE OF CYTOSKELETON POLARITY	7	1.67e-02	8.73e-02	0.63500	6.24e-01	1.18e-01	4.23e-03	5.90e-01
GOBP REGULATION OF MESODERMAL CELL DIFFERENTIATION	10	2.52e-03	2.11e-02	0.63400	8.09e-02	6.29e-01	6.58e-01	5.69e-04
Beta defensins	26	1.47e-06	4.08e-05	0.63400	-5.55e-01	-3.06e-01	9.57e-07	6.97e-03
GOBP POSITIVE REGULATION OF MICROTUBULE NUCLEATION	7	3.17e-02	1.37e-01	0.63200	4.32e-01	4.61e-01	4.79e-02	3.47e-02
GOBP VITAMIN B6 METABOLIC PROCESS	5	6.96e-02	2.31e-01	0.63100	2.34e-01	5.86e-01	3.64e-01	2.33e-02
Ciprofloxacin ADME	5	4.54e-02	1.76e-01	0.63100	-1.66e-02	-6.31e-01	9.49e-01	1.46e-02
GOBP INTESTINAL CHOLESTEROL ABSORPTION	18	1.28e-05	2.67e-04	0.63000	5.35e-03	-6.30e-01	9.69e-01	3.68e-06
GOBP NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I	10	7.22e-03	4.68e-02	0.62900	4.97e-01	3.85e-01	6.46e-03	3.49e-02
NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis	5	5.84e-02	2.07e-01	0.62800	6.15e-01	1.24e-01	1.72e-02	6.32e-01
GOMF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY	13	1.75e-03	1.58e-02	0.62800	-4.81e-01	-4.03e-01	2.66e-03	1.19e-02
Biosynthesis of maresin-like SPMs	6	5.10e-02	1.91e-01	0.62600	-3.41e-01	-5.25e-01	1.48e-01	2.59e-02
GOBP REGULATION OF PROTEIN MONOUBIQUITINATION	6	5.48e-02	1.99e-01	0.62600	4.36e-01	4.50e-01	6.46e-02	5.65e-02
GOMF DENEDDYLASE ACTIVITY	6	5.41e-02	1.98e-01	0.62600	3.98e-01	4.83e-01	9.10e-02	4.06e-02
GOMF OLIGOSACCHARYL TRANSFERASE ACTIVITY	5	8.87e-02	2.70e-01	0.62600	4.13e-01	4.70e-01	1.09e-01	6.90e-02
Highly calcium permeable nicotinic acetylcholine receptors	9	2.75e-03	2.25e-02	0.62600	-6.18e-01	9.58e-02	1.32e-03	6.19e-01
GOBP TOLL LIKE RECEPTOR 7 SIGNALING PATHWAY	8	3.63e-03	2.78e-02	0.62500	-5.84e-01	2.23e-01	4.20e-03	2.75e-01
GOBP TYPE II HYPERSENSITIVITY	5	3.33e-02	1.42e-01	0.62500	-6.04e-01	1.61e-01	1.93e-02	5.33e-01
GOMF C3HC4 TYPE RING FINGER DOMAIN BINDING	6	4.84e-02	1.84e-01	0.62400	2.90e-01	5.53e-01	2.18e-01	1.90e-02
GOBP RECOGNITION OF APOPTOTIC CELL	7	3.54e-02	1.48e-01	0.62100	-4.09e-01	-4.67e-01	6.12e-02	3.23e-02
GOBP REGULATION OF SODIUM DEPENDENT PHOSPHATE TRANSPORT	5	8.32e-02	2.59e-01	0.62100	5.46e-01	2.95e-01	3.44e-02	2.54e-01
Activated NTRK2 signals through PI3K	7	2.30e-02	1.10e-01	0.62000	5.98e-01	1.64e-01	6.12e-03	4.54e-01
Vitamin C (ascorbate) metabolism	8	1.82e-02	9.29e-02	0.62000	2.77e-01	5.55e-01	1.75e-01	6.57e-03
GOBP INDOLE CONTAINING COMPOUND BIOSYNTHETIC PROCESS	5	9.09e-02	2.74e-01	0.62000	-3.74e-01	-4.95e-01	1.48e-01	5.55e-02
GOMF STRUCTURAL CONSTITUENT OF SKIN EPIDERMIS	36	3.25e-08	1.30e-06	0.61900	-4.96e-01	-3.71e-01	2.53e-07	1.19e-04
NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose	5	9.05e-02	2.73e-01	0.61900	5.02e-01	3.62e-01	5.18e-02	1.60e-01
GOBP RESPONSE TO L LEUCINE	15	4.87e-04	5.90e-03	0.61900	5.68e-01	2.46e-01	1.38e-04	9.93e-02
GOBP SENSORY PERCEPTION OF TOUCH	5	4.87e-02	1.85e-01	0.61900	-4.55e-03	6.19e-01	9.86e-01	1.65e-02
GOBP POSITIVE REGULATION OF INTERLEUKIN 23 PRODUCTION	7	2.04e-02	1.01e-01	0.61900	-6.09e-01	-1.13e-01	5.29e-03	6.05e-01
GOBP INTRACELLULAR SPHINGOLIPID HOMEOSTASIS	5	9.39e-02	2.79e-01	0.61900	4.26e-01	4.49e-01	9.90e-02	8.22e-02
GOBP MICTURITION	8	2.28e-02	1.09e-01	0.61900	-4.31e-01	-4.44e-01	3.48e-02	2.98e-02
GOBP TYPE II PNEUMOCYTE DIFFERENTIATION	6	2.92e-02	1.29e-01	0.61800	6.17e-01	2.59e-02	8.84e-03	9.13e-01
GOBP NEGATIVE REGULATION OF PHOTORECEPTOR CELL DIFFERENTIATION	6	1.68e-02	8.76e-02	0.61700	-5.80e-01	2.10e-01	1.38e-02	3.72e-01
GOBP HEME B METABOLIC PROCESS	9	1.10e-02	6.43e-02	0.61600	2.53e-01	5.62e-01	1.89e-01	3.49e-03
GOMF MORPHOGEN ACTIVITY	8	1.72e-02	8.92e-02	0.61600	2.30e-01	5.71e-01	2.59e-01	5.13e-03
GOCC VOLTAGE GATED SODIUM CHANNEL COMPLEX	14	1.41e-03	1.35e-02	0.61500	-4.07e-01	-4.62e-01	8.39e-03	2.78e-03
GOBP HYPERSENSITIVITY	12	5.95e-04	6.94e-03	0.61500	-6.12e-01	5.90e-02	2.40e-04	7.23e-01
GOMF O PALMITOYLTRANSFERASE ACTIVITY	5	6.66e-02	2.25e-01	0.61400	6.01e-01	1.27e-01	1.99e-02	6.23e-01
GOBP ELASTIC FIBER ASSEMBLY	9	9.43e-03	5.74e-02	0.61400	5.84e-01	1.89e-01	2.41e-03	3.25e-01
GOBP POSITIVE REGULATION OF PINOCYTOSIS	7	2.21e-02	1.07e-01	0.61400	6.03e-01	1.18e-01	5.76e-03	5.89e-01
GOBP METANEPHRIC TUBULE FORMATION	6	4.30e-02	1.70e-01	0.61400	-5.89e-01	-1.72e-01	1.24e-02	4.67e-01
GOCC CCAAT BINDING FACTOR COMPLEX	5	9.40e-02	2.79e-01	0.61400	3.53e-01	5.02e-01	1.72e-01	5.18e-02
GOMF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY INVOLVED IN CARDIAC MUSCLE CELL ACTION POTENTIAL	5	9.79e-02	2.86e-01	0.61300	-4.20e-01	-4.47e-01	1.04e-01	8.37e-02
GOBP RESPONSE TO 2 3 7 8 TETRACHLORODIBENZODIOXINE	5	9.81e-02	2.87e-01	0.61200	-4.01e-01	-4.63e-01	1.20e-01	7.32e-02
GOBP APOPTOTIC PROCESS INVOLVED IN HEART MORPHOGENESIS	7	2.87e-02	1.28e-01	0.61200	2.09e-01	5.75e-01	3.38e-01	8.44e-03
GOMF ACROSIN BINDING	5	8.29e-02	2.58e-01	0.61200	-5.64e-01	-2.36e-01	2.89e-02	3.60e-01
GOMF LYSINE N ACETYLTRANSFERASE ACTIVITY ACTING ON ACETYL PHOSPHATE AS DONOR	6	3.96e-02	1.61e-01	0.61200	5.99e-01	1.23e-01	1.11e-02	6.01e-01
Digestion and absorption	22	3.39e-05	6.30e-04	0.61200	-3.60e-01	-4.95e-01	3.50e-03	5.90e-05
GOBP NORADRENERGIC NEURON DIFFERENTIATION	10	5.93e-03	4.03e-02	0.61100	5.81e-01	1.91e-01	1.47e-03	2.96e-01
Sensory Perception	550	9.28e-113	1.63e-109	0.61100	-5.24e-01	-3.14e-01	5.43e-99	2.06e-36
GOBP LOBAR BRONCHUS DEVELOPMENT	6	6.28e-02	2.17e-01	0.61000	-4.01e-01	-4.60e-01	8.91e-02	5.08e-02
GOBP FOREBRAIN NEURON FATE COMMITMENT	7	4.01e-02	1.62e-01	0.61000	4.40e-01	4.22e-01	4.38e-02	5.30e-02
GOCC FIBRILLAR COLLAGEN TRIMER	12	2.05e-04	2.82e-03	0.61000	3.92e-01	-4.67e-01	1.86e-02	5.11e-03
GOBP RESPONSE TO CELL CYCLE CHECKPOINT SIGNALING	8	2.51e-02	1.17e-01	0.61000	4.61e-01	3.99e-01	2.39e-02	5.07e-02
GOMF IMMUNOGLOBULIN RECEPTOR ACTIVITY	9	2.46e-03	2.08e-02	0.60800	-5.65e-01	2.25e-01	3.33e-03	2.42e-01
GOBP OXYGEN METABOLIC PROCESS	6	5.16e-02	1.92e-01	0.60700	5.65e-01	2.22e-01	1.66e-02	3.47e-01
Formation of the active cofactor, UDP-glucuronate	5	4.06e-02	1.64e-01	0.60700	5.86e-01	-1.58e-01	2.33e-02	5.41e-01
GOBP MEIOTIC CELL CYCLE PROCESS INVOLVED IN OOCYTE MATURATION	6	4.31e-02	1.70e-01	0.60700	5.91e-01	1.37e-01	1.22e-02	5.62e-01
Removal of aminoterminal propeptides from gamma-carboxylated proteins	8	2.42e-02	1.14e-01	0.60700	-3.32e-01	-5.08e-01	1.04e-01	1.28e-02
GOMF K48 LINKED POLYUBIQUITIN MODIFICATION DEPENDENT PROTEIN BINDING	10	1.00e-02	6.00e-02	0.60600	3.58e-01	4.90e-01	5.02e-02	7.31e-03
GOMF CARBOHYDRATE PROTON SYMPORTER ACTIVITY	7	3.52e-02	1.48e-01	0.60500	-5.43e-01	-2.67e-01	1.28e-02	2.21e-01
GOBP REGULATION OF MIRNA CATABOLIC PROCESS	8	2.68e-02	1.22e-01	0.60500	4.08e-01	4.47e-01	4.56e-02	2.87e-02
Defective GALNT3 causes HFTC	18	2.11e-04	2.89e-03	0.60500	-5.29e-01	-2.92e-01	1.01e-04	3.18e-02
GOCC CDC73 PAF1 COMPLEX	7	2.04e-02	1.01e-01	0.60400	6.02e-01	4.14e-02	5.78e-03	8.49e-01
Maturation of spike protein 9683686	5	7.41e-02	2.41e-01	0.60300	1.30e-01	5.89e-01	6.14e-01	2.25e-02
VLDLR internalisation and degradation	16	5.43e-04	6.43e-03	0.60300	5.33e-01	2.80e-01	2.20e-04	5.25e-02
GOBP CORTICOSTERONE SECRETION	6	2.31e-02	1.10e-01	0.60200	-5.84e-01	1.47e-01	1.32e-02	5.33e-01
GOBP EPOXIDE METABOLIC PROCESS	5	3.96e-02	1.61e-01	0.60200	5.69e-01	-1.96e-01	2.74e-02	4.47e-01
GOBP NEGATIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION	5	1.08e-01	3.03e-01	0.60100	4.37e-01	4.12e-01	9.06e-02	1.10e-01
GOBP LIPID DIGESTION	21	8.11e-06	1.82e-04	0.60000	-1.67e-02	-5.99e-01	8.95e-01	1.97e-06
GOBP NEGATIVE REGULATION OF LAMELLIPODIUM ASSEMBLY	5	4.61e-02	1.78e-01	0.59900	5.84e-01	-1.33e-01	2.38e-02	6.06e-01
GOBP REGULATION OF LUNG BLOOD PRESSURE	5	1.08e-01	3.05e-01	0.59800	4.64e-01	3.77e-01	7.24e-02	1.44e-01
POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation	9	1.88e-02	9.51e-02	0.59800	4.18e-01	4.28e-01	2.99e-02	2.63e-02
GOMF 11 CIS RETINAL BINDING	7	4.50e-02	1.75e-01	0.59800	-3.83e-01	-4.59e-01	7.96e-02	3.55e-02
GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY	13	2.55e-03	2.13e-02	0.59700	2.85e-01	5.25e-01	7.52e-02	1.06e-03
GOBP NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT	6	6.71e-02	2.26e-01	0.59700	5.00e-01	3.25e-01	3.38e-02	1.68e-01
GOCC OUTER DYNEIN ARM	10	1.21e-02	6.89e-02	0.59600	-3.71e-01	-4.66e-01	4.22e-02	1.07e-02
GOBP NEURAL PLATE PATTERN SPECIFICATION	8	2.99e-02	1.31e-01	0.59600	4.45e-01	3.95e-01	2.91e-02	5.28e-02
GOBP CARDIAC CHAMBER FORMATION	12	4.30e-03	3.17e-02	0.59500	2.91e-01	5.18e-01	8.06e-02	1.87e-03
GOBP REGULATION OF MONOCYTE EXTRAVASATION	7	4.43e-02	1.73e-01	0.59400	-3.29e-01	-4.95e-01	1.32e-01	2.34e-02
GOMF PYRIMIDINE NUCLEOSIDE TRANSMEMBRANE TRANSPORTER ACTIVITY	8	1.47e-02	7.96e-02	0.59400	-6.56e-02	-5.90e-01	7.48e-01	3.86e-03
Highly calcium permeable postsynaptic nicotinic acetylcholine receptors	11	2.20e-03	1.90e-02	0.59300	-5.93e-01	7.31e-03	6.55e-04	9.67e-01
GOBP POSITIVE REGULATION OF PROTEIN NEDDYLATION	5	7.18e-02	2.36e-01	0.59300	5.89e-01	6.51e-02	2.25e-02	8.01e-01
TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation	5	8.12e-02	2.55e-01	0.59300	1.29e-01	5.79e-01	6.18e-01	2.50e-02
GOBP POSITIVE REGULATION OF DNA DAMAGE CHECKPOINT	5	3.88e-02	1.58e-01	0.59300	5.24e-01	-2.77e-01	4.25e-02	2.83e-01
Defective ST3GAL3 causes MCT12 and EIEE15	8	4.79e-03	3.42e-02	0.59200	4.35e-01	-4.01e-01	3.31e-02	4.95e-02
GOBP IMMUNE RESPONSE INHIBITING SIGNAL TRANSDUCTION	11	6.17e-03	4.17e-02	0.59100	-5.41e-01	-2.40e-01	1.90e-03	1.68e-01
GOBP CELLULAR GLUCURONIDATION	19	2.23e-04	3.03e-03	0.59100	-3.16e-01	-5.00e-01	1.71e-02	1.63e-04
GOCC PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX CLASS III	8	2.51e-02	1.17e-01	0.59100	5.39e-01	2.42e-01	8.30e-03	2.36e-01
GOBP NEGATIVE REGULATION OF VASCULAR WOUND HEALING	7	2.40e-02	1.13e-01	0.59000	-3.65e-02	-5.89e-01	8.67e-01	6.96e-03
GOCC LSM2 8 COMPLEX	7	4.09e-02	1.65e-01	0.59000	5.34e-01	2.52e-01	1.45e-02	2.49e-01
GOBP REGULATION OF RIBOSOME BIOGENESIS	6	7.57e-02	2.44e-01	0.59000	4.01e-01	4.33e-01	8.91e-02	6.64e-02
GOBP POSITIVE REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY	5	5.68e-02	2.03e-01	0.59000	-6.83e-02	5.86e-01	7.91e-01	2.33e-02
Presynaptic depolarization and calcium channel opening	12	5.72e-03	3.92e-02	0.59000	-4.41e-01	-3.92e-01	8.20e-03	1.88e-02
GOMF ICOSANOID RECEPTOR ACTIVITY	14	1.38e-03	1.33e-02	0.59000	2.05e-01	5.53e-01	1.84e-01	3.40e-04
GOCC R2TP COMPLEX	5	1.02e-01	2.94e-01	0.58900	5.34e-01	2.49e-01	3.88e-02	3.35e-01
Keratinization	209	1.68e-40	6.86e-38	0.58800	-5.04e-01	-3.02e-01	2.43e-36	5.05e-14
GOBP NEGATIVE REGULATION OF VITAMIN D BIOSYNTHETIC PROCESS	5	5.50e-02	1.99e-01	0.58700	-9.88e-02	5.79e-01	7.02e-01	2.50e-02
Malate-aspartate shuttle	9	1.89e-02	9.53e-02	0.58700	5.09e-01	2.93e-01	8.21e-03	1.28e-01
GOBP REGULATION OF CENTROMERE COMPLEX ASSEMBLY	6	7.37e-02	2.40e-01	0.58700	4.89e-01	3.25e-01	3.80e-02	1.69e-01
GOBP SECRETION OF LYSOSOMAL ENZYMES	7	4.82e-02	1.83e-01	0.58700	3.30e-01	4.85e-01	1.31e-01	2.61e-02
GOCC NPBAF COMPLEX	14	1.34e-03	1.30e-02	0.58700	5.58e-01	1.81e-01	3.00e-04	2.40e-01
GOBP REACTIVE GLIOSIS	6	2.05e-02	1.01e-01	0.58700	4.86e-01	-3.28e-01	3.92e-02	1.64e-01
Recycling of eIF2:GDP	7	2.94e-02	1.30e-01	0.58600	5.79e-01	9.42e-02	7.99e-03	6.66e-01
GOMF LIPOTEICHOIC ACID BINDING	5	7.30e-02	2.39e-01	0.58600	-5.85e-01	-4.32e-02	2.35e-02	8.67e-01
APC truncation mutants have impaired AXIN binding	13	1.90e-03	1.68e-02	0.58600	5.66e-01	1.52e-01	4.08e-04	3.42e-01
AXIN missense mutants destabilize the destruction complex	13	1.90e-03	1.68e-02	0.58600	5.66e-01	1.52e-01	4.08e-04	3.42e-01
Signaling by AMER1 mutants	13	1.90e-03	1.68e-02	0.58600	5.66e-01	1.52e-01	4.08e-04	3.42e-01
Signaling by APC mutants	13	1.90e-03	1.68e-02	0.58600	5.66e-01	1.52e-01	4.08e-04	3.42e-01
Signaling by AXIN mutants	13	1.90e-03	1.68e-02	0.58600	5.66e-01	1.52e-01	4.08e-04	3.42e-01
Truncations of AMER1 destabilize the destruction complex	13	1.90e-03	1.68e-02	0.58600	5.66e-01	1.52e-01	4.08e-04	3.42e-01
GOBP PUTRESCINE BIOSYNTHETIC PROCESS	5	4.70e-02	1.80e-01	0.58600	-1.92e-01	5.54e-01	4.57e-01	3.20e-02
GOBP LOBAR BRONCHUS EPITHELIUM DEVELOPMENT	5	1.20e-01	3.22e-01	0.58600	-4.14e-01	-4.15e-01	1.09e-01	1.08e-01
GOCC PALMITOYLTRANSFERASE COMPLEX	10	1.44e-02	7.82e-02	0.58600	3.93e-01	4.35e-01	3.15e-02	1.73e-02
GOBP ALANINE METABOLIC PROCESS	5	1.18e-01	3.19e-01	0.58600	-4.65e-01	-3.56e-01	7.20e-02	1.68e-01
GOBP MONOCYTE EXTRAVASATION	11	9.31e-03	5.69e-02	0.58600	-3.78e-01	-4.48e-01	3.01e-02	1.02e-02
GOBP REGULATION OF MITOCHONDRIAL DNA METABOLIC PROCESS	6	6.21e-02	2.15e-01	0.58500	2.02e-01	5.49e-01	3.92e-01	1.98e-02
GOMF TRNA CYTIDINE 5 METHYLTRANSFERASE ACTIVITY	5	1.22e-01	3.24e-01	0.58400	4.15e-01	4.11e-01	1.08e-01	1.12e-01
GOBP NEURAL PLATE REGIONALIZATION	6	7.97e-02	2.52e-01	0.58400	3.97e-01	4.29e-01	9.25e-02	6.90e-02
GOCC MEMBRANE ATTACK COMPLEX	7	5.23e-02	1.93e-01	0.58400	-3.97e-01	-4.28e-01	6.89e-02	4.98e-02
GOBP SEPTUM PRIMUM DEVELOPMENT	5	1.15e-01	3.14e-01	0.58400	4.96e-01	3.08e-01	5.49e-02	2.32e-01
GOBP REGULATION OF OPSONIZATION	10	1.49e-02	8.04e-02	0.58400	-4.24e-01	-4.01e-01	2.01e-02	2.83e-02
GOMF ENONE REDUCTASE ACTIVITY	5	4.29e-02	1.70e-01	0.58300	-5.15e-01	2.74e-01	4.60e-02	2.89e-01
GOBP DETECTION OF STIMULUS	574	1.34e-108	2.06e-105	0.58200	-5.16e-01	-2.70e-01	4.20e-100	1.73e-28
GOBP REGULATION OF FOCAL ADHESION DISASSEMBLY	6	6.82e-02	2.28e-01	0.58200	2.38e-01	5.31e-01	3.14e-01	2.42e-02
GOCC TROPONIN COMPLEX	9	2.11e-02	1.03e-01	0.58200	-3.12e-01	-4.91e-01	1.05e-01	1.08e-02
GOBP POSITIVE REGULATION OF GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT	5	9.54e-02	2.81e-01	0.58200	5.58e-01	1.66e-01	3.08e-02	5.21e-01
GOMF IGG BINDING	7	1.20e-02	6.84e-02	0.58200	-5.01e-01	2.96e-01	2.18e-02	1.75e-01
Sulfide oxidation to sulfate	5	6.59e-02	2.23e-01	0.58200	-3.15e-02	5.81e-01	9.03e-01	2.45e-02
GOBP SENSORY PERCEPTION OF UMAMI TASTE	7	3.57e-02	1.49e-01	0.58100	-5.63e-01	-1.45e-01	9.90e-03	5.07e-01
GOBP REGULATION OF LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR	5	9.61e-02	2.83e-01	0.58100	5.57e-01	1.66e-01	3.10e-02	5.20e-01
GOBP ASPARAGINE METABOLIC PROCESS	5	1.13e-01	3.13e-01	0.58100	2.76e-01	5.11e-01	2.86e-01	4.76e-02
GOCC SODIUM CHANNEL COMPLEX	24	3.99e-05	7.22e-04	0.58100	-3.42e-01	-4.70e-01	3.74e-03	6.79e-05
GOCC ELASTIC FIBER	5	9.86e-02	2.88e-01	0.58100	5.52e-01	1.79e-01	3.24e-02	4.88e-01
GOBP BEHAVIORAL RESPONSE TO NICOTINE	8	1.46e-02	7.92e-02	0.58000	-5.80e-01	-2.37e-03	4.47e-03	9.91e-01
GOMF G PROTEIN COUPLED ADENOSINE RECEPTOR ACTIVITY	5	4.59e-02	1.77e-01	0.57900	-5.19e-01	2.56e-01	4.44e-02	3.21e-01
GOCC SIN3 TYPE COMPLEX	20	2.52e-04	3.38e-03	0.57900	4.30e-01	3.88e-01	8.79e-04	2.67e-03
GOBP REGULATION OF HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE	10	1.02e-02	6.08e-02	0.57900	-1.84e-01	-5.49e-01	3.12e-01	2.66e-03
GOMF SODIUM INDEPENDENT ORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY	16	1.23e-03	1.23e-02	0.57800	-3.37e-01	-4.70e-01	1.97e-02	1.13e-03
GOMF MEMBRANE INSERTASE ACTIVITY	16	1.09e-03	1.12e-02	0.57800	4.98e-01	2.94e-01	5.67e-04	4.16e-02
GOMF INTERLEUKIN 6 RECEPTOR BINDING	7	4.46e-02	1.74e-01	0.57800	2.24e-01	5.33e-01	3.05e-01	1.47e-02
GOBP PANCREATIC A CELL DIFFERENTIATION	10	1.62e-02	8.56e-02	0.57700	4.34e-01	3.80e-01	1.74e-02	3.74e-02
GOBP POSITIVE REGULATION OF CYTOPLASMIC MRNA PROCESSING BODY ASSEMBLY	6	8.45e-02	2.61e-01	0.57700	4.37e-01	3.76e-01	6.37e-02	1.11e-01
GOCC PROTEIN COMPLEX INVOLVED IN CELL CELL ADHESION	5	9.76e-02	2.86e-01	0.57600	5.56e-01	1.51e-01	3.13e-02	5.58e-01
GOCC U6 SNRNP	8	2.57e-02	1.19e-01	0.57600	5.49e-01	1.73e-01	7.12e-03	3.98e-01
GOCC ER UBIQUITIN LIGASE COMPLEX	5	1.29e-01	3.37e-01	0.57600	4.18e-01	3.96e-01	1.06e-01	1.25e-01
GOBP P BODY ASSEMBLY	22	5.00e-05	8.72e-04	0.57500	5.43e-01	1.91e-01	1.05e-05	1.22e-01
GOBP ANTIGEN PROCESSING AND PRESENTATION OF LIPID ANTIGEN VIA MHC CLASS IB	7	4.44e-02	1.74e-01	0.57300	-5.38e-01	-1.97e-01	1.37e-02	3.67e-01
GOBP MINERALOCORTICOID BIOSYNTHETIC PROCESS	12	1.95e-03	1.72e-02	0.57300	-5.73e-01	1.16e-02	5.90e-04	9.45e-01
GOCC PRP19 COMPLEX	14	1.97e-03	1.74e-02	0.57200	5.39e-01	1.92e-01	4.78e-04	2.14e-01
GOMF CYSTEINE TYPE EXOPEPTIDASE ACTIVITY	7	5.22e-02	1.93e-01	0.57200	2.71e-01	5.03e-01	2.14e-01	2.11e-02
GOMF PROTEASOME ACTIVATING ACTIVITY	6	5.75e-02	2.04e-01	0.57100	5.63e-01	9.81e-02	1.69e-02	6.77e-01
GOCC G PROTEIN COUPLED RECEPTOR DIMERIC COMPLEX	7	5.46e-02	1.99e-01	0.57100	-2.98e-01	-4.88e-01	1.73e-01	2.54e-02
GOMF IMPORTIN ALPHA FAMILY PROTEIN BINDING	9	2.65e-02	1.21e-01	0.57100	3.87e-01	4.21e-01	4.46e-02	2.88e-02
GOBP PURINE NUCLEOSIDE TRANSMEMBRANE TRANSPORT	5	5.29e-02	1.95e-01	0.57100	2.10e-01	-5.31e-01	4.17e-01	3.96e-02
GOCC PINOSOME	9	6.55e-03	4.36e-02	0.57100	5.58e-01	-1.23e-01	3.75e-03	5.24e-01
GOBP POSITIVE REGULATION OF MAINTENANCE OF SISTER CHROMATID COHESION	6	7.38e-02	2.40e-01	0.57100	5.27e-01	2.21e-01	2.55e-02	3.48e-01
GOMF N ACETYLLACTOSAMINIDE BETA 1 3 N ACETYLGLUCOSAMINYLTRANSFERASE ACTIVITY	6	2.94e-02	1.30e-01	0.57100	-5.30e-01	2.11e-01	2.45e-02	3.70e-01
GOBP RESPONSE TO METHIONINE	5	4.48e-02	1.75e-01	0.57100	3.94e-01	-4.13e-01	1.27e-01	1.10e-01
GOBP RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE	9	3.73e-03	2.84e-02	0.57100	4.11e-01	-3.95e-01	3.25e-02	4.00e-02
GOCC B CELL RECEPTOR COMPLEX	5	4.53e-02	1.76e-01	0.57100	-3.61e-01	4.42e-01	1.62e-01	8.69e-02
GOBP PURINE NUCLEOBASE TRANSMEMBRANE TRANSPORT	8	2.46e-02	1.16e-01	0.56900	-1.24e-01	-5.56e-01	5.42e-01	6.50e-03
LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production	5	1.04e-01	2.97e-01	0.56900	5.48e-01	1.51e-01	3.37e-02	5.59e-01
FOXO-mediated transcription of cell cycle genes	16	1.22e-03	1.23e-02	0.56900	5.05e-01	2.62e-01	4.75e-04	6.92e-02
GOBP DOUBLE STRAND BREAK REPAIR VIA SINGLE STRAND ANNEALING	6	8.47e-02	2.62e-01	0.56800	2.93e-01	4.87e-01	2.14e-01	3.89e-02
GOBP OVULATION FROM OVARIAN FOLLICLE	9	4.28e-03	3.16e-02	0.56800	4.78e-01	-3.07e-01	1.30e-02	1.11e-01
Defensins	32	9.67e-07	2.85e-05	0.56800	-5.29e-01	-2.07e-01	2.24e-07	4.27e-02
GOBP REGULATION OF EXIT FROM MITOSIS	18	7.73e-04	8.63e-03	0.56800	4.06e-01	3.97e-01	2.89e-03	3.52e-03
GOBP MIRNA CATABOLIC PROCESS	17	1.17e-03	1.18e-02	0.56700	4.02e-01	4.00e-01	4.10e-03	4.29e-03
GOBP SMOOTH MUSCLE CELL MATRIX ADHESION	6	9.03e-02	2.73e-01	0.56700	3.45e-01	4.50e-01	1.43e-01	5.63e-02
GOBP EQUILIBRIOCEPTION	8	4.14e-02	1.66e-01	0.56700	-4.28e-01	-3.72e-01	3.61e-02	6.85e-02
GOBP REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY	6	2.93e-02	1.30e-01	0.56700	2.42e-01	-5.13e-01	3.05e-01	2.97e-02
GOBP ALPHA KETOGLUTARATE TRANSPORT	7	3.50e-02	1.47e-01	0.56700	-6.86e-02	-5.63e-01	7.53e-01	9.95e-03
GOMF ACETYLCHOLINE BINDING	10	1.31e-02	7.29e-02	0.56600	-5.31e-01	-1.96e-01	3.63e-03	2.82e-01
GOBP APOPTOTIC CHROMOSOME CONDENSATION	6	7.51e-02	2.42e-01	0.56600	5.29e-01	2.02e-01	2.49e-02	3.91e-01
GOCC SPERM HEAD PLASMA MEMBRANE	6	7.78e-02	2.48e-01	0.56600	-5.21e-01	-2.21e-01	2.72e-02	3.47e-01
GOBP TRICARBOXYLIC ACID TRANSPORT	5	1.22e-01	3.25e-01	0.56600	-5.13e-01	-2.39e-01	4.70e-02	3.56e-01
GOMF GAMMA AMINOBUTYRIC ACID SODIUM CHLORIDE SYMPORTER ACTIVITY	5	1.06e-01	3.01e-01	0.56500	-5.46e-01	-1.45e-01	3.43e-02	5.74e-01
GOBP REGULATION OF ACROSOME REACTION	18	8.28e-04	9.11e-03	0.56500	-4.13e-01	-3.86e-01	2.44e-03	4.59e-03
Defective CHST6 causes MCDC1	8	8.22e-03	5.19e-02	0.56400	3.19e-01	-4.65e-01	1.18e-01	2.27e-02
GOBP REGULATION OF PRIMARY MIRNA PROCESSING	5	7.54e-02	2.43e-01	0.56400	-4.72e-02	5.62e-01	8.55e-01	2.96e-02
GOBP POSITIVE REGULATION OF APOPTOTIC CELL CLEARANCE	8	4.34e-02	1.71e-01	0.56400	-3.99e-01	-3.98e-01	5.08e-02	5.11e-02
Regulation of FOXO transcriptional activity by acetylation	9	2.15e-02	1.05e-01	0.56300	5.25e-01	2.04e-01	6.38e-03	2.89e-01
GOBP RESPONSE TO INTERLEUKIN 9	5	1.05e-01	2.98e-01	0.56300	1.26e-01	5.49e-01	6.25e-01	3.36e-02
CTNNB1 S33 mutants aren’t phosphorylated	14	1.61e-03	1.49e-02	0.56300	5.53e-01	1.04e-01	3.38e-04	5.02e-01
CTNNB1 S37 mutants aren’t phosphorylated	14	1.61e-03	1.49e-02	0.56300	5.53e-01	1.04e-01	3.38e-04	5.02e-01
CTNNB1 S45 mutants aren’t phosphorylated	14	1.61e-03	1.49e-02	0.56300	5.53e-01	1.04e-01	3.38e-04	5.02e-01
CTNNB1 T41 mutants aren’t phosphorylated	14	1.61e-03	1.49e-02	0.56300	5.53e-01	1.04e-01	3.38e-04	5.02e-01
Signaling by CTNNB1 phospho-site mutants	14	1.61e-03	1.49e-02	0.56300	5.53e-01	1.04e-01	3.38e-04	5.02e-01
Signaling by GSK3beta mutants	14	1.61e-03	1.49e-02	0.56300	5.53e-01	1.04e-01	3.38e-04	5.02e-01
GOBP POSITIVE REGULATION OF DNA LIGATION	5	1.39e-01	3.51e-01	0.56300	3.46e-01	4.44e-01	1.80e-01	8.57e-02
GOBP POLY A DEPENDENT SNORNA 3 END PROCESSING	8	3.55e-02	1.49e-01	0.56300	5.12e-01	2.32e-01	1.21e-02	2.55e-01
GOBP VAGINA DEVELOPMENT	10	1.96e-02	9.81e-02	0.56200	3.48e-01	4.41e-01	5.65e-02	1.56e-02
GOCC KERATIN FILAMENT	87	7.78e-16	8.30e-14	0.56200	-4.76e-01	-3.00e-01	1.66e-14	1.35e-06
GOMF ICOSANOID TRANSMEMBRANE TRANSPORTER ACTIVITY	13	5.55e-03	3.83e-02	0.56200	-3.01e-01	-4.74e-01	5.99e-02	3.09e-03
GOBP PROTEIN LIPOYLATION	5	5.78e-02	2.05e-01	0.56100	5.19e-01	-2.14e-01	4.44e-02	4.07e-01
GOBP POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT	6	5.40e-02	1.98e-01	0.56100	-5.60e-01	-2.06e-02	1.74e-02	9.30e-01
GOCC COPI VESICLE COAT	13	2.63e-03	2.18e-02	0.56100	5.52e-01	9.89e-02	5.71e-04	5.37e-01
GOMF INTRACELLULARLY CGMP ACTIVATED CATION CHANNEL ACTIVITY	6	6.36e-02	2.18e-01	0.56000	-9.26e-02	-5.53e-01	6.94e-01	1.90e-02
GOBP POSITIVE REGULATION OF PROTEIN MONOUBIQUITINATION	5	1.44e-01	3.57e-01	0.56000	3.93e-01	4.00e-01	1.28e-01	1.22e-01
GOBP REDUCTION OF FOOD INTAKE IN RESPONSE TO DIETARY EXCESS	6	5.61e-02	2.02e-01	0.56000	-5.59e-01	-3.48e-02	1.77e-02	8.83e-01
GOBP REGULATION OF XENOBIOTIC DETOXIFICATION BY TRANSMEMBRANE EXPORT ACROSS THE PLASMA MEMBRANE	12	8.35e-03	5.25e-02	0.56000	-2.94e-01	-4.77e-01	7.76e-02	4.24e-03
GOBP SINOATRIAL NODE CELL DIFFERENTIATION	5	1.31e-01	3.39e-01	0.56000	2.58e-01	4.97e-01	3.19e-01	5.40e-02
GOBP SMOOTH MUSCLE ADAPTATION	5	6.66e-02	2.25e-01	0.56000	-5.44e-01	1.33e-01	3.52e-02	6.05e-01
GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY	6	9.51e-02	2.81e-01	0.56000	3.32e-01	4.51e-01	1.59e-01	5.57e-02
GOMF OXYGEN SENSOR ACTIVITY	5	1.06e-01	3.01e-01	0.56000	5.47e-01	1.18e-01	3.41e-02	6.48e-01
Interleukin-36 pathway	7	6.67e-02	2.25e-01	0.56000	-3.96e-01	-3.95e-01	6.95e-02	7.03e-02
GOMF DISACCHARIDE BINDING	5	7.84e-02	2.49e-01	0.55900	-4.62e-02	5.58e-01	8.58e-01	3.08e-02
GOBP REGULATION OF MONOATOMIC ANION TRANSMEMBRANE TRANSPORT	5	5.11e-02	1.91e-01	0.55900	4.19e-01	-3.70e-01	1.05e-01	1.52e-01
GOBP MEMBRANE DEPOLARIZATION DURING SA NODE CELL ACTION POTENTIAL	5	1.37e-01	3.49e-01	0.55900	-2.92e-01	-4.76e-01	2.58e-01	6.51e-02
GOBP ETHANOLAMINE CONTAINING COMPOUND METABOLIC PROCESS	8	8.56e-03	5.35e-02	0.55800	-3.97e-01	3.92e-01	5.16e-02	5.46e-02
Aspirin ADME	41	1.26e-07	4.47e-06	0.55800	-3.46e-01	-4.38e-01	1.24e-04	1.22e-06
GOBP REGULATION OF HYPERSENSITIVITY	7	2.88e-02	1.28e-01	0.55800	-5.56e-01	4.78e-02	1.09e-02	8.27e-01
GOMF INITIATOR METHIONYL AMINOPEPTIDASE ACTIVITY	5	1.16e-01	3.16e-01	0.55800	1.63e-01	5.33e-01	5.27e-01	3.90e-02
Activation of the phototransduction cascade	11	1.94e-03	1.71e-02	0.55700	2.36e-01	-5.05e-01	1.76e-01	3.74e-03
GOCC CYTOPLASMIC UBIQUITIN LIGASE COMPLEX	8	3.67e-02	1.52e-01	0.55700	2.14e-01	5.14e-01	2.94e-01	1.18e-02
Miscellaneous substrates	12	7.71e-03	4.93e-02	0.55700	-5.02e-01	-2.41e-01	2.61e-03	1.48e-01
Assembly of the ORC complex at the origin of replication	32	4.93e-06	1.19e-04	0.55600	3.97e-01	3.90e-01	1.01e-04	1.36e-04
GOMF TRANSMEMBRANE RECEPTOR PROTEIN PHOSPHATASE ACTIVITY	17	1.26e-03	1.25e-02	0.55600	-4.73e-01	-2.93e-01	7.42e-04	3.65e-02
GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY NOREPINEPHRINE EPINEPHRINE	6	9.79e-02	2.86e-01	0.55600	4.52e-01	3.24e-01	5.54e-02	1.69e-01
CD22 mediated BCR regulation	5	5.43e-02	1.98e-01	0.55500	-3.25e-01	4.50e-01	2.09e-01	8.12e-02
GOBP NEGATIVE REGULATION OF INTERLEUKIN 5 PRODUCTION	7	6.78e-02	2.27e-01	0.55500	-4.42e-01	-3.35e-01	4.27e-02	1.24e-01
Melanin biosynthesis	5	1.49e-01	3.63e-01	0.55500	-3.98e-01	-3.87e-01	1.24e-01	1.34e-01
Regulation of gene expression by Hypoxia-inducible Factor	10	1.77e-02	9.12e-02	0.55500	5.01e-01	2.40e-01	6.13e-03	1.89e-01
Defective factor VIII causes hemophilia A	5	5.96e-02	2.09e-01	0.55500	2.38e-01	-5.01e-01	3.56e-01	5.24e-02
GOBP POLY A PLUS MRNA EXPORT FROM NUCLEUS	18	7.88e-04	8.79e-03	0.55500	4.88e-01	2.64e-01	3.36e-04	5.28e-02
GOBP MUSCULAR SEPTUM MORPHOGENESIS	5	1.12e-01	3.10e-01	0.55500	1.24e-01	5.41e-01	6.31e-01	3.63e-02
GOMF PROTEIN PHOSPHATASE 2B BINDING	6	1.01e-01	2.92e-01	0.55500	3.46e-01	4.34e-01	1.42e-01	6.59e-02
GOBP REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE	22	2.38e-04	3.22e-03	0.55400	3.87e-01	3.96e-01	1.66e-03	1.29e-03
GOCC TRNA METHYLTRANSFERASE COMPLEX	6	7.77e-02	2.48e-01	0.55400	5.31e-01	1.58e-01	2.43e-02	5.02e-01
GOMF HISTONE H3K14 ACETYLTRANSFERASE ACTIVITY	9	1.78e-02	9.13e-02	0.55400	5.46e-01	9.29e-02	4.57e-03	6.29e-01
GOBP METANEPHRIC GLOMERULAR MESANGIUM DEVELOPMENT	5	1.49e-01	3.63e-01	0.55400	4.26e-01	3.54e-01	9.93e-02	1.70e-01
GOBP GLYCINE BIOSYNTHETIC PROCESS	5	1.09e-01	3.06e-01	0.55300	-5.43e-01	-1.06e-01	3.54e-02	6.81e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN REDUCED ASCORBATE AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN	5	5.80e-02	2.06e-01	0.55300	-4.82e-01	2.72e-01	6.21e-02	2.92e-01
GOMF PEPTIDOGLYCAN IMMUNE RECEPTOR ACTIVITY	5	5.48e-02	1.99e-01	0.55300	-3.41e-01	4.35e-01	1.86e-01	9.20e-02
GOBP MEMBRANE TUBULATION	5	1.34e-01	3.44e-01	0.55300	5.01e-01	2.34e-01	5.23e-02	3.65e-01
GOBP FERMENTATION	5	8.39e-02	2.60e-01	0.55300	-4.19e-02	5.51e-01	8.71e-01	3.28e-02
GOBP PLASMA MEMBRANE FUSION	30	9.80e-06	2.12e-04	0.55200	-3.03e-01	-4.61e-01	4.10e-03	1.21e-05
GOMF RNA POLYMERASE II C TERMINAL DOMAIN BINDING	10	1.59e-02	8.42e-02	0.55100	5.21e-01	1.81e-01	4.34e-03	3.21e-01
GOBP CELLULAR RESPONSE TO L LEUCINE	12	7.11e-03	4.63e-02	0.55100	5.19e-01	1.86e-01	1.86e-03	2.66e-01
Defective C1GALT1C1 causes TNPS	18	8.38e-04	9.17e-03	0.55100	-4.90e-01	-2.52e-01	3.22e-04	6.39e-02
GOBP REGULATION OF LIPOPHAGY	5	1.32e-01	3.40e-01	0.55100	5.10e-01	2.07e-01	4.82e-02	4.23e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN REDUCED IRON SULFUR PROTEIN AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN	9	2.00e-02	9.97e-02	0.55000	-5.38e-01	-1.14e-01	5.16e-03	5.53e-01
GOBP METANEPHRIC MESENCHYMAL CELL DIFFERENTIATION	5	5.66e-02	2.02e-01	0.55000	-3.39e-01	4.33e-01	1.89e-01	9.37e-02
Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)	8	1.03e-02	6.13e-02	0.54900	4.35e-01	-3.35e-01	3.31e-02	1.01e-01
GOBP REGULATION OF MITOCHONDRIAL ATP SYNTHESIS COUPLED ELECTRON TRANSPORT	7	1.81e-02	9.23e-02	0.54900	-3.60e-01	4.14e-01	9.93e-02	5.77e-02
GOCC MITOCHONDRIAL PROTON TRANSPORTING ATP SYNTHASE COMPLEX COUPLING FACTOR F O	10	2.44e-02	1.14e-01	0.54800	3.82e-01	3.93e-01	3.64e-02	3.13e-02
GOMF MRNA METHYLTRANSFERASE ACTIVITY	13	5.10e-03	3.59e-02	0.54800	5.14e-01	1.91e-01	1.34e-03	2.34e-01
GOBP VENTRICULAR COMPACT MYOCARDIUM MORPHOGENESIS	8	4.32e-02	1.71e-01	0.54700	2.33e-01	4.95e-01	2.54e-01	1.53e-02
GOMF CALCIUM POTASSIUM SODIUM ANTIPORTER ACTIVITY	5	8.52e-02	2.63e-01	0.54700	6.22e-02	-5.43e-01	8.10e-01	3.54e-02
GOMF DESUMOYLASE ACTIVITY	7	6.99e-02	2.32e-01	0.54700	2.86e-01	4.66e-01	1.90e-01	3.27e-02
GOMF N N DIMETHYLANILINE MONOOXYGENASE ACTIVITY	5	5.84e-02	2.07e-01	0.54700	4.25e-01	-3.43e-01	9.95e-02	1.84e-01
GOBP DOUBLE STRAND BREAK REPAIR VIA SYNTHESIS DEPENDENT STRAND ANNEALING	8	2.15e-02	1.05e-01	0.54600	5.46e-01	-3.00e-02	7.53e-03	8.83e-01
GOMF DEAD H BOX RNA HELICASE BINDING	8	3.74e-02	1.54e-01	0.54500	5.21e-01	1.60e-01	1.07e-02	4.34e-01
GOCC PROTON TRANSPORTING ATP SYNTHASE COMPLEX COUPLING FACTOR F O	12	1.21e-02	6.89e-02	0.54500	3.59e-01	4.10e-01	3.14e-02	1.39e-02
GOCC CLATHRIN COAT OF COATED PIT	18	3.89e-04	4.85e-03	0.54500	5.38e-01	8.33e-02	7.63e-05	5.40e-01
GOMF ANDROSTAN 3 ALPHA 17 BETA DIOL DEHYDROGENASE ACTIVITY	8	3.22e-02	1.39e-01	0.54500	-1.03e-01	-5.35e-01	6.15e-01	8.78e-03
GOBP NEGATIVE REGULATION OF MAST CELL DEGRANULATION	5	8.36e-02	2.59e-01	0.54400	-8.72e-02	5.37e-01	7.36e-01	3.76e-02
NFE2L2 regulating ER-stress associated genes	5	1.54e-01	3.70e-01	0.54400	4.57e-01	2.95e-01	7.68e-02	2.54e-01
GOBP INTERKINETIC NUCLEAR MIGRATION	5	1.60e-01	3.79e-01	0.54400	4.06e-01	3.62e-01	1.16e-01	1.61e-01
GOBP REGULATION OF CEREBELLAR GRANULE CELL PRECURSOR PROLIFERATION	9	3.16e-02	1.37e-01	0.54400	4.84e-01	2.48e-01	1.19e-02	1.97e-01
GOBP NEGATIVE REGULATION OF RIG I SIGNALING PATHWAY	8	5.19e-02	1.92e-01	0.54400	3.20e-01	4.39e-01	1.16e-01	3.14e-02
GOMF METAL DEPENDENT DEUBIQUITINASE ACTIVITY	11	7.55e-03	4.86e-02	0.54400	5.41e-01	5.54e-02	1.90e-03	7.50e-01
GOBP NEURON GLIAL CELL SIGNALING	5	1.60e-01	3.79e-01	0.54400	-4.14e-01	-3.52e-01	1.09e-01	1.73e-01
GOBP SERINE PHOSPHORYLATION OF STAT PROTEIN	20	6.45e-04	7.46e-03	0.54300	-3.35e-01	-4.28e-01	9.48e-03	9.27e-04
GOBP LIPID HYDROXYLATION	7	3.58e-02	1.50e-01	0.54300	3.33e-02	-5.42e-01	8.79e-01	1.30e-02
GOBP RESPONSE TO OXYGEN GLUCOSE DEPRIVATION	9	2.02e-02	1.00e-01	0.54300	8.21e-02	5.37e-01	6.70e-01	5.30e-03
GOBP MRNA 3 END PROCESSING BY STEM LOOP BINDING AND CLEAVAGE	6	1.10e-01	3.07e-01	0.54300	3.26e-01	4.34e-01	1.66e-01	6.59e-02
GOCC U7 SNRNP	7	7.49e-02	2.42e-01	0.54200	4.49e-01	3.04e-01	3.97e-02	1.64e-01
GOBP REGULATION OF LYSOSOME ORGANIZATION	12	9.47e-03	5.75e-02	0.54200	4.95e-01	2.20e-01	2.96e-03	1.88e-01
GOBP POSITIVE REGULATION OF MONOCYTE EXTRAVASATION	5	1.52e-01	3.68e-01	0.54200	-2.66e-01	-4.72e-01	3.03e-01	6.78e-02
GOMF CGMP BINDING	15	3.30e-03	2.58e-02	0.54200	-2.46e-01	-4.82e-01	9.90e-02	1.22e-03
Nef Mediated CD8 Down-regulation	7	5.89e-02	2.08e-01	0.54100	5.17e-01	1.61e-01	1.79e-02	4.60e-01
GOMF CHROMO SHADOW DOMAIN BINDING	5	1.43e-01	3.56e-01	0.54100	4.97e-01	2.14e-01	5.41e-02	4.08e-01
GOCC POLAR MICROTUBULE	5	1.60e-01	3.79e-01	0.54100	3.21e-01	4.36e-01	2.14e-01	9.15e-02
GOBP HEME A METABOLIC PROCESS	10	2.01e-02	1.00e-01	0.54100	2.07e-01	5.00e-01	2.58e-01	6.17e-03
GOBP TRANS SYNAPTIC SIGNALING BY LIPID	7	7.71e-02	2.47e-01	0.54100	-4.36e-01	-3.20e-01	4.58e-02	1.42e-01
GOBP PURINE NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS	5	1.29e-01	3.37e-01	0.54100	1.44e-01	5.21e-01	5.77e-01	4.35e-02
Glucocorticoid biosynthesis	10	1.44e-02	7.82e-02	0.54000	-5.32e-01	-9.66e-02	3.59e-03	5.97e-01
GOBP AIM2 INFLAMMASOME COMPLEX ASSEMBLY	5	1.65e-01	3.86e-01	0.54000	-3.85e-01	-3.79e-01	1.36e-01	1.42e-01
mRNA decay by 5’ to 3’ exoribonuclease	15	2.10e-03	1.83e-02	0.54000	5.23e-01	1.33e-01	4.49e-04	3.71e-01
GOMF ICOSANOID BINDING	8	1.24e-02	7.00e-02	0.53900	-4.46e-01	3.03e-01	2.88e-02	1.38e-01
GOBP URETER MORPHOGENESIS	7	2.22e-02	1.07e-01	0.53900	-4.57e-01	2.86e-01	3.63e-02	1.91e-01
GOBP MODULATION BY VIRUS OF HOST PROCESS	6	1.01e-01	2.92e-01	0.53800	2.21e-01	4.91e-01	3.49e-01	3.74e-02
GOBP PROTEIN DENEDDYLATION	11	1.65e-02	8.66e-02	0.53800	4.74e-01	2.55e-01	6.53e-03	1.43e-01
Glycine degradation	6	1.02e-01	2.94e-01	0.53800	4.88e-01	2.26e-01	3.85e-02	3.38e-01
GOBP REGULATION OF INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY	11	2.52e-03	2.11e-02	0.53700	4.40e-01	-3.07e-01	1.15e-02	7.75e-02
GOBP POSITIVE REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE	11	2.00e-02	9.95e-02	0.53700	3.71e-01	3.88e-01	3.31e-02	2.59e-02
GOMF PYRIMIDINE NUCLEOBASE TRANSMEMBRANE TRANSPORTER ACTIVITY	7	5.17e-02	1.92e-01	0.53600	-8.04e-02	-5.30e-01	7.13e-01	1.51e-02
GOBP REGULATION OF DNA LIGATION	6	1.19e-01	3.20e-01	0.53600	3.79e-01	3.79e-01	1.08e-01	1.08e-01
GOBP NEGATIVE REGULATION OF MUSCLE ORGAN DEVELOPMENT	9	1.88e-02	9.53e-02	0.53500	2.53e-02	5.35e-01	8.96e-01	5.47e-03
GOBP CHONDROCYTE HYPERTROPHY	6	7.67e-02	2.46e-01	0.53500	6.21e-02	5.32e-01	7.92e-01	2.41e-02
GOBP TACHYKININ RECEPTOR SIGNALING PATHWAY	8	2.90e-02	1.29e-01	0.53500	5.35e-01	2.04e-02	8.81e-03	9.21e-01
Formation of the cornified envelope	124	6.28e-20	9.29e-18	0.53400	-4.34e-01	-3.12e-01	6.44e-17	2.04e-09
GOCC BASAL CORTEX	5	1.15e-01	3.15e-01	0.53400	5.32e-01	4.48e-02	3.94e-02	8.62e-01
GOCC VCP NPL4 UFD1 AAA ATPASE COMPLEX	8	5.88e-02	2.08e-01	0.53400	4.18e-01	3.31e-01	4.05e-02	1.05e-01
GOCC ZONULA ADHERENS	8	1.42e-02	7.77e-02	0.53400	2.75e-01	-4.57e-01	1.78e-01	2.50e-02
GOBP ROSTROCAUDAL NEURAL TUBE PATTERNING	10	1.88e-02	9.51e-02	0.53400	1.44e-01	5.14e-01	4.29e-01	4.91e-03
TRAIL signaling	8	1.74e-02	9.00e-02	0.53400	-1.74e-01	5.04e-01	3.93e-01	1.35e-02
GOBP VESICLE TETHERING TO GOLGI	5	1.67e-01	3.88e-01	0.53400	4.41e-01	3.01e-01	8.79e-02	2.44e-01
GOBP REGULATION OF PRE MIRNA PROCESSING	6	1.18e-01	3.18e-01	0.53300	4.35e-01	3.09e-01	6.51e-02	1.90e-01
GOBP RRNA CATABOLIC PROCESS	14	6.43e-03	4.30e-02	0.53300	4.51e-01	2.85e-01	3.48e-03	6.53e-02
GOBP AMACRINE CELL DIFFERENTIATION	12	9.87e-03	5.92e-02	0.53300	1.83e-01	5.01e-01	2.73e-01	2.67e-03
GOCC AP 2 ADAPTOR COMPLEX	11	1.15e-02	6.66e-02	0.53300	5.20e-01	1.15e-01	2.81e-03	5.10e-01
GOMF NUCLEASE INHIBITOR ACTIVITY	6	1.21e-01	3.24e-01	0.53300	4.09e-01	3.41e-01	8.25e-02	1.49e-01
GOCC MITOCHONDRIAL INTERMEMBRANE SPACE PROTEIN TRANSPORTER COMPLEX	5	8.35e-02	2.59e-01	0.53200	5.12e-01	-1.48e-01	4.76e-02	5.67e-01
GOMF RIBOSOMAL SMALL SUBUNIT BINDING	16	3.23e-03	2.54e-02	0.53200	2.88e-01	4.48e-01	4.59e-02	1.93e-03
GOMF C PALMITOYLTRANSFERASE ACTIVITY	5	1.70e-01	3.92e-01	0.53200	4.31e-01	3.11e-01	9.48e-02	2.29e-01
GOMF S METHYLTRANSFERASE ACTIVITY	10	1.87e-02	9.51e-02	0.53100	5.15e-01	1.32e-01	4.84e-03	4.70e-01
GOCC H3 HISTONE ACETYLTRANSFERASE COMPLEX	8	5.46e-02	1.99e-01	0.53100	4.66e-01	2.54e-01	2.24e-02	2.13e-01
GOBP NEGATIVE REGULATION OF PROTEIN KINASE ACTIVITY BY REGULATION OF PROTEIN PHOSPHORYLATION	6	1.00e-01	2.91e-01	0.53100	1.78e-01	5.00e-01	4.50e-01	3.38e-02
GOMF 5 DEOXYRIBOSE 5 PHOSPHATE LYASE ACTIVITY	7	4.23e-02	1.69e-01	0.53100	5.30e-01	-2.64e-02	1.52e-02	9.04e-01
GOBP URIDINE TRANSMEMBRANE TRANSPORT	6	8.38e-02	2.60e-01	0.53000	-8.22e-02	-5.24e-01	7.27e-01	2.62e-02
GOBP COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY	16	2.32e-03	1.97e-02	0.53000	-4.96e-01	-1.86e-01	5.87e-04	1.98e-01
GOBP REGULATION OF MAINTENANCE OF SISTER CHROMATID COHESION	7	6.96e-02	2.31e-01	0.52900	4.99e-01	1.74e-01	2.22e-02	4.25e-01
GOBP INTERLEUKIN 23 PRODUCTION	10	1.46e-02	7.93e-02	0.52800	-5.26e-01	-4.62e-02	3.94e-03	8.00e-01
GOBP ATRIAL SEPTUM MORPHOGENESIS	15	5.68e-03	3.89e-02	0.52800	3.83e-01	3.64e-01	1.03e-02	1.46e-02
GOBP RESPONSE TO OZONE	5	1.54e-01	3.69e-01	0.52700	-1.89e-01	-4.92e-01	4.65e-01	5.66e-02
Mineralocorticoid biosynthesis	6	1.23e-01	3.27e-01	0.52700	-4.33e-01	-3.00e-01	6.61e-02	2.03e-01
GOCC OLIGOSACCHARYLTRANSFERASE COMPLEX	13	9.77e-03	5.88e-02	0.52700	4.58e-01	2.61e-01	4.26e-03	1.03e-01
GOBP POSITIVE REGULATION OF METALLOENDOPEPTIDASE ACTIVITY	5	1.55e-01	3.70e-01	0.52700	-4.91e-01	-1.91e-01	5.71e-02	4.60e-01
GOMF 5S RRNA BINDING	9	2.75e-02	1.24e-01	0.52700	5.16e-01	1.06e-01	7.34e-03	5.82e-01
GOMF CCR1 CHEMOKINE RECEPTOR BINDING	5	1.68e-01	3.90e-01	0.52700	-4.60e-01	-2.57e-01	7.51e-02	3.20e-01
GOBP NEGATIVE REGULATION OF ASTROCYTE ACTIVATION	5	1.23e-01	3.27e-01	0.52600	-4.70e-02	-5.24e-01	8.56e-01	4.23e-02
GOBP NEGATIVE REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION	5	7.67e-02	2.46e-01	0.52600	2.55e-01	-4.60e-01	3.23e-01	7.50e-02
GOBP NEGATIVE REGULATION OF INTERFERON ALPHA PRODUCTION	6	9.28e-02	2.77e-01	0.52500	-5.14e-01	-1.05e-01	2.92e-02	6.55e-01
GOMF SINGLE STRANDED DNA ENDODEOXYRIBONUCLEASE ACTIVITY	11	2.26e-02	1.08e-01	0.52500	4.25e-01	3.07e-01	1.46e-02	7.78e-02
GOBP DUMP METABOLIC PROCESS	7	3.29e-02	1.41e-01	0.52400	-4.97e-01	1.66e-01	2.26e-02	4.47e-01
Role of ABL in ROBO-SLIT signaling	8	4.76e-02	1.82e-01	0.52400	5.02e-01	1.51e-01	1.40e-02	4.59e-01
GOBP MOTOR LEARNING	8	5.47e-02	1.99e-01	0.52400	2.11e-01	4.80e-01	3.02e-01	1.88e-02
GOBP CARBON DIOXIDE TRANSPORT	15	1.80e-03	1.62e-02	0.52400	-5.23e-01	-2.69e-02	4.52e-04	8.57e-01
GOMF TESTOSTERONE DEHYDROGENASE NAD P ACTIVITY	10	2.96e-02	1.30e-01	0.52300	-4.57e-01	-2.55e-01	1.23e-02	1.63e-01
GOMF HEMOGLOBIN BINDING	9	4.08e-02	1.64e-01	0.52300	-4.65e-01	-2.39e-01	1.56e-02	2.14e-01
Defective GALNT12 causes CRCS1	18	1.78e-03	1.61e-02	0.52300	-4.57e-01	-2.55e-01	7.93e-04	6.09e-02
GOBP CORTISOL METABOLIC PROCESS	12	1.04e-02	6.15e-02	0.52300	-5.03e-01	-1.43e-01	2.57e-03	3.90e-01
GOBP ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY	9	4.68e-02	1.80e-01	0.52300	-4.13e-01	-3.20e-01	3.19e-02	9.62e-02
GOMF G PROTEIN COUPLED GLUTAMATE RECEPTOR ACTIVITY	9	4.68e-02	1.80e-01	0.52300	-4.13e-01	-3.20e-01	3.19e-02	9.62e-02
GOBP REGULATION OF CORTICOTROPIN SECRETION	5	1.29e-01	3.36e-01	0.52200	5.33e-02	5.20e-01	8.36e-01	4.42e-02
GOBP SODIUM INDEPENDENT ORGANIC ANION TRANSPORT	15	6.15e-03	4.16e-02	0.52200	-4.10e-01	-3.24e-01	5.97e-03	3.00e-02
GOBP UTERUS MORPHOGENESIS	6	6.14e-02	2.14e-01	0.52200	1.06e-01	-5.11e-01	6.52e-01	3.01e-02
CDC6 association with the ORC:origin complex	8	6.32e-02	2.17e-01	0.52200	4.41e-01	2.80e-01	3.09e-02	1.71e-01
GOMF TELOMERASE INHIBITOR ACTIVITY	5	1.79e-01	4.03e-01	0.52200	4.38e-01	2.83e-01	8.97e-02	2.73e-01
GOBP RESPONSE TO SELENIUM ION	9	3.63e-02	1.51e-01	0.52200	1.80e-01	4.90e-01	3.51e-01	1.10e-02
GOMF NETRIN RECEPTOR ACTIVITY	5	8.64e-02	2.65e-01	0.52100	-4.85e-01	1.91e-01	6.03e-02	4.59e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN REDUCED PTERIDINE AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN	7	7.23e-02	2.37e-01	0.52100	-4.98e-01	-1.54e-01	2.25e-02	4.80e-01
GOMF PHOSPHOTRANSFERASE ACTIVITY NITROGENOUS GROUP AS ACCEPTOR	6	1.20e-01	3.22e-01	0.52100	2.32e-01	4.66e-01	3.25e-01	4.79e-02
GOMF MRF BINDING	5	1.64e-01	3.84e-01	0.52100	4.81e-01	2.00e-01	6.25e-02	4.39e-01
GOBP NEGATIVE REGULATION OF LAMELLIPODIUM ORGANIZATION	7	3.26e-02	1.40e-01	0.52100	4.83e-01	-1.94e-01	2.69e-02	3.73e-01
Sodium-coupled sulphate, di- and tri-carboxylate transporters	5	1.62e-01	3.82e-01	0.52100	-1.92e-01	-4.84e-01	4.57e-01	6.09e-02
GOBP DETECTION OF TEMPERATURE STIMULUS INVOLVED IN THERMOCEPTION	5	1.35e-01	3.45e-01	0.52100	-7.39e-02	-5.15e-01	7.75e-01	4.60e-02
GOBP HORMONE MEDIATED APOPTOTIC SIGNALING PATHWAY	5	1.84e-01	4.09e-01	0.52000	-3.05e-01	-4.21e-01	2.37e-01	1.03e-01
GOCC BBAF COMPLEX	10	1.80e-02	9.20e-02	0.52000	5.16e-01	6.69e-02	4.73e-03	7.14e-01
GOBP DETECTION OF VIRUS	6	8.89e-02	2.70e-01	0.52000	5.16e-01	6.02e-02	2.86e-02	7.98e-01
GOBP POSITIVE REGULATION OF METALLOPEPTIDASE ACTIVITY	8	4.95e-02	1.87e-01	0.52000	-4.99e-01	-1.44e-01	1.45e-02	4.80e-01
Vasopressin-like receptors	5	1.38e-01	3.49e-01	0.51900	8.01e-02	5.13e-01	7.56e-01	4.69e-02
GOCC MESSENGER RIBONUCLEOPROTEIN COMPLEX	6	1.33e-01	3.42e-01	0.51900	4.10e-01	3.18e-01	8.17e-02	1.77e-01
GOBP PEPTIDE ANTIGEN ASSEMBLY WITH MHC CLASS I PROTEIN COMPLEX	6	1.22e-01	3.24e-01	0.51900	2.27e-01	4.66e-01	3.35e-01	4.81e-02
GOMF MRNA REGULATORY ELEMENT BINDING TRANSLATION REPRESSOR ACTIVITY	15	6.59e-03	4.39e-02	0.51800	3.17e-01	4.10e-01	3.33e-02	5.98e-03
GOCC SPERM MITOCHONDRIAL SHEATH	6	1.35e-01	3.45e-01	0.51700	-3.15e-01	-4.10e-01	1.81e-01	8.20e-02
GOMF FIBRINOGEN BINDING	6	9.70e-02	2.84e-01	0.51700	-9.21e-02	-5.09e-01	6.96e-01	3.08e-02
GOBP APOPTOTIC PROCESS IN BONE MARROW CELL	6	8.65e-02	2.66e-01	0.51700	-5.16e-01	-3.59e-02	2.86e-02	8.79e-01
GOBP PROTEIN INSERTION INTO ER MEMBRANE BY STOP TRANSFER MEMBRANE ANCHOR SEQUENCE	10	3.43e-02	1.45e-01	0.51700	4.32e-01	2.83e-01	1.79e-02	1.21e-01
GOBP POSITIVE REGULATION OF OPSONIZATION	8	7.10e-02	2.35e-01	0.51700	-3.89e-01	-3.40e-01	5.66e-02	9.58e-02
GOMF KETOSTEROID MONOOXYGENASE ACTIVITY	5	1.85e-01	4.11e-01	0.51700	-2.83e-01	-4.32e-01	2.73e-01	9.42e-02
GOBP DCMP CATABOLIC PROCESS	6	5.29e-02	1.95e-01	0.51600	-4.64e-01	2.26e-01	4.89e-02	3.37e-01
GOMF NAADP SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY	5	1.56e-01	3.73e-01	0.51600	1.44e-01	4.96e-01	5.78e-01	5.48e-02
GOBP REGULATION OF INTESTINAL LIPID ABSORPTION	10	1.54e-02	8.27e-02	0.51600	-1.47e-03	-5.16e-01	9.94e-01	4.75e-03
Interleukin-6 signaling	11	1.44e-02	7.84e-02	0.51500	9.37e-02	5.07e-01	5.91e-01	3.60e-03
GOBP RNA 3 URIDYLATION	5	1.88e-01	4.15e-01	0.51500	4.26e-01	2.90e-01	9.91e-02	2.61e-01
GOMF NAD P H DEHYDROGENASE QUINONE ACTIVITY	5	1.94e-01	4.23e-01	0.51500	3.69e-01	3.60e-01	1.53e-01	1.64e-01
GOBP CD4 POSITIVE CD25 POSITIVE ALPHA BETA REGULATORY T CELL DIFFERENTIATION	8	5.25e-02	1.94e-01	0.51500	-4.94e-01	-1.47e-01	1.55e-02	4.73e-01
GOBP SUGAR MEDIATED SIGNALING PATHWAY	9	4.40e-02	1.73e-01	0.51500	4.64e-01	2.24e-01	1.59e-02	2.44e-01
GOCC COPII VESICLE COAT	16	4.29e-03	3.16e-02	0.51500	4.49e-01	2.52e-01	1.86e-03	8.12e-02
GOBP DNA STRAND INVASION	6	1.15e-01	3.15e-01	0.51500	4.85e-01	1.73e-01	3.98e-02	4.62e-01
GOBP THREONINE METABOLIC PROCESS	5	1.39e-01	3.50e-01	0.51500	5.11e-01	6.21e-02	4.79e-02	8.10e-01
GOCC GINS COMPLEX	5	1.25e-01	3.30e-01	0.51400	-1.37e-04	5.14e-01	1.00e+00	4.64e-02
RHO GTPases activate CIT	19	8.52e-04	9.28e-03	0.51400	4.98e-01	1.28e-01	1.73e-04	3.32e-01
GOBP COMPARTMENT PATTERN SPECIFICATION	5	1.11e-01	3.09e-01	0.51400	-5.09e-01	7.05e-02	4.87e-02	7.85e-01
GOCC COMPLEX OF COLLAGEN TRIMERS	19	1.04e-04	1.59e-03	0.51400	2.17e-01	-4.66e-01	1.01e-01	4.42e-04
GOBP REGULATION OF TOOTH MINERALIZATION	11	6.90e-03	4.53e-02	0.51400	1.11e-01	-5.02e-01	5.23e-01	3.96e-03
GOBP SENSORY PERCEPTION OF SWEET TASTE	7	9.75e-02	2.85e-01	0.51400	-4.27e-01	-2.85e-01	5.02e-02	1.92e-01
GOBP POSITIVE REGULATION OF CEREBELLAR GRANULE CELL PRECURSOR PROLIFERATION	6	1.24e-01	3.28e-01	0.51300	4.69e-01	2.09e-01	4.67e-02	3.75e-01
GOMF CXCR3 CHEMOKINE RECEPTOR BINDING	5	8.54e-02	2.63e-01	0.51300	2.66e-01	-4.39e-01	3.03e-01	8.93e-02
RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs)	9	2.24e-02	1.08e-01	0.51300	-5.12e-01	2.39e-02	7.76e-03	9.01e-01
GOCC KAINATE SELECTIVE GLUTAMATE RECEPTOR COMPLEX	5	1.68e-01	3.89e-01	0.51300	-1.73e-01	-4.83e-01	5.02e-01	6.15e-02
GOMF KAINATE SELECTIVE GLUTAMATE RECEPTOR ACTIVITY	5	1.68e-01	3.89e-01	0.51300	-1.73e-01	-4.83e-01	5.02e-01	6.15e-02
GOMF SOMATOSTATIN RECEPTOR ACTIVITY	5	1.11e-01	3.09e-01	0.51300	-7.50e-02	5.07e-01	7.71e-01	4.95e-02
GOCC TRAPPIII PROTEIN COMPLEX	11	2.30e-02	1.10e-01	0.51300	2.25e-01	4.60e-01	1.95e-01	8.21e-03
GOBP NOREPINEPHRINE BIOSYNTHETIC PROCESS	8	2.57e-02	1.19e-01	0.51200	-4.94e-01	1.36e-01	1.55e-02	5.06e-01
GOMF ALPHA KETOGLUTARATE TRANSMEMBRANE TRANSPORTER ACTIVITY	6	9.74e-02	2.85e-01	0.51200	-7.07e-02	-5.07e-01	7.64e-01	3.14e-02
GOMF BETA 2 MICROGLOBULIN BINDING	9	2.18e-02	1.06e-01	0.51200	-3.81e-02	5.11e-01	8.43e-01	7.99e-03
GOMF ATPASE INHIBITOR ACTIVITY	5	1.97e-01	4.27e-01	0.51200	3.30e-01	3.91e-01	2.01e-01	1.30e-01
GOBP ACTIN MODIFICATION	5	1.97e-01	4.27e-01	0.51200	3.97e-01	3.23e-01	1.24e-01	2.11e-01
GOBP REGULATION OF COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY	5	1.46e-01	3.59e-01	0.51200	-5.06e-01	-7.74e-02	5.01e-02	7.64e-01
GOMF SMALL PROTEIN ACTIVATING ENZYME BINDING	5	9.11e-02	2.74e-01	0.51200	4.63e-01	-2.17e-01	7.29e-02	4.00e-01
GOCC BRAHMA COMPLEX	14	5.88e-03	4.00e-02	0.51200	4.94e-01	1.34e-01	1.38e-03	3.86e-01
GOBP MAINTENANCE OF SISTER CHROMATID COHESION	11	1.63e-02	8.60e-02	0.51200	4.99e-01	1.11e-01	4.12e-03	5.23e-01
GOBP REGULATION OF GLUCOCORTICOID RECEPTOR SIGNALING PATHWAY	7	7.95e-02	2.52e-01	0.51100	4.89e-01	1.50e-01	2.51e-02	4.92e-01
GOBP PROTEIN LOCALIZATION TO CELL LEADING EDGE	5	1.79e-01	4.03e-01	0.51100	2.12e-01	4.65e-01	4.11e-01	7.17e-02
GOBP ATRIOVENTRICULAR NODE DEVELOPMENT	9	4.12e-02	1.66e-01	0.51100	4.81e-01	1.72e-01	1.25e-02	3.72e-01
ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression	38	4.39e-06	1.07e-04	0.51100	4.05e-01	3.11e-01	1.58e-05	8.93e-04
GOBP MAINTENANCE OF CENTROSOME LOCATION	6	1.20e-01	3.22e-01	0.51000	4.80e-01	1.72e-01	4.15e-02	4.66e-01
GOBP REGULATION OF PINOCYTOSIS	12	1.64e-02	8.62e-02	0.51000	4.63e-01	2.14e-01	5.43e-03	2.00e-01
GOBP HYDROGEN SULFIDE METABOLIC PROCESS	5	1.35e-01	3.45e-01	0.51000	5.10e-01	2.38e-02	4.84e-02	9.27e-01
GOCC CYTOPLASMIC SIDE OF ROUGH ENDOPLASMIC RETICULUM MEMBRANE	5	1.91e-01	4.18e-01	0.51000	4.37e-01	2.62e-01	9.03e-02	3.11e-01
GOBP MRNA 3 SPLICE SITE RECOGNITION	6	1.10e-01	3.07e-01	0.51000	4.95e-01	1.22e-01	3.58e-02	6.04e-01
GOBP REGULATION OF APOPTOTIC PROCESS IN BONE MARROW CELL	5	1.26e-01	3.32e-01	0.50900	-5.09e-01	1.74e-02	4.87e-02	9.46e-01
GOBP CARDIAC VENTRICLE FORMATION	8	5.99e-02	2.10e-01	0.50900	1.73e-01	4.79e-01	3.98e-01	1.90e-02
GOMF NADPH OXIDASE H202 FORMING ACTIVITY	5	2.01e-01	4.31e-01	0.50900	3.34e-01	3.84e-01	1.96e-01	1.37e-01
GOBP COPI COATED VESICLE BUDDING	6	1.04e-01	2.96e-01	0.50900	5.02e-01	8.57e-02	3.34e-02	7.16e-01
GOCC BARR BODY	7	1.06e-01	3.00e-01	0.50900	3.21e-01	3.95e-01	1.42e-01	7.06e-02
GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY	6	1.21e-01	3.23e-01	0.50800	1.66e-01	4.80e-01	4.81e-01	4.15e-02
GOBP NEGATIVE REGULATION OF INTRACELLULAR LIPID TRANSPORT	5	1.39e-01	3.50e-01	0.50800	-5.07e-01	-3.20e-02	4.95e-02	9.01e-01
GOBP NEURON CELL CELL ADHESION	13	1.22e-02	6.92e-02	0.50800	-4.59e-01	-2.17e-01	4.13e-03	1.75e-01
Orexin and neuropeptides FF and QRFP bind to their respective receptors	8	5.81e-02	2.06e-01	0.50800	-1.54e-01	-4.84e-01	4.51e-01	1.77e-02
GOBP REGULATION OF FEMALE RECEPTIVITY	8	7.80e-02	2.49e-01	0.50800	3.47e-01	3.71e-01	8.91e-02	6.93e-02
GOBP DNA INTEGRATION	8	4.44e-02	1.74e-01	0.50800	5.06e-01	4.68e-02	1.33e-02	8.19e-01
GOMF GLUCOSYLTRANSFERASE ACTIVITY	19	7.92e-04	8.81e-03	0.50800	5.00e-01	8.65e-02	1.59e-04	5.14e-01
GOCC PROTEIN PHOSPHATASE TYPE 1 COMPLEX	18	3.21e-03	2.53e-02	0.50700	3.31e-01	3.85e-01	1.50e-02	4.72e-03
GOMF EPOXIDE HYDROLASE ACTIVITY	8	5.46e-02	1.99e-01	0.50700	4.92e-01	1.23e-01	1.60e-02	5.46e-01
GOMF 5ALPHA ANDROSTANE 3BETA 17BETA DIOL DEHYDROGENASE ACTIVITY	6	1.01e-01	2.93e-01	0.50700	-6.68e-02	-5.03e-01	7.77e-01	3.30e-02
GOBP REGULATION OF CHROMOSOME CONDENSATION	13	1.15e-02	6.64e-02	0.50600	4.70e-01	1.88e-01	3.31e-03	2.41e-01
GOBP HEPOXILIN METABOLIC PROCESS	8	3.80e-02	1.56e-01	0.50600	5.06e-01	-1.66e-02	1.32e-02	9.35e-01
GOCC NUCLEAR EXOSOME RNASE COMPLEX	16	5.01e-03	3.54e-02	0.50600	4.46e-01	2.39e-01	2.00e-03	9.75e-02
GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION INDEPENDENT DECAY	7	6.96e-02	2.31e-01	0.50600	5.02e-01	6.51e-02	2.14e-02	7.66e-01
SLBP independent Processing of Histone Pre-mRNAs	10	3.89e-02	1.59e-01	0.50600	4.28e-01	2.71e-01	1.92e-02	1.38e-01
NFE2L2 regulating inflammation associated genes	5	1.99e-01	4.29e-01	0.50600	4.22e-01	2.80e-01	1.03e-01	2.78e-01
GOBP OPSONIZATION	16	5.73e-03	3.92e-02	0.50600	-4.21e-01	-2.80e-01	3.54e-03	5.23e-02
GOCC EXORIBONUCLEASE COMPLEX	24	2.80e-04	3.70e-03	0.50600	4.67e-01	1.94e-01	7.41e-05	1.01e-01
GOBP MONOTERPENOID METABOLIC PROCESS	6	1.50e-01	3.64e-01	0.50600	-3.42e-01	-3.73e-01	1.47e-01	1.14e-01
GOBP POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE	6	8.59e-02	2.64e-01	0.50600	5.05e-01	-2.20e-02	3.22e-02	9.26e-01
GOBP POSITIVE REGULATION OF SULFUR METABOLIC PROCESS	5	1.34e-01	3.43e-01	0.50600	5.06e-01	-1.03e-03	5.03e-02	9.97e-01
GOBP LIPOPHAGY	7	1.09e-01	3.06e-01	0.50500	3.33e-01	3.80e-01	1.27e-01	8.14e-02
GOMF MAP KINASE KINASE KINASE KINASE ACTIVITY	6	1.48e-01	3.62e-01	0.50500	4.02e-01	3.06e-01	8.84e-02	1.94e-01
GOBP NEGATIVE REGULATION OF INTERLEUKIN 13 PRODUCTION	7	1.11e-01	3.08e-01	0.50500	-3.52e-01	-3.62e-01	1.07e-01	9.76e-02
Transcriptional regulation of pluripotent stem cells	28	8.64e-05	1.38e-03	0.50400	4.58e-01	2.12e-01	2.76e-05	5.27e-02
GOBP PHAGOCYTOSIS RECOGNITION	27	2.05e-04	2.82e-03	0.50400	-3.28e-01	-3.83e-01	3.18e-03	5.78e-04
RNA Polymerase I Promoter Opening	26	2.84e-04	3.73e-03	0.50400	3.78e-01	3.33e-01	8.48e-04	3.27e-03
GOMF LIPOPROTEIN LIPASE ACTIVITY	9	2.48e-02	1.16e-01	0.50400	-5.03e-01	3.50e-02	9.03e-03	8.56e-01
GOBP CENTRAL NERVOUS SYSTEM MATURATION	6	1.52e-01	3.68e-01	0.50400	3.33e-01	3.77e-01	1.57e-01	1.09e-01
Activated NTRK2 signals through RAS	9	5.05e-02	1.90e-01	0.50300	4.54e-01	2.17e-01	1.83e-02	2.59e-01
GOBP NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY	5	1.71e-01	3.93e-01	0.50300	4.84e-01	1.39e-01	6.10e-02	5.91e-01
GOMF RNA POLYMERASE II CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING	19	2.24e-03	1.91e-02	0.50300	2.66e-01	4.27e-01	4.46e-02	1.27e-03
GOBP RESPONSE TO MISFOLDED PROTEIN	18	3.60e-03	2.77e-02	0.50300	3.68e-01	3.43e-01	6.87e-03	1.18e-02
GOMF HISTONE ACETYLTRANSFERASE BINDING	23	7.49e-04	8.44e-03	0.50300	3.25e-01	3.83e-01	6.97e-03	1.46e-03
GOBP NEGATIVE REGULATION OF MYOFIBROBLAST DIFFERENTIATION	6	1.53e-01	3.69e-01	0.50200	3.81e-01	3.27e-01	1.06e-01	1.65e-01
GOCC DEATH INDUCING SIGNALING COMPLEX	9	5.28e-02	1.95e-01	0.50200	4.46e-01	2.31e-01	2.06e-02	2.30e-01
CYP2E1 reactions	10	3.44e-02	1.45e-01	0.50200	-4.65e-01	-1.88e-01	1.08e-02	3.04e-01
GOMF 3 5 RNA HELICASE ACTIVITY	6	5.76e-02	2.05e-01	0.50200	4.10e-01	-2.89e-01	8.16e-02	2.21e-01
GOMF NEUROTROPHIN TRK RECEPTOR BINDING	6	1.32e-01	3.41e-01	0.50200	4.66e-01	1.86e-01	4.82e-02	4.29e-01
GOBP POSITIVE REGULATION OF ANTIMICROBIAL HUMORAL RESPONSE	8	8.31e-02	2.59e-01	0.50100	-3.30e-01	-3.77e-01	1.06e-01	6.49e-02
GOCC ZONA PELLUCIDA RECEPTOR COMPLEX	8	6.33e-02	2.17e-01	0.50100	4.77e-01	1.53e-01	1.95e-02	4.54e-01
GOMF LIPOPEPTIDE BINDING	10	1.67e-02	8.73e-02	0.50100	-4.98e-01	4.65e-02	6.34e-03	7.99e-01
GOCC ISWI TYPE COMPLEX	11	2.78e-02	1.25e-01	0.50000	4.47e-01	2.26e-01	1.03e-02	1.95e-01
GOMF RETINYL PALMITATE ESTERASE ACTIVITY	6	1.52e-01	3.67e-01	0.50000	-2.87e-01	-4.10e-01	2.23e-01	8.22e-02
GOBP POSITIVE REGULATION OF FERTILIZATION	5	1.94e-01	4.23e-01	0.50000	-2.14e-01	-4.52e-01	4.08e-01	7.99e-02
GOBP REGULATION BY VIRUS OF VIRAL PROTEIN LEVELS IN HOST CELL	7	1.01e-01	2.92e-01	0.50000	2.14e-01	4.52e-01	3.26e-01	3.85e-02
GOBP INTERLEUKIN 18 PRODUCTION	14	4.46e-03	3.24e-02	0.50000	-5.00e-01	-1.78e-02	1.21e-03	9.08e-01
GOBP UDP GLUCOSE METABOLIC PROCESS	6	9.65e-02	2.84e-01	0.50000	5.00e-01	9.02e-03	3.40e-02	9.69e-01
Protein lipoylation	10	1.96e-02	9.81e-02	0.50000	5.00e-01	-2.77e-03	6.21e-03	9.88e-01
GOMF AMINE TRANSMEMBRANE TRANSPORTER ACTIVITY	6	1.21e-01	3.24e-01	0.50000	-4.84e-01	-1.23e-01	4.00e-02	6.02e-01
GOMF DIHYDROPYRIMIDINASE ACTIVITY	6	1.57e-01	3.74e-01	0.49900	-3.27e-01	-3.77e-01	1.65e-01	1.09e-01
Eicosanoid ligand-binding receptors	14	1.08e-02	6.33e-02	0.49900	2.28e-01	4.44e-01	1.40e-01	3.99e-03
GOCC EARP COMPLEX	5	1.16e-01	3.16e-01	0.49900	4.85e-01	-1.18e-01	6.03e-02	6.47e-01
Defective CSF2RA causes SMDP4	7	5.11e-02	1.91e-01	0.49900	-4.89e-01	1.01e-01	2.51e-02	6.44e-01
Defective CSF2RB causes SMDP5	7	5.11e-02	1.91e-01	0.49900	-4.89e-01	1.01e-01	2.51e-02	6.44e-01
GOBP PROTOPORPHYRINOGEN IX BIOSYNTHETIC PROCESS	8	7.74e-02	2.47e-01	0.49900	2.45e-01	4.35e-01	2.30e-01	3.32e-02
GOCC LIPOPOLYSACCHARIDE RECEPTOR COMPLEX	5	1.10e-01	3.06e-01	0.49900	-1.59e-01	4.73e-01	5.39e-01	6.69e-02
GOMF FERRIC IRON BINDING	9	3.21e-02	1.38e-01	0.49900	-4.98e-01	-2.76e-02	9.63e-03	8.86e-01
GOMF HISTONE H2A DEUBIQUITINASE ACTIVITY	5	1.25e-01	3.30e-01	0.49900	4.94e-01	-7.24e-02	5.59e-02	7.79e-01
GOMF CAMP RESPONSE ELEMENT BINDING PROTEIN BINDING	8	5.51e-02	2.00e-01	0.49900	4.91e-01	8.78e-02	1.61e-02	6.67e-01
GOBP POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION	6	1.42e-01	3.55e-01	0.49900	2.17e-01	4.49e-01	3.58e-01	5.66e-02
GOBP INTESTINAL LIPID ABSORPTION	22	1.35e-04	1.98e-03	0.49900	4.26e-02	-4.97e-01	7.30e-01	5.43e-05
GOBP REGULATION OF ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE	9	6.32e-02	2.17e-01	0.49800	3.58e-01	3.46e-01	6.27e-02	7.19e-02
GOMF MITOCHONDRIAL RIBOSOME BINDING	9	6.34e-02	2.18e-01	0.49800	3.58e-01	3.46e-01	6.30e-02	7.19e-02
GOMF G PROTEIN COUPLED RECEPTOR ACTIVITY	743	2.95e-104	4.03e-101	0.49800	-4.56e-01	-1.99e-01	1.56e-100	2.24e-20
GOBP NEGATIVE REGULATION OF AUTOPHAGOSOME MATURATION	5	2.16e-01	4.48e-01	0.49800	3.27e-01	3.75e-01	2.05e-01	1.47e-01
GOBP MITOCHONDRIAL TRANSLATIONAL ELONGATION	5	1.41e-01	3.54e-01	0.49800	4.98e-01	-5.92e-03	5.40e-02	9.82e-01
GOCC CBM COMPLEX	5	9.43e-02	2.80e-01	0.49700	-3.53e-01	3.51e-01	1.72e-01	1.74e-01
GOBP NEGATIVE REGULATION OF INTERLEUKIN 1 ALPHA PRODUCTION	5	1.29e-01	3.36e-01	0.49700	6.49e-02	-4.93e-01	8.01e-01	5.62e-02
GOBP REGULATION OF CALCIDIOL 1 MONOOXYGENASE ACTIVITY	7	5.49e-02	1.99e-01	0.49700	-4.91e-01	7.86e-02	2.45e-02	7.19e-01
GOBP MEIOTIC SISTER CHROMATID COHESION	13	5.27e-03	3.68e-02	0.49700	4.95e-01	-4.51e-02	1.99e-03	7.78e-01
GOBP EMBRYONIC PROCESS INVOLVED IN FEMALE PREGNANCY	6	1.53e-01	3.69e-01	0.49700	2.69e-01	4.18e-01	2.53e-01	7.62e-02
GOMF CALCIUM DEPENDENT PHOSPHOLIPASE A2 ACTIVITY	17	2.20e-03	1.90e-02	0.49700	-8.65e-02	-4.90e-01	5.37e-01	4.73e-04
GOBP REGULATION OF LEUKOCYTE ADHESION TO ARTERIAL ENDOTHELIAL CELL	5	2.18e-01	4.51e-01	0.49700	-3.42e-01	-3.61e-01	1.86e-01	1.63e-01
GOMF 7S RNA BINDING	7	8.94e-02	2.71e-01	0.49700	4.79e-01	1.33e-01	2.83e-02	5.42e-01
Antimicrobial peptides	74	4.55e-11	3.09e-09	0.49700	-4.47e-01	-2.17e-01	2.98e-11	1.23e-03
RHOBTB1 GTPase cycle	22	8.99e-04	9.65e-03	0.49700	4.39e-01	2.33e-01	3.66e-04	5.89e-02
Scavenging by Class B Receptors	6	1.51e-01	3.66e-01	0.49600	-2.51e-01	-4.28e-01	2.87e-01	6.94e-02
Defective LFNG causes SCDO3	5	2.18e-01	4.52e-01	0.49600	-3.70e-01	-3.30e-01	1.52e-01	2.01e-01
GOMF RNA DNA HYBRID RIBONUCLEASE ACTIVITY	6	1.62e-01	3.81e-01	0.49600	3.53e-01	3.48e-01	1.35e-01	1.39e-01
Signaling by LTK	10	4.51e-02	1.75e-01	0.49600	4.13e-01	2.75e-01	2.39e-02	1.33e-01
SARS-CoV-1 targets host intracellular signalling and regulatory pathways	16	3.77e-03	2.86e-02	0.49500	4.82e-01	1.14e-01	8.38e-04	4.31e-01
Transport of organic anions	10	4.38e-02	1.72e-01	0.49500	-4.25e-01	-2.55e-01	2.00e-02	1.63e-01
GOCC PHOTORECEPTOR DISC MEMBRANE	19	6.84e-04	7.81e-03	0.49500	-6.00e-03	-4.95e-01	9.64e-01	1.85e-04
GOBP NEGATIVE REGULATION OF MEIOTIC CHROMOSOME SEPARATION	5	1.85e-01	4.11e-01	0.49500	4.72e-01	1.48e-01	6.74e-02	5.66e-01
GOCC GOLGI TRANS CISTERNA	9	3.26e-02	1.40e-01	0.49500	1.33e-02	4.95e-01	9.45e-01	1.02e-02
GOCC RSC TYPE COMPLEX	15	2.19e-03	1.89e-02	0.49400	4.89e-01	-7.36e-02	1.04e-03	6.22e-01
GOBP NEGATIVE REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE	5	1.98e-01	4.28e-01	0.49400	1.97e-01	4.53e-01	4.45e-01	7.93e-02
GOBP CATECHOL CONTAINING COMPOUND CATABOLIC PROCESS	6	7.02e-02	2.33e-01	0.49400	-4.55e-01	1.92e-01	5.33e-02	4.16e-01
GOMF INOSITOL 1 3 4 5 TETRAKISPHOSPHATE BINDING	5	9.80e-02	2.86e-01	0.49400	-3.78e-01	3.18e-01	1.43e-01	2.18e-01
GOMF PRE MRNA 5 SPLICE SITE BINDING	6	1.60e-01	3.79e-01	0.49400	3.99e-01	2.92e-01	9.07e-02	2.16e-01
GOBP RESPONSE TO PEPTIDOGLYCAN	13	3.59e-03	2.76e-02	0.49400	-4.68e-01	1.57e-01	3.46e-03	3.27e-01
GOBP NEGATIVE REGULATION OF LEUKOCYTE DEGRANULATION	11	6.18e-03	4.18e-02	0.49400	-3.01e-01	3.92e-01	8.40e-02	2.45e-02
Activation of Matrix Metalloproteinases	30	9.12e-05	1.44e-03	0.49300	-2.54e-01	-4.23e-01	1.60e-02	6.05e-05
GOBP C21 STEROID HORMONE BIOSYNTHETIC PROCESS	20	1.10e-03	1.13e-02	0.49300	-4.76e-01	-1.30e-01	2.29e-04	3.14e-01
GOCC BCL 2 FAMILY PROTEIN COMPLEX	10	3.68e-02	1.52e-01	0.49300	1.67e-01	4.64e-01	3.60e-01	1.10e-02
GOCC CCR4 NOT CORE COMPLEX	6	1.28e-01	3.35e-01	0.49300	4.78e-01	1.21e-01	4.27e-02	6.07e-01
GOBP PEPTIDYL SERINE AUTOPHOSPHORYLATION	8	5.96e-02	2.09e-01	0.49300	4.85e-01	8.99e-02	1.76e-02	6.60e-01
GOBP SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION	10	4.93e-02	1.86e-01	0.49300	3.75e-01	3.20e-01	4.01e-02	7.96e-02
GOBP POSITIVE REGULATION OF PODOSOME ASSEMBLY	10	2.43e-02	1.14e-01	0.49300	-4.92e-01	-3.05e-02	7.06e-03	8.67e-01
GOBP NEGATIVE REGULATION OF POST TRANSCRIPTIONAL GENE SILENCING	13	1.87e-02	9.48e-02	0.49300	4.10e-01	2.74e-01	1.05e-02	8.73e-02
PP2A-mediated dephosphorylation of key metabolic factors	6	1.22e-01	3.25e-01	0.49200	4.84e-01	9.16e-02	4.02e-02	6.98e-01
GOBP POSITIVE REGULATION OF LEUKOCYTE TETHERING OR ROLLING	13	8.88e-03	5.50e-02	0.49200	-4.89e-01	-5.21e-02	2.25e-03	7.45e-01
GOBP NEGATIVE REGULATION OF TYPE B PANCREATIC CELL APOPTOTIC PROCESS	6	1.36e-01	3.46e-01	0.49100	4.69e-01	1.47e-01	4.68e-02	5.33e-01
GOMF ADP D RIBOSE MODIFICATION DEPENDENT PROTEIN BINDING	6	1.22e-01	3.26e-01	0.49100	8.83e-02	4.83e-01	7.08e-01	4.05e-02
GOBP NEGATIVE REGULATION OF ADIPOSE TISSUE DEVELOPMENT	5	1.93e-01	4.21e-01	0.49100	1.58e-01	4.65e-01	5.41e-01	7.18e-02
GOBP IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION	10	2.35e-02	1.12e-01	0.49100	4.91e-01	1.04e-02	7.20e-03	9.54e-01
Signaling by MST1	5	1.09e-01	3.06e-01	0.49100	-4.40e-01	2.17e-01	8.84e-02	4.00e-01
GOBP ISOCITRATE METABOLIC PROCESS	5	2.14e-01	4.46e-01	0.49100	2.45e-01	4.25e-01	3.43e-01	9.96e-02
GOBP PEPTIDYL LYSINE HYDROXYLATION	8	4.33e-02	1.71e-01	0.49100	4.89e-01	-4.34e-02	1.67e-02	8.32e-01
GOBP NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY	9	6.89e-02	2.29e-01	0.49100	3.50e-01	3.44e-01	6.93e-02	7.38e-02
GOBP RESPONSE TO LUTEINIZING HORMONE	7	5.96e-02	2.10e-01	0.49000	4.84e-01	-7.73e-02	2.66e-02	7.23e-01
Gain-of-function MRAS complexes activate RAF signaling	7	5.89e-02	2.08e-01	0.49000	4.83e-01	-8.30e-02	2.69e-02	7.04e-01
SHOC2 M1731 mutant abolishes MRAS complex function	7	5.89e-02	2.08e-01	0.49000	4.83e-01	-8.30e-02	2.69e-02	7.04e-01
Signaling by MRAS-complex mutants	7	5.89e-02	2.08e-01	0.49000	4.83e-01	-8.30e-02	2.69e-02	7.04e-01
GOCC EMC COMPLEX	9	6.73e-02	2.26e-01	0.49000	3.93e-01	2.93e-01	4.14e-02	1.28e-01
GOMF RNA POLYMERASE II INTRONIC TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING	8	7.54e-02	2.43e-01	0.49000	4.58e-01	1.74e-01	2.50e-02	3.94e-01
Post-transcriptional silencing by small RNAs	7	7.73e-02	2.47e-01	0.49000	4.88e-01	3.31e-02	2.52e-02	8.80e-01
GOMF PROTEIN TYROSINE KINASE INHIBITOR ACTIVITY	7	6.15e-02	2.14e-01	0.49000	-6.72e-02	4.85e-01	7.58e-01	2.63e-02
GOBP POSITIVE REGULATION OF LYSOSOMAL PROTEIN CATABOLIC PROCESS	5	1.29e-01	3.37e-01	0.48900	4.78e-01	-1.05e-01	6.44e-02	6.84e-01
GOBP CARBON CATABOLITE REGULATION OF TRANSCRIPTION	7	1.10e-01	3.07e-01	0.48900	4.46e-01	2.00e-01	4.09e-02	3.60e-01
GOBP MITOTIC NUCLEAR MEMBRANE DISASSEMBLY	8	2.70e-02	1.23e-01	0.48800	-2.88e-01	3.95e-01	1.59e-01	5.32e-02
Endosomal/Vacuolar pathway	12	1.01e-02	6.03e-02	0.48800	-2.73e-02	4.87e-01	8.70e-01	3.48e-03
GOBP RESPONSE TO SODIUM ARSENITE	6	1.23e-01	3.27e-01	0.48700	7.32e-02	4.81e-01	7.56e-01	4.11e-02
GOBP MAST CELL CYTOKINE PRODUCTION	6	1.53e-01	3.69e-01	0.48700	2.02e-01	4.43e-01	3.92e-01	6.02e-02
GOCC TRAMP COMPLEX	5	2.16e-01	4.48e-01	0.48700	4.30e-01	2.27e-01	9.55e-02	3.79e-01
GOBP REGULATION OF LYMPHANGIOGENESIS	7	4.24e-02	1.69e-01	0.48700	-3.60e-01	3.27e-01	9.86e-02	1.34e-01
GOBP POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE	23	9.08e-04	9.72e-03	0.48600	-4.27e-01	-2.34e-01	3.98e-04	5.24e-02
Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)	12	2.51e-02	1.17e-01	0.48600	2.21e-01	4.33e-01	1.85e-01	9.39e-03
GOBP PROTECTION FROM NATURAL KILLER CELL MEDIATED CYTOTOXICITY	6	6.70e-02	2.26e-01	0.48600	-3.47e-01	3.40e-01	1.41e-01	1.49e-01
GOBP NEGATIVE REGULATION OF CGMP MEDIATED SIGNALING	6	1.69e-01	3.91e-01	0.48600	-2.79e-01	-3.98e-01	2.36e-01	9.17e-02
GOBP FAT PAD DEVELOPMENT	9	7.27e-02	2.38e-01	0.48600	3.42e-01	3.45e-01	7.59e-02	7.30e-02
GOBP IMMATURE B CELL DIFFERENTIATION	12	2.14e-02	1.05e-01	0.48500	4.58e-01	1.62e-01	6.05e-03	3.31e-01
GOBP REGULATION OF ESTABLISHMENT OF T CELL POLARITY	6	1.72e-01	3.94e-01	0.48500	2.96e-01	3.84e-01	2.09e-01	1.03e-01
MET Receptor Activation	6	1.01e-01	2.92e-01	0.48500	-4.84e-01	3.62e-02	4.01e-02	8.78e-01
GOBP DNA TEMPLATED TRANSCRIPTION TERMINATION	24	7.31e-04	8.30e-03	0.48500	4.19e-01	2.44e-01	3.75e-04	3.87e-02
Regulation of endogenous retroelements by KRAB-ZFP proteins	70	6.26e-10	3.46e-08	0.48500	4.27e-01	2.30e-01	6.62e-10	8.54e-04
GOBP GLOMERULAR ENDOTHELIUM DEVELOPMENT	5	1.26e-01	3.31e-01	0.48500	4.62e-01	-1.46e-01	7.34e-02	5.72e-01
GOBP NEGATIVE REGULATION OF TELOMERE CAPPING	8	5.82e-02	2.06e-01	0.48500	4.83e-01	4.20e-02	1.80e-02	8.37e-01
GOBP POSITIVE REGULATION OF CARDIAC MUSCLE ADAPTATION	9	2.42e-02	1.14e-01	0.48400	-1.43e-01	4.63e-01	4.58e-01	1.62e-02
GOMF SODIUM BICARBONATE SYMPORTER ACTIVITY	6	1.70e-01	3.92e-01	0.48400	-4.02e-01	-2.70e-01	8.79e-02	2.53e-01
GOBP POSITIVE REGULATION OF FEVER GENERATION	7	8.83e-02	2.69e-01	0.48400	-4.79e-01	-6.76e-02	2.80e-02	7.57e-01
GOBP REGULATION OF LONG TERM SYNAPTIC DEPRESSION	12	2.67e-02	1.22e-01	0.48400	-2.31e-01	-4.25e-01	1.66e-01	1.08e-02
GOBP ER OVERLOAD RESPONSE	11	4.15e-02	1.66e-01	0.48400	3.29e-01	3.55e-01	5.87e-02	4.16e-02
GOBP POSITIVE REGULATION OF BASEMENT MEMBRANE ASSEMBLY INVOLVED IN EMBRYONIC BODY MORPHOGENESIS	5	1.45e-01	3.58e-01	0.48400	4.81e-01	-5.52e-02	6.27e-02	8.31e-01
GOBP NOREPINEPHRINE SECRETION	14	2.66e-03	2.20e-02	0.48400	-1.86e-01	4.47e-01	2.29e-01	3.80e-03
GOBP TRANSCRIPTION DEPENDENT TETHERING OF RNA POLYMERASE II GENE DNA AT NUCLEAR PERIPHERY	7	1.23e-01	3.27e-01	0.48400	4.17e-01	2.46e-01	5.62e-02	2.61e-01
Organic cation/anion/zwitterion transport	15	1.31e-02	7.31e-02	0.48400	-3.31e-01	-3.52e-01	2.62e-02	1.82e-02
GOMF INOSITOL 1 4 5 TRISPHOSPHATE 5 PHOSPHATASE ACTIVITY	6	8.26e-02	2.58e-01	0.48400	4.58e-01	-1.56e-01	5.22e-02	5.07e-01
GOCC SMC5 SMC6 COMPLEX	9	7.46e-02	2.41e-01	0.48300	3.54e-01	3.29e-01	6.61e-02	8.74e-02
GOBP PHAGOSOME ACIDIFICATION	7	9.48e-02	2.81e-01	0.48300	-4.74e-01	-9.43e-02	3.00e-02	6.66e-01
GOBP NUCLEAR PORE ORGANIZATION	15	3.24e-03	2.55e-02	0.48300	4.80e-01	-4.97e-02	1.28e-03	7.39e-01
GOBP INTERLEUKIN 10 MEDIATED SIGNALING PATHWAY	12	1.66e-02	8.72e-02	0.48300	-4.76e-01	-7.64e-02	4.26e-03	6.47e-01
Synthesis of wybutosine at G37 of tRNA(Phe)	6	1.31e-01	3.39e-01	0.48200	4.75e-01	8.30e-02	4.38e-02	7.25e-01
GOBP NUCLEOLAR CHROMATIN ORGANIZATION	9	3.00e-02	1.32e-01	0.48200	4.77e-01	-7.41e-02	1.33e-02	7.00e-01
GOCC GAMMA SECRETASE COMPLEX	7	1.34e-01	3.43e-01	0.48200	3.26e-01	3.55e-01	1.35e-01	1.03e-01
GOBP CELLULAR RESPONSE TO PEPTIDOGLYCAN	6	1.76e-01	3.99e-01	0.48200	-2.95e-01	-3.82e-01	2.11e-01	1.06e-01
GOBP REGULATION OF CELL FATE SPECIFICATION	23	1.32e-03	1.29e-02	0.48200	3.10e-01	3.70e-01	1.02e-02	2.14e-03
GOBP REGULATION OF MESODERMAL CELL FATE SPECIFICATION	6	1.18e-01	3.19e-01	0.48200	2.81e-02	4.81e-01	9.05e-01	4.12e-02
GOMF SALT TRANSMEMBRANE TRANSPORTER ACTIVITY	9	6.03e-02	2.11e-01	0.48200	-1.75e-01	-4.49e-01	3.63e-01	1.97e-02
Activation of caspases through apoptosome-mediated cleavage	5	2.37e-01	4.74e-01	0.48200	3.66e-01	3.14e-01	1.57e-01	2.24e-01
GOMF KERATIN FILAMENT BINDING	6	1.79e-01	4.04e-01	0.48200	-3.49e-01	-3.32e-01	1.39e-01	1.59e-01
GOCC DNA DEPENDENT PROTEIN KINASE COMPLEX	5	1.92e-01	4.21e-01	0.48200	4.69e-01	1.10e-01	6.95e-02	6.69e-01
GOBP CORTISOL BIOSYNTHETIC PROCESS	10	2.88e-02	1.28e-01	0.48100	-4.80e-01	-2.79e-02	8.54e-03	8.79e-01
GOCC NUCLEOLAR RIBONUCLEASE P COMPLEX	7	1.30e-01	3.37e-01	0.48100	2.68e-01	4.00e-01	2.20e-01	6.71e-02
GOBP MYOBLAST FATE COMMITMENT	6	1.66e-01	3.88e-01	0.48100	4.25e-01	2.24e-01	7.11e-02	3.41e-01
GOBP AV NODE CELL TO BUNDLE OF HIS CELL SIGNALING	11	3.74e-02	1.54e-01	0.48100	-4.24e-01	-2.26e-01	1.48e-02	1.94e-01
GOMF UBIQUINONE BINDING	5	2.29e-01	4.64e-01	0.48100	4.12e-01	2.48e-01	1.11e-01	3.37e-01
GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR	7	9.86e-02	2.88e-01	0.48100	1.02e-01	4.70e-01	6.41e-01	3.13e-02
GOMF CARBONYL REDUCTASE NADPH ACTIVITY	9	3.20e-02	1.38e-01	0.48100	-6.05e-02	4.77e-01	7.53e-01	1.32e-02
GOCC CYTOPLASMIC EXOSOME RNASE COMPLEX	16	4.76e-03	3.41e-02	0.48100	4.72e-01	9.00e-02	1.08e-03	5.33e-01
GOBP DENTINOGENESIS	6	9.46e-02	2.80e-01	0.48000	9.60e-02	-4.71e-01	6.84e-01	4.59e-02
GOCC CENTRAL ELEMENT	7	4.65e-02	1.79e-01	0.48000	3.75e-01	-3.01e-01	8.61e-02	1.69e-01
GOCC NEUROFIBRILLARY TANGLE	5	1.74e-01	3.97e-01	0.48000	4.79e-01	3.99e-02	6.38e-02	8.77e-01
GOBP POSITIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY	7	5.58e-02	2.01e-01	0.48000	-1.66e-01	4.50e-01	4.48e-01	3.91e-02
GOBP NEGATIVE REGULATION OF IMMATURE T CELL PROLIFERATION	5	2.06e-01	4.37e-01	0.48000	1.49e-01	4.56e-01	5.65e-01	7.72e-02
GOBP FEMALE MEIOSIS CHROMOSOME SEGREGATION	6	7.33e-02	2.39e-01	0.48000	2.82e-01	-3.88e-01	2.31e-01	9.97e-02
GOMF PROTEIN CARRIER CHAPERONE	34	5.32e-05	9.14e-04	0.48000	3.96e-01	2.70e-01	6.32e-05	6.35e-03
RUNX1 regulates transcription of genes involved in differentiation of keratinocytes	8	4.24e-02	1.69e-01	0.48000	-1.06e-01	4.68e-01	6.04e-01	2.19e-02
Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells	15	4.59e-03	3.32e-02	0.48000	4.80e-01	8.35e-03	1.30e-03	9.55e-01
GOBP REGULATION OF PROTEIN FOLDING	9	7.38e-02	2.40e-01	0.47900	2.67e-01	3.98e-01	1.66e-01	3.86e-02
GOBP REGULATION OF SNRNA TRANSCRIPTION BY RNA POLYMERASE II	5	2.39e-01	4.77e-01	0.47900	3.81e-01	2.91e-01	1.41e-01	2.60e-01
GOMF HISTONE H3 ACETYLTRANSFERASE ACTIVITY	15	7.21e-03	4.68e-02	0.47900	4.68e-01	9.96e-02	1.69e-03	5.04e-01
Opsins	7	1.31e-01	3.39e-01	0.47900	-2.56e-01	-4.04e-01	2.40e-01	6.40e-02
GOBP REGULATION OF NUCLEOTIDE EXCISION REPAIR	28	2.04e-04	2.82e-03	0.47900	4.39e-01	1.90e-01	5.78e-05	8.11e-02
GOBP REGULATION OF MACROPHAGE PROLIFERATION	7	4.82e-02	1.83e-01	0.47800	2.82e-01	-3.86e-01	1.96e-01	7.67e-02
GOBP INTERNAL PROTEIN AMINO ACID ACETYLATION	10	2.18e-02	1.06e-01	0.47800	4.73e-01	-7.20e-02	9.60e-03	6.94e-01
GOMF PHOSPHATIDYLINOSITOL PHOSPHATE 4 PHOSPHATASE ACTIVITY	8	1.03e-01	2.95e-01	0.47800	3.76e-01	2.96e-01	6.56e-02	1.48e-01
GOBP MEIOTIC SPINDLE ORGANIZATION	18	5.33e-03	3.71e-02	0.47800	4.09e-01	2.48e-01	2.69e-03	6.82e-02
GOBP CYTOCHROME METABOLIC PROCESS	5	1.62e-01	3.82e-01	0.47800	-4.77e-01	1.69e-02	6.45e-02	9.48e-01
GOBP MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA	16	1.10e-02	6.43e-02	0.47800	3.52e-01	3.23e-01	1.49e-02	2.51e-02
GOBP NEGATIVE REGULATION OF RECEPTOR RECYCLING	5	1.16e-01	3.16e-01	0.47800	2.78e-01	-3.88e-01	2.82e-01	1.33e-01
GOBP PYRIMIDINE DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS	6	8.09e-02	2.54e-01	0.47700	-2.11e-01	4.28e-01	3.70e-01	6.93e-02
GOMF GLYCOLIPID MANNOSYLTRANSFERASE ACTIVITY	5	2.37e-01	4.74e-01	0.47700	2.58e-01	4.01e-01	3.17e-01	1.20e-01
GOMF TESTOSTERONE DEHYDROGENASE NADPLUS ACTIVITY	7	1.06e-01	3.01e-01	0.47700	-4.62e-01	-1.18e-01	3.44e-02	5.88e-01
GOBP PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS	8	4.93e-02	1.86e-01	0.47700	-4.73e-01	6.06e-02	2.06e-02	7.67e-01
Cardiogenesis	26	6.60e-04	7.59e-03	0.47600	3.68e-01	3.03e-01	1.18e-03	7.45e-03
GOCC NUCLEAR PORE CENTRAL TRANSPORT CHANNEL	5	2.21e-01	4.55e-01	0.47600	4.39e-01	1.86e-01	8.94e-02	4.71e-01
GOCC CD95 DEATH INDUCING SIGNALING COMPLEX	6	1.79e-01	4.04e-01	0.47600	3.99e-01	2.60e-01	9.06e-02	2.69e-01
GOBP POSITIVE REGULATION OF AMYLOID FIBRIL FORMATION	5	2.27e-01	4.62e-01	0.47600	4.28e-01	2.09e-01	9.76e-02	4.18e-01
GOBP REGULATION OF PHOSPHOLIPID TRANSLOCATION	6	1.71e-01	3.93e-01	0.47600	-4.24e-01	-2.18e-01	7.24e-02	3.56e-01
GOMF EUKARYOTIC INITIATION FACTOR 4E BINDING	9	7.08e-02	2.34e-01	0.47600	4.23e-01	2.18e-01	2.78e-02	2.58e-01
GOBP POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS	5	2.16e-01	4.48e-01	0.47600	4.46e-01	1.67e-01	8.41e-02	5.19e-01
GOBP WYBUTOSINE METABOLIC PROCESS	6	9.17e-02	2.75e-01	0.47600	4.56e-01	-1.38e-01	5.33e-02	5.59e-01
GOBP POSITIVE REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY	8	6.99e-02	2.32e-01	0.47600	4.70e-01	7.34e-02	2.13e-02	7.19e-01
GOBP LIPOXIN METABOLIC PROCESS	5	1.22e-01	3.26e-01	0.47600	4.16e-01	-2.31e-01	1.07e-01	3.71e-01
GOMF INTERFERON RECEPTOR ACTIVITY	5	2.18e-01	4.52e-01	0.47500	4.44e-01	1.71e-01	8.57e-02	5.08e-01
GOMF HYDROPEROXY ICOSATETRAENOATE DEHYDRATASE ACTIVITY	7	4.97e-02	1.87e-01	0.47500	3.76e-01	-2.90e-01	8.46e-02	1.83e-01
RHO GTPases Activate ROCKs	19	3.65e-03	2.79e-02	0.47500	4.28e-01	2.06e-01	1.23e-03	1.19e-01
GOCC LAMININ COMPLEX	9	5.57e-02	2.01e-01	0.47500	-1.09e-01	-4.62e-01	5.71e-01	1.63e-02
Biosynthesis of maresins	8	9.13e-02	2.74e-01	0.47500	-1.89e-01	-4.36e-01	3.54e-01	3.28e-02
GOCC ENDOLYSOSOME LUMEN	5	1.64e-01	3.84e-01	0.47500	4.74e-01	-2.38e-02	6.62e-02	9.27e-01
GOBP LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE	19	3.94e-03	2.95e-02	0.47500	-4.20e-01	-2.22e-01	1.54e-03	9.33e-02
GOBP INTERCELLULAR TRANSPORT	10	5.08e-02	1.90e-01	0.47500	-4.34e-01	-1.92e-01	1.74e-02	2.94e-01
GOBP TRNA DECAY	16	6.82e-03	4.49e-02	0.47500	4.54e-01	1.38e-01	1.66e-03	3.40e-01
GOMF TRANSLATION TERMINATION FACTOR ACTIVITY	6	1.82e-01	4.08e-01	0.47500	3.94e-01	2.64e-01	9.46e-02	2.62e-01
N-glycan trimming and elongation in the cis-Golgi	5	1.24e-01	3.28e-01	0.47400	-2.26e-01	4.17e-01	3.81e-01	1.06e-01
Specification of the neural plate border	16	1.04e-02	6.15e-02	0.47400	2.49e-01	4.03e-01	8.45e-02	5.22e-03
GOBP SKELETAL MUSCLE SATELLITE CELL ACTIVATION	9	8.23e-02	2.57e-01	0.47400	-3.37e-01	-3.33e-01	7.99e-02	8.35e-02
GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 3 COMPLEX EIF3M	7	1.38e-01	3.49e-01	0.47300	3.99e-01	2.55e-01	6.78e-02	2.43e-01
GOMF PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE PHOSPHATASE ACTIVITY	11	2.18e-02	1.06e-01	0.47300	4.73e-01	1.15e-02	6.61e-03	9.47e-01
GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT POSTSYNAPTIC ENDOSOME TO LYSOSOME	7	1.45e-01	3.57e-01	0.47300	-3.25e-01	-3.44e-01	1.36e-01	1.15e-01
GOBP PROTEIN FOLDING IN ENDOPLASMIC RETICULUM	12	2.12e-02	1.04e-01	0.47300	9.78e-02	4.63e-01	5.58e-01	5.51e-03
GOMF HISTONE DEACETYLASE REGULATOR ACTIVITY	6	1.41e-01	3.54e-01	0.47300	7.97e-02	4.66e-01	7.35e-01	4.80e-02
Proton-coupled monocarboxylate transport	6	1.30e-01	3.38e-01	0.47300	-4.71e-01	-3.51e-02	4.55e-02	8.82e-01
GOBP MESENCHYMAL CELL DEVELOPMENT	6	9.20e-02	2.75e-01	0.47300	-1.55e-01	4.47e-01	5.12e-01	5.81e-02
GOMF BMP RECEPTOR ACTIVITY	8	4.65e-02	1.79e-01	0.47300	4.61e-01	-1.04e-01	2.39e-02	6.10e-01
GOBP RETINAL BLOOD VESSEL MORPHOGENESIS	5	1.19e-01	3.21e-01	0.47200	3.11e-01	-3.56e-01	2.28e-01	1.68e-01
GOBP CELLULAR DETOXIFICATION OF ALDEHYDE	9	5.20e-02	1.93e-01	0.47200	4.67e-01	6.99e-02	1.52e-02	7.17e-01
GOCC LSM1 7 PAT1 COMPLEX	5	1.98e-01	4.28e-01	0.47200	4.64e-01	8.56e-02	7.22e-02	7.40e-01
GOMF HISTONE H3K36 TRIMETHYLTRANSFERASE ACTIVITY	5	1.27e-01	3.32e-01	0.47200	4.13e-01	-2.28e-01	1.09e-01	3.78e-01
GOMF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE INHIBITOR ACTIVITY	12	3.67e-02	1.52e-01	0.47200	3.15e-01	3.52e-01	5.90e-02	3.49e-02
GOMF COLLAGEN BINDING INVOLVED IN CELL MATRIX ADHESION	5	1.20e-01	3.22e-01	0.47200	3.11e-01	-3.55e-01	2.28e-01	1.69e-01
GOMF INTERLEUKIN 12 RECEPTOR BINDING	5	1.23e-01	3.26e-01	0.47200	-3.88e-01	2.68e-01	1.33e-01	2.99e-01
GOBP GLUCOCORTICOID BIOSYNTHETIC PROCESS	16	3.79e-03	2.87e-02	0.47200	-4.72e-01	-2.80e-03	1.09e-03	9.85e-01
GOBP POSITIVE REGULATION OF I KAPPAB PHOSPHORYLATION	6	1.21e-01	3.24e-01	0.47100	7.85e-03	-4.71e-01	9.73e-01	4.55e-02
GOCC SWR1 COMPLEX	13	2.21e-02	1.07e-01	0.47100	4.30e-01	1.93e-01	7.24e-03	2.29e-01
GOMF FATTY ACYL COA SYNTHASE ACTIVITY	7	1.39e-01	3.51e-01	0.47100	-3.99e-01	-2.51e-01	6.74e-02	2.51e-01
GOBP INHIBITION OF NEUROEPITHELIAL CELL DIFFERENTIATION	6	1.21e-01	3.24e-01	0.47100	-1.08e-02	4.71e-01	9.63e-01	4.58e-02
GOMF RNA POLYMERASE I TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING	9	3.13e-02	1.36e-01	0.47000	4.54e-01	-1.21e-01	1.82e-02	5.29e-01
TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain	19	4.51e-03	3.27e-02	0.47000	2.27e-01	4.12e-01	8.62e-02	1.90e-03
GOMF METAL ION SEQUESTERING ACTIVITY	5	2.03e-01	4.34e-01	0.47000	-4.61e-01	-9.32e-02	7.43e-02	7.18e-01
GOBP POSITIVE REGULATION OF HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE	7	9.12e-02	2.74e-01	0.47000	-1.59e-02	-4.70e-01	9.42e-01	3.14e-02
GOBP METANEPHRIC GLOMERULUS VASCULATURE DEVELOPMENT	9	7.62e-02	2.45e-01	0.47000	2.16e-01	4.17e-01	2.63e-01	3.02e-02
GOBP SERINE TRANSPORT	9	5.80e-02	2.06e-01	0.46900	4.59e-01	9.67e-02	1.70e-02	6.15e-01
GOBP POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION	44	7.17e-07	2.19e-05	0.46900	4.63e-01	7.72e-02	1.08e-07	3.76e-01
GOMF OXIDATIVE RNA DEMETHYLASE ACTIVITY	5	1.43e-01	3.56e-01	0.46900	4.47e-01	-1.43e-01	8.36e-02	5.81e-01
GOBP POSITIVE REGULATION OF CHONDROCYTE PROLIFERATION	8	1.01e-01	2.93e-01	0.46900	2.11e-01	4.19e-01	3.01e-01	4.03e-02
Alpha-defensins	6	8.71e-02	2.67e-01	0.46900	-4.14e-01	2.21e-01	7.94e-02	3.49e-01
GOBP POSITIVE REGULATION OF NEUROEPITHELIAL CELL DIFFERENTIATION	8	1.08e-01	3.04e-01	0.46900	2.50e-01	3.96e-01	2.21e-01	5.22e-02
GOBP NEGATIVE REGULATION OF NOREPINEPHRINE SECRETION	6	9.69e-02	2.84e-01	0.46900	-1.47e-01	4.45e-01	5.34e-01	5.90e-02
GOCC HEMIDESMOSOME	8	1.14e-01	3.14e-01	0.46900	-3.25e-01	-3.37e-01	1.11e-01	9.86e-02
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL CORTEX	6	1.61e-01	3.80e-01	0.46800	4.49e-01	1.33e-01	5.68e-02	5.72e-01
GOBP POSITIVE REGULATION OF PSEUDOPODIUM ASSEMBLY	12	3.41e-02	1.45e-01	0.46800	2.31e-01	4.08e-01	1.67e-01	1.45e-02
GOMF RNA POLYMERASE II CTD HEPTAPEPTIDE REPEAT KINASE ACTIVITY	10	5.58e-02	2.01e-01	0.46800	4.25e-01	1.96e-01	1.98e-02	2.83e-01
GOBP NEGATIVE REGULATION OF B CELL DIFFERENTIATION	6	1.81e-01	4.06e-01	0.46800	2.13e-01	4.17e-01	3.66e-01	7.69e-02
GOBP REGULATION OF MRNA EXPORT FROM NUCLEUS	9	6.85e-02	2.28e-01	0.46800	4.41e-01	1.57e-01	2.19e-02	4.15e-01
GOBP CELLULAR RESPONSE TO ALDOSTERONE	7	1.43e-01	3.56e-01	0.46800	-3.98e-01	-2.46e-01	6.81e-02	2.60e-01
GOBP ATRIOVENTRICULAR CANAL DEVELOPMENT	13	2.94e-02	1.30e-01	0.46800	3.58e-01	3.01e-01	2.55e-02	5.99e-02
GOMF RNA POLYMERASE II CTD HEPTAPEPTIDE REPEAT MODIFYING ACTIVITY	17	7.28e-03	4.71e-02	0.46800	4.28e-01	1.88e-01	2.23e-03	1.79e-01
GOBP SUBTELOMERIC HETEROCHROMATIN FORMATION	8	9.83e-02	2.87e-01	0.46800	1.87e-01	4.29e-01	3.60e-01	3.57e-02
GOCC CARDIAC MYOFIBRIL	6	1.21e-01	3.24e-01	0.46800	2.68e-02	-4.67e-01	9.10e-01	4.76e-02
GOMF PYRUVATE TRANSMEMBRANE TRANSPORTER ACTIVITY	5	1.47e-01	3.60e-01	0.46800	-4.48e-01	1.32e-01	8.24e-02	6.08e-01
GOBP ANTIMICROBIAL PEPTIDE PRODUCTION	12	2.42e-02	1.14e-01	0.46700	-1.09e-01	-4.55e-01	5.15e-01	6.38e-03
GOCC SMN COMPLEX	9	6.34e-02	2.17e-01	0.46700	4.52e-01	1.19e-01	1.90e-02	5.37e-01
GOMF RNA POLYMERASE II CTD HEPTAPEPTIDE REPEAT PHOSPHATASE ACTIVITY	7	1.30e-01	3.38e-01	0.46700	4.32e-01	1.77e-01	4.78e-02	4.17e-01
Maturation of hRSV A proteins	13	3.02e-02	1.32e-01	0.46700	3.23e-01	3.37e-01	4.37e-02	3.54e-02
GOBP CUT METABOLIC PROCESS	5	1.98e-01	4.28e-01	0.46700	4.63e-01	5.94e-02	7.30e-02	8.18e-01
GOMF PORIN ACTIVITY	6	1.97e-01	4.27e-01	0.46600	3.64e-01	2.92e-01	1.23e-01	2.16e-01
CLEC7A/inflammasome pathway	6	1.26e-01	3.31e-01	0.46600	-1.12e-02	4.66e-01	9.62e-01	4.79e-02
GOBP MICROGLIAL CELL PROLIFERATION	8	4.48e-02	1.75e-01	0.46600	4.39e-01	-1.57e-01	3.15e-02	4.42e-01
GOBP REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY	10	4.25e-02	1.69e-01	0.46600	4.59e-01	8.22e-02	1.20e-02	6.53e-01
GOBP MICROGLIAL CELL MEDIATED CYTOTOXICITY	5	1.62e-01	3.82e-01	0.46500	-7.48e-02	4.59e-01	7.72e-01	7.52e-02
GOBP DEFINITIVE HEMOPOIESIS	19	4.44e-03	3.24e-02	0.46500	1.94e-01	4.23e-01	1.43e-01	1.41e-03
GOCC SPLICEOSOMAL TRI SNRNP COMPLEX	40	7.46e-06	1.69e-04	0.46500	4.40e-01	1.52e-01	1.46e-06	9.72e-02
TGFBR3 expression	28	3.40e-04	4.34e-03	0.46500	4.24e-01	1.92e-01	1.03e-04	7.88e-02
GOBP SPLEEN DEVELOPMENT	38	3.91e-05	7.10e-04	0.46500	3.34e-01	3.24e-01	3.62e-04	5.56e-04
GOBP POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE	26	4.24e-05	7.56e-04	0.46400	-4.33e-01	1.67e-01	1.31e-04	1.41e-01
GOBP KERATINOCYTE APOPTOTIC PROCESS	8	1.13e-01	3.11e-01	0.46400	2.49e-01	3.92e-01	2.22e-01	5.51e-02
STAT5 Activation	7	1.46e-01	3.59e-01	0.46400	3.99e-01	2.37e-01	6.74e-02	2.78e-01
GOBP POSITIVE REGULATION OF MYOBLAST PROLIFERATION	14	1.80e-02	9.21e-02	0.46400	4.28e-01	1.78e-01	5.51e-03	2.48e-01
GOBP REGULATION OF GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT	9	8.88e-02	2.70e-01	0.46400	3.73e-01	2.76e-01	5.27e-02	1.52e-01
GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM CALCIUM ION CONCENTRATION	6	1.92e-01	4.21e-01	0.46400	3.99e-01	2.36e-01	9.04e-02	3.16e-01
GOCC GEMINI OF COILED BODIES	11	4.36e-02	1.72e-01	0.46400	4.25e-01	1.86e-01	1.47e-02	2.86e-01
GOCC CELL TIP	7	9.10e-02	2.74e-01	0.46400	4.63e-01	-1.52e-02	3.38e-02	9.44e-01
GOBP ESTABLISHMENT OF MITOTIC SISTER CHROMATID COHESION	5	1.72e-01	3.94e-01	0.46300	4.61e-01	-4.81e-02	7.42e-02	8.52e-01
GOBP NEGATIVE REGULATION OF PROTEIN K63 LINKED UBIQUITINATION	5	1.29e-01	3.37e-01	0.46300	-3.32e-01	3.23e-01	1.98e-01	2.12e-01
GOBP REGULATION OF MICROVILLUS LENGTH	7	1.54e-01	3.70e-01	0.46300	-2.85e-01	-3.65e-01	1.92e-01	9.42e-02
GOBP NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS	17	2.90e-03	2.34e-02	0.46300	4.62e-01	-2.26e-02	9.62e-04	8.72e-01
GOMF AP 2 ADAPTOR COMPLEX BINDING	10	2.89e-02	1.29e-01	0.46300	-5.69e-02	4.59e-01	7.55e-01	1.19e-02
GOMF HETEROTRIMERIC G PROTEIN BINDING	5	2.62e-01	5.01e-01	0.46300	-2.73e-01	-3.74e-01	2.91e-01	1.48e-01
GOMF HISTONE H4K16 ACETYLTRANSFERASE ACTIVITY	8	1.14e-01	3.14e-01	0.46300	3.91e-01	2.48e-01	5.58e-02	2.25e-01
Termination of O-glycan biosynthesis	25	9.64e-04	1.02e-02	0.46200	-4.12e-01	-2.09e-01	3.58e-04	7.01e-02
Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex	32	2.00e-04	2.77e-03	0.46200	3.67e-01	2.82e-01	3.32e-04	5.80e-03
GOMF ATP DEPENDENT PEPTIDASE ACTIVITY	7	1.38e-01	3.49e-01	0.46200	1.84e-01	4.24e-01	3.99e-01	5.20e-02
Gamma-carboxylation of protein precursors	8	9.82e-02	2.87e-01	0.46200	-1.56e-01	-4.35e-01	4.45e-01	3.31e-02
Eicosanoids	12	3.65e-02	1.52e-01	0.46200	-2.18e-01	-4.07e-01	1.90e-01	1.45e-02
GOBP DETERMINATION OF DORSAL VENTRAL ASYMMETRY	11	4.91e-02	1.85e-01	0.46200	4.02e-01	2.28e-01	2.09e-02	1.90e-01
GOBP POSITIVE REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS	6	1.54e-01	3.69e-01	0.46200	4.56e-01	7.64e-02	5.33e-02	7.46e-01
GOBP POSITIVE REGULATION BY HOST OF VIRAL GENOME REPLICATION	10	5.72e-02	2.04e-01	0.46200	1.70e-01	4.29e-01	3.51e-01	1.87e-02
GOBP REGULATION OF VERY LOW DENSITY LIPOPROTEIN PARTICLE REMODELING	6	1.37e-01	3.48e-01	0.46200	-1.33e-02	-4.62e-01	9.55e-01	5.02e-02
GOMF CELL MATRIX ADHESION MEDIATOR ACTIVITY	9	3.81e-02	1.56e-01	0.46200	4.52e-01	-9.24e-02	1.88e-02	6.31e-01
GOBP PROTOPORPHYRINOGEN IX METABOLIC PROCESS	10	7.14e-02	2.36e-01	0.46200	3.00e-01	3.51e-01	1.00e-01	5.49e-02
GOBP NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING	12	4.19e-02	1.68e-01	0.46200	3.57e-01	2.93e-01	3.23e-02	7.93e-02
Formation of intermediate mesoderm	8	4.20e-02	1.68e-01	0.46100	-2.31e-01	3.99e-01	2.58e-01	5.06e-02
GOBP CGMP CATABOLIC PROCESS	5	2.62e-01	5.01e-01	0.46100	-2.56e-01	-3.83e-01	3.21e-01	1.38e-01
GOMF UBIQUITIN LIGASE COMPLEX SCAFFOLD ACTIVITY	6	2.07e-01	4.38e-01	0.46100	3.35e-01	3.16e-01	1.55e-01	1.80e-01
GOCC RNA POLYMERASE II TRANSCRIPTION REPRESSOR COMPLEX	15	1.90e-02	9.60e-02	0.46100	3.60e-01	2.87e-01	1.56e-02	5.41e-02
MET activates PI3K/AKT signaling	6	1.69e-01	3.90e-01	0.46100	4.44e-01	1.24e-01	5.97e-02	5.99e-01
GOMF PRIMARY AMINE OXIDASE ACTIVITY	7	6.55e-02	2.23e-01	0.46100	4.15e-01	-2.00e-01	5.72e-02	3.60e-01
GOCC RAGULATOR COMPLEX	6	1.68e-01	3.90e-01	0.46100	4.45e-01	1.21e-01	5.93e-02	6.08e-01
GOBP AXIAL MESODERM DEVELOPMENT	8	8.48e-02	2.62e-01	0.46100	8.15e-02	4.53e-01	6.90e-01	2.64e-02
GOBP URATE TRANSPORT	11	4.21e-02	1.68e-01	0.46000	-1.55e-01	-4.34e-01	3.73e-01	1.28e-02
Formation of xylulose-5-phosphate	5	1.83e-01	4.09e-01	0.46000	-2.11e-02	4.60e-01	9.35e-01	7.50e-02
GOBP GLUCURONATE CATABOLIC PROCESS TO XYLULOSE 5 PHOSPHATE	5	1.83e-01	4.09e-01	0.46000	-2.11e-02	4.60e-01	9.35e-01	7.50e-02
E2F-enabled inhibition of pre-replication complex formation	9	8.83e-02	2.69e-01	0.46000	2.38e-01	3.94e-01	2.16e-01	4.07e-02
GOBP MESENCHYMAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT	6	1.01e-01	2.92e-01	0.46000	-1.70e-01	4.27e-01	4.70e-01	6.98e-02
GOBP PANCREATIC JUICE SECRETION	11	3.10e-02	1.35e-01	0.46000	4.57e-01	5.45e-02	8.70e-03	7.54e-01
GOMF CYCLIC NUCLEOTIDE ACTIVATED MONOATOMIC ION CHANNEL ACTIVITY	10	6.82e-02	2.28e-01	0.46000	-2.44e-01	-3.90e-01	1.82e-01	3.27e-02
Activated NTRK2 signals through FRS2 and FRS3	11	4.15e-02	1.66e-01	0.46000	4.36e-01	1.47e-01	1.23e-02	3.98e-01
GOBP XENOBIOTIC EXPORT FROM CELL	26	8.90e-04	9.61e-03	0.46000	-2.32e-01	-3.97e-01	4.10e-02	4.54e-04
GOBP NEGATIVE REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT	12	3.72e-02	1.54e-01	0.46000	4.09e-01	2.10e-01	1.42e-02	2.07e-01
GOMF U1 SNRNA BINDING	8	1.21e-01	3.24e-01	0.45900	2.70e-01	3.71e-01	1.86e-01	6.88e-02
GOCC EXTRINSIC COMPONENT OF MITOCHONDRIAL INNER MEMBRANE	6	1.25e-01	3.30e-01	0.45900	4.57e-01	-4.90e-02	5.27e-02	8.35e-01
GOBP POSITIVE REGULATION OF TRANSCRIPTION BY GLUCOSE	6	1.98e-01	4.28e-01	0.45900	3.97e-01	2.32e-01	9.26e-02	3.26e-01
BBSome-mediated cargo-targeting to cilium	23	1.30e-03	1.28e-02	0.45900	4.36e-01	1.44e-01	2.96e-04	2.30e-01
GOBP AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION	14	2.53e-02	1.17e-01	0.45900	-3.64e-01	-2.79e-01	1.83e-02	7.03e-02
GOMF INTRONIC TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING	11	4.59e-02	1.77e-01	0.45900	4.23e-01	1.77e-01	1.51e-02	3.08e-01
GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY	8	1.25e-01	3.29e-01	0.45900	3.04e-01	3.44e-01	1.37e-01	9.24e-02
GOMF DNA DNA TETHERING ACTIVITY	7	1.43e-01	3.56e-01	0.45900	4.19e-01	1.86e-01	5.49e-02	3.93e-01
GOMF N ACETYLGALACTOSAMINE 4 O SULFOTRANSFERASE ACTIVITY	5	1.52e-01	3.68e-01	0.45900	-4.30e-01	1.60e-01	9.61e-02	5.35e-01
GOMF CTPASE ACTIVITY	5	2.57e-01	4.95e-01	0.45800	4.04e-01	2.16e-01	1.17e-01	4.02e-01
GOBP POSITIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	6	1.52e-01	3.68e-01	0.45800	-4.55e-01	-5.44e-02	5.35e-02	8.18e-01
GOBP MEDIUM CHAIN FATTY ACYL COA METABOLIC PROCESS	6	9.30e-02	2.77e-01	0.45800	-2.60e-01	3.77e-01	2.69e-01	1.10e-01
GOBP REGULATION OF PROTEIN NEDDYLATION	19	4.73e-03	3.39e-02	0.45800	4.27e-01	1.67e-01	1.28e-03	2.07e-01
Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs)	60	1.30e-07	4.56e-06	0.45800	3.82e-01	2.52e-01	2.98e-07	7.33e-04
GOBP INTESTINAL HEXOSE ABSORPTION	5	2.48e-01	4.87e-01	0.45800	-1.80e-01	-4.21e-01	4.85e-01	1.03e-01
GOBP REGULATION OF REGULATORY NCRNA PROCESSING	16	1.59e-02	8.43e-02	0.45800	3.17e-01	3.30e-01	2.79e-02	2.23e-02
GOBP TRANSDIFFERENTIATION	7	1.49e-01	3.63e-01	0.45800	4.07e-01	2.10e-01	6.22e-02	3.37e-01
GOBP MINERALOCORTICOID SECRETION	7	6.87e-02	2.29e-01	0.45800	1.91e-01	-4.16e-01	3.82e-01	5.66e-02
GOBP ESTABLISHMENT OF GOLGI LOCALIZATION	8	9.06e-02	2.73e-01	0.45800	4.47e-01	9.65e-02	2.84e-02	6.36e-01
GOBP CHROMATIN LOOPING	15	2.05e-02	1.01e-01	0.45800	3.43e-01	3.03e-01	2.14e-02	4.21e-02
GOCC TRICARBOXYLIC ACID CYCLE HETEROMERIC ENZYME COMPLEX	17	5.97e-03	4.06e-02	0.45800	4.48e-01	9.27e-02	1.37e-03	5.08e-01
GOBP HEMOGLOBIN BIOSYNTHETIC PROCESS	13	3.44e-02	1.45e-01	0.45800	3.43e-01	3.03e-01	3.22e-02	5.86e-02
GOBP PROTEIN LOCALIZATION TO CENP A CONTAINING CHROMATIN	16	1.59e-02	8.42e-02	0.45800	3.39e-01	3.08e-01	1.90e-02	3.29e-02
GOCC ORIGIN RECOGNITION COMPLEX	8	1.20e-01	3.22e-01	0.45800	2.45e-01	3.87e-01	2.30e-01	5.83e-02
GOMF TFIID CLASS TRANSCRIPTION FACTOR COMPLEX BINDING	10	4.85e-02	1.84e-01	0.45800	4.49e-01	8.69e-02	1.39e-02	6.34e-01
RHO GTPases activate PAKs	19	3.12e-03	2.47e-02	0.45700	4.50e-01	8.22e-02	6.85e-04	5.35e-01
GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CHROMATIN	6	1.15e-01	3.15e-01	0.45700	-1.08e-01	4.44e-01	6.47e-01	5.96e-02
GOMF PHOSPHATIDYLINOSITOL 3 4 5 TRISPHOSPHATE 3 PHOSPHATASE ACTIVITY	5	2.00e-01	4.30e-01	0.45700	2.08e-02	4.57e-01	9.36e-01	7.71e-02
GOBP FORMATE METABOLIC PROCESS	6	1.96e-01	4.25e-01	0.45700	-2.05e-01	-4.08e-01	3.84e-01	8.33e-02
GOBP MINERALOCORTICOID METABOLIC PROCESS	14	1.19e-02	6.79e-02	0.45600	-4.55e-01	-3.47e-02	3.19e-03	8.22e-01
GOCC EGG COAT	5	2.51e-01	4.89e-01	0.45600	-1.79e-01	-4.20e-01	4.89e-01	1.04e-01
GOCC RIBONUCLEASE P COMPLEX	13	3.53e-02	1.48e-01	0.45600	3.37e-01	3.07e-01	3.53e-02	5.51e-02
HDL clearance	5	1.41e-01	3.53e-01	0.45600	-2.62e-01	3.73e-01	3.10e-01	1.49e-01
GOBP REGULATION OF ELECTRON TRANSFER ACTIVITY	5	2.67e-01	5.06e-01	0.45600	3.88e-01	2.39e-01	1.33e-01	3.54e-01
GOBP CELLULAR RESPONSE TO INDOLE 3 METHANOL	5	1.42e-01	3.56e-01	0.45600	2.49e-01	-3.81e-01	3.34e-01	1.40e-01
SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs	11	5.96e-02	2.10e-01	0.45500	3.31e-01	3.13e-01	5.73e-02	7.24e-02
GOCC MITOCHONDRIAL LARGE RIBOSOMAL SUBUNIT	56	5.63e-07	1.75e-05	0.45500	3.51e-01	2.90e-01	5.53e-06	1.72e-04
GOBP BUD ELONGATION INVOLVED IN LUNG BRANCHING	7	1.67e-01	3.88e-01	0.45500	3.30e-01	3.13e-01	1.30e-01	1.51e-01
GOMF GLYCOGEN BINDING	7	9.99e-02	2.90e-01	0.45500	-1.34e-02	4.55e-01	9.51e-01	3.73e-02
GOBP DETECTION OF MUSCLE STRETCH	7	8.32e-02	2.59e-01	0.45500	1.02e-01	-4.43e-01	6.40e-01	4.24e-02
GOBP POSITIVE REGULATION OF GENE EXPRESSION VIA CHROMOSOMAL CPG ISLAND DEMETHYLATION	14	2.72e-02	1.23e-01	0.45400	2.73e-01	3.63e-01	7.68e-02	1.87e-02
GOBP EXIT FROM MITOSIS	31	3.68e-04	4.63e-03	0.45400	3.42e-01	2.99e-01	9.79e-04	4.00e-03
Regulation of CDH19 Expression and Function	7	1.03e-01	2.94e-01	0.45400	5.29e-03	-4.54e-01	9.81e-01	3.76e-02
GOMF DOUBLE STRANDED METHYLATED DNA BINDING	5	2.75e-01	5.14e-01	0.45400	2.59e-01	3.73e-01	3.16e-01	1.49e-01
GOBP RIBOSOMAL LARGE SUBUNIT EXPORT FROM NUCLEUS	7	1.65e-01	3.86e-01	0.45400	2.66e-01	3.68e-01	2.24e-01	9.21e-02
GOBP GASTRIC MOTILITY	5	2.67e-01	5.06e-01	0.45400	2.21e-01	3.96e-01	3.92e-01	1.25e-01
Cohesin Loading onto Chromatin	8	4.64e-02	1.79e-01	0.45300	3.90e-01	-2.31e-01	5.60e-02	2.58e-01
GOCC COPI COATED VESICLE MEMBRANE	18	5.33e-03	3.71e-02	0.45300	4.40e-01	1.08e-01	1.22e-03	4.26e-01
GOBP POSITIVE REGULATION OF PHOSPHOLIPID TRANSLOCATION	5	2.72e-01	5.12e-01	0.45300	-3.84e-01	-2.41e-01	1.37e-01	3.51e-01
GOMF GLUTAMATE RECEPTOR ACTIVITY	25	1.71e-03	1.56e-02	0.45300	-3.53e-01	-2.84e-01	2.26e-03	1.39e-02
GOBP CELLULAR RESPONSE TO LEUCINE STARVATION	11	5.64e-02	2.02e-01	0.45300	3.88e-01	2.33e-01	2.57e-02	1.81e-01
GOMF PHOSPHATASE ACTIVATOR ACTIVITY	19	7.08e-03	4.61e-02	0.45300	3.86e-01	2.37e-01	3.61e-03	7.33e-02
GOMF LIGAND GATED SODIUM CHANNEL ACTIVITY	16	1.74e-02	9.00e-02	0.45300	-3.26e-01	-3.14e-01	2.39e-02	2.96e-02
GOMF RIBONUCLEASE P ACTIVITY	12	4.80e-02	1.83e-01	0.45300	3.27e-01	3.13e-01	4.98e-02	6.05e-02
GOCC TRANSLOCON COMPLEX	5	2.27e-01	4.61e-01	0.45300	4.45e-01	8.50e-02	8.51e-02	7.42e-01
GOBP BERGMANN GLIAL CELL DIFFERENTIATION	11	2.50e-02	1.17e-01	0.45300	4.50e-01	-4.43e-02	9.68e-03	7.99e-01
GOBP G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY	10	5.58e-02	2.01e-01	0.45200	-4.38e-01	-1.12e-01	1.64e-02	5.40e-01
GOMF G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR ACTIVITY	10	5.58e-02	2.01e-01	0.45200	-4.38e-01	-1.12e-01	1.64e-02	5.40e-01
GOMF NUCLEAR GLUCOCORTICOID RECEPTOR BINDING	12	4.59e-02	1.77e-01	0.45200	3.71e-01	2.59e-01	2.61e-02	1.21e-01
GOCC SARCOPLASMIC RETICULUM LUMEN	9	6.63e-02	2.24e-01	0.45200	4.47e-01	6.56e-02	2.01e-02	7.33e-01
GOBP VITAMIN A METABOLIC PROCESS	8	4.42e-02	1.73e-01	0.45200	3.30e-01	-3.09e-01	1.06e-01	1.31e-01
GOCC U2 TYPE CATALYTIC STEP 2 SPLICEOSOME	30	2.16e-04	2.95e-03	0.45200	4.31e-01	1.37e-01	4.41e-05	1.94e-01
GOMF CYSTEINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY	34	9.32e-05	1.46e-03	0.45200	-1.70e-01	-4.19e-01	8.61e-02	2.36e-05
GOBP NADPH OXIDATION	6	1.44e-01	3.57e-01	0.45200	4.52e-01	-6.16e-03	5.52e-02	9.79e-01
GOBP REGULATION OF SERINE TYPE PEPTIDASE ACTIVITY	6	2.04e-01	4.35e-01	0.45200	-4.02e-01	-2.07e-01	8.83e-02	3.81e-01
GOCC SET1C COMPASS COMPLEX	14	2.80e-02	1.26e-01	0.45200	3.65e-01	2.66e-01	1.81e-02	8.45e-02
GOBP OPTIC CUP MORPHOGENESIS INVOLVED IN CAMERA TYPE EYE DEVELOPMENT	7	1.51e-01	3.66e-01	0.45100	1.80e-01	4.14e-01	4.10e-01	5.78e-02
GOBP REGULATION OF GLOMERULUS DEVELOPMENT	5	1.74e-01	3.97e-01	0.45100	-9.87e-02	4.41e-01	7.02e-01	8.80e-02
GOMF HAPTOGLOBIN BINDING	10	3.94e-02	1.60e-01	0.45100	-4.51e-01	1.24e-02	1.35e-02	9.46e-01
GOCC CYTOSKELETON OF PRESYNAPTIC ACTIVE ZONE	8	1.32e-01	3.41e-01	0.45100	-3.51e-01	-2.83e-01	8.52e-02	1.66e-01
GOBP REGULATION OF RNA BINDING	6	1.80e-01	4.04e-01	0.45100	4.36e-01	1.12e-01	6.41e-02	6.35e-01
GOCC MHC CLASS I PROTEIN COMPLEX	10	3.13e-02	1.36e-01	0.45000	-9.24e-02	4.41e-01	6.13e-01	1.58e-02
GOCC ENZYME ACTIVATOR COMPLEX	13	3.12e-02	1.35e-01	0.45000	4.09e-01	1.89e-01	1.07e-02	2.38e-01
GOBP U4 SNRNA 3 END PROCESSING	8	1.15e-01	3.14e-01	0.45000	4.17e-01	1.69e-01	4.11e-02	4.07e-01
HDR through MMEJ (alt-NHEJ)	12	4.86e-02	1.84e-01	0.45000	3.56e-01	2.76e-01	3.30e-02	9.82e-02
GOBP REGULATION OF PROSTATIC BUD FORMATION	5	1.75e-01	3.97e-01	0.45000	-1.06e-01	4.37e-01	6.82e-01	9.06e-02
GOBP ACYLGLYCEROL TRANSPORT	8	7.13e-02	2.35e-01	0.44900	4.47e-01	-4.34e-02	2.85e-02	8.32e-01
GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I	8	5.65e-02	2.02e-01	0.44900	-1.48e-01	4.24e-01	4.69e-01	3.77e-02
GOBP EOSINOPHIL ACTIVATION	8	5.41e-02	1.98e-01	0.44900	-4.15e-01	1.72e-01	4.22e-02	4.00e-01
GOBP RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION	14	3.06e-02	1.33e-01	0.44900	3.02e-01	3.32e-01	5.03e-02	3.15e-02
Regulation of TP53 Activity through Acetylation	28	5.47e-04	6.46e-03	0.44900	4.15e-01	1.71e-01	1.46e-04	1.17e-01
GOBP PEPTIDYL LYSINE ACETYLATION	22	1.55e-03	1.45e-02	0.44800	4.42e-01	7.26e-02	3.27e-04	5.56e-01
GOMF PRERIBOSOME BINDING	8	1.35e-01	3.44e-01	0.44800	2.71e-01	3.57e-01	1.84e-01	8.03e-02
GOBP CEREBELLAR GRANULAR LAYER FORMATION	6	2.26e-01	4.60e-01	0.44800	-3.08e-01	-3.26e-01	1.91e-01	1.67e-01
GOMF MUTLALPHA COMPLEX BINDING	7	1.75e-01	3.99e-01	0.44800	3.37e-01	2.95e-01	1.22e-01	1.76e-01
GOBP NEGATIVE REGULATION OF MACROPHAGE CHEMOTAXIS	7	8.27e-02	2.58e-01	0.44800	-4.25e-01	1.42e-01	5.16e-02	5.14e-01
GOBP POSITIVE REGULATION OF DENDRITIC CELL DIFFERENTIATION	6	1.72e-01	3.94e-01	0.44800	4.42e-01	7.27e-02	6.08e-02	7.58e-01
GOBP REGULATION OF PEPTIDYL SERINE DEPHOSPHORYLATION	7	1.46e-01	3.59e-01	0.44800	4.25e-01	1.42e-01	5.15e-02	5.16e-01
GOBP MEIOTIC CHROMOSOME CONDENSATION	6	1.08e-01	3.04e-01	0.44800	3.93e-01	-2.14e-01	9.53e-02	3.64e-01
GOMF PROTEIN TYROSINE THREONINE PHOSPHATASE ACTIVITY	9	3.88e-02	1.58e-01	0.44800	-4.16e-01	1.64e-01	3.05e-02	3.93e-01
GOBP WOUND HEALING INVOLVED IN INFLAMMATORY RESPONSE	8	9.57e-02	2.82e-01	0.44800	-4.42e-01	-7.20e-02	3.05e-02	7.24e-01
GOMF DNA RNA HYBRID BINDING	5	2.35e-01	4.72e-01	0.44700	4.39e-01	8.42e-02	8.90e-02	7.44e-01
GOBP POSITIVE REGULATION OF SISTER CHROMATID COHESION	9	6.59e-02	2.23e-01	0.44700	4.45e-01	4.05e-02	2.07e-02	8.33e-01
Alpha-oxidation of phytanate	6	1.44e-01	3.57e-01	0.44700	-3.04e-02	4.46e-01	8.97e-01	5.84e-02
DNA methylation	28	9.75e-04	1.03e-02	0.44700	2.90e-01	3.40e-01	7.89e-03	1.83e-03
GOBP DTTP METABOLIC PROCESS	5	1.58e-01	3.76e-01	0.44700	-2.03e-01	3.98e-01	4.31e-01	1.23e-01
GOBP PYRIMIDINE DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS	11	1.96e-02	9.81e-02	0.44700	-4.20e-01	1.54e-01	1.60e-02	3.75e-01
GOBP TRANSFORMING GROWTH FACTOR BETA2 PRODUCTION	8	1.19e-01	3.21e-01	0.44700	4.12e-01	1.72e-01	4.34e-02	3.99e-01
Diseases of branched-chain amino acid catabolism	13	4.02e-02	1.63e-01	0.44700	3.37e-01	2.93e-01	3.51e-02	6.75e-02
Gamma-carboxylation, transport, and amino-terminal cleavage of proteins	9	9.50e-02	2.81e-01	0.44700	-1.92e-01	-4.03e-01	3.18e-01	3.62e-02
GOBP NITROGEN UTILIZATION	5	2.57e-01	4.95e-01	0.44700	-4.22e-01	-1.48e-01	1.03e-01	5.67e-01
GOMF NUCLEAR IMPORT SIGNAL RECEPTOR ACTIVITY	20	7.11e-03	4.63e-02	0.44700	3.41e-01	2.88e-01	8.22e-03	2.57e-02
GOBP SNRNA TRANSCRIPTION BY RNA POLYMERASE II	16	1.95e-02	9.80e-02	0.44600	3.20e-01	3.11e-01	2.65e-02	3.13e-02
GOBP L ASCORBIC ACID METABOLIC PROCESS	10	8.26e-02	2.58e-01	0.44600	2.62e-01	3.62e-01	1.52e-01	4.77e-02
GOBP RETROGRADE TRANS SYNAPTIC SIGNALING BY LIPID	5	2.79e-01	5.19e-01	0.44600	-3.87e-01	-2.22e-01	1.34e-01	3.90e-01
GOCC PARASPECKLES	8	1.38e-01	3.49e-01	0.44600	3.49e-01	2.78e-01	8.73e-02	1.74e-01
GOMF NITRITE REDUCTASE ACTIVITY	7	9.17e-02	2.75e-01	0.44600	4.35e-01	-9.88e-02	4.63e-02	6.51e-01
GOBP BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS	13	8.01e-03	5.08e-02	0.44600	-3.81e-01	2.31e-01	1.74e-02	1.49e-01
GOCC CHROMOSOME CENTROMERIC CORE DOMAIN	17	1.53e-02	8.22e-02	0.44600	3.37e-01	2.91e-01	1.60e-02	3.76e-02
GOBP FOREBRAIN REGIONALIZATION	24	1.97e-03	1.74e-02	0.44600	1.94e-01	4.01e-01	1.00e-01	6.67e-04
GOMF HMG BOX DOMAIN BINDING	13	4.14e-02	1.66e-01	0.44500	3.15e-01	3.15e-01	4.93e-02	4.92e-02
GOBP AMYGDALA DEVELOPMENT	5	2.93e-01	5.32e-01	0.44500	3.30e-01	2.99e-01	2.01e-01	2.47e-01
Citric acid cycle (TCA cycle)	32	3.05e-04	3.97e-03	0.44500	3.84e-01	2.26e-01	1.72e-04	2.69e-02
GOBP REGULATION OF HEMOGLOBIN BIOSYNTHETIC PROCESS	8	1.03e-01	2.96e-01	0.44500	4.35e-01	9.54e-02	3.32e-02	6.40e-01
GOBP RETICULOPHAGY	21	5.77e-03	3.94e-02	0.44500	2.88e-01	3.39e-01	2.21e-02	7.14e-03
GOMF HISTONE H2AX KINASE ACTIVITY	5	2.39e-01	4.76e-01	0.44500	4.37e-01	8.57e-02	9.07e-02	7.40e-01
HDACs deacetylate histones	54	1.65e-06	4.55e-05	0.44500	3.53e-01	2.71e-01	7.17e-06	5.68e-04
GOBP PLASMA MEMBRANE TO ENDOSOME TRANSPORT	8	1.03e-01	2.96e-01	0.44500	4.35e-01	9.29e-02	3.31e-02	6.49e-01
GOBP NEGATIVE REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS	5	2.80e-01	5.19e-01	0.44500	-3.90e-01	-2.15e-01	1.31e-01	4.06e-01
GOBP CONVERGENT EXTENSION INVOLVED IN ORGANOGENESIS	5	1.92e-01	4.21e-01	0.44500	-6.32e-02	4.40e-01	8.07e-01	8.82e-02
GOCC SWI SNF COMPLEX	30	3.34e-04	4.29e-03	0.44500	4.16e-01	1.57e-01	7.93e-05	1.37e-01
GOBP POSITIVE REGULATION OF FIBROBLAST MIGRATION	15	5.50e-03	3.80e-02	0.44500	4.26e-01	-1.26e-01	4.24e-03	3.98e-01
GOBP PEPTIDYL HISTIDINE MODIFICATION	9	1.01e-01	2.92e-01	0.44500	2.14e-01	3.90e-01	2.66e-01	4.30e-02
GOBP CELLULAR RESPONSE TO SALT	6	1.72e-01	3.94e-01	0.44400	5.80e-02	4.41e-01	8.06e-01	6.16e-02
GOBP TOXIN METABOLIC PROCESS	15	1.45e-02	7.86e-02	0.44400	4.34e-01	9.40e-02	3.61e-03	5.28e-01
GOMF MISFOLDED PROTEIN BINDING	15	2.52e-02	1.17e-01	0.44400	2.74e-01	3.49e-01	6.60e-02	1.92e-02
GOBP POSITIVE REGULATION OF PYROPTOSIS	5	2.96e-01	5.35e-01	0.44400	3.03e-01	3.24e-01	2.40e-01	2.09e-01
GOMF CYCLASE ACTIVATOR ACTIVITY	11	1.76e-02	9.06e-02	0.44400	2.25e-01	-3.82e-01	1.95e-01	2.81e-02
GOBP ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS BY CYTOCHROME C	5	2.92e-01	5.32e-01	0.44400	3.56e-01	2.65e-01	1.69e-01	3.04e-01
GOBP URINARY BLADDER SMOOTH MUSCLE CONTRACTION	7	7.24e-02	2.38e-01	0.44400	2.92e-01	-3.34e-01	1.81e-01	1.26e-01
GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE 5 PHOSPHATASE ACTIVITY	5	1.90e-01	4.17e-01	0.44400	4.36e-01	-7.94e-02	9.11e-02	7.58e-01
GOBP POSITIVE REGULATION OF GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION	5	2.17e-01	4.50e-01	0.44400	1.30e-02	4.43e-01	9.60e-01	8.60e-02
GOBP GLUTAMATE CATABOLIC PROCESS	7	1.52e-01	3.68e-01	0.44400	1.42e-01	4.20e-01	5.17e-01	5.41e-02
GOCC DNA REPLICATION FACTOR A COMPLEX	12	5.42e-02	1.98e-01	0.44300	3.23e-01	3.04e-01	5.30e-02	6.79e-02
GOMF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE ACTIVATOR ACTIVITY	15	1.11e-02	6.48e-02	0.44300	3.00e-02	4.42e-01	8.41e-01	3.01e-03
Signaling by ERBB2 ECD mutants	16	1.02e-02	6.08e-02	0.44300	4.37e-01	7.58e-02	2.48e-03	6.00e-01
GOBP REGULATION OF SISTER CHROMATID COHESION	15	1.12e-02	6.51e-02	0.44300	4.42e-01	3.11e-02	3.02e-03	8.35e-01
GOBP SNO S RNA PROCESSING	12	2.80e-02	1.26e-01	0.44300	4.42e-01	3.65e-02	8.04e-03	8.27e-01
GOCC OMEGASOME	5	2.57e-01	4.95e-01	0.44300	4.24e-01	1.29e-01	1.01e-01	6.17e-01
GOMF NUCLEOSIDE TRANSMEMBRANE TRANSPORTER ACTIVITY	10	5.39e-02	1.98e-01	0.44300	-5.59e-02	-4.40e-01	7.59e-01	1.61e-02
GOMF HYDROLASE ACTIVITY ACTING ON ETHER BONDS	10	4.60e-02	1.77e-01	0.44300	4.43e-01	1.60e-03	1.53e-02	9.93e-01
Aberrant regulation of mitotic exit in cancer due to RB1 defects	20	7.87e-03	5.02e-02	0.44300	3.07e-01	3.19e-01	1.73e-02	1.35e-02
GOBP FUSED ANTRUM STAGE	6	1.66e-01	3.88e-01	0.44300	4.42e-01	3.02e-02	6.09e-02	8.98e-01
GOBP MEMBRANOUS SEPTUM MORPHOGENESIS	8	1.33e-01	3.42e-01	0.44300	2.15e-01	3.87e-01	2.92e-01	5.79e-02
GOBP METANEPHRIC TUBULE MORPHOGENESIS	10	6.79e-02	2.27e-01	0.44300	-4.21e-01	-1.37e-01	2.12e-02	4.52e-01
GOBP REGULATION OF DNA STRAND ELONGATION	17	1.22e-02	6.92e-02	0.44300	4.05e-01	1.79e-01	3.85e-03	2.02e-01
GOBP SPERMIDINE METABOLIC PROCESS	6	1.89e-01	4.16e-01	0.44200	1.02e-01	4.31e-01	6.65e-01	6.78e-02
Constitutive Signaling by Overexpressed ERBB2	11	6.68e-02	2.25e-01	0.44200	3.64e-01	2.51e-01	3.64e-02	1.50e-01
GOMF NATURAL KILLER CELL LECTIN LIKE RECEPTOR BINDING	8	7.34e-02	2.39e-01	0.44200	-6.54e-02	4.37e-01	7.49e-01	3.22e-02
GOBP CORNIFIED ENVELOPE ASSEMBLY	6	2.10e-01	4.42e-01	0.44200	4.07e-01	1.73e-01	8.44e-02	4.63e-01
GOBP RESPONSE TO VASOPRESSIN	8	1.12e-01	3.11e-01	0.44200	-1.17e-01	-4.26e-01	5.67e-01	3.68e-02
GOBP FATTY ACYL COA CATABOLIC PROCESS	5	1.58e-01	3.76e-01	0.44200	-2.55e-01	3.61e-01	3.23e-01	1.62e-01
GOBP RETINAL CONE CELL DIFFERENTIATION	13	2.91e-02	1.29e-01	0.44200	-1.20e-01	-4.25e-01	4.52e-01	7.97e-03
GOBP INTERMEDIATE FILAMENT ORGANIZATION	72	3.03e-08	1.21e-06	0.44200	-3.08e-01	-3.16e-01	6.01e-06	3.47e-06
GOBP NUCLEAR PORE COMPLEX ASSEMBLY	11	2.40e-02	1.13e-01	0.44200	4.27e-01	-1.14e-01	1.43e-02	5.12e-01
GOBP URINARY TRACT SMOOTH MUSCLE CONTRACTION	9	3.77e-02	1.55e-01	0.44100	3.78e-01	-2.27e-01	4.93e-02	2.38e-01
SUMOylation of transcription factors	20	7.01e-03	4.58e-02	0.44100	3.78e-01	2.28e-01	3.42e-03	7.79e-02
GOMF NUCLEOCYTOPLASMIC CARRIER ACTIVITY	32	4.20e-04	5.20e-03	0.44100	3.54e-01	2.64e-01	5.32e-04	9.85e-03
RUNX3 regulates NOTCH signaling	13	1.73e-02	8.95e-02	0.44100	4.41e-01	-2.16e-02	5.94e-03	8.93e-01
GOMF RNA POLYMERASE II GENERAL TRANSCRIPTION INITIATION FACTOR BINDING	22	3.54e-03	2.73e-02	0.44100	4.02e-01	1.82e-01	1.10e-03	1.39e-01
GOCC UBIQUINONE BIOSYNTHESIS COMPLEX	6	1.86e-01	4.12e-01	0.44100	4.32e-01	8.88e-02	6.68e-02	7.06e-01
Interleukin-18 signaling	8	1.45e-01	3.58e-01	0.44100	-3.40e-01	-2.81e-01	9.55e-02	1.69e-01
Regulation of endogenous retroelements	103	4.90e-12	3.73e-10	0.44100	3.95e-01	1.96e-01	4.04e-12	6.01e-04
GOBP REGULATION OF TYPE B PANCREATIC CELL DEVELOPMENT	9	1.11e-01	3.08e-01	0.44100	3.62e-01	2.52e-01	6.02e-02	1.90e-01
Hormone ligand-binding receptors	13	3.90e-02	1.59e-01	0.44100	-2.16e-01	-3.84e-01	1.77e-01	1.64e-02
GOBP NEGATIVE REGULATION OF CELL VOLUME	5	1.68e-01	3.89e-01	0.44100	3.95e-01	-1.95e-01	1.26e-01	4.49e-01
GOMF PROMOTER ENHANCER LOOP ANCHORING ACTIVITY	6	2.20e-01	4.54e-01	0.44100	3.93e-01	2.00e-01	9.58e-02	3.96e-01
GOBP DEADENYLATION DEPENDENT DECAPPING OF NUCLEAR TRANSCRIBED MRNA	11	5.17e-02	1.92e-01	0.44100	4.22e-01	1.26e-01	1.53e-02	4.71e-01
GOMF ATP DEPENDENT PROTEIN DISAGGREGASE ACTIVITY	6	2.28e-01	4.62e-01	0.44100	3.74e-01	2.34e-01	1.13e-01	3.22e-01
PRC2 methylates histones and DNA	35	2.28e-04	3.08e-03	0.44000	3.26e-01	2.97e-01	8.57e-04	2.38e-03
GOMF ESTROGEN 16 ALPHA HYDROXYLASE ACTIVITY	8	5.36e-02	1.97e-01	0.44000	2.50e-01	-3.62e-01	2.20e-01	7.59e-02
Abacavir ADME	8	8.22e-02	2.57e-01	0.44000	2.56e-02	-4.40e-01	9.00e-01	3.13e-02
CREB3 factors activate genes	8	1.45e-01	3.58e-01	0.44000	2.75e-01	3.44e-01	1.78e-01	9.21e-02
GOBP INOSITOL TRISPHOSPHATE BIOSYNTHETIC PROCESS	6	2.14e-01	4.47e-01	0.44000	-4.03e-01	-1.76e-01	8.70e-02	4.54e-01
GOBP NEGATIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE	11	5.65e-02	2.02e-01	0.44000	-4.12e-01	-1.56e-01	1.81e-02	3.71e-01
GOBP RETINAL CONE CELL DEVELOPMENT	11	3.73e-02	1.54e-01	0.44000	-1.71e-02	-4.40e-01	9.22e-01	1.16e-02
GOCC SEX CHROMATIN	6	2.08e-01	4.39e-01	0.44000	4.13e-01	1.52e-01	7.98e-02	5.20e-01
GOMF SODIUM CHANNEL ACTIVITY	47	1.36e-05	2.83e-04	0.44000	-3.09e-01	-3.13e-01	2.45e-04	2.08e-04
Phase 1 - inactivation of fast Na+ channels	6	2.04e-01	4.35e-01	0.44000	-4.17e-01	-1.39e-01	7.69e-02	5.55e-01
GOBP RESPONSE TO UV C	14	3.30e-02	1.41e-01	0.44000	3.67e-01	2.43e-01	1.76e-02	1.16e-01
GOBP N ACYLETHANOLAMINE METABOLIC PROCESS	5	1.76e-01	3.99e-01	0.44000	-1.61e-01	4.09e-01	5.32e-01	1.13e-01
GOBP REGULATION OF CD4 POSITIVE CD25 POSITIVE ALPHA BETA REGULATORY T CELL DIFFERENTIATION	5	2.55e-01	4.92e-01	0.43900	-4.27e-01	-1.04e-01	9.83e-02	6.87e-01
GOBP GOLGI VESICLE BUDDING	10	4.97e-02	1.87e-01	0.43900	4.39e-01	1.01e-02	1.62e-02	9.56e-01
GOMF 5 3 DNA EXONUCLEASE ACTIVITY	9	9.04e-02	2.73e-01	0.43900	1.28e-01	4.20e-01	5.08e-01	2.90e-02
GOBP NEGATIVE REGULATION OF PINOCYTOSIS	5	3.01e-01	5.41e-01	0.43900	2.68e-01	3.47e-01	2.99e-01	1.79e-01
GOCC LEWY BODY	8	1.34e-01	3.43e-01	0.43900	1.92e-01	3.95e-01	3.48e-01	5.32e-02
Free fatty acid receptors	5	1.60e-01	3.78e-01	0.43900	-2.94e-01	3.26e-01	2.55e-01	2.07e-01
GOBP DENDRITE SELF AVOIDANCE	14	3.43e-02	1.45e-01	0.43900	-2.57e-01	-3.55e-01	9.55e-02	2.13e-02
GOMF C ACETYLTRANSFERASE ACTIVITY	7	1.87e-01	4.13e-01	0.43900	2.72e-01	3.44e-01	2.12e-01	1.15e-01
GOCC ENDOLYSOSOME MEMBRANE	17	1.02e-02	6.07e-02	0.43800	4.24e-01	1.11e-01	2.48e-03	4.30e-01
PI5P Regulates TP53 Acetylation	8	1.45e-01	3.58e-01	0.43800	3.62e-01	2.46e-01	7.60e-02	2.28e-01
Interaction between L1 and Ankyrins	30	8.23e-04	9.06e-03	0.43800	-3.18e-01	-3.01e-01	2.56e-03	4.34e-03
GOBP SPINAL CORD OLIGODENDROCYTE CELL DIFFERENTIATION	5	1.63e-01	3.84e-01	0.43800	3.56e-01	-2.55e-01	1.68e-01	3.23e-01
Apoptosis induced DNA fragmentation	13	4.53e-02	1.76e-01	0.43800	3.40e-01	2.76e-01	3.38e-02	8.51e-02
GOBP NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION	22	5.42e-03	3.75e-02	0.43800	2.87e-01	3.30e-01	1.97e-02	7.31e-03
GOBP RETINAL CELL PROGRAMMED CELL DEATH	6	2.11e-01	4.43e-01	0.43800	1.52e-01	4.10e-01	5.19e-01	8.17e-02
GOBP EMBRYONIC SKELETAL JOINT MORPHOGENESIS	11	7.40e-02	2.40e-01	0.43800	3.24e-01	2.94e-01	6.25e-02	9.17e-02
GOBP AMINO ACID BETAINE BIOSYNTHETIC PROCESS	5	2.30e-01	4.65e-01	0.43700	-2.32e-02	-4.37e-01	9.28e-01	9.08e-02
GOBP NUCLEAR PORE LOCALIZATION	5	1.62e-01	3.82e-01	0.43700	3.25e-01	-2.92e-01	2.08e-01	2.58e-01
GOCC CYTOSOLIC PROTEASOME COMPLEX	5	2.94e-01	5.33e-01	0.43700	3.79e-01	2.18e-01	1.42e-01	3.99e-01
GOCC ACTIVIN RECEPTOR COMPLEX	6	1.73e-01	3.95e-01	0.43700	2.52e-02	4.36e-01	9.15e-01	6.42e-02
GOMF D LOOP DNA BINDING	5	2.94e-01	5.33e-01	0.43700	2.16e-01	3.80e-01	4.02e-01	1.42e-01
GOBP CILIARY NEUROTROPHIC FACTOR MEDIATED SIGNALING PATHWAY	5	2.86e-01	5.24e-01	0.43700	1.86e-01	3.95e-01	4.72e-01	1.26e-01
GOCC SERINE TYPE PEPTIDASE COMPLEX	13	1.60e-02	8.46e-02	0.43700	-4.32e-01	6.37e-02	6.99e-03	6.91e-01
Diseases associated with surfactant metabolism	9	7.29e-02	2.39e-01	0.43700	-4.36e-01	-2.93e-02	2.36e-02	8.79e-01
GOBP NEGATIVE REGULATION OF THYMOCYTE APOPTOTIC PROCESS	9	3.90e-02	1.59e-01	0.43700	-2.55e-01	3.54e-01	1.85e-01	6.58e-02
Constitutive Signaling by EGFRvIII	15	1.78e-02	9.13e-02	0.43700	4.23e-01	1.08e-01	4.56e-03	4.69e-01
Signaling by EGFRvIII in Cancer	15	1.78e-02	9.13e-02	0.43700	4.23e-01	1.08e-01	4.56e-03	4.69e-01
Deposition of new CENPA-containing nucleosomes at the centromere	46	1.67e-05	3.35e-04	0.43600	3.59e-01	2.48e-01	2.52e-05	3.57e-03
Nucleosome assembly	46	1.67e-05	3.35e-04	0.43600	3.59e-01	2.48e-01	2.52e-05	3.57e-03
GOCC INNER KINETOCHORE	17	1.70e-02	8.83e-02	0.43600	3.62e-01	2.44e-01	9.82e-03	8.12e-02
GOBP TERMINATION OF RNA POLYMERASE II TRANSCRIPTION	10	8.86e-02	2.70e-01	0.43600	3.73e-01	2.27e-01	4.12e-02	2.14e-01
GOBP COMMA SHAPED BODY MORPHOGENESIS	5	1.67e-01	3.88e-01	0.43600	-3.62e-01	2.43e-01	1.60e-01	3.47e-01
GOBP SECONDARY HEART FIELD SPECIFICATION	11	4.15e-02	1.66e-01	0.43600	3.38e-02	4.35e-01	8.46e-01	1.25e-02
GOBP CARDIAC RIGHT VENTRICLE MORPHOGENESIS	21	4.69e-03	3.38e-02	0.43600	1.60e-01	4.06e-01	2.05e-01	1.28e-03
GOBP METANEPHRIC NEPHRON TUBULE MORPHOGENESIS	8	1.10e-01	3.07e-01	0.43600	-4.29e-01	-8.09e-02	3.58e-02	6.92e-01
GOBP 2FE 2S CLUSTER ASSEMBLY	9	1.01e-01	2.92e-01	0.43600	4.05e-01	1.63e-01	3.55e-02	3.98e-01
GOMF GLUCOSE SODIUM SYMPORTER ACTIVITY	7	1.45e-01	3.58e-01	0.43600	-4.28e-01	-8.19e-02	4.96e-02	7.07e-01
Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants	19	5.90e-03	4.01e-02	0.43600	4.24e-01	1.00e-01	1.36e-03	4.49e-01
Signaling by Ligand-Responsive EGFR Variants in Cancer	19	5.90e-03	4.01e-02	0.43600	4.24e-01	1.00e-01	1.36e-03	4.49e-01
GOBP REGULATION OF LYSOSOME SIZE	8	1.44e-01	3.57e-01	0.43600	2.23e-01	3.75e-01	2.74e-01	6.65e-02
GOCC BORC COMPLEX	8	1.44e-01	3.57e-01	0.43600	2.23e-01	3.75e-01	2.74e-01	6.65e-02
GOCC DNA DEPENDENT PROTEIN KINASE DNA LIGASE 4 COMPLEX	7	1.04e-01	2.97e-01	0.43600	4.28e-01	-8.47e-02	5.00e-02	6.98e-01
GOBP LEUKOCYTE ADHESION TO ARTERIAL ENDOTHELIAL CELL	6	2.44e-01	4.82e-01	0.43600	-3.15e-01	-3.02e-01	1.82e-01	2.01e-01
GOCC SM LIKE PROTEIN FAMILY COMPLEX	89	7.82e-11	5.16e-09	0.43600	4.16e-01	1.30e-01	1.13e-11	3.45e-02
GOBP PROTEIN TARGETING TO PEROXISOME	9	1.07e-01	3.02e-01	0.43600	3.93e-01	1.89e-01	4.13e-02	3.27e-01
Negative regulation of FLT3	15	2.61e-02	1.20e-01	0.43600	2.19e-01	3.77e-01	1.42e-01	1.15e-02
GOBP AGGRESSIVE BEHAVIOR	8	1.10e-01	3.07e-01	0.43600	7.83e-02	4.29e-01	7.01e-01	3.57e-02
GOMF VIRION BINDING	10	7.95e-02	2.52e-01	0.43500	-1.64e-01	-4.03e-01	3.70e-01	2.72e-02
GOBP DISACCHARIDE METABOLIC PROCESS	10	7.54e-02	2.43e-01	0.43500	-4.12e-01	-1.41e-01	2.42e-02	4.41e-01
GOMF MHC CLASS IB PROTEIN BINDING	7	1.47e-01	3.61e-01	0.43500	-4.27e-01	-8.36e-02	5.04e-02	7.02e-01
GOBP XYLULOSE 5 PHOSPHATE METABOLIC PROCESS	6	1.65e-01	3.87e-01	0.43500	-8.40e-03	4.35e-01	9.72e-01	6.50e-02
GOCC NUCLEAR REPLICATION FORK	39	4.82e-05	8.50e-04	0.43500	4.07e-01	1.54e-01	1.10e-05	9.55e-02
GOMF NUCLEAR EXPORT SIGNAL RECEPTOR ACTIVITY	12	5.53e-02	2.00e-01	0.43500	3.74e-01	2.22e-01	2.49e-02	1.82e-01
NOSTRIN mediated eNOS trafficking	5	2.36e-01	4.73e-01	0.43500	4.34e-01	2.96e-02	9.30e-02	9.09e-01
GOMF QUINONE BINDING	15	3.01e-02	1.32e-01	0.43500	3.21e-01	2.93e-01	3.12e-02	4.95e-02
Transcriptional regulation of granulopoiesis	53	3.27e-06	8.31e-05	0.43500	2.36e-01	3.65e-01	2.90e-03	4.39e-06
GOMF ADP TRANSMEMBRANE TRANSPORTER ACTIVITY	9	9.23e-02	2.76e-01	0.43400	1.13e-01	4.20e-01	5.58e-01	2.93e-02
Formation of ATP by chemiosmotic coupling	18	1.45e-02	7.90e-02	0.43400	3.45e-01	2.64e-01	1.14e-02	5.21e-02
Signaling by LTK in cancer	7	1.36e-01	3.46e-01	0.43400	4.33e-01	3.81e-02	4.75e-02	8.62e-01
GOBP CHROMOSOME ATTACHMENT TO THE NUCLEAR ENVELOPE	7	8.61e-02	2.65e-01	0.43400	3.80e-01	-2.11e-01	8.20e-02	3.34e-01
GOBP NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION	7	1.94e-01	4.23e-01	0.43400	3.38e-01	2.73e-01	1.22e-01	2.11e-01
GOBP CENTROMERE COMPLEX ASSEMBLY	28	9.32e-04	9.90e-03	0.43400	3.98e-01	1.74e-01	2.71e-04	1.10e-01
GOBP TRANSCRIPTION INITIATION AT RNA POLYMERASE III PROMOTER	8	9.09e-02	2.74e-01	0.43400	4.34e-01	-1.31e-02	3.36e-02	9.49e-01
Activation of HOX genes during differentiation	83	2.59e-09	1.31e-07	0.43400	3.68e-01	2.30e-01	6.93e-09	2.85e-04
Activation of anterior HOX genes in hindbrain development during early embryogenesis	83	2.59e-09	1.31e-07	0.43400	3.68e-01	2.30e-01	6.93e-09	2.85e-04
GOBP MIDBRAIN HINDBRAIN BOUNDARY DEVELOPMENT	7	1.62e-01	3.82e-01	0.43400	1.28e-01	4.14e-01	5.57e-01	5.76e-02
GOBP GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT	10	9.75e-02	2.85e-01	0.43400	3.23e-01	2.90e-01	7.74e-02	1.12e-01
GOBP ENDOPLASMIC RETICULUM MEMBRANE ORGANIZATION	12	4.78e-02	1.82e-01	0.43400	4.05e-01	1.55e-01	1.51e-02	3.54e-01
GOBP NEGATIVE REGULATION OF MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION	6	1.38e-01	3.49e-01	0.43400	1.26e-01	-4.15e-01	5.94e-01	7.83e-02
GOBP POSITIVE REGULATION OF PROTEIN SUMOYLATION	12	6.18e-02	2.14e-01	0.43300	2.99e-01	3.14e-01	7.31e-02	5.97e-02
GOCC CCR4 NOT COMPLEX	16	2.05e-02	1.01e-01	0.43300	3.84e-01	2.00e-01	7.83e-03	1.65e-01
GOCC PROTEIN PHOSPHATASE 4 COMPLEX	5	2.03e-01	4.34e-01	0.43300	4.25e-01	-8.40e-02	9.99e-02	7.45e-01
GOMF TYPE 1 ANGIOTENSIN RECEPTOR BINDING	6	1.35e-01	3.44e-01	0.43300	4.09e-01	-1.44e-01	8.31e-02	5.42e-01
GOBP BONE MARROW DEVELOPMENT	9	1.20e-01	3.22e-01	0.43300	3.58e-01	2.43e-01	6.27e-02	2.07e-01
GOBP CONSTITUTIVE HETEROCHROMATIN FORMATION	10	8.76e-02	2.68e-01	0.43300	1.97e-01	3.86e-01	2.81e-01	3.47e-02
Signal regulatory protein family interactions	15	5.52e-03	3.81e-02	0.43300	-3.82e-01	2.03e-01	1.03e-02	1.74e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN ANOTHER COMPOUND AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN	7	1.87e-01	4.13e-01	0.43300	2.18e-01	3.74e-01	3.17e-01	8.68e-02
GOCC GROWTH FACTOR COMPLEX	8	1.52e-01	3.68e-01	0.43300	3.55e-01	2.48e-01	8.24e-02	2.24e-01
Chromatin modifications during the maternal to zygotic transition (MZT)	32	6.13e-04	7.12e-03	0.43300	3.04e-01	3.08e-01	2.90e-03	2.57e-03
GOBP POSITIVE REGULATION OF LONG TERM SYNAPTIC DEPRESSION	6	2.42e-01	4.80e-01	0.43300	-2.38e-01	-3.61e-01	3.13e-01	1.25e-01
GOMF BMP BINDING	20	4.89e-03	3.47e-02	0.43300	4.21e-01	9.89e-02	1.11e-03	4.44e-01
GOBP CELLULAR RESPONSE TO GAMMA RADIATION	26	1.46e-03	1.38e-02	0.43300	4.03e-01	1.58e-01	3.76e-04	1.64e-01
GOBP ARTERIAL ENDOTHELIAL CELL DIFFERENTIATION	6	1.19e-01	3.21e-01	0.43300	-2.57e-01	3.48e-01	2.75e-01	1.40e-01
GOBP POSITIVE REGULATION OF TOOTH MINERALIZATION	7	1.20e-01	3.23e-01	0.43200	3.09e-02	-4.31e-01	8.87e-01	4.83e-02
GOBP CONDITIONED PLACE PREFERENCE	5	1.71e-01	3.93e-01	0.43200	-3.48e-01	2.56e-01	1.77e-01	3.22e-01
GOMF BASAL TRANSCRIPTION MACHINERY BINDING	58	2.81e-07	9.29e-06	0.43200	4.16e-01	1.17e-01	4.26e-08	1.23e-01
GOBP ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS	23	1.81e-03	1.63e-02	0.43200	-4.27e-01	-6.40e-02	3.90e-04	5.95e-01
GOMF INOSITOL TETRAKISPHOSPHATE KINASE ACTIVITY	5	2.68e-01	5.07e-01	0.43200	1.05e-01	4.19e-01	6.85e-01	1.05e-01
YAP1- and WWTR1 (TAZ)-stimulated gene expression	14	3.38e-02	1.44e-01	0.43200	3.84e-01	1.97e-01	1.28e-02	2.02e-01
GOMF RNA POLYMERASE CORE ENZYME BINDING	42	1.50e-05	3.07e-04	0.43200	4.20e-01	9.92e-02	2.46e-06	2.66e-01
GOCC SMALL NUCLEAR RIBONUCLEOPROTEIN COMPLEX	79	1.86e-09	9.68e-08	0.43200	4.09e-01	1.36e-01	3.09e-10	3.62e-02
GOCC STEREOCILIA ANKLE LINK COMPLEX	6	2.32e-01	4.67e-01	0.43200	-1.86e-01	-3.89e-01	4.29e-01	9.87e-02
Abacavir transmembrane transport	5	2.51e-01	4.89e-01	0.43100	-5.53e-02	-4.28e-01	8.30e-01	9.76e-02
GOBP NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS	44	4.07e-05	7.33e-04	0.43100	2.86e-01	3.23e-01	1.03e-03	2.13e-04
Regulation of TP53 Activity through Methylation	19	7.43e-03	4.78e-02	0.43100	4.13e-01	1.22e-01	1.81e-03	3.57e-01
GOBP SNRNA MODIFICATION	6	1.45e-01	3.58e-01	0.43100	4.18e-01	-1.04e-01	7.60e-02	6.58e-01
GOBP SPLICEOSOMAL SNRNP ASSEMBLY	43	1.59e-05	3.21e-04	0.43100	4.12e-01	1.25e-01	2.86e-06	1.55e-01
GOMF NAD P H OXIDASE H2O2 FORMING ACTIVITY	8	1.32e-01	3.40e-01	0.43100	1.40e-01	4.08e-01	4.93e-01	4.59e-02
GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE	15	3.14e-02	1.36e-01	0.43100	3.36e-01	2.70e-01	2.42e-02	7.06e-02
GOBP XENOBIOTIC TRANSPORT ACROSS BLOOD BRAIN BARRIER	6	2.08e-01	4.39e-01	0.43100	-1.06e-01	-4.18e-01	6.51e-01	7.65e-02
GOBP POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE REGENERATION	5	2.30e-01	4.65e-01	0.43100	-6.98e-03	4.31e-01	9.78e-01	9.53e-02
GOBP REGULATION OF MACROPHAGE FUSION	5	2.10e-01	4.42e-01	0.43000	-4.24e-01	7.50e-02	1.01e-01	7.71e-01
GOMF HEPARAN SULFATE GLUCOSAMINE 3 SULFOTRANSFERASE 1 ACTIVITY	7	1.35e-01	3.45e-01	0.43000	-4.30e-01	-1.61e-02	4.88e-02	9.41e-01
GOBP POSITIVE REGULATION OF PLASMINOGEN ACTIVATION	8	6.09e-02	2.12e-01	0.43000	-3.49e-01	2.52e-01	8.74e-02	2.18e-01
GOBP CENTRAL NERVOUS SYSTEM MYELIN MAINTENANCE	5	2.96e-01	5.36e-01	0.43000	3.90e-01	1.81e-01	1.31e-01	4.83e-01
GOBP OBSERVATIONAL LEARNING	7	1.90e-01	4.17e-01	0.43000	-2.12e-01	-3.74e-01	3.32e-01	8.63e-02
GOCC TRNA SPLICING LIGASE COMPLEX	8	1.48e-01	3.61e-01	0.43000	3.79e-01	2.03e-01	6.33e-02	3.20e-01
Synthesis of Dolichyl-phosphate	6	1.21e-01	3.24e-01	0.43000	-2.74e-01	3.31e-01	2.45e-01	1.60e-01
GOCC POST MRNA RELEASE SPLICEOSOMAL COMPLEX	11	5.99e-02	2.10e-01	0.43000	4.11e-01	1.24e-01	1.81e-02	4.76e-01
GOCC PROTEASOME REGULATORY PARTICLE BASE SUBCOMPLEX	11	4.08e-02	1.64e-01	0.43000	4.30e-01	-2.83e-03	1.36e-02	9.87e-01
GOBP REGULATION OF NATURAL KILLER CELL CHEMOTAXIS	8	6.81e-02	2.27e-01	0.43000	-3.93e-01	1.74e-01	5.42e-02	3.95e-01
GOBP ACTIN MYOSIN FILAMENT SLIDING	16	1.52e-02	8.20e-02	0.43000	-1.01e-01	-4.18e-01	4.85e-01	3.83e-03
GOBP LATERAL MESODERM DEVELOPMENT	16	2.26e-02	1.08e-01	0.42900	2.08e-01	3.76e-01	1.50e-01	9.28e-03
GOBP UBIQUITIN RECYCLING	13	4.85e-02	1.84e-01	0.42900	2.34e-01	3.60e-01	1.44e-01	2.46e-02
GOBP TRNA THREONYLCARBAMOYLADENOSINE MODIFICATION	5	2.91e-01	5.30e-01	0.42900	3.99e-01	1.57e-01	1.22e-01	5.42e-01
GOBP COMPLEMENT ACTIVATION LECTIN PATHWAY	11	8.02e-02	2.53e-01	0.42900	-2.60e-01	-3.41e-01	1.35e-01	5.03e-02
GOBP POSITIVE REGULATION OF THYROID HORMONE GENERATION	5	3.17e-01	5.56e-01	0.42900	-3.44e-01	-2.55e-01	1.82e-01	3.23e-01
GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL	5	1.74e-01	3.97e-01	0.42900	3.29e-01	-2.75e-01	2.03e-01	2.86e-01
GOBP RIBONUCLEOPROTEIN COMPLEX LOCALIZATION	11	6.44e-02	2.20e-01	0.42800	4.04e-01	1.44e-01	2.05e-02	4.09e-01
GOBP REGULATION OF ISOMERASE ACTIVITY	7	1.83e-01	4.09e-01	0.42800	1.76e-01	3.91e-01	4.21e-01	7.34e-02
GOBP MEMBRANE DEPOLARIZATION DURING AV NODE CELL ACTION POTENTIAL	6	2.48e-01	4.86e-01	0.42800	-3.60e-01	-2.32e-01	1.26e-01	3.26e-01
Synthesis of 15-eicosatetraenoic acid derivatives	6	2.56e-01	4.94e-01	0.42800	3.19e-01	2.85e-01	1.75e-01	2.27e-01
GOCC PARALLEL FIBER TO PURKINJE CELL SYNAPSE	17	1.07e-02	6.32e-02	0.42800	-7.47e-02	-4.22e-01	5.94e-01	2.62e-03
GOBP RESPONSE TO NEMATODE	7	1.94e-01	4.23e-01	0.42800	3.69e-01	2.17e-01	9.08e-02	3.20e-01
GOBP PROTEIN DESUMOYLATION	9	1.28e-01	3.36e-01	0.42800	2.64e-01	3.37e-01	1.70e-01	8.00e-02
GOBP FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE	12	6.23e-02	2.15e-01	0.42800	3.58e-01	2.35e-01	3.18e-02	1.59e-01
GOBP NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT	12	6.13e-02	2.13e-01	0.42800	2.25e-01	3.64e-01	1.78e-01	2.89e-02
Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA	17	2.00e-02	9.95e-02	0.42800	3.53e-01	2.42e-01	1.17e-02	8.44e-02
GOBP EGG ACTIVATION	11	6.43e-02	2.20e-01	0.42800	-1.41e-01	-4.04e-01	4.20e-01	2.03e-02
GOCC HISTONE DEACETYLASE COMPLEX	76	2.37e-08	9.69e-07	0.42800	3.60e-01	2.31e-01	5.81e-08	4.85e-04
GOBP BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS	12	6.58e-02	2.23e-01	0.42800	2.74e-01	3.28e-01	9.98e-02	4.91e-02
GOMF NARROW PORE CHANNEL ACTIVITY	19	1.18e-02	6.74e-02	0.42800	-3.70e-01	-2.14e-01	5.25e-03	1.06e-01
GOMF IMMUNOGLOBULIN BINDING	22	1.54e-03	1.44e-02	0.42800	-4.27e-01	2.52e-02	5.29e-04	8.38e-01
GOMF GUANYLYLTRANSFERASE ACTIVITY	7	1.71e-01	3.93e-01	0.42700	4.08e-01	1.27e-01	6.16e-02	5.59e-01
GOBP REGULATION OF ANTIMICROBIAL PEPTIDE PRODUCTION	9	1.03e-01	2.95e-01	0.42700	-1.25e-01	-4.09e-01	5.18e-01	3.37e-02
GOBP POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL	7	1.86e-01	4.13e-01	0.42700	3.88e-01	1.80e-01	7.58e-02	4.10e-01
GOBP POSITIVE REGULATION OF STEM CELL POPULATION MAINTENANCE	46	3.10e-05	5.82e-04	0.42700	3.22e-01	2.80e-01	1.55e-04	1.00e-03
GOBP BLOOD VESSEL MATURATION	8	8.45e-02	2.61e-01	0.42700	4.20e-01	-7.85e-02	3.97e-02	7.01e-01
GOCC CLATHRIN SCULPTED GAMMA AMINOBUTYRIC ACID TRANSPORT VESICLE	8	1.14e-01	3.13e-01	0.42700	5.36e-02	4.24e-01	7.93e-01	3.79e-02
GOMF EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT CONFERRING TENSILE STRENGTH	42	4.36e-05	7.75e-04	0.42700	-1.82e-01	-3.87e-01	4.18e-02	1.46e-05
IRE1alpha activates chaperones	45	2.96e-05	5.58e-04	0.42700	3.65e-01	2.22e-01	2.27e-05	1.01e-02
GOMF CAMP RESPONSE ELEMENT BINDING	12	6.61e-02	2.24e-01	0.42700	3.34e-01	2.66e-01	4.53e-02	1.11e-01
SIRT1 negatively regulates rRNA expression	30	1.14e-03	1.16e-02	0.42700	3.30e-01	2.70e-01	1.75e-03	1.04e-02
GOBP ADAPTIVE IMMUNE MEMORY RESPONSE	5	3.19e-01	5.57e-01	0.42700	3.49e-01	2.45e-01	1.76e-01	3.44e-01
Metallothioneins bind metals	11	3.44e-02	1.45e-01	0.42700	-7.22e-02	4.20e-01	6.79e-01	1.58e-02
GOCC RPAP3 R2TP PREFOLDIN LIKE COMPLEX	10	9.86e-02	2.88e-01	0.42600	3.65e-01	2.21e-01	4.56e-02	2.27e-01
Regulation of NPAS4 mRNA translation	9	1.09e-01	3.06e-01	0.42600	4.00e-01	1.47e-01	3.76e-02	4.46e-01
GOMF EXTRACELLULARLY ATP GATED MONOATOMIC CATION CHANNEL ACTIVITY	7	1.54e-01	3.69e-01	0.42600	6.30e-02	4.22e-01	7.73e-01	5.34e-02
GOMF PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ACTIVITY	9	9.63e-02	2.83e-01	0.42600	-9.08e-02	-4.16e-01	6.37e-01	3.05e-02
GOCC REPLISOME	22	5.62e-03	3.86e-02	0.42600	3.79e-01	1.96e-01	2.11e-03	1.12e-01
GOMF TYPE 2 FIBROBLAST GROWTH FACTOR RECEPTOR BINDING	5	2.55e-01	4.93e-01	0.42600	4.24e-01	4.41e-02	1.01e-01	8.64e-01
GOBP POSITIVE REGULATION OF RNA EXPORT FROM NUCLEUS	5	2.86e-01	5.24e-01	0.42600	4.06e-01	1.28e-01	1.16e-01	6.19e-01
Beta-catenin phosphorylation cascade	16	2.26e-02	1.08e-01	0.42600	3.83e-01	1.88e-01	8.06e-03	1.94e-01
Reversal of alkylation damage by DNA dioxygenases	7	1.16e-01	3.16e-01	0.42600	4.18e-01	-8.07e-02	5.52e-02	7.12e-01
Type I hemidesmosome assembly	11	6.95e-02	2.31e-01	0.42600	-3.94e-01	-1.61e-01	2.36e-02	3.54e-01
XBP1(S) activates chaperone genes	43	4.25e-05	7.57e-04	0.42600	3.76e-01	2.01e-01	2.00e-05	2.29e-02
GOBP POSITIVE REGULATION OF RNA SPLICING	41	6.37e-05	1.06e-03	0.42600	3.80e-01	1.92e-01	2.52e-05	3.34e-02
GOCC COPI COATED VESICLE	25	1.51e-03	1.41e-02	0.42600	4.16e-01	8.90e-02	3.12e-04	4.41e-01
MAP3K8 (TPL2)-dependent MAPK1/3 activation	15	2.04e-02	1.01e-01	0.42600	4.16e-01	9.02e-02	5.26e-03	5.45e-01
GOMF HISTONE H4K5 ACETYLTRANSFERASE ACTIVITY	11	7.41e-02	2.41e-01	0.42600	3.82e-01	1.88e-01	2.82e-02	2.80e-01
GOBP POSITIVE REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I	10	3.63e-02	1.51e-01	0.42600	3.86e-01	-1.80e-01	3.46e-02	3.25e-01
Metabolism of Angiotensinogen to Angiotensins	15	3.39e-02	1.44e-01	0.42600	-3.36e-01	-2.62e-01	2.44e-02	7.92e-02
GOMF PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE 5 PHOSPHATASE ACTIVITY	9	5.14e-02	1.91e-01	0.42600	3.89e-01	-1.72e-01	4.32e-02	3.71e-01
GOBP CELLULAR RESPONSE TO NITROSATIVE STRESS	6	1.92e-01	4.20e-01	0.42600	4.24e-01	3.40e-02	7.19e-02	8.85e-01
GOCC BRCA1 A COMPLEX	7	2.09e-01	4.41e-01	0.42600	2.98e-01	3.04e-01	1.72e-01	1.64e-01
GOBP POSITIVE REGULATION OF TRANSLATION IN RESPONSE TO STRESS	5	1.99e-01	4.29e-01	0.42600	4.02e-01	-1.40e-01	1.20e-01	5.87e-01
GOCC CORNIFIED ENVELOPE	57	1.55e-06	4.29e-05	0.42600	-3.79e-01	-1.94e-01	7.52e-07	1.13e-02
GOBP REGULATION OF DNA TOPOISOMERASE ATP HYDROLYZING ACTIVITY	5	2.99e-01	5.39e-01	0.42500	1.63e-01	3.93e-01	5.28e-01	1.28e-01
GOBP PYRIMIDINE DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS	6	1.35e-01	3.45e-01	0.42500	-1.92e-01	3.80e-01	4.16e-01	1.07e-01
GOMF DOUBLE STRANDED TELOMERIC DNA BINDING	9	1.19e-01	3.21e-01	0.42500	3.83e-01	1.84e-01	4.64e-02	3.40e-01
GOBP PEPTIDYL LYSINE DEACETYLATION	5	2.66e-01	5.05e-01	0.42500	4.20e-01	6.83e-02	1.04e-01	7.92e-01
GOMF PHOSPHATIDYLINOSITOL PHOSPHATE 5 PHOSPHATASE ACTIVITY	12	2.35e-02	1.12e-01	0.42500	4.12e-01	-1.03e-01	1.34e-02	5.36e-01
GOBP METANEPHRIC S SHAPED BODY MORPHOGENESIS	5	1.96e-01	4.25e-01	0.42500	-1.59e-01	3.94e-01	5.39e-01	1.27e-01
GOBP HISTONE MRNA METABOLIC PROCESS	24	4.38e-03	3.21e-02	0.42500	3.46e-01	2.47e-01	3.34e-03	3.63e-02
GOBP REGULATION OF CELL PROJECTION SIZE	11	7.99e-02	2.52e-01	0.42500	-2.22e-01	-3.62e-01	2.02e-01	3.74e-02
RMTs methylate histone arginines	43	3.77e-05	6.88e-04	0.42500	3.85e-01	1.80e-01	1.26e-05	4.07e-02
Signaling by cytosolic FGFR1 fusion mutants	18	1.81e-02	9.24e-02	0.42500	3.00e-01	3.01e-01	2.73e-02	2.73e-02
GOBP REGULATION OF TRANSCRIPTION BY GLUCOSE	8	1.35e-01	3.45e-01	0.42500	4.07e-01	1.20e-01	4.60e-02	5.57e-01
Mitochondrial translation elongation	87	2.82e-09	1.41e-07	0.42500	3.51e-01	2.38e-01	1.45e-08	1.22e-04
Mitochondrial translation termination	87	2.97e-09	1.48e-07	0.42500	3.48e-01	2.43e-01	1.95e-08	9.03e-05
GOBP POSITIVE REGULATION OF HEMOGLOBIN BIOSYNTHETIC PROCESS	6	2.24e-01	4.58e-01	0.42400	4.06e-01	1.23e-01	8.47e-02	6.03e-01
PCNA-Dependent Long Patch Base Excision Repair	21	8.55e-03	5.35e-02	0.42400	2.36e-01	3.53e-01	6.12e-02	5.15e-03
GOCC DNA RECOMBINASE MEDIATOR COMPLEX	7	1.44e-01	3.57e-01	0.42400	4.24e-01	2.01e-02	5.22e-02	9.27e-01
Interleukin-27 signaling	11	5.06e-02	1.90e-01	0.42400	4.00e-02	4.22e-01	8.18e-01	1.53e-02
GOBP HEMATOPOIETIC STEM CELL PROLIFERATION	33	4.45e-04	5.46e-03	0.42400	1.90e-01	3.79e-01	5.95e-02	1.63e-04
GOBP PEPTIDYL ARGININE MODIFICATION	13	4.78e-02	1.82e-01	0.42400	3.79e-01	1.90e-01	1.80e-02	2.35e-01
GOBP EMBRYONIC BODY MORPHOGENESIS	11	6.26e-02	2.16e-01	0.42400	4.09e-01	1.10e-01	1.88e-02	5.29e-01
GOBP IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE	20	6.94e-03	4.55e-02	0.42400	1.22e-01	4.06e-01	3.45e-01	1.68e-03
GOBP POSITIVE REGULATION OF MICROGLIAL CELL ACTIVATION	10	4.26e-02	1.69e-01	0.42300	-4.05e-01	1.24e-01	2.67e-02	4.96e-01
Signaling by Activin	17	1.22e-02	6.89e-02	0.42300	7.96e-02	4.16e-01	5.70e-01	2.99e-03
GOBP MAMMARY GLAND INVOLUTION	8	1.69e-01	3.91e-01	0.42300	2.73e-01	3.24e-01	1.82e-01	1.13e-01
GOBP SPHINGOMYELIN BIOSYNTHETIC PROCESS	11	7.92e-02	2.51e-01	0.42300	3.71e-01	2.04e-01	3.32e-02	2.41e-01
Translation of Replicase and Assembly of the Replication Transcription Complex 9694676	14	4.51e-02	1.75e-01	0.42300	2.79e-01	3.18e-01	7.07e-02	3.95e-02
GOCC CYTOPLASMIC SIDE OF LYSOSOMAL MEMBRANE	13	4.95e-02	1.87e-01	0.42300	1.98e-01	3.74e-01	2.16e-01	1.97e-02
GOBP GLUCOCORTICOID METABOLIC PROCESS	24	1.11e-03	1.14e-02	0.42300	-4.23e-01	9.00e-03	3.36e-04	9.39e-01
Removal of the Flap Intermediate	13	4.83e-02	1.84e-01	0.42300	3.79e-01	1.87e-01	1.79e-02	2.43e-01
WNT mediated activation of DVL	8	1.70e-01	3.92e-01	0.42300	3.25e-01	2.71e-01	1.12e-01	1.85e-01
Unfolded Protein Response (UPR)	86	4.46e-09	2.15e-07	0.42300	3.47e-01	2.42e-01	2.75e-08	1.06e-04
GOBP NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY	21	1.09e-03	1.12e-02	0.42200	-3.86e-01	1.72e-01	2.21e-03	1.72e-01
GOBP ADIPONECTIN ACTIVATED SIGNALING PATHWAY	7	2.03e-01	4.34e-01	0.42200	3.64e-01	2.14e-01	9.54e-02	3.26e-01
Respiratory syncytial virus (RSV) genome replication, transcription and translation	16	2.84e-02	1.27e-01	0.42200	2.56e-01	3.36e-01	7.67e-02	1.98e-02
GOCC AXOLEMMA	15	3.13e-02	1.36e-01	0.42200	-3.74e-01	-1.95e-01	1.20e-02	1.90e-01
KSRP (KHSRP) binds and destabilizes mRNA	17	2.15e-02	1.05e-01	0.42200	3.57e-01	2.26e-01	1.08e-02	1.07e-01
GOBP SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY	19	1.02e-02	6.09e-02	0.42200	3.96e-01	1.46e-01	2.79e-03	2.71e-01
GOMF BUBBLE DNA BINDING	8	1.72e-01	3.94e-01	0.42200	3.10e-01	2.87e-01	1.29e-01	1.60e-01
GOBP REGULATION OF XENOPHAGY	9	4.98e-02	1.88e-01	0.42200	2.19e-01	-3.61e-01	2.55e-01	6.09e-02
Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation	11	3.63e-02	1.51e-01	0.42200	4.14e-01	-7.88e-02	1.73e-02	6.51e-01
GOMF ACYL COA HYDROLASE ACTIVITY	22	7.57e-03	4.87e-02	0.42200	3.37e-01	2.53e-01	6.14e-03	3.99e-02
mRNA decay by 3’ to 5’ exoribonuclease	16	2.87e-02	1.28e-01	0.42200	3.38e-01	2.52e-01	1.93e-02	8.06e-02
GOMF FOLIC ACID BINDING	13	4.70e-02	1.80e-01	0.42100	-3.86e-01	-1.69e-01	1.60e-02	2.90e-01
GOMF POLY A RNA POLYMERASE ACTIVITY	11	8.96e-02	2.71e-01	0.42100	2.98e-01	2.98e-01	8.71e-02	8.70e-02
GOBP BONE TRABECULA FORMATION	11	7.79e-02	2.49e-01	0.42100	3.79e-01	1.84e-01	2.96e-02	2.89e-01
Signaling by FGFR4 in disease	11	4.72e-02	1.81e-01	0.42100	4.21e-01	4.94e-03	1.55e-02	9.77e-01
GOMF BILE ACID SODIUM SYMPORTER ACTIVITY	5	1.98e-01	4.28e-01	0.42100	-1.72e-01	3.84e-01	5.05e-01	1.37e-01
GOBP POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS	14	4.56e-02	1.76e-01	0.42100	3.31e-01	2.60e-01	3.18e-02	9.25e-02
GOBP ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE	8	1.53e-01	3.69e-01	0.42100	3.86e-01	1.68e-01	5.87e-02	4.10e-01
GOMF INTERLEUKIN 1 BINDING	9	6.10e-02	2.13e-01	0.42100	1.19e-01	-4.04e-01	5.35e-01	3.60e-02
GOMF ARACHIDONIC ACID MONOOXYGENASE ACTIVITY	17	2.36e-02	1.12e-01	0.42100	-2.61e-01	-3.31e-01	6.29e-02	1.83e-02
GOBP ZYGOTIC DETERMINATION OF ANTERIOR POSTERIOR AXIS EMBRYO	6	2.62e-01	5.01e-01	0.42100	-2.32e-01	-3.51e-01	3.24e-01	1.37e-01
GOBP REGULATION OF GUANYLATE CYCLASE ACTIVITY	6	2.38e-01	4.75e-01	0.42100	-1.46e-01	-3.95e-01	5.37e-01	9.40e-02
GOCC MITOTIC COHESIN COMPLEX	5	1.85e-01	4.11e-01	0.42100	2.85e-01	-3.09e-01	2.70e-01	2.31e-01
Gap-filling DNA repair synthesis and ligation in GG-NER	25	3.87e-03	2.92e-02	0.42100	2.40e-01	3.45e-01	3.74e-02	2.81e-03
Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3	29	1.69e-03	1.55e-02	0.42100	3.31e-01	2.59e-01	2.02e-03	1.57e-02
mRNA Splicing	199	4.81e-21	7.38e-19	0.42000	3.90e-01	1.57e-01	2.11e-21	1.39e-04
GOMF G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR ACTIVITY	7	1.21e-01	3.24e-01	0.42000	-4.12e-01	8.46e-02	5.92e-02	6.98e-01
GOBP INDUCTION OF BACTERIAL AGGLUTINATION	6	1.61e-01	3.80e-01	0.42000	-4.09e-01	9.68e-02	8.27e-02	6.81e-01
GOBP POSITIVE REGULATION OF MAPKKK CASCADE BY FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	5	2.79e-01	5.19e-01	0.42000	-7.92e-02	-4.13e-01	7.59e-01	1.10e-01
GOBP CELLULAR RESPONSE TO SODIUM ARSENITE	5	2.25e-01	4.59e-01	0.42000	-7.57e-02	4.13e-01	7.69e-01	1.10e-01
GOBP TUBULIN COMPLEX ASSEMBLY	8	1.52e-01	3.67e-01	0.42000	3.89e-01	1.59e-01	5.68e-02	4.37e-01
GOBP REGULATION OF MYOFIBROBLAST DIFFERENTIATION	9	1.09e-01	3.05e-01	0.42000	4.05e-01	1.12e-01	3.55e-02	5.60e-01
Branched-chain amino acid catabolism	20	1.27e-02	7.15e-02	0.42000	2.78e-01	3.15e-01	3.14e-02	1.48e-02
GOCC GTPASE ACTIVATOR COMPLEX	11	7.67e-02	2.46e-01	0.42000	3.85e-01	1.69e-01	2.72e-02	3.32e-01
GOBP NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS	35	4.08e-04	5.05e-03	0.42000	3.53e-01	2.27e-01	2.96e-04	2.02e-02
GOBP NEGATIVE REGULATION OF VITAMIN METABOLIC PROCESS	7	1.05e-01	2.99e-01	0.42000	-1.76e-01	3.81e-01	4.20e-01	8.06e-02
GOMF CAMP DEPENDENT PROTEIN KINASE ACTIVITY	5	3.37e-01	5.75e-01	0.42000	2.98e-01	2.95e-01	2.48e-01	2.53e-01
GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE ADAPTATION	8	1.16e-01	3.16e-01	0.42000	4.19e-01	2.72e-02	4.02e-02	8.94e-01
GOCC NETWORK FORMING COLLAGEN TRIMER	6	2.06e-01	4.38e-01	0.42000	-4.91e-02	-4.17e-01	8.35e-01	7.70e-02
GOBP NEGATIVE REGULATION OF CELL ADHESION MOLECULE PRODUCTION	10	1.05e-01	2.99e-01	0.42000	-3.64e-01	-2.09e-01	4.63e-02	2.53e-01
GOBP NEGATIVE REGULATION OF FEEDING BEHAVIOR	6	2.21e-01	4.54e-01	0.42000	-4.10e-01	-8.97e-02	8.21e-02	7.04e-01
GOCC PRECATALYTIC SPLICEOSOME	50	5.53e-06	1.31e-04	0.41900	4.00e-01	1.26e-01	9.89e-07	1.22e-01
GOBP CARBOHYDRATE MEDIATED SIGNALING	11	7.53e-02	2.43e-01	0.41900	3.89e-01	1.58e-01	2.56e-02	3.65e-01
FLT3 signaling by CBL mutants	7	2.01e-01	4.31e-01	0.41900	3.76e-01	1.86e-01	8.53e-02	3.94e-01
GOBP RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME	13	4.51e-02	1.75e-01	0.41900	-3.94e-01	-1.42e-01	1.38e-02	3.76e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON METAL IONS OXYGEN AS ACCEPTOR	5	2.31e-01	4.67e-01	0.41900	-4.15e-01	5.96e-02	1.08e-01	8.17e-01
GOBP CELLULAR RESPONSE TO WATER STIMULUS	6	2.53e-01	4.91e-01	0.41900	1.86e-01	3.75e-01	4.29e-01	1.11e-01
GOMF RNA POLYMERASE II ACTIVITY	9	8.14e-02	2.55e-01	0.41900	4.19e-01	-1.06e-02	2.96e-02	9.56e-01
GOBP RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR	17	1.20e-02	6.84e-02	0.41900	-4.15e-01	-5.52e-02	3.03e-03	6.93e-01
GOCC BETA CATENIN DESTRUCTION COMPLEX	12	7.34e-02	2.40e-01	0.41900	3.23e-01	2.67e-01	5.29e-02	1.09e-01
Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA	17	2.52e-02	1.17e-01	0.41900	3.02e-01	2.90e-01	3.12e-02	3.82e-02
Complement cascade	54	8.47e-06	1.88e-04	0.41900	-2.86e-01	-3.06e-01	2.82e-04	9.94e-05
GOBP INTRACELLULAR CORTICOSTEROID RECEPTOR SIGNALING PATHWAY	14	4.29e-02	1.70e-01	0.41900	3.65e-01	2.05e-01	1.81e-02	1.84e-01
GOCC NADPH OXIDASE COMPLEX	13	1.31e-02	7.29e-02	0.41900	-3.16e-01	2.74e-01	4.84e-02	8.68e-02
GOBP SPINAL CORD MOTOR NEURON DIFFERENTIATION	28	2.15e-03	1.87e-02	0.41900	3.40e-01	2.44e-01	1.82e-03	2.57e-02
Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy	15	3.60e-02	1.50e-01	0.41900	2.26e-01	3.52e-01	1.30e-01	1.81e-02
GOBP REGULATION OF RNA EXPORT FROM NUCLEUS	15	2.76e-02	1.25e-01	0.41800	3.97e-01	1.33e-01	7.83e-03	3.71e-01
NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis	9	1.09e-01	3.06e-01	0.41800	4.05e-01	1.06e-01	3.56e-02	5.80e-01
GOMF CARBOXYLESTERASE ACTIVITY	6	2.52e-01	4.90e-01	0.41800	-1.78e-01	-3.78e-01	4.49e-01	1.09e-01
GOBP PROTEIN LOCALIZATION TO NUCLEOPLASM	13	3.29e-02	1.41e-01	0.41800	4.16e-01	4.39e-02	9.41e-03	7.84e-01
GOBP REGULATION OF METAPHASE PLATE CONGRESSION	14	4.49e-02	1.75e-01	0.41800	2.24e-01	3.53e-01	1.47e-01	2.21e-02
GOBP NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING	32	5.45e-04	6.44e-03	0.41800	3.90e-01	1.52e-01	1.35e-04	1.38e-01
GOCC PROTON TRANSPORTING ATP SYNTHASE COMPLEX CATALYTIC CORE F 1	6	1.58e-01	3.76e-01	0.41800	4.00e-01	-1.22e-01	8.97e-02	6.06e-01
GOMF SNRNA BINDING	48	2.27e-05	4.40e-04	0.41800	3.60e-01	2.13e-01	1.61e-05	1.07e-02
GOBP RAP PROTEIN SIGNAL TRANSDUCTION	12	6.48e-02	2.21e-01	0.41800	1.84e-01	3.75e-01	2.69e-01	2.44e-02
GOMF L SERINE TRANSMEMBRANE TRANSPORTER ACTIVITY	8	1.26e-01	3.32e-01	0.41800	4.14e-01	5.66e-02	4.25e-02	7.82e-01
Formyl peptide receptors bind formyl peptides and many other ligands	8	1.75e-01	3.98e-01	0.41800	-3.32e-01	-2.54e-01	1.04e-01	2.13e-01
Mitochondrial translation initiation	87	6.81e-09	3.09e-07	0.41800	3.22e-01	2.66e-01	1.99e-07	1.81e-05
GOBP BOX C D SNORNP ASSEMBLY	10	5.44e-02	1.98e-01	0.41800	4.13e-01	-6.01e-02	2.36e-02	7.42e-01
GOBP INNER CELL MASS CELL DIFFERENTIATION	8	1.14e-01	3.14e-01	0.41800	4.18e-01	1.13e-02	4.08e-02	9.56e-01
GOCC VESICLE COAT	62	4.33e-07	1.37e-05	0.41800	3.93e-01	1.41e-01	8.51e-08	5.54e-02
Dectin-2 family	28	1.56e-03	1.45e-02	0.41800	-3.83e-01	-1.67e-01	4.56e-04	1.26e-01
GOBP HEMIDESMOSOME ASSEMBLY	6	2.74e-01	5.14e-01	0.41700	-2.72e-01	-3.16e-01	2.48e-01	1.79e-01
GOBP IRIS MORPHOGENESIS	9	1.44e-01	3.57e-01	0.41700	3.03e-01	2.87e-01	1.16e-01	1.36e-01
GOBP POSITIVE REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY	5	1.92e-01	4.20e-01	0.41700	3.29e-01	-2.56e-01	2.02e-01	3.22e-01
GOCC SIGNAL PEPTIDASE COMPLEX	5	3.35e-01	5.73e-01	0.41700	2.32e-01	3.46e-01	3.68e-01	1.80e-01
GOBP REGULATION OF OVARIAN FOLLICLE DEVELOPMENT	6	2.76e-01	5.16e-01	0.41700	-2.98e-01	-2.91e-01	2.07e-01	2.16e-01
GOBP NEGATIVE REGULATION OF CYTOPLASMIC TRANSLATION	9	1.15e-01	3.15e-01	0.41700	3.98e-01	1.22e-01	3.85e-02	5.27e-01
GOCC BASEMENT MEMBRANE COLLAGEN TRIMER	6	2.17e-01	4.49e-01	0.41600	-6.38e-02	-4.12e-01	7.87e-01	8.08e-02
GOCC ARP2 3 PROTEIN COMPLEX	9	1.33e-01	3.42e-01	0.41600	1.97e-01	3.67e-01	3.06e-01	5.66e-02
GOMF TRANSCRIPTION REGULATOR INHIBITOR ACTIVITY	27	2.86e-03	2.32e-02	0.41600	2.43e-01	3.38e-01	2.86e-02	2.38e-03
GOBP PRIMITIVE STREAK FORMATION	10	9.28e-02	2.77e-01	0.41600	1.30e-01	3.95e-01	4.76e-01	3.03e-02
Impaired BRCA2 binding to PALB2	24	5.47e-03	3.79e-02	0.41600	3.39e-01	2.42e-01	4.09e-03	4.00e-02
GOCC SERINE TYPE ENDOPEPTIDASE COMPLEX	11	4.61e-02	1.78e-01	0.41600	-4.15e-01	2.72e-02	1.71e-02	8.76e-01
GOMF 3 KETO STEROL REDUCTASE ACTIVITY	5	3.39e-01	5.78e-01	0.41600	2.51e-01	3.32e-01	3.30e-01	1.99e-01
GOBP BRANCHED CHAIN AMINO ACID BIOSYNTHETIC PROCESS	5	1.92e-01	4.20e-01	0.41600	2.90e-01	-2.98e-01	2.61e-01	2.48e-01
GOBP PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS	23	6.60e-03	4.39e-02	0.41600	2.30e-01	3.47e-01	5.65e-02	3.97e-03
GOBP POSITIVE REGULATION OF NATURAL KILLER CELL CHEMOTAXIS	5	2.68e-01	5.07e-01	0.41600	-4.15e-01	-2.98e-02	1.08e-01	9.08e-01
RHOBTB GTPase Cycle	34	5.68e-04	6.69e-03	0.41600	3.55e-01	2.16e-01	3.35e-04	2.94e-02
GOBP NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO WOUNDING	9	1.45e-01	3.58e-01	0.41600	-2.62e-01	-3.23e-01	1.74e-01	9.35e-02
GOBP NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE	20	1.27e-02	7.15e-02	0.41600	3.48e-01	2.27e-01	7.02e-03	7.89e-02
GOMF PHOSPHATIDYLINOSITOL 3 4 5 TRISPHOSPHATE 5 PHOSPHATASE ACTIVITY	6	1.39e-01	3.51e-01	0.41600	2.67e-01	-3.18e-01	2.57e-01	1.77e-01
GOBP MUSCLE ATROPHY	11	8.85e-02	2.70e-01	0.41500	3.58e-01	2.10e-01	3.95e-02	2.28e-01
GOBP REGULATION OF HIPPOCAMPAL NEURON APOPTOTIC PROCESS	5	2.83e-01	5.22e-01	0.41500	-6.69e-02	-4.10e-01	7.95e-01	1.13e-01
GOBP PUTRESCINE METABOLIC PROCESS	7	1.13e-01	3.12e-01	0.41500	-1.58e-01	3.84e-01	4.68e-01	7.86e-02
GOMF MAP KINASE TYROSINE SERINE THREONINE PHOSPHATASE ACTIVITY	11	3.01e-02	1.32e-01	0.41500	-3.67e-01	1.93e-01	3.48e-02	2.67e-01
GOMF LIPOPOLYSACCHARIDE IMMUNE RECEPTOR ACTIVITY	6	1.40e-01	3.53e-01	0.41500	-2.58e-01	3.25e-01	2.73e-01	1.68e-01
GOCC CIS GOLGI NETWORK MEMBRANE	10	1.19e-01	3.21e-01	0.41500	2.76e-01	3.09e-01	1.30e-01	9.02e-02
GOMF UBIQUITIN LIKE MODIFIER ACTIVATING ENZYME ACTIVITY	9	1.38e-01	3.49e-01	0.41500	3.58e-01	2.10e-01	6.28e-02	2.76e-01
RNA Polymerase III Transcription Termination	23	4.74e-03	3.40e-02	0.41500	3.89e-01	1.44e-01	1.24e-03	2.32e-01
GOBP RESPONSE TO STILBENOID	8	1.28e-01	3.35e-01	0.41500	-4.93e-02	-4.12e-01	8.09e-01	4.36e-02
GOBP SENSORY PERCEPTION OF SOUR TASTE	9	1.46e-01	3.59e-01	0.41500	-2.58e-01	-3.25e-01	1.80e-01	9.16e-02
GOBP GLIAL CELL FATE SPECIFICATION	7	1.92e-01	4.20e-01	0.41500	3.94e-01	1.29e-01	7.09e-02	5.55e-01
Interleukin-2 signaling	11	4.14e-02	1.66e-01	0.41500	-7.01e-02	4.09e-01	6.87e-01	1.89e-02
p75NTR regulates axonogenesis	9	1.46e-01	3.59e-01	0.41500	-3.22e-01	-2.61e-01	9.44e-02	1.75e-01
GOCC U2 TYPE SPLICEOSOMAL COMPLEX	91	3.47e-10	1.99e-08	0.41400	3.99e-01	1.11e-01	4.51e-11	6.67e-02
GOBP ISOPRENOID TRANSPORT	5	3.37e-01	5.76e-01	0.41400	-3.50e-01	-2.22e-01	1.76e-01	3.90e-01
Defective EXT1 causes exostoses 1, TRPS2 and CHDS	12	7.87e-02	2.50e-01	0.41400	-2.93e-01	-2.93e-01	7.92e-02	7.87e-02
Defective EXT2 causes exostoses 2	12	7.87e-02	2.50e-01	0.41400	-2.93e-01	-2.93e-01	7.92e-02	7.87e-02
GOBP POSITIVE REGULATION OF PHOSPHOLIPASE A2 ACTIVITY	5	3.43e-01	5.81e-01	0.41400	3.30e-01	2.50e-01	2.01e-01	3.32e-01
GOCC ENDOPLASMIC RETICULUM CHAPERONE COMPLEX	11	7.69e-02	2.46e-01	0.41400	1.38e-01	3.90e-01	4.28e-01	2.49e-02
GOBP AORTA SMOOTH MUSCLE TISSUE MORPHOGENESIS	6	1.69e-01	3.91e-01	0.41400	4.02e-01	-9.96e-02	8.82e-02	6.73e-01
Mitochondrial translation	93	2.31e-09	1.18e-07	0.41400	3.35e-01	2.44e-01	2.41e-08	4.82e-05
GOBP BASEMENT MEMBRANE ASSEMBLY	9	6.75e-02	2.27e-01	0.41400	3.98e-01	-1.13e-01	3.85e-02	5.59e-01
GOCC SYNAPSE ASSOCIATED EXTRACELLULAR MATRIX	12	4.78e-02	1.82e-01	0.41400	-4.10e-01	-5.71e-02	1.39e-02	7.32e-01
GOCC RIPOPTOSOME	6	2.80e-01	5.20e-01	0.41400	2.77e-01	3.08e-01	2.40e-01	1.92e-01
GOBP NEURON PROJECTION MAINTENANCE	11	8.32e-02	2.59e-01	0.41400	3.78e-01	1.69e-01	3.01e-02	3.31e-01
GOBP PROTEIN HISTIDYL MODIFICATION TO DIPHTHAMIDE	7	2.06e-01	4.37e-01	0.41400	1.69e-01	3.77e-01	4.38e-01	8.38e-02
Fatty acids	15	3.63e-02	1.51e-01	0.41400	-3.65e-01	-1.95e-01	1.44e-02	1.92e-01
GOBP STABILIZATION OF MEMBRANE POTENTIAL	17	2.50e-02	1.17e-01	0.41400	-3.50e-01	-2.20e-01	1.24e-02	1.16e-01
GOBP ACROSOMAL VESICLE EXOCYTOSIS	9	1.01e-01	2.91e-01	0.41400	-4.88e-02	-4.11e-01	8.00e-01	3.29e-02
GOBP POSITIVE REGULATION OF DNA CATABOLIC PROCESS	5	3.14e-01	5.54e-01	0.41300	1.42e-01	3.88e-01	5.83e-01	1.33e-01
GOCC DYNACTIN COMPLEX	8	1.49e-01	3.63e-01	0.41300	3.97e-01	1.14e-01	5.16e-02	5.78e-01
mRNA Splicing - Major Pathway	189	1.49e-19	2.08e-17	0.41300	3.87e-01	1.44e-01	3.87e-20	6.27e-04
GOBP NEURON FATE DETERMINATION	10	1.05e-01	2.99e-01	0.41300	1.70e-01	3.77e-01	3.53e-01	3.91e-02
SUMOylation of transcription cofactors	44	5.89e-05	1.00e-03	0.41300	3.68e-01	1.87e-01	2.37e-05	3.19e-02
GOCC NUCLEOLAR EXOSOME RNASE COMPLEX	10	1.01e-01	2.91e-01	0.41300	3.86e-01	1.47e-01	3.46e-02	4.21e-01
GOBP NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY	12	6.64e-02	2.25e-01	0.41300	3.79e-01	1.64e-01	2.30e-02	3.26e-01
GOMF TRANSFORMING GROWTH FACTOR BETA RECEPTOR ACTIVITY TYPE I	5	2.69e-01	5.08e-01	0.41300	4.12e-01	1.84e-02	1.10e-01	9.43e-01
TICAM1,TRAF6-dependent induction of TAK1 complex	10	9.06e-02	2.73e-01	0.41300	4.00e-01	1.02e-01	2.86e-02	5.76e-01
Formation of axial mesoderm	14	2.77e-02	1.25e-01	0.41300	4.10e-02	4.11e-01	7.90e-01	7.80e-03
GOBP APOLIPOPROTEIN A I MEDIATED SIGNALING PATHWAY	7	2.02e-01	4.32e-01	0.41300	-1.50e-01	-3.84e-01	4.92e-01	7.82e-02
Regulation of PTEN localization	8	1.62e-01	3.81e-01	0.41300	3.83e-01	1.55e-01	6.10e-02	4.49e-01
Na+/Cl- dependent neurotransmitter transporters	18	2.20e-02	1.06e-01	0.41300	-2.50e-01	-3.28e-01	6.67e-02	1.59e-02
GOBP HEAT ACCLIMATION	5	2.18e-01	4.52e-01	0.41200	-1.42e-01	3.87e-01	5.83e-01	1.34e-01
GOMF LYSOZYME ACTIVITY	9	9.58e-02	2.82e-01	0.41200	-2.38e-02	-4.12e-01	9.02e-01	3.25e-02
GOBP CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT	9	1.45e-01	3.58e-01	0.41200	2.29e-01	3.43e-01	2.34e-01	7.50e-02
GOBP CELLULAR RESPONSE TO LUTEINIZING HORMONE STIMULUS	5	2.10e-01	4.42e-01	0.41200	3.71e-01	-1.81e-01	1.51e-01	4.85e-01
GOCC INTRACILIARY TRANSPORT PARTICLE B	19	1.86e-02	9.45e-02	0.41200	2.99e-01	2.83e-01	2.40e-02	3.24e-02
GOCC INO80 TYPE COMPLEX	27	2.14e-03	1.86e-02	0.41200	3.83e-01	1.51e-01	5.63e-04	1.76e-01
GOBP ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS	24	6.47e-03	4.32e-02	0.41200	2.69e-01	3.12e-01	2.24e-02	8.19e-03
GOMF NADH DEHYDROGENASE UBIQUINONE ACTIVITY	33	2.92e-04	3.84e-03	0.41200	4.05e-01	7.21e-02	5.54e-05	4.73e-01
GOBP POSITIVE REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS	7	2.19e-01	4.52e-01	0.41200	3.56e-01	2.07e-01	1.03e-01	3.44e-01
Vitamins	6	1.79e-01	4.03e-01	0.41200	-7.58e-02	4.05e-01	7.48e-01	8.61e-02
GOMF 5 N 7 METHYLGUANOSINE 5 TRIPHOSPHO MRNA HYDROLASE ACTIVITY	10	1.23e-01	3.26e-01	0.41200	2.73e-01	3.08e-01	1.35e-01	9.17e-02
Collagen chain trimerization	42	9.18e-05	1.45e-03	0.41200	-1.79e-01	-3.71e-01	4.46e-02	3.23e-05
GOBP PROTEIN TARGETING TO VACUOLE INVOLVED IN AUTOPHAGY	5	3.41e-01	5.79e-01	0.41100	2.14e-01	3.51e-01	4.07e-01	1.74e-01
GOMF SUMO BINDING	16	3.48e-02	1.47e-01	0.41100	3.16e-01	2.63e-01	2.85e-02	6.85e-02
GOBP REGULATION OF KILLING OF CELLS OF ANOTHER ORGANISM	9	9.14e-02	2.74e-01	0.41100	-4.11e-01	-2.54e-05	3.26e-02	1.00e+00
GOBP ARTICULAR CARTILAGE DEVELOPMENT	5	2.59e-01	4.98e-01	0.41100	4.11e-01	-1.44e-02	1.11e-01	9.55e-01
GOBP NEGATIVE REGULATION OF ERAD PATHWAY	7	2.24e-01	4.58e-01	0.41100	2.23e-01	3.46e-01	3.07e-01	1.13e-01
GOMF STRUCTURAL CONSTITUENT OF CHROMATIN	78	8.73e-08	3.21e-06	0.41100	2.84e-01	2.98e-01	1.48e-05	5.42e-06
GOBP RESPONSE TO HYDROXYUREA	11	8.18e-02	2.56e-01	0.41100	3.84e-01	1.47e-01	2.75e-02	3.97e-01
GOBP DIADENOSINE POLYPHOSPHATE METABOLIC PROCESS	6	2.71e-01	5.11e-01	0.41100	1.98e-01	3.60e-01	4.01e-01	1.26e-01
GOBP REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION	10	8.45e-02	2.62e-01	0.41100	6.71e-02	4.05e-01	7.13e-01	2.64e-02
GOBP REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I	43	5.15e-05	8.90e-04	0.41100	3.88e-01	1.35e-01	1.07e-05	1.25e-01
GOMF PHOSPHATIDYLETHANOLAMINE FLIPPASE ACTIVITY	5	3.53e-01	5.90e-01	0.41100	-2.84e-01	-2.97e-01	2.72e-01	2.50e-01
GOBP PROTEIN INSERTION INTO MEMBRANE FROM INNER SIDE	5	3.03e-01	5.43e-01	0.41100	3.99e-01	9.68e-02	1.22e-01	7.08e-01
GOCC ORGANELLAR RIBOSOME	89	7.77e-09	3.48e-07	0.41100	3.28e-01	2.48e-01	9.10e-08	5.39e-05
GOMF ADENOSINE 3 5 BISPHOSPHATE TRANSMEMBRANE TRANSPORTER ACTIVITY	5	3.50e-01	5.87e-01	0.41100	3.24e-01	2.52e-01	2.09e-01	3.29e-01
GOCC METHYLOSOME	13	5.46e-02	1.99e-01	0.41100	3.77e-01	1.62e-01	1.85e-02	3.11e-01
GOBP TRICARBOXYLIC ACID CYCLE	28	1.25e-03	1.24e-02	0.41100	3.99e-01	9.65e-02	2.57e-04	3.77e-01
GOBP POSITIVE REGULATION OF PROTEOGLYCAN BIOSYNTHETIC PROCESS	5	2.05e-01	4.36e-01	0.41100	2.27e-01	-3.42e-01	3.78e-01	1.86e-01
Condensation of Prometaphase Chromosomes	11	1.01e-01	2.92e-01	0.41100	2.86e-01	2.94e-01	1.00e-01	9.10e-02
GOBP DETECTION OF MOLECULE OF BACTERIAL ORIGIN	13	4.04e-02	1.63e-01	0.41000	-4.05e-01	-6.55e-02	1.14e-02	6.83e-01
GOBP REGULATION OF CHROMATIN ORGANIZATION	32	7.41e-04	8.37e-03	0.41000	3.81e-01	1.53e-01	1.92e-04	1.35e-01
Advanced glycosylation endproduct receptor signaling	13	2.87e-02	1.28e-01	0.41000	4.09e-01	-3.23e-02	1.07e-02	8.40e-01
GOBP NEGATIVE REGULATION OF INTERLEUKIN 18 PRODUCTION	5	2.31e-01	4.66e-01	0.41000	-3.96e-01	1.07e-01	1.25e-01	6.79e-01
GOBP TAIL ANCHORED MEMBRANE PROTEIN INSERTION INTO ER MEMBRANE	15	2.97e-02	1.31e-01	0.41000	3.94e-01	1.12e-01	8.17e-03	4.52e-01
GOBP DIRECT OSSIFICATION	7	1.44e-01	3.57e-01	0.41000	4.07e-01	-4.74e-02	6.21e-02	8.28e-01
Diseases associated with visual transduction	11	3.74e-02	1.54e-01	0.41000	1.35e-01	-3.87e-01	4.40e-01	2.62e-02
Diseases of the neuronal system	11	3.74e-02	1.54e-01	0.41000	1.35e-01	-3.87e-01	4.40e-01	2.62e-02
Retinoid cycle disease events	11	3.74e-02	1.54e-01	0.41000	1.35e-01	-3.87e-01	4.40e-01	2.62e-02
GOMF SIALIC ACID BINDING	22	5.17e-03	3.63e-02	0.41000	-4.00e-01	-9.06e-02	1.18e-03	4.62e-01
Creatine metabolism	8	9.53e-02	2.81e-01	0.40900	-1.15e-01	3.93e-01	5.73e-01	5.42e-02
GOBP NEGATIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION	5	2.46e-01	4.84e-01	0.40900	4.05e-01	-6.18e-02	1.17e-01	8.11e-01
Activation of RAC1 downstream of NMDARs	7	2.33e-01	4.68e-01	0.40900	2.58e-01	3.18e-01	2.37e-01	1.45e-01
Processive synthesis on the lagging strand	14	4.72e-02	1.81e-01	0.40900	3.66e-01	1.84e-01	1.78e-02	2.33e-01
GOCC APICOLATERAL PLASMA MEMBRANE	23	3.01e-03	2.41e-02	0.40900	-4.07e-01	-3.87e-02	7.17e-04	7.48e-01
GOBP CARDIAC MUSCLE CELL FATE COMMITMENT	8	1.74e-01	3.97e-01	0.40900	3.67e-01	1.81e-01	7.22e-02	3.76e-01
GOBP MEMBRANE DISASSEMBLY	13	3.50e-02	1.47e-01	0.40900	1.85e-02	4.09e-01	9.08e-01	1.07e-02
GOMF TRIGLYCERIDE LIPASE ACTIVITY	24	5.84e-03	3.98e-02	0.40900	-3.56e-01	-2.02e-01	2.57e-03	8.68e-02
GOCC DENDRITIC SPINE HEAD	7	1.10e-01	3.07e-01	0.40900	2.35e-01	-3.34e-01	2.82e-01	1.25e-01
GOBP ADP TRANSPORT	10	1.16e-01	3.16e-01	0.40900	1.96e-01	3.59e-01	2.84e-01	4.96e-02
GOBP REGULATION OF MUCUS SECRETION	9	1.44e-01	3.57e-01	0.40800	-1.92e-01	-3.61e-01	3.19e-01	6.10e-02
GOBP MACROPHAGE PROLIFERATION	12	2.33e-02	1.11e-01	0.40800	3.43e-01	-2.22e-01	3.98e-02	1.83e-01
GOBP ANTIBACTERIAL PEPTIDE PRODUCTION	10	6.31e-02	2.17e-01	0.40800	5.27e-02	-4.05e-01	7.73e-01	2.66e-02
GOBP POSITIVE REGULATION OF T HELPER 17 CELL DIFFERENTIATION	12	8.12e-02	2.55e-01	0.40800	3.36e-01	2.32e-01	4.40e-02	1.65e-01
GOBP SEMINIFEROUS TUBULE DEVELOPMENT	14	5.64e-02	2.02e-01	0.40800	2.97e-01	2.79e-01	5.44e-02	7.03e-02
GOBP REGULATION OF RRNA PROCESSING	16	2.65e-02	1.21e-01	0.40800	3.86e-01	1.32e-01	7.56e-03	3.60e-01
GOMF POTASSIUM CHANNEL ACTIVATOR ACTIVITY	5	3.17e-01	5.56e-01	0.40800	1.21e-01	3.89e-01	6.40e-01	1.32e-01
GOBP MITOCHONDRIAL RNA 3 END PROCESSING	6	2.07e-01	4.39e-01	0.40800	4.08e-01	-4.18e-03	8.38e-02	9.86e-01
Deadenylation-dependent mRNA decay	53	9.71e-06	2.11e-04	0.40700	3.69e-01	1.72e-01	3.28e-06	3.03e-02
GOMF SUMO POLYMER BINDING	5	3.58e-01	5.95e-01	0.40700	3.08e-01	2.67e-01	2.33e-01	3.02e-01
GOMF OPSONIN RECEPTOR ACTIVITY	5	2.07e-01	4.38e-01	0.40700	-2.56e-01	3.17e-01	3.22e-01	2.20e-01
GOBP REGULATION OF ENDOSOME SIZE	13	6.59e-02	2.23e-01	0.40700	2.24e-01	3.40e-01	1.62e-01	3.39e-02
GOCC CHROMOSOME PASSENGER COMPLEX	6	2.86e-01	5.25e-01	0.40700	3.36e-01	2.30e-01	1.54e-01	3.29e-01
GOBP SNRNA TRANSCRIPTION	20	1.67e-02	8.74e-02	0.40700	2.92e-01	2.83e-01	2.35e-02	2.84e-02
GOBP POSITIVE REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE	11	1.01e-01	2.92e-01	0.40700	-2.29e-01	-3.36e-01	1.88e-01	5.34e-02
GOBP TYPE III INTERFERON PRODUCTION	5	2.18e-01	4.51e-01	0.40700	3.64e-01	-1.82e-01	1.59e-01	4.81e-01
GOCC HAPTOGLOBIN HEMOGLOBIN COMPLEX	11	6.05e-02	2.12e-01	0.40700	-4.06e-01	-1.79e-02	1.96e-02	9.18e-01
GOBP CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT	16	2.93e-02	1.30e-01	0.40700	3.76e-01	1.55e-01	9.21e-03	2.83e-01
GOMF COMPLEMENT RECEPTOR ACTIVITY	11	5.91e-02	2.08e-01	0.40700	-4.07e-01	-1.04e-02	1.95e-02	9.52e-01
GOBP NEGATIVE REGULATION OF EPINEPHRINE SECRETION	5	2.27e-01	4.61e-01	0.40700	-3.80e-01	1.44e-01	1.41e-01	5.78e-01
GOBP EOSINOPHIL MEDIATED IMMUNITY	8	8.04e-02	2.53e-01	0.40700	-2.78e-01	2.97e-01	1.73e-01	1.46e-01
GOMF ALCOHOL DEHYDROGENASE NADPLUS ACTIVITY ZINC DEPENDENT	7	1.48e-01	3.61e-01	0.40600	5.10e-02	-4.03e-01	8.15e-01	6.48e-02
GOMF DOUBLE STRANDED RNA ADENOSINE DEAMINASE ACTIVITY	6	1.59e-01	3.76e-01	0.40600	-3.54e-01	1.99e-01	1.33e-01	3.99e-01
GOBP REGULATION OF TOLL SIGNALING PATHWAY	5	3.05e-01	5.44e-01	0.40600	8.06e-02	3.98e-01	7.55e-01	1.23e-01
Signaling by CSF3 (G-CSF)	30	2.22e-03	1.91e-02	0.40600	2.76e-01	2.98e-01	8.77e-03	4.79e-03
CD163 mediating an anti-inflammatory response	9	6.33e-02	2.17e-01	0.40600	-2.00e-01	3.53e-01	2.98e-01	6.65e-02
TRIF-mediated programmed cell death	9	9.51e-02	2.81e-01	0.40600	-8.92e-03	4.06e-01	9.63e-01	3.50e-02
GOBP RNA POLYMERASE I PREINITIATION COMPLEX ASSEMBLY	9	7.20e-02	2.37e-01	0.40600	3.85e-01	-1.29e-01	4.54e-02	5.04e-01
GOBP COMMON BILE DUCT DEVELOPMENT	5	2.23e-01	4.57e-01	0.40600	-1.65e-01	3.71e-01	5.22e-01	1.51e-01
GOBP POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION	40	1.50e-04	2.15e-03	0.40600	3.76e-01	1.52e-01	3.79e-05	9.67e-02
GOBP NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS	21	1.48e-03	1.40e-02	0.40600	-2.28e-01	3.36e-01	7.03e-02	7.75e-03
GOMF EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT CONFERRING COMPRESSION RESISTANCE	19	3.10e-03	2.47e-02	0.40600	1.87e-01	-3.60e-01	1.58e-01	6.56e-03
SHC-related events triggered by IGF1R	9	1.51e-01	3.67e-01	0.40600	3.48e-01	2.09e-01	7.09e-02	2.77e-01
GOBP PROTEIN IMPORT INTO PEROXISOME MEMBRANE	6	2.91e-01	5.30e-01	0.40600	3.26e-01	2.41e-01	1.67e-01	3.06e-01
Signaling by TGFBR3	48	4.53e-05	8.03e-04	0.40500	3.44e-01	2.15e-01	3.71e-05	1.01e-02
GOBP AMMONIUM HOMEOSTASIS	5	3.60e-01	5.97e-01	0.40500	-2.56e-01	-3.15e-01	3.22e-01	2.23e-01
GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OSMOTIC STRESS	8	1.63e-01	3.83e-01	0.40500	3.87e-01	1.22e-01	5.82e-02	5.51e-01
GOBP POSITIVE REGULATION OF T HELPER 17 CELL LINEAGE COMMITMENT	8	1.92e-01	4.20e-01	0.40500	3.31e-01	2.33e-01	1.05e-01	2.53e-01
Interleukin-1 processing	9	1.49e-01	3.63e-01	0.40500	-3.55e-01	-1.96e-01	6.53e-02	3.09e-01
GOBP ASTRAL MICROTUBULE ORGANIZATION	9	1.42e-01	3.55e-01	0.40500	1.63e-01	3.71e-01	3.96e-01	5.41e-02
GOBP HISTONE MRNA CATABOLIC PROCESS	15	3.95e-02	1.61e-01	0.40500	3.67e-01	1.70e-01	1.38e-02	2.54e-01
GOBP PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION	15	4.65e-02	1.79e-01	0.40500	3.24e-01	2.42e-01	2.98e-02	1.04e-01
GOBP DE NOVO NAD BIOSYNTHETIC PROCESS	8	1.95e-01	4.24e-01	0.40500	-3.21e-01	-2.47e-01	1.16e-01	2.27e-01
GOMF DNA DEMETHYLASE ACTIVITY	5	2.63e-01	5.03e-01	0.40500	4.03e-01	-3.50e-02	1.19e-01	8.92e-01
GOBP ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE	53	2.01e-05	3.96e-04	0.40500	3.24e-01	2.42e-01	4.47e-05	2.28e-03
NCAM1 interactions	41	2.38e-04	3.22e-03	0.40400	-3.19e-01	-2.48e-01	4.05e-04	5.91e-03
GOBP ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY	6	2.62e-01	5.02e-01	0.40400	-3.82e-01	-1.33e-01	1.05e-01	5.74e-01
GOMF FOUR WAY JUNCTION DNA BINDING	16	3.12e-02	1.35e-01	0.40400	3.71e-01	1.61e-01	1.02e-02	2.66e-01
GOBP REGULATION OF NEUTROPHIL DEGRANULATION	8	1.05e-01	2.99e-01	0.40400	-9.41e-02	3.93e-01	6.45e-01	5.42e-02
GOBP NEGATIVE REGULATION OF SEQUESTERING OF TRIGLYCERIDE	6	1.97e-01	4.27e-01	0.40400	-4.01e-01	5.18e-02	8.92e-02	8.26e-01
GOBP CENP A CONTAINING CHROMATIN ASSEMBLY	9	1.41e-01	3.54e-01	0.40400	3.73e-01	1.55e-01	5.26e-02	4.22e-01
GOCC X CHROMOSOME	11	1.09e-01	3.06e-01	0.40400	2.99e-01	2.72e-01	8.64e-02	1.18e-01
GOBP EYELID DEVELOPMENT IN CAMERA TYPE EYE	13	6.93e-02	2.31e-01	0.40400	3.35e-01	2.26e-01	3.66e-02	1.59e-01
GOBP LACTONE METABOLIC PROCESS	13	6.97e-02	2.31e-01	0.40400	2.29e-01	3.32e-01	1.52e-01	3.80e-02
GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DEVELOPMENT	12	7.94e-02	2.52e-01	0.40400	1.87e-01	3.58e-01	2.63e-01	3.18e-02
GOCC MICROTUBULE MINUS END	7	2.23e-01	4.58e-01	0.40300	3.67e-01	1.67e-01	9.28e-02	4.43e-01
GOBP LYMPHOCYTE MIGRATION INTO LYMPHOID ORGANS	9	6.31e-02	2.17e-01	0.40300	-3.30e-01	2.32e-01	8.67e-02	2.28e-01
GOBP MRNA METHYLGUANOSINE CAP DECAPPING	16	2.35e-02	1.12e-01	0.40300	3.95e-01	7.84e-02	6.18e-03	5.87e-01
GOBP POSITIVE REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION	6	1.58e-01	3.76e-01	0.40300	3.26e-01	-2.37e-01	1.67e-01	3.14e-01
GOBP NEGATIVE REGULATION OF GLUCOCORTICOID METABOLIC PROCESS	5	2.14e-01	4.46e-01	0.40300	-2.56e-01	3.11e-01	3.22e-01	2.28e-01
GOBP RESPONSE TO INDOLE 3 METHANOL	6	1.66e-01	3.88e-01	0.40300	3.58e-01	-1.85e-01	1.29e-01	4.33e-01
GOBP PRIMARY ALCOHOL BIOSYNTHETIC PROCESS	14	4.30e-02	1.70e-01	0.40300	-3.86e-01	-1.16e-01	1.25e-02	4.52e-01
GOBP XMP METABOLIC PROCESS	7	1.16e-01	3.16e-01	0.40300	3.19e-01	-2.46e-01	1.44e-01	2.60e-01
GOBP HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE	17	1.15e-02	6.66e-02	0.40300	2.91e-02	-4.02e-01	8.36e-01	4.15e-03
GOCC TOM COMPLEX	7	2.46e-01	4.84e-01	0.40300	2.90e-01	2.79e-01	1.84e-01	2.00e-01
Response to metal ions	14	3.34e-02	1.42e-01	0.40200	4.32e-02	4.00e-01	7.79e-01	9.54e-03
Cobalamin (Cbl) metabolism	7	1.74e-01	3.97e-01	0.40200	4.02e-01	1.64e-02	6.56e-02	9.40e-01
GOBP REGULATION OF VITAMIN D RECEPTOR SIGNALING PATHWAY	10	1.35e-01	3.45e-01	0.40200	2.70e-01	2.98e-01	1.40e-01	1.02e-01
rRNA processing in the mitochondrion	9	1.37e-01	3.49e-01	0.40200	3.80e-01	1.31e-01	4.83e-02	4.95e-01
GOBP HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION	8	1.83e-01	4.09e-01	0.40200	1.71e-01	3.64e-01	4.02e-01	7.48e-02
GOBP MRNA 5 SPLICE SITE RECOGNITION	10	1.35e-01	3.45e-01	0.40200	3.09e-01	2.57e-01	9.09e-02	1.59e-01
GOCC ANAPHASE PROMOTING COMPLEX	22	1.25e-02	7.03e-02	0.40200	2.82e-01	2.86e-01	2.20e-02	2.02e-02
GOMF PROTON TRANSPORTING ATP SYNTHASE ACTIVITY ROTATIONAL MECHANISM	16	3.64e-02	1.51e-01	0.40200	3.50e-01	1.97e-01	1.54e-02	1.72e-01
GOBP GOLGI LOCALIZATION	14	2.66e-02	1.21e-01	0.40200	4.01e-01	-2.11e-02	9.37e-03	8.91e-01
GOMF PH DOMAIN BINDING	8	1.63e-01	3.83e-01	0.40200	3.88e-01	1.03e-01	5.72e-02	6.15e-01
GOBP NEGATIVE REGULATION OF MUSCLE ADAPTATION	11	7.25e-02	2.38e-01	0.40200	3.98e-01	5.54e-02	2.24e-02	7.50e-01
GOBP REGULATION OF RESPONSE TO DRUG	16	3.56e-02	1.49e-01	0.40200	-1.88e-01	-3.55e-01	1.93e-01	1.40e-02
GOBP NEGATIVE REGULATION OF SCHWANN CELL PROLIFERATION	8	1.00e-01	2.90e-01	0.40100	3.77e-01	-1.36e-01	6.45e-02	5.04e-01
GOBP REGULATION OF HEMATOPOIETIC STEM CELL PROLIFERATION	15	3.97e-02	1.61e-01	0.40100	1.51e-01	3.72e-01	3.11e-01	1.27e-02
GOMF PHOSPHATIDYLCHOLINE STEROL O ACYLTRANSFERASE ACTIVATOR ACTIVITY	6	1.59e-01	3.76e-01	0.40100	2.72e-01	-2.95e-01	2.48e-01	2.11e-01
GOBP FREE UBIQUITIN CHAIN POLYMERIZATION	9	1.58e-01	3.75e-01	0.40100	2.06e-01	3.44e-01	2.85e-01	7.36e-02
GOBP SKELETAL MUSCLE ATROPHY	5	3.59e-01	5.96e-01	0.40100	3.44e-01	2.06e-01	1.83e-01	4.25e-01
Defective pyroptosis	34	1.05e-03	1.09e-02	0.40100	3.30e-01	2.27e-01	8.57e-04	2.19e-02
GOMF LARGE RIBOSOMAL SUBUNIT RRNA BINDING	5	3.40e-01	5.78e-01	0.40100	3.74e-01	1.44e-01	1.48e-01	5.76e-01
GOMF U4 SNRNA BINDING	6	2.53e-01	4.91e-01	0.40100	3.91e-01	8.89e-02	9.75e-02	7.06e-01
Hydrolysis of LPC	9	1.46e-01	3.59e-01	0.40100	-1.53e-01	-3.70e-01	4.26e-01	5.45e-02
Metalloprotease DUBs	27	3.47e-03	2.69e-02	0.40100	3.61e-01	1.74e-01	1.18e-03	1.17e-01
GOBP REGULATION OF ADIPONECTIN SECRETION	7	1.35e-01	3.45e-01	0.40100	1.32e-01	-3.78e-01	5.45e-01	8.31e-02
SUMO is transferred from E1 to E2 (UBE2I, UBC9)	7	1.64e-01	3.84e-01	0.40100	4.00e-01	-2.35e-02	6.69e-02	9.14e-01
GOBP NEGATIVE REGULATION OF MYOBLAST PROLIFERATION	9	1.53e-01	3.69e-01	0.40000	-1.80e-01	-3.58e-01	3.50e-01	6.32e-02
GOBP HIS PURKINJE SYSTEM DEVELOPMENT	7	2.39e-01	4.76e-01	0.40000	2.04e-01	3.44e-01	3.50e-01	1.15e-01
GOCC MULTIVESICULAR BODY INTERNAL VESICLE	6	2.08e-01	4.39e-01	0.40000	3.98e-01	-3.83e-02	9.11e-02	8.71e-01
GOBP REGULATION OF HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS	7	1.32e-01	3.40e-01	0.40000	3.70e-01	-1.52e-01	8.98e-02	4.87e-01
GOMF LONG CHAIN FATTY ACYL COA HYDROLASE ACTIVITY	12	7.60e-02	2.44e-01	0.40000	3.72e-01	1.46e-01	2.55e-02	3.81e-01
GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY	61	2.24e-06	5.96e-05	0.40000	3.70e-01	1.50e-01	5.56e-07	4.24e-02
GOMF ARMADILLO REPEAT DOMAIN BINDING	8	1.74e-01	3.96e-01	0.40000	3.79e-01	1.26e-01	6.31e-02	5.37e-01
GOBP PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION	38	4.87e-04	5.90e-03	0.40000	3.30e-01	2.26e-01	4.37e-04	1.58e-02
GOBP CARDIAC NEURAL CREST CELL DEVELOPMENT INVOLVED IN OUTFLOW TRACT MORPHOGENESIS	13	6.31e-02	2.17e-01	0.40000	3.68e-01	1.55e-01	2.15e-02	3.33e-01
GOBP ELASTIN CATABOLIC PROCESS	5	2.37e-01	4.74e-01	0.40000	1.47e-01	-3.72e-01	5.70e-01	1.50e-01
GOBP REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION	6	2.60e-01	4.98e-01	0.39900	3.87e-01	1.00e-01	1.01e-01	6.71e-01
GOBP NEGATIVE REGULATION OF AMYLOID FIBRIL FORMATION	12	7.28e-02	2.38e-01	0.39900	3.79e-01	1.26e-01	2.31e-02	4.49e-01
GOCC GOLGI MEDIAL CISTERNA	11	1.01e-01	2.92e-01	0.39900	1.74e-01	3.59e-01	3.18e-01	3.90e-02
GOBP REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH	12	3.58e-02	1.50e-01	0.39900	-1.05e-01	3.85e-01	5.29e-01	2.09e-02
GOBP REGULATION OF T CELL CHEMOTAXIS	15	2.07e-02	1.02e-01	0.39900	3.11e-02	-3.98e-01	8.35e-01	7.63e-03
GOBP MALE MATING BEHAVIOR	7	1.86e-01	4.12e-01	0.39900	3.58e-02	3.97e-01	8.70e-01	6.86e-02
GOBP NEURAL PLATE DEVELOPMENT	8	1.79e-01	4.04e-01	0.39900	3.73e-01	1.41e-01	6.75e-02	4.91e-01
GOBP REGULATION OF NEUTROPHIL ACTIVATION	6	2.53e-01	4.91e-01	0.39900	-7.94e-02	-3.91e-01	7.36e-01	9.73e-02
GOBP DOPAMINERGIC NEURON DIFFERENTIATION	39	3.12e-04	4.04e-03	0.39900	1.78e-01	3.57e-01	5.48e-02	1.14e-04
GOBP REGULATION OF CHRONIC INFLAMMATORY RESPONSE	8	1.34e-01	3.43e-01	0.39900	-3.99e-01	5.40e-03	5.08e-02	9.79e-01
GOBP RESCUE OF STALLED RIBOSOME	33	1.22e-03	1.22e-02	0.39900	3.46e-01	1.99e-01	5.87e-04	4.83e-02
GOBP POSITIVE REGULATION OF SKELETAL MUSCLE FIBER DEVELOPMENT	9	1.38e-01	3.49e-01	0.39900	1.16e-01	3.81e-01	5.48e-01	4.75e-02
Phase 0 - rapid depolarisation	31	2.30e-03	1.96e-02	0.39800	-2.79e-01	-2.84e-01	7.16e-03	6.11e-03
GOBP SENSORY PERCEPTION	871	6.70e-75	6.86e-72	0.39800	-3.42e-01	-2.04e-01	2.37e-66	1.52e-24
GOCC SPERM HEAD	17	3.24e-02	1.39e-01	0.39800	-2.08e-01	-3.39e-01	1.37e-01	1.54e-02
GOMF ACETYL COA C ACYLTRANSFERASE ACTIVITY	7	2.49e-01	4.87e-01	0.39800	3.25e-01	2.31e-01	1.37e-01	2.90e-01
Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function	25	7.00e-03	4.57e-02	0.39800	3.24e-01	2.32e-01	5.08e-03	4.48e-02
Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function	25	7.00e-03	4.57e-02	0.39800	3.24e-01	2.32e-01	5.08e-03	4.48e-02
Defective homologous recombination repair (HRR) due to BRCA1 loss of function	25	7.00e-03	4.57e-02	0.39800	3.24e-01	2.32e-01	5.08e-03	4.48e-02
Defective homologous recombination repair (HRR) due to PALB2 loss of function	25	7.00e-03	4.57e-02	0.39800	3.24e-01	2.32e-01	5.08e-03	4.48e-02
GOBP RIBOSOMAL SMALL SUBUNIT EXPORT FROM NUCLEUS	8	2.06e-01	4.38e-01	0.39800	3.15e-01	2.44e-01	1.23e-01	2.32e-01
GOBP NEGATIVE REGULATION OF METALLOENDOPEPTIDASE ACTIVITY	5	3.12e-01	5.52e-01	0.39800	6.15e-02	3.93e-01	8.12e-01	1.28e-01
GOBP MAINTENANCE OF DNA REPEAT ELEMENTS	7	2.15e-01	4.47e-01	0.39800	3.81e-01	1.15e-01	8.08e-02	5.98e-01
GOCC NUCLEOTIDE EXCISION REPAIR COMPLEX	11	1.06e-01	3.01e-01	0.39800	1.91e-01	3.49e-01	2.74e-01	4.47e-02
GOCC ELONGIN COMPLEX	5	2.25e-01	4.60e-01	0.39800	-2.19e-01	3.33e-01	3.97e-01	1.98e-01
GOMF CALCIUM ACTIVATED POTASSIUM CHANNEL ACTIVITY	13	7.80e-02	2.49e-01	0.39800	-2.60e-01	-3.01e-01	1.04e-01	6.02e-02
Positive epigenetic regulation of rRNA expression	68	1.45e-06	4.05e-05	0.39800	3.21e-01	2.36e-01	4.73e-06	7.82e-04
GOBP RIBOSOME ASSOCIATED UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS	7	1.43e-01	3.56e-01	0.39800	3.81e-01	-1.14e-01	8.06e-02	6.02e-01
GOBP OMEGA HYDROXYLASE P450 PATHWAY	11	1.16e-01	3.15e-01	0.39800	-2.59e-01	-3.02e-01	1.37e-01	8.28e-02
GOMF STAT FAMILY PROTEIN BINDING	11	4.10e-02	1.65e-01	0.39800	-1.73e-01	3.58e-01	3.21e-01	3.96e-02
GOBP SCHWANN CELL PROLIFERATION	9	7.15e-02	2.36e-01	0.39800	3.50e-01	-1.89e-01	6.92e-02	3.25e-01
GOBP HOST MEDIATED REGULATION OF INTESTINAL MICROBIOTA COMPOSITION	9	1.53e-01	3.69e-01	0.39800	-3.62e-01	-1.64e-01	6.00e-02	3.94e-01
SARS-CoV-2 modulates autophagy	11	9.12e-02	2.74e-01	0.39800	3.79e-01	1.20e-01	2.95e-02	4.91e-01
GOBP LONG CHAIN FATTY ACID CATABOLIC PROCESS	8	1.90e-01	4.17e-01	0.39700	-3.60e-01	-1.68e-01	7.76e-02	4.11e-01
Muscarinic acetylcholine receptors	5	2.58e-01	4.96e-01	0.39700	-3.88e-01	8.73e-02	1.33e-01	7.35e-01
GOBP TONIC SMOOTH MUSCLE CONTRACTION	11	3.73e-02	1.54e-01	0.39700	2.35e-01	-3.20e-01	1.77e-01	6.57e-02
GOBP REGULATION OF ACUTE INFLAMMATORY RESPONSE	45	1.42e-05	2.93e-04	0.39700	-3.97e-01	1.32e-03	3.99e-06	9.88e-01
GOBP MRNA 3 END PROCESSING	38	5.33e-04	6.34e-03	0.39700	3.29e-01	2.23e-01	4.52e-04	1.75e-02
GOBP PH REDUCTION	6	2.72e-01	5.12e-01	0.39700	-1.21e-01	-3.78e-01	6.09e-01	1.09e-01
GOMF TOLL LIKE RECEPTOR 4 BINDING	5	2.57e-01	4.95e-01	0.39700	-9.31e-02	3.86e-01	7.18e-01	1.35e-01
GOMF LYSOPHOSPHATIDIC ACID BINDING	7	1.95e-01	4.24e-01	0.39700	-5.42e-02	-3.93e-01	8.04e-01	7.16e-02
GOCC CATALYTIC STEP 2 SPLICEOSOME	86	3.56e-09	1.74e-07	0.39700	3.89e-01	7.94e-02	4.45e-10	2.03e-01
GOBP DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS	9	1.30e-01	3.37e-01	0.39700	7.85e-02	3.89e-01	6.84e-01	4.33e-02
GOBP NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION	8	2.10e-01	4.41e-01	0.39700	3.04e-01	2.55e-01	1.36e-01	2.12e-01
Regulated proteolysis of p75NTR	11	1.14e-01	3.14e-01	0.39700	2.33e-01	3.21e-01	1.81e-01	6.49e-02
GOBP CGMP BIOSYNTHETIC PROCESS	10	1.11e-01	3.09e-01	0.39700	1.09e-01	3.82e-01	5.52e-01	3.67e-02
GOBP REGULATION OF RESTING MEMBRANE POTENTIAL	10	1.43e-01	3.57e-01	0.39600	-2.86e-01	-2.74e-01	1.17e-01	1.33e-01
RHO GTPases activate PKNs	56	1.48e-05	3.03e-04	0.39600	3.34e-01	2.14e-01	1.53e-05	5.69e-03
GOBP NEGATIVE REGULATION OF TROPHOBLAST CELL MIGRATION	7	1.50e-01	3.64e-01	0.39600	-9.43e-02	3.85e-01	6.66e-01	7.78e-02
GOBP NEGATIVE REGULATION OF FERTILIZATION	7	2.09e-01	4.41e-01	0.39600	-8.94e-02	-3.86e-01	6.82e-01	7.70e-02
GOBP POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT	23	9.93e-03	5.95e-02	0.39600	1.99e-01	3.43e-01	9.92e-02	4.45e-03
GOBP FLAVONOID METABOLIC PROCESS	11	9.92e-02	2.89e-01	0.39600	-1.47e-01	-3.68e-01	4.00e-01	3.46e-02
GOBP POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION	6	2.89e-01	5.28e-01	0.39600	3.60e-01	1.64e-01	1.26e-01	4.87e-01
GOBP FATTY ACID OMEGA OXIDATION	5	3.68e-01	6.05e-01	0.39600	-2.05e-01	-3.39e-01	4.28e-01	1.89e-01
GOBP BUNDLE OF HIS CELL TO PURKINJE MYOCYTE SIGNALING	7	2.51e-01	4.89e-01	0.39600	-2.21e-01	-3.29e-01	3.12e-01	1.32e-01
Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)	8	1.46e-01	3.59e-01	0.39600	-2.16e-02	-3.95e-01	9.16e-01	5.29e-02
GOBP POSITIVE REGULATION OF CHEMOKINE C X C MOTIF LIGAND 1 PRODUCTION	5	3.50e-01	5.87e-01	0.39600	-3.68e-01	-1.46e-01	1.54e-01	5.73e-01
GOMF HISTONE H3K4 MONOMETHYLTRANSFERASE ACTIVITY	8	1.15e-01	3.15e-01	0.39600	3.85e-01	-9.36e-02	5.96e-02	6.47e-01
GOBP GAP JUNCTION MEDIATED INTERCELLULAR TRANSPORT	6	2.85e-01	5.23e-01	0.39600	-3.67e-01	-1.48e-01	1.20e-01	5.30e-01
Condensation of Prophase Chromosomes	36	9.08e-04	9.72e-03	0.39600	2.44e-01	3.11e-01	1.14e-02	1.22e-03
GOBP POSITIVE REGULATION OF CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION	5	3.04e-01	5.44e-01	0.39600	-3.94e-01	-2.86e-02	1.27e-01	9.12e-01
GOBP PHARYNGEAL ARCH ARTERY MORPHOGENESIS	10	1.13e-01	3.11e-01	0.39500	3.81e-01	1.07e-01	3.71e-02	5.59e-01
GOBP ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY	8	1.25e-01	3.30e-01	0.39500	-3.92e-01	5.40e-02	5.51e-02	7.91e-01
GOBP NEGATIVE REGULATION OF HORMONE BIOSYNTHETIC PROCESS	10	5.17e-02	1.92e-01	0.39500	-2.41e-01	3.13e-01	1.87e-01	8.62e-02
GOMF BILE ACID BINDING	10	1.37e-01	3.47e-01	0.39500	-2.03e-01	-3.39e-01	2.66e-01	6.35e-02
GOBP CEREBELLAR GRANULAR LAYER MORPHOGENESIS	8	2.14e-01	4.46e-01	0.39500	-2.71e-01	-2.88e-01	1.85e-01	1.59e-01
GOMF MAP KINASE PHOSPHATASE ACTIVITY	15	1.27e-02	7.16e-02	0.39500	-3.42e-01	1.98e-01	2.19e-02	1.83e-01
GOCC SPECTRIN ASSOCIATED CYTOSKELETON	9	1.76e-01	4.00e-01	0.39500	-2.80e-01	-2.79e-01	1.46e-01	1.48e-01
GOBP CORONARY ARTERY MORPHOGENESIS	9	1.73e-01	3.96e-01	0.39500	2.39e-01	3.14e-01	2.14e-01	1.02e-01
GOBP REGULATION OF ASTROCYTE ACTIVATION	8	2.14e-01	4.46e-01	0.39500	-2.83e-01	-2.75e-01	1.65e-01	1.77e-01
GOBP REGULATION OF BILE ACID BIOSYNTHETIC PROCESS	12	9.95e-02	2.89e-01	0.39500	-2.82e-01	-2.76e-01	9.10e-02	9.75e-02
GOBP SNRNA TRANSCRIPTION BY RNA POLYMERASE III	9	1.69e-01	3.91e-01	0.39500	3.33e-01	2.11e-01	8.33e-02	2.73e-01
GOBP PROGESTERONE RECEPTOR SIGNALING PATHWAY	11	1.20e-01	3.22e-01	0.39400	3.01e-01	2.55e-01	8.35e-02	1.44e-01
GOBP REGULATION OF PROTEIN COMPLEX STABILITY	14	3.48e-02	1.47e-01	0.39400	3.94e-01	1.75e-02	1.07e-02	9.10e-01
GOCC SWI SNF SUPERFAMILY TYPE COMPLEX	90	9.55e-09	4.20e-07	0.39400	3.61e-01	1.59e-01	3.20e-09	9.23e-03
GOCC HOST CELLULAR COMPONENT	9	1.55e-01	3.70e-01	0.39400	3.64e-01	1.51e-01	5.84e-02	4.33e-01
GOBP HYPOTHALAMUS CELL MIGRATION	6	2.74e-01	5.14e-01	0.39400	-1.13e-01	-3.78e-01	6.32e-01	1.09e-01
GOBP GERMINAL CENTER B CELL DIFFERENTIATION	8	1.07e-01	3.02e-01	0.39400	-3.67e-01	1.44e-01	7.24e-02	4.79e-01
GOBP TROPHECTODERMAL CELL DIFFERENTIATION	19	2.58e-02	1.19e-01	0.39400	2.53e-01	3.02e-01	5.66e-02	2.25e-02
GOBP RELAXATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE	6	1.73e-01	3.95e-01	0.39400	-3.24e-01	2.25e-01	1.70e-01	3.41e-01
GOBP REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS	15	4.24e-02	1.69e-01	0.39400	-3.71e-01	-1.32e-01	1.28e-02	3.76e-01
GOMF NFAT PROTEIN BINDING	5	3.63e-01	6.00e-01	0.39400	1.72e-01	3.54e-01	5.05e-01	1.70e-01
GOBP NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR	14	6.35e-02	2.18e-01	0.39400	2.06e-01	3.35e-01	1.82e-01	2.98e-02
GOBP REGULATION OF MICROTUBULE NUCLEATION	17	3.85e-02	1.57e-01	0.39400	2.60e-01	2.95e-01	6.30e-02	3.52e-02
GOCC TELOMERASE HOLOENZYME COMPLEX	20	1.05e-02	6.21e-02	0.39300	3.89e-01	5.88e-02	2.59e-03	6.49e-01
GOBP NUCLEOBASE CATABOLIC PROCESS	10	1.48e-01	3.61e-01	0.39300	-2.74e-01	-2.82e-01	1.33e-01	1.22e-01
GOCC ACETYLCHOLINE GATED CHANNEL COMPLEX	17	1.48e-02	8.01e-02	0.39300	-3.93e-01	1.78e-02	5.02e-03	8.99e-01
HDR through Single Strand Annealing (SSA)	37	8.16e-04	9.02e-03	0.39300	3.09e-01	2.43e-01	1.15e-03	1.04e-02
GOBP URONIC ACID METABOLIC PROCESS	24	1.01e-02	6.03e-02	0.39300	-2.55e-01	-3.00e-01	3.09e-02	1.10e-02
GOBP MITOTIC SISTER CHROMATID COHESION	26	4.25e-03	3.14e-02	0.39300	3.71e-01	1.31e-01	1.07e-03	2.47e-01
APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway	7	2.50e-01	4.89e-01	0.39300	1.96e-01	3.41e-01	3.70e-01	1.18e-01
IRAK1 recruits IKK complex	12	7.33e-02	2.39e-01	0.39300	3.81e-01	9.75e-02	2.24e-02	5.59e-01
IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation	12	7.33e-02	2.39e-01	0.39300	3.81e-01	9.75e-02	2.24e-02	5.59e-01
GOBP PROTEIN LOCALIZATION TO CYTOPLASMIC STRESS GRANULE	7	2.54e-01	4.91e-01	0.39300	3.33e-01	2.08e-01	1.27e-01	3.41e-01
GOMF ALL TRANS RETINAL BINDING	5	3.08e-01	5.48e-01	0.39300	-3.92e-01	-2.74e-02	1.29e-01	9.15e-01
GOCC G PROTEIN COUPLED RECEPTOR COMPLEX	11	1.02e-01	2.94e-01	0.39300	-1.43e-01	-3.66e-01	4.11e-01	3.56e-02
Pexophagy	10	1.36e-01	3.46e-01	0.39300	3.47e-01	1.85e-01	5.75e-02	3.12e-01
GOBP NEGATIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY	9	7.21e-02	2.37e-01	0.39300	-2.35e-01	3.15e-01	2.22e-01	1.02e-01
GOBP CANNABINOID SIGNALING PATHWAY	7	2.27e-01	4.61e-01	0.39300	-1.22e-01	-3.73e-01	5.77e-01	8.71e-02
GOBP PROTEIN NEDDYLATION	28	2.99e-03	2.40e-02	0.39300	3.67e-01	1.40e-01	7.77e-04	2.01e-01
GOBP PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER	15	3.60e-02	1.50e-01	0.39300	7.96e-02	3.84e-01	5.93e-01	9.94e-03
GOCC NURD COMPLEX	15	5.56e-02	2.01e-01	0.39300	3.16e-01	2.33e-01	3.40e-02	1.19e-01
GOBP NATURAL KILLER CELL CHEMOTAXIS	10	6.37e-02	2.18e-01	0.39300	-3.69e-01	1.34e-01	4.33e-02	4.63e-01
Calnexin/calreticulin cycle	26	3.82e-03	2.89e-02	0.39200	3.77e-01	1.09e-01	8.77e-04	3.36e-01
GOBP RETINAL CELL APOPTOTIC PROCESS	7	1.29e-01	3.37e-01	0.39200	3.03e-01	-2.49e-01	1.64e-01	2.54e-01
GOBP RESPONSE TO INTERLEUKIN 13	5	3.49e-01	5.87e-01	0.39200	-1.26e-01	-3.72e-01	6.26e-01	1.50e-01
Histidine catabolism	8	2.00e-01	4.30e-01	0.39200	-1.70e-01	-3.54e-01	4.06e-01	8.32e-02
Oncogene Induced Senescence	35	1.29e-03	1.27e-02	0.39200	2.93e-01	2.61e-01	2.74e-03	7.46e-03
Class C/3 (Metabotropic glutamate/pheromone receptors)	39	6.10e-04	7.10e-03	0.39200	-2.73e-01	-2.81e-01	3.15e-03	2.35e-03
GOCC SPLICEOSOMAL COMPLEX	186	1.33e-17	1.65e-15	0.39200	3.71e-01	1.26e-01	2.23e-18	3.09e-03
GOBP RESPONSE TO PHEROMONE	7	2.46e-01	4.84e-01	0.39200	-3.51e-01	-1.75e-01	1.08e-01	4.22e-01
GOBP RESPONSE TO GLYCOPROTEIN	11	4.47e-02	1.74e-01	0.39200	-1.75e-01	3.51e-01	3.15e-01	4.41e-02
GOMF PHOTORECEPTOR ACTIVITY	13	5.20e-02	1.92e-01	0.39200	-5.28e-02	-3.88e-01	7.42e-01	1.53e-02
GOBP SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION	23	9.02e-03	5.56e-02	0.39200	1.50e-01	3.62e-01	2.14e-01	2.64e-03
GOBP GROWTH PLATE CARTILAGE DEVELOPMENT	19	1.75e-02	9.03e-02	0.39200	3.76e-01	1.12e-01	4.59e-03	4.00e-01
GOCC MYOSIN II COMPLEX	26	2.17e-03	1.88e-02	0.39200	-1.96e-02	-3.91e-01	8.62e-01	5.52e-04
GOMF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR BINDING	10	1.16e-01	3.16e-01	0.39200	3.79e-01	1.00e-01	3.81e-02	5.82e-01
GOBP CELL SURFACE RECEPTOR PROTEIN TYROSINE PHOSPHATASE SIGNALING PATHWAY	6	2.35e-01	4.72e-01	0.39200	1.06e-04	-3.92e-01	1.00e+00	9.66e-02
GOCC WASH COMPLEX	13	4.47e-02	1.75e-01	0.39200	3.92e-01	7.67e-03	1.45e-02	9.62e-01
GOBP NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS	16	9.60e-03	5.81e-02	0.39100	2.37e-01	-3.12e-01	1.01e-01	3.07e-02
Senescence-Associated Secretory Phenotype (SASP)	74	8.44e-07	2.53e-05	0.39100	2.62e-01	2.91e-01	9.62e-05	1.54e-05
GOBP POSITIVE REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION	8	1.06e-01	3.01e-01	0.39100	-3.53e-01	1.69e-01	8.36e-02	4.09e-01
GOBP CARDIAC MUSCLE TISSUE REGENERATION	8	2.05e-01	4.36e-01	0.39100	3.47e-01	1.82e-01	8.96e-02	3.74e-01
GOBP POSITIVE REGULATION OF RRNA PROCESSING	10	9.48e-02	2.81e-01	0.39100	3.91e-01	1.78e-02	3.24e-02	9.22e-01
GOCC FAR SIN STRIPAK COMPLEX	16	2.41e-02	1.14e-01	0.39100	3.90e-01	2.76e-02	6.91e-03	8.49e-01
TFAP2 (AP-2) family regulates transcription of cell cycle factors	5	3.43e-01	5.81e-01	0.39100	1.03e-01	3.77e-01	6.89e-01	1.44e-01
GOBP ACUTE PHASE RESPONSE	45	1.51e-04	2.17e-03	0.39100	-1.93e-01	-3.40e-01	2.48e-02	8.11e-05
GOMF HISTONE H3K4 TRIMETHYLTRANSFERASE ACTIVITY	10	6.72e-02	2.26e-01	0.39100	3.72e-01	-1.21e-01	4.19e-02	5.09e-01
GOBP POSITIVE REGULATION OF T HELPER 2 CELL CYTOKINE PRODUCTION	9	9.19e-02	2.75e-01	0.39100	-3.78e-01	9.99e-02	4.97e-02	6.04e-01
GOBP NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR PRODUCTION	6	2.03e-01	4.33e-01	0.39100	-3.76e-01	1.04e-01	1.10e-01	6.59e-01
GOBP FORELIMB MORPHOGENESIS	40	5.39e-04	6.39e-03	0.39100	2.75e-01	2.78e-01	2.65e-03	2.37e-03
HATs acetylate histones	97	6.31e-09	2.88e-07	0.39100	3.39e-01	1.95e-01	8.19e-09	9.25e-04
GOBP PLASMA CELL DIFFERENTIATION	9	1.64e-01	3.84e-01	0.39000	1.62e-01	3.55e-01	4.00e-01	6.49e-02
Assembly of the pre-replicative complex	96	1.08e-08	4.74e-07	0.39000	3.22e-01	2.20e-01	4.83e-08	1.89e-04
GOBP MAINTENANCE OF GASTROINTESTINAL EPITHELIUM	23	1.11e-02	6.49e-02	0.39000	-3.40e-01	-1.91e-01	4.73e-03	1.12e-01
GOMF ABC TYPE GLUTATHIONE S CONJUGATE TRANSPORTER ACTIVITY	8	2.02e-01	4.32e-01	0.39000	-1.65e-01	-3.54e-01	4.20e-01	8.31e-02
GOBP POSITIVE REGULATION OF COMPLEMENT ACTIVATION	7	2.39e-01	4.76e-01	0.39000	-3.64e-01	-1.41e-01	9.56e-02	5.18e-01
GOBP MOTOR BEHAVIOR	22	1.52e-02	8.20e-02	0.39000	2.31e-01	3.14e-01	6.03e-02	1.08e-02
GOBP REGULATION OF ALDOSTERONE METABOLIC PROCESS	8	1.58e-01	3.75e-01	0.39000	-3.89e-01	-3.23e-02	5.69e-02	8.74e-01
GOMF VOLTAGE GATED SODIUM CHANNEL ACTIVITY	23	1.23e-02	6.97e-02	0.39000	-3.20e-01	-2.22e-01	7.80e-03	6.49e-02
GOBP CYTOSOLIC RIBOSOME ASSEMBLY	8	1.44e-01	3.57e-01	0.39000	3.90e-01	-1.29e-02	5.63e-02	9.50e-01
GOBP CHIASMA ASSEMBLY	6	1.95e-01	4.24e-01	0.39000	3.65e-01	-1.38e-01	1.22e-01	5.57e-01
GOCC STEREOCILIUM BASE	8	2.21e-01	4.55e-01	0.39000	-2.50e-01	-2.99e-01	2.21e-01	1.43e-01
GOCC HIGH DENSITY LIPOPROTEIN PARTICLE	25	7.91e-04	8.81e-03	0.39000	3.25e-01	-2.15e-01	4.91e-03	6.24e-02
GOBP INTRACILIARY ANTEROGRADE TRANSPORT	19	2.27e-02	1.09e-01	0.39000	3.53e-01	1.66e-01	7.77e-03	2.11e-01
GOBP PROSTATE GLANDULAR ACINUS MORPHOGENESIS	6	2.82e-01	5.20e-01	0.39000	3.74e-01	1.08e-01	1.12e-01	6.45e-01
GOBP POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT	19	2.07e-02	1.02e-01	0.38900	1.39e-01	3.64e-01	2.94e-01	6.05e-03
GOBP PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION	26	3.13e-03	2.48e-02	0.38900	3.84e-01	6.30e-02	6.94e-04	5.78e-01
Stabilization of p53	43	1.12e-04	1.69e-03	0.38900	3.75e-01	1.04e-01	2.07e-05	2.38e-01
GOBP EMBRYONIC FORELIMB MORPHOGENESIS	33	2.08e-03	1.82e-02	0.38900	2.60e-01	2.90e-01	9.79e-03	3.97e-03
NFE2L2 regulates pentose phosphate pathway genes	7	2.27e-01	4.61e-01	0.38900	1.02e-01	3.75e-01	6.40e-01	8.55e-02
GOMF NUCLEAR ESTROGEN RECEPTOR BINDING	39	2.73e-04	3.63e-03	0.38900	3.74e-01	1.08e-01	5.35e-05	2.45e-01
GOBP N TERMINAL PROTEIN AMINO ACID ACETYLATION	14	5.64e-02	2.02e-01	0.38900	3.66e-01	1.30e-01	1.76e-02	3.98e-01
Beta oxidation of octanoyl-CoA to hexanoyl-CoA	5	3.57e-01	5.94e-01	0.38900	3.67e-01	1.27e-01	1.55e-01	6.22e-01
GOMF PRIMARY MIRNA BINDING	9	1.50e-01	3.64e-01	0.38900	3.74e-01	1.06e-01	5.20e-02	5.83e-01
GOBP SNORNA LOCALIZATION	6	2.37e-01	4.74e-01	0.38900	3.88e-01	-1.01e-02	9.94e-02	9.66e-01
GOMF THYROID HORMONE BINDING	6	1.90e-01	4.18e-01	0.38900	1.66e-01	-3.51e-01	4.81e-01	1.36e-01
GOMF HISTONE H2A UBIQUITIN LIGASE ACTIVITY	6	3.04e-01	5.44e-01	0.38800	1.64e-01	3.52e-01	4.86e-01	1.35e-01
GOCC B WICH COMPLEX	7	2.52e-01	4.90e-01	0.38800	3.48e-01	1.73e-01	1.11e-01	4.29e-01
Sodium-coupled phosphate cotransporters	5	3.08e-01	5.48e-01	0.38800	-4.68e-03	-3.88e-01	9.86e-01	1.33e-01
GOBP FOREBRAIN DORSAL VENTRAL PATTERN FORMATION	7	2.65e-01	5.04e-01	0.38800	2.19e-01	3.21e-01	3.17e-01	1.42e-01
GOCC N TERMINAL PROTEIN ACETYLTRANSFERASE COMPLEX	9	1.83e-01	4.08e-01	0.38800	3.17e-01	2.24e-01	1.00e-01	2.44e-01
GOBP COMMON MYELOID PROGENITOR CELL PROLIFERATION	9	1.83e-01	4.09e-01	0.38800	2.29e-01	3.13e-01	2.34e-01	1.03e-01
GOBP MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE	43	1.08e-04	1.64e-03	0.38800	3.76e-01	9.50e-02	1.95e-05	2.81e-01
GOBP POSITIVE REGULATION OF HAIR FOLLICLE MATURATION	5	3.55e-01	5.93e-01	0.38800	1.20e-01	3.69e-01	6.43e-01	1.53e-01
GOBP REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS	11	1.06e-01	3.01e-01	0.38800	3.64e-01	1.33e-01	3.63e-02	4.44e-01
Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)	14	7.15e-02	2.36e-01	0.38800	3.15e-01	2.26e-01	4.10e-02	1.44e-01
GOBP RESPONSE TO HYPEROXIA	17	3.75e-02	1.54e-01	0.38800	3.38e-01	1.90e-01	1.58e-02	1.75e-01
GOMF IRON ION TRANSMEMBRANE TRANSPORTER ACTIVITY	9	1.81e-01	4.06e-01	0.38800	2.10e-01	3.26e-01	2.74e-01	9.06e-02
GOCC SPHERICAL HIGH DENSITY LIPOPROTEIN PARTICLE	8	1.02e-01	2.93e-01	0.38800	3.03e-01	-2.42e-01	1.37e-01	2.37e-01
GOMF HISTONE DEUBIQUITINASE ACTIVITY	7	1.68e-01	3.90e-01	0.38800	3.81e-01	-7.22e-02	8.10e-02	7.41e-01
GOBP PROPIONATE METABOLIC PROCESS	5	3.10e-01	5.50e-01	0.38800	-6.63e-03	-3.88e-01	9.80e-01	1.33e-01
GOBP REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE	14	5.33e-02	1.96e-01	0.38800	1.07e-01	3.73e-01	4.90e-01	1.57e-02
GOCC IRON SULFUR CLUSTER ASSEMBLY COMPLEX	10	1.53e-01	3.69e-01	0.38800	3.10e-01	2.32e-01	8.93e-02	2.04e-01
GOBP REGULATION OF TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE	19	1.99e-02	9.93e-02	0.38700	3.69e-01	1.19e-01	5.40e-03	3.70e-01
GOMF POTASSIUM ION LEAK CHANNEL ACTIVITY	16	4.37e-02	1.72e-01	0.38700	-3.48e-01	-1.71e-01	1.61e-02	2.36e-01
GOBP PEPTIDYL PROLINE HYDROXYLATION TO 4 HYDROXY L PROLINE	8	2.09e-01	4.41e-01	0.38700	3.48e-01	1.70e-01	8.82e-02	4.06e-01
GOMF PEPTIDYL PROLINE 4 DIOXYGENASE ACTIVITY	8	2.09e-01	4.41e-01	0.38700	3.48e-01	1.70e-01	8.82e-02	4.06e-01
HDMs demethylate histones	18	1.49e-02	8.05e-02	0.38700	3.87e-01	6.89e-03	4.46e-03	9.60e-01
Tandem pore domain potassium channels	12	9.53e-02	2.81e-01	0.38700	-3.48e-01	-1.69e-01	3.66e-02	3.12e-01
GOBP REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS	121	2.08e-10	1.22e-08	0.38700	2.71e-01	2.76e-01	2.60e-07	1.50e-07
GOBP POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION	10	1.16e-01	3.16e-01	0.38700	3.79e-01	7.96e-02	3.80e-02	6.63e-01
GOCC PRE SNORNP COMPLEX	7	1.44e-01	3.57e-01	0.38700	3.42e-01	-1.81e-01	1.17e-01	4.06e-01
RUNX1 regulates expression of components of tight junctions	5	2.65e-01	5.04e-01	0.38700	-1.23e-01	3.67e-01	6.35e-01	1.55e-01
Defective F9 activation	5	2.81e-01	5.20e-01	0.38700	-3.80e-01	7.32e-02	1.41e-01	7.77e-01
GOBP RESPONSE TO GRAM POSITIVE BACTERIUM	6	3.22e-01	5.60e-01	0.38700	2.12e-01	3.23e-01	3.68e-01	1.70e-01
GOBP MESENCHYMAL CELL PROLIFERATION INVOLVED IN LUNG DEVELOPMENT	6	2.99e-01	5.38e-01	0.38700	3.61e-01	1.38e-01	1.26e-01	5.57e-01
Anchoring fibril formation	13	5.65e-02	2.02e-01	0.38700	-5.43e-02	-3.83e-01	7.35e-01	1.68e-02
GOMF ANKYRIN REPEAT BINDING	6	1.81e-01	4.06e-01	0.38700	2.97e-01	-2.48e-01	2.08e-01	2.93e-01
GOMF TELOMERIC DNA BINDING	38	3.95e-04	4.92e-03	0.38700	3.69e-01	1.15e-01	8.17e-05	2.20e-01
GOBP RESPONSE TO WATER DEPRIVATION	5	2.49e-01	4.87e-01	0.38600	-1.93e-01	3.35e-01	4.54e-01	1.95e-01
RHOT1 GTPase cycle	5	3.91e-01	6.24e-01	0.38600	2.17e-01	3.20e-01	4.00e-01	2.16e-01
GOBP POSITIVE REGULATION OF MUCUS SECRETION	6	2.72e-01	5.12e-01	0.38600	-6.78e-02	-3.80e-01	7.74e-01	1.07e-01
GOMF THIAMINE TRANSMEMBRANE TRANSPORTER ACTIVITY	7	2.52e-01	4.90e-01	0.38600	-1.59e-01	-3.52e-01	4.66e-01	1.07e-01
GOCC INO80 COMPLEX	16	3.69e-02	1.53e-01	0.38600	3.69e-01	1.13e-01	1.05e-02	4.35e-01
GOBP BRANCHED CHAIN AMINO ACID CATABOLIC PROCESS	21	2.06e-02	1.02e-01	0.38600	2.47e-01	2.97e-01	4.99e-02	1.86e-02
SMAD2/3 Phosphorylation Motif Mutants in Cancer	6	2.79e-01	5.18e-01	0.38600	8.33e-02	3.77e-01	7.24e-01	1.10e-01
TGFBR1 KD Mutants in Cancer	6	2.79e-01	5.18e-01	0.38600	8.33e-02	3.77e-01	7.24e-01	1.10e-01
GOBP EPIGENETIC PROGRAMING OF MALE PRONUCLEUS	5	2.46e-01	4.84e-01	0.38600	2.16e-01	-3.20e-01	4.04e-01	2.15e-01
GOCC IMMUNOGLOBULIN COMPLEX	10	7.97e-02	2.52e-01	0.38600	-3.79e-01	7.46e-02	3.82e-02	6.83e-01
GOBP POSITIVE REGULATION OF 3 UTR MEDIATED MRNA STABILIZATION	5	3.76e-01	6.11e-01	0.38600	3.50e-01	1.62e-01	1.75e-01	5.31e-01
GOBP POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA	24	8.85e-03	5.49e-02	0.38600	1.55e-01	3.53e-01	1.90e-01	2.72e-03
GOCC MITOCHONDRIAL SMALL RIBOSOMAL SUBUNIT	32	2.40e-03	2.03e-02	0.38600	3.27e-01	2.05e-01	1.38e-03	4.47e-02
Degradation of cysteine and homocysteine	14	7.32e-02	2.39e-01	0.38600	2.20e-01	3.17e-01	1.54e-01	4.02e-02
GOBP REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS	13	5.68e-02	2.03e-01	0.38600	-3.82e-01	-5.02e-02	1.70e-02	7.54e-01
GOBP G0 TO G1 TRANSITION	36	9.20e-04	9.81e-03	0.38600	3.47e-01	1.68e-01	3.13e-04	8.10e-02
ER Quality Control Compartment (ERQC)	21	8.53e-03	5.34e-02	0.38600	3.85e-01	2.56e-02	2.27e-03	8.39e-01
GOBP PYRUVATE TRANSPORT	7	1.37e-01	3.49e-01	0.38600	-2.81e-01	2.64e-01	1.99e-01	2.26e-01
DNA Replication Pre-Initiation	111	9.94e-10	5.40e-08	0.38600	3.21e-01	2.13e-01	4.99e-09	1.03e-04
GOBP LEUKOTRIENE TRANSPORT	7	2.48e-01	4.86e-01	0.38500	-1.42e-01	-3.58e-01	5.16e-01	1.01e-01
GOMF CASPASE BINDING	13	9.12e-02	2.74e-01	0.38500	-2.47e-01	-2.96e-01	1.24e-01	6.45e-02
GOBP C21 STEROID HORMONE METABOLIC PROCESS	36	1.13e-03	1.15e-02	0.38500	-3.28e-01	-2.02e-01	6.54e-04	3.61e-02
GOBP SNRNA PROCESSING	26	2.97e-03	2.39e-02	0.38500	3.84e-01	3.63e-02	7.09e-04	7.49e-01
GOCC OXOGLUTARATE DEHYDROGENASE COMPLEX	10	1.18e-01	3.18e-01	0.38500	3.78e-01	7.59e-02	3.86e-02	6.78e-01
GOBP OTOLITH MORPHOGENESIS	5	3.62e-01	5.99e-01	0.38500	3.66e-01	1.21e-01	1.57e-01	6.40e-01
GOBP CORNIFICATION	9	1.35e-01	3.45e-01	0.38500	-3.83e-01	-4.07e-02	4.66e-02	8.33e-01
GOBP REPLICATIVE SENESCENCE	17	3.01e-02	1.32e-01	0.38500	3.70e-01	1.08e-01	8.34e-03	4.41e-01
GOBP PROTEIN LOCALIZATION TO NUCLEAR BODY	11	8.30e-02	2.59e-01	0.38500	3.84e-01	2.54e-02	2.74e-02	8.84e-01
GOBP PROTEIN REFOLDING	26	7.86e-03	5.02e-02	0.38500	2.16e-01	3.19e-01	5.65e-02	4.93e-03
GOBP LEUKOCYTE AGGREGATION	12	3.71e-02	1.54e-01	0.38500	-3.38e-01	1.84e-01	4.28e-02	2.69e-01
GOBP NEGATIVE REGULATION OF NEUROBLAST PROLIFERATION	12	1.03e-01	2.95e-01	0.38500	1.91e-01	3.34e-01	2.52e-01	4.52e-02
GOBP CENTRIOLE ELONGATION	7	2.76e-01	5.16e-01	0.38500	2.41e-01	3.00e-01	2.70e-01	1.69e-01
GOBP REGULATION OF TRANSLATIONAL ELONGATION	11	1.32e-01	3.40e-01	0.38500	3.04e-01	2.35e-01	8.05e-02	1.77e-01
GOMF SUPERCOILED DNA BINDING	6	3.25e-01	5.64e-01	0.38400	3.25e-01	2.05e-01	1.68e-01	3.84e-01
HuR (ELAVL1) binds and stabilizes mRNA	10	1.58e-01	3.76e-01	0.38400	2.33e-01	3.06e-01	2.02e-01	9.41e-02
RUNX3 regulates BCL2L11 (BIM) transcription	5	3.28e-01	5.67e-01	0.38400	3.83e-01	3.54e-02	1.38e-01	8.91e-01
GOMF UBIQUITIN MODIFIED HISTONE READER ACTIVITY	7	2.78e-01	5.17e-01	0.38400	2.94e-01	2.47e-01	1.78e-01	2.57e-01
GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS	12	9.16e-02	2.75e-01	0.38400	1.35e-01	3.60e-01	4.17e-01	3.10e-02
GOBP OLEFINIC COMPOUND BIOSYNTHETIC PROCESS	28	3.52e-03	2.71e-02	0.38400	-3.64e-01	-1.23e-01	8.52e-04	2.62e-01
GOBP LUTEOLYSIS	6	3.23e-01	5.61e-01	0.38400	-3.31e-01	-1.95e-01	1.60e-01	4.08e-01
Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)	14	7.81e-02	2.49e-01	0.38400	2.74e-01	2.69e-01	7.54e-02	8.18e-02
GOBP NEGATIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY	9	1.40e-01	3.53e-01	0.38400	-3.80e-01	-5.23e-02	4.81e-02	7.86e-01
GOMF GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE NADPLUS NON PHOSPHORYLATING ACTIVITY	7	1.88e-01	4.15e-01	0.38400	2.72e-02	-3.83e-01	9.01e-01	7.94e-02
GOBP NEGATIVE REGULATION OF FATTY ACID TRANSPORT	7	2.28e-01	4.62e-01	0.38400	-7.96e-02	-3.75e-01	7.15e-01	8.55e-02
GOBP REGULATION OF 3 UTR MEDIATED MRNA STABILIZATION	7	2.33e-01	4.68e-01	0.38400	3.73e-01	9.13e-02	8.78e-02	6.76e-01
Processing of Capped Intron-Containing Pre-mRNA	265	5.06e-23	8.62e-21	0.38400	3.53e-01	1.50e-01	3.87e-23	2.77e-05
GOBP NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION	25	9.64e-03	5.83e-02	0.38300	2.10e-01	3.21e-01	6.93e-02	5.47e-03
GOMF CARBON NITROGEN LIGASE ACTIVITY WITH GLUTAMINE AS AMIDO N DONOR	10	8.23e-02	2.57e-01	0.38300	3.76e-01	-7.36e-02	3.93e-02	6.87e-01
GOBP 4FE 4S CLUSTER ASSEMBLY	5	3.70e-01	6.07e-01	0.38300	3.59e-01	1.33e-01	1.64e-01	6.05e-01
GOBP POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I	32	1.44e-03	1.37e-02	0.38300	3.68e-01	1.07e-01	3.11e-04	2.96e-01
Spry regulation of FGF signaling	16	5.19e-02	1.92e-01	0.38300	3.17e-01	2.15e-01	2.81e-02	1.36e-01
GOBP HYALOID VASCULAR PLEXUS REGRESSION	7	2.80e-01	5.20e-01	0.38300	-2.62e-01	-2.80e-01	2.30e-01	2.00e-01
GOBP POSITIVE REGULATION OF INTRACELLULAR LIPID TRANSPORT	5	4.00e-01	6.32e-01	0.38300	-2.31e-01	-3.06e-01	3.71e-01	2.36e-01
GOBP CELLULAR RESPONSE TO UV C	5	3.78e-01	6.13e-01	0.38300	3.52e-01	1.53e-01	1.73e-01	5.54e-01
GOBP NEGATIVE REGULATION OF CELL KILLING	28	1.17e-03	1.18e-02	0.38300	-3.81e-01	4.11e-02	4.82e-04	7.06e-01
GOBP REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN	17	3.01e-02	1.32e-01	0.38300	-3.70e-01	-9.87e-02	8.23e-03	4.81e-01
GOCC STEREOCILIA COUPLING LINK	8	2.06e-01	4.38e-01	0.38300	-1.37e-01	-3.58e-01	5.01e-01	7.99e-02
mitochondrial fatty acid beta-oxidation of unsaturated fatty acids	6	3.32e-01	5.71e-01	0.38300	2.25e-01	3.10e-01	3.40e-01	1.89e-01
Resolution of AP sites via the multiple-nucleotide patch replacement pathway	25	1.09e-02	6.38e-02	0.38300	2.65e-01	2.76e-01	2.16e-02	1.69e-02
GOCC EXON EXON JUNCTION COMPLEX	19	1.13e-02	6.55e-02	0.38300	3.82e-01	-2.27e-02	3.93e-03	8.64e-01
Bicarbonate transporters	10	1.61e-01	3.80e-01	0.38300	-3.03e-01	-2.34e-01	9.70e-02	2.01e-01
GOBP MYOSIN FILAMENT ORGANIZATION	6	1.98e-01	4.28e-01	0.38300	3.42e-01	-1.71e-01	1.46e-01	4.68e-01
GOBP DE NOVO CENTRIOLE ASSEMBLY	6	3.17e-01	5.56e-01	0.38300	1.67e-01	3.44e-01	4.78e-01	1.44e-01
Regulation of TLR by endogenous ligand	21	3.60e-03	2.77e-02	0.38300	-3.46e-01	1.63e-01	6.06e-03	1.95e-01
GOBP DEOXYRIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS	8	1.22e-01	3.24e-01	0.38200	-1.40e-01	3.56e-01	4.94e-01	8.11e-02
GOBP HYDROCARBON METABOLIC PROCESS	7	1.74e-01	3.97e-01	0.38200	8.08e-02	-3.74e-01	7.11e-01	8.69e-02
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO HYDROGEN PEROXIDE	9	8.34e-02	2.59e-01	0.38200	3.11e-01	-2.22e-01	1.06e-01	2.49e-01
GOCC TRANSCRIPTION REPRESSOR COMPLEX	75	1.30e-06	3.68e-05	0.38200	2.94e-01	2.44e-01	1.06e-05	2.58e-04
GOBP REGULATION OF CELL CHEMOTAXIS TO FIBROBLAST GROWTH FACTOR	8	1.70e-01	3.92e-01	0.38200	-3.04e-02	-3.81e-01	8.82e-01	6.22e-02
GOCC PROTEIN PHOSPHATASE TYPE 2A COMPLEX	17	2.90e-02	1.29e-01	0.38200	3.73e-01	8.33e-02	7.80e-03	5.52e-01
GOMF CARBOHYDRATE MONOATOMIC CATION SYMPORTER ACTIVITY	16	3.60e-02	1.50e-01	0.38200	-3.72e-01	-8.52e-02	9.95e-03	5.55e-01
GOMF IGE BINDING	5	2.70e-01	5.09e-01	0.38200	-3.56e-01	1.38e-01	1.68e-01	5.94e-01
Ligand-receptor interactions	8	1.64e-01	3.84e-01	0.38200	3.82e-01	1.01e-02	6.16e-02	9.61e-01
GOBP NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS	28	6.52e-03	4.34e-02	0.38200	-2.71e-01	-2.69e-01	1.31e-02	1.38e-02
GOBP INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY	49	1.46e-04	2.10e-03	0.38200	2.91e-01	2.47e-01	4.23e-04	2.79e-03
GOBP PYRIMIDINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT	16	4.28e-02	1.70e-01	0.38200	-1.32e-01	-3.58e-01	3.60e-01	1.32e-02
GOCC CYTOPLASMIC DYNEIN COMPLEX	22	1.09e-02	6.40e-02	0.38200	3.70e-01	9.32e-02	2.66e-03	4.49e-01
GOCC BBSOME	8	2.27e-01	4.61e-01	0.38100	3.27e-01	1.97e-01	1.10e-01	3.35e-01
GOBP XENOPHAGY	14	2.08e-02	1.02e-01	0.38100	2.44e-01	-2.93e-01	1.13e-01	5.79e-02
GOBP ANTERIOR COMMISSURE MORPHOGENESIS	7	2.76e-01	5.16e-01	0.38100	2.05e-01	3.21e-01	3.47e-01	1.41e-01
GOBP CENTRAL NERVOUS SYSTEM MYELIN FORMATION	8	2.11e-01	4.43e-01	0.38100	-3.54e-01	-1.42e-01	8.30e-02	4.88e-01
GOBP REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE	30	4.38e-03	3.21e-02	0.38100	2.31e-01	3.03e-01	2.84e-02	4.06e-03
GOBP RIBOSOME DISASSEMBLY	40	6.32e-04	7.33e-03	0.38100	3.23e-01	2.02e-01	4.04e-04	2.69e-02
GOBP HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY	13	2.78e-02	1.25e-01	0.38100	3.01e-01	-2.34e-01	6.03e-02	1.44e-01
GOBP BRANCH ELONGATION INVOLVED IN MAMMARY GLAND DUCT BRANCHING	5	2.77e-01	5.17e-01	0.38100	-1.16e-01	3.63e-01	6.54e-01	1.60e-01
GOBP ADENINE TRANSPORT	5	4.03e-01	6.35e-01	0.38100	-2.23e-01	-3.09e-01	3.88e-01	2.31e-01
N-glycan trimming in the ER and Calnexin/Calreticulin cycle	35	1.11e-03	1.14e-02	0.38100	3.54e-01	1.41e-01	2.90e-04	1.48e-01
GOCC CONE PHOTORECEPTOR OUTER SEGMENT	8	1.44e-01	3.57e-01	0.38100	5.67e-02	-3.77e-01	7.81e-01	6.50e-02
GOBP EARLY ENDOSOME TO RECYCLING ENDOSOME TRANSPORT	7	2.65e-01	5.04e-01	0.38100	1.66e-01	3.43e-01	4.46e-01	1.16e-01
Signaling by PDGFRA extracellular domain mutants	12	1.16e-01	3.16e-01	0.38100	2.87e-01	2.50e-01	8.48e-02	1.34e-01
Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants	12	1.16e-01	3.16e-01	0.38100	2.87e-01	2.50e-01	8.48e-02	1.34e-01
GOBP CO TRANSCRIPTIONAL RNA 3 END PROCESSING CLEAVAGE AND POLYADENYLATION PATHWAY	10	1.42e-01	3.56e-01	0.38100	3.55e-01	1.38e-01	5.20e-02	4.50e-01
GOMF AZOLE TRANSMEMBRANE TRANSPORTER ACTIVITY	13	8.05e-02	2.53e-01	0.38100	-1.42e-01	-3.53e-01	3.76e-01	2.75e-02
GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY	19	3.28e-02	1.41e-01	0.38000	2.38e-01	2.97e-01	7.31e-02	2.49e-02
GOBP TRYPTOPHAN CATABOLIC PROCESS TO KYNURENINE	5	4.09e-01	6.41e-01	0.38000	-2.55e-01	-2.82e-01	3.24e-01	2.74e-01
GOBP POSITIVE REGULATION OF MEMBRANE DEPOLARIZATION	11	7.06e-02	2.34e-01	0.38000	3.77e-01	-5.38e-02	3.06e-02	7.58e-01
GOBP CONVERGENT EXTENSION INVOLVED IN AXIS ELONGATION	5	2.53e-01	4.91e-01	0.38000	-2.35e-01	2.99e-01	3.62e-01	2.47e-01
GOBP PEPTIDYL ARGININE METHYLATION	10	1.52e-01	3.68e-01	0.38000	3.40e-01	1.71e-01	6.29e-02	3.48e-01
GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS IB	18	1.67e-02	8.75e-02	0.38000	-4.62e-04	3.80e-01	9.97e-01	5.22e-03
GOBP REGULATION OF OOCYTE MATURATION	7	2.66e-01	5.05e-01	0.38000	1.66e-01	3.42e-01	4.48e-01	1.17e-01
GOBP POSITIVE REGULATION OF ODONTOGENESIS	8	2.25e-01	4.59e-01	0.38000	1.81e-01	3.34e-01	3.75e-01	1.01e-01
GOMF ACTIVIN BINDING	11	1.26e-01	3.32e-01	0.38000	1.71e-01	3.39e-01	3.25e-01	5.13e-02
GOMF SMALL RIBOSOMAL SUBUNIT RRNA BINDING	8	2.37e-01	4.74e-01	0.38000	2.33e-01	3.01e-01	2.55e-01	1.41e-01
GOCC REPLICATION FORK	72	7.85e-07	2.38e-05	0.38000	3.57e-01	1.31e-01	1.61e-07	5.48e-02
GOMF AMINOACYL TRNA HYDROLASE ACTIVITY	5	4.05e-01	6.38e-01	0.38000	2.25e-01	3.06e-01	3.83e-01	2.35e-01
GOBP NUCLEOTIDE EXCISION REPAIR	79	3.61e-07	1.16e-05	0.38000	3.40e-01	1.70e-01	1.70e-07	9.18e-03
GOBP SPERM EJACULATION	6	2.66e-01	5.05e-01	0.38000	2.59e-02	3.79e-01	9.12e-01	1.08e-01
GOMF NEUROLIGIN FAMILY PROTEIN BINDING	5	4.07e-01	6.39e-01	0.38000	-3.00e-01	-2.33e-01	2.45e-01	3.66e-01
GOCC RIBONUCLEASE MRP COMPLEX	9	1.99e-01	4.29e-01	0.38000	2.41e-01	2.94e-01	2.11e-01	1.26e-01
GOBP MITOTIC DNA REPLICATION	16	4.09e-02	1.65e-01	0.38000	3.63e-01	1.11e-01	1.18e-02	4.44e-01
GOMF NUCLEAR VITAMIN D RECEPTOR BINDING	13	9.72e-02	2.85e-01	0.38000	2.97e-01	2.37e-01	6.41e-02	1.38e-01
GOBP CHEMOKINE C X C MOTIF LIGAND 1 PRODUCTION	6	2.54e-01	4.92e-01	0.38000	-3.80e-01	6.59e-03	1.07e-01	9.78e-01
GOBP RESPONSE TO COBALT ION	9	1.97e-01	4.27e-01	0.38000	2.21e-01	3.09e-01	2.51e-01	1.09e-01
GOBP MRNA CIS SPLICING VIA SPLICEOSOME	30	2.41e-03	2.03e-02	0.38000	3.65e-01	1.03e-01	5.32e-04	3.28e-01
GOBP MACROPHAGE COLONY STIMULATING FACTOR SIGNALING PATHWAY	7	2.56e-01	4.94e-01	0.38000	-3.55e-01	-1.33e-01	1.03e-01	5.42e-01
GOBP REGULATION OF NK T CELL PROLIFERATION	7	2.15e-01	4.47e-01	0.37900	2.68e-02	3.79e-01	9.02e-01	8.28e-02
GOBP SNRNA 3 END PROCESSING	20	1.35e-02	7.49e-02	0.37900	3.77e-01	4.26e-02	3.51e-03	7.42e-01
GOCC ENDOPLASMIC RETICULUM PROTEIN CONTAINING COMPLEX	118	5.61e-10	3.11e-08	0.37900	3.15e-01	2.12e-01	3.55e-09	6.87e-05
RNA Polymerase I Promoter Clearance	71	2.61e-06	6.76e-05	0.37900	3.17e-01	2.08e-01	3.80e-06	2.48e-03
RNA Polymerase I Transcription	71	2.61e-06	6.76e-05	0.37900	3.17e-01	2.08e-01	3.80e-06	2.48e-03
GOBP VITAMIN D RECEPTOR SIGNALING PATHWAY	12	1.15e-01	3.15e-01	0.37900	2.20e-01	3.09e-01	1.87e-01	6.41e-02
GOCC SMN SM PROTEIN COMPLEX	16	4.41e-02	1.73e-01	0.37900	3.57e-01	1.27e-01	1.34e-02	3.81e-01
GOBP REGULATION OF LIPID TRANSPORTER ACTIVITY	6	2.19e-01	4.52e-01	0.37900	1.14e-01	-3.61e-01	6.29e-01	1.25e-01
GOMF TRANSLATION INITIATION FACTOR BINDING	28	6.12e-03	4.14e-02	0.37900	3.22e-01	2.00e-01	3.20e-03	6.75e-02
Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane	10	1.57e-01	3.74e-01	0.37900	-1.77e-01	-3.35e-01	3.33e-01	6.68e-02
GOBP DNA LIGATION	16	5.87e-02	2.07e-01	0.37900	2.83e-01	2.52e-01	5.01e-02	8.15e-02
GOMF TELOMERASE RNA BINDING	21	1.16e-02	6.67e-02	0.37900	3.75e-01	5.00e-02	2.91e-03	6.92e-01
GOMF GLUCURONOSYLTRANSFERASE ACTIVITY	33	2.67e-03	2.20e-02	0.37800	-2.17e-01	-3.10e-01	3.07e-02	2.07e-03
Maturation of TCA enzymes and regulation of TCA cycle	20	2.91e-02	1.29e-01	0.37800	2.81e-01	2.53e-01	2.97e-02	4.98e-02
GOBP VITAMIN K METABOLIC PROCESS	11	8.69e-02	2.66e-01	0.37800	1.06e-02	3.78e-01	9.51e-01	2.99e-02
Formation of WDR5-containing histone-modifying complexes	38	3.15e-04	4.07e-03	0.37800	3.75e-01	4.88e-02	6.30e-05	6.02e-01
GOBP REGULATION OF VASCULAR WOUND HEALING	14	5.68e-02	2.03e-01	0.37800	-7.92e-02	-3.70e-01	6.08e-01	1.66e-02
GOMF G RICH STRAND TELOMERIC DNA BINDING	10	1.66e-01	3.88e-01	0.37800	3.14e-01	2.10e-01	8.58e-02	2.50e-01
Translation of Replicase and Assembly of the Replication Transcription Complex 9679504	13	1.01e-01	2.92e-01	0.37700	2.52e-01	2.81e-01	1.16e-01	7.93e-02
GOBP DIACYLGLYCEROL CATABOLIC PROCESS	5	3.18e-01	5.57e-01	0.37700	2.05e-02	-3.77e-01	9.37e-01	1.45e-01
GOMF TAU PROTEIN KINASE ACTIVITY	22	9.65e-03	5.83e-02	0.37700	3.74e-01	5.00e-02	2.39e-03	6.85e-01
GOBP PERICARDIUM DEVELOPMENT	19	3.47e-02	1.46e-01	0.37700	2.34e-01	2.96e-01	7.71e-02	2.56e-02
GOMF MAP KINASE KINASE KINASE ACTIVITY	24	8.53e-03	5.34e-02	0.37700	3.63e-01	1.02e-01	2.07e-03	3.87e-01
GOBP REGULATION OF GLOMERULAR FILTRATION	8	2.00e-01	4.30e-01	0.37700	-3.66e-01	-8.89e-02	7.27e-02	6.63e-01
GOMF NADPLUS PROTEIN ASPARTATE ADP RIBOSYLTRANSFERASE ACTIVITY	5	3.94e-01	6.27e-01	0.37700	3.41e-01	1.61e-01	1.87e-01	5.33e-01
GOBP CDP CHOLINE PATHWAY	6	2.80e-01	5.20e-01	0.37700	4.52e-02	3.74e-01	8.48e-01	1.12e-01
ATF4 activates genes in response to endoplasmic reticulum stress	27	8.79e-03	5.46e-02	0.37700	2.71e-01	2.62e-01	1.50e-02	1.82e-02
GOBP PEPTIDE CROSS LINKING	26	1.01e-02	6.05e-02	0.37700	-2.96e-01	-2.33e-01	9.02e-03	3.94e-02
Phosphorylation of the APC/C	20	2.17e-02	1.05e-01	0.37700	1.32e-01	3.53e-01	3.06e-01	6.30e-03
GOBP RESPONSE TO YEAST	7	2.85e-01	5.24e-01	0.37700	-3.14e-01	-2.08e-01	1.50e-01	3.41e-01
GOMF TESTOSTERONE 17 BETA DEHYDROGENASE NADPPLUS ACTIVITY	9	2.06e-01	4.38e-01	0.37700	-2.83e-01	-2.49e-01	1.42e-01	1.96e-01
GOBP ADULT FEEDING BEHAVIOR	9	2.00e-01	4.30e-01	0.37700	3.14e-01	2.08e-01	1.03e-01	2.79e-01
GOMF NMDA GLUTAMATE RECEPTOR ACTIVITY	7	2.53e-01	4.91e-01	0.37700	-3.60e-01	-1.09e-01	9.88e-02	6.17e-01
GOBP POSITIVE REGULATION OF COA TRANSFERASE ACTIVITY	8	1.53e-01	3.69e-01	0.37600	4.72e-02	-3.73e-01	8.17e-01	6.73e-02
GOBP REGULATION OF COMPLEMENT DEPENDENT CYTOTOXICITY	11	7.80e-02	2.49e-01	0.37600	-3.75e-01	3.65e-02	3.14e-02	8.34e-01
GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL MATRIX ADHESION VIA FIBRONECTIN	5	2.97e-01	5.37e-01	0.37600	-3.68e-01	8.08e-02	1.55e-01	7.54e-01
GOBP NEGATIVE REGULATION OF NEURON MIGRATION	9	1.06e-01	3.02e-01	0.37600	1.09e-01	-3.60e-01	5.71e-01	6.13e-02
Intestinal absorption	5	3.96e-01	6.29e-01	0.37600	-1.60e-01	-3.40e-01	5.35e-01	1.88e-01
GOBP CARTILAGE MORPHOGENESIS	10	1.74e-01	3.97e-01	0.37600	2.74e-01	2.57e-01	1.34e-01	1.59e-01
RNA Polymerase I Promoter Escape	53	9.30e-05	1.46e-03	0.37600	2.92e-01	2.37e-01	2.37e-04	2.86e-03
GOBP REGULATION OF ISOTYPE SWITCHING TO IGE ISOTYPES	6	3.47e-01	5.85e-01	0.37600	2.23e-01	3.03e-01	3.45e-01	1.99e-01
GOMF PEPTIDE LYSINE N ACETYLTRANSFERASE ACTIVITY	43	3.27e-04	4.21e-03	0.37600	3.44e-01	1.51e-01	9.40e-05	8.75e-02
Transcriptional Regulation by VENTX	41	7.73e-04	8.63e-03	0.37600	2.42e-01	2.87e-01	7.34e-03	1.45e-03
GOBP SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY	12	7.61e-02	2.45e-01	0.37600	3.75e-01	2.82e-02	2.46e-02	8.66e-01
Formation of the beta-catenin:TCF transactivating complex	55	5.86e-05	9.99e-04	0.37600	3.10e-01	2.12e-01	6.86e-05	6.61e-03
GOBP CONNECTIVE TISSUE REPLACEMENT INVOLVED IN INFLAMMATORY RESPONSE WOUND HEALING	6	3.15e-01	5.54e-01	0.37600	-3.55e-01	-1.23e-01	1.32e-01	6.03e-01
Hh mutants are degraded by ERAD	43	2.76e-04	3.67e-03	0.37600	3.52e-01	1.30e-01	6.38e-05	1.40e-01
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OSMOTIC STRESS	10	1.31e-01	3.40e-01	0.37600	3.68e-01	7.48e-02	4.39e-02	6.82e-01
GOMF SEQUENCE SPECIFIC MRNA BINDING	12	6.38e-02	2.18e-01	0.37500	3.74e-01	-3.18e-02	2.49e-02	8.49e-01
RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function	59	2.88e-05	5.44e-04	0.37500	3.12e-01	2.08e-01	3.35e-05	5.64e-03
GOBP PROLACTIN SECRETION	5	2.62e-01	5.01e-01	0.37500	2.86e-01	-2.43e-01	2.68e-01	3.47e-01
GOBP POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE	9	1.61e-01	3.80e-01	0.37500	3.68e-01	7.32e-02	5.60e-02	7.04e-01
BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members	9	1.36e-01	3.46e-01	0.37500	-1.75e-03	3.75e-01	9.93e-01	5.14e-02
GOCC U5 SNRNP	22	1.39e-02	7.66e-02	0.37500	3.59e-01	1.09e-01	3.59e-03	3.74e-01
MET activates RAS signaling	11	1.34e-01	3.44e-01	0.37500	3.35e-01	1.69e-01	5.47e-02	3.33e-01
GOBP CD8 POSITIVE ALPHA BETA T CELL PROLIFERATION	8	1.24e-01	3.28e-01	0.37500	-3.24e-01	1.87e-01	1.12e-01	3.59e-01
GOMF ALPHA ADRENERGIC RECEPTOR ACTIVITY	6	2.62e-01	5.01e-01	0.37500	-3.74e-01	1.22e-02	1.12e-01	9.59e-01
Loss of Function of SMAD2/3 in Cancer	7	2.87e-01	5.25e-01	0.37500	1.96e-01	3.19e-01	3.69e-01	1.44e-01
GOCC BOX C D RNP COMPLEX	6	2.01e-01	4.31e-01	0.37500	2.49e-01	-2.80e-01	2.91e-01	2.36e-01
GOBP NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING	25	1.09e-02	6.38e-02	0.37400	3.30e-01	1.77e-01	4.30e-03	1.25e-01
GOBP IP 10 PRODUCTION	5	2.73e-01	5.12e-01	0.37400	1.78e-01	-3.30e-01	4.92e-01	2.02e-01
GOBP NUCLEOBASE TRANSPORT	12	7.89e-02	2.51e-01	0.37400	-3.47e-02	-3.73e-01	8.35e-01	2.53e-02
RHOBTB2 GTPase cycle	22	2.01e-02	1.00e-01	0.37400	3.16e-01	2.00e-01	1.02e-02	1.04e-01
GOBP RECEPTOR MEDIATED ENDOCYTOSIS INVOLVED IN CHOLESTEROL TRANSPORT	9	1.78e-01	4.02e-01	0.37400	-3.55e-01	-1.18e-01	6.50e-02	5.41e-01
GOBP REGULATION OF T CELL COSTIMULATION	5	2.92e-01	5.31e-01	0.37400	-3.58e-01	1.09e-01	1.66e-01	6.73e-01
GOBP POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III	17	3.01e-02	1.32e-01	0.37400	3.70e-01	5.53e-02	8.26e-03	6.93e-01
MAPK3 (ERK1) activation	10	1.52e-01	3.67e-01	0.37400	1.33e-01	3.50e-01	4.66e-01	5.56e-02
Glucuronidation	24	6.22e-03	4.20e-02	0.37400	-3.21e-02	-3.73e-01	7.85e-01	1.58e-03
RUNX1 regulates transcription of genes involved in differentiation of HSCs	79	9.84e-07	2.89e-05	0.37400	3.06e-01	2.15e-01	2.53e-06	9.61e-04
GOBP POSITIVE REGULATION OF MITOCHONDRIAL DEPOLARIZATION	9	1.36e-01	3.46e-01	0.37400	3.74e-01	-8.61e-03	5.21e-02	9.64e-01
GOBP MACROMOLECULE DEPALMITOYLATION	14	8.90e-02	2.70e-01	0.37400	2.55e-01	2.74e-01	9.85e-02	7.64e-02
GOMF PALMITOYL HYDROLASE ACTIVITY	14	8.90e-02	2.70e-01	0.37400	2.55e-01	2.74e-01	9.85e-02	7.64e-02
GOMF RETROMER COMPLEX BINDING	9	1.58e-01	3.76e-01	0.37400	3.69e-01	5.94e-02	5.52e-02	7.58e-01
GOBP 10 FORMYLTETRAHYDROFOLATE METABOLIC PROCESS	5	2.77e-01	5.16e-01	0.37400	1.67e-01	-3.35e-01	5.19e-01	1.95e-01
GOBP POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION	15	7.50e-02	2.42e-01	0.37400	2.76e-01	2.52e-01	6.41e-02	9.11e-02
GOBP MRNA EXPORT FROM NUCLEUS	64	7.02e-06	1.61e-04	0.37400	3.44e-01	1.45e-01	1.89e-06	4.45e-02
GOBP NEGATIVE REGULATION OF NUCLEASE ACTIVITY	7	2.91e-01	5.30e-01	0.37400	2.04e-01	3.13e-01	3.49e-01	1.52e-01
GOBP RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY	52	8.45e-05	1.35e-03	0.37400	3.31e-01	1.74e-01	3.69e-05	3.01e-02
GOCC PROTON TRANSPORTING ATP SYNTHASE COMPLEX	21	2.50e-02	1.17e-01	0.37400	3.09e-01	2.10e-01	1.43e-02	9.55e-02
GOMF ATPASE COUPLED INORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY	10	1.29e-01	3.37e-01	0.37400	-5.93e-02	-3.69e-01	7.46e-01	4.34e-02
GOBP REGULATION OF MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS	7	2.62e-01	5.01e-01	0.37400	-3.55e-01	-1.16e-01	1.04e-01	5.96e-01
GOMF UDP GLUCOSYLTRANSFERASE ACTIVITY	10	1.29e-01	3.36e-01	0.37300	3.69e-01	5.66e-02	4.33e-02	7.57e-01
GOMF CALCIUM DEPENDENT CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY	16	6.08e-02	2.12e-01	0.37300	-2.13e-01	-3.07e-01	1.41e-01	3.37e-02
GOBP COMPLEMENT ACTIVATION	56	6.54e-05	1.09e-03	0.37300	-2.80e-01	-2.46e-01	2.86e-04	1.42e-03
NoRC negatively regulates rRNA expression	68	6.72e-06	1.55e-04	0.37300	3.10e-01	2.07e-01	9.60e-06	3.12e-03
GOMF FATZ BINDING	5	2.66e-01	5.05e-01	0.37300	2.35e-01	-2.90e-01	3.63e-01	2.62e-01
POLB-Dependent Long Patch Base Excision Repair	8	1.79e-01	4.04e-01	0.37300	3.73e-01	1.49e-02	6.78e-02	9.42e-01
GOBP RNA SPLICING VIA TRANSESTERIFICATION REACTIONS	289	3.58e-24	6.77e-22	0.37300	3.51e-01	1.27e-01	9.09e-25	2.13e-04
GOBP TELOMERE MAINTENANCE VIA RECOMBINATION	14	3.62e-02	1.51e-01	0.37300	3.65e-01	-7.54e-02	1.79e-02	6.25e-01
GOBP OXALOACETATE METABOLIC PROCESS	9	1.75e-01	3.99e-01	0.37300	3.58e-01	1.05e-01	6.29e-02	5.86e-01
GOBP ISOPENTENYL DIPHOSPHATE BIOSYNTHETIC PROCESS	5	3.17e-01	5.56e-01	0.37300	-4.44e-02	3.70e-01	8.64e-01	1.52e-01
GOBP NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY	21	5.58e-03	3.85e-02	0.37300	-1.20e-01	3.53e-01	3.40e-01	5.10e-03
GOBP PROTEIN DEMETHYLATION	8	2.07e-01	4.38e-01	0.37300	3.63e-01	8.73e-02	7.58e-02	6.69e-01
GOBP MITOTIC NUCLEAR MEMBRANE ORGANIZATION	10	1.79e-01	4.04e-01	0.37300	2.53e-01	2.74e-01	1.66e-01	1.34e-01
B-WICH complex positively regulates rRNA expression	54	9.19e-05	1.45e-03	0.37300	2.87e-01	2.38e-01	2.61e-04	2.51e-03
GOBP LYMPH NODE DEVELOPMENT	19	1.17e-02	6.69e-02	0.37300	-6.50e-02	3.67e-01	6.24e-01	5.60e-03
GOBP NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS	48	2.61e-04	3.49e-03	0.37300	2.83e-01	2.42e-01	6.80e-04	3.70e-03
Translesion Synthesis by POLH	18	4.57e-02	1.77e-01	0.37300	2.67e-01	2.60e-01	4.97e-02	5.64e-02
GOCC L TYPE VOLTAGE GATED CALCIUM CHANNEL COMPLEX	12	1.24e-01	3.28e-01	0.37300	-3.05e-01	-2.14e-01	6.74e-02	1.99e-01
GOBP MITOCHONDRIAL TRANSLATION	130	1.19e-10	7.46e-09	0.37200	3.19e-01	1.93e-01	3.46e-10	1.47e-04
GOBP REGULATION OF FERTILIZATION	17	4.75e-02	1.82e-01	0.37200	-1.74e-01	-3.29e-01	2.14e-01	1.88e-02
Processing and activation of SUMO	10	1.23e-01	3.26e-01	0.37200	3.71e-01	3.18e-02	4.22e-02	8.62e-01
GOBP REGULATION OF PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION	5	3.22e-01	5.60e-01	0.37200	3.71e-01	-3.55e-02	1.51e-01	8.91e-01
GOMF POTASSIUM CHANNEL INHIBITOR ACTIVITY	5	3.46e-01	5.84e-01	0.37200	3.72e-01	2.18e-02	1.50e-01	9.33e-01
Global Genome Nucleotide Excision Repair (GG-NER)	81	8.99e-07	2.67e-05	0.37200	2.92e-01	2.30e-01	5.32e-06	3.42e-04
DNA Damage Recognition in GG-NER	36	1.52e-03	1.42e-02	0.37200	3.33e-01	1.66e-01	5.39e-04	8.55e-02
Resolution of D-loop Structures through Holliday Junction Intermediates	34	2.96e-03	2.38e-02	0.37200	2.82e-01	2.43e-01	4.46e-03	1.42e-02
GOBP TELOMERASE RNA LOCALIZATION	18	3.10e-02	1.35e-01	0.37200	3.58e-01	1.01e-01	8.56e-03	4.57e-01
GOBP PEPTIDYL PROLINE HYDROXYLATION	11	1.28e-01	3.35e-01	0.37200	3.49e-01	1.28e-01	4.51e-02	4.63e-01
GOBP CALCITONIN FAMILY RECEPTOR SIGNALING PATHWAY	8	2.49e-01	4.87e-01	0.37100	-3.08e-01	-2.08e-01	1.31e-01	3.09e-01
Axonal growth inhibition (RHOA activation)	8	2.53e-01	4.91e-01	0.37100	-2.93e-01	-2.28e-01	1.52e-01	2.63e-01
GOBP REGULATION OF BARBED END ACTIN FILAMENT CAPPING	5	2.72e-01	5.12e-01	0.37100	3.01e-01	-2.17e-01	2.43e-01	4.01e-01
GOMF PHOSPHOLIPASE ACTIVATOR ACTIVITY	15	7.17e-02	2.36e-01	0.37100	1.90e-01	3.19e-01	2.02e-01	3.25e-02
GOMF 1 PHOSPHATIDYLINOSITOL 3 KINASE REGULATOR ACTIVITY	15	3.99e-02	1.62e-01	0.37100	7.05e-03	3.71e-01	9.62e-01	1.28e-02
CD209 (DC-SIGN) signaling	20	1.77e-02	9.09e-02	0.37100	3.66e-01	5.93e-02	4.55e-03	6.46e-01
GOBP REGULATION OF HETEROCHROMATIN FORMATION	22	1.36e-02	7.52e-02	0.37100	3.61e-01	8.61e-02	3.37e-03	4.85e-01
GOBP PURINE DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS	7	2.68e-01	5.08e-01	0.37100	1.21e-01	3.51e-01	5.81e-01	1.08e-01
GOBP PYRIMIDINE NUCLEOBASE CATABOLIC PROCESS	8	2.55e-01	4.92e-01	0.37100	-2.87e-01	-2.35e-01	1.60e-01	2.49e-01
GOBP NEGATIVE REGULATION OF METALLOPEPTIDASE ACTIVITY	8	2.54e-01	4.92e-01	0.37100	2.91e-01	2.31e-01	1.55e-01	2.59e-01
GOCC GARP COMPLEX	5	3.37e-01	5.75e-01	0.37100	3.71e-01	-5.50e-03	1.51e-01	9.83e-01
GOBP MYOFIBROBLAST DIFFERENTIATION	14	5.35e-02	1.97e-01	0.37100	3.70e-01	2.81e-02	1.66e-02	8.55e-01
GOBP ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION	40	1.00e-03	1.05e-02	0.37100	3.06e-01	2.10e-01	8.24e-04	2.15e-02
GOBP RESPONSE TO PHORBOL 13 ACETATE 12 MYRISTATE	10	7.26e-02	2.38e-01	0.37100	-2.62e-01	2.63e-01	1.52e-01	1.51e-01
GOBP RESPONSE TO MITOCHONDRIAL DEPOLARISATION	19	3.93e-02	1.60e-01	0.37100	2.38e-01	2.84e-01	7.27e-02	3.19e-02
GOCC MULTIMERIC RIBONUCLEASE P COMPLEX	10	1.82e-01	4.07e-01	0.37100	2.39e-01	2.84e-01	1.91e-01	1.20e-01
GOMF RIBONUCLEASE P RNA BINDING	10	1.82e-01	4.07e-01	0.37100	2.39e-01	2.84e-01	1.91e-01	1.20e-01
GOBP ERBB4 ERBB4 SIGNALING PATHWAY	6	2.44e-01	4.82e-01	0.37100	7.96e-02	-3.62e-01	7.36e-01	1.25e-01
GOCC HISTONE METHYLTRANSFERASE COMPLEX	63	1.52e-05	3.09e-04	0.37100	3.23e-01	1.81e-01	9.01e-06	1.29e-02
Activation of the TFAP2 (AP-2) family of transcription factors	11	1.37e-01	3.48e-01	0.37000	1.54e-01	3.37e-01	3.76e-01	5.32e-02
GOBP DEPYRIMIDINATION	8	2.51e-01	4.89e-01	0.37000	3.09e-01	2.05e-01	1.31e-01	3.16e-01
DAP12 interactions	38	5.86e-05	9.99e-04	0.37000	-1.95e-01	3.14e-01	3.71e-02	7.94e-04
PERK regulates gene expression	31	5.20e-03	3.64e-02	0.37000	2.82e-01	2.39e-01	6.50e-03	2.11e-02
rRNA modification in the mitochondrion	6	3.62e-01	6.00e-01	0.37000	2.70e-01	2.53e-01	2.51e-01	2.84e-01
GOMF HISTONE UBIQUITIN LIGASE ACTIVITY	10	1.29e-01	3.37e-01	0.37000	4.21e-02	3.68e-01	8.18e-01	4.41e-02
GOCC ENDOPLASMIC RETICULUM TUBULAR NETWORK	27	7.62e-03	4.89e-02	0.37000	3.38e-01	1.51e-01	2.39e-03	1.74e-01
GOMF ACETYLCHOLINE GATED MONOATOMIC CATION SELECTIVE CHANNEL ACTIVITY	17	2.47e-02	1.16e-01	0.37000	-3.70e-01	1.04e-02	8.29e-03	9.41e-01
GOBP PERICYTE CELL DIFFERENTIATION	11	6.32e-02	2.17e-01	0.37000	-1.60e-01	3.33e-01	3.57e-01	5.55e-02
GOBP CARDIAC CONDUCTION SYSTEM DEVELOPMENT	36	1.82e-03	1.64e-02	0.37000	1.84e-01	3.21e-01	5.63e-02	8.55e-04
Negative epigenetic regulation of rRNA expression	70	5.42e-06	1.29e-04	0.37000	3.14e-01	1.95e-01	5.49e-06	4.74e-03
Formation of the anterior neural plate	10	1.83e-01	4.09e-01	0.37000	2.35e-01	2.85e-01	1.98e-01	1.19e-01
GOBP REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS	13	9.63e-02	2.83e-01	0.37000	3.37e-01	1.53e-01	3.56e-02	3.40e-01
GOBP NEGATIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS	10	1.76e-01	4.00e-01	0.37000	1.95e-01	3.14e-01	2.87e-01	8.53e-02
Mitochondrial iron-sulfur cluster biogenesis	13	1.10e-01	3.08e-01	0.37000	2.35e-01	2.85e-01	1.43e-01	7.48e-02
Cristae formation	29	6.85e-03	4.50e-02	0.37000	3.06e-01	2.07e-01	4.30e-03	5.40e-02
GOMF ATPASE COUPLED LIPID TRANSMEMBRANE TRANSPORTER ACTIVITY	8	1.70e-01	3.92e-01	0.37000	-3.68e-01	2.89e-02	7.12e-02	8.87e-01
GOBP NEGATIVE REGULATION OF LIPOPROTEIN METABOLIC PROCESS	5	3.04e-01	5.44e-01	0.37000	9.93e-02	-3.56e-01	7.01e-01	1.68e-01
GOBP POSITIVE REGULATION OF SODIUM PROTON ANTIPORTER ACTIVITY	5	2.72e-01	5.12e-01	0.37000	-2.62e-01	2.60e-01	3.10e-01	3.13e-01
GOBP NEGATIVE REGULATION OF CENTROSOME DUPLICATION	12	1.32e-01	3.41e-01	0.36900	2.68e-01	2.54e-01	1.07e-01	1.28e-01
GOBP FEVER GENERATION	11	1.54e-01	3.70e-01	0.36900	-2.26e-01	-2.92e-01	1.94e-01	9.36e-02
GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2	42	3.24e-04	4.18e-03	0.36900	3.57e-01	9.49e-02	6.26e-05	2.87e-01
GOBP C TERMINAL PROTEIN LIPIDATION	8	1.29e-01	3.37e-01	0.36900	2.01e-01	-3.10e-01	3.26e-01	1.29e-01
GOCC CELL POLE	9	1.36e-01	3.46e-01	0.36900	3.68e-01	-3.04e-02	5.60e-02	8.74e-01
Synthesis of PIPs at the late endosome membrane	10	1.32e-01	3.41e-01	0.36900	3.66e-01	4.81e-02	4.51e-02	7.92e-01
GOMF P TYPE POTASSIUM TRANSMEMBRANE TRANSPORTER ACTIVITY	8	2.52e-01	4.90e-01	0.36900	-2.02e-01	-3.09e-01	3.22e-01	1.30e-01
GOBP PYRIMIDINE RIBONUCLEOTIDE CATABOLIC PROCESS	8	1.26e-01	3.32e-01	0.36900	-2.89e-01	2.30e-01	1.58e-01	2.60e-01
GOBP REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION	12	1.30e-01	3.38e-01	0.36900	2.96e-01	2.21e-01	7.61e-02	1.86e-01
Protein repair	6	2.11e-01	4.43e-01	0.36900	-2.79e-01	2.41e-01	2.36e-01	3.07e-01
GOBP PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM EXIT SITE	6	2.26e-01	4.60e-01	0.36900	1.50e-01	-3.37e-01	5.25e-01	1.53e-01
GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN LINEAR AMIDINES	11	1.46e-01	3.59e-01	0.36900	-1.81e-01	-3.22e-01	3.00e-01	6.48e-02
Acetylcholine inhibits contraction of outer hair cells	5	3.47e-01	5.85e-01	0.36900	-8.20e-03	-3.69e-01	9.75e-01	1.53e-01
GOBP SUCKLING BEHAVIOR	12	1.33e-01	3.42e-01	0.36900	2.61e-01	2.61e-01	1.18e-01	1.18e-01
GOBP TRICUSPID VALVE DEVELOPMENT	7	2.87e-01	5.26e-01	0.36900	1.57e-01	3.33e-01	4.71e-01	1.27e-01
GOBP DNA DOUBLE STRAND BREAK PROCESSING	20	3.38e-02	1.44e-01	0.36800	2.95e-01	2.21e-01	2.24e-02	8.76e-02
GOBP REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS	79	1.85e-06	5.00e-05	0.36800	2.57e-01	2.64e-01	8.03e-05	4.88e-05
STAT3 nuclear events downstream of ALK signaling	10	1.81e-01	4.06e-01	0.36800	2.05e-01	3.06e-01	2.61e-01	9.39e-02
GOMF FOUR WAY JUNCTION HELICASE ACTIVITY	6	3.34e-01	5.73e-01	0.36800	3.44e-01	1.32e-01	1.45e-01	5.76e-01
Sensory perception of taste	47	3.48e-04	4.41e-03	0.36800	-2.16e-01	-2.98e-01	1.04e-02	4.05e-04
GOBP REGULATION OF ENDOTHELIAL TUBE MORPHOGENESIS	6	2.41e-01	4.78e-01	0.36800	1.03e-01	-3.54e-01	6.63e-01	1.34e-01
GOBP NATURAL KILLER CELL CYTOKINE PRODUCTION	9	9.79e-02	2.86e-01	0.36800	-2.77e-01	2.43e-01	1.51e-01	2.07e-01
GOCC PERINEURONAL NET	10	1.07e-01	3.03e-01	0.36800	-3.66e-01	4.19e-02	4.53e-02	8.19e-01
Meiotic recombination	52	1.10e-04	1.67e-03	0.36800	3.27e-01	1.69e-01	4.55e-05	3.49e-02
GOBP HISTIDINE METABOLIC PROCESS	9	2.03e-01	4.34e-01	0.36800	-1.59e-01	-3.32e-01	4.08e-01	8.49e-02
GOMF PYRIMIDINE NUCLEOTIDE BINDING	5	3.09e-01	5.49e-01	0.36800	-9.39e-02	3.56e-01	7.16e-01	1.69e-01
GOBP TESTOSTERONE BIOSYNTHETIC PROCESS	11	1.55e-01	3.72e-01	0.36800	-2.98e-01	-2.15e-01	8.70e-02	2.16e-01
GOBP RETINAL PIGMENT EPITHELIUM DEVELOPMENT	6	2.28e-01	4.62e-01	0.36800	-1.52e-01	3.35e-01	5.20e-01	1.55e-01
GOBP ENDOCRINE PANCREAS DEVELOPMENT	44	5.35e-04	6.35e-03	0.36800	1.96e-01	3.11e-01	2.48e-02	3.51e-04
Inhibition of DNA recombination at telomere	43	7.48e-04	8.43e-03	0.36800	2.82e-01	2.35e-01	1.35e-03	7.59e-03
Autodegradation of the E3 ubiquitin ligase COP1	38	9.18e-04	9.80e-03	0.36800	3.47e-01	1.20e-01	2.10e-04	2.00e-01
GOMF NUCLEOBASE TRANSMEMBRANE TRANSPORTER ACTIVITY	10	1.39e-01	3.51e-01	0.36800	-6.14e-02	-3.62e-01	7.37e-01	4.72e-02
GOBP EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS	17	5.53e-02	2.00e-01	0.36800	3.06e-01	2.03e-01	2.89e-02	1.47e-01
Nef mediated downregulation of MHC class I complex cell surface expression	9	1.42e-01	3.56e-01	0.36800	-1.76e-02	3.67e-01	9.27e-01	5.65e-02
GOBP REGULATION OF RESPONSE TO FOOD	16	5.76e-02	2.05e-01	0.36700	1.49e-01	3.36e-01	3.03e-01	2.00e-02
GOBP REGULATION OF TETRAPYRROLE METABOLIC PROCESS	8	1.28e-01	3.34e-01	0.36700	2.55e-01	-2.64e-01	2.11e-01	1.96e-01
GOBP POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEPARATION	18	4.70e-02	1.80e-01	0.36700	3.05e-01	2.05e-01	2.51e-02	1.33e-01
Termination of translesion DNA synthesis	32	4.83e-03	3.44e-02	0.36700	2.46e-01	2.73e-01	1.62e-02	7.52e-03
GOMF NF KAPPAB BINDING	28	6.70e-03	4.44e-02	0.36700	3.37e-01	1.45e-01	2.01e-03	1.84e-01
GOBP REGULATION OF NEUTROPHIL EXTRAVASATION	5	3.78e-01	6.13e-01	0.36700	-3.60e-01	-6.97e-02	1.63e-01	7.87e-01
GOBP ONE CARBON COMPOUND TRANSPORT	26	2.83e-03	2.30e-02	0.36700	-3.62e-01	5.83e-02	1.38e-03	6.07e-01
Interleukin-15 signaling	13	1.15e-01	3.14e-01	0.36700	2.75e-01	2.42e-01	8.56e-02	1.30e-01
GOMF CHLORIDE CHANNEL INHIBITOR ACTIVITY	7	3.11e-01	5.51e-01	0.36700	2.32e-01	2.84e-01	2.87e-01	1.93e-01
GOCC PYRUVATE DEHYDROGENASE COMPLEX	5	4.08e-01	6.41e-01	0.36700	3.38e-01	1.41e-01	1.90e-01	5.84e-01
GOCC INNER DYNEIN ARM	5	2.78e-01	5.17e-01	0.36700	2.55e-01	-2.63e-01	3.23e-01	3.08e-01
Transcription-Coupled Nucleotide Excision Repair (TC-NER)	74	3.79e-06	9.49e-05	0.36700	3.03e-01	2.06e-01	6.48e-06	2.17e-03
GOMF IMMUNOGLOBULIN RECEPTOR BINDING	10	9.52e-02	2.81e-01	0.36700	-3.52e-01	1.02e-01	5.38e-02	5.78e-01
Packaging Of Telomere Ends	29	8.22e-03	5.19e-02	0.36600	2.55e-01	2.63e-01	1.75e-02	1.42e-02
GOMF NUCLEAR ANDROGEN RECEPTOR BINDING	25	1.59e-02	8.42e-02	0.36600	2.45e-01	2.73e-01	3.43e-02	1.83e-02
GOBP REGULATION OF PHOSPHATE TRANSPORT	7	2.69e-01	5.08e-01	0.36600	3.53e-01	9.82e-02	1.06e-01	6.53e-01
Terminal pathway of complement	8	2.66e-01	5.05e-01	0.36600	-2.50e-01	-2.67e-01	2.20e-01	1.91e-01
Ethanol oxidation	12	7.59e-02	2.44e-01	0.36600	1.76e-02	-3.66e-01	9.16e-01	2.83e-02
Sema4D induced cell migration and growth-cone collapse	20	2.67e-02	1.22e-01	0.36600	3.43e-01	1.27e-01	7.84e-03	3.27e-01
GOMF NUCLEOSOMAL DNA BINDING	60	2.88e-05	5.45e-04	0.36600	3.28e-01	1.61e-01	1.09e-05	3.09e-02
GOMF TRNA SPECIFIC RIBONUCLEASE ACTIVITY	16	6.72e-02	2.26e-01	0.36600	3.05e-01	2.01e-01	3.45e-02	1.63e-01
GOBP PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE	7	2.80e-01	5.20e-01	0.36600	3.44e-01	1.23e-01	1.15e-01	5.73e-01
GOBP PYRIMIDINE NUCLEOBASE BIOSYNTHETIC PROCESS	7	1.71e-01	3.93e-01	0.36600	3.01e-01	-2.08e-01	1.69e-01	3.40e-01
GOBP POSITIVE REGULATION OF GASTRULATION	6	2.92e-01	5.32e-01	0.36600	2.07e-02	3.65e-01	9.30e-01	1.22e-01
GOBP NEGATIVE REGULATION OF CYTOKINESIS	7	1.68e-01	3.90e-01	0.36600	-2.52e-01	2.65e-01	2.49e-01	2.24e-01
GOMF BMP RECEPTOR BINDING	12	5.13e-02	1.91e-01	0.36600	-3.22e-01	1.74e-01	5.37e-02	2.97e-01
GOBP POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING	14	9.87e-02	2.88e-01	0.36600	2.40e-01	2.76e-01	1.20e-01	7.43e-02
GOBP REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE	13	8.38e-02	2.60e-01	0.36600	3.57e-01	8.01e-02	2.60e-02	6.17e-01
Defective homologous recombination repair (HRR) due to BRCA2 loss of function	41	1.15e-03	1.17e-02	0.36500	2.75e-01	2.41e-01	2.34e-03	7.55e-03
Diseases of DNA Double-Strand Break Repair	41	1.15e-03	1.17e-02	0.36500	2.75e-01	2.41e-01	2.34e-03	7.55e-03
Small interfering RNA (siRNA) biogenesis	9	1.60e-01	3.78e-01	0.36500	3.65e-01	2.39e-02	5.82e-02	9.01e-01
GOBP NEGATIVE REGULATION OF INTERLEUKIN 4 PRODUCTION	7	1.69e-01	3.91e-01	0.36500	-2.34e-01	2.80e-01	2.84e-01	1.99e-01
GOCC POSTSYNAPTIC ENDOCYTIC ZONE	5	3.82e-01	6.16e-01	0.36500	3.58e-01	7.02e-02	1.65e-01	7.86e-01
GOBP MECHANOSENSORY BEHAVIOR	14	5.09e-02	1.90e-01	0.36500	1.33e-02	-3.65e-01	9.31e-01	1.81e-02
GOBP MULTINUCLEAR OSTEOCLAST DIFFERENTIATION	8	1.31e-01	3.39e-01	0.36500	-2.57e-01	2.59e-01	2.08e-01	2.05e-01
GOBP REGULATION OF APOPTOTIC CELL CLEARANCE	10	1.87e-01	4.13e-01	0.36500	-2.02e-01	-3.04e-01	2.68e-01	9.62e-02
Antigen Presentation: Folding, assembly and peptide loading of class I MHC	29	8.32e-03	5.24e-02	0.36500	2.31e-01	2.82e-01	3.10e-02	8.56e-03
GOMF CD4 RECEPTOR BINDING	8	2.66e-01	5.05e-01	0.36500	2.24e-01	2.88e-01	2.73e-01	1.58e-01
GOBP LATERAL VENTRICLE DEVELOPMENT	12	1.02e-01	2.93e-01	0.36500	3.56e-01	7.75e-02	3.25e-02	6.42e-01
GOBP NEGATIVE REGULATION OF PROTEIN ACETYLATION	6	3.04e-01	5.44e-01	0.36500	3.62e-01	4.38e-02	1.25e-01	8.52e-01
GOBP CELLULAR RESPONSE TO X RAY	11	1.57e-01	3.74e-01	0.36500	3.07e-01	1.96e-01	7.77e-02	2.59e-01
GOBP REGULATION OF ODONTOGENESIS	19	2.83e-02	1.27e-01	0.36400	8.83e-02	3.54e-01	5.05e-01	7.61e-03
GOCC ENDOLYSOSOME	26	9.57e-03	5.80e-02	0.36400	3.40e-01	1.30e-01	2.66e-03	2.51e-01
Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase	20	3.74e-02	1.54e-01	0.36400	2.40e-01	2.74e-01	6.35e-02	3.36e-02
GOBP REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING	15	5.53e-02	2.00e-01	0.36400	3.59e-01	6.43e-02	1.62e-02	6.66e-01
GOMF CO SMAD BINDING	9	2.12e-01	4.44e-01	0.36400	1.64e-01	3.25e-01	3.94e-01	9.11e-02
Chromosome Maintenance	109	1.22e-08	5.23e-07	0.36400	3.06e-01	1.97e-01	3.24e-08	3.82e-04
GOBP ALDITOL BIOSYNTHETIC PROCESS	5	3.71e-01	6.07e-01	0.36400	-4.12e-02	-3.62e-01	8.73e-01	1.61e-01
GOBP EMBRYONIC CAMERA TYPE EYE DEVELOPMENT	37	2.23e-03	1.91e-02	0.36400	2.23e-01	2.88e-01	1.89e-02	2.43e-03
GOCC AXONEMAL B TUBULE INNER SHEATH	11	8.85e-02	2.70e-01	0.36400	-4.98e-02	3.61e-01	7.75e-01	3.83e-02
GOBP SNRNA METABOLIC PROCESS	55	5.01e-05	8.74e-04	0.36400	3.43e-01	1.21e-01	1.05e-05	1.21e-01
Recognition of DNA damage by PCNA-containing replication complex	29	8.69e-03	5.42e-02	0.36400	2.48e-01	2.67e-01	2.09e-02	1.30e-02
GOBP REGULATION OF STRIATED MUSCLE TISSUE DEVELOPMENT	19	4.21e-02	1.68e-01	0.36400	3.01e-01	2.04e-01	2.30e-02	1.23e-01
Dual Incision in GG-NER	39	1.69e-03	1.54e-02	0.36400	2.42e-01	2.71e-01	8.79e-03	3.35e-03
GOBP TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY	64	1.19e-05	2.51e-04	0.36400	3.38e-01	1.34e-01	2.86e-06	6.30e-02
Regulation of CDH11 mRNA translation by microRNAs	11	1.22e-01	3.24e-01	0.36400	3.57e-01	6.85e-02	4.01e-02	6.94e-01
GOMF HEXOKINASE ACTIVITY	5	4.35e-01	6.63e-01	0.36400	-3.00e-01	-2.05e-01	2.45e-01	4.27e-01
GOBP CARDIAC ATRIUM MORPHOGENESIS	29	7.96e-03	5.07e-02	0.36400	2.02e-01	3.02e-01	5.94e-02	4.82e-03
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR	43	8.91e-04	9.61e-03	0.36400	2.69e-01	2.45e-01	2.30e-03	5.41e-03
Homologous DNA Pairing and Strand Exchange	43	8.46e-04	9.25e-03	0.36400	2.88e-01	2.21e-01	1.07e-03	1.20e-02
Signaling by CSF1 (M-CSF) in myeloid cells	30	5.65e-03	3.88e-02	0.36300	3.27e-01	1.58e-01	1.93e-03	1.33e-01
GOBP MITOCHONDRIAL PROTEIN PROCESSING	13	1.01e-01	2.92e-01	0.36300	3.36e-01	1.37e-01	3.57e-02	3.92e-01
Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA	6	2.86e-01	5.24e-01	0.36300	3.63e-01	-5.03e-03	1.23e-01	9.83e-01
GOBP SNO S RNA METABOLIC PROCESS	15	6.64e-02	2.25e-01	0.36300	3.45e-01	1.15e-01	2.08e-02	4.42e-01
GOBP REGULATION OF SULFUR METABOLIC PROCESS	13	8.59e-02	2.64e-01	0.36300	3.55e-01	7.76e-02	2.67e-02	6.28e-01
GOBP REGULATION OF MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL	6	3.72e-01	6.08e-01	0.36300	-2.92e-01	-2.17e-01	2.16e-01	3.58e-01
GOCC PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX PROTON TRANSPORTING DOMAIN	23	2.31e-02	1.10e-01	0.36300	2.27e-01	2.84e-01	5.99e-02	1.85e-02
GOCC CYCLIN CDK POSITIVE TRANSCRIPTION ELONGATION FACTOR COMPLEX	8	2.69e-01	5.08e-01	0.36300	2.24e-01	2.85e-01	2.72e-01	1.62e-01
GOBP NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS	7	3.08e-01	5.48e-01	0.36300	1.84e-01	3.13e-01	4.00e-01	1.51e-01
GOBP NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING	6	2.91e-01	5.30e-01	0.36300	3.63e-01	4.81e-03	1.24e-01	9.84e-01
GOMF HISTONE H4K12 ACETYLTRANSFERASE ACTIVITY	12	9.50e-02	2.81e-01	0.36300	3.60e-01	4.48e-02	3.07e-02	7.88e-01
GOBP VENTRAL SPINAL CORD DEVELOPMENT	45	6.70e-04	7.67e-03	0.36300	2.51e-01	2.62e-01	3.61e-03	2.33e-03
GOBP TRANSCRIPTION BY RNA POLYMERASE I	68	6.73e-06	1.55e-04	0.36300	3.35e-01	1.39e-01	1.75e-06	4.75e-02
GOBP PROTON MOTIVE FORCE DRIVEN ATP SYNTHESIS	65	1.40e-05	2.91e-04	0.36300	3.27e-01	1.57e-01	5.04e-06	2.91e-02
Removal of the Flap Intermediate from the C-strand	17	6.34e-02	2.17e-01	0.36300	2.58e-01	2.54e-01	6.51e-02	6.95e-02
Interleukin-6 family signaling	24	3.93e-03	2.95e-02	0.36300	-1.05e-01	3.47e-01	3.75e-01	3.24e-03
Mitophagy	37	1.96e-03	1.73e-02	0.36300	3.16e-01	1.78e-01	8.84e-04	6.11e-02
GOBP NEUROBLAST DIFFERENTIATION	8	1.50e-01	3.64e-01	0.36200	-1.37e-01	3.35e-01	5.02e-01	1.00e-01
GOBP REGULATION OF CELLULAR RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR STIMULUS	6	2.51e-01	4.89e-01	0.36200	-3.48e-01	1.02e-01	1.40e-01	6.66e-01
GOBP MESODERMAL CELL FATE SPECIFICATION	13	7.23e-02	2.37e-01	0.36200	1.71e-02	3.62e-01	9.15e-01	2.39e-02
GOBP ANDROGEN BIOSYNTHETIC PROCESS	10	1.85e-01	4.11e-01	0.36200	-3.17e-01	-1.76e-01	8.27e-02	3.36e-01
GOMF COBALAMIN BINDING	9	2.30e-01	4.65e-01	0.36200	2.83e-01	2.26e-01	1.42e-01	2.40e-01
GOCC METHYLTRANSFERASE COMPLEX	94	1.10e-07	3.92e-06	0.36200	3.24e-01	1.61e-01	5.38e-08	6.96e-03
GOBP CELL CELL JUNCTION DISASSEMBLY	5	3.61e-01	5.98e-01	0.36200	3.62e-01	9.23e-03	1.61e-01	9.72e-01
GOCC CUL4A RING E3 UBIQUITIN LIGASE COMPLEX	13	1.19e-01	3.21e-01	0.36200	2.19e-01	2.89e-01	1.72e-01	7.17e-02
GOBP NUCLEAR RNA SURVEILLANCE	15	6.77e-02	2.27e-01	0.36200	3.44e-01	1.14e-01	2.12e-02	4.45e-01
GOMF PHOSPHATIDYLCHOLINE TRANSFER ACTIVITY	5	4.06e-01	6.38e-01	0.36200	3.45e-01	1.10e-01	1.82e-01	6.70e-01
GOBP FAS SIGNALING PATHWAY	8	2.59e-01	4.97e-01	0.36200	3.19e-01	1.72e-01	1.19e-01	4.01e-01
GOMF HISTONE H4 ACETYLTRANSFERASE ACTIVITY	21	3.01e-02	1.32e-01	0.36200	3.10e-01	1.86e-01	1.38e-02	1.40e-01
GOBP CHRONIC INFLAMMATORY RESPONSE	18	2.63e-02	1.20e-01	0.36200	-3.61e-01	-1.37e-02	7.92e-03	9.20e-01
GOMF GLUTAMATE GATED RECEPTOR ACTIVITY	15	8.63e-02	2.65e-01	0.36200	-2.90e-01	-2.17e-01	5.21e-02	1.46e-01
GOBP PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY	8	1.41e-01	3.54e-01	0.36200	-3.07e-01	1.91e-01	1.32e-01	3.50e-01
GOBP REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION	12	1.42e-01	3.56e-01	0.36200	2.29e-01	2.80e-01	1.70e-01	9.27e-02
GOBP SINOATRIAL NODE DEVELOPMENT	11	1.21e-01	3.24e-01	0.36200	5.56e-02	3.57e-01	7.50e-01	4.02e-02
GOCC CLATHRIN SCULPTED VESICLE	12	1.26e-01	3.31e-01	0.36100	1.45e-01	3.31e-01	3.83e-01	4.72e-02
GLI3 is processed to GLI3R by the proteasome	47	1.26e-04	1.87e-03	0.36100	3.57e-01	5.78e-02	2.31e-05	4.93e-01
Physiological factors	14	1.02e-01	2.94e-01	0.36100	2.87e-01	2.19e-01	6.29e-02	1.55e-01
GOMF NUCLEAR RECEPTOR COACTIVATOR ACTIVITY	52	1.75e-04	2.46e-03	0.36100	3.11e-01	1.84e-01	1.05e-04	2.16e-02
GOCC NBAF COMPLEX	16	6.15e-02	2.14e-01	0.36100	3.34e-01	1.37e-01	2.05e-02	3.43e-01
GOBP POSITIVE REGULATION OF MRNA PROCESSING	30	5.03e-03	3.55e-02	0.36100	3.39e-01	1.25e-01	1.31e-03	2.35e-01
GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVATOR ACTIVITY	5	3.15e-01	5.54e-01	0.36100	-1.13e-01	3.43e-01	6.62e-01	1.84e-01
GOBP MYCOTOXIN METABOLIC PROCESS	7	2.94e-01	5.33e-01	0.36100	3.36e-01	1.33e-01	1.24e-01	5.43e-01
Biosynthesis of E-series 18(S)-resolvins	5	3.43e-01	5.80e-01	0.36100	-3.84e-02	3.59e-01	8.82e-01	1.64e-01
TICAM1-dependent activation of IRF3/IRF7	13	5.69e-02	2.03e-01	0.36100	3.55e-01	-6.50e-02	2.66e-02	6.85e-01
PINK1-PRKN Mediated Mitophagy	31	5.62e-03	3.86e-02	0.36100	3.14e-01	1.78e-01	2.46e-03	8.67e-02
GOBP NEGATIVE REGULATION OF SOMATIC STEM CELL POPULATION MAINTENANCE	5	3.80e-01	6.15e-01	0.36100	-4.77e-02	-3.58e-01	8.53e-01	1.66e-01
GOBP NEGATIVE REGULATION OF T HELPER 2 CELL DIFFERENTIATION	5	4.05e-01	6.38e-01	0.36100	3.46e-01	1.03e-01	1.80e-01	6.89e-01
GOBP POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE	18	3.50e-02	1.47e-01	0.36100	-3.52e-01	-7.78e-02	9.62e-03	5.68e-01
UCH proteinases	80	1.66e-06	4.57e-05	0.36100	3.13e-01	1.80e-01	1.31e-06	5.35e-03
GOMF CYCLASE REGULATOR ACTIVITY	16	2.50e-02	1.17e-01	0.36100	1.12e-01	-3.43e-01	4.36e-01	1.75e-02
GOBP VESICLE TARGETING ROUGH ER TO CIS GOLGI	25	1.74e-02	8.99e-02	0.36100	2.20e-01	2.86e-01	5.74e-02	1.32e-02
Telomere Maintenance	86	8.41e-07	2.52e-05	0.36100	2.94e-01	2.09e-01	2.45e-06	7.96e-04
Regulation of mRNA stability by proteins that bind AU-rich elements	76	3.45e-06	8.73e-05	0.36100	3.10e-01	1.85e-01	3.06e-06	5.23e-03
GOMF UBIQUITIN LIKE PROTEIN READER ACTIVITY	20	3.72e-02	1.54e-01	0.36100	3.04e-01	1.95e-01	1.87e-02	1.31e-01
GOCC PIP BODY	5	4.05e-01	6.37e-01	0.36100	-3.46e-01	-1.01e-01	1.80e-01	6.97e-01
GOBP POSITIVE REGULATION OF CHROMOSOME SEGREGATION	27	1.06e-02	6.26e-02	0.36100	3.20e-01	1.66e-01	4.00e-03	1.35e-01
Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template	38	2.25e-03	1.92e-02	0.36000	2.40e-01	2.68e-01	1.03e-02	4.19e-03
GOBP POSITIVE REGULATION OF CELLULAR PH REDUCTION	5	3.26e-01	5.65e-01	0.36000	-8.52e-02	3.50e-01	7.41e-01	1.75e-01
NIK–>noncanonical NF-kB signaling	46	3.09e-04	4.01e-03	0.36000	3.39e-01	1.23e-01	7.04e-05	1.49e-01
GOMF CCR2 CHEMOKINE RECEPTOR BINDING	5	4.42e-01	6.69e-01	0.36000	-2.03e-01	-2.97e-01	4.31e-01	2.49e-01
GOBP CELL ADHESION MOLECULE PRODUCTION	18	5.48e-02	1.99e-01	0.36000	-2.83e-01	-2.23e-01	3.76e-02	1.02e-01
GOBP REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT	25	1.58e-02	8.40e-02	0.36000	1.79e-01	3.12e-01	1.21e-01	6.87e-03
GOBP NEGATIVE REGULATION OF TELOMERE MAINTENANCE	33	3.83e-03	2.89e-02	0.36000	3.22e-01	1.62e-01	1.38e-03	1.08e-01
GOBP NEGATIVE REGULATION OF OSTEOCLAST DEVELOPMENT	5	3.31e-01	5.70e-01	0.36000	7.40e-02	-3.52e-01	7.75e-01	1.72e-01
GOBP MESODERMAL CELL FATE COMMITMENT	18	3.09e-02	1.35e-01	0.36000	4.35e-02	3.57e-01	7.50e-01	8.67e-03
Keratan sulfate degradation	15	2.53e-02	1.17e-01	0.36000	2.13e-01	-2.90e-01	1.54e-01	5.16e-02
Sema4D in semaphorin signaling	24	1.44e-02	7.82e-02	0.36000	3.41e-01	1.16e-01	3.86e-03	3.26e-01
Cellular response to hypoxia	61	3.29e-05	6.15e-04	0.36000	3.25e-01	1.55e-01	1.15e-05	3.62e-02
GOBP OXIDATIVE DEMETHYLATION	10	1.53e-01	3.69e-01	0.36000	-6.58e-02	-3.54e-01	7.19e-01	5.28e-02
GOMF INORGANIC DIPHOSPHATE PHOSPHATASE ACTIVITY	5	2.99e-01	5.38e-01	0.36000	-1.87e-01	3.07e-01	4.70e-01	2.34e-01
GOBP RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM	50	6.78e-05	1.12e-03	0.35900	3.57e-01	4.48e-02	1.28e-05	5.83e-01
GOBP LYMPHOCYTE ANERGY	7	2.50e-01	4.89e-01	0.35900	2.07e-02	3.59e-01	9.24e-01	1.00e-01
GOMF CALCIUM DEPENDENT PROTEIN SERINE THREONINE PHOSPHATASE ACTIVITY	7	2.83e-01	5.22e-01	0.35900	3.46e-01	9.59e-02	1.13e-01	6.60e-01
GOMF HISTONE H3K4 METHYLTRANSFERASE ACTIVITY	19	1.44e-02	7.82e-02	0.35900	3.48e-01	-8.82e-02	8.60e-03	5.06e-01
GOCC CLATHRIN ADAPTOR COMPLEX	26	9.37e-03	5.71e-02	0.35900	3.45e-01	9.83e-02	2.30e-03	3.86e-01
GOBP MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION	7	2.79e-01	5.18e-01	0.35900	8.51e-02	3.49e-01	6.97e-01	1.10e-01
GOMF PHOSPHATIDYL PHOSPHOLIPASE B ACTIVITY	11	1.62e-01	3.82e-01	0.35900	-1.76e-01	-3.13e-01	3.13e-01	7.22e-02
GOCC 3M COMPLEX	5	3.63e-01	6.00e-01	0.35900	3.59e-01	-1.07e-03	1.65e-01	9.97e-01
GOBP G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY	15	9.19e-02	2.75e-01	0.35900	-2.63e-01	-2.45e-01	7.83e-02	1.01e-01
Nucleotide-like (purinergic) receptors	13	9.35e-02	2.78e-01	0.35900	-3.49e-01	-8.53e-02	2.95e-02	5.94e-01
GOBP POSITIVE REGULATION OF FEEDING BEHAVIOR	10	1.67e-01	3.89e-01	0.35900	1.01e-01	3.44e-01	5.79e-01	5.94e-02
GOMF INOSITOL TETRAKISPHOSPHATE PHOSPHATASE ACTIVITY	7	2.14e-01	4.46e-01	0.35900	3.50e-01	-7.78e-02	1.09e-01	7.21e-01
GOBP GALACTOSE CATABOLIC PROCESS	6	2.34e-01	4.70e-01	0.35900	1.99e-01	-2.98e-01	3.99e-01	2.05e-01
GOBP NUCLEOSIDE TRANSMEMBRANE TRANSPORT	8	2.25e-01	4.59e-01	0.35900	-6.60e-02	-3.53e-01	7.47e-01	8.42e-02
GOBP ACROSOME REACTION	41	1.25e-03	1.24e-02	0.35900	-1.89e-01	-3.05e-01	3.58e-02	7.40e-04
TRAF6-mediated induction of TAK1 complex within TLR4 complex	15	7.47e-02	2.41e-01	0.35900	1.29e-01	3.35e-01	3.87e-01	2.49e-02
GOBP NOTOCHORD MORPHOGENESIS	8	1.43e-01	3.56e-01	0.35800	-2.17e-01	2.86e-01	2.89e-01	1.62e-01
GOBP POSITIVE REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY	9	2.38e-01	4.75e-01	0.35800	-2.26e-01	-2.78e-01	2.40e-01	1.49e-01
RUNX1 regulates transcription of genes involved in WNT signaling	5	4.06e-01	6.39e-01	0.35800	9.32e-02	3.46e-01	7.18e-01	1.80e-01
GOBP REGULATION OF PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS	5	4.33e-01	6.61e-01	0.35800	1.59e-01	3.21e-01	5.39e-01	2.14e-01
Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)	27	1.23e-02	6.93e-02	0.35800	3.05e-01	1.88e-01	6.08e-03	9.12e-02
GOCC MANNOSYLTRANSFERASE COMPLEX	5	3.03e-01	5.43e-01	0.35800	3.11e-01	-1.77e-01	2.28e-01	4.92e-01
GOBP EMBRYONIC BRAIN DEVELOPMENT	16	7.44e-02	2.41e-01	0.35800	3.03e-01	1.91e-01	3.60e-02	1.86e-01
GOBP POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY	10	1.82e-01	4.08e-01	0.35800	3.29e-01	1.41e-01	7.15e-02	4.41e-01
GOBP RRNA 3 END PROCESSING	10	1.05e-01	2.99e-01	0.35800	3.43e-01	-1.04e-01	6.07e-02	5.69e-01
GOMF DOLICHYL PHOSPHATE MANNOSE PROTEIN MANNOSYLTRANSFERASE ACTIVITY	8	1.52e-01	3.67e-01	0.35800	1.60e-01	-3.20e-01	4.33e-01	1.17e-01
GOBP CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS	31	4.72e-03	3.39e-02	0.35800	3.35e-01	1.26e-01	1.24e-03	2.25e-01
GOBP SATELLITE CELL ACTIVATION INVOLVED IN SKELETAL MUSCLE REGENERATION	6	3.71e-01	6.07e-01	0.35800	-3.15e-01	-1.71e-01	1.82e-01	4.69e-01
GOBP POSITIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY	12	8.29e-02	2.59e-01	0.35800	3.57e-01	-2.61e-02	3.23e-02	8.75e-01
GOMF STRUCTURAL CONSTITUENT OF POSTSYNAPTIC ACTIN CYTOSKELETON	7	1.86e-01	4.12e-01	0.35800	-3.02e-01	1.93e-01	1.67e-01	3.77e-01
GOBP POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC	54	1.16e-04	1.75e-03	0.35800	3.24e-01	1.52e-01	3.81e-05	5.32e-02
tRNA modification in the nucleus and cytosol	41	7.34e-04	8.33e-03	0.35800	3.41e-01	1.09e-01	1.59e-04	2.27e-01
Inactivation of CSF3 (G-CSF) signaling	25	1.87e-02	9.51e-02	0.35800	2.23e-01	2.80e-01	5.35e-02	1.55e-02
GOBP POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY	8	1.77e-01	4.01e-01	0.35800	3.52e-01	-6.33e-02	8.46e-02	7.56e-01
GOBP NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN	11	1.49e-01	3.62e-01	0.35800	3.36e-01	1.22e-01	5.35e-02	4.83e-01
GOCC LARGE RIBOSOMAL SUBUNIT	107	4.34e-08	1.70e-06	0.35700	2.81e-01	2.21e-01	5.10e-07	7.77e-05
GOBP RECEPTOR DIFFUSION TRAPPING	10	2.06e-01	4.38e-01	0.35700	-2.63e-01	-2.42e-01	1.50e-01	1.85e-01
GOMF RDNA BINDING	9	2.29e-01	4.64e-01	0.35700	3.10e-01	1.78e-01	1.07e-01	3.56e-01
GOBP CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS	10	1.90e-01	4.17e-01	0.35700	3.19e-01	1.61e-01	8.07e-02	3.78e-01
WNT5A-dependent internalization of FZD4	15	7.37e-02	2.40e-01	0.35700	3.37e-01	1.17e-01	2.37e-02	4.32e-01
Processive synthesis on the C-strand of the telomere	19	5.01e-02	1.88e-01	0.35700	2.44e-01	2.61e-01	6.56e-02	4.90e-02
GOBP REGULATION OF CALCIUM IMPORT INTO THE MITOCHONDRION	6	2.58e-01	4.97e-01	0.35700	-1.10e-01	3.40e-01	6.40e-01	1.50e-01
GOBP NEGATIVE REGULATION OF HORMONE METABOLIC PROCESS	12	5.41e-02	1.98e-01	0.35700	-2.62e-01	2.42e-01	1.16e-01	1.46e-01
GOMF PHOSPHATIDYLSERINE 1 ACYLHYDROLASE ACTIVITY	11	7.09e-02	2.34e-01	0.35700	-2.06e-01	2.92e-01	2.37e-01	9.39e-02
GOBP PROTEIN LOCALIZATION TO NUCLEOLUS	17	6.86e-02	2.28e-01	0.35700	2.69e-01	2.34e-01	5.44e-02	9.49e-02
GOBP GRANULOCYTE COLONY STIMULATING FACTOR SIGNALING PATHWAY	5	4.55e-01	6.80e-01	0.35700	2.67e-01	2.37e-01	3.01e-01	3.59e-01
GOCC NUCLEOSOME	114	1.12e-08	4.90e-07	0.35700	3.01e-01	1.91e-01	2.76e-08	4.19e-04
GOBP NETRIN ACTIVATED SIGNALING PATHWAY	9	1.44e-01	3.57e-01	0.35600	-3.50e-01	6.58e-02	6.87e-02	7.33e-01
FLT3 Signaling	38	2.59e-03	2.16e-02	0.35600	2.47e-01	2.57e-01	8.41e-03	6.12e-03
GOBP TRNA SURVEILLANCE	8	1.93e-01	4.21e-01	0.35600	3.56e-01	-2.56e-02	8.16e-02	9.00e-01
GOMF SEMAPHORIN RECEPTOR ACTIVITY	10	2.03e-01	4.34e-01	0.35600	-2.04e-01	-2.92e-01	2.63e-01	1.10e-01
GOBP REGULATION OF MDA 5 SIGNALING PATHWAY	6	3.48e-01	5.86e-01	0.35600	3.41e-01	1.03e-01	1.48e-01	6.61e-01
GOBP MITOTIC G2 M TRANSITION CHECKPOINT	52	2.59e-04	3.47e-03	0.35600	2.91e-01	2.05e-01	2.83e-04	1.04e-02
GOCC ROUGH ENDOPLASMIC RETICULUM MEMBRANE	23	2.35e-02	1.12e-01	0.35600	3.12e-01	1.73e-01	9.70e-03	1.52e-01
GOBP REGULATION OF CIRCULATING FIBRINOGEN LEVELS	5	4.57e-01	6.82e-01	0.35600	-2.60e-01	-2.43e-01	3.13e-01	3.47e-01
Cellular response to mitochondrial stress	8	1.48e-01	3.61e-01	0.35600	2.94e-01	-2.00e-01	1.49e-01	3.27e-01
Formation of the posterior neural plate	10	1.84e-01	4.10e-01	0.35600	1.35e-01	3.29e-01	4.59e-01	7.14e-02
GOBP REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION	9	1.73e-01	3.95e-01	0.35600	-1.61e-02	-3.56e-01	9.33e-01	6.47e-02
GOMF TRANSPORTER ACTIVATOR ACTIVITY	8	2.75e-01	5.15e-01	0.35600	3.05e-01	1.84e-01	1.35e-01	3.69e-01
GOCC GBAF COMPLEX	14	1.07e-01	3.03e-01	0.35600	2.95e-01	1.99e-01	5.57e-02	1.98e-01
GOBP MATURATION OF LSU RRNA	23	2.67e-02	1.22e-01	0.35600	2.80e-01	2.20e-01	2.02e-02	6.78e-02
GOBP POSITIVE REGULATION OF CHROMATIN ORGANIZATION	14	7.06e-02	2.34e-01	0.35600	3.54e-01	4.03e-02	2.20e-02	7.94e-01
GOBP REGULATION OF TRANSLATION INITIATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS	8	2.79e-01	5.19e-01	0.35600	2.95e-01	1.98e-01	1.48e-01	3.32e-01
GOBP DNA REPLICATION SYNTHESIS OF PRIMER	6	2.76e-01	5.16e-01	0.35600	3.49e-01	-6.69e-02	1.39e-01	7.77e-01
GOMF OXALATE TRANSMEMBRANE TRANSPORTER ACTIVITY	10	9.65e-02	2.84e-01	0.35500	-3.14e-01	1.67e-01	8.57e-02	3.60e-01
GOMF NUCLEAR LOCALIZATION SEQUENCE BINDING	24	2.14e-02	1.05e-01	0.35500	1.89e-01	3.01e-01	1.08e-01	1.07e-02
Regulation of RUNX2 expression and activity	59	8.69e-05	1.39e-03	0.35500	2.93e-01	2.01e-01	9.74e-05	7.70e-03
GOBP EMBRYONIC NEUROCRANIUM MORPHOGENESIS	8	1.48e-01	3.61e-01	0.35500	2.86e-01	-2.11e-01	1.61e-01	3.02e-01
GOBP REGULATION OF MAST CELL CHEMOTAXIS	7	2.12e-01	4.44e-01	0.35500	-1.03e-01	3.40e-01	6.38e-01	1.19e-01
GOBP PROGESTERONE METABOLIC PROCESS	16	8.24e-02	2.57e-01	0.35500	-2.33e-01	-2.68e-01	1.06e-01	6.36e-02
Uptake of dietary cobalamins into enterocytes	9	2.45e-01	4.84e-01	0.35500	-2.69e-01	-2.31e-01	1.62e-01	2.29e-01
GOMF RIBOSOMAL PROTEIN S6 KINASE ACTIVITY	5	3.91e-01	6.25e-01	0.35500	4.30e-02	3.52e-01	8.68e-01	1.73e-01
HDR through Homologous Recombination (HRR)	68	2.62e-05	5.02e-04	0.35500	2.50e-01	2.52e-01	3.64e-04	3.28e-04
GOMF XENOBIOTIC TRANSMEMBRANE TRANSPORTER ACTIVITY	32	6.25e-03	4.21e-02	0.35500	-1.95e-01	-2.96e-01	5.62e-02	3.73e-03
Signaling by FLT3 fusion proteins	19	4.46e-02	1.74e-01	0.35500	3.17e-01	1.58e-01	1.67e-02	2.32e-01
Oxidative Stress Induced Senescence	88	1.22e-06	3.49e-05	0.35500	2.53e-01	2.48e-01	3.98e-05	5.77e-05
GOBP NEURAL PLATE MORPHOGENESIS	5	4.57e-01	6.82e-01	0.35400	2.83e-01	2.13e-01	2.72e-01	4.10e-01
Chromatin modifying enzymes	216	1.23e-16	1.44e-14	0.35400	3.34e-01	1.17e-01	2.29e-17	3.02e-03
Chromatin organization	216	1.23e-16	1.44e-14	0.35400	3.34e-01	1.17e-01	2.29e-17	3.02e-03
GOBP GLYCOSIDE TRANSPORT	5	4.57e-01	6.82e-01	0.35400	-2.83e-01	-2.14e-01	2.74e-01	4.08e-01
GOBP INTESTINAL EPITHELIAL STRUCTURE MAINTENANCE	8	2.22e-01	4.55e-01	0.35400	-3.52e-01	-3.65e-02	8.45e-02	8.58e-01
GOMF MHC CLASS II PROTEIN BINDING	7	3.31e-01	5.70e-01	0.35400	1.96e-01	2.95e-01	3.69e-01	1.77e-01
Cleavage of the damaged pyrimidine	38	2.81e-03	2.29e-02	0.35400	2.50e-01	2.51e-01	7.75e-03	7.41e-03
Depyrimidination	38	2.81e-03	2.29e-02	0.35400	2.50e-01	2.51e-01	7.75e-03	7.41e-03
Recognition and association of DNA glycosylase with site containing an affected pyrimidine	38	2.81e-03	2.29e-02	0.35400	2.50e-01	2.51e-01	7.75e-03	7.41e-03
GOBP RNA SPLICING	423	4.12e-31	1.26e-28	0.35400	3.29e-01	1.30e-01	2.89e-31	4.42e-06
GOBP REGULATION OF POLYAMINE TRANSMEMBRANE TRANSPORT	5	4.60e-01	6.84e-01	0.35400	2.29e-01	2.70e-01	3.76e-01	2.95e-01
GOMF ORNITHINE DECARBOXYLASE REGULATOR ACTIVITY	5	4.60e-01	6.84e-01	0.35400	2.29e-01	2.70e-01	3.76e-01	2.95e-01
NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux	43	1.10e-04	1.68e-03	0.35400	3.48e-01	-6.53e-02	7.89e-05	4.59e-01
mRNA Splicing - Minor Pathway	52	1.30e-04	1.92e-03	0.35400	3.37e-01	1.08e-01	2.60e-05	1.79e-01
GOBP TERMINAL BUTTON ORGANIZATION	6	2.83e-01	5.22e-01	0.35400	3.49e-01	-5.69e-02	1.38e-01	8.09e-01
GOCC NSL COMPLEX	9	1.86e-01	4.12e-01	0.35400	3.52e-01	4.14e-02	6.78e-02	8.30e-01
GOBP REGULATION OF T CELL EXTRAVASATION	5	3.53e-01	5.91e-01	0.35400	-3.51e-01	4.74e-02	1.74e-01	8.54e-01
Impaired BRCA2 binding to RAD51	35	4.52e-03	3.28e-02	0.35400	2.51e-01	2.50e-01	1.03e-02	1.06e-02
GOBP RESPONSE TO BILE ACID	7	3.39e-01	5.77e-01	0.35400	-2.61e-01	-2.39e-01	2.32e-01	2.74e-01
GOBP CELL PROLIFERATION IN MIDBRAIN	8	1.50e-01	3.65e-01	0.35300	-2.16e-01	2.80e-01	2.91e-01	1.70e-01
GOBP FERROPTOSIS	9	1.53e-01	3.69e-01	0.35300	-5.07e-02	3.50e-01	7.92e-01	6.92e-02
GOMF OXIDOREDUCTION DRIVEN ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY	53	1.12e-04	1.69e-03	0.35300	3.37e-01	1.07e-01	2.22e-05	1.76e-01
Diseases associated with O-glycosylation of proteins	68	2.63e-05	5.03e-04	0.35300	-2.18e-01	-2.78e-01	1.88e-03	7.26e-05
GOBP STRESS GRANULE ASSEMBLY	32	3.68e-03	2.81e-02	0.35300	3.41e-01	9.06e-02	8.27e-04	3.75e-01
GOBP REGULATION OF CELL FATE COMMITMENT	43	1.32e-03	1.29e-02	0.35300	2.36e-01	2.63e-01	7.44e-03	2.85e-03
IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation	14	1.06e-01	3.02e-01	0.35300	1.74e-01	3.07e-01	2.59e-01	4.65e-02
GOBP NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION	26	6.67e-03	4.42e-02	0.35300	3.53e-01	1.34e-02	1.84e-03	9.06e-01
GOBP CEREBELLAR PURKINJE CELL LAYER FORMATION	14	1.15e-01	3.15e-01	0.35300	2.64e-01	2.34e-01	8.69e-02	1.29e-01
GOMF INOSITOL POLYPHOSPHATE 5 PHOSPHATASE ACTIVITY	6	2.45e-01	4.83e-01	0.35300	1.95e-01	-2.94e-01	4.07e-01	2.12e-01
Autodegradation of Cdh1 by Cdh1:APC/C	54	1.85e-04	2.58e-03	0.35300	3.05e-01	1.77e-01	1.04e-04	2.42e-02
GOMF ATP DEPENDENT CHROMATIN REMODELER ACTIVITY	33	2.29e-03	1.95e-02	0.35300	3.50e-01	4.87e-02	5.07e-04	6.28e-01
GOMF UBIQUITIN LIGASE ACTIVATOR ACTIVITY	10	2.14e-01	4.47e-01	0.35300	2.59e-01	2.40e-01	1.57e-01	1.88e-01
Acyl chain remodeling of CL	5	3.26e-01	5.64e-01	0.35300	3.28e-01	-1.30e-01	2.04e-01	6.13e-01
IRAK2 mediated activation of TAK1 complex	9	2.39e-01	4.77e-01	0.35300	3.03e-01	1.80e-01	1.15e-01	3.50e-01
GOBP L LEUCINE IMPORT ACROSS PLASMA MEMBRANE	5	4.63e-01	6.86e-01	0.35300	2.45e-01	2.54e-01	3.42e-01	3.26e-01
Lysosphingolipid and LPA receptors	14	3.61e-02	1.50e-01	0.35300	-2.48e-01	2.51e-01	1.08e-01	1.04e-01
GOBP REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS	177	1.60e-12	1.31e-10	0.35300	2.74e-01	2.22e-01	3.12e-10	3.53e-07
Presynaptic phase of homologous DNA pairing and strand exchange	40	2.08e-03	1.82e-02	0.35300	2.76e-01	2.19e-01	2.53e-03	1.63e-02
GOCC TETRASPANIN ENRICHED MICRODOMAIN	10	9.36e-02	2.78e-01	0.35200	-2.46e-01	2.52e-01	1.77e-01	1.68e-01
GOBP DETOXIFICATION OF INORGANIC COMPOUND	22	5.83e-03	3.97e-02	0.35200	-1.99e-01	2.91e-01	1.06e-01	1.82e-02
Regulation of Complement cascade	43	1.30e-03	1.28e-02	0.35200	-2.13e-01	-2.80e-01	1.55e-02	1.47e-03
GOBP REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR	36	3.57e-03	2.75e-02	0.35200	1.93e-01	2.95e-01	4.52e-02	2.21e-03
RNA polymerase II transcribes snRNA genes	74	4.94e-06	1.19e-04	0.35200	3.26e-01	1.34e-01	1.26e-06	4.62e-02
GOMF UBIQUITIN PROTEIN TRANSFERASE ACTIVATOR ACTIVITY	16	8.03e-02	2.53e-01	0.35200	3.00e-01	1.85e-01	3.78e-02	2.01e-01
GOBP MIDDLE EAR MORPHOGENESIS	21	4.00e-02	1.62e-01	0.35200	2.62e-01	2.35e-01	3.73e-02	6.25e-02
NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10	12	1.29e-01	3.37e-01	0.35200	3.35e-01	1.08e-01	4.43e-02	5.18e-01
GOBP PROTEIN HYDROXYLATION	23	1.07e-02	6.32e-02	0.35200	3.52e-01	-1.04e-02	3.47e-03	9.31e-01
GOBP FRUCTOSE TRANSMEMBRANE TRANSPORT	10	2.03e-01	4.33e-01	0.35200	-3.09e-01	-1.69e-01	9.07e-02	3.55e-01
GOBP T HELPER 2 CELL CYTOKINE PRODUCTION	13	7.89e-02	2.51e-01	0.35200	-3.52e-01	2.97e-03	2.80e-02	9.85e-01
GOBP RESPONSE TO X RAY	27	1.57e-02	8.38e-02	0.35200	2.76e-01	2.19e-01	1.32e-02	4.93e-02
GOBP EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION	18	6.12e-02	2.13e-01	0.35200	2.03e-01	2.87e-01	1.36e-01	3.47e-02
Formation of the nephric duct	17	2.08e-02	1.02e-01	0.35200	-1.59e-01	3.14e-01	2.56e-01	2.51e-02
GOBP RETROGRADE TRANS SYNAPTIC SIGNALING	10	2.17e-01	4.49e-01	0.35200	-2.55e-01	-2.42e-01	1.62e-01	1.85e-01
Defects in cobalamin (B12) metabolism	13	1.29e-01	3.37e-01	0.35200	3.01e-01	1.81e-01	6.00e-02	2.57e-01
GOBP INNER CELL MASS CELL PROLIFERATION	14	1.17e-01	3.17e-01	0.35200	2.68e-01	2.28e-01	8.26e-02	1.40e-01
GOMF SECONDARY ACTIVE SULFATE TRANSMEMBRANE TRANSPORTER ACTIVITY	11	8.97e-02	2.72e-01	0.35200	-3.34e-01	1.11e-01	5.53e-02	5.24e-01
Translesion synthesis by POLK	17	7.35e-02	2.40e-01	0.35200	2.73e-01	2.22e-01	5.16e-02	1.13e-01
Base Excision Repair	68	3.08e-05	5.81e-04	0.35200	2.30e-01	2.66e-01	1.01e-03	1.52e-04
Androgen biosynthesis	11	1.68e-01	3.89e-01	0.35100	-3.19e-01	-1.48e-01	6.71e-02	3.96e-01
GOMF RIBOSOMAL LARGE SUBUNIT BINDING	14	1.11e-01	3.08e-01	0.35100	3.01e-01	1.81e-01	5.11e-02	2.41e-01
GOBP REGULATION OF I KAPPAB PHOSPHORYLATION	8	2.26e-01	4.60e-01	0.35100	-3.52e-02	-3.50e-01	8.63e-01	8.68e-02
GOMF POLY ADP D RIBOSE BINDING	5	4.67e-01	6.89e-01	0.35100	2.47e-01	2.50e-01	3.38e-01	3.34e-01
GOBP NEGATIVE REGULATION OF VIRAL TRANSCRIPTION	14	1.13e-01	3.11e-01	0.35100	2.96e-01	1.90e-01	5.56e-02	2.19e-01
GOBP POSITIVE REGULATION OF STEM CELL DIFFERENTIATION	21	2.67e-02	1.22e-01	0.35100	9.32e-02	3.39e-01	4.60e-01	7.22e-03
GOBP FACE DEVELOPMENT	50	2.31e-04	3.13e-03	0.35100	3.31e-01	1.17e-01	5.10e-05	1.52e-01
GOBP POSITIVE REGULATION OF AGGREPHAGY	6	2.86e-01	5.24e-01	0.35100	3.45e-01	-6.48e-02	1.43e-01	7.83e-01
GOBP REGULATION OF ODONTOBLAST DIFFERENTIATION	10	1.80e-01	4.05e-01	0.35100	9.80e-02	3.37e-01	5.92e-01	6.50e-02
GOBP REGULATION OF MYOSIN LIGHT CHAIN PHOSPHATASE ACTIVITY	7	2.09e-01	4.41e-01	0.35100	1.40e-01	-3.22e-01	5.21e-01	1.41e-01
GOBP NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS	49	4.27e-04	5.26e-03	0.35100	3.08e-01	1.67e-01	1.89e-04	4.26e-02
GOBP CELLULAR RESPONSE TO HYDROPEROXIDE	9	2.44e-01	4.82e-01	0.35100	-1.82e-01	-3.00e-01	3.44e-01	1.19e-01
GOBP REGULATION OF ANGIOTENSIN LEVELS IN BLOOD	8	2.81e-01	5.20e-01	0.35100	-3.08e-01	-1.67e-01	1.31e-01	4.13e-01
GOBP FACE MORPHOGENESIS	31	4.37e-03	3.21e-02	0.35100	3.42e-01	7.74e-02	9.81e-04	4.56e-01
Resolution of Abasic Sites (AP sites)	38	3.10e-03	2.47e-02	0.35000	2.27e-01	2.67e-01	1.53e-02	4.45e-03
Signaling by WNT in cancer	32	1.65e-03	1.52e-02	0.35000	3.49e-01	-3.19e-02	6.35e-04	7.55e-01
GOMF PROTEIN PRENYLTRANSFERASE ACTIVITY	6	2.76e-01	5.16e-01	0.35000	3.37e-01	-9.49e-02	1.53e-01	6.87e-01
GOBP CELL PROLIFERATION IN HINDBRAIN	14	1.13e-01	3.12e-01	0.35000	2.99e-01	1.83e-01	5.30e-02	2.36e-01
GOBP EMBRYONIC APPENDAGE MORPHOGENESIS	121	1.15e-08	4.99e-07	0.35000	2.64e-01	2.30e-01	5.37e-07	1.22e-05
Nucleotide Excision Repair	105	9.03e-08	3.31e-06	0.35000	2.94e-01	1.89e-01	1.85e-07	7.98e-04
FLT3 signaling in disease	28	1.20e-02	6.86e-02	0.35000	3.08e-01	1.67e-01	4.85e-03	1.26e-01
GOBP POSITIVE REGULATION OF CARDIAC MUSCLE CONTRACTION	8	1.84e-01	4.10e-01	0.35000	-3.40e-01	8.32e-02	9.59e-02	6.84e-01
GOMF ALPHA 2A ADRENERGIC RECEPTOR BINDING	5	3.28e-01	5.68e-01	0.35000	-3.20e-01	1.42e-01	2.16e-01	5.82e-01
GOCC INTERMEDIATE FILAMENT CYTOSKELETON	237	2.38e-16	2.73e-14	0.35000	-2.84e-01	-2.05e-01	5.35e-14	5.55e-08
GOBP TRYPTOPHAN TRANSPORT	5	4.66e-01	6.88e-01	0.35000	2.06e-01	2.83e-01	4.26e-01	2.74e-01
GOBP DE NOVO AMP BIOSYNTHETIC PROCESS	8	1.63e-01	3.83e-01	0.34900	1.68e-01	-3.06e-01	4.10e-01	1.34e-01
RAS signaling downstream of NF1 loss-of-function variants	7	3.47e-01	5.84e-01	0.34900	2.26e-01	2.67e-01	3.01e-01	2.21e-01
GOBP RESPONSE TO ZINC ION STARVATION	9	2.30e-01	4.65e-01	0.34900	1.30e-01	3.24e-01	4.99e-01	9.21e-02
GOBP ENDOTHELIAL CELL MATRIX ADHESION	8	2.71e-01	5.11e-01	0.34900	-3.23e-01	-1.32e-01	1.13e-01	5.17e-01
GOBP OLFACTORY BULB INTERNEURON DEVELOPMENT	7	3.05e-01	5.45e-01	0.34900	-3.35e-01	-9.83e-02	1.25e-01	6.52e-01
GOMF RNA ENDONUCLEASE ACTIVITY PRODUCING 5 PHOSPHOMONOESTERS	31	7.76e-03	4.96e-02	0.34900	3.06e-01	1.69e-01	3.23e-03	1.03e-01
GOBP AZOLE TRANSMEMBRANE TRANSPORT	14	1.04e-01	2.98e-01	0.34900	-1.40e-01	-3.20e-01	3.65e-01	3.82e-02
GOBP RESPONSE TO INCREASED OXYGEN LEVELS	23	3.03e-02	1.33e-01	0.34900	2.78e-01	2.11e-01	2.09e-02	7.97e-02
Estrogen-stimulated signaling through PRKCZ	6	3.54e-01	5.91e-01	0.34900	3.40e-01	8.03e-02	1.50e-01	7.33e-01
GOMF TRNA GUANINE METHYLTRANSFERASE ACTIVITY	11	1.48e-01	3.61e-01	0.34900	7.65e-02	3.41e-01	6.61e-01	5.04e-02
GOMF L LEUCINE TRANSMEMBRANE TRANSPORTER ACTIVITY	6	3.78e-01	6.13e-01	0.34900	3.21e-01	1.36e-01	1.73e-01	5.64e-01
GOCC CORVET COMPLEX	7	3.25e-01	5.64e-01	0.34900	3.18e-01	1.45e-01	1.46e-01	5.08e-01
TGFBR3 PTM regulation	10	1.97e-01	4.27e-01	0.34900	3.23e-01	1.33e-01	7.72e-02	4.68e-01
GOMF PEPTIDE N ACETYLTRANSFERASE ACTIVITY	47	6.02e-04	7.02e-03	0.34900	3.11e-01	1.59e-01	2.29e-04	5.98e-02
GOBP CHORIONIC TROPHOBLAST CELL PROLIFERATION	5	3.23e-01	5.61e-01	0.34900	-3.04e-01	1.71e-01	2.39e-01	5.08e-01
Organic cation transport	10	1.84e-01	4.10e-01	0.34900	-3.35e-01	-9.61e-02	6.66e-02	5.99e-01
Processing of Capped Intronless Pre-mRNA	28	1.47e-02	7.96e-02	0.34900	2.70e-01	2.20e-01	1.34e-02	4.36e-02
GOBP PRIMARY AMINO COMPOUND BIOSYNTHETIC PROCESS	6	3.64e-01	6.01e-01	0.34800	-3.34e-01	-9.92e-02	1.56e-01	6.74e-01
GOBP NEGATIVE REGULATION OF CENTRIOLE REPLICATION	7	3.14e-01	5.54e-01	0.34800	3.29e-01	1.14e-01	1.31e-01	6.02e-01
GOMF SEQUENCE SPECIFIC SINGLE STRANDED DNA BINDING	14	9.49e-02	2.81e-01	0.34800	3.34e-01	9.96e-02	3.06e-02	5.19e-01
GOBP RESPONSE TO NITROSATIVE STRESS	10	2.21e-01	4.55e-01	0.34800	2.73e-01	2.17e-01	1.35e-01	2.35e-01
GOMF DEUBIQUITINASE ACTIVATOR ACTIVITY	7	2.04e-01	4.35e-01	0.34800	2.97e-01	-1.82e-01	1.74e-01	4.05e-01
GOMF ALKANE 1 MONOOXYGENASE ACTIVITY	5	4.48e-01	6.74e-01	0.34800	-3.19e-01	-1.40e-01	2.17e-01	5.89e-01
GOBP REGULATION OF FEVER GENERATION	9	2.48e-01	4.86e-01	0.34800	-3.01e-01	-1.75e-01	1.18e-01	3.65e-01
Epigenetic regulation of gene expression	269	4.82e-19	6.50e-17	0.34800	3.13e-01	1.51e-01	8.24e-19	1.99e-05
GOBP MYOTUBE DIFFERENTIATION INVOLVED IN SKELETAL MUSCLE REGENERATION	8	2.38e-01	4.75e-01	0.34800	3.45e-01	4.64e-02	9.14e-02	8.20e-01
GOBP CELL PROLIFERATION IN FOREBRAIN	26	2.02e-02	1.00e-01	0.34800	2.70e-01	2.19e-01	1.72e-02	5.29e-02
GOMF TRANSCRIPTION COREPRESSOR BINDING	45	8.22e-04	9.06e-03	0.34800	3.13e-01	1.52e-01	2.80e-04	7.85e-02
GOCC PHOSPHATASE COMPLEX	52	2.95e-04	3.87e-03	0.34800	3.08e-01	1.61e-01	1.21e-04	4.45e-02
GOBP REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION	13	5.57e-02	2.01e-01	0.34800	3.12e-01	-1.54e-01	5.16e-02	3.37e-01
GOCC CHROMATIN SILENCING COMPLEX	12	1.16e-01	3.16e-01	0.34700	3.45e-01	4.37e-02	3.87e-02	7.93e-01
GOMF METALLOENDOPEPTIDASE INHIBITOR ACTIVITY	13	1.43e-01	3.56e-01	0.34700	-2.20e-01	-2.69e-01	1.70e-01	9.32e-02
GOBP PULMONARY ARTERY MORPHOGENESIS	6	4.06e-01	6.38e-01	0.34700	2.77e-01	2.09e-01	2.40e-01	3.74e-01
GOMF SYNDECAN BINDING	5	4.74e-01	6.94e-01	0.34700	-2.28e-01	-2.62e-01	3.78e-01	3.10e-01
GOBP REGULATION OF MUSCLE TISSUE DEVELOPMENT	44	1.45e-03	1.37e-02	0.34700	2.51e-01	2.40e-01	3.96e-03	5.94e-03
GOBP LNCRNA MEDIATED POST TRANSCRIPTIONAL GENE SILENCING	8	2.68e-01	5.07e-01	0.34700	3.29e-01	1.11e-01	1.07e-01	5.86e-01
GOBP PROTEIN LOCALIZATION TO SITE OF DOUBLE STRAND BREAK	14	1.21e-01	3.24e-01	0.34700	2.04e-01	2.81e-01	1.86e-01	6.90e-02
GOBP MISMATCH REPAIR	34	5.62e-03	3.86e-02	0.34700	2.93e-01	1.86e-01	3.12e-03	6.02e-02
GOBP REGULATION OF CYTOPLASMIC TRANSLATIONAL INITIATION	7	2.03e-01	4.34e-01	0.34700	2.79e-01	-2.06e-01	2.00e-01	3.46e-01
Formation of Incision Complex in GG-NER	40	2.32e-03	1.97e-02	0.34700	2.89e-01	1.93e-01	1.59e-03	3.49e-02
Activation of RAS in B cells	5	4.63e-01	6.86e-01	0.34700	3.01e-01	1.73e-01	2.44e-01	5.03e-01
GOBP PANCREAS DEVELOPMENT	77	1.10e-05	2.35e-04	0.34700	2.43e-01	2.48e-01	2.28e-04	1.70e-04
GOBP MITOCHONDRIAL PROTON TRANSPORTING ATP SYNTHASE COMPLEX ASSEMBLY	8	2.72e-01	5.12e-01	0.34700	3.25e-01	1.21e-01	1.11e-01	5.53e-01
Resolution of D-Loop Structures	35	5.48e-03	3.79e-02	0.34700	2.59e-01	2.31e-01	8.07e-03	1.79e-02
Ubiquitin Mediated Degradation of Phosphorylated Cdc25A	39	1.14e-03	1.16e-02	0.34700	3.41e-01	6.55e-02	2.32e-04	4.79e-01
p53-Independent DNA Damage Response	39	1.14e-03	1.16e-02	0.34700	3.41e-01	6.55e-02	2.32e-04	4.79e-01
p53-Independent G1/S DNA damage checkpoint	39	1.14e-03	1.16e-02	0.34700	3.41e-01	6.55e-02	2.32e-04	4.79e-01
GOCC UNIPLEX COMPLEX	6	2.74e-01	5.14e-01	0.34700	3.25e-01	-1.21e-01	1.68e-01	6.06e-01
GOBP DNA STRAND ELONGATION	36	3.46e-03	2.69e-02	0.34700	3.13e-01	1.49e-01	1.15e-03	1.22e-01
GOBP PERIPHERAL NERVOUS SYSTEM AXON REGENERATION	8	1.68e-01	3.90e-01	0.34700	1.66e-01	-3.04e-01	4.17e-01	1.36e-01
Incretin synthesis, secretion, and inactivation	23	2.69e-02	1.22e-01	0.34700	3.13e-01	1.50e-01	9.43e-03	2.14e-01
GOBP DENDRITIC TRANSPORT	12	1.61e-01	3.79e-01	0.34700	1.83e-01	2.94e-01	2.72e-01	7.76e-02
GOBP UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS	14	1.03e-01	2.94e-01	0.34600	1.17e-01	3.26e-01	4.50e-01	3.47e-02
GOMF NADH DEHYDROGENASE ACTIVITY	8	2.98e-01	5.38e-01	0.34600	2.90e-01	1.88e-01	1.55e-01	3.56e-01
GOCC CUL4B RING E3 UBIQUITIN LIGASE COMPLEX	5	4.76e-01	6.95e-01	0.34600	2.21e-01	2.66e-01	3.92e-01	3.02e-01
GOBP MUCOCILIARY CLEARANCE	8	3.00e-01	5.40e-01	0.34600	-1.97e-01	-2.85e-01	3.35e-01	1.63e-01
GOBP REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY	23	1.75e-02	9.03e-02	0.34600	3.42e-01	5.23e-02	4.52e-03	6.64e-01
Propionyl-CoA catabolism	5	4.77e-01	6.95e-01	0.34600	2.26e-01	2.62e-01	3.82e-01	3.10e-01
GOMF DOUBLE STRANDED DNA EXODEOXYRIBONUCLEASE ACTIVITY	6	4.10e-01	6.42e-01	0.34600	2.68e-01	2.19e-01	2.56e-01	3.54e-01
GOCC CUL5 RING UBIQUITIN LIGASE COMPLEX	10	2.26e-01	4.60e-01	0.34600	2.14e-01	2.72e-01	2.41e-01	1.37e-01
Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)	9	2.64e-01	5.03e-01	0.34600	-2.27e-01	-2.61e-01	2.39e-01	1.75e-01
GOBP POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS	17	2.31e-02	1.10e-01	0.34600	-1.67e-01	3.03e-01	2.34e-01	3.06e-02
Transcription of E2F targets under negative control by DREAM complex	19	5.39e-02	1.98e-01	0.34600	3.03e-01	1.66e-01	2.22e-02	2.10e-01
GOBP REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III	28	1.15e-02	6.65e-02	0.34600	3.20e-01	1.30e-01	3.37e-03	2.33e-01
Downstream signal transduction	29	1.18e-02	6.77e-02	0.34600	3.00e-01	1.71e-01	5.11e-03	1.11e-01
GOBP POSITIVE REGULATION OF T HELPER 2 CELL DIFFERENTIATION	7	2.74e-01	5.13e-01	0.34600	1.08e-02	3.45e-01	9.61e-01	1.14e-01
GOCC NF KAPPAB COMPLEX	5	4.76e-01	6.95e-01	0.34500	2.18e-01	2.68e-01	3.99e-01	2.99e-01
GOBP REGULATION OF ADHERENS JUNCTION ORGANIZATION	5	4.70e-01	6.92e-01	0.34500	1.86e-01	2.91e-01	4.72e-01	2.60e-01
GOMF N ACETYLTRANSFERASE ACTIVITY	62	8.89e-05	1.41e-03	0.34500	2.90e-01	1.87e-01	7.79e-05	1.08e-02
Fanconi Anemia Pathway	34	4.89e-03	3.47e-02	0.34500	3.13e-01	1.45e-01	1.58e-03	1.42e-01
GOBP NEGATIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY	6	3.73e-01	6.09e-01	0.34500	3.29e-01	1.04e-01	1.63e-01	6.60e-01
Presynaptic nicotinic acetylcholine receptors	12	7.08e-02	2.34e-01	0.34500	-3.03e-01	1.65e-01	6.93e-02	3.21e-01
GOBP RNA 3 END PROCESSING	84	1.03e-06	3.00e-05	0.34500	3.30e-01	1.01e-01	1.71e-07	1.11e-01
Inhibition of replication initiation of damaged DNA by RB1/E2F1	11	1.06e-01	3.01e-01	0.34500	3.37e-01	-7.57e-02	5.33e-02	6.64e-01
GOMF TOXIC SUBSTANCE BINDING	10	1.95e-01	4.24e-01	0.34500	-1.06e-01	-3.28e-01	5.63e-01	7.22e-02
GOBP POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS	10	1.09e-01	3.06e-01	0.34500	-2.97e-01	1.75e-01	1.04e-01	3.37e-01
GOMF SULFATE TRANSMEMBRANE TRANSPORTER ACTIVITY	16	3.94e-02	1.60e-01	0.34500	-3.38e-01	6.77e-02	1.92e-02	6.39e-01
GOBP DETERMINATION OF DIGESTIVE TRACT LEFT RIGHT ASYMMETRY	5	4.70e-01	6.92e-01	0.34500	-1.83e-01	-2.92e-01	4.78e-01	2.58e-01
GOMF VITAMIN D BINDING	6	4.09e-01	6.41e-01	0.34500	-2.82e-01	-1.99e-01	2.32e-01	4.00e-01
GOBP PITUITARY GLAND DEVELOPMENT	40	2.83e-03	2.30e-02	0.34500	2.35e-01	2.52e-01	1.01e-02	5.79e-03
GOBP TROPHOBLAST GIANT CELL DIFFERENTIATION	12	6.70e-02	2.26e-01	0.34500	-2.73e-01	2.10e-01	1.01e-01	2.07e-01
GOBP PEPTIDE ANTIGEN ASSEMBLY WITH MHC CLASS II PROTEIN COMPLEX	14	4.20e-02	1.68e-01	0.34500	-2.42e-01	2.45e-01	1.17e-01	1.12e-01
GOBP PEPTIDYL LYSINE TRIMETHYLATION	9	2.58e-01	4.97e-01	0.34500	2.91e-01	1.85e-01	1.31e-01	3.37e-01
GOBP NUCLEOSIDE TRANSPORT	10	2.14e-01	4.46e-01	0.34400	-1.57e-01	-3.07e-01	3.91e-01	9.29e-02
GOBP REGULATION OF BASEMENT MEMBRANE ORGANIZATION	11	8.97e-02	2.72e-01	0.34400	1.60e-01	-3.05e-01	3.59e-01	7.97e-02
GOBP MITOCHONDRIAL RESPIRASOME ASSEMBLY	10	1.07e-01	3.03e-01	0.34400	2.84e-01	-1.94e-01	1.20e-01	2.87e-01
GOMF RIBONUCLEOPROTEIN COMPLEX BINDING	154	9.09e-11	5.93e-09	0.34400	2.95e-01	1.78e-01	2.70e-10	1.37e-04
GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO HYDROGEN PEROXIDE	6	2.59e-01	4.98e-01	0.34400	2.69e-01	-2.15e-01	2.54e-01	3.61e-01
GOBP RNA SURVEILLANCE	18	4.83e-02	1.84e-01	0.34400	3.35e-01	7.85e-02	1.38e-02	5.64e-01
GOBP NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON INTRINSIC APOPTOTIC SIGNALING PATHWAY	12	7.44e-02	2.41e-01	0.34400	-1.45e-01	3.12e-01	3.84e-01	6.13e-02
GOBP VESICLE TETHERING	31	1.08e-02	6.35e-02	0.34400	2.44e-01	2.42e-01	1.86e-02	1.95e-02
GOBP FORMATION OF TRANSLATION PREINITIATION COMPLEX	6	2.59e-01	4.98e-01	0.34400	2.17e-01	-2.67e-01	3.58e-01	2.57e-01
GOBP DEFENSE RESPONSE TO FUNGUS	50	3.65e-04	4.60e-03	0.34400	-3.20e-01	-1.27e-01	9.23e-05	1.20e-01
GOBP COMPLEMENT ACTIVATION CLASSICAL PATHWAY	34	5.75e-03	3.93e-02	0.34400	-1.68e-01	-3.00e-01	8.91e-02	2.48e-03
Alpha-protein kinase 1 signaling pathway	10	1.47e-01	3.60e-01	0.34400	3.43e-01	-2.53e-02	6.04e-02	8.90e-01
GOBP ACTIVATION OF PROTEIN KINASE C ACTIVITY	5	3.78e-01	6.13e-01	0.34400	3.42e-01	-3.79e-02	1.86e-01	8.83e-01
GOBP LEUKOTRIENE CATABOLIC PROCESS	6	3.75e-01	6.11e-01	0.34400	-3.28e-01	-1.02e-01	1.64e-01	6.67e-01
GOBP LEARNED VOCALIZATION BEHAVIOR OR VOCAL LEARNING	10	2.17e-01	4.49e-01	0.34400	-1.60e-01	-3.04e-01	3.81e-01	9.56e-02
GOBP KINETOCHORE ORGANIZATION	20	3.84e-02	1.57e-01	0.34400	3.28e-01	1.03e-01	1.11e-02	4.27e-01
GOMF ANKYRIN BINDING	19	5.37e-02	1.97e-01	0.34400	-3.08e-01	-1.52e-01	2.01e-02	2.50e-01
GOMF PIRNA BINDING	5	4.21e-01	6.51e-01	0.34400	-3.39e-01	-5.41e-02	1.89e-01	8.34e-01
GOBP POSITIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY	10	1.40e-01	3.53e-01	0.34400	-4.81e-02	3.40e-01	7.92e-01	6.25e-02
Degradation of GLI1 by the proteasome	47	2.78e-04	3.67e-03	0.34400	3.40e-01	4.81e-02	5.44e-05	5.69e-01
GOBP EMBRYONIC DIGIT MORPHOGENESIS	58	2.13e-04	2.91e-03	0.34400	2.29e-01	2.57e-01	2.61e-03	7.25e-04
GOCC TRAPPII PROTEIN COMPLEX	11	1.86e-01	4.12e-01	0.34400	1.59e-01	3.04e-01	3.61e-01	8.04e-02
GOBP ESTABLISHMENT OF SISTER CHROMATID COHESION	8	2.00e-01	4.30e-01	0.34300	3.36e-01	-6.97e-02	9.95e-02	7.33e-01
Xenobiotics	23	3.06e-02	1.33e-01	0.34300	-1.66e-01	-3.00e-01	1.67e-01	1.26e-02
GOBP NEGATIVE REGULATION OF PROGRAMMED NECROTIC CELL DEATH	22	3.49e-02	1.47e-01	0.34300	3.04e-01	1.60e-01	1.37e-02	1.93e-01
Lagging Strand Synthesis	19	5.97e-02	2.10e-01	0.34300	2.84e-01	1.94e-01	3.24e-02	1.44e-01
GOBP REGULATION OF HEART MORPHOGENESIS	8	1.68e-01	3.90e-01	0.34300	-2.79e-01	2.00e-01	1.72e-01	3.27e-01
Reactions specific to the complex N-glycan synthesis pathway	10	2.33e-01	4.69e-01	0.34300	-2.46e-01	-2.40e-01	1.78e-01	1.90e-01
GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I	37	1.38e-03	1.32e-02	0.34300	2.99e-02	3.42e-01	7.53e-01	3.18e-04
Phase 4 - resting membrane potential	19	6.28e-02	2.17e-01	0.34300	-2.57e-01	-2.28e-01	5.27e-02	8.56e-02
Ub-specific processing proteases	162	2.43e-11	1.69e-09	0.34300	3.01e-01	1.64e-01	3.59e-11	3.04e-04
RORA activates gene expression	17	6.87e-02	2.29e-01	0.34300	3.18e-01	1.29e-01	2.31e-02	3.58e-01
GOMF RRNA ADENINE METHYLTRANSFERASE ACTIVITY	8	3.12e-01	5.52e-01	0.34300	2.49e-01	2.36e-01	2.23e-01	2.47e-01
GOCC MYOSIN FILAMENT	24	1.93e-02	9.71e-02	0.34300	-9.12e-02	-3.31e-01	4.39e-01	5.04e-03
GOCC MHC CLASS I PEPTIDE LOADING COMPLEX	8	3.01e-01	5.41e-01	0.34300	1.76e-01	2.94e-01	3.88e-01	1.49e-01
GOBP SUCCINYL COA CATABOLIC PROCESS	6	4.17e-01	6.48e-01	0.34300	2.27e-01	2.57e-01	3.36e-01	2.75e-01
GOBP POSITIVE REGULATION OF NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY	7	2.64e-01	5.03e-01	0.34300	-2.41e-02	3.42e-01	9.12e-01	1.17e-01
GOBP BLASTOCYST GROWTH	21	4.18e-02	1.67e-01	0.34300	3.01e-01	1.65e-01	1.71e-02	1.91e-01
GOBP POSITIVE REGULATION OF DOPAMINE SECRETION	6	3.56e-01	5.93e-01	0.34300	-3.38e-01	-5.40e-02	1.51e-01	8.19e-01
GOCC ATPASE COMPLEX	142	4.13e-10	2.33e-08	0.34300	3.07e-01	1.53e-01	2.77e-10	1.65e-03
GOBP NODAL SIGNALING PATHWAY	16	3.80e-02	1.56e-01	0.34300	-9.01e-02	3.31e-01	5.33e-01	2.21e-02
GOBP NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY	33	2.49e-03	2.10e-02	0.34300	3.42e-01	1.10e-02	6.63e-04	9.13e-01
GOCC NUCLEAR CYCLIN DEPENDENT PROTEIN KINASE HOLOENZYME COMPLEX	13	1.43e-01	3.56e-01	0.34300	1.77e-01	2.94e-01	2.70e-01	6.69e-02
GOBP REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY	7	3.62e-01	6.00e-01	0.34200	2.54e-01	2.30e-01	2.44e-01	2.93e-01
GOBP RESPONSE TO MUSCLE INACTIVITY	9	1.36e-01	3.46e-01	0.34200	2.05e-01	-2.74e-01	2.87e-01	1.54e-01
GOBP REGULATION OF LEUKOCYTE TETHERING OR ROLLING	18	5.15e-02	1.91e-01	0.34200	-3.31e-01	-8.66e-02	1.50e-02	5.25e-01
GOBP PROTEIN ACETYLATION	53	1.64e-04	2.33e-03	0.34200	3.31e-01	8.70e-02	3.04e-05	2.73e-01
GOBP REGULATION OF PROTEIN ACETYLATION	20	3.30e-02	1.41e-01	0.34200	3.37e-01	5.91e-02	9.05e-03	6.47e-01
GOCC CARBOXY TERMINAL DOMAIN PROTEIN KINASE COMPLEX	18	7.39e-02	2.40e-01	0.34200	2.53e-01	2.30e-01	6.31e-02	9.05e-02
GOMF MINOR GROOVE OF ADENINE THYMINE RICH DNA BINDING	10	2.35e-01	4.71e-01	0.34200	2.55e-01	2.29e-01	1.63e-01	2.11e-01
GOBP REGULATION OF CHROMOSOME ORGANIZATION	240	5.57e-17	6.71e-15	0.34200	3.19e-01	1.24e-01	1.66e-17	9.16e-04
GOBP CDP DIACYLGLYCEROL BIOSYNTHETIC PROCESS	12	1.76e-01	3.99e-01	0.34200	2.58e-01	2.25e-01	1.21e-01	1.78e-01
Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal	91	2.46e-07	8.22e-06	0.34200	3.34e-01	7.17e-02	3.46e-08	2.37e-01
Amplification of signal from the kinetochores	91	2.46e-07	8.22e-06	0.34200	3.34e-01	7.17e-02	3.46e-08	2.37e-01
GOMF MICROTUBULE PLUS END BINDING	21	4.43e-02	1.74e-01	0.34200	2.90e-01	1.81e-01	2.14e-02	1.50e-01
Homology Directed Repair	116	5.40e-08	2.07e-06	0.34200	2.59e-01	2.23e-01	1.42e-06	3.28e-05
GOBP MALONYL COA METABOLIC PROCESS	6	3.18e-01	5.57e-01	0.34200	-3.13e-02	3.40e-01	8.94e-01	1.49e-01
GOBP RESPONSE TO ODORANT	5	3.80e-01	6.15e-01	0.34200	3.39e-01	-4.22e-02	1.89e-01	8.70e-01
Regulation of PTEN gene transcription	59	1.64e-04	2.34e-03	0.34200	2.88e-01	1.84e-01	1.29e-04	1.45e-02
GOBP REGULATION OF PROTEIN LOCALIZATION TO LYSOSOME	5	4.07e-01	6.40e-01	0.34200	3.41e-01	1.73e-02	1.86e-01	9.47e-01
GOCC TRAPP COMPLEX	16	9.36e-02	2.78e-01	0.34200	1.82e-01	2.89e-01	2.07e-01	4.52e-02
GOBP DE NOVO PYRIMIDINE NUCLEOBASE BIOSYNTHETIC PROCESS	6	2.63e-01	5.02e-01	0.34200	2.52e-01	-2.30e-01	2.84e-01	3.28e-01
APC/C:Cdc20 mediated degradation of Cyclin B	24	2.92e-02	1.30e-01	0.34200	1.88e-01	2.85e-01	1.11e-01	1.56e-02
GOBP EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS	26	1.56e-02	8.35e-02	0.34200	1.07e-01	3.24e-01	3.45e-01	4.18e-03
GOBP VOCALIZATION BEHAVIOR	15	1.08e-01	3.04e-01	0.34200	-1.79e-01	-2.91e-01	2.30e-01	5.09e-02
GOBP U2 TYPE PRESPLICEOSOME ASSEMBLY	23	2.57e-02	1.18e-01	0.34200	3.23e-01	1.11e-01	7.29e-03	3.58e-01
GOCC DNA REPAIR COMPLEX	22	2.51e-02	1.17e-01	0.34200	3.34e-01	6.99e-02	6.64e-03	5.70e-01
GOBP HYPOTHALAMUS DEVELOPMENT	26	2.36e-02	1.12e-01	0.34200	2.33e-01	2.49e-01	3.94e-02	2.77e-02
GOMF NEUROTROPHIN BINDING	10	2.35e-01	4.72e-01	0.34100	-2.65e-01	-2.15e-01	1.47e-01	2.39e-01
GOBP ENDOPLASMIC RETICULUM TUBULAR NETWORK FORMATION	5	4.84e-01	6.99e-01	0.34100	2.71e-01	2.08e-01	2.95e-01	4.21e-01
GOMF HISTONE DEACETYLASE BINDING	109	9.63e-08	3.48e-06	0.34100	2.94e-01	1.73e-01	1.09e-07	1.83e-03
GOBP POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL	25	1.47e-02	7.96e-02	0.34100	-3.36e-01	-6.23e-02	3.68e-03	5.90e-01
GOBP FOLLICLE STIMULATING HORMONE SECRETION	8	2.38e-01	4.75e-01	0.34100	3.41e-01	1.55e-02	9.50e-02	9.39e-01
GOMF K48 LINKED DEUBIQUITINASE ACTIVITY	14	1.28e-01	3.34e-01	0.34100	2.86e-01	1.86e-01	6.39e-02	2.28e-01
GOBP DETERMINATION OF LEFT RIGHT ASYMMETRY IN LATERAL MESODERM	8	2.10e-01	4.42e-01	0.34100	-5.39e-02	3.37e-01	7.92e-01	9.90e-02
GOBP CARDIOLIPIN ACYL CHAIN REMODELING	5	4.47e-01	6.74e-01	0.34100	3.26e-01	9.99e-02	2.07e-01	6.99e-01
PKMTs methylate histone lysines	42	5.31e-04	6.34e-03	0.34100	3.41e-01	1.28e-02	1.33e-04	8.86e-01
GOCC LATE ENDOSOME LUMEN	8	2.61e-01	5.00e-01	0.34100	-3.35e-01	-6.51e-02	1.01e-01	7.50e-01
Metabolism of RNA	677	2.87e-44	1.31e-41	0.34100	3.07e-01	1.48e-01	1.79e-42	5.58e-11
GOMF MOLECULAR TRANSDUCER ACTIVITY	1364	4.40e-88	5.40e-85	0.34100	-3.17e-01	-1.26e-01	1.60e-86	7.28e-15
GOBP REGULATION OF T HELPER 17 CELL LINEAGE COMMITMENT	10	2.38e-01	4.75e-01	0.34100	2.36e-01	2.46e-01	1.96e-01	1.78e-01
GOBP INTRACELLULAR ZINC ION HOMEOSTASIS	36	4.76e-04	5.79e-03	0.34100	-1.46e-01	3.08e-01	1.30e-01	1.38e-03
GOBP REGULATION OF TESTOSTERONE BIOSYNTHETIC PROCESS	7	3.65e-01	6.02e-01	0.34100	-2.60e-01	-2.20e-01	2.34e-01	3.13e-01
GOBP INTERMEDIATE FILAMENT BASED PROCESS	94	1.31e-06	3.71e-05	0.34100	-2.09e-01	-2.69e-01	4.68e-04	6.42e-06
Degradation of GLI2 by the proteasome	47	2.98e-04	3.90e-03	0.34100	3.38e-01	4.12e-02	6.03e-05	6.25e-01
GOCC ALPHA KETOACID DEHYDROGENASE COMPLEX	14	8.89e-02	2.70e-01	0.34100	3.38e-01	4.16e-02	2.85e-02	7.88e-01
GOBP REGULATION OF MEMBRANE REPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL	7	3.35e-01	5.74e-01	0.34100	-1.23e-01	-3.18e-01	5.73e-01	1.46e-01
GOBP POSITIVE REGULATION OF RESPONSE TO TYPE II INTERFERON	6	4.23e-01	6.52e-01	0.34100	-2.55e-01	-2.26e-01	2.79e-01	3.38e-01
RNA Polymerase III Abortive And Retractive Initiation	41	1.47e-03	1.39e-02	0.34100	3.24e-01	1.05e-01	3.31e-04	2.44e-01
RNA Polymerase III Transcription	41	1.47e-03	1.39e-02	0.34100	3.24e-01	1.05e-01	3.31e-04	2.44e-01
MET activates PTK2 signaling	30	3.38e-03	2.63e-02	0.34100	3.34e-02	-3.39e-01	7.51e-01	1.31e-03
GOBP POSITIVE REGULATION OF G0 TO G1 TRANSITION	5	3.54e-01	5.91e-01	0.34100	-1.19e-01	3.19e-01	6.45e-01	2.17e-01
Dual incision in TC-NER	61	1.34e-04	1.97e-03	0.34000	2.85e-01	1.86e-01	1.15e-04	1.21e-02
GOBP MRNA PROCESSING	455	7.79e-31	2.23e-28	0.34000	3.16e-01	1.27e-01	6.61e-31	3.21e-06
Formation of TC-NER Pre-Incision Complex	49	5.01e-04	6.03e-03	0.34000	3.16e-01	1.26e-01	1.27e-04	1.28e-01
GOCC SYNAPTOBREVIN 2 SNAP 25 SYNTAXIN 1A COMPLEX	5	4.65e-01	6.88e-01	0.34000	1.38e-01	3.11e-01	5.92e-01	2.29e-01
GOMF ACETYLATION DEPENDENT PROTEIN BINDING	25	7.41e-03	4.78e-02	0.34000	3.34e-01	-6.41e-02	3.82e-03	5.79e-01
GOBP ATRIAL CARDIAC MUSCLE TISSUE DEVELOPMENT	20	5.71e-02	2.03e-01	0.34000	2.26e-01	2.54e-01	8.02e-02	4.89e-02
GOBP EXOCYST LOCALIZATION	5	4.02e-01	6.35e-01	0.34000	-3.40e-01	4.29e-04	1.88e-01	9.99e-01
GOMF FRUCTOSE TRANSMEMBRANE TRANSPORTER ACTIVITY	9	2.67e-01	5.07e-01	0.34000	-2.87e-01	-1.83e-01	1.36e-01	3.43e-01
GOBP UBIQUITIN DEPENDENT GLYCOPROTEIN ERAD PATHWAY	7	2.28e-01	4.62e-01	0.34000	-1.43e-01	3.09e-01	5.13e-01	1.57e-01
GOMF MANNOSYL OLIGOSACCHARIDE 1 2 ALPHA MANNOSIDASE ACTIVITY	7	2.28e-01	4.62e-01	0.34000	-1.43e-01	3.09e-01	5.13e-01	1.57e-01
NGF-stimulated transcription	38	2.79e-03	2.28e-02	0.34000	1.26e-01	3.16e-01	1.79e-01	7.50e-04
GOBP NEGATIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS	5	3.69e-01	6.06e-01	0.34000	-3.31e-01	7.92e-02	2.00e-01	7.59e-01
GOBP REGULATION OF PROTEIN ADP RIBOSYLATION	8	3.16e-01	5.55e-01	0.34000	2.68e-01	2.09e-01	1.90e-01	3.05e-01
GOBP REGULATION OF ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II	5	3.79e-01	6.14e-01	0.34000	-3.36e-01	5.45e-02	1.94e-01	8.33e-01
GOBP REGULATION OF ANTIBACTERIAL PEPTIDE PRODUCTION	7	2.40e-01	4.77e-01	0.34000	1.01e-01	-3.25e-01	6.43e-01	1.37e-01
Mitotic Spindle Checkpoint	108	4.52e-08	1.76e-06	0.34000	3.21e-01	1.13e-01	8.49e-09	4.25e-02
Synthesis of 12-eicosatetraenoic acid derivatives	7	3.55e-01	5.92e-01	0.34000	2.95e-01	1.68e-01	1.76e-01	4.41e-01
GOBP RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION	14	5.09e-02	1.91e-01	0.34000	3.04e-01	-1.53e-01	4.93e-02	3.22e-01
GOMF THIOESTERASE BINDING	9	2.07e-01	4.38e-01	0.34000	2.75e-02	3.39e-01	8.87e-01	7.85e-02
GOMF CALMODULIN DEPENDENT PROTEIN PHOSPHATASE ACTIVITY	5	4.90e-01	7.04e-01	0.34000	2.44e-01	2.36e-01	3.44e-01	3.61e-01
GOBP RESPONSE TO HUMAN CHORIONIC GONADOTROPIN	5	4.47e-01	6.74e-01	0.34000	3.27e-01	9.29e-02	2.06e-01	7.19e-01
Defective CFTR causes cystic fibrosis	48	3.31e-04	4.25e-03	0.34000	3.34e-01	6.28e-02	6.29e-05	4.52e-01
GOBP TRNA 5 LEADER REMOVAL	13	1.55e-01	3.70e-01	0.34000	2.68e-01	2.08e-01	9.38e-02	1.94e-01
GOBP SISTER CHROMATID COHESION	53	1.08e-04	1.64e-03	0.34000	3.37e-01	3.78e-02	2.13e-05	6.34e-01
GOBP ESCRT COMPLEX DISASSEMBLY	10	2.34e-01	4.69e-01	0.34000	1.88e-01	2.83e-01	3.03e-01	1.22e-01
GOBP MITOCHONDRIAL GENE EXPRESSION	166	2.86e-11	1.97e-09	0.34000	2.92e-01	1.73e-01	8.13e-11	1.20e-04
GOBP REGULATION OF ASYMMETRIC CELL DIVISION	5	3.34e-01	5.73e-01	0.33900	2.21e-01	-2.57e-01	3.91e-01	3.19e-01
GOBP REGULATION OF FAS SIGNALING PATHWAY	6	4.07e-01	6.40e-01	0.33900	1.54e-01	3.03e-01	5.14e-01	1.99e-01
GOBP PROTEIN NITROSYLATION	15	4.10e-02	1.65e-01	0.33900	-3.00e-01	1.59e-01	4.45e-02	2.85e-01
Acetylcholine binding and downstream events	14	6.10e-02	2.13e-01	0.33900	-3.28e-01	8.58e-02	3.34e-02	5.78e-01
Postsynaptic nicotinic acetylcholine receptors	14	6.10e-02	2.13e-01	0.33900	-3.28e-01	8.58e-02	3.34e-02	5.78e-01
GOBP NEGATIVE REGULATION OF FERROPTOSIS	8	2.09e-01	4.41e-01	0.33900	-6.62e-02	3.33e-01	7.46e-01	1.03e-01
GOBP REGULATION OF VACUOLE ORGANIZATION	56	1.05e-04	1.61e-03	0.33900	3.31e-01	7.60e-02	1.88e-05	3.25e-01
GOMF TELETHONIN BINDING	7	3.19e-01	5.57e-01	0.33900	-7.83e-02	-3.30e-01	7.20e-01	1.31e-01
Mismatch Repair	15	1.19e-01	3.20e-01	0.33900	2.53e-01	2.25e-01	8.94e-02	1.31e-01
DNA Replication	146	9.34e-10	5.10e-08	0.33900	2.69e-01	2.07e-01	2.05e-08	1.64e-05
GOBP REGULATION OF TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY	14	1.21e-01	3.24e-01	0.33900	1.44e-01	3.07e-01	3.50e-01	4.71e-02
G2/M DNA damage checkpoint	72	3.77e-05	6.88e-04	0.33900	2.33e-01	2.46e-01	6.14e-04	3.14e-04
GOBP IMMUNOLOGICAL MEMORY PROCESS	19	5.99e-02	2.10e-01	0.33900	2.99e-01	1.59e-01	2.40e-02	2.30e-01
GOMF ACETYLCHOLINE RECEPTOR ACTIVITY	22	1.30e-02	7.25e-02	0.33900	-3.29e-01	7.89e-02	7.50e-03	5.22e-01
GOBP PROGESTERONE BIOSYNTHETIC PROCESS	6	3.75e-01	6.11e-01	0.33900	-3.30e-01	-7.55e-02	1.62e-01	7.49e-01
GOBP POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS	26	2.31e-02	1.10e-01	0.33800	-2.85e-01	-1.82e-01	1.18e-02	1.08e-01
Association of TriC/CCT with target proteins during biosynthesis	38	4.32e-03	3.18e-02	0.33800	2.75e-01	1.98e-01	3.39e-03	3.49e-02
GOMF CHROMATIN DNA BINDING	135	3.90e-09	1.90e-07	0.33800	2.80e-01	1.90e-01	1.87e-08	1.42e-04
GOBP TRABECULA FORMATION	27	1.94e-02	9.77e-02	0.33800	2.91e-01	1.73e-01	8.86e-03	1.21e-01
GOCC P BODY	99	1.71e-07	5.87e-06	0.33800	3.23e-01	1.01e-01	2.78e-08	8.35e-02
TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest	18	7.61e-02	2.45e-01	0.33800	1.98e-01	2.74e-01	1.45e-01	4.42e-02
GOCC SPECTRIN	9	2.80e-01	5.20e-01	0.33800	-2.45e-01	-2.33e-01	2.02e-01	2.27e-01
GOCC AXONEMAL DYNEIN COMPLEX	21	3.08e-02	1.34e-01	0.33800	-6.22e-02	-3.32e-01	6.22e-01	8.37e-03
GOCC FIBRINOGEN COMPLEX	8	2.45e-01	4.83e-01	0.33800	-1.62e-02	-3.38e-01	9.37e-01	9.81e-02
GOBP PROTEIN O LINKED MANNOSYLATION	19	2.76e-02	1.25e-01	0.33800	4.21e-02	-3.35e-01	7.51e-01	1.14e-02
GOBP ISOLEUCINE METABOLIC PROCESS	6	2.76e-01	5.16e-01	0.33800	2.85e-01	-1.81e-01	2.26e-01	4.42e-01
GOBP POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY	14	1.35e-01	3.45e-01	0.33800	2.74e-01	1.98e-01	7.62e-02	2.00e-01
GOBP CELLULAR RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR STIMULUS	13	1.12e-01	3.11e-01	0.33800	-3.34e-01	-4.94e-02	3.70e-02	7.58e-01
Regulation of Apoptosis	40	1.61e-03	1.49e-02	0.33800	3.27e-01	8.31e-02	3.39e-04	3.63e-01
Cleavage of the damaged purine	33	9.33e-03	5.69e-02	0.33800	2.11e-01	2.64e-01	3.57e-02	8.79e-03
Depurination	33	9.33e-03	5.69e-02	0.33800	2.11e-01	2.64e-01	3.57e-02	8.79e-03
Recognition and association of DNA glycosylase with site containing an affected purine	33	9.33e-03	5.69e-02	0.33800	2.11e-01	2.64e-01	3.57e-02	8.79e-03
GOBP POST CHAPERONIN TUBULIN FOLDING PATHWAY	6	4.30e-01	6.58e-01	0.33800	2.37e-01	2.40e-01	3.15e-01	3.08e-01
GOMF NUCLEOSOME BINDING	89	1.80e-06	4.87e-05	0.33800	3.04e-01	1.46e-01	7.00e-07	1.69e-02
GOBP POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR	88	1.75e-06	4.77e-05	0.33800	3.10e-01	1.34e-01	5.03e-07	2.98e-02
GOBP DENSE CORE GRANULE EXOCYTOSIS	10	2.33e-01	4.68e-01	0.33800	-2.92e-01	-1.70e-01	1.10e-01	3.53e-01
GOBP ANTRAL OVARIAN FOLLICLE GROWTH	12	1.04e-01	2.98e-01	0.33700	3.35e-01	-4.16e-02	4.45e-02	8.03e-01
GOBP OXALATE TRANSPORT	12	9.46e-02	2.80e-01	0.33700	-3.28e-01	7.99e-02	4.92e-02	6.32e-01
GOBP CYTOPLASMIC TRANSLATIONAL ELONGATION	5	4.15e-01	6.46e-01	0.33700	3.37e-01	1.42e-02	1.92e-01	9.56e-01
GOBP KIDNEY MESENCHYME DEVELOPMENT	16	6.79e-02	2.27e-01	0.33700	4.79e-02	3.34e-01	7.40e-01	2.07e-02
GOMF GENERAL TRANSCRIPTION INITIATION FACTOR BINDING	51	3.85e-04	4.82e-03	0.33700	3.17e-01	1.15e-01	8.81e-05	1.57e-01
GOBP TRNA 5 END PROCESSING	15	1.13e-01	3.11e-01	0.33700	2.92e-01	1.68e-01	5.00e-02	2.59e-01
GOBP VOLUNTARY MUSCULOSKELETAL MOVEMENT	7	3.55e-01	5.93e-01	0.33700	3.00e-01	1.53e-01	1.69e-01	4.82e-01
GOCC KINETOCHORE MICROTUBULE	20	6.02e-02	2.11e-01	0.33700	2.29e-01	2.47e-01	7.62e-02	5.54e-02
GOBP POSITIVE REGULATION OF NECROPTOTIC PROCESS	7	2.20e-01	4.54e-01	0.33700	-2.19e-01	2.57e-01	3.16e-01	2.40e-01
Modulation by Mtb of host immune system	6	4.13e-01	6.45e-01	0.33700	1.55e-01	2.99e-01	5.10e-01	2.04e-01
RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known	37	4.47e-03	3.25e-02	0.33700	2.96e-01	1.61e-01	1.83e-03	9.00e-02
GOBP THROMBOPOIETIN MEDIATED SIGNALING PATHWAY	5	3.47e-01	5.85e-01	0.33700	-1.71e-01	2.90e-01	5.08e-01	2.61e-01
GOBP NEGATIVE REGULATION OF TRANSLATIONAL INITIATION	21	1.86e-02	9.45e-02	0.33700	3.33e-01	-5.12e-02	8.25e-03	6.85e-01
GOBP NEGATIVE REGULATION OF P38MAPK CASCADE	8	2.82e-01	5.21e-01	0.33700	-3.24e-01	-9.26e-02	1.13e-01	6.50e-01
GOCC CLATHRIN VESICLE COAT	34	4.94e-03	3.50e-02	0.33700	3.21e-01	1.01e-01	1.19e-03	3.06e-01
TICAM1, RIP1-mediated IKK complex recruitment	18	5.70e-02	2.03e-01	0.33700	3.25e-01	8.68e-02	1.68e-02	5.24e-01
MET activates PTPN11	5	4.73e-01	6.94e-01	0.33700	3.07e-01	1.37e-01	2.34e-01	5.94e-01
Transcriptional regulation by small RNAs	70	3.72e-05	6.81e-04	0.33700	2.95e-01	1.62e-01	1.92e-05	1.93e-02
GOMF VINCULIN BINDING	11	9.62e-02	2.83e-01	0.33700	2.83e-01	-1.82e-01	1.04e-01	2.95e-01
GOBP REGULATION OF EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS	7	3.54e-01	5.92e-01	0.33700	3.03e-01	1.47e-01	1.65e-01	5.01e-01
GOMF PEPTIDYL PROLINE DIOXYGENASE ACTIVITY	12	1.12e-01	3.10e-01	0.33700	3.36e-01	-1.97e-02	4.39e-02	9.06e-01
GOBP NEGATIVE REGULATION OF GONADOTROPIN SECRETION	8	2.69e-01	5.09e-01	0.33700	6.32e-02	3.31e-01	7.57e-01	1.05e-01
GOBP GDP MANNOSE METABOLIC PROCESS	8	2.32e-01	4.67e-01	0.33600	2.14e-02	-3.36e-01	9.16e-01	1.00e-01
GOBP INTRACILIARY RETROGRADE TRANSPORT	14	5.11e-02	1.91e-01	0.33600	2.83e-01	-1.82e-01	6.69e-02	2.38e-01
GOBP ADENOSINE METABOLIC PROCESS	10	2.34e-01	4.69e-01	0.33600	2.94e-01	1.64e-01	1.08e-01	3.70e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON CH OR CH2 GROUPS	11	1.85e-01	4.11e-01	0.33600	-1.13e-01	-3.17e-01	5.18e-01	6.89e-02
GOBP CARDIAC CELL FATE COMMITMENT	13	1.58e-01	3.75e-01	0.33600	1.91e-01	2.77e-01	2.34e-01	8.39e-02
GOBP G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY	1173	1.82e-72	1.72e-69	0.33600	-3.02e-01	-1.47e-01	1.53e-68	1.65e-17
Degradation of AXIN	42	1.41e-03	1.35e-02	0.33600	3.22e-01	9.78e-02	3.09e-04	2.73e-01
GOBP THIAMINE TRANSPORT	8	3.21e-01	5.59e-01	0.33600	-1.90e-01	-2.77e-01	3.52e-01	1.75e-01
GOBP SUCCINYL COA METABOLIC PROCESS	10	2.48e-01	4.86e-01	0.33600	2.36e-01	2.39e-01	1.97e-01	1.90e-01
GOCC BRISC COMPLEX	5	4.96e-01	7.08e-01	0.33600	2.11e-01	2.61e-01	4.14e-01	3.11e-01
Sphingolipid catabolism	12	1.85e-01	4.11e-01	0.33600	-2.02e-01	-2.68e-01	2.25e-01	1.08e-01
DNA Damage Bypass	46	1.68e-03	1.54e-02	0.33600	2.38e-01	2.36e-01	5.16e-03	5.55e-03
GOBP URATE METABOLIC PROCESS	12	1.04e-01	2.98e-01	0.33500	5.15e-02	-3.32e-01	7.58e-01	4.67e-02
GOBP POSITIVE REGULATION OF CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION	9	2.83e-01	5.22e-01	0.33500	2.66e-01	2.04e-01	1.67e-01	2.88e-01
GOBP MAINTENANCE OF CELL NUMBER	179	1.42e-12	1.17e-10	0.33500	3.17e-01	1.08e-01	2.39e-13	1.26e-02
GOBP POSITIVE REGULATION OF VASCULOGENESIS	12	1.86e-01	4.12e-01	0.33500	2.69e-01	2.00e-01	1.07e-01	2.30e-01
GOBP REGULATION OF INTESTINAL ABSORPTION	12	1.03e-01	2.96e-01	0.33500	5.75e-02	-3.30e-01	7.30e-01	4.78e-02
GOBP BLEB ASSEMBLY	11	1.55e-01	3.71e-01	0.33500	3.34e-01	3.02e-02	5.54e-02	8.63e-01
GOBP CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE	40	3.89e-03	2.93e-02	0.33500	-2.52e-01	-2.21e-01	5.84e-03	1.57e-02
GOMF POLY A SPECIFIC RIBONUCLEASE ACTIVITY	13	1.48e-01	3.61e-01	0.33500	3.02e-01	1.44e-01	5.90e-02	3.69e-01
GOBP INSULIN METABOLIC PROCESS	16	1.06e-01	3.02e-01	0.33500	2.00e-01	2.69e-01	1.66e-01	6.29e-02
GOBP REGULATION OF SKELETAL MUSCLE FIBER DEVELOPMENT	11	1.84e-01	4.09e-01	0.33500	1.03e-01	3.19e-01	5.55e-01	6.73e-02
GOMF RRNA BINDING	62	1.90e-04	2.65e-03	0.33500	2.31e-01	2.42e-01	1.66e-03	9.63e-04
GOBP POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS	8	2.92e-01	5.30e-01	0.33500	-3.19e-01	-1.03e-01	1.19e-01	6.15e-01
GOBP MEIOTIC SPINDLE ASSEMBLY	12	1.43e-01	3.56e-01	0.33500	3.29e-01	6.38e-02	4.87e-02	7.02e-01
WNT5A-dependent internalization of FZD2, FZD5 and ROR2	13	1.15e-01	3.14e-01	0.33400	3.32e-01	4.01e-02	3.82e-02	8.02e-01
GOBP REGULATION OF RESPONSE TO NUTRIENT LEVELS	30	1.18e-02	6.76e-02	0.33400	1.34e-01	3.06e-01	2.05e-01	3.67e-03
GOBP POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION	31	1.28e-02	7.19e-02	0.33400	2.76e-01	1.88e-01	7.74e-03	6.98e-02
GOBP NEGATIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN	9	1.65e-01	3.86e-01	0.33400	-3.13e-01	1.17e-01	1.04e-01	5.45e-01
GOBP REGULATION OF T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL	6	2.84e-01	5.23e-01	0.33400	-2.82e-01	1.79e-01	2.31e-01	4.48e-01
GOBP ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE	25	3.14e-02	1.36e-01	0.33400	2.57e-01	2.14e-01	2.61e-02	6.44e-02
GOBP REGULATION OF INWARD RECTIFIER POTASSIUM CHANNEL ACTIVITY	6	3.32e-01	5.71e-01	0.33400	3.64e-02	-3.32e-01	8.77e-01	1.59e-01
GOMF 5 3 DNA HELICASE ACTIVITY	9	1.76e-01	4.00e-01	0.33400	3.24e-01	-8.05e-02	9.21e-02	6.76e-01
AUF1 (hnRNP D0) binds and destabilizes mRNA	42	1.89e-03	1.68e-02	0.33400	3.10e-01	1.24e-01	5.01e-04	1.65e-01
GOBP DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION	14	1.44e-01	3.57e-01	0.33400	2.56e-01	2.15e-01	9.74e-02	1.64e-01
GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION	75	2.67e-05	5.10e-04	0.33400	2.79e-01	1.84e-01	3.03e-05	5.78e-03
GOMF SPHINGOLIPID TRANSFER ACTIVITY	9	2.77e-01	5.17e-01	0.33400	1.68e-01	2.88e-01	3.81e-01	1.34e-01
GOMF INTERLEUKIN 17 RECEPTOR ACTIVITY	8	2.44e-01	4.82e-01	0.33400	-4.35e-03	3.34e-01	9.83e-01	1.02e-01
GOBP MEIOTIC METAPHASE CHROMOSOME ALIGNMENT	5	4.91e-01	7.04e-01	0.33400	2.88e-01	1.69e-01	2.65e-01	5.13e-01
GOBP RESPONSE TO HEPARIN	6	2.94e-01	5.33e-01	0.33400	-3.01e-01	1.44e-01	2.02e-01	5.40e-01
SMAC (DIABLO) binds to IAPs	6	4.34e-01	6.62e-01	0.33400	2.66e-01	2.01e-01	2.59e-01	3.94e-01
SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes	6	4.34e-01	6.62e-01	0.33400	2.66e-01	2.01e-01	2.59e-01	3.94e-01
SMAC, XIAP-regulated apoptotic response	6	4.34e-01	6.62e-01	0.33400	2.66e-01	2.01e-01	2.59e-01	3.94e-01
GOBP REGULATION OF VITAMIN D BIOSYNTHETIC PROCESS	7	2.36e-01	4.72e-01	0.33400	-2.93e-01	1.60e-01	1.80e-01	4.62e-01
GOBP CARDIOBLAST DIFFERENTIATION	17	8.87e-02	2.70e-01	0.33400	2.89e-01	1.66e-01	3.89e-02	2.36e-01
Activation of NIMA Kinases NEK9, NEK6, NEK7	7	2.57e-01	4.96e-01	0.33400	-8.75e-02	3.22e-01	6.88e-01	1.40e-01
GOBP RESPONSE TO GAMMA RADIATION	51	7.70e-04	8.62e-03	0.33400	2.81e-01	1.80e-01	5.24e-04	2.59e-02
GOBP SPONTANEOUS NEUROTRANSMITTER SECRETION	8	2.43e-01	4.80e-01	0.33400	-3.33e-01	1.01e-02	1.03e-01	9.61e-01
GOCC CONTRACTILE RING	11	2.18e-01	4.52e-01	0.33400	2.08e-01	2.61e-01	2.33e-01	1.34e-01
GOBP RIBOSOMAL SUBUNIT EXPORT FROM NUCLEUS	15	1.07e-01	3.03e-01	0.33300	3.10e-01	1.22e-01	3.76e-02	4.12e-01
GOBP NEURONAL DENSE CORE VESICLE EXOCYTOSIS	7	3.80e-01	6.15e-01	0.33300	-2.09e-01	-2.60e-01	3.39e-01	2.34e-01
GOMF D1 DOPAMINE RECEPTOR BINDING	6	3.94e-01	6.28e-01	0.33300	8.94e-02	3.21e-01	7.05e-01	1.73e-01
GOMF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 BINDING	9	1.91e-01	4.18e-01	0.33300	3.30e-01	-4.33e-02	8.61e-02	8.22e-01
Metabolism of amine-derived hormones	17	8.82e-02	2.69e-01	0.33300	-2.92e-01	-1.61e-01	3.72e-02	2.51e-01
GOBP ENDOTHELIN RECEPTOR SIGNALING PATHWAY	11	1.28e-01	3.35e-01	0.33300	3.28e-01	-5.59e-02	5.92e-02	7.48e-01
GOBP PROSTATIC BUD FORMATION	8	2.98e-01	5.38e-01	0.33300	1.09e-01	3.15e-01	5.93e-01	1.23e-01
Translesion synthesis by REV1	16	1.09e-01	3.06e-01	0.33300	2.66e-01	2.00e-01	6.53e-02	1.65e-01
GOBP NEGATIVE REGULATION OF GENE EXPRESSION VIA CHROMOSOMAL CPG ISLAND METHYLATION	14	1.03e-01	2.95e-01	0.33300	3.29e-01	5.32e-02	3.31e-02	7.30e-01
GOBP INTERLEUKIN 2 MEDIATED SIGNALING PATHWAY	8	2.00e-01	4.30e-01	0.33300	-1.31e-01	3.06e-01	5.22e-01	1.33e-01
GOBP DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN	15	1.20e-01	3.22e-01	0.33300	-1.71e-01	-2.86e-01	2.53e-01	5.51e-02
Regulation of cytoskeletal remodeling and cell spreading by IPP complex components	7	3.83e-01	6.17e-01	0.33300	2.43e-01	2.28e-01	2.66e-01	2.96e-01
GOBP TRICARBOXYLIC ACID METABOLIC PROCESS	15	7.25e-02	2.38e-01	0.33300	3.33e-01	-3.61e-03	2.56e-02	9.81e-01
GOBP DERMATAN SULFATE BIOSYNTHETIC PROCESS	5	4.94e-01	7.06e-01	0.33300	1.72e-01	2.85e-01	5.05e-01	2.70e-01
GOMF NUCLEAR THYROID HORMONE RECEPTOR BINDING	27	1.35e-02	7.48e-02	0.33300	3.26e-01	6.61e-02	3.33e-03	5.52e-01
GOCC INSULIN RESPONSIVE COMPARTMENT	7	3.62e-01	6.00e-01	0.33300	1.44e-01	3.00e-01	5.09e-01	1.69e-01
GOBP MITOTIC G2 DNA DAMAGE CHECKPOINT SIGNALING	34	9.56e-03	5.79e-02	0.33300	2.45e-01	2.26e-01	1.36e-02	2.28e-02
GOBP ENDODERMAL CELL FATE COMMITMENT	15	8.49e-02	2.62e-01	0.33300	3.30e-01	4.32e-02	2.69e-02	7.72e-01
GOBP POSITIVE REGULATION OF PROTEIN ACETYLATION	14	1.07e-01	3.03e-01	0.33300	3.26e-01	6.57e-02	3.45e-02	6.71e-01
GOCC TRANSCRIPTION FACTOR TFIIH HOLO COMPLEX	10	2.48e-01	4.86e-01	0.33300	2.76e-01	1.86e-01	1.31e-01	3.08e-01
GOBP BRANCHED CHAIN AMINO ACID METABOLIC PROCESS	27	2.45e-02	1.15e-01	0.33300	2.59e-01	2.09e-01	1.99e-02	6.02e-02
GOBP MATURATION OF SSU RRNA	52	7.41e-04	8.37e-03	0.33300	2.72e-01	1.91e-01	6.85e-04	1.71e-02
GOMF RNA POLYMERASE II GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY	36	3.42e-03	2.66e-02	0.33300	3.24e-01	7.31e-02	7.52e-04	4.48e-01
GOBP SMOOTH MUSCLE CELL CHEMOTAXIS	9	1.50e-01	3.64e-01	0.33300	2.21e-01	-2.48e-01	2.51e-01	1.97e-01
GOMF FUCOSE BINDING	8	2.08e-01	4.40e-01	0.33300	-3.15e-01	1.06e-01	1.23e-01	6.04e-01
GOBP PROTEASOME MEDIATED UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS	387	2.10e-23	3.63e-21	0.33300	2.52e-01	2.16e-01	1.42e-17	2.65e-13
GOBP PROXIMAL DISTAL PATTERN FORMATION	34	8.91e-03	5.52e-02	0.33200	1.87e-01	2.74e-01	5.85e-02	5.60e-03
GOBP REGULATION OF TELOMERE MAINTENANCE	100	4.79e-07	1.49e-05	0.33200	3.04e-01	1.34e-01	1.49e-07	2.02e-02
GOMF DEOXYNUCLEOSIDE KINASE ACTIVITY	5	3.95e-01	6.28e-01	0.33200	-5.67e-02	3.27e-01	8.26e-01	2.05e-01
GOBP PROTEIN LOCALIZATION TO MOTILE CILIUM	6	3.08e-01	5.48e-01	0.33200	1.09e-01	-3.13e-01	6.42e-01	1.84e-01
GOBP REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY	41	1.41e-03	1.35e-02	0.33200	3.27e-01	5.89e-02	2.94e-04	5.14e-01
GOMF ROUNDABOUT BINDING	8	3.36e-01	5.75e-01	0.33200	-2.46e-01	-2.23e-01	2.28e-01	2.76e-01
GOBP ATP EXPORT	6	3.93e-01	6.26e-01	0.33200	-3.22e-01	-7.96e-02	1.72e-01	7.36e-01
HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)	110	3.29e-07	1.07e-05	0.33200	2.49e-01	2.19e-01	6.48e-06	6.98e-05
Laminin interactions	28	7.95e-03	5.06e-02	0.33200	-3.33e-04	-3.32e-01	9.98e-01	2.38e-03
GOBP NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION	27	2.56e-02	1.18e-01	0.33200	2.32e-01	2.37e-01	3.72e-02	3.27e-02
CDH11 homotypic and heterotypic interactions	7	2.99e-01	5.39e-01	0.33200	-1.05e-03	-3.32e-01	9.96e-01	1.29e-01
GLI proteins bind promoters of Hh responsive genes to promote transcription	7	2.30e-01	4.65e-01	0.33200	2.31e-01	-2.38e-01	2.91e-01	2.75e-01
GOMF GLUTAMATE GATED CALCIUM ION CHANNEL ACTIVITY	7	3.21e-01	5.60e-01	0.33200	-3.28e-01	-4.74e-02	1.33e-01	8.28e-01
GOBP REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS	15	1.24e-01	3.28e-01	0.33100	2.80e-01	1.78e-01	6.08e-02	2.33e-01
Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks	55	3.63e-04	4.58e-03	0.33100	3.01e-01	1.39e-01	1.15e-04	7.35e-02
Activation of ATR in response to replication stress	37	4.80e-03	3.42e-02	0.33100	3.01e-01	1.38e-01	1.52e-03	1.47e-01
GOMF UDP GALACTOSE BETA N ACETYLGLUCOSAMINE BETA 1 3 GALACTOSYLTRANSFERASE ACTIVITY	12	8.69e-02	2.66e-01	0.33100	-2.90e-01	1.60e-01	8.18e-02	3.38e-01
GOMF CHROMATIN PROTEIN ADAPTOR ACTIVITY	28	1.97e-02	9.88e-02	0.33100	2.86e-01	1.66e-01	8.73e-03	1.27e-01
GOBP KINETOCHORE ASSEMBLY	16	9.31e-02	2.78e-01	0.33100	3.11e-01	1.15e-01	3.14e-02	4.28e-01
GOBP POSITIVE REGULATION OF CELL CYCLE CHECKPOINT	19	2.61e-02	1.20e-01	0.33100	3.18e-01	-9.13e-02	1.63e-02	4.91e-01
GOBP MESENCHYMAL CELL APOPTOTIC PROCESS	15	1.16e-01	3.16e-01	0.33100	1.42e-01	2.99e-01	3.42e-01	4.48e-02
GOBP XENOBIOTIC TRANSPORT	60	1.43e-04	2.07e-03	0.33100	-1.17e-01	-3.10e-01	1.16e-01	3.33e-05
GOBP INTERLEUKIN 12 MEDIATED SIGNALING PATHWAY	9	1.54e-01	3.69e-01	0.33100	-2.61e-01	2.04e-01	1.75e-01	2.89e-01
Signaling by TGF-beta Receptor Complex in Cancer	8	3.35e-01	5.74e-01	0.33100	1.99e-01	2.64e-01	3.30e-01	1.95e-01
GOMF INSULIN LIKE GROWTH FACTOR I BINDING	13	1.13e-01	3.13e-01	0.33100	3.30e-01	2.09e-02	3.92e-02	8.96e-01
SCF-beta-TrCP mediated degradation of Emi1	42	1.73e-03	1.57e-02	0.33100	3.17e-01	9.61e-02	3.83e-04	2.81e-01
GOBP NEGATIVE REGULATION OF DNA REPAIR	37	6.22e-03	4.20e-02	0.33100	1.90e-01	2.71e-01	4.59e-02	4.31e-03
Protein hydroxylation	17	3.10e-02	1.35e-01	0.33100	1.70e-01	-2.84e-01	2.26e-01	4.26e-02
Tie2 Signaling	18	8.75e-02	2.68e-01	0.33100	2.48e-01	2.18e-01	6.81e-02	1.09e-01
GOBP MAMMARY GLAND EPITHELIAL CELL PROLIFERATION	26	1.95e-02	9.78e-02	0.33100	9.47e-02	3.17e-01	4.03e-01	5.17e-03
FOXO-mediated transcription of cell death genes	15	1.31e-01	3.40e-01	0.33100	2.16e-01	2.50e-01	1.48e-01	9.30e-02
GOMF DINUCLEOTIDE PHOSPHATASE ACTIVITY	8	3.40e-01	5.78e-01	0.33000	2.34e-01	2.33e-01	2.51e-01	2.54e-01
Atorvastatin ADME	9	2.77e-01	5.17e-01	0.33000	-1.45e-01	-2.97e-01	4.53e-01	1.23e-01
GOBP AMINO ACID BETAINE METABOLIC PROCESS	16	1.11e-01	3.08e-01	0.33000	2.75e-01	1.84e-01	5.72e-02	2.03e-01
GOBP UBIQUINONE METABOLIC PROCESS	18	6.18e-02	2.14e-01	0.33000	3.21e-01	7.76e-02	1.83e-02	5.69e-01
GOBP POSITIVE REGULATION OF CHROMOSOME CONDENSATION	8	2.22e-01	4.55e-01	0.33000	3.21e-01	-7.82e-02	1.16e-01	7.02e-01
GOCC CONDENSIN COMPLEX	8	2.22e-01	4.55e-01	0.33000	3.21e-01	-7.82e-02	1.16e-01	7.02e-01
GOCC TORC1 COMPLEX	6	2.97e-01	5.36e-01	0.33000	1.59e-01	-2.89e-01	4.99e-01	2.20e-01
GOBP VESICLE FUSION WITH GOLGI APPARATUS	9	2.93e-01	5.32e-01	0.33000	2.67e-01	1.95e-01	1.65e-01	3.12e-01
GOBP NEGATIVE REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS	6	2.87e-01	5.26e-01	0.33000	-2.18e-01	2.48e-01	3.56e-01	2.92e-01
Signaling by EGFR in Cancer	25	2.34e-02	1.11e-01	0.33000	3.15e-01	9.99e-02	6.43e-03	3.87e-01
GOBP REGULATION OF MYOBLAST DIFFERENTIATION	73	4.30e-06	1.05e-04	0.33000	3.30e-01	7.61e-03	1.07e-06	9.10e-01
GOBP RNA DECAPPING	19	5.46e-02	1.99e-01	0.33000	3.19e-01	8.52e-02	1.60e-02	5.20e-01
GOBP REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS	13	1.73e-01	3.95e-01	0.33000	-2.49e-01	-2.17e-01	1.20e-01	1.76e-01
GOMF GLUTAMATE SODIUM SYMPORTER ACTIVITY	5	4.81e-01	6.97e-01	0.33000	-3.07e-01	-1.20e-01	2.34e-01	6.41e-01
GOBP T HELPER 17 CELL LINEAGE COMMITMENT	19	4.21e-02	1.68e-01	0.33000	2.04e-02	3.30e-01	8.77e-01	1.29e-02
GOBP BLASTOCYST FORMATION	45	1.59e-03	1.47e-02	0.33000	3.00e-01	1.37e-01	4.94e-04	1.11e-01
GOMF MITOCHONDRION TARGETING SEQUENCE BINDING	6	4.13e-01	6.45e-01	0.33000	1.15e-01	3.09e-01	6.26e-01	1.89e-01
GOBP REGULATION OF ARACHIDONIC ACID SECRETION	7	2.42e-01	4.80e-01	0.33000	-2.86e-01	1.65e-01	1.90e-01	4.50e-01
GOCC GUANYL NUCLEOTIDE EXCHANGE FACTOR COMPLEX	21	5.63e-02	2.02e-01	0.33000	2.74e-01	1.84e-01	2.98e-02	1.45e-01
GOBP OVULATION	16	4.65e-02	1.79e-01	0.33000	3.15e-01	-9.83e-02	2.92e-02	4.96e-01
GOBP RESPONSE TO CORTISOL	6	3.79e-01	6.14e-01	0.33000	3.27e-01	4.26e-02	1.65e-01	8.57e-01
GOBP GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION	18	4.08e-02	1.64e-01	0.33000	-3.28e-01	3.17e-02	1.59e-02	8.16e-01
Regulation of ornithine decarboxylase (ODC)	38	4.13e-03	3.07e-02	0.33000	3.04e-01	1.28e-01	1.19e-03	1.71e-01
Hh mutants abrogate ligand secretion	46	1.28e-03	1.26e-02	0.33000	3.05e-01	1.26e-01	3.50e-04	1.39e-01
GOBP ONCOGENE INDUCED CELL SENESCENCE	6	3.17e-01	5.56e-01	0.33000	-3.15e-01	9.83e-02	1.82e-01	6.77e-01
Circadian Clock	65	6.14e-05	1.03e-03	0.33000	3.14e-01	1.00e-01	1.19e-05	1.62e-01
Collagen degradation	61	6.83e-05	1.12e-03	0.33000	-6.01e-02	-3.24e-01	4.17e-01	1.20e-05
GOBP ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA	9	2.75e-01	5.15e-01	0.33000	1.35e-01	3.00e-01	4.82e-01	1.19e-01
GOBP REGULATION OF HEXOKINASE ACTIVITY	6	3.75e-01	6.10e-01	0.33000	3.16e-02	3.28e-01	8.93e-01	1.64e-01
GOBP ECTODERMAL CELL DIFFERENTIATION	6	4.37e-01	6.65e-01	0.33000	2.80e-01	1.74e-01	2.36e-01	4.59e-01
Specification of primordial germ cells	11	1.73e-01	3.96e-01	0.32900	5.10e-02	3.25e-01	7.69e-01	6.16e-02
Signaling by FGFR1 in disease	38	5.06e-03	3.57e-02	0.32900	2.87e-01	1.61e-01	2.18e-03	8.61e-02
GOMF RIBOSOME BINDING	94	2.17e-06	5.82e-05	0.32900	2.87e-01	1.62e-01	1.52e-06	6.80e-03
GOBP NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS	18	6.85e-02	2.28e-01	0.32900	-3.13e-01	-1.01e-01	2.14e-02	4.56e-01
GOBP CORTICOSPINAL TRACT MORPHOGENESIS	8	1.99e-01	4.29e-01	0.32900	-1.65e-01	2.85e-01	4.19e-01	1.63e-01
GOMF NEDD8 TRANSFERASE ACTIVITY	7	3.73e-01	6.09e-01	0.32900	2.94e-01	1.48e-01	1.78e-01	4.97e-01
SUMOylation	170	5.49e-11	3.68e-09	0.32900	2.90e-01	1.55e-01	6.37e-11	5.03e-04
GOBP TOLL SIGNALING PATHWAY	11	1.44e-01	3.57e-01	0.32900	-2.90e-02	3.28e-01	8.68e-01	5.98e-02
GOBP TRANSCRIPTION INITIATION AT RNA POLYMERASE I PROMOTER	13	1.16e-01	3.16e-01	0.32900	3.28e-01	1.91e-02	4.03e-02	9.05e-01
GOBP IRON ION TRANSMEMBRANE TRANSPORT	19	5.63e-02	2.02e-01	0.32900	8.69e-02	3.17e-01	5.12e-01	1.67e-02
GOBP REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING	6	4.12e-01	6.44e-01	0.32900	1.05e-01	3.12e-01	6.55e-01	1.86e-01
GOBP TONGUE DEVELOPMENT	21	6.05e-02	2.12e-01	0.32900	2.26e-01	2.39e-01	7.27e-02	5.82e-02
Synthesis of 5-eicosatetraenoic acids	9	2.07e-01	4.38e-01	0.32900	-2.33e-02	3.28e-01	9.04e-01	8.84e-02
GOBP REGULATION OF SISTER CHROMATID SEGREGATION	104	3.26e-07	1.06e-05	0.32900	3.04e-01	1.25e-01	8.53e-08	2.71e-02
GOBP VESICLE TARGETING TO FROM OR WITHIN GOLGI	32	1.40e-02	7.72e-02	0.32900	2.36e-01	2.29e-01	2.07e-02	2.53e-02
Interleukin-7 signaling	21	3.91e-02	1.59e-01	0.32900	7.09e-02	3.21e-01	5.74e-01	1.09e-02
GOBP REGULATION OF PEPTIDYL LYSINE ACETYLATION	10	2.31e-01	4.65e-01	0.32900	3.10e-01	1.10e-01	9.00e-02	5.46e-01
GOBP PHOTORECEPTOR CELL MORPHOGENESIS	5	3.76e-01	6.12e-01	0.32900	3.03e-01	-1.27e-01	2.40e-01	6.24e-01
GOMF FILAMIN BINDING	14	1.14e-01	3.13e-01	0.32800	-6.55e-02	-3.22e-01	6.71e-01	3.71e-02
GOBP LACTATE TRANSMEMBRANE TRANSPORT	8	3.12e-01	5.52e-01	0.32800	-3.08e-01	-1.15e-01	1.32e-01	5.73e-01
GOBP POSITIVE REGULATION OF AUTOPHAGOSOME MATURATION	7	2.58e-01	4.97e-01	0.32800	3.07e-01	-1.16e-01	1.59e-01	5.97e-01
Vpu mediated degradation of CD4	39	2.60e-03	2.16e-02	0.32800	3.19e-01	7.75e-02	5.64e-04	4.02e-01
GOBP ATRIAL SEPTUM DEVELOPMENT	23	4.58e-02	1.77e-01	0.32800	2.59e-01	2.02e-01	3.19e-02	9.29e-02
GOMF SERINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY	95	2.72e-06	7.01e-05	0.32800	-1.87e-01	-2.70e-01	1.60e-03	5.57e-06
GOBP NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY	14	1.53e-01	3.69e-01	0.32800	-2.59e-01	-2.01e-01	9.28e-02	1.93e-01
Regulation of activated PAK-2p34 by proteasome mediated degradation	37	3.47e-03	2.69e-02	0.32800	3.20e-01	7.48e-02	7.67e-04	4.31e-01
GOBP PEPTIDE MODIFICATION	5	5.14e-01	7.21e-01	0.32800	2.27e-01	2.37e-01	3.79e-01	3.59e-01
GOBP REGULATION OF POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE	8	3.38e-01	5.76e-01	0.32800	2.72e-01	1.83e-01	1.82e-01	3.70e-01
GOBP RESPONSE TO DEXAMETHASONE	44	2.20e-03	1.90e-02	0.32800	2.90e-01	1.53e-01	8.66e-04	7.89e-02
GOBP NEGATIVE REGULATION OF GLUTAMATE SECRETION	5	5.01e-01	7.11e-01	0.32800	-1.60e-01	-2.86e-01	5.35e-01	2.67e-01
NOTCH4 Activation and Transmission of Signal to the Nucleus	11	2.29e-01	4.64e-01	0.32800	2.59e-01	2.01e-01	1.37e-01	2.48e-01
GOBP NEGATIVE REGULATION OF JUN KINASE ACTIVITY	12	1.42e-01	3.55e-01	0.32800	3.27e-01	2.80e-02	5.00e-02	8.66e-01
GOBP BLOOD COAGULATION INTRINSIC PATHWAY	6	3.23e-01	5.61e-01	0.32800	-9.23e-02	3.15e-01	6.95e-01	1.82e-01
GOBP CHAPERONE MEDIATED PROTEIN FOLDING	75	4.01e-05	7.25e-04	0.32800	2.72e-01	1.84e-01	4.75e-05	5.97e-03
GOBP NOREPINEPHRINE UPTAKE	8	3.41e-01	5.79e-01	0.32800	-2.65e-01	-1.93e-01	1.94e-01	3.44e-01
Purine salvage	11	1.41e-01	3.53e-01	0.32800	-4.31e-02	3.25e-01	8.05e-01	6.20e-02
GOBP POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE	13	1.60e-01	3.78e-01	0.32800	1.39e-01	2.97e-01	3.87e-01	6.38e-02
Base-Excision Repair, AP Site Formation	40	4.97e-03	3.52e-02	0.32800	2.22e-01	2.41e-01	1.53e-02	8.23e-03
GOMF LBD DOMAIN BINDING	6	2.93e-01	5.32e-01	0.32800	-2.20e-01	2.43e-01	3.50e-01	3.03e-01
GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 3 COMPLEX	13	1.50e-01	3.64e-01	0.32800	3.09e-01	1.10e-01	5.39e-02	4.94e-01
GOCC CUL4 RING E3 UBIQUITIN LIGASE COMPLEX	33	1.20e-02	6.84e-02	0.32800	2.64e-01	1.94e-01	8.74e-03	5.32e-02
Negative regulation of NOTCH4 signaling	44	1.11e-03	1.14e-02	0.32800	3.21e-01	6.38e-02	2.26e-04	4.64e-01
GOBP NEGATIVE REGULATION OF DOPAMINE SECRETION	5	4.70e-01	6.92e-01	0.32700	-3.17e-01	-8.07e-02	2.19e-01	7.55e-01
GOMF UBIQUITIN LIKE PROTEIN CONJUGATING ENZYME BINDING	37	6.00e-03	4.07e-02	0.32700	2.89e-01	1.54e-01	2.37e-03	1.04e-01
RUNX1 regulates estrogen receptor mediated transcription	6	4.47e-01	6.73e-01	0.32700	1.89e-01	2.67e-01	4.22e-01	2.57e-01
GOBP BODY MORPHOGENESIS	47	8.62e-04	9.34e-03	0.32700	3.16e-01	8.43e-02	1.76e-04	3.17e-01
GOBP REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION	79	1.99e-05	3.92e-04	0.32700	2.85e-01	1.61e-01	1.19e-05	1.34e-02
GOBP GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT	42	2.73e-03	2.24e-02	0.32700	2.97e-01	1.38e-01	8.77e-04	1.21e-01
GOBP ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT	27	2.29e-02	1.09e-01	0.32700	1.42e-01	2.95e-01	2.01e-01	8.04e-03
Synthesis of PIPs at the early endosome membrane	15	1.17e-01	3.17e-01	0.32700	3.03e-01	1.23e-01	4.20e-02	4.09e-01
Ubiquitin-dependent degradation of Cyclin D	39	3.13e-03	2.48e-02	0.32700	3.13e-01	9.59e-02	7.24e-04	3.00e-01
GOBP REGULATION OF BONE DEVELOPMENT	9	1.81e-01	4.06e-01	0.32700	1.05e-01	-3.10e-01	5.85e-01	1.07e-01
GOBP NEGATIVE REGULATION OF RUFFLE ASSEMBLY	7	2.63e-01	5.02e-01	0.32700	-1.09e-01	3.08e-01	6.17e-01	1.58e-01
GOMF PROMOTER SPECIFIC CHROMATIN BINDING	64	1.74e-04	2.46e-03	0.32700	2.76e-01	1.76e-01	1.34e-04	1.52e-02
GOBP DENDRITIC CELL CYTOKINE PRODUCTION	18	3.26e-02	1.40e-01	0.32700	-3.09e-01	1.07e-01	2.31e-02	4.34e-01
GOBP COPII COATED VESICLE BUDDING	43	3.42e-03	2.66e-02	0.32700	2.41e-01	2.21e-01	6.16e-03	1.23e-02
Signaling by FLT3 ITD and TKD mutants	16	1.19e-01	3.20e-01	0.32700	2.60e-01	1.99e-01	7.22e-02	1.69e-01
Regulation of RUNX3 expression and activity	45	1.22e-03	1.22e-02	0.32700	3.15e-01	8.70e-02	2.56e-04	3.12e-01
GOBP POSITIVE REGULATION OF DNA REPAIR	129	1.76e-08	7.34e-07	0.32700	2.92e-01	1.46e-01	9.66e-09	4.20e-03
GOCC CHROMOSOME TELOMERIC REGION	166	2.63e-10	1.53e-08	0.32700	2.65e-01	1.91e-01	3.70e-09	2.18e-05
Cellular hexose transport	22	5.45e-02	1.99e-01	0.32700	-2.48e-01	-2.13e-01	4.39e-02	8.42e-02
GOBP PROTEIN INSERTION INTO MITOCHONDRIAL OUTER MEMBRANE	15	1.38e-01	3.50e-01	0.32700	2.40e-01	2.22e-01	1.08e-01	1.37e-01
GOBP NEGATIVE REGULATION OF T CELL MIGRATION	6	4.53e-01	6.79e-01	0.32700	2.23e-01	2.39e-01	3.44e-01	3.11e-01
GOMF INSULIN LIKE GROWTH FACTOR RECEPTOR BINDING	16	1.21e-01	3.24e-01	0.32700	2.40e-01	2.21e-01	9.62e-02	1.25e-01
GOBP REGULATION OF BILE ACID METABOLIC PROCESS	15	1.37e-01	3.48e-01	0.32600	-2.54e-01	-2.05e-01	8.85e-02	1.69e-01
Sensory perception of sweet, bitter, and umami (glutamate) taste	41	4.21e-03	3.12e-02	0.32600	-1.89e-01	-2.66e-01	3.66e-02	3.16e-03
GOBP MAINTENANCE OF ORGANELLE LOCATION	12	1.59e-01	3.78e-01	0.32600	3.19e-01	6.69e-02	5.53e-02	6.88e-01
FGFR1b ligand binding and activation	8	2.03e-01	4.34e-01	0.32600	2.77e-01	-1.72e-01	1.74e-01	4.00e-01
GOMF INTERMEDIATE FILAMENT BINDING	10	2.48e-01	4.86e-01	0.32600	-1.41e-01	-2.94e-01	4.41e-01	1.07e-01
RNA Polymerase III Transcription Initiation From Type 3 Promoter	28	2.06e-02	1.02e-01	0.32600	2.92e-01	1.45e-01	7.43e-03	1.84e-01
Regulation of BACH1 activity	15	6.26e-02	2.16e-01	0.32600	3.16e-01	-8.28e-02	3.44e-02	5.79e-01
Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)	20	5.26e-02	1.94e-01	0.32600	3.12e-01	9.40e-02	1.56e-02	4.67e-01
GOBP POINTED END ACTIN FILAMENT CAPPING	7	3.82e-01	6.16e-01	0.32600	2.88e-01	1.52e-01	1.87e-01	4.85e-01
GOBP UV DAMAGE EXCISION REPAIR	12	2.06e-01	4.38e-01	0.32600	2.45e-01	2.15e-01	1.42e-01	1.97e-01
GOCC MHC PROTEIN COMPLEX	24	9.31e-03	5.69e-02	0.32600	-1.42e-01	2.94e-01	2.30e-01	1.28e-02
GOBP LENS FIBER CELL MORPHOGENESIS	6	3.27e-01	5.66e-01	0.32600	-9.28e-02	3.12e-01	6.94e-01	1.85e-01
GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS	123	1.18e-08	5.07e-07	0.32600	3.15e-01	8.41e-02	1.60e-09	1.07e-01
GOCC RIBOSOMAL SUBUNIT	174	1.24e-10	7.71e-09	0.32600	2.54e-01	2.05e-01	7.72e-09	3.21e-06
GOBP CELLULAR HYPEROSMOTIC RESPONSE	19	7.42e-02	2.41e-01	0.32600	2.87e-01	1.55e-01	3.06e-02	2.42e-01
GOCC NUCLEAR CHROMOSOME	221	6.85e-14	6.23e-12	0.32600	2.92e-01	1.46e-01	7.77e-14	1.93e-04
GOBP NEURAL FOLD FORMATION	7	2.43e-01	4.81e-01	0.32600	-2.50e-01	2.09e-01	2.52e-01	3.38e-01
RNA Polymerase III Chain Elongation	18	8.33e-02	2.59e-01	0.32600	2.91e-01	1.46e-01	3.25e-02	2.83e-01
GOCC RNA POLYMERASE III COMPLEX	18	8.33e-02	2.59e-01	0.32600	2.91e-01	1.46e-01	3.25e-02	2.83e-01
GOBP CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT	27	2.91e-02	1.29e-01	0.32600	2.22e-01	2.38e-01	4.60e-02	3.19e-02
Binding of TCF/LEF:CTNNB1 to target gene promoters	8	3.35e-01	5.74e-01	0.32600	2.86e-01	1.56e-01	1.62e-01	4.44e-01
SUMO E3 ligases SUMOylate target proteins	164	2.06e-10	1.21e-08	0.32600	2.87e-01	1.55e-01	2.36e-10	6.27e-04
GOBP SEQUESTERING OF IRON ION	6	3.53e-01	5.90e-01	0.32600	-3.24e-02	3.24e-01	8.91e-01	1.69e-01
Translesion synthesis by POLI	17	1.05e-01	2.99e-01	0.32600	2.64e-01	1.90e-01	5.94e-02	1.74e-01
GOMF CROSSOVER JUNCTION DNA ENDONUCLEASE ACTIVITY	7	2.76e-01	5.16e-01	0.32600	3.15e-01	-8.16e-02	1.49e-01	7.08e-01
GOCC MITOCHONDRIAL PROTEIN CONTAINING COMPLEX	263	2.88e-16	3.18e-14	0.32500	2.89e-01	1.49e-01	6.19e-16	3.21e-05
GOCC MLL1 2 COMPLEX	28	2.20e-02	1.06e-01	0.32500	2.86e-01	1.56e-01	8.89e-03	1.53e-01
GOCC SITE OF DNA DAMAGE	125	7.98e-08	2.96e-06	0.32500	2.50e-01	2.08e-01	1.37e-06	5.76e-05
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H OXYGEN AS ACCEPTOR	12	1.34e-01	3.43e-01	0.32500	-5.71e-03	3.25e-01	9.73e-01	5.10e-02
GOBP CALCIUM ION IMPORT INTO SARCOPLASMIC RETICULUM	5	5.14e-01	7.21e-01	0.32500	2.69e-01	1.83e-01	2.98e-01	4.79e-01
GOBP ISG15 PROTEIN CONJUGATION	6	3.41e-01	5.79e-01	0.32500	-6.10e-02	3.19e-01	7.96e-01	1.75e-01
GOBP ERK5 CASCADE	5	5.20e-01	7.26e-01	0.32500	2.38e-01	2.22e-01	3.57e-01	3.90e-01
GOBP PURKINJE MYOCYTE TO VENTRICULAR CARDIAC MUSCLE CELL COMMUNICATION	6	4.56e-01	6.81e-01	0.32500	-2.49e-01	-2.09e-01	2.91e-01	3.75e-01
GOBP PROTEIN DNA COMPLEX ASSEMBLY	201	2.07e-12	1.63e-10	0.32500	2.80e-01	1.66e-01	7.98e-12	5.06e-05
GOBP CELLULAR RESPONSE TO GLUCOSE STARVATION	44	3.17e-03	2.50e-02	0.32500	2.12e-01	2.47e-01	1.52e-02	4.60e-03
GOCC MEMBRANE COAT	96	7.24e-07	2.21e-05	0.32500	3.13e-01	8.66e-02	1.12e-07	1.43e-01
Leading Strand Synthesis	13	1.66e-01	3.88e-01	0.32500	2.93e-01	1.41e-01	6.76e-02	3.78e-01
Polymerase switching	13	1.66e-01	3.88e-01	0.32500	2.93e-01	1.41e-01	6.76e-02	3.78e-01
GOBP NEGATIVE REGULATION OF MOTOR NEURON APOPTOTIC PROCESS	11	1.62e-01	3.82e-01	0.32500	2.73e-03	3.25e-01	9.87e-01	6.20e-02
GOBP CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION	7	3.08e-01	5.48e-01	0.32500	3.25e-01	-1.16e-02	1.37e-01	9.57e-01
GOBP NUCLEAR MRNA SURVEILLANCE	11	2.06e-01	4.38e-01	0.32500	3.06e-01	1.08e-01	7.84e-02	5.36e-01
GOMF MELANOCORTIN RECEPTOR ACTIVITY	6	3.78e-01	6.13e-01	0.32500	-3.24e-01	-1.69e-02	1.69e-01	9.43e-01
GOCC INTRACILIARY TRANSPORT PARTICLE	26	2.88e-02	1.28e-01	0.32500	2.88e-01	1.51e-01	1.11e-02	1.83e-01
GOBP POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS	6	3.84e-01	6.18e-01	0.32500	-3.24e-01	-2.80e-02	1.70e-01	9.06e-01
GOMF XMP 5 NUCLEOSIDASE ACTIVITY	6	4.41e-01	6.69e-01	0.32500	2.87e-01	1.52e-01	2.24e-01	5.18e-01
GOBP POSITIVE REGULATION OF PROSTAGLANDIN BIOSYNTHETIC PROCESS	6	4.51e-01	6.76e-01	0.32500	2.70e-01	1.81e-01	2.53e-01	4.43e-01
GOCC NUCLEAR PROTEIN CONTAINING COMPLEX	1191	5.28e-67	4.05e-64	0.32500	2.79e-01	1.66e-01	1.37e-59	5.56e-22
GOBP HEMATOPOIETIC STEM CELL MIGRATION	8	3.24e-01	5.63e-01	0.32500	-3.00e-01	-1.23e-01	1.41e-01	5.47e-01
GOCC MULTIVESICULAR BODY LUMEN	6	4.58e-01	6.82e-01	0.32500	-2.23e-01	-2.36e-01	3.45e-01	3.16e-01
GOBP POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION	66	1.45e-04	2.09e-03	0.32500	2.78e-01	1.67e-01	9.28e-05	1.88e-02
GOBP NEGATIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS	8	2.46e-01	4.84e-01	0.32500	-4.51e-02	3.21e-01	8.25e-01	1.15e-01
GOBP NEGATIVE REGULATION OF HAIR FOLLICLE DEVELOPMENT	5	3.87e-01	6.21e-01	0.32500	-1.20e-01	3.02e-01	6.43e-01	2.43e-01
GOBP TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY	9	1.85e-01	4.11e-01	0.32500	-1.07e-01	3.06e-01	5.77e-01	1.12e-01
FGFR1 mutant receptor activation	31	1.76e-02	9.06e-02	0.32500	2.46e-01	2.11e-01	1.76e-02	4.17e-02
GOMF PROTEIN ARGININE N METHYLTRANSFERASE ACTIVITY	12	1.64e-01	3.84e-01	0.32400	3.17e-01	6.84e-02	5.71e-02	6.81e-01
GOBP PROTEIN K11 LINKED UBIQUITINATION	34	1.15e-02	6.64e-02	0.32400	2.61e-01	1.93e-01	8.53e-03	5.11e-02
GOBP REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS	158	1.31e-09	7.02e-08	0.32400	2.42e-01	2.16e-01	1.51e-07	2.75e-06
GOBP ENDONUCLEOLYTIC CLEAVAGE OF TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA	16	8.75e-02	2.68e-01	0.32400	6.12e-02	3.19e-01	6.72e-01	2.73e-02
GOMF UNMETHYLATED CPG BINDING	9	2.80e-01	5.19e-01	0.32400	1.17e-01	3.03e-01	5.45e-01	1.16e-01
GOBP NEGATIVE REGULATION OF ORGANELLE ASSEMBLY	44	3.09e-03	2.46e-02	0.32400	2.61e-01	1.93e-01	2.75e-03	2.68e-02
GOBP INTERSTRAND CROSS LINK REPAIR	40	3.51e-03	2.71e-02	0.32400	3.02e-01	1.17e-01	9.33e-04	1.99e-01
GOBP MICROTUBULE ANCHORING	23	4.98e-02	1.88e-01	0.32400	2.08e-01	2.49e-01	8.40e-02	3.89e-02
GOBP REGULATION OF GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS	7	2.51e-01	4.89e-01	0.32400	1.74e-01	-2.74e-01	4.26e-01	2.10e-01
GOBP MRNA PSEUDOURIDINE SYNTHESIS	8	2.05e-01	4.36e-01	0.32400	2.67e-01	-1.83e-01	1.90e-01	3.69e-01
GOBP UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE C END DEGRON RULE PATHWAY	12	2.01e-01	4.31e-01	0.32400	1.70e-01	2.76e-01	3.09e-01	9.73e-02
GOBP PINOCYTOSIS	22	4.88e-02	1.85e-01	0.32400	2.92e-01	1.41e-01	1.79e-02	2.51e-01
GOBP REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY	30	2.02e-02	1.00e-01	0.32400	2.11e-01	2.46e-01	4.58e-02	1.95e-02
GOBP REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT	20	4.73e-02	1.81e-01	0.32400	3.19e-01	5.77e-02	1.35e-02	6.55e-01
GOBP REGULATION OF MEIOSIS I	6	3.70e-01	6.07e-01	0.32400	3.24e-01	-2.42e-03	1.69e-01	9.92e-01
GOMF LOW DENSITY LIPOPROTEIN PARTICLE BINDING	17	1.10e-01	3.07e-01	0.32400	-2.20e-01	-2.38e-01	1.16e-01	8.99e-02
GOCC ATG1 ULK1 KINASE COMPLEX	9	2.51e-01	4.89e-01	0.32400	3.20e-01	5.29e-02	9.68e-02	7.83e-01
Phosphorylation of Emi1	6	3.03e-01	5.43e-01	0.32400	-2.57e-01	1.97e-01	2.75e-01	4.03e-01
GOBP RIBOFLAVIN TRANSPORT	6	3.56e-01	5.93e-01	0.32400	3.22e-01	-3.29e-02	1.72e-01	8.89e-01
GOMF RIBOFLAVIN TRANSMEMBRANE TRANSPORTER ACTIVITY	6	3.56e-01	5.93e-01	0.32400	3.22e-01	-3.29e-02	1.72e-01	8.89e-01
GOBP B CELL PROLIFERATION INVOLVED IN IMMUNE RESPONSE	6	3.04e-01	5.43e-01	0.32400	-1.94e-01	2.59e-01	4.10e-01	2.71e-01
GOBP TRANSCRIPTION ELONGATION COUPLED CHROMATIN REMODELING	9	3.02e-01	5.41e-01	0.32400	1.70e-01	2.75e-01	3.76e-01	1.53e-01
GOBP CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS	24	4.48e-02	1.75e-01	0.32400	2.24e-01	2.33e-01	5.70e-02	4.78e-02
DNA Double Strand Break Response	56	4.67e-04	5.70e-03	0.32400	2.92e-01	1.40e-01	1.57e-04	6.99e-02
GOBP REGULATION OF STEM CELL POPULATION MAINTENANCE	71	7.94e-05	1.28e-03	0.32400	2.76e-01	1.69e-01	5.66e-05	1.40e-02
GOCC EUCHROMATIN	59	3.63e-04	4.58e-03	0.32400	2.82e-01	1.59e-01	1.78e-04	3.49e-02
GOBP POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY	19	3.96e-02	1.61e-01	0.32400	-2.48e-02	3.23e-01	8.52e-01	1.49e-02
GOBP VOLUNTARY SKELETAL MUSCLE CONTRACTION	5	4.14e-01	6.45e-01	0.32400	5.44e-02	-3.19e-01	8.33e-01	2.17e-01
GOCC ACETYLTRANSFERASE COMPLEX	91	5.24e-06	1.25e-04	0.32300	2.81e-01	1.60e-01	3.62e-06	8.19e-03
GOBP PORE COMPLEX ASSEMBLY	19	4.20e-02	1.68e-01	0.32300	3.23e-01	-1.16e-02	1.47e-02	9.30e-01
GOBP REGULATION OF HEART RATE BY CHEMICAL SIGNAL	6	3.04e-01	5.44e-01	0.32300	2.55e-01	-1.98e-01	2.79e-01	4.00e-01
HS-GAG biosynthesis	28	2.64e-02	1.21e-01	0.32300	-2.53e-01	-2.02e-01	2.07e-02	6.46e-02
GOBP RESPONSE TO L PHENYLALANINE DERIVATIVE	6	4.60e-01	6.84e-01	0.32300	2.43e-01	2.13e-01	3.02e-01	3.66e-01
GOBP REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT	18	6.65e-02	2.25e-01	0.32300	3.17e-01	6.35e-02	1.99e-02	6.41e-01
GOBP INTRA GOLGI VESICLE MEDIATED TRANSPORT	32	1.16e-02	6.68e-02	0.32300	2.99e-01	1.23e-01	3.43e-03	2.29e-01
GOMF PATCHED BINDING	8	3.56e-01	5.93e-01	0.32300	2.33e-01	2.24e-01	2.55e-01	2.72e-01
GOBP NEGATIVE REGULATION OF NATURAL KILLER CELL ACTIVATION	10	1.54e-01	3.70e-01	0.32300	-1.13e-01	3.03e-01	5.36e-01	9.75e-02
GOBP THELARCHE	5	3.75e-01	6.11e-01	0.32300	-2.71e-01	1.76e-01	2.94e-01	4.96e-01
GOBP REGULATION OF MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL	6	3.77e-01	6.12e-01	0.32300	3.23e-01	5.84e-03	1.71e-01	9.80e-01
Loss of Function of TGFBR1 in Cancer	7	3.68e-01	6.05e-01	0.32300	1.03e-01	3.06e-01	6.38e-01	1.61e-01
GOCC PERICENTRIOLAR MATERIAL	22	5.89e-02	2.08e-01	0.32300	2.25e-01	2.32e-01	6.81e-02	5.96e-02
GOMF 5 3 EXONUCLEASE ACTIVITY	18	9.36e-02	2.78e-01	0.32300	1.77e-01	2.70e-01	1.92e-01	4.75e-02
GOBP N TERMINAL PEPTIDYL METHIONINE ACETYLATION	5	4.75e-01	6.95e-01	0.32300	3.15e-01	6.97e-02	2.22e-01	7.87e-01
GOBP NEGATIVE REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS	62	3.30e-04	4.24e-03	0.32300	2.52e-01	2.02e-01	6.00e-04	5.96e-03
Wax and plasmalogen biosynthesis	5	5.09e-01	7.17e-01	0.32300	1.48e-01	2.87e-01	5.67e-01	2.66e-01
GOBP POSITIVE REGULATION OF DEVELOPMENTAL PIGMENTATION	9	3.12e-01	5.52e-01	0.32300	2.07e-01	2.48e-01	2.83e-01	1.98e-01
GOBP CHROMOSOME SEPARATION	81	9.37e-06	2.05e-04	0.32300	3.07e-01	9.85e-02	1.72e-06	1.25e-01
GOBP CELL FATE SPECIFICATION	107	1.10e-06	3.17e-05	0.32300	2.35e-01	2.21e-01	2.58e-05	7.90e-05
Acyl chain remodelling of PG	18	4.38e-02	1.72e-01	0.32300	4.80e-02	-3.19e-01	7.24e-01	1.91e-02
Downstream signaling of activated FGFR3	24	2.84e-02	1.27e-01	0.32300	3.15e-01	7.11e-02	7.61e-03	5.47e-01
GOMF ANNEALING ACTIVITY	8	3.22e-01	5.60e-01	0.32300	3.04e-01	1.07e-01	1.36e-01	6.00e-01
GOBP PROTEIN K48 LINKED UBIQUITINATION	98	2.37e-06	6.23e-05	0.32300	2.77e-01	1.66e-01	2.18e-06	4.60e-03
GOBP BRUSH BORDER ASSEMBLY	8	3.56e-01	5.93e-01	0.32300	-2.47e-01	-2.08e-01	2.27e-01	3.09e-01
DNA Double-Strand Break Repair	146	5.28e-09	2.48e-07	0.32300	2.69e-01	1.78e-01	1.97e-08	2.09e-04
GOBP REGULATION OF BLOOD VOLUME BY RENIN ANGIOTENSIN	5	3.94e-01	6.27e-01	0.32200	1.14e-01	-3.02e-01	6.59e-01	2.43e-01
GOMF ACYL COA BINDING	19	5.40e-02	1.98e-01	0.32200	3.19e-01	4.47e-02	1.60e-02	7.36e-01
GOCC HEMOGLOBIN COMPLEX	12	1.40e-01	3.51e-01	0.32200	-3.22e-01	4.23e-03	5.32e-02	9.80e-01
GOBP REGULATION OF ANTIMICROBIAL HUMORAL RESPONSE	12	1.74e-01	3.97e-01	0.32200	-8.38e-02	-3.11e-01	6.15e-01	6.20e-02
GOBP RESPONSE TO FUNGUS	60	1.89e-04	2.63e-03	0.32200	-3.07e-01	-9.69e-02	3.81e-05	1.94e-01
E2F mediated regulation of DNA replication	20	6.53e-02	2.22e-01	0.32200	2.92e-01	1.36e-01	2.36e-02	2.93e-01
GOBP AUDITORY RECEPTOR CELL DEVELOPMENT	26	3.42e-02	1.45e-01	0.32200	-1.90e-01	-2.61e-01	9.43e-02	2.14e-02
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO HYPOXIA	9	3.14e-01	5.54e-01	0.32200	2.07e-01	2.47e-01	2.81e-01	2.00e-01
GOBP LEPTIN MEDIATED SIGNALING PATHWAY	10	2.42e-01	4.80e-01	0.32200	3.05e-01	1.04e-01	9.50e-02	5.70e-01
TFAP2 (AP-2) family regulates transcription of growth factors and their receptors	12	2.15e-01	4.47e-01	0.32200	2.32e-01	2.24e-01	1.65e-01	1.80e-01
GOBP NEGATIVE REGULATION OF WOUND HEALING SPREADING OF EPIDERMAL CELLS	5	5.24e-01	7.28e-01	0.32200	2.56e-01	1.96e-01	3.22e-01	4.49e-01
GOMF 3 CHLOROALLYL ALDEHYDE DEHYDROGENASE ACTIVITY	5	5.15e-01	7.22e-01	0.32200	-1.62e-01	-2.78e-01	5.29e-01	2.82e-01
GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS	14	1.61e-01	3.79e-01	0.32200	-1.77e-01	-2.68e-01	2.51e-01	8.20e-02
GOCC ANKYRIN 1 COMPLEX	7	2.56e-01	4.93e-01	0.32200	1.78e-01	-2.68e-01	4.14e-01	2.20e-01
GOCC NONHOMOLOGOUS END JOINING COMPLEX	9	2.12e-01	4.44e-01	0.32200	3.19e-01	-4.43e-02	9.78e-02	8.18e-01
GOBP GAMMA AMINOBUTYRIC ACID BIOSYNTHETIC PROCESS	6	4.31e-01	6.59e-01	0.32200	1.10e-01	3.02e-01	6.42e-01	2.00e-01
GOMF RNA POLYMERASE BINDING	58	3.81e-04	4.78e-03	0.32200	2.92e-01	1.35e-01	1.21e-04	7.48e-02
GOBP KILLING BY HOST OF SYMBIONT CELLS	24	4.12e-02	1.66e-01	0.32200	-2.81e-01	-1.56e-01	1.71e-02	1.85e-01
GOCC NADH DEHYDROGENASE COMPLEX	42	1.68e-03	1.54e-02	0.32200	3.18e-01	4.78e-02	3.61e-04	5.92e-01
GOBP TRANSCRIPTION INITIATION AT RNA POLYMERASE II PROMOTER	150	1.45e-09	7.63e-08	0.32200	2.93e-01	1.32e-01	5.63e-10	5.19e-03
GOCC CONDENSED CHROMOSOME CENTROMERIC REGION	174	9.67e-11	6.21e-09	0.32200	2.83e-01	1.53e-01	1.18e-10	5.08e-04
GOMF ACETYLTRANSFERASE ACTIVITY	89	9.38e-06	2.05e-04	0.32200	2.69e-01	1.77e-01	1.19e-05	3.94e-03
GOBP PSEUDOPODIUM ORGANIZATION	15	1.40e-01	3.52e-01	0.32200	2.73e-01	1.70e-01	6.72e-02	2.55e-01
GOBP NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION	16	1.20e-01	3.23e-01	0.32200	1.61e-01	2.79e-01	2.66e-01	5.37e-02
GOBP TRIGLYCERIDE CATABOLIC PROCESS	27	3.11e-02	1.35e-01	0.32100	-2.53e-01	-1.98e-01	2.27e-02	7.52e-02
GOBP ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION	21	5.81e-02	2.06e-01	0.32100	2.91e-01	1.36e-01	2.10e-02	2.79e-01
GOBP MITOCHONDRIAL RIBOSOME ASSEMBLY	12	1.89e-01	4.17e-01	0.32100	2.99e-01	1.17e-01	7.26e-02	4.82e-01
GOMF DAMAGED DNA BINDING	72	1.04e-04	1.60e-03	0.32100	2.18e-01	2.36e-01	1.36e-03	5.40e-04
POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation	10	2.47e-01	4.85e-01	0.32100	3.02e-01	1.10e-01	9.82e-02	5.47e-01
GOBP CMP METABOLIC PROCESS	8	2.08e-01	4.40e-01	0.32100	-2.04e-01	2.48e-01	3.18e-01	2.24e-01
GOBP HEART VALVE FORMATION	15	5.26e-02	1.94e-01	0.32100	-2.47e-01	2.05e-01	9.73e-02	1.69e-01
GOBP FOREGUT MORPHOGENESIS	10	2.54e-01	4.91e-01	0.32100	1.27e-01	2.95e-01	4.88e-01	1.06e-01
GOCC ENDOPLASMIC RETICULUM QUALITY CONTROL COMPARTMENT	15	1.47e-01	3.60e-01	0.32100	2.09e-01	2.44e-01	1.62e-01	1.01e-01
GOMF RISC COMPLEX BINDING	5	4.75e-01	6.95e-01	0.32100	3.15e-01	6.29e-02	2.23e-01	8.08e-01
GOBP TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE	32	1.43e-02	7.82e-02	0.32100	2.82e-01	1.55e-01	5.84e-03	1.30e-01
Orc1 removal from chromatin	58	2.43e-04	3.27e-03	0.32100	3.09e-01	8.79e-02	4.72e-05	2.47e-01
GOBP DNA TEMPLATED TRANSCRIPTION INITIATION	188	8.21e-12	6.11e-10	0.32100	2.95e-01	1.28e-01	3.12e-12	2.56e-03
GOMF UBIQUITIN CONJUGATING ENZYME BINDING	31	1.81e-02	9.24e-02	0.32100	2.65e-01	1.82e-01	1.07e-02	8.01e-02
GOMF COPPER CHAPERONE ACTIVITY	6	3.25e-01	5.64e-01	0.32100	-1.28e-01	2.94e-01	5.86e-01	2.12e-01
GOMF CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING	40	6.04e-03	4.09e-02	0.32100	2.48e-01	2.03e-01	6.56e-03	2.61e-02
Retrograde transport at the Trans-Golgi-Network	47	2.22e-03	1.91e-02	0.32100	2.69e-01	1.75e-01	1.41e-03	3.81e-02
GOCC CHROMOSOME CENTROMERIC REGION	246	1.25e-14	1.22e-12	0.32100	2.76e-01	1.64e-01	8.98e-14	9.41e-06
GOBP SUBSTRATE INDEPENDENT TELENCEPHALIC TANGENTIAL MIGRATION	9	3.11e-01	5.51e-01	0.32100	-1.77e-01	-2.68e-01	3.58e-01	1.64e-01
Sperm Motility And Taxes	9	1.94e-01	4.24e-01	0.32100	9.83e-02	-3.05e-01	6.10e-01	1.13e-01
GOBP POSITIVE REGULATION OF BLOOD BRAIN BARRIER PERMEABILITY	5	5.09e-01	7.17e-01	0.32100	-2.91e-01	-1.36e-01	2.61e-01	5.98e-01
GOBP ESTABLISHMENT OF SPINDLE ORIENTATION	42	4.19e-03	3.11e-02	0.32100	2.71e-01	1.71e-01	2.33e-03	5.52e-02
GOBP MITOCHONDRION ENDOPLASMIC RETICULUM MEMBRANE TETHERING	7	3.74e-01	6.10e-01	0.32100	1.03e-01	3.04e-01	6.38e-01	1.64e-01
GOBP TRANS SYNAPTIC SIGNALING MODULATING SYNAPTIC TRANSMISSION	11	2.46e-01	4.84e-01	0.32100	-2.07e-01	-2.45e-01	2.34e-01	1.60e-01
GOBP REGULATION OF TOLERANCE INDUCTION	18	3.33e-02	1.42e-01	0.32100	-1.43e-01	2.87e-01	2.93e-01	3.52e-02
NF-kB is activated and signals survival	12	2.09e-01	4.41e-01	0.32000	2.73e-01	1.67e-01	1.01e-01	3.16e-01
Signaling by NTRK2 (TRKB)	25	2.78e-02	1.25e-01	0.32000	3.09e-01	8.62e-02	7.56e-03	4.56e-01
GOBP MULTI PASS TRANSMEMBRANE PROTEIN INSERTION INTO ER MEMBRANE	6	3.17e-01	5.56e-01	0.32000	-1.62e-01	2.76e-01	4.91e-01	2.41e-01
GOCC MULTI PASS TRANSLOCON COMPLEX	6	3.17e-01	5.56e-01	0.32000	-1.62e-01	2.76e-01	4.91e-01	2.41e-01
GOBP GERM CELL MIGRATION	9	1.72e-01	3.94e-01	0.32000	-2.23e-01	2.30e-01	2.47e-01	2.31e-01
GOMF TRANSFORMING GROWTH FACTOR BETA RECEPTOR ACTIVITY	13	1.83e-01	4.09e-01	0.32000	2.74e-01	1.67e-01	8.76e-02	2.98e-01
GOMF SNAP RECEPTOR ACTIVITY	36	8.65e-03	5.40e-02	0.32000	2.81e-01	1.54e-01	3.56e-03	1.09e-01
GOCC CALCIUM AND CALMODULIN DEPENDENT PROTEIN KINASE COMPLEX	5	4.40e-01	6.67e-01	0.32000	1.38e-02	-3.20e-01	9.57e-01	2.15e-01
GOBP PRIMARY ALCOHOL CATABOLIC PROCESS	13	1.92e-01	4.20e-01	0.32000	-2.13e-01	-2.39e-01	1.83e-01	1.35e-01
GOBP LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR	11	1.75e-01	3.97e-01	0.32000	3.20e-01	1.20e-02	6.60e-02	9.45e-01
GOBP TRANSLATIONAL ELONGATION	70	8.16e-05	1.32e-03	0.32000	2.90e-01	1.35e-01	2.64e-05	5.05e-02
GOCC CORTICAL ENDOPLASMIC RETICULUM	6	4.65e-01	6.88e-01	0.32000	1.99e-01	2.51e-01	3.99e-01	2.87e-01
GOMF INTRAMOLECULAR PHOSPHOTRANSFERASE ACTIVITY	10	1.81e-01	4.06e-01	0.32000	3.17e-01	-4.72e-02	8.29e-02	7.96e-01
GOCC CHROMOSOMAL REGION	384	4.22e-22	7.09e-20	0.32000	2.72e-01	1.69e-01	5.41e-20	1.30e-08
GOBP SIGNAL PEPTIDE PROCESSING	13	1.93e-01	4.22e-01	0.32000	2.23e-01	2.30e-01	1.65e-01	1.51e-01
RNA Polymerase I Transcription Initiation	45	2.11e-03	1.84e-02	0.32000	2.97e-01	1.19e-01	5.64e-04	1.68e-01
GOBP GLYCINE IMPORT ACROSS PLASMA MEMBRANE	5	3.94e-01	6.27e-01	0.32000	2.92e-01	-1.30e-01	2.58e-01	6.16e-01
E3 ubiquitin ligases ubiquitinate target proteins	55	9.74e-04	1.02e-02	0.32000	2.27e-01	2.26e-01	3.63e-03	3.80e-03
GOBP SYNAPTIC VESICLE DOCKING	9	3.07e-01	5.47e-01	0.32000	-1.57e-01	-2.79e-01	4.16e-01	1.47e-01
GOBP POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY	14	1.19e-01	3.21e-01	0.32000	3.17e-01	4.04e-02	3.99e-02	7.94e-01
GOBP NEGATIVE REGULATION OF MEGAKARYOCYTE DIFFERENTIATION	18	1.03e-01	2.95e-01	0.32000	2.38e-01	2.14e-01	8.04e-02	1.17e-01
GOBP POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION	17	8.46e-02	2.62e-01	0.32000	3.11e-01	7.29e-02	2.63e-02	6.03e-01
GOBP POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY	9	2.84e-01	5.23e-01	0.32000	1.01e-01	3.03e-01	5.99e-01	1.15e-01
GOMF MONOATOMIC ION GATED CHANNEL ACTIVITY	30	1.86e-02	9.46e-02	0.32000	-1.43e-01	-2.86e-01	1.74e-01	6.79e-03
GOBP ACTIVATION OF MEIOSIS	6	3.63e-01	6.00e-01	0.31900	3.17e-01	-4.07e-02	1.79e-01	8.63e-01
GOBP ENAMEL MINERALIZATION	20	4.75e-02	1.81e-01	0.31900	-3.70e-02	-3.17e-01	7.74e-01	1.40e-02
GOMF G PROTEIN ACTIVITY	46	2.64e-03	2.18e-02	0.31900	1.71e-01	2.70e-01	4.50e-02	1.54e-03
GOMF INTRAMOLECULAR TRANSFERASE ACTIVITY	27	5.33e-03	3.71e-02	0.31900	2.45e-01	-2.04e-01	2.73e-02	6.60e-02
ECM proteoglycans	73	9.74e-06	2.11e-04	0.31900	-8.29e-03	-3.19e-01	9.03e-01	2.39e-06
GOCC CAJAL BODY	78	3.30e-06	8.37e-05	0.31900	3.19e-01	-9.52e-03	1.09e-06	8.84e-01
GOMF DNA BINDING TRANSCRIPTION ACTIVATOR ACTIVITY	456	2.59e-25	5.29e-23	0.31900	2.05e-01	2.45e-01	5.76e-14	3.19e-19
GOBP NEGATIVE REGULATION OF TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY	7	4.01e-01	6.34e-01	0.31900	-2.77e-01	-1.59e-01	2.04e-01	4.67e-01
Protein ubiquitination	73	1.05e-04	1.60e-03	0.31900	2.26e-01	2.26e-01	8.44e-04	8.58e-04
GOBP PEPTIDYL LYSINE MONOMETHYLATION	9	3.22e-01	5.60e-01	0.31900	2.17e-01	2.34e-01	2.61e-01	2.23e-01
GOMF ATP GATED ION CHANNEL ACTIVITY	9	3.19e-01	5.57e-01	0.31900	1.92e-01	2.55e-01	3.18e-01	1.85e-01
Pyrimidine catabolism	12	1.09e-01	3.06e-01	0.31900	-2.94e-01	1.25e-01	7.81e-02	4.54e-01
Activation of the pre-replicative complex	31	1.59e-02	8.42e-02	0.31900	2.89e-01	1.35e-01	5.32e-03	1.94e-01
RNA Pol II CTD phosphorylation and interaction with CE	26	1.98e-02	9.90e-02	0.31900	3.16e-01	4.23e-02	5.25e-03	7.09e-01
RNA Pol II CTD phosphorylation and interaction with CE during HIV infection	26	1.98e-02	9.90e-02	0.31900	3.16e-01	4.23e-02	5.25e-03	7.09e-01
GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS	6	4.49e-01	6.75e-01	0.31900	-1.35e-01	-2.89e-01	5.67e-01	2.20e-01
GOBP EPITHELIAL STRUCTURE MAINTENANCE	35	1.08e-02	6.33e-02	0.31900	-2.74e-01	-1.63e-01	5.03e-03	9.52e-02
Respiratory electron transport	142	8.09e-09	3.61e-07	0.31900	2.84e-01	1.45e-01	5.26e-09	2.80e-03
GOBP MDA 5 SIGNALING PATHWAY	10	2.68e-01	5.07e-01	0.31900	2.83e-01	1.46e-01	1.21e-01	4.24e-01
GOCC ROD PHOTORECEPTOR OUTER SEGMENT	7	3.96e-01	6.29e-01	0.31900	-1.41e-01	-2.86e-01	5.19e-01	1.90e-01
GOBP AUDITORY RECEPTOR CELL MORPHOGENESIS	21	7.18e-02	2.36e-01	0.31900	-2.12e-01	-2.38e-01	9.27e-02	5.93e-02
GOBP COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE	24	2.78e-02	1.25e-01	0.31800	3.15e-01	4.69e-02	7.57e-03	6.91e-01
GOCC U2 SNRNP	23	4.84e-02	1.84e-01	0.31800	2.84e-01	1.44e-01	1.84e-02	2.32e-01
GOMF NUCLEAR RETINOID X RECEPTOR BINDING	17	1.16e-01	3.16e-01	0.31800	2.57e-01	1.88e-01	6.71e-02	1.78e-01
GOBP APPENDAGE MORPHOGENESIS	147	8.28e-09	3.67e-07	0.31800	2.62e-01	1.81e-01	4.30e-08	1.48e-04
GOBP URETER DEVELOPMENT	18	3.67e-02	1.52e-01	0.31800	-1.24e-01	2.93e-01	3.63e-01	3.13e-02
TRAF6 mediated NF-kB activation	24	3.03e-02	1.33e-01	0.31800	3.12e-01	6.31e-02	8.19e-03	5.92e-01
Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes	94	6.17e-06	1.43e-04	0.31800	2.68e-01	1.72e-01	7.16e-06	4.04e-03
Epigenetic regulation of gene expression by MLL3 and MLL4 complexes	94	6.17e-06	1.43e-04	0.31800	2.68e-01	1.72e-01	7.16e-06	4.04e-03
MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis	94	6.17e-06	1.43e-04	0.31800	2.68e-01	1.72e-01	7.16e-06	4.04e-03
GOBP REGULATION OF SYNAPSE STRUCTURAL PLASTICITY	7	2.68e-01	5.07e-01	0.31800	2.76e-01	-1.58e-01	2.06e-01	4.69e-01
GOMF CCR CHEMOKINE RECEPTOR BINDING	39	6.77e-03	4.48e-02	0.31800	-1.70e-01	-2.69e-01	6.66e-02	3.65e-03
Deadenylation of mRNA	22	5.47e-02	1.99e-01	0.31800	2.86e-01	1.39e-01	2.03e-02	2.58e-01
GOBP CHORIONIC TROPHOBLAST CELL DIFFERENTIATION	7	2.60e-01	4.98e-01	0.31800	-2.39e-01	2.10e-01	2.74e-01	3.37e-01
GOBP RNA EXPORT FROM NUCLEUS	84	1.46e-05	3.00e-04	0.31800	2.89e-01	1.33e-01	4.71e-06	3.56e-02
Negative regulators of DDX58/IFIH1 signaling	34	1.16e-02	6.69e-02	0.31800	2.83e-01	1.44e-01	4.28e-03	1.45e-01
GOBP CELLULAR RESPONSE TO IONIZING RADIATION	70	1.18e-04	1.76e-03	0.31800	2.77e-01	1.56e-01	6.14e-05	2.43e-02
Degradation of beta-catenin by the destruction complex	71	6.07e-05	1.02e-03	0.31800	2.99e-01	1.06e-01	1.29e-05	1.21e-01
GOCC CUL2 RING UBIQUITIN LIGASE COMPLEX	23	5.71e-02	2.03e-01	0.31800	2.17e-01	2.32e-01	7.19e-02	5.41e-02
GOMF UBIQUITIN LIKE PROTEIN BINDING	118	4.28e-07	1.36e-05	0.31700	2.07e-01	2.40e-01	1.01e-04	6.39e-06
GOBP POSITIVE REGULATION OF SPINDLE CHECKPOINT	13	1.14e-01	3.14e-01	0.31700	3.15e-01	-3.98e-02	4.93e-02	8.04e-01
GOBP REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION	12	2.03e-01	4.34e-01	0.31700	2.89e-01	1.31e-01	8.28e-02	4.32e-01
GOMF ATP DEPENDENT ACTIVITY ACTING ON DNA	117	1.72e-08	7.24e-07	0.31700	3.17e-01	2.26e-02	3.28e-09	6.73e-01
GOBP VESICLE CARGO LOADING	31	9.82e-03	5.90e-02	0.31700	3.15e-01	4.25e-02	2.44e-03	6.82e-01
GOBP REGULATION OF INFLAMMATORY RESPONSE TO WOUNDING	12	1.99e-01	4.29e-01	0.31700	-1.19e-01	-2.94e-01	4.76e-01	7.75e-02
GOBP MODULATION OF PROCESS OF ANOTHER ORGANISM	17	3.86e-02	1.58e-01	0.31700	-2.44e-01	2.03e-01	8.15e-02	1.48e-01
GOBP MITOTIC INTRA S DNA DAMAGE CHECKPOINT SIGNALING	17	8.61e-02	2.65e-01	0.31700	3.10e-01	6.66e-02	2.68e-02	6.35e-01
GOBP INTRACELLULAR PHOSPHATE ION HOMEOSTASIS	10	2.52e-01	4.90e-01	0.31700	-1.01e-01	-3.01e-01	5.79e-01	9.97e-02
GOMF HISTONE H3K36 METHYLTRANSFERASE ACTIVITY	13	1.36e-01	3.46e-01	0.31700	3.16e-01	2.23e-02	4.82e-02	8.89e-01
GOBP METAPHASE CHROMOSOME ALIGNMENT	102	3.13e-06	7.98e-05	0.31700	2.42e-01	2.05e-01	2.43e-05	3.40e-04
GOBP REGULATION OF MITOCHONDRIAL RNA CATABOLIC PROCESS	5	4.31e-01	6.59e-01	0.31700	3.13e-01	-4.84e-02	2.25e-01	8.51e-01
GOBP REGULATION OF DNA DAMAGE CHECKPOINT	20	6.74e-02	2.26e-01	0.31700	2.95e-01	1.17e-01	2.24e-02	3.66e-01
GOBP REGULATION OF MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL	5	4.38e-01	6.65e-01	0.31700	3.15e-01	-3.37e-02	2.22e-01	8.96e-01
GOCC CULLIN RING UBIQUITIN LIGASE COMPLEX	177	3.07e-10	1.78e-08	0.31700	2.06e-01	2.41e-01	2.37e-06	2.99e-08
AKT phosphorylates targets in the cytosol	14	1.49e-01	3.63e-01	0.31700	2.97e-01	1.11e-01	5.42e-02	4.74e-01
GOMF HISTAMINE RECEPTOR ACTIVITY	6	3.33e-01	5.72e-01	0.31700	-2.89e-01	1.29e-01	2.20e-01	5.83e-01
GOBP TELOMERE ORGANIZATION	181	9.42e-11	6.09e-09	0.31700	2.74e-01	1.60e-01	2.15e-10	2.00e-04
GOBP LABYRINTHINE LAYER MORPHOGENESIS	22	1.83e-02	9.31e-02	0.31700	-2.92e-01	1.23e-01	1.78e-02	3.16e-01
GOMF UBIQUITIN SPECIFIC PROTEASE BINDING	18	5.08e-02	1.90e-01	0.31700	3.15e-01	-3.70e-02	2.08e-02	7.86e-01
Gap-filling DNA repair synthesis and ligation in TC-NER	60	5.25e-04	6.28e-03	0.31700	2.61e-01	1.80e-01	4.72e-04	1.62e-02
GOBP POSITIVE REGULATION OF CONNECTIVE TISSUE REPLACEMENT	12	1.68e-01	3.90e-01	0.31700	4.30e-02	3.14e-01	7.96e-01	5.98e-02
GOBP POSITIVE REGULATION OF DENDRITIC CELL CYTOKINE PRODUCTION	12	1.03e-01	2.96e-01	0.31700	-2.59e-01	1.82e-01	1.20e-01	2.75e-01
Vif-mediated degradation of APOBEC3G	41	3.28e-03	2.57e-02	0.31700	3.04e-01	8.75e-02	7.44e-04	3.33e-01
GOBP REGULATION OF MITOTIC CENTROSOME SEPARATION	9	1.98e-01	4.28e-01	0.31700	-1.13e-01	2.96e-01	5.58e-01	1.24e-01
GOCC CIS GOLGI NETWORK	54	1.23e-03	1.23e-02	0.31700	2.45e-01	2.01e-01	1.87e-03	1.07e-02
Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha	52	1.18e-03	1.19e-02	0.31600	2.81e-01	1.45e-01	4.53e-04	7.01e-02
GOCC TRANSCRIPTION EXPORT COMPLEX	11	2.56e-01	4.94e-01	0.31600	2.34e-01	2.13e-01	1.80e-01	2.20e-01
GOCC TRANS GOLGI NETWORK TRANSPORT VESICLE	36	1.17e-02	6.72e-02	0.31600	2.30e-01	2.18e-01	1.71e-02	2.38e-02
Zinc efflux and compartmentalization by the SLC30 family	5	4.22e-01	6.52e-01	0.31600	-3.08e-01	7.40e-02	2.34e-01	7.75e-01
GOBP STEROID HORMONE BIOSYNTHETIC PROCESS	44	1.89e-03	1.68e-02	0.31600	-3.09e-01	-6.98e-02	3.98e-04	4.23e-01
GOBP GABAERGIC NEURON DIFFERENTIATION	18	8.22e-02	2.57e-01	0.31600	8.95e-02	3.03e-01	5.11e-01	2.59e-02
GOBP NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION	18	6.46e-02	2.21e-01	0.31600	-3.15e-01	-2.32e-02	2.05e-02	8.65e-01
GOBP REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I	15	7.89e-02	2.51e-01	0.31600	3.11e-01	-5.92e-02	3.73e-02	6.91e-01
GOCC PERICILIARY MEMBRANE COMPARTMENT	5	5.14e-01	7.21e-01	0.31600	-2.92e-01	-1.22e-01	2.59e-01	6.36e-01
GOBP VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION	14	1.28e-01	3.35e-01	0.31600	3.12e-01	4.83e-02	4.30e-02	7.55e-01
GOCC NUCLEAR PORE NUCLEAR BASKET	11	1.46e-01	3.59e-01	0.31600	3.04e-01	-8.70e-02	8.10e-02	6.17e-01
GOBP REGULATION OF ERAD PATHWAY	22	6.49e-02	2.21e-01	0.31600	2.50e-01	1.94e-01	4.25e-02	1.16e-01
GOBP REGULATION OF CHAPERONE MEDIATED AUTOPHAGY	8	2.40e-01	4.77e-01	0.31600	-1.09e-01	2.97e-01	5.95e-01	1.46e-01
DNA Damage Reversal	8	2.40e-01	4.77e-01	0.31600	2.97e-01	-1.07e-01	1.45e-01	6.01e-01
GOBP GOLGI RIBBON FORMATION	11	1.24e-01	3.28e-01	0.31600	2.41e-01	-2.05e-01	1.67e-01	2.39e-01
GOBP POSITIVE REGULATION OF CAMP MEDIATED SIGNALING	9	1.83e-01	4.09e-01	0.31600	-1.85e-01	2.56e-01	3.38e-01	1.83e-01
GOBP PROTEIN TARGETING TO LYSOSOME	31	2.20e-02	1.06e-01	0.31600	2.28e-01	2.19e-01	2.80e-02	3.51e-02
GOBP NUCLEAR MEMBRANE REASSEMBLY	25	3.81e-02	1.56e-01	0.31600	1.35e-01	2.86e-01	2.42e-01	1.35e-02
Metabolism of non-coding RNA	52	8.13e-04	9.00e-03	0.31600	3.00e-01	9.75e-02	1.78e-04	2.24e-01
snRNP Assembly	52	8.13e-04	9.00e-03	0.31600	3.00e-01	9.75e-02	1.78e-04	2.24e-01
GOBP GAMMA AMINOBUTYRIC ACID METABOLIC PROCESS	8	3.36e-01	5.75e-01	0.31600	1.02e-01	2.99e-01	6.17e-01	1.43e-01
GOBP PROTEIN POLY ADP RIBOSYLATION	10	2.07e-01	4.39e-01	0.31600	-2.88e-03	3.16e-01	9.87e-01	8.38e-02
GOBP CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE	16	6.02e-02	2.11e-01	0.31600	-9.37e-02	3.02e-01	5.16e-01	3.68e-02
Caspase-mediated cleavage of cytoskeletal proteins	12	2.28e-01	4.63e-01	0.31600	2.27e-01	2.19e-01	1.73e-01	1.88e-01
GOBP CARDIAC NEURAL CREST CELL MIGRATION INVOLVED IN OUTFLOW TRACT MORPHOGENESIS	11	2.23e-01	4.57e-01	0.31600	2.99e-01	1.00e-01	8.56e-02	5.65e-01
GOCC PRESYNAPTIC ACTIVE ZONE CYTOPLASMIC COMPONENT	17	1.12e-01	3.11e-01	0.31600	-1.50e-01	-2.78e-01	2.86e-01	4.72e-02
GOMF PROTEIN ANTIGEN BINDING	7	4.09e-01	6.41e-01	0.31600	-2.74e-01	-1.57e-01	2.09e-01	4.73e-01
GOBP NEUTROPHIL MEDIATED CYTOTOXICITY	15	1.58e-01	3.75e-01	0.31600	-2.35e-01	-2.11e-01	1.16e-01	1.57e-01
GOBP PRO B CELL DIFFERENTIATION	12	1.13e-01	3.13e-01	0.31500	2.87e-01	-1.30e-01	8.47e-02	4.36e-01
GOCC OUTER MITOCHONDRIAL MEMBRANE PROTEIN COMPLEX	21	7.33e-02	2.39e-01	0.31500	2.56e-01	1.83e-01	4.19e-02	1.46e-01
Hedgehog ‘on’ state	73	1.16e-05	2.46e-04	0.31500	3.15e-01	8.46e-05	3.20e-06	9.99e-01
GOBP VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS	14	1.21e-01	3.24e-01	0.31500	2.45e-02	3.14e-01	8.74e-01	4.18e-02
GOMF NUCLEAR RECEPTOR BINDING	131	5.49e-08	2.09e-06	0.31500	2.78e-01	1.49e-01	3.94e-08	3.31e-03
GOBP ANTERIOR POSTERIOR PATTERN SPECIFICATION	209	8.09e-12	6.06e-10	0.31500	2.01e-01	2.43e-01	5.41e-07	1.46e-09
GOBP NEGATIVE REGULATION OF MRNA PROCESSING	20	4.89e-02	1.85e-01	0.31500	3.14e-01	2.39e-02	1.50e-02	8.53e-01
GOBP THORAX AND ANTERIOR ABDOMEN DETERMINATION	5	5.26e-01	7.30e-01	0.31500	-1.48e-01	-2.78e-01	5.67e-01	2.81e-01
GOBP DOLICHYL DIPHOSPHATE METABOLIC PROCESS	5	3.88e-01	6.22e-01	0.31500	-2.11e-01	2.34e-01	4.13e-01	3.66e-01
GOBP OUTFLOW TRACT SEPTUM MORPHOGENESIS	26	3.48e-02	1.47e-01	0.31500	2.82e-01	1.41e-01	1.29e-02	2.14e-01
GOBP NEGATIVE REGULATION OF RNA SPLICING	24	2.00e-02	9.97e-02	0.31500	3.13e-01	-3.40e-02	7.92e-03	7.73e-01
GOBP MYOBLAST DIFFERENTIATION	112	2.26e-07	7.60e-06	0.31500	3.01e-01	9.20e-02	3.62e-08	9.26e-02
GOBP POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY	16	6.53e-02	2.22e-01	0.31500	3.07e-01	-7.17e-02	3.37e-02	6.19e-01
GOBP PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES	20	2.53e-02	1.17e-01	0.31500	2.76e-01	-1.51e-01	3.24e-02	2.43e-01
GOBP CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT	29	1.58e-02	8.40e-02	0.31500	6.05e-02	3.09e-01	5.73e-01	3.97e-03
Dectin-1 mediated noncanonical NF-kB signaling	49	1.42e-03	1.35e-02	0.31500	2.95e-01	1.09e-01	3.47e-04	1.87e-01
GOBP REGULATION OF CONNECTIVE TISSUE REPLACEMENT	15	1.02e-01	2.94e-01	0.31500	1.69e-02	3.14e-01	9.10e-01	3.50e-02
GOCC PLATELET DENSE GRANULE MEMBRANE	5	4.06e-01	6.39e-01	0.31500	-1.26e-01	2.89e-01	6.27e-01	2.64e-01
GOMF S ADENOSYL L METHIONINE BINDING	18	6.42e-02	2.20e-01	0.31500	3.14e-01	1.42e-02	2.09e-02	9.17e-01
GOBP COMPLEMENT DEPENDENT CYTOTOXICITY	13	1.38e-01	3.49e-01	0.31500	-3.14e-01	-1.52e-02	4.98e-02	9.24e-01
GOBP PEPTIDYL ARGININE METHYLATION TO ASYMMETRICAL DIMETHYL ARGININE	8	3.40e-01	5.78e-01	0.31500	2.97e-01	1.04e-01	1.46e-01	6.09e-01
GOBP CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE	63	8.56e-06	1.89e-04	0.31500	1.69e-01	-2.65e-01	2.05e-02	2.69e-04
GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION	23	1.31e-02	7.33e-02	0.31400	2.09e-01	-2.35e-01	8.21e-02	5.14e-02
GOCC SAGA COMPLEX	23	5.49e-02	1.99e-01	0.31400	2.71e-01	1.60e-01	2.46e-02	1.84e-01
GOMF DOPAMINE RECEPTOR BINDING	14	1.69e-01	3.91e-01	0.31400	2.74e-01	1.54e-01	7.55e-02	3.20e-01
GOBP MONOUBIQUITINATED PROTEIN DEUBIQUITINATION	8	3.75e-01	6.11e-01	0.31400	2.02e-01	2.41e-01	3.24e-01	2.37e-01
GOBP COMPLEMENT RECEPTOR MEDIATED SIGNALING PATHWAY	14	1.38e-01	3.49e-01	0.31400	-3.07e-01	-6.57e-02	4.64e-02	6.70e-01
GOBP CELLULAR RESPONSE TO EXOGENOUS DSRNA	16	1.29e-01	3.37e-01	0.31400	2.78e-01	1.46e-01	5.38e-02	3.13e-01
mRNA Capping	28	1.75e-02	9.03e-02	0.31400	3.10e-01	5.04e-02	4.50e-03	6.44e-01
GOBP POSITIVE REGULATION OF SARCOMERE ORGANIZATION	6	4.78e-01	6.96e-01	0.31400	-1.92e-01	-2.48e-01	4.15e-01	2.92e-01
GOMF ACTIVIN RECEPTOR ACTIVITY	9	3.09e-01	5.49e-01	0.31400	1.26e-01	2.88e-01	5.11e-01	1.35e-01
GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR	135	5.01e-08	1.93e-06	0.31400	2.66e-01	1.66e-01	8.94e-08	8.57e-04
APC/C:Cdc20 mediated degradation of Securin	55	9.70e-04	1.02e-02	0.31400	2.73e-01	1.55e-01	4.64e-04	4.62e-02
GOMF CARD DOMAIN BINDING	16	1.42e-01	3.55e-01	0.31400	-2.39e-01	-2.04e-01	9.83e-02	1.58e-01
GOBP POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY	7	4.10e-01	6.42e-01	0.31400	-2.77e-01	-1.48e-01	2.05e-01	4.98e-01
GOCC DESMOSOME	26	4.25e-02	1.69e-01	0.31400	-2.20e-01	-2.24e-01	5.20e-02	4.85e-02
GOBP NUCLEOLUS ORGANIZATION	16	8.82e-02	2.69e-01	0.31400	3.13e-01	1.33e-02	3.00e-02	9.26e-01
GOBP POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION	13	8.96e-02	2.72e-01	0.31300	-2.56e-01	1.81e-01	1.10e-01	2.58e-01
GOBP VITAMIN CATABOLIC PROCESS	15	7.18e-02	2.37e-01	0.31300	-1.07e-01	2.95e-01	4.73e-01	4.82e-02
GOBP CELLULAR RESPONSE TO ESTRADIOL STIMULUS	37	9.45e-03	5.74e-02	0.31300	2.74e-01	1.53e-01	3.98e-03	1.08e-01
Ribavirin ADME	11	2.42e-01	4.80e-01	0.31300	2.84e-01	1.32e-01	1.03e-01	4.48e-01
Negative regulation of activity of TFAP2 (AP-2) family transcription factors	10	2.74e-01	5.14e-01	0.31300	2.86e-01	1.28e-01	1.18e-01	4.82e-01
GOCC CYTOPLASMIC SIDE OF ENDOPLASMIC RETICULUM MEMBRANE	20	7.46e-02	2.41e-01	0.31300	2.87e-01	1.26e-01	2.65e-02	3.28e-01
Extension of Telomeres	49	2.24e-03	1.92e-02	0.31300	2.67e-01	1.64e-01	1.23e-03	4.68e-02
GOBP EPIGENETIC PROGRAMMING IN THE ZYGOTIC PRONUCLEI	14	7.31e-02	2.39e-01	0.31300	2.09e-01	-2.33e-01	1.76e-01	1.31e-01
GOBP UV PROTECTION	12	2.33e-01	4.69e-01	0.31300	2.31e-01	2.11e-01	1.66e-01	2.05e-01
GOBP RECOMBINATIONAL REPAIR	181	1.71e-10	1.02e-08	0.31300	2.69e-01	1.60e-01	4.02e-10	2.12e-04
GOMF RNA POLYMERASE I ACTIVITY	10	2.81e-01	5.20e-01	0.31300	2.77e-01	1.46e-01	1.29e-01	4.24e-01
GOCC AP 1 ADAPTOR COMPLEX	11	2.63e-01	5.03e-01	0.31300	2.34e-01	2.08e-01	1.79e-01	2.32e-01
GOBP POSITIVE REGULATION OF WOUND HEALING SPREADING OF EPIDERMAL CELLS	5	5.04e-01	7.13e-01	0.31300	-8.34e-02	-3.02e-01	7.47e-01	2.43e-01
GOBP REGULATION OF STORE OPERATED CALCIUM CHANNEL ACTIVITY	6	4.80e-01	6.97e-01	0.31300	2.51e-01	1.87e-01	2.87e-01	4.27e-01
GOCC SUMO LIGASE COMPLEX	13	1.52e-01	3.67e-01	0.31300	3.10e-01	4.23e-02	5.29e-02	7.92e-01
tRNA processing	105	1.42e-06	3.99e-05	0.31300	2.84e-01	1.32e-01	4.97e-07	1.98e-02
GOBP POSITIVE REGULATION OF KIDNEY DEVELOPMENT	9	1.93e-01	4.21e-01	0.31300	-1.62e-01	2.67e-01	3.99e-01	1.65e-01
GOCC RIBOSOME	221	2.01e-12	1.60e-10	0.31300	2.57e-01	1.78e-01	4.56e-11	4.81e-06
GOCC GID COMPLEX	5	4.96e-01	7.08e-01	0.31300	3.06e-01	6.65e-02	2.37e-01	7.97e-01
GOBP SUPPRESSION OF VIRAL RELEASE BY HOST	15	1.25e-01	3.30e-01	0.31300	3.04e-01	7.49e-02	4.17e-02	6.16e-01
GOBP DNA SYNTHESIS INVOLVED IN DNA REPAIR	41	5.59e-03	3.85e-02	0.31300	2.77e-01	1.45e-01	2.13e-03	1.09e-01
GOBP NEGATIVE REGULATION OF HYDROGEN PEROXIDE MEDIATED PROGRAMMED CELL DEATH	12	1.07e-01	3.02e-01	0.31300	2.32e-01	-2.10e-01	1.65e-01	2.07e-01
GOBP REGULATION OF ENDODERMAL CELL DIFFERENTIATION	7	2.95e-01	5.35e-01	0.31300	-1.04e-01	2.95e-01	6.32e-01	1.77e-01
GOBP CORTICOTROPIN SECRETION	7	3.77e-01	6.12e-01	0.31300	6.91e-02	3.05e-01	7.52e-01	1.63e-01
GOBP G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS	9	2.95e-01	5.35e-01	0.31300	2.99e-01	8.95e-02	1.20e-01	6.42e-01
GOBP POSITIVE REGULATION OF PLATELET ACTIVATION	12	1.17e-01	3.18e-01	0.31300	-2.83e-01	1.32e-01	8.93e-02	4.29e-01
GOCC BETA CATENIN TCF COMPLEX	13	2.01e-01	4.31e-01	0.31300	2.62e-01	1.70e-01	1.01e-01	2.90e-01
Signaling by FGFR2 IIIa TM	19	5.78e-02	2.05e-01	0.31200	3.12e-01	1.58e-02	1.85e-02	9.05e-01
GOBP REGULATION OF INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION	9	1.89e-01	4.17e-01	0.31200	-1.88e-01	2.49e-01	3.29e-01	1.95e-01
GOBP DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING	69	2.11e-04	2.89e-03	0.31200	2.60e-01	1.74e-01	1.93e-04	1.26e-02
Complex IV assembly	44	4.72e-03	3.39e-02	0.31200	2.51e-01	1.86e-01	3.95e-03	3.31e-02
GOBP ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE	9	3.35e-01	5.74e-01	0.31200	1.92e-01	2.46e-01	3.18e-01	2.01e-01
GOMF MYOSIN LIGHT CHAIN BINDING	8	3.24e-01	5.62e-01	0.31200	-5.90e-02	-3.07e-01	7.73e-01	1.33e-01
GOBP RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE	19	2.96e-02	1.30e-01	0.31200	2.40e-01	-2.00e-01	7.02e-02	1.32e-01
Transcriptional Regulation by E2F6	32	1.49e-02	8.04e-02	0.31200	2.92e-01	1.09e-01	4.19e-03	2.85e-01
GOBP SEQUESTERING OF METAL ION	10	1.56e-01	3.73e-01	0.31200	-2.17e-01	2.24e-01	2.34e-01	2.20e-01
GOCC ROUGH ENDOPLASMIC RETICULUM	56	9.56e-04	1.01e-02	0.31200	2.69e-01	1.58e-01	4.99e-04	4.04e-02
GOMF DNA REPLICATION ORIGIN BINDING	15	1.18e-01	3.20e-01	0.31200	3.08e-01	5.21e-02	3.91e-02	7.27e-01
Collagen biosynthesis and modifying enzymes	65	1.26e-04	1.87e-03	0.31200	-7.09e-02	-3.04e-01	3.23e-01	2.26e-05
GOBP SPINDLE ELONGATION	13	2.07e-01	4.39e-01	0.31200	2.45e-01	1.93e-01	1.26e-01	2.28e-01
GOBP NEUTROPHIL ACTIVATION INVOLVED IN IMMUNE RESPONSE	20	2.65e-02	1.21e-01	0.31200	-2.68e-01	1.59e-01	3.77e-02	2.18e-01
Degradation of the extracellular matrix	134	1.78e-08	7.42e-07	0.31200	-9.57e-02	-2.97e-01	5.58e-02	2.90e-09
Retrograde neurotrophin signalling	14	1.36e-01	3.46e-01	0.31200	3.08e-01	4.86e-02	4.59e-02	7.53e-01
APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1	61	5.75e-04	6.75e-03	0.31200	2.59e-01	1.73e-01	4.58e-04	1.94e-02
GOBP CEMENTUM MINERALIZATION	5	5.06e-01	7.15e-01	0.31200	3.01e-01	8.17e-02	2.44e-01	7.52e-01
GOBP RESPONSE TO THYROXINE	5	5.41e-01	7.40e-01	0.31200	1.70e-01	2.61e-01	5.09e-01	3.12e-01
GOMF SPHINGOSINE 1 PHOSPHATE RECEPTOR ACTIVITY	8	2.35e-01	4.72e-01	0.31200	-1.55e-01	2.70e-01	4.47e-01	1.85e-01
GOBP DETOXIFICATION OF COPPER ION	15	6.31e-02	2.17e-01	0.31200	-1.89e-01	2.48e-01	2.04e-01	9.69e-02
GOBP PROTEIN LOCALIZATION TO CILIARY MEMBRANE	11	2.14e-01	4.47e-01	0.31200	3.06e-01	6.10e-02	7.92e-02	7.26e-01
GOBP EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT	10	2.98e-01	5.38e-01	0.31200	2.46e-01	1.91e-01	1.77e-01	2.96e-01
GOBP NEGATIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION	7	4.29e-01	6.58e-01	0.31200	2.43e-01	1.95e-01	2.65e-01	3.72e-01
Synthesis of DNA	107	2.17e-06	5.82e-05	0.31200	2.59e-01	1.73e-01	3.59e-06	2.02e-03
SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription	36	1.34e-02	7.43e-02	0.31100	2.32e-01	2.07e-01	1.58e-02	3.13e-02
Apoptotic factor-mediated response	18	1.11e-01	3.08e-01	0.31100	2.59e-01	1.72e-01	5.68e-02	2.05e-01
O-glycosylation of TSR domain-containing proteins	38	7.41e-03	4.78e-02	0.31100	-1.19e-01	-2.88e-01	2.04e-01	2.15e-03
GOMF KINASE INHIBITOR ACTIVITY	79	5.31e-05	9.13e-04	0.31100	1.48e-01	2.74e-01	2.27e-02	2.59e-05
GOBP ROOF OF MOUTH DEVELOPMENT	90	2.16e-05	4.23e-04	0.31100	2.31e-01	2.09e-01	1.52e-04	6.26e-04
GOBP ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT	128	6.52e-08	2.46e-06	0.31100	2.89e-01	1.15e-01	1.55e-08	2.53e-02
GOBP REGULATION OF SECONDARY HEART FIELD CARDIOBLAST PROLIFERATION	10	3.02e-01	5.42e-01	0.31100	2.13e-01	2.27e-01	2.43e-01	2.14e-01
GOBP GOLGI TO PLASMA MEMBRANE TRANSPORT	64	2.96e-04	3.88e-03	0.31100	2.82e-01	1.31e-01	9.48e-05	6.91e-02
GOBP CELL FATE DETERMINATION	42	1.98e-03	1.74e-02	0.31100	1.77e-02	3.11e-01	8.43e-01	4.94e-04
MAPK1 (ERK2) activation	9	3.40e-01	5.78e-01	0.31100	2.04e-01	2.35e-01	2.89e-01	2.23e-01
GOBP INTERLEUKIN 5 MEDIATED SIGNALING PATHWAY	6	4.88e-01	7.02e-01	0.31100	-2.18e-01	-2.21e-01	3.54e-01	3.48e-01
GOBP RNA TEMPLATED DNA BIOSYNTHETIC PROCESS	70	9.93e-05	1.54e-03	0.31100	2.94e-01	1.01e-01	2.08e-05	1.44e-01
GOMF LEUCINE ZIPPER DOMAIN BINDING	11	2.69e-01	5.08e-01	0.31100	2.15e-01	2.25e-01	2.18e-01	1.96e-01
GOBP NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION	89	6.51e-06	1.51e-04	0.31100	2.99e-01	8.60e-02	1.10e-06	1.61e-01
GOCC MEDIATOR COMPLEX	34	1.72e-02	8.91e-02	0.31100	2.35e-01	2.03e-01	1.76e-02	4.04e-02
GOBP REGULATION OF AUTOPHAGOSOME ASSEMBLY	45	1.79e-03	1.62e-02	0.31100	3.06e-01	5.34e-02	3.80e-04	5.36e-01
TGFBR3 regulates TGF-beta signaling	8	3.64e-01	6.01e-01	0.31100	1.35e-01	2.80e-01	5.08e-01	1.71e-01
GOBP REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA	43	3.84e-03	2.90e-02	0.31100	1.14e-01	2.89e-01	1.97e-01	1.04e-03
GOCC SUPER ELONGATION COMPLEX	5	5.46e-01	7.44e-01	0.31100	2.52e-01	1.81e-01	3.29e-01	4.82e-01
GOBP LUNG SECRETORY CELL DIFFERENTIATION	11	1.37e-01	3.48e-01	0.31100	2.63e-01	-1.65e-01	1.30e-01	3.44e-01
GOBP PARENTAL BEHAVIOR	13	1.31e-01	3.40e-01	0.31100	-2.23e-02	3.10e-01	8.89e-01	5.31e-02
GOBP POSITIVE REGULATION OF CHOLESTEROL STORAGE	8	3.83e-01	6.17e-01	0.31000	-1.93e-01	-2.43e-01	3.44e-01	2.34e-01
The activation of arylsulfatases	8	3.86e-01	6.20e-01	0.31000	2.21e-01	2.18e-01	2.80e-01	2.85e-01
GOBP CHONDROCYTE PROLIFERATION	25	4.23e-02	1.69e-01	0.31000	2.81e-01	1.31e-01	1.48e-02	2.57e-01
GOBP NEGATIVE REGULATION OF CELL FATE COMMITMENT	10	2.41e-01	4.78e-01	0.31000	4.30e-02	3.07e-01	8.14e-01	9.23e-02
RUNX3 regulates CDKN1A transcription	7	3.42e-01	5.80e-01	0.31000	3.10e-01	-9.25e-03	1.55e-01	9.66e-01
GOBP POSITIVE REGULATION OF TORC1 SIGNALING	50	1.31e-03	1.28e-02	0.31000	2.96e-01	9.20e-02	2.87e-04	2.60e-01
GOBP PENILE ERECTION	7	2.78e-01	5.18e-01	0.31000	-1.92e-01	2.44e-01	3.79e-01	2.64e-01
GOMF HISTONE H3K9ME2 METHYLTRANSFERASE ACTIVITY	7	3.04e-01	5.44e-01	0.31000	2.95e-01	-9.56e-02	1.76e-01	6.62e-01
GOMF MHC CLASS II RECEPTOR ACTIVITY	9	2.84e-01	5.23e-01	0.31000	-3.05e-01	-5.57e-02	1.13e-01	7.72e-01
Processing of DNA double-strand break ends	75	1.27e-04	1.89e-03	0.31000	2.47e-01	1.88e-01	2.22e-04	4.83e-03
GOBP HRI MEDIATED SIGNALING	6	4.10e-01	6.42e-01	0.31000	3.10e-01	1.28e-02	1.89e-01	9.57e-01
GOBP HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS	52	1.12e-04	1.70e-03	0.31000	1.27e-01	-2.83e-01	1.13e-01	4.21e-04
GOBP MUSCLE CELL FATE COMMITMENT	17	1.24e-01	3.28e-01	0.31000	2.68e-01	1.56e-01	5.60e-02	2.65e-01
GOBP NEGATIVE REGULATION OF DEPHOSPHORYLATION	31	7.46e-03	4.80e-02	0.31000	3.08e-01	-3.48e-02	3.00e-03	7.38e-01
GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME	11	2.25e-01	4.59e-01	0.31000	3.01e-01	7.52e-02	8.43e-02	6.66e-01
Interaction With Cumulus Cells And The Zona Pellucida	11	2.66e-01	5.05e-01	0.31000	-2.52e-01	-1.80e-01	1.47e-01	3.02e-01
GOMF EUKARYOTIC TRANSLATION INITIATION FACTOR 2ALPHA KINASE ACTIVITY	6	4.91e-01	7.04e-01	0.31000	2.16e-01	2.22e-01	3.59e-01	3.47e-01
GOMF GABA RECEPTOR BINDING	18	1.10e-01	3.08e-01	0.31000	1.58e-01	2.66e-01	2.45e-01	5.05e-02
GOMF NADPLUS PROTEIN CYSTEINE ADP RIBOSYLTRANSFERASE ACTIVITY	6	3.40e-01	5.78e-01	0.31000	1.63e-01	-2.63e-01	4.89e-01	2.64e-01
GOBP OOCYTE ANTERIOR POSTERIOR AXIS SPECIFICATION	6	3.65e-01	6.02e-01	0.31000	-8.55e-02	2.98e-01	7.17e-01	2.07e-01
GOBP MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION	17	1.30e-01	3.37e-01	0.31000	2.52e-01	1.80e-01	7.19e-02	1.99e-01
Epigenetic regulation by WDR5-containing histone modifying complexes	123	3.01e-07	9.95e-06	0.31000	2.68e-01	1.56e-01	2.90e-07	2.89e-03
GOBP GALACTOSE CATABOLIC PROCESS VIA UDP GALACTOSE	5	4.02e-01	6.34e-01	0.31000	2.37e-01	-1.99e-01	3.59e-01	4.41e-01
MAPK6/MAPK4 signaling	78	6.13e-05	1.03e-03	0.31000	2.76e-01	1.39e-01	2.42e-05	3.33e-02
SOS-mediated signalling	7	4.09e-01	6.41e-01	0.31000	2.86e-01	1.19e-01	1.90e-01	5.85e-01
GOCC SITE OF DOUBLE STRAND BREAK	94	1.43e-05	2.94e-04	0.31000	2.41e-01	1.94e-01	5.32e-05	1.14e-03
GOBP NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS	12	1.70e-01	3.92e-01	0.31000	1.38e-02	3.09e-01	9.34e-01	6.36e-02
GOBP INTESTINAL ABSORPTION	41	2.60e-03	2.16e-02	0.31000	-2.49e-02	-3.09e-01	7.83e-01	6.29e-04
GOCC BRCA1 C COMPLEX	6	4.64e-01	6.87e-01	0.30900	2.87e-01	1.17e-01	2.24e-01	6.20e-01
GOBP DORSAL ROOT GANGLION DEVELOPMENT	7	3.34e-01	5.73e-01	0.30900	3.08e-01	-3.05e-02	1.58e-01	8.89e-01
GOBP IRON ION IMPORT ACROSS PLASMA MEMBRANE	5	4.01e-01	6.34e-01	0.30900	-2.20e-01	2.17e-01	3.94e-01	4.00e-01
GOBP POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION	35	1.60e-02	8.48e-02	0.30900	2.21e-01	2.17e-01	2.39e-02	2.63e-02
GOBP GOLGI TO ENDOSOME TRANSPORT	17	4.77e-02	1.82e-01	0.30900	2.64e-01	-1.61e-01	5.95e-02	2.49e-01
GOCC PROTEASOME ACCESSORY COMPLEX	23	4.02e-02	1.63e-01	0.30900	3.05e-01	5.14e-02	1.13e-02	6.70e-01
GOBP REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION	17	1.13e-01	3.12e-01	0.30900	2.88e-01	1.14e-01	4.01e-02	4.16e-01
GOBP POSITIVE REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY	5	4.42e-01	6.69e-01	0.30900	3.03e-01	-6.28e-02	2.41e-01	8.08e-01
GOMF MONOATOMIC ANION SODIUM SYMPORTER ACTIVITY	17	1.34e-01	3.43e-01	0.30900	-2.30e-01	-2.06e-01	1.00e-01	1.41e-01
GOBP REGULATION OF HELICASE ACTIVITY	9	3.41e-01	5.79e-01	0.30900	2.49e-01	1.83e-01	1.95e-01	3.42e-01
Regulation of TP53 Degradation	36	8.03e-03	5.09e-02	0.30900	2.99e-01	7.95e-02	1.92e-03	4.09e-01
GOBP PEPTIDYL PROLINE MODIFICATION	29	3.13e-02	1.36e-01	0.30900	2.50e-01	1.82e-01	1.98e-02	9.04e-02
GOBP SOMATOSTATIN RECEPTOR SIGNALING PATHWAY	6	3.55e-01	5.92e-01	0.30900	-1.17e-01	2.86e-01	6.19e-01	2.25e-01
Cell Cycle Checkpoints	252	2.33e-14	2.22e-12	0.30900	2.81e-01	1.28e-01	1.42e-14	4.79e-04
GOMF SODIUM CHANNEL INHIBITOR ACTIVITY	8	2.96e-01	5.35e-01	0.30900	-1.08e-02	3.09e-01	9.58e-01	1.30e-01
GOBP NEURON FATE COMMITMENT	74	1.02e-04	1.57e-03	0.30900	1.36e-01	2.77e-01	4.32e-02	3.68e-05
GOBP IMMUNOLOGICAL MEMORY FORMATION PROCESS	14	1.72e-01	3.95e-01	0.30900	2.81e-01	1.28e-01	6.88e-02	4.06e-01
GOBP PROTEASOMAL PROTEIN CATABOLIC PROCESS	507	3.83e-26	8.39e-24	0.30900	2.28e-01	2.09e-01	1.60e-18	8.79e-16
GOBP INTERLEUKIN 3 MEDIATED SIGNALING PATHWAY	6	3.41e-01	5.79e-01	0.30900	-2.56e-01	1.72e-01	2.77e-01	4.67e-01
GOBP COPII COATED VESICLE CARGO LOADING	18	1.05e-01	2.99e-01	0.30900	2.80e-01	1.30e-01	3.97e-02	3.41e-01
Postmitotic nuclear pore complex (NPC) reformation	27	2.83e-02	1.27e-01	0.30800	2.96e-01	8.71e-02	7.79e-03	4.33e-01
GOBP NEGATIVE REGULATION OF MYOSIN LIGHT CHAIN PHOSPHATASE ACTIVITY	5	4.81e-01	6.97e-01	0.30800	-1.39e-02	-3.08e-01	9.57e-01	2.33e-01
GOBP B CELL CHEMOTAXIS	7	3.89e-01	6.23e-01	0.30800	7.24e-02	3.00e-01	7.40e-01	1.70e-01
GOBP MAMMALIAN OOGENESIS STAGE	12	1.30e-01	3.38e-01	0.30800	2.89e-01	-1.07e-01	8.27e-02	5.23e-01
GOCC TRANSLATION PREINITIATION COMPLEX	16	1.48e-01	3.61e-01	0.30800	2.55e-01	1.74e-01	7.80e-02	2.28e-01
HIV Transcription Initiation	43	2.71e-03	2.22e-02	0.30800	3.03e-01	5.72e-02	5.87e-04	5.16e-01
RNA Polymerase II HIV Promoter Escape	43	2.71e-03	2.22e-02	0.30800	3.03e-01	5.72e-02	5.87e-04	5.16e-01
RNA Polymerase II Promoter Escape	43	2.71e-03	2.22e-02	0.30800	3.03e-01	5.72e-02	5.87e-04	5.16e-01
RNA Polymerase II Transcription Initiation	43	2.71e-03	2.22e-02	0.30800	3.03e-01	5.72e-02	5.87e-04	5.16e-01
RNA Polymerase II Transcription Initiation And Promoter Clearance	43	2.71e-03	2.22e-02	0.30800	3.03e-01	5.72e-02	5.87e-04	5.16e-01
RNA Polymerase II Transcription Pre-Initiation And Promoter Opening	43	2.71e-03	2.22e-02	0.30800	3.03e-01	5.72e-02	5.87e-04	5.16e-01
GOBP REGULATION OF CHROMOSOME SEGREGATION	129	5.49e-08	2.09e-06	0.30800	2.93e-01	9.70e-02	9.41e-09	5.70e-02
GOCC NMDA SELECTIVE GLUTAMATE RECEPTOR COMPLEX	9	2.70e-01	5.09e-01	0.30800	-3.08e-01	-1.82e-02	1.10e-01	9.25e-01
GOBP NEGATIVE REGULATION OF CATECHOLAMINE SECRETION	13	1.01e-01	2.93e-01	0.30800	-2.71e-01	1.47e-01	9.06e-02	3.60e-01
GOBP MRNA TRANSCRIPTION	47	3.94e-03	2.95e-02	0.30800	2.39e-01	1.94e-01	4.54e-03	2.12e-02
Chylomicron remodeling	10	2.84e-01	5.22e-01	0.30800	-1.22e-01	-2.83e-01	5.04e-01	1.21e-01
GOMF INSULIN LIKE GROWTH FACTOR BINDING	19	5.52e-02	2.00e-01	0.30800	3.08e-01	-1.64e-02	2.02e-02	9.02e-01
GOBP RESPONSE TO LIGHT INTENSITY	15	8.88e-02	2.70e-01	0.30800	6.08e-02	-3.02e-01	6.83e-01	4.29e-02
GOBP PREPULSE INHIBITION	13	2.12e-01	4.44e-01	0.30800	-1.74e-01	-2.54e-01	2.76e-01	1.13e-01
GOBP NEGATIVE REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY	19	1.08e-01	3.04e-01	0.30800	-2.07e-01	-2.28e-01	1.18e-01	8.53e-02
GOBP BASE EXCISION REPAIR	42	7.37e-03	4.76e-02	0.30800	2.20e-01	2.16e-01	1.37e-02	1.56e-02
GOBP CELLULAR RESPONSE TO DSRNA	22	7.63e-02	2.45e-01	0.30800	2.20e-01	2.15e-01	7.39e-02	8.06e-02
GOBP NEGATIVE REGULATION OF CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION	5	4.06e-01	6.38e-01	0.30800	-2.32e-01	2.02e-01	3.69e-01	4.34e-01
Regulation of MITF-M-dependent genes involved in pigmentation	41	4.26e-03	3.14e-02	0.30800	2.98e-01	7.67e-02	9.63e-04	3.95e-01
GOBP MEIOTIC CHROMOSOME SEPARATION	10	2.29e-01	4.64e-01	0.30800	3.07e-01	6.74e-03	9.23e-02	9.71e-01
GOBP REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION	10	2.77e-01	5.17e-01	0.30700	-2.89e-01	-1.04e-01	1.13e-01	5.68e-01
GOBP REGULATION OF DNA REPAIR	215	9.88e-12	7.31e-10	0.30700	2.53e-01	1.74e-01	1.50e-10	1.06e-05
GOBP REGULATION OF ADIPOSE TISSUE DEVELOPMENT	16	1.28e-01	3.36e-01	0.30700	1.04e-01	2.89e-01	4.73e-01	4.50e-02
HCMV Early Events	99	9.41e-06	2.05e-04	0.30700	2.39e-01	1.94e-01	4.07e-05	8.64e-04
GOBP REGULATION OF BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS	9	2.19e-01	4.52e-01	0.30700	2.89e-01	-1.05e-01	1.33e-01	5.86e-01
GOCC PHAGOPHORE ASSEMBLY SITE	37	1.11e-02	6.49e-02	0.30700	2.70e-01	1.47e-01	4.47e-03	1.23e-01
G1/S DNA Damage Checkpoints	54	6.85e-04	7.81e-03	0.30700	3.00e-01	6.51e-02	1.35e-04	4.08e-01
Cytochrome c-mediated apoptotic response	12	2.35e-01	4.72e-01	0.30700	2.65e-01	1.55e-01	1.12e-01	3.52e-01
GOBP CORTISOL SECRETION	5	4.65e-01	6.88e-01	0.30700	-2.34e-02	3.06e-01	9.28e-01	2.36e-01
GOBP NEGATIVE REGULATION OF CELLULAR RESPIRATION	9	2.93e-01	5.32e-01	0.30700	-3.02e-01	-5.74e-02	1.17e-01	7.66e-01
Signaling by PDGFR in disease	20	9.32e-02	2.78e-01	0.30700	2.54e-01	1.72e-01	4.91e-02	1.82e-01
GOBP DE NOVO CENTRIOLE ASSEMBLY INVOLVED IN MULTI CILIATED EPITHELIAL CELL DIFFERENTIATION	5	5.14e-01	7.21e-01	0.30700	7.64e-02	2.97e-01	7.67e-01	2.49e-01
GOBP LIPID DROPLET FORMATION	13	1.67e-01	3.89e-01	0.30700	5.21e-02	3.03e-01	7.45e-01	5.88e-02
Deubiquitination	231	9.10e-13	7.55e-11	0.30700	2.68e-01	1.50e-01	2.27e-12	8.33e-05
GOCC SPINDLE POLE CENTROSOME	13	2.20e-01	4.54e-01	0.30700	2.12e-01	2.23e-01	1.87e-01	1.65e-01
GOCC TRANSCRIPTION PREINITIATION COMPLEX	13	1.99e-01	4.29e-01	0.30700	2.79e-01	1.28e-01	8.16e-02	4.23e-01
GOMF GLUTATHIONE TRANSFERASE ACTIVITY	24	4.29e-02	1.70e-01	0.30700	2.95e-01	8.46e-02	1.23e-02	4.73e-01
G2/M Checkpoints	132	1.30e-07	4.56e-06	0.30700	2.66e-01	1.53e-01	1.26e-07	2.44e-03
GOBP S ADENOSYLMETHIONINE METABOLIC PROCESS	16	1.31e-01	3.40e-01	0.30700	2.87e-01	1.09e-01	4.70e-02	4.50e-01
GOMF N ACETYLLACTOSAMINE SYNTHASE ACTIVITY	5	5.50e-01	7.46e-01	0.30700	1.64e-01	2.60e-01	5.26e-01	3.15e-01
GOBP REGULATION OF DOPAMINE SECRETION	25	1.30e-02	7.28e-02	0.30700	-2.73e-01	1.40e-01	1.81e-02	2.26e-01
GOBP CLUSTERING OF VOLTAGE GATED SODIUM CHANNELS	6	4.42e-01	6.69e-01	0.30700	-5.95e-02	-3.01e-01	8.01e-01	2.02e-01
GOMF HISTONE H4K20 MONOMETHYLTRANSFERASE ACTIVITY	6	4.96e-01	7.08e-01	0.30700	2.35e-01	1.97e-01	3.18e-01	4.04e-01
Intrinsic Pathway of Fibrin Clot Formation	21	5.10e-02	1.91e-01	0.30700	-2.99e-02	-3.05e-01	8.12e-01	1.54e-02
DNA Repair	298	3.38e-16	3.70e-14	0.30700	2.68e-01	1.50e-01	1.73e-15	8.84e-06
GOBP AUTOCRINE SIGNALING	7	3.56e-01	5.93e-01	0.30700	-3.07e-01	-2.12e-03	1.60e-01	9.92e-01
GOBP NEGATIVE REGULATION OF PHOSPHATASE ACTIVITY	20	6.03e-02	2.11e-01	0.30700	3.05e-01	3.62e-02	1.83e-02	7.79e-01
Defective B3GALTL causes PpS	37	1.00e-02	6.00e-02	0.30700	-1.23e-01	-2.81e-01	1.94e-01	3.12e-03
GOBP HINDLIMB MORPHOGENESIS	35	1.67e-02	8.75e-02	0.30700	2.40e-01	1.91e-01	1.39e-02	5.09e-02
GOCC SAGA TYPE COMPLEX	35	1.61e-02	8.51e-02	0.30700	2.52e-01	1.75e-01	9.91e-03	7.35e-02
GOCC 9PLUS0 MOTILE CILIUM	5	4.63e-01	6.86e-01	0.30700	-3.05e-01	3.14e-02	2.38e-01	9.03e-01
GOBP TRANSCRIPTION BY RNA POLYMERASE III	59	6.12e-04	7.12e-03	0.30600	2.84e-01	1.15e-01	1.59e-04	1.27e-01
GOBP MEMBRANE RAFT LOCALIZATION	7	4.13e-01	6.45e-01	0.30600	1.11e-01	2.86e-01	6.10e-01	1.91e-01
GOBP REGULATION OF METANEPHROS DEVELOPMENT	5	5.28e-01	7.31e-01	0.30600	-2.89e-01	-1.02e-01	2.63e-01	6.94e-01
GOBP REGULATION OF AMYLOID FIBRIL FORMATION	16	1.35e-01	3.45e-01	0.30600	2.83e-01	1.18e-01	5.03e-02	4.13e-01
GOBP RESPONSE TO TESTOSTERONE	41	8.64e-03	5.39e-02	0.30600	2.04e-01	2.28e-01	2.36e-02	1.15e-02
GOBP NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS	22	2.19e-02	1.06e-01	0.30600	-2.70e-01	1.45e-01	2.85e-02	2.38e-01
GOCC PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX	29	3.28e-02	1.41e-01	0.30600	1.73e-01	2.53e-01	1.08e-01	1.84e-02
Acyl chain remodelling of PS	22	3.39e-02	1.44e-01	0.30600	3.18e-02	-3.05e-01	7.96e-01	1.34e-02
GOBP NEUROFILAMENT CYTOSKELETON ORGANIZATION	10	2.97e-01	5.36e-01	0.30600	2.72e-01	1.41e-01	1.37e-01	4.39e-01
Synthesis of GDP-mannose	6	3.89e-01	6.22e-01	0.30600	3.02e-01	-5.01e-02	2.00e-01	8.32e-01
GOBP REGULATION OF SPINDLE CHECKPOINT	22	5.30e-02	1.95e-01	0.30600	2.98e-01	6.76e-02	1.54e-02	5.83e-01
GOBP POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION	40	8.21e-04	9.06e-03	0.30600	-2.40e-01	1.90e-01	8.55e-03	3.80e-02
GOBP PERK MEDIATED UNFOLDED PROTEIN RESPONSE	20	9.67e-02	2.84e-01	0.30600	2.45e-01	1.83e-01	5.77e-02	1.57e-01
GOBP NEGATIVE REGULATION OF MACROPHAGE MIGRATION	14	8.91e-02	2.70e-01	0.30600	-1.41e-01	2.71e-01	3.61e-01	7.87e-02
GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE	29	3.23e-02	1.39e-01	0.30600	1.64e-01	2.58e-01	1.25e-01	1.62e-02
GOMF OSMOSENSOR ACTIVITY	5	4.49e-01	6.75e-01	0.30600	6.54e-02	-2.99e-01	8.00e-01	2.47e-01
Transport and synthesis of PAPS	6	3.43e-01	5.81e-01	0.30600	-2.26e-01	2.05e-01	3.37e-01	3.83e-01
GDP-fucose biosynthesis	6	4.10e-01	6.42e-01	0.30600	-3.06e-01	8.05e-03	1.95e-01	9.73e-01
GOMF HEPARAN SULFATE PROTEOGLYCAN BINDING	18	1.24e-01	3.28e-01	0.30600	-2.36e-01	-1.95e-01	8.33e-02	1.53e-01
GOBP SYNAPTIC VESICLE ENDOSOMAL PROCESSING	8	2.86e-01	5.25e-01	0.30600	3.02e-01	-4.67e-02	1.39e-01	8.19e-01
GOMF SIGNAL SEQUENCE BINDING	47	4.44e-03	3.24e-02	0.30600	2.05e-01	2.26e-01	1.48e-02	7.31e-03
GOBP SPLICEOSOMAL COMPLEX ASSEMBLY	76	6.07e-05	1.02e-03	0.30500	2.90e-01	9.49e-02	1.20e-05	1.53e-01
GOBP SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE TRANSLOCATION	8	3.81e-01	6.15e-01	0.30500	2.70e-01	1.42e-01	1.86e-01	4.86e-01
GOMF 3 HYDROXYACYL COA DEHYDROGENASE ACTIVITY	5	5.28e-01	7.31e-01	0.30500	2.90e-01	9.58e-02	2.62e-01	7.11e-01
GOCC VOLTAGE GATED CALCIUM CHANNEL COMPLEX	44	6.35e-03	4.27e-02	0.30500	-2.20e-01	-2.11e-01	1.14e-02	1.53e-02
p53-Dependent G1 DNA Damage Response	52	1.07e-03	1.11e-02	0.30500	2.96e-01	7.38e-02	2.19e-04	3.57e-01
p53-Dependent G1/S DNA damage checkpoint	52	1.07e-03	1.11e-02	0.30500	2.96e-01	7.38e-02	2.19e-04	3.57e-01
GOBP POSITIVE REGULATION OF CHROMOSOME SEPARATION	29	3.03e-02	1.32e-01	0.30500	2.71e-01	1.41e-01	1.16e-02	1.89e-01
GOCC INTEGRATOR COMPLEX	17	7.42e-02	2.41e-01	0.30500	3.03e-01	-3.30e-02	3.03e-02	8.14e-01
GOMF MISMATCH REPAIR COMPLEX BINDING	11	2.70e-01	5.09e-01	0.30500	2.63e-01	1.54e-01	1.31e-01	3.75e-01
GOBP PEROXISOMAL TRANSPORT	20	8.99e-02	2.72e-01	0.30500	2.70e-01	1.42e-01	3.65e-02	2.72e-01
GOBP BRADYKININ CATABOLIC PROCESS	7	4.01e-01	6.34e-01	0.30500	7.93e-02	2.95e-01	7.16e-01	1.77e-01
GOBP RESPONSE TO CORTICOSTERONE	15	7.93e-02	2.51e-01	0.30500	-1.21e-01	2.80e-01	4.17e-01	6.04e-02
GOBP INTESTINAL EPITHELIAL CELL DIFFERENTIATION	27	1.93e-02	9.73e-02	0.30500	-1.37e-04	3.05e-01	9.99e-01	6.07e-03
GOBP RESPONSE TO MUSCLE STRETCH	24	2.16e-02	1.05e-01	0.30500	2.97e-01	-6.88e-02	1.17e-02	5.60e-01
GOCC AMPHISOME	13	1.65e-01	3.87e-01	0.30500	3.83e-02	3.03e-01	8.11e-01	5.89e-02
GOBP LENS MORPHOGENESIS IN CAMERA TYPE EYE	21	8.36e-02	2.60e-01	0.30500	1.60e-01	2.60e-01	2.04e-01	3.95e-02
GOBP NEGATIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY	12	2.10e-01	4.42e-01	0.30500	2.94e-01	8.20e-02	7.81e-02	6.23e-01
GOBP REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS	212	2.73e-11	1.89e-09	0.30500	2.39e-01	1.89e-01	1.83e-09	2.15e-06
GOBP PRE MIRNA PROCESSING	17	1.12e-01	3.10e-01	0.30500	2.92e-01	8.61e-02	3.69e-02	5.39e-01
GOMF CLATHRIN HEAVY CHAIN BINDING	11	1.70e-01	3.92e-01	0.30500	2.95e-01	-7.57e-02	9.01e-02	6.64e-01
GOBP MAST CELL CHEMOTAXIS	11	1.45e-01	3.58e-01	0.30500	-2.46e-01	1.80e-01	1.58e-01	3.01e-01
GOMF UBIQUITIN BINDING	100	9.44e-06	2.06e-04	0.30500	1.79e-01	2.47e-01	2.00e-03	2.03e-05
RUNX3 regulates YAP1-mediated transcription	7	2.95e-01	5.34e-01	0.30500	2.53e-01	-1.70e-01	2.46e-01	4.37e-01
Beta oxidation of butanoyl-CoA to acetyl-CoA	5	5.24e-01	7.28e-01	0.30500	-8.39e-02	-2.93e-01	7.45e-01	2.57e-01
GOCC DENSE CORE GRANULE MEMBRANE	7	4.45e-01	6.72e-01	0.30400	-1.82e-01	-2.44e-01	4.05e-01	2.63e-01
Regulation of TP53 Expression and Degradation	37	9.19e-03	5.63e-02	0.30400	2.89e-01	9.61e-02	2.36e-03	3.12e-01
GOBP MRNA MODIFICATION	19	4.59e-02	1.77e-01	0.30400	2.92e-01	-8.46e-02	2.74e-02	5.23e-01
GOBP INDOLE CONTAINING COMPOUND CATABOLIC PROCESS	9	3.55e-01	5.93e-01	0.30400	-2.36e-01	-1.92e-01	2.20e-01	3.18e-01
GOBP PRIMITIVE HEMOPOIESIS	8	3.10e-01	5.50e-01	0.30400	3.04e-01	-5.22e-03	1.36e-01	9.80e-01
GOBP UTERINE SMOOTH MUSCLE CONTRACTION	10	3.19e-01	5.57e-01	0.30400	2.06e-01	2.24e-01	2.60e-01	2.20e-01
Regulation of RAS by GAPs	54	1.23e-03	1.23e-02	0.30400	2.84e-01	1.10e-01	3.12e-04	1.63e-01
GOMF OXYGEN BINDING	32	2.45e-02	1.15e-01	0.30400	-1.75e-01	-2.49e-01	8.69e-02	1.49e-02
GOBP POSITIVE REGULATION OF PROTEIN GLYCOSYLATION	7	3.69e-01	6.05e-01	0.30400	-1.35e-02	-3.04e-01	9.51e-01	1.64e-01
GOBP SODIUM DEPENDENT PHOSPHATE TRANSPORT	12	1.68e-01	3.90e-01	0.30400	3.04e-01	-1.61e-02	6.86e-02	9.23e-01
GOBP POLYAMINE BIOSYNTHETIC PROCESS	12	1.74e-01	3.97e-01	0.30400	-1.85e-03	3.04e-01	9.91e-01	6.83e-02
GOBP MITOTIC DNA REPLICATION CHECKPOINT SIGNALING	11	2.72e-01	5.11e-01	0.30400	2.65e-01	1.49e-01	1.29e-01	3.91e-01
GOBP REGULATION OF PROTEIN K48 LINKED UBIQUITINATION	6	4.55e-01	6.80e-01	0.30400	2.96e-01	6.92e-02	2.09e-01	7.69e-01
GOBP NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	12	2.41e-01	4.79e-01	0.30400	2.65e-01	1.49e-01	1.12e-01	3.70e-01
GOBP REGULATION OF VITAMIN METABOLIC PROCESS	12	1.24e-01	3.28e-01	0.30400	-2.50e-01	1.73e-01	1.34e-01	3.01e-01
GOMF NEUROTROPHIN RECEPTOR BINDING	11	2.64e-01	5.03e-01	0.30400	2.75e-01	1.29e-01	1.14e-01	4.59e-01
GOCC CORTICAL GRANULE	6	4.34e-01	6.62e-01	0.30400	-2.92e-02	-3.02e-01	9.01e-01	2.00e-01
Acyl chain remodelling of PC	27	1.69e-02	8.80e-02	0.30400	3.12e-02	-3.02e-01	7.79e-01	6.58e-03
GOBP POSITIVE REGULATION OF GRANULOCYTE DIFFERENTIATION	9	2.09e-01	4.41e-01	0.30400	-2.50e-01	1.72e-01	1.94e-01	3.72e-01
GOBP PARAXIAL MESODERM DEVELOPMENT	18	1.29e-01	3.37e-01	0.30400	2.14e-01	2.15e-01	1.15e-01	1.15e-01
GOBP DOUBLE STRAND BREAK REPAIR	304	2.61e-16	2.91e-14	0.30400	2.70e-01	1.40e-01	6.00e-16	2.85e-05
GOBP MIRNA PROCESSING	44	4.60e-03	3.33e-02	0.30400	2.79e-01	1.18e-01	1.34e-03	1.74e-01
Estrogen-dependent gene expression	113	1.55e-06	4.29e-05	0.30300	2.67e-01	1.44e-01	9.06e-07	8.36e-03
Formation of apoptosome	10	3.00e-01	5.40e-01	0.30300	2.73e-01	1.33e-01	1.35e-01	4.68e-01
Regulation of the apoptosome activity	10	3.00e-01	5.40e-01	0.30300	2.73e-01	1.33e-01	1.35e-01	4.68e-01
IRF3-mediated induction of type I IFN	13	1.41e-01	3.54e-01	0.30300	3.02e-01	-2.99e-02	5.94e-02	8.52e-01
GOBP S SHAPED BODY MORPHOGENESIS	7	3.12e-01	5.52e-01	0.30300	-1.14e-01	2.81e-01	6.00e-01	1.98e-01
GOCC PML BODY	103	6.29e-06	1.46e-04	0.30300	2.57e-01	1.61e-01	6.61e-06	4.65e-03
GOBP RELEASE OF CYTOCHROME C FROM MITOCHONDRIA	55	8.52e-04	9.28e-03	0.30300	8.04e-02	2.92e-01	3.02e-01	1.75e-04
NR1H2 and NR1H3-mediated signaling	53	1.72e-04	2.44e-03	0.30300	2.86e-01	-1.00e-01	3.12e-04	2.07e-01
GOBP REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL	18	1.29e-01	3.37e-01	0.30300	2.24e-01	2.05e-01	1.00e-01	1.33e-01
GOBP NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE	30	3.29e-02	1.41e-01	0.30300	-2.33e-01	-1.94e-01	2.74e-02	6.55e-02
GOBP REGULATION OF PRO B CELL DIFFERENTIATION	8	2.87e-01	5.25e-01	0.30300	2.97e-01	-5.94e-02	1.45e-01	7.71e-01
HCMV Late Events	81	9.41e-05	1.47e-03	0.30300	2.44e-01	1.80e-01	1.47e-04	5.14e-03
GOBP REGULATION OF MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL	10	2.98e-01	5.38e-01	0.30300	-1.25e-01	-2.76e-01	4.93e-01	1.31e-01
GOBP PROTEIN RNA COMPLEX ORGANIZATION	201	6.04e-12	4.58e-10	0.30300	2.94e-01	7.45e-02	6.86e-13	6.87e-02
GOBP NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION	21	8.61e-02	2.65e-01	0.30300	-2.59e-01	-1.57e-01	3.98e-02	2.13e-01
GOBP NAD TRANSPORT	5	5.67e-01	7.58e-01	0.30300	2.22e-01	2.06e-01	3.90e-01	4.25e-01
RAF activation	32	1.35e-02	7.51e-02	0.30300	2.99e-01	4.66e-02	3.41e-03	6.48e-01
GOBP RETINAL BIPOLAR NEURON DIFFERENTIATION	7	2.97e-01	5.37e-01	0.30300	1.80e-01	-2.43e-01	4.10e-01	2.65e-01
Regulation of PTEN mRNA translation	25	1.81e-02	9.25e-02	0.30300	2.90e-01	-8.53e-02	1.20e-02	4.61e-01
GOBP CERAMIDE 1 PHOSPHATE TRANSPORT	7	3.95e-01	6.28e-01	0.30300	5.55e-02	2.97e-01	7.99e-01	1.73e-01
GOMF CERAMIDE 1 PHOSPHATE TRANSFER ACTIVITY	7	3.95e-01	6.28e-01	0.30300	5.55e-02	2.97e-01	7.99e-01	1.73e-01
GOBP NEGATIVE REGULATION OF MATRIX METALLOPEPTIDASE SECRETION	6	5.06e-01	7.15e-01	0.30200	-1.91e-01	-2.34e-01	4.17e-01	3.20e-01
GOBP REGULATION OF POTASSIUM ION IMPORT	5	5.23e-01	7.27e-01	0.30200	7.18e-02	2.94e-01	7.81e-01	2.55e-01
GOBP PEPTIDE ANTIGEN ASSEMBLY WITH MHC PROTEIN COMPLEX	19	4.57e-02	1.77e-01	0.30200	-9.85e-02	2.86e-01	4.57e-01	3.10e-02
GOMF ALDEHYDE DEHYDROGENASE NAD P PLUS ACTIVITY	17	7.86e-02	2.50e-01	0.30200	3.00e-02	-3.01e-01	8.30e-01	3.18e-02
GOBP ENDOCARDIUM MORPHOGENESIS	6	3.62e-01	5.99e-01	0.30200	-2.66e-01	1.44e-01	2.60e-01	5.40e-01
GOBP VESICLE TARGETING	65	6.58e-04	7.57e-03	0.30200	2.24e-01	2.03e-01	1.76e-03	4.75e-03
GOMF GPI ANCHOR BINDING	8	2.99e-01	5.39e-01	0.30200	-3.00e-01	3.68e-02	1.42e-01	8.57e-01
GOBP RESPIRATORY CHAIN COMPLEX III ASSEMBLY	12	1.36e-01	3.46e-01	0.30200	-1.23e-01	2.76e-01	4.62e-01	9.78e-02
GOBP MITOCHONDRIAL ELECTRON TRANSPORT CYTOCHROME C TO OXYGEN	18	7.47e-02	2.41e-01	0.30200	3.02e-01	-5.05e-03	2.66e-02	9.70e-01
GOBP INTERLEUKIN 5 PRODUCTION	19	9.95e-02	2.89e-01	0.30200	-2.79e-01	-1.15e-01	3.53e-02	3.84e-01
GOBP ERROR PRONE TRANSLESION SYNTHESIS	12	2.23e-01	4.58e-01	0.30200	2.87e-01	9.46e-02	8.56e-02	5.71e-01
GOMF CHROMATIN BINDING	581	2.89e-29	7.56e-27	0.30200	2.57e-01	1.58e-01	2.66e-26	8.05e-11
GOBP NOREPINEPHRINE TRANSPORT	23	1.86e-02	9.44e-02	0.30200	-2.27e-01	1.99e-01	5.95e-02	9.88e-02
GOBP REGULATION OF CYTOPLASMIC TRANSLATION	32	2.08e-02	1.02e-01	0.30200	2.78e-01	1.17e-01	6.47e-03	2.52e-01
GOBP NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY	10	3.25e-01	5.64e-01	0.30200	-2.17e-01	-2.10e-01	2.35e-01	2.51e-01
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE	101	1.11e-05	2.36e-04	0.30200	1.84e-01	2.39e-01	1.38e-03	3.34e-05
GOMF MEMBRANE POTENTIAL DRIVEN UNIPORTER ACTIVITY	5	4.81e-01	6.97e-01	0.30200	-1.62e-02	3.01e-01	9.50e-01	2.44e-01
SUMOylation of SUMOylation proteins	35	9.30e-03	5.69e-02	0.30200	2.98e-01	4.52e-02	2.27e-03	6.43e-01
GOBP RRNA METHYLATION	23	7.53e-02	2.43e-01	0.30200	2.26e-01	2.00e-01	6.07e-02	9.74e-02
GOBP POSITIVE REGULATION OF CGMP MEDIATED SIGNALING	5	4.98e-01	7.09e-01	0.30100	1.76e-02	3.01e-01	9.46e-01	2.44e-01
GOMF BITTER TASTE RECEPTOR ACTIVITY	24	5.87e-02	2.07e-01	0.30100	-1.35e-01	-2.69e-01	2.51e-01	2.24e-02
GOMF HEXOSE TRANSMEMBRANE TRANSPORTER ACTIVITY	25	3.76e-02	1.54e-01	0.30100	-2.96e-01	-5.73e-02	1.04e-02	6.20e-01
GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR	16	1.37e-01	3.48e-01	0.30100	9.67e-02	2.85e-01	5.03e-01	4.81e-02
GOBP AXONAL TRANSPORT OF MITOCHONDRION	16	9.38e-02	2.79e-01	0.30100	-2.59e-02	3.00e-01	8.57e-01	3.76e-02
GOCC ENDONUCLEASE COMPLEX	38	1.40e-02	7.69e-02	0.30100	2.31e-01	1.94e-01	1.38e-02	3.89e-02
GOBP DOUBLE STRAND BREAK REPAIR VIA CLASSICAL NONHOMOLOGOUS END JOINING	9	3.52e-01	5.90e-01	0.30100	2.60e-01	1.52e-01	1.76e-01	4.31e-01
GOBP DNA REPAIR DEPENDENT CHROMATIN REMODELING	20	1.01e-01	2.91e-01	0.30100	2.54e-01	1.61e-01	4.89e-02	2.12e-01
Activation of SMO	18	4.83e-02	1.84e-01	0.30100	2.63e-01	-1.47e-01	5.35e-02	2.81e-01
GOBP EOSINOPHIL MIGRATION	28	3.50e-02	1.47e-01	0.30100	-1.22e-01	-2.75e-01	2.62e-01	1.17e-02
GOMF TRANSCRIPTION COREGULATOR BINDING	110	3.71e-06	9.34e-05	0.30100	2.49e-01	1.69e-01	6.15e-06	2.26e-03
GOMF CYCLIC NUCLEOTIDE BINDING	36	1.69e-02	8.79e-02	0.30100	-1.75e-01	-2.45e-01	6.95e-02	1.09e-02
GOBP NEGATIVE REGULATION OF KIDNEY DEVELOPMENT	5	4.31e-01	6.59e-01	0.30100	-1.48e-01	2.62e-01	5.67e-01	3.10e-01
GOBP CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS	28	4.14e-02	1.66e-01	0.30100	2.48e-01	1.70e-01	2.31e-02	1.18e-01
Displacement of DNA glycosylase by APEX1	9	3.66e-01	6.03e-01	0.30100	2.08e-01	2.17e-01	2.80e-01	2.59e-01
GOMF TRANSCRIPTION COACTIVATOR ACTIVITY	257	6.40e-14	5.86e-12	0.30100	2.74e-01	1.23e-01	3.46e-14	6.85e-04
GOCC PROTEIN DNA COMPLEX	1362	2.59e-63	1.87e-60	0.30100	2.29e-01	1.95e-01	8.04e-46	1.35e-33
GOBP POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION	8	2.96e-01	5.35e-01	0.30100	2.96e-01	-5.13e-02	1.47e-01	8.02e-01
GOBP GALACTOLIPID METABOLIC PROCESS	9	3.48e-01	5.85e-01	0.30100	-2.67e-01	-1.37e-01	1.65e-01	4.76e-01
GOBP POSITIVE REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY	11	1.99e-01	4.29e-01	0.30100	2.43e-02	-3.00e-01	8.89e-01	8.54e-02
GOBP REGULATION OF GLYCOGEN CATABOLIC PROCESS	6	3.56e-01	5.93e-01	0.30000	-2.01e-01	2.23e-01	3.93e-01	3.44e-01
Switching of origins to a post-replicative state	79	8.76e-05	1.39e-03	0.30000	2.72e-01	1.27e-01	2.82e-05	5.18e-02
GOMF RACEMASE AND EPIMERASE ACTIVITY	17	1.48e-01	3.61e-01	0.30000	2.38e-01	1.84e-01	9.00e-02	1.89e-01
GOBP INTESTINAL STEM CELL HOMEOSTASIS	6	5.06e-01	7.15e-01	0.30000	-1.69e-01	-2.48e-01	4.73e-01	2.93e-01
GOBP POSITIVE REGULATION OF BONE RESORPTION	19	5.21e-02	1.93e-01	0.30000	-2.92e-01	7.11e-02	2.77e-02	5.92e-01
GOBP REGULATION OF PHOSPHOLIPASE A2 ACTIVITY	7	3.84e-01	6.18e-01	0.30000	2.99e-01	2.42e-02	1.70e-01	9.12e-01
GOCC CUL3 RING UBIQUITIN LIGASE COMPLEX	37	1.62e-02	8.55e-02	0.30000	2.26e-01	1.97e-01	1.73e-02	3.77e-02
GOBP SPERM EGG RECOGNITION	51	3.46e-03	2.69e-02	0.30000	-2.06e-01	-2.19e-01	1.11e-02	6.89e-03
GOBP POSITIVE REGULATION OF TRANSCRIPTION ELONGATION BY RNA POLYMERASE II	48	4.15e-03	3.08e-02	0.30000	2.55e-01	1.58e-01	2.20e-03	5.89e-02
Assembly of collagen fibrils and other multimeric structures	59	8.36e-04	9.16e-03	0.30000	-1.13e-01	-2.78e-01	1.34e-01	2.21e-04
GOMF PROTEIN PHOSPHATASE 2A BINDING	27	4.06e-02	1.64e-01	0.30000	2.74e-01	1.23e-01	1.38e-02	2.68e-01
Regulation of glycolysis by fructose 2,6-bisphosphate metabolism	11	2.10e-01	4.42e-01	0.30000	3.00e-01	-2.12e-03	8.49e-02	9.90e-01
GOCC ELONGATOR HOLOENZYME COMPLEX	6	5.12e-01	7.19e-01	0.30000	2.31e-01	1.91e-01	3.27e-01	4.18e-01
Signaling by NOTCH4	71	1.17e-04	1.75e-03	0.30000	2.92e-01	6.91e-02	2.09e-05	3.14e-01
Synthesis of active ubiquitin: roles of E1 and E2 enzymes	27	4.84e-02	1.84e-01	0.30000	2.39e-01	1.82e-01	3.18e-02	1.02e-01
GOBP CELLULAR RESPONSE TO NICOTINE	9	2.21e-01	4.54e-01	0.30000	-2.58e-01	1.53e-01	1.80e-01	4.26e-01
GOBP MITOTIC METAPHASE CHROMOSOME ALIGNMENT	62	1.02e-03	1.06e-02	0.30000	1.96e-01	2.27e-01	7.50e-03	2.01e-03
GOBP NEUTROPHIL DEGRANULATION	13	1.08e-01	3.03e-01	0.30000	-2.13e-01	2.11e-01	1.83e-01	1.88e-01
GOBP PROTEIN DEPALMITOYLATION	8	4.09e-01	6.41e-01	0.30000	1.86e-01	2.35e-01	3.61e-01	2.50e-01
Activation of NF-kappaB in B cells	53	1.85e-03	1.66e-02	0.30000	2.74e-01	1.21e-01	5.51e-04	1.27e-01
GOMF STEROL ESTERASE ACTIVITY	7	3.10e-01	5.51e-01	0.30000	1.48e-01	-2.61e-01	4.99e-01	2.32e-01
GOBP REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY	33	2.30e-02	1.10e-01	0.30000	2.57e-01	1.54e-01	1.07e-02	1.25e-01
Mitochondrial protein degradation	86	5.66e-05	9.68e-04	0.30000	2.55e-01	1.57e-01	4.34e-05	1.17e-02
GOBP REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION	15	1.68e-01	3.89e-01	0.30000	1.19e-01	2.75e-01	4.26e-01	6.50e-02
GOBP POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY	18	1.36e-01	3.46e-01	0.30000	2.24e-01	1.99e-01	9.94e-02	1.45e-01
GOBP TRNA METHYLATION	38	1.37e-02	7.57e-02	0.30000	2.49e-01	1.67e-01	7.95e-03	7.51e-02
GOCC CHROMAFFIN GRANULE MEMBRANE	9	2.19e-01	4.52e-01	0.30000	-1.64e-01	2.50e-01	3.93e-01	1.93e-01
GOBP SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE	182	2.00e-09	1.03e-07	0.30000	2.19e-01	2.05e-01	3.57e-07	1.91e-06
GOBP REGULATION OF GLUCOKINASE ACTIVITY	5	4.76e-01	6.95e-01	0.29900	-3.89e-02	2.97e-01	8.80e-01	2.50e-01
GOBP NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS	23	2.56e-02	1.18e-01	0.29900	-9.89e-02	2.82e-01	4.12e-01	1.90e-02
GOBP HARD PALATE DEVELOPMENT	8	4.04e-01	6.36e-01	0.29900	2.52e-01	1.61e-01	2.17e-01	4.30e-01
GOBP PROTEIN CATABOLIC PROCESS IN THE VACUOLE	23	5.35e-02	1.97e-01	0.29900	2.91e-01	6.77e-02	1.55e-02	5.74e-01
CDK-mediated phosphorylation and removal of Cdc6	60	9.64e-04	1.02e-02	0.29900	2.65e-01	1.38e-01	3.75e-04	6.48e-02
GOBP NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY	25	5.42e-02	1.98e-01	0.29900	2.68e-01	1.32e-01	2.02e-02	2.53e-01
GOBP BRONCHUS DEVELOPMENT	11	2.91e-01	5.30e-01	0.29900	-2.45e-01	-1.71e-01	1.59e-01	3.27e-01
GOBP CYTOLYSIS BY HOST OF SYMBIONT CELLS	6	3.82e-01	6.16e-01	0.29900	1.06e-01	-2.80e-01	6.53e-01	2.36e-01
GOCC TRANSCRIPTION REGULATOR COMPLEX	488	1.01e-23	1.77e-21	0.29900	2.24e-01	1.98e-01	1.93e-17	7.42e-14
Signaling by KIT in disease	20	1.10e-01	3.06e-01	0.29900	2.00e-01	2.22e-01	1.21e-01	8.56e-02
Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants	20	1.10e-01	3.06e-01	0.29900	2.00e-01	2.22e-01	1.21e-01	8.56e-02
GOBP NEGATIVE REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS	5	4.30e-01	6.58e-01	0.29900	1.71e-01	-2.45e-01	5.07e-01	3.43e-01
GOBP REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY	35	2.05e-02	1.01e-01	0.29900	1.87e-01	2.33e-01	5.55e-02	1.69e-02
GOBP DICARBOXYLIC ACID CATABOLIC PROCESS	17	1.45e-01	3.57e-01	0.29900	1.55e-01	2.56e-01	2.69e-01	6.79e-02
GOMF G PROTEIN COUPLED NEUROTRANSMITTER RECEPTOR ACTIVITY	12	1.68e-01	3.89e-01	0.29900	-2.96e-01	4.21e-02	7.59e-02	8.01e-01
GOMF BH DOMAIN BINDING	11	2.79e-01	5.19e-01	0.29900	1.35e-01	2.67e-01	4.38e-01	1.26e-01
Folding of actin by CCT/TriC	10	2.82e-01	5.20e-01	0.29900	2.91e-01	6.91e-02	1.12e-01	7.05e-01
GOBP REGULATION OF MITOTIC SPINDLE ASSEMBLY	22	8.46e-02	2.62e-01	0.29900	1.68e-01	2.47e-01	1.73e-01	4.49e-02
GOCC UBIQUITIN LIGASE COMPLEX	298	8.05e-15	7.91e-13	0.29900	2.12e-01	2.10e-01	2.79e-10	4.37e-10
GOMF DNA SECONDARY STRUCTURE BINDING	36	1.59e-02	8.42e-02	0.29900	2.63e-01	1.41e-01	6.25e-03	1.43e-01
GOBP GLUTAMATE REUPTAKE	6	3.80e-01	6.14e-01	0.29900	2.76e-01	-1.15e-01	2.42e-01	6.26e-01
GOBP SPINAL CORD PATTERNING	18	1.15e-01	3.14e-01	0.29900	2.80e-01	1.05e-01	4.00e-02	4.41e-01
Signaling by FGFR3	39	9.01e-03	5.56e-02	0.29900	2.81e-01	1.01e-01	2.41e-03	2.73e-01
GOBP NATURAL KILLER CELL DIFFERENTIATION	23	7.39e-02	2.40e-01	0.29900	2.54e-01	1.56e-01	3.46e-02	1.95e-01
Diseases of DNA repair	51	3.65e-03	2.79e-02	0.29800	2.24e-01	1.98e-01	5.71e-03	1.46e-02
GOMF INSULIN RECEPTOR SUBSTRATE BINDING	13	2.12e-01	4.44e-01	0.29800	2.77e-01	1.10e-01	8.33e-02	4.92e-01
GOMF APOLIPOPROTEIN A I BINDING	5	5.48e-01	7.45e-01	0.29800	-1.05e-01	-2.79e-01	6.85e-01	2.79e-01
GOMF ATP ACTIVATED INWARD RECTIFIER POTASSIUM CHANNEL ACTIVITY	6	4.69e-01	6.91e-01	0.29800	-2.90e-01	-7.07e-02	2.19e-01	7.64e-01
GOBP ENDOTHELIAL CELL FATE COMMITMENT	8	3.51e-01	5.89e-01	0.29800	4.55e-02	2.95e-01	8.24e-01	1.49e-01
NFE2L2 regulating MDR associated enzymes	8	4.11e-01	6.43e-01	0.29800	2.41e-01	1.75e-01	2.37e-01	3.91e-01
Regulation of TP53 Activity	155	3.31e-08	1.31e-06	0.29800	2.46e-01	1.68e-01	1.23e-07	3.00e-04
GOMF BHLH TRANSCRIPTION FACTOR BINDING	31	3.34e-02	1.42e-01	0.29800	2.12e-01	2.09e-01	4.06e-02	4.39e-02
GOMF SEQUENCE SPECIFIC DNA BINDING	1564	6.60e-71	5.40e-68	0.29800	2.32e-01	1.87e-01	2.60e-53	4.63e-35
GOBP REGULATION OF T CELL APOPTOTIC PROCESS	39	1.63e-03	1.50e-02	0.29800	-1.44e-01	2.61e-01	1.20e-01	4.80e-03
GOMF ENDOPEPTIDASE REGULATOR ACTIVITY	177	3.09e-09	1.52e-07	0.29800	-1.70e-01	-2.44e-01	9.26e-05	2.00e-08
GOBP REGULATION OF RNA SPLICING	168	3.54e-09	1.74e-07	0.29800	2.70e-01	1.26e-01	1.55e-09	4.83e-03
GOCC CORE MEDIATOR COMPLEX	25	6.08e-02	2.12e-01	0.29800	2.50e-01	1.62e-01	3.07e-02	1.60e-01
GOBP REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN REGULATION OF CONTRACTION	7	3.56e-01	5.93e-01	0.29800	2.95e-01	-4.10e-02	1.77e-01	8.51e-01
GOBP PYRAMIDAL NEURON DIFFERENTIATION	13	1.77e-01	4.01e-01	0.29800	3.05e-02	2.96e-01	8.49e-01	6.46e-02
Fructose catabolism	5	4.35e-01	6.63e-01	0.29800	2.48e-01	-1.65e-01	3.37e-01	5.24e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H QUINONE OR SIMILAR COMPOUND AS ACCEPTOR	50	1.74e-03	1.57e-02	0.29800	2.91e-01	6.00e-02	3.63e-04	4.63e-01
GOMF SOLUTE INORGANIC ANION ANTIPORTER ACTIVITY	31	2.99e-02	1.32e-01	0.29700	-2.58e-01	-1.49e-01	1.30e-02	1.52e-01
GOBP POSITIVE REGULATION OF STORE OPERATED CALCIUM CHANNEL ACTIVITY	5	5.69e-01	7.59e-01	0.29700	2.55e-01	1.53e-01	3.23e-01	5.54e-01
GOMF FATTY ACID OMEGA HYDROXYLASE ACTIVITY	7	4.65e-01	6.88e-01	0.29700	-2.04e-01	-2.16e-01	3.49e-01	3.22e-01
GOBP HEAD MORPHOGENESIS	36	1.15e-02	6.64e-02	0.29700	2.87e-01	7.65e-02	2.84e-03	4.27e-01
GOBP POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION	14	1.03e-01	2.96e-01	0.29700	-1.28e-01	2.69e-01	4.09e-01	8.17e-02
GOBP POSITIVE REGULATION OF PHAGOCYTOSIS	66	3.55e-04	4.49e-03	0.29700	-2.81e-01	-9.70e-02	7.80e-05	1.73e-01
GOBP MICROVILLUS ASSEMBLY	20	1.11e-01	3.08e-01	0.29700	1.83e-01	2.34e-01	1.56e-01	6.99e-02
Heme biosynthesis	13	2.16e-01	4.48e-01	0.29700	1.13e-01	2.75e-01	4.81e-01	8.58e-02
GOBP REGULATION OF PROTEIN SUMOYLATION	21	8.71e-02	2.67e-01	0.29700	2.70e-01	1.24e-01	3.22e-02	3.24e-01
GOBP MARGINAL ZONE B CELL DIFFERENTIATION	8	2.60e-01	4.99e-01	0.29700	-1.93e-01	2.26e-01	3.43e-01	2.69e-01
Signaling by FGFR2	72	1.82e-04	2.54e-03	0.29700	2.80e-01	1.00e-01	4.03e-05	1.41e-01
GOBP REGULATION OF LEUKOCYTE DEGRANULATION	39	2.27e-03	1.93e-02	0.29700	-9.22e-02	2.83e-01	3.19e-01	2.26e-03
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A HEME GROUP OF DONORS	12	1.89e-01	4.17e-01	0.29700	2.97e-01	-1.14e-04	7.48e-02	9.99e-01
GOBP ESTABLISHMENT OF LEFT RIGHT ASYMMETRY	6	3.86e-01	6.20e-01	0.29700	-1.07e-01	2.77e-01	6.50e-01	2.40e-01
Separation of Sister Chromatids	170	2.03e-09	1.04e-07	0.29700	2.77e-01	1.08e-01	4.71e-10	1.56e-02
GOBP PROTEIN TO MEMBRANE DOCKING	5	5.32e-01	7.35e-01	0.29700	6.32e-02	2.90e-01	8.07e-01	2.61e-01
GOMF TRANSLATION FACTOR ACTIVITY RNA BINDING	75	1.46e-04	2.11e-03	0.29700	2.76e-01	1.10e-01	3.66e-05	9.86e-02
GOBP APPENDAGE DEVELOPMENT	182	1.97e-09	1.02e-07	0.29700	2.45e-01	1.67e-01	1.10e-08	1.02e-04
S Phase	147	8.52e-08	3.14e-06	0.29700	2.49e-01	1.62e-01	1.88e-07	7.11e-04
GOBP PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE	9	3.40e-01	5.78e-01	0.29700	2.80e-01	9.88e-02	1.46e-01	6.08e-01
GOBP REGULATION OF PLASMA MEMBRANE REPAIR	6	4.74e-01	6.94e-01	0.29700	7.14e-02	2.88e-01	7.62e-01	2.22e-01
GOBP POSITIVE REGULATION OF DNA RECOMBINATION	73	1.41e-04	2.05e-03	0.29700	2.84e-01	8.68e-02	2.76e-05	2.00e-01
GOBP NADH DEHYDROGENASE COMPLEX ASSEMBLY	52	1.89e-03	1.68e-02	0.29700	2.82e-01	9.18e-02	4.33e-04	2.52e-01
GOBP POSITIVE REGULATION OF VIRAL LIFE CYCLE	23	6.42e-02	2.20e-01	0.29700	2.79e-01	1.00e-01	2.05e-02	4.05e-01
GOBP TELOMERE MAINTENANCE	152	3.77e-08	1.49e-06	0.29700	2.59e-01	1.44e-01	3.40e-08	2.17e-03
GOMF 2 OXOGLUTARATE DEPENDENT DIOXYGENASE ACTIVITY	54	5.33e-04	6.34e-03	0.29700	2.96e-01	-8.11e-03	1.64e-04	9.18e-01
GOBP CORPUS CALLOSUM MORPHOGENESIS	6	4.96e-01	7.08e-01	0.29700	2.73e-01	1.16e-01	2.47e-01	6.24e-01
GOBP CELLULAR RESPONSE TO THYROID HORMONE STIMULUS	12	2.66e-01	5.05e-01	0.29700	1.71e-01	2.42e-01	3.06e-01	1.46e-01
GOBP REGULATION OF NEURON MATURATION	8	2.63e-01	5.02e-01	0.29700	-1.85e-01	2.32e-01	3.66e-01	2.56e-01
GOBP POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS	12	2.66e-01	5.05e-01	0.29700	-2.43e-01	-1.71e-01	1.46e-01	3.06e-01
GOBP REGULATION OF THYMOCYTE APOPTOTIC PROCESS	13	1.17e-01	3.17e-01	0.29600	-1.63e-01	2.48e-01	3.10e-01	1.22e-01
GOMF ATP DEPENDENT DNA DAMAGE SENSOR ACTIVITY	19	6.52e-02	2.22e-01	0.29600	2.95e-01	-2.85e-02	2.59e-02	8.30e-01
GOMF PROLINE SODIUM SYMPORTER ACTIVITY	5	4.54e-01	6.79e-01	0.29600	-2.77e-01	1.06e-01	2.84e-01	6.81e-01
GOBP OVIDUCT DEVELOPMENT	6	4.88e-01	7.02e-01	0.29600	-2.80e-01	-9.83e-02	2.35e-01	6.77e-01
GOBP NEGATIVE REGULATION OF MUSCLE HYPERTROPHY	36	7.71e-03	4.93e-02	0.29600	2.96e-01	1.40e-02	2.11e-03	8.84e-01
GOMF QUATERNARY AMMONIUM GROUP TRANSMEMBRANE TRANSPORTER ACTIVITY	13	2.32e-01	4.67e-01	0.29600	-2.57e-01	-1.48e-01	1.09e-01	3.55e-01
Telomere C-strand (Lagging Strand) Synthesis	33	2.72e-02	1.23e-01	0.29600	2.32e-01	1.84e-01	2.09e-02	6.73e-02
PTEN Regulation	139	4.97e-08	1.92e-06	0.29600	2.84e-01	8.61e-02	7.68e-09	7.98e-02
GOBP POSITIVE REGULATION OF ANOIKIS	5	5.81e-01	7.67e-01	0.29600	2.24e-01	1.95e-01	3.87e-01	4.51e-01
Complex I biogenesis	58	8.16e-04	9.02e-03	0.29600	2.86e-01	7.86e-02	1.67e-04	3.00e-01
Relaxin receptors	8	3.00e-01	5.40e-01	0.29600	6.51e-02	-2.89e-01	7.50e-01	1.57e-01
GOBP GASTRULATION WITH MOUTH FORMING SECOND	26	5.94e-02	2.09e-01	0.29600	2.23e-01	1.95e-01	4.93e-02	8.46e-02
GOCC NLRP3 INFLAMMASOME COMPLEX	7	3.18e-01	5.57e-01	0.29600	-2.56e-01	1.49e-01	2.41e-01	4.94e-01
GOBP RESPIRATORY CHAIN COMPLEX IV ASSEMBLY	28	4.47e-02	1.74e-01	0.29600	1.59e-01	2.50e-01	1.45e-01	2.21e-02
GOBP POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION	16	1.68e-01	3.90e-01	0.29600	2.52e-01	1.56e-01	8.13e-02	2.80e-01
GOBP SENSORY PERCEPTION OF BITTER TASTE	44	8.59e-03	5.37e-02	0.29600	-2.11e-01	-2.08e-01	1.56e-02	1.69e-02
GOCC ENDOPLASMIC RETICULUM TUBULAR NETWORK MEMBRANE	5	4.74e-01	6.94e-01	0.29600	2.90e-01	-5.93e-02	2.61e-01	8.19e-01
GOBP SEQUESTERING OF TRIGLYCERIDE	18	9.01e-02	2.73e-01	0.29600	-2.95e-01	-1.98e-02	3.00e-02	8.84e-01
GOBP REGULATION OF ATRIAL CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION	6	3.69e-01	6.06e-01	0.29600	1.81e-01	-2.34e-01	4.42e-01	3.21e-01
Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA	5	5.79e-01	7.67e-01	0.29600	2.37e-01	1.77e-01	3.59e-01	4.92e-01
GOMF MICROTUBULE SEVERING ATPASE ACTIVITY	9	2.93e-01	5.32e-01	0.29600	-2.96e-01	-5.17e-03	1.24e-01	9.79e-01
GOCC BASEMENT MEMBRANE	87	3.69e-05	6.77e-04	0.29600	-1.07e-01	-2.76e-01	8.59e-02	8.61e-06
GOMF 4 GALACTOSYL N ACETYLGLUCOSAMINIDE 3 ALPHA L FUCOSYLTRANSFERASE ACTIVITY	6	4.74e-01	6.94e-01	0.29600	-2.88e-01	-6.77e-02	2.22e-01	7.74e-01
GOMF OLEATE TRANSMEMBRANE TRANSPORTER ACTIVITY	6	5.22e-01	7.26e-01	0.29600	-1.91e-01	-2.26e-01	4.17e-01	3.39e-01
GOBP ERAD PATHWAY	109	4.95e-06	1.19e-04	0.29600	1.42e-01	2.59e-01	1.02e-02	2.94e-06
GOBP PRIMARY MIRNA PROCESSING	18	1.41e-01	3.53e-01	0.29600	2.35e-01	1.79e-01	8.42e-02	1.88e-01
GOBP REGULATION OF MITOCHONDRIAL FUSION	13	2.39e-01	4.76e-01	0.29600	1.63e-01	2.47e-01	3.09e-01	1.24e-01
GOMF L ASCORBIC ACID BINDING	20	6.16e-02	2.14e-01	0.29600	2.95e-01	-1.11e-02	2.22e-02	9.32e-01
GOBP REGULATION OF SOMITOGENESIS	6	3.68e-01	6.05e-01	0.29500	-2.12e-01	2.05e-01	3.68e-01	3.84e-01
GOBP POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING	20	1.09e-01	3.06e-01	0.29500	2.50e-01	1.57e-01	5.27e-02	2.25e-01
GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL APOPTOTIC PROCESS	11	3.05e-01	5.45e-01	0.29500	2.18e-01	1.99e-01	2.10e-01	2.53e-01
GOBP POSITIVE REGULATION OF CELL MATURATION	9	2.24e-01	4.58e-01	0.29500	-2.19e-01	1.98e-01	2.55e-01	3.04e-01
GOMF ABC TYPE XENOBIOTIC TRANSPORTER ACTIVITY	14	1.93e-01	4.22e-01	0.29500	-1.05e-01	-2.76e-01	4.96e-01	7.38e-02
GOBP RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN	151	9.54e-08	3.46e-06	0.29500	2.11e-01	2.07e-01	7.68e-06	1.16e-05
GOBP POST TRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE	14	1.63e-01	3.83e-01	0.29500	2.93e-01	3.69e-02	5.77e-02	8.11e-01
GOBP INTRACELLULAR WATER HOMEOSTASIS	6	4.82e-01	6.97e-01	0.29500	2.84e-01	7.95e-02	2.28e-01	7.36e-01
GOBP CHROMATIN REMODELING	630	6.77e-31	1.98e-28	0.29500	2.63e-01	1.35e-01	1.89e-29	7.48e-09
Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors	34	2.59e-02	1.19e-01	0.29500	2.11e-01	2.06e-01	3.29e-02	3.77e-02
GOBP REGULATION OF MITOCHONDRIAL TRANSLATION	25	6.21e-02	2.15e-01	0.29500	2.54e-01	1.50e-01	2.78e-02	1.95e-01
GOMF TRANSLATION INITIATION FACTOR ACTIVITY	44	7.72e-03	4.94e-02	0.29500	2.51e-01	1.54e-01	3.90e-03	7.62e-02
Activation of TRKA receptors	6	4.96e-01	7.08e-01	0.29500	-2.74e-01	-1.09e-01	2.45e-01	6.44e-01
Synthesis of PIPs at the Golgi membrane	17	1.43e-01	3.56e-01	0.29500	2.68e-01	1.24e-01	5.59e-02	3.76e-01
MyD88 deficiency (TLR2/4)	16	7.62e-02	2.45e-01	0.29500	-1.38e-01	2.61e-01	3.40e-01	7.08e-02
GOBP POSITIVE REGULATION OF STEROID METABOLIC PROCESS	27	5.50e-02	1.99e-01	0.29500	-2.12e-01	-2.05e-01	5.60e-02	6.56e-02
GOBP PHOSPHATIDYLSERINE EXPOSURE ON APOPTOTIC CELL SURFACE	8	3.31e-01	5.70e-01	0.29500	-2.95e-01	8.04e-03	1.49e-01	9.69e-01
Diseases of programmed cell death	66	7.36e-04	8.33e-03	0.29500	2.45e-01	1.64e-01	5.83e-04	2.08e-02
GOMF PEPTIDE ALPHA N ACETYLTRANSFERASE ACTIVITY	7	4.18e-01	6.49e-01	0.29500	6.27e-02	2.88e-01	7.74e-01	1.87e-01
GOBP REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING	59	1.14e-03	1.16e-02	0.29500	2.70e-01	1.18e-01	3.29e-04	1.18e-01
GOCC COMMITMENT COMPLEX	5	4.43e-01	6.70e-01	0.29500	1.55e-01	-2.51e-01	5.49e-01	3.31e-01
Gastrulation	116	3.74e-06	9.38e-05	0.29500	1.80e-01	2.33e-01	7.85e-04	1.45e-05
GOBP REGULATION OF MITOCHONDRIAL TRANSCRIPTION	8	4.24e-01	6.53e-01	0.29500	1.99e-01	2.18e-01	3.30e-01	2.86e-01
FBXL7 down-regulates AURKA during mitotic entry and in early mitosis	42	7.05e-03	4.59e-02	0.29500	2.78e-01	9.80e-02	1.83e-03	2.72e-01
GOBP POSITIVE REGULATION OF HEMATOPOIETIC STEM CELL PROLIFERATION	9	3.78e-01	6.13e-01	0.29500	1.82e-01	2.31e-01	3.44e-01	2.29e-01
GOBP TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING	78	1.15e-04	1.74e-03	0.29500	2.74e-01	1.07e-01	2.78e-05	1.01e-01
GOCC SPERM PLASMA MEMBRANE	14	2.17e-01	4.49e-01	0.29500	-1.65e-01	-2.44e-01	2.84e-01	1.14e-01
GOBP GAS TRANSPORT	22	5.15e-02	1.91e-01	0.29500	-2.94e-01	-6.88e-03	1.68e-02	9.55e-01
GOBP NOTCH RECEPTOR PROCESSING	9	3.81e-01	6.16e-01	0.29400	2.13e-01	2.04e-01	2.69e-01	2.90e-01
GOBP IODIDE TRANSPORT	9	3.11e-01	5.51e-01	0.29400	-2.93e-01	-3.25e-02	1.28e-01	8.66e-01
Biosynthesis of EPA-derived SPMs	6	4.93e-01	7.06e-01	0.29400	9.88e-02	2.77e-01	6.75e-01	2.39e-01
GOBP DORSAL AORTA MORPHOGENESIS	8	4.22e-01	6.52e-01	0.29400	2.31e-01	1.83e-01	2.59e-01	3.70e-01
GOBP REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION	29	1.66e-02	8.71e-02	0.29400	2.93e-01	-2.66e-02	6.28e-03	8.04e-01
TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain	13	2.30e-01	4.65e-01	0.29400	1.31e-01	2.64e-01	4.14e-01	9.97e-02
GOBP RRNA METABOLIC PROCESS	253	4.96e-13	4.20e-11	0.29400	2.64e-01	1.29e-01	4.35e-13	3.91e-04
GOBP DAMP METABOLIC PROCESS	7	4.05e-01	6.38e-01	0.29400	3.62e-02	2.92e-01	8.68e-01	1.81e-01
GOBP CELL DIFFERENTIATION IN SPINAL CORD	49	5.28e-03	3.68e-02	0.29400	2.23e-01	1.92e-01	7.01e-03	1.98e-02
GOBP POSITIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	9	2.44e-01	4.82e-01	0.29400	2.71e-01	-1.15e-01	1.59e-01	5.51e-01
GOCC PERICENTRIC HETEROCHROMATIN	29	3.96e-02	1.61e-01	0.29400	1.42e-01	2.58e-01	1.86e-01	1.63e-02
GOMF MOLECULAR CARRIER ACTIVITY	93	4.99e-05	8.72e-04	0.29400	2.09e-01	2.07e-01	4.97e-04	5.55e-04
GOBP OOCYTE CONSTRUCTION	8	3.83e-01	6.17e-01	0.29400	8.47e-02	2.82e-01	6.78e-01	1.68e-01
NRIF signals cell death from the nucleus	16	1.81e-01	4.06e-01	0.29400	2.14e-01	2.02e-01	1.39e-01	1.61e-01
GOBP G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY	11	1.72e-01	3.95e-01	0.29400	-2.60e-01	1.37e-01	1.35e-01	4.33e-01
GOBP DIAPEDESIS	6	4.70e-01	6.92e-01	0.29400	-2.90e-01	-5.15e-02	2.19e-01	8.27e-01
GOBP NEGATIVE REGULATION OF TELOMERASE ACTIVITY	9	3.21e-01	5.59e-01	0.29400	4.86e-02	2.90e-01	8.01e-01	1.32e-01
GOMF BICARBONATE MONOATOMIC ANION ANTIPORTER ACTIVITY	12	2.39e-01	4.77e-01	0.29400	-2.80e-01	-8.86e-02	9.26e-02	5.95e-01
GOBP DNA REPLICATION DEPENDENT CHROMATIN ASSEMBLY	6	5.27e-01	7.31e-01	0.29400	2.00e-01	2.15e-01	3.96e-01	3.61e-01
GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE PHOSPHATASE ACTIVITY	11	1.67e-01	3.89e-01	0.29400	2.44e-01	-1.64e-01	1.61e-01	3.47e-01
GOMF CIS REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING	1143	2.71e-51	1.45e-48	0.29400	2.20e-01	1.95e-01	3.99e-36	7.96e-29
GOCC APICAL CORTEX	8	3.48e-01	5.85e-01	0.29400	-1.82e-02	-2.93e-01	9.29e-01	1.51e-01
GOBP POSITIVE REGULATION OF STEROID HORMONE SECRETION	11	1.97e-01	4.27e-01	0.29400	-2.87e-01	6.31e-02	9.93e-02	7.17e-01
GOBP SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS	46	5.17e-03	3.63e-02	0.29400	1.15e-01	2.70e-01	1.76e-01	1.52e-03
GOMF ADENYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY	15	1.81e-01	4.06e-01	0.29400	2.68e-01	1.19e-01	7.18e-02	4.25e-01
GOMF E BOX BINDING	58	2.03e-03	1.78e-02	0.29400	2.29e-01	1.84e-01	2.54e-03	1.56e-02
Purine catabolism	17	1.52e-01	3.67e-01	0.29400	1.42e-01	2.57e-01	3.12e-01	6.64e-02
Sensing of DNA Double Strand Breaks	6	4.94e-01	7.07e-01	0.29300	2.77e-01	9.56e-02	2.39e-01	6.85e-01
Miro GTPase Cycle	8	3.83e-01	6.17e-01	0.29300	2.82e-01	8.11e-02	1.67e-01	6.91e-01
GOCC TIM22 MITOCHONDRIAL IMPORT INNER MEMBRANE INSERTION COMPLEX	7	4.74e-01	6.94e-01	0.29300	2.21e-01	1.93e-01	3.11e-01	3.76e-01
GOBP FAT SOLUBLE VITAMIN CATABOLIC PROCESS	12	1.44e-01	3.57e-01	0.29300	-1.56e-01	2.49e-01	3.50e-01	1.36e-01
GOMF ATP TRANSMEMBRANE TRANSPORTER ACTIVITY	12	2.67e-01	5.06e-01	0.29300	1.48e-01	2.54e-01	3.76e-01	1.28e-01
SUMOylation of immune response proteins	11	2.81e-01	5.20e-01	0.29300	2.73e-01	1.07e-01	1.17e-01	5.39e-01
Polo-like kinase mediated events	16	1.83e-01	4.08e-01	0.29300	2.05e-01	2.10e-01	1.56e-01	1.46e-01
GOCC GOLGI LUMEN	93	4.69e-05	8.28e-04	0.29300	-2.36e-01	-1.74e-01	8.30e-05	3.71e-03
GOBP POSITIVE REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION	9	2.28e-01	4.63e-01	0.29300	-2.10e-01	2.04e-01	2.74e-01	2.89e-01
GOBP METANEPHRIC MESENCHYME DEVELOPMENT	14	1.37e-01	3.47e-01	0.29300	-3.64e-02	2.91e-01	8.14e-01	5.94e-02
STING mediated induction of host immune responses	16	8.85e-02	2.70e-01	0.29300	2.80e-01	-8.77e-02	5.27e-02	5.43e-01
GOBP SNRNA CATABOLIC PROCESS	5	5.37e-01	7.37e-01	0.29300	2.88e-01	5.46e-02	2.65e-01	8.33e-01
Translation	277	1.58e-13	1.39e-11	0.29300	2.38e-01	1.71e-01	8.75e-12	9.98e-07
GOMF SUPEROXIDE GENERATING NAD P H OXIDASE ACTIVITY	7	3.30e-01	5.70e-01	0.29300	-1.33e-01	2.61e-01	5.42e-01	2.32e-01
GOBP ATP SYNTHESIS COUPLED ELECTRON TRANSPORT	84	6.34e-05	1.06e-03	0.29300	2.73e-01	1.06e-01	1.50e-05	9.36e-02
GOCC RNA POLYMERASE COMPLEX	96	1.17e-05	2.48e-04	0.29300	2.80e-01	8.58e-02	2.10e-06	1.46e-01
GOBP PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY	26	3.17e-02	1.37e-01	0.29300	-9.84e-03	-2.93e-01	9.31e-01	9.76e-03
GOMF STRUCTURAL CONSTITUENT OF RIBOSOME	154	8.52e-08	3.14e-06	0.29300	2.24e-01	1.89e-01	1.65e-06	5.12e-05
GOBP ACTOMYOSIN CONTRACTILE RING ORGANIZATION	10	3.44e-01	5.81e-01	0.29300	1.82e-01	2.30e-01	3.20e-01	2.08e-01
Deactivation of the beta-catenin transactivating complex	39	1.54e-02	8.28e-02	0.29300	2.34e-01	1.75e-01	1.13e-02	5.79e-02
GOBP POSITIVE REGULATION OF MEMORY T CELL DIFFERENTIATION	9	3.86e-01	6.20e-01	0.29300	2.06e-01	2.08e-01	2.85e-01	2.79e-01
DNA strand elongation	31	3.55e-02	1.48e-01	0.29300	2.42e-01	1.65e-01	1.99e-02	1.11e-01
GOBP REGULATION OF MITOCHONDRIAL GENE EXPRESSION	33	2.87e-02	1.28e-01	0.29300	2.41e-01	1.66e-01	1.66e-02	9.81e-02
GOBP POST EMBRYONIC CAMERA TYPE EYE DEVELOPMENT	8	3.71e-01	6.07e-01	0.29300	5.56e-02	2.87e-01	7.85e-01	1.59e-01
GOBP REGULATION OF BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS	5	5.18e-01	7.24e-01	0.29300	1.57e-02	2.92e-01	9.52e-01	2.58e-01
IKK complex recruitment mediated by RIP1	22	9.72e-02	2.85e-01	0.29300	1.95e-01	2.19e-01	1.14e-01	7.60e-02
GOBP DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM	86	2.24e-05	4.36e-04	0.29300	-2.88e-01	-5.03e-02	3.78e-06	4.20e-01
GOBP FIBROBLAST MIGRATION	54	1.41e-03	1.35e-02	0.29300	2.85e-01	6.67e-02	2.91e-04	3.96e-01
GOBP REPLICATION BORN DOUBLE STRAND BREAK REPAIR VIA SISTER CHROMATID EXCHANGE	6	4.29e-01	6.57e-01	0.29300	2.91e-01	-3.41e-02	2.18e-01	8.85e-01
GOBP FACULTATIVE HETEROCHROMATIN FORMATION	40	4.79e-03	3.42e-02	0.29300	2.93e-01	4.46e-03	1.36e-03	9.61e-01
GOBP CITRULLINE METABOLIC PROCESS	7	4.18e-01	6.49e-01	0.29300	2.88e-01	5.15e-02	1.87e-01	8.13e-01
GOBP POSITIVE REGULATION OF CHROMOSOME ORGANIZATION	105	4.60e-06	1.11e-04	0.29300	2.78e-01	9.11e-02	8.45e-07	1.07e-01
VLDL assembly	5	5.65e-01	7.57e-01	0.29300	1.11e-01	2.71e-01	6.68e-01	2.94e-01
GOBP REGULATION OF MRNA SPLICING VIA SPLICEOSOME	100	7.83e-06	1.76e-04	0.29300	2.79e-01	8.79e-02	1.41e-06	1.29e-01
FGFR2 alternative splicing	26	5.29e-02	1.95e-01	0.29200	2.68e-01	1.18e-01	1.82e-02	2.97e-01
GOBP PROTEIN DNA COMPLEX ORGANIZATION	851	1.15e-40	4.86e-38	0.29200	2.64e-01	1.27e-01	4.10e-39	3.53e-10
GOCC NEURONAL DENSE CORE VESICLE MEMBRANE	5	5.87e-01	7.71e-01	0.29200	-2.31e-01	-1.79e-01	3.71e-01	4.88e-01
GOMF DNA EXONUCLEASE ACTIVITY	24	7.97e-02	2.52e-01	0.29200	2.06e-01	2.07e-01	8.08e-02	7.87e-02
GOBP CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING	32	3.18e-02	1.37e-01	0.29200	2.45e-01	1.59e-01	1.64e-02	1.19e-01
Erythrocytes take up oxygen and release carbon dioxide	8	2.81e-01	5.20e-01	0.29200	-2.55e-01	1.42e-01	2.11e-01	4.86e-01
GOBP MITOTIC DNA INTEGRITY CHECKPOINT SIGNALING	85	1.26e-04	1.88e-03	0.29200	2.26e-01	1.85e-01	3.13e-04	3.21e-03
GOMF LIPID TRANSMEMBRANE TRANSPORTER ACTIVITY	54	3.25e-03	2.55e-02	0.29200	-2.31e-01	-1.79e-01	3.32e-03	2.30e-02
GOBP RIGHTING REFLEX	8	3.31e-01	5.70e-01	0.29200	-2.91e-01	2.21e-02	1.54e-01	9.14e-01
GOBP CARDIAC MYOFIBRIL ASSEMBLY	19	6.56e-02	2.23e-01	0.29200	4.90e-02	-2.88e-01	7.12e-01	2.98e-02
G beta:gamma signalling through CDC42	19	1.16e-01	3.16e-01	0.29200	2.69e-01	1.12e-01	4.20e-02	3.96e-01
GOBP NEGATIVE REGULATION OF MEMBRANE PERMEABILITY	21	5.01e-02	1.88e-01	0.29200	-4.54e-02	2.88e-01	7.19e-01	2.22e-02
GOBP MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA	24	7.47e-02	2.41e-01	0.29200	2.48e-01	1.53e-01	3.53e-02	1.93e-01
GOBP TRACHEA DEVELOPMENT	18	1.44e-01	3.57e-01	0.29200	1.58e-01	2.45e-01	2.45e-01	7.17e-02
GOBP OOCYTE MATURATION	35	2.07e-02	1.02e-01	0.29200	2.61e-01	1.30e-01	7.52e-03	1.82e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS WITH A FLAVIN AS ACCEPTOR	13	2.33e-01	4.68e-01	0.29200	2.66e-01	1.21e-01	9.73e-02	4.51e-01
GOMF RNA METHYLTRANSFERASE ACTIVITY	62	1.23e-03	1.23e-02	0.29200	2.49e-01	1.52e-01	7.00e-04	3.81e-02
GOBP REGULATION OF CHLORIDE TRANSPORT	6	5.11e-01	7.19e-01	0.29200	-1.22e-01	-2.65e-01	6.05e-01	2.61e-01
GOBP REGULATION OF MAST CELL DEGRANULATION	24	2.95e-02	1.30e-01	0.29200	-6.96e-02	2.83e-01	5.55e-01	1.63e-02
GOBP HEMOGLOBIN METABOLIC PROCESS	17	1.67e-01	3.88e-01	0.29200	2.22e-01	1.89e-01	1.13e-01	1.77e-01
GOBP RESPONSE TO PROTOZOAN	29	9.63e-03	5.82e-02	0.29200	-1.64e-01	2.41e-01	1.26e-01	2.47e-02
GOMF RNA POLYMERASE II SPECIFIC DNA BINDING TRANSCRIPTION FACTOR BINDING	329	6.85e-16	7.37e-14	0.29200	2.45e-01	1.58e-01	2.11e-14	8.17e-07
GOBP POSITIVE REGULATION OF RECEPTOR BINDING	5	4.80e-01	6.97e-01	0.29200	2.83e-01	-6.91e-02	2.73e-01	7.89e-01
GOCC CELL TRAILING EDGE	14	1.69e-01	3.91e-01	0.29200	3.39e-02	2.90e-01	8.26e-01	6.07e-02
GOBP MEIOTIC DNA DOUBLE STRAND BREAK FORMATION	8	3.15e-01	5.54e-01	0.29200	5.68e-02	-2.86e-01	7.81e-01	1.61e-01
GOBP FIBROBLAST APOPTOTIC PROCESS	25	6.51e-02	2.22e-01	0.29100	2.55e-01	1.40e-01	2.71e-02	2.24e-01
GOBP RRNA PROCESSING	212	9.14e-11	5.94e-09	0.29100	2.58e-01	1.35e-01	9.16e-11	6.84e-04
FBXW7 Mutants and NOTCH1 in Cancer	5	4.45e-01	6.72e-01	0.29100	2.11e-01	-2.01e-01	4.13e-01	4.37e-01
Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling	5	4.45e-01	6.72e-01	0.29100	2.11e-01	-2.01e-01	4.13e-01	4.37e-01
GOBP RETINOIC ACID RECEPTOR SIGNALING PATHWAY	32	2.68e-02	1.22e-01	0.29100	2.69e-01	1.11e-01	8.37e-03	2.76e-01
GOBP RESPONSE TO IONIZING RADIATION	138	3.19e-07	1.04e-05	0.29100	2.54e-01	1.42e-01	2.53e-07	3.88e-03
Cross-presentation of soluble exogenous antigens (endosomes)	34	1.56e-02	8.33e-02	0.29100	2.86e-01	5.59e-02	3.92e-03	5.73e-01
GOBP PROTEIN INSERTION INTO ER MEMBRANE	26	5.67e-02	2.03e-01	0.29100	2.60e-01	1.30e-01	2.15e-02	2.50e-01
GOBP NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM	8	2.81e-01	5.20e-01	0.29100	-2.47e-01	1.54e-01	2.26e-01	4.51e-01
GOCC ESC E Z COMPLEX	15	2.01e-01	4.31e-01	0.29100	2.42e-01	1.62e-01	1.04e-01	2.78e-01
GOMF UBIQUITIN LIKE LIGASE SUBSTRATE ADAPTOR ACTIVITY	56	2.84e-03	2.31e-02	0.29100	1.92e-01	2.19e-01	1.28e-02	4.65e-03
Mitotic Telophase/Cytokinesis	11	2.23e-01	4.57e-01	0.29100	2.91e-01	-1.66e-02	9.51e-02	9.24e-01
GOMF GAP JUNCTION CHANNEL ACTIVITY	22	9.92e-02	2.89e-01	0.29100	-2.24e-01	-1.86e-01	6.91e-02	1.31e-01
Phase 2 - plateau phase	14	2.31e-01	4.66e-01	0.29100	-2.14e-01	-1.98e-01	1.66e-01	2.01e-01
MASTL Facilitates Mitotic Progression	10	3.51e-01	5.88e-01	0.29100	2.16e-01	1.95e-01	2.36e-01	2.87e-01
GOCC CRD MEDIATED MRNA STABILITY COMPLEX	6	4.73e-01	6.94e-01	0.29100	2.88e-01	4.33e-02	2.22e-01	8.54e-01
GOMF GUANINE NUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY	5	5.58e-01	7.51e-01	0.29100	-2.77e-01	-8.79e-02	2.83e-01	7.34e-01
GOBP CHROMOSOME LOCALIZATION	122	2.38e-06	6.24e-05	0.29100	2.42e-01	1.62e-01	4.01e-06	2.00e-03
GOMF DISORDERED DOMAIN SPECIFIC BINDING	29	3.74e-02	1.54e-01	0.29100	2.70e-01	1.07e-01	1.17e-02	3.17e-01
GOBP ANTIFUNGAL INNATE IMMUNE RESPONSE	19	1.11e-01	3.09e-01	0.29100	-2.75e-01	-9.38e-02	3.77e-02	4.79e-01
GOBP INTERNEURON MIGRATION FROM THE SUBPALLIUM TO THE CORTEX	6	4.83e-01	6.98e-01	0.29100	-6.02e-02	-2.85e-01	7.98e-01	2.27e-01
GOBP CELLULAR RESPONSE TO STEROL	25	6.33e-02	2.17e-01	0.29100	-1.27e-01	-2.61e-01	2.71e-01	2.36e-02
GOBP REGULATION OF MRNA 3 END PROCESSING	9	3.84e-01	6.18e-01	0.29100	1.63e-01	2.41e-01	3.98e-01	2.11e-01
GOMF ALPHA CATENIN BINDING	10	2.65e-01	5.04e-01	0.29100	3.65e-05	-2.91e-01	1.00e+00	1.11e-01
Inactivation of CDC42 and RAC1	8	2.75e-01	5.15e-01	0.29100	2.02e-01	-2.09e-01	3.23e-01	3.06e-01
GOMF TRANSCRIPTION FACTOR BINDING	570	1.05e-26	2.34e-24	0.29100	2.48e-01	1.51e-01	3.80e-24	6.65e-10
GOCC POSTSYNAPTIC RECYCLING ENDOSOME	7	4.75e-01	6.95e-01	0.29100	2.41e-01	1.62e-01	2.69e-01	4.57e-01
GOBP NON MOTILE CILIUM ASSEMBLY	62	1.36e-03	1.32e-02	0.29000	2.44e-01	1.58e-01	9.05e-04	3.13e-02
GOCC PARANODAL JUNCTION	8	2.92e-01	5.31e-01	0.29000	-2.64e-01	1.21e-01	1.96e-01	5.52e-01
GOCC RNA POLYMERASE II HOLOENZYME	67	3.41e-04	4.35e-03	0.29000	2.82e-01	6.87e-02	6.50e-05	3.31e-01
GOMF CYCLASE INHIBITOR ACTIVITY	5	5.80e-01	7.67e-01	0.29000	-1.36e-01	-2.56e-01	5.97e-01	3.21e-01
RHO GTPases Activate WASPs and WAVEs	34	2.86e-02	1.28e-01	0.29000	2.27e-01	1.81e-01	2.23e-02	6.72e-02
GOBP NUCLEOSIDE BISPHOSPHATE CATABOLIC PROCESS	11	2.39e-01	4.77e-01	0.29000	1.21e-02	2.90e-01	9.45e-01	9.59e-02
GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE	37	2.09e-02	1.03e-01	0.29000	1.82e-01	2.26e-01	5.53e-02	1.74e-02
GOMF GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY	49	2.53e-03	2.12e-02	0.29000	2.85e-01	5.23e-02	5.48e-04	5.27e-01
GOBP INOSITOL METABOLIC PROCESS	8	3.03e-01	5.43e-01	0.29000	-9.13e-02	2.75e-01	6.55e-01	1.77e-01
GOBP PEPTIDYL SERINE DEPHOSPHORYLATION	14	2.29e-01	4.63e-01	0.29000	2.35e-01	1.70e-01	1.28e-01	2.71e-01
GOBP NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION	40	9.41e-03	5.73e-02	0.29000	2.78e-01	8.22e-02	2.33e-03	3.68e-01
GOBP PROTEIN LOCALIZATION TO CONDENSED CHROMOSOME	15	1.91e-01	4.18e-01	0.29000	2.63e-01	1.22e-01	7.79e-02	4.12e-01
GOBP REGULATION OF TRANSLATION IN RESPONSE TO STRESS	20	1.24e-01	3.28e-01	0.29000	2.25e-01	1.83e-01	8.11e-02	1.58e-01
GOBP REGULATION OF CELL CYCLE CHECKPOINT	43	7.20e-03	4.67e-02	0.29000	2.75e-01	9.29e-02	1.83e-03	2.92e-01
GOBP NEGATIVE REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE	7	4.48e-01	6.74e-01	0.29000	2.74e-01	9.35e-02	2.09e-01	6.68e-01
GOCC ATP BINDING CASSETTE ABC TRANSPORTER COMPLEX	6	4.78e-01	6.96e-01	0.29000	-4.70e-02	-2.86e-01	8.42e-01	2.25e-01
GOBP NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY	30	2.87e-02	1.28e-01	0.29000	-2.81e-01	-7.15e-02	7.76e-03	4.98e-01
GOBP RIBOSOMAL SMALL SUBUNIT BIOGENESIS	101	2.26e-05	4.38e-04	0.29000	2.44e-01	1.56e-01	2.18e-05	6.88e-03
GOBP HEXOSE PHOSPHATE TRANSPORT	7	4.65e-01	6.88e-01	0.29000	-2.59e-01	-1.30e-01	2.36e-01	5.51e-01
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO PEROXISOME	19	1.20e-01	3.22e-01	0.29000	2.67e-01	1.13e-01	4.42e-02	3.93e-01
GOBP MULTI CILIATED EPITHELIAL CELL DIFFERENTIATION	9	3.02e-01	5.42e-01	0.29000	-5.31e-03	2.90e-01	9.78e-01	1.32e-01
GOCC DERLIN 1 RETROTRANSLOCATION COMPLEX	8	4.27e-01	6.55e-01	0.29000	2.46e-01	1.53e-01	2.29e-01	4.53e-01
GOBP HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN	47	7.69e-03	4.93e-02	0.29000	-2.14e-01	-1.95e-01	1.10e-02	2.08e-02
GOMF U1 SNRNP BINDING	6	4.96e-01	7.08e-01	0.29000	2.79e-01	7.95e-02	2.37e-01	7.36e-01
GOBP POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL	7	4.83e-01	6.99e-01	0.29000	-2.19e-01	-1.90e-01	3.16e-01	3.85e-01
GOCC MRE11 COMPLEX	5	4.89e-01	7.03e-01	0.29000	2.84e-01	-5.80e-02	2.72e-01	8.22e-01
GOBP NEGATIVE REGULATION OF SYNAPSE ASSEMBLY	8	2.78e-01	5.18e-01	0.29000	-2.09e-01	2.00e-01	3.06e-01	3.27e-01
GOBP RIBONUCLEOPROTEIN COMPLEX BIOGENESIS	437	2.85e-21	4.54e-19	0.29000	2.63e-01	1.22e-01	4.45e-21	1.22e-05
GOCC CONDENSED CHROMOSOME	268	1.10e-13	9.79e-12	0.29000	2.69e-01	1.06e-01	2.98e-14	2.87e-03
GOBP REGULATION OF SKELETAL MUSCLE CONTRACTION BY CALCIUM ION SIGNALING	7	4.15e-01	6.45e-01	0.29000	2.88e-01	3.05e-02	1.87e-01	8.89e-01
GOCC CONNEXIN COMPLEX	19	1.31e-01	3.39e-01	0.28900	-2.49e-01	-1.47e-01	5.98e-02	2.67e-01
Downstream signaling of activated FGFR2	29	2.56e-02	1.18e-01	0.28900	2.88e-01	2.69e-02	7.22e-03	8.02e-01
GOMF I SMAD BINDING	16	1.85e-01	4.11e-01	0.28900	2.40e-01	1.62e-01	9.71e-02	2.61e-01
GOCC DEUTEROSOME	6	5.28e-01	7.32e-01	0.28900	1.51e-01	2.47e-01	5.21e-01	2.95e-01
GOBP TRANSLATIONAL TERMINATION	15	1.79e-01	4.04e-01	0.28900	2.74e-01	9.14e-02	6.57e-02	5.40e-01
Aerobic respiration and respiratory electron transport	236	1.29e-11	9.21e-10	0.28900	2.51e-01	1.43e-01	2.78e-11	1.57e-04
GOBP DETECTION OF LIPOPOLYSACCHARIDE	5	5.84e-01	7.69e-01	0.28900	-2.53e-01	-1.39e-01	3.27e-01	5.89e-01
Regulation of innate immune responses to cytosolic DNA	15	1.71e-01	3.92e-01	0.28900	2.80e-01	7.17e-02	6.03e-02	6.31e-01
MicroRNA (miRNA) biogenesis	26	3.06e-02	1.33e-01	0.28900	2.89e-01	-1.49e-02	1.08e-02	8.96e-01
GOBP NEGATIVE REGULATION OF HEPATOCYTE APOPTOTIC PROCESS	7	4.80e-01	6.97e-01	0.28900	2.37e-01	1.66e-01	2.78e-01	4.47e-01
GOMF TRANSCRIPTION REGULATOR ACTIVITY	1836	2.84e-77	3.17e-74	0.28900	2.27e-01	1.79e-01	1.32e-58	2.34e-37
GOBP INTERLEUKIN 17A MEDIATED SIGNALING PATHWAY	6	5.37e-01	7.38e-01	0.28900	2.21e-01	1.87e-01	3.49e-01	4.28e-01
GOMF RNA STEM LOOP BINDING	14	2.04e-01	4.34e-01	0.28900	2.73e-01	9.58e-02	7.73e-02	5.35e-01
GOBP SODIUM ION IMPORT ACROSS PLASMA MEMBRANE	23	9.29e-02	2.77e-01	0.28900	-1.90e-01	-2.17e-01	1.14e-01	7.10e-02
Cyclin E associated events during G1/S transition	73	3.12e-04	4.04e-03	0.28900	2.66e-01	1.14e-01	8.64e-05	9.34e-02
SUMOylation of DNA replication proteins	46	4.68e-03	3.38e-02	0.28900	2.79e-01	7.67e-02	1.08e-03	3.68e-01
GOBP PYRAMIDAL NEURON DEVELOPMENT	9	2.64e-01	5.03e-01	0.28900	-9.05e-02	2.74e-01	6.38e-01	1.54e-01
GOBP REGULATION OF AGGREPHAGY	7	4.29e-01	6.58e-01	0.28900	2.84e-01	5.42e-02	1.94e-01	8.04e-01
GOBP DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION	36	2.40e-02	1.14e-01	0.28900	-1.81e-01	-2.25e-01	5.98e-02	1.95e-02
GOBP REGULATION OF B CELL APOPTOTIC PROCESS	19	7.67e-02	2.46e-01	0.28900	-2.14e-02	2.88e-01	8.72e-01	2.97e-02
GOCC INTRACILIARY TRANSPORT PARTICLE A	8	2.86e-01	5.24e-01	0.28900	2.44e-01	-1.55e-01	2.32e-01	4.49e-01
GOBP NEGATIVE REGULATION OF AMYLOID BETA CLEARANCE	11	1.98e-01	4.28e-01	0.28900	8.68e-02	-2.75e-01	6.18e-01	1.14e-01
Beta-oxidation of pristanoyl-CoA	9	2.85e-01	5.23e-01	0.28900	2.85e-01	-4.48e-02	1.38e-01	8.16e-01
GOCC TRANS GOLGI NETWORK TRANSPORT VESICLE MEMBRANE	19	1.25e-01	3.30e-01	0.28900	2.61e-01	1.23e-01	4.87e-02	3.53e-01
GOCC CATALYTIC COMPLEX	1617	5.19e-71	4.55e-68	0.28900	2.53e-01	1.39e-01	8.15e-65	8.94e-21
GOBP DIET INDUCED THERMOGENESIS	13	1.67e-01	3.89e-01	0.28900	2.87e-01	-3.47e-02	7.36e-02	8.28e-01
GOBP REGULATION OF AUTOPHAGOSOME MATURATION	16	1.36e-01	3.46e-01	0.28900	2.87e-01	3.22e-02	4.70e-02	8.23e-01
GOMF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE ACTIVITY	19	1.38e-01	3.49e-01	0.28900	2.34e-01	1.69e-01	7.74e-02	2.02e-01
GOMF EPHRIN RECEPTOR BINDING	26	4.59e-02	1.77e-01	0.28900	6.50e-02	2.81e-01	5.66e-01	1.31e-02
GOBP EPIGENETIC REGULATION OF GENE EXPRESSION	265	2.56e-13	2.21e-11	0.28900	2.65e-01	1.14e-01	1.02e-13	1.45e-03
GOBP NUCLEOSOME ORGANIZATION	119	4.02e-06	9.99e-05	0.28900	2.39e-01	1.61e-01	6.42e-06	2.41e-03
Mitotic Anaphase	213	8.57e-11	5.62e-09	0.28900	2.63e-01	1.19e-01	3.78e-11	2.70e-03
Neddylation	221	1.30e-10	8.03e-09	0.28900	2.30e-01	1.74e-01	3.50e-09	8.64e-06
GOBP MITOCHONDRIAL DNA REPAIR	6	5.16e-01	7.22e-01	0.28900	1.17e-01	2.64e-01	6.21e-01	2.63e-01
GOCC SEMAPHORIN RECEPTOR COMPLEX	11	3.22e-01	5.60e-01	0.28800	-1.88e-01	-2.19e-01	2.80e-01	2.09e-01
GOCC PROTEASOME COMPLEX	61	1.25e-03	1.25e-02	0.28800	2.63e-01	1.19e-01	3.82e-04	1.09e-01
GOMF DNA DNA ANNEALING ACTIVITY	7	4.39e-01	6.67e-01	0.28800	2.80e-01	7.06e-02	2.00e-01	7.47e-01
Signaling by Hippo	19	5.18e-02	1.92e-01	0.28800	2.44e-01	-1.53e-01	6.53e-02	2.47e-01
GOBP NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING	9	3.49e-01	5.86e-01	0.28800	-7.29e-02	-2.79e-01	7.05e-01	1.47e-01
GOBP REGULATION OF SMOOTHENED SIGNALING PATHWAY	85	1.38e-05	2.87e-04	0.28800	2.88e-01	-7.04e-03	4.32e-06	9.11e-01
GOMF ABC TYPE TRANSPORTER ACTIVITY	46	5.76e-03	3.93e-02	0.28800	-1.01e-01	-2.70e-01	2.35e-01	1.53e-03
GOBP POSITIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS	76	3.73e-04	4.68e-03	0.28800	1.68e-01	2.34e-01	1.12e-02	4.16e-04
GOCC MHC CLASS II PROTEIN COMPLEX	15	9.42e-02	2.79e-01	0.28800	-1.75e-01	2.29e-01	2.40e-01	1.25e-01
GOCC GAMMA TUBULIN RING COMPLEX	9	3.94e-01	6.27e-01	0.28800	1.76e-01	2.28e-01	3.60e-01	2.36e-01
Prefoldin mediated transfer of substrate to CCT/TriC	26	6.71e-02	2.26e-01	0.28800	1.69e-01	2.33e-01	1.35e-01	3.95e-02
GOBP BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION	15	2.13e-01	4.46e-01	0.28800	-2.21e-01	-1.85e-01	1.38e-01	2.16e-01
GOBP CHROMOSOME MOVEMENT TOWARDS SPINDLE POLE	7	4.84e-01	6.99e-01	0.28800	1.73e-01	2.31e-01	4.29e-01	2.90e-01
Collagen formation	88	3.87e-05	7.03e-04	0.28800	-7.88e-02	-2.77e-01	2.02e-01	6.91e-06
GOBP NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS	18	5.84e-02	2.07e-01	0.28800	-2.22e-01	1.84e-01	1.03e-01	1.78e-01
Regulation of TP53 Activity through Phosphorylation	89	1.04e-04	1.60e-03	0.28800	2.28e-01	1.76e-01	2.04e-04	4.02e-03
GOBP NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR	33	3.23e-02	1.39e-01	0.28800	1.66e-01	2.36e-01	9.96e-02	1.91e-02
GOCC MALE PRONUCLEUS	8	2.84e-01	5.22e-01	0.28800	1.79e-01	-2.26e-01	3.80e-01	2.69e-01
GOMF N ACYLSPHINGOSINE AMIDOHYDROLASE ACTIVITY	7	4.17e-01	6.47e-01	0.28800	-2.87e-01	-2.76e-02	1.89e-01	8.99e-01
Cellular Senescence	159	9.40e-08	3.41e-06	0.28800	2.04e-01	2.03e-01	9.13e-06	9.59e-06
GOBP CELLULAR RESPONSE TO TEMPERATURE STIMULUS	5	4.76e-01	6.95e-01	0.28800	2.70e-01	-1.00e-01	2.96e-01	6.98e-01
GOMF HISTONE CHAPERONE ACTIVITY	12	2.93e-01	5.32e-01	0.28800	2.11e-01	1.96e-01	2.06e-01	2.39e-01
GOBP INTRACILIARY TRANSPORT	48	1.89e-03	1.68e-02	0.28800	2.88e-01	-3.53e-03	5.61e-04	9.66e-01
GOBP ROUNDABOUT SIGNALING PATHWAY	5	5.98e-01	7.77e-01	0.28800	-2.25e-01	-1.80e-01	3.85e-01	4.86e-01
GOBP MAINTENANCE OF LENS TRANSPARENCY	7	4.35e-01	6.63e-01	0.28800	2.82e-01	5.92e-02	1.97e-01	7.86e-01
GOBP EPOXYGENASE P450 PATHWAY	17	1.74e-01	3.96e-01	0.28800	-1.76e-01	-2.28e-01	2.09e-01	1.04e-01
GOBP NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC	161	2.68e-08	1.09e-06	0.28800	2.62e-01	1.19e-01	9.88e-09	9.06e-03
GAB1 signalosome	17	1.76e-01	3.99e-01	0.28800	2.17e-01	1.88e-01	1.21e-01	1.79e-01
GOMF ESTRADIOL 17 BETA DEHYDROGENASE NAD P ACTIVITY	18	1.16e-01	3.15e-01	0.28700	-5.21e-02	-2.83e-01	7.02e-01	3.79e-02
GOBP THYROID GLAND DEVELOPMENT	31	2.43e-02	1.14e-01	0.28700	2.83e-01	5.15e-02	6.43e-03	6.20e-01
GOBP SISTER CHROMATID SEGREGATION	226	4.19e-11	2.86e-09	0.28700	2.54e-01	1.35e-01	4.95e-11	4.68e-04
Hedgehog ligand biogenesis	52	3.99e-03	2.98e-02	0.28700	2.53e-01	1.37e-01	1.62e-03	8.83e-02
GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY	42	1.88e-03	1.68e-02	0.28700	2.64e-01	-1.12e-01	3.02e-03	2.08e-01
GOMF URIDYLYLTRANSFERASE ACTIVITY	7	3.90e-01	6.24e-01	0.28700	2.86e-01	-2.52e-02	1.90e-01	9.08e-01
GOBP PYRIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS	28	5.66e-02	2.02e-01	0.28700	-1.77e-01	-2.26e-01	1.04e-01	3.86e-02
GOBP REGULATION OF T HELPER 2 CELL DIFFERENTIATION	12	2.84e-01	5.23e-01	0.28700	1.50e-01	2.45e-01	3.67e-01	1.42e-01
GOBP AMINO ACID ACTIVATION	43	8.98e-03	5.55e-02	0.28700	2.65e-01	1.11e-01	2.66e-03	2.07e-01
GOMF NEUROTROPHIN RECEPTOR ACTIVITY	5	5.50e-01	7.46e-01	0.28700	-2.82e-01	-5.34e-02	2.75e-01	8.36e-01
GOBP GENERAL ADAPTATION SYNDROME BEHAVIORAL PROCESS	5	5.98e-01	7.77e-01	0.28700	-2.28e-01	-1.74e-01	3.76e-01	5.01e-01
GOBP NEGATIVE REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS	5	4.65e-01	6.87e-01	0.28700	-1.42e-01	2.50e-01	5.83e-01	3.34e-01
GOMF TRNA METHYLTRANSFERASE ACTIVITY	32	3.78e-02	1.55e-01	0.28700	2.25e-01	1.78e-01	2.75e-02	8.14e-02
GOBP NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION	26	6.77e-02	2.27e-01	0.28700	2.37e-01	1.61e-01	3.62e-02	1.54e-01
Cyclin A:Cdk2-associated events at S phase entry	75	2.83e-04	3.73e-03	0.28700	2.64e-01	1.14e-01	7.94e-05	8.90e-02
GOBP PROTEIN LOCALIZATION TO NUCLEAR ENVELOPE	13	1.90e-01	4.17e-01	0.28700	2.87e-01	6.86e-03	7.34e-02	9.66e-01
GOMF DYNEIN COMPLEX BINDING	23	8.39e-02	2.60e-01	0.28700	2.59e-01	1.23e-01	3.15e-02	3.07e-01
GOCC 90S PRERIBOSOME	27	6.33e-02	2.17e-01	0.28700	2.25e-01	1.77e-01	4.26e-02	1.11e-01
GOBP POSITIVE REGULATION OF SYNAPSE MATURATION	8	4.04e-01	6.37e-01	0.28700	-2.73e-01	-8.60e-02	1.81e-01	6.74e-01
RNA Polymerase III Transcription Initiation From Type 1 Promoter	28	3.88e-02	1.58e-01	0.28700	2.78e-01	6.91e-02	1.09e-02	5.27e-01
Common Pathway of Fibrin Clot Formation	21	1.19e-01	3.21e-01	0.28700	-2.00e-01	-2.05e-01	1.13e-01	1.03e-01
GOBP HEART FIELD SPECIFICATION	17	9.51e-02	2.81e-01	0.28700	-4.98e-02	2.82e-01	7.22e-01	4.40e-02
P2Y receptors	9	4.01e-01	6.34e-01	0.28600	-2.16e-01	-1.88e-01	2.61e-01	3.29e-01
HCMV Infection	123	3.91e-06	9.73e-05	0.28600	2.20e-01	1.84e-01	2.53e-05	4.38e-04
GOBP TORC2 SIGNALING	11	3.04e-01	5.44e-01	0.28600	1.17e-01	2.61e-01	5.02e-01	1.33e-01
GOBP MALE SEX DETERMINATION	11	3.05e-01	5.44e-01	0.28600	1.19e-01	2.61e-01	4.96e-01	1.35e-01
N-Glycan antennae elongation	15	1.09e-01	3.06e-01	0.28600	-1.07e-01	2.65e-01	4.71e-01	7.53e-02
Mitotic Metaphase and Anaphase	214	1.10e-10	6.97e-09	0.28600	2.61e-01	1.17e-01	4.54e-11	3.15e-03
GOMF INTERLEUKIN 1 RECEPTOR BINDING	17	1.45e-01	3.58e-01	0.28600	-2.74e-01	-8.24e-02	5.05e-02	5.56e-01
Drug ADME	101	1.97e-05	3.91e-04	0.28600	-1.20e-01	-2.60e-01	3.72e-02	6.42e-06
Downregulation of SMAD2/3:SMAD4 transcriptional activity	29	4.08e-02	1.64e-01	0.28600	2.68e-01	1.01e-01	1.26e-02	3.45e-01
GOMF HELICASE ACTIVITY	149	1.85e-08	7.66e-07	0.28600	2.83e-01	4.43e-02	2.56e-09	3.50e-01
GOBP RESPONSE TO SORBITOL	6	4.82e-01	6.98e-01	0.28600	3.70e-02	2.84e-01	8.75e-01	2.29e-01
GOMF THIOLESTER HYDROLASE ACTIVITY	40	1.76e-02	9.08e-02	0.28600	2.12e-01	1.92e-01	2.06e-02	3.54e-02
GOCC TRANSFERASE COMPLEX	793	5.34e-35	1.82e-32	0.28600	2.36e-01	1.61e-01	8.57e-30	1.38e-14
Acyl chain remodelling of PI	17	1.18e-01	3.19e-01	0.28600	-1.37e-02	-2.86e-01	9.22e-01	4.15e-02
GOBP REGULATION OF MONOATOMIC ANION TRANSPORT	13	1.33e-01	3.41e-01	0.28600	1.84e-01	-2.19e-01	2.51e-01	1.72e-01
GOBP CATECHOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS	22	4.84e-02	1.84e-01	0.28600	-2.81e-01	4.97e-02	2.23e-02	6.87e-01
Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells	30	2.83e-02	1.27e-01	0.28600	2.81e-01	5.00e-02	7.63e-03	6.36e-01
GOBP ATRIOVENTRICULAR VALVE DEVELOPMENT	30	3.65e-02	1.52e-01	0.28600	9.96e-02	2.68e-01	3.45e-01	1.11e-02
GOMF PROCOLLAGEN PROLINE DIOXYGENASE ACTIVITY	8	2.95e-01	5.34e-01	0.28600	2.44e-01	-1.48e-01	2.31e-01	4.68e-01
GOBP POSITIVE REGULATION OF APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS	5	4.69e-01	6.91e-01	0.28600	-1.36e-01	2.51e-01	5.97e-01	3.31e-01
GOBP ESTROUS CYCLE	16	1.86e-01	4.13e-01	0.28600	1.38e-01	2.50e-01	3.40e-01	8.31e-02
GOBP CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN	102	3.51e-05	6.50e-04	0.28600	2.15e-01	1.88e-01	1.79e-04	1.01e-03
GOBP LEUKOTRIENE B4 METABOLIC PROCESS	5	6.04e-01	7.82e-01	0.28600	-2.11e-01	-1.93e-01	4.15e-01	4.55e-01
GOCC CUTICULAR PLATE	8	3.14e-01	5.53e-01	0.28600	9.29e-02	-2.70e-01	6.49e-01	1.86e-01
GOBP DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE	46	9.67e-03	5.84e-02	0.28600	-1.86e-01	-2.16e-01	2.89e-02	1.11e-02
GOMF COMPLEMENT BINDING	23	9.29e-02	2.77e-01	0.28600	-2.42e-01	-1.52e-01	4.47e-02	2.08e-01
GOBP RNA 5 END PROCESSING	36	2.55e-02	1.18e-01	0.28500	2.32e-01	1.67e-01	1.61e-02	8.33e-02
GOBP RESPONSE TO SYMBIONT	6	5.30e-01	7.33e-01	0.28500	-2.54e-01	-1.29e-01	2.81e-01	5.83e-01
GOCC MISMATCH REPAIR COMPLEX	10	3.27e-01	5.66e-01	0.28500	2.71e-01	8.79e-02	1.37e-01	6.30e-01
GOBP REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE	13	1.95e-01	4.24e-01	0.28500	2.85e-01	1.19e-02	7.51e-02	9.41e-01
GOCC U1 SNRNP	19	1.48e-01	3.61e-01	0.28500	1.94e-01	2.09e-01	1.43e-01	1.15e-01
GOMF FLAP ENDONUCLEASE ACTIVITY	6	5.47e-01	7.44e-01	0.28500	1.91e-01	2.12e-01	4.18e-01	3.68e-01
GOBP REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR ALPHA SIGNALING PATHWAY	5	5.87e-01	7.71e-01	0.28500	1.24e-01	2.57e-01	6.30e-01	3.20e-01
GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MICROTUBULE	5	5.91e-01	7.73e-01	0.28500	2.52e-01	1.33e-01	3.29e-01	6.06e-01
GOBP NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS	12	2.90e-01	5.29e-01	0.28500	-2.42e-01	-1.50e-01	1.46e-01	3.68e-01
Adenylate cyclase activating pathway	10	3.56e-01	5.93e-01	0.28500	-2.44e-01	-1.48e-01	1.82e-01	4.17e-01
GOMF DNA APURINIC OR APYRIMIDINIC SITE ENDONUCLEASE ACTIVITY	12	3.00e-01	5.40e-01	0.28500	1.99e-01	2.04e-01	2.34e-01	2.20e-01
GOBP POSITIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE	15	2.22e-01	4.56e-01	0.28500	2.13e-01	1.89e-01	1.53e-01	2.04e-01
GOMF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY	1370	4.22e-57	2.59e-54	0.28500	2.13e-01	1.89e-01	5.58e-40	4.96e-32
GOMF INOSITOL PHOSPHATE PHOSPHATASE ACTIVITY	18	1.08e-01	3.04e-01	0.28500	2.84e-01	2.01e-02	3.69e-02	8.82e-01
GOBP VIRAL TRANSLATIONAL TERMINATION REINITIATION	5	4.63e-01	6.86e-01	0.28500	2.25e-01	-1.75e-01	3.84e-01	4.99e-01
ADP signalling through P2Y purinoceptor 12	22	9.27e-02	2.77e-01	0.28500	2.63e-01	1.08e-01	3.25e-02	3.81e-01
GOMF PHOSPHOLIPASE C ACTIVITY	29	5.39e-02	1.98e-01	0.28500	-1.76e-01	-2.23e-01	1.00e-01	3.72e-02
Gene Silencing by RNA	104	1.42e-05	2.93e-04	0.28500	2.62e-01	1.11e-01	3.83e-06	5.09e-02
GOBP NEGATIVE REGULATION OF GLIAL CELL MIGRATION	6	5.08e-01	7.16e-01	0.28500	7.81e-02	2.74e-01	7.40e-01	2.46e-01
Mitochondrial tRNA aminoacylation	20	1.18e-01	3.18e-01	0.28500	2.60e-01	1.15e-01	4.39e-02	3.73e-01
RNA Polymerase II Transcription Termination	62	1.34e-03	1.30e-02	0.28500	2.60e-01	1.16e-01	4.06e-04	1.13e-01
Assembly of active LPL and LIPC lipase complexes	18	1.62e-01	3.82e-01	0.28400	-1.68e-01	-2.29e-01	2.16e-01	9.20e-02
GOBP REGULATION OF SEQUESTERING OF TRIGLYCERIDE	15	1.20e-01	3.23e-01	0.28400	-2.74e-01	7.61e-02	6.61e-02	6.10e-01
GOBP DORSAL AORTA DEVELOPMENT	10	3.49e-01	5.87e-01	0.28400	1.28e-01	2.54e-01	4.83e-01	1.65e-01
GOBP REGULATION OF MRNA PROCESSING	121	2.26e-06	5.98e-05	0.28400	2.63e-01	1.08e-01	5.77e-07	4.01e-02
GOBP EMBRYONIC RETINA MORPHOGENESIS IN CAMERA TYPE EYE	6	4.51e-01	6.76e-01	0.28400	-2.97e-02	2.83e-01	9.00e-01	2.30e-01
GOMF CALCIUM SODIUM ANTIPORTER ACTIVITY	10	2.84e-01	5.22e-01	0.28400	-5.47e-03	-2.84e-01	9.76e-01	1.20e-01
GOBP DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS	14	1.25e-01	3.29e-01	0.28400	-1.28e-01	2.54e-01	4.07e-01	1.00e-01
GOBP MITOTIC SISTER CHROMATID SEPARATION	62	6.51e-04	7.49e-03	0.28400	2.81e-01	4.41e-02	1.31e-04	5.48e-01
RNA Polymerase III Transcription Initiation	36	1.99e-02	9.93e-02	0.28400	2.66e-01	1.01e-01	5.79e-03	2.95e-01
GOBP NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY	68	7.24e-05	1.18e-03	0.28400	-2.74e-01	7.40e-02	9.12e-05	2.92e-01
GOCC CLATHRIN COAT	50	2.23e-03	1.91e-02	0.28400	2.83e-01	2.32e-02	5.33e-04	7.76e-01
GOCC LOW DENSITY LIPOPROTEIN PARTICLE	14	1.32e-01	3.41e-01	0.28400	9.92e-02	-2.66e-01	5.20e-01	8.47e-02
GOMF MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE BINDING	16	1.89e-01	4.17e-01	0.28400	2.50e-01	1.35e-01	8.36e-02	3.50e-01
GOBP POSITIVE REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE	7	3.91e-01	6.24e-01	0.28400	-3.97e-02	2.81e-01	8.56e-01	1.98e-01
GOBP SPINDLE LOCALIZATION	62	1.71e-03	1.56e-02	0.28400	2.45e-01	1.44e-01	8.55e-04	5.00e-02
Cell-extracellular matrix interactions	16	1.46e-01	3.59e-01	0.28400	2.82e-01	3.43e-02	5.09e-02	8.12e-01
Resolution of Sister Chromatid Cohesion	119	2.17e-06	5.82e-05	0.28400	2.69e-01	9.17e-02	4.09e-07	8.41e-02
Gene expression (Transcription)	1503	3.48e-63	2.37e-60	0.28400	2.39e-01	1.53e-01	1.76e-54	3.52e-23
GOBP REGULATION OF PROTEIN GLYCOSYLATION	11	3.09e-01	5.49e-01	0.28400	-1.13e-01	-2.60e-01	5.18e-01	1.35e-01
GOMF OLFACTORY RECEPTOR BINDING	6	5.47e-01	7.44e-01	0.28400	-1.69e-01	-2.28e-01	4.73e-01	3.34e-01
GOBP 3 UTR MEDIATED MRNA STABILIZATION	21	1.23e-01	3.26e-01	0.28400	2.21e-01	1.78e-01	8.00e-02	1.57e-01
GOBP RESPONSE TO GRAVITY	9	4.01e-01	6.34e-01	0.28400	-2.37e-01	-1.55e-01	2.17e-01	4.20e-01
GOBP HETEROCHROMATIN FORMATION	127	1.13e-06	3.24e-05	0.28400	2.65e-01	1.01e-01	2.50e-07	4.86e-02
GOCC COLLAGEN TRIMER	83	2.27e-04	3.07e-03	0.28400	-1.57e-01	-2.36e-01	1.33e-02	2.01e-04
GOBP POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS	34	3.43e-02	1.45e-01	0.28400	2.05e-01	1.95e-01	3.82e-02	4.85e-02
GOBP REGULATION OF MESENCHYMAL STEM CELL DIFFERENTIATION	10	2.30e-01	4.64e-01	0.28400	-2.57e-01	1.21e-01	1.60e-01	5.09e-01
GOBP NEGATIVE REGULATION OF STEM CELL POPULATION MAINTENANCE	24	8.44e-02	2.61e-01	0.28300	2.47e-01	1.40e-01	3.65e-02	2.36e-01
GOMF DEMETHYLASE ACTIVITY	35	1.07e-02	6.30e-02	0.28300	2.83e-01	-1.92e-02	3.79e-03	8.44e-01
GOCC EUKARYOTIC 48S PREINITIATION COMPLEX	14	2.15e-01	4.47e-01	0.28300	2.69e-01	8.97e-02	8.16e-02	5.61e-01
Cyclin A/B1/B2 associated events during G2/M transition	24	8.03e-02	2.53e-01	0.28300	2.56e-01	1.22e-01	3.01e-02	3.00e-01
RNA Polymerase II Transcription	1287	2.28e-54	1.29e-51	0.28300	2.37e-01	1.55e-01	1.66e-46	7.58e-21
GOBP NOREPINEPHRINE METABOLIC PROCESS	13	1.51e-01	3.66e-01	0.28300	-2.61e-01	1.11e-01	1.04e-01	4.88e-01
Signaling by ERBB2 in Cancer	26	3.76e-02	1.54e-01	0.28300	2.83e-01	-1.35e-03	1.24e-02	9.90e-01
GOBP PROTEIN TARGETING TO VACUOLE	46	8.92e-03	5.52e-02	0.28300	2.46e-01	1.41e-01	3.94e-03	9.82e-02
GOBP NEGATIVE REGULATION OF CHROMOSOME SEGREGATION	50	2.69e-03	2.22e-02	0.28300	2.80e-01	3.98e-02	6.02e-04	6.26e-01
GOMF TRANSCRIPTION COACTIVATOR BINDING	42	1.50e-02	8.11e-02	0.28300	2.26e-01	1.71e-01	1.12e-02	5.58e-02
GOBP NEURON FATE SPECIFICATION	36	2.82e-02	1.27e-01	0.28300	1.86e-01	2.13e-01	5.28e-02	2.69e-02
GOBP NECROPTOTIC SIGNALING PATHWAY	8	4.09e-01	6.41e-01	0.28300	-7.80e-02	-2.72e-01	7.02e-01	1.82e-01
GOBP LIPID DROPLET DISASSEMBLY	6	4.83e-01	6.98e-01	0.28300	2.45e-02	2.82e-01	9.17e-01	2.32e-01
GOBP NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT	8	3.50e-01	5.87e-01	0.28300	-2.82e-01	2.83e-02	1.68e-01	8.90e-01
GOMF ADENOSINE DEAMINASE ACTIVITY	12	1.63e-01	3.84e-01	0.28300	-1.59e-01	2.34e-01	3.39e-01	1.61e-01
GOBP TERTIARY ALCOHOL METABOLIC PROCESS	22	1.08e-01	3.05e-01	0.28300	-2.36e-01	-1.57e-01	5.56e-02	2.03e-01
EML4 and NUDC in mitotic spindle formation	112	5.03e-06	1.20e-04	0.28300	2.68e-01	9.13e-02	9.65e-07	9.52e-02
Regulation of signaling by NODAL	9	3.57e-01	5.94e-01	0.28300	6.11e-02	2.76e-01	7.51e-01	1.51e-01
GOMF GTP DEPENDENT PROTEIN BINDING	20	1.23e-01	3.27e-01	0.28300	1.23e-01	2.55e-01	3.39e-01	4.87e-02
GOBP FUNGIFORM PAPILLA DEVELOPMENT	6	5.33e-01	7.35e-01	0.28300	1.22e-01	2.56e-01	6.06e-01	2.78e-01
GOMF CATALYTIC ACTIVITY ACTING ON A RRNA	22	1.08e-01	3.05e-01	0.28300	2.37e-01	1.55e-01	5.48e-02	2.08e-01
GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY	29	5.66e-02	2.02e-01	0.28300	2.14e-01	1.85e-01	4.60e-02	8.47e-02
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH2 GROUP OF DONORS OXYGEN AS ACCEPTOR	14	1.32e-01	3.41e-01	0.28300	2.62e-01	-1.07e-01	8.99e-02	4.87e-01
GOBP CARNITINE METABOLIC PROCESS	11	3.34e-01	5.73e-01	0.28300	2.25e-01	1.71e-01	1.96e-01	3.26e-01
GOMF OXYGEN CARRIER ACTIVITY	14	1.84e-01	4.10e-01	0.28300	-2.82e-01	-2.59e-02	6.81e-02	8.67e-01
GOCC NUCLEAR BODY	812	5.72e-37	2.20e-34	0.28300	2.60e-01	1.11e-01	1.49e-36	8.49e-08
GOBP MAINTENANCE OF ANIMAL ORGAN IDENTITY	5	5.35e-01	7.37e-01	0.28300	-3.24e-03	-2.83e-01	9.90e-01	2.74e-01
GOBP MATURE B CELL DIFFERENTIATION	34	6.74e-03	4.46e-02	0.28300	-1.27e-01	2.53e-01	2.00e-01	1.08e-02
GOMF SINGLE STRANDED DNA HELICASE ACTIVITY	23	1.01e-01	2.92e-01	0.28300	2.26e-01	1.70e-01	6.07e-02	1.58e-01
GOCC NUCLEAR SPECK	393	8.59e-19	1.13e-16	0.28300	2.64e-01	1.02e-01	2.62e-19	5.38e-04
GOMF INSULIN LIKE GROWTH FACTOR II BINDING	8	3.70e-01	6.06e-01	0.28300	2.83e-01	6.69e-03	1.66e-01	9.74e-01
GOBP POSITIVE REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT	6	4.26e-01	6.55e-01	0.28300	-2.67e-01	9.19e-02	2.57e-01	6.97e-01
GOCC SMALL RIBOSOMAL SUBUNIT	70	9.95e-04	1.04e-02	0.28300	2.15e-01	1.83e-01	1.85e-03	8.01e-03
GOBP DNA INTEGRITY CHECKPOINT SIGNALING	132	2.28e-06	6.00e-05	0.28300	2.14e-01	1.85e-01	2.21e-05	2.45e-04
Golgi Cisternae Pericentriolar Stack Reorganization	14	2.33e-01	4.69e-01	0.28300	1.27e-01	2.53e-01	4.11e-01	1.02e-01
GOCC EXTERNAL SIDE OF APICAL PLASMA MEMBRANE	6	4.48e-01	6.74e-01	0.28300	-2.79e-01	4.48e-02	2.37e-01	8.49e-01
GOBP REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION	98	4.91e-05	8.59e-04	0.28300	2.42e-01	1.47e-01	3.59e-05	1.21e-02
GOBP ENTRAINMENT OF CIRCADIAN CLOCK	29	5.45e-02	1.98e-01	0.28300	2.34e-01	1.59e-01	2.95e-02	1.38e-01
GOBP LUNG VASCULATURE DEVELOPMENT	9	2.86e-01	5.24e-01	0.28200	-7.52e-02	2.72e-01	6.96e-01	1.57e-01
GOMF TBP CLASS PROTEIN BINDING	24	5.15e-02	1.91e-01	0.28200	2.82e-01	8.63e-03	1.67e-02	9.42e-01
GOMF OLIGOSACCHARIDE BINDING	17	7.73e-02	2.47e-01	0.28200	-1.64e-01	2.30e-01	2.42e-01	1.01e-01
GOBP TRACHEA CARTILAGE DEVELOPMENT	7	4.71e-01	6.93e-01	0.28200	2.64e-01	9.97e-02	2.26e-01	6.48e-01
GOBP SIGNAL COMPLEX ASSEMBLY	8	4.55e-01	6.80e-01	0.28200	1.94e-01	2.05e-01	3.41e-01	3.16e-01
GOMF ACYLTRANSFERASE ACTIVITY ACYL GROUPS CONVERTED INTO ALKYL ON TRANSFER	5	4.74e-01	6.94e-01	0.28200	2.39e-01	-1.50e-01	3.54e-01	5.61e-01
GOBP REGULATION OF LIGASE ACTIVITY	7	4.87e-01	7.01e-01	0.28200	1.34e-01	2.49e-01	5.40e-01	2.55e-01
GOBP POSITIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY	9	3.75e-01	6.11e-01	0.28200	2.67e-01	9.11e-02	1.65e-01	6.36e-01
GOMF STRUCTURAL CONSTITUENT OF MYELIN SHEATH	9	2.81e-01	5.20e-01	0.28200	-8.92e-02	2.68e-01	6.43e-01	1.64e-01
GOMF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE REGULATOR ACTIVITY	47	5.25e-03	3.68e-02	0.28200	7.19e-02	2.73e-01	3.94e-01	1.21e-03
GOMF RNA EXONUCLEASE ACTIVITY PRODUCING 5 PHOSPHOMONOESTERS	40	1.84e-02	9.39e-02	0.28200	2.32e-01	1.61e-01	1.12e-02	7.80e-02
GOMF PROCOLLAGEN PROLINE 4 DIOXYGENASE ACTIVITY	5	5.74e-01	7.64e-01	0.28200	2.71e-01	7.71e-02	2.93e-01	7.65e-01
GOBP POSITIVE REGULATION OF ERAD PATHWAY	15	2.20e-01	4.54e-01	0.28200	2.39e-01	1.49e-01	1.09e-01	3.16e-01
ChREBP activates metabolic gene expression	8	3.04e-01	5.44e-01	0.28200	2.40e-01	-1.48e-01	2.40e-01	4.69e-01
GOMF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY	42	1.57e-02	8.37e-02	0.28200	-1.73e-01	-2.23e-01	5.31e-02	1.24e-02
GOBP STRESS INDUCED PREMATURE SENESCENCE	8	4.47e-01	6.73e-01	0.28200	2.38e-01	1.51e-01	2.43e-01	4.61e-01
GOMF ATPASE REGULATOR ACTIVITY	47	9.19e-03	5.64e-02	0.28200	2.32e-01	1.60e-01	5.83e-03	5.85e-02
GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING	27	6.77e-02	2.27e-01	0.28200	1.61e-01	2.31e-01	1.48e-01	3.74e-02
GOBP SIALYLATION	10	3.60e-01	5.98e-01	0.28200	-2.46e-01	-1.38e-01	1.78e-01	4.51e-01
The canonical retinoid cycle in rods (twilight vision)	22	8.06e-02	2.54e-01	0.28200	-5.55e-02	-2.76e-01	6.52e-01	2.48e-02
GOMF TASTE RECEPTOR ACTIVITY	30	4.32e-02	1.70e-01	0.28200	-1.15e-01	-2.57e-01	2.76e-01	1.47e-02
Defective B3GALT6 causes EDSP2 and SEMDJL1	17	1.89e-01	4.16e-01	0.28200	-1.93e-01	-2.05e-01	1.68e-01	1.43e-01
GOBP REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION	20	7.34e-02	2.39e-01	0.28200	-2.80e-01	3.17e-02	3.02e-02	8.06e-01
GOCC AUTOLYSOSOME	13	1.44e-01	3.57e-01	0.28200	-1.51e-01	2.38e-01	3.46e-01	1.38e-01
SUMOylation of DNA damage response and repair proteins	74	3.47e-04	4.41e-03	0.28200	2.66e-01	9.31e-02	7.71e-05	1.66e-01
GOBP ATRIOVENTRICULAR VALVE FORMATION	8	3.04e-01	5.44e-01	0.28200	-2.37e-01	1.51e-01	2.45e-01	4.58e-01
GOBP AMINOGLYCOSIDE ANTIBIOTIC METABOLIC PROCESS	10	2.64e-01	5.04e-01	0.28100	4.56e-02	-2.78e-01	8.03e-01	1.28e-01
GOMF DNA BINDING TRANSCRIPTION FACTOR BINDING	451	7.86e-20	1.14e-17	0.28100	2.30e-01	1.62e-01	4.77e-17	4.05e-09
GOBP DNA MODIFICATION	43	1.49e-02	8.05e-02	0.28100	2.11e-01	1.86e-01	1.66e-02	3.48e-02
COPII-mediated vesicle transport	67	1.16e-03	1.18e-02	0.28100	2.43e-01	1.42e-01	5.93e-04	4.39e-02
GOBP ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE	75	6.68e-04	7.65e-03	0.28100	1.94e-01	2.04e-01	3.75e-03	2.24e-03
GOBP REGULATION OF LONG CHAIN FATTY ACID IMPORT INTO CELL	8	4.57e-01	6.82e-01	0.28100	2.12e-01	1.85e-01	3.00e-01	3.64e-01
GOBP FUCOSE CATABOLIC PROCESS	9	3.25e-01	5.63e-01	0.28100	-2.81e-01	4.39e-03	1.44e-01	9.82e-01
GOBP NEGATIVE REGULATION OF FIBRINOLYSIS	13	1.93e-01	4.22e-01	0.28100	2.81e-01	-1.21e-02	7.95e-02	9.40e-01
rRNA processing	190	7.31e-09	3.29e-07	0.28100	2.32e-01	1.59e-01	3.60e-08	1.55e-04
Phosphate bond hydrolysis by NUDT proteins	7	5.05e-01	7.14e-01	0.28100	2.01e-01	1.97e-01	3.58e-01	3.67e-01
SUMO is proteolytically processed	6	5.31e-01	7.33e-01	0.28100	2.60e-01	1.06e-01	2.69e-01	6.54e-01
Signaling by SCF-KIT	42	1.36e-02	7.53e-02	0.28100	1.28e-01	2.50e-01	1.50e-01	5.06e-03
RNA Polymerase III Transcription Initiation From Type 2 Promoter	27	4.70e-02	1.80e-01	0.28100	2.75e-01	5.79e-02	1.34e-02	6.03e-01
GOMF O ACETYLTRANSFERASE ACTIVITY	9	4.15e-01	6.46e-01	0.28100	1.87e-01	2.09e-01	3.30e-01	2.77e-01
GOCC RNA POLYMERASE II CORE COMPLEX	13	2.54e-01	4.91e-01	0.28100	2.60e-01	1.05e-01	1.04e-01	5.10e-01
GOBP RIBOSOME BIOGENESIS	298	1.17e-13	1.04e-11	0.28100	2.44e-01	1.40e-01	4.34e-13	3.42e-05
GOBP AMYLOID BETA CLEARANCE BY TRANSCYTOSIS	7	3.88e-01	6.21e-01	0.28100	2.74e-01	-6.18e-02	2.09e-01	7.77e-01
GOMF IODIDE TRANSMEMBRANE TRANSPORTER ACTIVITY	5	5.16e-01	7.22e-01	0.28100	-2.77e-01	4.40e-02	2.83e-01	8.65e-01
Transcriptional regulation by RUNX3	84	9.47e-05	1.48e-03	0.28100	2.71e-01	7.28e-02	1.72e-05	2.49e-01
GOBP CGAS STING SIGNALING PATHWAY	17	1.26e-01	3.32e-01	0.28100	2.81e-01	1.19e-02	4.52e-02	9.32e-01
GOBP MICROTUBULE NUCLEATION	42	1.67e-02	8.73e-02	0.28100	2.11e-01	1.85e-01	1.78e-02	3.81e-02
GOCC CELL BODY FIBER	8	3.04e-01	5.44e-01	0.28100	-1.61e-01	2.30e-01	4.30e-01	2.60e-01
GOBP HIPPOCAMPAL NEURON APOPTOTIC PROCESS	6	4.27e-01	6.56e-01	0.28100	1.02e-01	-2.61e-01	6.65e-01	2.67e-01
GOBP SOMATIC STEM CELL POPULATION MAINTENANCE	64	1.16e-03	1.17e-02	0.28100	2.62e-01	1.02e-01	2.95e-04	1.58e-01
GOMF MONOCARBOXYLATE SODIUM SYMPORTER ACTIVITY	13	1.99e-01	4.29e-01	0.28100	-2.81e-01	1.96e-03	7.97e-02	9.90e-01
GOBP CELL RECOGNITION	154	3.29e-07	1.07e-05	0.28100	-1.85e-01	-2.11e-01	7.26e-05	6.25e-06
GOBP REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL	10	3.33e-01	5.71e-01	0.28100	-2.70e-01	-7.50e-02	1.39e-01	6.81e-01
GOBP MITOTIC CELL CYCLE CHECKPOINT SIGNALING	142	6.18e-07	1.90e-05	0.28100	2.45e-01	1.36e-01	4.49e-07	5.02e-03
GOMF NEUROPEPTIDE ACTIVITY	29	3.03e-02	1.33e-01	0.28100	1.63e-02	2.80e-01	8.79e-01	9.02e-03
Caspase activation via Death Receptors in the presence of ligand	16	1.18e-01	3.18e-01	0.28100	-5.48e-02	2.75e-01	7.04e-01	5.68e-02
GOCC DNA POLYMERASE COMPLEX	19	1.45e-01	3.58e-01	0.28000	2.47e-01	1.33e-01	6.23e-02	3.16e-01
GOCC CYTOPLASMIC STRESS GRANULE	86	9.73e-05	1.51e-03	0.28000	2.66e-01	8.82e-02	1.98e-05	1.57e-01
Processing of Intronless Pre-mRNAs	19	1.53e-01	3.69e-01	0.28000	2.30e-01	1.60e-01	8.20e-02	2.28e-01
GOBP REGULATION OF MUSCLE ORGAN DEVELOPMENT	24	9.50e-02	2.81e-01	0.28000	2.25e-01	1.68e-01	5.66e-02	1.55e-01
GOBP POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION	57	3.71e-03	2.82e-02	0.28000	2.27e-01	1.64e-01	2.97e-03	3.24e-02
GOBP INSULIN PROCESSING	8	4.36e-01	6.63e-01	0.28000	1.14e-01	2.56e-01	5.77e-01	2.10e-01
GOMF MONOATOMIC CATION BICARBONATE SYMPORTER ACTIVITY	13	2.73e-01	5.12e-01	0.28000	-2.40e-01	-1.45e-01	1.34e-01	3.65e-01
GOBP ENDOSOME TO LYSOSOME TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY	17	1.57e-01	3.74e-01	0.28000	7.84e-02	2.69e-01	5.76e-01	5.49e-02
Trafficking and processing of endosomal TLR	11	3.43e-01	5.81e-01	0.28000	2.15e-01	1.79e-01	2.16e-01	3.03e-01
Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer	49	7.34e-03	4.74e-02	0.28000	2.43e-01	1.40e-01	3.27e-03	9.11e-02
GOBP CYTOCHROME COMPLEX ASSEMBLY	38	1.78e-02	9.13e-02	0.28000	9.68e-02	2.63e-01	3.02e-01	5.05e-03
GOMF METHYL CPG BINDING	24	9.61e-02	2.83e-01	0.28000	2.21e-01	1.72e-01	6.10e-02	1.44e-01
GOMF DOPAMINE BINDING	6	5.57e-01	7.51e-01	0.28000	-1.73e-01	-2.20e-01	4.62e-01	3.51e-01
Downstream signaling events of B Cell Receptor (BCR)	67	9.41e-04	9.98e-03	0.28000	2.58e-01	1.09e-01	2.61e-04	1.23e-01
GOBP REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION	54	2.51e-03	2.11e-02	0.28000	2.72e-01	6.55e-02	5.41e-04	4.05e-01
GOBP BILE ACID SIGNALING PATHWAY	11	2.17e-01	4.49e-01	0.28000	8.90e-02	-2.65e-01	6.09e-01	1.28e-01
GOMF DNA HELICASE ACTIVITY	59	1.07e-03	1.11e-02	0.28000	2.77e-01	3.63e-02	2.27e-04	6.30e-01
GOCC GRANULAR COMPONENT	7	4.75e-01	6.95e-01	0.28000	9.34e-02	2.64e-01	6.69e-01	2.27e-01
GOBP AMP CATABOLIC PROCESS	5	4.76e-01	6.95e-01	0.28000	-2.21e-01	1.72e-01	3.93e-01	5.06e-01
GOBP CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION	19	1.24e-01	3.28e-01	0.28000	-2.70e-01	-7.24e-02	4.14e-02	5.85e-01
GOBP ACETYL COA BIOSYNTHETIC PROCESS	16	2.09e-01	4.41e-01	0.28000	1.64e-01	2.27e-01	2.56e-01	1.17e-01
GOCC AP 3 ADAPTOR COMPLEX	11	2.22e-01	4.56e-01	0.28000	2.69e-01	-7.68e-02	1.22e-01	6.59e-01
GOBP ANGIOGENESIS INVOLVED IN CORONARY VASCULAR MORPHOGENESIS	5	5.97e-01	7.77e-01	0.28000	2.55e-01	1.15e-01	3.24e-01	6.55e-01
GOBP REGULATION OF BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS	19	5.94e-02	2.09e-01	0.28000	-1.79e-01	2.15e-01	1.77e-01	1.05e-01
tRNA processing in the nucleus	58	3.12e-03	2.47e-02	0.28000	2.40e-01	1.43e-01	1.55e-03	5.98e-02
GOBP POSITIVE REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION	6	5.27e-01	7.31e-01	0.28000	9.01e-02	2.65e-01	7.02e-01	2.62e-01
GOBP RIBOSOMAL SMALL SUBUNIT ASSEMBLY	19	1.47e-01	3.61e-01	0.28000	2.46e-01	1.33e-01	6.34e-02	3.16e-01
GOBP POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY	15	2.25e-01	4.59e-01	0.27900	2.40e-01	1.43e-01	1.08e-01	3.36e-01
GOBP ALDEHYDE BIOSYNTHETIC PROCESS	18	9.53e-02	2.81e-01	0.27900	-2.76e-01	4.29e-02	4.25e-02	7.53e-01
GOBP VESICLE COATING	38	2.51e-02	1.17e-01	0.27900	2.19e-01	1.74e-01	1.96e-02	6.38e-02
GOMF SEMAPHORIN RECEPTOR BINDING	23	9.96e-02	2.89e-01	0.27900	-1.36e-01	-2.44e-01	2.61e-01	4.26e-02
GOBP RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES	15	1.69e-01	3.90e-01	0.27900	2.79e-01	2.03e-02	6.18e-02	8.92e-01
GOBP T HELPER 17 CELL DIFFERENTIATION	34	2.50e-02	1.17e-01	0.27900	7.66e-02	2.69e-01	4.40e-01	6.73e-03
GOCC RISC LOADING COMPLEX	8	3.87e-01	6.21e-01	0.27900	2.78e-01	2.06e-02	1.73e-01	9.20e-01
GOBP TRNA 3 END PROCESSING	6	4.58e-01	6.83e-01	0.27900	2.76e-01	-4.09e-02	2.41e-01	8.62e-01
Signaling by FGFR4	40	1.66e-02	8.72e-02	0.27900	2.54e-01	1.17e-01	5.52e-03	2.01e-01
GOBP NEUROTRANSMITTER LOADING INTO SYNAPTIC VESICLE	7	4.49e-01	6.75e-01	0.27900	2.76e-01	4.41e-02	2.07e-01	8.40e-01
GOBP REGULATION OF BRANCHING MORPHOGENESIS OF A NERVE	5	5.60e-01	7.52e-01	0.27900	3.38e-02	2.77e-01	8.96e-01	2.83e-01
GOCC CATENIN COMPLEX	31	4.99e-02	1.88e-01	0.27900	-1.75e-01	-2.18e-01	9.25e-02	3.59e-02
GOBP REGULATION OF LYMPHOID PROGENITOR CELL DIFFERENTIATION	12	1.86e-01	4.12e-01	0.27900	2.60e-01	-1.01e-01	1.19e-01	5.43e-01
GOBP ALKANESULFONATE TRANSMEMBRANE TRANSPORT	8	3.06e-01	5.45e-01	0.27900	-1.79e-01	2.14e-01	3.80e-01	2.95e-01
FGFR2b ligand binding and activation	10	2.50e-01	4.88e-01	0.27900	2.63e-01	-9.31e-02	1.50e-01	6.10e-01
DNA replication initiation	7	5.10e-01	7.17e-01	0.27900	2.09e-01	1.84e-01	3.37e-01	3.99e-01
GOMF AROMATASE ACTIVITY	26	6.16e-02	2.14e-01	0.27900	-8.33e-02	-2.66e-01	4.62e-01	1.88e-02
GOBP ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE	12	2.27e-01	4.62e-01	0.27900	-6.89e-03	2.79e-01	9.67e-01	9.46e-02
GOBP TRANS SYNAPTIC SIGNALING BY TRANS SYNAPTIC COMPLEX	7	5.04e-01	7.14e-01	0.27900	-1.57e-01	-2.30e-01	4.71e-01	2.91e-01
GOBP HOMOCYSTEINE METABOLIC PROCESS	12	2.49e-01	4.87e-01	0.27900	2.77e-01	3.35e-02	9.69e-02	8.41e-01
GOBP REGULATION OF CARDIAC MUSCLE CELL MEMBRANE POTENTIAL	7	5.11e-01	7.19e-01	0.27900	2.00e-01	1.94e-01	3.59e-01	3.74e-01
GOBP CELL AGGREGATION	23	3.36e-02	1.43e-01	0.27900	2.17e-01	-1.75e-01	7.12e-02	1.47e-01
M Phase	354	9.57e-16	1.01e-13	0.27900	2.39e-01	1.43e-01	9.58e-15	3.95e-06
GOMF LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR BINDING	24	7.42e-02	2.41e-01	0.27900	2.68e-01	7.53e-02	2.29e-02	5.23e-01
GOMF ENZYME SUBSTRATE ADAPTOR ACTIVITY	69	1.33e-03	1.29e-02	0.27900	1.82e-01	2.11e-01	9.00e-03	2.41e-03
Gluconeogenesis	25	8.86e-02	2.70e-01	0.27900	-2.24e-01	-1.66e-01	5.28e-02	1.51e-01
Nef Mediated CD4 Down-regulation	9	3.28e-01	5.68e-01	0.27900	2.78e-01	-9.46e-03	1.48e-01	9.61e-01
GOBP TAURINE METABOLIC PROCESS	9	2.77e-01	5.17e-01	0.27900	2.50e-01	-1.22e-01	1.93e-01	5.25e-01
GOBP RETROGRADE TRANSPORT VESICLE RECYCLING WITHIN GOLGI	9	3.97e-01	6.30e-01	0.27800	2.55e-01	1.11e-01	1.85e-01	5.64e-01
GOMF PSEUDOURIDINE SYNTHASE ACTIVITY	12	1.70e-01	3.92e-01	0.27800	1.89e-01	-2.04e-01	2.57e-01	2.20e-01
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells	6	4.86e-01	7.00e-01	0.27800	8.70e-03	2.78e-01	9.71e-01	2.38e-01
GOBP RESOLUTION OF DNA RECOMBINATION INTERMEDIATES	6	5.04e-01	7.13e-01	0.27800	2.75e-01	3.99e-02	2.43e-01	8.66e-01
GOBP ECTODERM DEVELOPMENT	20	1.44e-01	3.57e-01	0.27800	1.64e-01	2.24e-01	2.03e-01	8.22e-02
GOCC CYTOPLASMIC SIDE OF ENDOSOME MEMBRANE	6	5.13e-01	7.20e-01	0.27800	2.72e-01	5.58e-02	2.48e-01	8.13e-01
GOMF C X C CHEMOKINE RECEPTOR ACTIVITY	7	5.08e-01	7.16e-01	0.27800	-1.64e-01	-2.25e-01	4.53e-01	3.03e-01
GOCC INTRACELLULAR PROTEIN CONTAINING COMPLEX	860	8.99e-36	3.15e-33	0.27800	2.29e-01	1.57e-01	2.72e-30	4.71e-15
GOBP TRANSLESION SYNTHESIS	26	7.71e-02	2.47e-01	0.27800	2.39e-01	1.42e-01	3.49e-02	2.09e-01
GOMF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE BINDING	21	4.54e-02	1.76e-01	0.27800	-2.08e-01	1.84e-01	9.88e-02	1.43e-01
GOBP REGULATION OF SPINDLE ORGANIZATION	45	1.04e-02	6.14e-02	0.27800	1.16e-01	2.53e-01	1.78e-01	3.36e-03
GOBP AUTOPHAGOSOME LYSOSOME FUSION	12	3.16e-01	5.55e-01	0.27800	1.77e-01	2.14e-01	2.88e-01	1.99e-01
Meiosis	82	1.78e-04	2.49e-03	0.27800	2.63e-01	8.91e-02	3.74e-05	1.63e-01
GOBP PIGMENT CATABOLIC PROCESS	11	3.00e-01	5.39e-01	0.27800	-2.70e-01	-6.45e-02	1.21e-01	7.11e-01
GOCC AMINOACYL TRNA SYNTHETASE MULTIENZYME COMPLEX	10	3.29e-01	5.68e-01	0.27800	2.72e-01	5.52e-02	1.36e-01	7.63e-01
GOBP RESPONSE TO FOLIC ACID	9	4.23e-01	6.52e-01	0.27800	2.13e-01	1.78e-01	2.68e-01	3.54e-01
GOBP MRNA SPLICE SITE RECOGNITION	35	3.17e-02	1.37e-01	0.27800	2.40e-01	1.40e-01	1.40e-02	1.53e-01
GOBP CELL CYCLE CHECKPOINT SIGNALING	189	1.13e-08	4.90e-07	0.27800	2.34e-01	1.50e-01	2.97e-08	3.81e-04
RNA Polymerase II Pre-transcription Events	77	4.97e-04	6.00e-03	0.27800	2.43e-01	1.35e-01	2.32e-04	4.06e-02
Negative feedback regulation of MAPK pathway	6	5.02e-01	7.12e-01	0.27800	2.76e-01	3.35e-02	2.42e-01	8.87e-01
GOBP MACROPHAGE FUSION	6	4.26e-01	6.55e-01	0.27800	-2.46e-01	1.28e-01	2.96e-01	5.87e-01
GOBP POSITIVE REGULATION OF MITOCHONDRIAL FUSION	5	6.21e-01	7.92e-01	0.27700	2.03e-01	1.89e-01	4.31e-01	4.65e-01
GOBP POSITIVE REGULATION OF PROTEIN DEACETYLATION	6	5.50e-01	7.46e-01	0.27700	-2.45e-01	-1.30e-01	2.99e-01	5.81e-01
Export of Viral Ribonucleoproteins from Nucleus	33	3.35e-02	1.43e-01	0.27700	2.57e-01	1.04e-01	1.05e-02	3.03e-01
Mitochondrial Fatty Acid Beta-Oxidation	36	2.50e-02	1.17e-01	0.27700	2.56e-01	1.07e-01	7.83e-03	2.68e-01
Regulation of APC/C activators between G1/S and early anaphase	68	1.36e-03	1.32e-02	0.27700	2.33e-01	1.51e-01	9.00e-04	3.15e-02
GOBP CATECHOLAMINE UPTAKE	18	1.76e-01	4.00e-01	0.27700	-2.26e-01	-1.61e-01	9.75e-02	2.36e-01
GOMF GLYCOSPHINGOLIPID BINDING	10	3.15e-01	5.54e-01	0.27700	-2.76e-01	-2.89e-02	1.31e-01	8.74e-01
GOCC INNER MITOCHONDRIAL MEMBRANE PROTEIN COMPLEX	141	3.58e-07	1.15e-05	0.27700	2.64e-01	8.45e-02	6.07e-08	8.32e-02
GOCC AP TYPE MEMBRANE COAT ADAPTOR COMPLEX	40	1.26e-02	7.09e-02	0.27700	2.70e-01	6.24e-02	3.10e-03	4.95e-01
GOMF CARGO ADAPTOR ACTIVITY	20	1.49e-01	3.63e-01	0.27700	2.11e-01	1.80e-01	1.03e-01	1.63e-01
Mitotic Prophase	104	4.56e-05	8.08e-04	0.27700	2.27e-01	1.59e-01	6.28e-05	5.05e-03
GOBP FATTY ACID DERIVATIVE CATABOLIC PROCESS	16	1.01e-01	2.92e-01	0.27700	-1.39e-01	2.40e-01	3.36e-01	9.67e-02
Signaling by FGFR2 in disease	42	6.21e-03	4.19e-02	0.27700	2.77e-01	-2.06e-03	1.88e-03	9.82e-01
GOCC ENDODEOXYRIBONUCLEASE COMPLEX	5	5.35e-01	7.37e-01	0.27700	-2.42e-02	2.76e-01	9.25e-01	2.85e-01
GOBP REGULATION OF HUMORAL IMMUNE RESPONSE	46	1.28e-02	7.17e-02	0.27700	-2.03e-01	-1.89e-01	1.73e-02	2.66e-02
Retinoid metabolism and transport	42	9.31e-03	5.69e-02	0.27700	-5.05e-02	-2.73e-01	5.71e-01	2.24e-03
GOMF LONG CHAIN FATTY ACID BINDING	17	9.27e-02	2.77e-01	0.27700	-2.53e-01	1.13e-01	7.08e-02	4.20e-01
GOBP INTESTINAL EPITHELIAL CELL DEVELOPMENT	17	1.06e-01	3.01e-01	0.27700	-6.26e-02	2.70e-01	6.55e-01	5.39e-02
PI3K events in ERBB2 signaling	16	1.04e-01	2.97e-01	0.27700	2.47e-01	-1.25e-01	8.66e-02	3.87e-01
GOBP HOMOLOGOUS CHROMOSOME SEGREGATION	65	1.13e-04	1.70e-03	0.27700	1.15e-01	-2.52e-01	1.09e-01	4.36e-04
Elevation of cytosolic Ca2+ levels	16	1.59e-01	3.76e-01	0.27700	2.97e-02	2.76e-01	8.37e-01	5.64e-02
GOBP POLYOL TRANSMEMBRANE TRANSPORT	10	2.99e-01	5.39e-01	0.27700	-3.65e-04	2.77e-01	9.98e-01	1.29e-01
Nonhomologous End-Joining (NHEJ)	46	1.16e-02	6.67e-02	0.27700	2.33e-01	1.50e-01	6.33e-03	7.74e-02
GOMF ENDONUCLEASE ACTIVITY ACTIVE WITH EITHER RIBO OR DEOXYRIBONUCLEIC ACIDS AND PRODUCING 5 PHOSPHOMONOESTERS	37	2.54e-02	1.18e-01	0.27700	2.45e-01	1.29e-01	9.81e-03	1.75e-01
GOMF 2 IRON 2 SULFUR CLUSTER BINDING	24	9.56e-02	2.82e-01	0.27700	1.42e-01	2.38e-01	2.29e-01	4.36e-02
GOCC SNO S RNA CONTAINING RIBONUCLEOPROTEIN COMPLEX	26	8.00e-02	2.52e-01	0.27700	2.34e-01	1.48e-01	3.89e-02	1.91e-01
Cytosolic tRNA aminoacylation	22	1.25e-01	3.29e-01	0.27700	1.98e-01	1.94e-01	1.08e-01	1.15e-01
GOBP NEGATIVE REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION	6	5.66e-01	7.57e-01	0.27700	-2.04e-01	-1.88e-01	3.88e-01	4.26e-01
GOBP STRESS GRANULE DISASSEMBLY	7	4.03e-01	6.35e-01	0.27700	2.72e-01	-5.14e-02	2.13e-01	8.14e-01
GOBP B CELL APOPTOTIC PROCESS	25	7.62e-02	2.45e-01	0.27700	1.00e-01	2.58e-01	3.86e-01	2.55e-02
GOMF EXONUCLEASE ACTIVITY ACTIVE WITH EITHER RIBO OR DEOXYRIBONUCLEIC ACIDS AND PRODUCING 5 PHOSPHOMONOESTERS	60	3.26e-03	2.56e-02	0.27700	2.21e-01	1.66e-01	3.04e-03	2.58e-02
GOBP HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS ENZYMATIC MODIFICATION	11	2.90e-01	5.29e-01	0.27700	-2.73e-01	-4.27e-02	1.16e-01	8.06e-01
GOBP POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS	65	1.05e-03	1.10e-02	0.27700	2.64e-01	8.19e-02	2.28e-04	2.53e-01
GOBP STRIATED MUSCLE ATROPHY	7	4.58e-01	6.82e-01	0.27700	2.73e-01	4.68e-02	2.12e-01	8.30e-01
GOBP NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY	58	5.60e-04	6.60e-03	0.27700	-2.72e-01	5.03e-02	3.40e-04	5.08e-01
Signaling by ERBB2 KD Mutants	25	4.31e-02	1.70e-01	0.27600	2.75e-01	-3.14e-02	1.75e-02	7.86e-01
GOBP NEGATIVE REGULATION OF NEURON DIFFERENTIATION	71	9.11e-04	9.74e-03	0.27600	1.29e-01	2.45e-01	6.05e-02	3.66e-04
GOMF RAGE RECEPTOR BINDING	10	2.80e-01	5.19e-01	0.27600	-2.74e-01	3.94e-02	1.34e-01	8.29e-01
GOBP DECIDUALIZATION	24	9.26e-02	2.77e-01	0.27600	1.26e-01	2.46e-01	2.87e-01	3.68e-02
GOMF G QUADRUPLEX RNA BINDING	6	5.61e-01	7.54e-01	0.27600	2.30e-01	1.53e-01	3.28e-01	5.17e-01
GOBP REGULATION OF VIRAL TRANSCRIPTION	18	1.69e-01	3.91e-01	0.27600	2.45e-01	1.29e-01	7.25e-02	3.44e-01
GOBP INTERLEUKIN 10 PRODUCTION	58	2.77e-04	3.67e-03	0.27600	-2.43e-01	1.32e-01	1.37e-03	8.29e-02
GOBP ACUTE INFLAMMATORY RESPONSE	100	5.53e-05	9.47e-04	0.27600	-2.43e-01	-1.32e-01	2.74e-05	2.24e-02
GOBP POSITIVE REGULATION OF MYELINATION	18	1.66e-01	3.88e-01	0.27600	-1.21e-01	-2.48e-01	3.74e-01	6.81e-02
Formation of RNA Pol II elongation complex	57	4.34e-03	3.19e-02	0.27600	2.24e-01	1.61e-01	3.38e-03	3.53e-02
RNA Polymerase II Transcription Elongation	57	4.34e-03	3.19e-02	0.27600	2.24e-01	1.61e-01	3.38e-03	3.53e-02
GOCC SMALL SUBUNIT PROCESSOME	69	9.55e-04	1.01e-02	0.27600	2.53e-01	1.11e-01	2.78e-04	1.11e-01
GOBP CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS	15	1.77e-01	4.01e-01	0.27600	2.75e-01	2.40e-02	6.50e-02	8.72e-01
GOBP PROTEIN LOCALIZATION TO CHROMOSOME	122	8.36e-06	1.86e-04	0.27600	2.31e-01	1.52e-01	1.09e-05	3.70e-03
GOMF TRANSCRIPTION ELONGATION FACTOR ACTIVITY	7	4.26e-01	6.55e-01	0.27600	-1.07e-02	2.76e-01	9.61e-01	2.06e-01
GOMF STRUCTURAL CONSTITUENT OF NUCLEAR PORE	23	9.18e-02	2.75e-01	0.27600	2.61e-01	9.10e-02	3.04e-02	4.50e-01
GOBP DETECTION OF MECHANICAL STIMULUS	54	5.28e-03	3.68e-02	0.27600	-1.41e-01	-2.37e-01	7.34e-02	2.53e-03
GOBP NEGATIVE REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY	8	4.27e-01	6.56e-01	0.27600	-7.48e-02	-2.66e-01	7.14e-01	1.93e-01
GOCC HIPPOCAMPAL MOSSY FIBER	6	5.40e-01	7.39e-01	0.27600	-9.84e-02	-2.58e-01	6.76e-01	2.74e-01
GOBP PHOTOTRANSDUCTION	41	5.49e-03	3.79e-02	0.27600	4.01e-02	-2.73e-01	6.57e-01	2.47e-03
IkBA variant leads to EDA-ID	6	5.08e-01	7.16e-01	0.27600	2.74e-01	3.69e-02	2.46e-01	8.76e-01
GOBP REGULATION OF CORTISOL BIOSYNTHETIC PROCESS	7	4.25e-01	6.54e-01	0.27600	-2.76e-01	1.29e-02	2.07e-01	9.53e-01
TP53 Regulates Metabolic Genes	80	3.09e-04	4.01e-03	0.27600	2.54e-01	1.08e-01	8.45e-05	9.64e-02
Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7	14	2.47e-01	4.85e-01	0.27600	2.49e-01	1.19e-01	1.06e-01	4.42e-01
FCERI mediated NF-kB activation	66	1.44e-03	1.36e-02	0.27600	2.48e-01	1.21e-01	4.96e-04	8.83e-02
GOMF GABA RECEPTOR ACTIVITY	19	1.05e-01	2.99e-01	0.27600	-5.05e-03	-2.76e-01	9.70e-01	3.73e-02
GOBP NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION	6	4.27e-01	6.56e-01	0.27600	-2.39e-01	1.38e-01	3.11e-01	5.58e-01
GOBP NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION	22	1.02e-01	2.93e-01	0.27600	2.61e-01	8.89e-02	3.39e-02	4.71e-01
Erythropoietin activates RAS	14	2.66e-01	5.05e-01	0.27600	2.15e-01	1.73e-01	1.65e-01	2.61e-01
Viral Messenger RNA Synthesis	44	7.04e-03	4.59e-02	0.27600	2.73e-01	3.69e-02	1.70e-03	6.72e-01
GOBP TOLERANCE INDUCTION	29	1.68e-02	8.77e-02	0.27600	-2.42e-01	1.32e-01	2.38e-02	2.20e-01
Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1	16	2.15e-01	4.47e-01	0.27600	1.52e-01	2.30e-01	2.94e-01	1.11e-01
FLT3 signaling through SRC family kinases	6	5.36e-01	7.37e-01	0.27600	2.61e-01	8.99e-02	2.69e-01	7.03e-01
Release of Hh-Np from the secreting cell	8	3.14e-01	5.54e-01	0.27600	-1.77e-01	2.12e-01	3.87e-01	2.99e-01
Plasma lipoprotein clearance	37	2.79e-02	1.26e-01	0.27600	2.36e-01	1.42e-01	1.29e-02	1.34e-01
Phenylalanine metabolism	6	4.24e-01	6.53e-01	0.27600	-2.30e-01	1.52e-01	3.30e-01	5.18e-01
GOBP REGULATION OF CELLULAR PH REDUCTION	7	4.00e-01	6.32e-01	0.27600	-6.41e-02	2.68e-01	7.69e-01	2.19e-01
GOCC PROTEASOME REGULATORY PARTICLE LID SUBCOMPLEX	7	5.15e-01	7.22e-01	0.27600	2.20e-01	1.66e-01	3.13e-01	4.47e-01
GOBP GLIAL CELL DERIVED NEUROTROPHIC FACTOR RECEPTOR SIGNALING PATHWAY	15	1.41e-01	3.53e-01	0.27600	-2.68e-01	6.37e-02	7.21e-02	6.70e-01
rRNA processing in the nucleus and cytosol	181	3.75e-08	1.49e-06	0.27600	2.24e-01	1.60e-01	1.98e-07	1.97e-04
GOMF LIGASE ACTIVITY FORMING PHOSPHORIC ESTER BONDS	6	5.56e-01	7.50e-01	0.27600	1.31e-01	2.42e-01	5.78e-01	3.04e-01
GOBP NEPHRIC DUCT FORMATION	5	6.00e-01	7.79e-01	0.27500	-2.57e-01	-9.99e-02	3.20e-01	6.99e-01
GOBP PHARYNGEAL SYSTEM DEVELOPMENT	31	5.34e-02	1.96e-01	0.27500	1.67e-01	2.19e-01	1.08e-01	3.47e-02
GOBP POSITIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS	9	3.23e-01	5.61e-01	0.27500	3.51e-02	-2.73e-01	8.55e-01	1.56e-01
GOMF CLASS I DNA APURINIC OR APYRIMIDINIC SITE ENDONUCLEASE ACTIVITY	8	4.72e-01	6.93e-01	0.27500	1.78e-01	2.10e-01	3.83e-01	3.04e-01
GOBP REGULATION OF ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS	5	6.24e-01	7.93e-01	0.27500	1.70e-01	2.17e-01	5.11e-01	4.01e-01
Nucleotide biosynthesis	12	1.95e-01	4.24e-01	0.27500	2.57e-01	-9.98e-02	1.24e-01	5.49e-01
GOCC GLYCOGEN GRANULE	6	4.44e-01	6.71e-01	0.27500	-9.38e-02	2.59e-01	6.91e-01	2.72e-01
GOBP TRNA AMINOACYLATION FOR MITOCHONDRIAL PROTEIN TRANSLATION	8	3.65e-01	6.02e-01	0.27500	2.73e-01	-3.75e-02	1.82e-01	8.54e-01
Signaling by BMP	30	5.26e-02	1.94e-01	0.27500	2.45e-01	1.26e-01	2.04e-02	2.32e-01
GOBP RHOMBOMERE DEVELOPMENT	8	3.68e-01	6.05e-01	0.27500	-3.21e-02	2.73e-01	8.75e-01	1.81e-01
GOBP POSITIVE REGULATION OF PROGRAMMED NECROTIC CELL DEATH	10	2.36e-01	4.73e-01	0.27500	-2.04e-01	1.85e-01	2.65e-01	3.11e-01
GOBP CHROMOSOME ORGANIZATION	614	5.96e-27	1.38e-24	0.27500	2.54e-01	1.05e-01	4.94e-27	8.66e-06
GOMF PHOSPHODIESTERASE I ACTIVITY	5	4.86e-01	7.00e-01	0.27500	1.97e-01	-1.92e-01	4.47e-01	4.57e-01
GOBP EMBRYONIC SKELETAL SYSTEM DEVELOPMENT	126	7.13e-06	1.63e-04	0.27500	1.63e-01	2.22e-01	1.61e-03	1.73e-05
GOBP MITOCHONDRIAL ATP TRANSMEMBRANE TRANSPORT	6	4.78e-01	6.96e-01	0.27500	-2.33e-02	2.74e-01	9.21e-01	2.45e-01
GOBP TRANSCRIPTION ELONGATION BY RNA POLYMERASE I	7	5.18e-01	7.24e-01	0.27500	1.70e-01	2.16e-01	4.36e-01	3.22e-01
GOMF CHITIN BINDING	8	4.55e-01	6.80e-01	0.27500	-2.46e-01	-1.22e-01	2.28e-01	5.49e-01
GOBP OSMOSENSORY SIGNALING PATHWAY	7	4.20e-01	6.51e-01	0.27500	-2.73e-01	2.79e-02	2.10e-01	8.98e-01
Cyclin D associated events in G1	46	1.21e-02	6.89e-02	0.27500	2.35e-01	1.43e-01	5.85e-03	9.43e-02
G1 Phase	46	1.21e-02	6.89e-02	0.27500	2.35e-01	1.43e-01	5.85e-03	9.43e-02
GOMF RNA POLYMERASE I GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY	5	5.40e-01	7.39e-01	0.27500	2.74e-01	-2.53e-02	2.89e-01	9.22e-01
GOBP POSITIVE REGULATION OF GONAD DEVELOPMENT	8	3.98e-01	6.31e-01	0.27500	1.91e-02	2.74e-01	9.26e-01	1.80e-01
Induction of Cell-Cell Fusion	12	2.98e-01	5.38e-01	0.27400	-2.55e-01	-1.02e-01	1.27e-01	5.40e-01
GOMF UBIQUITIN LIKE PROTEIN PEPTIDASE ACTIVITY	101	6.09e-05	1.03e-03	0.27400	2.38e-01	1.37e-01	3.56e-05	1.77e-02
Asymmetric localization of PCP proteins	51	6.41e-03	4.29e-02	0.27400	2.50e-01	1.14e-01	2.04e-03	1.60e-01
SUMOylation of intracellular receptors	29	6.30e-02	2.17e-01	0.27400	2.32e-01	1.47e-01	3.06e-02	1.72e-01
GOBP POSITIVE REGULATION OF VITAMIN D RECEPTOR SIGNALING PATHWAY	6	5.53e-01	7.48e-01	0.27400	1.17e-01	2.48e-01	6.19e-01	2.93e-01
GOBP TOOTH ERUPTION	5	6.03e-01	7.81e-01	0.27400	-1.01e-01	-2.55e-01	6.97e-01	3.23e-01
GOBP REGULATION OF NK T CELL DIFFERENTIATION	6	4.35e-01	6.63e-01	0.27400	2.45e-01	-1.23e-01	2.99e-01	6.00e-01
GOBP POSITIVE REGULATION OF MITOPHAGY IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION	8	4.28e-01	6.56e-01	0.27400	2.66e-01	6.72e-02	1.93e-01	7.42e-01
GOBP REGULATION OF DNA DIRECTED DNA POLYMERASE ACTIVITY	9	4.14e-01	6.45e-01	0.27400	1.21e-01	2.46e-01	5.29e-01	2.01e-01
Interleukin-9 signaling	7	4.79e-01	6.96e-01	0.27400	7.26e-02	2.64e-01	7.40e-01	2.26e-01
Generic Transcription Pathway	1169	2.61e-46	1.28e-43	0.27400	2.25e-01	1.57e-01	1.67e-38	1.43e-19
GOBP MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER	13	2.56e-01	4.93e-01	0.27400	7.39e-02	2.64e-01	6.45e-01	9.95e-02
GOBP NEGATIVE REGULATION OF FIBROBLAST APOPTOTIC PROCESS	7	4.09e-01	6.41e-01	0.27400	2.69e-01	-5.40e-02	2.18e-01	8.05e-01
GOBP PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING	9	3.62e-01	5.99e-01	0.27400	-2.74e-02	-2.73e-01	8.87e-01	1.57e-01
GOBP ENUCLEATE ERYTHROCYTE DIFFERENTIATION	13	2.20e-01	4.54e-01	0.27400	8.45e-03	2.74e-01	9.58e-01	8.73e-02
Downregulation of ERBB4 signaling	9	3.71e-01	6.07e-01	0.27400	2.71e-01	4.18e-02	1.60e-01	8.28e-01
Cell Cycle, Mitotic	495	1.16e-20	1.73e-18	0.27400	2.29e-01	1.50e-01	2.67e-18	1.00e-08
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE	34	4.08e-02	1.64e-01	0.27400	2.25e-01	1.55e-01	2.29e-02	1.17e-01
GOMF POTASSIUM ION BINDING	13	2.64e-01	5.03e-01	0.27400	8.70e-02	2.60e-01	5.87e-01	1.05e-01
GOBP PHOSPHATIDYLGLYCEROL BIOSYNTHETIC PROCESS	9	4.02e-01	6.34e-01	0.27400	2.57e-01	9.54e-02	1.83e-01	6.20e-01
GOBP NEGATIVE REGULATION OF RELAXATION OF MUSCLE	7	4.95e-01	7.08e-01	0.27400	-1.01e-01	-2.54e-01	6.43e-01	2.44e-01
GOBP NEGATIVE REGULATION OF DENDRITIC CELL DIFFERENTIATION	5	5.64e-01	7.56e-01	0.27400	-2.73e-01	-1.71e-02	2.90e-01	9.47e-01
GOBP MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA	34	3.69e-02	1.53e-01	0.27400	2.43e-01	1.25e-01	1.41e-02	2.06e-01
EGFR downregulation	30	3.34e-02	1.42e-01	0.27400	2.73e-01	2.27e-02	9.74e-03	8.29e-01
Mitochondrial Uncoupling	6	4.57e-01	6.82e-01	0.27400	-2.64e-01	7.25e-02	2.63e-01	7.59e-01
Interleukin-23 signaling	9	3.79e-01	6.13e-01	0.27300	5.35e-02	2.68e-01	7.81e-01	1.64e-01
Crosslinking of collagen fibrils	16	1.56e-01	3.73e-01	0.27300	-6.63e-03	-2.73e-01	9.63e-01	5.84e-02
GOBP ENDOCARDIAL CUSHION DEVELOPMENT	54	6.79e-03	4.48e-02	0.27300	1.77e-01	2.09e-01	2.47e-02	8.01e-03
GOBP CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER	33	4.73e-02	1.81e-01	0.27300	1.78e-01	2.07e-01	7.64e-02	3.94e-02
GOBP HYPEROSMOTIC RESPONSE	25	7.47e-02	2.41e-01	0.27300	2.62e-01	7.68e-02	2.32e-02	5.06e-01
tRNA Aminoacylation	40	2.36e-02	1.12e-01	0.27300	2.24e-01	1.56e-01	1.42e-02	8.68e-02
GOCC CILIARY TIP	47	4.55e-03	3.30e-02	0.27300	2.73e-01	1.30e-02	1.21e-03	8.78e-01
GOBP TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING	12	2.29e-01	4.63e-01	0.27300	3.08e-02	-2.71e-01	8.53e-01	1.03e-01
GOMF AXON GUIDANCE RECEPTOR ACTIVITY	10	3.21e-01	5.59e-01	0.27300	-1.88e-02	-2.73e-01	9.18e-01	1.36e-01
GOBP PEPTIDYL LYSINE MODIFICATION	141	3.02e-07	9.96e-06	0.27300	2.67e-01	5.67e-02	4.27e-08	2.45e-01
GOBP MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS	594	4.85e-24	8.75e-22	0.27300	2.11e-01	1.73e-01	1.24e-18	5.84e-13
GOMF L PROLINE TRANSMEMBRANE TRANSPORTER ACTIVITY	7	4.14e-01	6.45e-01	0.27300	-2.69e-01	4.81e-02	2.18e-01	8.25e-01
GOMF CHEMOKINE ACTIVITY	46	1.40e-02	7.69e-02	0.27300	-1.66e-01	-2.17e-01	5.17e-02	1.09e-02
GOBP MANNOSE METABOLIC PROCESS	9	2.92e-01	5.30e-01	0.27300	2.46e-01	-1.19e-01	2.02e-01	5.35e-01
GOBP HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS	14	1.71e-01	3.93e-01	0.27300	2.69e-01	-4.90e-02	8.17e-02	7.51e-01
GOBP RESPONSE TO PROGESTERONE	44	1.05e-02	6.22e-02	0.27300	7.68e-02	2.62e-01	3.78e-01	2.63e-03
GOBP DNA REPAIR	579	3.96e-24	7.35e-22	0.27300	2.36e-01	1.38e-01	2.89e-22	1.42e-08
GOBP REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE DEPOLARIZATION	8	3.27e-01	5.66e-01	0.27300	-2.30e-01	1.47e-01	2.59e-01	4.73e-01
GOBP REGULATION OF NEUROBLAST PROLIFERATION	54	6.90e-03	4.53e-02	0.27300	1.79e-01	2.06e-01	2.31e-02	8.69e-03
GOBP REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY	5	6.08e-01	7.84e-01	0.27300	-2.53e-01	-1.04e-01	3.28e-01	6.88e-01
GOBP POSITIVE REGULATION OF PROTEIN KINASE C SIGNALING	9	4.04e-01	6.36e-01	0.27300	-2.56e-01	-9.47e-02	1.83e-01	6.23e-01
GOBP REGULATION OF GLUCOCORTICOID METABOLIC PROCESS	11	2.63e-01	5.02e-01	0.27300	-2.72e-01	2.39e-02	1.18e-01	8.91e-01
GOBP SNRNA TRANSPORT	6	5.41e-01	7.40e-01	0.27300	8.36e-02	2.60e-01	7.23e-01	2.70e-01
GOBP NUCLEOSIDE SALVAGE	11	3.47e-01	5.85e-01	0.27300	1.28e-01	2.41e-01	4.64e-01	1.66e-01
GOBP PROSTATE GLAND MORPHOGENESIS	27	5.13e-02	1.91e-01	0.27300	3.80e-02	2.70e-01	7.32e-01	1.51e-02
GOBP MESENDODERM DEVELOPMENT	9	4.29e-01	6.58e-01	0.27300	1.50e-01	2.28e-01	4.35e-01	2.37e-01
GOCC PRESPLICEOSOME	17	1.30e-01	3.38e-01	0.27300	2.72e-01	-1.66e-02	5.19e-02	9.06e-01
GOBP BRONCHIOLE DEVELOPMENT	6	4.41e-01	6.68e-01	0.27300	1.17e-01	-2.46e-01	6.19e-01	2.96e-01
GOBP POSITIVE REGULATION OF TOLERANCE INDUCTION	10	2.45e-01	4.83e-01	0.27300	-1.63e-01	2.19e-01	3.73e-01	2.31e-01
GOBP NEURONAL ION CHANNEL CLUSTERING	12	2.54e-01	4.92e-01	0.27300	-1.51e-02	-2.72e-01	9.28e-01	1.02e-01
GOBP POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE	79	1.51e-05	3.07e-04	0.27300	-1.66e-01	2.17e-01	1.10e-02	8.69e-04
GOBP POSITIVE REGULATION OF CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS	5	6.15e-01	7.88e-01	0.27300	2.46e-01	1.18e-01	3.41e-01	6.49e-01
GOBP NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH	12	3.32e-01	5.71e-01	0.27300	1.83e-01	2.03e-01	2.74e-01	2.24e-01
GOCC SERINE PROTEASE INHIBITOR COMPLEX	6	5.40e-01	7.39e-01	0.27300	8.05e-02	2.60e-01	7.33e-01	2.69e-01
GOBP POSITIVE REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT	9	4.15e-01	6.46e-01	0.27300	1.14e-01	2.48e-01	5.55e-01	1.98e-01
GOMF PHOSPHATIDYLINOSITOL 3 KINASE BINDING	25	5.65e-02	2.02e-01	0.27300	8.99e-03	2.72e-01	9.38e-01	1.84e-02
GOCC RNA POLYMERASE II TRANSCRIPTION REGULATOR COMPLEX	236	4.89e-10	2.73e-08	0.27300	1.92e-01	1.93e-01	3.67e-07	3.12e-07
Major pathway of rRNA processing in the nucleolus and cytosol	172	1.21e-07	4.32e-06	0.27200	2.24e-01	1.56e-01	4.22e-07	4.24e-04
GOBP SULFATE TRANSPORT	17	1.13e-01	3.12e-01	0.27200	-2.65e-01	6.53e-02	5.90e-02	6.41e-01
GOMF HEPARAN SULFATE SULFOTRANSFERASE ACTIVITY	14	2.49e-01	4.88e-01	0.27200	-2.52e-01	-1.02e-01	1.02e-01	5.07e-01
GOMF PROTEIN SERINE THREONINE KINASE INHIBITOR ACTIVITY	39	2.61e-02	1.20e-01	0.27200	1.50e-01	2.27e-01	1.06e-01	1.40e-02
GOBP REGULATION OF GLUCOSYLCERAMIDE CATABOLIC PROCESS	5	5.45e-01	7.42e-01	0.27200	-2.71e-01	2.73e-02	2.94e-01	9.16e-01
GOCC ACTOMYOSIN	91	4.46e-06	1.09e-04	0.27200	2.46e-01	-1.17e-01	5.04e-05	5.36e-02
GOBP CELLULAR RESPONSE TO ZINC ION	23	4.28e-02	1.70e-01	0.27200	-1.28e-01	2.40e-01	2.90e-01	4.59e-02
GOBP PYRUVATE FAMILY AMINO ACID CATABOLIC PROCESS	10	2.90e-01	5.29e-01	0.27200	-2.69e-01	3.99e-02	1.40e-01	8.27e-01
GOBP POSITIVE REGULATION OF CELLULAR EXTRAVASATION	16	2.25e-01	4.59e-01	0.27200	-2.26e-01	-1.52e-01	1.17e-01	2.94e-01
GOBP RESPONSE TO INTERLEUKIN 7	15	1.39e-01	3.50e-01	0.27200	-8.85e-02	2.57e-01	5.53e-01	8.43e-02
GOBP MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS	160	4.57e-07	1.44e-05	0.27200	1.76e-01	2.07e-01	1.18e-04	5.98e-06
GOBP REGULATION OF SYNAPTIC VESICLE TRANSPORT	5	5.75e-01	7.65e-01	0.27200	-2.70e-01	-3.24e-02	2.95e-01	9.00e-01
GOBP DNA DAMAGE RESPONSE	857	2.70e-34	8.96e-32	0.27200	2.28e-01	1.49e-01	9.13e-30	1.27e-13
GOMF PHOSPHATIDYLINOSITOL MONOPHOSPHATE PHOSPHATASE ACTIVITY	11	2.47e-01	4.85e-01	0.27200	2.65e-01	-6.14e-02	1.28e-01	7.24e-01
GOBP REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION	13	2.96e-01	5.36e-01	0.27200	1.48e-01	2.28e-01	3.57e-01	1.54e-01
GOCC NUCLEAR PORE OUTER RING	10	3.07e-01	5.47e-01	0.27200	2.72e-01	-9.76e-03	1.37e-01	9.57e-01
NCAM signaling for neurite out-growth	62	3.34e-03	2.61e-02	0.27200	-1.65e-01	-2.16e-01	2.48e-02	3.23e-03
GOBP REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY	11	3.03e-01	5.43e-01	0.27200	-4.19e-02	-2.69e-01	8.10e-01	1.23e-01
GOBP NK T CELL PROLIFERATION	8	3.60e-01	5.98e-01	0.27200	-6.44e-02	2.64e-01	7.52e-01	1.96e-01
GOBP NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION	8	4.81e-01	6.97e-01	0.27200	1.80e-01	2.03e-01	3.77e-01	3.19e-01
GOBP POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT	32	2.83e-02	1.27e-01	0.27200	2.50e-02	2.71e-01	8.07e-01	8.05e-03
GOBP DNA CONFORMATION CHANGE	87	1.80e-04	2.52e-03	0.27200	2.54e-01	9.78e-02	4.32e-05	1.15e-01
GOMF HISTONE METHYLTRANSFERASE ACTIVITY	69	5.81e-04	6.81e-03	0.27200	2.68e-01	4.31e-02	1.16e-04	5.36e-01
GOMF 1 4 ALPHA OLIGOGLUCAN PHOSPHORYLASE ACTIVITY	5	5.96e-01	7.76e-01	0.27200	-7.04e-02	-2.62e-01	7.85e-01	3.10e-01
Cdc20:Phospho-APC/C mediated degradation of Cyclin A	60	3.50e-03	2.71e-02	0.27200	2.35e-01	1.36e-01	1.63e-03	6.82e-02
ESR-mediated signaling	183	1.52e-08	6.42e-07	0.27200	2.53e-01	9.92e-02	3.57e-09	2.06e-02
GOBP ADENOSINE TRANSPORT	5	6.34e-01	8.00e-01	0.27200	-1.91e-01	-1.93e-01	4.59e-01	4.55e-01
GOCC SORTING ENDOSOME	6	4.52e-01	6.78e-01	0.27200	2.54e-01	-9.54e-02	2.81e-01	6.86e-01
GOBP T CELL EXTRAVASATION	11	2.21e-01	4.54e-01	0.27200	-2.35e-01	1.37e-01	1.78e-01	4.33e-01
GOBP SERTOLI CELL PROLIFERATION	5	5.48e-01	7.45e-01	0.27200	-2.44e-02	2.70e-01	9.25e-01	2.95e-01
GOBP MATURATION OF 5 8S RRNA	34	4.26e-02	1.69e-01	0.27100	2.26e-01	1.51e-01	2.27e-02	1.28e-01
GOBP CELLULAR RESPONSE TO CHOLESTEROL	20	1.38e-01	3.49e-01	0.27100	-9.76e-02	-2.53e-01	4.50e-01	4.99e-02
GOBP REGULATION OF MATRIX METALLOPEPTIDASE SECRETION	10	3.57e-01	5.94e-01	0.27100	-2.62e-01	-7.22e-02	1.52e-01	6.93e-01
GOMF G QUADRUPLEX DNA BINDING	11	3.64e-01	6.01e-01	0.27100	2.16e-01	1.65e-01	2.15e-01	3.45e-01
Interleukin-35 Signalling	12	2.44e-01	4.82e-01	0.27100	-1.03e-02	2.71e-01	9.51e-01	1.04e-01
GOMF PHOSPHATIDYLINOSITOL PHOSPHATE PHOSPHATASE ACTIVITY	26	6.13e-02	2.13e-01	0.27100	2.67e-01	4.58e-02	1.82e-02	6.86e-01
GOBP POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS	19	8.51e-02	2.63e-01	0.27100	8.06e-02	-2.59e-01	5.43e-01	5.06e-02
GOBP RRNA MODIFICATION	31	5.86e-02	2.07e-01	0.27100	2.13e-01	1.68e-01	4.00e-02	1.06e-01
Signaling by FGFR3 in disease	21	9.33e-02	2.78e-01	0.27100	2.71e-01	1.45e-02	3.16e-02	9.08e-01
GOBP MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY	92	2.22e-04	3.03e-03	0.27100	2.16e-01	1.65e-01	3.52e-04	6.32e-03
Regulation of NFE2L2 gene expression	8	4.75e-01	6.95e-01	0.27100	2.28e-01	1.47e-01	2.64e-01	4.72e-01
Regulation of PTEN stability and activity	55	3.13e-03	2.48e-02	0.27100	2.65e-01	5.90e-02	6.84e-04	4.49e-01
GOBP POSITIVE REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS	8	4.79e-01	6.97e-01	0.27100	-1.61e-01	-2.18e-01	4.30e-01	2.85e-01
GOBP REGULATION OF CELL PROLIFERATION IN BONE MARROW	8	3.28e-01	5.68e-01	0.27100	-1.62e-01	2.17e-01	4.27e-01	2.87e-01
GOBP NEGATIVE REGULATION OF DNA TEMPLATED DNA REPLICATION	10	4.01e-01	6.34e-01	0.27100	2.12e-01	1.70e-01	2.47e-01	3.53e-01
GOMF SINGLE STRANDED DNA 5 3 DNA EXONUCLEASE ACTIVITY	5	4.97e-01	7.09e-01	0.27100	-1.71e-01	2.11e-01	5.09e-01	4.15e-01
GOMF LRR DOMAIN BINDING	16	1.82e-01	4.07e-01	0.27100	2.67e-01	4.96e-02	6.49e-02	7.31e-01
GOBP POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN	6	4.77e-01	6.95e-01	0.27100	4.40e-02	-2.67e-01	8.52e-01	2.57e-01
GOBP REGULATION OF DNA CATABOLIC PROCESS	11	3.62e-01	6.00e-01	0.27100	1.54e-01	2.23e-01	3.78e-01	2.00e-01
GOBP REGULATION OF MEMBRANE TUBULATION	5	5.89e-01	7.72e-01	0.27100	5.25e-02	2.66e-01	8.39e-01	3.03e-01
GOBP RESPONSE TO INTERLEUKIN 12	12	2.32e-01	4.68e-01	0.27100	-2.69e-01	3.51e-02	1.07e-01	8.33e-01
GOBP NEGATIVE REGULATION OF PROTEIN POLYUBIQUITINATION	8	3.95e-01	6.28e-01	0.27100	-4.53e-03	2.71e-01	9.82e-01	1.85e-01
Cell Cycle	620	3.06e-25	6.15e-23	0.27100	2.32e-01	1.40e-01	6.37e-23	2.30e-09
GOCC OUTER KINETOCHORE	20	1.08e-01	3.04e-01	0.27100	2.70e-01	2.09e-02	3.65e-02	8.71e-01
GOMF INTRACELLULARLY CALCIUM GATED CHLORIDE CHANNEL ACTIVITY	20	1.56e-01	3.72e-01	0.27100	-2.29e-01	-1.44e-01	7.61e-02	2.63e-01
GOBP MIRNA METABOLIC PROCESS	104	8.24e-05	1.32e-03	0.27100	1.79e-01	2.03e-01	1.61e-03	3.41e-04
GOBP PROTEIN LOCALIZATION TO CHROMATIN	58	5.26e-03	3.68e-02	0.27100	1.83e-01	2.00e-01	1.60e-02	8.49e-03
KEAP1-NFE2L2 pathway	113	2.66e-05	5.09e-04	0.27100	2.33e-01	1.38e-01	1.86e-05	1.13e-02
GOMF EPHRIN RECEPTOR ACTIVITY	18	1.48e-01	3.61e-01	0.27100	-2.66e-01	-4.97e-02	5.05e-02	7.15e-01
GOCC NLS DEPENDENT PROTEIN NUCLEAR IMPORT COMPLEX	10	3.78e-01	6.13e-01	0.27100	1.08e-01	2.48e-01	5.55e-01	1.74e-01
GOBP EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS	93	2.05e-04	2.82e-03	0.27100	1.61e-01	2.18e-01	7.43e-03	2.79e-04
GOBP PROTEIN RNA COMPLEX DISASSEMBLY	10	3.14e-01	5.54e-01	0.27100	2.71e-01	-3.61e-03	1.38e-01	9.84e-01
PI-3K cascade:FGFR3	17	1.62e-01	3.82e-01	0.27100	2.67e-01	4.48e-02	5.68e-02	7.49e-01
GOBP REGULATION OF CELLULAR EXTRAVASATION	39	1.47e-02	7.95e-02	0.27100	-2.68e-01	-3.67e-02	3.77e-03	6.92e-01
Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding	31	5.64e-02	2.02e-01	0.27100	1.44e-01	2.29e-01	1.66e-01	2.71e-02
GOMF TRANSLATION REGULATOR ACTIVITY NUCLEIC ACID BINDING	95	1.16e-04	1.74e-03	0.27000	2.44e-01	1.17e-01	3.96e-05	4.92e-02
GOBP COPPER ION HOMEOSTASIS	18	9.10e-02	2.74e-01	0.27000	-1.11e-01	2.47e-01	4.17e-01	6.99e-02
GOMF METALLOCHAPERONE ACTIVITY	12	1.90e-01	4.18e-01	0.27000	-1.59e-01	2.19e-01	3.41e-01	1.89e-01
GOBP PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS	21	9.36e-02	2.78e-01	0.27000	2.70e-01	1.09e-02	3.21e-02	9.31e-01
SUMOylation of ubiquitinylation proteins	39	1.34e-02	7.46e-02	0.27000	2.69e-01	2.28e-02	3.60e-03	8.05e-01
TP53 Regulates Transcription of Cell Cycle Genes	47	9.29e-03	5.68e-02	0.27000	8.78e-02	2.56e-01	2.97e-01	2.42e-03
GOBP POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II	1191	4.09e-45	1.93e-42	0.27000	2.01e-01	1.81e-01	1.48e-31	6.65e-26
GOBP DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION	32	2.21e-02	1.07e-01	0.27000	2.69e-01	-2.52e-02	8.45e-03	8.05e-01
GOBP REGULATION OF EOSINOPHIL MIGRATION	5	5.00e-01	7.10e-01	0.27000	-2.11e-01	1.69e-01	4.14e-01	5.14e-01
GOBP ESTABLISHMENT OF MEIOTIC SPINDLE LOCALIZATION	6	5.34e-01	7.36e-01	0.27000	5.62e-02	2.64e-01	8.12e-01	2.62e-01
GOBP VIRAL TRANSLATION	19	9.09e-02	2.74e-01	0.27000	2.62e-01	-6.62e-02	4.82e-02	6.17e-01
GOBP NUCLEAR MEMBRANE ORGANIZATION	45	1.53e-02	8.22e-02	0.27000	1.38e-01	2.32e-01	1.09e-01	7.08e-03
GOCC ER TO GOLGI TRANSPORT VESICLE MEMBRANE	60	3.14e-03	2.48e-02	0.27000	1.11e-01	2.46e-01	1.38e-01	9.65e-04
GOBP FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS	12	2.12e-01	4.44e-01	0.27000	-2.56e-01	8.53e-02	1.24e-01	6.09e-01
GOBP WHITE FAT CELL DIFFERENTIATION	17	1.53e-01	3.69e-01	0.27000	2.69e-01	2.27e-02	5.48e-02	8.71e-01
GOBP RESPONSE TO ARSENIC CONTAINING SUBSTANCE	30	5.59e-02	2.01e-01	0.27000	1.10e-01	2.46e-01	2.95e-01	1.95e-02
rRNA modification in the nucleus and cytosol	57	4.39e-03	3.21e-02	0.27000	2.44e-01	1.17e-01	1.47e-03	1.28e-01
GOMF ANGIOTENSIN RECEPTOR BINDING	9	3.13e-01	5.53e-01	0.27000	2.56e-01	-8.40e-02	1.83e-01	6.63e-01
Defective B3GAT3 causes JDSSDHD	17	2.15e-01	4.47e-01	0.27000	-2.10e-01	-1.70e-01	1.34e-01	2.25e-01
GOBP EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION	13	3.07e-01	5.47e-01	0.27000	1.63e-01	2.15e-01	3.09e-01	1.79e-01
GOBP INNATE IMMUNE RESPONSE IN MUCOSA	22	7.23e-02	2.37e-01	0.27000	-2.81e-02	2.68e-01	8.20e-01	2.93e-02
GOBP CELLULAR RESPONSE TO GLUCOCORTICOID STIMULUS	54	7.84e-03	5.01e-02	0.27000	1.86e-01	1.96e-01	1.84e-02	1.27e-02
GOBP MITOTIC SPINDLE ORGANIZATION	127	1.02e-05	2.19e-04	0.27000	1.61e-01	2.16e-01	1.70e-03	2.54e-05
Killing mechanisms	11	2.24e-01	4.58e-01	0.27000	-2.30e-01	1.41e-01	1.87e-01	4.18e-01
WNT5:FZD7-mediated leishmania damping	11	2.24e-01	4.58e-01	0.27000	-2.30e-01	1.41e-01	1.87e-01	4.18e-01
GOBP REGULATION OF SYNAPTIC ASSEMBLY AT NEUROMUSCULAR JUNCTION	6	5.49e-01	7.45e-01	0.27000	-8.26e-02	-2.57e-01	7.26e-01	2.76e-01
Attachment and Entry 9694614	16	2.24e-01	4.58e-01	0.27000	-2.35e-01	-1.31e-01	1.03e-01	3.63e-01
GOMF RNA 2 O METHYLTRANSFERASE ACTIVITY	8	4.64e-01	6.87e-01	0.27000	1.11e-01	2.46e-01	5.86e-01	2.29e-01
GOBP L METHIONINE SALVAGE FROM METHYLTHIOADENOSINE	5	6.23e-01	7.93e-01	0.27000	-2.41e-01	-1.22e-01	3.51e-01	6.38e-01
GOBP POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS	14	1.44e-01	3.57e-01	0.27000	-2.07e-01	1.73e-01	1.80e-01	2.62e-01
GOBP POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION	13	1.66e-01	3.88e-01	0.27000	-1.69e-01	2.10e-01	2.90e-01	1.90e-01
GOBP REGULATION OF MICROTUBULE DEPOLYMERIZATION	27	8.78e-02	2.68e-01	0.27000	2.07e-01	1.73e-01	6.26e-02	1.20e-01
Synthesis of Leukotrienes (LT) and Eoxins (EX)	20	1.66e-01	3.88e-01	0.27000	-1.96e-01	-1.85e-01	1.30e-01	1.51e-01
GOBP REGULATION OF T HELPER 17 CELL DIFFERENTIATION	23	1.24e-01	3.28e-01	0.27000	1.60e-01	2.17e-01	1.83e-01	7.21e-02
GOCC GLYCOSYLPHOSPHATIDYLINOSITOL N ACETYLGLUCOSAMINYLTRANSFERASE GPI GNT COMPLEX	6	4.85e-01	6.99e-01	0.26900	2.67e-01	-3.67e-02	2.57e-01	8.76e-01
GOBP CELLULAR RESPONSE TO UV	87	3.95e-04	4.91e-03	0.26900	2.12e-01	1.66e-01	6.15e-04	7.52e-03
Inactivation of APC/C via direct inhibition of the APC/C complex	21	1.48e-01	3.61e-01	0.26900	1.53e-01	2.22e-01	2.25e-01	7.86e-02
Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components	21	1.48e-01	3.61e-01	0.26900	1.53e-01	2.22e-01	2.25e-01	7.86e-02
GOBP ABSCISSION	6	4.75e-01	6.95e-01	0.26900	-5.72e-02	2.63e-01	8.08e-01	2.64e-01
GOBP TELOMERE TETHERING AT NUCLEAR PERIPHERY	6	4.36e-01	6.64e-01	0.26900	1.90e-01	-1.91e-01	4.20e-01	4.19e-01
TCF dependent signaling in response to WNT	180	4.55e-08	1.77e-06	0.26900	2.42e-01	1.19e-01	2.23e-08	5.98e-03
GOBP NEGATIVE REGULATION OF MONOCYTE CHEMOTAXIS	6	4.79e-01	6.96e-01	0.26900	-4.93e-02	2.65e-01	8.34e-01	2.62e-01
GOMF LIGASE ACTIVITY FORMING CARBON OXYGEN BONDS	39	2.78e-02	1.25e-01	0.26900	2.28e-01	1.42e-01	1.36e-02	1.24e-01
GOBP POSITIVE REGULATION OF AMINE METABOLIC PROCESS	6	4.37e-01	6.64e-01	0.26900	-1.77e-01	2.02e-01	4.52e-01	3.91e-01
GOBP NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION	9	3.98e-01	6.31e-01	0.26900	6.60e-02	2.61e-01	7.32e-01	1.75e-01
GOMF METAL ION SENSOR ACTIVITY	8	4.85e-01	7.00e-01	0.26900	-1.62e-01	-2.15e-01	4.28e-01	2.92e-01
GOBP POSITIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS	104	8.21e-05	1.32e-03	0.26900	2.20e-01	1.55e-01	1.05e-04	6.38e-03
Degradation of DVL	44	9.67e-03	5.84e-02	0.26900	2.65e-01	4.53e-02	2.34e-03	6.03e-01
GOBP B CELL LINEAGE COMMITMENT	6	5.34e-01	7.36e-01	0.26900	2.64e-01	5.14e-02	2.63e-01	8.27e-01
GOBP OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS	21	1.36e-01	3.46e-01	0.26900	2.44e-01	1.13e-01	5.31e-02	3.68e-01
GOBP POSITIVE REGULATION OF ISOTYPE SWITCHING TO IGG ISOTYPES	11	3.12e-01	5.52e-01	0.26900	-4.36e-02	-2.65e-01	8.02e-01	1.28e-01
GOMF OUTWARD RECTIFIER POTASSIUM CHANNEL ACTIVITY	26	6.99e-02	2.32e-01	0.26900	-2.61e-01	-6.34e-02	2.11e-02	5.75e-01
GOBP PROTEIN FOLDING	211	6.45e-09	2.93e-07	0.26900	2.14e-01	1.62e-01	8.01e-08	4.83e-05
GOMF NUCLEOSIDE KINASE ACTIVITY	9	4.24e-01	6.53e-01	0.26900	1.09e-01	2.46e-01	5.70e-01	2.02e-01
Glycoprotein hormones	9	4.41e-01	6.68e-01	0.26900	-1.50e-01	-2.23e-01	4.34e-01	2.47e-01
GOBP CELL MOTILITY INVOLVED IN CEREBRAL CORTEX RADIAL GLIA GUIDED MIGRATION	6	4.91e-01	7.04e-01	0.26900	2.90e-02	-2.67e-01	9.02e-01	2.57e-01
GOBP POSITIVE REGULATION OF CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION	5	6.09e-01	7.85e-01	0.26900	2.55e-01	8.37e-02	3.23e-01	7.46e-01
Disassembly of the destruction complex and recruitment of AXIN to the membrane	30	6.41e-02	2.19e-01	0.26900	2.28e-01	1.42e-01	3.05e-02	1.79e-01
GOBP ENDOCARDIAL CUSHION FORMATION	31	6.21e-02	2.15e-01	0.26900	1.66e-01	2.11e-01	1.10e-01	4.20e-02
GOBP REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR	105	9.00e-05	1.42e-03	0.26900	1.84e-01	1.96e-01	1.14e-03	5.27e-04
GOBP QUINONE METABOLIC PROCESS	23	9.08e-02	2.74e-01	0.26800	2.64e-01	5.02e-02	2.85e-02	6.77e-01
GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC	33	5.07e-02	1.90e-01	0.26800	-2.20e-01	-1.54e-01	2.89e-02	1.25e-01
GOBP RNA METHYLATION	75	1.20e-03	1.21e-02	0.26800	2.14e-01	1.61e-01	1.32e-03	1.56e-02
GOBP CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION	40	2.84e-02	1.27e-01	0.26800	1.79e-01	2.00e-01	5.02e-02	2.86e-02
GOBP REGULATION OF L GLUTAMATE IMPORT ACROSS PLASMA MEMBRANE	8	3.47e-01	5.85e-01	0.26800	2.42e-01	-1.17e-01	2.37e-01	5.67e-01
GOBP BRANCHING MORPHOGENESIS OF A NERVE	10	3.18e-01	5.56e-01	0.26800	-8.25e-03	2.68e-01	9.64e-01	1.42e-01
GOBP REGULATION OF PROTEIN LOCALIZATION TO NUCLEOLUS	9	4.03e-01	6.35e-01	0.26800	2.59e-01	6.96e-02	1.78e-01	7.18e-01
GOMF POLY G BINDING	7	5.08e-01	7.16e-01	0.26800	2.50e-01	9.66e-02	2.52e-01	6.58e-01
GOBP 7 METHYLGUANOSINE CAP HYPERMETHYLATION	8	4.67e-01	6.89e-01	0.26800	2.46e-01	1.08e-01	2.29e-01	5.97e-01
activated TAK1 mediates p38 MAPK activation	20	1.65e-01	3.86e-01	0.26800	2.19e-01	1.54e-01	8.95e-02	2.32e-01
Transport of Mature mRNA derived from an Intron-Containing Transcript	69	1.01e-03	1.06e-02	0.26800	2.58e-01	7.34e-02	2.12e-04	2.92e-01
GOMF SIGNAL RECOGNITION PARTICLE BINDING	8	4.50e-01	6.75e-01	0.26800	2.57e-01	7.52e-02	2.08e-01	7.13e-01
GOBP NEGATIVE REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY	5	5.51e-01	7.47e-01	0.26800	3.40e-02	-2.66e-01	8.95e-01	3.03e-01
GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR	33	4.77e-02	1.82e-01	0.26800	1.30e-01	2.34e-01	1.95e-01	2.00e-02
GOBP NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS	17	2.11e-01	4.42e-01	0.26800	1.36e-01	2.31e-01	3.32e-01	9.92e-02
GOMF MEDIUM CHAIN FATTY ACID COA LIGASE ACTIVITY	10	4.05e-01	6.38e-01	0.26800	-2.22e-01	-1.49e-01	2.23e-01	4.13e-01
Downstream signaling of activated FGFR1	31	3.31e-02	1.41e-01	0.26800	2.67e-01	1.52e-02	9.95e-03	8.84e-01
NFE2L2 regulating anti-oxidant/detoxification enzymes	19	1.84e-01	4.09e-01	0.26800	2.10e-01	1.66e-01	1.12e-01	2.11e-01
GOBP ESTABLISHMENT OF RNA LOCALIZATION	150	8.89e-07	2.65e-05	0.26800	2.40e-01	1.20e-01	4.03e-07	1.14e-02
GOBP INTERNEURON MIGRATION	13	2.71e-01	5.10e-01	0.26800	2.59e-01	6.98e-02	1.06e-01	6.63e-01
LDL clearance	19	1.33e-01	3.43e-01	0.26800	2.65e-01	3.73e-02	4.54e-02	7.78e-01
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR	81	7.72e-04	8.63e-03	0.26800	1.78e-01	2.00e-01	5.70e-03	1.82e-03
GOBP INNER EAR RECEPTOR CELL FATE COMMITMENT	5	6.42e-01	8.05e-01	0.26800	-1.89e-01	-1.90e-01	4.64e-01	4.63e-01
Metabolism of ingested SeMet, Sec, MeSec into H2Se	7	4.41e-01	6.68e-01	0.26800	2.48e-02	-2.67e-01	9.10e-01	2.22e-01
GOMF CHONDROITIN SULFATE BINDING	9	4.18e-01	6.49e-01	0.26800	-9.27e-02	-2.51e-01	6.30e-01	1.92e-01
GOBP RESPONSE TO INTERLEUKIN 2	9	3.34e-01	5.73e-01	0.26800	-5.27e-02	2.62e-01	7.84e-01	1.73e-01
GOBP RESPONSE TO MANGANESE ION	17	1.70e-01	3.92e-01	0.26800	2.63e-01	4.68e-02	6.00e-02	7.38e-01
GOBP POSITIVE REGULATION OF MITOTIC CYTOKINESIS	13	3.02e-01	5.41e-01	0.26800	2.35e-01	1.29e-01	1.43e-01	4.22e-01
GOBP DE NOVO PROTEIN FOLDING	42	2.28e-02	1.09e-01	0.26700	2.22e-01	1.49e-01	1.27e-02	9.53e-02
GOBP REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL	12	1.98e-01	4.28e-01	0.26700	-1.52e-01	2.20e-01	3.63e-01	1.86e-01
GOMF ATP DEPENDENT ACTIVITY ACTING ON RNA	75	2.75e-04	3.66e-03	0.26700	2.67e-01	1.53e-02	6.39e-05	8.19e-01
GOBP ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS	25	1.10e-01	3.07e-01	0.26700	1.88e-01	1.91e-01	1.05e-01	9.90e-02
GOBP PROSTATE GLAND DEVELOPMENT	48	1.46e-02	7.92e-02	0.26700	1.86e-01	1.92e-01	2.55e-02	2.16e-02
GOBP DNA REPLICATION CHECKPOINT SIGNALING	20	1.57e-01	3.74e-01	0.26700	2.38e-01	1.22e-01	6.56e-02	3.45e-01
Defects in vitamin and cofactor metabolism	21	1.41e-01	3.53e-01	0.26700	2.41e-01	1.16e-01	5.60e-02	3.59e-01
Signaling by Retinoic Acid	39	3.04e-02	1.33e-01	0.26700	1.52e-01	2.20e-01	1.00e-01	1.76e-02
Mitotic G1 phase and G1/S transition	136	4.17e-06	1.03e-04	0.26700	2.32e-01	1.32e-01	2.86e-06	7.93e-03
GOCC NUCLEAR UBIQUITIN LIGASE COMPLEX	45	1.78e-02	9.14e-02	0.26700	1.52e-01	2.20e-01	7.76e-02	1.08e-02
GOBP REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION	12	2.43e-01	4.80e-01	0.26700	2.65e-01	-3.32e-02	1.12e-01	8.42e-01
GOBP MAINTENANCE OF PROTEIN LOCATION IN EXTRACELLULAR REGION	8	4.60e-01	6.83e-01	0.26700	2.52e-01	8.80e-02	2.17e-01	6.66e-01
GOBP T HELPER CELL LINEAGE COMMITMENT	23	7.87e-02	2.50e-01	0.26700	8.19e-03	2.67e-01	9.46e-01	2.67e-02
Defective B4GALT7 causes EDS, progeroid type	17	2.22e-01	4.56e-01	0.26700	-2.05e-01	-1.71e-01	1.43e-01	2.23e-01
GOCC PSEUDOPODIUM	16	1.30e-01	3.37e-01	0.26700	2.50e-01	-9.27e-02	8.29e-02	5.21e-01
GOBP HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS POLYSACCHARIDE CHAIN BIOSYNTHETIC PROCESS	8	3.37e-01	5.75e-01	0.26700	1.85e-01	-1.92e-01	3.64e-01	3.47e-01
GOMF MALATE DEHYDROGENASE ACTIVITY	8	3.51e-01	5.89e-01	0.26700	2.41e-01	-1.16e-01	2.39e-01	5.71e-01
GOCC TRANSCRIPTION ELONGATION FACTOR COMPLEX	51	1.09e-02	6.41e-02	0.26700	2.11e-01	1.64e-01	9.26e-03	4.28e-02
Formation of paraxial mesoderm	58	3.53e-03	2.72e-02	0.26700	2.53e-01	8.44e-02	8.50e-04	2.66e-01
GOBP REGULATION OF MIRNA METABOLIC PROCESS	87	4.07e-04	5.05e-03	0.26700	1.46e-01	2.24e-01	1.89e-02	3.09e-04
GOBP REGULATION OF INTRACELLULAR LIPID TRANSPORT	13	2.38e-01	4.74e-01	0.26700	-2.67e-01	-7.52e-03	9.58e-02	9.63e-01
GOBP ENTEROENDOCRINE CELL DIFFERENTIATION	35	4.39e-02	1.72e-01	0.26700	1.53e-01	2.19e-01	1.18e-01	2.50e-02
Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex	13	3.15e-01	5.54e-01	0.26700	1.60e-01	2.13e-01	3.17e-01	1.83e-01
Smooth Muscle Contraction	42	4.00e-03	2.99e-02	0.26700	2.36e-01	-1.25e-01	8.18e-03	1.62e-01
GOCC BOX H ACA RNP COMPLEX	7	5.28e-01	7.31e-01	0.26700	2.32e-01	1.32e-01	2.88e-01	5.46e-01
GOBP DOPAMINE SECRETION	30	2.01e-02	1.00e-01	0.26700	-2.41e-01	1.14e-01	2.23e-02	2.80e-01
GOMF MYRISTOYLTRANSFERASE ACTIVITY	10	3.79e-01	6.14e-01	0.26700	2.52e-01	8.72e-02	1.68e-01	6.33e-01
GOBP RESPIRATORY BURST	32	1.48e-02	8.02e-02	0.26700	-2.35e-01	1.27e-01	2.16e-02	2.15e-01
GOBP NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS	33	5.34e-02	1.96e-01	0.26700	2.15e-01	1.58e-01	3.29e-02	1.16e-01
GOMF OPIOID RECEPTOR BINDING	7	4.72e-01	6.94e-01	0.26600	-2.65e-01	-2.46e-02	2.24e-01	9.10e-01
Mitochondrial biogenesis	88	3.55e-04	4.49e-03	0.26600	2.29e-01	1.36e-01	2.02e-04	2.76e-02
GOBP SYNAPTIC VESICLE LUMEN ACIDIFICATION	15	2.43e-01	4.80e-01	0.26600	2.46e-01	1.03e-01	9.95e-02	4.90e-01
GOBP PROTEIN DNA COVALENT CROSS LINKING REPAIR	8	4.28e-01	6.57e-01	0.26600	2.65e-01	3.06e-02	1.95e-01	8.81e-01
APC/C-mediated degradation of cell cycle proteins	75	1.26e-03	1.25e-02	0.26600	2.20e-01	1.50e-01	9.68e-04	2.51e-02
Regulation of mitotic cell cycle	75	1.26e-03	1.25e-02	0.26600	2.20e-01	1.50e-01	9.68e-04	2.51e-02
GOBP MAINTENANCE OF PROTEIN LOCATION IN MITOCHONDRION	5	5.38e-01	7.38e-01	0.26600	-7.28e-02	2.56e-01	7.78e-01	3.21e-01
GOBP CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION	60	5.17e-03	3.63e-02	0.26600	-1.72e-01	-2.04e-01	2.15e-02	6.36e-03
GOMF GUANYLATE CYCLASE ACTIVITY	7	4.48e-01	6.74e-01	0.26600	-1.89e-02	2.66e-01	9.31e-01	2.24e-01
GOBP CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT	24	4.53e-02	1.76e-01	0.26600	-2.44e-01	1.07e-01	3.87e-02	3.63e-01
GOBP MEIOTIC ATTACHMENT OF TELOMERE TO NUCLEAR ENVELOPE	5	5.09e-01	7.17e-01	0.26600	1.71e-01	-2.04e-01	5.09e-01	4.28e-01
GOBP RESPONSE TO EPIDERMAL GROWTH FACTOR	46	1.60e-02	8.48e-02	0.26600	2.26e-01	1.40e-01	7.92e-03	1.00e-01
GOBP RNA SECONDARY STRUCTURE UNWINDING	8	3.64e-01	6.01e-01	0.26600	2.50e-01	-8.98e-02	2.20e-01	6.60e-01
GOBP POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS	11	3.63e-01	6.00e-01	0.26600	-2.38e-01	-1.19e-01	1.72e-01	4.93e-01
GOBP REGULATION OF HYDROGEN PEROXIDE MEDIATED PROGRAMMED CELL DEATH	15	1.45e-01	3.58e-01	0.26600	2.44e-01	-1.07e-01	1.02e-01	4.74e-01
GOBP NEGATIVE REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY	9	3.39e-01	5.77e-01	0.26600	5.15e-02	-2.61e-01	7.89e-01	1.75e-01
GOBP REGULATION OF MICROVILLUS ORGANIZATION	13	3.14e-01	5.54e-01	0.26600	-1.49e-01	-2.21e-01	3.54e-01	1.68e-01
GOCC ACTIN FILAMENT BUNDLE	92	5.64e-06	1.34e-04	0.26600	2.30e-01	-1.34e-01	1.37e-04	2.68e-02
GOMF SUPEROXIDE DISMUTASE ACTIVITY	5	6.46e-01	8.08e-01	0.26600	1.99e-01	1.76e-01	4.40e-01	4.96e-01
GOBP ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB	25	3.58e-02	1.50e-01	0.26600	-1.51e-01	2.19e-01	1.91e-01	5.84e-02
GOBP AUTOPHAGOSOME ORGANIZATION	118	2.08e-05	4.08e-04	0.26600	2.37e-01	1.20e-01	8.55e-06	2.47e-02
GOBP REGULATION OF CELLULAR RESPONSE TO STRESS	499	2.40e-19	3.31e-17	0.26600	2.08e-01	1.66e-01	1.87e-15	2.37e-10
GOMF HISTONE H3K27 METHYLTRANSFERASE ACTIVITY	6	5.41e-01	7.40e-01	0.26600	2.61e-01	4.78e-02	2.68e-01	8.39e-01
GOBP ER NUCLEUS SIGNALING PATHWAY	47	1.44e-02	7.86e-02	0.26600	2.30e-01	1.32e-01	6.28e-03	1.18e-01
GOBP REGULATION OF SPINDLE ASSEMBLY	31	6.50e-02	2.21e-01	0.26500	1.55e-01	2.16e-01	1.36e-01	3.76e-02
GOMF HISTONE READER ACTIVITY	17	2.05e-01	4.36e-01	0.26500	2.43e-01	1.06e-01	8.24e-02	4.49e-01
GOBP POSITIVE REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION	11	3.68e-01	6.05e-01	0.26500	2.33e-01	1.27e-01	1.81e-01	4.67e-01
GOBP HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES	51	7.13e-03	4.63e-02	0.26500	-2.53e-01	-7.95e-02	1.76e-03	3.26e-01
GOMF C X C CHEMOKINE BINDING	5	5.26e-01	7.30e-01	0.26500	2.42e-01	-1.09e-01	3.49e-01	6.73e-01
Noncanonical activation of NOTCH3	8	4.97e-01	7.09e-01	0.26500	1.69e-01	2.04e-01	4.07e-01	3.17e-01
GOMF SINGLE STRANDED DNA BINDING	115	1.49e-05	3.05e-04	0.26500	2.53e-01	7.92e-02	2.72e-06	1.42e-01
Synthesis of diphthamide-EEF2	8	4.85e-01	6.99e-01	0.26500	1.29e-01	2.32e-01	5.28e-01	2.56e-01
GOBP REGULATION OF VESICLE SIZE	20	1.74e-01	3.97e-01	0.26500	1.67e-01	2.06e-01	1.96e-01	1.11e-01
The NLRP3 inflammasome	16	1.79e-01	4.04e-01	0.26500	1.75e-02	2.65e-01	9.04e-01	6.68e-02
GOBP PIGMENT GRANULE MATURATION	10	3.82e-01	6.17e-01	0.26500	8.49e-02	2.51e-01	6.42e-01	1.69e-01
GOBP INHIBITORY POSTSYNAPTIC POTENTIAL	16	2.28e-01	4.63e-01	0.26500	-2.40e-01	-1.12e-01	9.62e-02	4.37e-01
GOMF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR ACTIVITY	7	5.05e-01	7.14e-01	0.26500	-7.45e-02	-2.54e-01	7.33e-01	2.44e-01
GOMF AMINOACYLASE ACTIVITY	5	5.19e-01	7.25e-01	0.26500	-1.34e-01	2.28e-01	6.03e-01	3.76e-01
GOBP GRANULOCYTE COLONY STIMULATING FACTOR PRODUCTION	5	5.25e-01	7.29e-01	0.26500	-1.14e-01	2.39e-01	6.59e-01	3.54e-01
GOBP DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR	70	2.17e-03	1.88e-02	0.26500	1.58e-01	2.13e-01	2.27e-02	2.04e-03
GOCC PRERIBOSOME	102	7.58e-05	1.23e-03	0.26500	2.44e-01	1.03e-01	2.06e-05	7.11e-02
GOBP DIENCEPHALON DEVELOPMENT	75	1.44e-03	1.37e-02	0.26500	1.62e-01	2.10e-01	1.55e-02	1.66e-03
Triglyceride biosynthesis	12	2.45e-01	4.84e-01	0.26500	-2.62e-01	3.84e-02	1.16e-01	8.18e-01
GOMF PROTEIN FOLDING CHAPERONE	67	3.05e-03	2.43e-02	0.26500	1.88e-01	1.87e-01	7.95e-03	8.06e-03
G1/S Transition	118	2.08e-05	4.08e-04	0.26500	2.39e-01	1.15e-01	7.57e-06	3.06e-02
GOMF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY	156	1.41e-06	3.96e-05	0.26500	-1.73e-01	-2.01e-01	1.94e-04	1.51e-05
GOBP NEGATIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY	7	4.67e-01	6.89e-01	0.26500	2.65e-01	7.91e-03	2.25e-01	9.71e-01
GOCC ATAC COMPLEX	13	2.83e-01	5.21e-01	0.26500	2.54e-01	7.56e-02	1.13e-01	6.37e-01
GOBP PROTEIN MONOUBIQUITINATION	46	1.54e-02	8.25e-02	0.26500	2.35e-01	1.21e-01	5.74e-03	1.55e-01
Linoleic acid (LA) metabolism	7	4.12e-01	6.44e-01	0.26500	-2.45e-01	1.01e-01	2.62e-01	6.43e-01
GOBP NEGATIVE REGULATION OF VASOCONSTRICTION	12	2.01e-01	4.31e-01	0.26500	1.91e-01	-1.83e-01	2.51e-01	2.73e-01
GOMF CILIARY NEUROTROPHIC FACTOR RECEPTOR BINDING	6	4.61e-01	6.84e-01	0.26500	-1.21e-01	2.35e-01	6.08e-01	3.18e-01
DNA Damage/Telomere Stress Induced Senescence	57	6.39e-03	4.28e-02	0.26500	2.24e-01	1.41e-01	3.42e-03	6.62e-02
GOMF HISTONE H3 METHYLTRANSFERASE ACTIVITY	42	9.10e-03	5.59e-02	0.26500	2.64e-01	-1.16e-02	3.03e-03	8.97e-01
GOBP DNA TEMPLATED TRANSCRIPTION ELONGATION	132	6.78e-06	1.56e-04	0.26500	2.34e-01	1.23e-01	3.30e-06	1.49e-02
GOCC INTERPHOTORECEPTOR MATRIX	6	4.74e-01	6.94e-01	0.26500	8.65e-02	-2.50e-01	7.14e-01	2.89e-01
GOBP DISTAL CONVOLUTED TUBULE DEVELOPMENT	5	5.61e-01	7.53e-01	0.26500	-2.62e-01	3.28e-02	3.09e-01	8.99e-01
GOMF PRE MRNA BINDING	40	2.86e-02	1.28e-01	0.26500	2.26e-01	1.38e-01	1.34e-02	1.32e-01
GOMF METALLOCARBOXYPEPTIDASE ACTIVITY	29	6.47e-02	2.21e-01	0.26400	-9.22e-02	-2.48e-01	3.90e-01	2.09e-02
GOBP PLATELET DEGRANULATION	7	3.94e-01	6.27e-01	0.26400	-1.74e-01	1.99e-01	4.25e-01	3.62e-01
GOBP SKELETAL MUSCLE CONTRACTION	44	1.21e-02	6.89e-02	0.26400	-5.41e-02	-2.59e-01	5.34e-01	2.98e-03
GOBP POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY	41	5.35e-03	3.71e-02	0.26400	-1.11e-01	2.40e-01	2.18e-01	7.88e-03
GOBP TRNA PSEUDOURIDINE SYNTHESIS	6	4.50e-01	6.76e-01	0.26400	1.70e-01	-2.02e-01	4.70e-01	3.91e-01
Lipid particle organization	6	5.54e-01	7.48e-01	0.26400	-6.55e-02	-2.56e-01	7.81e-01	2.77e-01
Chaperonin-mediated protein folding	89	4.75e-04	5.78e-03	0.26400	1.90e-01	1.84e-01	1.97e-03	2.70e-03
GOCC PHOTORECEPTOR OUTER SEGMENT MEMBRANE	16	2.52e-01	4.90e-01	0.26400	-1.93e-01	-1.81e-01	1.82e-01	2.11e-01
GOBP NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION	8	4.31e-01	6.59e-01	0.26400	2.63e-01	2.55e-02	1.98e-01	9.01e-01
GOCC MIB COMPLEX	11	3.66e-01	6.03e-01	0.26400	2.38e-01	1.14e-01	1.71e-01	5.12e-01
GOMF BIOACTIVE LIPID RECEPTOR ACTIVITY	14	1.57e-01	3.74e-01	0.26400	-2.10e-01	1.60e-01	1.74e-01	2.99e-01
RHO GTPases Activate Formins	134	4.13e-06	1.02e-04	0.26400	2.44e-01	1.01e-01	1.07e-06	4.36e-02
GOBP CIRCADIAN REGULATION OF GENE EXPRESSION	66	2.51e-03	2.11e-02	0.26400	2.37e-01	1.17e-01	8.74e-04	1.01e-01
GOMF EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT	156	4.68e-07	1.46e-05	0.26400	-9.31e-02	-2.47e-01	4.48e-02	1.01e-07
GOMF ALKALINE PHOSPHATASE ACTIVITY	6	4.65e-01	6.88e-01	0.26400	-2.39e-01	1.12e-01	3.11e-01	6.34e-01
Nuclear Receptor transcription pathway	51	6.51e-03	4.34e-02	0.26400	2.57e-01	6.09e-02	1.51e-03	4.51e-01
GOBP REGULATION OF SYNAPTIC VESICLE PRIMING	8	4.03e-01	6.35e-01	0.26400	2.63e-01	-2.40e-02	1.98e-01	9.06e-01
GOCC PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX CATALYTIC DOMAIN	19	1.39e-01	3.50e-01	0.26400	2.62e-01	3.02e-02	4.80e-02	8.20e-01
GOBP EMBRYONIC PLACENTA MORPHOGENESIS	26	3.41e-02	1.45e-01	0.26400	-2.26e-01	1.36e-01	4.60e-02	2.30e-01
GOBP COBALT ION TRANSPORT	6	5.32e-01	7.35e-01	0.26400	2.38e-02	2.63e-01	9.20e-01	2.65e-01
DAP12 signaling	27	5.03e-02	1.89e-01	0.26400	-8.86e-03	2.64e-01	9.36e-01	1.78e-02
GOCC WNT SIGNALOSOME	13	2.73e-01	5.12e-01	0.26400	2.58e-01	5.36e-02	1.07e-01	7.38e-01
GOMF BRANCHED CHAIN AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY	9	4.26e-01	6.55e-01	0.26400	2.49e-01	8.69e-02	1.96e-01	6.52e-01
Purine ribonucleoside monophosphate biosynthesis	9	3.38e-01	5.77e-01	0.26400	2.55e-01	-6.54e-02	1.85e-01	7.34e-01
GOCC DYSTROGLYCAN COMPLEX	7	5.20e-01	7.26e-01	0.26400	-9.61e-02	-2.45e-01	6.60e-01	2.61e-01
GOCC EXTRINSIC COMPONENT OF ORGANELLE MEMBRANE	23	9.51e-02	2.81e-01	0.26400	2.61e-01	3.88e-02	3.04e-02	7.47e-01
GOBP REGULATION OF BLOOD BRAIN BARRIER PERMEABILITY	9	4.46e-01	6.72e-01	0.26400	-2.33e-01	-1.23e-01	2.26e-01	5.22e-01
Signaling by EGFR	52	6.40e-03	4.29e-02	0.26300	2.54e-01	6.88e-02	1.51e-03	3.91e-01
Telomere Extension By Telomerase	22	1.30e-01	3.37e-01	0.26300	2.44e-01	9.84e-02	4.72e-02	4.24e-01
Metabolism of polyamines	44	2.15e-02	1.05e-01	0.26300	2.18e-01	1.47e-01	1.22e-02	9.06e-02
GOCC DYSTROPHIN ASSOCIATED GLYCOPROTEIN COMPLEX	17	1.93e-01	4.21e-01	0.26300	-7.15e-02	-2.54e-01	6.10e-01	7.03e-02
GOBP CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS	20	1.57e-01	3.74e-01	0.26300	2.44e-01	9.99e-02	5.92e-02	4.39e-01
Signal attenuation	10	3.32e-01	5.71e-01	0.26300	2.63e-01	-7.51e-03	1.49e-01	9.67e-01
GOBP NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE ACTIVITY	23	1.07e-01	3.02e-01	0.26300	2.54e-01	6.79e-02	3.47e-02	5.73e-01
GOBP THYMOCYTE APOPTOTIC PROCESS	19	1.24e-01	3.28e-01	0.26300	-6.49e-03	2.63e-01	9.61e-01	4.70e-02
GOMF TOLL LIKE RECEPTOR BINDING	14	1.70e-01	3.92e-01	0.26300	-1.10e-01	2.39e-01	4.76e-01	1.21e-01
Transcriptional regulation by RUNX1	192	4.96e-08	1.92e-06	0.26300	2.26e-01	1.36e-01	7.06e-08	1.17e-03
Nuclear Events (kinase and transcription factor activation)	59	5.49e-03	3.79e-02	0.26300	1.34e-01	2.26e-01	7.48e-02	2.62e-03
GOBP POSITIVE REGULATION OF TELOMERE MAINTENANCE	67	2.20e-03	1.90e-02	0.26300	2.41e-01	1.07e-01	6.59e-04	1.31e-01
GOMF PRE MRNA INTRONIC BINDING	13	2.59e-01	4.98e-01	0.26300	2.62e-01	2.79e-02	1.02e-01	8.62e-01
GOBP SYNAPTIC TRANSMISSION GLYCINERGIC	5	5.18e-01	7.24e-01	0.26300	2.05e-01	-1.65e-01	4.27e-01	5.23e-01
GOMF HISTONE MODIFYING ACTIVITY	197	5.34e-09	2.50e-07	0.26300	2.55e-01	6.58e-02	7.00e-10	1.11e-01
Cytoprotection by HMOX1	54	7.06e-03	4.60e-02	0.26300	2.42e-01	1.03e-01	2.10e-03	1.90e-01
GOBP ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN	25	7.67e-02	2.46e-01	0.26300	3.35e-02	2.61e-01	7.72e-01	2.40e-02
GOBP TORC1 SIGNALING	98	1.11e-04	1.69e-03	0.26300	2.46e-01	9.31e-02	2.58e-05	1.11e-01
GOMF UBIQUITIN LIKE PROTEIN LIGASE BINDING	306	6.23e-12	4.70e-10	0.26300	1.90e-01	1.82e-01	1.08e-08	4.53e-08
GOBP KERATAN SULFATE METABOLIC PROCESS	18	2.15e-01	4.47e-01	0.26300	-1.85e-01	-1.87e-01	1.75e-01	1.69e-01
GOMF G PROTEIN COUPLED RECEPTOR KINASE ACTIVITY	7	4.45e-01	6.72e-01	0.26300	4.09e-02	-2.60e-01	8.51e-01	2.34e-01
APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint	61	4.72e-03	3.39e-02	0.26300	2.25e-01	1.35e-01	2.34e-03	6.75e-02
GOMF LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY INVOLVED IN REGULATION OF PRESYNAPTIC MEMBRANE POTENTIAL	15	2.59e-01	4.97e-01	0.26300	-1.16e-01	-2.36e-01	4.38e-01	1.14e-01
GOMF HISTONE METHYLTRANSFERASE BINDING	14	2.90e-01	5.28e-01	0.26300	2.28e-01	1.30e-01	1.39e-01	4.00e-01
Protein folding	95	3.16e-04	4.07e-03	0.26300	1.88e-01	1.83e-01	1.53e-03	2.03e-03
Diseases of mitotic cell cycle	37	4.26e-02	1.70e-01	0.26300	1.72e-01	1.98e-01	6.96e-02	3.70e-02
GOBP NEGATIVE REGULATION OF T CELL CYTOKINE PRODUCTION	10	3.62e-01	6.00e-01	0.26300	-2.60e-01	-3.87e-02	1.55e-01	8.32e-01
SCF(Skp2)-mediated degradation of p27/p21	50	9.02e-03	5.56e-02	0.26300	2.49e-01	8.34e-02	2.32e-03	3.07e-01
GOMF DNA BINDING TRANSCRIPTION REPRESSOR ACTIVITY	265	1.26e-10	7.82e-09	0.26300	1.45e-01	2.19e-01	4.85e-05	8.45e-10
GOBP ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME	69	2.04e-03	1.79e-02	0.26300	2.36e-01	1.15e-01	7.00e-04	9.84e-02
GOMF SINGLE STRANDED DNA 3 5 DNA EXONUCLEASE ACTIVITY	6	4.81e-01	6.97e-01	0.26200	8.29e-02	-2.49e-01	7.25e-01	2.91e-01
GOBP ERBB3 SIGNALING PATHWAY	10	3.38e-01	5.76e-01	0.26200	2.62e-01	-1.96e-03	1.51e-01	9.91e-01
GOCC GAMMA TUBULIN COMPLEX	18	2.16e-01	4.49e-01	0.26200	1.79e-01	1.92e-01	1.88e-01	1.59e-01
Transcriptional Regulation by TP53	347	1.85e-13	1.61e-11	0.26200	2.06e-01	1.62e-01	3.78e-11	2.17e-07
GOBP NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION	12	3.56e-01	5.93e-01	0.26200	1.57e-01	2.10e-01	3.46e-01	2.07e-01
GOBP INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY	7	4.74e-01	6.94e-01	0.26200	2.62e-01	8.45e-03	2.30e-01	9.69e-01
GOBP ARGININE CATABOLIC PROCESS	10	2.74e-01	5.13e-01	0.26200	1.47e-01	-2.17e-01	4.20e-01	2.35e-01
GOMF CALCIUM DEPENDENT PROTEIN KINASE ACTIVITY	10	3.30e-01	5.70e-01	0.26200	-1.52e-02	2.62e-01	9.34e-01	1.52e-01
GOBP REGULATION OF CDC42 PROTEIN SIGNAL TRANSDUCTION	8	4.33e-01	6.61e-01	0.26200	-2.01e-02	-2.61e-01	9.22e-01	2.00e-01
GOMF CAMP BINDING	22	1.51e-01	3.65e-01	0.26200	-1.54e-01	-2.13e-01	2.12e-01	8.44e-02
GOBP POSITIVE REGULATION OF GONADOTROPIN SECRETION	7	5.50e-01	7.46e-01	0.26200	2.04e-01	1.64e-01	3.49e-01	4.52e-01
GOBP AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS	25	9.08e-02	2.74e-01	0.26200	-2.53e-01	-7.04e-02	2.88e-02	5.42e-01
The phototransduction cascade	32	1.64e-02	8.62e-02	0.26200	1.37e-01	-2.23e-01	1.79e-01	2.88e-02
GOBP REGULATION OF FIBROBLAST MIGRATION	40	1.68e-02	8.75e-02	0.26200	2.60e-01	3.17e-02	4.41e-03	7.28e-01
GOBP GOLGI VESICLE TRANSPORT	290	1.88e-12	1.52e-10	0.26200	2.49e-01	8.17e-02	2.90e-13	1.66e-02
GOMF PRENYLTRANSFERASE ACTIVITY	16	2.48e-01	4.86e-01	0.26200	2.23e-01	1.37e-01	1.22e-01	3.41e-01
GOBP REGULATION OF FOREBRAIN NEURON DIFFERENTIATION	5	5.23e-01	7.27e-01	0.26200	-1.50e-01	2.15e-01	5.62e-01	4.05e-01
GOBP RHODOPSIN MEDIATED SIGNALING PATHWAY	11	2.67e-01	5.06e-01	0.26200	7.19e-02	-2.52e-01	6.80e-01	1.48e-01
GOBP CARDIAC ATRIUM DEVELOPMENT	37	4.33e-02	1.71e-01	0.26200	1.72e-01	1.97e-01	6.99e-02	3.77e-02
GOBP GLUTAMINE TRANSPORT	9	3.13e-01	5.52e-01	0.26200	2.17e-01	-1.47e-01	2.59e-01	4.47e-01
GOMF MECHANOSENSITIVE MONOATOMIC ION CHANNEL ACTIVITY	17	1.97e-01	4.27e-01	0.26200	-2.52e-01	-7.13e-02	7.20e-02	6.11e-01
GOBP REGULATION OF DNA REPLICATION	124	1.81e-05	3.63e-04	0.26200	2.30e-01	1.25e-01	9.34e-06	1.66e-02
Visual phototransduction	92	6.76e-05	1.12e-03	0.26200	-1.71e-02	-2.61e-01	7.77e-01	1.47e-05
GOBP REGULATION OF CELL KILLING	111	1.07e-06	3.08e-05	0.26200	-2.41e-01	1.03e-01	1.17e-05	6.11e-02
GOBP PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS	729	1.01e-26	2.30e-24	0.26200	1.91e-01	1.78e-01	1.25e-18	2.15e-16
GOBP MITOTIC SISTER CHROMATID SEGREGATION	185	1.09e-07	3.91e-06	0.26200	2.25e-01	1.34e-01	1.38e-07	1.61e-03
GOMF UBIQUITIN LIKE PROTEIN SPECIFIC ENDOPEPTIDASE ACTIVITY	5	6.10e-01	7.85e-01	0.26200	2.57e-01	5.04e-02	3.20e-01	8.45e-01
SUMOylation of RNA binding proteins	47	9.80e-03	5.89e-02	0.26200	2.56e-01	5.22e-02	2.35e-03	5.36e-01
GOCC SNARE COMPLEX	49	1.51e-02	8.14e-02	0.26200	2.12e-01	1.53e-01	1.01e-02	6.40e-02
GOMF PROFILIN BINDING	10	4.22e-01	6.52e-01	0.26200	1.46e-01	2.17e-01	4.23e-01	2.35e-01
GOBP B CELL RECEPTOR SIGNALING PATHWAY	61	4.45e-04	5.46e-03	0.26200	-1.24e-01	2.30e-01	9.26e-02	1.89e-03
GOMF LEUKOTRIENE C4 SYNTHASE ACTIVITY	5	6.32e-01	7.99e-01	0.26200	2.43e-01	9.66e-02	3.47e-01	7.08e-01
GOBP REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS	57	1.04e-03	1.08e-02	0.26200	-7.96e-02	2.49e-01	2.99e-01	1.14e-03
GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH	27	9.17e-02	2.75e-01	0.26100	2.32e-01	1.21e-01	3.71e-02	2.76e-01
GOCC JUXTAPARANODE REGION OF AXON	12	2.45e-01	4.83e-01	0.26100	-2.55e-01	5.80e-02	1.26e-01	7.28e-01
GOBP REGULATION OF STEM CELL DIFFERENTIATION	83	8.98e-04	9.65e-03	0.26100	2.01e-01	1.67e-01	1.54e-03	8.50e-03
NEP/NS2 Interacts with the Cellular Export Machinery	32	5.11e-02	1.91e-01	0.26100	2.47e-01	8.66e-02	1.57e-02	3.97e-01
GOBP LIPID GLYCOSYLATION	12	2.20e-01	4.54e-01	0.26100	-2.32e-01	1.20e-01	1.63e-01	4.73e-01
GOMF STEROID DEHYDROGENASE ACTIVITY ACTING ON THE CH OH GROUP OF DONORS NAD OR NADP AS ACCEPTOR	29	5.93e-02	2.09e-01	0.26100	-5.71e-02	-2.55e-01	5.94e-01	1.74e-02
GOBP CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION	12	3.61e-01	5.98e-01	0.26100	-2.05e-01	-1.62e-01	2.19e-01	3.31e-01
GOBP DERMATAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS	8	4.83e-01	6.98e-01	0.26100	1.00e-01	2.41e-01	6.24e-01	2.37e-01
GOBP PROTEIN PEPTIDYL PROLYL ISOMERIZATION	17	2.38e-01	4.75e-01	0.26100	1.97e-01	1.72e-01	1.60e-01	2.19e-01
APC-Cdc20 mediated degradation of Nek2A	26	1.12e-01	3.10e-01	0.26100	1.76e-01	1.93e-01	1.21e-01	8.79e-02
Erythropoietin activates STAT5	7	5.23e-01	7.27e-01	0.26100	8.83e-02	2.46e-01	6.86e-01	2.60e-01
GOBP DNA DEAMINATION	13	3.35e-01	5.73e-01	0.26100	1.83e-01	1.86e-01	2.52e-01	2.46e-01
Nuclear import of Rev protein	34	4.93e-02	1.86e-01	0.26100	2.33e-01	1.18e-01	1.88e-02	2.33e-01
GOBP NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY	11	3.79e-01	6.13e-01	0.26100	-2.31e-01	-1.21e-01	1.84e-01	4.86e-01
GOMF DEATH RECEPTOR BINDING	19	1.95e-01	4.24e-01	0.26100	2.18e-01	1.44e-01	1.00e-01	2.78e-01
GOMF ARP2 3 COMPLEX BINDING	14	2.47e-01	4.85e-01	0.26100	2.58e-01	4.06e-02	9.48e-02	7.93e-01
Transcriptional regulation by RUNX2	104	1.32e-04	1.95e-03	0.26100	2.20e-01	1.41e-01	1.08e-04	1.30e-02
GOBP NEGATIVE REGULATION OF B CELL ACTIVATION	29	2.43e-02	1.14e-01	0.26100	-1.47e-01	2.16e-01	1.71e-01	4.44e-02
GOBP MESODERMAL CELL DIFFERENTIATION	35	4.75e-02	1.82e-01	0.26100	1.31e-01	2.26e-01	1.81e-01	2.08e-02
GOBP PROTEIN N LINKED GLYCOSYLATION VIA ASPARAGINE	23	1.33e-01	3.43e-01	0.26100	1.26e-01	2.28e-01	2.95e-01	5.78e-02
GOMF CALCIUM DEPENDENT PROTEIN SERINE THREONINE PHOSPHATASE REGULATOR ACTIVITY	5	6.48e-01	8.09e-01	0.26100	-1.33e-01	-2.24e-01	6.05e-01	3.85e-01
RUNX2 regulates osteoblast differentiation	22	1.32e-01	3.40e-01	0.26100	2.45e-01	9.02e-02	4.68e-02	4.64e-01
GOBP PLANAR CELL POLARITY PATHWAY INVOLVED IN AXIS ELONGATION	6	4.74e-01	6.94e-01	0.26100	-2.37e-01	1.10e-01	3.15e-01	6.41e-01
Regulation of cholesterol biosynthesis by SREBP (SREBF)	53	1.17e-02	6.71e-02	0.26100	1.90e-01	1.78e-01	1.65e-02	2.46e-02
GOBP REGULATION OF GENE SILENCING BY REGULATORY NCRNA	27	1.03e-01	2.95e-01	0.26100	1.99e-01	1.69e-01	7.38e-02	1.29e-01
GOBP SURFACTANT HOMEOSTASIS	20	1.55e-01	3.72e-01	0.26100	-8.16e-02	-2.48e-01	5.27e-01	5.53e-02
GOBP KERATINOCYTE DIFFERENTIATION	171	1.66e-07	5.71e-06	0.26100	-2.45e-01	-9.01e-02	3.40e-08	4.21e-02
GOBP TYPE B PANCREATIC CELL DIFFERENTIATION	29	7.17e-02	2.36e-01	0.26100	9.72e-02	2.42e-01	3.65e-01	2.42e-02
Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE)	18	2.20e-01	4.54e-01	0.26100	1.97e-01	1.71e-01	1.48e-01	2.10e-01
Modulation of host responses by IFN-stimulated genes	18	2.14e-01	4.46e-01	0.26000	2.18e-01	1.42e-01	1.09e-01	2.98e-01
GOBP NEGATIVE REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION	6	4.80e-01	6.97e-01	0.26000	2.42e-01	-9.73e-02	3.06e-01	6.80e-01
GOBP GROWTH INVOLVED IN HEART MORPHOGENESIS	5	5.44e-01	7.42e-01	0.26000	-2.44e-01	9.19e-02	3.46e-01	7.22e-01
GOMF DEUBIQUITINASE ACTIVITY	88	3.69e-04	4.65e-03	0.26000	2.40e-01	1.02e-01	1.01e-04	9.97e-02
GOBP T CELL LINEAGE COMMITMENT	35	3.53e-02	1.48e-01	0.26000	6.40e-02	2.52e-01	5.12e-01	9.78e-03
GOBP NERVOUS SYSTEM PROCESS	1383	1.85e-49	9.47e-47	0.26000	-2.22e-01	-1.36e-01	1.03e-43	2.18e-17
GOBP MRNA TRANSPORT	118	2.52e-05	4.84e-04	0.26000	2.40e-01	1.01e-01	6.70e-06	5.86e-02
GOBP RESPONSE TO ENDOPLASMIC RETICULUM STRESS	259	3.48e-10	1.99e-08	0.26000	1.49e-01	2.13e-01	3.50e-05	3.49e-09
GOMF PHOSPHOTRANSFERASE ACTIVITY FOR OTHER SUBSTITUTED PHOSPHATE GROUPS	22	1.50e-01	3.64e-01	0.26000	2.23e-01	1.34e-01	7.01e-02	2.77e-01
GOMF POLY PURINE TRACT BINDING	27	7.87e-02	2.50e-01	0.26000	2.50e-01	7.22e-02	2.46e-02	5.16e-01
GOMF PLATELET DERIVED GROWTH FACTOR BINDING	11	2.44e-01	4.82e-01	0.26000	2.09e-01	-1.55e-01	2.31e-01	3.72e-01
Processing of SMDT1	14	2.04e-01	4.35e-01	0.26000	2.57e-01	-4.21e-02	9.63e-02	7.85e-01
GOBP BASE EXCISION REPAIR AP SITE FORMATION	12	3.65e-01	6.01e-01	0.26000	1.63e-01	2.03e-01	3.29e-01	2.24e-01
GOBP MRNA METABOLIC PROCESS	778	6.11e-31	1.83e-28	0.26000	2.46e-01	8.39e-02	1.31e-31	6.83e-05
Zygotic genome activation (ZGA)	13	3.33e-01	5.71e-01	0.26000	-1.53e-01	-2.11e-01	3.41e-01	1.89e-01
GOMF LIGAND ACTIVATED TRANSCRIPTION FACTOR ACTIVITY	52	8.57e-03	5.36e-02	0.26000	2.45e-01	8.79e-02	2.28e-03	2.73e-01
GOBP OPTIC NERVE MORPHOGENESIS	6	5.99e-01	7.78e-01	0.26000	-2.18e-01	-1.41e-01	3.54e-01	5.50e-01
GOBP CELLULAR RESPONSE TO MANGANESE ION	10	4.23e-01	6.53e-01	0.26000	2.22e-01	1.35e-01	2.24e-01	4.59e-01
p75NTR signals via NF-kB	15	2.82e-01	5.20e-01	0.26000	2.10e-01	1.54e-01	1.60e-01	3.03e-01
GOCC PROTEASOME CORE COMPLEX ALPHA SUBUNIT COMPLEX	8	4.32e-01	6.59e-01	0.26000	2.60e-01	6.66e-03	2.03e-01	9.74e-01
GOCC RNA POLYMERASE I COMPLEX	13	3.38e-01	5.76e-01	0.26000	1.91e-01	1.76e-01	2.33e-01	2.71e-01
GOBP INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE	121	3.66e-05	6.74e-04	0.26000	-2.13e-01	-1.48e-01	5.05e-05	4.79e-03
GOBP REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE	5	6.59e-01	8.17e-01	0.26000	-1.78e-01	-1.89e-01	4.90e-01	4.64e-01
GOCC TRANSCRIPTION FACTOR TFTC COMPLEX	17	2.41e-01	4.78e-01	0.26000	2.01e-01	1.64e-01	1.51e-01	2.40e-01
GOBP NEGATIVE REGULATION OF TOR SIGNALING	68	3.28e-03	2.57e-02	0.26000	2.09e-01	1.54e-01	2.87e-03	2.79e-02
GOBP NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II	841	3.29e-30	9.19e-28	0.26000	1.99e-01	1.67e-01	9.48e-23	2.03e-16
GOMF TRANSCRIPTION COREGULATOR ACTIVITY	467	3.92e-18	4.97e-16	0.26000	2.31e-01	1.19e-01	1.19e-17	1.04e-05
GOMF RNA ENDONUCLEASE ACTIVITY	70	2.97e-03	2.39e-02	0.26000	1.77e-01	1.90e-01	1.05e-02	5.92e-03
GOBP TERPENOID CATABOLIC PROCESS	8	3.78e-01	6.13e-01	0.26000	-9.53e-02	2.42e-01	6.41e-01	2.37e-01
Signaling by membrane-tethered fusions of PDGFRA or PDGFRB	5	6.59e-01	8.17e-01	0.26000	1.71e-01	1.96e-01	5.08e-01	4.49e-01
GOBP SENSORY PERCEPTION OF TASTE	66	3.95e-03	2.96e-02	0.26000	-1.58e-01	-2.06e-01	2.68e-02	3.74e-03
GOBP REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY	15	2.68e-01	5.08e-01	0.26000	2.32e-01	1.17e-01	1.20e-01	4.34e-01
GOBP CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS	18	2.24e-01	4.58e-01	0.26000	1.86e-01	1.81e-01	1.71e-01	1.84e-01
GOBP NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY	25	6.62e-02	2.24e-01	0.26000	-1.62e-02	2.59e-01	8.88e-01	2.49e-02
Antigen activates B Cell Receptor (BCR) leading to generation of second messengers	28	6.28e-02	2.17e-01	0.26000	4.00e-02	2.56e-01	7.14e-01	1.88e-02
Interleukin-1 signaling	98	1.39e-04	2.02e-03	0.26000	2.43e-01	9.07e-02	3.18e-05	1.21e-01
GOBP CELLULAR RESPONSE TO ANTIBIOTIC	11	3.71e-01	6.07e-01	0.25900	2.41e-01	9.67e-02	1.67e-01	5.79e-01
GOBP TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS	14	3.05e-01	5.44e-01	0.25900	2.17e-01	1.43e-01	1.60e-01	3.56e-01
GOBP PHOSPHATIDYLINOSITOL PHOSPHATE BIOSYNTHETIC PROCESS	63	4.75e-03	3.40e-02	0.25900	2.18e-01	1.40e-01	2.75e-03	5.41e-02
GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE 3 PHOSPHATASE ACTIVITY	8	3.58e-01	5.95e-01	0.25900	1.82e-01	-1.85e-01	3.73e-01	3.65e-01
GOBP POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL	13	3.39e-01	5.77e-01	0.25900	1.69e-01	1.96e-01	2.91e-01	2.20e-01
GOMF TRNA BINDING	75	1.47e-03	1.39e-02	0.25900	2.30e-01	1.19e-01	5.58e-04	7.55e-02
GOCC PROTEASOME CORE COMPLEX BETA SUBUNIT COMPLEX	11	3.78e-01	6.13e-01	0.25900	2.36e-01	1.07e-01	1.75e-01	5.38e-01
GOBP NEGATIVE REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE	10	3.16e-01	5.55e-01	0.25900	-5.70e-02	2.53e-01	7.55e-01	1.66e-01
GOBP PHOTOTRANSDUCTION VISIBLE LIGHT	17	1.33e-01	3.43e-01	0.25900	7.83e-02	-2.47e-01	5.76e-01	7.79e-02
GOBP DORSAL VENTRAL PATTERN FORMATION	90	5.33e-04	6.34e-03	0.25900	2.10e-01	1.52e-01	5.77e-04	1.28e-02
GOBP MEGAKARYOCYTE DIFFERENTIATION	62	4.45e-03	3.24e-02	0.25900	1.14e-01	2.33e-01	1.21e-01	1.54e-03
GOBP RNA LOCALIZATION	187	7.79e-08	2.90e-06	0.25900	2.35e-01	1.09e-01	2.93e-08	1.05e-02
GOBP CLEARANCE OF FOREIGN INTRACELLULAR NUCLEIC ACIDS	6	6.06e-01	7.83e-01	0.25900	1.57e-01	2.06e-01	5.04e-01	3.83e-01
GOBP ESTABLISHMENT OF MITOCHONDRION LOCALIZATION MICROTUBULE MEDIATED	24	1.16e-01	3.16e-01	0.25900	9.65e-02	2.40e-01	4.13e-01	4.16e-02
GOBP NEGATIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	9	3.31e-01	5.70e-01	0.25900	-1.11e-01	2.34e-01	5.64e-01	2.25e-01
GOMF TAURINE TRANSMEMBRANE TRANSPORTER ACTIVITY	5	5.69e-01	7.59e-01	0.25900	-2.55e-01	4.36e-02	3.23e-01	8.66e-01
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS	62	5.81e-03	3.97e-02	0.25900	1.62e-01	2.02e-01	2.75e-02	5.97e-03
GOBP POSITIVE REGULATION OF CERAMIDE BIOSYNTHETIC PROCESS	7	5.00e-01	7.10e-01	0.25900	-2.56e-01	-3.55e-02	2.40e-01	8.71e-01
GOBP AORTA MORPHOGENESIS	38	3.47e-02	1.46e-01	0.25900	2.37e-01	1.04e-01	1.15e-02	2.67e-01
GOBP REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY	50	2.88e-03	2.33e-02	0.25900	-7.21e-02	2.48e-01	3.78e-01	2.37e-03
GOMF LIPASE ACTIVATOR ACTIVITY	19	2.07e-01	4.39e-01	0.25900	1.68e-01	1.97e-01	2.05e-01	1.38e-01
GOMF RNA EXONUCLEASE ACTIVITY	45	2.43e-02	1.14e-01	0.25900	1.93e-01	1.72e-01	2.52e-02	4.55e-02
GOBP FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX	13	3.24e-01	5.62e-01	0.25900	2.30e-01	1.18e-01	1.51e-01	4.62e-01
GOBP REGULATION OF CAVEOLIN MEDIATED ENDOCYTOSIS	6	6.09e-01	7.85e-01	0.25900	-1.75e-01	-1.91e-01	4.59e-01	4.19e-01
GOCC U12 TYPE SPLICEOSOMAL COMPLEX	25	1.16e-01	3.16e-01	0.25900	2.28e-01	1.23e-01	4.88e-02	2.89e-01
RUNX1 regulates transcription of genes involved in interleukin signaling	5	5.63e-01	7.56e-01	0.25800	-5.76e-02	2.52e-01	8.23e-01	3.29e-01
GOBP MEIOTIC CELL CYCLE CHECKPOINT SIGNALING	10	3.78e-01	6.13e-01	0.25800	2.54e-01	4.53e-02	1.64e-01	8.04e-01
GOMF ATPASE ACTIVATOR ACTIVITY	25	1.17e-01	3.18e-01	0.25800	2.25e-01	1.26e-01	5.10e-02	2.74e-01
GOBP REGULATION OF CELL CYCLE G2 M PHASE TRANSITION	112	9.64e-05	1.50e-03	0.25800	2.00e-01	1.64e-01	2.54e-04	2.79e-03
Germ layer formation at gastrulation	16	2.13e-01	4.45e-01	0.25800	4.77e-02	2.54e-01	7.41e-01	7.86e-02
GOBP VENOUS BLOOD VESSEL MORPHOGENESIS	9	3.54e-01	5.92e-01	0.25800	-6.17e-02	2.51e-01	7.49e-01	1.92e-01
GOBP GRANULOCYTE ACTIVATION	48	4.65e-03	3.36e-02	0.25800	-2.55e-01	4.20e-02	2.24e-03	6.15e-01
GOBP PROTEIN PROCESSING INVOLVED IN PROTEIN TARGETING TO MITOCHONDRION	7	5.11e-01	7.19e-01	0.25800	2.53e-01	5.20e-02	2.46e-01	8.12e-01
G beta:gamma signalling through BTK	17	2.04e-01	4.34e-01	0.25800	2.50e-01	6.63e-02	7.48e-02	6.36e-01
GOCC MRNA CLEAVAGE FACTOR COMPLEX	22	1.34e-01	3.43e-01	0.25800	2.45e-01	8.10e-02	4.65e-02	5.11e-01
GOBP AUTOPHAGIC CELL DEATH	9	3.21e-01	5.60e-01	0.25800	-2.08e-01	1.53e-01	2.79e-01	4.28e-01
GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION	25	4.30e-02	1.70e-01	0.25800	1.50e-01	-2.10e-01	1.95e-01	6.88e-02
GOMF L ASPARTATE TRANSMEMBRANE TRANSPORTER ACTIVITY	9	4.77e-01	6.95e-01	0.25800	1.85e-01	1.80e-01	3.37e-01	3.49e-01
GOBP MATERNAL PLACENTA DEVELOPMENT	33	5.89e-02	2.08e-01	0.25800	1.23e-01	2.27e-01	2.22e-01	2.40e-02
GOBP CYTOPLASMIC TRANSLATIONAL INITIATION	38	1.85e-02	9.41e-02	0.25800	2.58e-01	-3.16e-03	5.92e-03	9.73e-01
GOMF TRANSMEMBRANE EPHRIN RECEPTOR ACTIVITY	15	2.55e-01	4.92e-01	0.25800	-2.45e-01	-8.16e-02	1.01e-01	5.84e-01
GOCC OTHER ORGANISM PART	5	6.51e-01	8.12e-01	0.25800	-1.24e-01	-2.26e-01	6.31e-01	3.81e-01
GOBP LONG TERM SYNAPTIC DEPRESSION	30	7.77e-02	2.48e-01	0.25800	-1.29e-01	-2.24e-01	2.23e-01	3.40e-02
Strand-asynchronous mitochondrial DNA replication	10	4.00e-01	6.32e-01	0.25800	7.76e-02	2.46e-01	6.71e-01	1.78e-01
GOMF TORC2 COMPLEX BINDING	5	5.81e-01	7.67e-01	0.25800	-2.57e-01	2.41e-02	3.20e-01	9.26e-01
GOBP G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY	21	7.58e-02	2.44e-01	0.25800	-2.28e-01	1.20e-01	7.01e-02	3.42e-01
Transport of bile salts and organic acids, metal ions and amine compounds	82	1.12e-03	1.14e-02	0.25800	-2.08e-01	-1.53e-01	1.14e-03	1.70e-02
GOBP REGULATION OF PHOSPHATIDYLCHOLINE METABOLIC PROCESS	10	4.21e-01	6.51e-01	0.25800	1.15e-01	2.31e-01	5.30e-01	2.06e-01
GOBP CELLULAR RESPONSE TO UV B	12	3.71e-01	6.07e-01	0.25800	2.03e-01	1.59e-01	2.23e-01	3.41e-01
GOBP REGULATION OF GAMMA AMINOBUTYRIC ACID SECRETION	8	5.16e-01	7.22e-01	0.25800	2.03e-01	1.58e-01	3.19e-01	4.38e-01
GOMF HISTONE KINASE ACTIVITY	23	1.22e-01	3.26e-01	0.25800	2.46e-01	7.83e-02	4.15e-02	5.15e-01
GOBP CORONARY VASCULATURE MORPHOGENESIS	19	2.10e-01	4.42e-01	0.25800	1.91e-01	1.73e-01	1.50e-01	1.91e-01
O-linked glycosylation of mucins	62	2.82e-03	2.30e-02	0.25800	-2.52e-01	-5.50e-02	6.11e-04	4.54e-01
GOBP POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION	19	1.41e-01	3.54e-01	0.25800	7.24e-03	2.57e-01	9.56e-01	5.20e-02
GOBP DENDRITIC TRANSPORT OF RIBONUCLEOPROTEIN COMPLEX	5	6.15e-01	7.88e-01	0.25700	4.05e-02	2.54e-01	8.75e-01	3.25e-01
GOBP GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS	23	1.44e-01	3.57e-01	0.25700	2.19e-01	1.35e-01	6.86e-02	2.63e-01
GOMF PROTEIN SEQUESTERING ACTIVITY	27	6.55e-02	2.23e-01	0.25700	1.79e-02	2.57e-01	8.72e-01	2.09e-02
GOBP TRNA THIO MODIFICATION	5	5.51e-01	7.47e-01	0.25700	9.26e-02	-2.40e-01	7.20e-01	3.52e-01
Regulation of CDH11 gene transcription	10	4.16e-01	6.47e-01	0.25700	1.03e-01	2.36e-01	5.71e-01	1.97e-01
GOBP SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR	170	1.00e-06	2.94e-05	0.25700	1.79e-01	1.85e-01	5.64e-05	3.19e-05
GOBP STEROID HORMONE MEDIATED SIGNALING PATHWAY	129	2.39e-05	4.61e-04	0.25700	2.09e-01	1.50e-01	4.12e-05	3.26e-03
GOBP PIECEMEAL MICROAUTOPHAGY OF THE NUCLEUS	17	1.72e-01	3.94e-01	0.25700	2.57e-01	1.95e-03	6.63e-02	9.89e-01
GOBP REGULATION OF CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION	8	5.19e-01	7.25e-01	0.25700	-1.95e-01	-1.68e-01	3.41e-01	4.10e-01
Sphingolipid de novo biosynthesis	37	4.88e-02	1.85e-01	0.25700	1.75e-01	1.88e-01	6.55e-02	4.74e-02
GOBP REGULATION OF CHONDROCYTE DEVELOPMENT	6	5.22e-01	7.26e-01	0.25700	-2.67e-02	2.56e-01	9.10e-01	2.78e-01
GOBP REGULATION OF GOLGI ORGANIZATION	17	2.35e-01	4.71e-01	0.25700	2.26e-01	1.22e-01	1.06e-01	3.85e-01
GOBP CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS	14	3.17e-01	5.56e-01	0.25700	-1.60e-01	-2.01e-01	2.99e-01	1.93e-01
GOBP REGULATION OF PLASMINOGEN ACTIVATION	18	1.04e-01	2.97e-01	0.25700	-1.90e-01	1.73e-01	1.63e-01	2.03e-01
GOBP SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING	13	2.94e-01	5.34e-01	0.25700	-5.70e-02	-2.50e-01	7.22e-01	1.18e-01
GOCC JUNCTIONAL MEMBRANE COMPLEX	6	6.13e-01	7.87e-01	0.25700	1.76e-01	1.87e-01	4.54e-01	4.28e-01
GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE BINDING	27	4.21e-02	1.68e-01	0.25700	2.43e-01	-8.41e-02	2.90e-02	4.50e-01
GOMF GLUTATHIONE DISULFIDE OXIDOREDUCTASE ACTIVITY	5	6.44e-01	8.07e-01	0.25700	9.77e-02	2.37e-01	7.05e-01	3.58e-01
GOCC MYOSIN COMPLEX	57	5.34e-03	3.71e-02	0.25700	-6.99e-02	-2.47e-01	3.61e-01	1.25e-03
GOBP MIDBODY ABSCISSION	17	2.48e-01	4.86e-01	0.25700	1.57e-01	2.03e-01	2.61e-01	1.48e-01
Myogenesis	29	7.12e-02	2.35e-01	0.25700	2.46e-01	7.46e-02	2.21e-02	4.87e-01
Beta-oxidation of very long chain fatty acids	10	3.50e-01	5.88e-01	0.25700	-8.27e-03	2.57e-01	9.64e-01	1.60e-01
GOMF RNA POLYMERASE ACTIVITY	30	6.52e-02	2.22e-01	0.25700	2.45e-01	7.53e-02	2.00e-02	4.75e-01
GOCC PCG PROTEIN COMPLEX	46	2.30e-02	1.10e-01	0.25700	2.04e-01	1.56e-01	1.66e-02	6.79e-02
Regulation of commissural axon pathfinding by SLIT and ROBO	10	4.39e-01	6.67e-01	0.25700	-2.07e-01	-1.52e-01	2.58e-01	4.05e-01
Meiotic synapsis	54	9.49e-03	5.76e-02	0.25700	2.32e-01	1.09e-01	3.14e-03	1.67e-01
GOBP ELECTRON TRANSPORT CHAIN	114	7.21e-05	1.18e-03	0.25600	2.21e-01	1.30e-01	4.52e-05	1.66e-02
GOBP SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION	10	4.38e-01	6.66e-01	0.25600	1.48e-01	2.09e-01	4.16e-01	2.52e-01
GOBP NEGATIVE REGULATION OF AXON EXTENSION INVOLVED IN AXON GUIDANCE	8	3.97e-01	6.30e-01	0.25600	-2.46e-01	7.33e-02	2.29e-01	7.20e-01
Insulin processing	24	1.14e-01	3.13e-01	0.25600	7.69e-02	2.45e-01	5.15e-01	3.80e-02
GOMF DIOXYGENASE ACTIVITY	86	1.26e-04	1.87e-03	0.25600	2.56e-01	-8.72e-03	4.00e-05	8.89e-01
GOMF MOLECULAR TAG ACTIVITY	13	2.82e-01	5.21e-01	0.25600	2.54e-01	3.47e-02	1.13e-01	8.29e-01
GOBP POSITIVE REGULATION OF MIRNA METABOLIC PROCESS	63	4.97e-03	3.52e-02	0.25600	1.25e-01	2.24e-01	8.55e-02	2.14e-03
GOCC NUCLEAR STRESS GRANULE	6	6.08e-01	7.84e-01	0.25600	2.15e-01	1.39e-01	3.61e-01	5.55e-01
GOBP POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION	9	4.73e-01	6.94e-01	0.25600	1.38e-01	2.16e-01	4.73e-01	2.62e-01
GOBP RIBOSOME ASSEMBLY	57	6.09e-03	4.12e-02	0.25600	2.43e-01	8.25e-02	1.53e-03	2.81e-01
GOBP NUCLEAR MIGRATION	25	9.13e-02	2.74e-01	0.25600	2.53e-01	4.31e-02	2.88e-02	7.09e-01
GOBP NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY	15	2.94e-01	5.34e-01	0.25600	2.00e-01	1.60e-01	1.80e-01	2.82e-01
GOMF CHEMOKINE RECEPTOR BINDING	63	5.83e-03	3.97e-02	0.25600	-1.54e-01	-2.04e-01	3.40e-02	5.03e-03
GOBP HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES	164	1.50e-09	7.85e-08	0.25600	1.62e-01	-1.99e-01	3.56e-04	1.12e-05
GOMF CALCITONIN FAMILY RECEPTOR ACTIVITY	6	5.07e-01	7.15e-01	0.25600	6.11e-02	-2.49e-01	7.95e-01	2.91e-01
Nuclear events mediated by NFE2L2	85	9.52e-04	1.01e-02	0.25600	2.08e-01	1.50e-01	9.36e-04	1.68e-02
GOBP FOREBRAIN NEURON DIFFERENTIATION	42	2.90e-02	1.29e-01	0.25600	1.23e-01	2.25e-01	1.67e-01	1.18e-02
GOBP NEURAL CREST CELL FATE COMMITMENT	6	4.78e-01	6.96e-01	0.25600	1.39e-01	-2.15e-01	5.55e-01	3.62e-01
GOBP NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION	68	4.11e-03	3.06e-02	0.25600	1.75e-01	1.87e-01	1.27e-02	7.61e-03
GOMF UNFOLDED PROTEIN BINDING	114	6.48e-05	1.08e-03	0.25600	2.27e-01	1.18e-01	2.74e-05	2.99e-02
Signal transduction by L1	20	1.33e-01	3.42e-01	0.25600	2.56e-01	1.16e-02	4.78e-02	9.28e-01
GOBP CARDIAC MUSCLE CELL CARDIAC MUSCLE CELL ADHESION	7	4.91e-01	7.04e-01	0.25600	-2.56e-01	-7.27e-03	2.41e-01	9.73e-01
GOCC BLEB	9	4.81e-01	6.97e-01	0.25600	1.99e-01	1.61e-01	3.01e-01	4.03e-01
Formation of annular gap junctions	11	3.80e-01	6.15e-01	0.25600	2.38e-01	9.33e-02	1.71e-01	5.92e-01
GOBP DEOXYRIBONUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS	14	1.90e-01	4.17e-01	0.25600	-2.36e-01	9.95e-02	1.27e-01	5.19e-01
GOBP NEUTROPHIL EXTRAVASATION	11	2.90e-01	5.28e-01	0.25600	-2.49e-01	5.84e-02	1.53e-01	7.37e-01
GOMF NUCLEOTIDE RECEPTOR ACTIVITY	17	1.31e-01	3.39e-01	0.25600	-2.32e-01	1.08e-01	9.77e-02	4.42e-01
GOMF FUCOSYLTRANSFERASE ACTIVITY	13	3.37e-01	5.76e-01	0.25600	-2.21e-01	-1.28e-01	1.67e-01	4.23e-01
GOBP CARDIAC MUSCLE CELL PROLIFERATION	58	9.05e-03	5.57e-02	0.25600	2.01e-01	1.59e-01	8.25e-03	3.67e-02
GOBP RECEPTOR GUANYLYL CYCLASE SIGNALING PATHWAY	10	4.42e-01	6.69e-01	0.25600	1.53e-01	2.04e-01	4.01e-01	2.63e-01
GOBP CENTROSOME SEPARATION	16	1.91e-01	4.19e-01	0.25600	-4.46e-03	2.56e-01	9.75e-01	7.68e-02
GOBP NUCLEAR ENVELOPE ORGANIZATION	55	1.19e-02	6.81e-02	0.25600	1.86e-01	1.75e-01	1.69e-02	2.47e-02
GOMF PHOSPHATIDYLINOSITOL TRANSFER ACTIVITY	10	3.36e-01	5.75e-01	0.25600	2.53e-01	-3.77e-02	1.66e-01	8.37e-01
Regulation of MECP2 expression and activity	30	7.42e-02	2.41e-01	0.25500	2.35e-01	9.98e-02	2.58e-02	3.44e-01
GOMF SPHINGOSINE N ACYLTRANSFERASE ACTIVITY	7	5.67e-01	7.58e-01	0.25500	1.63e-01	1.96e-01	4.54e-01	3.68e-01
GOBP MUCUS SECRETION	19	2.09e-01	4.41e-01	0.25500	-2.13e-01	-1.41e-01	1.08e-01	2.89e-01
GOBP SALIVA SECRETION	13	3.43e-01	5.81e-01	0.25500	-2.13e-01	-1.40e-01	1.83e-01	3.81e-01
GOBP REGULATION OF MICROGLIAL CELL ACTIVATION	20	8.33e-02	2.59e-01	0.25500	-1.89e-01	1.72e-01	1.43e-01	1.84e-01
mRNA 3’-end processing	53	8.62e-03	5.39e-02	0.25500	2.43e-01	7.69e-02	2.16e-03	3.33e-01
Protein methylation	15	2.98e-01	5.38e-01	0.25500	1.92e-01	1.68e-01	1.97e-01	2.60e-01
GOBP NEGATIVE T CELL SELECTION	13	3.42e-01	5.80e-01	0.25500	-2.15e-01	-1.37e-01	1.79e-01	3.91e-01
GOBP REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS	13	3.14e-01	5.54e-01	0.25500	8.21e-02	2.42e-01	6.08e-01	1.31e-01
GOCC PRERIBOSOME SMALL SUBUNIT PRECURSOR	15	2.42e-01	4.80e-01	0.25500	2.51e-01	4.64e-02	9.23e-02	7.56e-01
GOBP T CELL CHEMOTAXIS	24	8.54e-02	2.63e-01	0.25500	1.21e-03	-2.55e-01	9.92e-01	3.04e-02
GOBP REGULATION OF DENDRITE EXTENSION	26	4.34e-02	1.71e-01	0.25500	-2.24e-01	1.23e-01	4.85e-02	2.78e-01
GOBP REGULATION OF GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY	7	4.62e-01	6.86e-01	0.25500	-4.75e-02	2.51e-01	8.28e-01	2.51e-01
Prostacyclin signalling through prostacyclin receptor	19	2.00e-01	4.30e-01	0.25500	2.28e-01	1.14e-01	8.50e-02	3.91e-01
GOBP NUCLEAR EXPORT	157	1.75e-06	4.77e-05	0.25500	2.29e-01	1.12e-01	7.14e-07	1.55e-02
GOCC MITOCHONDRIA ASSOCIATED ENDOPLASMIC RETICULUM MEMBRANE CONTACT SITE	19	1.76e-01	3.99e-01	0.25500	6.43e-02	2.47e-01	6.27e-01	6.26e-02
GOBP REGULATION OF HEPATOCYTE APOPTOTIC PROCESS	9	3.98e-01	6.31e-01	0.25500	2.55e-01	-1.40e-03	1.85e-01	9.94e-01
GOCC SECONDARY LYSOSOME	20	8.59e-02	2.64e-01	0.25500	-1.48e-01	2.07e-01	2.50e-01	1.09e-01
RHO GTPase Effectors	273	1.62e-10	9.78e-09	0.25500	2.23e-01	1.23e-01	2.27e-10	4.46e-04
GOBP MITOTIC RECOMBINATION	25	5.99e-02	2.10e-01	0.25500	2.46e-01	-6.45e-02	3.29e-02	5.77e-01
Interleukin-21 signaling	9	3.79e-01	6.13e-01	0.25500	-3.47e-02	2.52e-01	8.57e-01	1.90e-01
GOBP ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS	13	2.52e-01	4.90e-01	0.25500	2.54e-01	-2.37e-02	1.13e-01	8.83e-01
RHO GTPases activate KTN1	11	4.14e-01	6.45e-01	0.25500	1.84e-01	1.76e-01	2.90e-01	3.13e-01
GOMF NEUROTRANSMITTER RECEPTOR ACTIVITY INVOLVED IN REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL	53	1.16e-02	6.68e-02	0.25500	-2.27e-01	-1.15e-01	4.25e-03	1.46e-01
GOMF MANNOSYL OLIGOSACCHARIDE MANNOSIDASE ACTIVITY	9	3.71e-01	6.07e-01	0.25500	-4.98e-02	2.50e-01	7.96e-01	1.95e-01
GOBP BRANCHIOMOTOR NEURON AXON GUIDANCE	6	5.72e-01	7.62e-01	0.25500	-5.21e-02	-2.49e-01	8.25e-01	2.90e-01
Acrosome Reaction and Sperm:Oocyte Membrane Binding	6	4.78e-01	6.96e-01	0.25500	-1.57e-01	2.00e-01	5.05e-01	3.95e-01
GOBP REGULATION OF GRANULOCYTE DIFFERENTIATION	16	1.39e-01	3.51e-01	0.25400	-1.65e-01	1.93e-01	2.52e-01	1.81e-01
GOBP REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION	24	1.45e-01	3.58e-01	0.25400	-1.57e-01	-2.00e-01	1.84e-01	8.92e-02
Netrin mediated repulsion signals	8	3.96e-01	6.29e-01	0.25400	-2.38e-01	8.88e-02	2.43e-01	6.64e-01
GOBP NEGATIVE REGULATION OF FAT CELL PROLIFERATION	5	6.53e-01	8.13e-01	0.25400	-2.32e-01	-1.05e-01	3.69e-01	6.85e-01
GOBP GLYCEROL TRANSMEMBRANE TRANSPORT	7	5.70e-01	7.60e-01	0.25400	1.62e-01	1.96e-01	4.59e-01	3.68e-01
GOMF GLYCEROL TRANSMEMBRANE TRANSPORTER ACTIVITY	7	5.70e-01	7.60e-01	0.25400	1.62e-01	1.96e-01	4.59e-01	3.68e-01
GOBP MITOTIC CHROMOSOME CONDENSATION	19	1.49e-01	3.63e-01	0.25400	2.54e-01	7.67e-03	5.51e-02	9.54e-01
Notch-HLH transcription pathway	24	7.59e-02	2.44e-01	0.25400	2.52e-01	-3.48e-02	3.26e-02	7.68e-01
GOBP RESPONSE TO PHENYLPROPANOID	5	6.68e-01	8.25e-01	0.25400	-1.55e-01	-2.02e-01	5.49e-01	4.35e-01
GOCC VARICOSITY	9	3.73e-01	6.09e-01	0.25400	-2.50e-01	4.76e-02	1.95e-01	8.05e-01
GOBP POSITIVE REGULATION OF TYPE II INTERFERON PRODUCTION	74	1.35e-04	1.98e-03	0.25400	-2.17e-01	1.32e-01	1.23e-03	5.02e-02
GOCC FANCONI ANAEMIA NUCLEAR COMPLEX	11	3.56e-01	5.93e-01	0.25400	2.50e-01	4.42e-02	1.51e-01	8.00e-01
Regulation of pyruvate metabolism	31	7.12e-02	2.35e-01	0.25400	2.32e-01	1.03e-01	2.53e-02	3.20e-01
GOBP CELL PROLIFERATION IN BONE MARROW	10	2.96e-01	5.35e-01	0.25400	-1.47e-01	2.07e-01	4.20e-01	2.57e-01
GOBP REGULATION OF SENSORY PERCEPTION	17	1.58e-01	3.76e-01	0.25400	-2.51e-01	4.17e-02	7.36e-02	7.66e-01
GOBP VERY LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS	13	3.01e-01	5.40e-01	0.25400	-2.48e-01	-5.39e-02	1.21e-01	7.37e-01
GOMF PEPTIDASE ACTIVATOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS	23	1.60e-01	3.78e-01	0.25400	1.69e-01	1.89e-01	1.60e-01	1.16e-01
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE	6	5.30e-01	7.33e-01	0.25400	2.63e-02	-2.53e-01	9.11e-01	2.84e-01
Transcriptional activation of mitochondrial biogenesis	51	1.50e-02	8.10e-02	0.25400	2.19e-01	1.28e-01	6.72e-03	1.14e-01
GOMF INOSITOL TRISPHOSPHATE PHOSPHATASE ACTIVITY	12	2.52e-01	4.90e-01	0.25400	2.40e-01	-8.41e-02	1.51e-01	6.14e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON OTHER NITROGENOUS COMPOUNDS AS DONORS	12	2.55e-01	4.92e-01	0.25400	2.42e-01	-7.72e-02	1.47e-01	6.43e-01
GOBP MEIOTIC CYTOKINESIS	8	4.88e-01	7.02e-01	0.25400	7.14e-02	2.44e-01	7.26e-01	2.33e-01
GOBP CHROMOSOME CONDENSATION	46	1.06e-02	6.24e-02	0.25400	2.54e-01	1.30e-02	2.92e-03	8.79e-01
GOBP VESTIBULOCOCHLEAR NERVE MORPHOGENESIS	7	5.53e-01	7.48e-01	0.25400	-1.08e-01	-2.30e-01	6.20e-01	2.93e-01
GOBP NEGATIVE REGULATION OF SYNAPSE ORGANIZATION	11	3.53e-01	5.90e-01	0.25400	3.95e-02	2.51e-01	8.21e-01	1.50e-01
GOBP NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION	25	1.20e-01	3.22e-01	0.25400	1.06e-01	2.31e-01	3.58e-01	4.60e-02
TRAF3-dependent IRF activation pathway	15	2.40e-01	4.77e-01	0.25400	2.51e-01	3.65e-02	9.20e-02	8.07e-01
GOMF LACTATE TRANSMEMBRANE TRANSPORTER ACTIVITY	6	5.23e-01	7.27e-01	0.25400	-2.51e-01	4.03e-02	2.88e-01	8.64e-01
GOBP REGULATION OF PROTEIN LOCALIZATION TO CELL CORTEX	9	4.73e-01	6.94e-01	0.25400	2.24e-01	1.19e-01	2.45e-01	5.35e-01
GOBP POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION	15	1.91e-01	4.18e-01	0.25400	-2.48e-01	5.51e-02	9.66e-02	7.12e-01
GOBP ATP BIOSYNTHETIC PROCESS	86	8.34e-04	9.15e-03	0.25400	2.21e-01	1.25e-01	3.93e-04	4.56e-02
GOBP CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS	14	3.00e-01	5.40e-01	0.25400	2.35e-01	9.68e-02	1.28e-01	5.31e-01
GOCC NUCLEAR PORE	90	5.57e-04	6.57e-03	0.25400	2.25e-01	1.17e-01	2.19e-04	5.55e-02
GOMF UNIPORTER ACTIVITY	9	4.23e-01	6.53e-01	0.25400	3.37e-02	2.52e-01	8.61e-01	1.91e-01
GOBP REGULATION OF PROTEIN LOCALIZATION TO CHROMATIN	9	4.26e-01	6.55e-01	0.25400	3.83e-02	2.51e-01	8.42e-01	1.92e-01
Regulation of NPAS4 gene expression	13	3.10e-01	5.51e-01	0.25400	2.44e-01	6.82e-02	1.27e-01	6.70e-01
GOBP MESENCHYMAL STEM CELL DIFFERENTIATION	12	3.07e-01	5.47e-01	0.25400	-2.53e-01	-1.61e-02	1.29e-01	9.23e-01
GOBP BICARBONATE TRANSPORT	37	3.34e-02	1.42e-01	0.25400	-2.48e-01	-5.51e-02	9.12e-03	5.62e-01
Co-inhibition by CTLA4	21	1.88e-01	4.14e-01	0.25400	1.92e-01	1.66e-01	1.28e-01	1.88e-01
GOBP REGULATION OF ASPARTIC TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS	6	6.16e-01	7.89e-01	0.25400	1.48e-01	2.06e-01	5.30e-01	3.82e-01
GOMF SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY	29	7.25e-02	2.38e-01	0.25400	-2.46e-01	-6.35e-02	2.21e-02	5.54e-01
GOBP LATE ENDOSOME TO VACUOLE TRANSPORT	36	5.75e-02	2.04e-01	0.25400	1.75e-01	1.83e-01	6.85e-02	5.73e-02
GOBP REGULATION OF AXON GUIDANCE	11	4.10e-01	6.42e-01	0.25400	2.11e-01	1.41e-01	2.27e-01	4.17e-01
Antigen processing: Ubiquitination & Proteasome degradation	283	1.86e-10	1.11e-08	0.25400	2.01e-01	1.55e-01	6.07e-09	7.38e-06
GOBP PROTEIN HEXAMERIZATION	9	4.77e-01	6.95e-01	0.25400	1.26e-01	2.20e-01	5.12e-01	2.53e-01
GOBP ESTABLISHMENT OF BLOOD BRAIN BARRIER	14	2.12e-01	4.44e-01	0.25400	2.47e-01	-5.89e-02	1.10e-01	7.03e-01
GOBP STOMACH DEVELOPMENT	5	5.57e-01	7.51e-01	0.25400	1.02e-01	-2.32e-01	6.92e-01	3.69e-01
GOBP MACROMOLECULE METHYLATION	123	4.86e-05	8.55e-04	0.25400	2.12e-01	1.39e-01	4.96e-05	7.60e-03
GOBP VERY LONG CHAIN FATTY ACID CATABOLIC PROCESS	6	6.21e-01	7.92e-01	0.25400	1.89e-01	1.68e-01	4.22e-01	4.75e-01
GOCC TUBULAR ENDOSOME	5	6.23e-01	7.93e-01	0.25300	3.84e-02	2.51e-01	8.82e-01	3.32e-01
GOBP ETHANOL METABOLIC PROCESS	11	4.17e-01	6.47e-01	0.25300	-1.65e-01	-1.93e-01	3.45e-01	2.68e-01
GOMF DNA BINDING BENDING	16	2.43e-01	4.80e-01	0.25300	7.64e-02	2.42e-01	5.97e-01	9.42e-02
GOMF RETINAL BINDING	19	2.22e-01	4.55e-01	0.25300	-1.73e-01	-1.85e-01	1.92e-01	1.62e-01
Cellular responses to stress	735	1.50e-25	3.17e-23	0.25300	2.04e-01	1.51e-01	4.93e-21	3.33e-12
GOBP REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING	16	2.74e-01	5.14e-01	0.25300	2.11e-01	1.40e-01	1.43e-01	3.33e-01
GOBP CATECHOLAMINE SECRETION	48	2.88e-03	2.33e-02	0.25300	-1.95e-01	1.62e-01	1.97e-02	5.19e-02
GOBP GROWTH PLATE CARTILAGE CHONDROCYTE DEVELOPMENT	5	6.72e-01	8.27e-01	0.25300	1.94e-01	1.63e-01	4.54e-01	5.27e-01
GOBP REGULATION OF CHOLESTEROL STORAGE	19	2.10e-01	4.42e-01	0.25300	-2.20e-01	-1.25e-01	9.67e-02	3.44e-01
GOBP BILE ACID SECRETION	12	3.77e-01	6.13e-01	0.25300	-2.14e-01	-1.36e-01	2.00e-01	4.15e-01
GOBP OLFACTORY BEHAVIOR	11	3.18e-01	5.56e-01	0.25300	2.06e-02	-2.52e-01	9.06e-01	1.47e-01
GOBP REGULATION OF PIGMENT CELL DIFFERENTIATION	8	5.12e-01	7.20e-01	0.25300	2.27e-01	1.12e-01	2.66e-01	5.84e-01
GOBP REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION	348	3.13e-13	2.69e-11	0.25300	2.28e-01	1.10e-01	2.44e-13	4.46e-04
GOBP REGULATION OF RESPIRATORY BURST	16	1.55e-01	3.72e-01	0.25300	-2.32e-01	1.00e-01	1.08e-01	4.87e-01
NR1H2 & NR1H3 regulate gene expression linked to lipogenesis	9	4.76e-01	6.95e-01	0.25300	2.21e-01	1.23e-01	2.50e-01	5.24e-01
GOBP BLASTOCYST DEVELOPMENT	113	6.07e-05	1.02e-03	0.25300	2.37e-01	8.96e-02	1.39e-05	9.98e-02
Downregulation of TGF-beta receptor signaling	26	1.09e-01	3.06e-01	0.25300	9.62e-02	2.34e-01	3.96e-01	3.90e-02
GOBP POSITIVE REGULATION OF RNA METABOLIC PROCESS	1835	1.43e-59	9.25e-57	0.25300	2.05e-01	1.48e-01	2.60e-48	7.77e-26
GOMF CULLIN FAMILY PROTEIN BINDING	24	1.17e-01	3.18e-01	0.25300	2.44e-01	6.77e-02	3.88e-02	5.66e-01
GOBP ICOSANOID TRANSPORT	64	5.73e-03	3.92e-02	0.25300	-1.37e-01	-2.13e-01	5.82e-02	3.27e-03
GOMF RNA POLYMERASE III ACTIVITY	10	4.25e-01	6.54e-01	0.25300	2.35e-01	9.45e-02	1.99e-01	6.05e-01
HDL assembly	8	4.45e-01	6.72e-01	0.25300	5.41e-03	-2.53e-01	9.79e-01	2.16e-01
SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion	13	3.04e-01	5.44e-01	0.25300	2.47e-01	5.29e-02	1.23e-01	7.41e-01
GOMF GUANYLATE KINASE ACTIVITY	7	5.66e-01	7.57e-01	0.25300	-1.32e-01	-2.15e-01	5.44e-01	3.24e-01
GOBP PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS	23	6.59e-02	2.23e-01	0.25300	-1.20e-01	2.22e-01	3.18e-01	6.50e-02
GOBP MACROPINOCYTOSIS	10	4.54e-01	6.79e-01	0.25300	1.73e-01	1.84e-01	3.42e-01	3.14e-01
GOMF SODIUM PHOSPHATE SYMPORTER ACTIVITY	13	2.48e-01	4.86e-01	0.25300	4.22e-02	-2.49e-01	7.92e-01	1.20e-01
GOBP LUTEINIZING HORMONE SECRETION	11	3.15e-01	5.55e-01	0.25300	2.51e-01	-2.74e-02	1.49e-01	8.75e-01
GOBP NEUTROPHIL MEDIATED KILLING OF SYMBIONT CELL	13	3.52e-01	5.90e-01	0.25300	-2.08e-01	-1.43e-01	1.94e-01	3.72e-01
RUNX2 regulates chondrocyte maturation	5	5.52e-01	7.48e-01	0.25300	-2.20e-01	1.24e-01	3.95e-01	6.30e-01
GOBP PEROXISOME ORGANIZATION	34	6.65e-02	2.25e-01	0.25300	2.04e-01	1.49e-01	3.96e-02	1.33e-01
GOMF G PROTEIN COUPLED CHEMOATTRACTANT RECEPTOR ACTIVITY	25	1.21e-01	3.24e-01	0.25300	-1.01e-01	-2.31e-01	3.81e-01	4.52e-02
Regulation of PLK1 Activity at G2/M Transition	83	1.39e-03	1.33e-02	0.25200	2.01e-01	1.53e-01	1.55e-03	1.61e-02
GOBP POSITIVE REGULATION OF DNA BINDING	37	5.08e-02	1.90e-01	0.25200	2.12e-01	1.37e-01	2.54e-02	1.51e-01
GOBP SKELETAL MUSCLE SATELLITE CELL DIFFERENTIATION	13	2.50e-01	4.89e-01	0.25200	2.49e-01	-3.85e-02	1.19e-01	8.10e-01
SHC1 events in EGFR signaling	14	2.89e-01	5.28e-01	0.25200	2.42e-01	7.01e-02	1.16e-01	6.50e-01
GOBP PLATELET ACTIVATING FACTOR METABOLIC PROCESS	8	5.14e-01	7.21e-01	0.25200	-1.09e-01	-2.28e-01	5.94e-01	2.65e-01
GOBP DNA REPLICATION	273	3.62e-10	2.06e-08	0.25200	2.13e-01	1.35e-01	1.42e-09	1.19e-04
GOCC NODE OF RANVIER	16	2.43e-01	4.80e-01	0.25200	-2.42e-01	-6.93e-02	9.33e-02	6.31e-01
GOBP REGULATION OF STRESS GRANULE ASSEMBLY	11	3.84e-01	6.18e-01	0.25200	2.39e-01	8.02e-02	1.70e-01	6.45e-01
Class I peroxisomal membrane protein import	19	2.25e-01	4.59e-01	0.25200	1.78e-01	1.78e-01	1.78e-01	1.79e-01
GOBP SEROTONERGIC NEURON AXON GUIDANCE	5	6.09e-01	7.85e-01	0.25200	3.33e-03	2.52e-01	9.90e-01	3.29e-01
GOBP PROTEIN LIPID COMPLEX ASSEMBLY	30	3.20e-02	1.38e-01	0.25200	2.33e-01	-9.56e-02	2.70e-02	3.65e-01
GOCC SCF UBIQUITIN LIGASE COMPLEX	66	4.48e-03	3.25e-02	0.25200	1.18e-01	2.23e-01	9.86e-02	1.74e-03
GOBP ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE	36	1.41e-02	7.73e-02	0.25200	-1.30e-01	2.15e-01	1.76e-01	2.53e-02
GOBP REGULATION OF MIRNA TRANSCRIPTION	74	2.18e-03	1.89e-02	0.25200	1.08e-01	2.27e-01	1.08e-01	7.17e-04
Neurotoxicity of clostridium toxins	10	3.13e-01	5.53e-01	0.25200	-1.09e-01	2.27e-01	5.50e-01	2.14e-01
GOBP POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS	19	1.21e-01	3.24e-01	0.25200	7.08e-02	-2.41e-01	5.93e-01	6.84e-02
GOBP ACTIN FILAMENT SEVERING	16	2.85e-01	5.24e-01	0.25200	1.92e-01	1.63e-01	1.84e-01	2.59e-01
Regulation of HSF1-mediated heat shock response	80	1.37e-03	1.32e-02	0.25100	2.26e-01	1.09e-01	4.63e-04	9.06e-02
GOBP EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS	10	4.49e-01	6.75e-01	0.25100	1.35e-01	2.12e-01	4.60e-01	2.46e-01
GOMF HISTONE H3K9 DEMETHYLASE ACTIVITY	12	2.47e-01	4.85e-01	0.25100	2.24e-01	-1.14e-01	1.79e-01	4.94e-01
GOMF AMINO ACID PROTON SYMPORTER ACTIVITY	6	6.23e-01	7.93e-01	0.25100	2.01e-01	1.51e-01	3.94e-01	5.22e-01
GOBP LEUKOCYTE CHEMOTAXIS INVOLVED IN INFLAMMATORY RESPONSE	8	4.66e-01	6.88e-01	0.25100	-2.50e-01	-2.26e-02	2.20e-01	9.12e-01
GOBP EMBRYONIC EYE MORPHOGENESIS	35	6.17e-02	2.14e-01	0.25100	1.38e-01	2.10e-01	1.57e-01	3.17e-02
Transport of RCbl within the body	8	5.32e-01	7.34e-01	0.25100	1.47e-01	2.04e-01	4.71e-01	3.19e-01
GOBP PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION	28	7.07e-02	2.34e-01	0.25100	2.50e-01	2.59e-02	2.22e-02	8.13e-01
GOBP RNA IMPORT INTO MITOCHONDRION	5	6.74e-01	8.28e-01	0.25100	1.46e-01	2.05e-01	5.73e-01	4.28e-01
GOCC RESPIRATORY CHAIN COMPLEX IV	22	1.12e-01	3.10e-01	0.25100	2.51e-01	-3.19e-03	4.15e-02	9.79e-01
GOMF CYCLIN BINDING	34	6.67e-02	2.25e-01	0.25100	2.11e-01	1.36e-01	3.32e-02	1.70e-01
GOCC MITOTIC SPINDLE MICROTUBULE	13	3.37e-01	5.75e-01	0.25100	9.85e-02	2.31e-01	5.39e-01	1.50e-01
RHOT2 GTPase cycle	7	5.43e-01	7.41e-01	0.25100	2.40e-01	7.31e-02	2.71e-01	7.38e-01
GOCC SYMMETRIC SYNAPSE	8	4.24e-01	6.54e-01	0.25100	-4.96e-02	2.46e-01	8.08e-01	2.28e-01
GOCC FLEMMING BODY	34	7.06e-02	2.34e-01	0.25100	1.62e-01	1.92e-01	1.02e-01	5.30e-02
RNA Polymerase I Transcription Termination	29	9.39e-02	2.79e-01	0.25100	2.23e-01	1.15e-01	3.76e-02	2.84e-01
GOBP SUCCINATE METABOLIC PROCESS	7	5.66e-01	7.57e-01	0.25100	2.21e-01	1.19e-01	3.11e-01	5.87e-01
GOBP POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS	17	2.22e-01	4.56e-01	0.25100	2.43e-01	6.35e-02	8.32e-02	6.50e-01
GOBP NEPHRIC DUCT MORPHOGENESIS	10	3.08e-01	5.48e-01	0.25100	-2.14e-01	1.31e-01	2.42e-01	4.73e-01
GOBP PROTEIN STABILIZATION	203	5.92e-08	2.25e-06	0.25100	2.27e-01	1.06e-01	2.28e-08	9.55e-03
GOMF ACID PHOSPHATASE ACTIVITY	9	4.97e-01	7.09e-01	0.25100	1.83e-01	1.72e-01	3.42e-01	3.73e-01
GOBP TRANSFERRIN TRANSPORT	10	3.34e-01	5.73e-01	0.25100	2.42e-01	-6.64e-02	1.86e-01	7.16e-01
GOBP R LOOP PROCESSING	9	3.79e-01	6.13e-01	0.25100	2.45e-01	-5.52e-02	2.04e-01	7.74e-01
GOBP NADH OXIDATION	6	6.03e-01	7.81e-01	0.25100	-2.34e-01	-9.10e-02	3.22e-01	6.99e-01
GOMF NUCLEAR RETINOIC ACID RECEPTOR BINDING	25	1.32e-01	3.40e-01	0.25100	2.21e-01	1.19e-01	5.60e-02	3.05e-01
GOBP NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION	67	3.26e-03	2.55e-02	0.25100	2.37e-01	8.15e-02	7.93e-04	2.49e-01
GOBP DUCTUS ARTERIOSUS CLOSURE	5	6.68e-01	8.25e-01	0.25100	2.19e-01	1.22e-01	3.96e-01	6.37e-01
GOBP AMINOACYL TRNA METABOLISM INVOLVED IN TRANSLATIONAL FIDELITY	13	3.09e-01	5.49e-01	0.25100	2.46e-01	5.00e-02	1.25e-01	7.55e-01
GOMF AMINOACYL TRNA EDITING ACTIVITY	13	3.09e-01	5.49e-01	0.25100	2.46e-01	5.00e-02	1.25e-01	7.55e-01
RHOV GTPase cycle	36	4.46e-02	1.74e-01	0.25100	2.39e-01	7.56e-02	1.31e-02	4.33e-01
GOMF INWARD RECTIFIER POTASSIUM CHANNEL ACTIVITY	27	1.13e-01	3.13e-01	0.25100	-2.19e-01	-1.22e-01	4.91e-02	2.72e-01
MET promotes cell motility	41	1.20e-02	6.86e-02	0.25100	5.65e-02	-2.44e-01	5.32e-01	6.83e-03
GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN EXECUTION PHASE OF APOPTOSIS	5	6.07e-01	7.83e-01	0.25100	-7.29e-03	2.50e-01	9.77e-01	3.32e-01
GOBP PYRIMIDINE DEOXYRIBONUCLEOSIDE METABOLIC PROCESS	5	5.57e-01	7.51e-01	0.25100	-1.26e-01	2.17e-01	6.26e-01	4.02e-01
GOMF GLYCOLIPID BINDING	29	7.25e-02	2.38e-01	0.25100	-2.46e-01	-4.86e-02	2.20e-02	6.50e-01
GOBP NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION	19	1.12e-01	3.10e-01	0.25000	-2.24e-01	1.12e-01	9.12e-02	3.97e-01
GOBP PYRIMIDINE RIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS	7	5.15e-01	7.22e-01	0.25000	2.49e-01	2.28e-02	2.53e-01	9.17e-01
GOBP RISC COMPLEX ASSEMBLY	10	4.61e-01	6.84e-01	0.25000	1.85e-01	1.68e-01	3.10e-01	3.56e-01
GOBP NEURAL TUBE PATTERNING	31	8.88e-02	2.70e-01	0.25000	1.51e-01	2.00e-01	1.45e-01	5.44e-02
GOBP HYPOTHALAMUS CELL DIFFERENTIATION	12	3.93e-01	6.26e-01	0.25000	1.56e-01	1.96e-01	3.49e-01	2.41e-01
GOBP SYNAPTONEMAL COMPLEX ORGANIZATION	26	4.62e-02	1.78e-01	0.25000	1.45e-01	-2.04e-01	2.02e-01	7.13e-02
GOBP MYOBLAST PROLIFERATION	34	6.66e-02	2.25e-01	0.25000	2.14e-01	1.29e-01	3.07e-02	1.91e-01
GOBP ISOPRENOID CATABOLIC PROCESS	10	3.55e-01	5.93e-01	0.25000	-3.11e-02	2.48e-01	8.65e-01	1.74e-01
GOMF DEATH RECEPTOR ACTIVITY	11	3.12e-01	5.52e-01	0.25000	-2.46e-01	4.54e-02	1.58e-01	7.94e-01
GOBP MYELOID DENDRITIC CELL CYTOKINE PRODUCTION	7	4.83e-01	6.99e-01	0.25000	-3.33e-02	2.48e-01	8.79e-01	2.56e-01
GOBP REGULATION OF PROTEIN DEPHOSPHORYLATION	73	7.64e-04	8.59e-03	0.25000	2.50e-01	-1.74e-03	2.20e-04	9.79e-01
GOBP REGULATION OF MESONEPHROS DEVELOPMENT	5	6.19e-01	7.90e-01	0.25000	-2.50e-01	-1.36e-02	3.34e-01	9.58e-01
GOBP PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY	23	1.54e-01	3.69e-01	0.25000	2.24e-01	1.11e-01	6.30e-02	3.57e-01
GOBP L SERINE BIOSYNTHETIC PROCESS	6	6.29e-01	7.97e-01	0.25000	1.86e-01	1.67e-01	4.31e-01	4.78e-01
GOBP RIBONUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS	14	1.89e-01	4.16e-01	0.25000	-1.80e-01	1.73e-01	2.43e-01	2.62e-01
GOMF NADPLUS PROTEIN ARGININE ADP RIBOSYLTRANSFERASE ACTIVITY	6	6.12e-01	7.86e-01	0.25000	1.07e-01	2.26e-01	6.51e-01	3.38e-01
TLR3-mediated TICAM1-dependent programmed cell death	6	6.29e-01	7.97e-01	0.25000	1.65e-01	1.88e-01	4.84e-01	4.26e-01
GOBP NEUROBLAST DIVISION	14	2.78e-01	5.18e-01	0.25000	2.47e-01	4.06e-02	1.10e-01	7.92e-01
GOCC PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX	48	2.38e-02	1.13e-01	0.25000	2.02e-01	1.47e-01	1.56e-02	7.76e-02
GOBP PARAXIAL MESODERM MORPHOGENESIS	10	3.84e-01	6.18e-01	0.25000	1.39e-02	2.49e-01	9.39e-01	1.72e-01
Cytosolic sensors of pathogen-associated DNA	63	4.58e-03	3.32e-02	0.25000	2.38e-01	7.67e-02	1.11e-03	2.92e-01
GOBP RESPONSE TO INSECTICIDE	6	4.95e-01	7.07e-01	0.25000	2.07e-01	-1.39e-01	3.79e-01	5.56e-01
GOBP PLASMINOGEN ACTIVATION	26	8.76e-02	2.68e-01	0.25000	-2.48e-01	-2.49e-02	2.84e-02	8.26e-01
GOBP MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION	16	2.13e-01	4.46e-01	0.25000	7.50e-03	2.49e-01	9.59e-01	8.41e-02
GOBP HOMOLOGOUS RECOMBINATION	66	1.12e-03	1.15e-02	0.24900	2.47e-01	-3.24e-02	5.10e-04	6.49e-01
GOBP INTEGRATED STRESS RESPONSE SIGNALING	48	2.51e-02	1.17e-01	0.24900	1.80e-01	1.72e-01	3.08e-02	3.87e-02
GOMF BETA GALACTOSIDE CMP ALPHA 2 3 SIALYLTRANSFERASE ACTIVITY	7	5.42e-01	7.41e-01	0.24900	-6.40e-02	-2.41e-01	7.69e-01	2.69e-01
GOBP CAMP BIOSYNTHETIC PROCESS	10	4.62e-01	6.86e-01	0.24900	-1.91e-01	-1.60e-01	2.95e-01	3.81e-01
GOBP NEGATIVE CHEMOTAXIS	46	2.91e-02	1.29e-01	0.24900	-1.63e-01	-1.89e-01	5.55e-02	2.69e-02
GOMF FERROUS IRON TRANSMEMBRANE TRANSPORTER ACTIVITY	5	6.81e-01	8.33e-01	0.24900	1.85e-01	1.67e-01	4.74e-01	5.17e-01
Metabolism of nitric oxide: NOS3 activation and regulation	17	1.98e-01	4.28e-01	0.24900	2.49e-01	1.45e-02	7.56e-02	9.18e-01
GOBP DETECTION OF TEMPERATURE STIMULUS	26	1.36e-01	3.46e-01	0.24900	-1.81e-01	-1.71e-01	1.10e-01	1.31e-01
GOBP PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS	9	4.91e-01	7.04e-01	0.24900	2.13e-01	1.30e-01	2.69e-01	5.01e-01
GOBP PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER	37	5.43e-02	1.98e-01	0.24900	1.31e-01	2.12e-01	1.67e-01	2.58e-02
GOBP POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION	11	4.10e-01	6.42e-01	0.24900	-2.23e-01	-1.10e-01	1.99e-01	5.27e-01
Fibronectin matrix formation	6	5.38e-01	7.38e-01	0.24900	-3.44e-02	2.47e-01	8.84e-01	2.95e-01
Amyloid fiber formation	73	2.08e-03	1.82e-02	0.24900	2.36e-01	8.02e-02	4.91e-04	2.36e-01
GOBP POSITIVE REGULATION OF MUSCLE ADAPTATION	13	2.15e-01	4.47e-01	0.24900	-1.86e-01	1.66e-01	2.46e-01	3.00e-01
GOBP REGULATION OF SKELETAL MUSCLE ADAPTATION	14	2.84e-01	5.22e-01	0.24900	-4.55e-02	-2.45e-01	7.68e-01	1.13e-01
GOCC CYCLIN DEPENDENT PROTEIN KINASE HOLOENZYME COMPLEX	52	1.15e-02	6.64e-02	0.24900	7.12e-02	2.39e-01	3.74e-01	2.90e-03
GOBP DITERPENOID BIOSYNTHETIC PROCESS	10	3.96e-01	6.30e-01	0.24900	2.47e-01	2.97e-02	1.76e-01	8.71e-01
GOBP VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT	10	4.42e-01	6.69e-01	0.24900	2.26e-01	1.04e-01	2.15e-01	5.70e-01
GOBP GALACTOSE TRANSMEMBRANE TRANSPORT	5	6.63e-01	8.21e-01	0.24900	-2.28e-01	-9.97e-02	3.77e-01	6.99e-01
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell	124	2.10e-06	5.66e-05	0.24900	-2.44e-01	5.16e-02	2.77e-06	3.21e-01
GOBP POSITIVE REGULATION OF CELL KILLING	75	1.75e-04	2.46e-03	0.24900	-2.15e-01	1.26e-01	1.30e-03	5.90e-02
Insertion of tail-anchored proteins into the endoplasmic reticulum membrane	20	2.14e-01	4.47e-01	0.24900	1.57e-01	1.94e-01	2.25e-01	1.34e-01
GOBP PHENOL CONTAINING COMPOUND CATABOLIC PROCESS	8	4.08e-01	6.41e-01	0.24900	-2.31e-01	9.38e-02	2.59e-01	6.46e-01
GOBP PROTEIN IMPORT INTO PEROXISOME MATRIX RECEPTOR RECYCLING	6	5.18e-01	7.24e-01	0.24900	2.37e-01	-7.61e-02	3.15e-01	7.47e-01
Formation of definitive endoderm	16	2.80e-01	5.19e-01	0.24900	1.22e-01	2.17e-01	4.00e-01	1.33e-01
Interleukin-10 signaling	42	1.89e-02	9.56e-02	0.24900	-2.48e-01	-1.64e-02	5.35e-03	8.54e-01
GOMF SMAD BINDING	74	2.10e-03	1.83e-02	0.24900	2.33e-01	8.75e-02	5.32e-04	1.93e-01
Transport of Ribonucleoproteins into the Host Nucleus	32	5.90e-02	2.08e-01	0.24900	2.43e-01	5.31e-02	1.74e-02	6.03e-01
GOBP RETINA HOMEOSTASIS	54	6.25e-03	4.21e-02	0.24900	-1.82e-02	-2.48e-01	8.18e-01	1.62e-03
GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY	109	2.15e-04	2.93e-03	0.24900	1.40e-01	2.06e-01	1.17e-02	2.08e-04
GOBP REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING	32	8.42e-02	2.61e-01	0.24900	2.02e-01	1.46e-01	4.85e-02	1.54e-01
GOCC CYTOSOLIC LARGE RIBOSOMAL SUBUNIT	51	1.93e-02	9.74e-02	0.24900	2.03e-01	1.44e-01	1.23e-02	7.53e-02
Mitotic Prometaphase	192	2.12e-07	7.16e-06	0.24900	2.23e-01	1.10e-01	9.73e-08	8.71e-03
Ubiquinol biosynthesis	13	3.09e-01	5.49e-01	0.24900	2.45e-01	4.12e-02	1.26e-01	7.97e-01
GOBP G2 MI TRANSITION OF MEIOTIC CELL CYCLE	6	5.41e-01	7.40e-01	0.24900	2.47e-01	-3.17e-02	2.96e-01	8.93e-01
GOBP CELLULAR RESPONSE TO SALT STRESS	14	3.10e-01	5.51e-01	0.24800	2.33e-01	8.55e-02	1.31e-01	5.80e-01
GOBP GANGLION DEVELOPMENT	17	2.15e-01	4.47e-01	0.24800	2.45e-01	3.95e-02	7.99e-02	7.78e-01
GOCC MCRD MEDIATED MRNA STABILITY COMPLEX	5	6.38e-01	8.02e-01	0.24800	2.45e-01	4.26e-02	3.43e-01	8.69e-01
GOMF MITOGEN ACTIVATED PROTEIN KINASE P38 BINDING	7	5.49e-01	7.45e-01	0.24800	2.38e-01	6.99e-02	2.75e-01	7.49e-01
Prevention of phagosomal-lysosomal fusion	9	4.95e-01	7.08e-01	0.24800	2.09e-01	1.34e-01	2.77e-01	4.86e-01
GOBP REGULATION OF MITOTIC RECOMBINATION	7	4.65e-01	6.88e-01	0.24800	7.83e-02	-2.36e-01	7.20e-01	2.80e-01
GOBP REGULATION OF T CELL MEDIATED CYTOTOXICITY	50	2.90e-03	2.34e-02	0.24800	-1.53e-01	1.95e-01	6.05e-02	1.69e-02
GOMF CATALYTIC ACTIVITY ACTING ON DNA	234	2.50e-09	1.27e-07	0.24800	2.38e-01	7.15e-02	3.62e-10	5.95e-02
SARS-CoV-2 modulates host translation machinery	45	3.19e-02	1.38e-01	0.24800	1.54e-01	1.95e-01	7.37e-02	2.38e-02
GOBP REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION	226	3.97e-08	1.56e-06	0.24800	1.80e-01	1.71e-01	3.10e-06	9.53e-06
GOMF POLY A BINDING	22	1.40e-01	3.52e-01	0.24800	2.44e-01	4.46e-02	4.74e-02	7.17e-01
GOBP CELLULAR RESPONSE TO CADMIUM ION	35	5.11e-02	1.91e-01	0.24800	7.30e-02	2.37e-01	4.55e-01	1.52e-02
GOBP DEVELOPMENT OF SECONDARY SEXUAL CHARACTERISTICS	10	3.48e-01	5.85e-01	0.24800	-5.46e-02	2.42e-01	7.65e-01	1.85e-01
GOBP MITOTIC CYTOKINESIS	88	1.27e-03	1.25e-02	0.24800	1.68e-01	1.82e-01	6.43e-03	3.08e-03
GOBP NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS	26	1.02e-01	2.93e-01	0.24800	-2.42e-01	-5.40e-02	3.26e-02	6.34e-01
GOBP MITOCHONDRIAL DNA METABOLIC PROCESS	22	1.87e-01	4.13e-01	0.24800	1.58e-01	1.91e-01	1.99e-01	1.21e-01
GOBP REGULATION OF VOLTAGE GATED SODIUM CHANNEL ACTIVITY	8	4.35e-01	6.63e-01	0.24800	-4.55e-02	2.44e-01	8.24e-01	2.32e-01
Aberrant regulation of mitotic cell cycle due to RB1 defects	36	6.48e-02	2.21e-01	0.24800	1.65e-01	1.86e-01	8.74e-02	5.40e-02
GOBP PURINE NUCLEOTIDE SALVAGE	10	3.15e-01	5.55e-01	0.24800	-1.34e-01	2.08e-01	4.62e-01	2.54e-01
GOBP POSITIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION	61	1.37e-03	1.32e-02	0.24800	-2.37e-01	7.38e-02	1.38e-03	3.19e-01
GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN	37	1.79e-02	9.16e-02	0.24800	-7.81e-02	2.35e-01	4.11e-01	1.33e-02
GOCC DENDRITE TERMINUS	12	3.30e-01	5.70e-01	0.24800	2.47e-01	2.51e-02	1.39e-01	8.81e-01
PI-3K cascade:FGFR1	21	1.26e-01	3.31e-01	0.24800	2.48e-01	-1.30e-02	4.96e-02	9.18e-01
GOBP COENZYME A METABOLIC PROCESS	18	1.89e-01	4.16e-01	0.24800	2.27e-02	2.47e-01	8.68e-01	6.99e-02
GOBP REGULATION OF MITOCHONDRIAL DEPOLARIZATION	19	2.37e-01	4.74e-01	0.24800	1.68e-01	1.82e-01	2.05e-01	1.69e-01
GOBP REGULATION OF EPIDERMIS DEVELOPMENT	65	1.48e-03	1.39e-02	0.24800	-2.44e-02	2.47e-01	7.33e-01	5.86e-04
GOBP ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE	24	1.43e-01	3.56e-01	0.24800	2.27e-01	1.00e-01	5.47e-02	3.95e-01
GOMF CYSTEINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS	17	2.65e-01	5.04e-01	0.24800	-2.12e-01	-1.29e-01	1.31e-01	3.58e-01
GOBP PARANODAL JUNCTION ASSEMBLY	6	6.34e-01	8.00e-01	0.24800	1.64e-01	1.86e-01	4.87e-01	4.31e-01
GOBP PLASMA MEMBRANE TUBULATION	19	2.36e-01	4.72e-01	0.24800	1.58e-01	1.90e-01	2.32e-01	1.51e-01
GOBP POSITIVE REGULATION OF NEURON DIFFERENTIATION	89	1.10e-03	1.13e-02	0.24800	1.43e-01	2.02e-01	1.93e-02	9.99e-04
GOBP INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY	7	4.49e-01	6.75e-01	0.24800	-1.27e-01	2.12e-01	5.61e-01	3.30e-01
GOBP REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION	66	3.34e-03	2.61e-02	0.24800	2.40e-01	6.02e-02	7.40e-04	3.98e-01
GOBP CYTOPLASMIC TRANSLATION	147	8.73e-06	1.92e-04	0.24800	2.21e-01	1.11e-01	3.69e-06	1.98e-02
GOBP PURINE DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS	5	5.83e-01	7.69e-01	0.24800	-7.26e-02	2.37e-01	7.79e-01	3.60e-01
GOBP POST GOLGI VESICLE MEDIATED TRANSPORT	108	8.73e-05	1.39e-03	0.24700	2.41e-01	5.75e-02	1.55e-05	3.02e-01
GOBP SPINDLE ORGANIZATION	191	4.60e-07	1.44e-05	0.24700	1.40e-01	2.04e-01	8.63e-04	1.13e-06
GOBP RRNA TRANSCRIPTION	40	3.77e-02	1.55e-01	0.24700	2.30e-01	9.11e-02	1.18e-02	3.19e-01
GOBP PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS	17	1.76e-01	4.00e-01	0.24700	-3.66e-02	2.45e-01	7.94e-01	8.08e-02
SUMO is conjugated to E1 (UBA2:SAE1)	5	6.49e-01	8.10e-01	0.24700	2.40e-01	6.03e-02	3.53e-01	8.15e-01
Signaling by the B Cell Receptor (BCR)	94	7.95e-04	8.84e-03	0.24700	1.96e-01	1.50e-01	1.01e-03	1.17e-02
Class I MHC mediated antigen processing & presentation	349	4.85e-12	3.72e-10	0.24700	1.88e-01	1.61e-01	1.70e-09	2.32e-07
GOBP ASPARTATE METABOLIC PROCESS	8	4.13e-01	6.45e-01	0.24700	9.50e-02	-2.28e-01	6.42e-01	2.64e-01
GOBP VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION	13	3.65e-01	6.02e-01	0.24700	2.10e-01	1.31e-01	1.91e-01	4.14e-01
GOMF C X3 C CHEMOKINE BINDING	5	5.72e-01	7.62e-01	0.24700	2.24e-01	-1.04e-01	3.85e-01	6.87e-01
GOBP ATRIAL CARDIAC MUSCLE TISSUE MORPHOGENESIS	6	5.35e-01	7.37e-01	0.24700	2.42e-01	-5.00e-02	3.05e-01	8.32e-01
GOMF AMINO ACID SODIUM SYMPORTER ACTIVITY	21	1.77e-01	4.00e-01	0.24700	-2.32e-01	-8.54e-02	6.59e-02	4.98e-01
GOCC MRNA CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR COMPLEX	17	1.80e-01	4.05e-01	0.24700	2.45e-01	-3.00e-02	8.00e-02	8.31e-01
MET interacts with TNS proteins	5	6.83e-01	8.34e-01	0.24700	-1.47e-01	-1.99e-01	5.69e-01	4.42e-01
GOMF BICARBONATE TRANSMEMBRANE TRANSPORTER ACTIVITY	32	6.78e-02	2.27e-01	0.24700	-2.36e-01	-7.35e-02	2.10e-02	4.72e-01
APC/C:Cdc20 mediated degradation of mitotic proteins	63	8.06e-03	5.12e-02	0.24700	2.04e-01	1.40e-01	5.17e-03	5.52e-02
GOBP LIMB JOINT MORPHOGENESIS	7	5.69e-01	7.59e-01	0.24700	2.25e-01	1.01e-01	3.02e-01	6.44e-01
GOBP BONE GROWTH	31	4.49e-02	1.75e-01	0.24700	2.45e-01	-2.65e-02	1.80e-02	7.98e-01
GOBP TRNA METABOLIC PROCESS	195	2.67e-07	8.90e-06	0.24700	2.15e-01	1.21e-01	2.23e-07	3.50e-03
GOBP SOMITOGENESIS	63	8.78e-03	5.46e-02	0.24700	1.81e-01	1.68e-01	1.29e-02	2.12e-02
GOCC RNA POLYMERASE III TRANSCRIPTION REGULATOR COMPLEX	9	3.71e-01	6.07e-01	0.24700	2.28e-01	-9.48e-02	2.36e-01	6.23e-01
GOBP NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS	1158	6.15e-37	2.29e-34	0.24700	1.92e-01	1.55e-01	2.97e-28	4.91e-19
GOBP NEGATIVE REGULATION OF TORC1 SIGNALING	47	2.12e-02	1.04e-01	0.24700	2.31e-01	8.70e-02	6.18e-03	3.02e-01
GOBP AMELOGENESIS	25	1.18e-01	3.19e-01	0.24700	-6.20e-02	-2.39e-01	5.92e-01	3.88e-02
GOBP SOMITE DEVELOPMENT	81	2.32e-03	1.97e-02	0.24700	1.80e-01	1.69e-01	5.18e-03	8.61e-03
GOBP HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS	15	2.63e-01	5.02e-01	0.24700	-2.43e-01	-3.93e-02	1.03e-01	7.92e-01
GOBP REGULATION OF LAMELLIPODIUM ASSEMBLY	37	4.73e-02	1.81e-01	0.24600	2.32e-01	8.25e-02	1.45e-02	3.85e-01
GOCC PROTEIN LIPID COMPLEX	38	1.41e-02	7.75e-02	0.24600	2.18e-01	-1.14e-01	1.98e-02	2.23e-01
G2/M Transition	178	1.51e-06	4.20e-05	0.24600	1.97e-01	1.48e-01	5.55e-06	6.81e-04
Potential therapeutics for SARS	92	8.20e-04	9.05e-03	0.24600	2.12e-01	1.25e-01	4.35e-04	3.78e-02
GOBP REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS	52	1.00e-02	6.00e-02	0.24600	-2.43e-01	-4.08e-02	2.44e-03	6.11e-01
Transcriptional regulation of brown and beige adipocyte differentiation	29	1.01e-01	2.92e-01	0.24600	2.20e-01	1.10e-01	4.00e-02	3.05e-01
Transcriptional regulation of brown and beige adipocyte differentiation by EBF2	29	1.01e-01	2.92e-01	0.24600	2.20e-01	1.10e-01	4.00e-02	3.05e-01
GOBP NON LYTIC VIRAL RELEASE	14	2.90e-01	5.28e-01	0.24600	4.15e-02	2.43e-01	7.88e-01	1.16e-01
GOBP NEURAL CREST CELL MIGRATION INVOLVED IN AUTONOMIC NERVOUS SYSTEM DEVELOPMENT	6	5.04e-01	7.13e-01	0.24600	1.39e-01	-2.03e-01	5.55e-01	3.89e-01
GOBP NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION	19	1.57e-01	3.74e-01	0.24600	2.46e-01	-1.29e-02	6.35e-02	9.22e-01
GOBP NEUROENDOCRINE CELL DIFFERENTIATION	16	2.74e-01	5.14e-01	0.24600	9.42e-02	2.28e-01	5.14e-01	1.15e-01
GOMF RNA POLYMERASE III TYPE 3 PROMOTER SEQUENCE SPECIFIC DNA BINDING	6	6.23e-01	7.93e-01	0.24600	1.10e-01	2.20e-01	6.39e-01	3.51e-01
GOBP POSITIVE REGULATION OF MEMBRANE POTENTIAL	12	3.86e-01	6.20e-01	0.24600	2.22e-01	1.06e-01	1.83e-01	5.25e-01
GOCC SCHMIDT LANTERMAN INCISURE	11	3.30e-01	5.69e-01	0.24600	-3.44e-02	2.44e-01	8.43e-01	1.62e-01
GOBP NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION	62	3.33e-03	2.60e-02	0.24600	-2.45e-01	-1.80e-02	8.27e-04	8.06e-01
GOBP NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION	16	2.66e-01	5.05e-01	0.24600	7.89e-02	2.33e-01	5.85e-01	1.07e-01
Negative regulation of FGFR3 signaling	28	1.10e-01	3.06e-01	0.24600	2.21e-01	1.08e-01	4.28e-02	3.24e-01
GOMF DNA N GLYCOSYLASE ACTIVITY	14	3.43e-01	5.81e-01	0.24600	1.34e-01	2.06e-01	3.85e-01	1.82e-01
GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION	12	3.38e-01	5.77e-01	0.24600	2.44e-01	2.77e-02	1.43e-01	8.68e-01
CLEC7A (Dectin-1) signaling	85	1.65e-03	1.52e-02	0.24600	1.99e-01	1.44e-01	1.52e-03	2.13e-02
GOBP SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR	11	4.28e-01	6.57e-01	0.24600	2.12e-01	1.25e-01	2.24e-01	4.73e-01
GOCC GOLGI TRANSPORT COMPLEX	10	4.28e-01	6.57e-01	0.24600	2.38e-01	6.31e-02	1.93e-01	7.30e-01
Synthesis of glycosylphosphatidylinositol (GPI)	17	2.24e-01	4.59e-01	0.24600	2.42e-01	4.23e-02	8.41e-02	7.63e-01
GOMF IMMUNE RECEPTOR ACTIVITY	134	4.12e-06	1.02e-04	0.24600	-2.45e-01	-1.09e-02	9.26e-07	8.28e-01
GOBP INOSITOL TRISPHOSPHATE METABOLIC PROCESS	10	3.97e-01	6.31e-01	0.24600	-2.45e-01	-1.52e-02	1.79e-01	9.33e-01
GOBP DOUBLE STRAND BREAK REPAIR VIA ALTERNATIVE NONHOMOLOGOUS END JOINING	8	5.46e-01	7.44e-01	0.24600	2.00e-01	1.43e-01	3.28e-01	4.83e-01
GOBP LENS FIBER CELL DIFFERENTIATION	36	6.31e-02	2.17e-01	0.24600	2.10e-01	1.27e-01	2.89e-02	1.89e-01
GOMF PROTEIN TRANSMEMBRANE TRANSPORTER ACTIVITY	26	1.29e-01	3.37e-01	0.24600	2.20e-01	1.08e-01	5.17e-02	3.40e-01
GOCC GABA RECEPTOR COMPLEX	18	1.70e-01	3.92e-01	0.24600	2.29e-02	-2.44e-01	8.66e-01	7.26e-02
GOBP GROWTH PLATE CARTILAGE CHONDROCYTE DIFFERENTIATION	9	4.99e-01	7.09e-01	0.24500	2.14e-01	1.21e-01	2.67e-01	5.29e-01
GOBP ANTIVIRAL INNATE IMMUNE RESPONSE	54	1.34e-02	7.46e-02	0.24500	2.26e-01	9.66e-02	4.12e-03	2.19e-01
GOBP NUCLEAR TRANSPORT	317	1.20e-11	8.71e-10	0.24500	2.27e-01	9.33e-02	3.60e-12	4.30e-03
GOBP POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR	30	8.86e-02	2.70e-01	0.24500	8.95e-02	2.28e-01	3.96e-01	3.03e-02
GOCC POSTSYNAPTIC ACTIN CYTOSKELETON	8	4.19e-01	6.49e-01	0.24500	-9.36e-02	2.27e-01	6.47e-01	2.67e-01
GOCC NUCLEOCYTOPLASMIC TRANSPORT COMPLEX	12	3.77e-01	6.12e-01	0.24500	8.53e-02	2.30e-01	6.09e-01	1.68e-01
GOBP SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE	19	1.77e-01	4.00e-01	0.24500	2.44e-01	2.03e-02	6.50e-02	8.78e-01
InlA-mediated entry of Listeria monocytogenes into host cells	9	4.06e-01	6.38e-01	0.24500	2.43e-01	-3.51e-02	2.07e-01	8.55e-01
GOBP EPINEPHRINE TRANSPORT	11	4.33e-01	6.61e-01	0.24500	-2.07e-01	-1.32e-01	2.36e-01	4.48e-01
GOBP POSITIVE REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY	9	5.06e-01	7.15e-01	0.24500	2.02e-01	1.38e-01	2.93e-01	4.72e-01
Initiation of Nuclear Envelope (NE) Reformation	18	2.53e-01	4.91e-01	0.24500	2.08e-01	1.29e-01	1.26e-01	3.43e-01
GOBP POSTSYNAPTIC MEMBRANE ASSEMBLY	7	5.82e-01	7.68e-01	0.24500	-1.18e-01	-2.15e-01	5.89e-01	3.25e-01
GOBP MESODERMAL CELL MIGRATION	5	6.86e-01	8.36e-01	0.24500	-2.02e-01	-1.39e-01	4.34e-01	5.90e-01
GOBP VASCULAR WOUND HEALING	23	7.89e-02	2.51e-01	0.24500	1.09e-01	-2.19e-01	3.64e-01	6.87e-02
GOBP SYNAPSE PRUNING	14	3.54e-01	5.92e-01	0.24500	-1.71e-01	-1.75e-01	2.68e-01	2.56e-01
Chemokine receptors bind chemokines	55	1.69e-02	8.82e-02	0.24500	-1.61e-01	-1.85e-01	3.87e-02	1.79e-02
GOBP REGULATION OF KERATINOCYTE MIGRATION	14	2.57e-01	4.95e-01	0.24500	2.44e-01	-1.69e-02	1.13e-01	9.13e-01
GOBP REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY	67	6.00e-03	4.07e-02	0.24500	2.11e-01	1.25e-01	2.86e-03	7.72e-02
GOBP OLFACTORY LOBE DEVELOPMENT	36	5.85e-02	2.07e-01	0.24500	1.02e-01	2.23e-01	2.90e-01	2.08e-02
GOBP CHORIO ALLANTOIC FUSION	7	4.79e-01	6.97e-01	0.24500	-2.35e-01	6.89e-02	2.82e-01	7.52e-01
GOBP FATTY ACID BETA OXIDATION	73	4.43e-03	3.24e-02	0.24500	1.90e-01	1.55e-01	5.08e-03	2.21e-02
GOMF HISTONE H3K4 DEMETHYLASE ACTIVITY	6	5.19e-01	7.25e-01	0.24500	2.23e-01	-1.00e-01	3.43e-01	6.71e-01
GOBP REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY	23	7.37e-02	2.40e-01	0.24500	-1.46e-01	1.96e-01	2.25e-01	1.03e-01
GOBP POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS	16	2.04e-01	4.35e-01	0.24500	3.13e-02	-2.43e-01	8.28e-01	9.27e-02
GOBP CELL CYCLE G2 M PHASE TRANSITION	148	1.24e-05	2.60e-04	0.24500	2.13e-01	1.21e-01	7.80e-06	1.12e-02
GOBP REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY	52	5.27e-03	3.68e-02	0.24500	-2.41e-01	4.30e-02	2.65e-03	5.91e-01
GOBP MITOTIC CELL CYCLE PROCESS	746	1.49e-24	2.90e-22	0.24500	2.07e-01	1.30e-01	5.32e-22	1.41e-09
GOBP VIRAL PROTEIN PROCESSING	31	5.07e-02	1.90e-01	0.24500	-1.37e-02	2.44e-01	8.95e-01	1.86e-02
Regulation of IFNG signaling	14	2.70e-01	5.09e-01	0.24500	2.92e-03	2.45e-01	9.85e-01	1.13e-01
GOBP MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL	16	3.06e-01	5.46e-01	0.24500	-1.65e-01	-1.80e-01	2.52e-01	2.12e-01
GOBP LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT	19	1.70e-01	3.92e-01	0.24500	4.20e-03	2.45e-01	9.75e-01	6.49e-02
GOBP DNA STRAND RESECTION INVOLVED IN REPLICATION FORK PROCESSING	10	4.55e-01	6.80e-01	0.24500	1.02e-01	2.22e-01	5.78e-01	2.23e-01
Organic anion transporters	12	4.01e-01	6.34e-01	0.24500	1.26e-01	2.10e-01	4.50e-01	2.09e-01
GOBP SMOOTHENED SIGNALING PATHWAY	140	2.56e-06	6.67e-05	0.24500	2.44e-01	8.90e-03	5.95e-07	8.56e-01
GOBP REGULATION OF PEPTIDYL CYSTEINE S NITROSYLATION	10	3.21e-01	5.59e-01	0.24500	-1.87e-01	1.58e-01	3.07e-01	3.87e-01
Mitotic G2-G2/M phases	180	1.68e-06	4.60e-05	0.24400	1.93e-01	1.50e-01	8.17e-06	4.98e-04
GOBP POSITIVE REGULATION OF HEAT GENERATION	10	4.24e-01	6.53e-01	0.24400	-2.39e-01	-5.01e-02	1.90e-01	7.84e-01
GOMF DNA DIRECTED DNA POLYMERASE ACTIVITY	22	1.80e-01	4.05e-01	0.24400	2.19e-01	1.09e-01	7.55e-02	3.77e-01
GOBP REGULATION OF PROTEIN UBIQUITINATION	177	2.24e-06	5.96e-05	0.24400	1.58e-01	1.87e-01	2.90e-04	1.85e-05
Regulation of HMOX1 expression and activity	5	5.87e-01	7.71e-01	0.24400	-8.10e-02	2.31e-01	7.54e-01	3.72e-01
GOBP RENAL SODIUM ION TRANSPORT	15	1.89e-01	4.17e-01	0.24400	2.13e-01	-1.19e-01	1.53e-01	4.24e-01
GOBP REGULATION OF HORMONE BIOSYNTHETIC PROCESS	24	6.56e-02	2.23e-01	0.24400	-1.57e-01	1.87e-01	1.83e-01	1.12e-01
Activation of RAC1	12	2.59e-01	4.97e-01	0.24400	2.00e-01	-1.40e-01	2.30e-01	4.00e-01
GOCC NUCLEOTIDE ACTIVATED PROTEIN KINASE COMPLEX	10	4.77e-01	6.95e-01	0.24400	1.56e-01	1.88e-01	3.92e-01	3.04e-01
Defective CHST14 causes EDS, musculocontractural type	7	5.84e-01	7.70e-01	0.24400	1.18e-01	2.14e-01	5.88e-01	3.28e-01
GOBP HEMATOPOIETIC OR LYMPHOID ORGAN DEVELOPMENT	99	5.83e-04	6.83e-03	0.24400	1.31e-01	2.06e-01	2.39e-02	4.01e-04
GOBP CEREBRAL CORTEX NEURON DIFFERENTIATION	23	1.70e-01	3.92e-01	0.24400	1.13e-01	2.16e-01	3.47e-01	7.27e-02
GOBP NEGATIVE REGULATION OF DNA RECOMBINATION	47	3.05e-02	1.33e-01	0.24400	1.96e-01	1.46e-01	2.04e-02	8.31e-02
GOMF 2 ACYLGLYCEROL O ACYLTRANSFERASE ACTIVITY	6	5.30e-01	7.33e-01	0.24400	-2.31e-01	7.80e-02	3.27e-01	7.41e-01
GOMF MRNA 3 UTR AU RICH REGION BINDING	29	1.14e-01	3.13e-01	0.24400	2.03e-01	1.35e-01	5.83e-02	2.08e-01
GOBP RIBOSOMAL LARGE SUBUNIT BIOGENESIS	66	5.38e-03	3.73e-02	0.24400	2.25e-01	9.35e-02	1.54e-03	1.89e-01
GOBP POSITIVE REGULATION OF UTERINE SMOOTH MUSCLE CONTRACTION	8	5.55e-01	7.50e-01	0.24400	1.67e-01	1.78e-01	4.15e-01	3.83e-01
GOBP FLAVIN CONTAINING COMPOUND METABOLIC PROCESS	6	5.88e-01	7.72e-01	0.24400	2.42e-01	3.11e-02	3.05e-01	8.95e-01
Mitochondrial unfolded protein response (UPRmt)	18	2.59e-01	4.97e-01	0.24400	1.33e-01	2.04e-01	3.27e-01	1.34e-01
GOBP BONE TRABECULA MORPHOGENESIS	14	3.42e-01	5.80e-01	0.24400	2.15e-01	1.15e-01	1.64e-01	4.55e-01
GOMF GLYCEROPHOSPHOLIPID FLIPPASE ACTIVITY	12	4.13e-01	6.45e-01	0.24400	-1.86e-01	-1.58e-01	2.65e-01	3.44e-01
GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II	34	2.50e-02	1.17e-01	0.24400	-1.02e-01	2.21e-01	3.02e-01	2.55e-02
GOBP GLYOXYLATE METABOLIC PROCESS	8	4.10e-01	6.42e-01	0.24400	-1.29e-01	2.07e-01	5.28e-01	3.11e-01
Downstream signaling of activated FGFR4	26	1.22e-01	3.26e-01	0.24400	2.30e-01	8.11e-02	4.24e-02	4.74e-01
GOMF MINUS END DIRECTED MICROTUBULE MOTOR ACTIVITY	17	2.37e-01	4.74e-01	0.24400	-5.36e-02	-2.38e-01	7.02e-01	8.96e-02
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH OXIDATION OF A PAIR OF DONORS RESULTING IN THE REDUCTION OF MOLECULAR OXYGEN TO TWO MOLECULES OF WATER	10	3.30e-01	5.70e-01	0.24400	-2.10e-01	1.24e-01	2.51e-01	4.97e-01
GOCC PRESYNAPTIC CYTOSOL	12	4.02e-01	6.34e-01	0.24400	1.22e-01	2.11e-01	4.65e-01	2.06e-01
GOBP REGULATION OF ACTIVATION OF JANUS KINASE ACTIVITY	8	4.13e-01	6.45e-01	0.24400	2.11e-01	-1.21e-01	3.01e-01	5.52e-01
GOBP NEGATIVE REGULATION OF NEUTROPHIL MIGRATION	5	5.75e-01	7.64e-01	0.24400	-1.24e-01	2.09e-01	6.30e-01	4.17e-01
GOBP PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY	28	5.96e-02	2.09e-01	0.24400	-2.39e-01	4.73e-02	2.87e-02	6.65e-01
GOBP NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS	28	1.08e-01	3.04e-01	0.24400	8.87e-02	2.27e-01	4.16e-01	3.78e-02
GOBP NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS	1386	1.81e-42	7.94e-40	0.24300	1.90e-01	1.52e-01	1.22e-32	2.53e-21
GOMF OLIGOPEPTIDE BINDING	11	3.92e-01	6.26e-01	0.24300	2.38e-01	4.93e-02	1.71e-01	7.77e-01
GOBP REGULATION OF SEROTONIN SECRETION	6	5.10e-01	7.18e-01	0.24300	-1.46e-01	1.95e-01	5.36e-01	4.09e-01
GABA synthesis, release, reuptake and degradation	19	1.17e-01	3.18e-01	0.24300	-1.66e-01	1.78e-01	2.11e-01	1.79e-01
GOBP DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION	20	2.32e-01	4.67e-01	0.24300	-1.62e-01	-1.82e-01	2.11e-01	1.60e-01
GOBP REGULATION OF MITOTIC CYTOKINESIS	16	3.07e-01	5.47e-01	0.24300	1.95e-01	1.45e-01	1.77e-01	3.14e-01
GOBP CD8 POSITIVE ALPHA BETA T CELL ACTIVATION	28	6.76e-02	2.27e-01	0.24300	-2.42e-01	2.11e-02	2.65e-02	8.47e-01
GOMF GLYCINE BINDING	10	4.80e-01	6.97e-01	0.24300	-1.87e-01	-1.55e-01	3.05e-01	3.96e-01
GOMF METALLODIPEPTIDASE ACTIVITY	8	5.50e-01	7.46e-01	0.24300	-2.05e-01	-1.31e-01	3.16e-01	5.21e-01
GOBP REGULATION OF SUPEROXIDE ANION GENERATION	20	1.15e-01	3.14e-01	0.24300	-1.05e-01	2.19e-01	4.17e-01	8.96e-02
GOBP NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION	14	2.15e-01	4.47e-01	0.24300	2.11e-01	-1.21e-01	1.72e-01	4.34e-01
GOBP NEGATIVE REGULATION OF HIPPO SIGNALING	21	1.63e-01	3.83e-01	0.24300	2.40e-01	3.88e-02	5.72e-02	7.58e-01
GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 4F COMPLEX	13	3.59e-01	5.95e-01	0.24300	2.25e-01	9.08e-02	1.60e-01	5.71e-01
RHOU GTPase cycle	37	5.69e-02	2.03e-01	0.24300	2.21e-01	1.02e-01	2.03e-02	2.84e-01
GOBP REGULATION OF KIDNEY DEVELOPMENT	33	2.46e-02	1.15e-01	0.24300	-1.64e-01	1.79e-01	1.03e-01	7.47e-02
PI-3K cascade:FGFR2	22	1.27e-01	3.33e-01	0.24300	2.43e-01	-7.42e-03	4.87e-02	9.52e-01
GOBP NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I	24	1.08e-01	3.04e-01	0.24300	2.43e-01	-1.94e-03	3.95e-02	9.87e-01
GOMF PROTEIN CARBOXYL O METHYLTRANSFERASE ACTIVITY	6	6.45e-01	8.08e-01	0.24300	1.60e-01	1.83e-01	4.98e-01	4.38e-01
GOBP NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION	20	2.10e-01	4.42e-01	0.24300	9.81e-02	2.22e-01	4.48e-01	8.55e-02
GOBP NEGATIVE REGULATION OF CHOLESTEROL STORAGE	11	3.88e-01	6.21e-01	0.24300	-2.39e-01	-3.97e-02	1.69e-01	8.20e-01
GOBP REGULATION OF PROTEIN KINASE C ACTIVITY	5	5.94e-01	7.75e-01	0.24300	2.31e-01	-7.50e-02	3.71e-01	7.72e-01
Interactions of Rev with host cellular proteins	37	5.40e-02	1.98e-01	0.24300	2.26e-01	8.90e-02	1.75e-02	3.49e-01
GOCC CHROMAFFIN GRANULE	14	2.46e-01	4.84e-01	0.24300	-4.89e-02	2.38e-01	7.52e-01	1.24e-01
GOBP SEROTONIN SECRETION	9	3.72e-01	6.09e-01	0.24200	-1.24e-01	2.08e-01	5.20e-01	2.79e-01
GOBP EXCITATORY CHEMICAL SYNAPTIC TRANSMISSION	10	3.39e-01	5.78e-01	0.24200	-2.17e-01	1.08e-01	2.35e-01	5.53e-01
GOMF ALPHA GLUCOSIDASE ACTIVITY	6	6.45e-01	8.08e-01	0.24200	-1.89e-01	-1.52e-01	4.23e-01	5.20e-01
TP53 Regulates Transcription of DNA Repair Genes	61	1.21e-02	6.86e-02	0.24200	1.77e-01	1.66e-01	1.69e-02	2.51e-02
GOBP NEGATIVE REGULATION OF MONONUCLEAR CELL MIGRATION	35	2.26e-02	1.08e-01	0.24200	-1.11e-01	2.15e-01	2.55e-01	2.75e-02
HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand	54	1.99e-02	9.93e-02	0.24200	1.60e-01	1.82e-01	4.21e-02	2.06e-02
GOBP CYCLOOXYGENASE PATHWAY	9	3.90e-01	6.23e-01	0.24200	8.09e-02	-2.28e-01	6.74e-01	2.35e-01
GOBP NEGATIVE REGULATION OF RESPONSE TO NUTRIENT LEVELS	12	3.61e-01	5.99e-01	0.24200	4.60e-02	2.38e-01	7.82e-01	1.54e-01
GOMF VOLTAGE GATED CHANNEL ACTIVITY	168	2.71e-06	7.00e-05	0.24200	-2.18e-01	-1.05e-01	1.03e-06	1.92e-02
GOBP PHAGOSOME MATURATION	28	6.10e-02	2.13e-01	0.24200	-4.87e-02	2.37e-01	6.56e-01	2.98e-02
GOBP MITOCHONDRIAL TRNA PROCESSING	13	3.44e-01	5.81e-01	0.24200	2.34e-01	6.30e-02	1.44e-01	6.94e-01
GOMF DIPEPTIDYL PEPTIDASE ACTIVITY	12	2.97e-01	5.37e-01	0.24200	5.63e-02	-2.35e-01	7.35e-01	1.58e-01
GOBP DENDRITIC CELL CHEMOTAXIS	23	1.87e-01	4.13e-01	0.24200	-1.92e-01	-1.47e-01	1.11e-01	2.21e-01
GOBP REGULATION OF RIBONUCLEASE ACTIVITY	9	4.91e-01	7.04e-01	0.24200	2.26e-01	8.60e-02	2.40e-01	6.55e-01
GOBP EXCRETION	30	8.81e-02	2.69e-01	0.24200	-7.08e-02	-2.32e-01	5.02e-01	2.82e-02
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants	54	1.43e-02	7.81e-02	0.24200	2.26e-01	8.73e-02	4.10e-03	2.67e-01
Constitutive Signaling by NOTCH1 PEST Domain Mutants	54	1.43e-02	7.81e-02	0.24200	2.26e-01	8.73e-02	4.10e-03	2.67e-01
Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer	54	1.43e-02	7.81e-02	0.24200	2.26e-01	8.73e-02	4.10e-03	2.67e-01
Signaling by NOTCH1 PEST Domain Mutants in Cancer	54	1.43e-02	7.81e-02	0.24200	2.26e-01	8.73e-02	4.10e-03	2.67e-01
Signaling by NOTCH1 in Cancer	54	1.43e-02	7.81e-02	0.24200	2.26e-01	8.73e-02	4.10e-03	2.67e-01
GOBP HUMORAL IMMUNE RESPONSE	255	7.07e-09	3.19e-07	0.24200	-2.05e-01	-1.28e-01	1.61e-08	4.26e-04
GOMF SERINE TYPE CARBOXYPEPTIDASE ACTIVITY	5	5.86e-01	7.71e-01	0.24200	2.21e-01	-9.88e-02	3.92e-01	7.02e-01
GOBP ADENYLATE CYCLASE ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY	23	1.72e-01	3.94e-01	0.24200	1.06e-01	2.18e-01	3.80e-01	7.07e-02
GOCC HETEROCHROMATIN	77	3.86e-03	2.91e-02	0.24200	1.78e-01	1.64e-01	6.80e-03	1.31e-02
GOBP REGULATION OF PODOSOME ASSEMBLY	13	3.35e-01	5.74e-01	0.24200	-2.37e-01	-4.94e-02	1.39e-01	7.58e-01
GOCC GOLGI ASSOCIATED VESICLE MEMBRANE	55	8.20e-03	5.18e-02	0.24200	2.40e-01	2.78e-02	2.04e-03	7.22e-01
GOMF PHOSPHATIDYLSERINE FLOPPASE ACTIVITY	8	5.59e-01	7.52e-01	0.24200	-1.87e-01	-1.54e-01	3.61e-01	4.51e-01
GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT	25	1.31e-01	3.39e-01	0.24200	-2.32e-01	-6.77e-02	4.44e-02	5.58e-01
GOBP NUCLEAR CHROMOSOME SEGREGATION	312	1.22e-11	8.78e-10	0.24200	2.33e-01	6.60e-02	1.53e-12	4.51e-02
GOBP NEUROEPITHELIAL CELL DIFFERENTIATION	42	2.89e-02	1.29e-01	0.24200	4.67e-02	2.37e-01	6.01e-01	7.78e-03
GOBP PROTEIN DEGLYCOSYLATION	15	3.01e-01	5.41e-01	0.24200	7.69e-02	2.29e-01	6.06e-01	1.24e-01
HSF1 activation	26	1.46e-01	3.59e-01	0.24200	2.05e-01	1.29e-01	7.09e-02	2.56e-01
IL-6-type cytokine receptor ligand interactions	17	1.51e-01	3.67e-01	0.24200	-1.53e-01	1.87e-01	2.74e-01	1.82e-01
GOBP RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE	23	1.86e-01	4.13e-01	0.24200	-1.43e-01	-1.95e-01	2.36e-01	1.05e-01
GOMF MDM2 MDM4 FAMILY PROTEIN BINDING	11	3.74e-01	6.10e-01	0.24200	1.52e-02	2.41e-01	9.30e-01	1.66e-01
GOBP FUCOSYLATION	17	2.15e-01	4.47e-01	0.24200	-2.42e-01	-7.47e-03	8.46e-02	9.57e-01
GOBP RNA STABILIZATION	68	7.44e-03	4.79e-02	0.24200	1.81e-01	1.61e-01	1.00e-02	2.20e-02
GOBP POSITIVE REGULATION OF GLUTAMATE SECRETION	11	3.01e-01	5.41e-01	0.24200	-1.25e-01	2.07e-01	4.73e-01	2.35e-01
GOMF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY	68	5.38e-03	3.73e-02	0.24200	-2.20e-01	-9.91e-02	1.68e-03	1.57e-01
GOCC HOPS COMPLEX	14	3.25e-01	5.64e-01	0.24200	2.30e-01	7.39e-02	1.36e-01	6.32e-01
Polymerase switching on the C-strand of the telomere	25	1.57e-01	3.74e-01	0.24200	2.06e-01	1.26e-01	7.43e-02	2.76e-01
RHOJ GTPase cycle	50	1.13e-02	6.54e-02	0.24200	2.41e-01	1.11e-02	3.15e-03	8.92e-01
Mitochondrial protein import	58	1.22e-02	6.91e-02	0.24200	2.17e-01	1.07e-01	4.31e-03	1.60e-01
Signaling by FGFR in disease	62	5.81e-03	3.97e-02	0.24200	2.36e-01	5.33e-02	1.33e-03	4.68e-01
GOBP FOREBRAIN GENERATION OF NEURONS	52	2.33e-02	1.11e-01	0.24200	1.53e-01	1.87e-01	5.64e-02	1.97e-02
GOBP POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION	27	6.13e-02	2.13e-01	0.24200	-2.29e-01	7.68e-02	3.94e-02	4.90e-01
GOBP POSTREPLICATION REPAIR	35	6.99e-02	2.32e-01	0.24100	2.17e-01	1.06e-01	2.65e-02	2.76e-01
GOBP ENGULFMENT OF APOPTOTIC CELL	15	2.07e-01	4.39e-01	0.24100	-2.25e-01	8.80e-02	1.32e-01	5.55e-01
GOBP EMBRYONIC CAMERA TYPE EYE FORMATION	11	4.16e-01	6.46e-01	0.24100	7.63e-02	2.29e-01	6.61e-01	1.88e-01
GOBP LUNG SACCULE DEVELOPMENT	10	4.62e-01	6.85e-01	0.24100	2.21e-01	9.62e-02	2.25e-01	5.98e-01
GOBP POSITIVE REGULATION OF NEUROTRANSMITTER UPTAKE	6	5.50e-01	7.46e-01	0.24100	5.03e-02	-2.36e-01	8.31e-01	3.17e-01
GOMF CELL ADHESIVE PROTEIN BINDING INVOLVED IN BUNDLE OF HIS CELL PURKINJE MYOCYTE COMMUNICATION	5	6.38e-01	8.02e-01	0.24100	-2.41e-01	-1.09e-02	3.50e-01	9.66e-01
GOBP XENOBIOTIC TRANSMEMBRANE TRANSPORT	17	2.43e-01	4.82e-01	0.24100	-5.32e-02	-2.35e-01	7.04e-01	9.28e-02
Transcriptional regulation of white adipocyte differentiation	81	2.50e-03	2.10e-02	0.24100	2.07e-01	1.25e-01	1.30e-03	5.23e-02
GOBP NLS BEARING PROTEIN IMPORT INTO NUCLEUS	19	2.39e-01	4.77e-01	0.24100	2.13e-01	1.13e-01	1.08e-01	3.94e-01
Cellular response to chemical stress	188	1.23e-06	3.51e-05	0.24100	1.97e-01	1.40e-01	3.31e-06	9.48e-04
GOMF CCR5 CHEMOKINE RECEPTOR BINDING	7	5.12e-01	7.20e-01	0.24100	-2.51e-02	2.40e-01	9.08e-01	2.72e-01
GOBP CARDIAC LEFT VENTRICLE MORPHOGENESIS	16	3.17e-01	5.56e-01	0.24100	1.70e-01	1.71e-01	2.40e-01	2.35e-01
GOBP REGULATION OF HEPATIC STELLATE CELL ACTIVATION	7	5.57e-01	7.51e-01	0.24100	2.36e-01	4.91e-02	2.79e-01	8.22e-01
GOBP INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY	25	1.26e-01	3.32e-01	0.24100	2.35e-01	5.46e-02	4.20e-02	6.36e-01
GOMF RNA POLYMERASE III TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING	8	4.82e-01	6.98e-01	0.24100	5.48e-04	2.41e-01	9.98e-01	2.38e-01
Cargo trafficking to the periciliary membrane	49	1.37e-02	7.57e-02	0.24100	2.40e-01	2.21e-02	3.64e-03	7.89e-01
GOBP RESPONSE TO GROWTH HORMONE	35	7.58e-02	2.44e-01	0.24100	2.05e-01	1.26e-01	3.56e-02	1.96e-01
GOBP POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION	10	3.32e-01	5.71e-01	0.24100	-1.49e-01	1.90e-01	4.16e-01	2.99e-01
GOBP MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL	22	1.57e-01	3.75e-01	0.24100	-4.48e-02	-2.37e-01	7.16e-01	5.46e-02
GOCC CASPASE COMPLEX	10	4.73e-01	6.94e-01	0.24100	2.12e-01	1.15e-01	2.46e-01	5.30e-01
GOBP NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS	43	4.57e-02	1.77e-01	0.24100	1.58e-01	1.82e-01	7.39e-02	3.87e-02
Glycosphingolipid transport	8	4.21e-01	6.51e-01	0.24100	1.23e-01	-2.07e-01	5.46e-01	3.11e-01
GOBP ANGIOGENESIS INVOLVED IN WOUND HEALING	32	2.92e-02	1.30e-01	0.24100	1.63e-01	-1.78e-01	1.11e-01	8.22e-02
GOBP POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS	99	8.34e-04	9.15e-03	0.24100	1.55e-01	1.85e-01	7.89e-03	1.50e-03
GOBP PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY	30	9.40e-02	2.79e-01	0.24100	2.27e-01	7.94e-02	3.12e-02	4.52e-01
GOCC CHROMOCENTER	13	3.83e-01	6.17e-01	0.24100	2.07e-01	1.23e-01	1.97e-01	4.42e-01
GOBP NEGATIVE REGULATION OF NUCLEOTIDE CATABOLIC PROCESS	18	2.03e-01	4.34e-01	0.24100	1.52e-02	2.40e-01	9.11e-01	7.77e-02
GOMF PROTEIN TRANSPORTER ACTIVITY	40	5.44e-02	1.98e-01	0.24100	1.99e-01	1.35e-01	2.92e-02	1.40e-01
GOBP DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM	107	6.59e-05	1.09e-03	0.24100	-2.41e-01	-3.60e-03	1.71e-05	9.49e-01
Receptor Mediated Mitophagy	10	4.78e-01	6.96e-01	0.24100	2.07e-01	1.22e-01	2.56e-01	5.04e-01
GOBP AMINO SUGAR BIOSYNTHETIC PROCESS	11	4.47e-01	6.74e-01	0.24100	1.30e-01	2.02e-01	4.54e-01	2.46e-01
GOBP REGULATION OF TORC2 SIGNALING	5	6.93e-01	8.40e-01	0.24000	1.27e-01	2.04e-01	6.23e-01	4.29e-01
GOBP TRNA PROCESSING	131	8.17e-05	1.32e-03	0.24000	1.93e-01	1.43e-01	1.36e-04	4.58e-03
GOCC TERTIARY GRANULE MEMBRANE	69	5.15e-04	6.17e-03	0.24000	-1.58e-01	1.81e-01	2.32e-02	9.28e-03
Butyrophilin (BTN) family interactions	12	3.54e-01	5.91e-01	0.24000	2.39e-01	2.59e-02	1.52e-01	8.77e-01
GOBP POSITIVE REGULATION OF VACUOLE ORGANIZATION	24	1.31e-01	3.39e-01	0.24000	2.37e-01	3.69e-02	4.41e-02	7.54e-01
GOMF STEROID HYDROXYLASE ACTIVITY	26	1.54e-01	3.70e-01	0.24000	-1.45e-01	-1.92e-01	2.01e-01	9.09e-02
GOCC H4 HISTONE ACETYLTRANSFERASE COMPLEX	37	5.93e-02	2.09e-01	0.24000	2.20e-01	9.61e-02	2.05e-02	3.12e-01
GOBP NEURONAL ACTION POTENTIAL PROPAGATION	10	4.77e-01	6.95e-01	0.24000	-1.19e-01	-2.09e-01	5.16e-01	2.53e-01
Cellular response to heat stress	97	4.94e-04	5.96e-03	0.24000	2.27e-01	7.74e-02	1.09e-04	1.88e-01
GOBP AGGREPHAGY	16	1.82e-01	4.07e-01	0.24000	2.12e-01	-1.12e-01	1.42e-01	4.37e-01
GOBP REGULATION OF MYOBLAST PROLIFERATION	25	9.01e-02	2.73e-01	0.24000	2.37e-01	-3.62e-02	4.00e-02	7.54e-01
GOBP CARTILAGE CONDENSATION	19	1.30e-01	3.38e-01	0.24000	2.08e-01	-1.20e-01	1.17e-01	3.64e-01
GOBP POLYAMINE METABOLIC PROCESS	15	2.63e-01	5.02e-01	0.24000	8.21e-03	2.40e-01	9.56e-01	1.08e-01
GOBP GLYCOLIPID TRANSPORT	8	5.66e-01	7.57e-01	0.24000	1.69e-01	1.71e-01	4.09e-01	4.03e-01
GOMF N ACYLTRANSFERASE ACTIVITY	86	1.65e-03	1.52e-02	0.24000	2.14e-01	1.09e-01	6.17e-04	7.99e-02
GOBP 5S CLASS RRNA TRANSCRIPTION BY RNA POLYMERASE III	6	5.41e-01	7.39e-01	0.24000	2.26e-01	-7.95e-02	3.37e-01	7.36e-01
GOCC TRANSCRIPTION FACTOR TFIIIC COMPLEX	6	5.41e-01	7.39e-01	0.24000	2.26e-01	-7.95e-02	3.37e-01	7.36e-01
GOBP HEART TRABECULA FORMATION	15	3.44e-01	5.81e-01	0.24000	1.81e-01	1.57e-01	2.25e-01	2.92e-01
GOMF DEAMINASE ACTIVITY	32	5.70e-02	2.03e-01	0.24000	4.67e-03	2.40e-01	9.64e-01	1.89e-02
GOBP ANIMAL ORGAN FORMATION	68	7.70e-03	4.93e-02	0.24000	1.43e-01	1.92e-01	4.10e-02	6.15e-03
GOBP POSITIVE REGULATION OF DENDRITIC SPINE MAINTENANCE	5	5.78e-01	7.66e-01	0.24000	1.69e-01	-1.70e-01	5.13e-01	5.11e-01
GOBP NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION	17	1.91e-01	4.18e-01	0.24000	2.35e-01	-4.68e-02	9.35e-02	7.39e-01
GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN	69	1.65e-03	1.52e-02	0.24000	-1.81e-02	2.39e-01	7.95e-01	6.01e-04
GOBP CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER	21	1.69e-01	3.91e-01	0.23900	-2.37e-01	-3.42e-02	6.00e-02	7.86e-01
Formation of the Early Elongation Complex	32	7.90e-02	2.51e-01	0.23900	2.29e-01	6.94e-02	2.48e-02	4.97e-01
Formation of the HIV-1 Early Elongation Complex	32	7.90e-02	2.51e-01	0.23900	2.29e-01	6.94e-02	2.48e-02	4.97e-01
Other semaphorin interactions	18	2.52e-01	4.90e-01	0.23900	-2.22e-01	-8.96e-02	1.03e-01	5.10e-01
GOMF PROTEIN METHYLTRANSFERASE ACTIVITY	95	3.56e-04	4.50e-03	0.23900	2.36e-01	3.86e-02	6.90e-05	5.16e-01
GOBP AUTOPHAGY OF PEROXISOME	15	2.12e-01	4.44e-01	0.23900	2.22e-01	-8.95e-02	1.37e-01	5.48e-01
GOCC EXTRINSIC COMPONENT OF PRESYNAPTIC MEMBRANE	6	5.42e-01	7.40e-01	0.23900	8.01e-02	-2.26e-01	7.34e-01	3.39e-01
Choline catabolism	6	6.38e-01	8.02e-01	0.23900	1.04e-01	2.16e-01	6.60e-01	3.60e-01
GOBP DISRUPTION OF ANATOMICAL STRUCTURE IN ANOTHER ORGANISM	86	1.72e-03	1.57e-02	0.23900	-2.13e-01	-1.10e-01	6.54e-04	7.83e-02
Formation of Senescence-Associated Heterochromatin Foci (SAHF)	17	2.47e-01	4.85e-01	0.23900	2.34e-01	4.88e-02	9.45e-02	7.27e-01
GOBP NEGATIVE REGULATION OF CELLULAR EXTRAVASATION	9	4.74e-01	6.94e-01	0.23900	-2.35e-01	-4.38e-02	2.22e-01	8.20e-01
GOBP EMBRYONIC HINDLIMB MORPHOGENESIS	27	1.48e-01	3.62e-01	0.23900	1.78e-01	1.60e-01	1.10e-01	1.50e-01
GOBP SPHINGOMYELIN CATABOLIC PROCESS	8	4.28e-01	6.57e-01	0.23900	-2.10e-01	1.14e-01	3.04e-01	5.75e-01
GOBP SOFT PALATE DEVELOPMENT	5	6.68e-01	8.25e-01	0.23900	2.32e-01	5.92e-02	3.70e-01	8.19e-01
GOBP NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING	8	5.62e-01	7.55e-01	0.23900	1.33e-01	1.99e-01	5.15e-01	3.31e-01
GOBP POSITIVE REGULATION OF TRANSMISSION OF NERVE IMPULSE	7	4.66e-01	6.89e-01	0.23900	1.74e-01	-1.64e-01	4.26e-01	4.52e-01
GOBP ENDOCRINE SYSTEM DEVELOPMENT	134	8.27e-05	1.33e-03	0.23900	1.73e-01	1.65e-01	5.56e-04	9.62e-04
GOMF NEUREGULIN BINDING	5	6.47e-01	8.08e-01	0.23900	2.38e-01	1.54e-02	3.56e-01	9.52e-01
Regulation of pyruvate dehydrogenase (PDH) complex	13	3.21e-01	5.59e-01	0.23900	2.38e-01	1.34e-02	1.37e-01	9.33e-01
GOBP POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION	17	1.86e-01	4.12e-01	0.23900	5.98e-02	-2.31e-01	6.70e-01	9.88e-02
Transport of Mature Transcript to Cytoplasm	78	2.55e-03	2.13e-02	0.23900	2.23e-01	8.56e-02	6.63e-04	1.91e-01
GOMF PROLINE RICH REGION BINDING	17	3.00e-01	5.40e-01	0.23900	1.50e-01	1.85e-01	2.83e-01	1.86e-01
Activation of NOXA and translocation to mitochondria	5	6.84e-01	8.35e-01	0.23900	9.14e-02	2.21e-01	7.23e-01	3.93e-01
GOBP CELLULAR RESPONSE TO IRON ION	7	4.73e-01	6.94e-01	0.23900	-1.29e-01	2.01e-01	5.54e-01	3.57e-01
GOBP MITOTIC CELL CYCLE PHASE TRANSITION	441	1.83e-14	1.76e-12	0.23900	2.07e-01	1.18e-01	7.86e-14	2.06e-05
GOBP THERMOCEPTION	8	5.51e-01	7.47e-01	0.23900	-1.05e-01	-2.14e-01	6.07e-01	2.94e-01
GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE	33	9.58e-02	2.82e-01	0.23900	1.91e-01	1.43e-01	5.73e-02	1.55e-01
GOMF FLOPPASE ACTIVITY	15	2.68e-01	5.07e-01	0.23900	-2.38e-01	-1.03e-02	1.10e-01	9.45e-01
GOMF METHYLATION DEPENDENT PROTEIN BINDING	69	2.53e-03	2.12e-02	0.23900	2.38e-01	1.68e-02	6.24e-04	8.09e-01
GOMF N METHYLTRANSFERASE ACTIVITY	97	2.68e-04	3.57e-03	0.23900	2.37e-01	2.76e-02	5.45e-05	6.39e-01
GOBP NATURAL KILLER CELL MEDIATED IMMUNITY	81	2.01e-04	2.77e-03	0.23900	-2.10e-01	1.13e-01	1.06e-03	7.97e-02
GOMF AMIDINE LYASE ACTIVITY	7	5.17e-01	7.23e-01	0.23900	-3.02e-02	2.37e-01	8.90e-01	2.78e-01
GOBP ESTABLISHMENT OF LYMPHOCYTE POLARITY	16	2.79e-01	5.19e-01	0.23900	6.19e-02	2.30e-01	6.68e-01	1.11e-01
GOBP ANTEROGRADE DENDRITIC TRANSPORT	9	5.31e-01	7.34e-01	0.23900	1.72e-01	1.66e-01	3.72e-01	3.90e-01
GOBP RRNA 5 END PROCESSING	5	6.87e-01	8.37e-01	0.23800	9.83e-02	2.17e-01	7.03e-01	4.00e-01
GOBP FEMALE GENITALIA DEVELOPMENT	19	2.51e-01	4.89e-01	0.23800	2.07e-01	1.18e-01	1.18e-01	3.71e-01
GOMF DNA NUCLEASE ACTIVITY	60	1.43e-02	7.82e-02	0.23800	1.90e-01	1.44e-01	1.10e-02	5.30e-02
GOBP MESENCHYME MORPHOGENESIS	61	1.39e-02	7.66e-02	0.23800	1.61e-01	1.76e-01	2.96e-02	1.75e-02
GOBP CHROMOSOME SEGREGATION	409	2.52e-14	2.38e-12	0.23800	2.26e-01	7.50e-02	3.93e-15	9.21e-03
GOCC SPECIFIC GRANULE LUMEN	60	6.79e-03	4.48e-02	0.23800	-2.35e-01	-3.70e-02	1.61e-03	6.20e-01
GOMF BETA GALACTOSIDASE ACTIVITY	5	6.88e-01	8.38e-01	0.23800	-1.01e-01	-2.16e-01	6.97e-01	4.03e-01
GOMF 14 3 3 PROTEIN BINDING	31	1.10e-01	3.07e-01	0.23800	1.94e-01	1.38e-01	6.15e-02	1.83e-01
GOBP PHAGOLYSOSOME ASSEMBLY	17	2.33e-01	4.68e-01	0.23800	2.16e-02	2.37e-01	8.78e-01	9.03e-02
Adipogenesis	105	4.88e-04	5.91e-03	0.23800	2.08e-01	1.16e-01	2.32e-04	3.95e-02
GOBP EMBRYONIC HEART TUBE DEVELOPMENT	84	2.68e-03	2.21e-02	0.23800	1.44e-01	1.90e-01	2.25e-02	2.66e-03
GOBP REGULATION OF ISOTYPE SWITCHING	36	8.06e-02	2.53e-01	0.23800	1.62e-01	1.74e-01	9.16e-02	7.08e-02
GOBP RENAL SODIUM ION ABSORPTION	12	2.73e-01	5.13e-01	0.23800	1.65e-01	-1.71e-01	3.22e-01	3.04e-01
GOBP INFLAMMATORY RESPONSE TO WOUNDING	27	1.44e-01	3.57e-01	0.23800	-2.01e-01	-1.28e-01	7.08e-02	2.51e-01
GOBP REGULATION OF KIDNEY SIZE	5	6.23e-01	7.93e-01	0.23800	2.35e-01	-3.49e-02	3.62e-01	8.92e-01
GOBP GALACTOSE METABOLIC PROCESS	9	3.78e-01	6.13e-01	0.23800	1.69e-01	-1.68e-01	3.81e-01	3.83e-01
GOBP T HELPER 2 CELL DIFFERENTIATION	18	2.24e-01	4.58e-01	0.23800	3.64e-02	2.35e-01	7.89e-01	8.42e-02
SRP-dependent cotranslational protein targeting to membrane	105	6.50e-04	7.49e-03	0.23800	1.83e-01	1.52e-01	1.21e-03	7.06e-03
GOBP POSITIVE REGULATION OF NEUROBLAST PROLIFERATION	37	7.40e-02	2.40e-01	0.23800	1.88e-01	1.46e-01	4.77e-02	1.25e-01
GOBP PROTEIN SULFATION	6	6.33e-01	7.99e-01	0.23800	2.22e-01	8.48e-02	3.46e-01	7.19e-01
GOMF TAU PROTEIN BINDING	42	4.16e-02	1.67e-01	0.23800	2.21e-01	8.79e-02	1.32e-02	3.24e-01
GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC	15	3.19e-01	5.58e-01	0.23800	-2.22e-01	-8.52e-02	1.37e-01	5.68e-01
GOBP NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA	19	2.60e-01	4.99e-01	0.23800	1.38e-01	1.93e-01	2.97e-01	1.44e-01
GOMF FATTY ACID DERIVATIVE BINDING	18	2.12e-01	4.44e-01	0.23800	2.37e-01	1.58e-02	8.15e-02	9.08e-01
GOMF INSULIN RECEPTOR BINDING	21	2.09e-01	4.41e-01	0.23800	2.17e-01	9.73e-02	8.54e-02	4.40e-01
GOBP REGULATION OF MESODERM DEVELOPMENT	6	5.68e-01	7.58e-01	0.23800	-2.35e-01	3.56e-02	3.19e-01	8.80e-01
GOBP NEGATIVE REGULATION OF ANOIKIS	18	2.80e-01	5.19e-01	0.23800	1.94e-01	1.37e-01	1.54e-01	3.13e-01
GOBP REGULATION OF CELL MATURATION	22	9.38e-02	2.79e-01	0.23800	-1.77e-01	1.58e-01	1.50e-01	1.99e-01
GOBP REGULATION OF METALLOENDOPEPTIDASE ACTIVITY	10	3.56e-01	5.93e-01	0.23800	-2.15e-01	1.01e-01	2.39e-01	5.79e-01
GOBP REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY	16	3.22e-01	5.61e-01	0.23800	1.38e-01	1.94e-01	3.40e-01	1.80e-01
GOBP RESPONSE TO VITAMIN A	15	3.20e-01	5.58e-01	0.23800	2.22e-01	8.44e-02	1.36e-01	5.71e-01
GOBP SPINDLE ASSEMBLY INVOLVED IN FEMALE MEIOSIS	9	5.20e-01	7.25e-01	0.23700	2.09e-01	1.14e-01	2.79e-01	5.55e-01
GOBP MESANGIAL CELL DIFFERENTIATION	7	5.71e-01	7.61e-01	0.23700	5.50e-02	2.31e-01	8.01e-01	2.90e-01
GOMF BIOTIN BINDING	5	6.97e-01	8.43e-01	0.23700	-1.19e-01	-2.06e-01	6.46e-01	4.26e-01
GOMF BETA N ACETYLHEXOSAMINIDASE ACTIVITY	5	7.06e-01	8.48e-01	0.23700	1.77e-01	1.59e-01	4.94e-01	5.39e-01
Complex III assembly	24	1.81e-01	4.06e-01	0.23700	1.99e-01	1.29e-01	9.11e-02	2.74e-01
GOMF TRANSFERASE ACTIVITY TRANSFERRING ALKYL OR ARYL OTHER THAN METHYL GROUPS	55	1.70e-02	8.85e-02	0.23700	2.16e-01	9.84e-02	5.59e-03	2.07e-01
GOBP BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS	51	4.51e-03	3.27e-02	0.23700	-1.97e-01	1.33e-01	1.51e-02	1.01e-01
GOBP REGULATION OF PLASMA CELL DIFFERENTIATION	6	5.29e-01	7.33e-01	0.23700	-1.32e-01	1.97e-01	5.75e-01	4.03e-01
GOBP ORGANELLE DISASSEMBLY	175	3.82e-06	9.52e-05	0.23700	2.04e-01	1.22e-01	3.31e-06	5.51e-03
GOBP GOLGI TO LYSOSOME TRANSPORT	12	2.81e-01	5.20e-01	0.23700	1.28e-01	-2.00e-01	4.43e-01	2.31e-01
GOBP NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION	15	2.19e-01	4.53e-01	0.23700	2.21e-01	-8.58e-02	1.38e-01	5.65e-01
GOBP REGULATION OF ENDOSOME ORGANIZATION	5	7.06e-01	8.48e-01	0.23700	1.81e-01	1.53e-01	4.83e-01	5.53e-01
ER-Phagosome pathway	76	5.19e-03	3.64e-02	0.23700	1.71e-01	1.65e-01	1.01e-02	1.31e-02
GOBP MESENCHYMAL STEM CELL MAINTENANCE INVOLVED IN NEPHRON MORPHOGENESIS	6	6.36e-01	8.02e-01	0.23700	-8.70e-02	-2.21e-01	7.12e-01	3.50e-01
GOMF IONOTROPIC GLUTAMATE RECEPTOR BINDING	23	1.75e-01	3.97e-01	0.23700	-2.22e-01	-8.29e-02	6.52e-02	4.91e-01
GOBP REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY	15	3.24e-01	5.63e-01	0.23700	2.20e-01	8.89e-02	1.41e-01	5.51e-01
GOBP MICROTUBULE ORGANIZING CENTER ORGANIZATION	148	3.29e-05	6.15e-04	0.23700	1.42e-01	1.90e-01	2.94e-03	6.56e-05
GOBP RENAL VESICLE DEVELOPMENT	18	2.04e-01	4.34e-01	0.23700	-2.37e-01	1.44e-03	8.17e-02	9.92e-01
GOBP RECEPTOR MEDIATED ENDOCYTOSIS OF VIRUS BY HOST CELL	10	4.39e-01	6.66e-01	0.23700	2.34e-01	3.71e-02	2.00e-01	8.39e-01
GOBP NEGATIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION	7	5.90e-01	7.73e-01	0.23700	2.21e-01	8.60e-02	3.12e-01	6.93e-01
SUMOylation of chromatin organization proteins	57	1.60e-02	8.45e-02	0.23700	2.10e-01	1.09e-01	6.05e-03	1.53e-01
GOMF MACROMOLECULE TRANSMEMBRANE TRANSPORTER ACTIVITY	31	1.15e-01	3.15e-01	0.23700	1.85e-01	1.48e-01	7.41e-02	1.55e-01
GOBP MYOBLAST MIGRATION	13	3.89e-01	6.22e-01	0.23700	2.10e-01	1.10e-01	1.90e-01	4.92e-01
GOCC TRANSCRIPTION FACTOR TFIIA COMPLEX	5	5.96e-01	7.76e-01	0.23700	2.11e-01	-1.07e-01	4.13e-01	6.79e-01
GOBP DETECTION OF VISIBLE LIGHT	45	2.76e-02	1.25e-01	0.23700	-5.34e-02	-2.31e-01	5.35e-01	7.39e-03
Intra-Golgi traffic	43	2.86e-02	1.28e-01	0.23700	2.34e-01	3.40e-02	7.82e-03	7.00e-01
GOMF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR BINDING	12	2.95e-01	5.35e-01	0.23700	2.18e-01	-9.18e-02	1.90e-01	5.82e-01
GOBP PROTEIN SUMOYLATION	64	7.96e-03	5.07e-02	0.23700	2.22e-01	8.32e-02	2.16e-03	2.49e-01
GOBP LAMELLIPODIUM MORPHOGENESIS	18	2.87e-01	5.25e-01	0.23700	1.57e-01	1.77e-01	2.49e-01	1.93e-01
GOBP LUNG ASSOCIATED MESENCHYME DEVELOPMENT	9	3.84e-01	6.18e-01	0.23700	1.88e-01	-1.44e-01	3.29e-01	4.54e-01
GOBP REGULATION OF GASTRULATION	16	2.80e-01	5.20e-01	0.23700	5.54e-02	2.30e-01	7.01e-01	1.11e-01
GOMF COMPLEMENT COMPONENT C3B BINDING	8	5.74e-01	7.64e-01	0.23700	-1.56e-01	-1.78e-01	4.45e-01	3.83e-01
GOBP L LEUCINE CATABOLIC PROCESS	6	6.01e-01	7.79e-01	0.23700	2.01e-02	2.36e-01	9.32e-01	3.17e-01
GOBP NEGATIVE REGULATION OF BONE MINERALIZATION	18	1.70e-01	3.92e-01	0.23700	-2.26e-01	6.90e-02	9.63e-02	6.13e-01
MET activates RAP1 and RAC1	11	4.63e-01	6.86e-01	0.23700	1.92e-01	1.39e-01	2.71e-01	4.25e-01
GOMF PRE MIRNA BINDING	9	5.37e-01	7.37e-01	0.23700	1.72e-01	1.63e-01	3.73e-01	3.97e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON CH OR CH2 GROUPS DISULFIDE AS ACCEPTOR	5	6.31e-01	7.98e-01	0.23700	-2.66e-02	2.35e-01	9.18e-01	3.63e-01
GOMF RETINOL BINDING	16	3.30e-01	5.70e-01	0.23700	-1.78e-01	-1.56e-01	2.19e-01	2.79e-01
GOBP NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION	14	2.74e-01	5.14e-01	0.23700	-2.86e-02	2.35e-01	8.53e-01	1.28e-01
GOBP REGULATION OF CELL CYCLE PHASE TRANSITION	441	2.04e-14	1.96e-12	0.23600	2.11e-01	1.06e-01	2.58e-14	1.37e-04
GOBP RESPONSE TO LIPOTEICHOIC ACID	10	4.95e-01	7.07e-01	0.23600	-1.96e-01	-1.33e-01	2.84e-01	4.67e-01
GOBP REGULATION OF COPII VESICLE COATING	5	6.44e-01	8.07e-01	0.23600	-7.57e-04	2.36e-01	9.98e-01	3.60e-01
Signaling by Nuclear Receptors	258	4.29e-09	2.07e-07	0.23600	2.21e-01	8.28e-02	8.99e-10	2.21e-02
Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins	64	1.16e-02	6.67e-02	0.23600	1.90e-01	1.40e-01	8.43e-03	5.26e-02
GOBP LYSOSOMAL PROTEIN CATABOLIC PROCESS	20	2.07e-01	4.38e-01	0.23600	2.29e-01	5.77e-02	7.60e-02	6.55e-01
GOBP GEPHYRIN CLUSTERING INVOLVED IN POSTSYNAPTIC DENSITY ASSEMBLY	5	6.38e-01	8.02e-01	0.23600	1.38e-02	-2.36e-01	9.57e-01	3.61e-01
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CILIUM	7	4.75e-01	6.95e-01	0.23600	1.82e-01	-1.51e-01	4.05e-01	4.89e-01
GOMF RACEMASE AND EPIMERASE ACTIVITY ACTING ON CARBOHYDRATES AND DERIVATIVES	10	4.80e-01	6.97e-01	0.23600	2.14e-01	9.94e-02	2.40e-01	5.86e-01
GOBP NEGATIVE REGULATION OF RECEPTOR BINDING	12	3.08e-01	5.48e-01	0.23600	-6.89e-02	2.26e-01	6.80e-01	1.75e-01
GOBP MAINTENANCE OF PRESYNAPTIC ACTIVE ZONE STRUCTURE	5	7.05e-01	8.47e-01	0.23600	-1.92e-01	-1.38e-01	4.57e-01	5.94e-01
GOBP REGULATION OF DNA DEMETHYLATION	7	5.90e-01	7.73e-01	0.23600	-2.22e-01	-8.22e-02	3.10e-01	7.07e-01
HS-GAG degradation	21	2.35e-01	4.72e-01	0.23600	-1.68e-01	-1.66e-01	1.83e-01	1.88e-01
GOCC ALVEOLAR LAMELLAR BODY	8	4.67e-01	6.89e-01	0.23600	-2.31e-01	4.86e-02	2.58e-01	8.12e-01
GOBP CHEMOSENSORY BEHAVIOR	19	2.36e-01	4.72e-01	0.23600	-7.69e-02	-2.23e-01	5.62e-01	9.20e-02
GOMF DNA POLYMERASE BINDING	21	2.36e-01	4.72e-01	0.23600	1.62e-01	1.72e-01	1.99e-01	1.73e-01
GOMF VOLTAGE GATED MONOATOMIC CATION CHANNEL ACTIVITY	141	3.98e-05	7.22e-04	0.23600	-2.10e-01	-1.08e-01	1.70e-05	2.65e-02
GOBP PEPTIDYL LYSINE METHYLATION	23	1.57e-01	3.74e-01	0.23600	2.32e-01	4.45e-02	5.43e-02	7.12e-01
Transport of the SLBP independent Mature mRNA	35	7.94e-02	2.52e-01	0.23600	2.11e-01	1.06e-01	3.09e-02	2.78e-01
GOBP PLASMA MEMBRANE REPAIR	27	1.17e-01	3.18e-01	0.23600	5.16e-02	2.30e-01	6.42e-01	3.84e-02
GOBP RETROGRADE TRANSPORT ENDOSOME TO GOLGI	98	1.03e-03	1.08e-02	0.23600	1.98e-01	1.28e-01	6.84e-04	2.91e-02
GOBP COP9 SIGNALOSOME ASSEMBLY	5	6.54e-01	8.13e-01	0.23600	1.49e-02	2.35e-01	9.54e-01	3.62e-01
Cellular responses to stimuli	844	2.30e-25	4.79e-23	0.23600	1.92e-01	1.37e-01	2.70e-21	1.24e-11
GOBP PROTEIN LOCALIZATION TO NUCLEUS	307	1.59e-10	9.64e-09	0.23600	2.19e-01	8.81e-02	4.23e-11	7.94e-03
GOBP METHYLATION	209	3.10e-07	1.02e-05	0.23600	2.10e-01	1.07e-01	1.57e-07	7.92e-03
GOBP REGULATION OF T CIRCLE FORMATION	5	6.28e-01	7.96e-01	0.23600	2.33e-01	-3.65e-02	3.67e-01	8.88e-01
GOBP CHITIN METABOLIC PROCESS	6	6.41e-01	8.04e-01	0.23600	-2.18e-01	-9.09e-02	3.56e-01	7.00e-01
GOMF CHITINASE ACTIVITY	6	6.41e-01	8.04e-01	0.23600	-2.18e-01	-9.09e-02	3.56e-01	7.00e-01
Mucopolysaccharidoses	10	3.77e-01	6.12e-01	0.23600	6.80e-02	-2.26e-01	7.10e-01	2.16e-01
Signaling by Erythropoietin	25	1.68e-01	3.89e-01	0.23600	2.06e-01	1.14e-01	7.40e-02	3.25e-01
Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC)	32	7.27e-02	2.38e-01	0.23600	2.33e-01	3.38e-02	2.24e-02	7.41e-01
Regulation of Glucokinase by Glucokinase Regulatory Protein	32	7.27e-02	2.38e-01	0.23600	2.33e-01	3.38e-02	2.24e-02	7.41e-01
GOBP POSITIVE REGULATION OF VASCULAR WOUND HEALING	6	6.32e-01	7.99e-01	0.23600	-7.24e-02	-2.24e-01	7.59e-01	3.41e-01
GOMF CATALYTIC ACTIVITY ACTING ON A NUCLEIC ACID	597	9.77e-20	1.38e-17	0.23600	2.21e-01	8.13e-02	2.39e-20	6.91e-04
GOBP REGULATION OF SKELETAL MUSCLE CONTRACTION	16	1.96e-01	4.25e-01	0.23600	1.04e-01	-2.11e-01	4.72e-01	1.43e-01
GOBP POSITIVE REGULATION OF AXON EXTENSION INVOLVED IN AXON GUIDANCE	7	6.17e-01	7.90e-01	0.23600	-1.47e-01	-1.84e-01	5.00e-01	3.99e-01
GOBP NEGATIVE REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION	190	1.34e-06	3.78e-05	0.23600	2.08e-01	1.10e-01	7.55e-07	8.64e-03
GOBP SPINAL CORD DEVELOPMENT	96	1.41e-03	1.35e-02	0.23600	1.58e-01	1.75e-01	7.55e-03	3.06e-03
GOBP NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY	15	3.40e-01	5.78e-01	0.23600	1.08e-01	2.09e-01	4.69e-01	1.60e-01
GOBP REGULATION OF CILIUM BEAT FREQUENCY INVOLVED IN CILIARY MOTILITY	9	4.78e-01	6.96e-01	0.23600	2.33e-01	3.20e-02	2.25e-01	8.68e-01
GOBP NEGATIVE REGULATION OF SATELLITE CELL DIFFERENTIATION	5	6.31e-01	7.98e-01	0.23500	2.33e-01	-3.18e-02	3.66e-01	9.02e-01
GOBP IMPORT INTO NUCLEUS	165	5.95e-06	1.40e-04	0.23500	2.16e-01	9.42e-02	1.73e-06	3.67e-02
GOMF GATED CHANNEL ACTIVITY	307	4.18e-10	2.36e-08	0.23500	-2.06e-01	-1.14e-01	5.53e-10	5.69e-04
GOBP CYTOLYSIS	7	6.19e-01	7.90e-01	0.23500	1.57e-01	1.75e-01	4.72e-01	4.22e-01
SARS-CoV-1 Infection	135	1.01e-04	1.56e-03	0.23500	1.54e-01	1.78e-01	2.05e-03	3.53e-04
GOBP PYRUVATE FAMILY AMINO ACID METABOLIC PROCESS	12	3.18e-01	5.57e-01	0.23500	-2.29e-01	5.49e-02	1.70e-01	7.42e-01
GOMF MUTSALPHA COMPLEX BINDING	7	5.37e-01	7.38e-01	0.23500	2.35e-01	-1.22e-02	2.82e-01	9.56e-01
MITF-M-dependent gene expression	106	7.23e-04	8.22e-03	0.23500	1.78e-01	1.54e-01	1.54e-03	6.24e-03
GOBP DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION	15	3.58e-01	5.95e-01	0.23500	1.55e-01	1.77e-01	2.98e-01	2.36e-01
GOCC SEX CHROMOSOME	33	7.40e-02	2.40e-01	0.23500	2.30e-01	5.09e-02	2.25e-02	6.13e-01
GOBP EMBRYONIC PLACENTA DEVELOPMENT	85	3.43e-04	4.37e-03	0.23500	-4.75e-02	2.30e-01	4.49e-01	2.44e-04
GOMF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY	97	5.07e-04	6.09e-03	0.23500	-2.29e-01	-5.37e-02	9.83e-05	3.61e-01
GOBP NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION	23	1.67e-01	3.88e-01	0.23500	-5.78e-02	-2.28e-01	6.31e-01	5.86e-02
GOMF DNA DAMAGE SENSOR ACTIVITY	23	1.71e-01	3.93e-01	0.23500	2.26e-01	6.52e-02	6.10e-02	5.88e-01
GOBP ENDOPLASMIC RETICULUM ORGANIZATION	95	1.57e-03	1.46e-02	0.23500	1.74e-01	1.57e-01	3.30e-03	8.06e-03
GOBP REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY	26	1.57e-01	3.74e-01	0.23500	2.07e-01	1.11e-01	6.74e-02	3.29e-01
Selective autophagy	84	3.06e-03	2.44e-02	0.23500	1.91e-01	1.36e-01	2.43e-03	3.10e-02
GOBP MORPHOGENESIS OF AN EPITHELIAL BUD	14	3.85e-01	6.18e-01	0.23500	1.53e-01	1.78e-01	3.22e-01	2.48e-01
GOBP CELL CELL RECOGNITION	73	6.83e-03	4.49e-02	0.23500	-1.46e-01	-1.83e-01	3.06e-02	6.71e-03
GOBP VESICLE BUDDING FROM MEMBRANE	84	3.25e-03	2.55e-02	0.23500	1.82e-01	1.48e-01	3.87e-03	1.92e-02
GOBP DEFENSE RESPONSE TO TUMOR CELL	13	3.26e-01	5.64e-01	0.23500	-2.35e-01	-1.19e-03	1.43e-01	9.94e-01
GOBP DIGESTION	131	1.20e-04	1.80e-03	0.23500	-1.32e-01	-1.94e-01	9.01e-03	1.27e-04
GOBP POSITIVE REGULATION OF ARTERY MORPHOGENESIS	6	6.65e-01	8.22e-01	0.23500	-1.71e-01	-1.60e-01	4.68e-01	4.96e-01
GOBP T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL	10	3.52e-01	5.89e-01	0.23400	-1.81e-01	1.49e-01	3.22e-01	4.13e-01
GOBP REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE	9	4.96e-01	7.08e-01	0.23400	-5.45e-02	-2.28e-01	7.77e-01	2.36e-01
GOBP HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	12	3.20e-01	5.59e-01	0.23400	-5.59e-02	2.28e-01	7.37e-01	1.72e-01
GOBP PURINE RIBONUCLEOTIDE SALVAGE	7	5.57e-01	7.51e-01	0.23400	1.82e-02	2.34e-01	9.34e-01	2.84e-01
G2/M DNA replication checkpoint	5	5.94e-01	7.75e-01	0.23400	-1.85e-01	1.44e-01	4.75e-01	5.76e-01
GOBP PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX ASSEMBLY	15	3.02e-01	5.42e-01	0.23400	2.31e-01	4.14e-02	1.22e-01	7.81e-01
STAT5 activation downstream of FLT3 ITD mutants	10	4.91e-01	7.04e-01	0.23400	1.08e-01	2.08e-01	5.54e-01	2.55e-01
GOBP INTRACELLULAR MONOATOMIC ANION HOMEOSTASIS	10	5.00e-01	7.10e-01	0.23400	-1.27e-01	-1.97e-01	4.86e-01	2.81e-01
GOBP CELL MIGRATION IN HINDBRAIN	16	2.75e-01	5.15e-01	0.23400	3.54e-02	2.32e-01	8.06e-01	1.09e-01
Inactivation, recovery and regulation of the phototransduction cascade	31	4.27e-02	1.70e-01	0.23400	1.13e-01	-2.05e-01	2.77e-01	4.79e-02
2-LTR circle formation	7	5.38e-01	7.38e-01	0.23400	2.34e-01	-1.46e-02	2.84e-01	9.47e-01
GOBP MITOCHONDRIAL RNA CATABOLIC PROCESS	6	6.05e-01	7.82e-01	0.23400	2.34e-01	1.45e-02	3.22e-01	9.51e-01
GOBP POSITIVE REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION	120	3.05e-04	3.97e-03	0.23400	1.56e-01	1.74e-01	3.12e-03	9.67e-04
GP1b-IX-V activation signalling	11	4.74e-01	6.94e-01	0.23400	1.51e-01	1.79e-01	3.85e-01	3.05e-01
GOBP ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM	15	3.00e-01	5.40e-01	0.23400	3.71e-02	2.31e-01	8.03e-01	1.21e-01
GOBP STRIATED MUSCLE CELL APOPTOTIC PROCESS	58	1.04e-02	6.15e-02	0.23400	2.29e-01	4.65e-02	2.51e-03	5.40e-01
GOBP POSITIVE REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS	10	4.99e-01	7.10e-01	0.23400	-1.98e-01	-1.25e-01	2.79e-01	4.93e-01
GOMF UBIQUITIN PROTEIN TRANSFERASE REGULATOR ACTIVITY	31	1.23e-01	3.26e-01	0.23400	1.57e-01	1.74e-01	1.31e-01	9.41e-02
GOBP POSITIVE REGULATION OF MYOBLAST FUSION	15	2.18e-01	4.52e-01	0.23400	-2.06e-01	1.11e-01	1.67e-01	4.56e-01
GOBP VESICLE MEDIATED CHOLESTEROL TRANSPORT	9	5.04e-01	7.14e-01	0.23400	2.24e-01	6.60e-02	2.44e-01	7.32e-01
Signaling by NTRK3 (TRKC)	17	3.17e-01	5.56e-01	0.23400	1.65e-01	1.66e-01	2.40e-01	2.36e-01
GOCC CALCIUM CHANNEL COMPLEX	68	8.71e-03	5.43e-02	0.23400	-1.18e-01	-2.02e-01	9.38e-02	3.94e-03
GOBP MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL	28	1.31e-01	3.40e-01	0.23400	-9.24e-02	-2.15e-01	3.97e-01	4.92e-02
Sensory processing of sound by outer hair cells of the cochlea	50	3.40e-02	1.44e-01	0.23400	-1.79e-01	-1.51e-01	2.90e-02	6.48e-02
GOBP GOLGI ORGANIZATION	138	4.17e-05	7.47e-04	0.23400	2.18e-01	8.40e-02	9.69e-06	8.85e-02
GOBP GLYCOPROTEIN CATABOLIC PROCESS	33	3.45e-02	1.45e-01	0.23400	-1.22e-01	1.99e-01	2.24e-01	4.77e-02
Regulation of signaling by CBL	22	1.85e-01	4.11e-01	0.23400	2.26e-01	5.96e-02	6.66e-02	6.28e-01
GOCC SIGNAL RECOGNITION PARTICLE	8	4.81e-01	6.97e-01	0.23400	2.31e-01	-3.71e-02	2.59e-01	8.56e-01
GOBP REGULATION OF TRANSLATIONAL INITIATION	77	4.36e-03	3.20e-02	0.23300	2.08e-01	1.06e-01	1.60e-03	1.08e-01
GOBP UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS	9	5.09e-01	7.17e-01	0.23300	7.07e-02	2.22e-01	7.13e-01	2.48e-01
GOCC TRANSFERASE COMPLEX TRANSFERRING PHOSPHORUS CONTAINING GROUPS	273	9.42e-09	4.16e-07	0.23300	1.92e-01	1.33e-01	4.76e-08	1.58e-04
Downstream TCR signaling	81	2.92e-03	2.36e-02	0.23300	2.14e-01	9.24e-02	8.53e-04	1.51e-01
GOBP POST EMBRYONIC EYE MORPHOGENESIS	7	4.99e-01	7.10e-01	0.23300	9.54e-02	-2.13e-01	6.62e-01	3.29e-01
GOBP SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION	14	3.80e-01	6.14e-01	0.23300	1.99e-01	1.21e-01	1.97e-01	4.32e-01
GOBP POSITIVE REGULATION OF TRANSLATIONAL INITIATION	22	1.67e-01	3.88e-01	0.23300	2.32e-01	2.55e-02	5.98e-02	8.36e-01
GOCC TRANSCRIPTION FACTOR TFIID COMPLEX	30	9.32e-02	2.78e-01	0.23300	2.30e-01	4.03e-02	2.95e-02	7.02e-01
GOBP REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION	101	1.06e-03	1.10e-02	0.23300	1.36e-01	1.89e-01	1.81e-02	1.01e-03
GOBP MAMMARY GLAND ALVEOLUS DEVELOPMENT	19	1.70e-01	3.92e-01	0.23300	-5.12e-02	2.27e-01	6.99e-01	8.62e-02
Signaling by FGFR1	51	2.01e-02	1.00e-01	0.23300	2.26e-01	5.66e-02	5.23e-03	4.84e-01
GOBP MACROPHAGE INFLAMMATORY PROTEIN 1 ALPHA PRODUCTION	6	6.09e-01	7.85e-01	0.23300	-2.32e-01	-1.71e-02	3.24e-01	9.42e-01
GOBP SUBSTANTIA NIGRA DEVELOPMENT	40	6.79e-02	2.27e-01	0.23300	1.48e-01	1.80e-01	1.05e-01	4.90e-02
Nectin/Necl trans heterodimerization	7	5.98e-01	7.77e-01	0.23300	-7.99e-02	-2.19e-01	7.14e-01	3.16e-01
Formation of Fibrin Clot (Clotting Cascade)	37	8.31e-02	2.59e-01	0.23300	-1.48e-01	-1.80e-01	1.20e-01	5.80e-02
GOBP CELLULAR RESPONSE TO GLUCAGON STIMULUS	11	4.78e-01	6.96e-01	0.23300	-1.53e-01	-1.75e-01	3.78e-01	3.15e-01
GOBP CYTOKINETIC PROCESS	46	4.55e-02	1.76e-01	0.23300	1.48e-01	1.80e-01	8.23e-02	3.50e-02
GOBP REGULATION OF APOPTOTIC DNA FRAGMENTATION	10	4.97e-01	7.09e-01	0.23300	1.11e-01	2.05e-01	5.43e-01	2.63e-01
GOMF METALLOENDOPEPTIDASE ACTIVITY	106	5.19e-04	6.21e-03	0.23300	-9.35e-02	-2.13e-01	9.63e-02	1.50e-04
GOCC PROCENTRIOLE REPLICATION COMPLEX	5	6.02e-01	7.80e-01	0.23300	1.96e-01	-1.25e-01	4.47e-01	6.29e-01
GOBP NEGATIVE REGULATION OF MACROPHAGE ACTIVATION	15	2.90e-01	5.28e-01	0.23300	1.52e-02	2.32e-01	9.19e-01	1.20e-01
GOBP POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION	24	8.67e-02	2.66e-01	0.23300	-1.31e-01	1.92e-01	2.66e-01	1.03e-01
GOMF POTASSIUM CHANNEL ACTIVITY	123	1.48e-04	2.13e-03	0.23300	-2.15e-01	-8.98e-02	3.96e-05	8.54e-02
GOBP PRESYNAPTIC MEMBRANE ORGANIZATION	6	6.57e-01	8.16e-01	0.23300	-1.08e-01	-2.06e-01	6.46e-01	3.83e-01
GOBP REGULATION OF OSTEOCLAST PROLIFERATION	6	5.47e-01	7.44e-01	0.23300	-2.03e-01	1.14e-01	3.90e-01	6.30e-01
GOBP LIPOXYGENASE PATHWAY	11	4.72e-01	6.94e-01	0.23200	1.95e-01	1.27e-01	2.64e-01	4.65e-01
GOBP POSITIVE REGULATION OF MACROPHAGE ACTIVATION	30	8.31e-02	2.59e-01	0.23200	-2.32e-01	-1.22e-02	2.78e-02	9.08e-01
GOBP DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS	24	8.48e-02	2.62e-01	0.23200	-1.54e-01	1.74e-01	1.93e-01	1.39e-01
GOMF MIRNA BINDING	38	5.15e-02	1.91e-01	0.23200	2.28e-01	4.34e-02	1.49e-02	6.43e-01
GOCC FLOTILLIN COMPLEX	9	4.92e-01	7.05e-01	0.23200	2.29e-01	3.98e-02	2.34e-01	8.36e-01
GOBP CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS	20	1.89e-01	4.17e-01	0.23200	2.32e-01	1.02e-02	7.23e-02	9.37e-01
Sulfur amino acid metabolism	26	1.77e-01	4.00e-01	0.23200	1.60e-01	1.68e-01	1.57e-01	1.38e-01
GOBP NEGATIVE REGULATION OF DNA REPLICATION	25	1.88e-01	4.15e-01	0.23200	1.75e-01	1.52e-01	1.29e-01	1.87e-01
GOMF SECONDARY ACTIVE MONOCARBOXYLATE TRANSMEMBRANE TRANSPORTER ACTIVITY	17	2.15e-01	4.47e-01	0.23200	-2.29e-01	3.73e-02	1.02e-01	7.90e-01
GOBP REGULATION OF DNA RECOMBINATION	135	9.58e-05	1.49e-03	0.23200	2.00e-01	1.18e-01	5.90e-05	1.81e-02
GOMF C C CHEMOKINE BINDING	23	2.15e-01	4.47e-01	0.23200	-1.76e-01	-1.51e-01	1.44e-01	2.09e-01
GOBP RESPONSE TO HYDROGEN PEROXIDE	94	1.81e-03	1.63e-02	0.23200	1.38e-01	1.86e-01	2.03e-02	1.78e-03
Transport of vitamins, nucleosides, and related molecules	38	7.98e-02	2.52e-01	0.23200	-1.59e-01	-1.69e-01	8.89e-02	7.17e-02
GOCC CLATHRIN COATED PIT	75	2.29e-03	1.95e-02	0.23200	2.31e-01	2.19e-02	5.38e-04	7.42e-01
GOCC CYTOSOLIC RIBOSOME	107	6.93e-04	7.90e-03	0.23200	1.96e-01	1.24e-01	4.57e-04	2.64e-02
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM	41	5.35e-02	1.97e-01	0.23200	2.13e-01	9.16e-02	1.81e-02	3.10e-01
GOMF BILE ACID TRANSMEMBRANE TRANSPORTER ACTIVITY	20	2.53e-01	4.90e-01	0.23200	-2.00e-01	-1.17e-01	1.21e-01	3.64e-01
GOBP FARNESYL DIPHOSPHATE METABOLIC PROCESS	6	6.55e-01	8.14e-01	0.23200	1.01e-01	2.09e-01	6.69e-01	3.75e-01
GOBP POSITIVE REGULATION OF STEM CELL PROLIFERATION	54	1.80e-02	9.21e-02	0.23200	2.22e-01	6.73e-02	4.76e-03	3.92e-01
GOBP CEREBELLAR GRANULAR LAYER DEVELOPMENT	12	4.51e-01	6.76e-01	0.23200	-1.61e-01	-1.67e-01	3.33e-01	3.18e-01
GOBP QUATERNARY AMMONIUM GROUP TRANSPORT	17	2.77e-01	5.17e-01	0.23200	-2.24e-01	-5.91e-02	1.10e-01	6.73e-01
GOBP DOPAMINERGIC NEURON AXON GUIDANCE	6	5.41e-01	7.40e-01	0.23200	-1.74e-01	1.53e-01	4.60e-01	5.16e-01
GOBP AEROBIC RESPIRATION	169	8.55e-06	1.89e-04	0.23200	2.05e-01	1.08e-01	4.21e-06	1.53e-02
Gap junction degradation	12	4.22e-01	6.52e-01	0.23200	2.15e-01	8.63e-02	1.97e-01	6.05e-01
GOCC ORGANELLE INNER MEMBRANE	521	1.21e-15	1.27e-13	0.23200	1.90e-01	1.33e-01	1.19e-13	2.04e-07
BMAL1:CLOCK,NPAS2 activates circadian gene expression	24	1.89e-01	4.17e-01	0.23200	2.05e-01	1.08e-01	8.21e-02	3.60e-01
Signaling by ALK	27	1.53e-01	3.69e-01	0.23200	1.07e-01	2.05e-01	3.35e-01	6.47e-02
GOCC PHAGOPHORE ASSEMBLY SITE MEMBRANE	20	2.58e-01	4.97e-01	0.23200	1.93e-01	1.28e-01	1.34e-01	3.24e-01
ER to Golgi Anterograde Transport	152	1.87e-05	3.73e-04	0.23200	2.16e-01	8.41e-02	4.38e-06	7.35e-02
GOBP REGULATION OF VASCULOGENESIS	16	3.33e-01	5.72e-01	0.23200	1.15e-01	2.01e-01	4.27e-01	1.64e-01
GOBP PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX	19	2.84e-01	5.22e-01	0.23200	1.73e-01	1.54e-01	1.93e-01	2.44e-01
Detoxification of Reactive Oxygen Species	33	5.23e-02	1.93e-01	0.23200	-3.45e-02	2.29e-01	7.32e-01	2.28e-02
AURKA Activation by TPX2	68	1.12e-02	6.53e-02	0.23100	1.61e-01	1.66e-01	2.16e-02	1.78e-02
GOMF PYRUVATE DEHYDROGENASE ACETYL TRANSFERRING PHOSPHATASE ACTIVITY	5	6.79e-01	8.32e-01	0.23100	4.37e-02	2.27e-01	8.66e-01	3.79e-01
GOMF UDP XYLOSYLTRANSFERASE ACTIVITY	11	4.70e-01	6.92e-01	0.23100	1.15e-01	2.01e-01	5.08e-01	2.49e-01
GOBP CELL CYCLE DNA REPLICATION	43	3.31e-02	1.41e-01	0.23100	2.29e-01	3.09e-02	9.26e-03	7.26e-01
GOBP MITOCHONDRIAL FUSION	34	1.04e-01	2.96e-01	0.23100	1.84e-01	1.40e-01	6.35e-02	1.56e-01
GOBP BASE EXCISION REPAIR GAP FILLING	14	3.77e-01	6.13e-01	0.23100	2.07e-01	1.04e-01	1.80e-01	5.02e-01
GOBP MITOCHONDRIAL TRANSCRIPTION	22	2.22e-01	4.56e-01	0.23100	2.00e-01	1.17e-01	1.05e-01	3.44e-01
GOBP TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY	18	2.19e-01	4.52e-01	0.23100	-2.31e-01	2.80e-03	8.95e-02	9.84e-01
Constitutive Signaling by AKT1 E17K in Cancer	25	1.41e-01	3.54e-01	0.23100	2.28e-01	3.70e-02	4.83e-02	7.49e-01
MITF-M-regulated melanocyte development	155	3.28e-05	6.15e-04	0.23100	1.89e-01	1.33e-01	4.98e-05	4.14e-03
GOBP POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY	27	1.25e-01	3.30e-01	0.23100	-2.27e-01	-4.55e-02	4.15e-02	6.82e-01
GOBP INTRACELLULAR SODIUM ION HOMEOSTASIS	22	2.24e-01	4.58e-01	0.23100	-1.19e-01	-1.98e-01	3.33e-01	1.08e-01
GOBP DNA RECOMBINATION	327	1.50e-10	9.18e-09	0.23100	2.09e-01	9.82e-02	7.68e-11	2.26e-03
GOMF RNA NUCLEASE ACTIVITY	127	2.25e-04	3.05e-03	0.23100	1.83e-01	1.41e-01	3.73e-04	5.99e-03
GOBP OXIDATIVE PHOSPHORYLATION	125	1.95e-04	2.71e-03	0.23100	2.02e-01	1.11e-01	9.31e-05	3.15e-02
Post-chaperonin tubulin folding pathway	22	1.44e-01	3.57e-01	0.23100	-2.86e-02	2.29e-01	8.17e-01	6.29e-02
GOBP MYELOID LEUKOCYTE CYTOKINE PRODUCTION	49	1.43e-02	7.82e-02	0.23100	-1.96e-02	2.30e-01	8.13e-01	5.34e-03
GOBP PURINE RIBONUCLEOSIDE SALVAGE	6	6.58e-01	8.17e-01	0.23100	2.08e-01	1.01e-01	3.78e-01	6.69e-01
GOBP NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY	13	3.87e-01	6.21e-01	0.23100	7.30e-02	2.19e-01	6.48e-01	1.72e-01
GOMF GLUCURONOSYL N ACETYLGALACTOSAMINYL PROTEOGLYCAN 4 BETA N ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY	6	5.57e-01	7.51e-01	0.23100	-2.08e-01	9.97e-02	3.77e-01	6.72e-01
GOBP REGULATION OF GASTRIC ACID SECRETION	6	6.70e-01	8.26e-01	0.23100	-1.87e-01	-1.36e-01	4.28e-01	5.65e-01
GOBP NEGATIVE REGULATION OF PROTEIN UBIQUITINATION	69	1.07e-02	6.29e-02	0.23100	1.48e-01	1.77e-01	3.34e-02	1.11e-02
GOMF PROTEIN KINASE B BINDING	10	4.36e-01	6.64e-01	0.23100	2.31e-01	3.81e-03	2.07e-01	9.83e-01
GOBP SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING	5	6.09e-01	7.85e-01	0.23100	1.99e-01	-1.16e-01	4.40e-01	6.53e-01
GOBP CELLULAR RESPONSE TO ESTROGEN STIMULUS	19	2.87e-01	5.25e-01	0.23100	1.54e-01	1.71e-01	2.44e-01	1.96e-01
GOBP SKELETAL MUSCLE SATELLITE CELL MAINTENANCE INVOLVED IN SKELETAL MUSCLE REGENERATION	5	6.20e-01	7.91e-01	0.23100	2.15e-01	-8.24e-02	4.04e-01	7.50e-01
GOMF G PROTEIN COUPLED AMINE RECEPTOR ACTIVITY	39	4.47e-02	1.75e-01	0.23100	-2.29e-01	-2.44e-02	1.32e-02	7.92e-01
GOMF CATALYTIC ACTIVITY ACTING ON RNA	389	1.67e-12	1.36e-10	0.23100	2.13e-01	8.83e-02	5.45e-13	2.80e-03
GOBP NEGATIVE REGULATION OF EXOCYTOSIS	31	5.17e-02	1.92e-01	0.23000	-8.47e-02	2.14e-01	4.15e-01	3.89e-02
GOBP SYNAPTIC VESICLE MATURATION	21	2.27e-01	4.61e-01	0.23000	2.13e-01	8.88e-02	9.18e-02	4.81e-01
GOBP REGULATION OF NEURON DIFFERENTIATION	186	2.97e-06	7.61e-05	0.23000	1.04e-01	2.05e-01	1.44e-02	1.34e-06
GOBP RENAL WATER ABSORPTION	6	6.11e-01	7.86e-01	0.23000	7.57e-03	2.30e-01	9.74e-01	3.29e-01
Serine biosynthesis	9	5.40e-01	7.39e-01	0.23000	2.03e-01	1.09e-01	2.92e-01	5.71e-01
GOBP POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION	15	3.64e-01	6.01e-01	0.23000	1.19e-01	1.97e-01	4.24e-01	1.87e-01
GOBP MICROAUTOPHAGY	22	1.99e-01	4.29e-01	0.23000	2.20e-01	6.68e-02	7.37e-02	5.87e-01
GOBP PSEUDOURIDINE SYNTHESIS	17	1.81e-01	4.06e-01	0.23000	1.80e-01	-1.44e-01	2.00e-01	3.04e-01
GOMF GTPASE INHIBITOR ACTIVITY	12	4.12e-01	6.44e-01	0.23000	6.19e-02	2.22e-01	7.11e-01	1.84e-01
GOBP MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE	29	6.66e-02	2.25e-01	0.23000	-7.02e-02	2.19e-01	5.13e-01	4.11e-02
GOBP CELL KILLING	216	8.23e-09	3.66e-07	0.23000	-2.29e-01	2.47e-02	6.85e-09	5.32e-01
GOBP NUCLEUS LOCALIZATION	32	7.37e-02	2.40e-01	0.23000	2.30e-01	1.00e-02	2.45e-02	9.22e-01
GOBP CELL CYCLE PHASE TRANSITION	539	2.41e-16	2.74e-14	0.23000	2.03e-01	1.09e-01	8.14e-16	1.56e-05
Signaling by WNT	276	5.24e-09	2.48e-07	0.23000	2.10e-01	9.34e-02	1.85e-09	7.55e-03
GOBP DNA METABOLIC PROCESS	957	1.04e-27	2.62e-25	0.23000	1.99e-01	1.15e-01	1.53e-25	1.67e-09
GOBP LYSOSOMAL LUMEN ACIDIFICATION	21	2.39e-01	4.76e-01	0.23000	2.02e-01	1.09e-01	1.08e-01	3.86e-01
GOBP RESPONSE TO AUDITORY STIMULUS	33	1.04e-01	2.98e-01	0.23000	-1.05e-01	-2.04e-01	2.96e-01	4.21e-02
Activation of Ca-permeable Kainate Receptor	9	4.88e-01	7.02e-01	0.23000	-2.12e-02	-2.29e-01	9.12e-01	2.35e-01
Ionotropic activity of kainate receptors	9	4.88e-01	7.02e-01	0.23000	-2.12e-02	-2.29e-01	9.12e-01	2.35e-01
GOMF LIGAND GATED MONOATOMIC CATION CHANNEL ACTIVITY	134	1.08e-04	1.64e-03	0.23000	-2.04e-01	-1.05e-01	4.35e-05	3.61e-02
GOCC SPINDLE POLE	171	1.55e-05	3.15e-04	0.23000	1.60e-01	1.65e-01	3.19e-04	1.91e-04
GOMF 3 5 EXONUCLEASE ACTIVITY	59	1.44e-02	7.86e-02	0.23000	2.17e-01	7.51e-02	3.91e-03	3.19e-01
GOMF DIACYLGLYCEROL O ACYLTRANSFERASE ACTIVITY	5	6.23e-01	7.93e-01	0.23000	-2.15e-01	8.01e-02	4.04e-01	7.56e-01
GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS ANTIGEN	46	9.91e-03	5.94e-02	0.23000	-1.50e-01	1.74e-01	7.80e-02	4.14e-02
GOMF TRNA PSEUDOURIDINE SYNTHASE ACTIVITY	8	4.51e-01	6.76e-01	0.23000	1.88e-01	-1.31e-01	3.56e-01	5.20e-01
TNFR1-induced NF-kappa-B signaling pathway	30	8.97e-02	2.72e-01	0.23000	2.29e-01	1.60e-02	2.98e-02	8.80e-01
GOBP NEGATIVE REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY	5	6.68e-01	8.24e-01	0.23000	-1.34e-02	-2.29e-01	9.59e-01	3.75e-01
GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 SIGNALING PATHWAY	6	6.51e-01	8.12e-01	0.23000	2.16e-01	7.91e-02	3.60e-01	7.37e-01
GOBP NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM	10	3.66e-01	6.03e-01	0.23000	-1.67e-01	1.57e-01	3.60e-01	3.89e-01
GOBP POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS	19	2.73e-01	5.12e-01	0.23000	-1.04e-01	-2.04e-01	4.31e-01	1.23e-01
Carnitine shuttle	13	4.19e-01	6.50e-01	0.22900	1.95e-01	1.20e-01	2.23e-01	4.52e-01
COPI-mediated anterograde transport	100	6.46e-04	7.46e-03	0.22900	2.21e-01	5.98e-02	1.30e-04	3.02e-01
GOMF S ADENOSYLMETHIONINE DEPENDENT METHYLTRANSFERASE ACTIVITY	159	1.52e-05	3.10e-04	0.22900	2.12e-01	8.70e-02	3.87e-06	5.84e-02
GOCC FEMALE PRONUCLEUS	10	3.70e-01	6.06e-01	0.22900	1.35e-01	-1.85e-01	4.59e-01	3.10e-01
GOBP NATURAL KILLER CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL	11	4.77e-01	6.95e-01	0.22900	-1.98e-01	-1.15e-01	2.55e-01	5.09e-01
Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol	23	9.99e-02	2.90e-01	0.22900	1.66e-01	-1.58e-01	1.68e-01	1.89e-01
Co-stimulation by CD28	47	4.76e-02	1.82e-01	0.22900	1.58e-01	1.66e-01	6.10e-02	4.88e-02
GOBP ENDOCHONDRAL BONE MORPHOGENESIS	57	1.75e-02	9.03e-02	0.22900	2.15e-01	7.84e-02	4.92e-03	3.06e-01
GOBP REGULATION OF SYNAPTIC VESICLE CYCLE	12	4.25e-01	6.54e-01	0.22900	-7.70e-02	-2.16e-01	6.44e-01	1.96e-01
GOMF MICROFIBRIL BINDING	6	6.47e-01	8.09e-01	0.22900	-2.19e-01	-6.77e-02	3.53e-01	7.74e-01
GOBP REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC	73	8.49e-03	5.33e-02	0.22900	-1.83e-01	-1.38e-01	6.79e-03	4.22e-02
GOBP AMINE BIOSYNTHETIC PROCESS	37	2.53e-02	1.17e-01	0.22900	-1.81e-01	1.40e-01	5.66e-02	1.40e-01
GOBP SULFUR AMINO ACID CATABOLIC PROCESS	9	4.12e-01	6.44e-01	0.22900	1.92e-01	-1.24e-01	3.18e-01	5.18e-01
GOBP VACUOLE ORGANIZATION	224	4.42e-07	1.40e-05	0.22900	1.89e-01	1.30e-01	1.14e-06	8.12e-04
GOBP LIPID OXIDATION	111	4.38e-04	5.39e-03	0.22900	2.12e-01	8.71e-02	1.16e-04	1.13e-01
GOBP HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE	33	1.05e-01	3.00e-01	0.22900	1.02e-01	2.05e-01	3.09e-01	4.18e-02
GOBP N ACETYLGLUCOSAMINE METABOLIC PROCESS	16	2.61e-01	5.00e-01	0.22900	2.29e-01	-1.06e-02	1.13e-01	9.41e-01
GOBP PEPTIDYL LYSINE OXIDATION	5	7.04e-01	8.47e-01	0.22900	-8.38e-02	-2.13e-01	7.45e-01	4.10e-01
GOMF PROTEIN LYSINE 6 OXIDASE ACTIVITY	5	7.04e-01	8.47e-01	0.22900	-8.38e-02	-2.13e-01	7.45e-01	4.10e-01
GOMF MIRNA INHIBITOR ACTIVITY VIA BASE PAIRING	7	5.48e-01	7.44e-01	0.22900	2.27e-01	-2.49e-02	2.97e-01	9.09e-01
GOCC RNAI EFFECTOR COMPLEX	358	2.19e-11	1.54e-09	0.22900	-8.91e-02	-2.11e-01	3.78e-03	7.31e-12
GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION	16	3.53e-01	5.90e-01	0.22900	1.42e-01	1.79e-01	3.24e-01	2.15e-01
GOBP SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION	11	4.87e-01	7.01e-01	0.22900	-1.85e-01	-1.34e-01	2.88e-01	4.40e-01
GOCC NLRP1 INFLAMMASOME COMPLEX	6	5.80e-01	7.67e-01	0.22900	-2.21e-01	5.71e-02	3.48e-01	8.09e-01
GOMF PHOSPHATASE REGULATOR ACTIVITY	101	8.53e-04	9.28e-03	0.22900	2.13e-01	8.32e-02	2.16e-04	1.48e-01
GOBP NEGATIVE REGULATION OF AMINE METABOLIC PROCESS	6	6.74e-01	8.28e-01	0.22900	1.88e-01	1.30e-01	4.24e-01	5.82e-01
GOCC CENTRIOLAR SUBDISTAL APPENDAGE	9	5.39e-01	7.39e-01	0.22900	2.07e-01	9.60e-02	2.81e-01	6.18e-01
GOBP POSITIVE REGULATION OF HEPATIC STELLATE CELL ACTIVATION	5	6.42e-01	8.05e-01	0.22900	2.24e-01	-4.32e-02	3.85e-01	8.67e-01
GOBP PROSTAGLANDIN TRANSPORT	29	1.41e-01	3.54e-01	0.22800	-1.06e-01	-2.02e-01	3.22e-01	5.93e-02
GOBP REGULATION OF ANOIKIS	23	2.25e-01	4.59e-01	0.22800	1.78e-01	1.43e-01	1.40e-01	2.34e-01
GOBP NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS	36	3.48e-02	1.47e-01	0.22800	-7.91e-02	2.14e-01	4.11e-01	2.61e-02
GOBP POSITIVE REGULATION OF MIRNA TRANSCRIPTION	54	2.64e-02	1.21e-01	0.22800	1.07e-01	2.02e-01	1.75e-01	1.03e-02
GOCC RESPIRASOME	88	1.33e-03	1.29e-02	0.22800	2.24e-01	4.27e-02	2.75e-04	4.89e-01
GOBP TYPE II INTERFERON PRODUCTION	113	1.66e-05	3.34e-04	0.22800	-1.92e-01	1.23e-01	4.09e-04	2.40e-02
GOBP REGULATION OF INOSITOL 1 4 5 TRISPHOSPHATE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY	5	6.09e-01	7.85e-01	0.22800	1.71e-01	-1.51e-01	5.07e-01	5.59e-01
GOMF P53 BINDING	65	1.39e-02	7.65e-02	0.22800	1.92e-01	1.23e-01	7.31e-03	8.64e-02
O-linked glycosylation	110	8.36e-04	9.16e-03	0.22800	-1.77e-01	-1.44e-01	1.35e-03	8.93e-03
GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY	62	1.71e-02	8.89e-02	0.22800	1.25e-01	1.91e-01	8.78e-02	9.38e-03
GOBP NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS	110	7.34e-04	8.33e-03	0.22800	1.92e-01	1.24e-01	5.10e-04	2.49e-02
GOBP RESPONSE TO STEROL	35	1.06e-01	3.00e-01	0.22800	-1.62e-01	-1.61e-01	9.73e-02	9.97e-02
GOBP DEVELOPMENT OF SECONDARY FEMALE SEXUAL CHARACTERISTICS	7	5.30e-01	7.33e-01	0.22800	-5.93e-02	2.20e-01	7.86e-01	3.13e-01
GOMF PHOSPHOTYROSINE RESIDUE BINDING	46	2.43e-02	1.14e-01	0.22800	5.62e-03	2.28e-01	9.47e-01	7.43e-03
Sema4D mediated inhibition of cell attachment and migration	8	5.21e-01	7.26e-01	0.22800	2.28e-01	1.92e-03	2.64e-01	9.93e-01
TAK1-dependent IKK and NF-kappa-B activation	41	5.76e-02	2.05e-01	0.22800	2.12e-01	8.47e-02	1.89e-02	3.48e-01
GOBP VACUOLE FUSION	12	4.01e-01	6.34e-01	0.22800	3.75e-02	2.25e-01	8.22e-01	1.77e-01
GOCC MITOCHONDRIAL MATRIX	479	3.03e-14	2.84e-12	0.22800	1.96e-01	1.17e-01	2.00e-13	1.22e-05
GOBP MITOTIC CELL CYCLE	893	4.18e-25	8.27e-23	0.22800	1.88e-01	1.29e-01	1.48e-21	6.00e-11
Signaling by TGFB family members	157	4.08e-05	7.34e-04	0.22800	1.81e-01	1.38e-01	9.00e-05	2.75e-03
GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY	182	7.21e-06	1.64e-04	0.22800	1.26e-01	1.90e-01	3.36e-03	9.85e-06
GOCC PHAGOLYSOSOME	7	5.24e-01	7.28e-01	0.22800	-2.15e-01	7.49e-02	3.24e-01	7.31e-01
GOBP NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN	10	4.24e-01	6.54e-01	0.22800	-2.26e-01	2.71e-02	2.15e-01	8.82e-01
GOBP NEGATIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS	16	3.13e-01	5.53e-01	0.22800	-5.99e-02	-2.20e-01	6.78e-01	1.28e-01
GOBP EMBRYONIC HEART TUBE MORPHOGENESIS	70	9.63e-03	5.82e-02	0.22800	1.12e-01	1.98e-01	1.04e-01	4.16e-03
GOMF TRANSFERASE ACTIVITY TRANSFERRING ONE CARBON GROUPS	206	8.15e-07	2.47e-05	0.22800	2.09e-01	9.14e-02	2.46e-07	2.37e-02
GOCC GATOR1 COMPLEX	5	6.54e-01	8.13e-01	0.22800	2.27e-01	-2.26e-02	3.80e-01	9.30e-01
Voltage gated Potassium channels	42	3.12e-02	1.35e-01	0.22800	-2.28e-01	8.13e-03	1.07e-02	9.27e-01
GOBP MICROGLIAL CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE	5	6.18e-01	7.90e-01	0.22800	1.99e-01	-1.10e-01	4.41e-01	6.69e-01
GOBP GTP METABOLIC PROCESS	24	1.95e-01	4.24e-01	0.22800	9.51e-02	2.07e-01	4.20e-01	7.95e-02
IRAK4 deficiency (TLR2/4)	17	1.95e-01	4.24e-01	0.22800	-1.10e-01	1.99e-01	4.34e-01	1.55e-01
GOBP POSITIVE REGULATION OF VIRAL GENOME REPLICATION	30	6.76e-02	2.27e-01	0.22800	2.20e-01	-5.75e-02	3.69e-02	5.86e-01
GOBP DENDRITIC CELL APOPTOTIC PROCESS	11	3.37e-01	5.76e-01	0.22800	-1.66e-01	1.56e-01	3.41e-01	3.71e-01
Regulation of beta-cell development	41	3.47e-02	1.46e-01	0.22800	2.27e-01	-5.07e-03	1.17e-02	9.55e-01
GOBP NEGATIVE REGULATION OF CILIUM ASSEMBLY	20	2.44e-01	4.82e-01	0.22800	7.48e-02	2.15e-01	5.62e-01	9.62e-02
GOBP REGULATION OF BRANCHING INVOLVED IN LUNG MORPHOGENESIS	6	6.18e-01	7.90e-01	0.22800	-2.27e-01	-6.54e-03	3.35e-01	9.78e-01
GOCC DNA REPLICATION FACTOR C COMPLEX	5	6.93e-01	8.40e-01	0.22700	5.30e-02	2.21e-01	8.37e-01	3.92e-01
GOBP REGULATION OF ATPASE COUPLED CALCIUM TRANSMEMBRANE TRANSPORTER ACTIVITY	5	6.44e-01	8.07e-01	0.22700	-4.48e-02	2.23e-01	8.62e-01	3.88e-01
GOBP REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC	35	6.73e-02	2.26e-01	0.22700	-2.26e-01	-2.64e-02	2.08e-02	7.87e-01
GOBP MEIOTIC CHROMOSOME SEGREGATION	91	1.35e-04	1.98e-03	0.22700	1.76e-01	-1.43e-01	3.65e-03	1.80e-02
GOBP REGULATION OF PROTEIN STABILITY	308	7.63e-10	4.18e-08	0.22700	2.11e-01	8.56e-02	2.05e-10	9.75e-03
GOMF THIAMINE PYROPHOSPHATE BINDING	7	5.30e-01	7.33e-01	0.22700	6.58e-02	-2.18e-01	7.63e-01	3.19e-01
GOCC BLOC 1 COMPLEX	15	3.79e-01	6.13e-01	0.22700	1.86e-01	1.31e-01	2.12e-01	3.81e-01
GOBP SEX DETERMINATION	18	2.68e-01	5.07e-01	0.22700	5.30e-02	2.21e-01	6.97e-01	1.05e-01
GOBP NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION	17	2.16e-01	4.48e-01	0.22700	2.19e-01	-6.18e-02	1.19e-01	6.59e-01
Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion	8	5.91e-01	7.73e-01	0.22700	-1.95e-01	-1.16e-01	3.40e-01	5.69e-01
GOBP NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY	32	6.30e-02	2.17e-01	0.22700	-3.71e-02	2.24e-01	7.16e-01	2.84e-02
mTORC1-mediated signalling	23	1.87e-01	4.13e-01	0.22700	2.20e-01	5.35e-02	6.72e-02	6.57e-01
GOBP SARCOMERE ORGANIZATION	51	2.50e-02	1.17e-01	0.22700	-5.68e-02	-2.20e-01	4.83e-01	6.66e-03
GOBP ENDOTHELIAL CELL MORPHOGENESIS	9	4.17e-01	6.48e-01	0.22700	1.85e-01	-1.31e-01	3.36e-01	4.97e-01
GOBP COLLAGEN FIBRIL ORGANIZATION	65	1.73e-03	1.57e-02	0.22700	1.54e-01	-1.66e-01	3.17e-02	2.04e-02
GOMF EXONUCLEASE ACTIVITY	86	3.54e-03	2.72e-02	0.22700	1.97e-01	1.13e-01	1.61e-03	7.10e-02
Nuclear Pore Complex (NPC) Disassembly	36	8.87e-02	2.70e-01	0.22700	2.05e-01	9.69e-02	3.34e-02	3.14e-01
Regulation of expression of SLITs and ROBOs	149	7.59e-05	1.23e-03	0.22700	1.80e-01	1.38e-01	1.47e-04	3.74e-03
GOBP RENAL VESICLE FORMATION	8	6.02e-01	7.80e-01	0.22700	-1.67e-01	-1.53e-01	4.13e-01	4.53e-01
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY	309	2.69e-09	1.35e-07	0.22700	1.27e-01	1.88e-01	1.26e-04	1.34e-08
GOMF PROTEOGLYCAN BINDING	36	1.00e-01	2.91e-01	0.22700	-1.40e-01	-1.78e-01	1.47e-01	6.39e-02
GOBP POSITIVE REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE	6	5.78e-01	7.66e-01	0.22700	-7.34e-02	2.14e-01	7.56e-01	3.63e-01
RHO GTPases Activate NADPH Oxidases	21	1.32e-01	3.40e-01	0.22700	-1.88e-01	1.26e-01	1.35e-01	3.18e-01
GOBP VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL	35	1.09e-01	3.06e-01	0.22700	-1.65e-01	-1.56e-01	9.21e-02	1.11e-01
GOBP TOOTH MINERALIZATION	30	6.34e-02	2.18e-01	0.22600	8.00e-02	-2.12e-01	4.48e-01	4.46e-02
GOBP NEGATIVE REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE	20	2.79e-01	5.18e-01	0.22600	1.37e-01	1.80e-01	2.87e-01	1.63e-01
GOBP POSITIVE REGULATION OF DNA METABOLIC PROCESS	289	5.06e-09	2.42e-07	0.22600	2.03e-01	9.99e-02	2.76e-09	3.47e-03
GOMF P TYPE CALCIUM TRANSPORTER ACTIVITY	8	4.70e-01	6.92e-01	0.22600	2.02e-01	-1.02e-01	3.22e-01	6.18e-01
GOMF TYPE II TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING	11	4.61e-01	6.84e-01	0.22600	6.94e-02	2.15e-01	6.90e-01	2.16e-01
Pre-NOTCH Transcription and Translation	68	1.24e-02	6.99e-02	0.22600	1.90e-01	1.24e-01	6.84e-03	7.80e-02
SARS-CoV-1 modulates host translation machinery	33	1.03e-01	2.94e-01	0.22600	8.00e-02	2.12e-01	4.26e-01	3.53e-02
GOCC CILIARY ROOTLET	14	3.78e-01	6.13e-01	0.22600	7.70e-02	2.13e-01	6.18e-01	1.68e-01
GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR	22	2.40e-01	4.77e-01	0.22600	1.21e-01	1.91e-01	3.26e-01	1.20e-01
GOBP CELLULAR RESPONSE TO RADIATION	171	8.23e-06	1.84e-04	0.22600	2.11e-01	8.10e-02	1.86e-06	6.77e-02
FOXO-mediated transcription	65	1.65e-02	8.68e-02	0.22600	1.54e-01	1.66e-01	3.21e-02	2.06e-02
GOMF MHC PROTEIN BINDING	32	6.12e-02	2.13e-01	0.22600	-4.69e-02	2.21e-01	6.46e-01	3.02e-02
Protein localization	153	6.20e-05	1.04e-03	0.22600	1.78e-01	1.39e-01	1.39e-04	2.99e-03
GOBP RNA CAPPING	15	3.85e-01	6.19e-01	0.22600	1.78e-01	1.40e-01	2.33e-01	3.48e-01
TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway	16	2.11e-01	4.43e-01	0.22600	-1.43e-01	1.75e-01	3.21e-01	2.26e-01
p38MAPK events	13	3.74e-01	6.10e-01	0.22600	3.16e-02	2.24e-01	8.44e-01	1.62e-01
GOBP POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR	16	3.16e-01	5.55e-01	0.22600	5.58e-02	2.19e-01	6.99e-01	1.29e-01
GOBP POST TRANSLATIONAL PROTEIN TARGETING TO MEMBRANE TRANSLOCATION	8	5.80e-01	7.67e-01	0.22600	2.08e-01	8.80e-02	3.08e-01	6.66e-01
Macroautophagy	135	1.08e-04	1.64e-03	0.22600	2.08e-01	8.76e-02	2.88e-05	7.89e-02
GOMF CYCLOSPORIN A BINDING	17	3.31e-01	5.70e-01	0.22600	1.93e-01	1.17e-01	1.68e-01	4.02e-01
GOBP ERYTHROCYTE HOMEOSTASIS	139	1.39e-04	2.02e-03	0.22600	1.27e-01	1.87e-01	9.68e-03	1.42e-04
GOBP POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION	31	1.41e-01	3.53e-01	0.22600	1.74e-01	1.45e-01	9.42e-02	1.64e-01
GOBP CELL CELL ADHESION INVOLVED IN GASTRULATION	11	4.13e-01	6.45e-01	0.22600	-1.85e-03	2.26e-01	9.92e-01	1.94e-01
GOBP LEUKOCYTE MEDIATED CYTOTOXICITY	139	3.12e-06	7.98e-05	0.22600	-2.11e-01	8.12e-02	1.77e-05	9.86e-02
GOBP BRANCH ELONGATION OF AN EPITHELIUM	20	2.61e-01	5.00e-01	0.22600	9.38e-02	2.05e-01	4.68e-01	1.12e-01
GOBP REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION	90	3.50e-03	2.71e-02	0.22600	1.52e-01	1.67e-01	1.27e-02	6.14e-03
GOBP CELLULAR RESPIRATION	214	1.06e-06	3.06e-05	0.22600	1.93e-01	1.18e-01	1.16e-06	3.04e-03
GOBP REGULATION OF TELOMERASE ACTIVITY	43	6.66e-02	2.25e-01	0.22600	1.69e-01	1.49e-01	5.47e-02	9.01e-02
GOBP POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY	33	6.22e-02	2.15e-01	0.22600	-2.24e-01	2.77e-02	2.59e-02	7.83e-01
GOCC MITOCHONDRIAL ENVELOPE	763	4.15e-21	6.53e-19	0.22600	1.80e-01	1.36e-01	2.34e-17	1.64e-10
GOBP REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS	15	3.56e-01	5.93e-01	0.22600	-2.12e-01	-7.80e-02	1.56e-01	6.01e-01
GOBP DNA CATABOLIC PROCESS	29	1.49e-01	3.63e-01	0.22600	1.06e-01	1.99e-01	3.21e-01	6.36e-02
GOBP FATTY ACYL COA METABOLIC PROCESS	37	3.40e-02	1.44e-01	0.22600	-8.11e-02	2.11e-01	3.93e-01	2.67e-02
GOBP MALATE METABOLIC PROCESS	9	4.47e-01	6.74e-01	0.22600	2.16e-01	-6.50e-02	2.62e-01	7.36e-01
GOMF MICROFILAMENT MOTOR ACTIVITY	37	7.59e-02	2.44e-01	0.22600	-7.09e-02	-2.14e-01	4.56e-01	2.41e-02
GOBP INTERLEUKIN 4 PRODUCTION	32	4.51e-02	1.75e-01	0.22600	-1.48e-01	1.71e-01	1.48e-01	9.50e-02
GOBP MIDBRAIN DEVELOPMENT	85	4.45e-03	3.24e-02	0.22600	1.29e-01	1.85e-01	4.02e-02	3.15e-03
GOBP CELL VOLUME HOMEOSTASIS	34	4.22e-02	1.69e-01	0.22600	2.04e-01	-9.66e-02	3.97e-02	3.30e-01
GOMF DOUBLE STRANDED RNA BINDING	71	7.94e-03	5.06e-02	0.22500	2.10e-01	8.22e-02	2.22e-03	2.31e-01
GOBP ENDOCARDIAL CUSHION MORPHOGENESIS	44	5.96e-02	2.09e-01	0.22500	1.23e-01	1.89e-01	1.59e-01	3.01e-02
GOBP BINDING OF SPERM TO ZONA PELLUCIDA	38	9.09e-02	2.74e-01	0.22500	-1.40e-01	-1.77e-01	1.36e-01	5.92e-02
GOBP PLACENTA BLOOD VESSEL DEVELOPMENT	31	6.24e-02	2.16e-01	0.22500	-6.77e-02	2.15e-01	5.14e-01	3.83e-02
GOBP ODONTOBLAST DIFFERENTIATION	16	2.64e-01	5.03e-01	0.22500	-2.32e-02	2.24e-01	8.72e-01	1.21e-01
GOBP UREA TRANSPORT	11	3.46e-01	5.84e-01	0.22500	-1.43e-01	1.74e-01	4.12e-01	3.17e-01
GOBP POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION	27	1.84e-01	4.10e-01	0.22500	1.67e-01	1.51e-01	1.32e-01	1.75e-01
GOBP RRNA BASE METHYLATION	8	5.93e-01	7.74e-01	0.22500	1.98e-01	1.08e-01	3.33e-01	5.98e-01
GOBP NEGATIVE REGULATION OF STEROID METABOLIC PROCESS	32	4.68e-02	1.80e-01	0.22500	-1.84e-01	1.31e-01	7.24e-02	2.01e-01
GOBP REGULATION OF DNA METABOLIC PROCESS	494	3.22e-14	3.00e-12	0.22500	1.90e-01	1.21e-01	4.77e-13	4.06e-06
Regulation of KIT signaling	16	2.87e-01	5.26e-01	0.22500	1.10e-02	2.25e-01	9.39e-01	1.19e-01
GOBP CELLULAR RESPONSE TO NUTRIENT	46	3.82e-02	1.56e-01	0.22500	2.17e-01	5.83e-02	1.07e-02	4.94e-01
GOCC UNCONVENTIONAL MYOSIN COMPLEX	9	5.46e-01	7.44e-01	0.22500	8.84e-02	2.07e-01	6.46e-01	2.82e-01
GOBP THYMIC T CELL SELECTION	24	2.04e-01	4.34e-01	0.22500	-9.64e-02	-2.03e-01	4.14e-01	8.47e-02
GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION	46	1.19e-02	6.79e-02	0.22500	1.59e-01	-1.59e-01	6.21e-02	6.18e-02
GOBP REGULATION OF COMPLEMENT ACTIVATION CLASSICAL PATHWAY	9	5.46e-01	7.44e-01	0.22500	-2.07e-01	-8.79e-02	2.82e-01	6.48e-01
PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases	14	4.17e-01	6.47e-01	0.22500	1.67e-01	1.51e-01	2.80e-01	3.28e-01
GOBP CYTIDINE METABOLIC PROCESS	13	4.08e-01	6.41e-01	0.22500	7.36e-02	2.12e-01	6.46e-01	1.85e-01
GRB2 events in ERBB2 signaling	16	2.20e-01	4.53e-01	0.22500	1.90e-01	-1.20e-01	1.88e-01	4.06e-01
GOMF DNA TOPOISOMERASE ACTIVITY	7	6.17e-01	7.90e-01	0.22500	2.13e-01	7.27e-02	3.30e-01	7.39e-01
GOBP NUCLEOTIDE SUGAR METABOLIC PROCESS	38	6.77e-02	2.27e-01	0.22500	2.17e-01	5.74e-02	2.05e-02	5.41e-01
GOBP TYPE I PNEUMOCYTE DIFFERENTIATION	8	5.18e-01	7.24e-01	0.22500	2.24e-01	-1.94e-02	2.73e-01	9.24e-01
GOBP TRANSLATIONAL READTHROUGH	9	5.17e-01	7.23e-01	0.22500	2.21e-01	4.07e-02	2.51e-01	8.33e-01
GOCC RIBONUCLEOPROTEIN GRANULE	261	4.30e-08	1.68e-06	0.22500	2.01e-01	1.01e-01	2.28e-08	5.16e-03
GOBP REGULATION OF LAMELLIPODIUM ORGANIZATION	49	3.88e-02	1.58e-01	0.22500	2.04e-01	9.36e-02	1.34e-02	2.57e-01
GOBP NEGATIVE REGULATION OF RESPONSE TO TUMOR CELL	8	4.72e-01	6.93e-01	0.22500	-1.94e-01	1.13e-01	3.42e-01	5.80e-01
GOBP POSITIVE REGULATION OF COLLATERAL SPROUTING	9	4.63e-01	6.86e-01	0.22500	-4.27e-02	2.20e-01	8.24e-01	2.52e-01
GOMF NUCLEAR STEROID RECEPTOR ACTIVITY	25	2.09e-01	4.41e-01	0.22500	1.74e-01	1.42e-01	1.33e-01	2.18e-01
GOBP REGULATION OF DENDRITIC SPINE MAINTENANCE	12	3.22e-01	5.60e-01	0.22500	1.90e-01	-1.19e-01	2.54e-01	4.74e-01
GOMF C METHYLTRANSFERASE ACTIVITY	6	5.86e-01	7.71e-01	0.22400	6.82e-02	-2.14e-01	7.72e-01	3.64e-01
GOBP POSITIVE REGULATION OF MUSCLE HYPERTROPHY	37	8.57e-02	2.64e-01	0.22400	2.05e-01	9.22e-02	3.12e-02	3.32e-01
GOBP NEGATIVE REGULATION OF CELL CYCLE PROCESS	304	5.89e-09	2.70e-07	0.22400	1.83e-01	1.30e-01	4.21e-08	9.27e-05
GOBP EMBRYONIC DIGESTIVE TRACT DEVELOPMENT	33	9.32e-02	2.78e-01	0.22400	2.19e-01	4.84e-02	2.94e-02	6.31e-01
GOCC FILAMENTOUS ACTIN	32	8.55e-02	2.64e-01	0.22400	1.44e-02	2.24e-01	8.88e-01	2.84e-02
GOCC TRIGLYCERIDE RICH PLASMA LIPOPROTEIN PARTICLE	19	1.80e-01	4.05e-01	0.22400	2.10e-01	-7.94e-02	1.13e-01	5.49e-01
Transport of the SLBP Dependant Mature mRNA	36	1.02e-01	2.93e-01	0.22400	1.87e-01	1.24e-01	5.18e-02	1.99e-01
GOBP REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT	5	6.71e-01	8.26e-01	0.22400	2.24e-01	-4.28e-03	3.85e-01	9.87e-01
GOBP CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE	119	1.16e-05	2.46e-04	0.22400	-1.64e-01	1.53e-01	2.05e-03	3.83e-03
GOBP FUCOSE METABOLIC PROCESS	16	2.82e-01	5.20e-01	0.22400	-2.24e-01	1.04e-03	1.20e-01	9.94e-01
Activation of gene expression by SREBF (SREBP)	41	7.80e-02	2.49e-01	0.22400	1.72e-01	1.44e-01	5.69e-02	1.11e-01
GOBP DETECTION OF EXTERNAL BIOTIC STIMULUS	26	1.25e-01	3.30e-01	0.22400	-2.24e-01	7.61e-03	4.81e-02	9.46e-01
Defective Intrinsic Pathway for Apoptosis	25	1.80e-01	4.05e-01	0.22400	2.12e-01	7.22e-02	6.64e-02	5.32e-01
GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN	15	3.74e-01	6.10e-01	0.22400	-2.02e-01	-9.76e-02	1.76e-01	5.13e-01
GOCC PWP2P CONTAINING SUBCOMPLEX OF 90S PRERIBOSOME	5	6.70e-01	8.25e-01	0.22400	2.24e-01	-9.43e-03	3.86e-01	9.71e-01
Transcription of the HIV genome	66	1.61e-02	8.52e-02	0.22400	1.80e-01	1.32e-01	1.12e-02	6.27e-02
GOCC APICAL DENDRITE	16	3.64e-01	6.01e-01	0.22400	1.24e-01	1.86e-01	3.89e-01	1.98e-01
Role of LAT2/NTAL/LAB on calcium mobilization	16	3.66e-01	6.03e-01	0.22400	1.28e-01	1.83e-01	3.74e-01	2.04e-01
GOMF PHOSPHATIDYLINOSITOL 5 PHOSPHATE BINDING	20	1.79e-01	4.04e-01	0.22400	4.92e-02	-2.18e-01	7.03e-01	9.09e-02
GOBP EPINEPHRINE SECRETION	7	6.04e-01	7.82e-01	0.22400	-2.19e-01	-4.58e-02	3.15e-01	8.34e-01
GOBP PHOTOPERIODISM	27	1.78e-01	4.02e-01	0.22400	1.93e-01	1.13e-01	8.20e-02	3.11e-01
GOMF FATTY ACID ELONGASE ACTIVITY	7	5.83e-01	7.69e-01	0.22400	-2.23e-01	-1.05e-02	3.06e-01	9.62e-01
GOBP MITOTIC SPINDLE ELONGATION	11	4.98e-01	7.09e-01	0.22400	1.89e-01	1.19e-01	2.77e-01	4.94e-01
GOBP VIRAL RELEASE FROM HOST CELL	28	1.31e-01	3.40e-01	0.22400	4.06e-02	2.20e-01	7.10e-01	4.40e-02
GOMF CLATHRIN LIGHT CHAIN BINDING	7	5.43e-01	7.41e-01	0.22400	-5.93e-02	2.16e-01	7.86e-01	3.23e-01
M-decay: degradation of maternal mRNAs by maternally stored factors	45	4.97e-02	1.87e-01	0.22400	2.07e-01	8.45e-02	1.63e-02	3.26e-01
Synthesis of bile acids and bile salts via 27-hydroxycholesterol	14	2.91e-01	5.30e-01	0.22400	6.78e-02	-2.13e-01	6.61e-01	1.67e-01
GOBP NUCLEIC ACID CATABOLIC PROCESS	755	6.93e-22	1.15e-19	0.22400	2.07e-01	8.56e-02	4.05e-22	6.28e-05
GOCC CMG COMPLEX	11	5.07e-01	7.16e-01	0.22400	1.56e-01	1.60e-01	3.70e-01	3.58e-01
GOBP REGULATION OF RESPIRATORY BURST INVOLVED IN INFLAMMATORY RESPONSE	7	5.74e-01	7.63e-01	0.22400	-2.23e-01	5.25e-03	3.06e-01	9.81e-01
GOBP RESPONSE TO ESTRADIOL	116	7.52e-04	8.47e-03	0.22400	1.36e-01	1.78e-01	1.16e-02	9.50e-04
GOBP ACTIN FILAMENT NETWORK FORMATION	8	4.74e-01	6.94e-01	0.22300	1.92e-01	-1.14e-01	3.47e-01	5.75e-01
GOBP CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT	7	5.78e-01	7.66e-01	0.22300	1.94e-03	2.23e-01	9.93e-01	3.06e-01
GOBP PROTEIN POLYUBIQUITINATION	264	7.71e-08	2.88e-06	0.22300	1.84e-01	1.27e-01	2.72e-07	3.79e-04
GOBP NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION	6	6.30e-01	7.98e-01	0.22300	9.55e-03	2.23e-01	9.68e-01	3.44e-01
GOMF COLLAGEN RECEPTOR ACTIVITY	6	6.48e-01	8.09e-01	0.22300	-4.09e-02	-2.20e-01	8.62e-01	3.52e-01
GOBP POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION	25	9.28e-02	2.77e-01	0.22300	-1.61e-01	1.55e-01	1.64e-01	1.80e-01
Fc epsilon receptor (FCERI) signaling	115	8.09e-04	8.98e-03	0.22300	1.77e-01	1.36e-01	1.01e-03	1.20e-02
GOBP NUCLEOPHAGY	21	1.56e-01	3.73e-01	0.22300	2.12e-01	-7.06e-02	9.28e-02	5.75e-01
GOBP HORMONE BIOSYNTHETIC PROCESS	65	8.19e-03	5.18e-02	0.22300	-2.21e-01	-2.86e-02	2.01e-03	6.90e-01
GOBP DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN	28	1.66e-01	3.88e-01	0.22300	-1.09e-01	-1.95e-01	3.20e-01	7.39e-02
GOBP GLIAL CELL PROLIFERATION	55	2.17e-02	1.06e-01	0.22300	2.15e-01	5.86e-02	5.73e-03	4.53e-01
GOBP POSITIVE REGULATION OF CHEMOKINE PRODUCTION	70	1.39e-03	1.33e-02	0.22300	-1.80e-01	1.32e-01	9.36e-03	5.54e-02
GOMF BETA 1 3 GALACTOSYLTRANSFERASE ACTIVITY	14	2.69e-01	5.08e-01	0.22300	-1.83e-01	1.28e-01	2.36e-01	4.08e-01
Somitogenesis	45	4.78e-02	1.82e-01	0.22300	2.10e-01	7.42e-02	1.46e-02	3.89e-01
GOBP AUTOPHAGOSOME MATURATION	64	1.92e-02	9.69e-02	0.22300	1.75e-01	1.39e-01	1.56e-02	5.53e-02
GOBP NEGATIVE REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY	16	3.27e-01	5.67e-01	0.22300	-2.15e-01	-5.77e-02	1.36e-01	6.90e-01
GOBP REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY	39	9.14e-02	2.74e-01	0.22300	-1.59e-01	-1.57e-01	8.65e-02	9.03e-02
Negative regulation of FGFR1 signaling	32	1.09e-01	3.06e-01	0.22300	2.14e-01	6.18e-02	3.60e-02	5.45e-01
GOBP POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION	29	1.23e-01	3.27e-01	0.22300	2.19e-01	3.97e-02	4.09e-02	7.11e-01
GOBP FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA	13	4.47e-01	6.73e-01	0.22300	1.78e-01	1.34e-01	2.67e-01	4.02e-01
GOBP REGULATION OF CELLULAR RESPONSE TO HEAT	16	3.35e-01	5.74e-01	0.22300	2.12e-01	6.81e-02	1.42e-01	6.37e-01
GOMF MONOATOMIC ANION MONOATOMIC CATION SYMPORTER ACTIVITY	24	2.11e-01	4.43e-01	0.22300	-2.01e-01	-9.69e-02	8.89e-02	4.11e-01
GOCC MIDBODY	199	3.59e-06	9.07e-05	0.22300	1.93e-01	1.12e-01	2.73e-06	6.59e-03
GOBP FOREBRAIN MORPHOGENESIS	13	4.37e-01	6.65e-01	0.22300	1.11e-01	1.93e-01	4.90e-01	2.27e-01
VLDL clearance	6	6.88e-01	8.37e-01	0.22300	1.26e-01	1.84e-01	5.93e-01	4.36e-01
Activation of BAD and translocation to mitochondria	15	3.86e-01	6.20e-01	0.22300	1.92e-01	1.12e-01	1.97e-01	4.51e-01
GOBP PROTEIN TARGETING TO MITOCHONDRION	101	2.09e-03	1.82e-02	0.22300	1.67e-01	1.47e-01	3.71e-03	1.06e-02
GOBP POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS	124	4.67e-04	5.70e-03	0.22300	1.82e-01	1.28e-01	4.64e-04	1.37e-02
GOBP CONVERGENT EXTENSION	15	2.80e-01	5.19e-01	0.22300	-4.92e-02	2.17e-01	7.41e-01	1.46e-01
A tetrasaccharide linker sequence is required for GAG synthesis	24	2.26e-01	4.60e-01	0.22200	-1.80e-01	-1.31e-01	1.27e-01	2.68e-01
GOMF MYOSIN HEAVY CHAIN BINDING	13	4.52e-01	6.77e-01	0.22200	-1.55e-01	-1.60e-01	3.33e-01	3.19e-01
GOCC PROTEIN FOLDING CHAPERONE COMPLEX	40	8.55e-02	2.64e-01	0.22200	1.75e-01	1.38e-01	5.60e-02	1.32e-01
GOMF N ACETYLGLUCOSAMINE 6 O SULFOTRANSFERASE ACTIVITY	6	6.09e-01	7.85e-01	0.22200	3.41e-02	-2.20e-01	8.85e-01	3.51e-01
GOBP RESPONSE TO VITAMIN E	9	5.54e-01	7.49e-01	0.22200	8.80e-02	2.04e-01	6.48e-01	2.89e-01
GOCC COMPACT MYELIN	14	3.32e-01	5.71e-01	0.22200	-6.73e-03	2.22e-01	9.65e-01	1.50e-01
GOBP PROTEIN LOCALIZATION TO ORGANELLE	930	6.87e-26	1.48e-23	0.22200	2.01e-01	9.47e-02	2.22e-25	9.79e-07
GOBP POSITIVE REGULATION OF CELL SIZE	10	5.43e-01	7.41e-01	0.22200	-1.65e-01	-1.49e-01	3.66e-01	4.15e-01
GOCC SPERM MIDPIECE	54	3.73e-02	1.54e-01	0.22200	-1.56e-01	-1.58e-01	4.70e-02	4.46e-02
GOBP REGULATION OF NK T CELL ACTIVATION	11	4.38e-01	6.66e-01	0.22200	1.76e-02	2.22e-01	9.20e-01	2.03e-01
RUNX2 regulates bone development	29	1.34e-01	3.43e-01	0.22200	2.15e-01	5.70e-02	4.52e-02	5.95e-01
GOBP NEGATIVE REGULATION OF MIRNA METABOLIC PROCESS	28	1.48e-01	3.61e-01	0.22200	6.47e-02	2.13e-01	5.54e-01	5.15e-02
GOBP REVERSE CHOLESTEROL TRANSPORT	20	2.01e-01	4.31e-01	0.22200	1.75e-02	-2.22e-01	8.92e-01	8.63e-02
GOCC NEUROTRANSMITTER RECEPTOR COMPLEX	42	6.79e-02	2.27e-01	0.22200	-1.98e-01	-1.01e-01	2.64e-02	2.59e-01
Defective CHST3 causes SEDCJD	7	5.73e-01	7.63e-01	0.22200	2.22e-01	-1.37e-02	3.10e-01	9.50e-01
Rev-mediated nuclear export of HIV RNA	35	9.12e-02	2.74e-01	0.22200	2.13e-01	6.27e-02	2.92e-02	5.21e-01
GOBP REGULATION OF SYNAPSE PRUNING	6	6.17e-01	7.90e-01	0.22200	-2.21e-01	2.09e-02	3.49e-01	9.29e-01
GOBP POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY	8	5.19e-01	7.25e-01	0.22200	2.20e-01	-3.08e-02	2.82e-01	8.80e-01
GOBP ANIMAL ORGAN MATURATION	30	1.52e-01	3.68e-01	0.22200	-1.91e-01	-1.13e-01	7.03e-02	2.84e-01
GOMF PROTEIN LYSINE DEACETYLASE ACTIVITY	21	2.47e-01	4.85e-01	0.22200	2.08e-01	7.64e-02	9.84e-02	5.45e-01
GOBP T CELL TOLERANCE INDUCTION	14	2.72e-01	5.11e-01	0.22200	-1.79e-01	1.32e-01	2.47e-01	3.94e-01
GOBP NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION	22	2.57e-01	4.95e-01	0.22200	1.27e-01	1.82e-01	3.03e-01	1.39e-01
Scavenging of heme from plasma	12	4.57e-01	6.82e-01	0.22200	-8.72e-02	-2.04e-01	6.01e-01	2.21e-01
Regulation of MITF-M-dependent genes involved in apoptosis	19	2.95e-01	5.34e-01	0.22200	2.00e-01	9.62e-02	1.32e-01	4.68e-01
Aflatoxin activation and detoxification	18	2.43e-01	4.81e-01	0.22200	9.46e-03	-2.22e-01	9.45e-01	1.04e-01
GOBP POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS	32	1.25e-01	3.29e-01	0.22200	2.03e-01	8.85e-02	4.66e-02	3.86e-01
GOBP BEHAVIORAL RESPONSE TO PAIN	19	3.10e-01	5.51e-01	0.22200	-1.80e-01	-1.29e-01	1.74e-01	3.30e-01
GOBP PROTEIN RETENTION IN GOLGI APPARATUS	5	6.37e-01	8.02e-01	0.22200	2.00e-01	-9.55e-02	4.39e-01	7.11e-01
GOBP NUCLEUS ORGANIZATION	145	8.73e-05	1.39e-03	0.22200	2.02e-01	9.11e-02	2.65e-05	5.83e-02
GOBP MYELOID DENDRITIC CELL ACTIVATION	29	9.16e-02	2.75e-01	0.22200	-2.19e-01	3.59e-02	4.14e-02	7.38e-01
GOBP ENDOSOME TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY	40	8.86e-02	2.70e-01	0.22200	1.57e-01	1.56e-01	8.50e-02	8.76e-02
GOBP ORNITHINE TRANSPORT	6	6.22e-01	7.93e-01	0.22200	2.21e-01	-1.34e-02	3.48e-01	9.55e-01
GOBP NEGATIVE REGULATION OF CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION	5	6.26e-01	7.95e-01	0.22200	1.60e-01	-1.53e-01	5.35e-01	5.53e-01
GOBP CELLULAR RESPONSE TO TESTOSTERONE STIMULUS	8	6.04e-01	7.82e-01	0.22200	1.08e-01	1.93e-01	5.96e-01	3.44e-01
GOBP PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS	46	2.38e-02	1.13e-01	0.22100	-2.20e-01	2.91e-02	9.99e-03	7.33e-01
GOBP NEUROBLAST PROLIFERATION	82	7.02e-03	4.58e-02	0.22100	1.65e-01	1.47e-01	9.64e-03	2.11e-02
GOBP NEGATIVE REGULATION OF TRANSLATIONAL ELONGATION	5	7.27e-01	8.60e-01	0.22100	9.97e-02	1.98e-01	6.99e-01	4.44e-01
GOBP PATTERN SPECIFICATION PROCESS	453	2.07e-12	1.63e-10	0.22100	1.58e-01	1.55e-01	8.65e-09	1.42e-08
GOMF LAMININ 1 BINDING	7	5.80e-01	7.67e-01	0.22100	5.08e-03	-2.21e-01	9.81e-01	3.11e-01
TBC/RABGAPs	41	7.99e-02	2.52e-01	0.22100	1.24e-01	1.83e-01	1.70e-01	4.21e-02
GOBP NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION	9	5.56e-01	7.51e-01	0.22100	2.04e-01	8.64e-02	2.90e-01	6.54e-01
GOBP MITOTIC SPINDLE ASSEMBLY	70	1.45e-02	7.87e-02	0.22100	1.67e-01	1.46e-01	1.59e-02	3.50e-02
GOBP INTRACELLULAR TRIGLYCERIDE HOMEOSTASIS	9	4.42e-01	6.69e-01	0.22100	-1.95e-01	1.05e-01	3.11e-01	5.87e-01
Cargo concentration in the ER	32	1.42e-01	3.56e-01	0.22100	1.74e-01	1.37e-01	8.82e-02	1.81e-01
Organelle biogenesis and maintenance	277	2.06e-08	8.49e-07	0.22100	2.02e-01	9.07e-02	7.30e-09	9.36e-03
GOBP POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE	11	4.37e-01	6.64e-01	0.22100	-2.21e-01	-1.13e-02	2.04e-01	9.48e-01
GOBP ACTIVIN RECEPTOR SIGNALING PATHWAY	46	4.42e-02	1.73e-01	0.22100	6.32e-02	2.12e-01	4.59e-01	1.28e-02
Negative regulation of FGFR2 signaling	33	1.07e-01	3.02e-01	0.22100	2.12e-01	6.33e-02	3.50e-02	5.29e-01
GOBP HEPARIN METABOLIC PROCESS	17	2.05e-01	4.36e-01	0.22100	1.69e-01	-1.43e-01	2.29e-01	3.07e-01
GOMF SERINE HYDROLASE ACTIVITY	188	7.25e-06	1.64e-04	0.22100	-1.02e-01	-1.96e-01	1.61e-02	3.39e-06
GOBP NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS	18	1.89e-01	4.16e-01	0.22100	-1.76e-01	1.34e-01	1.96e-01	3.25e-01
GOBP BONE MATURATION	26	2.03e-01	4.34e-01	0.22100	-1.80e-01	-1.28e-01	1.11e-01	2.58e-01
GOCC RNA N6 METHYLADENOSINE METHYLTRANSFERASE COMPLEX	9	5.16e-01	7.22e-01	0.22100	2.20e-01	2.22e-02	2.53e-01	9.08e-01
GOBP SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT	22	2.54e-01	4.91e-01	0.22100	1.90e-01	1.13e-01	1.23e-01	3.58e-01
Multifunctional anion exchangers	9	5.75e-01	7.65e-01	0.22100	-1.25e-01	-1.82e-01	5.16e-01	3.44e-01
GOBP TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY	17	2.29e-01	4.64e-01	0.22100	-2.09e-01	7.07e-02	1.35e-01	6.14e-01
GOBP HYDROGEN PEROXIDE CATABOLIC PROCESS	30	9.55e-02	2.82e-01	0.22100	-2.21e-01	1.08e-02	3.64e-02	9.18e-01
GOBP POSITIVE REGULATION OF TROPHOBLAST CELL MIGRATION	7	6.38e-01	8.02e-01	0.22100	2.01e-01	9.22e-02	3.58e-01	6.73e-01
GOBP POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY	10	4.16e-01	6.47e-01	0.22100	-7.90e-02	2.06e-01	6.66e-01	2.58e-01
GOBP PHOSPHOLIPID EFFLUX	14	3.48e-01	5.85e-01	0.22100	-7.83e-03	-2.21e-01	9.60e-01	1.53e-01
GOBP NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT	23	1.87e-01	4.13e-01	0.22100	-2.43e-02	-2.19e-01	8.40e-01	6.84e-02
GOBP REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY	21	2.70e-01	5.10e-01	0.22100	1.91e-01	1.11e-01	1.30e-01	3.78e-01
GOBP GLOSSOPHARYNGEAL NERVE DEVELOPMENT	5	6.37e-01	8.02e-01	0.22100	-1.04e-01	1.95e-01	6.86e-01	4.51e-01
GOBP REGULATION OF ANIMAL ORGAN FORMATION	27	1.94e-01	4.23e-01	0.22100	1.34e-01	1.75e-01	2.29e-01	1.15e-01
Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding	38	8.21e-02	2.57e-01	0.22100	2.07e-01	7.65e-02	2.72e-02	4.15e-01
GOBP POSITIVE REGULATION OF HIPPO SIGNALING	11	3.74e-01	6.10e-01	0.22100	1.98e-01	-9.66e-02	2.55e-01	5.79e-01
GOBP POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION INVOLVED IN WOUND HEALING	10	4.48e-01	6.74e-01	0.22100	2.65e-02	-2.19e-01	8.85e-01	2.30e-01
GOBP REGULATION OF CELL CYCLE PROCESS	718	8.26e-20	1.18e-17	0.22100	1.96e-01	1.01e-01	3.46e-19	3.73e-06
GOBP REGULATION OF ESTABLISHMENT OF PLANAR POLARITY	14	2.97e-01	5.36e-01	0.22100	-7.41e-02	2.08e-01	6.31e-01	1.78e-01
GOBP POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY	23	1.57e-01	3.74e-01	0.22100	-2.19e-01	2.78e-02	6.92e-02	8.18e-01
GOCC SPINDLE MICROTUBULE	77	9.08e-03	5.58e-02	0.22100	1.24e-01	1.83e-01	6.05e-02	5.60e-03
GOBP CENTRIOLE ASSEMBLY	46	6.26e-02	2.16e-01	0.22100	1.70e-01	1.41e-01	4.65e-02	9.82e-02
MAP kinase activation	58	2.72e-02	1.23e-01	0.22100	1.91e-01	1.10e-01	1.18e-02	1.47e-01
GOCC FASCIA ADHERENS	9	4.64e-01	6.86e-01	0.22100	2.11e-01	-6.31e-02	2.72e-01	7.43e-01
GOBP B CELL HOMEOSTASIS	31	1.52e-01	3.67e-01	0.22100	1.29e-01	1.79e-01	2.13e-01	8.50e-02
GOBP CELLULAR RESPONSE TO ACIDIC PH	14	3.64e-01	6.01e-01	0.22100	-2.83e-02	-2.19e-01	8.54e-01	1.57e-01
Beta oxidation of hexanoyl-CoA to butanoyl-CoA	5	6.86e-01	8.36e-01	0.22000	2.20e-01	6.31e-03	3.93e-01	9.81e-01
GOCC DNA REPLICATION PREINITIATION COMPLEX	13	4.58e-01	6.83e-01	0.22000	1.50e-01	1.62e-01	3.50e-01	3.13e-01
GOBP KETONE BODY BIOSYNTHETIC PROCESS	6	6.79e-01	8.32e-01	0.22000	-2.03e-01	-8.61e-02	3.89e-01	7.15e-01
GOBP REGULATION OF DNA BINDING	72	1.29e-02	7.23e-02	0.22000	1.75e-01	1.34e-01	1.01e-02	5.01e-02
GOBP REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS	44	4.29e-02	1.70e-01	0.22000	-2.18e-01	-3.16e-02	1.23e-02	7.17e-01
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE	64	2.14e-02	1.05e-01	0.22000	1.68e-01	1.42e-01	1.98e-02	4.93e-02
GOMF PEPTIDOGLYCAN MURALYTIC ACTIVITY	13	4.46e-01	6.73e-01	0.22000	-1.10e-01	-1.91e-01	4.90e-01	2.34e-01
GOBP DEOXYRIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS	5	6.94e-01	8.41e-01	0.22000	-2.19e-01	-2.17e-02	3.96e-01	9.33e-01
GOMF TRANSFORMING GROWTH FACTOR BETA BINDING	23	2.52e-01	4.90e-01	0.22000	1.62e-01	1.49e-01	1.79e-01	2.15e-01
GOBP POSITIVE REGULATION OF SPINDLE ASSEMBLY	7	6.52e-01	8.12e-01	0.22000	1.23e-01	1.83e-01	5.74e-01	4.02e-01
GOBP REGULATION OF MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE	6	6.40e-01	8.04e-01	0.22000	1.31e-02	2.20e-01	9.56e-01	3.51e-01
GOBP TELOMERE LOCALIZATION	12	3.30e-01	5.69e-01	0.22000	1.59e-01	-1.52e-01	3.40e-01	3.62e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN REDUCED FLAVIN OR FLAVOPROTEIN AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN	42	7.97e-02	2.52e-01	0.22000	-1.36e-01	-1.73e-01	1.27e-01	5.22e-02
GOMF BETA 2 ADRENERGIC RECEPTOR BINDING	6	5.87e-01	7.71e-01	0.22000	-9.50e-02	1.99e-01	6.87e-01	4.00e-01
GOBP EPITHELIAL FLUID TRANSPORT	12	3.30e-01	5.70e-01	0.22000	1.55e-01	-1.56e-01	3.51e-01	3.50e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS OXYGEN AS ACCEPTOR	11	5.06e-01	7.15e-01	0.22000	1.90e-01	1.11e-01	2.76e-01	5.23e-01
GOBP ALDITOL METABOLIC PROCESS	22	2.44e-01	4.82e-01	0.22000	-8.70e-02	-2.02e-01	4.80e-01	1.01e-01
GOBP REGULATION OF AMYLOID BETA CLEARANCE	19	1.88e-01	4.14e-01	0.22000	8.97e-02	-2.01e-01	4.99e-01	1.30e-01
GOBP COCHLEA MORPHOGENESIS	23	1.43e-01	3.56e-01	0.22000	-6.07e-02	2.11e-01	6.14e-01	7.92e-02
GOBP MITOCHONDRIAL RNA PROCESSING	21	2.46e-01	4.84e-01	0.22000	2.10e-01	6.54e-02	9.57e-02	6.04e-01
GOBP PARAXIAL MESODERM FORMATION	7	5.29e-01	7.32e-01	0.22000	-1.22e-01	1.83e-01	5.77e-01	4.01e-01
GOBP DNA DEMETHYLATION	22	2.65e-01	5.04e-01	0.22000	1.77e-01	1.31e-01	1.52e-01	2.87e-01
GOBP CELLULAR RESPONSE TO STEROID HORMONE STIMULUS	202	5.91e-06	1.39e-04	0.22000	1.71e-01	1.38e-01	2.66e-05	7.37e-04
Regulation of NF-kappa B signaling	17	3.43e-01	5.81e-01	0.22000	1.97e-01	9.87e-02	1.61e-01	4.81e-01
GOBP CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES	16	2.94e-01	5.33e-01	0.22000	2.20e-01	-3.66e-03	1.28e-01	9.80e-01
Lysosome Vesicle Biogenesis	33	1.12e-01	3.10e-01	0.22000	6.75e-02	2.09e-01	5.02e-01	3.75e-02
GOBP TRANSLATIONAL INITIATION	109	1.42e-03	1.35e-02	0.22000	1.77e-01	1.30e-01	1.39e-03	1.89e-02
Centrosome maturation	77	9.86e-03	5.92e-02	0.22000	1.35e-01	1.73e-01	3.99e-02	8.60e-03
Recruitment of mitotic centrosome proteins and complexes	77	9.86e-03	5.92e-02	0.22000	1.35e-01	1.73e-01	3.99e-02	8.60e-03
GOBP ELASTIN METABOLIC PROCESS	8	4.80e-01	6.97e-01	0.22000	1.39e-01	-1.70e-01	4.96e-01	4.04e-01
GOCC SPINDLE	411	2.88e-11	1.97e-09	0.22000	1.73e-01	1.36e-01	1.93e-09	2.18e-06
GOBP DNA BIOSYNTHETIC PROCESS	187	9.97e-06	2.15e-04	0.22000	1.92e-01	1.07e-01	5.97e-06	1.16e-02
GOCC STEREOCILIUM MEMBRANE	6	6.40e-01	8.04e-01	0.22000	-2.19e-01	-9.99e-03	3.52e-01	9.66e-01
GOBP ERROR FREE TRANSLESION SYNTHESIS	5	6.65e-01	8.22e-01	0.22000	2.16e-01	-4.02e-02	4.03e-01	8.76e-01
GOMF VOLTAGE GATED SODIUM CHANNEL ACTIVITY INVOLVED IN CARDIAC MUSCLE CELL ACTION POTENTIAL	5	7.38e-01	8.66e-01	0.22000	-1.83e-01	-1.21e-01	4.78e-01	6.39e-01
GOBP POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION	42	2.14e-02	1.04e-01	0.22000	-1.70e-01	1.39e-01	5.60e-02	1.20e-01
GOBP POSITIVE REGULATION OF T HELPER 1 CELL DIFFERENTIATION	6	6.88e-01	8.38e-01	0.22000	-1.04e-01	-1.94e-01	6.59e-01	4.12e-01
GOBP POSITIVE REGULATION OF ASPARTIC TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS	5	7.30e-01	8.62e-01	0.22000	9.65e-02	1.97e-01	7.09e-01	4.45e-01
GOBP NITRIC OXIDE CGMP MEDIATED SIGNALING	9	4.37e-01	6.65e-01	0.22000	1.57e-01	-1.53e-01	4.13e-01	4.27e-01
GOBP POSITIVE REGULATION OF MACROPHAGE MIGRATION	26	1.17e-01	3.17e-01	0.22000	4.77e-02	-2.14e-01	6.74e-01	5.86e-02
GOBP VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION	29	1.69e-01	3.91e-01	0.21900	-1.13e-01	-1.88e-01	2.92e-01	7.95e-02
GOCC CHROMOSOME TELOMERIC REPEAT REGION	14	4.09e-01	6.41e-01	0.21900	2.01e-01	8.77e-02	1.92e-01	5.70e-01
Myoclonic epilepsy of Lafora	9	5.11e-01	7.19e-01	0.21900	2.19e-01	7.45e-03	2.55e-01	9.69e-01
GOMF GLUTAMATE BINDING	8	6.17e-01	7.90e-01	0.21900	1.80e-01	1.26e-01	3.79e-01	5.38e-01
GOMF MOLECULAR ADAPTOR ACTIVITY	1097	2.79e-29	7.45e-27	0.21900	1.97e-01	9.62e-02	2.44e-28	7.39e-08
NGF-independant TRKA activation	5	6.98e-01	8.43e-01	0.21900	-2.18e-01	-2.59e-02	3.99e-01	9.20e-01
GOMF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ADAPTOR ACTIVITY	17	3.48e-01	5.86e-01	0.21900	1.05e-01	1.93e-01	4.55e-01	1.69e-01
GOBP DNA TEMPLATED DNA REPLICATION MAINTENANCE OF FIDELITY	57	2.99e-02	1.31e-01	0.21900	1.91e-01	1.08e-01	1.26e-02	1.59e-01
GOBP POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS	17	3.64e-01	6.01e-01	0.21900	1.49e-01	1.61e-01	2.89e-01	2.50e-01
Heme signaling	45	5.78e-02	2.05e-01	0.21900	2.00e-01	9.01e-02	2.03e-02	2.96e-01
MyD88 cascade initiated on plasma membrane	91	3.77e-03	2.86e-02	0.21900	1.90e-01	1.10e-01	1.75e-03	7.01e-02
Toll Like Receptor 10 (TLR10) Cascade	91	3.77e-03	2.86e-02	0.21900	1.90e-01	1.10e-01	1.75e-03	7.01e-02
Toll Like Receptor 5 (TLR5) Cascade	91	3.77e-03	2.86e-02	0.21900	1.90e-01	1.10e-01	1.75e-03	7.01e-02
GOBP ERYTHROSE 4 PHOSPHATE PHOSPHOENOLPYRUVATE FAMILY AMINO ACID METABOLIC PROCESS	18	3.01e-01	5.41e-01	0.21900	-2.10e-01	-6.30e-02	1.23e-01	6.44e-01
GOBP REGULATION OF ERYTHROCYTE DIFFERENTIATION	44	6.50e-02	2.22e-01	0.21900	1.02e-01	1.94e-01	2.41e-01	2.60e-02
GOBP NITRIC OXIDE TRANSPORT	5	7.00e-01	8.44e-01	0.21900	2.17e-01	2.76e-02	4.00e-01	9.15e-01
GOCC SPINDLE MIDZONE	36	1.18e-01	3.20e-01	0.21900	1.50e-01	1.60e-01	1.19e-01	9.71e-02
GOBP IMPORT INTO THE MITOCHONDRION	49	5.51e-02	1.99e-01	0.21900	1.58e-01	1.52e-01	5.61e-02	6.56e-02
GOBP SMOOTH MUSCLE TISSUE DEVELOPMENT	27	1.82e-01	4.07e-01	0.21900	1.99e-01	9.09e-02	7.31e-02	4.13e-01
GOBP NEGATIVE REGULATION OF CGAS STING SIGNALING PATHWAY	12	4.13e-01	6.45e-01	0.21900	2.19e-01	1.10e-02	1.89e-01	9.48e-01
GOBP POSITIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY	19	2.88e-01	5.27e-01	0.21900	2.07e-01	7.06e-02	1.18e-01	5.94e-01
GOMF HISTONE H3K9 MONOMETHYLTRANSFERASE ACTIVITY	6	6.06e-01	7.83e-01	0.21900	2.11e-01	-5.80e-02	3.70e-01	8.06e-01
GOBP RESPONSE TO POTASSIUM ION	18	3.35e-01	5.74e-01	0.21900	-1.17e-01	-1.85e-01	3.90e-01	1.74e-01
GOBP EPITHELIAL CELL MATURATION	27	2.02e-01	4.33e-01	0.21900	1.54e-01	1.55e-01	1.65e-01	1.62e-01
GOBP TRABECULA MORPHOGENESIS	47	6.22e-02	2.15e-01	0.21900	1.50e-01	1.59e-01	7.49e-02	5.89e-02
GOBP REGULATION OF MUSCLE HYPERTROPHY	71	6.66e-03	4.42e-02	0.21900	2.17e-01	3.08e-02	1.59e-03	6.54e-01
GOBP PROTEIN LOCALIZATION TO GOLGI APPARATUS	30	1.24e-01	3.29e-01	0.21900	2.15e-01	3.94e-02	4.13e-02	7.09e-01
GOBP NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS	36	6.80e-02	2.27e-01	0.21900	2.19e-01	3.20e-03	2.31e-02	9.73e-01
GOBP INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS	75	8.07e-03	5.12e-02	0.21900	-2.04e-01	-7.84e-02	2.22e-03	2.40e-01
SARS-CoV-2 targets host intracellular signalling and regulatory pathways	12	4.60e-01	6.83e-01	0.21900	2.05e-01	7.55e-02	2.18e-01	6.51e-01
GOBP NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION	75	2.18e-03	1.89e-02	0.21900	-2.14e-01	4.69e-02	1.37e-03	4.83e-01
GOBP METANEPHRIC DISTAL TUBULE DEVELOPMENT	7	5.35e-01	7.37e-01	0.21900	-1.89e-01	1.11e-01	3.88e-01	6.11e-01
GOMF NITRIC OXIDE SYNTHASE BINDING	10	4.02e-01	6.34e-01	0.21900	1.47e-01	-1.62e-01	4.21e-01	3.75e-01
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE	436	2.24e-12	1.75e-10	0.21900	1.98e-01	9.36e-02	1.46e-12	7.99e-04
GOMF LIGAND GATED CHANNEL ACTIVITY	180	2.19e-05	4.29e-04	0.21900	-1.80e-01	-1.25e-01	3.25e-05	3.88e-03
GOBP PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL	99	2.49e-03	2.10e-02	0.21900	1.87e-01	1.14e-01	1.34e-03	4.98e-02
GOBP PROTEIN LOCALIZATION TO MITOCHONDRION	123	7.15e-04	8.13e-03	0.21900	1.65e-01	1.43e-01	1.57e-03	6.03e-03
GOMF 3 5 DNA EXONUCLEASE ACTIVITY	14	3.74e-01	6.10e-01	0.21900	2.16e-01	3.27e-02	1.61e-01	8.32e-01
GOBP SINGLE STRAND BREAK REPAIR	11	3.89e-01	6.22e-01	0.21900	2.04e-01	-7.89e-02	2.42e-01	6.51e-01
GOBP NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY	232	1.00e-06	2.93e-05	0.21900	1.23e-01	1.81e-01	1.24e-03	2.12e-06
GOBP POSITIVE REGULATION OF NON MOTILE CILIUM ASSEMBLY	7	6.45e-01	8.08e-01	0.21900	9.41e-02	1.97e-01	6.66e-01	3.66e-01
GOBP VIRION ASSEMBLY	34	1.29e-01	3.37e-01	0.21900	1.21e-01	1.82e-01	2.22e-01	6.63e-02
GOBP REGULATION OF MICROTUBULE POLYMERIZATION	59	3.06e-02	1.33e-01	0.21900	1.68e-01	1.40e-01	2.57e-02	6.33e-02
GOBP MICROGLIA DIFFERENTIATION	12	3.83e-01	6.17e-01	0.21900	-3.42e-02	2.16e-01	8.37e-01	1.96e-01
GOMF PROTEIN FOLDING CHAPERONE BINDING	129	4.99e-04	6.02e-03	0.21800	1.68e-01	1.39e-01	9.63e-04	6.27e-03
GOBP MULTIVESICULAR BODY SORTING PATHWAY	47	6.21e-02	2.15e-01	0.21800	1.68e-01	1.40e-01	4.63e-02	9.74e-02
cGMP effects	16	3.57e-01	5.93e-01	0.21800	-7.60e-02	-2.05e-01	5.99e-01	1.56e-01
GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION	24	1.73e-01	3.95e-01	0.21800	2.18e-01	1.19e-02	6.44e-02	9.20e-01
GOBP NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY	20	2.47e-01	4.85e-01	0.21800	3.37e-02	2.16e-01	7.94e-01	9.48e-02
Transport of Mature mRNA Derived from an Intronless Transcript	42	7.38e-02	2.40e-01	0.21800	1.96e-01	9.68e-02	2.82e-02	2.78e-01
Nucleotide salvage	20	1.86e-01	4.12e-01	0.21800	-6.61e-02	2.08e-01	6.09e-01	1.07e-01
GOBP G QUADRUPLEX DNA UNWINDING	7	6.46e-01	8.08e-01	0.21800	1.98e-01	9.28e-02	3.65e-01	6.71e-01
GOBP N ACYLPHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS	9	4.70e-01	6.92e-01	0.21800	-6.48e-02	2.08e-01	7.36e-01	2.79e-01
GOBP CELLULAR RESPONSE TO PARATHYROID HORMONE STIMULUS	8	5.03e-01	7.13e-01	0.21800	2.02e-01	-8.20e-02	3.22e-01	6.88e-01
GOMF CARDIOLIPIN BINDING	11	5.19e-01	7.24e-01	0.21800	-1.79e-01	-1.24e-01	3.04e-01	4.75e-01
GOBP PROTEIN TRANSPORT TO VACUOLE INVOLVED IN UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY	15	3.42e-01	5.80e-01	0.21800	2.17e-01	2.17e-02	1.46e-01	8.84e-01
Diseases associated with N-glycosylation of proteins	19	3.28e-01	5.67e-01	0.21800	1.45e-01	1.63e-01	2.75e-01	2.19e-01
GOBP COBALAMIN TRANSPORT	8	5.54e-01	7.48e-01	0.21800	4.52e-03	2.18e-01	9.82e-01	2.86e-01
GOBP OLIGOSACCHARIDE BIOSYNTHETIC PROCESS	29	1.14e-01	3.13e-01	0.21800	-2.18e-01	3.25e-03	4.24e-02	9.76e-01
GOBP PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS	25	1.49e-01	3.63e-01	0.21800	-1.21e-02	2.17e-01	9.16e-01	5.99e-02
GOMF FRUCTOSE BINDING	6	5.90e-01	7.73e-01	0.21800	1.06e-01	-1.90e-01	6.53e-01	4.20e-01
GOBP VESTIBULOCOCHLEAR NERVE DEVELOPMENT	11	3.77e-01	6.12e-01	0.21800	1.15e-01	-1.85e-01	5.08e-01	2.89e-01
GOMF NUCLEOSIDE TRIPHOSPHATE DIPHOSPHATASE ACTIVITY	9	5.72e-01	7.62e-01	0.21800	9.30e-02	1.97e-01	6.29e-01	3.07e-01
GOBP PROTEIN ACYLATION	87	3.17e-03	2.50e-02	0.21800	2.10e-01	5.72e-02	7.07e-04	3.57e-01
Loss of MECP2 binding ability to the NCoR/SMRT complex	5	7.04e-01	8.47e-01	0.21800	2.16e-01	2.87e-02	4.03e-01	9.11e-01
GOBP REGULATION OF PHENOTYPIC SWITCHING	6	6.50e-01	8.11e-01	0.21800	2.17e-01	1.76e-02	3.57e-01	9.41e-01
GOBP POSITIVE THYMIC T CELL SELECTION	15	2.63e-01	5.02e-01	0.21800	1.20e-01	-1.81e-01	4.20e-01	2.24e-01
Miscellaneous transport and binding events	24	1.26e-01	3.31e-01	0.21800	-1.98e-01	8.93e-02	9.24e-02	4.49e-01
GOBP POSITIVE REGULATION OF SYNAPTIC PLASTICITY	10	5.13e-01	7.21e-01	0.21800	2.11e-01	5.40e-02	2.49e-01	7.67e-01
GOBP LYTIC VACUOLE ORGANIZATION	105	2.18e-03	1.89e-02	0.21800	1.42e-01	1.65e-01	1.22e-02	3.45e-03
GOBP POSTSYNAPTIC SIGNAL TRANSDUCTION	48	1.77e-02	9.08e-02	0.21700	-2.05e-01	7.21e-02	1.39e-02	3.87e-01
GOBP CELL FATE COMMITMENT	284	7.27e-08	2.72e-06	0.21700	1.41e-01	1.66e-01	4.54e-05	1.52e-06
GOBP REGULATION OF SNARE COMPLEX ASSEMBLY	14	3.42e-01	5.80e-01	0.21700	2.17e-01	-1.70e-02	1.60e-01	9.12e-01
Abortive elongation of HIV-1 transcript in the absence of Tat	23	2.15e-01	4.47e-01	0.21700	2.11e-01	5.11e-02	7.95e-02	6.71e-01
Integrin cell surface interactions	83	4.21e-03	3.12e-02	0.21700	-5.72e-02	-2.10e-01	3.68e-01	9.61e-04
GOBP PROTEIN LOCALIZATION TO MICROTUBULE	17	3.44e-01	5.81e-01	0.21700	2.00e-01	8.45e-02	1.53e-01	5.46e-01
GOMF CHLORIDE CHANNEL REGULATOR ACTIVITY	14	4.38e-01	6.65e-01	0.21700	1.75e-01	1.29e-01	2.57e-01	4.04e-01
Signaling by Hedgehog	135	1.00e-04	1.55e-03	0.21700	2.14e-01	3.88e-02	1.79e-05	4.36e-01
GOBP PEROXISOME FISSION	9	5.60e-01	7.53e-01	0.21700	7.11e-02	2.05e-01	7.12e-01	2.86e-01
GOBP NEGATIVE REGULATION OF LIPID STORAGE	22	2.42e-01	4.80e-01	0.21700	-2.06e-01	-6.94e-02	9.47e-02	5.73e-01
GOBP NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY	38	3.78e-02	1.55e-01	0.21700	-9.23e-02	1.97e-01	3.25e-01	3.60e-02
GOMF DYNEIN HEAVY CHAIN BINDING	16	2.42e-01	4.80e-01	0.21700	1.81e-01	-1.20e-01	2.10e-01	4.05e-01
ERKs are inactivated	13	4.51e-01	6.77e-01	0.21700	1.93e-01	9.94e-02	2.28e-01	5.35e-01
GOBP COPPER ION IMPORT	6	6.70e-01	8.25e-01	0.21700	-2.11e-01	-5.09e-02	3.71e-01	8.29e-01
GOBP POSITIVE REGULATION OF CYTOKINESIS	47	5.04e-02	1.89e-01	0.21700	2.03e-01	7.58e-02	1.58e-02	3.69e-01
GOBP RIG I SIGNALING PATHWAY	27	1.77e-01	4.00e-01	0.21700	2.05e-01	7.10e-02	6.50e-02	5.23e-01
GOCC PI BODY	10	4.26e-01	6.55e-01	0.21700	-8.35e-02	2.00e-01	6.47e-01	2.73e-01
GOMF ADRENERGIC RECEPTOR BINDING	18	3.17e-01	5.56e-01	0.21700	7.41e-02	2.04e-01	5.86e-01	1.34e-01
GOBP NEGATIVE REGULATION OF DNA METABOLIC PROCESS	134	4.21e-04	5.21e-03	0.21700	1.65e-01	1.41e-01	9.85e-04	4.80e-03
Regulation of CDH11 function	10	4.76e-01	6.95e-01	0.21700	1.62e-03	-2.17e-01	9.93e-01	2.35e-01
GOBP PROTEIN LOCALIZATION TO VACUOLE	85	6.39e-03	4.28e-02	0.21700	1.83e-01	1.16e-01	3.48e-03	6.45e-02
GOBP PEPTIDYL LYSINE DIMETHYLATION	5	7.48e-01	8.71e-01	0.21700	1.57e-01	1.50e-01	5.43e-01	5.62e-01
Diseases of hemostasis	17	2.26e-01	4.60e-01	0.21700	1.08e-01	-1.88e-01	4.42e-01	1.79e-01
GOBP POSITIVE REGULATION OF ACTIN NUCLEATION	14	2.96e-01	5.35e-01	0.21700	1.02e-01	-1.91e-01	5.09e-01	2.15e-01
Signaling by ERBB4	57	1.77e-02	9.08e-02	0.21700	2.16e-01	1.95e-02	4.82e-03	7.99e-01
GOBP DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION	12	4.57e-01	6.82e-01	0.21700	2.08e-01	6.10e-02	2.12e-01	7.14e-01
GOBP POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS	14	4.15e-01	6.45e-01	0.21700	2.01e-01	8.04e-02	1.92e-01	6.02e-01
GOBP REGULATION OF CELL CYCLE	1072	2.11e-27	5.19e-25	0.21700	1.87e-01	1.09e-01	3.35e-25	1.66e-09
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H	75	9.12e-03	5.60e-02	0.21700	2.01e-01	8.11e-02	2.62e-03	2.24e-01
GOCC PRERIBOSOME LARGE SUBUNIT PRECURSOR	18	3.32e-01	5.71e-01	0.21700	1.95e-01	9.52e-02	1.53e-01	4.84e-01
GOBP POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST	14	3.20e-01	5.59e-01	0.21700	2.10e-01	-5.35e-02	1.74e-01	7.29e-01
GOBP CLATHRIN COAT ASSEMBLY	19	2.80e-01	5.19e-01	0.21700	2.12e-01	4.64e-02	1.10e-01	7.26e-01
Signal amplification	33	1.42e-01	3.55e-01	0.21700	1.81e-01	1.18e-01	7.14e-02	2.39e-01
GOBP CELL FATE COMMITMENT INVOLVED IN PATTERN SPECIFICATION	11	4.99e-01	7.10e-01	0.21700	2.02e-01	7.73e-02	2.45e-01	6.57e-01
GOBP CELLULAR RESPONSE TO OXYGEN LEVELS	161	4.33e-05	7.70e-04	0.21700	2.01e-01	8.04e-02	1.06e-05	7.83e-02
GOBP PROTEIN METHYLATION	50	4.88e-02	1.85e-01	0.21700	1.91e-01	1.03e-01	1.96e-02	2.10e-01
Coenzyme A biosynthesis	7	6.22e-01	7.93e-01	0.21700	2.13e-01	4.06e-02	3.30e-01	8.52e-01
SARS-CoV-1-host interactions	91	5.21e-03	3.65e-02	0.21600	1.61e-01	1.44e-01	7.78e-03	1.74e-02
GOMF ATPASE COUPLED ION TRANSMEMBRANE TRANSPORTER ACTIVITY	24	2.46e-01	4.84e-01	0.21600	1.73e-01	1.30e-01	1.43e-01	2.69e-01
RHOQ GTPase cycle	57	1.10e-02	6.43e-02	0.21600	2.13e-01	-3.99e-02	5.47e-03	6.02e-01
GOMF PYRIMIDINE NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY	10	5.09e-01	7.17e-01	0.21600	2.12e-01	4.22e-02	2.45e-01	8.17e-01
GOMF MANGANESE ION BINDING	64	1.89e-02	9.56e-02	0.21600	8.56e-02	1.99e-01	2.36e-01	5.96e-03
GOBP BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS	36	1.14e-01	3.13e-01	0.21600	1.91e-01	1.02e-01	4.75e-02	2.90e-01
GOCC MKS COMPLEX	13	4.55e-01	6.80e-01	0.21600	1.91e-01	1.01e-01	2.32e-01	5.29e-01
GOMF NITRIC OXIDE SYNTHASE REGULATOR ACTIVITY	7	6.60e-01	8.18e-01	0.21600	1.84e-01	1.14e-01	3.99e-01	6.03e-01
GOBP MITOTIC NUCLEAR DIVISION	274	1.05e-07	3.75e-06	0.21600	1.83e-01	1.15e-01	1.75e-07	1.07e-03
Clathrin-mediated endocytosis	139	1.36e-04	1.98e-03	0.21600	2.06e-01	6.51e-02	2.69e-05	1.85e-01
GOBP REGULATION OF SKELETAL MUSCLE TISSUE GROWTH	6	5.89e-01	7.73e-01	0.21600	-1.23e-01	1.78e-01	6.03e-01	4.50e-01
NOTCH4 Intracellular Domain Regulates Transcription	19	2.11e-01	4.43e-01	0.21600	2.08e-01	-6.05e-02	1.17e-01	6.48e-01
GOBP POSITIVE REGULATION OF VIRAL PROCESS	62	1.75e-02	9.06e-02	0.21600	2.08e-01	5.74e-02	4.54e-03	4.34e-01
GOBP POSITIVE REGULATION BY HOST OF VIRAL PROCESS	20	2.53e-01	4.91e-01	0.21600	3.26e-02	2.14e-01	8.01e-01	9.81e-02
GOBP MONOACYLGLYCEROL BIOSYNTHETIC PROCESS	7	6.67e-01	8.24e-01	0.21600	-1.63e-01	-1.41e-01	4.54e-01	5.17e-01
GOBP POSITIVE REGULATION OF LAMELLIPODIUM MORPHOGENESIS	7	6.52e-01	8.12e-01	0.21600	9.30e-02	1.95e-01	6.70e-01	3.71e-01
Activated NTRK3 signals through PI3K	6	6.91e-01	8.39e-01	0.21600	8.86e-02	1.97e-01	7.07e-01	4.03e-01
GOMF CYTOCHROME B5 REDUCTASE ACTIVITY ACTING ON NAD P H	6	7.08e-01	8.49e-01	0.21600	1.55e-01	1.50e-01	5.11e-01	5.23e-01
GOBP MORPHOGENESIS OF AN ENDOTHELIUM	17	2.21e-01	4.55e-01	0.21600	1.65e-01	-1.40e-01	2.40e-01	3.18e-01
GOMF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY	27	2.10e-01	4.42e-01	0.21600	1.39e-01	1.65e-01	2.10e-01	1.38e-01
GOMF BETA TUBULIN BINDING	37	1.13e-01	3.12e-01	0.21600	1.18e-01	1.81e-01	2.16e-01	5.65e-02
GOBP NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION	93	4.43e-03	3.24e-02	0.21600	1.25e-01	1.76e-01	3.71e-02	3.33e-03
GOMF ERBB 3 CLASS RECEPTOR BINDING	5	7.48e-01	8.71e-01	0.21600	1.33e-01	1.70e-01	6.06e-01	5.10e-01
Signaling by NTRK1 (TRKA)	113	1.51e-03	1.41e-02	0.21600	1.40e-01	1.64e-01	1.02e-02	2.54e-03
GOCC PHAGOCYTIC VESICLE MEMBRANE	73	6.76e-03	4.47e-02	0.21600	3.19e-02	2.13e-01	6.37e-01	1.61e-03
GOBP REGULATION OF KETONE BIOSYNTHETIC PROCESS	21	2.34e-01	4.69e-01	0.21600	-2.14e-01	-2.73e-02	8.94e-02	8.29e-01
Intra-Golgi and retrograde Golgi-to-ER traffic	198	6.08e-06	1.43e-04	0.21600	1.96e-01	9.13e-02	2.09e-06	2.68e-02
Formation of the dystrophin-glycoprotein complex (DGC)	34	7.96e-02	2.52e-01	0.21600	9.37e-03	-2.16e-01	9.25e-01	2.96e-02
GOMF ANTIGEN BINDING	66	6.78e-03	4.48e-02	0.21600	-2.15e-01	1.87e-02	2.53e-03	7.92e-01
GOBP SYNAPTIC VESICLE CLUSTERING	15	3.87e-01	6.20e-01	0.21600	-7.15e-02	-2.04e-01	6.32e-01	1.72e-01
GOBP QUINOLINATE METABOLIC PROCESS	5	7.29e-01	8.61e-01	0.21600	-7.13e-02	-2.04e-01	7.82e-01	4.31e-01
GOBP VITAMIN TRANSMEMBRANE TRANSPORT	19	2.95e-01	5.34e-01	0.21600	-6.29e-02	-2.06e-01	6.35e-01	1.20e-01
Proteasome assembly	51	3.09e-02	1.35e-01	0.21600	2.13e-01	3.35e-02	8.49e-03	6.79e-01
GOCC F ACTIN CAPPING PROTEIN COMPLEX	8	4.93e-01	7.06e-01	0.21600	1.38e-01	-1.66e-01	4.99e-01	4.17e-01
GOCC ZYMOGEN GRANULE	19	1.94e-01	4.23e-01	0.21600	-1.89e-01	1.04e-01	1.55e-01	4.31e-01
GOBP SYMPATHETIC GANGLION DEVELOPMENT	9	4.51e-01	6.76e-01	0.21600	1.60e-01	-1.44e-01	4.06e-01	4.53e-01
GOBP ERBB4 SIGNALING PATHWAY	10	4.18e-01	6.48e-01	0.21600	1.19e-01	-1.80e-01	5.15e-01	3.25e-01
GOBP REGULATION OF AMPA RECEPTOR ACTIVITY	18	3.42e-01	5.80e-01	0.21600	-1.88e-01	-1.05e-01	1.67e-01	4.39e-01
GOBP POSITIVE REGULATION OF STRESS GRANULE ASSEMBLY	7	5.70e-01	7.60e-01	0.21500	2.09e-01	-5.21e-02	3.38e-01	8.11e-01
GOBP NEGATIVE REGULATION OF GLIAL CELL APOPTOTIC PROCESS	9	4.67e-01	6.89e-01	0.21500	-1.96e-01	8.88e-02	3.08e-01	6.45e-01
GOMF SNORNA BINDING	31	1.49e-01	3.63e-01	0.21500	1.98e-01	8.56e-02	5.69e-02	4.09e-01
GOMF CHEMOREPELLENT ACTIVITY	28	1.99e-01	4.29e-01	0.21500	-1.32e-01	-1.70e-01	2.28e-01	1.18e-01
RIP-mediated NFkB activation via ZBP1	16	3.95e-01	6.29e-01	0.21500	1.26e-01	1.74e-01	3.81e-01	2.28e-01
GOBP NEGATIVE REGULATION OF GRANULOCYTE DIFFERENTIATION	8	5.31e-01	7.34e-01	0.21500	-4.37e-02	2.11e-01	8.31e-01	3.02e-01
GOMF CUPROUS ION BINDING	8	5.60e-01	7.53e-01	0.21500	2.10e-03	2.15e-01	9.92e-01	2.92e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS DISULFIDE AS ACCEPTOR	9	5.15e-01	7.22e-01	0.21500	-6.22e-03	2.15e-01	9.74e-01	2.64e-01
GOBP MULTICELLULAR ORGANISM GROWTH	146	1.48e-04	2.13e-03	0.21500	1.95e-01	9.22e-02	4.95e-05	5.45e-02
GOCC CANONICAL INFLAMMASOME COMPLEX	17	3.22e-01	5.60e-01	0.21500	-2.11e-01	-4.32e-02	1.32e-01	7.58e-01
GOBP POSITIVE REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT	8	5.26e-01	7.30e-01	0.21500	2.08e-01	-5.35e-02	3.07e-01	7.93e-01
GOBP PARALLEL ACTIN FILAMENT BUNDLE ASSEMBLY	7	5.88e-01	7.72e-01	0.21500	-2.14e-01	2.21e-02	3.27e-01	9.19e-01
Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane	18	2.81e-01	5.20e-01	0.21500	1.49e-02	2.14e-01	9.13e-01	1.15e-01
GOBP POSITIVE REGULATION OF PLATELET AGGREGATION	12	3.50e-01	5.88e-01	0.21500	-1.27e-01	1.73e-01	4.45e-01	2.99e-01
Peroxisomal protein import	62	2.93e-02	1.30e-01	0.21500	1.52e-01	1.52e-01	3.85e-02	3.84e-02
GOBP NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION	15	3.47e-01	5.85e-01	0.21500	1.42e-02	2.14e-01	9.24e-01	1.50e-01
GOBP PEPTIDYL TYROSINE DEPHOSPHORYLATION	30	8.71e-02	2.67e-01	0.21500	-2.05e-01	6.42e-02	5.19e-02	5.43e-01
GOBP PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING	14	3.08e-01	5.48e-01	0.21500	8.85e-02	-1.96e-01	5.67e-01	2.05e-01
GOMF L GLUTAMINE TRANSMEMBRANE TRANSPORTER ACTIVITY	8	5.21e-01	7.26e-01	0.21500	2.04e-01	-6.57e-02	3.17e-01	7.48e-01
GOMF PHOSPHATIDYLCHOLINE FLOPPASE ACTIVITY	8	5.78e-01	7.66e-01	0.21500	-2.13e-01	-2.82e-02	2.97e-01	8.90e-01
GOBP POSITIVE REGULATION OF MITOTIC CELL CYCLE	127	3.84e-04	4.80e-03	0.21500	2.01e-01	7.55e-02	9.12e-05	1.42e-01
GOCC SPERM PRINCIPAL PIECE	33	1.29e-01	3.36e-01	0.21500	-7.57e-02	-2.01e-01	4.52e-01	4.57e-02
GOBP DESMOSOME ORGANIZATION	10	4.98e-01	7.09e-01	0.21500	-2.14e-01	-1.91e-02	2.42e-01	9.17e-01
GOBP NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION	9	5.91e-01	7.73e-01	0.21500	-1.82e-01	-1.13e-01	3.43e-01	5.56e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH2 GROUP OF DONORS	17	2.50e-01	4.88e-01	0.21500	2.04e-01	-6.72e-02	1.46e-01	6.32e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON METAL IONS NAD OR NADP AS ACCEPTOR	6	6.51e-01	8.12e-01	0.21500	-2.15e-01	-6.40e-03	3.63e-01	9.78e-01
GOBP CHONDROCYTE DEVELOPMENT	32	1.39e-01	3.51e-01	0.21500	7.94e-02	1.99e-01	4.37e-01	5.09e-02
GOBP REGULATION OF PROTEIN CATABOLIC PROCESS	338	5.15e-09	2.45e-07	0.21500	1.68e-01	1.33e-01	1.08e-07	2.48e-05
Endosomal Sorting Complex Required For Transport (ESCRT)	31	1.71e-01	3.92e-01	0.21500	1.64e-01	1.38e-01	1.13e-01	1.84e-01
GOMF SOLUTE POTASSIUM ANTIPORTER ACTIVITY	17	2.62e-01	5.01e-01	0.21500	4.64e-02	-2.09e-01	7.41e-01	1.35e-01
GOBP POSITIVE REGULATION OF CELL FATE COMMITMENT	17	3.81e-01	6.15e-01	0.21500	1.50e-01	1.54e-01	2.85e-01	2.73e-01
GOBP MITOCHONDRIAL RNA METABOLIC PROCESS	55	3.29e-02	1.41e-01	0.21500	2.01e-01	7.47e-02	9.89e-03	3.38e-01
GOBP DNA TEMPLATED DNA REPLICATION	160	9.25e-05	1.45e-03	0.21500	1.82e-01	1.13e-01	6.93e-05	1.35e-02
GOBP ENDOSOME TO LYSOSOME TRANSPORT	70	1.89e-02	9.53e-02	0.21500	1.58e-01	1.45e-01	2.22e-02	3.59e-02
GOBP POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION	63	2.80e-02	1.26e-01	0.21500	1.46e-01	1.57e-01	4.51e-02	3.09e-02
GOBP RIBOSOMAL LARGE SUBUNIT ASSEMBLY	21	2.07e-01	4.38e-01	0.21400	2.14e-01	-1.95e-02	9.02e-02	8.77e-01
GOBP REGULATION OF MEGAKARYOCYTE DIFFERENTIATION	35	1.29e-01	3.37e-01	0.21400	1.11e-01	1.84e-01	2.56e-01	6.03e-02
GOBP POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY	67	3.04e-03	2.42e-02	0.21400	-1.23e-01	1.76e-01	8.28e-02	1.28e-02
GOBP FACIAL NERVE STRUCTURAL ORGANIZATION	8	6.27e-01	7.96e-01	0.21400	-1.82e-01	-1.14e-01	3.74e-01	5.77e-01
GOMF PROTEIN PHOSPHATASE 1 BINDING	25	2.21e-01	4.54e-01	0.21400	8.96e-02	1.95e-01	4.38e-01	9.18e-02
GOBP FRUCTOSE 1 6 BISPHOSPHATE METABOLIC PROCESS	9	5.58e-01	7.52e-01	0.21400	-2.08e-01	-5.32e-02	2.81e-01	7.82e-01
Thromboxane signalling through TP receptor	24	2.47e-01	4.85e-01	0.21400	1.82e-01	1.14e-01	1.23e-01	3.35e-01
TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling	11	5.35e-01	7.37e-01	0.21400	1.63e-01	1.39e-01	3.50e-01	4.23e-01
GOBP OLIGOSACCHARIDE CATABOLIC PROCESS	15	3.75e-01	6.11e-01	0.21400	-2.09e-01	-4.78e-02	1.61e-01	7.49e-01
GOBP NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION	48	3.70e-02	1.53e-01	0.21400	-2.13e-01	-2.29e-02	1.07e-02	7.84e-01
GOBP INTERLEUKIN 12 PRODUCTION	62	5.17e-03	3.63e-02	0.21400	-1.88e-01	1.03e-01	1.05e-02	1.61e-01
GOBP VESTIBULOCOCHLEAR NERVE FORMATION	5	7.41e-01	8.68e-01	0.21400	-9.43e-02	-1.92e-01	7.15e-01	4.56e-01
GOBP CELLULAR METABOLIC COMPOUND SALVAGE	32	1.08e-01	3.04e-01	0.21400	1.64e-02	2.14e-01	8.72e-01	3.65e-02
Amine ligand-binding receptors	40	6.03e-02	2.11e-01	0.21400	-2.14e-01	-1.23e-02	1.93e-02	8.93e-01
GOBP SKELETAL MYOFIBRIL ASSEMBLY	10	4.92e-01	7.05e-01	0.21400	2.14e-01	8.53e-03	2.41e-01	9.63e-01
GOBP MYELOID CELL HOMEOSTASIS	169	6.84e-05	1.12e-03	0.21400	1.31e-01	1.69e-01	3.31e-03	1.44e-04
GOBP AXIS ELONGATION	29	1.65e-01	3.86e-01	0.21400	7.28e-02	2.01e-01	4.97e-01	6.05e-02
Host Interactions of HIV factors	115	1.12e-03	1.14e-02	0.21400	1.90e-01	9.94e-02	4.40e-04	6.56e-02
Lysine catabolism	12	4.77e-01	6.95e-01	0.21400	2.00e-01	7.71e-02	2.31e-01	6.44e-01
GOBP POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT	6	6.31e-01	7.98e-01	0.21400	2.11e-01	-3.35e-02	3.70e-01	8.87e-01
GOBP PROLINE METABOLIC PROCESS	10	5.02e-01	7.12e-01	0.21400	-2.14e-02	-2.13e-01	9.07e-01	2.44e-01
GOBP REGULATION OF CENTROSOME CYCLE	53	4.40e-02	1.73e-01	0.21400	1.02e-01	1.88e-01	2.00e-01	1.77e-02
GOBP IMMUNOGLOBULIN V D J RECOMBINATION	8	4.98e-01	7.09e-01	0.21400	1.65e-01	-1.36e-01	4.18e-01	5.05e-01
GOMF SEROTONIN RECEPTOR ACTIVITY	6	6.02e-01	7.80e-01	0.21400	-1.89e-01	9.95e-02	4.22e-01	6.73e-01
GOBP POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION	24	1.23e-01	3.27e-01	0.21400	-1.48e-01	1.55e-01	2.10e-01	1.90e-01
Activated NTRK3 signals through RAS	8	6.32e-01	7.99e-01	0.21400	1.74e-01	1.24e-01	3.93e-01	5.45e-01
GOBP INTESTINAL EPITHELIAL CELL MATURATION	6	6.09e-01	7.85e-01	0.21400	-8.15e-02	1.98e-01	7.30e-01	4.02e-01
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME	7	6.25e-01	7.95e-01	0.21400	3.37e-02	2.11e-01	8.77e-01	3.33e-01
GOBP SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE	20	2.41e-01	4.78e-01	0.21400	2.14e-01	4.20e-03	9.79e-02	9.74e-01
GOBP REGULATION OF CELLULAR RESPONSE TO HYPOXIA	20	2.36e-01	4.73e-01	0.21400	2.14e-01	-2.45e-03	9.79e-02	9.85e-01
GOCC PROTON TRANSPORTING V TYPE ATPASE V1 DOMAIN	12	5.06e-01	7.15e-01	0.21400	1.35e-01	1.66e-01	4.19e-01	3.20e-01
GOMF CALCIUM DEPENDENT PHOSPHOLIPID BINDING	53	5.02e-02	1.89e-01	0.21400	-1.40e-01	-1.61e-01	7.75e-02	4.22e-02
GOBP REGULATION OF OPSIN MEDIATED SIGNALING PATHWAY	9	4.68e-01	6.90e-01	0.21400	9.94e-02	-1.89e-01	6.06e-01	3.26e-01
GOBP CXCL12 ACTIVATED CXCR4 SIGNALING PATHWAY	5	7.22e-01	8.58e-01	0.21400	-2.08e-01	-4.80e-02	4.20e-01	8.52e-01
GOBP PROTEIN TRANSMEMBRANE TRANSPORT	71	1.85e-02	9.40e-02	0.21400	1.55e-01	1.47e-01	2.39e-02	3.22e-02
GOBP MICROTUBULE ORGANIZING CENTER LOCALIZATION	32	1.53e-01	3.69e-01	0.21400	1.87e-01	1.03e-01	6.73e-02	3.11e-01
Loss of Nlp from mitotic centrosomes	65	2.60e-02	1.19e-01	0.21400	1.54e-01	1.48e-01	3.21e-02	3.89e-02
Loss of proteins required for interphase microtubule organization from the centrosome	65	2.60e-02	1.19e-01	0.21400	1.54e-01	1.48e-01	3.21e-02	3.89e-02
GOMF VERY LONG CHAIN FATTY ACID COA LIGASE ACTIVITY	9	5.56e-01	7.51e-01	0.21300	-2.09e-01	-4.54e-02	2.79e-01	8.14e-01
Striated Muscle Contraction	35	8.15e-02	2.56e-01	0.21300	9.67e-04	-2.13e-01	9.92e-01	2.89e-02
GOBP POSITIVE REGULATION OF MEGAKARYOCYTE DIFFERENTIATION	10	4.42e-01	6.69e-01	0.21300	-7.56e-02	2.00e-01	6.79e-01	2.74e-01
GOCC CEREBELLAR CLIMBING FIBER TO PURKINJE CELL SYNAPSE	7	6.20e-01	7.91e-01	0.21300	2.30e-02	2.12e-01	9.16e-01	3.31e-01
GOBP EMBRYONIC SKELETAL JOINT DEVELOPMENT	15	4.29e-01	6.58e-01	0.21300	1.39e-01	1.62e-01	3.50e-01	2.79e-01
GOBP TYPE B PANCREATIC CELL PROLIFERATION	26	1.67e-01	3.88e-01	0.21300	2.13e-01	1.79e-02	6.06e-02	8.74e-01
GOBP KERATINOCYTE DEVELOPMENT	13	4.14e-01	6.45e-01	0.21300	-2.12e-01	-2.56e-02	1.86e-01	8.73e-01
GOBP NEUROBLAST MIGRATION	7	5.65e-01	7.57e-01	0.21300	2.00e-01	-7.54e-02	3.61e-01	7.30e-01
GOMF ACETYLCHOLINE RECEPTOR BINDING	11	4.65e-01	6.87e-01	0.21300	-1.24e-02	-2.13e-01	9.43e-01	2.22e-01
GOBP NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION	27	1.10e-01	3.07e-01	0.21300	-1.99e-01	7.78e-02	7.42e-02	4.84e-01
GOBP NEGATIVE REGULATION OF MAST CELL ACTIVATION	10	5.57e-01	7.51e-01	0.21300	-1.87e-01	-1.02e-01	3.06e-01	5.76e-01
GOMF POLY PYRIMIDINE TRACT BINDING	26	1.46e-01	3.59e-01	0.21300	2.12e-01	-1.90e-02	6.10e-02	8.66e-01
FasL/ CD95L signaling	5	7.42e-01	8.69e-01	0.21300	9.09e-02	1.93e-01	7.25e-01	4.55e-01
GOBP NEURAL PRECURSOR CELL PROLIFERATION	165	1.02e-04	1.57e-03	0.21300	1.46e-01	1.55e-01	1.20e-03	5.87e-04
ERBB2 Regulates Cell Motility	15	2.88e-01	5.26e-01	0.21300	9.06e-02	-1.93e-01	5.44e-01	1.96e-01
GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	18	2.12e-01	4.44e-01	0.21300	-1.34e-01	1.66e-01	3.25e-01	2.24e-01
GOBP REGULATION OF PHOSPHATASE ACTIVITY	53	4.29e-02	1.70e-01	0.21300	1.93e-01	9.10e-02	1.53e-02	2.52e-01
GOBP CARDIAC SEPTUM MORPHOGENESIS	73	1.38e-02	7.62e-02	0.21300	9.77e-02	1.89e-01	1.49e-01	5.16e-03
GOBP AROMATIC AMINO ACID METABOLIC PROCESS	31	1.61e-01	3.80e-01	0.21300	-1.90e-01	-9.60e-02	6.69e-02	3.55e-01
Disorders of Developmental Biology	11	5.37e-01	7.37e-01	0.21300	1.70e-01	1.29e-01	3.30e-01	4.59e-01
Disorders of Nervous System Development	11	5.37e-01	7.37e-01	0.21300	1.70e-01	1.29e-01	3.30e-01	4.59e-01
Loss of function of MECP2 in Rett syndrome	11	5.37e-01	7.37e-01	0.21300	1.70e-01	1.29e-01	3.30e-01	4.59e-01
Pervasive developmental disorders	11	5.37e-01	7.37e-01	0.21300	1.70e-01	1.29e-01	3.30e-01	4.59e-01
GOMF LYSINE N METHYLTRANSFERASE ACTIVITY	62	1.14e-02	6.63e-02	0.21300	2.13e-01	-7.30e-03	3.75e-03	9.21e-01
GOBP NEGATIVE REGULATION OF GLUCONEOGENESIS	18	3.11e-01	5.52e-01	0.21300	-4.56e-02	-2.08e-01	7.38e-01	1.27e-01
TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation	95	4.83e-03	3.44e-02	0.21300	1.67e-01	1.32e-01	5.00e-03	2.57e-02
GOBP STRIATED MUSCLE CELL DEVELOPMENT	79	1.83e-03	1.64e-02	0.21300	6.50e-02	-2.03e-01	3.18e-01	1.85e-03
GOBP REGULATION OF CYTOKINESIS	89	7.01e-03	4.58e-02	0.21300	1.56e-01	1.44e-01	1.07e-02	1.88e-02
GOBP MORPHOGENESIS OF AN EPITHELIAL FOLD	23	2.61e-01	5.00e-01	0.21300	1.01e-01	1.87e-01	4.02e-01	1.20e-01
GOBP NEPHRIC DUCT DEVELOPMENT	14	3.27e-01	5.66e-01	0.21300	-2.03e-01	6.40e-02	1.89e-01	6.78e-01
GOBP MYELOID DENDRITIC CELL DIFFERENTIATION	20	3.00e-01	5.40e-01	0.21300	-1.96e-01	-8.28e-02	1.29e-01	5.22e-01
GOBP MULTICELLULAR ORGANISMAL LEVEL IRON ION HOMEOSTASIS	25	2.23e-01	4.58e-01	0.21300	1.95e-01	8.43e-02	9.11e-02	4.66e-01
Intrinsic Pathway for Apoptosis	53	5.17e-02	1.92e-01	0.21300	1.38e-01	1.61e-01	8.13e-02	4.20e-02
GOBP POSITIVE REGULATION OF TOR SIGNALING	68	1.28e-02	7.19e-02	0.21300	2.07e-01	4.87e-02	3.16e-03	4.87e-01
Thrombin signalling through proteinase activated receptors (PARs)	32	1.39e-01	3.50e-01	0.21300	2.01e-01	6.82e-02	4.87e-02	5.05e-01
GOBP PROTEIN LOCALIZATION TO LYSOSOME	57	4.13e-02	1.66e-01	0.21300	1.64e-01	1.36e-01	3.27e-02	7.63e-02
GOBP REGULATION OF CORE PROMOTER BINDING	5	6.62e-01	8.20e-01	0.21300	-8.93e-02	1.93e-01	7.29e-01	4.55e-01
GOBP POSITIVE REGULATION OF FATTY ACID OXIDATION	14	4.41e-01	6.68e-01	0.21300	9.82e-02	1.89e-01	5.25e-01	2.22e-01
GOBP BILE ACID AND BILE SALT TRANSPORT	29	1.89e-01	4.17e-01	0.21300	-1.11e-01	-1.81e-01	3.00e-01	9.14e-02
GOBP HEPATIC STELLATE CELL ACTIVATION	9	6.01e-01	7.79e-01	0.21300	1.72e-01	1.25e-01	3.71e-01	5.17e-01
GOMF MODIFICATION DEPENDENT PROTEIN BINDING	169	1.29e-05	2.70e-04	0.21200	2.11e-01	2.73e-02	2.28e-06	5.41e-01
GOBP OUTFLOW TRACT MORPHOGENESIS	82	1.05e-02	6.21e-02	0.21200	1.51e-01	1.49e-01	1.78e-02	1.96e-02
GOBP CELLULAR RESPONSE TO HYDROGEN PEROXIDE	65	2.60e-02	1.20e-01	0.21200	1.28e-01	1.69e-01	7.38e-02	1.82e-02
Fructose metabolism	7	5.80e-01	7.67e-01	0.21200	5.03e-02	-2.06e-01	8.18e-01	3.44e-01
GOMF FERROUS IRON BINDING	24	2.62e-01	5.01e-01	0.21200	1.41e-01	1.59e-01	2.32e-01	1.78e-01
GOBP INDUCTION OF POSITIVE CHEMOTAXIS	13	4.80e-01	6.97e-01	0.21200	-1.71e-01	-1.25e-01	2.84e-01	4.34e-01
GOBP OSTEOBLAST DEVELOPMENT	17	2.50e-01	4.88e-01	0.21200	-1.96e-01	8.21e-02	1.62e-01	5.58e-01
PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1	9	5.99e-01	7.78e-01	0.21200	1.17e-01	1.77e-01	5.43e-01	3.58e-01
COPI-independent Golgi-to-ER retrograde traffic	51	5.72e-02	2.04e-01	0.21200	1.69e-01	1.29e-01	3.70e-02	1.12e-01
GOBP NEGATIVE REGULATION OF DENDRITE DEVELOPMENT	8	5.55e-01	7.50e-01	0.21200	-2.11e-01	1.90e-02	3.00e-01	9.26e-01
GOBP PENTOSE PHOSPHATE SHUNT NON OXIDATIVE BRANCH	6	6.80e-01	8.32e-01	0.21200	4.65e-02	2.07e-01	8.43e-01	3.80e-01
GOBP MACROAUTOPHAGY	346	2.97e-09	1.48e-07	0.21200	1.83e-01	1.07e-01	4.54e-09	6.41e-04
GOMF GABA A RECEPTOR ACTIVITY	16	2.86e-01	5.24e-01	0.21200	5.43e-02	-2.05e-01	7.07e-01	1.55e-01
GOBP PIGMENT GRANULE ORGANIZATION	37	1.28e-01	3.35e-01	0.21200	1.45e-01	1.55e-01	1.27e-01	1.03e-01
Unwinding of DNA	12	5.07e-01	7.16e-01	0.21200	1.75e-01	1.20e-01	2.94e-01	4.71e-01
GOBP REGULATION OF CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION	8	5.13e-01	7.20e-01	0.21200	-1.86e-01	1.02e-01	3.62e-01	6.17e-01
Heme degradation	16	4.10e-01	6.42e-01	0.21200	-1.35e-01	-1.64e-01	3.50e-01	2.57e-01
GOBP NEGATIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION	8	5.08e-01	7.17e-01	0.21200	1.18e-01	-1.76e-01	5.62e-01	3.89e-01
GOBP PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS	5	7.52e-01	8.73e-01	0.21200	1.12e-01	1.80e-01	6.64e-01	4.87e-01
GOMF SPHINGOSINE 1 PHOSPHATE PHOSPHATASE ACTIVITY	7	6.37e-01	8.02e-01	0.21200	-4.42e-02	-2.07e-01	8.40e-01	3.42e-01
Josephin domain DUBs	10	5.63e-01	7.56e-01	0.21200	1.83e-01	1.07e-01	3.16e-01	5.59e-01
GOBP PODOCYTE CELL MIGRATION	7	6.46e-01	8.08e-01	0.21200	2.03e-01	5.87e-02	3.51e-01	7.88e-01
GOMF HISTONE BINDING	217	1.80e-06	4.87e-05	0.21200	2.01e-01	6.60e-02	3.23e-07	9.36e-02
PKR-mediated signaling	70	2.09e-02	1.02e-01	0.21200	1.57e-01	1.42e-01	2.32e-02	3.96e-02
GOBP PROTEIN K63 LINKED UBIQUITINATION	67	2.35e-02	1.12e-01	0.21200	1.72e-01	1.24e-01	1.50e-02	7.97e-02
GOMF CATALYTIC ACTIVITY ACTING ON A TRNA	134	4.80e-04	5.82e-03	0.21200	1.83e-01	1.06e-01	2.52e-04	3.36e-02
Post-translational modification: synthesis of GPI-anchored proteins	91	4.33e-03	3.19e-02	0.21200	-1.97e-01	-7.87e-02	1.19e-03	1.94e-01
Phosphate bond hydrolysis by NTPDase proteins	8	5.74e-01	7.63e-01	0.21200	-2.12e-01	-7.12e-03	3.00e-01	9.72e-01
GOBP TETRAPYRROLE BIOSYNTHETIC PROCESS	31	1.66e-01	3.88e-01	0.21200	1.87e-01	9.89e-02	7.13e-02	3.41e-01
Synthesis of IP2, IP, and Ins in the cytosol	13	4.54e-01	6.79e-01	0.21200	1.99e-01	7.20e-02	2.14e-01	6.53e-01
GOBP STRIATED MUSCLE CELL PROLIFERATION	81	1.15e-02	6.64e-02	0.21200	1.54e-01	1.46e-01	1.68e-02	2.36e-02
GOBP TELOMERIC D LOOP DISASSEMBLY	7	6.47e-01	8.09e-01	0.21200	5.99e-02	2.03e-01	7.84e-01	3.52e-01
GOBP RESPONSE TO INTERLEUKIN 3	6	6.58e-01	8.17e-01	0.21200	4.17e-03	2.12e-01	9.86e-01	3.70e-01
GOBP PROTEIN UNFOLDING	5	6.64e-01	8.22e-01	0.21200	1.92e-01	-8.87e-02	4.57e-01	7.31e-01
GOBP POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION	12	4.17e-01	6.47e-01	0.21200	2.11e-01	-1.90e-02	2.06e-01	9.09e-01
GOBP PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION	785	4.03e-19	5.50e-17	0.21200	1.69e-01	1.27e-01	7.85e-16	1.31e-09
GOMF DNA ENDONUCLEASE ACTIVITY	39	1.09e-01	3.05e-01	0.21200	1.81e-01	1.09e-01	5.02e-02	2.38e-01
GOBP REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION	13	3.72e-01	6.08e-01	0.21100	-2.07e-01	4.12e-02	1.95e-01	7.97e-01
GOBP ESTROGEN METABOLIC PROCESS	37	1.07e-01	3.03e-01	0.21100	-7.39e-02	-1.98e-01	4.37e-01	3.70e-02
GOBP POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE	46	7.12e-02	2.35e-01	0.21100	-1.85e-01	-1.02e-01	2.98e-02	2.30e-01
TNF signaling	54	2.94e-02	1.30e-01	0.21100	2.09e-01	3.44e-02	8.00e-03	6.62e-01
GOBP CELL MIGRATION INVOLVED IN HEART DEVELOPMENT	20	3.10e-01	5.50e-01	0.21100	1.91e-01	9.02e-02	1.39e-01	4.85e-01
GOBP NEGATIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS	5	6.54e-01	8.14e-01	0.21100	1.30e-01	-1.67e-01	6.15e-01	5.18e-01
Influenza Infection	149	2.63e-04	3.52e-03	0.21100	1.67e-01	1.30e-01	4.37e-04	6.25e-03
Metabolism of steroid hormones	35	1.02e-01	2.93e-01	0.21100	-2.09e-01	-3.45e-02	3.27e-02	7.24e-01
GOBP ACETATE ESTER METABOLIC PROCESS	6	7.16e-01	8.54e-01	0.21100	1.27e-01	1.69e-01	5.91e-01	4.73e-01
GOMF PEPTIDASE REGULATOR ACTIVITY	221	2.93e-06	7.53e-05	0.21100	-9.45e-02	-1.89e-01	1.55e-02	1.27e-06
Telomere C-strand synthesis initiation	12	4.49e-01	6.75e-01	0.21100	2.10e-01	2.44e-02	2.08e-01	8.84e-01
GOMF NUCLEASE ACTIVITY	210	8.21e-06	1.84e-04	0.21100	1.76e-01	1.17e-01	1.15e-05	3.35e-03
GOMF PROTEIN TYROSINE SERINE THREONINE PHOSPHATASE ACTIVITY	25	1.44e-01	3.57e-01	0.21100	-2.04e-01	5.37e-02	7.72e-02	6.42e-01
GOBP PROTEIN OXIDATION	12	5.02e-01	7.12e-01	0.21100	-1.01e-01	-1.86e-01	5.45e-01	2.66e-01
GOMF S100 PROTEIN BINDING	14	3.70e-01	6.07e-01	0.21100	2.11e-01	-6.89e-03	1.72e-01	9.64e-01
Dermatan sulfate biosynthesis	10	5.77e-01	7.66e-01	0.21100	1.47e-01	1.52e-01	4.22e-01	4.06e-01
GOBP CHOLINE METABOLIC PROCESS	6	6.06e-01	7.83e-01	0.21100	1.77e-01	-1.14e-01	4.52e-01	6.28e-01
GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS II	28	1.11e-01	3.08e-01	0.21100	-6.40e-02	2.01e-01	5.58e-01	6.56e-02
Attenuation phase	24	2.68e-01	5.07e-01	0.21100	1.53e-01	1.45e-01	1.93e-01	2.20e-01
Regulation of CDH11 Expression and Function	29	1.54e-01	3.70e-01	0.21100	2.07e-01	3.83e-02	5.33e-02	7.21e-01
Signaling by FGFR	87	5.00e-03	3.54e-02	0.21100	2.01e-01	6.48e-02	1.22e-03	2.96e-01
GOBP POSITIVE REGULATION OF SEQUESTERING OF TRIGLYCERIDE	9	4.80e-01	6.97e-01	0.21100	-1.90e-01	9.23e-02	3.25e-01	6.32e-01
GOBP INTERLEUKIN 13 PRODUCTION	21	1.95e-01	4.24e-01	0.21100	-2.03e-01	5.86e-02	1.08e-01	6.42e-01
GOBP REGULATION OF FATTY ACID OXIDATION	33	1.60e-01	3.79e-01	0.21100	1.70e-01	1.25e-01	9.12e-02	2.15e-01
InlB-mediated entry of Listeria monocytogenes into host cell	14	3.14e-01	5.54e-01	0.21100	1.83e-01	-1.05e-01	2.37e-01	4.96e-01
GOCC VESICLE TETHERING COMPLEX	65	2.82e-02	1.27e-01	0.21100	1.61e-01	1.36e-01	2.47e-02	5.83e-02
GOMF GLYCEROL CHANNEL ACTIVITY	5	7.60e-01	8.78e-01	0.21100	1.56e-01	1.42e-01	5.45e-01	5.84e-01
GOBP REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES	10	5.77e-01	7.66e-01	0.21100	1.37e-01	1.61e-01	4.55e-01	3.79e-01
MyD88-independent TLR4 cascade	104	3.04e-03	2.42e-02	0.21100	1.75e-01	1.17e-01	2.01e-03	3.93e-02
TRIF (TICAM1)-mediated TLR4 signaling	104	3.04e-03	2.42e-02	0.21100	1.75e-01	1.17e-01	2.01e-03	3.93e-02
Transport of connexons to the plasma membrane	19	2.51e-01	4.89e-01	0.21100	-2.10e-02	2.10e-01	8.74e-01	1.14e-01
GOBP GLUCOSE IMPORT ACROSS PLASMA MEMBRANE	5	6.59e-01	8.18e-01	0.21100	-1.77e-01	1.14e-01	4.93e-01	6.58e-01
GOBP NEGATIVE REGULATION OF MITOCHONDRIAL FUSION	7	6.69e-01	8.25e-01	0.21100	9.81e-02	1.86e-01	6.53e-01	3.93e-01
GOCC RIBBON SYNAPSE	15	3.64e-01	6.01e-01	0.21100	-1.60e-02	-2.10e-01	9.14e-01	1.59e-01
GOBP ENDOSOMAL VESICLE FUSION	15	3.40e-01	5.78e-01	0.21100	2.10e-01	-1.54e-02	1.59e-01	9.18e-01
GOBP MITOCHONDRIAL MEMBRANE ORGANIZATION	113	2.11e-03	1.84e-02	0.21100	1.48e-01	1.50e-01	6.62e-03	5.89e-03
GOBP REGULATION OF BROWN FAT CELL DIFFERENTIATION	24	1.68e-01	3.90e-01	0.21100	2.08e-01	-3.39e-02	7.80e-02	7.74e-01
G0 and Early G1	27	2.26e-01	4.60e-01	0.21100	1.66e-01	1.30e-01	1.36e-01	2.43e-01
GOBP ORGANELLE TRANSPORT ALONG MICROTUBULE	86	8.73e-03	5.44e-02	0.21000	1.68e-01	1.26e-01	6.92e-03	4.31e-02
GOBP HORMONE MEDIATED SIGNALING PATHWAY	185	3.67e-05	6.74e-04	0.21000	1.73e-01	1.20e-01	4.99e-05	4.88e-03
GOBP NEGATIVE REGULATION OF CHEMOTAXIS	47	1.97e-02	9.84e-02	0.21000	-1.70e-01	1.24e-01	4.40e-02	1.41e-01
GOBP NEGATIVE REGULATION OF LEUKOCYTE MIGRATION	54	1.29e-02	7.22e-02	0.21000	-8.68e-02	1.92e-01	2.70e-01	1.48e-02
GOBP VENOUS BLOOD VESSEL DEVELOPMENT	16	3.51e-01	5.88e-01	0.21000	2.88e-02	2.08e-01	8.42e-01	1.49e-01
GOBP RESPONSE TO MUSCLE ACTIVITY	28	1.05e-01	2.99e-01	0.21000	8.60e-02	-1.92e-01	4.31e-01	7.90e-02
GOBP GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT	11	4.05e-01	6.37e-01	0.21000	1.05e-01	-1.82e-01	5.48e-01	2.95e-01
GOBP MELANOSOME ASSEMBLY	18	3.48e-01	5.85e-01	0.21000	8.21e-02	1.93e-01	5.46e-01	1.55e-01
GOBP REGULATION OF DNA TEMPLATED DNA REPLICATION	48	7.20e-02	2.37e-01	0.21000	1.65e-01	1.31e-01	4.85e-02	1.18e-01
GOBP POSITIVE REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION	23	1.70e-01	3.92e-01	0.21000	-2.02e-01	5.67e-02	9.31e-02	6.38e-01
GOCC CATION CHANNEL COMPLEX	200	1.97e-05	3.91e-04	0.21000	-1.59e-01	-1.37e-01	1.07e-04	8.07e-04
GOMF GLUTATHIONE TRANSMEMBRANE TRANSPORTER ACTIVITY	7	6.13e-01	7.87e-01	0.21000	-4.58e-03	2.10e-01	9.83e-01	3.36e-01
Signaling by LRP5 mutants	6	6.44e-01	8.07e-01	0.21000	2.08e-01	-2.87e-02	3.78e-01	9.03e-01
GOBP INDOLALKYLAMINE METABOLIC PROCESS	11	5.49e-01	7.46e-01	0.21000	-1.45e-01	-1.52e-01	4.06e-01	3.82e-01
GOCC MITOTIC SPINDLE POLE	36	1.40e-01	3.53e-01	0.21000	1.33e-01	1.62e-01	1.67e-01	9.23e-02
GOBP MAST CELL MIGRATION	14	3.10e-01	5.50e-01	0.21000	-1.39e-01	1.57e-01	3.68e-01	3.09e-01
GOBP MHC CLASS II BIOSYNTHETIC PROCESS	19	2.05e-01	4.37e-01	0.21000	-1.27e-01	1.67e-01	3.38e-01	2.08e-01
GOCC PHOTORECEPTOR OUTER SEGMENT	85	3.09e-03	2.46e-02	0.21000	-5.84e-03	-2.10e-01	9.26e-01	8.38e-04
GOBP L LEUCINE METABOLIC PROCESS	8	5.81e-01	7.68e-01	0.21000	8.64e-03	2.09e-01	9.66e-01	3.05e-01
Regulation of TNFR1 signaling	46	4.55e-02	1.76e-01	0.21000	2.09e-01	1.25e-02	1.41e-02	8.83e-01
Antigen processing-Cross presentation	87	9.06e-03	5.57e-02	0.21000	1.52e-01	1.45e-01	1.46e-02	1.96e-02
GOBP LENS DEVELOPMENT IN CAMERA TYPE EYE	85	7.23e-03	4.69e-02	0.21000	1.92e-01	8.36e-02	2.19e-03	1.83e-01
Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence	6	7.07e-01	8.49e-01	0.21000	-8.80e-02	-1.90e-01	7.09e-01	4.20e-01
GOCC PEPTIDASE COMPLEX	118	1.56e-03	1.45e-02	0.20900	1.71e-01	1.21e-01	1.33e-03	2.33e-02
GOMF SPHINGOMYELIN PHOSPHODIESTERASE ACTIVITY	7	5.57e-01	7.51e-01	0.20900	-1.51e-01	1.45e-01	4.89e-01	5.06e-01
GOCC ENDOPLASMIC RETICULUM EXIT SITE	29	1.99e-01	4.29e-01	0.20900	1.78e-01	1.10e-01	9.71e-02	3.03e-01
GOBP DETECTION OF LIGHT STIMULUS	60	2.11e-02	1.04e-01	0.20900	-3.17e-02	-2.07e-01	6.71e-01	5.57e-03
GOMF PROTEIN DEMETHYLASE ACTIVITY	26	1.75e-01	3.98e-01	0.20900	2.09e-01	1.29e-02	6.52e-02	9.09e-01
GOBP PROTEIN LOCALIZATION TO CYTOSKELETON	59	4.12e-02	1.66e-01	0.20900	1.40e-01	1.56e-01	6.35e-02	3.83e-02
GOMF ENDOPEPTIDASE ACTIVATOR ACTIVITY	19	2.81e-01	5.20e-01	0.20900	1.35e-02	2.09e-01	9.19e-01	1.15e-01
GOBP NEGATIVE REGULATION OF DEFENSE RESPONSE TO BACTERIUM	5	7.08e-01	8.49e-01	0.20900	2.25e-03	-2.09e-01	9.93e-01	4.18e-01
FRS-mediated FGFR3 signaling	19	3.03e-01	5.43e-01	0.20900	2.05e-01	4.22e-02	1.22e-01	7.50e-01
Nuclear Envelope (NE) Reassembly	73	1.95e-02	9.78e-02	0.20900	1.56e-01	1.39e-01	2.08e-02	4.05e-02
GOBP POSITIVE REGULATION OF MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION	15	3.21e-01	5.59e-01	0.20900	-2.02e-01	5.23e-02	1.75e-01	7.26e-01
GOBP CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION	31	1.83e-01	4.08e-01	0.20900	-1.19e-01	-1.72e-01	2.51e-01	9.78e-02
GOMF INOSITOL BISPHOSPHATE PHOSPHATASE ACTIVITY	7	5.99e-01	7.78e-01	0.20900	2.06e-01	-3.35e-02	3.44e-01	8.78e-01
GOBP T HELPER 1 CELL DIFFERENTIATION	23	2.70e-01	5.09e-01	0.20900	9.29e-02	1.87e-01	4.40e-01	1.20e-01
EGFR Transactivation by Gastrin	9	5.40e-01	7.39e-01	0.20900	2.09e-01	1.11e-03	2.78e-01	9.95e-01
GOBP POSITIVE REGULATION OF GLUCONEOGENESIS	20	2.50e-01	4.88e-01	0.20900	5.46e-03	-2.09e-01	9.66e-01	1.06e-01
GOBP EPIDERMAL CELL DIFFERENTIATION	240	5.85e-07	1.81e-05	0.20900	-2.00e-01	-6.08e-02	9.57e-08	1.04e-01
GOBP NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION	30	1.65e-01	3.86e-01	0.20900	6.27e-02	1.99e-01	5.52e-01	5.89e-02
GOBP SKIN MORPHOGENESIS	13	3.74e-01	6.10e-01	0.20900	2.02e-01	-5.34e-02	2.08e-01	7.39e-01
GOBP CYTOSKELETON DEPENDENT CYTOKINESIS	116	1.95e-03	1.72e-02	0.20900	1.34e-01	1.60e-01	1.25e-02	2.92e-03
GOMF PEROXISOME TARGETING SEQUENCE BINDING	5	7.23e-01	8.58e-01	0.20900	2.67e-02	2.07e-01	9.18e-01	4.23e-01
GOBP ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION	44	6.18e-02	2.14e-01	0.20900	2.05e-01	3.70e-02	1.84e-02	6.71e-01
Formation of HIV elongation complex in the absence of HIV Tat	44	9.06e-02	2.73e-01	0.20900	1.20e-01	1.71e-01	1.68e-01	5.01e-02
Transport of Mature mRNAs Derived from Intronless Transcripts	43	9.35e-02	2.78e-01	0.20900	1.76e-01	1.12e-01	4.54e-02	2.05e-01
GOBP CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION	9	5.36e-01	7.37e-01	0.20900	-6.14e-03	2.09e-01	9.75e-01	2.79e-01
GOMF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY	157	1.77e-04	2.49e-03	0.20900	-1.78e-01	-1.09e-01	1.18e-04	1.86e-02
GOMF ARRESTIN FAMILY PROTEIN BINDING	9	5.32e-01	7.35e-01	0.20900	-1.20e-02	2.08e-01	9.50e-01	2.79e-01
GOBP NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING	14	4.47e-01	6.74e-01	0.20900	1.91e-01	8.49e-02	2.17e-01	5.82e-01
GOBP ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY	10	4.74e-01	6.94e-01	0.20900	-4.58e-02	2.04e-01	8.02e-01	2.65e-01
GOMF LIPOPROTEIN PARTICLE RECEPTOR BINDING	29	1.36e-01	3.46e-01	0.20900	2.09e-01	-4.07e-03	5.20e-02	9.70e-01
GOBP RESPONSE TO ANTIBIOTIC	36	1.19e-01	3.21e-01	0.20900	1.97e-01	6.92e-02	4.11e-02	4.72e-01
GOMF MRNA CDS BINDING	5	6.62e-01	8.20e-01	0.20900	1.30e-01	-1.63e-01	6.16e-01	5.27e-01
GOMF GLIAL CELL DERIVED NEUROTROPHIC FACTOR RECEPTOR ACTIVITY	5	6.63e-01	8.21e-01	0.20900	-1.70e-01	1.20e-01	5.10e-01	6.41e-01
GOMF TRANSFERRIN RECEPTOR BINDING	10	4.43e-01	6.70e-01	0.20800	1.12e-01	-1.76e-01	5.42e-01	3.35e-01
GOBP REGULATION OF KERATINOCYTE DIFFERENTIATION	39	5.11e-02	1.91e-01	0.20800	-6.01e-02	2.00e-01	5.16e-01	3.10e-02
VEGFR2 mediated cell proliferation	19	3.17e-01	5.56e-01	0.20800	5.77e-02	2.00e-01	6.63e-01	1.31e-01
GOBP SPECIFICATION OF ANIMAL ORGAN IDENTITY	36	1.39e-01	3.51e-01	0.20800	1.14e-01	1.75e-01	2.37e-01	6.99e-02
GOBP L HISTIDINE TRANSMEMBRANE TRANSPORT	5	7.65e-01	8.81e-01	0.20800	-1.44e-01	-1.50e-01	5.76e-01	5.61e-01
GOBP NEGATIVE REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION	83	1.16e-02	6.67e-02	0.20800	1.61e-01	1.33e-01	1.14e-02	3.65e-02
GOBP REGULATION OF GROWTH RATE	5	7.65e-01	8.81e-01	0.20800	1.43e-01	1.52e-01	5.80e-01	5.57e-01
GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE	37	1.19e-01	3.21e-01	0.20800	-8.30e-02	-1.91e-01	3.82e-01	4.42e-02
Cap-dependent Translation Initiation	110	2.60e-03	2.16e-02	0.20800	1.69e-01	1.22e-01	2.21e-03	2.70e-02
Eukaryotic Translation Initiation	110	2.60e-03	2.16e-02	0.20800	1.69e-01	1.22e-01	2.21e-03	2.70e-02
GOBP RIBONUCLEOSIDE METABOLIC PROCESS	35	1.42e-01	3.55e-01	0.20800	9.99e-02	1.83e-01	3.06e-01	6.13e-02
GOMF TRNA CYTIDINE METHYLTRANSFERASE ACTIVITY	9	6.16e-01	7.89e-01	0.20800	1.58e-01	1.35e-01	4.11e-01	4.82e-01
GOBP ALDITOL CATABOLIC PROCESS	6	6.95e-01	8.41e-01	0.20800	-2.01e-01	-5.58e-02	3.95e-01	8.13e-01
GOBP MITOTIC CYTOKINETIC PROCESS	31	1.87e-01	4.13e-01	0.20800	1.67e-01	1.24e-01	1.07e-01	2.32e-01
Toll Like Receptor 3 (TLR3) Cascade	100	3.49e-03	2.71e-02	0.20800	1.88e-01	8.95e-02	1.16e-03	1.22e-01
GOBP GLYCOPHAGY	11	4.12e-01	6.44e-01	0.20800	1.80e-01	-1.04e-01	3.01e-01	5.50e-01
GOBP REGULATION OF GERM CELL PROLIFERATION	7	6.60e-01	8.18e-01	0.20800	6.58e-02	1.97e-01	7.63e-01	3.66e-01
NrCAM interactions	6	6.64e-01	8.21e-01	0.20800	1.52e-03	-2.08e-01	9.95e-01	3.77e-01
GOMF NADPLUS NUCLEOTIDASE CYCLIC ADP RIBOSE GENERATING	14	3.16e-01	5.55e-01	0.20800	-1.35e-01	1.59e-01	3.83e-01	3.04e-01
GOBP SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE SIGNAL SEQUENCE RECOGNITION	6	6.13e-01	7.87e-01	0.20800	1.16e-01	-1.73e-01	6.24e-01	4.63e-01
GOBP NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION	57	2.57e-02	1.18e-01	0.20800	2.60e-02	2.06e-01	7.34e-01	7.03e-03
GOMF VASOPRESSIN RECEPTOR ACTIVITY	6	6.11e-01	7.86e-01	0.20800	1.31e-01	-1.61e-01	5.78e-01	4.94e-01
GOBP CELLULAR RESPONSE TO VITAMIN D	21	3.08e-01	5.48e-01	0.20800	9.49e-02	1.85e-01	4.51e-01	1.42e-01
GOBP REGULATION OF RESPONSE TO OSMOTIC STRESS	16	4.14e-01	6.45e-01	0.20800	1.79e-01	1.06e-01	2.15e-01	4.63e-01
GOBP MITOTIC G1 S TRANSITION CHECKPOINT SIGNALING	30	1.99e-01	4.29e-01	0.20800	1.25e-01	1.66e-01	2.37e-01	1.15e-01
GOBP REGULATION OF ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME	52	5.38e-02	1.97e-01	0.20800	1.86e-01	9.24e-02	2.02e-02	2.49e-01
GOMF HISTONE H3 KINASE ACTIVITY	11	5.54e-01	7.48e-01	0.20800	1.29e-01	1.63e-01	4.58e-01	3.50e-01
GOBP REGULATION OF MITOTIC CELL CYCLE	515	6.10e-13	5.13e-11	0.20800	1.84e-01	9.74e-02	9.76e-13	1.54e-04
Long-term potentiation	22	2.30e-01	4.65e-01	0.20800	-2.08e-01	-7.55e-03	9.17e-02	9.51e-01
GOMF APOLIPOPROTEIN BINDING	17	3.25e-01	5.63e-01	0.20800	-2.07e-01	-1.17e-02	1.39e-01	9.33e-01
GOBP TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION	9	6.03e-01	7.81e-01	0.20800	1.86e-01	9.26e-02	3.34e-01	6.31e-01
GOMF MONOATOMIC CATION CHANNEL ACTIVITY	326	2.14e-08	8.74e-07	0.20800	-1.77e-01	-1.08e-01	3.58e-08	7.97e-04
GOBP GLANDULAR EPITHELIAL CELL MATURATION	9	6.18e-01	7.90e-01	0.20800	1.37e-01	1.56e-01	4.76e-01	4.18e-01
GOBP REGULATION OF MOTOR NEURON APOPTOTIC PROCESS	15	4.27e-01	6.56e-01	0.20800	8.67e-02	1.89e-01	5.61e-01	2.06e-01
Late Phase of HIV Life Cycle	132	8.09e-04	8.98e-03	0.20800	1.71e-01	1.18e-01	6.92e-04	1.93e-02
Toll Like Receptor 9 (TLR9) Cascade	102	4.35e-03	3.20e-02	0.20800	1.60e-01	1.32e-01	5.23e-03	2.08e-02
ISG15 antiviral mechanism	74	1.88e-02	9.52e-02	0.20800	1.66e-01	1.25e-01	1.35e-02	6.37e-02
GOBP POSITIVE REGULATION OF RESPONSE TO TUMOR CELL	14	4.44e-01	6.71e-01	0.20800	-7.44e-02	-1.94e-01	6.30e-01	2.09e-01
GOBP RELAXATION OF SMOOTH MUSCLE	9	5.92e-01	7.73e-01	0.20800	-1.95e-01	-7.21e-02	3.12e-01	7.08e-01
GOBP CENTROSOME DUPLICATION	73	2.06e-02	1.02e-01	0.20800	1.38e-01	1.55e-01	4.08e-02	2.23e-02
GOBP NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING	15	4.29e-01	6.58e-01	0.20800	8.94e-02	1.87e-01	5.49e-01	2.09e-01
GOMF TRANSCRIPTION COREPRESSOR ACTIVITY	183	2.85e-05	5.40e-04	0.20800	1.92e-01	7.79e-02	7.11e-06	6.92e-02
GOMF ALKALI METAL ION BINDING	19	3.47e-01	5.85e-01	0.20800	9.78e-02	1.83e-01	4.61e-01	1.67e-01
GOBP VESICLE TETHERING INVOLVED IN EXOCYTOSIS	9	6.18e-01	7.90e-01	0.20800	1.30e-01	1.62e-01	4.99e-01	4.01e-01
GOBP MULTIVESICULAR BODY ORGANIZATION	32	1.82e-01	4.07e-01	0.20800	1.56e-01	1.37e-01	1.26e-01	1.81e-01
GOBP NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION	41	8.16e-02	2.56e-01	0.20800	-2.02e-01	-4.74e-02	2.52e-02	5.99e-01
GOBP CAMP METABOLIC PROCESS	23	2.65e-01	5.04e-01	0.20700	-1.93e-01	-7.52e-02	1.08e-01	5.32e-01
GOBP COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION	123	9.33e-04	9.91e-03	0.20700	8.29e-02	1.90e-01	1.12e-01	2.70e-04
GOMF HEPARIN BINDING	169	1.38e-05	2.86e-04	0.20700	-6.43e-03	-2.07e-01	8.85e-01	3.31e-06
GOMF TRANSLATION REPRESSOR ACTIVITY	290	2.39e-07	8.03e-06	0.20700	-1.38e-01	-1.55e-01	5.37e-05	5.58e-06
GOBP FEMALE MEIOTIC NUCLEAR DIVISION	39	5.47e-02	1.99e-01	0.20700	2.01e-01	-5.19e-02	3.00e-02	5.75e-01
GOBP CLATHRIN COATED VESICLE CARGO LOADING	7	5.80e-01	7.67e-01	0.20700	1.91e-01	-8.07e-02	3.82e-01	7.11e-01
GOMF ENDONUCLEASE ACTIVITY	119	1.68e-03	1.54e-02	0.20700	1.70e-01	1.19e-01	1.38e-03	2.50e-02
GOBP ALKALOID METABOLIC PROCESS	7	6.75e-01	8.29e-01	0.20700	-8.99e-02	-1.87e-01	6.81e-01	3.92e-01
Signaling by ROBO receptors	194	2.62e-05	5.02e-04	0.20700	1.78e-01	1.06e-01	1.87e-05	1.09e-02
GOCC RETROMER COMPLEX	20	3.45e-01	5.82e-01	0.20700	1.34e-01	1.58e-01	2.99e-01	2.21e-01
GOCC PROTEASOME CORE COMPLEX	20	2.85e-01	5.23e-01	0.20700	2.05e-01	3.38e-02	1.13e-01	7.94e-01
GOBP RESPONSE TO INTERFERON ALPHA	17	3.23e-01	5.62e-01	0.20700	7.05e-03	2.07e-01	9.60e-01	1.39e-01
SHC1 events in ERBB4 signaling	14	3.57e-01	5.93e-01	0.20700	2.02e-01	-4.58e-02	1.91e-01	7.67e-01
GOBP NEGATIVE REGULATION OF MRNA METABOLIC PROCESS	91	6.08e-03	4.12e-02	0.20700	1.87e-01	8.85e-02	2.01e-03	1.44e-01
GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN	20	3.45e-01	5.83e-01	0.20700	-1.34e-01	-1.58e-01	2.98e-01	2.22e-01
GOCC GOLGI ASSOCIATED VESICLE	89	4.94e-03	3.50e-02	0.20700	1.99e-01	5.62e-02	1.15e-03	3.59e-01
GOBP POSITIVE REGULATION OF PROTEIN UBIQUITINATION	97	5.56e-03	3.83e-02	0.20700	1.20e-01	1.69e-01	4.06e-02	4.12e-03
GOMF K63 LINKED DEUBIQUITINASE ACTIVITY	11	5.42e-01	7.40e-01	0.20700	9.33e-02	1.85e-01	5.92e-01	2.89e-01
GOCC MICROTUBULE END	34	1.54e-01	3.69e-01	0.20700	1.81e-01	9.96e-02	6.71e-02	3.15e-01
ERBB2 Activates PTK6 Signaling	13	4.03e-01	6.36e-01	0.20700	1.81e-02	-2.06e-01	9.10e-01	1.98e-01
GOBP SKELETAL SYSTEM MORPHOGENESIS	226	7.09e-06	1.62e-04	0.20700	1.53e-01	1.40e-01	7.63e-05	2.95e-04
GOBP PROTEIN CATABOLIC PROCESS	953	9.32e-22	1.53e-19	0.20700	1.54e-01	1.38e-01	6.33e-16	5.71e-13
GOBP ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT	16	2.81e-01	5.20e-01	0.20700	-9.86e-02	1.82e-01	4.95e-01	2.08e-01
PTK6 Regulates Proteins Involved in RNA Processing	5	6.74e-01	8.28e-01	0.20700	-1.84e-01	9.47e-02	4.77e-01	7.14e-01
GOBP INNER MITOCHONDRIAL MEMBRANE ORGANIZATION	41	9.96e-02	2.89e-01	0.20700	1.88e-01	8.57e-02	3.70e-02	3.42e-01
GOBP REGULATION OF STEROID BIOSYNTHETIC PROCESS	79	1.16e-02	6.67e-02	0.20700	-1.89e-01	-8.29e-02	3.61e-03	2.03e-01
GOBP LYSOSOMAL MEMBRANE ORGANIZATION	15	3.24e-01	5.63e-01	0.20700	-5.97e-02	1.98e-01	6.89e-01	1.84e-01
TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest	14	3.21e-01	5.60e-01	0.20700	-1.60e-01	1.31e-01	3.01e-01	3.95e-01
GOBP POSITIVE REGULATION OF DNA REPLICATION	42	1.04e-01	2.97e-01	0.20700	1.74e-01	1.11e-01	5.10e-02	2.12e-01
GOBP NON PROTEINOGENIC AMINO ACID BIOSYNTHETIC PROCESS	16	3.73e-01	6.09e-01	0.20700	2.03e-01	3.92e-02	1.60e-01	7.86e-01
GOMF MAGNESIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY	16	2.84e-01	5.22e-01	0.20700	-9.58e-02	1.83e-01	5.07e-01	2.05e-01
GOBP MESENCHYMAL EPITHELIAL CELL SIGNALING	9	6.15e-01	7.88e-01	0.20700	1.74e-01	1.11e-01	3.66e-01	5.63e-01
GOMF ACTIVIN RECEPTOR BINDING	9	5.11e-01	7.19e-01	0.20700	-5.64e-02	1.99e-01	7.70e-01	3.02e-01
GOBP SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS	76	1.84e-02	9.39e-02	0.20600	1.39e-01	1.52e-01	3.58e-02	2.16e-02
GOBP AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS	16	3.99e-01	6.32e-01	0.20600	-1.93e-01	-7.32e-02	1.81e-01	6.12e-01
GOBP NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING	22	2.69e-01	5.08e-01	0.20600	5.42e-02	1.99e-01	6.60e-01	1.06e-01
GOBP OOCYTE DIFFERENTIATION	66	2.67e-02	1.22e-01	0.20600	1.82e-01	9.73e-02	1.05e-02	1.71e-01
GOBP PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE	36	1.51e-01	3.65e-01	0.20600	1.42e-01	1.50e-01	1.42e-01	1.19e-01
GOMF PROTEIN KINASE C BINDING	51	6.43e-02	2.20e-01	0.20600	1.74e-01	1.12e-01	3.20e-02	1.67e-01
GOBP REGULATION OF NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY	10	4.80e-01	6.97e-01	0.20600	-4.74e-02	2.01e-01	7.95e-01	2.71e-01
GOBP RIBONUCLEOSIDE CATABOLIC PROCESS	20	3.05e-01	5.44e-01	0.20600	5.61e-02	1.99e-01	6.64e-01	1.24e-01
GOMF NEUROTRANSMITTER RECEPTOR ACTIVITY	91	6.32e-03	4.25e-02	0.20600	-1.86e-01	-8.85e-02	2.11e-03	1.44e-01
GOBP REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION	46	8.65e-02	2.66e-01	0.20600	1.67e-01	1.21e-01	5.00e-02	1.55e-01
GOCC HISTONE PRE MRNA 3 END PROCESSING COMPLEX	6	6.81e-01	8.32e-01	0.20600	2.00e-02	2.05e-01	9.32e-01	3.84e-01
GOBP ANATOMICAL STRUCTURE ARRANGEMENT	16	2.94e-01	5.33e-01	0.20600	-7.44e-02	1.92e-01	6.06e-01	1.83e-01
GOBP MESANGIAL CELL DEVELOPMENT	6	6.37e-01	8.02e-01	0.20600	-6.23e-02	1.97e-01	7.92e-01	4.04e-01
GOBP OXYGEN TRANSPORT	15	3.45e-01	5.83e-01	0.20600	-2.04e-01	2.93e-02	1.71e-01	8.44e-01
Non-integrin membrane-ECM interactions	75	3.68e-03	2.81e-02	0.20600	6.13e-02	-1.97e-01	3.59e-01	3.19e-03
GOMF PEROXIREDOXIN ACTIVITY	7	6.91e-01	8.39e-01	0.20600	1.60e-01	1.30e-01	4.63e-01	5.51e-01
GOBP CELL CYCLE	1601	6.09e-36	2.20e-33	0.20600	1.79e-01	1.03e-01	7.77e-33	6.05e-12
GOBP HEMATOPOIETIC STEM CELL DIFFERENTIATION	36	1.49e-01	3.63e-01	0.20600	1.62e-01	1.27e-01	9.19e-02	1.87e-01
GOBP REGULATION OF GLUCAGON SECRETION	8	5.23e-01	7.27e-01	0.20600	1.55e-01	-1.36e-01	4.48e-01	5.05e-01
HIV Infection	211	1.05e-05	2.25e-04	0.20600	1.81e-01	9.78e-02	5.56e-06	1.43e-02
GOBP AUTOSOME GENOMIC IMPRINTING	5	7.16e-01	8.54e-01	0.20600	2.06e-01	-5.57e-04	4.25e-01	9.98e-01
GOBP REGULATION OF DEVELOPMENT HETEROCHRONIC	13	4.56e-01	6.82e-01	0.20600	4.72e-02	2.01e-01	7.68e-01	2.10e-01
GOMF WD40 REPEAT DOMAIN BINDING	5	7.56e-01	8.75e-01	0.20600	1.87e-01	8.56e-02	4.68e-01	7.40e-01
GOBP TOLERANCE INDUCTION TO SELF ANTIGEN	5	6.74e-01	8.28e-01	0.20600	-1.79e-01	1.02e-01	4.88e-01	6.92e-01
Nephrin family interactions	21	2.69e-01	5.08e-01	0.20600	2.04e-01	3.06e-02	1.06e-01	8.08e-01
GOBP REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION	153	3.17e-04	4.08e-03	0.20600	1.23e-01	1.65e-01	8.38e-03	4.29e-04
GOCC CHECKPOINT CLAMP COMPLEX	5	7.67e-01	8.82e-01	0.20600	1.66e-01	1.22e-01	5.21e-01	6.36e-01
GOBP CEREBROSPINAL FLUID CIRCULATION	15	4.30e-01	6.58e-01	0.20600	-8.13e-02	-1.89e-01	5.86e-01	2.04e-01
PI3K events in ERBB4 signaling	10	4.47e-01	6.74e-01	0.20600	1.64e-01	-1.25e-01	3.71e-01	4.93e-01
GOBP DNA CYTOSINE DEAMINATION	9	6.24e-01	7.94e-01	0.20600	1.46e-01	1.45e-01	4.48e-01	4.50e-01
GOBP CELL CYCLE PROCESS	1244	7.47e-29	1.91e-26	0.20600	1.83e-01	9.44e-02	1.54e-27	2.14e-08
GOMF POLYAMINE TRANSMEMBRANE TRANSPORTER ACTIVITY	10	5.13e-01	7.21e-01	0.20600	6.30e-04	-2.06e-01	9.97e-01	2.59e-01
GOBP NEURONAL STEM CELL POPULATION MAINTENANCE	25	2.64e-01	5.03e-01	0.20600	1.17e-01	1.70e-01	3.12e-01	1.42e-01
GOBP CONVERGENT EXTENSION INVOLVED IN GASTRULATION	9	5.74e-01	7.63e-01	0.20600	-2.03e-01	-3.57e-02	2.92e-01	8.53e-01
GOBP REGULATION OF MODIFICATION OF POSTSYNAPTIC STRUCTURE	10	5.03e-01	7.13e-01	0.20600	2.05e-01	-1.56e-02	2.61e-01	9.32e-01
NOTCH3 Activation and Transmission of Signal to the Nucleus	25	2.11e-01	4.43e-01	0.20600	2.04e-01	3.10e-02	7.82e-02	7.88e-01
GOBP POSITIVE REGULATION OF CELL PROLIFERATION IN BONE MARROW	6	6.16e-01	7.89e-01	0.20600	-1.42e-01	1.49e-01	5.48e-01	5.26e-01
Membrane binding and targetting of GAG proteins	14	4.81e-01	6.97e-01	0.20600	1.49e-01	1.42e-01	3.36e-01	3.56e-01
Synthesis And Processing Of GAG, GAGPOL Polyproteins	14	4.81e-01	6.97e-01	0.20600	1.49e-01	1.42e-01	3.36e-01	3.56e-01
GOBP ANDROGEN CATABOLIC PROCESS	5	7.67e-01	8.82e-01	0.20600	-1.19e-01	-1.68e-01	6.44e-01	5.16e-01
GOMF O ACYLTRANSFERASE ACTIVITY	50	7.25e-02	2.38e-01	0.20600	1.30e-01	1.59e-01	1.11e-01	5.12e-02
GOBP CELLULAR RESPONSE TO COPPER ION	24	2.14e-01	4.47e-01	0.20600	1.64e-02	2.05e-01	8.89e-01	8.20e-02
GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO HYPOXIA	10	5.27e-01	7.31e-01	0.20600	2.05e-01	1.78e-02	2.62e-01	9.22e-01
GOBP CELLULAR RESPONSE TO STRESS	1768	3.53e-38	1.40e-35	0.20600	1.65e-01	1.23e-01	1.07e-30	7.20e-18
GOBP PROTEIN O LINKED GLYCOSYLATION VIA SERINE	10	5.12e-01	7.20e-01	0.20600	-3.12e-03	2.06e-01	9.86e-01	2.60e-01
GOMF ELECTRON TRANSFER ACTIVITY	99	2.83e-03	2.30e-02	0.20600	1.99e-01	5.21e-02	6.23e-04	3.71e-01
GOBP DENDRITIC SPINE MAINTENANCE	21	1.91e-01	4.19e-01	0.20600	1.04e-01	-1.77e-01	4.10e-01	1.59e-01
GOBP TELOMERE CAPPING	39	9.83e-02	2.87e-01	0.20600	1.99e-01	5.13e-02	3.14e-02	5.79e-01
Regulation of FZD by ubiquitination	21	1.84e-01	4.10e-01	0.20600	1.46e-01	-1.45e-01	2.48e-01	2.49e-01
GOBP PURINE RIBONUCLEOSIDE METABOLIC PROCESS	20	3.52e-01	5.90e-01	0.20600	1.48e-01	1.42e-01	2.51e-01	2.70e-01
GOMF MHC PROTEIN COMPLEX BINDING	34	7.62e-02	2.45e-01	0.20600	-1.92e-01	7.28e-02	5.24e-02	4.62e-01
GOBP REGULATION OF B CELL PROLIFERATION	62	1.00e-02	6.00e-02	0.20500	-1.96e-01	6.11e-02	7.54e-03	4.05e-01
GOMF ACETYLESTERASE ACTIVITY	5	7.01e-01	8.45e-01	0.20500	2.03e-01	-3.44e-02	4.33e-01	8.94e-01
GOBP DNA TOPOLOGICAL CHANGE	9	6.07e-01	7.84e-01	0.20500	1.86e-01	8.74e-02	3.34e-01	6.50e-01
Viral Infection Pathways	743	4.21e-17	5.12e-15	0.20500	1.60e-01	1.29e-01	1.30e-13	1.86e-09
Hyaluronan uptake and degradation	12	4.57e-01	6.82e-01	0.20500	2.05e-01	7.36e-03	2.18e-01	9.65e-01
GOBP HEME TRANSPORT	8	5.35e-01	7.37e-01	0.20500	-9.73e-02	1.81e-01	6.34e-01	3.76e-01
GOMF HEME TRANSMEMBRANE TRANSPORTER ACTIVITY	8	5.35e-01	7.37e-01	0.20500	-9.73e-02	1.81e-01	6.34e-01	3.76e-01
GOBP PHOTORECEPTOR CELL MAINTENANCE	43	6.29e-02	2.17e-01	0.20500	-1.27e-02	-2.05e-01	8.85e-01	2.01e-02
GOBP ESTABLISHMENT OF MITOCHONDRION LOCALIZATION	29	2.01e-01	4.31e-01	0.20500	8.60e-02	1.86e-01	4.23e-01	8.25e-02
GOBP POSITIVE REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY	8	6.14e-01	7.87e-01	0.20500	3.77e-02	2.02e-01	8.53e-01	3.23e-01
GOBP POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS	32	1.36e-01	3.46e-01	0.20500	-2.66e-02	-2.03e-01	7.95e-01	4.65e-02
GOMF 3 5 DNA HELICASE ACTIVITY	15	4.59e-01	6.83e-01	0.20500	1.40e-01	1.50e-01	3.47e-01	3.16e-01
Glutathione synthesis and recycling	12	4.22e-01	6.52e-01	0.20500	-2.00e-01	4.36e-02	2.29e-01	7.94e-01
GOBP NK T CELL DIFFERENTIATION	11	5.49e-01	7.45e-01	0.20500	1.82e-01	9.40e-02	2.95e-01	5.89e-01
GOMF TRANSPORTER INHIBITOR ACTIVITY	40	1.24e-01	3.28e-01	0.20500	1.62e-01	1.26e-01	7.71e-02	1.67e-01
GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS	18	2.40e-01	4.77e-01	0.20500	1.68e-01	-1.18e-01	2.18e-01	3.86e-01
GOBP REGULATION OF PHOSPHOLIPID TRANSPORT	15	4.59e-01	6.83e-01	0.20500	-1.43e-01	-1.46e-01	3.36e-01	3.26e-01
Erythrocytes take up carbon dioxide and release oxygen	12	3.99e-01	6.32e-01	0.20500	-1.87e-01	8.39e-02	2.62e-01	6.15e-01
O2/CO2 exchange in erythrocytes	12	3.99e-01	6.32e-01	0.20500	-1.87e-01	8.39e-02	2.62e-01	6.15e-01
GOBP GLOMERULAR EPITHELIAL CELL DEVELOPMENT	12	3.96e-01	6.29e-01	0.20500	1.83e-01	-9.18e-02	2.72e-01	5.82e-01
GOBP POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION	21	2.44e-01	4.82e-01	0.20500	-8.96e-03	2.05e-01	9.43e-01	1.04e-01
GOBP INTRACELLULAR TRANSPORT	1295	2.24e-29	6.10e-27	0.20500	1.79e-01	9.93e-02	2.10e-27	1.89e-09
GOMF CALCIUM MONOATOMIC CATION ANTIPORTER ACTIVITY	13	4.77e-01	6.95e-01	0.20500	-6.84e-02	-1.93e-01	6.70e-01	2.28e-01
GOBP POSITIVE REGULATION OF HORMONE METABOLIC PROCESS	15	3.44e-01	5.81e-01	0.20500	-2.01e-01	3.86e-02	1.77e-01	7.96e-01
GOMF PROTEIN PHOSPHORYLATED AMINO ACID BINDING	58	3.40e-02	1.44e-01	0.20500	5.61e-02	1.97e-01	4.60e-01	9.48e-03
GOMF 7SK SNRNA BINDING	9	6.25e-01	7.94e-01	0.20500	1.23e-01	1.63e-01	5.22e-01	3.96e-01
GOBP MEGAKARYOCYTE DEVELOPMENT	22	2.62e-01	5.01e-01	0.20500	3.58e-02	2.02e-01	7.71e-01	1.02e-01
GOCC MICROTUBULE PLUS END	24	2.89e-01	5.28e-01	0.20500	1.39e-01	1.50e-01	2.39e-01	2.02e-01
Translocation of SLC2A4 (GLUT4) to the plasma membrane	70	2.25e-02	1.08e-01	0.20500	9.34e-02	1.82e-01	1.77e-01	8.44e-03
Regulation of NPAS4 gene transcription	5	7.15e-01	8.53e-01	0.20500	-2.04e-01	9.34e-03	4.29e-01	9.71e-01
GOBP SODIUM ION TRANSMEMBRANE TRANSPORT	179	1.03e-04	1.58e-03	0.20500	-1.41e-01	-1.48e-01	1.14e-03	6.22e-04
GOMF GANGLIOSIDE BINDING	5	7.70e-01	8.84e-01	0.20500	-1.20e-01	-1.66e-01	6.42e-01	5.21e-01
GOBP REGULATION OF PROGRAMMED NECROTIC CELL DEATH	37	1.46e-01	3.59e-01	0.20500	1.27e-01	1.60e-01	1.82e-01	9.13e-02
Signaling by ERBB2 TMD/JMD mutants	22	2.04e-01	4.35e-01	0.20400	1.98e-01	-4.98e-02	1.07e-01	6.86e-01
GOBP REGULATION OF EMBRYONIC DEVELOPMENT	88	8.53e-03	5.34e-02	0.20400	1.82e-01	9.24e-02	3.11e-03	1.34e-01
GOBP CARDIOBLAST PROLIFERATION	12	5.32e-01	7.35e-01	0.20400	1.14e-01	1.69e-01	4.92e-01	3.10e-01
GOBP NEGATIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS	6	6.87e-01	8.37e-01	0.20400	2.18e-02	2.03e-01	9.26e-01	3.89e-01
GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION	46	7.96e-02	2.52e-01	0.20400	1.86e-01	8.38e-02	2.87e-02	3.26e-01
GOBP NEGATIVE REGULATION OF MACROAUTOPHAGY	33	1.33e-01	3.41e-01	0.20400	2.02e-01	3.16e-02	4.48e-02	7.53e-01
GOBP NEGATIVE REGULATION OF BONE REMODELING	18	3.44e-01	5.81e-01	0.20400	4.62e-02	1.99e-01	7.34e-01	1.44e-01
GOMF SELENIUM BINDING	9	6.06e-01	7.83e-01	0.20400	1.89e-01	7.79e-02	3.27e-01	6.86e-01
Antiviral mechanism by IFN-stimulated genes	144	5.83e-04	6.83e-03	0.20400	1.63e-01	1.23e-01	7.39e-04	1.07e-02
Pre-NOTCH Expression and Processing	84	1.28e-02	7.19e-02	0.20400	1.63e-01	1.23e-01	9.71e-03	5.19e-02
GOBP T CELL CYTOKINE PRODUCTION	36	6.84e-02	2.28e-01	0.20400	-1.91e-01	7.08e-02	4.68e-02	4.63e-01
GOMF HEPARAN SULFATE BINDING	7	6.84e-01	8.35e-01	0.20400	-1.83e-01	-9.06e-02	4.02e-01	6.78e-01
GOCC CYTOSOLIC SMALL RIBOSOMAL SUBUNIT	38	1.39e-01	3.51e-01	0.20400	1.21e-01	1.64e-01	1.98e-01	7.95e-02
GOBP ANOIKIS	32	1.77e-01	4.00e-01	0.20400	1.83e-01	9.06e-02	7.37e-02	3.75e-01
GOBP RESPONSE TO PROSTAGLANDIN	32	1.01e-01	2.93e-01	0.20400	1.98e-01	-4.68e-02	5.20e-02	6.47e-01
GOBP REGULATION OF SUPEROXIDE METABOLIC PROCESS	28	1.41e-01	3.53e-01	0.20400	-3.56e-02	2.01e-01	7.44e-01	6.60e-02
GOMF PROTEIN GLUTAMIC ACID LIGASE ACTIVITY	10	5.59e-01	7.52e-01	0.20400	-5.44e-02	-1.96e-01	7.66e-01	2.82e-01
Platelet sensitization by LDL	17	3.51e-01	5.89e-01	0.20400	2.02e-01	2.73e-02	1.49e-01	8.45e-01
GOBP STEM CELL PROLIFERATION	121	1.81e-03	1.63e-02	0.20400	1.70e-01	1.12e-01	1.23e-03	3.27e-02
GOBP POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION	114	1.30e-03	1.27e-02	0.20400	1.98e-01	5.02e-02	2.69e-04	3.55e-01
GOBP POLY N ACETYLLACTOSAMINE METABOLIC PROCESS	10	4.54e-01	6.79e-01	0.20400	-1.53e-01	1.34e-01	4.01e-01	4.63e-01
GOBP REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION	18	3.90e-01	6.23e-01	0.20400	-1.12e-01	-1.70e-01	4.12e-01	2.11e-01
GOBP TOR SIGNALING	158	2.06e-04	2.83e-03	0.20400	1.82e-01	9.07e-02	7.59e-05	4.91e-02
Maturation of nucleoprotein 9694631	15	4.25e-01	6.54e-01	0.20400	1.94e-01	6.25e-02	1.94e-01	6.75e-01
GOBP POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY	11	4.19e-01	6.50e-01	0.20400	-1.50e-01	1.37e-01	3.88e-01	4.30e-01
GOBP MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY	18	2.67e-01	5.06e-01	0.20400	-1.93e-01	6.37e-02	1.55e-01	6.40e-01
GOBP TRANSEPITHELIAL CHLORIDE TRANSPORT	8	6.28e-01	7.96e-01	0.20400	-5.24e-02	-1.97e-01	7.97e-01	3.35e-01
GOBP ENDOSOME ORGANIZATION	94	8.29e-03	5.23e-02	0.20400	1.43e-01	1.45e-01	1.69e-02	1.49e-02
GOCC FICOLIN 1 RICH GRANULE MEMBRANE	59	9.53e-03	5.78e-02	0.20400	-1.44e-01	1.44e-01	5.63e-02	5.53e-02
GOBP CARDIAC CELL DEVELOPMENT	92	1.43e-03	1.36e-02	0.20400	1.98e-01	-4.75e-02	1.03e-03	4.31e-01
GOMF ALPHA N ACETYLNEURAMINATE ALPHA 2 8 SIALYLTRANSFERASE ACTIVITY	6	6.33e-01	7.99e-01	0.20400	-9.07e-02	1.82e-01	7.01e-01	4.40e-01
GOCC CHAPERONIN CONTAINING T COMPLEX	10	4.94e-01	7.07e-01	0.20400	1.99e-01	-4.02e-02	2.75e-01	8.26e-01
GOBP POSITIVE REGULATION OF PROTEIN MATURATION	26	2.35e-01	4.71e-01	0.20300	-1.90e-01	-7.19e-02	9.32e-02	5.26e-01
GOBP POSITIVE REGULATION OF FATTY ACID BETA OXIDATION	10	6.00e-01	7.79e-01	0.20300	1.40e-01	1.48e-01	4.44e-01	4.19e-01
GOBP REGULATION OF CELL CYCLE G1 S PHASE TRANSITION	201	1.56e-05	3.16e-04	0.20300	1.89e-01	7.33e-02	3.61e-06	7.30e-02
GOBP NUCLEAR BODY ORGANIZATION	17	4.08e-01	6.41e-01	0.20300	1.75e-01	1.03e-01	2.12e-01	4.61e-01
GOCC AMPA GLUTAMATE RECEPTOR COMPLEX	22	2.89e-01	5.28e-01	0.20300	-1.92e-01	-6.46e-02	1.18e-01	6.00e-01
Autophagy	149	3.44e-04	4.38e-03	0.20300	1.83e-01	8.89e-02	1.20e-04	6.10e-02
GOBP NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY	95	8.08e-03	5.12e-02	0.20300	1.40e-01	1.47e-01	1.84e-02	1.33e-02
GOCC RNA CAP BINDING COMPLEX	16	4.27e-01	6.56e-01	0.20300	1.78e-01	9.68e-02	2.17e-01	5.03e-01
GOBP SEROTONIN RECEPTOR SIGNALING PATHWAY	8	5.71e-01	7.61e-01	0.20300	1.99e-01	-4.01e-02	3.30e-01	8.44e-01
GOBP PROTEIN LOCALIZATION TO CELL CORTEX	11	5.61e-01	7.54e-01	0.20300	1.05e-01	1.74e-01	5.47e-01	3.18e-01
GOBP T CELL APOPTOTIC PROCESS	57	2.26e-02	1.08e-01	0.20300	-1.40e-02	2.02e-01	8.55e-01	8.18e-03
GOBP METANEPHRIC LOOP OF HENLE DEVELOPMENT	6	6.47e-01	8.08e-01	0.20300	-6.09e-02	1.94e-01	7.96e-01	4.12e-01
Insulin receptor recycling	28	2.41e-01	4.79e-01	0.20300	1.37e-01	1.49e-01	2.08e-01	1.72e-01
Toll Like Receptor 7/8 (TLR7/8) Cascade	98	6.98e-03	4.57e-02	0.20300	1.50e-01	1.37e-01	1.03e-02	1.94e-02
GOBP 7 METHYLGUANOSINE RNA CAPPING	7	6.91e-01	8.39e-01	0.20300	1.00e-01	1.76e-01	6.46e-01	4.19e-01
GOBP BARBED END ACTIN FILAMENT CAPPING	25	1.44e-01	3.57e-01	0.20300	1.66e-01	-1.17e-01	1.52e-01	3.11e-01
GOBP REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT	10	5.79e-01	7.66e-01	0.20300	1.87e-01	7.84e-02	3.06e-01	6.68e-01
GOBP MIRNA MEDIATED GENE SILENCING BY MRNA DESTABILIZATION	96	6.64e-03	4.41e-02	0.20300	-1.03e-01	-1.74e-01	8.02e-02	3.14e-03
GOCC EXTERNAL ENCAPSULATING STRUCTURE	537	6.62e-13	5.53e-11	0.20300	-9.12e-02	-1.81e-01	3.00e-04	6.98e-13
GOBP DOPAMINE TRANSPORT	44	5.70e-02	2.03e-01	0.20300	-2.03e-01	5.00e-03	2.01e-02	9.54e-01
GOBP REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	24	1.64e-01	3.84e-01	0.20300	-9.00e-02	1.82e-01	4.45e-01	1.24e-01
GOBP ANAGEN	5	6.96e-01	8.42e-01	0.20300	1.93e-01	-6.07e-02	4.54e-01	8.14e-01
GOBP INTRACELLULAR PROTEIN TRANSMEMBRANE TRANSPORT	30	2.19e-01	4.52e-01	0.20300	1.39e-01	1.47e-01	1.86e-01	1.63e-01
GOBP NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION	15	3.12e-01	5.52e-01	0.20300	1.61e-01	-1.23e-01	2.81e-01	4.10e-01
GOBP INTRACELLULAR PROTEIN TRANSPORT	646	7.05e-15	6.98e-13	0.20200	1.70e-01	1.10e-01	1.48e-13	2.00e-06
GOBP POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND	10	5.62e-01	7.54e-01	0.20200	5.08e-02	1.96e-01	7.81e-01	2.83e-01
GOBP PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS	31	2.07e-01	4.38e-01	0.20200	-1.29e-01	-1.56e-01	2.13e-01	1.33e-01
GOBP NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION	13	4.51e-01	6.76e-01	0.20200	2.01e-01	2.35e-02	2.09e-01	8.84e-01
GOBP MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY	53	4.91e-02	1.85e-01	0.20200	5.64e-02	1.94e-01	4.78e-01	1.44e-02
Mitochondrial RNA degradation	10	5.16e-01	7.22e-01	0.20200	2.02e-01	-1.40e-02	2.69e-01	9.39e-01
MyD88 dependent cascade initiated on endosome	96	7.65e-03	4.91e-02	0.20200	1.59e-01	1.25e-01	7.15e-03	3.37e-02
GOBP PML BODY ORGANIZATION	7	6.77e-01	8.30e-01	0.20200	1.91e-01	6.69e-02	3.82e-01	7.59e-01
GOMF P TYPE TRANSMEMBRANE TRANSPORTER ACTIVITY	23	2.00e-01	4.30e-01	0.20200	4.24e-02	-1.98e-01	7.25e-01	1.00e-01
GOMF ATP DEPENDENT PROTEIN FOLDING CHAPERONE	35	1.52e-01	3.68e-01	0.20200	1.84e-01	8.43e-02	5.97e-02	3.88e-01
GOBP POSITIVE REGULATION OF CELL CYCLE PROCESS	258	3.59e-07	1.15e-05	0.20200	1.97e-01	4.65e-02	5.13e-08	1.98e-01
GOBP NEGATIVE REGULATION OF MEIOTIC CELL CYCLE PHASE TRANSITION	7	5.90e-01	7.73e-01	0.20200	1.80e-01	-9.26e-02	4.10e-01	6.71e-01
Formation of a pool of free 40S subunits	93	9.29e-03	5.68e-02	0.20200	1.44e-01	1.42e-01	1.64e-02	1.80e-02
GOBP FOLIC ACID TRANSPORT	10	5.73e-01	7.63e-01	0.20200	-1.91e-01	-6.65e-02	2.96e-01	7.16e-01
GOBP NEGATIVE REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY	9	4.97e-01	7.09e-01	0.20200	-1.28e-01	1.56e-01	5.05e-01	4.17e-01
RAF-independent MAPK1/3 activation	22	1.89e-01	4.17e-01	0.20200	-9.58e-02	1.78e-01	4.36e-01	1.48e-01
GOMF 1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE ACTIVITY	8	6.09e-01	7.85e-01	0.20200	1.61e-02	2.01e-01	9.37e-01	3.24e-01
GOBP REGULATION OF B CELL DIFFERENTIATION	33	9.11e-02	2.74e-01	0.20200	-6.64e-02	1.91e-01	5.09e-01	5.78e-02
GOBP POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION	31	2.07e-01	4.38e-01	0.20200	1.23e-01	1.60e-01	2.35e-01	1.23e-01
GOCC CALCITONIN FAMILY RECEPTOR COMPLEX	5	7.56e-01	8.75e-01	0.20200	-6.25e-02	-1.92e-01	8.09e-01	4.57e-01
GOCC PROTEIN KINASE COMPLEX	137	1.03e-03	1.07e-02	0.20200	1.51e-01	1.34e-01	2.24e-03	6.79e-03
GOBP REGULATION OF ACTIN NUCLEATION	38	5.64e-02	2.02e-01	0.20200	1.76e-01	-9.82e-02	5.97e-02	2.95e-01
GOBP TETRAHYDROFOLATE INTERCONVERSION	9	5.05e-01	7.14e-01	0.20200	-9.90e-02	1.76e-01	6.07e-01	3.60e-01
Binding and Uptake of Ligands by Scavenger Receptors	41	6.81e-02	2.27e-01	0.20200	1.14e-02	-2.02e-01	9.00e-01	2.55e-02
GOBP POSITIVE REGULATION OF ISOTYPE SWITCHING	28	2.08e-01	4.40e-01	0.20200	1.92e-01	6.11e-02	7.80e-02	5.76e-01
NOTCH1 Intracellular Domain Regulates Transcription	44	8.78e-02	2.68e-01	0.20200	1.90e-01	6.76e-02	2.91e-02	4.38e-01
GOBP REGULATION OF GLUTAMATE SECRETION NEUROTRANSMISSION	5	7.64e-01	8.81e-01	0.20200	8.33e-02	1.84e-01	7.47e-01	4.77e-01
GOMF PROTEIN SERINE THREONINE PHOSPHATASE INHIBITOR ACTIVITY	12	4.44e-01	6.71e-01	0.20200	2.00e-01	-2.68e-02	2.30e-01	8.72e-01
GOBP REGULATION OF DNA BIOSYNTHETIC PROCESS	114	2.96e-03	2.38e-02	0.20200	1.68e-01	1.12e-01	1.99e-03	3.83e-02
GOMF MHC CLASS II PROTEIN COMPLEX BINDING	25	1.44e-01	3.57e-01	0.20200	-1.40e-01	1.45e-01	2.26e-01	2.09e-01
GOMF PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR ACTIVITY	5	7.75e-01	8.87e-01	0.20200	1.62e-01	1.20e-01	5.30e-01	6.42e-01
GOBP PARACRINE SIGNALING	7	6.32e-01	7.99e-01	0.20200	-1.20e-02	2.01e-01	9.56e-01	3.56e-01
GOBP ANTERIOR POSTERIOR AXON GUIDANCE	7	5.82e-01	7.69e-01	0.20200	-1.57e-01	1.26e-01	4.71e-01	5.63e-01
GOBP GLYCOSIDE CATABOLIC PROCESS	8	6.69e-01	8.25e-01	0.20200	1.48e-01	1.37e-01	4.69e-01	5.02e-01
Interferon alpha/beta signaling	74	8.44e-03	5.29e-02	0.20200	-6.29e-03	2.02e-01	9.25e-01	2.72e-03
GOBP ZYMOGEN INHIBITION	7	5.85e-01	7.70e-01	0.20200	-1.14e-01	1.66e-01	6.02e-01	4.46e-01
GOMF 4 IRON 4 SULFUR CLUSTER BINDING	45	6.06e-02	2.12e-01	0.20200	2.01e-01	1.07e-02	1.95e-02	9.01e-01
GOBP GLUCOCORTICOID SECRETION	12	4.04e-01	6.37e-01	0.20200	-1.76e-01	9.81e-02	2.91e-01	5.56e-01
GOMF PHOSPHATIDYLINOSITOL 3 KINASE REGULATORY SUBUNIT BINDING	11	4.34e-01	6.62e-01	0.20200	-1.72e-01	1.05e-01	3.23e-01	5.46e-01
GOCC MONOATOMIC ION CHANNEL COMPLEX	327	6.66e-08	2.51e-06	0.20200	-1.68e-01	-1.11e-01	1.75e-07	5.37e-04
GOBP REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS	45	1.02e-01	2.93e-01	0.20200	1.18e-01	1.64e-01	1.72e-01	5.75e-02
GOCC INCLUSION BODY	70	2.86e-02	1.28e-01	0.20100	1.65e-01	1.16e-01	1.73e-02	9.25e-02
GOBP LYMPHOCYTE APOPTOTIC PROCESS	79	8.15e-03	5.16e-02	0.20100	2.01e-02	2.00e-01	7.58e-01	2.07e-03
GOBP LABYRINTHINE LAYER DEVELOPMENT	44	4.49e-02	1.75e-01	0.20100	-5.31e-02	1.94e-01	5.42e-01	2.58e-02
GOBP ESTABLISHMENT OF CENTROSOME LOCALIZATION	10	5.40e-01	7.39e-01	0.20100	-1.50e-02	-2.01e-01	9.35e-01	2.72e-01
GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY	9	5.37e-01	7.38e-01	0.20100	4.05e-02	-1.97e-01	8.33e-01	3.06e-01
GOBP REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY	55	5.22e-02	1.93e-01	0.20100	7.89e-02	1.85e-01	3.11e-01	1.76e-02
GOBP RESPONSE TO UV	150	5.11e-04	6.13e-03	0.20100	1.65e-01	1.15e-01	4.75e-04	1.53e-02
GOMF INTERLEUKIN 2 RECEPTOR BINDING	5	6.97e-01	8.42e-01	0.20100	-1.89e-01	6.77e-02	4.63e-01	7.93e-01
GOBP REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL	38	1.31e-01	3.39e-01	0.20100	-1.84e-01	-8.10e-02	4.95e-02	3.88e-01
GOCC OXIDOREDUCTASE COMPLEX	104	4.71e-03	3.39e-02	0.20100	1.74e-01	1.01e-01	2.20e-03	7.39e-02
GOBP CYTOKINESIS	179	1.40e-04	2.04e-03	0.20100	1.44e-01	1.41e-01	9.03e-04	1.18e-03
GOBP POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION	51	5.09e-02	1.90e-01	0.20100	1.97e-01	3.74e-02	1.47e-02	6.44e-01
GOBP NEUTRAL LIPID CATABOLIC PROCESS	37	1.58e-01	3.76e-01	0.20100	-1.44e-01	-1.41e-01	1.31e-01	1.39e-01
GOBP REGULATION OF MEMBRANE REPOLARIZATION	38	7.81e-02	2.49e-01	0.20100	2.78e-02	-1.99e-01	7.67e-01	3.37e-02
GOBP DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN	19	3.84e-01	6.18e-01	0.20100	-1.20e-01	-1.61e-01	3.66e-01	2.23e-01
GOBP CARDIOCYTE DIFFERENTIATION	161	4.90e-05	8.59e-04	0.20100	2.01e-01	1.03e-02	1.11e-05	8.22e-01
GOBP CONNECTIVE TISSUE REPLACEMENT	21	2.28e-01	4.62e-01	0.20100	-5.42e-02	1.93e-01	6.67e-01	1.25e-01
GOBP PLATELET DERIVED GROWTH FACTOR RECEPTOR ALPHA SIGNALING PATHWAY	7	6.24e-01	7.94e-01	0.20100	-2.90e-02	1.99e-01	8.94e-01	3.62e-01
GOBP NEGATIVE REGULATION OF CELL CYCLE	391	3.07e-09	1.52e-07	0.20100	1.68e-01	1.10e-01	1.13e-08	1.93e-04
GOBP ADHERENS JUNCTION MAINTENANCE	7	6.54e-01	8.13e-01	0.20100	-2.00e-02	-2.00e-01	9.27e-01	3.60e-01
GOBP REGULATION OF INCLUSION BODY ASSEMBLY	17	4.22e-01	6.52e-01	0.20100	1.13e-01	1.66e-01	4.20e-01	2.36e-01
Azathioprine ADME	22	1.93e-01	4.21e-01	0.20100	1.75e-01	-9.84e-02	1.55e-01	4.24e-01
GOMF PHOSPHATIDYLINOSITOL TRISPHOSPHATE PHOSPHATASE ACTIVITY	9	5.53e-01	7.48e-01	0.20100	2.00e-01	-1.91e-02	2.99e-01	9.21e-01
GOBP REGULATION OF CATECHOLAMINE METABOLIC PROCESS	16	3.87e-01	6.21e-01	0.20100	2.97e-02	1.99e-01	8.37e-01	1.69e-01
GOBP NUCLEOBASE BIOSYNTHETIC PROCESS	15	3.16e-01	5.55e-01	0.20100	1.41e-01	-1.43e-01	3.45e-01	3.38e-01
GOBP DETECTION OF BACTERIUM	16	2.93e-01	5.32e-01	0.20100	-1.40e-01	1.43e-01	3.31e-01	3.21e-01
GOBP POST TRANSLATIONAL PROTEIN MODIFICATION	918	6.62e-20	9.67e-18	0.20100	1.58e-01	1.24e-01	5.19e-16	1.85e-10
GOBP REGULATION OF MACROAUTOPHAGY	174	4.21e-05	7.53e-04	0.20100	1.97e-01	3.66e-02	7.22e-06	4.05e-01
Transcriptional and post-translational regulation of MITF-M expression and activity	60	4.30e-02	1.70e-01	0.20000	1.81e-01	8.72e-02	1.56e-02	2.43e-01
GOBP REGULATION OF CENTRIOLE REPLICATION	22	3.27e-01	5.66e-01	0.20000	1.09e-01	1.69e-01	3.78e-01	1.71e-01
GOBP ANTERIOR POSTERIOR AXIS SPECIFICATION	55	6.56e-02	2.23e-01	0.20000	1.45e-01	1.39e-01	6.32e-02	7.53e-02
GOBP CELL REDOX HOMEOSTASIS	38	1.44e-01	3.57e-01	0.20000	1.06e-01	1.70e-01	2.58e-01	6.97e-02
GOCC ORGANELLE ENVELOPE LUMEN	89	1.13e-02	6.55e-02	0.20000	1.66e-01	1.13e-01	6.84e-03	6.64e-02
GOBP LACRIMAL GLAND DEVELOPMENT	7	6.07e-01	7.83e-01	0.20000	-6.51e-02	1.90e-01	7.65e-01	3.85e-01
RHO GTPases activate IQGAPs	30	2.16e-01	4.48e-01	0.20000	1.04e-01	1.71e-01	3.25e-01	1.04e-01
GOBP DETOXIFICATION OF NITROGEN COMPOUND	5	7.13e-01	8.52e-01	0.20000	1.97e-01	-3.50e-02	4.45e-01	8.92e-01
GOBP HIPPOCAMPUS DEVELOPMENT	91	1.12e-02	6.50e-02	0.20000	1.40e-01	1.43e-01	2.09e-02	1.82e-02
GOBP NEGATIVE REGULATION OF MICROGLIAL CELL ACTIVATION	7	6.21e-01	7.92e-01	0.20000	-3.83e-02	1.97e-01	8.61e-01	3.68e-01
GOBP PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS	23	2.65e-01	5.04e-01	0.20000	3.99e-02	1.96e-01	7.40e-01	1.03e-01
GOBP RESPONSE TO GONADOTROPIN RELEASING HORMONE	6	7.40e-01	8.68e-01	0.20000	1.60e-01	1.20e-01	4.97e-01	6.10e-01
GOCC MICROBODY MEMBRANE	61	4.81e-02	1.83e-01	0.20000	1.26e-01	1.56e-01	8.97e-02	3.51e-02
GOBP COPPER ION TRANSMEMBRANE TRANSPORT	7	5.93e-01	7.74e-01	0.20000	-1.73e-01	1.00e-01	4.27e-01	6.46e-01
GOBP PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS	16	4.09e-01	6.41e-01	0.20000	5.50e-02	1.93e-01	7.03e-01	1.82e-01
GOMF CARBOHYDRATE TRANSMEMBRANE TRANSPORTER ACTIVITY	40	7.83e-02	2.49e-01	0.20000	-2.00e-01	5.60e-03	2.85e-02	9.51e-01
GOBP LIMBIC SYSTEM DEVELOPMENT	120	2.65e-03	2.19e-02	0.20000	1.52e-01	1.30e-01	3.94e-03	1.40e-02
GOCC MITOCHONDRION	1596	4.76e-33	1.54e-30	0.20000	1.61e-01	1.19e-01	5.28e-27	2.66e-15
GOBP REGULATION OF HIPPO SIGNALING	35	1.47e-01	3.60e-01	0.20000	1.90e-01	6.30e-02	5.17e-02	5.19e-01
Rab regulation of trafficking	110	3.40e-03	2.64e-02	0.20000	9.25e-02	1.77e-01	9.37e-02	1.30e-03
GOBP POSITIVE REGULATION OF B CELL DIFFERENTIATION	15	3.89e-01	6.23e-01	0.20000	2.65e-04	2.00e-01	9.99e-01	1.80e-01
GOMF PEPTIDOGLYCAN BINDING	18	2.75e-01	5.15e-01	0.20000	-1.88e-01	6.94e-02	1.68e-01	6.10e-01
Apoptosis	160	3.47e-04	4.40e-03	0.20000	1.62e-01	1.18e-01	4.07e-04	1.03e-02
GOBP RESPONSE TO HISTAMINE	10	6.01e-01	7.79e-01	0.20000	-1.04e-01	-1.71e-01	5.69e-01	3.49e-01
GOBP GANGLIOSIDE CATABOLIC PROCESS	7	6.08e-01	7.84e-01	0.20000	-6.42e-02	1.90e-01	7.69e-01	3.85e-01
GOMF CYTOKINE ACTIVITY	225	6.96e-06	1.60e-04	0.20000	-1.85e-01	-7.72e-02	1.84e-06	4.59e-02
GOMF INOSITOL 1 3 4 5 6 PENTAKISPHOSPHATE KINASE ACTIVITY	5	7.31e-01	8.63e-01	0.20000	-2.33e-03	-2.00e-01	9.93e-01	4.39e-01
GOBP POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION	34	1.78e-01	4.03e-01	0.20000	1.70e-01	1.06e-01	8.65e-02	2.87e-01
GOBP PROTEIN LOCALIZATION TO PHOTORECEPTOR OUTER SEGMENT	7	6.26e-01	7.95e-01	0.20000	1.98e-01	-3.07e-02	3.65e-01	8.88e-01
GOCC AXON INITIAL SEGMENT	21	3.53e-01	5.90e-01	0.20000	-1.54e-01	-1.27e-01	2.22e-01	3.12e-01
GOBP CELLULAR RESPONSE TO POTASSIUM ION	12	5.05e-01	7.14e-01	0.20000	-1.95e-01	-4.40e-02	2.42e-01	7.92e-01
GOBP IMMUNE SYSTEM DEVELOPMENT	197	3.55e-05	6.58e-04	0.20000	8.50e-02	1.81e-01	3.96e-02	1.19e-05
GOMF CARBOHYDRATE PHOSPHATASE ACTIVITY	9	5.13e-01	7.21e-01	0.20000	-1.75e-01	9.71e-02	3.64e-01	6.14e-01
GOMF ACYLTRANSFERASE ACTIVITY TRANSFERRING GROUPS OTHER THAN AMINO ACYL GROUPS	208	3.41e-05	6.32e-04	0.20000	1.61e-01	1.18e-01	6.25e-05	3.28e-03
GOBP CELLULAR RESPONSE TO LIGHT STIMULUS	113	1.88e-03	1.68e-02	0.20000	1.93e-01	5.31e-02	4.06e-04	3.29e-01
Cilium Assembly	189	4.02e-05	7.26e-04	0.20000	1.87e-01	6.89e-02	8.79e-06	1.03e-01
GOMF CYCLOHYDROLASE ACTIVITY	5	7.32e-01	8.63e-01	0.20000	-2.00e-01	-1.34e-03	4.39e-01	9.96e-01
GOMF DNA POLYMERASE ACTIVITY	28	2.21e-01	4.55e-01	0.20000	1.87e-01	6.91e-02	8.61e-02	5.27e-01
Extra-nuclear estrogen signaling	74	1.63e-02	8.60e-02	0.20000	1.92e-01	5.31e-02	4.20e-03	4.30e-01
GOBP LIPOPROTEIN CATABOLIC PROCESS	15	4.75e-01	6.95e-01	0.20000	1.59e-01	1.21e-01	2.88e-01	4.16e-01
GOBP NEGATIVE REGULATION OF RNA CATABOLIC PROCESS	81	1.78e-02	9.14e-02	0.20000	1.62e-01	1.17e-01	1.18e-02	6.93e-02
GOBP RIBOFLAVIN METABOLIC PROCESS	5	7.23e-01	8.58e-01	0.20000	1.99e-01	-1.69e-02	4.41e-01	9.48e-01
GOBP COBALAMIN METABOLIC PROCESS	9	6.40e-01	8.04e-01	0.20000	1.56e-01	1.24e-01	4.17e-01	5.20e-01
GOBP PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS	20	2.26e-01	4.60e-01	0.20000	-1.71e-01	1.03e-01	1.87e-01	4.23e-01
HIV elongation arrest and recovery	33	1.71e-01	3.92e-01	0.20000	7.11e-02	1.86e-01	4.80e-01	6.38e-02
Pausing and recovery of HIV elongation	33	1.71e-01	3.92e-01	0.20000	7.11e-02	1.86e-01	4.80e-01	6.38e-02
GOCC OUTER DENSE FIBER	6	7.45e-01	8.70e-01	0.19900	-1.43e-01	-1.39e-01	5.43e-01	5.57e-01
GOBP PRENYLATION	11	4.36e-01	6.64e-01	0.19900	1.58e-01	-1.21e-01	3.63e-01	4.86e-01
Synthesis of PE	13	4.63e-01	6.86e-01	0.19900	2.45e-02	1.98e-01	8.79e-01	2.17e-01
GOBP HEART TRABECULA MORPHOGENESIS	32	1.95e-01	4.24e-01	0.19900	9.61e-02	1.75e-01	3.47e-01	8.70e-02
GOBP POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS	192	7.30e-05	1.19e-03	0.19900	1.64e-01	1.13e-01	8.56e-05	6.96e-03
GOBP INTERLEUKIN 17 PRODUCTION	47	3.62e-02	1.51e-01	0.19900	-1.89e-01	6.49e-02	2.53e-02	4.41e-01
GOMF HISTONE H4 METHYLTRANSFERASE ACTIVITY	17	3.98e-01	6.31e-01	0.19900	1.88e-01	6.57e-02	1.79e-01	6.39e-01
GOMF STORE OPERATED CALCIUM CHANNEL ACTIVITY	9	5.86e-01	7.70e-01	0.19900	2.29e-02	1.98e-01	9.05e-01	3.03e-01
GOMF N6 METHYLADENOSINE CONTAINING RNA READER ACTIVITY	11	4.40e-01	6.67e-01	0.19900	1.68e-01	-1.08e-01	3.36e-01	5.35e-01
GOBP REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC	8	5.51e-01	7.46e-01	0.19900	-1.07e-01	1.68e-01	5.99e-01	4.11e-01
GOBP APOPTOTIC MITOCHONDRIAL CHANGES	103	3.75e-03	2.85e-02	0.19900	6.26e-02	1.89e-01	2.72e-01	9.05e-04
GOCC PARANODE REGION OF AXON	12	4.11e-01	6.44e-01	0.19900	-1.00e-01	1.72e-01	5.48e-01	3.01e-01
GOMF PHOSPHATE ION BINDING	11	5.77e-01	7.66e-01	0.19900	-1.10e-01	-1.66e-01	5.27e-01	3.40e-01
GOBP GDP METABOLIC PROCESS	9	6.01e-01	7.79e-01	0.19900	-4.44e-02	-1.94e-01	8.18e-01	3.13e-01
TCR signaling	100	7.27e-03	4.70e-02	0.19900	1.58e-01	1.21e-01	6.29e-03	3.63e-02
GOBP 2 OXOGLUTARATE METABOLIC PROCESS	16	4.31e-01	6.59e-01	0.19900	7.88e-02	1.83e-01	5.85e-01	2.05e-01
GOBP REGULATION OF CELLULAR SENESCENCE	53	5.56e-02	2.01e-01	0.19900	6.02e-02	1.90e-01	4.49e-01	1.68e-02
GOMF STRUCTURAL CONSTITUENT OF MUSCLE	41	8.56e-02	2.64e-01	0.19900	-1.67e-02	-1.98e-01	8.53e-01	2.79e-02
GOBP COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT	53	5.28e-02	1.95e-01	0.19900	5.16e-02	1.92e-01	5.16e-01	1.55e-02
GOBP NEGATIVE REGULATION OF CELL MATRIX ADHESION	37	8.03e-02	2.53e-01	0.19900	1.94e-01	-4.62e-02	4.15e-02	6.27e-01
GOBP REGULATION OF APOPTOTIC SIGNALING PATHWAY	378	5.60e-09	2.59e-07	0.19900	9.44e-02	1.75e-01	1.62e-03	4.95e-09
SHC-mediated cascade:FGFR3	17	4.01e-01	6.34e-01	0.19900	1.87e-01	6.70e-02	1.81e-01	6.33e-01
Peroxisomal lipid metabolism	27	2.36e-01	4.72e-01	0.19900	6.85e-02	1.87e-01	5.38e-01	9.29e-02
GOMF ALDOSE REDUCTASE NADPH ACTIVITY	12	5.39e-01	7.38e-01	0.19900	-1.78e-01	-8.84e-02	2.85e-01	5.96e-01
GOBP MITOCHONDRION ORGANIZATION	490	4.75e-11	3.20e-09	0.19900	1.62e-01	1.16e-01	8.96e-10	1.09e-05
GOBP REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME	12	5.05e-01	7.14e-01	0.19900	3.97e-02	1.95e-01	8.12e-01	2.43e-01
GOBP EXTRINSIC APOPTOTIC SIGNALING PATHWAY	222	1.41e-05	2.91e-04	0.19900	9.71e-02	1.74e-01	1.27e-02	8.35e-06
GOBP REGULATION OF REGULATED SECRETORY PATHWAY	104	6.95e-04	7.92e-03	0.19900	-6.38e-02	1.88e-01	2.61e-01	9.04e-04
DARPP-32 events	24	2.72e-01	5.11e-01	0.19900	1.89e-01	6.10e-02	1.09e-01	6.05e-01
GOBP RESPONSE TO ALDOSTERONE	17	3.56e-01	5.93e-01	0.19900	-1.99e-01	-9.94e-03	1.56e-01	9.43e-01
The role of GTSE1 in G2/M progression after G2 checkpoint	64	4.40e-02	1.73e-01	0.19900	1.50e-01	1.30e-01	3.76e-02	7.19e-02
GOMF WATER TRANSMEMBRANE TRANSPORTER ACTIVITY	18	4.14e-01	6.45e-01	0.19900	-1.52e-01	-1.29e-01	2.66e-01	3.45e-01
RSK activation	5	7.55e-01	8.75e-01	0.19900	4.53e-02	1.93e-01	8.61e-01	4.54e-01
GOBP VESICLE TRANSPORT ALONG MICROTUBULE	46	7.66e-02	2.45e-01	0.19900	1.93e-01	4.68e-02	2.35e-02	5.83e-01
GOBP NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY	12	4.84e-01	6.99e-01	0.19900	1.15e-02	1.98e-01	9.45e-01	2.34e-01
GOBP CYCLIC GMP AMP TRANSMEMBRANE IMPORT ACROSS PLASMA MEMBRANE	8	5.48e-01	7.45e-01	0.19900	-1.33e-01	1.48e-01	5.16e-01	4.69e-01
GOBP RESPONSE TO ISCHEMIA	64	3.65e-02	1.52e-01	0.19900	8.36e-02	1.80e-01	2.47e-01	1.27e-02
GOBP POSITIVE REGULATION OF MESENCHYMAL STEM CELL PROLIFERATION	6	6.87e-01	8.37e-01	0.19900	-1.99e-01	4.85e-03	4.00e-01	9.84e-01
GOBP POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY	19	3.86e-01	6.20e-01	0.19900	1.70e-01	1.03e-01	2.01e-01	4.35e-01
GOBP REGULATION OF RIG I SIGNALING PATHWAY	19	3.83e-01	6.17e-01	0.19900	1.73e-01	9.80e-02	1.93e-01	4.60e-01
Defective CHSY1 causes TPBS	7	7.11e-01	8.51e-01	0.19800	1.34e-01	1.46e-01	5.39e-01	5.02e-01
GOMF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVATOR ACTIVITY	6	7.04e-01	8.47e-01	0.19800	2.60e-02	1.97e-01	9.12e-01	4.04e-01
GOBP POSITIVE REGULATION OF GAMMA DELTA T CELL ACTIVATION	9	6.46e-01	8.08e-01	0.19800	-1.44e-01	-1.37e-01	4.55e-01	4.78e-01
GOBP ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS	311	1.28e-07	4.52e-06	0.19800	1.80e-01	8.36e-02	4.83e-08	1.13e-02
GOMF TUMOR NECROSIS FACTOR RECEPTOR ACTIVITY	8	6.44e-01	8.07e-01	0.19800	-5.28e-02	-1.91e-01	7.96e-01	3.49e-01
GOBP CELL CYCLE G1 S PHASE TRANSITION	251	3.08e-06	7.89e-05	0.19800	1.77e-01	8.99e-02	1.42e-06	1.41e-02
trans-Golgi Network Vesicle Budding	67	3.76e-02	1.54e-01	0.19800	1.59e-01	1.18e-01	2.44e-02	9.35e-02
GOBP CARDIOLIPIN METABOLIC PROCESS	14	4.84e-01	6.99e-01	0.19800	1.81e-01	8.16e-02	2.42e-01	5.97e-01
GOBP NEURON RECOGNITION	46	1.08e-01	3.03e-01	0.19800	-1.36e-01	-1.45e-01	1.12e-01	8.97e-02
FRS-mediated FGFR1 signaling	23	2.34e-01	4.71e-01	0.19800	1.98e-01	-1.02e-02	1.00e-01	9.32e-01
GOMF GLUTATHIONE PEROXIDASE ACTIVITY	21	3.59e-01	5.96e-01	0.19800	1.54e-01	1.24e-01	2.21e-01	3.24e-01
Influenza Viral RNA Transcription and Replication	130	1.56e-03	1.45e-02	0.19800	1.69e-01	1.03e-01	8.57e-04	4.26e-02
FGFR2 mutant receptor activation	32	1.29e-01	3.36e-01	0.19800	1.97e-01	-1.85e-02	5.34e-02	8.56e-01
GOBP MESONEPHRIC DUCT DEVELOPMENT	8	6.54e-01	8.13e-01	0.19800	-1.86e-01	-6.79e-02	3.62e-01	7.40e-01
GOBP POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION	58	5.59e-02	2.01e-01	0.19800	1.04e-01	1.69e-01	1.71e-01	2.63e-02
GOBP REGULATION OF TRANSLATIONAL FIDELITY	18	3.76e-01	6.12e-01	0.19800	1.90e-01	5.70e-02	1.64e-01	6.75e-01
GOBP RESPONSE TO L GLUTAMATE	15	4.24e-01	6.53e-01	0.19800	1.95e-01	3.31e-02	1.90e-01	8.24e-01
GOBP REGULATION OF EXTRACELLULAR MATRIX CONSTITUENT SECRETION	9	5.37e-01	7.38e-01	0.19800	-1.89e-01	5.86e-02	3.26e-01	7.61e-01
GOCC INTERCHROMATIN GRANULE	5	6.89e-01	8.38e-01	0.19800	1.33e-01	-1.47e-01	6.07e-01	5.70e-01
GOBP ARACHIDONIC ACID SECRETION	31	2.22e-01	4.56e-01	0.19800	-1.27e-01	-1.52e-01	2.20e-01	1.44e-01
GOCC NASCENT POLYPEPTIDE ASSOCIATED COMPLEX	5	6.95e-01	8.41e-01	0.19800	-9.77e-02	1.72e-01	7.05e-01	5.05e-01
GOBP FOCAL ADHESION ASSEMBLY	83	8.30e-03	5.23e-02	0.19800	1.96e-01	2.72e-02	2.02e-03	6.69e-01
GOBP RESPONSE TO GLUCAGON	20	3.18e-01	5.56e-01	0.19800	-3.17e-02	-1.95e-01	8.06e-01	1.31e-01
GOBP REGULATION OF IRON ION TRANSPORT	7	6.16e-01	7.89e-01	0.19800	-6.19e-02	1.88e-01	7.77e-01	3.89e-01
GOCC BASAL DENDRITE	6	6.47e-01	8.08e-01	0.19800	1.72e-01	-9.80e-02	4.67e-01	6.78e-01
GOBP PURINE DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS	11	5.35e-01	7.37e-01	0.19800	3.46e-02	1.95e-01	8.43e-01	2.64e-01
GOBP INTERLEUKIN 1 PRODUCTION	122	5.01e-04	6.03e-03	0.19800	-1.97e-01	9.69e-03	1.67e-04	8.53e-01
GOBP POSITIVE REGULATION OF NK T CELL ACTIVATION	9	5.65e-01	7.57e-01	0.19800	-1.61e-02	1.97e-01	9.33e-01	3.07e-01
GOCC POSTSYNAPTIC DENSITY MEMBRANE	97	8.80e-03	5.46e-02	0.19700	-1.62e-01	-1.13e-01	5.76e-03	5.53e-02
Phosphorylation of CD3 and TCR zeta chains	20	2.26e-01	4.60e-01	0.19700	-1.44e-01	1.35e-01	2.66e-01	2.94e-01
GOBP POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY	14	5.07e-01	7.15e-01	0.19700	1.20e-01	1.57e-01	4.37e-01	3.10e-01
GOBP PROTEIN LOCALIZATION TO NON MOTILE CILIUM	12	4.89e-01	7.02e-01	0.19700	1.97e-01	1.15e-02	2.37e-01	9.45e-01
GOBP CELLULAR SENESCENCE	107	5.03e-03	3.55e-02	0.19700	1.01e-01	1.70e-01	7.11e-02	2.44e-03
GOBP ACTIN MEDIATED CELL CONTRACTION	111	2.22e-03	1.91e-02	0.19700	-4.56e-02	-1.92e-01	4.07e-01	4.74e-04
GOBP MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS	13	3.91e-01	6.25e-01	0.19700	9.51e-02	-1.73e-01	5.53e-01	2.80e-01
p75NTR recruits signalling complexes	12	5.53e-01	7.48e-01	0.19700	1.67e-01	1.05e-01	3.16e-01	5.30e-01
GOBP SYNAPTIC VESICLE PRIMING	19	2.90e-01	5.28e-01	0.19700	3.13e-02	-1.95e-01	8.13e-01	1.42e-01
GOCC GPI ANCHOR TRANSAMIDASE COMPLEX	5	7.70e-01	8.84e-01	0.19700	1.84e-01	7.07e-02	4.76e-01	7.84e-01
Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)	107	4.03e-03	3.01e-02	0.19700	1.82e-01	7.66e-02	1.16e-03	1.71e-01
Nonsense-Mediated Decay (NMD)	107	4.03e-03	3.01e-02	0.19700	1.82e-01	7.66e-02	1.16e-03	1.71e-01
GOCC SODIUM POTASSIUM EXCHANGING ATPASE COMPLEX	11	5.01e-01	7.11e-01	0.19700	1.29e-02	-1.97e-01	9.41e-01	2.58e-01
GOBP NEGATIVE REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT	6	7.38e-01	8.67e-01	0.19700	-1.77e-01	-8.77e-02	4.54e-01	7.10e-01
GOBP REGULATION OF PHAGOCYTOSIS	95	4.04e-03	3.02e-02	0.19700	-1.96e-01	-2.16e-02	9.62e-04	7.16e-01
GOBP NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN	10	5.16e-01	7.22e-01	0.19700	-3.99e-02	1.93e-01	8.27e-01	2.90e-01
GOBP MIDGUT DEVELOPMENT	11	4.54e-01	6.79e-01	0.19700	1.75e-01	-9.07e-02	3.15e-01	6.02e-01
GOMF ATPASE BINDING	82	1.79e-02	9.17e-02	0.19700	1.06e-01	1.66e-01	9.74e-02	9.23e-03
GOMF GLUTATHIONE HYDROLASE ACTIVITY	5	7.76e-01	8.87e-01	0.19700	-8.58e-02	-1.77e-01	7.40e-01	4.92e-01
GOMF PROTON CHANNEL ACTIVITY	25	2.84e-01	5.22e-01	0.19700	1.76e-01	8.92e-02	1.28e-01	4.40e-01
GOBP MUCOSA ASSOCIATED LYMPHOID TISSUE DEVELOPMENT	8	5.78e-01	7.66e-01	0.19700	-6.07e-02	1.87e-01	7.66e-01	3.59e-01
GOCC SPERM ANNULUS	5	6.96e-01	8.42e-01	0.19700	1.69e-01	-1.02e-01	5.14e-01	6.94e-01
GOBP NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS	47	6.04e-02	2.11e-01	0.19700	1.97e-01	7.98e-03	1.97e-02	9.25e-01
Cargo recognition for clathrin-mediated endocytosis	100	3.97e-03	2.97e-02	0.19700	1.92e-01	4.14e-02	8.83e-04	4.75e-01
GOBP POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY	26	2.62e-01	5.01e-01	0.19700	1.82e-01	7.57e-02	1.09e-01	5.04e-01
GOBP CELLULAR RESPONSE TO COLD	13	5.00e-01	7.10e-01	0.19700	1.88e-01	5.92e-02	2.41e-01	7.12e-01
GOBP PROTEIN MATURATION BY 4FE 4S CLUSTER TRANSFER	8	6.54e-01	8.13e-01	0.19700	6.14e-02	1.87e-01	7.63e-01	3.60e-01
GOCC CENTROSOME	705	5.91e-15	5.95e-13	0.19700	1.48e-01	1.29e-01	1.97e-11	4.71e-09
Signaling by NODAL	20	3.24e-01	5.62e-01	0.19700	3.35e-02	1.94e-01	7.95e-01	1.33e-01
GOBP REGULATION OF SYNAPTIC TRANSMISSION CHOLINERGIC	8	6.36e-01	8.02e-01	0.19700	-1.94e-01	-3.26e-02	3.42e-01	8.73e-01
GOBP NEGATIVE REGULATION OF NUCLEAR DIVISION	62	3.14e-02	1.36e-01	0.19700	1.93e-01	3.73e-02	8.52e-03	6.12e-01
GOMF SOLUTE SODIUM SYMPORTER ACTIVITY	77	2.50e-02	1.17e-01	0.19700	-1.23e-01	-1.53e-01	6.14e-02	2.01e-02
GOBP C TERMINAL PROTEIN AMINO ACID MODIFICATION	15	3.51e-01	5.89e-01	0.19700	7.31e-02	-1.83e-01	6.24e-01	2.21e-01
GOBP CELL DIFFERENTIATION IN HINDBRAIN	21	3.64e-01	6.01e-01	0.19700	1.55e-01	1.21e-01	2.19e-01	3.37e-01
Budding and maturation of HIV virion	28	2.51e-01	4.89e-01	0.19700	1.00e-01	1.69e-01	3.59e-01	1.21e-01
GOBP PYRIMIDINE DIMER REPAIR	9	5.66e-01	7.57e-01	0.19700	1.96e-01	-1.87e-02	3.09e-01	9.23e-01
Suppression of apoptosis	7	6.15e-01	7.88e-01	0.19700	1.83e-01	-7.08e-02	4.01e-01	7.46e-01
GOBP ADHERENS JUNCTION ASSEMBLY	13	4.83e-01	6.99e-01	0.19700	1.93e-01	3.69e-02	2.28e-01	8.18e-01
GOBP NEGATIVE REGULATION OF B CELL PROLIFERATION	15	3.38e-01	5.76e-01	0.19700	-1.67e-01	1.04e-01	2.63e-01	4.87e-01
GOBP POSITIVE REGULATION OF INTERFERON BETA PRODUCTION	37	1.71e-01	3.92e-01	0.19700	1.29e-01	1.48e-01	1.74e-01	1.19e-01
GOBP MAMMARY GLAND BRANCHING INVOLVED IN PREGNANCY	6	6.46e-01	8.08e-01	0.19700	-1.13e-01	1.61e-01	6.31e-01	4.96e-01
Hedgehog ‘off’ state	98	3.62e-03	2.78e-02	0.19600	1.95e-01	2.34e-02	8.45e-04	6.89e-01
GOBP SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION	12	5.37e-01	7.38e-01	0.19600	7.24e-02	1.83e-01	6.64e-01	2.73e-01
GOBP METANEPHRIC GLOMERULUS DEVELOPMENT	16	4.23e-01	6.53e-01	0.19600	5.40e-02	1.89e-01	7.09e-01	1.91e-01
GOBP REGULATION OF T CELL MEDIATED IMMUNITY	98	9.09e-04	9.72e-03	0.19600	-1.71e-01	9.65e-02	3.41e-03	9.89e-02
GOBP PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS	10	6.17e-01	7.89e-01	0.19600	1.14e-01	1.60e-01	5.33e-01	3.81e-01
GOBP NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE	16	4.43e-01	6.70e-01	0.19600	1.79e-01	8.08e-02	2.15e-01	5.76e-01
GOMF CALCIUM INDUCED CALCIUM RELEASE ACTIVITY	6	7.14e-01	8.53e-01	0.19600	-1.93e-01	-3.43e-02	4.12e-01	8.84e-01
GOBP PHOSPHOLIPID DEPHOSPHORYLATION	40	1.01e-01	2.92e-01	0.19600	1.95e-01	2.43e-02	3.30e-02	7.91e-01
Pre-NOTCH Processing in the Endoplasmic Reticulum	6	7.42e-01	8.69e-01	0.19600	-9.29e-02	-1.73e-01	6.94e-01	4.63e-01
GOBP MIRNA MEDIATED GENE SILENCING BY INHIBITION OF TRANSLATION	94	1.10e-02	6.44e-02	0.19600	-1.58e-01	-1.16e-01	8.11e-03	5.11e-02
GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS	17	4.30e-01	6.58e-01	0.19600	1.73e-01	9.30e-02	2.18e-01	5.07e-01
GOBP TYPE B PANCREATIC CELL APOPTOTIC PROCESS	10	5.64e-01	7.56e-01	0.19600	1.95e-01	2.41e-02	2.86e-01	8.95e-01
GOBP POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION	71	9.07e-03	5.58e-02	0.19600	-1.91e-01	4.66e-02	5.50e-03	4.97e-01
GOBP FATTY ACID ALPHA OXIDATION	8	6.80e-01	8.32e-01	0.19600	1.15e-01	1.59e-01	5.72e-01	4.38e-01
GOBP GERMINAL CENTER FORMATION	14	5.14e-01	7.21e-01	0.19600	1.32e-01	1.45e-01	3.93e-01	3.47e-01
Metabolism of fat-soluble vitamins	46	7.44e-02	2.41e-01	0.19600	-2.91e-02	-1.94e-01	7.32e-01	2.29e-02
Synthesis of UDP-N-acetyl-glucosamine	7	6.67e-01	8.24e-01	0.19600	1.87e-02	1.95e-01	9.32e-01	3.71e-01
GOBP RESPONSE TO CADMIUM ION	57	5.34e-02	1.96e-01	0.19600	7.21e-02	1.82e-01	3.46e-01	1.73e-02
GOBP CELLULAR RESPONSE TO MINERALOCORTICOID STIMULUS	12	5.62e-01	7.55e-01	0.19600	-1.58e-01	-1.16e-01	3.43e-01	4.87e-01
GOMF LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR ACTIVITY	15	3.60e-01	5.97e-01	0.19600	6.23e-02	-1.86e-01	6.76e-01	2.13e-01
Defective RIPK1-mediated regulated necrosis	7	6.23e-01	7.93e-01	0.19600	-5.76e-02	1.87e-01	7.92e-01	3.91e-01
GOBP NEGATIVE REGULATION OF PROTEIN SUMOYLATION	8	5.87e-01	7.71e-01	0.19600	1.89e-01	-4.98e-02	3.53e-01	8.07e-01
GOBP EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING	662	3.86e-14	3.57e-12	0.19600	1.58e-01	1.15e-01	3.46e-12	4.28e-07
NOD1/2 Signaling Pathway	33	1.99e-01	4.29e-01	0.19600	1.69e-01	9.97e-02	9.37e-02	3.22e-01
GOBP HEART GROWTH	96	9.68e-03	5.84e-02	0.19600	1.64e-01	1.07e-01	5.39e-03	7.12e-02
GOBP REGULATION OF LYMPHOCYTE CHEMOTAXIS	25	3.06e-01	5.46e-01	0.19600	-1.42e-01	-1.35e-01	2.19e-01	2.43e-01
GOBP REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT	14	4.66e-01	6.88e-01	0.19600	-1.91e-01	-4.41e-02	2.17e-01	7.75e-01
FRS-mediated FGFR2 signaling	24	2.32e-01	4.68e-01	0.19600	1.96e-01	-5.17e-03	9.71e-02	9.65e-01
GOBP TUBULIN DEACETYLATION	19	3.23e-01	5.62e-01	0.19600	1.96e-01	5.33e-03	1.40e-01	9.68e-01
GOMF ALL TRANS RETINOL DEHYDROGENASE NADPPLUS ACTIVITY	13	4.26e-01	6.55e-01	0.19600	-4.22e-02	1.91e-01	7.92e-01	2.33e-01
Signaling by NOTCH3	48	6.47e-02	2.21e-01	0.19600	1.94e-01	2.30e-02	1.99e-02	7.83e-01
GOBP TRANSLATION	704	1.94e-15	1.98e-13	0.19600	1.74e-01	8.99e-02	3.85e-15	4.76e-05
GOBP AUTOPHAGOSOME MEMBRANE DOCKING	7	6.31e-01	7.98e-01	0.19600	-4.44e-02	1.90e-01	8.39e-01	3.83e-01
GOBP REGULATION OF APPETITE	21	2.77e-01	5.17e-01	0.19600	-8.17e-03	1.95e-01	9.48e-01	1.21e-01
GOMF LIPASE INHIBITOR ACTIVITY	17	4.09e-01	6.41e-01	0.19600	-5.95e-02	-1.86e-01	6.71e-01	1.84e-01
GOMF GDP DISSOCIATION INHIBITOR ACTIVITY	15	4.24e-01	6.54e-01	0.19500	2.20e-02	1.94e-01	8.83e-01	1.93e-01
Urea cycle	9	5.37e-01	7.38e-01	0.19500	7.37e-02	-1.81e-01	7.02e-01	3.47e-01
PIP3 activates AKT signaling	273	8.18e-07	2.47e-05	0.19500	1.84e-01	6.50e-02	1.59e-07	6.45e-02
GOBP POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE	34	9.73e-02	2.85e-01	0.19500	-7.05e-02	1.82e-01	4.77e-01	6.60e-02
Viral mRNA Translation	83	1.98e-02	9.90e-02	0.19500	1.22e-01	1.52e-01	5.39e-02	1.65e-02
GOBP POSITIVE REGULATION OF INTERLEUKIN 1 ALPHA PRODUCTION	6	7.53e-01	8.73e-01	0.19500	1.28e-01	1.47e-01	5.86e-01	5.32e-01
GOBP RESPONSE TO PROSTAGLANDIN E	24	2.37e-01	4.74e-01	0.19500	1.95e-01	-5.90e-04	9.77e-02	9.96e-01
GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION	10	5.36e-01	7.37e-01	0.19500	1.94e-01	-1.87e-02	2.87e-01	9.18e-01
Diseases associated with glycosaminoglycan metabolism	38	8.19e-02	2.56e-01	0.19500	4.73e-02	-1.89e-01	6.14e-01	4.33e-02
GOMF ASPARTIC TYPE PEPTIDASE ACTIVITY	26	2.55e-01	4.92e-01	0.19500	-5.81e-02	-1.86e-01	6.08e-01	9.99e-02
GOBP TRNA WOBBLE BASE MODIFICATION	20	3.86e-01	6.20e-01	0.19500	1.57e-01	1.16e-01	2.23e-01	3.71e-01
GOBP REGULATION OF DEPHOSPHORYLATION	97	3.40e-03	2.64e-02	0.19500	1.95e-01	8.10e-03	8.99e-04	8.90e-01
GOBP POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY	36	1.21e-01	3.24e-01	0.19500	1.95e-01	8.58e-03	4.29e-02	9.29e-01
Extracellular matrix organization	311	3.27e-08	1.30e-06	0.19500	-2.81e-02	-1.93e-01	3.94e-01	4.71e-09
Phenylalanine and tyrosine metabolism	11	4.88e-01	7.02e-01	0.19500	-1.90e-01	4.24e-02	2.74e-01	8.08e-01
GOBP LATE ENDOSOME TO LYSOSOME TRANSPORT	21	3.22e-01	5.60e-01	0.19500	4.53e-02	1.90e-01	7.19e-01	1.32e-01
GOBP REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY	20	3.38e-01	5.76e-01	0.19500	4.30e-02	1.90e-01	7.39e-01	1.41e-01
GOBP THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY	13	3.89e-01	6.23e-01	0.19500	-1.34e-01	1.42e-01	4.03e-01	3.76e-01
GOBP ACETYL COA METABOLIC PROCESS	31	2.26e-01	4.60e-01	0.19500	1.08e-01	1.62e-01	2.96e-01	1.18e-01
GOBP RESPONSE TO EPINEPHRINE	14	4.74e-01	6.94e-01	0.19500	1.88e-01	5.01e-02	2.22e-01	7.46e-01
GOMF 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE BINDING	9	5.57e-01	7.51e-01	0.19500	-1.91e-01	4.05e-02	3.22e-01	8.33e-01
Translation of Structural Proteins 9683701	29	2.40e-01	4.77e-01	0.19500	8.95e-02	1.73e-01	4.04e-01	1.06e-01
GOBP DENTATE GYRUS DEVELOPMENT	24	2.97e-01	5.36e-01	0.19500	1.80e-01	7.45e-02	1.27e-01	5.28e-01
GOBP NEGATIVE REGULATION OF PEPTIDYL CYSTEINE S NITROSYLATION	7	6.10e-01	7.85e-01	0.19500	-9.75e-02	1.69e-01	6.55e-01	4.40e-01
GOBP PHAGOSOME LYSOSOME FUSION	13	4.92e-01	7.05e-01	0.19500	3.90e-02	1.91e-01	8.08e-01	2.33e-01
GOBP LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY	26	2.95e-01	5.35e-01	0.19500	1.47e-01	1.28e-01	1.95e-01	2.58e-01
GOMF ACTIVIN RECEPTOR ACTIVITY TYPE I	5	7.91e-01	8.94e-01	0.19500	1.47e-01	1.28e-01	5.70e-01	6.20e-01
GOBP EPITHELIAL MESENCHYMAL CELL SIGNALING	5	7.01e-01	8.44e-01	0.19500	-1.05e-01	1.64e-01	6.84e-01	5.26e-01
GOBP PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS	21	2.52e-01	4.90e-01	0.19500	-4.85e-02	1.89e-01	7.00e-01	1.35e-01
GOBP BASEMENT MEMBRANE ORGANIZATION	38	6.71e-02	2.26e-01	0.19500	1.06e-01	-1.63e-01	2.58e-01	8.15e-02
GOMF METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY	433	1.40e-09	7.45e-08	0.19500	-1.64e-01	-1.05e-01	4.76e-09	1.85e-04
GOBP CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION	12	5.48e-01	7.45e-01	0.19500	1.78e-01	7.82e-02	2.85e-01	6.39e-01
Synthesis of Prostaglandins (PG) and Thromboxanes (TX)	15	3.38e-01	5.77e-01	0.19500	1.38e-01	-1.38e-01	3.56e-01	3.56e-01
GOMF MECHANOSENSITIVE MONOATOMIC CATION CHANNEL ACTIVITY	6	6.96e-01	8.42e-01	0.19500	-1.95e-01	6.31e-03	4.09e-01	9.79e-01
GOBP REGULATION OF GONAD DEVELOPMENT	12	5.58e-01	7.51e-01	0.19500	9.53e-02	1.70e-01	5.68e-01	3.09e-01
GOMF LNCRNA BINDING	23	1.96e-01	4.26e-01	0.19500	1.65e-01	-1.02e-01	1.70e-01	3.95e-01
GOMF PROTEIN PHOSPHATASE BINDING	140	1.45e-03	1.37e-02	0.19500	1.51e-01	1.23e-01	2.11e-03	1.18e-02
GOBP POSITIVE REGULATION OF TRANSLATION	119	2.34e-03	1.99e-02	0.19400	1.82e-01	6.77e-02	5.90e-04	2.02e-01
Aggrephagy	40	1.54e-01	3.70e-01	0.19400	1.45e-01	1.29e-01	1.12e-01	1.56e-01
GOBP PLANAR CELL POLARITY PATHWAY INVOLVED IN NEURAL TUBE CLOSURE	10	5.40e-01	7.39e-01	0.19400	-1.72e-02	1.94e-01	9.25e-01	2.89e-01
GOMF OMEGA PEPTIDASE ACTIVITY	12	5.66e-01	7.57e-01	0.19400	-1.59e-01	-1.12e-01	3.39e-01	5.04e-01
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE	17	4.31e-01	6.59e-01	0.19400	1.75e-01	8.38e-02	2.11e-01	5.50e-01
GOBP PROTEIN K29 LINKED UBIQUITINATION	11	5.98e-01	7.77e-01	0.19400	1.29e-01	1.45e-01	4.58e-01	4.05e-01
LTC4-CYSLTR mediated IL4 production	5	7.81e-01	8.90e-01	0.19400	-8.48e-02	-1.75e-01	7.43e-01	4.98e-01
mitochondrial fatty acid beta-oxidation of saturated fatty acids	11	4.95e-01	7.07e-01	0.19400	1.91e-01	-3.61e-02	2.73e-01	8.36e-01
GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS	46	1.11e-01	3.08e-01	0.19400	1.03e-01	1.65e-01	2.25e-01	5.35e-02
GOBP REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY	18	4.30e-01	6.58e-01	0.19400	1.21e-01	1.52e-01	3.76e-01	2.63e-01
GOBP GERM CELL PROLIFERATION	10	6.09e-01	7.85e-01	0.19400	8.18e-02	1.76e-01	6.54e-01	3.35e-01
GOBP REGULATION OF FEMALE GONAD DEVELOPMENT	7	6.85e-01	8.36e-01	0.19400	1.90e-01	4.16e-02	3.85e-01	8.49e-01
GOCC MITOCHONDRIAL CRISTA	8	6.80e-01	8.32e-01	0.19400	1.68e-01	9.83e-02	4.12e-01	6.30e-01
GOCC ORGANELLE ENVELOPE	1207	3.29e-24	6.31e-22	0.19400	1.58e-01	1.13e-01	2.17e-20	3.93e-11
IRF3 mediated activation of type 1 IFN	5	7.08e-01	8.49e-01	0.19400	-1.76e-01	8.29e-02	4.97e-01	7.48e-01
GOBP POSITIVE REGULATION OF PROTEIN POLYMERIZATION	89	1.19e-02	6.81e-02	0.19400	1.78e-01	7.73e-02	3.69e-03	2.08e-01
GOBP PROTEIN HETEROOLIGOMERIZATION	29	2.22e-01	4.55e-01	0.19400	1.85e-01	5.75e-02	8.41e-02	5.92e-01
GOCC POLE PLASM	24	1.81e-01	4.06e-01	0.19400	-1.15e-01	1.57e-01	3.31e-01	1.84e-01
GOBP GLUTAMATE RECEPTOR SIGNALING PATHWAY	48	1.07e-01	3.03e-01	0.19400	-1.28e-01	-1.46e-01	1.24e-01	8.08e-02
GOBP NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS	159	2.39e-04	3.23e-03	0.19400	5.05e-02	1.87e-01	2.72e-01	4.56e-05
GOBP N ACETYLNEURAMINATE METABOLIC PROCESS	11	5.98e-01	7.77e-01	0.19400	1.20e-01	1.52e-01	4.91e-01	3.82e-01
GOBP AMIDE CATABOLIC PROCESS	16	4.53e-01	6.78e-01	0.19400	-8.07e-02	-1.76e-01	5.76e-01	2.22e-01
GOBP REGULATION OF MACROPHAGE APOPTOTIC PROCESS	11	4.69e-01	6.91e-01	0.19400	8.23e-02	-1.76e-01	6.36e-01	3.13e-01
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE	63	4.47e-02	1.75e-01	0.19400	1.76e-01	8.13e-02	1.57e-02	2.64e-01
GOBP NEGATIVE REGULATION OF ORGAN GROWTH	35	1.60e-01	3.78e-01	0.19400	1.87e-01	5.25e-02	5.61e-02	5.91e-01
MTOR signalling	40	9.19e-02	2.75e-01	0.19400	1.94e-01	-5.73e-03	3.40e-02	9.50e-01
GOBP PROTEIN MATURATION BY PROTEIN FOLDING	7	6.13e-01	7.87e-01	0.19400	-9.78e-02	1.67e-01	6.54e-01	4.43e-01
GOMF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY INVOLVED IN VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL REPOLARIZATION	11	5.99e-01	7.78e-01	0.19400	-1.23e-01	-1.50e-01	4.81e-01	3.89e-01
GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION	34	1.24e-01	3.29e-01	0.19400	1.93e-01	-1.84e-02	5.16e-02	8.53e-01
GOMF PHOSPHOLIPASE INHIBITOR ACTIVITY	13	5.25e-01	7.29e-01	0.19400	-1.77e-01	-7.89e-02	2.69e-01	6.22e-01
GOBP G PROTEIN COUPLED SEROTONIN RECEPTOR SIGNALING PATHWAY	22	2.94e-01	5.33e-01	0.19400	-1.92e-01	-2.53e-02	1.19e-01	8.37e-01
GOBP DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND	15	4.84e-01	6.99e-01	0.19400	-9.17e-02	-1.71e-01	5.38e-01	2.53e-01
GOBP 4 HYDROXYPROLINE METABOLIC PROCESS	12	4.73e-01	6.94e-01	0.19400	1.92e-01	-2.77e-02	2.50e-01	8.68e-01
GOCC ARYL HYDROCARBON RECEPTOR COMPLEX	8	5.88e-01	7.71e-01	0.19400	-1.84e-01	6.13e-02	3.68e-01	7.64e-01
GOBP T CELL MEDIATED CYTOTOXICITY	59	1.58e-02	8.42e-02	0.19400	-1.62e-01	1.06e-01	3.12e-02	1.60e-01
Formation of HIV-1 elongation complex containing HIV-1 Tat	42	1.43e-01	3.56e-01	0.19400	1.25e-01	1.48e-01	1.62e-01	9.70e-02
HIV Transcription Elongation	42	1.43e-01	3.56e-01	0.19400	1.25e-01	1.48e-01	1.62e-01	9.70e-02
Tat-mediated elongation of the HIV-1 transcript	42	1.43e-01	3.56e-01	0.19400	1.25e-01	1.48e-01	1.62e-01	9.70e-02
GOBP TRIF DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY	11	5.88e-01	7.72e-01	0.19400	9.25e-02	1.70e-01	5.95e-01	3.29e-01
Free fatty acids regulate insulin secretion	10	6.17e-01	7.90e-01	0.19300	-9.20e-02	-1.70e-01	6.15e-01	3.51e-01
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME	27	2.71e-01	5.11e-01	0.19300	1.71e-01	9.07e-02	1.24e-01	4.15e-01
GOMF MISMATCHED DNA BINDING	14	4.98e-01	7.09e-01	0.19300	1.79e-01	7.38e-02	2.47e-01	6.33e-01
GOBP SOMATIC MOTOR NEURON DIFFERENTIATION	5	7.93e-01	8.95e-01	0.19300	1.46e-01	1.26e-01	5.71e-01	6.25e-01
Signaling by Rho GTPases	629	9.34e-14	8.37e-12	0.19300	1.75e-01	8.19e-02	6.56e-14	4.50e-04
GOMF LIPASE BINDING	7	7.05e-01	8.47e-01	0.19300	-7.19e-02	-1.79e-01	7.42e-01	4.11e-01
GOMF PROTEIN HETERODIMERIZATION ACTIVITY	308	6.68e-07	2.05e-05	0.19300	1.12e-01	1.58e-01	7.50e-04	1.96e-06
GOMF TAP BINDING	7	6.26e-01	7.95e-01	0.19300	-6.83e-02	1.81e-01	7.54e-01	4.08e-01
GOBP PROTEIN CONTAINING COMPLEX DISASSEMBLY	248	7.64e-06	1.72e-04	0.19300	1.69e-01	9.28e-02	4.37e-06	1.18e-02
GOBP PIRNA PROCESSING	21	2.38e-01	4.75e-01	0.19300	-1.73e-01	8.50e-02	1.69e-01	5.00e-01
Listeria monocytogenes entry into host cells	19	2.64e-01	5.03e-01	0.19300	1.59e-01	-1.09e-01	2.30e-01	4.11e-01
GOBP MEMBRANE FISSION	44	1.33e-01	3.41e-01	0.19300	1.34e-01	1.39e-01	1.25e-01	1.10e-01
GOBP REGULATION OF BILE ACID SECRETION	6	7.37e-01	8.66e-01	0.19300	-1.83e-01	-6.17e-02	4.38e-01	7.94e-01
GOBP POSTSYNAPTIC CYTOSKELETON ORGANIZATION	17	3.13e-01	5.53e-01	0.19300	-8.44e-02	1.74e-01	5.47e-01	2.15e-01
GOBP VENTRICULAR SEPTUM MORPHOGENESIS	44	9.73e-02	2.85e-01	0.19300	4.29e-02	1.88e-01	6.23e-01	3.09e-02
GOBP POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION	19	3.97e-01	6.30e-01	0.19300	-1.74e-01	-8.41e-02	1.90e-01	5.26e-01
GOBP TRNA TRANSCRIPTION	13	4.17e-01	6.48e-01	0.19300	1.78e-01	-7.35e-02	2.66e-01	6.46e-01
GOBP REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY	150	7.68e-04	8.61e-03	0.19300	8.99e-02	1.71e-01	5.73e-02	3.10e-04
GOBP GOLGI TO VACUOLE TRANSPORT	20	2.55e-01	4.92e-01	0.19300	1.73e-01	-8.54e-02	1.81e-01	5.08e-01
Signaling by NOTCH	197	7.74e-05	1.25e-03	0.19300	1.73e-01	8.55e-02	2.89e-05	3.86e-02
GOBP V D J RECOMBINATION	19	4.14e-01	6.45e-01	0.19300	1.56e-01	1.14e-01	2.40e-01	3.90e-01
GOBP POST ANAL TAIL MORPHOGENESIS	18	3.13e-01	5.53e-01	0.19300	-4.86e-02	1.87e-01	7.21e-01	1.71e-01
GOBP REGULATION OF SARCOMERE ORGANIZATION	9	6.24e-01	7.94e-01	0.19300	-4.81e-02	-1.87e-01	8.03e-01	3.32e-01
GOBP B CELL PROLIFERATION	97	2.48e-03	2.09e-02	0.19300	-1.91e-01	2.91e-02	1.18e-03	6.21e-01
GOBP DNA UNWINDING INVOLVED IN DNA REPLICATION	21	3.76e-01	6.12e-01	0.19300	1.12e-01	1.57e-01	3.75e-01	2.13e-01
GOBP MANNOSYLATION	25	2.14e-01	4.46e-01	0.19300	2.68e-02	-1.91e-01	8.17e-01	9.86e-02
Beta-catenin independent WNT signaling	133	1.28e-03	1.26e-02	0.19300	1.81e-01	6.58e-02	3.09e-04	1.90e-01
GOBP BLOOD COAGULATION FIBRIN CLOT FORMATION	14	5.08e-01	7.16e-01	0.19300	-1.73e-01	-8.53e-02	2.63e-01	5.81e-01
GOBP ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN	32	1.13e-01	3.11e-01	0.19300	-8.60e-02	1.72e-01	4.00e-01	9.14e-02
GOBP OVULATION CYCLE PROCESS	50	2.99e-02	1.31e-01	0.19300	1.16e-01	-1.54e-01	1.55e-01	6.01e-02
GOBP POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING	37	1.66e-01	3.88e-01	0.19300	1.74e-01	8.29e-02	6.72e-02	3.83e-01
GOBP VACUOLAR LOCALIZATION	80	1.33e-02	7.43e-02	0.19300	3.26e-02	1.90e-01	6.14e-01	3.33e-03
GOMF TRANSCRIPTION REGULATOR ACTIVATOR ACTIVITY	7	6.80e-01	8.32e-01	0.19300	1.91e-01	2.46e-02	3.82e-01	9.10e-01
GOBP POSITIVE REGULATION OF FOCAL ADHESION ASSEMBLY	26	2.72e-01	5.12e-01	0.19200	1.80e-01	6.70e-02	1.11e-01	5.55e-01
GOBP ASYMMETRIC CELL DIVISION	18	3.45e-01	5.82e-01	0.19200	1.92e-01	-8.05e-03	1.58e-01	9.53e-01
GOBP CALCIUM IMPORT INTO THE MITOCHONDRION	16	4.80e-01	6.97e-01	0.19200	1.46e-01	1.25e-01	3.12e-01	3.85e-01
GOBP NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS	30	2.25e-01	4.59e-01	0.19200	6.94e-02	1.79e-01	5.10e-01	8.90e-02
Formation of tubulin folding intermediates by CCT/TriC	25	2.77e-01	5.16e-01	0.19200	5.39e-02	1.85e-01	6.41e-01	1.10e-01
Regulation of TP53 Activity through Association with Co-factors	14	5.24e-01	7.28e-01	0.19200	1.16e-01	1.53e-01	4.53e-01	3.20e-01
GOBP CYTOSOLIC TRANSPORT	135	1.35e-03	1.31e-02	0.19200	1.77e-01	7.43e-02	3.75e-04	1.36e-01
GOBP NEGATIVE REGULATION OF GLIOGENESIS	44	1.14e-01	3.13e-01	0.19200	1.78e-01	7.17e-02	4.07e-02	4.11e-01
GOBP POLYKETIDE METABOLIC PROCESS	10	5.07e-01	7.16e-01	0.19200	8.48e-02	-1.72e-01	6.43e-01	3.45e-01
GOBP PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	57	6.07e-02	2.12e-01	0.19200	1.78e-01	7.34e-02	2.04e-02	3.38e-01
GOBP NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE	19	4.11e-01	6.43e-01	0.19200	-1.63e-01	-1.02e-01	2.19e-01	4.42e-01
GOBP PROTEIN LOCALIZATION TO ADHERENS JUNCTION	6	6.56e-01	8.15e-01	0.19200	1.33e-01	-1.39e-01	5.74e-01	5.56e-01
Response of EIF2AK4 (GCN2) to amino acid deficiency	94	1.39e-02	7.65e-02	0.19200	1.46e-01	1.25e-01	1.44e-02	3.68e-02
GOBP METHYLGLYOXAL METABOLIC PROCESS	6	7.61e-01	8.78e-01	0.19200	1.36e-01	1.35e-01	5.63e-01	5.66e-01
GOMF OPSONIN BINDING	18	4.22e-01	6.52e-01	0.19200	-8.53e-02	-1.72e-01	5.31e-01	2.07e-01
GOBP NEGATIVE REGULATION OF MITOTIC CELL CYCLE	243	1.11e-05	2.36e-04	0.19200	1.69e-01	9.17e-02	6.02e-06	1.38e-02
GOBP DETECTION OF ABIOTIC STIMULUS	135	1.32e-03	1.29e-02	0.19200	-7.03e-02	-1.78e-01	1.59e-01	3.43e-04
ROS and RNS production in phagocytes	33	1.44e-01	3.57e-01	0.19200	-7.62e-03	1.92e-01	9.40e-01	5.68e-02
GOBP HEPARAN SULFATE PROTEOGLYCAN CATABOLIC PROCESS	8	6.28e-01	7.96e-01	0.19200	3.72e-03	-1.92e-01	9.85e-01	3.48e-01
GOBP CELLULAR PIGMENTATION	60	6.59e-02	2.23e-01	0.19200	1.29e-01	1.41e-01	8.31e-02	5.80e-02
GOBP VENTRICULAR SYSTEM DEVELOPMENT	32	1.79e-01	4.03e-01	0.19200	1.89e-01	3.03e-02	6.39e-02	7.67e-01
Signaling by Rho GTPases, Miro GTPases and RHOBTB3	643	8.19e-14	7.39e-12	0.19200	1.73e-01	8.15e-02	5.90e-14	4.23e-04
GOBP REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM	24	1.94e-01	4.24e-01	0.19200	-9.44e-02	1.67e-01	4.24e-01	1.57e-01
Cytochrome P450 - arranged by substrate type	64	5.43e-02	1.98e-01	0.19200	-1.50e-01	-1.20e-01	3.85e-02	9.74e-02
GOBP COLUMNAR CUBOIDAL EPITHELIAL CELL MATURATION	15	5.07e-01	7.15e-01	0.19200	1.36e-01	1.35e-01	3.62e-01	3.65e-01
GOBP REGULATION OF FATTY ACID BETA OXIDATION	19	3.99e-01	6.32e-01	0.19200	7.86e-02	1.75e-01	5.53e-01	1.87e-01
GOBP MESENCHYMAL STEM CELL PROLIFERATION	10	6.24e-01	7.93e-01	0.19100	-9.19e-02	-1.68e-01	6.15e-01	3.58e-01
Diseases of glycosylation	139	1.14e-03	1.16e-02	0.19100	-7.19e-02	-1.77e-01	1.43e-01	3.03e-04
Negative regulation of FGFR4 signaling	30	2.53e-01	4.91e-01	0.19100	1.54e-01	1.14e-01	1.45e-01	2.80e-01
GOBP PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS	123	2.70e-03	2.22e-02	0.19100	1.74e-01	7.90e-02	8.36e-04	1.30e-01
GOCC SYNAPTONEMAL STRUCTURE	35	8.87e-02	2.70e-01	0.19100	1.54e-01	-1.14e-01	1.16e-01	2.43e-01
GOBP REGULATION OF GONADOTROPIN SECRETION	12	5.81e-01	7.67e-01	0.19100	1.27e-01	1.43e-01	4.45e-01	3.92e-01
GOMF PROTEIN CYSTEINE S STEAROYLTRANSFERASE ACTIVITY	6	7.62e-01	8.79e-01	0.19100	1.34e-01	1.37e-01	5.70e-01	5.62e-01
GOBP ADIPOSE TISSUE DEVELOPMENT	60	6.67e-02	2.25e-01	0.19100	1.40e-01	1.30e-01	6.06e-02	8.08e-02
GOBP CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION	92	3.60e-03	2.77e-02	0.19100	-3.08e-02	1.89e-01	6.09e-01	1.75e-03
Synthesis of bile acids and bile salts via 24-hydroxycholesterol	13	4.38e-01	6.65e-01	0.19100	4.91e-02	-1.85e-01	7.59e-01	2.49e-01
GOBP MACROMOLECULE CATABOLIC PROCESS	1407	4.61e-27	1.11e-24	0.19100	1.57e-01	1.09e-01	4.29e-23	8.69e-12
GOBP POSITIVE REGULATION OF INTEGRIN ACTIVATION	11	4.88e-01	7.02e-01	0.19100	-1.80e-01	6.43e-02	3.01e-01	7.12e-01
GOBP REGULATION OF FIBROBLAST APOPTOTIC PROCESS	19	3.92e-01	6.25e-01	0.19100	1.79e-01	6.66e-02	1.76e-01	6.15e-01
GOCC MITOTIC SPINDLE	175	3.04e-04	3.97e-03	0.19100	1.65e-01	9.71e-02	1.73e-04	2.67e-02
GOBP REGULATION OF TRANSLATION AT SYNAPSE MODULATING SYNAPTIC TRANSMISSION	5	7.73e-01	8.85e-01	0.19100	4.73e-02	1.85e-01	8.55e-01	4.73e-01
GOBP I KAPPAB PHOSPHORYLATION	14	4.39e-01	6.66e-01	0.19100	1.13e-02	-1.91e-01	9.42e-01	2.17e-01
GOCC BLOOD MICROPARTICLE	111	4.21e-03	3.12e-02	0.19100	-6.48e-02	-1.80e-01	2.38e-01	1.07e-03
GOBP SPINDLE MIDZONE ASSEMBLY	13	5.50e-01	7.46e-01	0.19100	1.59e-01	1.05e-01	3.20e-01	5.12e-01
GOBP ASYMMETRIC NEUROBLAST DIVISION	5	7.34e-01	8.64e-01	0.19100	1.87e-01	-3.66e-02	4.68e-01	8.87e-01
GOBP AXONOGENESIS INVOLVED IN INNERVATION	9	6.10e-01	7.85e-01	0.19100	1.90e-01	1.78e-02	3.24e-01	9.26e-01
GOBP IRON COORDINATION ENTITY TRANSPORT	11	4.93e-01	7.06e-01	0.19100	-1.82e-01	5.82e-02	2.97e-01	7.38e-01
GOMF PHOSPHATIDATE PHOSPHATASE ACTIVITY	14	4.83e-01	6.99e-01	0.19100	-1.86e-01	-4.19e-02	2.28e-01	7.86e-01
GOBP ZINC ION IMPORT ACROSS PLASMA MEMBRANE	10	6.17e-01	7.90e-01	0.19100	-1.75e-01	-7.59e-02	3.38e-01	6.78e-01
GOCC GAP JUNCTION	28	2.79e-01	5.19e-01	0.19100	-1.11e-01	-1.55e-01	3.10e-01	1.55e-01
GOBP N TERMINAL PROTEIN AMINO ACID MODIFICATION	26	2.92e-01	5.30e-01	0.19100	1.71e-01	8.46e-02	1.31e-01	4.56e-01
GOBP VACUOLAR PROTON TRANSPORTING V TYPE ATPASE COMPLEX ASSEMBLY	5	7.20e-01	8.56e-01	0.19100	7.12e-02	-1.77e-01	7.83e-01	4.93e-01
CHL1 interactions	9	5.64e-01	7.56e-01	0.19100	5.32e-02	-1.83e-01	7.82e-01	3.41e-01
GOBP CATECHOLAMINE TRANSPORT	63	1.59e-02	8.42e-02	0.19100	-1.76e-01	7.43e-02	1.59e-02	3.08e-01
GOMF NADPLUS PROTEIN ADP RIBOSYLTRANSFERASE ACTIVITY	28	2.62e-01	5.01e-01	0.19100	7.88e-02	1.74e-01	4.71e-01	1.12e-01
GTP hydrolysis and joining of the 60S ribosomal subunit	103	9.68e-03	5.84e-02	0.19100	1.49e-01	1.19e-01	8.99e-03	3.68e-02
GOBP REGULATION OF TRANSLATION AT SYNAPSE	8	6.92e-01	8.40e-01	0.19100	1.61e-01	1.01e-01	4.29e-01	6.19e-01
GOBP SYNAPTIC SIGNALING VIA NEUROPEPTIDE	6	7.28e-01	8.61e-01	0.19100	1.88e-01	3.27e-02	4.26e-01	8.90e-01
GOBP MUSCLE ADAPTATION	120	8.61e-04	9.33e-03	0.19100	1.90e-01	-1.56e-02	3.24e-04	7.68e-01
Regulation of lipid metabolism by PPARalpha	115	2.28e-03	1.94e-02	0.19100	1.88e-01	3.11e-02	4.94e-04	5.64e-01
GOBP REGULATION OF SPONTANEOUS SYNAPTIC TRANSMISSION	6	6.83e-01	8.34e-01	0.19100	1.83e-01	-5.32e-02	4.38e-01	8.21e-01
GOBP DOUBLE STRAND BREAK REPAIR INVOLVED IN MEIOTIC RECOMBINATION	11	4.67e-01	6.89e-01	0.19100	1.32e-01	-1.37e-01	4.47e-01	4.31e-01
Interleukin-12 family signaling	53	5.52e-02	2.00e-01	0.19000	1.77e-02	1.90e-01	8.23e-01	1.69e-02
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORS DISULFIDE AS ACCEPTOR	7	6.26e-01	7.95e-01	0.19000	1.70e-01	-8.57e-02	4.36e-01	6.94e-01
GOBP TYPE B PANCREATIC CELL DEVELOPMENT	24	2.65e-01	5.04e-01	0.19000	1.28e-02	1.90e-01	9.14e-01	1.07e-01
Amino acids regulate mTORC1	50	7.50e-02	2.42e-01	0.19000	1.86e-01	4.04e-02	2.28e-02	6.21e-01
NS1 Mediated Effects on Host Pathways	41	1.45e-01	3.57e-01	0.19000	1.70e-01	8.50e-02	5.91e-02	3.47e-01
GOCC PRESYNAPTIC ENDOCYTIC ZONE	9	5.44e-01	7.42e-01	0.19000	1.64e-01	-9.67e-02	3.94e-01	6.15e-01
GOMF EXTRACELLULAR LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY	68	3.88e-02	1.58e-01	0.19000	-1.74e-01	-7.72e-02	1.31e-02	2.71e-01
GOCC COPII COATED ER TO GOLGI TRANSPORT VESICLE	89	1.88e-02	9.51e-02	0.19000	1.26e-01	1.43e-01	3.99e-02	2.00e-02
GOBP POSITIVE REGULATION OF FAT CELL DIFFERENTIATION	67	4.65e-02	1.79e-01	0.19000	1.01e-01	1.61e-01	1.53e-01	2.25e-02
GOBP POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL	31	2.50e-01	4.89e-01	0.19000	-1.40e-01	-1.29e-01	1.77e-01	2.15e-01
GOBP NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION	35	2.02e-01	4.33e-01	0.19000	1.59e-01	1.04e-01	1.03e-01	2.87e-01
GOBP CELL SUBSTRATE JUNCTION ORGANIZATION	101	4.63e-03	3.34e-02	0.19000	1.88e-01	2.67e-02	1.08e-03	6.43e-01
GOMF TRNA SPECIFIC ADENOSINE DEAMINASE ACTIVITY	8	5.78e-01	7.66e-01	0.19000	-1.18e-01	1.49e-01	5.64e-01	4.65e-01
GOBP PYRIMIDINE NUCLEOBASE METABOLIC PROCESS	20	3.70e-01	6.06e-01	0.19000	-5.76e-02	-1.81e-01	6.56e-01	1.61e-01
GOMF ALPHA 1 3 FUCOSYLTRANSFERASE ACTIVITY	8	6.99e-01	8.44e-01	0.19000	-1.41e-01	-1.27e-01	4.89e-01	5.33e-01
Signaling by NTRKs	132	2.84e-03	2.31e-02	0.19000	1.27e-01	1.41e-01	1.16e-02	5.10e-03
GOCC CYTOCHROME COMPLEX	35	1.51e-01	3.65e-01	0.19000	1.89e-01	2.06e-02	5.31e-02	8.33e-01
GOBP HEART FORMATION	34	1.45e-01	3.58e-01	0.19000	-8.06e-04	1.90e-01	9.94e-01	5.51e-02
GOBP NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 1 SIGNALING PATHWAY	7	6.18e-01	7.90e-01	0.19000	-1.36e-01	1.33e-01	5.34e-01	5.43e-01
GOBP NEGATIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY	12	5.21e-01	7.26e-01	0.19000	1.82e-02	1.89e-01	9.13e-01	2.57e-01
Activation of BH3-only proteins	30	2.45e-01	4.83e-01	0.19000	8.52e-02	1.70e-01	4.19e-01	1.08e-01
Vitamin B1 (thiamin) metabolism	5	7.45e-01	8.70e-01	0.19000	-1.89e-01	1.81e-02	4.64e-01	9.44e-01
GOBP THIAMINE DIPHOSPHATE METABOLIC PROCESS	5	7.45e-01	8.70e-01	0.19000	-1.89e-01	1.81e-02	4.64e-01	9.44e-01
GOBP AMPA GLUTAMATE RECEPTOR CLUSTERING	10	5.16e-01	7.22e-01	0.19000	1.71e-01	-8.29e-02	3.50e-01	6.50e-01
GOBP REGULATION OF TELOMERE CAPPING	26	2.54e-01	4.92e-01	0.19000	1.87e-01	3.16e-02	9.84e-02	7.80e-01
Paracetamol ADME	26	3.04e-01	5.44e-01	0.19000	-9.96e-02	-1.62e-01	3.79e-01	1.54e-01
GOCC CILIARY TRANSITION FIBER	8	6.87e-01	8.37e-01	0.19000	8.39e-02	1.70e-01	6.81e-01	4.05e-01
GOMF CARBON SULFUR LYASE ACTIVITY	12	5.59e-01	7.52e-01	0.19000	1.77e-01	6.81e-02	2.88e-01	6.83e-01
GOBP NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION	13	4.32e-01	6.59e-01	0.19000	1.77e-01	-6.79e-02	2.69e-01	6.71e-01
GOBP POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT	59	5.86e-02	2.07e-01	0.19000	1.76e-01	7.06e-02	1.93e-02	3.48e-01
GOBP REGULATION OF PHOSPHOLIPID CATABOLIC PROCESS	7	6.92e-01	8.40e-01	0.19000	3.10e-02	1.87e-01	8.87e-01	3.91e-01
Intraflagellar transport	51	9.61e-02	2.83e-01	0.19000	1.64e-01	9.51e-02	4.27e-02	2.40e-01
Signaling by ALK fusions and activated point mutants	91	1.02e-02	6.09e-02	0.19000	1.83e-01	4.86e-02	2.50e-03	4.23e-01
Signaling by ALK in cancer	91	1.02e-02	6.09e-02	0.19000	1.83e-01	4.86e-02	2.50e-03	4.23e-01
GOBP REGULATION OF LIPOPROTEIN LIPASE ACTIVITY	14	4.39e-01	6.66e-01	0.19000	1.89e-01	-1.88e-02	2.22e-01	9.03e-01
GOBP POSITIVE REGULATION OF BINDING	104	9.89e-03	5.93e-02	0.19000	1.45e-01	1.22e-01	1.05e-02	3.17e-02
GOBP POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION	33	2.01e-01	4.31e-01	0.18900	1.78e-01	6.47e-02	7.67e-02	5.20e-01
GOBP SINGLE FERTILIZATION	161	7.68e-04	8.61e-03	0.18900	-1.12e-01	-1.53e-01	1.42e-02	8.24e-04
GOMF RNA POLYMERASE III GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY	12	5.35e-01	7.37e-01	0.18900	1.86e-01	3.36e-02	2.64e-01	8.40e-01
GOBP GLUTATHIONE METABOLIC PROCESS	47	1.14e-01	3.14e-01	0.18900	1.67e-01	9.00e-02	4.81e-02	2.86e-01
GOBP LUNG GROWTH	6	6.95e-01	8.42e-01	0.18900	1.86e-01	-3.38e-02	4.29e-01	8.86e-01
RHO GTPases Activate Rhotekin and Rhophilins	9	5.71e-01	7.61e-01	0.18900	-1.83e-01	4.79e-02	3.41e-01	8.04e-01
GOBP NEGATIVE REGULATION OF HYPOXIA INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY	6	7.66e-01	8.82e-01	0.18900	1.25e-01	1.42e-01	5.96e-01	5.47e-01
GOBP POSITIVE REGULATION OF CELL CYCLE	323	1.59e-07	5.50e-06	0.18900	1.80e-01	5.92e-02	2.74e-08	6.75e-02
GOMF SODIUM PROTON ANTIPORTER ACTIVITY	13	5.56e-01	7.51e-01	0.18900	-1.57e-01	-1.06e-01	3.28e-01	5.08e-01
Peptide chain elongation	83	2.55e-02	1.18e-01	0.18900	1.24e-01	1.43e-01	5.15e-02	2.40e-02
GOBP POSITIVE REGULATION OF ORGAN GROWTH	49	8.65e-02	2.66e-01	0.18900	1.82e-01	5.07e-02	2.72e-02	5.39e-01
GOBP ACTIVATION INDUCED CELL DEATH OF T CELLS	8	7.02e-01	8.45e-01	0.18900	1.34e-01	1.34e-01	5.11e-01	5.13e-01
GOBP UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY	5	7.17e-01	8.55e-01	0.18900	-9.09e-02	1.66e-01	7.25e-01	5.20e-01
GOBP MESODERM DEVELOPMENT	126	3.22e-03	2.54e-02	0.18900	9.51e-02	1.64e-01	6.52e-02	1.52e-03
GOBP NEGATIVE REGULATION OF DENDRITIC CELL APOPTOTIC PROCESS	8	6.30e-01	7.97e-01	0.18900	-1.89e-01	1.23e-02	3.55e-01	9.52e-01
GOBP NEGATIVE REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION	5	7.84e-01	8.91e-01	0.18900	1.79e-01	6.23e-02	4.89e-01	8.09e-01
GOCC MICOS COMPLEX	7	6.69e-01	8.25e-01	0.18900	9.94e-03	-1.89e-01	9.64e-01	3.87e-01
Recruitment of NuMA to mitotic centrosomes	89	1.84e-02	9.36e-02	0.18900	1.05e-01	1.57e-01	8.78e-02	1.03e-02
GOBP PROTEOGLYCAN CATABOLIC PROCESS	9	6.39e-01	8.03e-01	0.18900	-5.17e-02	-1.82e-01	7.88e-01	3.45e-01
GOBP ENERGY HOMEOSTASIS	81	1.35e-02	7.49e-02	0.18900	1.88e-01	2.23e-02	3.49e-03	7.29e-01
Signaling by TGF-beta Receptor Complex	92	1.61e-02	8.51e-02	0.18900	1.57e-01	1.05e-01	9.11e-03	8.24e-02
GOBP CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS	23	2.42e-01	4.80e-01	0.18900	-1.84e-01	4.51e-02	1.28e-01	7.08e-01
GOBP CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT	22	3.69e-01	6.05e-01	0.18900	9.89e-02	1.61e-01	4.22e-01	1.91e-01
GOBP PROTEIN LOCALIZATION TO CILIUM	72	1.99e-02	9.93e-02	0.18900	1.89e-01	1.23e-02	5.66e-03	8.56e-01
GOBP DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN CELL CYCLE ARREST	19	3.71e-01	6.07e-01	0.18900	3.12e-02	1.86e-01	8.14e-01	1.60e-01
GOBP REGULATION OF PROTEIN LOCALIZATION TO CILIUM	11	5.37e-01	7.38e-01	0.18900	1.89e-01	-3.90e-03	2.78e-01	9.82e-01
GOMF UBIQUITIN PROTEIN TRANSFERASE INHIBITOR ACTIVITY	12	5.55e-01	7.49e-01	0.18900	5.70e-02	1.80e-01	7.33e-01	2.80e-01
GOBP LYMPHANGIOGENESIS	19	2.90e-01	5.29e-01	0.18900	-1.71e-01	7.95e-02	1.96e-01	5.49e-01
GOMF CIS TRANS ISOMERASE ACTIVITY	38	1.87e-01	4.13e-01	0.18900	1.44e-01	1.22e-01	1.25e-01	1.92e-01
GOBP BONE MORPHOGENESIS	97	1.36e-02	7.52e-02	0.18900	1.52e-01	1.12e-01	9.77e-03	5.63e-02
GOBP VIRAL TRANSCRIPTION	50	9.93e-02	2.89e-01	0.18900	1.68e-01	8.55e-02	3.96e-02	2.96e-01
GOBP RETROGRADE AXONAL TRANSPORT	21	3.90e-01	6.24e-01	0.18900	1.56e-01	1.06e-01	2.15e-01	4.02e-01
GRB2 events in EGFR signaling	13	4.98e-01	7.09e-01	0.18900	1.88e-01	1.77e-02	2.41e-01	9.12e-01
GOMF O METHYLTRANSFERASE ACTIVITY	20	3.99e-01	6.31e-01	0.18900	8.81e-02	1.67e-01	4.95e-01	1.97e-01
GOBP VERY LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE	7	7.24e-01	8.59e-01	0.18900	1.67e-01	8.72e-02	4.44e-01	6.89e-01
GOBP CELL DIVISION	617	1.98e-12	1.59e-10	0.18900	1.57e-01	1.04e-01	2.66e-11	9.40e-06
GOBP CRANIAL NERVE STRUCTURAL ORGANIZATION	10	5.65e-01	7.57e-01	0.18900	-1.88e-01	9.92e-03	3.02e-01	9.57e-01
GOBP LACTATE METABOLIC PROCESS	18	4.44e-01	6.71e-01	0.18900	9.98e-02	1.60e-01	4.64e-01	2.40e-01
G beta:gamma signalling through PLC beta	20	3.36e-01	5.75e-01	0.18900	1.88e-01	1.09e-02	1.45e-01	9.33e-01
GOBP CONSTITUTIVE SECRETORY PATHWAY	7	6.99e-01	8.44e-01	0.18900	1.85e-01	3.84e-02	3.98e-01	8.60e-01
GOBP EPITHELIAL CELL FATE COMMITMENT	14	5.39e-01	7.39e-01	0.18900	1.18e-01	1.47e-01	4.45e-01	3.40e-01
GOBP SPINDLE ASSEMBLY	124	4.44e-03	3.24e-02	0.18800	1.38e-01	1.28e-01	7.94e-03	1.36e-02
Frs2-mediated activation	12	4.64e-01	6.86e-01	0.18800	1.75e-01	-7.00e-02	2.94e-01	6.74e-01
GOBP PROTEIN DNA COMPLEX DISASSEMBLY	23	3.46e-01	5.84e-01	0.18800	1.68e-01	8.48e-02	1.62e-01	4.81e-01
GOBP ERBB2 ERBB4 SIGNALING PATHWAY	5	7.71e-01	8.85e-01	0.18800	1.86e-01	3.09e-02	4.72e-01	9.05e-01
GOBP POSITIVE REGULATION OF TRIGLYCERIDE LIPASE ACTIVITY	8	5.86e-01	7.70e-01	0.18800	1.55e-01	-1.07e-01	4.47e-01	6.01e-01
GOBP MACROPHAGE CYTOKINE PRODUCTION	36	1.10e-01	3.07e-01	0.18800	-4.54e-02	1.83e-01	6.37e-01	5.77e-02
Eukaryotic Translation Termination	86	2.21e-02	1.07e-01	0.18800	1.09e-01	1.54e-01	8.11e-02	1.37e-02
Negative regulation of MAPK pathway	41	1.55e-01	3.72e-01	0.18800	1.64e-01	9.28e-02	6.95e-02	3.04e-01
GOBP LEUKOCYTE TETHERING OR ROLLING	34	1.98e-01	4.28e-01	0.18800	-1.76e-01	-6.72e-02	7.60e-02	4.98e-01
Pyrimidine salvage	10	5.09e-01	7.17e-01	0.18800	-1.26e-01	1.40e-01	4.89e-01	4.45e-01
GOBP MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C	12	5.90e-01	7.73e-01	0.18800	1.20e-01	1.45e-01	4.73e-01	3.83e-01
GOCC CHYLOMICRON	13	4.21e-01	6.51e-01	0.18800	1.03e-01	-1.57e-01	5.19e-01	3.26e-01
GOBP CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL	20	3.43e-01	5.81e-01	0.18800	-1.65e-02	-1.87e-01	8.98e-01	1.47e-01
GOBP SKELETAL MUSCLE ADAPTATION	25	1.86e-01	4.12e-01	0.18800	1.25e-01	-1.41e-01	2.80e-01	2.23e-01
GOBP POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION	97	1.50e-03	1.41e-02	0.18800	-1.21e-01	1.44e-01	3.95e-02	1.43e-02
GOBP CELLULAR HYPOTONIC RESPONSE	11	6.18e-01	7.90e-01	0.18800	-1.39e-01	-1.26e-01	4.24e-01	4.68e-01
GOMF TRANSLATION ELONGATION FACTOR ACTIVITY	18	3.30e-01	5.70e-01	0.18800	1.81e-01	-4.92e-02	1.83e-01	7.18e-01
GOBP POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS	20	3.50e-01	5.87e-01	0.18800	1.86e-01	2.32e-02	1.49e-01	8.58e-01
GOBP CERAMIDE TRANSPORT	17	3.76e-01	6.12e-01	0.18800	-1.67e-02	1.87e-01	9.05e-01	1.82e-01
GOBP POSITIVE REGULATION OF HORMONE BIOSYNTHETIC PROCESS	9	5.46e-01	7.44e-01	0.18800	-1.27e-01	1.38e-01	5.09e-01	4.73e-01
GOBP DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT	8	6.59e-01	8.18e-01	0.18800	-1.86e-01	-2.60e-02	3.63e-01	8.99e-01
GOCC FIBRILLAR CENTER	144	1.08e-03	1.12e-02	0.18800	1.76e-01	6.37e-02	2.57e-04	1.87e-01
GOMF BASIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY	17	3.34e-01	5.73e-01	0.18800	8.07e-02	-1.69e-01	5.65e-01	2.27e-01
Vpr-mediated nuclear import of PICs	34	1.81e-01	4.06e-01	0.18800	1.83e-01	3.95e-02	6.43e-02	6.90e-01
GOBP PHOSPHATIDYLINOSITOL METABOLIC PROCESS	155	7.37e-04	8.34e-03	0.18700	1.73e-01	7.22e-02	2.00e-04	1.21e-01
GOBP ISOTYPE SWITCHING TO IGA ISOTYPES	7	6.27e-01	7.95e-01	0.18700	1.47e-01	-1.16e-01	5.00e-01	5.95e-01
GOCC EXTRINSIC COMPONENT OF SYNAPTIC VESICLE MEMBRANE	11	5.43e-01	7.41e-01	0.18700	1.87e-01	-2.10e-03	2.82e-01	9.90e-01
GOCC ENDOPEPTIDASE COMPLEX	85	2.31e-02	1.10e-01	0.18700	1.58e-01	1.02e-01	1.20e-02	1.05e-01
GOBP SYNAPTIC TRANSMISSION GLUTAMATERGIC	104	1.12e-02	6.51e-02	0.18700	-1.34e-01	-1.31e-01	1.81e-02	2.11e-02
Inflammasomes	21	2.91e-01	5.30e-01	0.18700	-2.90e-02	1.85e-01	8.18e-01	1.42e-01
GOBP WATER SOLUBLE VITAMIN BIOSYNTHETIC PROCESS	11	5.92e-01	7.73e-01	0.18700	6.32e-02	1.76e-01	7.17e-01	3.11e-01
GOBP CARDIAC MUSCLE CELL ACTION POTENTIAL	81	2.68e-02	1.22e-01	0.18700	-9.48e-02	-1.62e-01	1.40e-01	1.19e-02
GOCC DENSE BODY	5	7.54e-01	8.74e-01	0.18700	-9.61e-03	1.87e-01	9.70e-01	4.69e-01
GOMF ISOPRENOID BINDING	45	1.42e-01	3.55e-01	0.18700	-1.41e-01	-1.23e-01	1.02e-01	1.52e-01
GOBP NEGATIVE REGULATION OF BEHAVIOR	12	4.57e-01	6.82e-01	0.18700	-1.63e-01	9.21e-02	3.28e-01	5.80e-01
GOBP IMP CATABOLIC PROCESS	5	7.97e-01	8.97e-01	0.18700	8.53e-02	1.67e-01	7.41e-01	5.19e-01
GOBP PROTEIN TARGETING	307	9.60e-07	2.84e-05	0.18700	1.68e-01	8.25e-02	4.09e-07	1.29e-02
GOBP SPHINGOSINE 1 PHOSPHATE RECEPTOR SIGNALING PATHWAY	15	3.69e-01	6.05e-01	0.18700	-1.47e-01	1.16e-01	3.24e-01	4.38e-01
GOBP REGULATION OF LEUKOCYTE MEDIATED IMMUNITY	238	1.52e-07	5.30e-06	0.18700	-1.45e-01	1.19e-01	1.18e-04	1.63e-03
GOMF GLUTAMATE RECEPTOR BINDING	44	1.23e-01	3.26e-01	0.18700	-1.77e-01	-6.11e-02	4.23e-02	4.83e-01
GOBP TETRAPYRROLE CATABOLIC PROCESS	13	5.19e-01	7.25e-01	0.18700	-1.83e-01	-3.73e-02	2.52e-01	8.16e-01
GOBP NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS	56	6.38e-02	2.19e-01	0.18700	1.81e-01	4.76e-02	1.91e-02	5.38e-01
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS	91	1.22e-02	6.89e-02	0.18700	1.80e-01	5.24e-02	3.07e-03	3.88e-01
GOMF CO RECEPTOR BINDING	13	5.38e-01	7.38e-01	0.18700	6.09e-02	1.77e-01	7.04e-01	2.70e-01
GOBP RETINOIC ACID METABOLIC PROCESS	33	1.70e-01	3.92e-01	0.18700	-8.86e-03	-1.87e-01	9.30e-01	6.33e-02
GOMF NERVE GROWTH FACTOR BINDING	6	7.69e-01	8.84e-01	0.18700	-1.11e-01	-1.50e-01	6.37e-01	5.24e-01
GOMF SUPEROXIDE GENERATING NADPH OXIDASE ACTIVATOR ACTIVITY	7	6.91e-01	8.39e-01	0.18700	-1.86e-01	-1.73e-02	3.94e-01	9.37e-01
GOMF PROTEIN SERINE THREONINE TYROSINE KINASE ACTIVITY	42	1.63e-01	3.83e-01	0.18700	1.40e-01	1.24e-01	1.17e-01	1.65e-01
GOMF NEUROTRANSMITTER RECEPTOR REGULATOR ACTIVITY	13	5.38e-01	7.38e-01	0.18700	-1.77e-01	-6.03e-02	2.70e-01	7.07e-01
GOBP CYSTEINE METABOLIC PROCESS	10	5.98e-01	7.78e-01	0.18700	1.85e-01	2.81e-02	3.12e-01	8.78e-01
Maternal to zygotic transition (MZT)	96	1.38e-02	7.63e-02	0.18700	1.63e-01	9.20e-02	5.89e-03	1.19e-01
Replacement of protamines by nucleosomes in the male pronucleus	22	3.87e-01	6.20e-01	0.18700	1.40e-01	1.23e-01	2.54e-01	3.17e-01
Phase I - Functionalization of compounds	102	9.04e-03	5.57e-02	0.18700	-7.37e-02	-1.72e-01	1.99e-01	2.74e-03
Cellular response to starvation	144	1.71e-03	1.56e-02	0.18700	1.60e-01	9.56e-02	8.86e-04	4.76e-02
GOBP ADENYLATE CYCLASE INHIBITING SEROTONIN RECEPTOR SIGNALING PATHWAY	7	7.31e-01	8.63e-01	0.18700	9.19e-02	1.63e-01	6.74e-01	4.56e-01
GOBP NEGATIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION	7	6.54e-01	8.13e-01	0.18700	-4.90e-02	1.80e-01	8.23e-01	4.09e-01
GOMF PHOSPHATIDYLINOSITOL 3 4 BISPHOSPHATE BINDING	26	2.76e-01	5.15e-01	0.18700	1.82e-01	4.21e-02	1.08e-01	7.10e-01
GOBP AORTA DEVELOPMENT	65	4.68e-02	1.80e-01	0.18700	1.75e-01	6.37e-02	1.44e-02	3.75e-01
GOBP VITAMIN E METABOLIC PROCESS	6	7.73e-01	8.85e-01	0.18700	1.28e-01	1.35e-01	5.86e-01	5.66e-01
GOBP COLLECTING DUCT DEVELOPMENT	15	5.21e-01	7.26e-01	0.18600	-1.50e-01	-1.11e-01	3.15e-01	4.57e-01
GOBP ENDODERMAL CELL FATE SPECIFICATION	8	7.08e-01	8.50e-01	0.18600	1.21e-01	1.42e-01	5.53e-01	4.87e-01
GOBP PURINE CONTAINING COMPOUND SALVAGE	14	4.59e-01	6.83e-01	0.18600	-8.70e-03	1.86e-01	9.55e-01	2.28e-01
GOCC NUCLEAR INCLUSION BODY	12	5.48e-01	7.45e-01	0.18600	1.83e-01	3.64e-02	2.73e-01	8.27e-01
GOMF PHOSPHATIDIC ACID BINDING	23	3.01e-01	5.40e-01	0.18600	1.85e-01	1.86e-02	1.24e-01	8.77e-01
GOBP N GLYCAN PROCESSING	17	4.44e-01	6.71e-01	0.18600	5.64e-02	1.78e-01	6.87e-01	2.05e-01
GOMF PHOSPHATIDYLINOSITOL 3 4 5 TRISPHOSPHATE BINDING	36	9.91e-02	2.89e-01	0.18600	1.64e-01	-8.80e-02	8.80e-02	3.61e-01
GOBP DNA REPLICATION INITIATION	35	1.81e-01	4.06e-01	0.18600	1.80e-01	4.67e-02	6.49e-02	6.33e-01
Diseases of signal transduction by growth factor receptors and second messengers	440	1.34e-09	7.16e-08	0.18600	1.76e-01	6.04e-02	2.34e-10	2.99e-02
GOBP ORNITHINE METABOLIC PROCESS	9	5.53e-01	7.48e-01	0.18600	1.18e-01	-1.44e-01	5.40e-01	4.54e-01
GOMF TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY BINDING	47	1.24e-01	3.28e-01	0.18600	9.12e-02	1.62e-01	2.79e-01	5.42e-02
GOMF MONOCARBOXYLIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY	68	3.20e-02	1.38e-01	0.18600	-1.84e-01	-3.01e-02	8.79e-03	6.68e-01
GOBP MACROPHAGE APOPTOTIC PROCESS	14	4.25e-01	6.54e-01	0.18600	1.77e-01	-5.67e-02	2.51e-01	7.13e-01
GOBP NEUROTROPHIN SIGNALING PATHWAY	39	1.87e-01	4.13e-01	0.18600	1.47e-01	1.14e-01	1.13e-01	2.16e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON METAL IONS	16	3.48e-01	5.85e-01	0.18600	-1.35e-01	1.28e-01	3.51e-01	3.74e-01
GOBP POSITIVE REGULATION OF ORGANELLE ORGANIZATION	501	2.00e-10	1.19e-08	0.18600	1.69e-01	7.76e-02	9.06e-11	2.93e-03
GOBP REGULATION OF MONOCYTE DIFFERENTIATION	20	4.20e-01	6.50e-01	0.18600	1.52e-01	1.07e-01	2.38e-01	4.08e-01
GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION	49	1.09e-01	3.06e-01	0.18600	1.68e-01	8.04e-02	4.23e-02	3.30e-01
Sealing of the nuclear envelope (NE) by ESCRT-III	30	2.10e-01	4.42e-01	0.18600	1.79e-02	1.85e-01	8.65e-01	7.93e-02
GOBP PROTEIN INSERTION INTO MITOCHONDRIAL INNER MEMBRANE	12	5.91e-01	7.73e-01	0.18600	1.57e-01	9.95e-02	3.46e-01	5.51e-01
GOBP MOTOR NEURON APOPTOTIC PROCESS	21	4.01e-01	6.34e-01	0.18600	1.04e-01	1.54e-01	4.09e-01	2.22e-01
GOBP REGULATION OF PROTEIN DEUBIQUITINATION	10	5.22e-01	7.26e-01	0.18600	1.55e-01	-1.02e-01	3.95e-01	5.76e-01
GOMF LIGAND GATED CALCIUM CHANNEL ACTIVITY	30	1.48e-01	3.61e-01	0.18600	-1.65e-01	8.62e-02	1.19e-01	4.14e-01
GOCC DENDRITIC GROWTH CONE	8	6.11e-01	7.86e-01	0.18600	6.30e-02	-1.75e-01	7.58e-01	3.92e-01
GOMF PHOSPHOPROTEIN BINDING	87	2.12e-02	1.04e-01	0.18600	8.86e-02	1.63e-01	1.53e-01	8.50e-03
GOCC MATRIX SIDE OF MITOCHONDRIAL INNER MEMBRANE	6	7.33e-01	8.63e-01	0.18600	1.85e-01	1.89e-02	4.33e-01	9.36e-01
GOBP EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS	80	2.82e-02	1.27e-01	0.18600	8.36e-02	1.66e-01	1.96e-01	1.04e-02
GOBP NEGATIVE REGULATION OF CELL SIZE	9	6.63e-01	8.21e-01	0.18500	1.70e-01	7.40e-02	3.77e-01	7.01e-01
GOBP GLANDULAR EPITHELIAL CELL DEVELOPMENT	36	1.86e-01	4.12e-01	0.18500	6.11e-02	1.75e-01	5.26e-01	6.90e-02
GOBP MULTICELLULAR ORGANISMAL LEVEL WATER HOMEOSTASIS	33	2.40e-01	4.77e-01	0.18500	-1.04e-01	-1.53e-01	2.99e-01	1.28e-01
GOBP WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY	5	7.23e-01	8.58e-01	0.18500	1.53e-01	-1.05e-01	5.54e-01	6.84e-01
GOBP T HELPER 17 TYPE IMMUNE RESPONSE	48	9.66e-02	2.84e-01	0.18500	4.32e-02	1.80e-01	6.04e-01	3.07e-02
GOMF MUSCLE ALPHA ACTININ BINDING	15	3.81e-01	6.15e-01	0.18500	1.58e-01	-9.74e-02	2.90e-01	5.14e-01
Respiratory syncytial virus (RSV) attachment and entry	21	4.09e-01	6.41e-01	0.18500	-1.41e-01	-1.21e-01	2.64e-01	3.38e-01
GOBP TRNA MODIFICATION	90	1.90e-02	9.56e-02	0.18500	1.63e-01	8.89e-02	7.67e-03	1.45e-01
GOBP REGULATION OF MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON	5	8.01e-01	9.00e-01	0.18500	-8.74e-02	-1.63e-01	7.35e-01	5.27e-01
ABC transporter disorders	64	2.75e-02	1.25e-01	0.18500	1.84e-01	-1.91e-02	1.08e-02	7.92e-01
GOBP PONS DEVELOPMENT	11	5.16e-01	7.22e-01	0.18500	-5.24e-02	1.78e-01	7.63e-01	3.08e-01
GOMF RNA DIRECTED DNA POLYMERASE ACTIVITY	7	6.87e-01	8.37e-01	0.18500	1.85e-01	1.82e-03	3.96e-01	9.93e-01
GOBP DEDIFFERENTIATION	11	5.91e-01	7.73e-01	0.18500	1.78e-01	4.99e-02	3.06e-01	7.75e-01
GOBP REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY	77	2.62e-02	1.20e-01	0.18500	5.37e-02	1.77e-01	4.15e-01	7.19e-03
GOBP CELLULAR RESPONSE TO AMMONIUM ION	5	7.25e-01	8.59e-01	0.18500	-1.55e-01	1.01e-01	5.48e-01	6.96e-01
Apoptotic execution phase	49	1.18e-01	3.18e-01	0.18500	1.60e-01	9.31e-02	5.29e-02	2.59e-01
GOBP DEHYDROASCORBIC ACID TRANSPORT	9	5.59e-01	7.52e-01	0.18500	-1.07e-01	1.51e-01	5.77e-01	4.34e-01
Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways	53	1.03e-01	2.96e-01	0.18500	1.06e-01	1.51e-01	1.80e-01	5.68e-02
PPARA activates gene expression	113	3.83e-03	2.89e-02	0.18500	1.82e-01	3.48e-02	8.51e-04	5.22e-01
GOMF PEPTIDASE ACTIVATOR ACTIVITY	57	8.73e-02	2.67e-01	0.18500	1.51e-01	1.07e-01	4.90e-02	1.62e-01
GOBP MONOATOMIC ANION HOMEOSTASIS	20	4.21e-01	6.51e-01	0.18500	-9.99e-02	-1.56e-01	4.39e-01	2.28e-01
Maturation of nucleoprotein 9683610	11	6.28e-01	7.96e-01	0.18500	1.38e-01	1.23e-01	4.27e-01	4.81e-01
GOMF PHOSPHOLIPASE A1 ACTIVITY	18	3.58e-01	5.95e-01	0.18500	-1.83e-01	2.80e-02	1.80e-01	8.37e-01
MyD88:MAL(TIRAP) cascade initiated on plasma membrane	106	1.16e-02	6.69e-02	0.18500	1.27e-01	1.34e-01	2.40e-02	1.69e-02
Toll Like Receptor TLR6:TLR2 Cascade	106	1.16e-02	6.69e-02	0.18500	1.27e-01	1.34e-01	2.40e-02	1.69e-02
GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE	7	7.29e-01	8.61e-01	0.18500	1.69e-01	7.42e-02	4.38e-01	7.34e-01
GOBP REGULATION OF OSTEOCLAST DEVELOPMENT	11	5.21e-01	7.26e-01	0.18500	-1.79e-01	4.62e-02	3.04e-01	7.91e-01
GOBP POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION	16	5.02e-01	7.12e-01	0.18500	-1.03e-01	-1.54e-01	4.78e-01	2.87e-01
GOBP ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS	53	6.95e-02	2.31e-01	0.18500	-1.83e-01	-2.60e-02	2.13e-02	7.43e-01
GOMF PATTERN RECOGNITION RECEPTOR ACTIVITY	32	1.33e-01	3.41e-01	0.18500	-1.63e-01	8.72e-02	1.11e-01	3.94e-01
GOBP CEREBRAL CORTEX DEVELOPMENT	119	5.96e-03	4.05e-02	0.18500	1.56e-01	9.84e-02	3.23e-03	6.36e-02
GOBP PIRNA MEDIATED RETROTRANSPOSON SILENCING BY HETEROCHROMATIN FORMATION	5	7.44e-01	8.69e-01	0.18500	4.62e-02	-1.79e-01	8.58e-01	4.89e-01
Toxicity of botulinum toxin type D (botD)	5	7.88e-01	8.92e-01	0.18500	5.03e-02	1.78e-01	8.46e-01	4.91e-01
Toxicity of botulinum toxin type F (botF)	5	7.88e-01	8.92e-01	0.18500	5.03e-02	1.78e-01	8.46e-01	4.91e-01
GOBP MEMBRANE HYPERPOLARIZATION	11	6.00e-01	7.79e-01	0.18500	1.74e-01	6.16e-02	3.17e-01	7.24e-01
GOBP PERIPHERAL NERVOUS SYSTEM AXON ENSHEATHMENT	29	2.27e-01	4.61e-01	0.18500	1.84e-01	1.89e-02	8.69e-02	8.60e-01
GOBP RESPONSE TO OXYGEN LEVELS	323	8.75e-07	2.61e-05	0.18500	1.61e-01	9.03e-02	6.44e-07	5.26e-03
GOMF GLUCOSIDASE ACTIVITY	14	4.56e-01	6.81e-01	0.18500	-1.83e-01	2.05e-02	2.35e-01	8.94e-01
GOBP VACUOLAR TRANSPORT	166	8.86e-04	9.56e-03	0.18500	1.49e-01	1.08e-01	8.93e-04	1.60e-02
GOBP G1 TO G0 TRANSITION	19	4.50e-01	6.75e-01	0.18500	1.33e-01	1.28e-01	3.17e-01	3.33e-01
GOBP POSITIVE REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY	10	5.23e-01	7.27e-01	0.18400	-1.35e-01	1.26e-01	4.60e-01	4.91e-01
GOBP APOPTOTIC SIGNALING PATHWAY	597	1.06e-11	7.81e-10	0.18400	9.39e-02	1.59e-01	8.92e-05	3.32e-11
GOBP PROTEIN IMPORT INTO PEROXISOME MATRIX	14	5.50e-01	7.46e-01	0.18400	1.51e-01	1.05e-01	3.27e-01	4.95e-01
GOBP GONADOTROPIN SECRETION	18	3.96e-01	6.29e-01	0.18400	1.84e-01	1.57e-02	1.77e-01	9.08e-01
GOBP NEGATIVE REGULATION OF ORGANELLE ORGANIZATION	337	3.71e-07	1.18e-05	0.18400	1.67e-01	7.92e-02	1.47e-07	1.24e-02
GOBP MITOCHONDRIAL TRANSPORT	176	5.70e-04	6.71e-03	0.18400	1.05e-01	1.52e-01	1.65e-02	5.12e-04
GOBP VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE	150	8.67e-04	9.39e-03	0.18400	1.77e-01	5.14e-02	1.81e-04	2.77e-01
GOBP SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS	64	6.80e-02	2.27e-01	0.18400	1.40e-01	1.20e-01	5.25e-02	9.74e-02
GOBP REGULATION OF HOMOPHILIC CELL ADHESION	5	7.86e-01	8.92e-01	0.18400	-4.45e-02	-1.79e-01	8.63e-01	4.88e-01
GOCC COLLAGEN CONTAINING EXTRACELLULAR MATRIX	405	1.44e-08	6.14e-07	0.18400	-6.96e-02	-1.71e-01	1.62e-02	3.77e-09
GOBP MYOTUBE CELL DEVELOPMENT	41	1.61e-01	3.79e-01	0.18400	7.72e-02	1.67e-01	3.93e-01	6.37e-02
GOBP PHOSPHATE ION HOMEOSTASIS	20	4.15e-01	6.46e-01	0.18400	-8.47e-02	-1.64e-01	5.12e-01	2.05e-01
GOMF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY	62	7.12e-02	2.35e-01	0.18400	-1.04e-01	-1.52e-01	1.58e-01	3.80e-02
GOMF PHOSPHATIDYLINOSITOL 3 KINASE REGULATOR ACTIVITY	11	6.18e-01	7.90e-01	0.18400	8.79e-02	1.62e-01	6.14e-01	3.52e-01
GOBP CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION	15	3.83e-01	6.18e-01	0.18400	-1.52e-01	1.03e-01	3.07e-01	4.88e-01
GOBP PROTEIN ACTIVATION CASCADE	18	4.51e-01	6.76e-01	0.18400	-8.19e-02	-1.65e-01	5.48e-01	2.26e-01
GOMF ACIDIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY	18	4.54e-01	6.79e-01	0.18400	1.63e-01	8.57e-02	2.31e-01	5.29e-01
GOMF STRUCTURAL CONSTITUENT OF EYE LENS	22	2.57e-01	4.95e-01	0.18400	1.68e-01	-7.58e-02	1.73e-01	5.38e-01
GOBP SKELETAL MUSCLE FIBER DIFFERENTIATION	12	4.79e-01	6.97e-01	0.18400	-7.05e-02	1.70e-01	6.72e-01	3.08e-01
GOBP RESPONSE TO BACTERIAL LIPOPROTEIN	10	5.98e-01	7.77e-01	0.18400	-1.83e-01	-1.40e-02	3.15e-01	9.39e-01
GOMF LIPASE ACTIVITY	133	3.50e-03	2.71e-02	0.18400	-1.54e-01	-1.01e-01	2.19e-03	4.45e-02
Stimuli-sensing channels	101	1.49e-02	8.07e-02	0.18400	-1.32e-01	-1.28e-01	2.14e-02	2.67e-02
GOBP CELLULAR RESPONSE TO LAMINAR FLUID SHEAR STRESS	8	7.14e-01	8.53e-01	0.18400	1.12e-01	1.46e-01	5.85e-01	4.74e-01
Formation of the ternary complex, and subsequently, the 43S complex	45	1.53e-01	3.69e-01	0.18400	1.32e-01	1.28e-01	1.25e-01	1.38e-01
GOBP POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY	19	3.40e-01	5.78e-01	0.18400	-3.06e-02	1.81e-01	8.17e-01	1.71e-01
GOBP HEMATOPOIETIC STEM CELL HOMEOSTASIS	20	2.79e-01	5.19e-01	0.18400	1.06e-01	-1.50e-01	4.12e-01	2.45e-01
GOBP MONOATOMIC ANION TRANSPORT	162	1.19e-03	1.20e-02	0.18400	-1.40e-01	-1.19e-01	2.08e-03	8.99e-03
Aryl hydrocarbon receptor signalling	7	7.46e-01	8.70e-01	0.18400	-1.41e-01	-1.18e-01	5.18e-01	5.90e-01
GOCC NUCLEAR PERIPHERY	142	2.63e-03	2.18e-02	0.18400	1.46e-01	1.12e-01	2.71e-03	2.13e-02
GOBP SKELETAL MUSCLE ORGAN DEVELOPMENT	176	6.46e-04	7.46e-03	0.18400	1.45e-01	1.13e-01	8.91e-04	9.98e-03
GOBP ARACHIDONIC ACID METABOLIC PROCESS	55	8.24e-02	2.57e-01	0.18400	-6.48e-02	-1.72e-01	4.06e-01	2.75e-02
GOBP MEMBRANE BIOGENESIS	61	6.25e-02	2.16e-01	0.18400	6.40e-02	1.72e-01	3.87e-01	2.01e-02
RHOD GTPase cycle	49	7.49e-02	2.42e-01	0.18400	1.84e-01	-5.98e-04	2.62e-02	9.94e-01
GOCC ENDOPLASMIC RETICULUM PLASMA MEMBRANE CONTACT SITE	12	5.14e-01	7.21e-01	0.18400	1.82e-01	-2.04e-02	2.74e-01	9.02e-01
TP53 Regulates Transcription of Death Receptors and Ligands	12	5.76e-01	7.65e-01	0.18400	5.96e-02	1.74e-01	7.21e-01	2.98e-01
GOMF JUN KINASE KINASE KINASE ACTIVITY	11	5.79e-01	7.67e-01	0.18300	1.82e-01	2.61e-02	2.97e-01	8.81e-01
GOBP HYPEROSMOTIC SALINITY RESPONSE	10	6.33e-01	7.99e-01	0.18300	1.73e-01	6.15e-02	3.44e-01	7.36e-01
GOBP REGULATION OF MUSCLE ADAPTATION	95	5.02e-03	3.55e-02	0.18300	1.82e-01	-2.52e-02	2.21e-03	6.71e-01
GOCC RADIAL SPOKE	15	4.34e-01	6.62e-01	0.18300	-2.37e-02	1.82e-01	8.74e-01	2.23e-01
SHC-mediated cascade:FGFR1	21	3.35e-01	5.73e-01	0.18300	1.83e-01	4.89e-03	1.46e-01	9.69e-01
GOBP POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE	18	3.16e-01	5.55e-01	0.18300	-1.25e-01	1.34e-01	3.60e-01	3.25e-01
GOBP SEQUESTERING OF ACTIN MONOMERS	6	7.48e-01	8.71e-01	0.18300	-3.58e-02	-1.80e-01	8.79e-01	4.46e-01
GOBP POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN	63	4.55e-02	1.76e-01	0.18300	-1.81e-01	-2.90e-02	1.30e-02	6.91e-01
GOBP SYNAPTIC VESICLE COATING	5	7.46e-01	8.70e-01	0.18300	5.10e-02	-1.76e-01	8.43e-01	4.96e-01
GOBP GAMMA DELTA T CELL DIFFERENTIATION	13	4.41e-01	6.68e-01	0.18300	-1.51e-01	1.03e-01	3.45e-01	5.20e-01
GOCC THO COMPLEX	5	8.12e-01	9.05e-01	0.18300	1.13e-01	1.44e-01	6.61e-01	5.78e-01
GOCC CLEAVAGE FURROW	52	8.98e-02	2.72e-01	0.18300	1.75e-01	5.21e-02	2.87e-02	5.16e-01
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMATIN	9	6.84e-01	8.35e-01	0.18300	1.53e-01	9.99e-02	4.26e-01	6.04e-01
GOBP VIRAL RNA GENOME REPLICATION	29	2.52e-01	4.90e-01	0.18300	1.78e-01	4.17e-02	9.71e-02	6.97e-01
GOMF NEUTRAL L AMINO ACID SODIUM SYMPORTER ACTIVITY	8	6.85e-01	8.36e-01	0.18300	1.77e-01	4.44e-02	3.85e-01	8.28e-01
GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION	46	5.40e-02	1.98e-01	0.18300	1.18e-01	-1.40e-01	1.67e-01	1.01e-01
GOBP PROTEIN KINASE A SIGNALING	39	1.58e-01	3.75e-01	0.18300	-1.78e-01	-4.25e-02	5.48e-02	6.46e-01
GOBP INTERLEUKIN 6 PRODUCTION	164	4.04e-05	7.29e-04	0.18300	-1.59e-01	9.02e-02	4.44e-04	4.63e-02
GOMF NAD BINDING	55	8.27e-02	2.58e-01	0.18300	1.72e-01	6.03e-02	2.70e-02	4.39e-01
GOBP FIBROBLAST GROWTH FACTOR PRODUCTION	10	5.66e-01	7.57e-01	0.18300	-3.82e-02	1.79e-01	8.34e-01	3.28e-01
GOBP RESPONSE TO CHEMOKINE	96	1.95e-02	9.78e-02	0.18300	-1.28e-01	-1.30e-01	2.99e-02	2.77e-02
L13a-mediated translational silencing of Ceruloplasmin expression	102	1.43e-02	7.81e-02	0.18300	1.50e-01	1.05e-01	9.00e-03	6.81e-02
p75NTR negatively regulates cell cycle via SC1	6	6.96e-01	8.42e-01	0.18300	-7.20e-02	1.68e-01	7.60e-01	4.77e-01
GOBP TETRAHYDROBIOPTERIN METABOLIC PROCESS	8	6.91e-01	8.39e-01	0.18300	5.20e-02	1.75e-01	7.99e-01	3.91e-01
GOCC BLOC COMPLEX	20	4.31e-01	6.59e-01	0.18300	1.53e-01	1.00e-01	2.37e-01	4.38e-01
GOBP NEURAL CREST FORMATION	15	4.93e-01	7.05e-01	0.18300	1.77e-01	4.29e-02	2.34e-01	7.73e-01
HIV Life Cycle	145	2.16e-03	1.87e-02	0.18300	1.58e-01	9.18e-02	1.04e-03	5.62e-02
GOCC PICLN SM PROTEIN COMPLEX	6	7.40e-01	8.68e-01	0.18200	1.82e-01	1.83e-02	4.41e-01	9.38e-01
GOBP REGULATION OF SYNAPSE MATURATION	21	4.20e-01	6.51e-01	0.18200	1.17e-01	1.40e-01	3.55e-01	2.66e-01
Synthesis of bile acids and bile salts	33	1.27e-01	3.33e-01	0.18200	1.52e-01	-1.00e-01	1.30e-01	3.19e-01
GOBP NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS	31	1.79e-01	4.04e-01	0.18200	-1.81e-01	2.61e-02	8.18e-02	8.02e-01
GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY ENDOTHELIN	6	7.09e-01	8.50e-01	0.18200	4.24e-02	-1.77e-01	8.57e-01	4.52e-01
GOBP POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION	41	8.16e-02	2.56e-01	0.18200	1.63e-01	-8.14e-02	7.05e-02	3.67e-01
GOMF POLYSACCHARIDE BINDING	21	4.21e-01	6.51e-01	0.18200	1.20e-01	1.38e-01	3.43e-01	2.75e-01
GOBP POSITIVE REGULATION OF OSSIFICATION	53	1.14e-01	3.13e-01	0.18200	1.32e-01	1.26e-01	9.69e-02	1.13e-01
GOCC TOR COMPLEX	12	5.58e-01	7.51e-01	0.18200	1.80e-01	2.94e-02	2.80e-01	8.60e-01
GOBP PIGMENT GRANULE LOCALIZATION	23	3.78e-01	6.13e-01	0.18200	1.56e-01	9.39e-02	1.95e-01	4.36e-01
GOBP MITOCHONDRIAL GENOME MAINTENANCE	30	2.66e-01	5.05e-01	0.18200	7.13e-02	1.68e-01	4.99e-01	1.12e-01
GOCC GLYCOPROTEIN COMPLEX	21	4.20e-01	6.51e-01	0.18200	-1.11e-01	-1.44e-01	3.79e-01	2.52e-01
Glutathione conjugation	33	2.25e-01	4.59e-01	0.18200	1.72e-01	5.89e-02	8.67e-02	5.58e-01
GOBP NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT	12	6.11e-01	7.86e-01	0.18200	1.39e-01	1.17e-01	4.03e-01	4.82e-01
GOBP MUSCLE CELL APOPTOTIC PROCESS	98	1.08e-02	6.37e-02	0.18200	1.76e-01	4.82e-02	2.67e-03	4.10e-01
GOMF PASSIVE TRANSMEMBRANE TRANSPORTER ACTIVITY	485	1.81e-09	9.44e-08	0.18200	-1.58e-01	-9.10e-02	2.73e-09	5.98e-04
GOCC CHITOSOME	20	2.85e-01	5.23e-01	0.18200	-1.11e-01	1.44e-01	3.91e-01	2.64e-01
GOBP REGULATION OF ORGANELLE ORGANIZATION	1165	4.51e-21	7.01e-19	0.18200	1.58e-01	9.07e-02	1.11e-19	1.80e-07
Selenocysteine synthesis	86	2.92e-02	1.30e-01	0.18200	1.11e-01	1.44e-01	7.65e-02	2.06e-02
GOBP REGULATORY NCRNA MEDIATED GENE SILENCING	601	1.54e-11	1.09e-09	0.18200	-8.80e-02	-1.59e-01	2.29e-04	2.63e-11
GOMF TUMOR NECROSIS FACTOR RECEPTOR BINDING	29	2.22e-01	4.56e-01	0.18200	-2.76e-04	1.82e-01	9.98e-01	9.01e-02
GOBP EMBRYONIC CLEAVAGE	8	6.58e-01	8.17e-01	0.18200	1.82e-01	-3.87e-03	3.73e-01	9.85e-01
GOBP POSITIVE REGULATION OF MACROAUTOPHAGY	83	1.02e-02	6.07e-02	0.18200	1.79e-01	-2.93e-02	4.72e-03	6.45e-01
GOBP LATERAL SPROUTING FROM AN EPITHELIUM	10	5.87e-01	7.71e-01	0.18200	-1.07e-02	1.81e-01	9.53e-01	3.20e-01
GOBP POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION	29	1.80e-01	4.04e-01	0.18200	-6.44e-02	1.70e-01	5.48e-01	1.13e-01
Glycogen metabolism	22	2.83e-01	5.22e-01	0.18200	1.76e-01	-4.66e-02	1.54e-01	7.05e-01
GOBP REGULATION OF NON MOTILE CILIUM ASSEMBLY	10	6.63e-01	8.21e-01	0.18200	1.43e-01	1.13e-01	4.35e-01	5.38e-01
GOBP CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION	172	9.22e-04	9.82e-03	0.18200	1.17e-01	1.39e-01	8.24e-03	1.64e-03
GOBP OLIGOSACCHARIDE METABOLIC PROCESS	62	3.51e-02	1.47e-01	0.18200	-1.81e-01	1.91e-02	1.39e-02	7.95e-01
GOBP RESPONSE TO ACETYLCHOLINE	46	5.76e-02	2.05e-01	0.18200	-1.50e-01	1.03e-01	7.87e-02	2.29e-01
Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)	88	2.81e-02	1.26e-01	0.18200	1.32e-01	1.24e-01	3.20e-02	4.36e-02
GOBP DIPEPTIDE TRANSMEMBRANE TRANSPORT	8	6.12e-01	7.87e-01	0.18200	-8.92e-02	1.58e-01	6.62e-01	4.39e-01
SHC-mediated cascade:FGFR2	22	3.29e-01	5.68e-01	0.18200	1.81e-01	9.69e-03	1.41e-01	9.37e-01
GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN CYCLIC AMIDINES	34	1.34e-01	3.44e-01	0.18100	-6.44e-02	1.70e-01	5.16e-01	8.69e-02
GOBP NEGATIVE REGULATION OF TYPE II INTERFERON PRODUCTION	40	9.34e-02	2.78e-01	0.18100	-1.68e-01	6.75e-02	6.54e-02	4.60e-01
GOBP PURINE DEOXYRIBONUCLEOTIDE CATABOLIC PROCESS	10	6.31e-01	7.98e-01	0.18100	4.72e-02	1.75e-01	7.96e-01	3.38e-01
GOBP INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS	26	2.81e-01	5.20e-01	0.18100	-1.80e-01	-2.35e-02	1.12e-01	8.36e-01
GOBP REGULATION OF GLUCOCORTICOID BIOSYNTHETIC PROCESS	9	5.84e-01	7.69e-01	0.18100	-1.66e-01	7.30e-02	3.88e-01	7.05e-01
GOBP MUSCLE TISSUE DEVELOPMENT	429	1.52e-08	6.42e-07	0.18100	1.62e-01	8.15e-02	8.77e-09	3.80e-03
GOBP REGULATION OF GAMMA DELTA T CELL ACTIVATION	11	5.54e-01	7.48e-01	0.18100	-1.80e-01	1.73e-02	3.00e-01	9.21e-01
GOMF NUCLEOSIDE DIPHOSPHATE PHOSPHATASE ACTIVITY	17	4.36e-01	6.64e-01	0.18100	2.31e-02	1.80e-01	8.69e-01	1.99e-01
GOMF SULFATIDE BINDING	6	7.50e-01	8.71e-01	0.18100	-2.96e-02	-1.79e-01	9.00e-01	4.48e-01
GOBP PYRIMIDINE CONTAINING COMPOUND SALVAGE	7	7.01e-01	8.45e-01	0.18100	6.56e-03	1.81e-01	9.76e-01	4.07e-01
GOBP L PHENYLALANINE METABOLIC PROCESS	8	6.08e-01	7.84e-01	0.18100	-1.43e-01	1.11e-01	4.84e-01	5.86e-01
GOCC CELL SUBSTRATE JUNCTION	419	1.41e-08	6.04e-07	0.18100	1.68e-01	6.72e-02	3.48e-09	1.84e-02
Anchoring of the basal body to the plasma membrane	92	2.31e-02	1.10e-01	0.18100	1.48e-01	1.04e-01	1.39e-02	8.56e-02
GOMF 1 ACYLGLYCEROPHOSPHOCHOLINE O ACYLTRANSFERASE ACTIVITY	7	7.34e-01	8.64e-01	0.18100	6.30e-02	1.70e-01	7.73e-01	4.37e-01
GOMF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY	138	3.81e-03	2.88e-02	0.18100	-1.38e-01	-1.17e-01	5.01e-03	1.80e-02
p130Cas linkage to MAPK signaling for integrins	15	4.91e-01	7.05e-01	0.18100	-3.40e-02	-1.78e-01	8.20e-01	2.33e-01
GOBP REGULATION OF INTEGRIN ACTIVATION	17	3.57e-01	5.94e-01	0.18100	-1.60e-01	8.48e-02	2.54e-01	5.45e-01
GOBP REGULATION OF MITOCHONDRION ORGANIZATION	143	2.98e-03	2.39e-02	0.18100	1.07e-01	1.46e-01	2.74e-02	2.59e-03
GOBP POSITIVE REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE	20	4.35e-01	6.63e-01	0.18100	1.54e-01	9.39e-02	2.32e-01	4.67e-01
GOBP GENITALIA MORPHOGENESIS	11	5.35e-01	7.37e-01	0.18100	4.69e-02	-1.75e-01	7.88e-01	3.16e-01
Reversible hydration of carbon dioxide	11	5.09e-01	7.17e-01	0.18100	-1.51e-01	1.00e-01	3.87e-01	5.66e-01
GOBP NEGATIVE REGULATION OF LYASE ACTIVITY	18	4.37e-01	6.64e-01	0.18100	-4.51e-02	-1.75e-01	7.40e-01	1.99e-01
GOBP AXIS SPECIFICATION	93	2.17e-02	1.05e-01	0.18100	1.52e-01	9.73e-02	1.12e-02	1.05e-01
Co-inhibition by PD-1	21	2.76e-01	5.16e-01	0.18100	-1.52e-01	9.85e-02	2.29e-01	4.35e-01
GOCC LATE ENDOSOME MEMBRANE	164	1.32e-03	1.29e-02	0.18100	1.09e-01	1.44e-01	1.64e-02	1.43e-03
GOMF POLYUBIQUITIN MODIFICATION DEPENDENT PROTEIN BINDING	52	9.12e-02	2.74e-01	0.18100	1.75e-01	4.31e-02	2.87e-02	5.91e-01
GOBP NEURAL TUBE FORMATION	101	1.74e-02	9.00e-02	0.18100	1.32e-01	1.23e-01	2.19e-02	3.23e-02
GOMF PROTEIN ARGININE OMEGA N MONOMETHYLTRANSFERASE ACTIVITY	5	8.07e-01	9.03e-01	0.18100	1.65e-01	7.41e-02	5.24e-01	7.74e-01
DDX58/IFIH1-mediated induction of interferon-alpha/beta	76	2.64e-02	1.21e-01	0.18000	1.78e-01	2.69e-02	7.15e-03	6.85e-01
GOMF POLYPEPTIDE N ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY	19	3.93e-01	6.26e-01	0.18000	-1.80e-01	-1.58e-02	1.75e-01	9.05e-01
GOBP TRUNK SEGMENTATION	5	8.18e-01	9.08e-01	0.18000	-1.21e-01	-1.34e-01	6.38e-01	6.05e-01
GOBP NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC	8	6.27e-01	7.96e-01	0.18000	6.29e-02	-1.69e-01	7.58e-01	4.08e-01
GOBP NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION	13	5.19e-01	7.24e-01	0.18000	-1.80e-01	-4.98e-03	2.60e-01	9.75e-01
GOBP INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION	35	1.98e-01	4.28e-01	0.18000	-1.76e-01	-4.05e-02	7.20e-02	6.78e-01
GOBP NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT	21	3.67e-01	6.04e-01	0.18000	-1.78e-01	-2.75e-02	1.57e-01	8.27e-01
Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells	5	8.09e-01	9.04e-01	0.18000	1.62e-01	7.97e-02	5.31e-01	7.58e-01
GOBP PROTEIN DESTABILIZATION	47	1.12e-01	3.11e-01	0.18000	1.76e-01	3.73e-02	3.64e-02	6.58e-01
GOMF AMP ACTIVATED PROTEIN KINASE ACTIVITY	8	6.10e-01	7.85e-01	0.18000	1.17e-01	-1.37e-01	5.66e-01	5.03e-01
GOMF G PROTEIN COUPLED SEROTONIN RECEPTOR ACTIVITY	21	3.28e-01	5.67e-01	0.18000	-1.79e-01	1.70e-02	1.55e-01	8.93e-01
GOBP ENDOSOMAL TRANSPORT	276	1.01e-05	2.16e-04	0.18000	1.61e-01	8.19e-02	4.41e-06	1.92e-02
GOBP REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS	13	4.70e-01	6.92e-01	0.18000	6.27e-02	-1.69e-01	6.95e-01	2.92e-01
GOBP MICROTUBULE POLYMERIZATION	91	2.19e-02	1.06e-01	0.18000	1.60e-01	8.20e-02	8.16e-03	1.77e-01
GOBP RNA MODIFICATION	162	1.25e-03	1.24e-02	0.18000	1.56e-01	8.95e-02	5.97e-04	4.93e-02
GOMF K63 LINKED POLYUBIQUITIN MODIFICATION DEPENDENT PROTEIN BINDING	24	2.69e-01	5.09e-01	0.18000	1.77e-01	-3.13e-02	1.33e-01	7.91e-01
GOBP COLLAGEN CATABOLIC PROCESS	44	1.14e-01	3.14e-01	0.18000	-1.27e-02	-1.80e-01	8.84e-01	3.93e-02
GOBP POST EMBRYONIC HEMOPOIESIS	5	8.10e-01	9.05e-01	0.18000	8.29e-02	1.60e-01	7.48e-01	5.36e-01
GOCC SPERMATOPROTEASOME COMPLEX	5	7.36e-01	8.65e-01	0.18000	1.43e-01	-1.09e-01	5.79e-01	6.73e-01
GOBP POSITIVE REGULATION OF CORTICOSTEROID HORMONE SECRETION	7	7.44e-01	8.70e-01	0.18000	-1.61e-01	-8.05e-02	4.61e-01	7.12e-01
GOBP CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION	19	3.34e-01	5.73e-01	0.18000	-5.95e-02	1.70e-01	6.53e-01	2.00e-01
GOBP POSITIVE REGULATION OF NEURON MIGRATION	16	4.61e-01	6.85e-01	0.18000	2.06e-02	1.79e-01	8.86e-01	2.16e-01
GOBP POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS	13	5.94e-01	7.75e-01	0.18000	1.37e-01	1.17e-01	3.93e-01	4.66e-01
GOBP PIGMENT ACCUMULATION	11	6.24e-01	7.94e-01	0.18000	7.25e-02	1.65e-01	6.77e-01	3.44e-01
GOBP POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS	21	2.85e-01	5.23e-01	0.18000	-1.59e-01	8.42e-02	2.07e-01	5.04e-01
GOBP POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY	62	6.75e-02	2.27e-01	0.18000	6.42e-02	1.68e-01	3.82e-01	2.21e-02
GOBP PROTEIN INSERTION INTO MEMBRANE	42	1.55e-01	3.72e-01	0.18000	1.71e-01	5.59e-02	5.53e-02	5.31e-01
GOBP SKELETAL MUSCLE CELL DIFFERENTIATION	78	4.32e-02	1.71e-01	0.18000	1.45e-01	1.07e-01	2.73e-02	1.03e-01
GOMF METAL CLUSTER BINDING	71	5.24e-02	1.94e-01	0.18000	1.58e-01	8.62e-02	2.15e-02	2.09e-01
GOMF ARACHIDONATE COA LIGASE ACTIVITY	10	5.95e-01	7.75e-01	0.18000	-1.01e-02	1.79e-01	9.56e-01	3.26e-01
GOBP 3 UTR MEDIATED MRNA DESTABILIZATION	19	4.35e-01	6.63e-01	0.18000	1.69e-01	6.11e-02	2.02e-01	6.45e-01
GOBP PROCESS UTILIZING AUTOPHAGIC MECHANISM	571	1.67e-10	1.01e-08	0.18000	1.46e-01	1.05e-01	2.62e-09	1.74e-05
GOBP CELLULAR RESPONSE TO NUTRIENT LEVELS	232	7.47e-05	1.22e-03	0.18000	1.56e-01	8.92e-02	4.26e-05	1.92e-02
GOMF UBIQUITIN UBIQUITIN LIGASE ACTIVITY	14	5.49e-01	7.46e-01	0.18000	1.65e-01	7.15e-02	2.86e-01	6.43e-01
Epithelial-Mesenchymal Transition (EMT) during gastrulation	7	7.36e-01	8.66e-01	0.18000	6.04e-02	1.69e-01	7.82e-01	4.38e-01
GOMF ASPARTIC TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY	7	6.50e-01	8.11e-01	0.18000	-1.33e-01	1.21e-01	5.42e-01	5.80e-01
GOBP NUCLEOBASE CONTAINING COMPOUND TRANSPORT	214	1.42e-04	2.06e-03	0.18000	1.59e-01	8.28e-02	5.89e-05	3.68e-02
Ca2+ pathway	62	4.26e-02	1.69e-01	0.18000	1.80e-01	-3.21e-03	1.45e-02	9.65e-01
GOBP ANDROGEN METABOLIC PROCESS	29	3.16e-01	5.55e-01	0.18000	-1.30e-01	-1.24e-01	2.26e-01	2.48e-01
GOBP NUCLEOTIDE SALVAGE	17	3.80e-01	6.15e-01	0.18000	-5.43e-02	1.71e-01	6.98e-01	2.22e-01
GOBP SEMAPHORIN PLEXIN SIGNALING PATHWAY	43	1.60e-01	3.79e-01	0.17900	-7.22e-02	-1.64e-01	4.12e-01	6.23e-02
GOBP LUTEINIZATION	12	5.57e-01	7.51e-01	0.17900	1.79e-01	1.51e-02	2.83e-01	9.28e-01
GOBP NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING	16	3.88e-01	6.22e-01	0.17900	1.61e-01	-7.87e-02	2.64e-01	5.86e-01
GOCC POSTSYNAPTIC SPECIALIZATION MEMBRANE	124	7.24e-03	4.69e-02	0.17900	-1.38e-01	-1.15e-01	7.92e-03	2.75e-02
Sodium/Calcium exchangers	11	6.22e-01	7.93e-01	0.17900	-6.61e-02	-1.67e-01	7.04e-01	3.38e-01
GOBP NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	20	2.97e-01	5.36e-01	0.17900	-1.03e-01	1.47e-01	4.25e-01	2.56e-01
GOBP PROTEIN CONTAINING COMPLEX ASSEMBLY	1526	4.73e-27	1.12e-24	0.17900	1.64e-01	7.26e-02	8.16e-27	2.14e-06
SLC-mediated transmembrane transport	238	8.53e-05	1.36e-03	0.17900	-1.31e-01	-1.23e-01	5.09e-04	1.10e-03
FGFR1c ligand binding and activation	13	5.89e-01	7.72e-01	0.17900	1.51e-01	9.62e-02	3.45e-01	5.48e-01
Synthesis of PC	27	3.23e-01	5.61e-01	0.17900	7.98e-02	1.61e-01	4.73e-01	1.49e-01
GOBP MITOCHONDRIAL PROTEIN CATABOLIC PROCESS	10	6.38e-01	8.02e-01	0.17900	4.76e-02	1.73e-01	7.94e-01	3.44e-01
GOBP GLYCOSYLCERAMIDE CATABOLIC PROCESS	10	5.53e-01	7.48e-01	0.17900	-1.59e-01	8.23e-02	3.83e-01	6.52e-01
GOMF NADPLUS BINDING	18	4.72e-01	6.94e-01	0.17900	8.15e-02	1.60e-01	5.49e-01	2.41e-01
NOTCH2 intracellular domain regulates transcription	11	5.64e-01	7.56e-01	0.17900	1.79e-01	-1.29e-02	3.04e-01	9.41e-01
GOBP POSITIVE REGULATION OF B CELL PROLIFERATION	43	1.06e-01	3.02e-01	0.17900	-1.79e-01	1.43e-02	4.26e-02	8.71e-01
GOBP TRANSITION BETWEEN FAST AND SLOW FIBER	9	6.91e-01	8.39e-01	0.17900	-9.04e-02	-1.55e-01	6.39e-01	4.21e-01
GOCC GOLGI CIS CISTERNA	13	5.78e-01	7.66e-01	0.17900	7.57e-02	1.62e-01	6.36e-01	3.11e-01
GOBP SODIUM ION HOMEOSTASIS	47	1.52e-01	3.68e-01	0.17900	-1.07e-01	-1.44e-01	2.04e-01	8.84e-02
GOBP VALINE METABOLIC PROCESS	7	7.28e-01	8.61e-01	0.17900	1.74e-01	4.31e-02	4.26e-01	8.43e-01
GOBP PROTEIN O LINKED FUCOSYLATION	5	7.36e-01	8.66e-01	0.17900	-1.21e-01	1.32e-01	6.39e-01	6.09e-01
GOCC COP9 SIGNALOSOME	34	2.61e-01	4.99e-01	0.17900	1.27e-01	1.26e-01	2.01e-01	2.02e-01
GOCC IMMUNOLOGICAL SYNAPSE	45	6.98e-02	2.32e-01	0.17900	-8.33e-02	1.58e-01	3.34e-01	6.58e-02
GOBP POSITIVE REGULATION OF HEART GROWTH	39	1.42e-01	3.55e-01	0.17900	1.79e-01	1.87e-03	5.30e-02	9.84e-01
GOCC NUCLEOID	43	1.62e-01	3.82e-01	0.17900	1.64e-01	7.24e-02	6.33e-02	4.11e-01
GOMF PHOSPHOLIPID SCRAMBLASE ACTIVITY	15	4.46e-01	6.72e-01	0.17900	-3.02e-02	1.76e-01	8.40e-01	2.37e-01
GOBP NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY	13	4.52e-01	6.78e-01	0.17900	-1.22e-01	1.31e-01	4.48e-01	4.13e-01
GOBP CELLULAR RESPONSE TO AMYLOID BETA	44	6.95e-02	2.31e-01	0.17900	1.09e-01	-1.42e-01	2.10e-01	1.04e-01
GOBP CELL CELL ADHESION MEDIATED BY INTEGRIN	18	3.95e-01	6.28e-01	0.17900	1.78e-01	-1.18e-02	1.90e-01	9.31e-01
GOBP NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY	36	2.40e-01	4.77e-01	0.17900	1.38e-01	1.13e-01	1.51e-01	2.39e-01
GOCC MAIN AXON	68	5.12e-02	1.91e-01	0.17900	-1.70e-01	-5.62e-02	1.55e-02	4.23e-01
GOBP REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION	28	2.88e-01	5.26e-01	0.17900	-4.98e-02	-1.72e-01	6.49e-01	1.16e-01
GOBP MONOCYTE DIFFERENTIATION	34	2.52e-01	4.90e-01	0.17900	9.53e-02	1.51e-01	3.36e-01	1.27e-01
GOBP PROTEIN HETEROTETRAMERIZATION	15	5.45e-01	7.43e-01	0.17900	1.50e-01	9.70e-02	3.14e-01	5.16e-01
RAB GEFs exchange GTP for GDP on RABs	80	3.81e-02	1.56e-01	0.17900	8.82e-02	1.55e-01	1.73e-01	1.62e-02
GOBP SPERMIDINE TRANSPORT	5	8.18e-01	9.08e-01	0.17900	-9.97e-02	-1.48e-01	7.00e-01	5.66e-01
GOBP IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE	55	1.06e-01	3.02e-01	0.17900	9.01e-02	1.54e-01	2.48e-01	4.78e-02
GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY	11	6.21e-01	7.92e-01	0.17900	1.68e-01	6.10e-02	3.35e-01	7.26e-01
GOBP NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION	21	2.82e-01	5.21e-01	0.17900	1.05e-01	-1.45e-01	4.05e-01	2.52e-01
Metabolism of proteins	1922	9.85e-32	3.10e-29	0.17900	1.52e-01	9.32e-02	1.89e-28	1.32e-11
GOBP TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION	11	5.14e-01	7.21e-01	0.17900	1.12e-01	-1.39e-01	5.21e-01	4.24e-01
GOBP NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS	106	1.56e-02	8.35e-02	0.17900	1.22e-01	1.31e-01	3.05e-02	2.00e-02
GOCC TIM23 MITOCHONDRIAL IMPORT INNER MEMBRANE TRANSLOCASE COMPLEX	14	5.34e-01	7.36e-01	0.17900	1.73e-01	4.53e-02	2.63e-01	7.69e-01
GOBP REGULATION OF ATP DEPENDENT ACTIVITY	60	9.45e-02	2.80e-01	0.17900	1.31e-01	1.21e-01	7.84e-02	1.05e-01
Trafficking of GluR2-containing AMPA receptors	15	4.15e-01	6.46e-01	0.17900	1.60e-01	-7.92e-02	2.83e-01	5.95e-01
Syndecan interactions	26	2.12e-01	4.44e-01	0.17900	9.51e-02	-1.51e-01	4.01e-01	1.82e-01
GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS	36	1.19e-01	3.20e-01	0.17800	1.55e-01	-8.89e-02	1.08e-01	3.56e-01
GOBP PROTEIN LOCALIZATION TO CILIARY TRANSITION ZONE	8	6.32e-01	7.99e-01	0.17800	1.66e-01	-6.47e-02	4.15e-01	7.51e-01
GOMF NADPLUS NUCLEOSIDASE ACTIVITY	9	5.80e-01	7.67e-01	0.17800	-1.39e-01	1.12e-01	4.70e-01	5.62e-01
GOBP DEOXYRIBONUCLEOTIDE METABOLIC PROCESS	42	1.14e-01	3.13e-01	0.17800	-1.47e-02	1.78e-01	8.69e-01	4.61e-02
PCP/CE pathway	79	4.36e-02	1.72e-01	0.17800	1.44e-01	1.06e-01	2.74e-02	1.04e-01
GOBP NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE	61	4.30e-02	1.70e-01	0.17800	-1.78e-01	1.45e-02	1.64e-02	8.45e-01
Synthesis, secretion, and deacylation of Ghrelin	19	4.59e-01	6.83e-01	0.17800	8.54e-02	1.57e-01	5.19e-01	2.38e-01
GOMF ACYLTRANSFERASE ACTIVITY	677	4.85e-12	3.72e-10	0.17800	1.42e-01	1.08e-01	2.86e-10	1.77e-06
Golgi Associated Vesicle Biogenesis	51	1.32e-01	3.40e-01	0.17800	1.45e-01	1.04e-01	7.31e-02	2.01e-01
GOBP PROTEIN EXIT FROM ENDOPLASMIC RETICULUM	47	1.56e-01	3.73e-01	0.17800	1.09e-01	1.41e-01	1.98e-01	9.39e-02
Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters	20	4.53e-01	6.79e-01	0.17800	1.08e-01	1.42e-01	4.04e-01	2.72e-01
GOBP SEGMENTATION	99	2.04e-02	1.01e-01	0.17800	1.10e-01	1.40e-01	5.89e-02	1.59e-02
GOBP IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY	21	3.88e-01	6.21e-01	0.17800	-1.74e-01	-4.00e-02	1.69e-01	7.51e-01
GOBP PROTEIN O LINKED GLYCOSYLATION VIA THREONINE	10	5.48e-01	7.44e-01	0.17800	-1.39e-01	1.11e-01	4.46e-01	5.43e-01
GOBP POSITIVE REGULATION OF RECEPTOR INTERNALIZATION	25	2.85e-01	5.23e-01	0.17800	3.66e-03	-1.78e-01	9.75e-01	1.23e-01
Tight junction interactions	28	2.31e-01	4.65e-01	0.17800	-1.77e-01	2.22e-02	1.06e-01	8.39e-01
GOCC CONDENSED NUCLEAR CHROMOSOME	74	1.97e-02	9.84e-02	0.17800	1.76e-01	-2.92e-02	8.99e-03	6.64e-01
CLEC7A (Dectin-1) induces NFAT activation	11	6.44e-01	8.07e-01	0.17800	1.48e-01	9.86e-02	3.95e-01	5.71e-01
GOBP REGULATION OF ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION	6	7.64e-01	8.81e-01	0.17800	1.73e-01	4.25e-02	4.63e-01	8.57e-01
GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION	11	5.97e-01	7.76e-01	0.17800	-1.76e-01	-2.34e-02	3.11e-01	8.93e-01
GOCC SEH1 ASSOCIATED COMPLEX	13	5.34e-01	7.36e-01	0.17800	1.77e-01	1.21e-02	2.68e-01	9.40e-01
GOBP REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY	67	2.25e-02	1.08e-01	0.17800	-6.37e-02	1.66e-01	3.67e-01	1.88e-02
GOBP REGULATION OF HEART GROWTH	70	5.17e-02	1.92e-01	0.17800	1.66e-01	6.49e-02	1.66e-02	3.48e-01
GOBP HIPPO SIGNALING	52	6.88e-02	2.29e-01	0.17800	1.77e-01	-1.60e-02	2.72e-02	8.42e-01
GOBP TRYPTOPHAN METABOLIC PROCESS	10	6.77e-01	8.30e-01	0.17800	-1.24e-01	-1.27e-01	4.97e-01	4.86e-01
ALK mutants bind TKIs	12	5.85e-01	7.70e-01	0.17800	1.73e-01	4.23e-02	3.00e-01	8.00e-01
GOBP REGULATION OF LIPID KINASE ACTIVITY	8	7.30e-01	8.62e-01	0.17800	1.41e-01	1.09e-01	4.91e-01	5.95e-01
GOBP RESPONSE TO WATER	13	4.79e-01	6.96e-01	0.17800	-6.39e-02	1.66e-01	6.90e-01	3.01e-01
GOCC MITOCHONDRIAL CRISTA JUNCTION	6	7.62e-01	8.79e-01	0.17800	1.74e-01	3.70e-02	4.61e-01	8.75e-01
Eukaryotic Translation Elongation	87	3.32e-02	1.42e-01	0.17800	1.09e-01	1.40e-01	8.01e-02	2.35e-02
GOBP RESPONSE TO AMINO ACID STARVATION	54	9.54e-02	2.81e-01	0.17800	1.70e-01	5.18e-02	3.09e-02	5.11e-01
GOBP REGULATION OF T HELPER CELL DIFFERENTIATION	44	1.31e-01	3.40e-01	0.17800	2.77e-02	1.75e-01	7.50e-01	4.42e-02
GOCC AXONEMAL A TUBULE INNER SHEATH	23	3.17e-01	5.56e-01	0.17700	4.20e-03	-1.77e-01	9.72e-01	1.41e-01
Glycosphingolipid catabolism	33	1.94e-01	4.23e-01	0.17700	-2.52e-03	1.77e-01	9.80e-01	7.78e-02
Zinc influx into cells by the SLC39 gene family	10	6.64e-01	8.22e-01	0.17700	1.58e-01	8.04e-02	3.87e-01	6.60e-01
GOBP PALLIUM DEVELOPMENT	182	8.96e-04	9.63e-03	0.17700	1.28e-01	1.23e-01	2.93e-03	4.23e-03
GOMF DNA ENDONUCLEASE ACTIVITY PRODUCING 3 PHOSPHOMONOESTERS	9	5.89e-01	7.73e-01	0.17700	1.52e-01	-9.08e-02	4.29e-01	6.37e-01
GOMF DYNEIN LIGHT CHAIN BINDING	9	5.84e-01	7.69e-01	0.17700	1.13e-01	-1.37e-01	5.58e-01	4.77e-01
GOCC ENDOPLASMIC RETICULUM GOLGI INTERMEDIATE COMPARTMENT	128	6.77e-03	4.48e-02	0.17700	1.42e-01	1.06e-01	5.58e-03	3.77e-02
GOBP CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS	63	8.25e-02	2.58e-01	0.17700	9.59e-02	1.49e-01	1.88e-01	4.09e-02
GOMF RNA ENDONUCLEASE ACTIVITY PRODUCING 3 PHOSPHOMONOESTERS	7	7.55e-01	8.75e-01	0.17700	1.54e-01	8.82e-02	4.82e-01	6.86e-01
GOBP FC GAMMA RECEPTOR SIGNALING PATHWAY	31	1.57e-01	3.74e-01	0.17700	-1.23e-01	1.28e-01	2.38e-01	2.19e-01
GOBP RESPONSE TO DIETARY EXCESS	35	1.40e-01	3.53e-01	0.17700	1.65e-01	-6.28e-02	9.04e-02	5.20e-01
GOBP TROPHOBLAST CELL MIGRATION	17	4.98e-01	7.09e-01	0.17700	7.58e-02	1.60e-01	5.88e-01	2.54e-01
GOMF MONOATOMIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY	134	4.42e-03	3.23e-02	0.17700	-1.58e-01	-7.98e-02	1.60e-03	1.11e-01
GOBP SPHINGOMYELIN METABOLIC PROCESS	20	4.46e-01	6.73e-01	0.17700	8.37e-02	1.56e-01	5.17e-01	2.28e-01
GOMF EXCITATORY EXTRACELLULAR LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY	35	1.53e-01	3.69e-01	0.17700	-1.72e-01	3.98e-02	7.78e-02	6.84e-01
GOBP PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING	11	5.92e-01	7.74e-01	0.17700	1.21e-02	1.76e-01	9.44e-01	3.11e-01
GOBP REGULATION OF BINDING	221	1.78e-04	2.49e-03	0.17700	9.68e-02	1.48e-01	1.31e-02	1.52e-04
Estrogen-dependent nuclear events downstream of ESR-membrane signaling	23	3.22e-01	5.60e-01	0.17700	1.77e-01	-1.87e-03	1.42e-01	9.88e-01
GOBP ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS	21	3.84e-01	6.18e-01	0.17700	1.74e-01	3.00e-02	1.67e-01	8.12e-01
GOBP POLYPRENOL METABOLIC PROCESS	25	3.27e-01	5.66e-01	0.17700	1.73e-01	3.68e-02	1.35e-01	7.50e-01
GOBP DETECTION OF BIOTIC STIMULUS	36	1.53e-01	3.68e-01	0.17700	-1.74e-01	2.77e-02	7.00e-02	7.74e-01
GOBP RESPONSE TO FORSKOLIN	14	5.33e-01	7.35e-01	0.17700	-3.50e-02	-1.73e-01	8.20e-01	2.62e-01
GOBP ORGAN INDUCTION	21	4.45e-01	6.72e-01	0.17700	1.31e-01	1.19e-01	3.00e-01	3.46e-01
GOBP DENDRITIC CELL MIGRATION	30	3.11e-01	5.51e-01	0.17700	-1.42e-01	-1.05e-01	1.79e-01	3.18e-01
GOBP HYPOTONIC RESPONSE	13	6.06e-01	7.83e-01	0.17700	-1.30e-01	-1.19e-01	4.16e-01	4.57e-01
GOBP ESTABLISHMENT OF ORGANELLE LOCALIZATION	459	2.62e-08	1.07e-06	0.17700	1.39e-01	1.09e-01	3.22e-07	6.61e-05
GOBP OUTER DYNEIN ARM ASSEMBLY	22	3.78e-01	6.13e-01	0.17700	-1.72e-01	-4.07e-02	1.63e-01	7.41e-01
GOMF UBIQUINOL CYTOCHROME C REDUCTASE ACTIVITY	5	7.69e-01	8.83e-01	0.17700	-3.05e-02	1.74e-01	9.06e-01	5.01e-01
GOBP STRIATED MUSCLE CONTRACTION	182	8.11e-04	9.00e-03	0.17600	-9.56e-02	-1.48e-01	2.61e-02	5.56e-04
SARS-CoV-2-host interactions	189	6.61e-04	7.59e-03	0.17600	1.44e-01	1.02e-01	6.48e-04	1.53e-02
Signaling by ERBB2	50	8.86e-02	2.70e-01	0.17600	1.76e-01	3.14e-03	3.09e-02	9.69e-01
GOBP REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY	118	6.33e-03	4.26e-02	0.17600	1.69e-01	5.13e-02	1.53e-03	3.36e-01
Vitamin D (calciferol) metabolism	12	5.33e-01	7.35e-01	0.17600	-3.07e-02	1.74e-01	8.54e-01	2.97e-01
GOBP MODULATION OF INHIBITORY POSTSYNAPTIC POTENTIAL	7	7.52e-01	8.73e-01	0.17600	-1.59e-01	-7.73e-02	4.67e-01	7.23e-01
JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1	19	4.67e-01	6.89e-01	0.17600	1.55e-01	8.39e-02	2.42e-01	5.26e-01
GOCC COATED VESICLE MEMBRANE	194	6.01e-04	7.01e-03	0.17600	1.34e-01	1.14e-01	1.24e-03	6.10e-03
Golgi-to-ER retrograde transport	132	3.92e-03	2.95e-02	0.17600	1.66e-01	5.94e-02	9.89e-04	2.39e-01
GOBP REGULATION OF GAMMA DELTA T CELL DIFFERENTIATION	9	6.13e-01	7.87e-01	0.17600	-4.94e-02	1.69e-01	7.98e-01	3.80e-01
GOBP POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION	31	3.04e-01	5.44e-01	0.17600	1.33e-01	1.15e-01	1.99e-01	2.67e-01
GOCC FICOLIN 1 RICH GRANULE LUMEN	121	8.99e-03	5.55e-02	0.17600	9.73e-02	1.47e-01	6.46e-02	5.27e-03
LDL remodeling	6	7.58e-01	8.76e-01	0.17600	2.18e-02	1.75e-01	9.26e-01	4.59e-01
GOBP ADULT HEART DEVELOPMENT	14	4.58e-01	6.82e-01	0.17600	1.64e-01	-6.44e-02	2.88e-01	6.76e-01
GOBP STEM CELL DIFFERENTIATION	243	6.81e-05	1.12e-03	0.17600	1.54e-01	8.51e-02	3.48e-05	2.24e-02
Signalling to RAS	20	4.00e-01	6.32e-01	0.17600	2.41e-02	1.74e-01	8.52e-01	1.77e-01
GOBP SYNAPTIC TRANSMISSION DOPAMINERGIC	28	2.25e-01	4.59e-01	0.17600	-1.71e-01	4.04e-02	1.16e-01	7.12e-01
GOBP REGULATION OF NUCLEASE ACTIVITY	21	4.28e-01	6.57e-01	0.17600	1.58e-01	7.83e-02	2.11e-01	5.34e-01
GOCC ENDOPLASMIC RETICULUM GOLGI INTERMEDIATE COMPARTMENT MEMBRANE	76	5.50e-02	1.99e-01	0.17600	1.22e-01	1.26e-01	6.49e-02	5.67e-02
GOBP T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE	85	2.19e-02	1.06e-01	0.17600	3.08e-02	1.73e-01	6.23e-01	5.74e-03
GOBP PARKIN MEDIATED STIMULATION OF MITOPHAGY IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION	5	7.47e-01	8.70e-01	0.17600	1.45e-01	-1.00e-01	5.75e-01	6.98e-01
GOBP REGULATION OF T HELPER 1 CELL DIFFERENTIATION	11	5.48e-01	7.45e-01	0.17600	-5.32e-02	1.68e-01	7.60e-01	3.35e-01
GOBP CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND	14	5.82e-01	7.69e-01	0.17600	-1.41e-01	-1.05e-01	3.61e-01	4.96e-01
GOBP STORE OPERATED CALCIUM ENTRY	22	3.42e-01	5.80e-01	0.17600	-2.44e-03	1.76e-01	9.84e-01	1.53e-01
GOBP ENTRY OF BACTERIUM INTO HOST CELL	9	5.98e-01	7.77e-01	0.17600	-8.25e-02	1.55e-01	6.68e-01	4.20e-01
GOCC PRONUCLEUS	14	5.00e-01	7.10e-01	0.17600	8.41e-03	-1.76e-01	9.57e-01	2.55e-01
Infectious disease	925	1.88e-15	1.93e-13	0.17600	1.30e-01	1.18e-01	1.99e-11	1.06e-09
GOBP POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION	72	2.84e-02	1.27e-01	0.17600	-9.03e-03	1.76e-01	8.95e-01	1.00e-02
GOBP MITOCHONDRIAL CALCIUM ION HOMEOSTASIS	23	4.16e-01	6.47e-01	0.17600	1.23e-01	1.26e-01	3.08e-01	2.97e-01
GOBP NEURON NEURON SYNAPTIC TRANSMISSION	8	6.37e-01	8.02e-01	0.17600	-7.38e-02	1.59e-01	7.18e-01	4.35e-01
GOBP POSITIVE REGULATION OF RECEPTOR CLUSTERING	10	6.76e-01	8.30e-01	0.17600	1.49e-01	9.38e-02	4.16e-01	6.07e-01
Regulation of actin dynamics for phagocytic cup formation	58	1.00e-01	2.90e-01	0.17600	8.37e-02	1.54e-01	2.70e-01	4.19e-02
GOBP FATTY ACID TRANSMEMBRANE TRANSPORT	19	4.78e-01	6.96e-01	0.17600	1.46e-01	9.79e-02	2.71e-01	4.60e-01
GOBP CALCIUM ION IMPORT	80	4.78e-02	1.82e-01	0.17600	-1.17e-01	-1.31e-01	7.05e-02	4.29e-02
GOBP VACUOLAR ACIDIFICATION	33	2.64e-01	5.03e-01	0.17600	1.58e-01	7.55e-02	1.15e-01	4.53e-01
GOBP REGULATION OF DEOXYRIBONUCLEASE ACTIVITY	10	6.83e-01	8.34e-01	0.17600	1.16e-01	1.32e-01	5.26e-01	4.70e-01
GOBP FACIAL NERVE MORPHOGENESIS	10	6.48e-01	8.09e-01	0.17500	-1.70e-01	-4.32e-02	3.52e-01	8.13e-01
GOBP NEGATIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS	7	7.02e-01	8.45e-01	0.17500	-1.86e-02	1.74e-01	9.32e-01	4.24e-01
GOBP NUCLEOTIDE TRANSMEMBRANE TRANSPORT	28	2.49e-01	4.87e-01	0.17500	-1.14e-02	1.75e-01	9.17e-01	1.09e-01
GOMF LIPOPROTEIN PARTICLE RECEPTOR ACTIVITY	18	3.65e-01	6.02e-01	0.17500	7.06e-02	-1.61e-01	6.04e-01	2.38e-01
GOBP REGULATION OF TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY	11	5.36e-01	7.37e-01	0.17500	-1.56e-01	8.00e-02	3.70e-01	6.46e-01
GOBP CELLULAR RESPONSE TO STARVATION	165	1.89e-03	1.68e-02	0.17500	1.37e-01	1.10e-01	2.42e-03	1.50e-02
GOBP POSITIVE REGULATION OF TELOMERASE ACTIVITY	29	3.13e-01	5.52e-01	0.17500	1.57e-01	7.77e-02	1.43e-01	4.69e-01
Sensory processing of sound	70	6.82e-02	2.28e-01	0.17500	-1.04e-01	-1.41e-01	1.33e-01	4.09e-02
GOBP STEM CELL DIVISION	32	2.80e-01	5.20e-01	0.17500	8.17e-02	1.55e-01	4.24e-01	1.29e-01
GOBP REGULATION OF CILIUM ASSEMBLY	95	2.75e-02	1.24e-01	0.17500	1.29e-01	1.19e-01	2.99e-02	4.54e-02
GOBP INTERLEUKIN 2 PRODUCTION	61	4.16e-02	1.66e-01	0.17500	-1.72e-01	3.45e-02	2.03e-02	6.41e-01
GOBP PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS	28	3.42e-01	5.80e-01	0.17500	1.06e-01	1.40e-01	3.32e-01	2.01e-01
Synthesis of Ketone Bodies	8	6.40e-01	8.04e-01	0.17500	-7.04e-02	1.60e-01	7.30e-01	4.32e-01
GOBP REGULATION OF CELL MATRIX ADHESION	121	5.66e-03	3.88e-02	0.17500	1.69e-01	4.62e-02	1.32e-03	3.80e-01
GOBP HINDGUT DEVELOPMENT	8	7.21e-01	8.57e-01	0.17500	6.82e-02	1.61e-01	7.38e-01	4.29e-01
GOBP SENSORY PERCEPTION OF TEMPERATURE STIMULUS	29	3.34e-01	5.72e-01	0.17500	-1.29e-01	-1.18e-01	2.29e-01	2.70e-01
GOBP SKELETAL MUSCLE THIN FILAMENT ASSEMBLY	7	6.90e-01	8.39e-01	0.17500	1.70e-01	-4.27e-02	4.37e-01	8.45e-01
GOBP INTRACELLULAR RECEPTOR SIGNALING PATHWAY	355	1.37e-06	3.86e-05	0.17500	1.46e-01	9.72e-02	2.45e-06	1.65e-03
GOBP INTERLEUKIN 1 ALPHA PRODUCTION	11	5.30e-01	7.33e-01	0.17500	9.96e-02	-1.44e-01	5.67e-01	4.09e-01
GOBP EPITHELIAL TO MESENCHYMAL TRANSITION	188	8.58e-04	9.32e-03	0.17500	1.29e-01	1.18e-01	2.28e-03	5.17e-03
GOBP NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION	89	3.27e-02	1.40e-01	0.17500	1.45e-01	9.75e-02	1.78e-02	1.12e-01
GOBP RESPIRATORY BURST INVOLVED IN DEFENSE RESPONSE	16	5.24e-01	7.28e-01	0.17500	-1.60e-01	-7.15e-02	2.69e-01	6.21e-01
GOBP POSITIVE REGULATION OF SPROUTING ANGIOGENESIS	30	1.75e-01	3.97e-01	0.17500	-1.12e-01	1.34e-01	2.87e-01	2.04e-01
GOBP REGULATION OF STEM CELL PROLIFERATION	92	2.63e-02	1.21e-01	0.17500	1.56e-01	7.98e-02	9.90e-03	1.86e-01
GOBP GLYCOSYLCERAMIDE BIOSYNTHETIC PROCESS	8	7.28e-01	8.61e-01	0.17500	7.97e-02	1.56e-01	6.96e-01	4.46e-01
Diseases associated with the TLR signaling cascade	29	2.55e-01	4.92e-01	0.17500	7.16e-03	1.75e-01	9.47e-01	1.03e-01
Diseases of Immune System	29	2.55e-01	4.92e-01	0.17500	7.16e-03	1.75e-01	9.47e-01	1.03e-01
GOBP REGULATION OF SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING	7	7.13e-01	8.52e-01	0.17500	-1.75e-01	2.95e-03	4.23e-01	9.89e-01
GOBP MESENCHYMAL CELL PROLIFERATION	44	1.83e-01	4.09e-01	0.17500	9.40e-02	1.47e-01	2.80e-01	9.11e-02
Early Phase of HIV Life Cycle	14	4.87e-01	7.01e-01	0.17500	2.96e-02	-1.72e-01	8.48e-01	2.65e-01
GOMF FATTY ACID TRANSMEMBRANE TRANSPORTER ACTIVITY	18	5.00e-01	7.11e-01	0.17500	-1.45e-01	-9.67e-02	2.85e-01	4.77e-01
GOBP PROTEIN EXPORT FROM NUCLEUS	57	1.17e-01	3.18e-01	0.17500	1.21e-01	1.26e-01	1.14e-01	1.00e-01
Toll Like Receptor 2 (TLR2) Cascade	109	1.58e-02	8.42e-02	0.17500	1.01e-01	1.42e-01	6.87e-02	1.02e-02
Toll Like Receptor TLR1:TLR2 Cascade	109	1.58e-02	8.42e-02	0.17500	1.01e-01	1.42e-01	6.87e-02	1.02e-02
GOBP REGULATION OF MEMBRANE LIPID METABOLIC PROCESS	20	4.16e-01	6.47e-01	0.17400	3.38e-02	1.71e-01	7.94e-01	1.85e-01
GOMF CELL CELL ADHESION MEDIATOR ACTIVITY	51	1.47e-01	3.61e-01	0.17400	-1.14e-01	-1.32e-01	1.58e-01	1.04e-01
RAC3 GTPase cycle	85	4.03e-02	1.63e-01	0.17400	1.39e-01	1.05e-01	2.65e-02	9.47e-02
GOCC PHOTORECEPTOR CONNECTING CILIUM	39	1.15e-01	3.15e-01	0.17400	1.58e-01	-7.34e-02	8.76e-02	4.27e-01
GOBP VIRAL GENE EXPRESSION	99	2.41e-02	1.14e-01	0.17400	1.36e-01	1.09e-01	1.92e-02	6.15e-02
GOBP TELOMERASE HOLOENZYME COMPLEX ASSEMBLY	6	7.98e-01	8.98e-01	0.17400	1.12e-01	1.33e-01	6.34e-01	5.72e-01
GOBP REGULATORY NCRNA PROCESSING	69	7.22e-02	2.37e-01	0.17400	1.44e-01	9.83e-02	3.87e-02	1.58e-01
GOBP APOPTOTIC DNA FRAGMENTATION	19	4.50e-01	6.75e-01	0.17400	5.05e-02	1.67e-01	7.03e-01	2.08e-01
GOMF WIDE PORE CHANNEL ACTIVITY	33	2.88e-01	5.26e-01	0.17400	-1.37e-01	-1.08e-01	1.74e-01	2.83e-01
GOBP ADENYLATE CYCLASE ACTIVATING DOPAMINE RECEPTOR SIGNALING PATHWAY	10	6.87e-01	8.37e-01	0.17400	1.23e-01	1.23e-01	5.00e-01	5.00e-01
GOBP PROTEIN K27 LINKED UBIQUITINATION	12	5.39e-01	7.38e-01	0.17400	1.71e-01	-3.40e-02	3.06e-01	8.38e-01
GOBP REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS	139	1.64e-03	1.51e-02	0.17400	1.74e-01	1.08e-02	4.03e-04	8.27e-01
GOBP COLLATERAL SPROUTING IN ABSENCE OF INJURY	5	7.68e-01	8.83e-01	0.17400	1.68e-01	-4.44e-02	5.14e-01	8.63e-01
GOBP NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS	37	1.77e-01	4.01e-01	0.17400	6.81e-03	1.74e-01	9.43e-01	6.71e-02
Fertilization	26	3.76e-01	6.11e-01	0.17400	-1.09e-01	-1.36e-01	3.36e-01	2.31e-01
GOMF PROTEIN LIPID COMPLEX BINDING	31	3.12e-01	5.52e-01	0.17400	-1.34e-01	-1.11e-01	1.97e-01	2.84e-01
GOBP RESPONSE TO STEROID HORMONE	325	6.16e-06	1.43e-04	0.17400	1.18e-01	1.28e-01	2.52e-04	7.41e-05
Transport to the Golgi and subsequent modification	183	8.60e-04	9.33e-03	0.17400	1.52e-01	8.56e-02	4.06e-04	4.59e-02
GOBP NEGATIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT	26	2.47e-01	4.85e-01	0.17400	-1.65e-01	5.64e-02	1.46e-01	6.19e-01
Reproduction	119	7.99e-03	5.08e-02	0.17400	1.63e-01	6.19e-02	2.19e-03	2.43e-01
GOBP NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION	44	8.57e-02	2.64e-01	0.17400	1.54e-01	-8.14e-02	7.79e-02	3.50e-01
GOBP LYSOSOMAL TRANSPORT	131	7.59e-03	4.88e-02	0.17400	1.33e-01	1.12e-01	8.65e-03	2.67e-02
GOBP REGULATION OF BONE MINERALIZATION INVOLVED IN BONE MATURATION	7	7.09e-01	8.50e-01	0.17400	-1.73e-01	1.51e-02	4.28e-01	9.45e-01
GOBP REGULATION OF AUTOPHAGY	349	1.28e-06	3.63e-05	0.17400	1.57e-01	7.54e-02	5.04e-07	1.55e-02
GOCC OUTER MEMBRANE	233	1.75e-04	2.46e-03	0.17400	1.35e-01	1.09e-01	3.71e-04	4.19e-03
CRMPs in Sema3A signaling	15	5.30e-01	7.33e-01	0.17400	-4.50e-02	-1.68e-01	7.63e-01	2.61e-01
GOBP NEGATIVE REGULATION OF GLUCOSE IMPORT	16	5.50e-01	7.46e-01	0.17400	-1.31e-01	-1.14e-01	3.65e-01	4.28e-01
GOBP PLUS END DIRECTED ORGANELLE TRANSPORT ALONG MICROTUBULE	7	6.95e-01	8.41e-01	0.17400	1.69e-01	-4.10e-02	4.40e-01	8.51e-01
GOBP NEGATIVE REGULATION OF FATTY ACID OXIDATION	14	4.78e-01	6.96e-01	0.17400	1.67e-01	-4.86e-02	2.80e-01	7.53e-01
GOBP ANTEROGRADE NEURONAL DENSE CORE VESICLE TRANSPORT	6	7.25e-01	8.59e-01	0.17400	-1.64e-01	5.65e-02	4.86e-01	8.11e-01
SHC1 events in ERBB2 signaling	22	3.18e-01	5.56e-01	0.17400	1.68e-01	-4.23e-02	1.72e-01	7.31e-01
GOMF 2 ACYLGLYCEROL 3 PHOSPHATE O ACYLTRANSFERASE ACTIVITY	9	6.89e-01	8.38e-01	0.17300	5.26e-02	1.65e-01	7.85e-01	3.90e-01
GOBP ESTABLISHMENT OF SKIN BARRIER	34	1.44e-01	3.57e-01	0.17300	-1.38e-01	1.05e-01	1.65e-01	2.87e-01
GOMF MOLECULAR CONDENSATE SCAFFOLD ACTIVITY	36	2.38e-01	4.74e-01	0.17300	1.60e-01	6.77e-02	9.74e-02	4.82e-01
GOBP VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY	12	5.99e-01	7.78e-01	0.17300	1.69e-01	3.93e-02	3.11e-01	8.14e-01
Negative regulation of MET activity	20	4.21e-01	6.51e-01	0.17300	1.70e-01	3.49e-02	1.88e-01	7.87e-01
GOBP TERPENOID BIOSYNTHETIC PROCESS	16	4.18e-01	6.49e-01	0.17300	1.60e-01	-6.71e-02	2.68e-01	6.42e-01
GOBP PHOSPHATIDYLSERINE METABOLIC PROCESS	23	3.83e-01	6.17e-01	0.17300	4.85e-02	1.66e-01	6.87e-01	1.67e-01
GOBP RESPONSE TO AMYLOID BETA	55	5.19e-02	1.92e-01	0.17300	6.11e-02	-1.62e-01	4.33e-01	3.74e-02
GOMF ENDONUCLEASE ACTIVITY ACTIVE WITH EITHER RIBO OR DEOXYRIBONUCLEIC ACIDS AND PRODUCING 3 PHOSPHOMONOESTERS	17	4.32e-01	6.59e-01	0.17300	1.72e-01	-1.88e-02	2.19e-01	8.93e-01
GOMF NUCLEOTIDYLTRANSFERASE ACTIVITY	136	4.22e-03	3.12e-02	0.17300	1.62e-01	6.24e-02	1.13e-03	2.09e-01
Pausing and recovery of Tat-mediated HIV elongation	31	2.95e-01	5.35e-01	0.17300	7.42e-02	1.57e-01	4.75e-01	1.31e-01
Tat-mediated HIV elongation arrest and recovery	31	2.95e-01	5.35e-01	0.17300	7.42e-02	1.57e-01	4.75e-01	1.31e-01
GOBP EMBRYONIC ORGAN DEVELOPMENT	448	6.31e-08	2.39e-06	0.17300	9.90e-02	1.42e-01	3.27e-04	2.42e-07
GOBP CELL CELL ADHESION MEDIATED BY CADHERIN	49	1.26e-01	3.31e-01	0.17300	-1.68e-01	-4.28e-02	4.19e-02	6.05e-01
Interactions of Vpr with host cellular proteins	35	2.27e-01	4.62e-01	0.17300	1.68e-01	4.27e-02	8.55e-02	6.62e-01
GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS	153	8.51e-04	9.28e-03	0.17300	5.79e-03	1.73e-01	9.02e-01	2.18e-04
GOBP L ASPARTATE TRANSMEMBRANE TRANSPORT	11	6.63e-01	8.21e-01	0.17300	1.35e-01	1.09e-01	4.39e-01	5.32e-01
GOBP REGULATION OF BMP SIGNALING PATHWAY	117	1.21e-02	6.89e-02	0.17300	1.45e-01	9.53e-02	6.87e-03	7.48e-02
GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS	37	2.48e-01	4.87e-01	0.17300	-9.93e-02	-1.42e-01	2.96e-01	1.35e-01
GOBP NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY	24	2.81e-01	5.20e-01	0.17300	5.20e-02	-1.65e-01	6.59e-01	1.61e-01
GOMF COMPLEMENT COMPONENT C1Q COMPLEX BINDING	8	7.43e-01	8.69e-01	0.17300	-1.16e-01	-1.29e-01	5.70e-01	5.29e-01
GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT ENDOSOME TO POSTSYNAPTIC MEMBRANE	10	6.63e-01	8.21e-01	0.17300	-1.64e-01	-5.47e-02	3.68e-01	7.64e-01
GOBP MESODERM MORPHOGENESIS	77	5.82e-02	2.06e-01	0.17300	1.16e-01	1.29e-01	7.89e-02	5.10e-02
GOBP POLYOL CATABOLIC PROCESS	9	6.27e-01	7.95e-01	0.17300	-1.67e-01	4.40e-02	3.85e-01	8.19e-01
GOBP RESPONSE TO MURAMYL DIPEPTIDE	20	4.25e-01	6.54e-01	0.17300	3.63e-02	1.69e-01	7.79e-01	1.91e-01
GOBP PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM	70	5.67e-02	2.03e-01	0.17300	1.65e-01	5.27e-02	1.72e-02	4.45e-01
Biosynthesis of DHA-derived SPMs	17	3.93e-01	6.27e-01	0.17300	7.74e-02	-1.54e-01	5.81e-01	2.70e-01
GOBP REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS	21	3.99e-01	6.31e-01	0.17300	-2.67e-02	-1.71e-01	8.32e-01	1.76e-01
GOBP REGULATION OF CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY	6	7.42e-01	8.69e-01	0.17300	1.71e-01	-2.45e-02	4.68e-01	9.17e-01
GOBP AGGRESOME ASSEMBLY	5	7.88e-01	8.92e-01	0.17300	6.56e-03	-1.73e-01	9.80e-01	5.04e-01
GOBP PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION	34	1.92e-01	4.20e-01	0.17300	-1.59e-02	1.72e-01	8.72e-01	8.29e-02
GOBP PLACENTA DEVELOPMENT	145	9.79e-04	1.03e-02	0.17300	-1.14e-02	1.72e-01	8.13e-01	3.46e-04
GOBP PROSTATE GLANDULAR ACINUS DEVELOPMENT	10	6.92e-01	8.40e-01	0.17300	1.28e-01	1.15e-01	4.83e-01	5.27e-01
GOBP B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE	83	2.52e-02	1.17e-01	0.17200	1.94e-02	1.71e-01	7.60e-01	6.95e-03
GOBP NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION	22	3.13e-01	5.53e-01	0.17200	-1.63e-01	5.52e-02	1.85e-01	6.54e-01
GOCC SEPTIN CYTOSKELETON	14	5.92e-01	7.73e-01	0.17200	9.62e-02	1.43e-01	5.33e-01	3.54e-01
GOMF ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY	34	1.53e-01	3.69e-01	0.17200	-1.50e-01	8.53e-02	1.31e-01	3.89e-01
GOBP POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM	34	1.46e-01	3.59e-01	0.17200	-1.17e-01	1.27e-01	2.39e-01	2.00e-01
GOBP INORGANIC ANION TRANSPORT	162	2.64e-03	2.19e-02	0.17200	-1.33e-01	-1.10e-01	3.50e-03	1.59e-02
GOBP REGULATION OF NEURON APOPTOTIC PROCESS	235	1.40e-04	2.04e-03	0.17200	8.48e-02	1.50e-01	2.51e-02	7.36e-05
GOMF EXTRACELLULAR MATRIX PROTEIN BINDING	6	7.74e-01	8.86e-01	0.17200	1.69e-01	3.51e-02	4.74e-01	8.81e-01
GOMF L GLUTAMATE TRANSMEMBRANE TRANSPORTER ACTIVITY	14	5.85e-01	7.70e-01	0.17200	1.51e-01	8.22e-02	3.27e-01	5.94e-01
GOBP CELL MIGRATION INVOLVED IN GASTRULATION	13	5.34e-01	7.36e-01	0.17200	-1.72e-01	1.39e-02	2.84e-01	9.31e-01
GOBP PODOSOME ASSEMBLY	21	4.63e-01	6.86e-01	0.17200	-1.19e-01	-1.24e-01	3.44e-01	3.24e-01
Membrane Trafficking	604	2.33e-10	1.36e-08	0.17200	1.47e-01	9.03e-02	7.25e-10	1.51e-04
RND1 GTPase cycle	41	2.23e-01	4.57e-01	0.17200	1.28e-01	1.15e-01	1.56e-01	2.02e-01
GOBP N ACETYLNEURAMINATE CATABOLIC PROCESS	6	7.85e-01	8.92e-01	0.17200	5.75e-02	1.62e-01	8.07e-01	4.91e-01
GOBP NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT	29	2.20e-01	4.53e-01	0.17200	5.17e-02	-1.64e-01	6.30e-01	1.26e-01
GOCC PERICHROMATIN FIBRILS	6	7.79e-01	8.89e-01	0.17200	1.67e-01	4.39e-02	4.80e-01	8.52e-01
GOBP CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES	22	4.34e-01	6.62e-01	0.17200	-1.49e-01	-8.58e-02	2.25e-01	4.86e-01
GOBP RNA CATABOLIC PROCESS	382	1.69e-07	5.80e-06	0.17200	1.66e-01	4.54e-02	2.48e-08	1.27e-01
GOBP POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT	15	4.83e-01	6.98e-01	0.17200	-1.74e-02	1.71e-01	9.07e-01	2.51e-01
GOBP EMBRYONIC MORPHOGENESIS	605	4.38e-10	2.46e-08	0.17200	1.24e-01	1.19e-01	1.94e-07	5.16e-07
PI Metabolism	78	3.61e-02	1.51e-01	0.17200	1.69e-01	3.37e-02	9.97e-03	6.07e-01
IGF1R signaling cascade	51	1.18e-01	3.19e-01	0.17200	1.67e-01	4.03e-02	3.87e-02	6.19e-01
GOBP NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION	21	4.63e-01	6.86e-01	0.17200	-1.11e-01	-1.31e-01	3.78e-01	2.97e-01
GOBP DETECTION OF OTHER ORGANISM	19	3.68e-01	6.05e-01	0.17200	-1.63e-01	5.59e-02	2.19e-01	6.73e-01
GOBP PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS	17	5.37e-01	7.37e-01	0.17200	1.29e-01	1.14e-01	3.59e-01	4.14e-01
GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION	22	2.89e-01	5.28e-01	0.17200	1.20e-01	-1.23e-01	3.30e-01	3.17e-01
GOMF PROTEIN RNA ADAPTOR ACTIVITY	19	4.08e-01	6.41e-01	0.17200	1.72e-01	-6.03e-03	1.95e-01	9.64e-01
GOMF CYTIDINE DEAMINASE ACTIVITY	12	6.31e-01	7.99e-01	0.17200	7.94e-02	1.53e-01	6.34e-01	3.60e-01
GOBP GROWTH HORMONE SECRETION	13	5.88e-01	7.72e-01	0.17200	5.06e-02	1.64e-01	7.52e-01	3.05e-01
GOMF HYDROLASE ACTIVITY HYDROLYZING N GLYCOSYL COMPOUNDS	38	1.94e-01	4.23e-01	0.17200	2.84e-02	1.70e-01	7.62e-01	7.04e-02
IFNG signaling activates MAPKs	8	6.88e-01	8.38e-01	0.17200	1.72e-01	-2.33e-03	4.00e-01	9.91e-01
GOMF MITOGEN ACTIVATED PROTEIN KINASE BINDING	29	3.14e-01	5.54e-01	0.17200	5.91e-02	1.61e-01	5.82e-01	1.33e-01
GOBP ANTIGEN PROCESSING AND PRESENTATION	111	3.23e-03	2.54e-02	0.17200	-4.97e-02	1.65e-01	3.66e-01	2.75e-03
GOBP T FOLLICULAR HELPER CELL DIFFERENTIATION	7	7.73e-01	8.85e-01	0.17200	1.06e-01	1.35e-01	6.27e-01	5.36e-01
GOBP MEMBRANE RAFT ASSEMBLY	12	5.15e-01	7.22e-01	0.17200	-9.06e-02	1.46e-01	5.87e-01	3.81e-01
Signaling by Insulin receptor	79	4.51e-02	1.75e-01	0.17200	1.59e-01	6.57e-02	1.47e-02	3.13e-01
GOMF UBIQUITIN LIKE PROTEIN LIGASE ACTIVITY	343	4.28e-06	1.05e-04	0.17200	1.31e-01	1.11e-01	2.99e-05	4.13e-04
GOBP HINDBRAIN TANGENTIAL CELL MIGRATION	5	7.83e-01	8.90e-01	0.17200	2.33e-02	-1.70e-01	9.28e-01	5.10e-01
GOBP CERAMIDE BIOSYNTHETIC PROCESS	69	6.35e-02	2.18e-01	0.17200	5.74e-02	1.62e-01	4.09e-01	2.01e-02
GOMF ATP DEPENDENT PROTEIN BINDING	6	8.04e-01	9.02e-01	0.17200	1.24e-01	1.18e-01	5.98e-01	6.16e-01
GOBP NEGATIVE REGULATION OF CYCLASE ACTIVITY	15	4.88e-01	7.02e-01	0.17200	1.30e-02	-1.71e-01	9.31e-01	2.51e-01
Acyl chain remodeling of DAG and TAG	5	7.67e-01	8.82e-01	0.17200	-1.60e-01	6.27e-02	5.36e-01	8.08e-01
Plasma lipoprotein assembly	19	3.56e-01	5.93e-01	0.17200	8.07e-02	-1.51e-01	5.43e-01	2.53e-01
GOMF INORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY	150	4.23e-03	3.13e-02	0.17200	-1.36e-01	-1.05e-01	4.08e-03	2.68e-02
GOCC TERTIARY GRANULE	158	1.49e-04	2.14e-03	0.17200	-1.22e-01	1.20e-01	8.00e-03	9.06e-03
Erythropoietin activates Phospholipase C gamma (PLCG)	7	6.84e-01	8.35e-01	0.17200	-7.94e-02	1.52e-01	7.16e-01	4.86e-01
GOCC ASTROCYTE PROJECTION	21	4.45e-01	6.72e-01	0.17100	-7.27e-02	-1.55e-01	5.64e-01	2.18e-01
GOBP POSITIVE REGULATION OF MHC CLASS I BIOSYNTHETIC PROCESS	6	7.23e-01	8.58e-01	0.17100	1.54e-01	-7.57e-02	5.14e-01	7.48e-01
GOBP G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER	54	7.05e-02	2.34e-01	0.17100	-1.69e-01	2.64e-02	3.13e-02	7.37e-01
GOMF PEPTIDE ANTIGEN BINDING	35	1.76e-01	4.00e-01	0.17100	-3.08e-02	1.69e-01	7.53e-01	8.43e-02
GOMF ADP RIBOSE DIPHOSPHATASE ACTIVITY	6	7.89e-01	8.93e-01	0.17100	6.16e-02	1.60e-01	7.94e-01	4.98e-01
GOBP ALPHA BETA T CELL DIFFERENTIATION	122	3.62e-03	2.78e-02	0.17100	-1.40e-03	1.71e-01	9.79e-01	1.08e-03
GOBP DNA ALKYLATION REPAIR	11	6.37e-01	8.02e-01	0.17100	1.65e-01	4.55e-02	3.43e-01	7.94e-01
Molybdenum cofactor biosynthesis	6	7.58e-01	8.76e-01	0.17100	2.59e-04	-1.71e-01	9.99e-01	4.67e-01
GOBP PROSTHETIC GROUP METABOLIC PROCESS	6	7.58e-01	8.76e-01	0.17100	2.59e-04	-1.71e-01	9.99e-01	4.67e-01
GOBP TONGUE MORPHOGENESIS	10	6.92e-01	8.40e-01	0.17100	9.95e-02	1.39e-01	5.86e-01	4.45e-01
GOCC CYTOPLASMIC MICROTUBULE	113	1.64e-02	8.62e-02	0.17100	1.36e-01	1.04e-01	1.27e-02	5.52e-02
Tryptophan catabolism	14	5.93e-01	7.74e-01	0.17100	-8.88e-02	-1.46e-01	5.65e-01	3.43e-01
GOCC PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX CLASS I	9	6.35e-01	8.01e-01	0.17100	-3.93e-02	1.67e-01	8.38e-01	3.87e-01
GOBP MITOPHAGY	63	7.29e-02	2.39e-01	0.17100	1.67e-01	3.85e-02	2.21e-02	5.97e-01
GOBP CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES	148	3.67e-03	2.81e-02	0.17100	1.53e-01	7.64e-02	1.31e-03	1.09e-01
GOMF PHOSPHOSERINE RESIDUE BINDING	10	6.85e-01	8.35e-01	0.17100	1.52e-01	7.89e-02	4.06e-01	6.66e-01
Programmed Cell Death	190	1.11e-03	1.14e-02	0.17100	1.24e-01	1.18e-01	3.25e-03	5.06e-03
GOMF FIBROBLAST GROWTH FACTOR BINDING	23	3.44e-01	5.81e-01	0.17100	4.63e-03	-1.71e-01	9.69e-01	1.56e-01
GOBP T CELL MEDIATED IMMUNITY	126	1.02e-03	1.06e-02	0.17100	-1.43e-01	9.43e-02	5.71e-03	6.74e-02
SARS-CoV Infections	390	9.64e-07	2.84e-05	0.17100	1.27e-01	1.14e-01	1.66e-05	1.05e-04
GOBP POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION	179	1.24e-03	1.23e-02	0.17100	1.51e-01	8.07e-02	5.09e-04	6.25e-02
GOBP NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS	42	1.90e-01	4.17e-01	0.17100	1.61e-01	5.73e-02	7.11e-02	5.20e-01
GOBP POSITIVE REGULATION OF NUCLEASE ACTIVITY	6	7.96e-01	8.97e-01	0.17100	1.54e-01	7.48e-02	5.15e-01	7.51e-01
GPVI-mediated activation cascade	34	1.80e-01	4.05e-01	0.17100	-4.19e-02	1.66e-01	6.73e-01	9.47e-02
GOBP POSITIVE REGULATION OF HELICASE ACTIVITY	6	7.88e-01	8.92e-01	0.17100	5.67e-02	1.61e-01	8.10e-01	4.94e-01
GOBP ORGAN GROWTH	171	1.49e-03	1.40e-02	0.17100	1.55e-01	7.16e-02	4.69e-04	1.06e-01
GOBP NEGATIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY	8	7.32e-01	8.63e-01	0.17100	-6.39e-02	-1.58e-01	7.54e-01	4.38e-01
GOMF SYMPORTER ACTIVITY	145	4.68e-03	3.38e-02	0.17100	-1.47e-01	-8.67e-02	2.23e-03	7.16e-02
GOBP NON MEMBRANE BOUNDED ORGANELLE ASSEMBLY	402	1.27e-07	4.48e-06	0.17100	1.63e-01	5.07e-02	2.04e-08	8.08e-02
HSF1-dependent transactivation	34	2.48e-01	4.87e-01	0.17100	1.65e-01	4.27e-02	9.55e-02	6.66e-01
GOMF KINASE REGULATOR ACTIVITY	268	5.97e-05	1.01e-03	0.17100	9.45e-02	1.42e-01	7.74e-03	6.22e-05
GOBP NEGATIVE REGULATION OF STRIATED MUSCLE CONTRACTION	9	6.61e-01	8.19e-01	0.17100	2.38e-03	-1.71e-01	9.90e-01	3.75e-01
Caspase activation via extrinsic apoptotic signalling pathway	25	3.29e-01	5.68e-01	0.17100	1.03e-02	1.70e-01	9.29e-01	1.40e-01
Kidney development	45	1.10e-01	3.07e-01	0.17100	-3.04e-02	1.68e-01	7.24e-01	5.14e-02
GOBP PHOSPHOLIPASE C ACTIVATING DOPAMINE RECEPTOR SIGNALING PATHWAY	9	7.12e-01	8.52e-01	0.17100	7.84e-02	1.51e-01	6.84e-01	4.31e-01
GOBP POSITIVE REGULATION OF CELL MORPHOGENESIS	32	2.70e-01	5.10e-01	0.17100	-4.31e-02	-1.65e-01	6.73e-01	1.06e-01
GOBP INTERLEUKIN 33 MEDIATED SIGNALING PATHWAY	7	7.31e-01	8.63e-01	0.17000	1.70e-01	8.56e-03	4.35e-01	9.69e-01
GOMF ATPASE COUPLED INTRAMEMBRANE LIPID TRANSPORTER ACTIVITY	26	3.84e-01	6.18e-01	0.17000	-1.44e-01	-9.11e-02	2.03e-01	4.21e-01
GOMF NUCLEOTIDASE ACTIVITY	14	5.91e-01	7.73e-01	0.17000	1.51e-01	7.93e-02	3.28e-01	6.08e-01
GOMF GTPASE BINDING	298	2.20e-05	4.30e-04	0.17000	1.40e-01	9.76e-02	3.34e-05	3.76e-03
Presynaptic function of Kainate receptors	21	3.81e-01	6.15e-01	0.17000	1.70e-01	-3.56e-03	1.77e-01	9.77e-01
GOBP CELLULAR EXTRAVASATION	72	5.53e-02	2.00e-01	0.17000	-1.63e-01	-4.81e-02	1.65e-02	4.81e-01
GOBP OLEFINIC COMPOUND METABOLIC PROCESS	156	3.07e-03	2.45e-02	0.17000	-8.21e-02	-1.49e-01	7.69e-02	1.30e-03
GOBP REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION	22	4.52e-01	6.78e-01	0.17000	1.06e-01	1.34e-01	3.91e-01	2.78e-01
GOCC CELL CORTEX REGION	35	1.49e-01	3.63e-01	0.17000	9.13e-02	-1.44e-01	3.50e-01	1.41e-01
GOBP REGULATION OF CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE	14	4.77e-01	6.95e-01	0.17000	-1.55e-01	7.05e-02	3.16e-01	6.48e-01
GOBP NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY	12	5.29e-01	7.32e-01	0.17000	-7.31e-02	1.54e-01	6.61e-01	3.57e-01
GOBP REGULATION OF LIPOPROTEIN METABOLIC PROCESS	17	3.98e-01	6.31e-01	0.17000	1.45e-01	-8.85e-02	3.00e-01	5.27e-01
GOMF MICROTUBULE MINUS END BINDING	13	6.28e-01	7.96e-01	0.17000	1.19e-01	1.22e-01	4.57e-01	4.48e-01
GOCC ATG12 ATG5 ATG16 COMPLEX	6	7.47e-01	8.70e-01	0.17000	2.67e-02	-1.68e-01	9.10e-01	4.76e-01
Nitric oxide stimulates guanylate cyclase	21	4.72e-01	6.94e-01	0.17000	-1.18e-01	-1.22e-01	3.48e-01	3.32e-01
GOBP VITAMIN BIOSYNTHETIC PROCESS	24	3.68e-01	6.05e-01	0.17000	3.33e-02	1.67e-01	7.78e-01	1.57e-01
Toll-like Receptor Cascades	161	3.06e-03	2.44e-02	0.17000	1.00e-01	1.37e-01	2.81e-02	2.63e-03
GOBP NEURAL NUCLEUS DEVELOPMENT	61	1.14e-01	3.13e-01	0.17000	1.21e-01	1.20e-01	1.03e-01	1.05e-01
GOBP LYMPHOCYTE CHEMOTAXIS	42	1.92e-01	4.20e-01	0.17000	-5.59e-02	-1.61e-01	5.31e-01	7.17e-02
GOBP NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION	61	9.57e-02	2.82e-01	0.17000	6.49e-02	1.57e-01	3.81e-01	3.37e-02
GOBP CARDIAC MUSCLE CELL CONTRACTION	81	4.64e-02	1.79e-01	0.17000	-7.12e-02	-1.54e-01	2.68e-01	1.63e-02
GOMF ACETYLCHOLINE RECEPTOR INHIBITOR ACTIVITY	7	6.80e-01	8.32e-01	0.17000	-1.29e-01	1.11e-01	5.55e-01	6.12e-01
GOBP ORGANELLE LOCALIZATION	581	1.28e-09	6.88e-08	0.17000	1.37e-01	1.00e-01	1.48e-08	3.77e-05
GOBP POSITIVE REGULATION OF BLOOD CIRCULATION	36	2.54e-01	4.91e-01	0.17000	6.96e-02	1.55e-01	4.70e-01	1.07e-01
ERK/MAPK targets	20	4.39e-01	6.66e-01	0.17000	1.66e-01	3.74e-02	1.99e-01	7.72e-01
ADP signalling through P2Y purinoceptor 1	25	3.73e-01	6.09e-01	0.17000	1.61e-01	5.40e-02	1.63e-01	6.40e-01
GOCC 9PLUS0 NON MOTILE CILIUM	120	2.25e-03	1.93e-02	0.17000	5.23e-02	-1.62e-01	3.22e-01	2.23e-03
GOMF GAP JUNCTION CHANNEL ACTIVITY INVOLVED IN CELL COMMUNICATION BY ELECTRICAL COUPLING	8	7.51e-01	8.72e-01	0.17000	-1.30e-01	-1.09e-01	5.24e-01	5.92e-01
GOBP EMBRYO DEVELOPMENT	1097	2.94e-17	3.61e-15	0.17000	1.42e-01	9.27e-02	1.70e-15	2.14e-07
GOBP NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS	10	6.37e-01	8.02e-01	0.17000	2.23e-03	1.70e-01	9.90e-01	3.53e-01
GOBP POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION	26	3.97e-01	6.30e-01	0.17000	1.21e-01	1.20e-01	2.88e-01	2.91e-01
GOBP IN UTERO EMBRYONIC DEVELOPMENT	389	8.21e-07	2.47e-05	0.17000	1.45e-01	8.89e-02	9.67e-07	2.62e-03
GOBP REGULATION OF INSULIN RECEPTOR SIGNALING PATHWAY	72	4.45e-02	1.74e-01	0.17000	1.69e-02	1.69e-01	8.04e-01	1.32e-02
Ketone body metabolism	9	6.36e-01	8.02e-01	0.17000	-4.60e-02	1.63e-01	8.11e-01	3.96e-01
GOBP NEGATIVE REGULATION OF T CELL DIFFERENTIATION	48	1.35e-01	3.45e-01	0.17000	3.05e-02	1.67e-01	7.14e-01	4.54e-02
GOBP SMOOTH MUSCLE CELL DIFFERENTIATION	75	6.57e-02	2.23e-01	0.17000	1.43e-01	9.19e-02	3.27e-02	1.69e-01
GOBP NEGATIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS	6	8.07e-01	9.03e-01	0.17000	1.06e-01	1.32e-01	6.52e-01	5.75e-01
GOCC ESCRT COMPLEX	29	3.29e-01	5.69e-01	0.17000	1.57e-01	6.51e-02	1.44e-01	5.44e-01
GOBP DORSAL VENTRAL NEURAL TUBE PATTERNING	16	5.66e-01	7.57e-01	0.17000	1.23e-01	1.16e-01	3.93e-01	4.21e-01
GOMF UBIQUITIN LIKE PROTEIN CONJUGATING ENZYME ACTIVITY	36	2.76e-01	5.16e-01	0.17000	1.34e-01	1.04e-01	1.65e-01	2.79e-01
GOBP REGULATION OF MEIOTIC NUCLEAR DIVISION	35	2.59e-01	4.98e-01	0.17000	1.58e-01	6.16e-02	1.06e-01	5.28e-01
GOBP REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT	108	1.65e-02	8.67e-02	0.17000	1.56e-01	6.67e-02	5.13e-03	2.31e-01
GOBP POSITIVE REGULATION OF CHOLESTEROL METABOLIC PROCESS	15	5.51e-01	7.47e-01	0.17000	-1.62e-01	-4.98e-02	2.77e-01	7.38e-01
GOBP REGULATION OF ORGANELLE ASSEMBLY	239	1.96e-04	2.72e-03	0.16900	1.39e-01	9.63e-02	2.04e-04	1.03e-02
GOBP VESICLE ORGANIZATION	357	3.68e-06	9.28e-05	0.16900	1.30e-01	1.08e-01	2.32e-05	4.45e-04
GOBP MITOCHONDRIAL DEPOLARIZATION	24	4.14e-01	6.45e-01	0.16900	8.45e-02	1.47e-01	4.74e-01	2.13e-01
GOBP REGULATION OF PROTEIN LIPIDATION	11	6.49e-01	8.10e-01	0.16900	1.61e-01	5.24e-02	3.55e-01	7.63e-01
GOBP LIPID DROPLET ORGANIZATION	35	2.90e-01	5.28e-01	0.16900	1.14e-01	1.25e-01	2.43e-01	2.00e-01
RHOH GTPase cycle	36	2.77e-01	5.17e-01	0.16900	1.04e-01	1.34e-01	2.81e-01	1.65e-01
GOCC H4 H2A HISTONE ACETYLTRANSFERASE COMPLEX	26	3.98e-01	6.31e-01	0.16900	1.12e-01	1.27e-01	3.23e-01	2.63e-01
GOBP REGULATION OF NATURAL KILLER CELL DIFFERENTIATION	12	6.52e-01	8.12e-01	0.16900	1.33e-01	1.04e-01	4.23e-01	5.33e-01
GOBP FIBROBLAST ACTIVATION	15	5.53e-01	7.48e-01	0.16900	5.04e-02	1.61e-01	7.35e-01	2.79e-01
GOBP REGULATION OF PRESYNAPTIC MEMBRANE POTENTIAL	28	3.59e-01	5.96e-01	0.16900	-8.46e-02	-1.46e-01	4.39e-01	1.80e-01
GOBP NEURON APOPTOTIC PROCESS	279	5.19e-05	8.94e-04	0.16900	9.86e-02	1.37e-01	4.58e-03	7.91e-05
GOBP MITOCHONDRIAL TRANSMEMBRANE TRANSPORT	93	3.77e-02	1.55e-01	0.16900	1.11e-01	1.28e-01	6.46e-02	3.34e-02
GOBP CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES	47	8.60e-02	2.65e-01	0.16900	7.19e-02	-1.53e-01	3.94e-01	6.96e-02
GOBP VENTRAL MIDLINE DEVELOPMENT	6	8.00e-01	9.00e-01	0.16900	1.51e-01	7.68e-02	5.23e-01	7.45e-01
MHC class II antigen presentation	121	1.43e-02	7.82e-02	0.16900	1.14e-01	1.25e-01	3.08e-02	1.76e-02
GOBP PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS	14	5.31e-01	7.33e-01	0.16900	-3.83e-03	1.69e-01	9.80e-01	2.74e-01
GOBP REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY	15	5.78e-01	7.66e-01	0.16900	-1.47e-01	-8.39e-02	3.26e-01	5.74e-01
GOBP AMINOPHOSPHOLIPID TRANSLOCATION	6	7.47e-01	8.70e-01	0.16900	-1.65e-01	3.48e-02	4.83e-01	8.83e-01
GOMF AMINOPHOSPHOLIPID FLIPPASE ACTIVITY	6	7.47e-01	8.70e-01	0.16900	-1.65e-01	3.48e-02	4.83e-01	8.83e-01
GOBP INTERFERON BETA PRODUCTION	56	1.37e-01	3.47e-01	0.16900	1.36e-01	1.00e-01	7.88e-02	1.94e-01
GOBP GPI ANCHOR METABOLIC PROCESS	32	3.05e-01	5.44e-01	0.16900	1.51e-01	7.46e-02	1.38e-01	4.65e-01
Tyrosine catabolism	5	8.35e-01	9.17e-01	0.16900	-1.43e-01	-8.95e-02	5.80e-01	7.29e-01
GOBP RESPONSE TO PEPTIDE	20	3.59e-01	5.96e-01	0.16900	6.14e-02	-1.57e-01	6.34e-01	2.24e-01
GOBP POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY	103	9.73e-03	5.86e-02	0.16900	1.69e-01	-4.06e-03	3.10e-03	9.43e-01
GOCC MICROTUBULE ORGANIZING CENTER	842	3.43e-13	2.92e-11	0.16900	1.33e-01	1.04e-01	5.86e-11	3.01e-07
GOCC INTEGRIN COMPLEX	30	1.97e-01	4.27e-01	0.16900	1.27e-01	-1.11e-01	2.28e-01	2.94e-01
TRAF6 mediated IRF7 activation	26	2.87e-01	5.26e-01	0.16900	3.01e-02	-1.66e-01	7.91e-01	1.43e-01
GOBP RECEPTOR CATABOLIC PROCESS	27	3.86e-01	6.20e-01	0.16900	1.30e-01	1.08e-01	2.43e-01	3.33e-01
GOBP ENDOTHELIAL CELL ACTIVATION	11	6.32e-01	7.99e-01	0.16900	1.66e-01	2.63e-02	3.39e-01	8.80e-01
GOBP CHORION DEVELOPMENT	10	5.92e-01	7.73e-01	0.16900	-7.82e-02	1.49e-01	6.69e-01	4.14e-01
Platelet calcium homeostasis	27	3.36e-01	5.74e-01	0.16800	3.74e-02	1.64e-01	7.37e-01	1.40e-01
GOBP PROTEIN IMPORT	9	6.52e-01	8.12e-01	0.16800	-2.70e-02	1.66e-01	8.89e-01	3.88e-01
GOMF HEAT SHOCK PROTEIN BINDING	126	1.15e-02	6.64e-02	0.16800	1.39e-01	9.55e-02	7.17e-03	6.41e-02
GOMF SOLUTE PROTON SYMPORTER ACTIVITY	24	3.73e-01	6.10e-01	0.16800	-1.65e-01	-3.10e-02	1.61e-01	7.92e-01
GOBP VENTRICULAR SEPTUM DEVELOPMENT	75	7.17e-02	2.36e-01	0.16800	1.04e-01	1.32e-01	1.19e-01	4.76e-02
GOMF STEROID DEHYDROGENASE ACTIVITY	35	2.65e-01	5.04e-01	0.16800	-6.15e-02	-1.57e-01	5.29e-01	1.09e-01
GOBP POSITIVE REGULATION OF INFLAMMATORY RESPONSE	150	4.93e-04	5.96e-03	0.16800	-1.56e-01	6.32e-02	9.84e-04	1.81e-01
GOCC XY BODY	15	4.46e-01	6.72e-01	0.16800	1.24e-01	-1.13e-01	4.04e-01	4.48e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON SINGLE DONORS WITH INCORPORATION OF MOLECULAR OXYGEN	24	3.12e-01	5.52e-01	0.16800	1.64e-01	-3.77e-02	1.65e-01	7.49e-01
GOBP REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE	17	5.50e-01	7.46e-01	0.16800	1.32e-01	1.05e-01	3.48e-01	4.55e-01
GOBP DENDRITE EXTENSION	35	1.97e-01	4.27e-01	0.16800	-1.67e-01	1.85e-02	8.70e-02	8.49e-01
GOBP NEGATIVE REGULATION BY HOST OF VIRAL GENOME REPLICATION	9	6.70e-01	8.25e-01	0.16800	-1.68e-01	6.03e-04	3.82e-01	9.97e-01
GOBP INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	52	1.63e-01	3.83e-01	0.16800	1.13e-01	1.25e-01	1.59e-01	1.20e-01
Iron uptake and transport	56	1.42e-01	3.55e-01	0.16800	1.22e-01	1.16e-01	1.15e-01	1.33e-01
GOBP PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION	13	4.97e-01	7.09e-01	0.16800	1.10e-01	-1.27e-01	4.92e-01	4.28e-01
GOBP METANEPHRIC TUBULE DEVELOPMENT	24	4.08e-01	6.41e-01	0.16800	-1.54e-01	-6.83e-02	1.93e-01	5.63e-01
LGI-ADAM interactions	14	4.97e-01	7.09e-01	0.16800	-5.17e-02	1.60e-01	7.38e-01	3.00e-01
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)	52	1.29e-01	3.37e-01	0.16800	1.62e-01	4.56e-02	4.36e-02	5.69e-01
GOBP REGULATION OF DNA TEMPLATED DNA REPLICATION INITIATION	15	5.92e-01	7.74e-01	0.16800	1.11e-01	1.26e-01	4.56e-01	3.98e-01
GOCC LAMELLIPODIUM MEMBRANE	22	4.62e-01	6.86e-01	0.16800	1.05e-01	1.31e-01	3.95e-01	2.86e-01
GOBP REELIN MEDIATED SIGNALING PATHWAY	8	7.57e-01	8.76e-01	0.16800	1.20e-01	1.17e-01	5.56e-01	5.65e-01
Integration of provirus	9	6.26e-01	7.95e-01	0.16800	1.49e-01	-7.67e-02	4.38e-01	6.90e-01
GOBP MODIFICATION OF SYNAPTIC STRUCTURE	27	3.90e-01	6.24e-01	0.16800	1.25e-01	1.12e-01	2.62e-01	3.12e-01
GOBP GLANDULAR EPITHELIAL CELL DIFFERENTIATION	71	8.06e-02	2.53e-01	0.16800	9.27e-02	1.40e-01	1.77e-01	4.13e-02
GOBP RESPONSE TO STARVATION	204	8.31e-04	9.13e-03	0.16800	1.32e-01	1.04e-01	1.18e-03	1.03e-02
GOMF DYSTROGLYCAN BINDING	10	6.67e-01	8.24e-01	0.16800	-3.46e-02	-1.64e-01	8.50e-01	3.68e-01
GOBP REGULATION OF WNT PROTEIN SECRETION	5	8.36e-01	9.17e-01	0.16800	1.44e-01	8.69e-02	5.78e-01	7.37e-01
GOBP WNT PROTEIN SECRETION	5	8.36e-01	9.17e-01	0.16800	1.44e-01	8.69e-02	5.78e-01	7.37e-01
GOMF PROTEIN KINASE A BINDING	50	1.75e-01	3.97e-01	0.16800	1.30e-01	1.07e-01	1.13e-01	1.92e-01
GOBP POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE	132	9.06e-04	9.71e-03	0.16800	-1.01e-01	1.34e-01	4.50e-02	7.85e-03
GOBP MODULATION BY HOST OF VIRAL GENOME REPLICATION	23	3.69e-01	6.06e-01	0.16800	7.75e-03	1.68e-01	9.49e-01	1.64e-01
Nucleotide catabolism	35	1.66e-01	3.88e-01	0.16800	-6.91e-02	1.53e-01	4.79e-01	1.18e-01
GOBP ASTROCYTE ACTIVATION	26	3.93e-01	6.27e-01	0.16800	-8.53e-02	-1.44e-01	4.52e-01	2.02e-01
Release of apoptotic factors from the mitochondria	6	7.73e-01	8.85e-01	0.16800	1.07e-02	1.67e-01	9.64e-01	4.78e-01
GOBP ACTIN NUCLEATION	56	8.07e-02	2.54e-01	0.16800	1.67e-01	-7.73e-03	3.01e-02	9.20e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS	55	1.10e-01	3.08e-01	0.16800	3.65e-02	1.64e-01	6.40e-01	3.58e-02
GOBP PENETRATION OF ZONA PELLUCIDA	9	7.20e-01	8.56e-01	0.16800	-7.59e-02	-1.49e-01	6.93e-01	4.38e-01
GOBP NEGATIVE REGULATION OF BMP SIGNALING PATHWAY	70	8.08e-02	2.54e-01	0.16800	1.46e-01	8.24e-02	3.48e-02	2.33e-01
GOBP REGULATION OF SPROUTING ANGIOGENESIS	65	7.18e-02	2.36e-01	0.16800	-1.65e-01	-3.15e-02	2.18e-02	6.60e-01
GOBP FOREBRAIN VENTRICULAR ZONE PROGENITOR CELL DIVISION	6	7.90e-01	8.93e-01	0.16800	4.35e-02	1.62e-01	8.54e-01	4.92e-01
GOBP HEAD DEVELOPMENT	734	1.65e-11	1.17e-09	0.16800	1.32e-01	1.03e-01	1.07e-09	2.03e-06
GOBP POSITIVE REGULATION OF ATP DEPENDENT ACTIVITY	38	2.68e-01	5.08e-01	0.16800	1.15e-01	1.22e-01	2.19e-01	1.94e-01
GOBP REGULATION OF POSITIVE CHEMOTAXIS	25	3.50e-01	5.88e-01	0.16700	-1.66e-01	-1.84e-02	1.50e-01	8.73e-01
PI-3K cascade:FGFR4	19	4.89e-01	7.03e-01	0.16700	1.56e-01	6.13e-02	2.40e-01	6.44e-01
GOMF TYPE 5 METABOTROPIC GLUTAMATE RECEPTOR BINDING	6	7.73e-01	8.85e-01	0.16700	-1.02e-02	-1.67e-01	9.65e-01	4.78e-01
GOBP OTOLITH DEVELOPMENT	10	6.13e-01	7.87e-01	0.16700	4.53e-02	-1.61e-01	8.04e-01	3.78e-01
GOBP REGULATION OF AXON EXTENSION INVOLVED IN AXON GUIDANCE	15	5.45e-01	7.43e-01	0.16700	-1.64e-01	-3.24e-02	2.71e-01	8.28e-01
GOBP PEPTIDE CATABOLIC PROCESS	19	3.82e-01	6.17e-01	0.16700	1.55e-01	-6.38e-02	2.43e-01	6.30e-01
GOBP POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS	25	2.65e-01	5.05e-01	0.16700	1.02e-01	-1.33e-01	3.78e-01	2.51e-01
GOBP TRACHEA MORPHOGENESIS	11	6.68e-01	8.25e-01	0.16700	1.51e-01	7.19e-02	3.86e-01	6.80e-01
GOBP GENERATION OF PRECURSOR METABOLITES AND ENERGY	435	3.55e-07	1.14e-05	0.16700	1.31e-01	1.04e-01	2.76e-06	2.01e-04
GOBP POSITIVE REGULATION OF TISSUE REMODELING	23	3.30e-01	5.70e-01	0.16700	-3.90e-02	1.63e-01	7.46e-01	1.77e-01
GOBP THYROID HORMONE MEDIATED SIGNALING PATHWAY	8	7.40e-01	8.68e-01	0.16700	1.56e-01	6.08e-02	4.45e-01	7.66e-01
GOCC INNER ACROSOMAL MEMBRANE	5	8.36e-01	9.18e-01	0.16700	1.44e-01	8.43e-02	5.76e-01	7.44e-01
GOBP BRAIN MORPHOGENESIS	38	2.61e-01	4.99e-01	0.16700	1.41e-01	8.94e-02	1.32e-01	3.40e-01
GOBP REGULATION OF ACTION POTENTIAL	57	1.25e-01	3.29e-01	0.16700	-7.21e-02	-1.51e-01	3.47e-01	4.88e-02
GOCC MICROBODY LUMEN	51	1.73e-01	3.95e-01	0.16700	1.17e-01	1.19e-01	1.48e-01	1.41e-01
GOMF SUMO TRANSFERASE ACTIVITY	25	3.72e-01	6.08e-01	0.16700	1.63e-01	3.91e-02	1.60e-01	7.35e-01
GOCC PROTON TRANSPORTING V TYPE ATPASE V0 DOMAIN	11	6.74e-01	8.29e-01	0.16700	8.22e-02	1.45e-01	6.37e-01	4.03e-01
GOBP AUTOPHAGY OF MITOCHONDRION	100	2.30e-02	1.10e-01	0.16700	1.57e-01	5.66e-02	6.59e-03	3.28e-01
GOBP BLOOD VESSEL ENDOTHELIAL CELL DIFFERENTIATION	14	4.98e-01	7.09e-01	0.16700	-5.56e-02	1.58e-01	7.19e-01	3.07e-01
GOCC PHAGOCYTIC CUP	28	2.84e-01	5.23e-01	0.16700	-1.67e-01	9.53e-03	1.27e-01	9.30e-01
eNOS activation	13	5.93e-01	7.74e-01	0.16700	1.64e-01	3.29e-02	3.07e-01	8.37e-01
CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde	8	6.58e-01	8.17e-01	0.16700	-8.98e-02	1.41e-01	6.60e-01	4.90e-01
GOBP CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS	32	3.32e-01	5.71e-01	0.16700	1.22e-01	1.14e-01	2.33e-01	2.64e-01
GOMF NEUROPEPTIDE Y RECEPTOR ACTIVITY	9	6.26e-01	7.95e-01	0.16700	-8.55e-02	1.43e-01	6.57e-01	4.56e-01
GOBP SELF PROTEOLYSIS	12	6.57e-01	8.16e-01	0.16700	9.38e-02	1.38e-01	5.74e-01	4.08e-01
GOBP APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS	26	3.31e-01	5.70e-01	0.16700	1.07e-02	1.67e-01	9.25e-01	1.42e-01
GOBP REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY	24	3.53e-01	5.90e-01	0.16700	2.78e-03	1.67e-01	9.81e-01	1.57e-01
GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL APOPTOTIC PROCESS	7	7.27e-01	8.61e-01	0.16700	-1.66e-01	1.58e-02	4.47e-01	9.42e-01
GOBP THYROID STIMULATING HORMONE SECRETING CELL DIFFERENTIATION	6	7.82e-01	8.90e-01	0.16700	2.37e-02	1.65e-01	9.20e-01	4.84e-01
GOBP REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN	20	3.48e-01	5.85e-01	0.16700	-1.31e-01	1.04e-01	3.12e-01	4.23e-01
GOBP NEURAL TUBE DEVELOPMENT	156	4.70e-03	3.38e-02	0.16700	1.31e-01	1.04e-01	4.85e-03	2.55e-02
GOBP POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY	36	2.69e-01	5.08e-01	0.16700	1.51e-01	7.01e-02	1.16e-01	4.67e-01
GOBP REGULATION OF DEFENSE RESPONSE TO VIRUS	60	1.19e-01	3.21e-01	0.16700	1.44e-01	8.36e-02	5.33e-02	2.63e-01
GOCC ACROSOMAL MEMBRANE	32	3.32e-01	5.71e-01	0.16700	-1.08e-01	-1.27e-01	2.91e-01	2.13e-01
GOMF AMINOACYLTRANSFERASE ACTIVITY	461	1.65e-07	5.69e-06	0.16700	1.31e-01	1.03e-01	1.48e-06	1.43e-04
GOBP CRD MEDIATED MRNA STABILIZATION	11	6.36e-01	8.02e-01	0.16700	1.65e-01	2.32e-02	3.43e-01	8.94e-01
GOMF PROTEINASE ACTIVATED RECEPTOR ACTIVITY	5	7.79e-01	8.89e-01	0.16700	-5.89e-02	1.56e-01	8.19e-01	5.46e-01
GOMF SEROTONIN BINDING	10	6.36e-01	8.02e-01	0.16700	1.66e-01	-1.42e-02	3.63e-01	9.38e-01
TGF-beta receptor signaling activates SMADs	47	1.97e-01	4.27e-01	0.16700	1.32e-01	1.02e-01	1.19e-01	2.26e-01
GOBP REGULATION OF RELAXATION OF CARDIAC MUSCLE	6	7.76e-01	8.87e-01	0.16700	1.26e-02	1.66e-01	9.57e-01	4.81e-01
GOBP NEGATIVE REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION	34	1.72e-01	3.94e-01	0.16700	-8.54e-02	1.43e-01	3.89e-01	1.49e-01
GOBP DEMETHYLATION	41	1.88e-01	4.14e-01	0.16700	1.65e-01	2.47e-02	6.79e-02	7.85e-01
GOBP PLATELET DENSE GRANULE ORGANIZATION	24	4.01e-01	6.34e-01	0.16700	5.14e-02	1.58e-01	6.63e-01	1.79e-01
GOCC CILIARY BASAL BODY	162	1.76e-03	1.59e-02	0.16700	1.62e-01	3.83e-02	3.69e-04	4.01e-01
GOBP POSITIVE REGULATION OF NATURAL KILLER CELL DIFFERENTIATION	7	7.46e-01	8.70e-01	0.16700	1.66e-01	1.61e-02	4.48e-01	9.41e-01
GOBP AXONEMAL DYNEIN COMPLEX ASSEMBLY	38	2.72e-01	5.12e-01	0.16700	-1.16e-01	-1.19e-01	2.14e-01	2.04e-01
GOBP REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS	43	2.01e-01	4.31e-01	0.16700	5.93e-02	1.56e-01	5.01e-01	7.74e-02
GOBP CARDIAC VENTRICLE MORPHOGENESIS	72	5.55e-02	2.00e-01	0.16700	3.00e-02	1.64e-01	6.60e-01	1.62e-02
GOBP NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION	34	2.83e-01	5.22e-01	0.16600	6.09e-02	1.55e-01	5.39e-01	1.18e-01
GOBP DORSAL VENTRAL AXIS SPECIFICATION	14	6.16e-01	7.89e-01	0.16600	1.34e-01	9.85e-02	3.85e-01	5.23e-01
GOBP TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION	185	6.72e-05	1.11e-03	0.16600	-1.36e-01	9.65e-02	1.46e-03	2.36e-02
GOBP NEGATIVE REGULATION OF CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE	8	6.71e-01	8.26e-01	0.16600	-1.55e-01	6.03e-02	4.47e-01	7.68e-01
GOBP ORGANELLE FISSION	485	2.78e-08	1.12e-06	0.16600	1.52e-01	6.71e-02	9.14e-09	1.14e-02
Asparagine N-linked glycosylation	300	2.70e-05	5.14e-04	0.16600	1.45e-01	8.17e-02	1.57e-05	1.49e-02
GOBP REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL	12	6.59e-01	8.17e-01	0.16600	-1.37e-01	-9.41e-02	4.11e-01	5.72e-01
GOBP PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS	14	5.92e-01	7.74e-01	0.16600	1.56e-01	5.76e-02	3.12e-01	7.09e-01
TNFR1-induced proapoptotic signaling	24	3.75e-01	6.11e-01	0.16600	1.65e-01	2.34e-02	1.63e-01	8.43e-01
GOBP REGULATION OF TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY	12	6.06e-01	7.83e-01	0.16600	-1.66e-01	-1.50e-02	3.21e-01	9.28e-01
GOBP ACTIN POLYMERIZATION OR DEPOLYMERIZATION	186	1.21e-03	1.22e-02	0.16600	1.51e-01	6.95e-02	3.80e-04	1.02e-01
GOCC POSTSYNAPTIC CYTOSKELETON	13	6.41e-01	8.04e-01	0.16600	1.10e-01	1.24e-01	4.91e-01	4.38e-01
GRB2:SOS provides linkage to MAPK signaling for Integrins	15	5.01e-01	7.11e-01	0.16600	2.42e-02	-1.64e-01	8.71e-01	2.70e-01
Infection with Mycobacterium tuberculosis	25	4.26e-01	6.55e-01	0.16600	1.10e-01	1.25e-01	3.43e-01	2.80e-01
GOBP REGULATION OF RETROGRADE TRANSPORT ENDOSOME TO GOLGI	7	7.35e-01	8.65e-01	0.16600	-6.21e-03	1.66e-01	9.77e-01	4.47e-01
GOCC PHOTORECEPTOR INNER SEGMENT	69	6.67e-02	2.25e-01	0.16600	-3.67e-02	-1.62e-01	5.98e-01	2.00e-02
GOBP CGMP MEDIATED SIGNALING	32	1.86e-01	4.12e-01	0.16600	1.17e-01	-1.18e-01	2.52e-01	2.49e-01
GOBP RESPONSE TO ZINC ION	48	8.05e-02	2.53e-01	0.16600	-1.14e-01	1.20e-01	1.70e-01	1.49e-01
GOMF CYCLIC NUCLEOTIDE DEPENDENT PROTEIN KINASE ACTIVITY	7	7.82e-01	8.90e-01	0.16600	8.66e-02	1.42e-01	6.92e-01	5.16e-01
GOBP FATTY ACYL COA BIOSYNTHETIC PROCESS	25	3.10e-01	5.50e-01	0.16600	-3.30e-02	1.63e-01	7.75e-01	1.59e-01
GOBP POST EMBRYONIC DEVELOPMENT	86	4.91e-02	1.86e-01	0.16600	8.40e-02	1.43e-01	1.78e-01	2.18e-02
Toll Like Receptor 4 (TLR4) Cascade	139	8.81e-03	5.47e-02	0.16600	1.02e-01	1.31e-01	3.73e-02	7.88e-03
GOBP VITAMIN D METABOLIC PROCESS	21	4.81e-01	6.97e-01	0.16600	-8.91e-02	-1.40e-01	4.80e-01	2.67e-01
GOBP VITAMIN D BIOSYNTHETIC PROCESS	10	5.95e-01	7.75e-01	0.16600	-1.36e-01	9.49e-02	4.57e-01	6.03e-01
GOBP POSITIVE REGULATION OF WNT SIGNALING PATHWAY	139	4.88e-03	3.47e-02	0.16600	1.60e-01	4.35e-02	1.13e-03	3.76e-01
GOBP DIGESTIVE SYSTEM PROCESS	105	2.51e-02	1.17e-01	0.16600	-8.19e-02	-1.44e-01	1.47e-01	1.07e-02
GOBP METANEPHRIC NEPHRON MORPHOGENESIS	24	3.31e-01	5.70e-01	0.16600	-1.64e-01	2.66e-02	1.65e-01	8.22e-01
GOBP CELLULAR RESPONSE TO OXIDATIVE STRESS	244	2.44e-04	3.28e-03	0.16600	1.35e-01	9.61e-02	2.78e-04	9.75e-03
GOBP ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS	71	3.65e-02	1.52e-01	0.16600	-3.27e-02	1.62e-01	6.34e-01	1.79e-02
RND2 GTPase cycle	41	2.24e-01	4.58e-01	0.16600	1.53e-01	6.40e-02	9.04e-02	4.78e-01
GOBP CARDIAC MUSCLE CELL DIFFERENTIATION	126	4.36e-03	3.20e-02	0.16600	1.66e-01	-2.28e-03	1.32e-03	9.65e-01
Heparan sulfate/heparin (HS-GAG) metabolism	53	1.67e-01	3.88e-01	0.16600	-1.21e-01	-1.13e-01	1.27e-01	1.56e-01
GOBP NEGATIVE REGULATION OF HEMOPOIESIS	113	1.11e-02	6.48e-02	0.16600	2.78e-02	1.63e-01	6.09e-01	2.72e-03
GOBP PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY	14	5.78e-01	7.66e-01	0.16600	1.62e-01	3.61e-02	2.95e-01	8.15e-01
DEx/H-box helicases activate type I IFN and inflammatory cytokines production	7	7.16e-01	8.54e-01	0.16600	-4.36e-02	1.60e-01	8.42e-01	4.64e-01
GOBP METAPHASE ANAPHASE TRANSITION OF MEIOTIC CELL CYCLE	7	7.77e-01	8.88e-01	0.16600	1.50e-01	7.01e-02	4.92e-01	7.48e-01
GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE	34	2.25e-01	4.59e-01	0.16500	-1.65e-01	8.00e-03	9.54e-02	9.36e-01
Sensory processing of sound by inner hair cells of the cochlea	63	1.14e-01	3.14e-01	0.16500	-9.06e-02	-1.38e-01	2.13e-01	5.76e-02
GOBP CORONARY VASCULATURE DEVELOPMENT	48	1.57e-01	3.74e-01	0.16500	1.61e-01	3.92e-02	5.43e-02	6.38e-01
GOMF GAMMA TUBULIN BINDING	30	3.62e-01	6.00e-01	0.16500	1.07e-01	1.26e-01	3.12e-01	2.32e-01
GOBP FATTY ACID ELONGATION SATURATED FATTY ACID	8	7.42e-01	8.69e-01	0.16500	-1.56e-01	-5.35e-02	4.44e-01	7.93e-01
GOMF SCAVENGER RECEPTOR ACTIVITY	27	2.53e-01	4.91e-01	0.16500	8.34e-02	-1.43e-01	4.53e-01	2.00e-01
GOBP CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS	40	2.57e-01	4.95e-01	0.16500	-1.01e-01	-1.31e-01	2.71e-01	1.52e-01
alpha-linolenic (omega3) and linoleic (omega6) acid metabolism	12	6.22e-01	7.93e-01	0.16500	3.05e-02	1.62e-01	8.55e-01	3.30e-01
alpha-linolenic acid (ALA) metabolism	12	6.22e-01	7.93e-01	0.16500	3.05e-02	1.62e-01	8.55e-01	3.30e-01
GOBP AXONEMAL CENTRAL APPARATUS ASSEMBLY	6	7.88e-01	8.92e-01	0.16500	2.93e-02	1.63e-01	9.01e-01	4.91e-01
GOBP NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION	16	4.75e-01	6.95e-01	0.16500	-1.62e-01	3.42e-02	2.63e-01	8.13e-01
GOBP EMBRYONIC ORGAN MORPHOGENESIS	293	5.09e-05	8.85e-04	0.16500	9.59e-02	1.34e-01	4.73e-03	7.54e-05
GOBP REGULATION OF CGMP MEDIATED SIGNALING	11	6.80e-01	8.32e-01	0.16500	-1.44e-01	-8.00e-02	4.07e-01	6.46e-01
GOBP CIRCADIAN SLEEP WAKE CYCLE	22	4.77e-01	6.95e-01	0.16500	-1.21e-01	-1.13e-01	3.27e-01	3.60e-01
GOBP ECTOPIC GERM CELL PROGRAMMED CELL DEATH	17	5.57e-01	7.51e-01	0.16500	-1.38e-01	-9.07e-02	3.25e-01	5.17e-01
GOBP REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT	13	5.47e-01	7.44e-01	0.16500	-1.62e-01	3.32e-02	3.13e-01	8.36e-01
CASP8 activity is inhibited	11	5.87e-01	7.71e-01	0.16500	-5.30e-02	1.56e-01	7.61e-01	3.69e-01
Dimerization of procaspase-8	11	5.87e-01	7.71e-01	0.16500	-5.30e-02	1.56e-01	7.61e-01	3.69e-01
Regulation by c-FLIP	11	5.87e-01	7.71e-01	0.16500	-5.30e-02	1.56e-01	7.61e-01	3.69e-01
GOBP POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION	18	5.06e-01	7.15e-01	0.16500	1.59e-01	4.53e-02	2.44e-01	7.39e-01
GOCC EXTRINSIC COMPONENT OF CYTOPLASMIC SIDE OF PLASMA MEMBRANE	48	1.84e-01	4.10e-01	0.16500	1.47e-01	7.52e-02	7.86e-02	3.68e-01
GOBP RESPONSE TO ACID CHEMICAL	132	8.99e-03	5.55e-02	0.16500	1.50e-01	6.73e-02	2.83e-03	1.82e-01
SUMOylation of DNA methylation proteins	16	5.63e-01	7.56e-01	0.16500	1.51e-01	6.72e-02	2.97e-01	6.42e-01
GOCC A BAND	39	1.93e-01	4.21e-01	0.16500	-3.87e-03	-1.65e-01	9.67e-01	7.50e-02
Ribosomal scanning and start codon recognition	52	1.75e-01	3.97e-01	0.16500	1.24e-01	1.09e-01	1.22e-01	1.76e-01
GOBP REGULATION OF VESICLE FUSION	23	4.21e-01	6.51e-01	0.16500	-1.58e-01	-4.64e-02	1.90e-01	7.00e-01
GOBP POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM	12	5.90e-01	7.73e-01	0.16400	-1.28e-02	1.64e-01	9.39e-01	3.25e-01
GOBP REGULATION OF FLAGELLATED SPERM MOTILITY	20	5.05e-01	7.14e-01	0.16400	-8.88e-02	-1.38e-01	4.92e-01	2.84e-01
GOBP RESPONSE TO REACTIVE OXYGEN SPECIES	197	1.38e-03	1.33e-02	0.16400	1.30e-01	1.00e-01	1.62e-03	1.51e-02
GOMF PEPTIDE HORMONE RECEPTOR BINDING	20	4.61e-01	6.84e-01	0.16400	-1.61e-01	-3.46e-02	2.13e-01	7.89e-01
GOBP AMP BIOSYNTHETIC PROCESS	12	5.44e-01	7.42e-01	0.16400	8.91e-02	-1.38e-01	5.93e-01	4.07e-01
GOMF SOLUTE MONOATOMIC CATION SYMPORTER ACTIVITY	114	2.15e-02	1.05e-01	0.16400	-1.33e-01	-9.66e-02	1.41e-02	7.48e-02
GOBP SUBSTRATE DEPENDENT CELL MIGRATION CELL EXTENSION	8	6.99e-01	8.44e-01	0.16400	-2.05e-02	1.63e-01	9.20e-01	4.24e-01
GOBP IMMUNOLOGICAL SYNAPSE FORMATION	16	5.09e-01	7.17e-01	0.16400	-1.64e-01	-1.48e-03	2.55e-01	9.92e-01
GOCC RIBONUCLEOPROTEIN COMPLEX	1008	6.24e-18	7.82e-16	0.16400	1.64e-01	1.19e-02	1.26e-18	5.21e-01
GOBP UROGENITAL SYSTEM DEVELOPMENT	65	1.14e-01	3.13e-01	0.16400	1.05e-01	1.26e-01	1.42e-01	7.85e-02
GOCC UBIQUITIN CONJUGATING ENZYME COMPLEX	7	7.78e-01	8.89e-01	0.16400	6.48e-02	1.51e-01	7.66e-01	4.89e-01
GOBP ANTIMICROBIAL HUMORAL RESPONSE	139	9.21e-03	5.64e-02	0.16400	-1.35e-01	-9.32e-02	5.89e-03	5.78e-02
GOMF BENZODIAZEPINE RECEPTOR ACTIVITY	9	6.30e-01	7.98e-01	0.16400	1.27e-01	-1.04e-01	5.10e-01	5.87e-01
GOBP RESPONSE TO NERVE GROWTH FACTOR	51	1.81e-01	4.06e-01	0.16400	1.30e-01	1.00e-01	1.08e-01	2.16e-01
GOBP LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS	26	3.19e-01	5.57e-01	0.16400	1.51e-02	-1.64e-01	8.94e-01	1.49e-01
GOMF DEACETYLASE ACTIVITY	36	1.58e-01	3.75e-01	0.16400	1.23e-01	-1.09e-01	2.01e-01	2.59e-01
GOCC POSTSYNAPTIC MEMBRANE	261	1.81e-04	2.53e-03	0.16400	-1.06e-01	-1.25e-01	3.12e-03	5.00e-04
GOBP CD4 POSITIVE ALPHA BETA T CELL ACTIVATION	115	6.72e-03	4.46e-02	0.16400	-1.24e-02	1.64e-01	8.19e-01	2.43e-03
GOBP REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION	55	8.17e-02	2.56e-01	0.16400	-3.04e-02	1.61e-01	6.97e-01	3.85e-02
GOBP REGULATION OF MEIOTIC CELL CYCLE	68	9.80e-02	2.86e-01	0.16400	1.40e-01	8.58e-02	4.60e-02	2.21e-01
GOBP SPERM DNA CONDENSATION	17	5.66e-01	7.57e-01	0.16400	-1.28e-01	-1.03e-01	3.61e-01	4.63e-01
GOMF PHOSPHATASE INHIBITOR ACTIVITY	46	2.16e-01	4.49e-01	0.16400	1.25e-01	1.07e-01	1.44e-01	2.10e-01
GOBP CELLULAR RESPONSE TO CHEMICAL STRESS	307	3.19e-05	5.98e-04	0.16400	1.39e-01	8.65e-02	2.65e-05	9.14e-03
GOMF PROTEIN ARGININE OMEGA N ASYMMETRIC METHYLTRANSFERASE ACTIVITY	7	7.15e-01	8.53e-01	0.16400	1.55e-01	-5.38e-02	4.78e-01	8.05e-01
GOBP NEGATIVE REGULATION OF AUTOPHAGY	87	4.89e-02	1.85e-01	0.16400	1.45e-01	7.66e-02	1.94e-02	2.17e-01
GOBP RELAXATION OF CARDIAC MUSCLE	17	5.30e-01	7.33e-01	0.16400	1.57e-01	4.59e-02	2.61e-01	7.43e-01
GOBP REGULATION OF CARDIAC MUSCLE ADAPTATION	18	5.38e-01	7.38e-01	0.16400	8.25e-02	1.42e-01	5.45e-01	2.98e-01
GOMF GLYCINE TRANSMEMBRANE TRANSPORTER ACTIVITY	9	7.42e-01	8.69e-01	0.16400	1.16e-01	1.16e-01	5.46e-01	5.47e-01
GOMF EXTRACELLULAR MATRIX CONSTITUENT CONFERRING ELASTICITY	10	6.94e-01	8.41e-01	0.16400	1.54e-01	5.50e-02	3.98e-01	7.63e-01
GOCC MPP7 DLG1 LIN7 COMPLEX	5	7.92e-01	8.94e-01	0.16400	1.59e-01	-4.16e-02	5.39e-01	8.72e-01
GOBP OLFACTORY BULB INTERNEURON DIFFERENTIATION	12	5.45e-01	7.42e-01	0.16400	-9.22e-02	1.36e-01	5.80e-01	4.16e-01
GOBP POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION	109	3.89e-03	2.93e-02	0.16400	-1.24e-01	1.07e-01	2.50e-02	5.38e-02
GOCC LAMIN FILAMENT	5	7.74e-01	8.86e-01	0.16400	1.21e-01	-1.11e-01	6.40e-01	6.68e-01
GOBP LUNG LOBE DEVELOPMENT	7	7.48e-01	8.71e-01	0.16400	7.14e-03	1.64e-01	9.74e-01	4.53e-01
GOBP POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS	17	5.68e-01	7.58e-01	0.16400	-1.26e-01	-1.05e-01	3.69e-01	4.54e-01
GOBP RESPONSE TO PARATHYROID HORMONE	10	6.01e-01	7.79e-01	0.16400	1.01e-01	-1.29e-01	5.78e-01	4.81e-01
GOMF PURINE RIBONUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY	20	4.70e-01	6.92e-01	0.16400	4.18e-02	1.58e-01	7.46e-01	2.20e-01
GOMF LIPOPOLYSACCHARIDE BINDING	39	1.46e-01	3.59e-01	0.16400	-1.47e-01	7.31e-02	1.13e-01	4.29e-01
GOBP POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY	145	6.26e-04	7.26e-03	0.16400	-1.18e-01	1.13e-01	1.38e-02	1.87e-02
Cholesterol biosynthesis	25	4.02e-01	6.34e-01	0.16400	5.41e-02	1.54e-01	6.39e-01	1.81e-01
Interferon Signaling	263	1.60e-04	2.28e-03	0.16400	9.43e-02	1.34e-01	8.43e-03	1.88e-04
GOMF RECEPTOR SERINE THREONINE KINASE BINDING	27	2.54e-01	4.91e-01	0.16400	-1.30e-01	1.00e-01	2.44e-01	3.68e-01
Surfactant metabolism	27	3.15e-01	5.54e-01	0.16400	-1.64e-01	6.74e-03	1.41e-01	9.52e-01
GOBP CARDIAC SEPTUM DEVELOPMENT	109	2.72e-02	1.23e-01	0.16400	1.25e-01	1.05e-01	2.37e-02	5.81e-02
GOBP POLYSACCHARIDE BIOSYNTHETIC PROCESS	64	6.15e-02	2.14e-01	0.16400	1.63e-01	-1.47e-02	2.42e-02	8.39e-01
GOBP REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT	8	7.08e-01	8.49e-01	0.16400	1.63e-01	-1.07e-02	4.24e-01	9.58e-01
GOBP MACROMOLECULE DEACYLATION	54	1.44e-01	3.57e-01	0.16400	1.53e-01	5.85e-02	5.22e-02	4.57e-01
GOMF RECEPTOR SIGNALING PROTEIN TYROSINE KINASE ACTIVATOR ACTIVITY	5	7.80e-01	8.90e-01	0.16400	7.93e-02	-1.43e-01	7.59e-01	5.80e-01
GOBP NEGATIVE REGULATION OF CELLULAR SENESCENCE	26	3.77e-01	6.12e-01	0.16400	4.17e-02	1.58e-01	7.13e-01	1.63e-01
GOBP REGULATION OF SMOOTH MUSCLE CELL CHEMOTAXIS	7	7.10e-01	8.50e-01	0.16300	6.97e-02	-1.48e-01	7.49e-01	4.98e-01
GOBP MACROPHAGE CHEMOTAXIS	41	1.96e-01	4.25e-01	0.16300	-1.91e-02	-1.62e-01	8.33e-01	7.22e-02
GOBP REGULATION OF CATABOLIC PROCESS	1061	4.21e-16	4.57e-14	0.16300	1.48e-01	6.98e-02	4.14e-16	1.22e-04
GOBP POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION	75	7.71e-02	2.47e-01	0.16300	7.98e-02	1.42e-01	2.32e-01	3.29e-02
GOMF DNA CLAMP LOADER ACTIVITY	9	7.31e-01	8.63e-01	0.16300	7.26e-02	1.46e-01	7.06e-01	4.47e-01
GOBP RESPONSE TO PAIN	36	2.14e-01	4.46e-01	0.16300	-1.63e-01	9.23e-03	9.04e-02	9.24e-01
GOBP FATTY ACID ELONGATION	13	6.01e-01	7.79e-01	0.16300	-1.61e-01	-2.47e-02	3.14e-01	8.77e-01
GOBP CELLULAR COMPONENT DISASSEMBLY	521	2.89e-08	1.16e-06	0.16300	1.41e-01	8.22e-02	3.54e-08	1.32e-03
GOBP DEFENSE RESPONSE TO BACTERIUM	296	2.28e-05	4.41e-04	0.16300	-1.55e-01	-5.08e-02	4.37e-06	1.33e-01
ZBP1(DAI) mediated induction of type I IFNs	20	5.16e-01	7.22e-01	0.16300	1.04e-01	1.25e-01	4.19e-01	3.32e-01
GOBP REGULATION OF BONE RESORPTION	43	1.14e-01	3.13e-01	0.16300	-1.27e-01	1.02e-01	1.49e-01	2.45e-01
GOBP ETHER METABOLIC PROCESS	26	2.76e-01	5.15e-01	0.16300	8.20e-02	-1.41e-01	4.69e-01	2.13e-01
GOBP POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION	39	2.66e-01	5.05e-01	0.16300	1.41e-01	8.23e-02	1.28e-01	3.74e-01
GOMF MHC CLASS I PROTEIN BINDING	18	4.20e-01	6.50e-01	0.16300	-6.45e-02	1.50e-01	6.36e-01	2.71e-01
GOMF PHOSPHATIDIC ACID TRANSFER ACTIVITY	7	7.01e-01	8.45e-01	0.16300	-1.11e-01	1.20e-01	6.12e-01	5.83e-01
GOBP POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING	56	1.29e-01	3.37e-01	0.16300	-1.55e-01	-4.92e-02	4.43e-02	5.24e-01
GOBP GLUCOSE IMPORT IN RESPONSE TO INSULIN STIMULUS	6	8.09e-01	9.04e-01	0.16300	-1.50e-01	-6.43e-02	5.25e-01	7.85e-01
GOBP POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY	40	1.75e-01	3.98e-01	0.16300	-1.81e-02	1.62e-01	8.43e-01	7.66e-02
Intracellular signaling by second messengers	312	1.58e-05	3.20e-04	0.16300	1.53e-01	5.51e-02	3.32e-06	9.42e-02
GOBP L SERINE METABOLIC PROCESS	11	6.08e-01	7.84e-01	0.16300	1.59e-01	-3.46e-02	3.61e-01	8.43e-01
GOBP SULFUR AMINO ACID BIOSYNTHETIC PROCESS	15	5.50e-01	7.46e-01	0.16300	1.62e-01	1.54e-02	2.78e-01	9.18e-01
GOBP CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT	195	1.31e-03	1.28e-02	0.16300	1.45e-01	7.44e-02	4.97e-04	7.31e-02
GOMF MAP KINASE KINASE ACTIVITY	15	5.68e-01	7.59e-01	0.16300	1.59e-01	3.64e-02	2.88e-01	8.07e-01
GOBP PENTOSE METABOLIC PROCESS	12	5.46e-01	7.44e-01	0.16300	-1.15e-01	1.15e-01	4.91e-01	4.90e-01
GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT TO PLASMA MEMBRANE	16	4.95e-01	7.07e-01	0.16300	-1.61e-01	2.27e-02	2.65e-01	8.75e-01
Insulin receptor signalling cascade	53	1.16e-01	3.16e-01	0.16200	1.62e-01	6.50e-03	4.09e-02	9.35e-01
GOBP PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY	111	2.43e-02	1.14e-01	0.16200	-1.39e-01	-8.32e-02	1.11e-02	1.30e-01
GOBP ORGANELLE FUSION	162	5.27e-03	3.68e-02	0.16200	1.08e-01	1.21e-01	1.76e-02	7.78e-03
GOBP SCHWANN CELL MIGRATION	5	8.39e-01	9.19e-01	0.16200	6.34e-02	1.49e-01	8.06e-01	5.63e-01
GOBP EPIGENETIC PROGRAMMING OF GENE EXPRESSION	30	2.39e-01	4.76e-01	0.16200	1.49e-01	-6.39e-02	1.57e-01	5.45e-01
GOMF PROTEIN CONTAINING COMPLEX BINDING	1684	6.92e-24	1.23e-21	0.16200	1.45e-01	7.37e-02	4.91e-23	4.80e-07
Glycogen synthesis	13	5.73e-01	7.63e-01	0.16200	1.62e-01	-1.33e-02	3.13e-01	9.34e-01
GOBP POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY	138	6.63e-03	4.40e-02	0.16200	4.57e-02	1.56e-01	3.54e-01	1.59e-03
GOBP REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY	36	2.49e-01	4.87e-01	0.16200	-1.60e-01	-2.44e-02	9.59e-02	8.00e-01
GOMF LIGASE ACTIVITY FORMING CARBON CARBON BONDS	7	7.05e-01	8.48e-01	0.16200	9.82e-02	-1.29e-01	6.53e-01	5.54e-01
GOBP INTRACELLULAR DISTRIBUTION OF MITOCHONDRIA	7	7.88e-01	8.92e-01	0.16200	-1.43e-01	-7.57e-02	5.11e-01	7.29e-01
GOBP LIPID MODIFICATION	187	1.08e-03	1.12e-02	0.16200	1.56e-01	4.28e-02	2.25e-04	3.13e-01
GOBP MITOCHONDRIAL DNA REPLICATION	14	5.60e-01	7.52e-01	0.16200	-1.73e-03	1.62e-01	9.91e-01	2.94e-01
GOBP FERTILIZATION	197	1.26e-03	1.25e-02	0.16200	-7.28e-02	-1.45e-01	7.81e-02	4.56e-04
GOBP ENDOCARDIAL CUSHION TO MESENCHYMAL TRANSITION	6	7.86e-01	8.92e-01	0.16200	1.00e-02	1.62e-01	9.66e-01	4.93e-01
GOMF PHOSPHATIDYLINOSITOL 3 PHOSPHATE BINDING	43	1.21e-01	3.24e-01	0.16200	8.52e-02	-1.38e-01	3.33e-01	1.18e-01
GOBP REGULATION OF COA TRANSFERASE ACTIVITY	10	6.51e-01	8.12e-01	0.16200	1.54e-02	-1.61e-01	9.33e-01	3.77e-01
GOBP NEGATIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE	8	7.29e-01	8.61e-01	0.16200	1.54e-02	1.61e-01	9.40e-01	4.30e-01
GOCC DYNEIN COMPLEX	52	8.13e-02	2.55e-01	0.16200	1.44e-01	-7.34e-02	7.16e-02	3.60e-01
GOBP REGULATION OF CYTOKINETIC PROCESS	7	7.96e-01	8.97e-01	0.16200	1.27e-01	9.99e-02	5.59e-01	6.47e-01
GOBP FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE	12	5.85e-01	7.70e-01	0.16200	1.58e-01	-3.29e-02	3.42e-01	8.43e-01
GOBP CARDIAC MUSCLE CONTRACTION	138	1.16e-02	6.69e-02	0.16200	-1.05e-01	-1.23e-01	3.32e-02	1.25e-02
GOBP REGULATION OF GLIAL CELL APOPTOTIC PROCESS	11	5.86e-01	7.71e-01	0.16200	-1.42e-01	7.83e-02	4.16e-01	6.53e-01
GOBP POSITIVE REGULATION OF DENDRITE DEVELOPMENT	15	5.47e-01	7.44e-01	0.16200	-8.48e-03	-1.62e-01	9.55e-01	2.79e-01
GOBP NEGATIVE REGULATION OF TISSUE REMODELING	21	4.40e-01	6.67e-01	0.16200	1.79e-02	1.61e-01	8.87e-01	2.02e-01
GOBP ORGANONITROGEN COMPOUND CATABOLIC PROCESS	1373	7.93e-19	1.06e-16	0.16200	1.11e-01	1.17e-01	4.89e-12	2.79e-13
GOBP CAMP MEDIATED SIGNALING	57	1.26e-01	3.31e-01	0.16200	-1.55e-01	-4.44e-02	4.24e-02	5.62e-01
GOBP VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS	47	2.16e-01	4.48e-01	0.16200	1.31e-01	9.41e-02	1.19e-01	2.64e-01
MECP2 regulates transcription of neuronal ligands	7	7.13e-01	8.52e-01	0.16200	-7.56e-02	1.43e-01	7.29e-01	5.13e-01
GOBP MUSCLE HYPERTROPHY	106	1.31e-02	7.30e-02	0.16200	1.62e-01	-9.24e-04	4.06e-03	9.87e-01
GOBP PEXOPHAGY	7	7.76e-01	8.87e-01	0.16200	1.55e-01	4.62e-02	4.78e-01	8.32e-01
FCGR3A-mediated phagocytosis	57	1.60e-01	3.79e-01	0.16200	1.12e-01	1.16e-01	1.44e-01	1.28e-01
Leishmania phagocytosis	57	1.60e-01	3.79e-01	0.16200	1.12e-01	1.16e-01	1.44e-01	1.28e-01
Parasite infection	57	1.60e-01	3.79e-01	0.16200	1.12e-01	1.16e-01	1.44e-01	1.28e-01
GOMF SPLICING FACTOR BINDING	6	7.55e-01	8.75e-01	0.16100	1.51e-01	-5.80e-02	5.23e-01	8.06e-01
Glutamate Neurotransmitter Release Cycle	24	3.04e-01	5.44e-01	0.16100	-1.09e-01	1.19e-01	3.57e-01	3.11e-01
GOCC COATED VESICLE	304	6.12e-05	1.03e-03	0.16100	1.25e-01	1.02e-01	1.80e-04	2.17e-03
GOCC CHROMATOID BODY	13	5.68e-01	7.58e-01	0.16100	-2.48e-02	1.59e-01	8.77e-01	3.20e-01
GOBP SOMATIC STEM CELL DIVISION	12	6.79e-01	8.32e-01	0.16100	1.25e-01	1.01e-01	4.52e-01	5.43e-01
GOMF WW DOMAIN BINDING	22	4.42e-01	6.69e-01	0.16100	3.46e-02	1.57e-01	7.79e-01	2.01e-01
GOBP POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS	68	1.13e-01	3.13e-01	0.16100	1.21e-01	1.06e-01	8.43e-02	1.30e-01
GOBP REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY	26	3.82e-01	6.17e-01	0.16100	1.57e-01	3.52e-02	1.65e-01	7.56e-01
GOCC AXON HILLOCK	7	7.73e-01	8.85e-01	0.16100	3.72e-02	1.57e-01	8.65e-01	4.73e-01
GOBP ICOSANOID CATABOLIC PROCESS	9	6.41e-01	8.04e-01	0.16100	-1.09e-01	1.18e-01	5.70e-01	5.39e-01
GOBP CELLULAR RESPONSE TO NITROGEN LEVELS	12	6.77e-01	8.30e-01	0.16100	1.32e-01	9.24e-02	4.29e-01	5.80e-01
GOBP METALLO SULFUR CLUSTER ASSEMBLY	26	4.36e-01	6.63e-01	0.16100	1.15e-01	1.13e-01	3.10e-01	3.20e-01
GOBP LAYER FORMATION IN CEREBRAL CORTEX	14	5.39e-01	7.39e-01	0.16100	1.58e-01	-3.24e-02	3.07e-01	8.34e-01
GOBP IMPORT ACROSS PLASMA MEMBRANE	194	1.79e-03	1.61e-02	0.16100	-1.37e-01	-8.50e-02	1.03e-03	4.11e-02
GOBP SYNAPTIC MEMBRANE ADHESION	26	3.43e-01	5.81e-01	0.16100	1.61e-01	-4.46e-03	1.56e-01	9.69e-01
GOBP POSITIVE REGULATION OF PROTEIN BINDING	49	2.07e-01	4.38e-01	0.16100	1.27e-01	9.84e-02	1.23e-01	2.33e-01
GOBP PURINE NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS	10	6.55e-01	8.14e-01	0.16100	-1.57e-02	1.60e-01	9.31e-01	3.81e-01
Thyroxine biosynthesis	10	7.26e-01	8.60e-01	0.16100	-1.10e-01	-1.17e-01	5.47e-01	5.21e-01
GOBP NEGATIVE REGULATION OF DNA BINDING	29	3.96e-01	6.29e-01	0.16100	1.20e-01	1.07e-01	2.64e-01	3.17e-01
GOMF MONOOXYGENASE ACTIVITY	104	2.67e-02	1.22e-01	0.16100	-1.51e-01	-5.55e-02	7.82e-03	3.28e-01
Nef and signal transduction	8	7.05e-01	8.47e-01	0.16100	-2.90e-02	1.58e-01	8.87e-01	4.39e-01
GOBP SPERM CAPACITATION	32	3.45e-01	5.82e-01	0.16100	-7.67e-02	-1.41e-01	4.53e-01	1.66e-01
GOBP NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING	8	7.49e-01	8.71e-01	0.16100	4.32e-02	1.55e-01	8.32e-01	4.48e-01
GOMF ANAPHASE PROMOTING COMPLEX BINDING	9	6.76e-01	8.30e-01	0.16100	-2.76e-02	1.58e-01	8.86e-01	4.11e-01
GOBP RESPONSE TO BMP	173	3.93e-03	2.95e-02	0.16100	1.29e-01	9.57e-02	3.40e-03	2.99e-02
GOBP GLUCAN BIOSYNTHETIC PROCESS	44	1.54e-01	3.69e-01	0.16100	1.59e-01	-1.97e-02	6.73e-02	8.21e-01
GOBP POSITIVE REGULATION OF BEHAVIOR	24	3.48e-01	5.86e-01	0.16100	-3.23e-02	1.57e-01	7.84e-01	1.82e-01
GOBP DENDRITIC CELL DIFFERENTIATION	44	1.35e-01	3.45e-01	0.16100	-1.53e-01	4.89e-02	7.91e-02	5.75e-01
Pyruvate metabolism	46	2.04e-01	4.35e-01	0.16100	1.49e-01	5.88e-02	7.95e-02	4.90e-01
GOBP REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY	182	1.86e-04	2.59e-03	0.16100	-1.43e-01	7.32e-02	8.82e-04	8.85e-02
GOBP POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT	88	6.08e-02	2.12e-01	0.16100	1.05e-01	1.22e-01	8.92e-02	4.86e-02
GOMF DISULFIDE OXIDOREDUCTASE ACTIVITY	40	1.93e-01	4.21e-01	0.16100	-6.75e-03	1.60e-01	9.41e-01	7.92e-02
GOBP RESPONSE TO THYROID HORMONE	24	4.64e-01	6.87e-01	0.16000	1.25e-01	1.01e-01	2.90e-01	3.92e-01
GOBP AMYLOID FIBRIL FORMATION	38	2.52e-01	4.90e-01	0.16000	1.56e-01	3.95e-02	9.71e-02	6.73e-01
GOMF HISTONE H3K36 DEMETHYLASE ACTIVITY	9	7.31e-01	8.63e-01	0.16000	1.50e-01	5.54e-02	4.34e-01	7.74e-01
GOCC CD40 RECEPTOR COMPLEX	11	6.02e-01	7.80e-01	0.16000	5.69e-02	-1.50e-01	7.44e-01	3.90e-01
GOBP POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY	9	7.52e-01	8.73e-01	0.16000	1.13e-01	1.14e-01	5.58e-01	5.54e-01
GOBP BROWN FAT CELL DIFFERENTIATION	53	1.77e-01	4.00e-01	0.16000	8.16e-02	1.38e-01	3.04e-01	8.25e-02
GOBP GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS	15	4.81e-01	6.97e-01	0.16000	-1.21e-01	1.05e-01	4.18e-01	4.80e-01
GOBP POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN TRANSCRIPTION OF P21 CLASS MEDIATOR	5	7.85e-01	8.92e-01	0.16000	-1.29e-01	9.47e-02	6.17e-01	7.14e-01
GOMF UBIQUITIN LIGASE INHIBITOR ACTIVITY	9	7.32e-01	8.63e-01	0.16000	5.53e-02	1.50e-01	7.74e-01	4.35e-01
GOBP POSITIVE REGULATION OF CHROMATIN BINDING	9	6.55e-01	8.14e-01	0.16000	-7.00e-02	1.44e-01	7.16e-01	4.54e-01
GOBP REGULATION OF SALIVA SECRETION	7	7.11e-01	8.52e-01	0.16000	1.26e-01	-9.88e-02	5.64e-01	6.51e-01
GOBP MUSCLE CELL PROLIFERATION	233	3.38e-04	4.33e-03	0.16000	1.50e-01	5.57e-02	7.91e-05	1.43e-01
GOBP REGULATION OF LYSOSOMAL LUMEN PH	28	4.13e-01	6.45e-01	0.16000	1.11e-01	1.15e-01	3.08e-01	2.92e-01
GOBP OSTEOCLAST FUSION	6	7.58e-01	8.76e-01	0.16000	-1.49e-01	5.95e-02	5.29e-01	8.01e-01
GOBP AXO DENDRITIC TRANSPORT	75	8.38e-02	2.60e-01	0.16000	7.39e-02	1.42e-01	2.68e-01	3.37e-02
GOBP CELLULAR RESPONSE TO PEPTIDE	13	5.30e-01	7.33e-01	0.16000	1.18e-01	-1.08e-01	4.61e-01	5.00e-01
GOBP REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY	19	3.97e-01	6.30e-01	0.16000	1.22e-01	-1.04e-01	3.59e-01	4.33e-01
Ovarian tumor domain proteases	36	3.00e-01	5.40e-01	0.16000	1.44e-01	6.89e-02	1.34e-01	4.74e-01
GOBP MESENCHYME DEVELOPMENT	322	3.67e-05	6.74e-04	0.16000	1.32e-01	9.04e-02	4.69e-05	5.29e-03
GOMF PHOSPHATE TRANSMEMBRANE TRANSPORTER ACTIVITY	16	4.86e-01	7.00e-01	0.16000	-4.87e-02	1.52e-01	7.36e-01	2.92e-01
GOCC DYNEIN AXONEMAL PARTICLE	20	4.48e-01	6.74e-01	0.16000	1.74e-04	1.60e-01	9.99e-01	2.16e-01
GOBP SYNAPTIC VESICLE BUDDING	12	5.58e-01	7.51e-01	0.16000	1.16e-01	-1.10e-01	4.87e-01	5.09e-01
GOMF 1 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY	10	6.27e-01	7.96e-01	0.16000	1.45e-01	-6.78e-02	4.28e-01	7.11e-01
GOBP POSITIVE REGULATION OF HEART RATE	25	4.43e-01	6.70e-01	0.16000	8.09e-02	1.38e-01	4.84e-01	2.33e-01
GOBP CHAPERONE MEDIATED AUTOPHAGY	14	5.37e-01	7.37e-01	0.16000	-4.31e-02	1.54e-01	7.80e-01	3.19e-01
GOMF GAP JUNCTION CHANNEL ACTIVITY INVOLVED IN CARDIAC CONDUCTION ELECTRICAL COUPLING	5	8.36e-01	9.17e-01	0.16000	-3.91e-02	-1.55e-01	8.80e-01	5.49e-01
GOMF SYNTAXIN 1 BINDING	19	5.13e-01	7.21e-01	0.16000	-4.75e-02	-1.52e-01	7.20e-01	2.50e-01
GOBP ENDOCARDIAL CELL DIFFERENTIATION	6	7.57e-01	8.76e-01	0.16000	-1.45e-01	6.54e-02	5.37e-01	7.81e-01
GOCC HIPPOCAMPAL MOSSY FIBER TO CA3 SYNAPSE	43	1.66e-01	3.88e-01	0.15900	1.79e-02	-1.58e-01	8.39e-01	7.23e-02
GOMF FK506 BINDING	10	6.94e-01	8.41e-01	0.15900	3.18e-02	1.56e-01	8.62e-01	3.93e-01
GOMF U3 SNORNA BINDING	10	6.65e-01	8.22e-01	0.15900	1.59e-01	-9.04e-03	3.84e-01	9.61e-01
GOBP STEM CELL FATE COMMITMENT	10	7.00e-01	8.44e-01	0.15900	4.07e-02	1.54e-01	8.23e-01	3.99e-01
GOCC CENTRIOLE	155	7.98e-03	5.07e-02	0.15900	1.08e-01	1.18e-01	2.08e-02	1.16e-02
GOBP NEUROTRANSMITTER UPTAKE	44	2.51e-01	4.89e-01	0.15900	-1.03e-01	-1.21e-01	2.37e-01	1.63e-01
Acetylcholine Neurotransmitter Release Cycle	17	5.15e-01	7.22e-01	0.15900	7.94e-03	1.59e-01	9.55e-01	2.56e-01
GOBP NEUROTRANSMITTER RECEPTOR INTERNALIZATION	33	2.84e-01	5.22e-01	0.15900	-1.53e-02	-1.59e-01	8.79e-01	1.15e-01
GOBP CLEAVAGE FURROW FORMATION	7	7.56e-01	8.75e-01	0.15900	-1.54e-03	1.59e-01	9.94e-01	4.66e-01
GOBP POSITIVE REGULATION OF CELLULAR SENESCENCE	17	4.84e-01	6.99e-01	0.15900	-2.68e-02	1.57e-01	8.48e-01	2.63e-01
GOCC LAMELLAR BODY	18	4.25e-01	6.54e-01	0.15900	-8.66e-02	1.34e-01	5.25e-01	3.27e-01
GOBP REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY	10	7.15e-01	8.53e-01	0.15900	6.31e-02	1.46e-01	7.30e-01	4.24e-01
GOBP VESICLE CYTOSKELETAL TRAFFICKING	58	1.26e-01	3.32e-01	0.15900	1.54e-01	3.88e-02	4.21e-02	6.09e-01
FCERI mediated MAPK activation	32	2.73e-01	5.12e-01	0.15900	-8.31e-03	1.59e-01	9.35e-01	1.20e-01
GOBP POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION	21	4.08e-01	6.41e-01	0.15900	-2.77e-02	1.57e-01	8.26e-01	2.14e-01
GOBP REGULATION OF MELANOCYTE DIFFERENTIATION	6	8.29e-01	9.14e-01	0.15900	1.08e-01	1.16e-01	6.46e-01	6.21e-01
GOBP L LYSINE TRANSMEMBRANE TRANSPORT	7	7.66e-01	8.81e-01	0.15900	1.58e-01	1.53e-02	4.68e-01	9.44e-01
GOMF L LYSINE TRANSMEMBRANE TRANSPORTER ACTIVITY	7	7.66e-01	8.81e-01	0.15900	1.58e-01	1.53e-02	4.68e-01	9.44e-01
GOCC PLATELET DENSE GRANULE LUMEN	14	5.21e-01	7.26e-01	0.15900	7.11e-02	-1.42e-01	6.45e-01	3.57e-01
GOBP NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION	32	3.66e-01	6.03e-01	0.15900	-1.25e-01	-9.88e-02	2.22e-01	3.33e-01
GOBP MEDIUM CHAIN FATTY ACID METABOLIC PROCESS	15	6.26e-01	7.95e-01	0.15900	-1.18e-01	-1.07e-01	4.30e-01	4.73e-01
GOBP REGULATION OF MICROTUBULE BASED PROCESS	248	4.66e-04	5.70e-03	0.15900	1.05e-01	1.19e-01	4.31e-03	1.23e-03
GOBP POSITIVE REGULATION OF FEAR RESPONSE	7	7.26e-01	8.60e-01	0.15900	-6.15e-02	1.47e-01	7.78e-01	5.02e-01
GOBP NEGATIVE REGULATION OF LIPID TRANSPORT	47	1.08e-01	3.04e-01	0.15900	8.65e-02	-1.33e-01	3.05e-01	1.14e-01
GOMF ACYLGLYCEROL O ACYLTRANSFERASE ACTIVITY	26	3.40e-01	5.78e-01	0.15900	-1.76e-02	1.58e-01	8.76e-01	1.64e-01
GOBP PROTEIN K11 LINKED DEUBIQUITINATION	9	6.49e-01	8.10e-01	0.15900	-1.11e-01	1.14e-01	5.65e-01	5.54e-01
GOBP NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY	77	5.42e-02	1.98e-01	0.15900	1.58e-01	1.56e-02	1.65e-02	8.13e-01
GOCC BASOLATERAL PLASMA MEMBRANE	249	2.31e-04	3.13e-03	0.15900	-1.48e-01	-5.64e-02	5.48e-05	1.25e-01
GOMF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY	27	3.36e-01	5.75e-01	0.15900	-1.59e-01	7.40e-03	1.54e-01	9.47e-01
GOBP FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS	13	6.04e-01	7.82e-01	0.15900	7.98e-03	1.59e-01	9.60e-01	3.22e-01
GOMF SINGLE STRANDED RNA BINDING	79	5.65e-02	2.02e-01	0.15900	1.56e-01	2.94e-02	1.66e-02	6.52e-01
GOBP REGULATION OF GLUCOCORTICOID SECRETION	10	6.19e-01	7.90e-01	0.15900	-1.21e-01	1.03e-01	5.09e-01	5.72e-01
GOBP LEUKOCYTE DEGRANULATION	74	3.06e-02	1.33e-01	0.15900	-8.57e-02	1.34e-01	2.02e-01	4.70e-02
GOBP SPECIFICATION OF SYMMETRY	138	1.40e-02	7.72e-02	0.15900	1.09e-01	1.15e-01	2.69e-02	1.95e-02
GOMF LIGAND GATED MONOATOMIC ANION CHANNEL ACTIVITY	43	2.46e-01	4.84e-01	0.15900	-7.23e-02	-1.41e-01	4.12e-01	1.09e-01
GOMF PROTEIN DOMAIN SPECIFIC BINDING	622	5.47e-09	2.54e-07	0.15900	1.27e-01	9.44e-02	5.65e-08	5.82e-05
GOBP PHOSPHATIDYLINOSITOL MEDIATED SIGNALING	23	3.36e-01	5.74e-01	0.15900	9.06e-02	-1.30e-01	4.52e-01	2.80e-01
GOCC PIGMENT GRANULE	109	3.30e-02	1.41e-01	0.15900	9.40e-02	1.28e-01	8.99e-02	2.12e-02
GOBP REGULATION OF NEUTROPHIL MEDIATED CYTOTOXICITY	5	8.55e-01	9.27e-01	0.15900	-1.27e-01	-9.43e-02	6.22e-01	7.15e-01
GOCC ASTROCYTE END FOOT	11	5.92e-01	7.73e-01	0.15900	1.25e-01	-9.79e-02	4.74e-01	5.74e-01
GOBP TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY	28	4.13e-01	6.45e-01	0.15900	1.31e-01	8.89e-02	2.29e-01	4.15e-01
GOBP REGULATION OF SREBP SIGNALING PATHWAY	8	7.79e-01	8.89e-01	0.15800	9.95e-02	1.23e-01	6.26e-01	5.46e-01
GOBP EXTRAEMBRYONIC MEMBRANE DEVELOPMENT	13	5.44e-01	7.42e-01	0.15800	-1.37e-01	7.96e-02	3.92e-01	6.19e-01
GOMF PROTEIN SERINE THREONINE KINASE ACTIVATOR ACTIVITY	67	1.25e-01	3.29e-01	0.15800	1.00e-01	1.23e-01	1.55e-01	8.28e-02
GOBP UBIQUITIN DEPENDENT ENDOCYTOSIS	7	7.97e-01	8.97e-01	0.15800	-7.35e-02	-1.40e-01	7.36e-01	5.20e-01
GOBP DISTAL TUBULE DEVELOPMENT	12	6.73e-01	8.28e-01	0.15800	6.67e-02	1.44e-01	6.89e-01	3.89e-01
GOBP CELL SURFACE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY	401	4.15e-06	1.03e-04	0.15800	1.29e-01	9.16e-02	8.94e-06	1.65e-03
Vesicle-mediated transport	642	1.41e-09	7.47e-08	0.15800	1.42e-01	7.08e-02	8.98e-10	2.19e-03
GOMF CHOLINE TRANSMEMBRANE TRANSPORTER ACTIVITY	7	8.04e-01	9.02e-01	0.15800	-1.24e-01	-9.80e-02	5.69e-01	6.53e-01
GOBP NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE	5	8.05e-01	9.02e-01	0.15800	1.54e-01	-3.80e-02	5.52e-01	8.83e-01
IRS activation	5	8.43e-01	9.21e-01	0.15800	-5.27e-02	-1.49e-01	8.38e-01	5.63e-01
GOBP D ASPARTATE TRANSMEMBRANE TRANSPORT	5	8.31e-01	9.16e-01	0.15800	-1.57e-01	-2.34e-02	5.44e-01	9.28e-01
GOMF COPPER ION TRANSMEMBRANE TRANSPORTER ACTIVITY	6	7.92e-01	8.94e-01	0.15800	-1.58e-01	-4.17e-03	5.02e-01	9.86e-01
tRNA modification in the mitochondrion	8	7.73e-01	8.85e-01	0.15800	1.38e-01	7.69e-02	4.98e-01	7.06e-01
GOMF PHOSPHOLIPASE A2 ACTIVITY	34	2.93e-01	5.32e-01	0.15800	-3.07e-02	-1.55e-01	7.56e-01	1.17e-01
GOBP MUSCLE STRUCTURE DEVELOPMENT	693	9.78e-11	6.25e-09	0.15800	1.50e-01	4.99e-02	1.58e-11	2.51e-02
GOCC PRESYNAPTIC CYTOSKELETON	11	7.05e-01	8.47e-01	0.15800	-8.31e-02	-1.35e-01	6.33e-01	4.39e-01
GOCC ER MEMBRANE INSERTION COMPLEX	10	7.29e-01	8.61e-01	0.15800	8.55e-02	1.33e-01	6.39e-01	4.66e-01
Respiratory Syncytial Virus Infection Pathway	110	3.03e-02	1.33e-01	0.15800	1.36e-01	8.04e-02	1.36e-02	1.45e-01
GOBP NEGATIVE REGULATION OF CATABOLIC PROCESS	332	3.64e-05	6.71e-04	0.15800	1.27e-01	9.45e-02	7.16e-05	3.06e-03
GOBP POSITIVE REGULATION OF ACTION POTENTIAL	8	7.80e-01	8.90e-01	0.15800	-1.01e-01	-1.21e-01	6.20e-01	5.52e-01
GOBP WATER TRANSPORT	28	4.22e-01	6.52e-01	0.15800	-1.12e-01	-1.11e-01	3.03e-01	3.09e-01
GOBP POSITIVE REGULATION OF NEURON PROJECTION ARBORIZATION	8	6.90e-01	8.39e-01	0.15800	7.85e-02	-1.37e-01	7.01e-01	5.02e-01
GOBP REGULATION OF RUFFLE ASSEMBLY	31	2.50e-01	4.88e-01	0.15800	-5.69e-02	1.47e-01	5.83e-01	1.56e-01
GOBP POSITIVE REGULATION OF ANTIBACTERIAL PEPTIDE PRODUCTION	5	8.21e-01	9.10e-01	0.15800	2.24e-03	-1.58e-01	9.93e-01	5.41e-01
GOCC ORGANELLE MEMBRANE CONTACT SITE	46	2.22e-01	4.55e-01	0.15800	1.44e-01	6.39e-02	9.11e-02	4.53e-01
Methylation	14	5.43e-01	7.41e-01	0.15800	1.51e-01	-4.63e-02	3.29e-01	7.64e-01
SARS-CoV-1 activates/modulates innate immune responses	39	3.03e-01	5.43e-01	0.15700	1.07e-01	1.16e-01	2.48e-01	2.11e-01
GOBP MAST CELL ACTIVATION	65	4.66e-02	1.79e-01	0.15700	-1.10e-01	1.12e-01	1.24e-01	1.17e-01
GOBP POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION	61	5.66e-02	2.02e-01	0.15700	-1.20e-01	1.02e-01	1.04e-01	1.70e-01
GOMF ALANINE TRANSMEMBRANE TRANSPORTER ACTIVITY	14	5.83e-01	7.69e-01	0.15700	4.04e-03	1.57e-01	9.79e-01	3.08e-01
GOBP REGULATION OF MALE GONAD DEVELOPMENT	8	7.71e-01	8.85e-01	0.15700	6.68e-02	1.42e-01	7.44e-01	4.85e-01
NOTCH3 Intracellular Domain Regulates Transcription	24	3.89e-01	6.22e-01	0.15700	1.57e-01	-4.98e-03	1.82e-01	9.66e-01
GOBP CADMIUM ION TRANSMEMBRANE TRANSPORT	6	7.65e-01	8.81e-01	0.15700	5.87e-02	-1.46e-01	8.03e-01	5.36e-01
GOBP PROTEIN TRANSPORT	1361	2.34e-18	3.02e-16	0.15700	1.37e-01	7.67e-02	1.99e-17	2.03e-06
GOBP ION CHANNEL MODULATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY	8	7.45e-01	8.70e-01	0.15700	-1.56e-01	-1.96e-02	4.45e-01	9.24e-01
GOBP GASTRULATION	192	3.01e-03	2.41e-02	0.15700	1.14e-01	1.08e-01	6.47e-03	9.79e-03
GOBP NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY	141	1.32e-02	7.35e-02	0.15700	9.21e-02	1.27e-01	5.90e-02	9.11e-03
GOBP MUSCLE ORGAN DEVELOPMENT	348	1.96e-05	3.91e-04	0.15700	1.36e-01	7.77e-02	1.21e-05	1.28e-02
GOCC SPECIFIC GRANULE MEMBRANE	88	1.90e-02	9.60e-02	0.15700	-6.73e-02	1.42e-01	2.75e-01	2.14e-02
Signaling by NOTCH1	69	1.06e-01	3.01e-01	0.15700	1.44e-01	6.36e-02	3.92e-02	3.61e-01
GOMF TROPOMYOSIN BINDING	15	4.94e-01	7.07e-01	0.15700	1.16e-01	-1.06e-01	4.36e-01	4.78e-01
GOBP KETONE BODY METABOLIC PROCESS	9	7.08e-01	8.49e-01	0.15700	-1.57e-01	-2.69e-03	4.15e-01	9.89e-01
GOMF MANNOSE BINDING	24	3.68e-01	6.05e-01	0.15700	2.85e-02	-1.54e-01	8.09e-01	1.91e-01
GOBP ESTABLISHMENT OF LOCALIZATION IN CELL	1868	4.01e-24	7.35e-22	0.15700	1.35e-01	7.97e-02	3.47e-22	1.12e-08
GOBP POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	12	6.86e-01	8.36e-01	0.15700	7.99e-02	1.35e-01	6.32e-01	4.18e-01
Activation of PUMA and translocation to mitochondria	9	7.07e-01	8.49e-01	0.15700	5.43e-04	1.57e-01	9.98e-01	4.15e-01
GOBP INTERLEUKIN 4 MEDIATED SIGNALING PATHWAY	9	6.69e-01	8.25e-01	0.15700	-1.44e-01	6.17e-02	4.54e-01	7.49e-01
GOMF KINETOCHORE BINDING	6	8.21e-01	9.09e-01	0.15700	5.87e-02	1.45e-01	8.03e-01	5.37e-01
GOMF LONG CHAIN FATTY ACID TRANSMEMBRANE TRANSPORTER ACTIVITY	15	6.34e-01	8.00e-01	0.15700	-1.15e-01	-1.06e-01	4.40e-01	4.76e-01
GOBP SECRETORY GRANULE LOCALIZATION	22	4.80e-01	6.97e-01	0.15700	-1.48e-01	-5.30e-02	2.31e-01	6.67e-01
GOBP REGULATION OF ACTIN FILAMENT LENGTH	148	8.13e-03	5.15e-02	0.15700	1.45e-01	6.09e-02	2.40e-03	2.01e-01
GOBP CALCIUM ION REGULATED EXOCYTOSIS	63	1.13e-01	3.13e-01	0.15700	-1.52e-01	-3.91e-02	3.71e-02	5.92e-01
GOBP RETROTRANSPOSON SILENCING BY HETEROCHROMATIN FORMATION	15	5.91e-01	7.73e-01	0.15700	-3.42e-02	-1.53e-01	8.18e-01	3.05e-01
GOBP POSITIVE REGULATION OF MAST CELL ACTIVATION	6	7.80e-01	8.90e-01	0.15700	-2.60e-02	1.55e-01	9.12e-01	5.12e-01
GOBP NEGATIVE REGULATION OF ACTION POTENTIAL	6	8.31e-01	9.15e-01	0.15700	-9.02e-02	-1.28e-01	7.02e-01	5.87e-01
GOBP NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY	28	4.23e-01	6.53e-01	0.15700	9.29e-02	1.26e-01	3.95e-01	2.48e-01
GOBP CENTRIOLE CENTRIOLE COHESION	15	6.13e-01	7.87e-01	0.15700	1.44e-01	6.10e-02	3.33e-01	6.83e-01
GOBP MYELOID LEUKOCYTE MEDIATED IMMUNITY	105	7.80e-03	4.98e-02	0.15700	-9.13e-02	1.27e-01	1.06e-01	2.41e-02
GOMF ENDOPEPTIDASE ACTIVITY	373	8.30e-06	1.85e-04	0.15700	-7.15e-02	-1.39e-01	1.77e-02	3.74e-06
GOBP PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING	24	3.25e-01	5.64e-01	0.15700	-1.13e-01	1.08e-01	3.37e-01	3.59e-01
GOBP METANEPHRIC PART OF URETERIC BUD DEVELOPMENT	6	7.97e-01	8.97e-01	0.15700	6.42e-03	1.57e-01	9.78e-01	5.07e-01
GOMF NADPH BINDING	16	6.13e-01	7.87e-01	0.15700	1.25e-01	9.50e-02	3.89e-01	5.11e-01
GOBP PROTEIN LOCALIZATION TO BASOLATERAL PLASMA MEMBRANE	7	7.92e-01	8.94e-01	0.15700	1.48e-01	5.19e-02	4.98e-01	8.12e-01
GOBP NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT	35	2.02e-01	4.32e-01	0.15700	7.97e-02	-1.35e-01	4.15e-01	1.68e-01
GOBP PROTEIN K48 LINKED DEUBIQUITINATION	24	4.26e-01	6.55e-01	0.15700	2.88e-02	1.54e-01	8.07e-01	1.92e-01
Potassium Channels	102	3.22e-02	1.39e-01	0.15700	-1.49e-01	-4.66e-02	9.10e-03	4.16e-01
GOBP REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY	309	9.46e-05	1.48e-03	0.15700	1.21e-01	9.97e-02	2.65e-04	2.57e-03
GOCC INTERCELLULAR CANALICULUS	6	7.73e-01	8.85e-01	0.15600	-1.51e-01	4.27e-02	5.23e-01	8.56e-01
GOBP SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL SIGNALING	9	7.53e-01	8.73e-01	0.15600	-1.37e-01	-7.61e-02	4.78e-01	6.93e-01
GOMF 3 5 CYCLIC AMP PHOSPHODIESTERASE ACTIVITY	22	4.85e-01	7.00e-01	0.15600	-5.68e-02	-1.46e-01	6.45e-01	2.37e-01
GOBP POSITIVE REGULATION OF BONE MINERALIZATION	43	2.72e-01	5.12e-01	0.15600	1.03e-01	1.18e-01	2.43e-01	1.81e-01
GOBP POSITIVE REGULATION OF LOW DENSITY LIPOPROTEIN RECEPTOR ACTIVITY	5	8.52e-01	9.26e-01	0.15600	1.41e-01	6.68e-02	5.84e-01	7.96e-01
GOBP FOREBRAIN DEVELOPMENT	393	8.59e-06	1.90e-04	0.15600	1.11e-01	1.10e-01	1.53e-04	1.84e-04
GOBP REGULATION OF TRANSLATIONAL TERMINATION	8	6.90e-01	8.39e-01	0.15600	1.25e-01	-9.41e-02	5.41e-01	6.45e-01
GOBP REGULATION OF T CELL DIFFERENTIATION IN THYMUS	26	3.15e-01	5.54e-01	0.15600	-6.37e-02	1.43e-01	5.74e-01	2.08e-01
GOBP PYRIMIDINE RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS	15	4.98e-01	7.09e-01	0.15600	-1.05e-01	1.15e-01	4.79e-01	4.39e-01
GOBP STRIATUM DEVELOPMENT	20	4.27e-01	6.56e-01	0.15600	1.51e-01	-4.14e-02	2.43e-01	7.49e-01
GOCC AUTOPHAGOSOME	109	3.65e-02	1.52e-01	0.15600	9.25e-02	1.26e-01	9.51e-02	2.32e-02
GOCC CILIARY MEMBRANE	74	3.34e-02	1.42e-01	0.15600	9.04e-02	-1.27e-01	1.79e-01	5.81e-02
GOBP VIRAL BUDDING	25	4.16e-01	6.46e-01	0.15600	3.07e-02	1.53e-01	7.91e-01	1.85e-01
GOMF MOLECULAR SEQUESTERING ACTIVITY	44	2.30e-01	4.65e-01	0.15600	4.86e-02	1.48e-01	5.77e-01	8.86e-02
GOBP CHEMOKINE PRODUCTION	101	1.03e-02	6.11e-02	0.15600	-1.34e-01	7.97e-02	1.97e-02	1.67e-01
GOBP REGULATION OF WNT SIGNALING PATHWAY	328	3.38e-05	6.30e-04	0.15600	1.40e-01	6.84e-02	1.24e-05	3.33e-02
GOBP MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION	129	2.05e-02	1.01e-01	0.15600	1.22e-01	9.76e-02	1.69e-02	5.56e-02
GOBP RESPONSE TO MAGNESIUM ION	20	5.45e-01	7.42e-01	0.15600	-9.43e-02	-1.24e-01	4.65e-01	3.36e-01
GOMF ACYL COA OXIDASE ACTIVITY	7	7.60e-01	8.78e-01	0.15600	9.18e-03	-1.56e-01	9.66e-01	4.75e-01
GOBP POSITIVE REGULATION OF VESICLE FUSION	10	6.73e-01	8.27e-01	0.15600	-1.55e-01	1.36e-02	3.95e-01	9.41e-01
GOBP REGULATION OF PROTEIN POLYMERIZATION	194	2.19e-03	1.89e-02	0.15600	1.41e-01	6.77e-02	7.39e-04	1.04e-01
GOBP POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION	26	3.00e-01	5.40e-01	0.15600	1.14e-01	-1.07e-01	3.16e-01	3.45e-01
GOBP SYNAPTIC ASSEMBLY AT NEUROMUSCULAR JUNCTION	10	6.64e-01	8.21e-01	0.15600	2.71e-02	-1.54e-01	8.82e-01	4.00e-01
GOBP NEGATIVE REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE	15	6.37e-01	8.02e-01	0.15600	1.06e-01	1.14e-01	4.78e-01	4.43e-01
GOBP SNARE COMPLEX ASSEMBLY	22	4.78e-01	6.96e-01	0.15600	1.49e-01	4.57e-02	2.26e-01	7.11e-01
Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer’s disease models	22	4.81e-01	6.97e-01	0.15600	1.48e-01	4.87e-02	2.29e-01	6.92e-01
Neurodegenerative Diseases	22	4.81e-01	6.97e-01	0.15600	1.48e-01	4.87e-02	2.29e-01	6.92e-01
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION	1627	2.30e-21	3.71e-19	0.15600	1.38e-01	7.21e-02	1.43e-20	1.26e-06
GOBP RESPONSE TO IRON II ION	6	8.18e-01	9.08e-01	0.15600	1.49e-01	4.70e-02	5.29e-01	8.42e-01
GOCC AXONEMAL MICROTUBULE	53	2.00e-01	4.30e-01	0.15600	1.26e-01	9.10e-02	1.11e-01	2.52e-01
GOMF INTRACELLULARLY GATED CALCIUM CHANNEL ACTIVITY	18	4.43e-01	6.71e-01	0.15600	-7.76e-02	1.35e-01	5.69e-01	3.21e-01
GOBP LOOP OF HENLE DEVELOPMENT	12	6.80e-01	8.32e-01	0.15600	6.20e-02	1.43e-01	7.10e-01	3.91e-01
Arachidonate metabolism	57	1.15e-01	3.15e-01	0.15600	-1.42e-03	-1.56e-01	9.85e-01	4.19e-02
GOBP NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY	123	2.53e-02	1.17e-01	0.15600	1.02e-01	1.17e-01	4.98e-02	2.46e-02
GOBP NITROGEN CYCLE METABOLIC PROCESS	12	6.98e-01	8.43e-01	0.15600	-1.15e-01	-1.05e-01	4.89e-01	5.30e-01
GOBP NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE	10	7.00e-01	8.44e-01	0.15600	-2.29e-02	-1.54e-01	9.00e-01	3.99e-01
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEOLUS	5	8.02e-01	9.00e-01	0.15600	1.42e-01	-6.43e-02	5.83e-01	8.03e-01
GOBP POSITIVE REGULATION OF ENDOCYTIC RECYCLING	8	7.21e-01	8.57e-01	0.15600	-1.53e-01	2.66e-02	4.53e-01	8.96e-01
GOBP CONNECTIVE TISSUE DEVELOPMENT	281	1.67e-04	2.37e-03	0.15600	1.38e-01	7.21e-02	7.00e-05	3.74e-02
Plasma lipoprotein remodeling	33	3.67e-01	6.04e-01	0.15600	-8.82e-02	-1.28e-01	3.81e-01	2.03e-01
GOCC JUNCTIONAL SARCOPLASMIC RETICULUM MEMBRANE	9	7.35e-01	8.65e-01	0.15600	-3.70e-02	-1.51e-01	8.47e-01	4.33e-01
GOBP DRINKING BEHAVIOR	9	7.62e-01	8.79e-01	0.15600	9.50e-02	1.23e-01	6.22e-01	5.22e-01
GOBP NEGATIVE REGULATION OF MONOCYTE DIFFERENTIATION	8	7.07e-01	8.49e-01	0.15500	-5.49e-02	1.45e-01	7.88e-01	4.76e-01
GOBP REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION	56	1.11e-01	3.08e-01	0.15500	-1.55e-01	1.32e-02	4.50e-02	8.65e-01
IRS-mediated signalling	47	1.82e-01	4.08e-01	0.15500	1.55e-01	1.61e-02	6.67e-02	8.48e-01
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS	62	1.57e-01	3.74e-01	0.15500	9.87e-02	1.20e-01	1.79e-01	1.02e-01
GOBP NATURAL KILLER CELL DEGRANULATION	10	6.69e-01	8.25e-01	0.15500	-1.54e-01	2.23e-02	4.00e-01	9.03e-01
GOBP ETHER BIOSYNTHETIC PROCESS	12	6.98e-01	8.43e-01	0.15500	-9.83e-02	-1.20e-01	5.55e-01	4.71e-01
ABC-family proteins mediated transport	87	2.49e-02	1.17e-01	0.15500	1.48e-01	-4.77e-02	1.72e-02	4.42e-01
GOBP POSITIVE REGULATION OF MITOPHAGY	14	5.86e-01	7.70e-01	0.15500	-1.55e-01	3.65e-03	3.15e-01	9.81e-01
GOBP INSULIN RECEPTOR SIGNALING PATHWAY	128	2.25e-02	1.08e-01	0.15500	1.15e-01	1.04e-01	2.46e-02	4.17e-02
Activated NTRK2 signals through CDK5	6	8.09e-01	9.04e-01	0.15500	2.52e-02	1.53e-01	9.15e-01	5.16e-01
RIPK1-mediated regulated necrosis	29	3.95e-01	6.28e-01	0.15500	6.01e-02	1.43e-01	5.76e-01	1.82e-01
Regulation of necroptotic cell death	29	3.95e-01	6.28e-01	0.15500	6.01e-02	1.43e-01	5.76e-01	1.82e-01
GOMF PROTEIN SERINE THREONINE KINASE BINDING	10	7.16e-01	8.54e-01	0.15500	1.49e-01	4.34e-02	4.15e-01	8.12e-01
GOBP DEOXYRIBONUCLEOTIDE CATABOLIC PROCESS	28	3.53e-01	5.90e-01	0.15500	5.44e-03	1.55e-01	9.60e-01	1.56e-01
GOCC ESCRT I COMPLEX	12	6.60e-01	8.19e-01	0.15500	1.52e-01	3.16e-02	3.62e-01	8.50e-01
Translation initiation complex formation	52	2.06e-01	4.38e-01	0.15500	1.30e-01	8.46e-02	1.05e-01	2.91e-01
GOMF CHLORIDE TRANSMEMBRANE TRANSPORTER ACTIVITY	110	3.55e-02	1.49e-01	0.15500	-1.31e-01	-8.32e-02	1.77e-02	1.32e-01
GOBP PATTERN SPECIFICATION INVOLVED IN KIDNEY DEVELOPMENT	8	7.48e-01	8.71e-01	0.15500	1.44e-02	1.54e-01	9.44e-01	4.49e-01
GOCC CLATHRIN COMPLEX	8	6.93e-01	8.40e-01	0.15500	1.03e-01	-1.16e-01	6.13e-01	5.71e-01
GOMF COLLAGEN BINDING	68	6.20e-02	2.15e-01	0.15500	3.16e-02	-1.52e-01	6.52e-01	3.04e-02
Metabolic disorders of biological oxidation enzymes	33	2.88e-01	5.27e-01	0.15500	-1.55e-01	-2.06e-04	1.23e-01	9.98e-01
GOBP REGULATION OF FAT CELL DIFFERENTIATION	141	1.54e-02	8.28e-02	0.15500	1.02e-01	1.17e-01	3.72e-02	1.64e-02
GOBP AXONAL TRANSPORT	63	1.53e-01	3.69e-01	0.15500	9.81e-02	1.20e-01	1.78e-01	9.94e-02
GOBP REGULATION OF NMDA RECEPTOR ACTIVITY	14	6.54e-01	8.13e-01	0.15500	-8.49e-02	-1.30e-01	5.82e-01	4.01e-01
GOBP POSITIVE REGULATION OF MACROPHAGE CYTOKINE PRODUCTION	23	3.56e-01	5.93e-01	0.15500	-8.12e-02	1.32e-01	5.00e-01	2.73e-01
GOBP DEVELOPMENTAL INDUCTION	32	3.40e-01	5.78e-01	0.15500	3.95e-02	1.50e-01	6.99e-01	1.42e-01
GOBP TYROSINE PHOSPHORYLATION OF STAT PROTEIN	77	5.91e-02	2.08e-01	0.15500	-1.55e-01	-8.68e-03	1.89e-02	8.95e-01
GOBP AMINO ACID BETAINE TRANSPORT	13	6.05e-01	7.82e-01	0.15500	-1.55e-01	9.18e-03	3.34e-01	9.54e-01
Cardiac conduction	125	2.48e-02	1.16e-01	0.15500	-1.03e-01	-1.16e-01	4.72e-02	2.51e-02
GOBP EMBRYONIC CRANIAL SKELETON MORPHOGENESIS	44	2.59e-01	4.98e-01	0.15500	7.76e-02	1.34e-01	3.73e-01	1.24e-01
TNFR2 non-canonical NF-kB pathway	83	8.32e-02	2.59e-01	0.15500	1.26e-01	8.96e-02	4.67e-02	1.58e-01
GOBP DIOL BIOSYNTHETIC PROCESS	21	5.17e-01	7.23e-01	0.15500	6.66e-02	1.40e-01	5.97e-01	2.68e-01
GOBP PEPTIDYL TYROSINE DEPHOSPHORYLATION INVOLVED IN INACTIVATION OF PROTEIN KINASE ACTIVITY	8	7.89e-01	8.93e-01	0.15500	-1.04e-01	-1.14e-01	6.09e-01	5.75e-01
Selenoamino acid metabolism	108	4.02e-02	1.63e-01	0.15500	1.23e-01	9.39e-02	2.71e-02	9.19e-02
GOMF NUCLEOSIDE BINDING	8	7.80e-01	8.89e-01	0.15500	1.38e-01	7.02e-02	4.99e-01	7.31e-01
GOBP OUTER EAR MORPHOGENESIS	8	7.76e-01	8.87e-01	0.15500	6.24e-02	1.42e-01	7.60e-01	4.88e-01
GOBP COLLAGEN ACTIVATED SIGNALING PATHWAY	13	6.23e-01	7.93e-01	0.15500	-1.20e-02	-1.54e-01	9.40e-01	3.36e-01
GOBP DOPAMINE RECEPTOR SIGNALING PATHWAY	39	3.04e-01	5.44e-01	0.15500	7.85e-02	1.33e-01	3.96e-01	1.50e-01
GOBP REGULATION OF COMPLEMENT ACTIVATION	22	5.22e-01	7.26e-01	0.15500	-1.05e-01	-1.13e-01	3.93e-01	3.57e-01
GOBP REGULATION OF PROGRAMMED CELL DEATH	1462	1.15e-18	1.50e-16	0.15500	8.43e-02	1.30e-01	6.83e-08	1.07e-16
GOBP REGULATION OF CIRCADIAN RHYTHM	109	3.09e-02	1.35e-01	0.15500	1.44e-01	5.70e-02	9.54e-03	3.04e-01
Signaling by activated point mutants of FGFR1	11	7.01e-01	8.45e-01	0.15500	1.45e-01	5.40e-02	4.06e-01	7.57e-01
GOBP NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY	190	3.70e-03	2.82e-02	0.15500	1.21e-01	9.58e-02	3.94e-03	2.27e-02
GOCC SMAD PROTEIN COMPLEX	9	7.61e-01	8.78e-01	0.15500	1.32e-01	8.04e-02	4.93e-01	6.76e-01
GOMF ALCOHOL TRANSMEMBRANE TRANSPORTER ACTIVITY	6	7.82e-01	8.90e-01	0.15500	-1.51e-01	3.42e-02	5.23e-01	8.85e-01
GOBP ADRENERGIC RECEPTOR SIGNALING PATHWAY	33	3.78e-01	6.13e-01	0.15400	1.07e-01	1.12e-01	2.88e-01	2.68e-01
Defects of contact activation system (CAS) and kallikrein/kinin system (KKS)	14	5.74e-01	7.64e-01	0.15400	2.11e-02	-1.53e-01	8.91e-01	3.22e-01
Gap junction assembly	35	2.38e-01	4.75e-01	0.15400	-1.50e-01	3.52e-02	1.24e-01	7.19e-01
GOMF METALLOPEPTIDASE ACTIVITY	179	1.43e-03	1.36e-02	0.15400	-5.62e-03	-1.54e-01	8.97e-01	3.68e-04
GOBP POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY	105	4.60e-02	1.77e-01	0.15400	1.12e-01	1.06e-01	4.68e-02	6.05e-02
GOBP SALIVARY GLAND DEVELOPMENT	36	1.95e-01	4.24e-01	0.15400	1.16e-01	-1.02e-01	2.29e-01	2.90e-01
GOCC I BAND	140	3.67e-03	2.80e-02	0.15400	2.77e-02	-1.52e-01	5.72e-01	1.91e-03
GOCC SPERM CONNECTING PIECE	11	6.58e-01	8.17e-01	0.15400	1.54e-01	-5.36e-03	3.76e-01	9.75e-01
GOBP POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS	37	3.37e-01	5.75e-01	0.15400	1.07e-01	1.12e-01	2.61e-01	2.40e-01
GOBP RESPONSE TO OXIDATIVE STRESS	386	1.41e-05	2.91e-04	0.15400	1.10e-01	1.08e-01	2.07e-04	2.58e-04
GOBP PROTEIN POLYMERIZATION	272	2.05e-04	2.82e-03	0.15400	1.42e-01	6.13e-02	5.77e-05	8.17e-02
GOBP EATING BEHAVIOR	39	1.73e-01	3.95e-01	0.15400	-9.27e-02	1.23e-01	3.16e-01	1.82e-01
N-glycan antennae elongation in the medial/trans-Golgi	26	3.50e-01	5.88e-01	0.15400	-1.52e-01	2.89e-02	1.81e-01	7.99e-01
GOBP XENOBIOTIC METABOLIC PROCESS	122	1.37e-02	7.57e-02	0.15400	-1.98e-02	-1.53e-01	7.06e-01	3.51e-03
GOMF GLYCOSAMINOGLYCAN BINDING	235	3.91e-04	4.88e-03	0.15400	-3.64e-02	-1.50e-01	3.36e-01	7.51e-05
GOCC PROTON TRANSPORTING V TYPE ATPASE COMPLEX	26	4.59e-01	6.83e-01	0.15400	8.56e-02	1.28e-01	4.50e-01	2.58e-01
GOBP REGULATION OF NEUROTRANSMITTER UPTAKE	18	5.39e-01	7.39e-01	0.15400	-2.98e-02	-1.51e-01	8.26e-01	2.66e-01
Erythropoietin activates Phosphoinositide-3-kinase (PI3K)	12	7.00e-01	8.44e-01	0.15400	9.12e-02	1.24e-01	5.84e-01	4.56e-01
GOBP REGULATION OF GROWTH HORMONE RECEPTOR SIGNALING PATHWAY	6	7.86e-01	8.92e-01	0.15400	-2.76e-02	1.52e-01	9.07e-01	5.20e-01
GOBP COENZYME A BIOSYNTHETIC PROCESS	10	7.43e-01	8.69e-01	0.15400	9.05e-02	1.25e-01	6.20e-01	4.94e-01
GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY	47	1.22e-01	3.24e-01	0.15400	8.98e-02	-1.25e-01	2.87e-01	1.37e-01
GOBP LEUKOTRIENE D4 METABOLIC PROCESS	8	7.53e-01	8.74e-01	0.15400	-1.53e-01	-1.86e-02	4.54e-01	9.27e-01
GOBP HAIR CELL DIFFERENTIATION	54	1.82e-01	4.08e-01	0.15400	-1.42e-01	-5.97e-02	7.10e-02	4.48e-01
GOBP ANDROGEN RECEPTOR SIGNALING PATHWAY	45	2.53e-01	4.91e-01	0.15400	1.36e-01	7.30e-02	1.16e-01	3.97e-01
GOBP RESPONSE TO HEAT	99	2.18e-02	1.06e-01	0.15400	1.53e-01	-1.53e-02	8.44e-03	7.92e-01
GOMF PHOSPHATASE BINDING	185	4.44e-03	3.24e-02	0.15400	1.22e-01	9.33e-02	4.11e-03	2.85e-02
GOBP REGULATION OF STEM CELL DIVISION	12	6.26e-01	7.95e-01	0.15400	-1.84e-02	1.53e-01	9.12e-01	3.60e-01
RAC2 GTPase cycle	81	9.02e-02	2.73e-01	0.15400	1.27e-01	8.61e-02	4.74e-02	1.80e-01
GOBP POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION	14	5.39e-01	7.39e-01	0.15400	-1.33e-01	7.79e-02	3.90e-01	6.14e-01
GOMF G PROTEIN BETA SUBUNIT BINDING	21	3.89e-01	6.22e-01	0.15400	-1.16e-01	1.01e-01	3.56e-01	4.25e-01
GOBP REGULATION OF CANONICAL WNT SIGNALING PATHWAY	255	4.03e-04	5.01e-03	0.15400	1.39e-01	6.60e-02	1.34e-04	6.96e-02
IRS-related events triggered by IGF1R	50	1.79e-01	4.03e-01	0.15400	1.52e-01	2.61e-02	6.38e-02	7.50e-01
Defective factor IX causes hemophilia B	7	7.77e-01	8.88e-01	0.15400	-1.53e-01	-1.08e-02	4.82e-01	9.60e-01
GOBP ERBB2 EGFR SIGNALING PATHWAY	8	7.82e-01	8.90e-01	0.15400	1.38e-01	6.81e-02	5.00e-01	7.39e-01
GOBP ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION	21	5.37e-01	7.38e-01	0.15400	1.25e-01	8.97e-02	3.22e-01	4.77e-01
GOBP POSITIVE REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS	6	8.39e-01	9.19e-01	0.15400	-1.08e-01	-1.09e-01	6.47e-01	6.42e-01
GOBP L PROLINE BIOSYNTHETIC PROCESS	6	8.31e-01	9.15e-01	0.15400	-6.73e-02	-1.38e-01	7.75e-01	5.58e-01
GOBP REGULATION OF HEART RATE BY CARDIAC CONDUCTION	39	3.16e-01	5.55e-01	0.15400	-1.24e-01	-9.02e-02	1.79e-01	3.30e-01
GOBP REGULATION OF ENDOCYTIC RECYCLING	19	4.27e-01	6.56e-01	0.15400	9.55e-02	-1.20e-01	4.71e-01	3.64e-01
GOBP MEIOTIC CELL CYCLE PHASE TRANSITION	14	5.80e-01	7.67e-01	0.15400	1.53e-01	-1.77e-02	3.23e-01	9.09e-01
GOBP NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS	15	5.36e-01	7.37e-01	0.15400	-4.54e-02	1.47e-01	7.61e-01	3.25e-01
GOBP POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST	29	4.20e-01	6.50e-01	0.15400	8.04e-02	1.31e-01	4.54e-01	2.23e-01
GOMF ADENYLYLTRANSFERASE ACTIVITY	29	3.64e-01	6.01e-01	0.15400	1.52e-01	2.13e-02	1.56e-01	8.43e-01
GOBP MONOAMINE TRANSPORT	74	3.98e-02	1.62e-01	0.15400	-1.35e-01	7.32e-02	4.48e-02	2.76e-01
Highly sodium permeable postsynaptic acetylcholine nicotinic receptors	7	7.59e-01	8.77e-01	0.15300	-1.52e-01	2.33e-02	4.87e-01	9.15e-01
GOCC STRIATED MUSCLE THIN FILAMENT	22	3.98e-01	6.31e-01	0.15300	5.08e-02	-1.45e-01	6.80e-01	2.40e-01
GOBP PROTEIN DEUBIQUITINATION	79	8.94e-02	2.71e-01	0.15300	1.37e-01	6.87e-02	3.50e-02	2.91e-01
GOCC STEREOCILIUM BUNDLE	64	1.55e-01	3.70e-01	0.15300	-9.63e-02	-1.19e-01	1.83e-01	9.86e-02
GOCC U4 SNRNP	10	7.41e-01	8.68e-01	0.15300	1.32e-01	7.83e-02	4.70e-01	6.68e-01
GOBP FUNGIFORM PAPILLA MORPHOGENESIS	5	8.34e-01	9.17e-01	0.15300	6.03e-03	1.53e-01	9.81e-01	5.53e-01
GOBP WNT SIGNALING PATHWAY	446	1.28e-06	3.64e-05	0.15300	1.40e-01	6.30e-02	4.13e-07	2.25e-02
GOBP AXO DENDRITIC PROTEIN TRANSPORT	9	7.33e-01	8.63e-01	0.15300	2.35e-02	1.51e-01	9.03e-01	4.31e-01
GOBP REVERSIBLE DIFFERENTIATION	11	6.28e-01	7.96e-01	0.15300	-1.42e-01	5.67e-02	4.14e-01	7.45e-01
Synthesis of PG	8	7.00e-01	8.44e-01	0.15300	-1.20e-01	9.47e-02	5.55e-01	6.43e-01
Nuclear Envelope Breakdown	52	2.03e-01	4.34e-01	0.15300	1.38e-01	6.70e-02	8.55e-02	4.03e-01
GOBP PHOSPHOLIPID BIOSYNTHETIC PROCESS	243	9.34e-04	9.91e-03	0.15300	1.11e-01	1.05e-01	2.83e-03	4.64e-03
Synthesis of very long-chain fatty acyl-CoAs	23	4.15e-01	6.45e-01	0.15300	-1.53e-01	1.37e-02	2.05e-01	9.09e-01
GOBP NEGATIVE REGULATION OF WNT SIGNALING PATHWAY	171	6.86e-03	4.51e-02	0.15300	1.23e-01	9.09e-02	5.40e-03	4.02e-02
GOBP POSITIVE REGULATION OF CILIUM ASSEMBLY	30	4.13e-01	6.45e-01	0.15300	1.26e-01	8.75e-02	2.33e-01	4.07e-01
GOBP NEURONAL ACTION POTENTIAL	34	3.48e-01	5.86e-01	0.15300	-1.40e-01	-6.18e-02	1.57e-01	5.33e-01
GOBP SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT	19	5.48e-01	7.44e-01	0.15300	1.44e-01	5.34e-02	2.79e-01	6.87e-01
GOBP REGULATION OF MRNA METABOLIC PROCESS	375	4.68e-06	1.13e-04	0.15300	1.49e-01	3.56e-02	7.31e-07	2.36e-01
GOBP POSITIVE REGULATION OF THE FORCE OF HEART CONTRACTION	5	8.54e-01	9.27e-01	0.15300	-5.52e-02	-1.43e-01	8.31e-01	5.80e-01
GOBP REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION	74	5.75e-02	2.05e-01	0.15300	-1.87e-02	1.52e-01	7.81e-01	2.39e-02
GOBP CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION	19	4.45e-01	6.72e-01	0.15300	-6.24e-02	1.40e-01	6.38e-01	2.92e-01
GOMF NEUROPEPTIDE RECEPTOR ACTIVITY	43	1.63e-01	3.83e-01	0.15300	-1.42e-01	5.72e-02	1.08e-01	5.17e-01
Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S	53	2.09e-01	4.41e-01	0.15300	1.28e-01	8.33e-02	1.06e-01	2.94e-01
GOBP PHOSPHATIDYLGLYCEROL METABOLIC PROCESS	33	2.30e-01	4.65e-01	0.15300	1.10e-01	-1.06e-01	2.74e-01	2.91e-01
GOBP NEGATIVE REGULATION OF RESPONSE TO WOUNDING	97	5.78e-02	2.05e-01	0.15300	-8.41e-02	-1.28e-01	1.53e-01	2.97e-02
GOBP POSITIVE REGULATION OF COAGULATION	30	4.00e-01	6.33e-01	0.15300	1.38e-01	6.63e-02	1.92e-01	5.30e-01
GOBP CELLULAR RESPONSE TO ATP	16	5.91e-01	7.73e-01	0.15300	1.48e-01	3.85e-02	3.06e-01	7.90e-01
GOBP NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY	33	3.65e-01	6.02e-01	0.15300	6.55e-02	1.38e-01	5.15e-01	1.70e-01
Cell recruitment (pro-inflammatory response)	26	3.15e-01	5.54e-01	0.15300	-1.15e-01	1.00e-01	3.09e-01	3.76e-01
Purinergic signaling in leishmaniasis infection	26	3.15e-01	5.54e-01	0.15300	-1.15e-01	1.00e-01	3.09e-01	3.76e-01
GOBP TENDON DEVELOPMENT	5	8.19e-01	9.09e-01	0.15300	-3.23e-02	1.49e-01	9.00e-01	5.63e-01
GOBP RUFFLE ORGANIZATION	56	1.77e-01	4.00e-01	0.15300	5.94e-02	1.41e-01	4.42e-01	6.86e-02
GOMF TOXIN TRANSMEMBRANE TRANSPORTER ACTIVITY	9	7.65e-01	8.81e-01	0.15300	-7.77e-02	-1.31e-01	6.86e-01	4.95e-01
GOBP TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY	240	8.94e-04	9.63e-03	0.15300	1.30e-01	8.03e-02	5.37e-04	3.22e-02
GOBP POSITIVE REGULATION OF BMP SIGNALING PATHWAY	39	3.27e-01	5.66e-01	0.15300	1.06e-01	1.10e-01	2.52e-01	2.36e-01
GOBP REGULATION OF FIBRINOLYSIS	18	4.80e-01	6.97e-01	0.15200	1.46e-01	-4.39e-02	2.84e-01	7.47e-01
GOBP NAD CATABOLIC PROCESS	20	4.53e-01	6.78e-01	0.15200	-1.49e-01	3.13e-02	2.48e-01	8.08e-01
GOBP MAGNESIUM ION TRANSPORT	17	4.84e-01	6.99e-01	0.15200	-6.73e-02	1.37e-01	6.31e-01	3.29e-01
Calcitonin-like ligand receptors	10	6.72e-01	8.27e-01	0.15200	-1.49e-01	3.22e-02	4.15e-01	8.60e-01
GOBP RNA GUANINE N7 METHYLATION	6	7.88e-01	8.92e-01	0.15200	1.49e-01	-3.32e-02	5.28e-01	8.88e-01
GOBP GLUTAMATERGIC NEURON DIFFERENTIATION	15	5.85e-01	7.70e-01	0.15200	-7.05e-03	-1.52e-01	9.62e-01	3.07e-01
GOBP RESPONSE TO VITAMIN D	37	2.47e-01	4.85e-01	0.15200	-1.38e-02	1.52e-01	8.84e-01	1.10e-01
GOBP NEGATIVE REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION	21	5.21e-01	7.26e-01	0.15200	1.41e-01	5.67e-02	2.62e-01	6.53e-01
GOBP REGULATION OF CD40 SIGNALING PATHWAY	6	8.42e-01	9.21e-01	0.15200	-1.06e-01	-1.10e-01	6.54e-01	6.42e-01
GOBP REGULATION OF TRIGLYCERIDE METABOLIC PROCESS	44	1.47e-01	3.60e-01	0.15200	8.55e-02	-1.26e-01	3.26e-01	1.48e-01
GOBP SERINE FAMILY AMINO ACID METABOLIC PROCESS	30	2.84e-01	5.23e-01	0.15200	1.40e-01	-5.96e-02	1.84e-01	5.72e-01
GOBP DIGESTIVE TRACT MORPHOGENESIS	48	2.49e-01	4.87e-01	0.15200	8.81e-02	1.24e-01	2.91e-01	1.37e-01
GOBP POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN	22	5.33e-01	7.35e-01	0.15200	-1.03e-01	-1.12e-01	4.05e-01	3.62e-01
Maturation of protein 3a 9683673	9	6.91e-01	8.39e-01	0.15200	-1.44e-01	4.88e-02	4.54e-01	8.00e-01
Maturation of protein 3a 9694719	9	6.91e-01	8.39e-01	0.15200	-1.44e-01	4.88e-02	4.54e-01	8.00e-01
GOBP AXONAL FASCICULATION	20	5.41e-01	7.40e-01	0.15200	-5.99e-02	-1.40e-01	6.43e-01	2.79e-01
GOBP LIPOPROTEIN METABOLIC PROCESS	133	6.99e-03	4.57e-02	0.15200	1.52e-01	-1.15e-02	2.52e-03	8.18e-01
GOBP REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY	405	1.03e-05	2.20e-04	0.15200	1.22e-01	9.14e-02	2.70e-05	1.59e-03
GOBP MELANOCYTE DIFFERENTIATION	24	3.64e-01	6.01e-01	0.15200	6.28e-02	-1.39e-01	5.95e-01	2.40e-01
GOBP TRACHEA FORMATION	7	8.15e-01	9.07e-01	0.15200	8.38e-02	1.27e-01	7.01e-01	5.61e-01
GOBP GENERAL ADAPTATION SYNDROME	6	8.00e-01	8.99e-01	0.15200	-1.52e-01	8.61e-03	5.20e-01	9.71e-01
GOBP REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS	30	2.72e-01	5.12e-01	0.15200	8.36e-02	-1.27e-01	4.28e-01	2.29e-01
GOMF NON MEMBRANE SPANNING PROTEIN TYROSINE KINASE ACTIVITY	43	2.78e-01	5.18e-01	0.15200	7.21e-02	1.34e-01	4.13e-01	1.29e-01
GOBP REGULATION OF TAU PROTEIN KINASE ACTIVITY	7	7.85e-01	8.92e-01	0.15200	1.51e-01	1.72e-02	4.89e-01	9.37e-01
GOBP ACTIN FILAMENT BASED MOVEMENT	135	1.22e-02	6.89e-02	0.15200	-3.44e-02	-1.48e-01	4.90e-01	2.99e-03
GOBP RESPONSE TO CATECHOLAMINE	59	1.86e-01	4.12e-01	0.15200	9.75e-02	1.16e-01	1.95e-01	1.22e-01
GOBP CELLULAR RESPONSE TO ACID CHEMICAL	89	6.33e-02	2.17e-01	0.15200	1.42e-01	5.34e-02	2.04e-02	3.84e-01
GOBP CARTILAGE DEVELOPMENT	200	2.28e-03	1.94e-02	0.15200	1.40e-01	5.89e-02	6.44e-04	1.51e-01
GOMF ZINC ION BINDING	787	6.86e-11	4.55e-09	0.15200	1.41e-01	5.73e-02	1.93e-11	6.30e-03
GOBP SUCCINATE TRANSMEMBRANE TRANSPORT	6	8.05e-01	9.02e-01	0.15200	-7.00e-04	-1.52e-01	9.98e-01	5.20e-01
GOMF SUCCINATE TRANSMEMBRANE TRANSPORTER ACTIVITY	6	8.05e-01	9.02e-01	0.15200	-7.00e-04	-1.52e-01	9.98e-01	5.20e-01
GOCC MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX III	12	7.09e-01	8.50e-01	0.15200	1.20e-01	9.33e-02	4.73e-01	5.76e-01
GOBP NEGATIVE REGULATION OF MYELINATION	9	6.76e-01	8.30e-01	0.15200	1.24e-01	-8.71e-02	5.19e-01	6.51e-01
Diseases of Base Excision Repair	5	8.35e-01	9.17e-01	0.15200	1.49e-03	1.52e-01	9.95e-01	5.57e-01
GOCC TRANS GOLGI NETWORK MEMBRANE	103	5.32e-02	1.96e-01	0.15200	1.19e-01	9.44e-02	3.73e-02	9.80e-02
GOBP RENAL TUBULAR SECRETION	20	4.35e-01	6.63e-01	0.15200	5.86e-02	-1.40e-01	6.50e-01	2.79e-01
GOBP DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS	11	7.01e-01	8.45e-01	0.15200	3.94e-02	1.46e-01	8.21e-01	4.00e-01
GOBP RESPONSE TO FUNGICIDE	7	7.97e-01	8.97e-01	0.15200	1.47e-01	3.77e-02	5.01e-01	8.63e-01
GOBP ENDOCYTOSIS INVOLVED IN VIRAL ENTRY INTO HOST CELL	12	7.03e-01	8.46e-01	0.15200	1.31e-01	7.65e-02	4.32e-01	6.46e-01
GOMF C ACYLTRANSFERASE ACTIVITY	20	5.67e-01	7.58e-01	0.15200	1.05e-01	1.10e-01	4.17e-01	3.96e-01
GOBP NEGATIVE REGULATION OF PROTEIN IMPORT INTO NUCLEUS	15	5.20e-01	7.26e-01	0.15200	9.14e-02	-1.21e-01	5.40e-01	4.17e-01
GOBP RESPONSE TO TYPE III INTERFERON	10	6.45e-01	8.08e-01	0.15200	-1.05e-01	1.10e-01	5.67e-01	5.48e-01
GOBP REGULATION OF MYOTUBE DIFFERENTIATION	47	1.79e-01	4.04e-01	0.15200	1.52e-01	-5.16e-03	7.23e-02	9.51e-01
GOMF MAGNESIUM ION BINDING	217	1.99e-03	1.75e-02	0.15200	1.25e-01	8.50e-02	1.44e-03	3.08e-02
GOBP MANCHETTE ASSEMBLY	9	7.73e-01	8.85e-01	0.15200	9.18e-02	1.21e-01	6.34e-01	5.31e-01
GOBP NEGATIVE REGULATION OF TRANSFERASE ACTIVITY	208	1.80e-03	1.62e-02	0.15200	5.76e-02	1.40e-01	1.52e-01	4.92e-04
GOBP T TUBULE ORGANIZATION	6	8.03e-01	9.01e-01	0.15200	3.98e-03	-1.52e-01	9.87e-01	5.20e-01
GOBP REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY	23	3.86e-01	6.20e-01	0.15200	5.65e-02	-1.41e-01	6.39e-01	2.43e-01
GOMF C2H2 ZINC FINGER DOMAIN BINDING	12	6.98e-01	8.43e-01	0.15100	1.36e-01	6.59e-02	4.13e-01	6.93e-01
GOBP CHOLESTEROL STORAGE	25	4.92e-01	7.05e-01	0.15100	-1.12e-01	-1.02e-01	3.31e-01	3.79e-01
Mitochondrial calcium ion transport	21	4.94e-01	7.06e-01	0.15100	1.50e-01	2.40e-02	2.36e-01	8.49e-01
GOCC EXTRINSIC COMPONENT OF SYNAPTIC MEMBRANE	13	5.69e-01	7.59e-01	0.15100	9.13e-02	-1.21e-01	5.69e-01	4.51e-01
GOBP SYNAPTIC TRANSMISSION CHOLINERGIC	32	3.46e-01	5.84e-01	0.15100	-1.49e-01	-2.81e-02	1.45e-01	7.83e-01
GOBP COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY	9	6.95e-01	8.42e-01	0.15100	4.51e-02	-1.44e-01	8.15e-01	4.53e-01
GOBP FOREBRAIN NEURON DEVELOPMENT	23	5.13e-01	7.20e-01	0.15100	7.97e-02	1.29e-01	5.08e-01	2.86e-01
GOBP CHEMOKINE C X C MOTIF LIGAND 12 SIGNALING PATHWAY	7	8.12e-01	9.06e-01	0.15100	-1.35e-01	-6.89e-02	5.37e-01	7.52e-01
GOBP POSITIVE REGULATION OF MAST CELL CHEMOTAXIS	5	8.67e-01	9.35e-01	0.15100	9.06e-02	1.21e-01	7.26e-01	6.39e-01
GOCC AXON CYTOPLASM	61	1.79e-01	4.04e-01	0.15100	1.04e-01	1.09e-01	1.59e-01	1.39e-01
GOBP DERMATAN SULFATE METABOLIC PROCESS	8	7.85e-01	8.92e-01	0.15100	6.17e-02	1.38e-01	7.63e-01	4.99e-01
GOBP REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION	121	3.24e-02	1.39e-01	0.15100	9.21e-02	1.20e-01	8.01e-02	2.27e-02
GOBP AMYLOID BETA CLEARANCE BY CELLULAR CATABOLIC PROCESS	8	7.14e-01	8.53e-01	0.15100	6.90e-02	-1.35e-01	7.35e-01	5.10e-01
Regulation of Expression and Function of Type II Classical Cadherins	32	3.12e-01	5.52e-01	0.15100	1.51e-01	-5.27e-03	1.39e-01	9.59e-01
Regulation of Homotypic Cell-Cell Adhesion	32	3.12e-01	5.52e-01	0.15100	1.51e-01	-5.27e-03	1.39e-01	9.59e-01
GOBP REGULATION OF MEMBRANE PERMEABILITY	70	7.55e-02	2.43e-01	0.15100	-1.13e-02	1.51e-01	8.70e-01	2.93e-02
GOBP CELLULAR RESPONSE TO INSULIN STIMULUS	210	2.75e-03	2.25e-02	0.15100	1.17e-01	9.61e-02	3.57e-03	1.64e-02
TYSND1 cleaves peroxisomal proteins	7	8.13e-01	9.06e-01	0.15100	7.01e-02	1.34e-01	7.48e-01	5.40e-01
GOBP NEGATIVE REGULATION OF PROTEIN BINDING	68	8.00e-02	2.52e-01	0.15100	-1.36e-02	1.50e-01	8.46e-01	3.19e-02
GOMF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVATOR ACTIVITY	18	6.02e-01	7.80e-01	0.15100	-1.00e-01	-1.13e-01	4.62e-01	4.06e-01
GOCC FEMALE GERM CELL NUCLEUS	17	6.08e-01	7.84e-01	0.15100	1.32e-01	7.35e-02	3.46e-01	6.00e-01
GOBP REGULATION OF RECEPTOR BINDING	16	5.45e-01	7.43e-01	0.15100	-2.07e-02	1.50e-01	8.86e-01	3.00e-01
GOCC FACIT COLLAGEN TRIMER	6	7.94e-01	8.95e-01	0.15100	-1.49e-01	2.65e-02	5.28e-01	9.10e-01
GOCC T TUBULE	52	1.38e-01	3.50e-01	0.15100	2.33e-02	-1.49e-01	7.72e-01	6.28e-02
GOBP POSITIVE CHEMOTAXIS	62	1.17e-01	3.18e-01	0.15100	-1.50e-01	-1.14e-02	4.04e-02	8.77e-01
GOBP MYELOID CELL APOPTOTIC PROCESS	37	2.82e-01	5.21e-01	0.15100	1.50e-01	1.49e-02	1.14e-01	8.75e-01
Synaptic adhesion-like molecules	19	4.93e-01	7.06e-01	0.15100	-1.50e-01	1.46e-02	2.57e-01	9.12e-01
GOBP RESPONSE TO KETONE	209	2.96e-03	2.38e-02	0.15100	1.07e-01	1.07e-01	7.85e-03	7.85e-03
GOBP ALPHA BETA T CELL PROLIFERATION	41	1.69e-01	3.91e-01	0.15100	-1.02e-01	1.11e-01	2.59e-01	2.18e-01
GOBP MICROTUBULE DEPOLYMERIZATION	43	2.79e-01	5.18e-01	0.15100	6.51e-02	1.36e-01	4.60e-01	1.23e-01
GOBP POSITIVE REGULATION OF CALCIUM ION IMPORT	24	3.56e-01	5.93e-01	0.15100	-9.16e-02	1.20e-01	4.37e-01	3.10e-01
GOBP ANTERIOR HEAD DEVELOPMENT	7	7.38e-01	8.67e-01	0.15100	-1.02e-01	1.11e-01	6.41e-01	6.10e-01
GOMF METALLOAMINOPEPTIDASE ACTIVITY	24	3.86e-01	6.20e-01	0.15100	1.45e-01	-4.08e-02	2.19e-01	7.29e-01
GOBP REGULATION OF EATING BEHAVIOR	7	7.58e-01	8.76e-01	0.15100	1.46e-01	-3.89e-02	5.05e-01	8.59e-01
GOBP REGULATION OF HISTAMINE SECRETION BY MAST CELL	6	8.05e-01	9.02e-01	0.15100	-4.78e-03	1.51e-01	9.84e-01	5.23e-01
Assembly Of The HIV Virion	16	6.39e-01	8.03e-01	0.15100	1.08e-01	1.05e-01	4.54e-01	4.68e-01
GOBP NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY	37	3.55e-01	5.93e-01	0.15100	1.05e-01	1.08e-01	2.69e-01	2.56e-01
GOBP TYPE 2 IMMUNE RESPONSE	42	1.81e-01	4.06e-01	0.15100	-5.48e-02	1.40e-01	5.39e-01	1.16e-01
Suppression of phagosomal maturation	13	6.94e-01	8.41e-01	0.15100	1.14e-01	9.83e-02	4.77e-01	5.39e-01
GOBP TANGENTIAL MIGRATION FROM THE SUBVENTRICULAR ZONE TO THE OLFACTORY BULB	7	8.22e-01	9.10e-01	0.15000	-9.74e-02	-1.15e-01	6.55e-01	5.99e-01
GOBP POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY	33	2.47e-01	4.85e-01	0.15000	1.27e-01	-8.08e-02	2.07e-01	4.22e-01
Signaling by NOTCH2	32	3.75e-01	6.11e-01	0.15000	1.41e-01	5.15e-02	1.67e-01	6.14e-01
GOMF GALACTOSIDASE ACTIVITY	6	8.14e-01	9.06e-01	0.15000	-1.18e-02	-1.50e-01	9.60e-01	5.25e-01
GOBP RUFFLE ASSEMBLY	44	2.30e-01	4.65e-01	0.15000	2.05e-02	1.49e-01	8.14e-01	8.73e-02
GOBP TYROSINE CATABOLIC PROCESS	6	8.18e-01	9.08e-01	0.15000	-1.49e-01	-1.93e-02	5.27e-01	9.35e-01
Signaling by Leptin	11	7.34e-01	8.64e-01	0.15000	9.37e-02	1.18e-01	5.91e-01	5.00e-01
GOBP METANEPHRIC COLLECTING DUCT DEVELOPMENT	10	7.36e-01	8.66e-01	0.15000	-5.09e-02	-1.41e-01	7.80e-01	4.39e-01
GOMF LYSOPHOSPHOLIPID ACYLTRANSFERASE ACTIVITY	20	5.59e-01	7.52e-01	0.15000	7.09e-02	1.32e-01	5.83e-01	3.05e-01
EPH-Ephrin signaling	90	8.01e-02	2.53e-01	0.15000	1.20e-01	9.03e-02	4.91e-02	1.39e-01
Energy dependent regulation of mTOR by LKB1-AMPK	28	3.40e-01	5.78e-01	0.15000	1.47e-01	-3.21e-02	1.79e-01	7.69e-01
GOCC LUMENAL SIDE OF ENDOPLASMIC RETICULUM MEMBRANE	32	3.75e-01	6.11e-01	0.15000	5.00e-02	1.42e-01	6.24e-01	1.66e-01
GOBP REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS	38	2.02e-01	4.32e-01	0.15000	-7.85e-02	1.28e-01	4.03e-01	1.72e-01
GOMF GDP BINDING	71	1.32e-01	3.40e-01	0.15000	1.28e-01	7.87e-02	6.26e-02	2.51e-01
GOBP RESPONSE TO NICOTINE	51	1.68e-01	3.90e-01	0.15000	-1.50e-01	-3.84e-03	6.38e-02	9.62e-01
GOBP REGULATION OF GLUTAMATE SECRETION	19	4.84e-01	6.99e-01	0.15000	-1.47e-01	2.85e-02	2.66e-01	8.30e-01
GOBP URETERIC BUD FORMATION	7	7.51e-01	8.72e-01	0.15000	-5.94e-02	1.38e-01	7.85e-01	5.28e-01
GOBP B CELL DIFFERENTIATION	145	5.09e-03	3.58e-02	0.15000	-1.27e-02	1.49e-01	7.92e-01	1.89e-03
GOBP REGULATION OF NEUTROPHIL MIGRATION	40	1.80e-01	4.05e-01	0.15000	-1.04e-01	1.08e-01	2.54e-01	2.38e-01
GOBP POSITIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION	9	6.80e-01	8.32e-01	0.15000	-1.08e-01	1.04e-01	5.75e-01	5.89e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H HEME PROTEIN AS ACCEPTOR	10	7.56e-01	8.75e-01	0.15000	9.11e-02	1.19e-01	6.18e-01	5.14e-01
GOBP NEGATIVE REGULATION OF ACTIN NUCLEATION	9	7.78e-01	8.89e-01	0.15000	1.17e-01	9.35e-02	5.43e-01	6.27e-01
GOBP ADENOSINE TO INOSINE EDITING	6	7.85e-01	8.92e-01	0.15000	-1.40e-01	5.36e-02	5.53e-01	8.20e-01
Downregulation of ERBB2:ERBB3 signaling	13	6.47e-01	8.09e-01	0.15000	1.49e-01	1.76e-02	3.53e-01	9.13e-01
GOBP RESPONSE TO INTERLEUKIN 4	34	2.89e-01	5.28e-01	0.15000	-1.49e-01	1.27e-02	1.32e-01	8.98e-01
Post-translational protein modification	1362	8.18e-17	9.75e-15	0.15000	1.32e-01	7.11e-02	3.21e-16	1.07e-05
GOCC MICROTUBULE CYTOSKELETON	1348	2.22e-16	2.57e-14	0.15000	1.27e-01	7.96e-02	5.42e-15	9.26e-07
GOMF ATP HYDROLYSIS ACTIVITY	404	4.17e-07	1.33e-05	0.15000	1.49e-01	-1.80e-02	2.95e-07	5.35e-01
GOBP EXTRACELLULAR MATRIX DISASSEMBLY	62	1.33e-01	3.42e-01	0.15000	-2.62e-02	-1.47e-01	7.21e-01	4.49e-02
Activation of AMPK downstream of NMDARs	27	3.72e-01	6.08e-01	0.15000	-1.50e-02	1.49e-01	8.92e-01	1.81e-01
GOBP REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY	47	1.90e-01	4.17e-01	0.15000	-2.56e-03	1.50e-01	9.76e-01	7.60e-02
GOBP EARLY ENDOSOME TO GOLGI TRANSPORT	17	6.23e-01	7.93e-01	0.15000	1.16e-01	9.41e-02	4.06e-01	5.02e-01
GOBP INTRACELLULAR LIPID TRANSPORT	50	2.51e-01	4.89e-01	0.15000	9.70e-02	1.14e-01	2.35e-01	1.64e-01
GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY	28	4.59e-01	6.83e-01	0.15000	1.19e-01	9.12e-02	2.78e-01	4.04e-01
GOBP BASOLATERAL PROTEIN SECRETION	5	8.08e-01	9.03e-01	0.15000	-1.03e-01	1.09e-01	6.91e-01	6.74e-01
GOBP REGULATION OF MULTICELLULAR ORGANISM GROWTH	64	1.68e-01	3.89e-01	0.15000	8.80e-02	1.21e-01	2.23e-01	9.44e-02
GOMF ORGANIC HYDROXY COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY	52	1.75e-01	3.97e-01	0.14900	-1.49e-01	-1.48e-02	6.35e-02	8.53e-01
GOBP REGULATION OF PENTOSE PHOSPHATE SHUNT	6	7.79e-01	8.89e-01	0.14900	7.53e-02	-1.29e-01	7.49e-01	5.84e-01
GOBP HISTAMINE METABOLIC PROCESS	6	7.83e-01	8.91e-01	0.14900	6.08e-02	-1.37e-01	7.97e-01	5.62e-01
Estrogen biosynthesis	6	8.25e-01	9.12e-01	0.14900	-1.46e-01	-3.03e-02	5.35e-01	8.98e-01
Translation of Structural Proteins 9694635	55	2.14e-01	4.46e-01	0.14900	8.32e-02	1.24e-01	2.86e-01	1.11e-01
GOCC MICROBODY	143	1.99e-02	9.93e-02	0.14900	1.09e-01	1.03e-01	2.51e-02	3.41e-02
GOBP POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY	60	1.85e-01	4.11e-01	0.14900	1.25e-01	8.14e-02	9.35e-02	2.76e-01
GOBP RANDOM INACTIVATION OF X CHROMOSOME	6	8.43e-01	9.21e-01	0.14900	1.29e-01	7.44e-02	5.83e-01	7.52e-01
Interleukin-17 signaling	66	1.58e-01	3.75e-01	0.14900	1.24e-01	8.36e-02	8.22e-02	2.40e-01
GOBP POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS	16	5.10e-01	7.17e-01	0.14900	-1.20e-01	8.81e-02	4.04e-01	5.42e-01
GOBP POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION	69	1.39e-01	3.51e-01	0.14900	7.18e-02	1.31e-01	3.02e-01	6.04e-02
GOBP REGULATION OF PLATELET ACTIVATION	51	1.15e-01	3.15e-01	0.14900	-1.06e-01	1.05e-01	1.92e-01	1.93e-01
GOBP INFLAMMASOME MEDIATED SIGNALING PATHWAY	41	2.31e-01	4.66e-01	0.14900	-1.49e-01	8.16e-03	9.89e-02	9.28e-01
GRB7 events in ERBB2 signaling	5	8.33e-01	9.17e-01	0.14900	-1.68e-02	1.48e-01	9.48e-01	5.66e-01
GOBP NUCLEOBASE METABOLIC PROCESS	37	2.51e-01	4.89e-01	0.14900	2.50e-02	-1.47e-01	7.92e-01	1.22e-01
Glycosphingolipid metabolism	52	1.50e-01	3.64e-01	0.14900	-1.65e-02	1.48e-01	8.37e-01	6.45e-02
GOMF CARBONATE DEHYDRATASE ACTIVITY	14	5.53e-01	7.48e-01	0.14900	-9.79e-02	1.12e-01	5.26e-01	4.66e-01
GOBP REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS	175	8.36e-03	5.26e-02	0.14900	1.13e-01	9.69e-02	9.71e-03	2.70e-02
GOBP EXPORT ACROSS PLASMA MEMBRANE	79	9.97e-02	2.89e-01	0.14900	-6.17e-02	-1.36e-01	3.43e-01	3.70e-02
GOBP POSITIVE REGULATION OF T CELL TOLERANCE INDUCTION	8	7.13e-01	8.52e-01	0.14900	-9.45e-02	1.15e-01	6.44e-01	5.72e-01
GOMF LIGASE ACTIVITY	161	6.43e-03	4.30e-02	0.14900	1.45e-01	3.41e-02	1.49e-03	4.55e-01
GOBP EYE PHOTORECEPTOR CELL DEVELOPMENT	36	2.91e-01	5.30e-01	0.14900	-5.67e-03	-1.49e-01	9.53e-01	1.22e-01
GOBP REGULATION OF PROTEIN KINASE A SIGNALING	20	4.73e-01	6.94e-01	0.14900	-1.47e-01	2.56e-02	2.56e-01	8.43e-01
GOBP HAIR FOLLICLE MATURATION	15	6.62e-01	8.20e-01	0.14900	1.14e-01	9.60e-02	4.45e-01	5.20e-01
GOCC PROXIMAL DENDRITE	6	7.81e-01	8.90e-01	0.14900	7.18e-02	-1.30e-01	7.61e-01	5.80e-01
FCERI mediated Ca+2 mobilization	30	3.13e-01	5.53e-01	0.14900	-4.03e-02	1.43e-01	7.02e-01	1.74e-01
GOBP REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY	26	4.90e-01	7.03e-01	0.14900	1.14e-01	9.64e-02	3.16e-01	3.95e-01
GOBP MONOCYTE AGGREGATION	5	8.11e-01	9.05e-01	0.14900	-8.78e-02	1.20e-01	7.34e-01	6.41e-01
Aspartate and asparagine metabolism	11	7.39e-01	8.68e-01	0.14900	1.12e-01	9.82e-02	5.20e-01	5.73e-01
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE	256	5.20e-04	6.22e-03	0.14900	1.39e-01	5.30e-02	1.27e-04	1.44e-01
GOCC 9PLUS2 MOTILE CILIUM	180	6.50e-03	4.34e-02	0.14900	-7.74e-02	-1.27e-01	7.32e-02	3.26e-03
GOMF NEUROPEPTIDE BINDING	30	3.50e-01	5.88e-01	0.14900	-1.93e-03	1.49e-01	9.85e-01	1.58e-01
GOBP RESPONSE TO L ASCORBIC ACID	5	8.52e-01	9.26e-01	0.14900	-2.79e-02	-1.46e-01	9.14e-01	5.71e-01
GOBP REGULATION OF PROTEIN POLYUBIQUITINATION	26	4.88e-01	7.02e-01	0.14900	8.82e-02	1.20e-01	4.36e-01	2.90e-01
GOBP NON PROTEINOGENIC AMINO ACID CATABOLIC PROCESS	16	6.17e-01	7.90e-01	0.14900	-4.85e-02	-1.41e-01	7.37e-01	3.30e-01
GOBP INTRACELLULAR IRON ION HOMEOSTASIS	66	1.15e-01	3.15e-01	0.14900	1.94e-02	1.47e-01	7.85e-01	3.83e-02
GOCC LATE ENDOSOME	295	3.39e-04	4.33e-03	0.14900	9.47e-02	1.15e-01	5.13e-03	7.07e-04
GOBP REFLEX	22	5.22e-01	7.26e-01	0.14900	-1.38e-01	-5.57e-02	2.63e-01	6.51e-01
GOCC AZUROPHIL GRANULE LUMEN	86	2.86e-02	1.28e-01	0.14900	-1.25e-01	8.01e-02	4.46e-02	1.99e-01
GOBP PROTEIN N LINKED GLYCOSYLATION	70	1.49e-01	3.62e-01	0.14900	1.01e-01	1.09e-01	1.43e-01	1.15e-01
GOBP REGULATION OF CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION	14	6.48e-01	8.09e-01	0.14900	1.44e-01	3.82e-02	3.52e-01	8.05e-01
GOBP POSITIVE REGULATION OF MRNA METABOLIC PROCESS	221	4.74e-04	5.77e-03	0.14900	1.48e-01	-3.09e-03	1.42e-04	9.37e-01
GOCC PEPTIDASE INHIBITOR COMPLEX	11	6.30e-01	7.97e-01	0.14900	-1.07e-01	1.03e-01	5.39e-01	5.55e-01
GOMF HISTONE H4K20 METHYLTRANSFERASE ACTIVITY	10	7.05e-01	8.48e-01	0.14800	1.48e-01	-3.02e-03	4.16e-01	9.87e-01
GOBP MICROTUBULE SEVERING	9	7.00e-01	8.44e-01	0.14800	-1.39e-01	5.30e-02	4.71e-01	7.83e-01
GOBP LYMPHOCYTE MEDIATED IMMUNITY	289	1.02e-05	2.18e-04	0.14800	-1.35e-01	6.25e-02	8.17e-05	6.78e-02
Platelet Adhesion to exposed collagen	16	5.20e-01	7.26e-01	0.14800	1.30e-01	-7.16e-02	3.68e-01	6.20e-01
GOCC EXTERNAL SIDE OF PLASMA MEMBRANE	373	4.99e-06	1.20e-04	0.14800	-1.48e-01	-1.32e-02	9.50e-07	6.61e-01
GOCC HFE TRANSFERRIN RECEPTOR COMPLEX	8	7.40e-01	8.68e-01	0.14800	1.45e-01	-3.14e-02	4.78e-01	8.78e-01
GOBP RENAL WATER HOMEOSTASIS	24	5.12e-01	7.20e-01	0.14800	-7.77e-02	-1.26e-01	5.10e-01	2.84e-01
GOBP NEGATIVE REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY	7	7.46e-01	8.70e-01	0.14800	-1.12e-01	9.76e-02	6.09e-01	6.55e-01
GOBP EMBRYONIC HEMOPOIESIS	23	5.35e-01	7.37e-01	0.14800	1.14e-01	9.44e-02	3.43e-01	4.33e-01
GOBP POSITIVE REGULATION OF MAST CELL DEGRANULATION	12	6.24e-01	7.93e-01	0.14800	-1.39e-01	5.22e-02	4.06e-01	7.54e-01
GOMF ARGININE BINDING	8	7.16e-01	8.54e-01	0.14800	-1.00e-01	1.09e-01	6.24e-01	5.93e-01
GOBP POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE	18	5.65e-01	7.57e-01	0.14800	-1.45e-01	-2.72e-02	2.86e-01	8.42e-01
GOBP PEPTIDYL TYROSINE AUTOPHOSPHORYLATION	16	6.47e-01	8.08e-01	0.14800	1.17e-01	9.11e-02	4.20e-01	5.28e-01
Biosynthesis of specialized proresolving mediators (SPMs)	19	4.75e-01	6.95e-01	0.14800	5.23e-02	-1.38e-01	6.93e-01	2.96e-01
GOBP RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS	208	3.75e-03	2.85e-02	0.14800	1.13e-01	9.48e-02	4.80e-03	1.85e-02
GOBP APOPTOTIC PROCESS	1853	5.87e-21	8.90e-19	0.14800	8.55e-02	1.21e-01	1.07e-09	7.34e-18
GOMF FIBROBLAST GROWTH FACTOR RECEPTOR BINDING	24	4.09e-01	6.41e-01	0.14800	1.45e-01	-3.01e-02	2.20e-01	7.98e-01
GOBP STRIATED MUSCLE ADAPTATION	56	1.15e-01	3.15e-01	0.14800	1.40e-01	-4.67e-02	6.95e-02	5.46e-01
GOBP FEMALE MEIOSIS I	13	5.91e-01	7.73e-01	0.14800	1.30e-01	-7.08e-02	4.18e-01	6.59e-01
Attachment of GPI anchor to uPAR	7	7.98e-01	8.98e-01	0.14800	1.46e-01	2.04e-02	5.03e-01	9.25e-01
GOBP NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE	22	5.52e-01	7.47e-01	0.14800	9.53e-02	1.13e-01	4.39e-01	3.59e-01
Cytosolic sulfonation of small molecules	22	5.34e-01	7.36e-01	0.14800	6.45e-02	1.33e-01	6.01e-01	2.80e-01
GOBP CELLULAR RESPONSE TO RETINOIC ACID	67	1.45e-01	3.58e-01	0.14800	5.96e-02	1.35e-01	3.99e-01	5.57e-02
GOBP REGULATION OF LAMELLIPODIUM MORPHOGENESIS	11	7.42e-01	8.69e-01	0.14800	9.15e-02	1.16e-01	5.99e-01	5.06e-01
GOBP CHONDROITIN SULFATE BIOSYNTHETIC PROCESS	18	5.21e-01	7.26e-01	0.14800	-1.46e-01	2.02e-02	2.83e-01	8.82e-01
GOCC FICOLIN 1 RICH GRANULE	180	3.04e-03	2.42e-02	0.14800	1.82e-02	1.47e-01	6.73e-01	6.97e-04
GOBP NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY	139	2.39e-02	1.13e-01	0.14800	1.13e-01	9.49e-02	2.14e-02	5.34e-02
GOMF PROTEIN DIMERIZATION ACTIVITY	1023	3.81e-12	2.96e-10	0.14800	1.00e-01	1.08e-01	5.65e-08	4.76e-09
Hyaluronan metabolism	17	5.40e-01	7.39e-01	0.14800	1.46e-01	-2.04e-02	2.97e-01	8.84e-01
GOBP REGULATION OF CAMP MEDIATED SIGNALING	21	4.84e-01	6.99e-01	0.14800	-1.48e-01	3.39e-03	2.42e-01	9.79e-01
GOBP NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION	10	7.44e-01	8.69e-01	0.14800	1.39e-01	4.91e-02	4.46e-01	7.88e-01
GOBP NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION	27	4.77e-01	6.96e-01	0.14700	1.23e-01	8.20e-02	2.70e-01	4.61e-01
GOMF PENTOSYLTRANSFERASE ACTIVITY	53	2.07e-01	4.38e-01	0.14700	4.68e-02	1.40e-01	5.56e-01	7.82e-02
GOBP MALE SEX DIFFERENTIATION	164	1.23e-02	6.93e-02	0.14700	9.24e-02	1.15e-01	4.11e-02	1.11e-02
GOBP GUANINE NUCLEOTIDE TRANSPORT	11	6.42e-01	8.05e-01	0.14700	-1.29e-01	7.16e-02	4.59e-01	6.81e-01
NTRK2 activates RAC1	5	8.20e-01	9.09e-01	0.14700	1.34e-01	-6.18e-02	6.05e-01	8.11e-01
GOCC CELL BODY MEMBRANE	32	3.66e-01	6.03e-01	0.14700	-1.45e-01	-2.74e-02	1.56e-01	7.89e-01
GOBP C X C CHEMOKINE RECEPTOR CXCR4 SIGNALING PATHWAY	6	7.92e-01	8.95e-01	0.14700	-1.38e-01	5.12e-02	5.58e-01	8.28e-01
GOMF DYNEIN INTERMEDIATE CHAIN BINDING	35	2.50e-01	4.88e-01	0.14700	6.27e-02	-1.33e-01	5.21e-01	1.72e-01
GOBP CELLULAR DEFENSE RESPONSE	48	2.30e-01	4.65e-01	0.14700	-1.43e-01	-3.56e-02	8.68e-02	6.69e-01
GOBP NEGATIVE REGULATION OF HEART RATE	11	6.35e-01	8.01e-01	0.14700	-9.84e-02	1.09e-01	5.72e-01	5.30e-01
GOBP LINOLEIC ACID METABOLIC PROCESS	19	4.57e-01	6.82e-01	0.14700	1.05e-01	-1.03e-01	4.28e-01	4.37e-01
GOBP GLUTATHIONE CATABOLIC PROCESS	7	8.16e-01	9.07e-01	0.14700	-1.37e-01	-5.45e-02	5.31e-01	8.03e-01
GOBP MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY	16	6.16e-01	7.89e-01	0.14700	3.84e-02	1.42e-01	7.90e-01	3.25e-01
GOBP PROLINE TRANSMEMBRANE TRANSPORT	9	6.99e-01	8.44e-01	0.14700	-6.55e-02	1.32e-01	7.33e-01	4.94e-01
GOMF ARYL HYDROCARBON RECEPTOR BINDING	8	7.41e-01	8.68e-01	0.14700	1.42e-01	-3.66e-02	4.85e-01	8.58e-01
GOBP TRANSEPITHELIAL TRANSPORT	35	3.77e-01	6.12e-01	0.14700	-6.97e-02	-1.29e-01	4.76e-01	1.85e-01
GOBP INORGANIC ANION TRANSMEMBRANE TRANSPORT	123	3.36e-02	1.43e-01	0.14700	-1.28e-01	-7.26e-02	1.43e-02	1.64e-01
GOMF ADENYLATE CYCLASE ACTIVITY	15	6.09e-01	7.85e-01	0.14700	-1.47e-01	-9.02e-03	3.25e-01	9.52e-01
GOBP POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS	35	3.41e-01	5.79e-01	0.14700	3.28e-02	1.43e-01	7.37e-01	1.42e-01
GOBP REGULATION OF CELLULAR CATABOLIC PROCESS	440	4.54e-06	1.10e-04	0.14700	1.34e-01	6.03e-02	1.42e-06	3.02e-02
GOMF COA LIGASE ACTIVITY	26	4.58e-01	6.83e-01	0.14700	-1.41e-01	-4.11e-02	2.13e-01	7.17e-01
GOCC INHIBITORY SYNAPSE	13	5.95e-01	7.75e-01	0.14700	-1.30e-01	6.93e-02	4.19e-01	6.65e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH GROUP OF DONORS	27	3.36e-01	5.75e-01	0.14700	-7.78e-02	1.25e-01	4.84e-01	2.63e-01
GOBP NEGATIVE REGULATION OF BINDING	106	3.91e-02	1.59e-01	0.14700	3.30e-02	1.43e-01	5.57e-01	1.09e-02
GOBP MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE	53	1.20e-01	3.23e-01	0.14700	-7.10e-02	1.29e-01	3.71e-01	1.06e-01
GOBP REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS	25	5.14e-01	7.21e-01	0.14700	-9.75e-02	-1.10e-01	3.99e-01	3.42e-01
GOBP MITRAL VALVE DEVELOPMENT	14	6.72e-01	8.27e-01	0.14700	6.11e-02	1.33e-01	6.92e-01	3.87e-01
GOMF PHOSPHOLIPASE D ACTIVITY	6	8.52e-01	9.26e-01	0.14700	-9.71e-02	-1.10e-01	6.80e-01	6.41e-01
Adaptive Immune System	720	5.27e-09	2.48e-07	0.14700	7.76e-02	1.25e-01	3.90e-04	1.23e-08
GOMF GTPASE ACTIVATING PROTEIN BINDING	11	7.37e-01	8.66e-01	0.14700	7.11e-02	1.28e-01	6.83e-01	4.61e-01
GOBP CRANIAL GANGLION DEVELOPMENT	5	8.74e-01	9.39e-01	0.14700	-8.37e-02	-1.20e-01	7.46e-01	6.41e-01
GOBP CELLULAR RESPONSE TO HISTAMINE	6	7.93e-01	8.95e-01	0.14700	5.36e-02	-1.37e-01	8.20e-01	5.62e-01
APOBEC3G mediated resistance to HIV-1 infection	5	8.48e-01	9.23e-01	0.14700	-9.59e-03	-1.46e-01	9.70e-01	5.71e-01
GOBP PEPTIDE METABOLIC PROCESS	72	8.11e-02	2.55e-01	0.14700	1.46e-01	-1.25e-02	3.21e-02	8.55e-01
GOBP GMP BIOSYNTHETIC PROCESS	13	5.96e-01	7.76e-01	0.14700	1.29e-01	-7.05e-02	4.22e-01	6.60e-01
GOBP THYMUS DEVELOPMENT	49	2.73e-01	5.12e-01	0.14700	1.06e-01	1.01e-01	1.97e-01	2.22e-01
GOBP POSITIVE REGULATION OF CHOLESTEROL EFFLUX	27	4.84e-01	6.99e-01	0.14700	-1.19e-01	-8.50e-02	2.83e-01	4.45e-01
GOBP POSITIVE REGULATION OF ADIPOSE TISSUE DEVELOPMENT	10	7.54e-01	8.74e-01	0.14700	6.14e-02	1.33e-01	7.37e-01	4.66e-01
GOBP REGULATION OF PROTON TRANSPORT	16	5.82e-01	7.68e-01	0.14700	-1.14e-03	1.47e-01	9.94e-01	3.10e-01
GOBP CELLULAR RESPONSE TO VITAMIN	28	4.19e-01	6.49e-01	0.14600	1.44e-01	2.62e-02	1.87e-01	8.10e-01
Effects of PIP2 hydrolysis	26	4.91e-01	7.04e-01	0.14600	-1.27e-01	-7.34e-02	2.64e-01	5.17e-01
GOBP POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS	26	4.18e-01	6.48e-01	0.14600	8.50e-04	1.46e-01	9.94e-01	1.96e-01
GOMF PHOSPHATIDYLINOSITOL KINASE ACTIVITY	26	4.99e-01	7.09e-01	0.14600	1.18e-01	8.66e-02	2.98e-01	4.45e-01
GOBP MITOCHONDRION LOCALIZATION	47	2.88e-01	5.26e-01	0.14600	1.11e-01	9.51e-02	1.87e-01	2.59e-01
GOBP RESPONSE TO INTERLEUKIN 15	11	6.88e-01	8.38e-01	0.14600	-3.08e-03	1.46e-01	9.86e-01	4.01e-01
GOBP GLYCOSYL COMPOUND CATABOLIC PROCESS	34	3.82e-01	6.16e-01	0.14600	5.86e-02	1.34e-01	5.54e-01	1.76e-01
GOBP NEURONAL SIGNAL TRANSDUCTION	7	7.62e-01	8.79e-01	0.14600	-5.78e-02	1.34e-01	7.91e-01	5.38e-01
GOBP POSITIVE REGULATION OF STEROL TRANSPORT	36	3.72e-01	6.08e-01	0.14600	-1.28e-01	-7.09e-02	1.84e-01	4.62e-01
GOBP CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR	7	7.88e-01	8.92e-01	0.14600	-1.46e-01	5.09e-03	5.03e-01	9.81e-01
GOBP POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION	131	2.96e-02	1.31e-01	0.14600	7.97e-02	1.23e-01	1.15e-01	1.54e-02
GOCC NON MOTILE CILIUM	155	2.19e-03	1.89e-02	0.14600	7.27e-02	-1.27e-01	1.18e-01	6.44e-03
GOBP ICOSANOID SECRETION	47	2.88e-01	5.26e-01	0.14600	-9.23e-02	-1.13e-01	2.74e-01	1.79e-01
GOBP GMP METABOLIC PROCESS	25	3.72e-01	6.08e-01	0.14600	7.00e-02	-1.28e-01	5.44e-01	2.67e-01
GOBP NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION	160	1.74e-03	1.58e-02	0.14600	-7.75e-02	1.24e-01	9.07e-02	6.88e-03
GOMF VOLUME SENSITIVE ANION CHANNEL ACTIVITY	9	7.26e-01	8.60e-01	0.14600	-2.06e-02	1.45e-01	9.15e-01	4.53e-01
Biotin transport and metabolism	10	6.83e-01	8.34e-01	0.14600	4.98e-02	-1.37e-01	7.85e-01	4.52e-01
GOBP POSITIVE REGULATION OF CATABOLIC PROCESS	601	1.76e-08	7.34e-07	0.14600	1.43e-01	3.11e-02	2.28e-09	1.92e-01
GOMF GAMMA AMINOBUTYRIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY	8	7.67e-01	8.82e-01	0.14600	-1.46e-01	-3.40e-03	4.75e-01	9.87e-01
GOBP PURINE RIBONUCLEOSIDE CATABOLIC PROCESS	5	8.75e-01	9.40e-01	0.14600	1.18e-01	8.60e-02	6.48e-01	7.39e-01
Unblocking of NMDA receptors, glutamate binding and activation	19	5.77e-01	7.66e-01	0.14600	-1.38e-01	-4.81e-02	2.99e-01	7.17e-01
GOBP RETINOL METABOLIC PROCESS	50	2.12e-01	4.44e-01	0.14600	-2.48e-02	-1.44e-01	7.62e-01	7.86e-02
GOBP REGULATION OF SOMATIC STEM CELL POPULATION MAINTENANCE	12	6.16e-01	7.89e-01	0.14600	1.13e-01	-9.16e-02	4.96e-01	5.83e-01
GOBP CLATHRIN DEPENDENT ENDOCYTOSIS	48	2.15e-01	4.47e-01	0.14600	1.45e-01	1.34e-02	8.18e-02	8.72e-01
GOMF SMALL MOLECULE SENSOR ACTIVITY	48	2.02e-01	4.32e-01	0.14600	1.46e-01	-2.36e-04	8.06e-02	9.98e-01
GOBP POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION	15	6.58e-01	8.17e-01	0.14600	1.32e-01	6.11e-02	3.75e-01	6.82e-01
GOMF PROTEIN KINASE A REGULATORY SUBUNIT BINDING	24	4.77e-01	6.95e-01	0.14600	1.43e-01	2.61e-02	2.24e-01	8.25e-01
GOBP GAMMA DELTA T CELL ACTIVATION	24	3.79e-01	6.14e-01	0.14600	-9.33e-02	1.12e-01	4.29e-01	3.42e-01
GOBP MAINTENANCE OF CELL POLARITY	17	6.18e-01	7.90e-01	0.14600	1.34e-01	5.63e-02	3.37e-01	6.88e-01
GOBP REGULATION OF STEROID METABOLIC PROCESS	101	6.29e-02	2.17e-01	0.14600	-1.29e-01	-6.75e-02	2.49e-02	2.41e-01
RHOB GTPase cycle	66	1.20e-01	3.22e-01	0.14600	1.45e-01	1.20e-02	4.13e-02	8.66e-01
GOMF OXIDIZED DNA BINDING	11	7.46e-01	8.70e-01	0.14600	8.34e-02	1.20e-01	6.32e-01	4.92e-01
GOBP SCHWANN CELL DIFFERENTIATION	48	2.13e-01	4.46e-01	0.14600	1.45e-01	1.13e-02	8.17e-02	8.92e-01
GOCC NUCLEAR INNER MEMBRANE	54	2.40e-01	4.77e-01	0.14600	1.17e-01	8.73e-02	1.38e-01	2.67e-01
GOBP SKELETAL MUSCLE CELL PROLIFERATION	24	5.20e-01	7.26e-01	0.14600	7.13e-02	1.27e-01	5.46e-01	2.82e-01
Generation of second messenger molecules	29	3.18e-01	5.56e-01	0.14600	-7.48e-02	1.25e-01	4.86e-01	2.44e-01
GOBP PROTEIN MATURATION	517	1.27e-06	3.63e-05	0.14600	1.23e-01	7.78e-02	1.67e-06	2.46e-03
GOBP NEGATIVE REGULATION OF AXON EXTENSION	28	4.81e-01	6.97e-01	0.14600	-9.77e-02	-1.08e-01	3.71e-01	3.23e-01
GOBP CYTOSOL TO ENDOPLASMIC RETICULUM TRANSPORT	5	8.61e-01	9.31e-01	0.14600	1.41e-01	3.49e-02	5.84e-01	8.92e-01
GOBP RESPONSE TO MINERALOCORTICOID	36	2.35e-01	4.71e-01	0.14600	-1.10e-01	9.48e-02	2.51e-01	3.25e-01
GOBP PROTEIN LOCALIZATION TO EARLY ENDOSOME	12	6.44e-01	8.07e-01	0.14600	-1.41e-01	3.51e-02	3.97e-01	8.33e-01
GOMF MANNOSYLTRANSFERASE ACTIVITY	24	4.89e-01	7.03e-01	0.14600	1.41e-01	3.65e-02	2.32e-01	7.57e-01
ABC transporters in lipid homeostasis	17	6.10e-01	7.85e-01	0.14500	-1.38e-01	-4.46e-02	3.23e-01	7.50e-01
GOBP ACID SECRETION	45	2.62e-01	5.01e-01	0.14500	-1.41e-01	-3.67e-02	1.02e-01	6.70e-01
Oncogenic MAPK signaling	78	8.73e-02	2.67e-01	0.14500	1.44e-01	1.94e-02	2.77e-02	7.66e-01
GOBP REGULATION OF GLUCONEOGENESIS	50	1.78e-01	4.02e-01	0.14500	1.36e-02	-1.45e-01	8.68e-01	7.64e-02
GOBP REGULATION OF PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY	6	8.50e-01	9.25e-01	0.14500	-7.37e-02	-1.25e-01	7.55e-01	5.95e-01
AKT phosphorylates targets in the nucleus	9	7.04e-01	8.47e-01	0.14500	6.69e-02	-1.29e-01	7.28e-01	5.02e-01
GOBP GLUTATHIONE TRANSMEMBRANE TRANSPORT	8	7.58e-01	8.76e-01	0.14500	-1.47e-02	1.45e-01	9.42e-01	4.79e-01
GOBP MEIOTIC CELL CYCLE PROCESS	212	8.96e-04	9.63e-03	0.14500	1.45e-01	-1.84e-03	2.63e-04	9.63e-01
GOBP POSITIVE REGULATION OF AUTOPHAGY	151	9.86e-03	5.92e-02	0.14500	1.43e-01	2.52e-02	2.39e-03	5.93e-01
GOCC GATOR2 COMPLEX	9	7.37e-01	8.66e-01	0.14500	1.45e-01	-7.56e-03	4.51e-01	9.69e-01
GOBP MYELOID CELL DIFFERENTIATION	424	9.84e-06	2.13e-04	0.14500	6.24e-02	1.31e-01	2.76e-02	3.49e-06
GOBP ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS	44	2.46e-01	4.84e-01	0.14500	1.45e-01	1.33e-02	9.67e-02	8.79e-01
GOBP WATER SOLUBLE VITAMIN METABOLIC PROCESS	61	1.95e-01	4.24e-01	0.14500	7.62e-02	1.24e-01	3.03e-01	9.47e-02
GOBP POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION	26	4.90e-01	7.04e-01	0.14500	6.58e-02	1.30e-01	5.62e-01	2.53e-01
Competing endogenous RNAs (ceRNAs) regulate PTEN translation	16	5.80e-01	7.67e-01	0.14500	1.45e-01	-9.41e-03	3.15e-01	9.48e-01
GOBP NEGATIVE REGULATION OF PROGRAMMED CELL DEATH	877	1.35e-10	8.31e-09	0.14500	7.38e-02	1.25e-01	2.09e-04	3.13e-10
GOBP BASIC AMINO ACID TRANSPORT	21	4.30e-01	6.58e-01	0.14500	1.10e-01	-9.48e-02	3.83e-01	4.52e-01
GOMF GALACTOSYLCERAMIDASE ACTIVITY	5	8.29e-01	9.14e-01	0.14500	-4.76e-02	1.37e-01	8.54e-01	5.95e-01
GOBP DNA PROTECTION	5	8.78e-01	9.41e-01	0.14500	1.01e-01	1.05e-01	6.97e-01	6.85e-01
GOBP AMYLOID BETA CLEARANCE	38	2.17e-01	4.50e-01	0.14500	1.02e-01	-1.03e-01	2.76e-01	2.70e-01
GOCC PHAGOCYTIC VESICLE	132	2.98e-02	1.31e-01	0.14500	7.68e-02	1.23e-01	1.28e-01	1.45e-02
GOBP NEGATIVE REGULATION OF CALCIUM ION EXPORT ACROSS PLASMA MEMBRANE	5	8.53e-01	9.26e-01	0.14500	1.44e-01	1.38e-02	5.76e-01	9.57e-01
GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL APOPTOTIC PROCESS	18	6.13e-01	7.87e-01	0.14500	6.88e-02	1.28e-01	6.13e-01	3.48e-01
GOBP MITOCHONDRIAL FRAGMENTATION INVOLVED IN APOPTOTIC PROCESS	10	7.65e-01	8.81e-01	0.14500	7.45e-02	1.25e-01	6.83e-01	4.95e-01
GOMF CADMIUM ION BINDING	5	8.77e-01	9.40e-01	0.14500	-1.17e-01	-8.62e-02	6.51e-01	7.38e-01
GOBP OSTEOBLAST PROLIFERATION	36	3.91e-01	6.24e-01	0.14500	1.12e-01	9.19e-02	2.44e-01	3.40e-01
GOBP POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE	52	1.50e-01	3.64e-01	0.14500	1.40e-01	-3.74e-02	8.03e-02	6.41e-01
GOBP NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION	92	3.03e-02	1.33e-01	0.14500	-1.34e-01	5.64e-02	2.67e-02	3.49e-01
GOBP REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST	40	3.19e-01	5.58e-01	0.14500	4.86e-02	1.37e-01	5.95e-01	1.35e-01
GOBP NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION	61	9.88e-02	2.88e-01	0.14500	1.34e-01	-5.55e-02	7.04e-02	4.53e-01
CD28 dependent Vav1 pathway	11	7.45e-01	8.70e-01	0.14500	7.57e-02	1.24e-01	6.64e-01	4.78e-01
GOBP REGULATION OF ANIMAL ORGAN MORPHOGENESIS	86	7.91e-02	2.51e-01	0.14500	3.61e-02	1.40e-01	5.63e-01	2.44e-02
GOBP PHOSPHOLIPID HOMEOSTASIS	17	5.37e-01	7.38e-01	0.14500	-3.77e-02	1.40e-01	7.88e-01	3.18e-01
GOBP REGULATION OF B CELL ACTIVATION	124	9.77e-03	5.88e-02	0.14500	-4.94e-02	1.36e-01	3.42e-01	8.80e-03
GOBP RESPONSE TO HEPATOCYTE GROWTH FACTOR	18	6.07e-01	7.83e-01	0.14500	1.32e-01	5.85e-02	3.30e-01	6.67e-01
GOMF MAP KINASE SCAFFOLD ACTIVITY	12	6.23e-01	7.93e-01	0.14500	8.06e-02	-1.20e-01	6.29e-01	4.71e-01
GOBP NEGATIVE REGULATION OF LIPID LOCALIZATION	65	1.54e-01	3.70e-01	0.14500	-4.44e-02	-1.38e-01	5.36e-01	5.47e-02
GOBP POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY	40	3.46e-01	5.84e-01	0.14500	7.74e-02	1.22e-01	3.97e-01	1.81e-01
GOCC POTASSIUM CHANNEL COMPLEX	99	4.36e-02	1.72e-01	0.14500	-1.44e-01	-1.15e-02	1.31e-02	8.43e-01
GOBP REGULATION OF NEUROINFLAMMATORY RESPONSE	41	3.41e-01	5.79e-01	0.14500	-1.19e-01	-8.24e-02	1.88e-01	3.61e-01
GOCC LAMELLIPODIUM	196	4.11e-03	3.06e-02	0.14500	1.35e-01	5.07e-02	1.07e-03	2.21e-01
GOMF GPI LINKED EPHRIN RECEPTOR ACTIVITY	6	8.08e-01	9.03e-01	0.14500	-1.42e-01	2.85e-02	5.47e-01	9.04e-01
GOBP POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL	42	2.01e-01	4.31e-01	0.14500	6.14e-02	-1.31e-01	4.91e-01	1.42e-01
GOBP PEPTIDYL CYSTEINE MODIFICATION	40	2.61e-01	4.99e-01	0.14500	-1.44e-01	8.49e-03	1.14e-01	9.26e-01
GOCC CALCINEURIN COMPLEX	6	8.13e-01	9.06e-01	0.14500	1.43e-01	-1.82e-02	5.43e-01	9.39e-01
GOBP CHOLESTEROL IMPORT	9	7.32e-01	8.63e-01	0.14400	1.43e-01	-1.95e-02	4.57e-01	9.19e-01
GOBP NEGATIVE REGULATION OF T CELL PROLIFERATION	69	7.08e-02	2.34e-01	0.14400	-1.29e-01	6.57e-02	6.46e-02	3.45e-01
GOBP MICROTUBULE BASED TRANSPORT	208	2.95e-03	2.37e-02	0.14400	1.36e-01	4.92e-02	7.37e-04	2.21e-01
GOBP CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS	137	4.78e-03	3.42e-02	0.14400	8.06e-02	-1.20e-01	1.03e-01	1.55e-02
GOBP POSITIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION	22	4.18e-01	6.48e-01	0.14400	-1.03e-01	1.01e-01	4.02e-01	4.12e-01
Cross-presentation of particulate exogenous antigens (phagosomes)	6	8.43e-01	9.21e-01	0.14400	-4.70e-02	-1.36e-01	8.42e-01	5.63e-01
GOMF PALMITOYLTRANSFERASE ACTIVITY	34	3.72e-01	6.08e-01	0.14400	1.39e-01	3.87e-02	1.61e-01	6.96e-01
GOMF TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING	26	5.12e-01	7.20e-01	0.14400	9.35e-02	1.10e-01	4.09e-01	3.32e-01
CREB phosphorylation	6	8.19e-01	9.09e-01	0.14400	-1.44e-01	5.35e-03	5.41e-01	9.82e-01
GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION	26	4.90e-01	7.04e-01	0.14400	5.89e-02	1.32e-01	6.03e-01	2.46e-01
GOBP ESTABLISHMENT OF CELL POLARITY	151	1.63e-02	8.58e-02	0.14400	1.32e-01	5.84e-02	5.20e-03	2.16e-01
GOBP NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY	92	9.26e-02	2.77e-01	0.14400	1.16e-01	8.52e-02	5.41e-02	1.58e-01
GOBP DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS	219	3.85e-03	2.90e-02	0.14400	1.02e-01	1.01e-01	9.07e-03	9.71e-03
GOBP CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND	509	2.25e-06	5.98e-05	0.14400	1.19e-01	8.04e-02	3.92e-06	1.90e-03
Glutamate and glutamine metabolism	12	7.34e-01	8.64e-01	0.14400	9.16e-02	1.11e-01	5.83e-01	5.05e-01
GOMF ALDEHYDE LYASE ACTIVITY	9	7.16e-01	8.54e-01	0.14400	4.95e-02	-1.35e-01	7.97e-01	4.82e-01
GOCC CELL CELL CONTACT ZONE	72	7.35e-02	2.40e-01	0.14400	4.10e-02	-1.38e-01	5.48e-01	4.29e-02
GOBP RESPONSE TO COLD	42	3.42e-01	5.80e-01	0.14400	1.01e-01	1.03e-01	2.58e-01	2.50e-01
GOMF NAD DEPENDENT PROTEIN LYSINE DEACETYLASE ACTIVITY	7	8.24e-01	9.11e-01	0.14400	1.34e-01	5.35e-02	5.40e-01	8.07e-01
GOBP GLUCOSYLCERAMIDE METABOLIC PROCESS	11	7.09e-01	8.50e-01	0.14400	1.32e-02	1.43e-01	9.40e-01	4.11e-01
Signaling by Non-Receptor Tyrosine Kinases	54	2.42e-01	4.80e-01	0.14400	1.23e-01	7.54e-02	1.19e-01	3.38e-01
Signaling by PTK6	54	2.42e-01	4.80e-01	0.14400	1.23e-01	7.54e-02	1.19e-01	3.38e-01
GOCC TRANS GOLGI NETWORK	251	1.68e-03	1.54e-02	0.14400	1.13e-01	8.90e-02	2.05e-03	1.52e-02
GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION	61	1.98e-01	4.28e-01	0.14400	1.26e-01	6.93e-02	8.88e-02	3.49e-01
GOBP POSITIVE REGULATION OF PROGRAMMED CELL DEATH	557	4.60e-07	1.44e-05	0.14400	6.53e-02	1.28e-01	8.40e-03	2.34e-07
GOBP CEREBELLAR CORTEX FORMATION	24	5.36e-01	7.37e-01	0.14400	8.18e-02	1.18e-01	4.88e-01	3.16e-01
GOBP ORGANELLE MEMBRANE FUSION	120	4.40e-02	1.73e-01	0.14400	7.75e-02	1.21e-01	1.42e-01	2.20e-02
GOBP VASCULOGENESIS	82	1.02e-01	2.94e-01	0.14400	1.35e-01	5.04e-02	3.51e-02	4.30e-01
GOBP OLIGODENDROCYTE PROGENITOR PROLIFERATION	8	7.57e-01	8.76e-01	0.14400	-2.49e-02	1.42e-01	9.03e-01	4.88e-01
GOBP SPERM MOTILITY	140	2.70e-02	1.23e-01	0.14400	-8.14e-02	-1.18e-01	9.64e-02	1.56e-02
Formation of the ureteric bud	21	4.47e-01	6.73e-01	0.14400	-7.15e-02	1.25e-01	5.71e-01	3.23e-01
GOCC COHESIN COMPLEX	9	7.40e-01	8.68e-01	0.14400	1.16e-02	-1.43e-01	9.52e-01	4.57e-01
GOBP SPHINGOLIPID MEDIATED SIGNALING PATHWAY	18	4.93e-01	7.06e-01	0.14400	-1.03e-01	9.97e-02	4.48e-01	4.64e-01
GOBP NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS	54	1.33e-01	3.41e-01	0.14300	-5.84e-02	1.31e-01	4.58e-01	9.57e-02
GOBP AMIDE BIOSYNTHETIC PROCESS	150	1.76e-02	9.06e-02	0.14300	5.96e-02	1.31e-01	2.08e-01	5.79e-03
GOBP NEGATIVE REGULATION OF CELL GROWTH	161	1.69e-02	8.79e-02	0.14300	9.13e-02	1.11e-01	4.56e-02	1.54e-02
GOBP CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION	10	7.32e-01	8.63e-01	0.14300	1.16e-02	1.43e-01	9.49e-01	4.34e-01
Nicotinamide salvaging	19	5.77e-01	7.66e-01	0.14300	-3.60e-02	-1.39e-01	7.86e-01	2.95e-01
GOMF RECEPTOR TYROSINE KINASE BINDING	79	1.30e-01	3.37e-01	0.14300	7.91e-02	1.20e-01	2.24e-01	6.61e-02
Fcgamma receptor (FCGR) dependent phagocytosis	83	1.19e-01	3.21e-01	0.14300	8.39e-02	1.16e-01	1.87e-01	6.71e-02
GOBP RESPONSE TO IRON ION	27	5.04e-01	7.13e-01	0.14300	9.52e-02	1.07e-01	3.92e-01	3.35e-01
GOBP NEUTROPHIL MEDIATED IMMUNITY	37	2.88e-01	5.26e-01	0.14300	-1.43e-01	1.49e-02	1.33e-01	8.76e-01
GOMF SULFUR COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY	60	1.83e-01	4.09e-01	0.14300	-1.37e-01	-4.27e-02	6.69e-02	5.67e-01
GOBP PRIMARY ALCOHOL METABOLIC PROCESS	96	8.55e-02	2.64e-01	0.14300	-8.35e-02	-1.16e-01	1.58e-01	4.86e-02
GOBP ANTEROGRADE DENDRITIC TRANSPORT OF NEUROTRANSMITTER RECEPTOR COMPLEX	5	8.81e-01	9.43e-01	0.14300	1.01e-01	1.02e-01	6.97e-01	6.93e-01
GOBP MICROTUBULE CYTOSKELETON ORGANIZATION	628	1.92e-07	6.52e-06	0.14300	1.00e-01	1.02e-01	1.78e-05	1.22e-05
GOBP REGULATION OF MYELOID CELL DIFFERENTIATION	209	4.59e-03	3.33e-02	0.14300	7.58e-02	1.21e-01	5.90e-02	2.48e-03
GOBP REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS	78	1.33e-01	3.42e-01	0.14300	7.63e-02	1.21e-01	2.44e-01	6.46e-02
GOBP NEGATIVE REGULATION OF FATTY ACID BETA OXIDATION	6	8.10e-01	9.04e-01	0.14300	-1.39e-01	3.23e-02	5.54e-01	8.91e-01
GOMF DNA INSERTION OR DELETION BINDING	6	8.57e-01	9.29e-01	0.14300	8.38e-02	1.16e-01	7.22e-01	6.23e-01
GOBP PRIMARY AMINO COMPOUND METABOLIC PROCESS	13	6.83e-01	8.34e-01	0.14300	3.02e-02	1.40e-01	8.51e-01	3.83e-01
GOBP RESPONSE TO TRANSFORMING GROWTH FACTOR BETA	302	2.83e-04	3.73e-03	0.14300	1.33e-01	5.30e-02	7.14e-05	1.13e-01
GOMF MANNOSIDASE ACTIVITY	15	5.93e-01	7.74e-01	0.14300	-2.86e-02	1.40e-01	8.48e-01	3.47e-01
GOBP LEUKOCYTE MEDIATED IMMUNITY	386	4.92e-07	1.53e-05	0.14300	-1.22e-01	7.51e-02	4.08e-05	1.13e-02
GOBP REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE	18	5.05e-01	7.14e-01	0.14300	6.94e-02	-1.25e-01	6.10e-01	3.59e-01
FGFRL1 modulation of FGFR1 signaling	13	6.03e-01	7.81e-01	0.14300	9.65e-02	-1.05e-01	5.47e-01	5.10e-01
GOBP REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION	371	4.18e-05	7.48e-04	0.14300	1.34e-01	4.96e-02	9.22e-06	1.01e-01
GOBP PYRIMIDINE NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS	9	7.97e-01	8.97e-01	0.14300	9.47e-02	1.07e-01	6.23e-01	5.78e-01
GOBP RNA PROCESSING	1247	2.46e-16	2.77e-14	0.14300	1.42e-01	1.60e-02	3.36e-17	3.42e-01
GOBP NEGATIVE REGULATION OF CELL DIFFERENTIATION	677	6.70e-08	2.51e-06	0.14300	1.01e-01	1.00e-01	6.87e-06	8.29e-06
Defects in biotin (Btn) metabolism	8	7.79e-01	8.89e-01	0.14300	1.42e-01	8.62e-03	4.85e-01	9.66e-01
GOBP CHEMOREPULSION OF AXON	6	8.43e-01	9.21e-01	0.14300	-1.37e-01	-3.88e-02	5.60e-01	8.69e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS NAD OR NADP AS ACCEPTOR	32	3.62e-01	6.00e-01	0.14300	-1.43e-01	-2.30e-03	1.63e-01	9.82e-01
GOBP CHLORIDE TRANSPORT	116	5.06e-02	1.90e-01	0.14300	-1.21e-01	-7.49e-02	2.40e-02	1.63e-01
GOBP VASCULAR TRANSPORT	84	1.09e-01	3.06e-01	0.14300	-6.41e-02	-1.27e-01	3.10e-01	4.36e-02
Ca2+ activated K+ channels	9	7.93e-01	8.95e-01	0.14300	-1.21e-01	-7.61e-02	5.31e-01	6.93e-01
GOBP NEGATIVE REGULATION OF RESPONSE TO TYPE II INTERFERON	7	7.94e-01	8.95e-01	0.14300	-1.14e-02	1.42e-01	9.58e-01	5.15e-01
GOBP GLYCOSAMINOGLYCAN CATABOLIC PROCESS	27	4.23e-01	6.53e-01	0.14300	-1.71e-04	-1.43e-01	9.99e-01	2.00e-01
GOBP CRANIOFACIAL SUTURE MORPHOGENESIS	19	4.81e-01	6.97e-01	0.14200	9.02e-02	-1.10e-01	4.96e-01	4.05e-01
GOBP PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE	7	8.39e-01	9.19e-01	0.14200	1.09e-01	9.19e-02	6.18e-01	6.74e-01
GOMF PLATELET DERIVED GROWTH FACTOR RECEPTOR BINDING	13	7.22e-01	8.57e-01	0.14200	1.04e-01	9.69e-02	5.15e-01	5.45e-01
GOBP PHOTORECEPTOR CELL DEVELOPMENT	51	1.57e-01	3.74e-01	0.14200	5.07e-02	-1.33e-01	5.31e-01	1.00e-01
GOBP ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY	17	6.53e-01	8.13e-01	0.14200	1.08e-01	9.28e-02	4.41e-01	5.08e-01
GOBP ENDOMEMBRANE SYSTEM ORGANIZATION	570	6.93e-07	2.12e-05	0.14200	1.18e-01	7.97e-02	1.47e-06	1.14e-03
GOMF NEUREXIN FAMILY PROTEIN BINDING	9	7.89e-01	8.93e-01	0.14200	6.39e-02	1.27e-01	7.40e-01	5.09e-01
GOBP POSITIVE REGULATION OF RIG I SIGNALING PATHWAY	9	7.43e-01	8.69e-01	0.14200	1.27e-02	-1.42e-01	9.47e-01	4.61e-01
GOBP REGULATION OF SKELETAL MUSCLE CELL PROLIFERATION	15	6.72e-01	8.27e-01	0.14200	1.28e-01	6.16e-02	3.90e-01	6.79e-01
GOCC SYNAPTIC MEMBRANE	375	9.79e-05	1.52e-03	0.14200	-9.62e-02	-1.05e-01	1.37e-03	4.91e-04
Interleukin-2 family signaling	39	2.22e-01	4.56e-01	0.14200	-1.05e-01	9.62e-02	2.57e-01	2.99e-01
GOBP REGULATION PROTEIN CATABOLIC PROCESS AT SYNAPSE	5	8.82e-01	9.43e-01	0.14200	-9.58e-02	-1.05e-01	7.11e-01	6.84e-01
GOBP GLYCEROPHOSPHOLIPID BIOSYNTHETIC PROCESS	200	5.60e-03	3.85e-02	0.14200	1.26e-01	6.68e-02	2.20e-03	1.03e-01
GOMF PEPTIDE RECEPTOR ACTIVITY	120	3.75e-02	1.54e-01	0.14200	-1.34e-01	-4.74e-02	1.12e-02	3.69e-01
GOBP REGULATION OF GTP BINDING	9	7.42e-01	8.69e-01	0.14200	-1.39e-02	1.42e-01	9.42e-01	4.62e-01
GOBP REGULATION OF NEURON PROJECTION ARBORIZATION	14	6.52e-01	8.12e-01	0.14200	1.42e-01	1.24e-02	3.59e-01	9.36e-01
GOBP REGULATION OF PROTEIN DEPOLYMERIZATION	83	9.80e-02	2.86e-01	0.14200	1.36e-01	3.99e-02	3.17e-02	5.30e-01
GOBP MOTOR NEURON AXON GUIDANCE	25	3.86e-01	6.20e-01	0.14200	-8.14e-02	1.16e-01	4.81e-01	3.14e-01
GOMF ATPASE COUPLED TRANSMEMBRANE TRANSPORTER ACTIVITY	94	5.46e-02	1.99e-01	0.14200	-6.56e-03	-1.42e-01	9.13e-01	1.75e-02
GOMF SULFOTRANSFERASE ACTIVITY	49	2.58e-01	4.96e-01	0.14200	-1.35e-01	-4.33e-02	1.02e-01	6.00e-01
GOMF INTRACELLULARLY LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY	30	4.57e-01	6.82e-01	0.14200	-1.26e-01	-6.47e-02	2.31e-01	5.39e-01
GOBP INTERLEUKIN 21 PRODUCTION	5	8.82e-01	9.43e-01	0.14200	-1.13e-01	-8.52e-02	6.60e-01	7.42e-01
GOBP REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS	24	5.04e-01	7.13e-01	0.14200	-1.38e-01	-3.26e-02	2.42e-01	7.82e-01
GOBP PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS	18	6.35e-01	8.01e-01	0.14200	8.16e-02	1.16e-01	5.49e-01	3.94e-01
GOBP POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION	102	7.03e-02	2.33e-01	0.14200	6.43e-02	1.26e-01	2.62e-01	2.73e-02
GOBP FATTY ACID CATABOLIC PROCESS	104	7.63e-02	2.45e-01	0.14200	9.79e-02	1.03e-01	8.44e-02	7.07e-02
Muscle contraction	196	3.37e-03	2.63e-02	0.14200	-2.45e-02	-1.40e-01	5.53e-01	7.47e-04
Signaling by MET	78	5.24e-02	1.94e-01	0.14200	1.17e-01	-8.04e-02	7.45e-02	2.20e-01
GOBP NEUROTRANSMITTER REUPTAKE	34	4.12e-01	6.45e-01	0.14200	-6.51e-02	-1.26e-01	5.11e-01	2.04e-01
GOCC MITOCHONDRIAL PERMEABILITY TRANSITION PORE COMPLEX	6	8.04e-01	9.02e-01	0.14200	-5.37e-02	1.31e-01	8.20e-01	5.78e-01
GOCC CELL DIVISION SITE	71	1.63e-01	3.83e-01	0.14200	1.22e-01	7.27e-02	7.62e-02	2.90e-01
GOBP LAMELLIPODIUM ASSEMBLY	67	1.58e-01	3.76e-01	0.14200	1.35e-01	4.41e-02	5.65e-02	5.33e-01
G1/S-Specific Transcription	28	4.98e-01	7.09e-01	0.14200	9.21e-02	1.08e-01	3.99e-01	3.24e-01
GOBP REGULATION OF MUSCLE CELL DIFFERENTIATION	158	1.04e-02	6.18e-02	0.14200	1.39e-01	2.67e-02	2.53e-03	5.62e-01
GOBP CHONDROCYTE DIFFERENTIATION	113	5.28e-02	1.95e-01	0.14200	1.27e-01	6.34e-02	1.99e-02	2.45e-01
GOBP FAT CELL DIFFERENTIATION	244	2.38e-03	2.01e-02	0.14200	8.62e-02	1.12e-01	2.04e-02	2.48e-03
The role of Nef in HIV-1 replication and disease pathogenesis	27	5.07e-01	7.15e-01	0.14200	8.17e-02	1.16e-01	4.62e-01	2.98e-01
GOBP TELENCEPHALON DEVELOPMENT	266	1.47e-03	1.39e-02	0.14200	9.46e-02	1.05e-01	7.91e-03	3.07e-03
GOBP RESPONSE TO HYDROPEROXIDE	19	5.96e-01	7.76e-01	0.14200	-4.77e-02	-1.33e-01	7.19e-01	3.14e-01
GOBP TRANSPORT OF VIRUS	21	5.92e-01	7.73e-01	0.14200	8.61e-02	1.12e-01	4.95e-01	3.73e-01
GOBP POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY	192	8.93e-03	5.53e-02	0.14100	1.06e-01	9.34e-02	1.11e-02	2.57e-02
GOBP REGULATION OF LUTEINIZING HORMONE SECRETION	7	7.82e-01	8.90e-01	0.14100	1.36e-01	-4.01e-02	5.34e-01	8.54e-01
Transferrin endocytosis and recycling	29	4.78e-01	6.96e-01	0.14100	1.21e-01	7.30e-02	2.59e-01	4.96e-01
GOMF HIGH DENSITY LIPOPROTEIN PARTICLE BINDING	13	6.93e-01	8.40e-01	0.14100	-3.41e-02	-1.37e-01	8.31e-01	3.92e-01
Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation	51	1.46e-01	3.59e-01	0.14100	1.15e-01	-8.29e-02	1.57e-01	3.06e-01
GOCC CILIARY TRANSITION ZONE	72	8.66e-02	2.66e-01	0.14100	1.38e-01	-2.89e-02	4.24e-02	6.72e-01
GOBP S ADENOSYLMETHIONINE CYCLE	7	8.03e-01	9.01e-01	0.14100	1.41e-01	-2.41e-04	5.17e-01	9.99e-01
GOBP REGULATION OF GERMINAL CENTER FORMATION	8	8.20e-01	9.09e-01	0.14100	1.10e-01	8.82e-02	5.89e-01	6.66e-01
GOBP GRANULOCYTE DIFFERENTIATION	39	2.95e-01	5.34e-01	0.14100	-1.65e-04	1.41e-01	9.99e-01	1.27e-01
GOMF CELL ADHESION MEDIATOR ACTIVITY	67	1.13e-01	3.12e-01	0.14100	1.37e-02	-1.41e-01	8.46e-01	4.66e-02
GOMF HISTONE H3K9 METHYLTRANSFERASE ACTIVITY	12	7.14e-01	8.53e-01	0.14100	1.37e-01	3.51e-02	4.12e-01	8.33e-01
GOBP INTERMEMBRANE LIPID TRANSFER	34	3.01e-01	5.40e-01	0.14100	1.34e-01	-4.46e-02	1.76e-01	6.52e-01
GOBP STRIATED MUSCLE TISSUE DEVELOPMENT	262	8.70e-04	9.41e-03	0.14100	1.34e-01	4.61e-02	1.98e-04	1.99e-01
Regulation of IFNA/IFNB signaling	22	5.04e-01	7.14e-01	0.14100	-1.41e-01	-2.18e-03	2.52e-01	9.86e-01
GOBP MAST CELL PROLIFERATION	7	7.70e-01	8.84e-01	0.14100	-7.32e-02	1.21e-01	7.37e-01	5.80e-01
GOBP NEGATIVE REGULATION OF MACROPHAGE APOPTOTIC PROCESS	8	7.67e-01	8.82e-01	0.14100	1.94e-02	-1.40e-01	9.24e-01	4.93e-01
GOBP GLOMERULAR EPITHELIUM DEVELOPMENT	26	3.73e-01	6.09e-01	0.14100	1.04e-01	-9.52e-02	3.58e-01	4.01e-01
GOMF PHOSPHOLIPASE BINDING	20	4.85e-01	6.99e-01	0.14100	5.71e-02	-1.29e-01	6.58e-01	3.18e-01
GOBP VESICLE DOCKING	56	2.45e-01	4.84e-01	0.14100	1.18e-01	7.73e-02	1.27e-01	3.17e-01
GOBP MAMMARY GLAND EPITHELIUM DEVELOPMENT	68	1.86e-01	4.12e-01	0.14100	8.50e-02	1.13e-01	2.26e-01	1.08e-01
GOBP REGULATION OF DENDRITIC CELL DIFFERENTIATION	13	6.90e-01	8.39e-01	0.14100	2.94e-02	1.38e-01	8.54e-01	3.89e-01
GOBP REGULATION OF GAP JUNCTION ASSEMBLY	9	7.55e-01	8.75e-01	0.14100	-1.41e-01	-4.56e-05	4.64e-01	1.00e+00
GOBP MICROGLIAL CELL MIGRATION	8	7.39e-01	8.67e-01	0.14100	-1.06e-01	9.23e-02	6.02e-01	6.51e-01
GOBP REGULATION OF ALPHA BETA T CELL DIFFERENTIATION	72	1.08e-01	3.04e-01	0.14100	2.18e-03	1.41e-01	9.75e-01	3.87e-02
GOBP REGULATION OF ORGAN GROWTH	96	8.16e-02	2.56e-01	0.14100	1.29e-01	5.76e-02	2.95e-02	3.30e-01
Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition	12	7.28e-01	8.61e-01	0.14100	5.34e-02	1.30e-01	7.49e-01	4.34e-01
GOBP POSITIVE REGULATION OF EXIT FROM MITOSIS	5	8.53e-01	9.26e-01	0.14100	-5.58e-03	1.41e-01	9.83e-01	5.86e-01
GOBP AMINO ACID NEUROTRANSMITTER REUPTAKE	10	7.55e-01	8.74e-01	0.14100	-3.24e-02	-1.37e-01	8.59e-01	4.53e-01
GOBP FOREBRAIN RADIAL GLIAL CELL DIFFERENTIATION	7	8.08e-01	9.03e-01	0.14100	1.40e-01	6.37e-03	5.20e-01	9.77e-01
GOMF SULFUR COMPOUND BINDING	260	1.45e-04	2.10e-03	0.14100	3.60e-02	-1.36e-01	3.18e-01	1.60e-04
GOCC SMOOTH ENDOPLASMIC RETICULUM MEMBRANE	7	8.41e-01	9.20e-01	0.14100	-1.15e-01	-8.13e-02	5.99e-01	7.09e-01
GOMF CARGO RECEPTOR ACTIVITY	72	8.30e-02	2.59e-01	0.14100	1.35e-01	-3.96e-02	4.77e-02	5.62e-01
GOBP NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY	21	4.75e-01	6.95e-01	0.14100	-4.96e-02	1.32e-01	6.94e-01	2.97e-01
GOBP NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT	23	4.24e-01	6.53e-01	0.14100	1.14e-01	-8.16e-02	3.42e-01	4.98e-01
GOBP CHONDROCYTE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS	8	7.49e-01	8.71e-01	0.14100	1.28e-01	-5.83e-02	5.31e-01	7.75e-01
Synthesis of PI	5	8.85e-01	9.45e-01	0.14100	-1.06e-01	-9.19e-02	6.81e-01	7.22e-01
GOBP PROTEIN KINASE C SIGNALING	35	3.11e-01	5.51e-01	0.14000	-1.38e-01	2.62e-02	1.58e-01	7.89e-01
GOMF PHOSPHOLIPASE ACTIVITY	107	6.52e-02	2.22e-01	0.14000	-1.25e-01	-6.38e-02	2.53e-02	2.54e-01
GOBP ORGANELLE ASSEMBLY	988	1.17e-11	8.52e-10	0.14000	1.32e-01	4.92e-02	2.52e-12	8.81e-03
GOBP THIOESTER BIOSYNTHETIC PROCESS	43	3.05e-01	5.44e-01	0.14000	3.61e-02	1.36e-01	6.82e-01	1.24e-01
GOBP REGULATION OF HYALURONAN BIOSYNTHETIC PROCESS	8	8.20e-01	9.09e-01	0.14000	8.02e-02	1.15e-01	6.95e-01	5.73e-01
GOBP INTRACELLULAR OXYGEN HOMEOSTASIS	7	8.33e-01	9.17e-01	0.14000	1.29e-01	5.53e-02	5.55e-01	8.00e-01
GOCC PLATELET DENSE TUBULAR NETWORK MEMBRANE	9	8.03e-01	9.02e-01	0.14000	1.01e-01	9.78e-02	6.01e-01	6.11e-01
GOBP REGULATION OF NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE	8	7.41e-01	8.68e-01	0.14000	9.01e-02	-1.08e-01	6.59e-01	5.98e-01
GOBP HEART DEVELOPMENT	601	1.76e-07	6.01e-06	0.14000	1.31e-01	4.92e-02	3.73e-08	3.92e-02
GOMF CDP ALCOHOL PHOSPHATIDYLTRANSFERASE ACTIVITY	8	8.23e-01	9.11e-01	0.14000	1.00e-01	9.84e-02	6.24e-01	6.30e-01
GOBP MUSCLE HYPERTROPHY IN RESPONSE TO STRESS	32	4.22e-01	6.52e-01	0.14000	1.33e-01	4.33e-02	1.92e-01	6.72e-01
RAB geranylgeranylation	57	1.44e-01	3.57e-01	0.14000	-3.52e-02	1.36e-01	6.46e-01	7.63e-02
Glyoxylate metabolism and glycine degradation	18	5.28e-01	7.31e-01	0.14000	1.30e-01	-5.33e-02	3.41e-01	6.95e-01
GOBP REGULATION OF GLIAL CELL PROLIFERATION	38	3.63e-01	6.00e-01	0.14000	1.32e-01	4.67e-02	1.59e-01	6.18e-01
GOCC VACUOLAR MEMBRANE	470	1.21e-05	2.55e-04	0.14000	8.13e-02	1.14e-01	2.54e-03	2.25e-05
GOBP SMAD PROTEIN SIGNAL TRANSDUCTION	94	8.17e-02	2.56e-01	0.14000	1.32e-01	4.58e-02	2.65e-02	4.43e-01
GOCC RUFFLE	179	1.00e-02	6.00e-02	0.14000	1.28e-01	5.72e-02	3.17e-03	1.87e-01
DCC mediated attractive signaling	14	5.92e-01	7.74e-01	0.14000	1.00e-01	-9.78e-02	5.16e-01	5.27e-01
GOBP NEGATIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY	9	7.59e-01	8.77e-01	0.14000	1.40e-01	1.25e-03	4.67e-01	9.95e-01
GOBP ACTION POTENTIAL	163	1.82e-02	9.31e-02	0.14000	-1.17e-01	-7.70e-02	1.00e-02	8.98e-02
GOBP SEGMENT SPECIFICATION	16	6.67e-01	8.24e-01	0.14000	1.24e-01	6.53e-02	3.91e-01	6.51e-01
GOBP REGULATION OF NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY	14	6.88e-01	8.38e-01	0.14000	4.56e-02	1.32e-01	7.68e-01	3.91e-01
Adrenoceptors	9	7.15e-01	8.53e-01	0.14000	-1.02e-01	9.61e-02	5.98e-01	6.18e-01
GOCC TERTIARY GRANULE LUMEN	54	1.41e-01	3.54e-01	0.14000	-1.22e-01	6.84e-02	1.21e-01	3.85e-01
GOMF METALLOEXOPEPTIDASE ACTIVITY	64	1.20e-01	3.23e-01	0.14000	2.63e-02	-1.37e-01	7.16e-01	5.74e-02
GOBP POSITIVE REGULATION OF HEPATOCYTE PROLIFERATION	10	7.13e-01	8.52e-01	0.14000	-1.35e-01	3.48e-02	4.58e-01	8.49e-01
GOMF G PROTEIN COUPLED OPIOID RECEPTOR ACTIVITY	7	8.44e-01	9.21e-01	0.14000	-9.03e-02	-1.07e-01	6.79e-01	6.25e-01
GOBP ALCOHOL CATABOLIC PROCESS	33	3.98e-01	6.31e-01	0.14000	-1.36e-01	-3.03e-02	1.75e-01	7.63e-01
GOBP PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS	44	2.94e-01	5.33e-01	0.14000	3.07e-02	1.36e-01	7.25e-01	1.18e-01
GOBP ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY	221	4.18e-03	3.11e-02	0.14000	1.21e-01	6.91e-02	1.87e-03	7.66e-02
GOMF INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY INTERCONVERTING ALDOSES AND KETOSES	6	8.07e-01	9.03e-01	0.14000	-5.87e-02	1.27e-01	8.03e-01	5.91e-01
GOBP CHOLESTEROL CATABOLIC PROCESS	9	8.02e-01	9.01e-01	0.14000	8.01e-02	1.14e-01	6.77e-01	5.52e-01
Electric Transmission Across Gap Junctions	5	8.68e-01	9.35e-01	0.14000	-2.43e-02	-1.38e-01	9.25e-01	5.94e-01
Transmission across Electrical Synapses	5	8.68e-01	9.35e-01	0.14000	-2.43e-02	-1.38e-01	9.25e-01	5.94e-01
GOMF AMINO ACID MONOATOMIC CATION SYMPORTER ACTIVITY	27	4.75e-01	6.95e-01	0.14000	-1.36e-01	-3.29e-02	2.22e-01	7.67e-01
GOMF ORGANOPHOSPHATE PHOSPHATE ANTIPORTER ACTIVITY	7	7.82e-01	8.90e-01	0.14000	-5.05e-02	1.30e-01	8.17e-01	5.51e-01
GOCC M BAND	27	4.47e-01	6.73e-01	0.14000	-7.89e-03	-1.39e-01	9.43e-01	2.10e-01
GOCC PERINUCLEAR ENDOPLASMIC RETICULUM	19	5.98e-01	7.77e-01	0.14000	1.34e-01	3.92e-02	3.12e-01	7.67e-01
GOBP REGULATION OF MEMBRANE INVAGINATION	15	6.82e-01	8.34e-01	0.14000	-1.26e-01	-6.06e-02	3.99e-01	6.84e-01
GOBP NEPHRON TUBULE FORMATION	20	5.99e-01	7.78e-01	0.14000	-1.27e-01	-5.80e-02	3.26e-01	6.53e-01
Response of endothelial cells to shear stress	92	5.41e-02	1.98e-01	0.13900	1.39e-01	-1.35e-02	2.14e-02	8.23e-01
GOMF T CELL RECEPTOR BINDING	11	7.36e-01	8.66e-01	0.13900	2.95e-02	1.36e-01	8.65e-01	4.34e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORS	47	1.79e-01	4.04e-01	0.13900	7.77e-02	-1.16e-01	3.57e-01	1.70e-01
Maturation of spike protein 9694548	35	3.34e-01	5.73e-01	0.13900	-8.68e-03	1.39e-01	9.29e-01	1.54e-01
GOBP NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS	18	6.31e-01	7.99e-01	0.13900	1.27e-01	5.82e-02	3.52e-01	6.69e-01
GOBP REGULATION OF CRISTAE FORMATION	5	8.35e-01	9.17e-01	0.13900	1.22e-01	-6.65e-02	6.35e-01	7.97e-01
GOBP MULTICELLULAR ORGANISMAL MOVEMENT	59	1.66e-01	3.88e-01	0.13900	-1.12e-04	-1.39e-01	9.99e-01	6.42e-02
GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION	20	6.05e-01	7.83e-01	0.13900	1.24e-01	6.35e-02	3.38e-01	6.23e-01
GOBP NUCLEOSIDE METABOLIC PROCESS	55	2.56e-01	4.94e-01	0.13900	6.87e-02	1.21e-01	3.78e-01	1.21e-01
GOBP REGULATION OF MYELOID CELL APOPTOTIC PROCESS	30	3.56e-01	5.93e-01	0.13900	1.31e-01	-4.70e-02	2.15e-01	6.56e-01
GOBP AMINOGLYCAN CATABOLIC PROCESS	33	4.13e-01	6.45e-01	0.13900	-3.97e-02	-1.33e-01	6.93e-01	1.85e-01
GOCC ALPHA BETA T CELL RECEPTOR COMPLEX	5	8.53e-01	9.26e-01	0.13900	1.43e-02	-1.38e-01	9.56e-01	5.92e-01
GOMF PEPTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY	9	7.23e-01	8.58e-01	0.13900	7.17e-02	-1.19e-01	7.09e-01	5.36e-01
GOMF PROTON TRANSMEMBRANE TRANSPORTER ACTIVITY	164	1.63e-02	8.61e-02	0.13900	1.25e-01	6.04e-02	5.68e-03	1.82e-01
GOBP NEUTROPHIL DIFFERENTIATION	11	6.93e-01	8.40e-01	0.13900	-3.37e-02	1.35e-01	8.46e-01	4.39e-01
GOBP CANONICAL WNT SIGNALING PATHWAY	310	5.32e-04	6.34e-03	0.13900	1.20e-01	7.05e-02	2.89e-04	3.28e-02
GOBP PROTEIN DEPHOSPHORYLATION	199	3.34e-03	2.61e-02	0.13900	1.38e-01	1.54e-02	7.84e-04	7.09e-01
GOMF CYTOSKELETAL MOTOR ACTIVITY	111	5.53e-02	2.00e-01	0.13900	-4.67e-02	-1.31e-01	3.95e-01	1.73e-02
GOBP MESENCHYMAL CELL DIFFERENTIATION	267	1.77e-03	1.60e-02	0.13900	1.10e-01	8.52e-02	2.04e-03	1.65e-02
GOCC MICROVESICLE	9	8.06e-01	9.02e-01	0.13900	-8.43e-02	-1.10e-01	6.62e-01	5.67e-01
GOBP PROTEIN LOCALIZATION TO MEMBRANE RAFT	9	8.07e-01	9.03e-01	0.13900	9.83e-02	9.79e-02	6.10e-01	6.11e-01
Activation of kainate receptors upon glutamate binding	29	3.57e-01	5.94e-01	0.13900	1.23e-01	-6.36e-02	2.50e-01	5.53e-01
Lewis blood group biosynthesis	18	5.83e-01	7.69e-01	0.13900	-1.39e-01	-2.81e-03	3.08e-01	9.84e-01
GOBP POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION	64	1.11e-01	3.08e-01	0.13900	1.30e-01	-4.89e-02	7.25e-02	4.99e-01
GOBP B CELL ACTIVATION	261	1.54e-04	2.21e-03	0.13900	-4.28e-02	1.32e-01	2.34e-01	2.44e-04
GOBP REGULATION OF LIPID STORAGE	54	2.77e-01	5.17e-01	0.13900	-1.05e-01	-9.04e-02	1.81e-01	2.51e-01
GOBP CELLULAR RESPONSE TO INORGANIC SUBSTANCE	205	7.05e-03	4.59e-02	0.13900	7.31e-02	1.18e-01	7.12e-02	3.66e-03
GOBP REGULATION OF INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY	11	6.77e-01	8.30e-01	0.13800	-6.55e-02	1.22e-01	7.07e-01	4.84e-01
GOMF VOLTAGE GATED MONOATOMIC ANION CHANNEL ACTIVITY	14	7.16e-01	8.54e-01	0.13800	-1.10e-01	-8.45e-02	4.77e-01	5.84e-01
GOCC EXCITATORY SYNAPSE	58	2.51e-01	4.89e-01	0.13800	-8.39e-02	-1.10e-01	2.69e-01	1.47e-01
GOBP POSITIVE REGULATION OF STRESS FIBER ASSEMBLY	51	2.97e-01	5.37e-01	0.13800	1.10e-01	8.39e-02	1.74e-01	3.00e-01
GOBP REGULATION OF SKELETAL MUSCLE TISSUE REGENERATION	8	7.51e-01	8.72e-01	0.13800	-1.18e-01	7.18e-02	5.63e-01	7.25e-01
GOBP CERAMIDE CATABOLIC PROCESS	24	4.39e-01	6.66e-01	0.13800	-1.29e-01	4.95e-02	2.74e-01	6.75e-01
GOMF ALCOHOL DEHYDROGENASE NAD P PLUS ACTIVITY	24	5.06e-01	7.15e-01	0.13800	-1.71e-02	-1.37e-01	8.84e-01	2.45e-01
GOBP POSITIVE REGULATION OF CELL DIVISION	93	7.37e-02	2.40e-01	0.13800	1.37e-01	2.03e-02	2.27e-02	7.35e-01
GOBP NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS	64	1.06e-01	3.00e-01	0.13800	-6.32e-02	1.23e-01	3.82e-01	8.92e-02
GOBP ACTIN FILAMENT DEPOLYMERIZATION	58	2.02e-01	4.32e-01	0.13800	1.36e-01	2.52e-02	7.37e-02	7.40e-01
GOBP CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES	270	8.36e-05	1.34e-03	0.13800	6.31e-02	-1.23e-01	7.41e-02	5.12e-04
GOBP OVULATION CYCLE	73	1.07e-01	3.03e-01	0.13800	1.38e-01	-8.42e-03	4.19e-02	9.01e-01
GOBP POSITIVE REGULATION OF GAP JUNCTION ASSEMBLY	6	8.26e-01	9.12e-01	0.13800	1.36e-01	-2.09e-02	5.63e-01	9.29e-01
GOCC ATPASE DEPENDENT TRANSMEMBRANE TRANSPORT COMPLEX	24	4.93e-01	7.06e-01	0.13800	-4.37e-03	-1.38e-01	9.70e-01	2.42e-01
GOBP LEUKOCYTE APOPTOTIC PROCESS	115	5.40e-02	1.98e-01	0.13800	5.08e-02	1.28e-01	3.47e-01	1.75e-02
GOCC LUMENAL SIDE OF MEMBRANE	42	3.14e-01	5.54e-01	0.13800	2.49e-02	1.36e-01	7.80e-01	1.28e-01
EPHB-mediated forward signaling	41	3.74e-01	6.10e-01	0.13800	7.53e-02	1.16e-01	4.04e-01	2.01e-01
GOBP MEIOTIC CELL CYCLE	279	5.72e-04	6.72e-03	0.13800	1.34e-01	3.09e-02	1.12e-04	3.75e-01
GOCC CELL SURFACE	845	3.10e-10	1.79e-08	0.13800	-1.34e-01	-3.27e-02	3.73e-11	1.06e-01
GOBP POSITIVE REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS	9	7.52e-01	8.73e-01	0.13800	-2.02e-02	1.36e-01	9.16e-01	4.79e-01
GOBP AORTIC VALVE MORPHOGENESIS	39	2.86e-01	5.24e-01	0.13800	-2.50e-02	1.36e-01	7.87e-01	1.43e-01
GOBP ACTIVATED T CELL PROLIFERATION	46	2.93e-01	5.32e-01	0.13800	3.46e-02	1.33e-01	6.85e-01	1.17e-01
GOBP REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION	17	6.71e-01	8.26e-01	0.13800	9.44e-02	1.00e-01	5.00e-01	4.74e-01
GOBP EXOCRINE SYSTEM DEVELOPMENT	48	2.12e-01	4.44e-01	0.13800	1.35e-01	-2.81e-02	1.06e-01	7.36e-01
GOBP REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY	43	3.51e-01	5.88e-01	0.13800	1.20e-01	6.72e-02	1.72e-01	4.46e-01
GOBP HINDBRAIN DEVELOPMENT	149	3.00e-02	1.32e-01	0.13800	8.29e-02	1.10e-01	8.06e-02	2.05e-02
GOBP ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY	13	6.80e-01	8.32e-01	0.13800	1.38e-01	1.76e-03	3.90e-01	9.91e-01
GOBP POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION	20	4.91e-01	7.04e-01	0.13800	7.50e-02	-1.15e-01	5.62e-01	3.71e-01
GOBP RESPONSE TO STEROL DEPLETION	18	6.29e-01	7.97e-01	0.13800	1.30e-01	4.64e-02	3.41e-01	7.33e-01
Keratan sulfate/keratin metabolism	36	3.49e-01	5.86e-01	0.13800	-4.76e-03	-1.37e-01	9.61e-01	1.53e-01
GOBP LIMB BUD FORMATION	9	8.09e-01	9.04e-01	0.13800	1.07e-01	8.63e-02	5.78e-01	6.54e-01
GOCC SPECIFIC GRANULE	155	4.92e-03	3.49e-02	0.13700	-1.25e-01	5.74e-02	7.30e-03	2.17e-01
GOBP REGULATION OF HEMOPOIESIS	413	5.30e-05	9.13e-04	0.13700	6.67e-02	1.20e-01	2.01e-02	2.80e-05
GOCC ASYMMETRIC GLUTAMATERGIC EXCITATORY SYNAPSE	13	6.76e-01	8.29e-01	0.13700	-5.34e-03	1.37e-01	9.73e-01	3.91e-01
GOBP REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT	112	7.45e-02	2.41e-01	0.13700	-9.74e-02	-9.68e-02	7.49e-02	7.66e-02
GOBP GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS	25	5.38e-01	7.38e-01	0.13700	1.25e-01	5.78e-02	2.81e-01	6.17e-01
GOBP REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE	183	1.50e-03	1.41e-02	0.13700	-8.50e-02	1.08e-01	4.74e-02	1.18e-02
GOBP BRANCHED CHAIN AMINO ACID TRANSPORT	13	7.11e-01	8.51e-01	0.13700	1.32e-01	3.76e-02	4.10e-01	8.15e-01
GOBP POSITIVE REGULATION OF EPITHELIAL TUBE FORMATION	8	7.80e-01	8.90e-01	0.13700	-1.60e-02	1.36e-01	9.38e-01	5.05e-01
GOBP PERICARDIUM MORPHOGENESIS	8	8.19e-01	9.09e-01	0.13700	5.39e-02	1.26e-01	7.92e-01	5.37e-01
GOBP REGULATION OF PIGMENTATION	17	6.73e-01	8.27e-01	0.13700	8.69e-02	1.06e-01	5.35e-01	4.49e-01
GOBP EXPLORATION BEHAVIOR	32	4.76e-01	6.95e-01	0.13700	9.76e-02	9.62e-02	3.39e-01	3.46e-01
GOBP REGULATION OF MYELINATION	46	2.22e-01	4.56e-01	0.13700	3.64e-02	-1.32e-01	6.70e-01	1.21e-01
GOBP MEIOSIS I CELL CYCLE PROCESS	135	8.30e-03	5.23e-02	0.13700	1.07e-01	-8.57e-02	3.18e-02	8.57e-02
GOBP TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY	64	2.24e-01	4.58e-01	0.13700	8.32e-02	1.09e-01	2.50e-01	1.32e-01
GOCC LATERAL ELEMENT	14	7.22e-01	8.57e-01	0.13700	-8.69e-02	-1.06e-01	5.74e-01	4.92e-01
GOBP REGULATION OF CELL PROJECTION ASSEMBLY	217	6.83e-03	4.49e-02	0.13700	9.32e-02	1.00e-01	1.80e-02	1.08e-02
GOMF INOSITOL PHOSPHATE KINASE ACTIVITY	11	7.75e-01	8.87e-01	0.13700	9.68e-02	9.70e-02	5.78e-01	5.77e-01
GOBP INFLAMMATORY CELL APOPTOTIC PROCESS	23	4.51e-01	6.76e-01	0.13700	1.22e-01	-6.30e-02	3.13e-01	6.01e-01
NOTCH2 Activation and Transmission of Signal to the Nucleus	22	5.86e-01	7.70e-01	0.13700	1.22e-01	6.29e-02	3.23e-01	6.10e-01
GOBP PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT	18	6.19e-01	7.90e-01	0.13700	3.14e-02	1.33e-01	8.18e-01	3.27e-01
GOBP NEGATIVE REGULATION OF INFLAMMATORY RESPONSE	191	4.63e-03	3.34e-02	0.13700	-1.36e-01	-1.21e-02	1.15e-03	7.74e-01
GOCC IKAPPAB KINASE COMPLEX	7	8.47e-01	9.23e-01	0.13700	1.15e-01	7.44e-02	5.98e-01	7.33e-01
GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION	84	1.08e-01	3.04e-01	0.13700	1.33e-01	3.22e-02	3.50e-02	6.10e-01
GOBP GLUCAN METABOLIC PROCESS	81	8.88e-02	2.70e-01	0.13700	1.37e-01	-5.72e-03	3.33e-02	9.29e-01
GOMF SECONDARY ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY	277	1.07e-03	1.11e-02	0.13700	-1.27e-01	-5.22e-02	2.89e-04	1.35e-01
GOBP MEDIUM CHAIN FATTY ACID CATABOLIC PROCESS	5	8.45e-01	9.22e-01	0.13700	-1.27e-01	5.08e-02	6.23e-01	8.44e-01
RND3 GTPase cycle	41	3.20e-01	5.58e-01	0.13700	1.36e-01	1.71e-02	1.32e-01	8.50e-01
GOMF CALCIUM ION BINDING	679	1.52e-08	6.42e-07	0.13700	-2.31e-02	-1.35e-01	3.06e-01	2.03e-09
Interleukin-1 family signaling	134	2.41e-02	1.14e-01	0.13700	1.36e-01	1.58e-02	6.60e-03	7.52e-01
GOBP NOTOCHORD DEVELOPMENT	19	5.91e-01	7.73e-01	0.13700	1.90e-02	1.35e-01	8.86e-01	3.07e-01
VEGF binds to VEGFR leading to receptor dimerization	7	8.20e-01	9.09e-01	0.13700	-1.22e-02	-1.36e-01	9.56e-01	5.32e-01
VEGF ligand-receptor interactions	7	8.20e-01	9.09e-01	0.13700	-1.22e-02	-1.36e-01	9.56e-01	5.32e-01
GOCC MEIOTIC COHESIN COMPLEX	6	8.65e-01	9.34e-01	0.13700	-1.20e-01	-6.49e-02	6.10e-01	7.83e-01
GOBP VACUOLAR TRANSMEMBRANE TRANSPORT	8	7.97e-01	8.97e-01	0.13700	-1.36e-01	-1.11e-02	5.04e-01	9.57e-01
GOMF NON MEMBRANE SPANNING PROTEIN TYROSINE PHOSPHATASE ACTIVITY	12	6.73e-01	8.28e-01	0.13700	-4.12e-02	1.30e-01	8.05e-01	4.34e-01
GOMF ADENYLATE KINASE ACTIVITY	9	7.82e-01	8.90e-01	0.13700	-2.24e-02	-1.35e-01	9.07e-01	4.84e-01
GOMF HSP90 PROTEIN BINDING	40	2.99e-01	5.38e-01	0.13700	1.36e-01	-9.85e-03	1.36e-01	9.14e-01
COPI-dependent Golgi-to-ER retrograde traffic	98	8.37e-02	2.60e-01	0.13700	1.29e-01	4.53e-02	2.74e-02	4.39e-01
GOMF TYPE 1 FIBROBLAST GROWTH FACTOR RECEPTOR BINDING	5	8.87e-01	9.45e-01	0.13700	6.52e-02	1.20e-01	8.01e-01	6.42e-01
GOBP STRESS FIBER ASSEMBLY	109	7.94e-02	2.52e-01	0.13700	1.11e-01	8.01e-02	4.60e-02	1.48e-01
GOBP REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION	46	3.16e-01	5.55e-01	0.13700	1.27e-01	4.92e-02	1.35e-01	5.64e-01
GOBP AXON MIDLINE CHOICE POINT RECOGNITION	5	8.80e-01	9.43e-01	0.13700	4.33e-02	1.30e-01	8.67e-01	6.16e-01
Signalling to ERKs	34	4.57e-01	6.82e-01	0.13700	9.07e-02	1.02e-01	3.60e-01	3.03e-01
GOBP BENZENE CONTAINING COMPOUND METABOLIC PROCESS	26	4.57e-01	6.82e-01	0.13600	9.23e-03	-1.36e-01	9.35e-01	2.29e-01
GOBP NEGATIVE REGULATION OF ATP DEPENDENT ACTIVITY	17	6.34e-01	8.00e-01	0.13600	1.34e-01	2.72e-02	3.40e-01	8.46e-01
GOMF TRANSITION METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY	41	3.72e-01	6.08e-01	0.13600	6.26e-02	1.21e-01	4.88e-01	1.79e-01
GOCC MICROVILLUS	97	5.32e-02	1.96e-01	0.13600	-1.36e-01	1.19e-02	2.07e-02	8.39e-01
GOBP UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY	35	4.46e-01	6.73e-01	0.13600	8.84e-02	1.04e-01	3.66e-01	2.87e-01
GOBP NEGATIVE REGULATION OF WOUND HEALING	74	1.64e-01	3.84e-01	0.13600	-5.72e-02	-1.24e-01	3.95e-01	6.54e-02
GOMF FLIPPASE ACTIVITY	15	6.93e-01	8.40e-01	0.13600	-1.24e-01	-5.79e-02	4.07e-01	6.98e-01
GOBP PURINE NUCLEOBASE METABOLIC PROCESS	18	5.30e-01	7.33e-01	0.13600	8.11e-02	-1.10e-01	5.52e-01	4.20e-01
GOBP REGULATION OF VASCULAR PERMEABILITY	49	1.95e-01	4.24e-01	0.13600	-1.27e-01	4.90e-02	1.23e-01	5.53e-01
Response of Mtb to phagocytosis	22	5.84e-01	7.69e-01	0.13600	1.24e-01	5.67e-02	3.14e-01	6.45e-01
GOBP CELLULAR RESPONSE TO ABIOTIC STIMULUS	321	4.39e-04	5.40e-03	0.13600	1.24e-01	5.77e-02	1.41e-04	7.57e-02
Role of second messengers in netrin-1 signaling	9	8.10e-01	9.05e-01	0.13600	-7.75e-02	-1.12e-01	6.87e-01	5.60e-01
GOBP RESPIRATORY BURST INVOLVED IN INFLAMMATORY RESPONSE	9	8.07e-01	9.03e-01	0.13600	-1.18e-01	-6.76e-02	5.39e-01	7.25e-01
GOMF PHOSPHORUS OXYGEN LYASE ACTIVITY	22	4.59e-01	6.83e-01	0.13600	-9.00e-02	1.02e-01	4.65e-01	4.06e-01
GOBP REGULATION OF MICROTUBULE BINDING	7	7.82e-01	8.90e-01	0.13600	8.36e-02	-1.08e-01	7.02e-01	6.22e-01
GOCC PHAGOCYTIC VESICLE LUMEN	5	8.78e-01	9.41e-01	0.13600	-3.47e-02	-1.32e-01	8.93e-01	6.10e-01
GOMF CUPRIC ION BINDING	5	8.59e-01	9.30e-01	0.13600	-1.48e-02	1.35e-01	9.54e-01	6.00e-01
GOBP MUSCLE CELL MIGRATION	102	3.49e-02	1.47e-01	0.13600	1.28e-01	-4.54e-02	2.51e-02	4.28e-01
GOBP REGULATION OF MACROPHAGE CHEMOTAXIS	28	4.85e-01	6.99e-01	0.13600	-3.62e-02	-1.31e-01	7.40e-01	2.30e-01
GOBP NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION	52	2.84e-01	5.23e-01	0.13600	-5.82e-02	-1.23e-01	4.68e-01	1.25e-01
TRP channels	27	5.22e-01	7.27e-01	0.13600	-1.22e-01	-6.04e-02	2.74e-01	5.87e-01
GOBP LUNG CELL DIFFERENTIATION	29	3.94e-01	6.28e-01	0.13600	1.31e-01	-3.55e-02	2.22e-01	7.41e-01
GOBP RESPONSE TO ELECTRICAL STIMULUS	44	3.61e-01	5.98e-01	0.13600	7.68e-02	1.12e-01	3.78e-01	1.98e-01
GOBP POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS	42	3.74e-01	6.10e-01	0.13600	1.15e-01	7.20e-02	1.96e-01	4.20e-01
Calcineurin activates NFAT	9	7.71e-01	8.85e-01	0.13600	1.36e-01	1.16e-03	4.80e-01	9.95e-01
GOBP ISOTYPE SWITCHING TO IGG ISOTYPES	15	7.00e-01	8.44e-01	0.13600	-6.58e-02	-1.19e-01	6.59e-01	4.25e-01
Interferon gamma signaling	92	6.38e-02	2.18e-01	0.13600	-1.13e-02	1.35e-01	8.52e-01	2.48e-02
GOBP IMMATURE T CELL PROLIFERATION	12	6.71e-01	8.26e-01	0.13600	-5.00e-02	1.26e-01	7.64e-01	4.49e-01
GOBP MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION	21	6.17e-01	7.90e-01	0.13600	-1.09e-01	-8.13e-02	3.88e-01	5.19e-01
GOBP REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION	41	3.67e-01	6.04e-01	0.13600	1.25e-01	5.36e-02	1.67e-01	5.53e-01
VEGFR2 mediated vascular permeability	26	4.15e-01	6.45e-01	0.13600	1.21e-01	-6.05e-02	2.84e-01	5.93e-01
GOBP INDOLE CONTAINING COMPOUND METABOLIC PROCESS	22	5.49e-01	7.46e-01	0.13600	-1.87e-02	-1.34e-01	8.79e-01	2.75e-01
GOCC WEIBEL PALADE BODY	5	8.52e-01	9.26e-01	0.13600	1.31e-01	-3.54e-02	6.12e-01	8.91e-01
GOBP ACYLGLYCEROL HOMEOSTASIS	44	3.39e-01	5.77e-01	0.13600	-1.26e-01	-5.05e-02	1.48e-01	5.62e-01
GOBP POSITIVE T CELL SELECTION	44	3.33e-01	5.71e-01	0.13600	4.48e-02	1.28e-01	6.07e-01	1.42e-01
GOBP MYOBLAST FUSION	46	3.11e-01	5.51e-01	0.13600	-3.96e-02	-1.30e-01	6.42e-01	1.28e-01
GOBP REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY	132	2.63e-02	1.21e-01	0.13600	1.31e-02	1.35e-01	7.95e-01	7.40e-03
GOBP DORSAL SPINAL CORD DEVELOPMENT	20	4.99e-01	7.09e-01	0.13600	-8.10e-02	1.09e-01	5.31e-01	4.00e-01
GOBP POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS	35	4.07e-01	6.39e-01	0.13600	3.58e-02	1.31e-01	7.14e-01	1.81e-01
GOCC TORC2 COMPLEX	9	7.89e-01	8.93e-01	0.13600	1.33e-01	2.80e-02	4.91e-01	8.84e-01
GOBP SERINE FAMILY AMINO ACID CATABOLIC PROCESS	11	7.16e-01	8.54e-01	0.13600	1.34e-01	-1.67e-02	4.40e-01	9.23e-01
PI3K Cascade	43	3.00e-01	5.40e-01	0.13600	1.35e-01	8.96e-03	1.25e-01	9.19e-01
GOBP REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE	12	7.48e-01	8.71e-01	0.13600	5.61e-02	1.23e-01	7.36e-01	4.59e-01
GOBP XENOBIOTIC CATABOLIC PROCESS	24	5.04e-01	7.14e-01	0.13500	-3.12e-03	-1.35e-01	9.79e-01	2.51e-01
GOBP GLIAL CELL APOPTOTIC PROCESS	16	6.93e-01	8.40e-01	0.13500	8.04e-02	1.09e-01	5.78e-01	4.51e-01
GOMF R SMAD BINDING	25	4.44e-01	6.71e-01	0.13500	-4.24e-02	1.29e-01	7.14e-01	2.66e-01
GOBP REGULATION OF PROTEIN BINDING	120	5.52e-02	2.00e-01	0.13500	5.40e-02	1.24e-01	3.07e-01	1.89e-02
GOBP POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT	36	3.16e-01	5.55e-01	0.13500	3.72e-02	-1.30e-01	6.99e-01	1.77e-01
GOBP REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION	77	1.49e-01	3.63e-01	0.13500	1.27e-01	4.63e-02	5.37e-02	4.83e-01
GOBP SMOOTH MUSCLE CELL MIGRATION	88	4.88e-02	1.85e-01	0.13500	1.12e-01	-7.54e-02	6.87e-02	2.21e-01
GOBP LIPID TRANSPORT ACROSS BLOOD BRAIN BARRIER	6	8.47e-01	9.23e-01	0.13500	-1.19e-02	-1.35e-01	9.60e-01	5.68e-01
GOBP SIRNA PROCESSING	8	8.19e-01	9.09e-01	0.13500	1.28e-01	4.40e-02	5.31e-01	8.29e-01
GOBP NEGATIVE REGULATION OF KINASE ACTIVITY	176	1.55e-02	8.32e-02	0.13500	5.96e-02	1.21e-01	1.73e-01	5.50e-03
GOBP REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE	33	4.68e-01	6.90e-01	0.13500	7.43e-02	1.13e-01	4.60e-01	2.62e-01
GOBP NEGATIVE REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT	6	8.26e-01	9.12e-01	0.13500	3.55e-02	-1.30e-01	8.80e-01	5.80e-01
RHO GTPase cycle	419	5.06e-05	8.81e-04	0.13500	1.23e-01	5.54e-02	1.53e-05	5.18e-02
RHOC GTPase cycle	70	1.17e-01	3.18e-01	0.13500	1.33e-01	-2.28e-02	5.43e-02	7.41e-01
GOMF CARBON NITROGEN LYASE ACTIVITY	13	6.54e-01	8.13e-01	0.13500	4.84e-02	-1.26e-01	7.62e-01	4.32e-01
Interleukin-4 and Interleukin-13 signaling	103	3.10e-02	1.35e-01	0.13500	-1.17e-01	6.70e-02	4.01e-02	2.40e-01
SARS-CoV-2 Infection	279	2.05e-03	1.79e-02	0.13500	9.41e-02	9.66e-02	6.81e-03	5.50e-03
GOBP FLUID TRANSPORT	38	3.95e-01	6.29e-01	0.13500	-4.83e-02	-1.26e-01	6.06e-01	1.80e-01
GOBP POSITIVE REGULATION OF CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION	11	6.83e-01	8.35e-01	0.13500	-1.00e-01	9.03e-02	5.66e-01	6.04e-01
GOBP NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION	589	2.25e-06	5.98e-05	0.13500	7.99e-02	1.08e-01	9.27e-04	6.91e-06
GOBP EXTRACELLULAR MATRIX CONSTITUENT SECRETION	13	6.39e-01	8.03e-01	0.13500	-8.31e-02	1.06e-01	6.04e-01	5.08e-01
GOBP NEGATIVE REGULATION OF CHOLESTEROL EFFLUX	22	5.28e-01	7.32e-01	0.13500	6.22e-03	-1.34e-01	9.60e-01	2.75e-01
G alpha (s) signalling events	155	2.04e-02	1.01e-01	0.13500	-1.30e-01	-3.63e-02	5.37e-03	4.36e-01
GOBP DITERPENOID METABOLIC PROCESS	87	1.15e-01	3.14e-01	0.13500	-4.02e-02	-1.28e-01	5.17e-01	3.85e-02
GOMF ARYLSULFATASE ACTIVITY	9	7.54e-01	8.74e-01	0.13500	-3.37e-02	1.30e-01	8.61e-01	4.99e-01
GOBP NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION	14	6.37e-01	8.02e-01	0.13400	-4.41e-02	1.27e-01	7.75e-01	4.11e-01
GOBP GLAND DEVELOPMENT	435	6.83e-05	1.12e-03	0.13400	1.05e-01	8.37e-02	1.68e-04	2.75e-03
GOBP DOPAMINE BIOSYNTHETIC PROCESS	12	7.52e-01	8.73e-01	0.13400	-1.22e-01	-5.67e-02	4.65e-01	7.34e-01
GOCC MYOFILAMENT	26	4.22e-01	6.52e-01	0.13400	5.99e-02	-1.20e-01	5.97e-01	2.88e-01
GOBP INTRACELLULAR GLUTAMATE HOMEOSTASIS	6	8.25e-01	9.12e-01	0.13400	-1.27e-01	4.36e-02	5.90e-01	8.53e-01
GOBP CARNITINE TRANSPORT	8	8.28e-01	9.14e-01	0.13400	-1.20e-01	-5.95e-02	5.55e-01	7.71e-01
GOMF PHOSPHATIDYLCHOLINE BINDING	28	4.59e-01	6.83e-01	0.13400	1.34e-01	5.71e-03	2.19e-01	9.58e-01
GOBP LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL	55	2.54e-01	4.91e-01	0.13400	-1.29e-01	-3.83e-02	9.88e-02	6.23e-01
GOBP NERVE GROWTH FACTOR SIGNALING PATHWAY	14	7.17e-01	8.55e-01	0.13400	5.58e-02	1.22e-01	7.18e-01	4.29e-01
GOMF NUCLEOSIDE MONOPHOSPHATE KINASE ACTIVITY	19	6.55e-01	8.14e-01	0.13400	-1.00e-01	-8.93e-02	4.50e-01	5.00e-01
GOBP O GLYCAN PROCESSING	42	2.37e-01	4.74e-01	0.13400	-9.17e-02	9.79e-02	3.04e-01	2.72e-01
Arachidonate production from DAG	5	8.87e-01	9.46e-01	0.13400	-1.24e-01	-5.23e-02	6.32e-01	8.40e-01
Regulation of MITF-M-dependent genes involved in cell cycle and proliferation	18	6.36e-01	8.02e-01	0.13400	3.57e-02	1.29e-01	7.93e-01	3.42e-01
GOBP CATECHOL CONTAINING COMPOUND METABOLIC PROCESS	49	2.26e-01	4.60e-01	0.13400	-2.43e-02	1.32e-01	7.69e-01	1.10e-01
Pentose phosphate pathway	12	7.18e-01	8.55e-01	0.13400	7.03e-03	1.34e-01	9.66e-01	4.22e-01
GOBP CELLULAR RESPONSE TO HORMONE STIMULUS	596	1.90e-06	5.13e-05	0.13400	1.12e-01	7.37e-02	2.97e-06	2.11e-03
TP53 Regulates Transcription of Cell Death Genes	43	3.40e-01	5.78e-01	0.13400	3.55e-02	1.29e-01	6.87e-01	1.43e-01
Neutrophil degranulation	458	3.44e-07	1.11e-05	0.13400	-6.17e-02	1.19e-01	2.37e-02	1.27e-05
GOBP LYMPH VESSEL MORPHOGENESIS	23	4.58e-01	6.82e-01	0.13400	-8.03e-02	1.07e-01	5.05e-01	3.73e-01
GOBP STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE	54	3.03e-01	5.43e-01	0.13400	9.48e-02	9.46e-02	2.28e-01	2.29e-01
GOBP POSITIVE REGULATION OF HEMOPOIESIS	189	1.40e-02	7.70e-02	0.13400	7.05e-02	1.14e-01	9.47e-02	6.95e-03
GOBP POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS	12	6.76e-01	8.29e-01	0.13400	5.49e-02	-1.22e-01	7.42e-01	4.64e-01
Recycling of bile acids and salts	18	6.67e-01	8.24e-01	0.13400	-7.63e-02	-1.10e-01	5.75e-01	4.19e-01
Biological oxidations	211	4.83e-03	3.44e-02	0.13400	-3.02e-02	-1.30e-01	4.49e-01	1.09e-03
GOBP SUPEROXIDE ANION GENERATION	37	2.83e-01	5.22e-01	0.13400	-9.07e-02	9.85e-02	3.40e-01	3.00e-01
GOMF DELTA CATENIN BINDING	9	7.35e-01	8.65e-01	0.13400	-1.00e-01	8.89e-02	6.03e-01	6.44e-01
GOBP REGULATION OF OSSIFICATION	119	6.59e-02	2.23e-01	0.13400	6.58e-02	1.16e-01	2.15e-01	2.82e-02
GOBP ENDOCYTIC RECYCLING	83	9.08e-02	2.74e-01	0.13400	1.33e-01	-1.01e-02	3.58e-02	8.73e-01
GOBP POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET	7	7.89e-01	8.93e-01	0.13400	1.07e-01	-7.99e-02	6.24e-01	7.14e-01
GOBP PROTEIN CONTAINING COMPLEX LOCALIZATION	187	8.22e-03	5.19e-02	0.13400	1.31e-01	2.48e-02	1.95e-03	5.59e-01
GOCC SECRETORY GRANULE MEMBRANE	307	3.30e-05	6.15e-04	0.13400	-9.16e-02	9.74e-02	5.79e-03	3.35e-03
GOBP REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY	8	8.05e-01	9.02e-01	0.13400	1.33e-01	1.14e-02	5.14e-01	9.55e-01
GOBP REGULATION OF NUCLEAR DIVISION	146	2.52e-02	1.17e-01	0.13400	1.30e-01	3.08e-02	6.68e-03	5.21e-01
GOBP SKELETAL SYSTEM DEVELOPMENT	510	1.65e-05	3.31e-04	0.13400	1.01e-01	8.71e-02	9.10e-05	7.56e-04
GOMF GTPASE ACTIVITY	303	1.32e-03	1.29e-02	0.13400	8.37e-02	1.04e-01	1.22e-02	1.84e-03
RUNX3 regulates p14-ARF	10	7.86e-01	8.92e-01	0.13300	1.26e-01	4.52e-02	4.92e-01	8.04e-01
Activation of the AP-1 family of transcription factors	10	7.88e-01	8.92e-01	0.13300	4.87e-02	1.24e-01	7.90e-01	4.97e-01
GOBP CILIUM MOVEMENT	204	8.71e-03	5.43e-02	0.13300	-5.51e-02	-1.21e-01	1.75e-01	2.77e-03
GOMF PROTEIN SERINE KINASE ACTIVITY	342	1.42e-04	2.06e-03	0.13300	1.32e-01	1.87e-02	2.70e-05	5.52e-01
GOBP NEGATIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION	7	8.50e-01	9.25e-01	0.13300	5.83e-02	1.20e-01	7.89e-01	5.83e-01
GOBP LOCOMOTORY EXPLORATION BEHAVIOR	16	6.81e-01	8.33e-01	0.13300	1.25e-01	4.60e-02	3.86e-01	7.50e-01
GOCC AXONAL GROWTH CONE	25	4.32e-01	6.59e-01	0.13300	7.89e-02	-1.07e-01	4.95e-01	3.52e-01
GOBP ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY	25	5.73e-01	7.63e-01	0.13300	1.09e-01	7.67e-02	3.46e-01	5.07e-01
GOBP FATTY ACID DERIVATIVE METABOLIC PROCESS	68	1.14e-01	3.13e-01	0.13300	-5.00e-02	1.23e-01	4.76e-01	7.83e-02
GOBP POSITIVE REGULATION OF CENTRIOLE REPLICATION	8	8.39e-01	9.19e-01	0.13300	1.01e-01	8.70e-02	6.21e-01	6.70e-01
GOMF ATP DEPENDENT ACTIVITY	561	1.02e-07	3.67e-06	0.13300	1.32e-01	-1.78e-02	9.11e-08	4.72e-01
Metabolism of cofactors	25	5.62e-01	7.55e-01	0.13300	1.19e-01	5.98e-02	3.03e-01	6.05e-01
GOMF ACTININ BINDING	36	3.11e-01	5.52e-01	0.13300	5.70e-02	-1.20e-01	5.54e-01	2.12e-01
GOCC MICROVILLUS MEMBRANE	32	3.40e-01	5.78e-01	0.13300	-9.74e-02	9.07e-02	3.40e-01	3.75e-01
GOBP SECONDARY PALATE DEVELOPMENT	26	5.39e-01	7.39e-01	0.13300	1.24e-01	4.86e-02	2.74e-01	6.68e-01
GOBP POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY	106	9.95e-02	2.89e-01	0.13300	9.78e-02	9.02e-02	8.20e-02	1.09e-01
GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION	19	5.67e-01	7.58e-01	0.13300	1.31e-01	-2.32e-02	3.23e-01	8.61e-01
GOBP PURINE NUCLEOSIDE CATABOLIC PROCESS	7	8.00e-01	8.99e-01	0.13300	1.24e-01	-4.91e-02	5.71e-01	8.22e-01
GOBP MAMMARY GLAND MORPHOGENESIS	45	3.69e-01	6.05e-01	0.13300	1.09e-01	7.56e-02	2.04e-01	3.80e-01
GOMF OXYSTEROL BINDING	16	6.64e-01	8.22e-01	0.13300	1.31e-01	2.51e-02	3.66e-01	8.62e-01
GOBP PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS	14	7.36e-01	8.66e-01	0.13300	8.52e-02	1.02e-01	5.81e-01	5.09e-01
GOBP REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY	23	5.97e-01	7.77e-01	0.13300	-1.13e-01	-6.94e-02	3.47e-01	5.64e-01
GOBP REGULATION OF PROTEIN TARGETING	75	1.44e-01	3.57e-01	0.13300	1.31e-01	2.08e-02	4.95e-02	7.55e-01
GOBP POSITIVE REGULATION OF PHOSPHATASE ACTIVITY	25	5.50e-01	7.46e-01	0.13300	1.25e-01	4.45e-02	2.79e-01	7.00e-01
GOCC SARCOLEMMA	136	4.10e-02	1.65e-01	0.13300	-4.91e-02	-1.23e-01	3.23e-01	1.30e-02
GOCC POLYPRENYL DIPHOSPHATE SYNTHASE COMPLEX	10	8.04e-01	9.02e-01	0.13300	9.56e-02	9.21e-02	6.01e-01	6.14e-01
WNT ligand biogenesis and trafficking	25	4.34e-01	6.62e-01	0.13300	-8.02e-02	1.06e-01	4.88e-01	3.60e-01
GOBP POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION	33	4.20e-01	6.51e-01	0.13300	-1.32e-01	-1.55e-02	1.90e-01	8.78e-01
Acyl chain remodelling of PE	29	4.01e-01	6.34e-01	0.13300	4.55e-02	-1.25e-01	6.71e-01	2.45e-01
GOCC RECYCLING ENDOSOME MEMBRANE	100	8.91e-02	2.70e-01	0.13300	3.99e-02	1.27e-01	4.91e-01	2.87e-02
GOBP REGULATION OF TRANSLATION	428	4.87e-05	8.56e-04	0.13300	1.24e-01	4.85e-02	1.17e-05	8.56e-02
GOBP POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION	44	2.76e-01	5.15e-01	0.13300	-1.91e-02	1.31e-01	8.26e-01	1.32e-01
GOCC CLATHRIN SCULPTED MONOAMINE TRANSPORT VESICLE	5	8.96e-01	9.49e-01	0.13300	7.68e-02	1.08e-01	7.66e-01	6.76e-01
GOBP ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY	182	7.31e-03	4.73e-02	0.13300	4.42e-03	1.33e-01	9.18e-01	2.04e-03
GOBP NEGATIVE REGULATION OF STEM CELL PROLIFERATION	26	5.16e-01	7.22e-01	0.13300	1.30e-01	2.43e-02	2.50e-01	8.30e-01
GOBP GANGLIOSIDE BIOSYNTHETIC PROCESS VIA LACTOSYLCERAMIDE	6	8.43e-01	9.21e-01	0.13200	1.01e-02	-1.32e-01	9.66e-01	5.75e-01
GOCC CONTRACTILE MUSCLE FIBER	243	4.24e-04	5.24e-03	0.13200	5.94e-02	-1.18e-01	1.11e-01	1.48e-03
GOBP SMOOTH MUSCLE CELL PROLIFERATION	162	1.55e-02	8.32e-02	0.13200	1.31e-01	1.86e-02	4.00e-03	6.82e-01
GOMF BH3 DOMAIN BINDING	6	8.45e-01	9.22e-01	0.13200	-5.49e-03	1.32e-01	9.81e-01	5.75e-01
GOBP REGULATION OF NODAL SIGNALING PATHWAY	5	8.86e-01	9.45e-01	0.13200	-1.27e-01	-3.74e-02	6.23e-01	8.85e-01
GOBP GLYCEROL ETHER METABOLIC PROCESS	21	5.97e-01	7.77e-01	0.13200	-3.42e-02	-1.28e-01	7.86e-01	3.11e-01
GOBP POSITIVE REGULATION OF CYTOKINE PRODUCTION	485	1.36e-07	4.75e-06	0.13200	-9.97e-02	8.68e-02	1.68e-04	1.06e-03
GOBP NEGATIVE REGULATION OF TRANSPORTER ACTIVITY	86	7.39e-02	2.40e-01	0.13200	3.40e-02	-1.28e-01	5.86e-01	4.05e-02
Regulation of T cell activation by CD28 family	69	2.00e-01	4.30e-01	0.13200	4.92e-02	1.23e-01	4.80e-01	7.78e-02
GOBP CARBOHYDRATE IMPORT ACROSS PLASMA MEMBRANE	6	8.34e-01	9.17e-01	0.13200	-1.28e-01	3.17e-02	5.86e-01	8.93e-01
GOBP GLYCOSIDE METABOLIC PROCESS	20	5.14e-01	7.21e-01	0.13200	8.71e-02	-9.94e-02	5.00e-01	4.42e-01
Keratan sulfate biosynthesis	28	4.70e-01	6.92e-01	0.13200	-5.25e-03	-1.32e-01	9.62e-01	2.26e-01
GOBP PROTON TRANSPORTING V TYPE ATPASE COMPLEX ASSEMBLY	7	8.02e-01	9.01e-01	0.13200	1.22e-01	-4.96e-02	5.75e-01	8.20e-01
GOCC INTERCALATED DISC	50	1.98e-01	4.28e-01	0.13200	6.47e-02	-1.15e-01	4.29e-01	1.59e-01
GOBP POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS	251	2.67e-04	3.56e-03	0.13200	-1.03e-01	8.22e-02	4.79e-03	2.49e-02
GOBP NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS	251	4.66e-03	3.36e-02	0.13200	1.01e-01	8.48e-02	5.76e-03	2.06e-02
GOBP REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING	61	2.67e-01	5.06e-01	0.13200	1.04e-01	8.10e-02	1.59e-01	2.74e-01
Glycolysis	72	1.62e-01	3.82e-01	0.13200	1.30e-01	2.30e-02	5.65e-02	7.35e-01
GOBP MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM	13	6.62e-01	8.20e-01	0.13200	-1.21e-01	5.38e-02	4.52e-01	7.37e-01
GOBP NEUTROPHIL CLEARANCE	6	8.70e-01	9.37e-01	0.13200	1.22e-01	5.02e-02	6.05e-01	8.31e-01
GOBP REGULATION OF DENDRITIC SPINE DEVELOPMENT	53	2.56e-01	4.93e-01	0.13200	-1.70e-02	-1.31e-01	8.30e-01	9.99e-02
GOBP FC RECEPTOR SIGNALING PATHWAY	53	1.74e-01	3.97e-01	0.13200	-9.09e-02	9.53e-02	2.52e-01	2.30e-01
GOBP MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS	24	5.14e-01	7.21e-01	0.13200	1.32e-01	-6.07e-03	2.65e-01	9.59e-01
FGFR3b ligand binding and activation	7	8.11e-01	9.05e-01	0.13200	-1.28e-01	3.21e-02	5.58e-01	8.83e-01
Chondroitin sulfate/dermatan sulfate metabolism	46	3.68e-01	6.05e-01	0.13200	-1.08e-01	-7.47e-02	2.03e-01	3.80e-01
GOMF VITAMIN TRANSMEMBRANE TRANSPORTER ACTIVITY	34	4.65e-01	6.87e-01	0.13200	-5.88e-02	-1.18e-01	5.53e-01	2.35e-01
Transcriptional Regulation by NPAS4	32	4.70e-01	6.92e-01	0.13200	1.24e-01	4.29e-02	2.24e-01	6.75e-01
GOBP CORTICAL CYTOSKELETON ORGANIZATION	52	3.18e-01	5.57e-01	0.13100	6.71e-02	1.13e-01	4.03e-01	1.58e-01
GOBP NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY	17	5.73e-01	7.63e-01	0.13100	8.17e-02	-1.03e-01	5.60e-01	4.62e-01
GOBP BLOOD VESSEL REMODELING	46	3.39e-01	5.77e-01	0.13100	1.24e-01	4.20e-02	1.44e-01	6.22e-01
GOBP MODIFICATION OF POSTSYNAPTIC STRUCTURE	22	6.24e-01	7.93e-01	0.13100	1.04e-01	8.06e-02	4.00e-01	5.13e-01
GOBP CRISTAE FORMATION	17	5.92e-01	7.73e-01	0.13100	1.23e-01	-4.53e-02	3.79e-01	7.46e-01
GOBP ANTEROGRADE AXONAL TRANSPORT	49	3.53e-01	5.90e-01	0.13100	9.09e-02	9.48e-02	2.71e-01	2.51e-01
GOBP DNA LIGATION INVOLVED IN DNA REPAIR	5	8.97e-01	9.50e-01	0.13100	7.07e-02	1.11e-01	7.84e-01	6.68e-01
GOBP POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY	14	6.34e-01	8.00e-01	0.13100	-1.06e-01	7.73e-02	4.92e-01	6.17e-01
GOBP DETERMINATION OF LIVER LEFT RIGHT ASYMMETRY	5	8.94e-01	9.49e-01	0.13100	-1.17e-01	-5.92e-02	6.50e-01	8.19e-01
GOBP MYELOID CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE	94	4.68e-02	1.80e-01	0.13100	-1.03e-01	8.16e-02	8.52e-02	1.71e-01
GOBP CELLULAR RESPONSE TO ETHER	6	8.68e-01	9.35e-01	0.13100	-4.18e-02	-1.24e-01	8.59e-01	5.98e-01
GOMF AMINOPEPTIDASE ACTIVITY	38	2.99e-01	5.39e-01	0.13100	1.16e-01	-6.13e-02	2.16e-01	5.13e-01
G beta:gamma signalling through PI3Kgamma	25	5.78e-01	7.66e-01	0.13100	1.13e-01	6.70e-02	3.29e-01	5.62e-01
GOBP HYALURONAN CATABOLIC PROCESS	16	5.98e-01	7.77e-01	0.13100	6.78e-02	-1.12e-01	6.39e-01	4.37e-01
GOBP SYNCYTIUM FORMATION	64	2.34e-01	4.71e-01	0.13100	-5.31e-02	-1.20e-01	4.63e-01	9.73e-02
GOBP PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS	50	2.30e-01	4.65e-01	0.13100	-2.85e-02	1.28e-01	7.27e-01	1.18e-01
GOBP REGULATION OF PROTEIN DEACETYLATION	26	4.40e-01	6.67e-01	0.13100	1.17e-01	-5.90e-02	3.02e-01	6.03e-01
GOCC ENDOSOME LUMEN	38	3.25e-01	5.64e-01	0.13100	-1.27e-01	3.09e-02	1.75e-01	7.42e-01
GOBP REGULATION OF HETEROTYPIC CELL CELL ADHESION	24	4.88e-01	7.02e-01	0.13100	-3.50e-02	1.26e-01	7.67e-01	2.85e-01
GOBP REGULATION OF MONOOXYGENASE ACTIVITY	37	3.81e-01	6.15e-01	0.13100	-1.31e-01	-9.27e-03	1.69e-01	9.22e-01
GOMF RECEPTOR ANTAGONIST ACTIVITY	16	5.94e-01	7.75e-01	0.13100	9.88e-02	-8.56e-02	4.94e-01	5.53e-01
GOBP REGULATION OF HORMONE METABOLIC PROCESS	39	2.87e-01	5.26e-01	0.13100	-1.11e-01	6.94e-02	2.31e-01	4.53e-01
GOMF REGULATORY RNA BINDING	50	2.96e-01	5.35e-01	0.13100	1.28e-01	2.83e-02	1.18e-01	7.29e-01
GOCC CYTOLYTIC GRANULE	14	6.41e-01	8.04e-01	0.13100	-1.13e-01	6.51e-02	4.63e-01	6.73e-01
GOBP NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY	18	5.57e-01	7.51e-01	0.13100	-8.46e-02	9.95e-02	5.34e-01	4.65e-01
GOBP REGULATION OF CYTOSKELETON ORGANIZATION	500	2.37e-05	4.58e-04	0.13100	1.12e-01	6.66e-02	1.69e-05	1.08e-02
GOMF ER RETENTION SEQUENCE BINDING	5	9.00e-01	9.51e-01	0.13100	9.51e-02	8.95e-02	7.13e-01	7.29e-01
GOMF ENOYL COA HYDRATASE ACTIVITY	11	7.31e-01	8.63e-01	0.13100	-1.96e-02	1.29e-01	9.10e-01	4.59e-01
GOBP PROTEIN AUTOUBIQUITINATION	72	1.73e-01	3.96e-01	0.13100	1.28e-01	2.76e-02	6.12e-02	6.85e-01
GOBP CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION	39	3.58e-01	5.95e-01	0.13000	-4.52e-03	-1.30e-01	9.61e-01	1.59e-01
GOBP ANTIBACTERIAL INNATE IMMUNE RESPONSE	10	7.38e-01	8.66e-01	0.13000	-4.50e-02	1.22e-01	8.05e-01	5.02e-01
GOBP HEPATICOBILIARY SYSTEM DEVELOPMENT	142	5.15e-02	1.91e-01	0.13000	9.22e-02	9.23e-02	5.78e-02	5.76e-02
GOBP ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS	1697	3.34e-15	3.39e-13	0.13000	1.04e-01	7.82e-02	7.98e-13	8.33e-08
GOBP CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION	26	4.83e-01	6.99e-01	0.13000	1.30e-01	-1.41e-02	2.52e-01	9.01e-01
GOBP AMMONIUM ION METABOLIC PROCESS	22	4.90e-01	7.04e-01	0.13000	9.36e-02	-9.08e-02	4.47e-01	4.61e-01
GOBP NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION	54	3.08e-01	5.48e-01	0.13000	1.14e-01	6.33e-02	1.47e-01	4.21e-01
Methionine salvage pathway	6	8.44e-01	9.21e-01	0.13000	-1.29e-01	1.75e-02	5.84e-01	9.41e-01
GOBP NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION	154	1.76e-02	9.06e-02	0.13000	1.30e-01	3.21e-03	5.25e-03	9.45e-01
GOMF CHONDROITIN SULFOTRANSFERASE ACTIVITY	5	8.88e-01	9.46e-01	0.13000	-1.26e-01	-3.48e-02	6.27e-01	8.93e-01
GOCC CIA COMPLEX	5	8.70e-01	9.37e-01	0.13000	1.30e-01	-1.25e-02	6.16e-01	9.61e-01
GOMF CHLORIDE CHANNEL ACTIVITY	74	2.10e-01	4.42e-01	0.13000	-7.86e-02	-1.04e-01	2.42e-01	1.23e-01
GOBP RESPONSE TO UV B	21	6.29e-01	7.97e-01	0.13000	5.83e-02	1.16e-01	6.44e-01	3.56e-01
GOBP HOMEOSTASIS OF NUMBER OF CELLS	306	1.75e-03	1.59e-02	0.13000	8.42e-02	9.94e-02	1.13e-02	2.79e-03
GOBP POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS	34	4.49e-01	6.75e-01	0.13000	3.63e-02	1.25e-01	7.14e-01	2.07e-01
GOBP NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	27	5.66e-01	7.57e-01	0.13000	7.93e-02	1.03e-01	4.76e-01	3.53e-01
GOBP REGULATION OF EPITHELIAL CELL DIFFERENTIATION	168	1.24e-02	7.00e-02	0.13000	3.08e-03	1.30e-01	9.45e-01	3.64e-03
GOMF SPHINGOLIPID BINDING	28	4.49e-01	6.75e-01	0.13000	-1.28e-01	2.37e-02	2.42e-01	8.28e-01
GOBP POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION	52	2.67e-01	5.06e-01	0.13000	1.32e-02	1.29e-01	8.69e-01	1.07e-01
ROBO receptors bind AKAP5	9	8.27e-01	9.13e-01	0.13000	1.05e-01	7.63e-02	5.85e-01	6.92e-01
GOBP POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION	70	1.33e-01	3.41e-01	0.13000	-2.80e-02	1.27e-01	6.85e-01	6.64e-02
GOMF ALPHA ACTININ BINDING	28	4.50e-01	6.75e-01	0.13000	2.35e-02	-1.28e-01	8.30e-01	2.42e-01
GOBP CILIUM DISASSEMBLY	5	8.70e-01	9.37e-01	0.13000	-1.50e-02	1.29e-01	9.54e-01	6.17e-01
GOBP SODIUM ION TRANSPORT	237	7.46e-03	4.80e-02	0.13000	-8.60e-02	-9.73e-02	2.25e-02	9.84e-03
GOMF PROTEIN SERINE THREONINE KINASE ACTIVITY	405	3.85e-05	7.01e-04	0.13000	1.29e-01	1.10e-02	7.82e-06	7.04e-01
GOMF CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY	26	5.80e-01	7.67e-01	0.13000	-7.94e-02	-1.03e-01	4.84e-01	3.65e-01
GOBP NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS	400	2.83e-04	3.73e-03	0.13000	9.58e-02	8.74e-02	1.00e-03	2.71e-03
GOBP POSITIVE REGULATION OF MEMBRANE PERMEABILITY	45	3.16e-01	5.55e-01	0.13000	8.93e-03	1.29e-01	9.17e-01	1.33e-01
GOBP RESPONSE TO LITHIUM ION	16	6.97e-01	8.42e-01	0.13000	1.21e-01	4.68e-02	4.03e-01	7.46e-01
PKA activation in glucagon signalling	17	6.97e-01	8.42e-01	0.13000	-1.10e-01	-6.88e-02	4.33e-01	6.23e-01
GOBP VESICLE LOCALIZATION	209	1.19e-02	6.79e-02	0.12900	1.11e-01	6.60e-02	5.48e-03	1.00e-01
GOBP CELLULAR RESPONSE TO UV A	10	8.10e-01	9.05e-01	0.12900	-1.06e-01	-7.40e-02	5.61e-01	6.85e-01
GOBP CENTRAL NERVOUS SYSTEM DEVELOPMENT	975	4.10e-09	1.99e-07	0.12900	9.61e-02	8.66e-02	3.75e-07	4.62e-06
GOBP REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS	26	5.06e-01	7.15e-01	0.12900	-4.43e-04	-1.29e-01	9.97e-01	2.54e-01
GOBP MORPHOGENESIS OF EMBRYONIC EPITHELIUM	148	4.79e-02	1.83e-01	0.12900	8.85e-02	9.42e-02	6.30e-02	4.78e-02
GOBP NAD METABOLIC PROCESS	63	2.55e-01	4.93e-01	0.12900	-1.15e-01	-5.80e-02	1.13e-01	4.26e-01
Establishment of Sister Chromatid Cohesion	9	7.70e-01	8.84e-01	0.12900	1.25e-01	-3.27e-02	5.16e-01	8.65e-01
GOBP NEGATIVE REGULATION OF GROWTH	216	1.20e-02	6.85e-02	0.12900	8.55e-02	9.69e-02	3.03e-02	1.41e-02
Prolonged ERK activation events	14	6.49e-01	8.10e-01	0.12900	1.14e-01	-6.06e-02	4.60e-01	6.95e-01
GOBP RESPONSE TO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR	9	8.28e-01	9.13e-01	0.12900	1.07e-01	7.24e-02	5.78e-01	7.07e-01
GOBP REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT	17	6.99e-01	8.43e-01	0.12900	1.09e-01	6.95e-02	4.37e-01	6.20e-01
GOBP MAMMARY GLAND FORMATION	7	8.45e-01	9.22e-01	0.12900	1.27e-01	2.41e-02	5.61e-01	9.12e-01
GOBP LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS	6	8.76e-01	9.40e-01	0.12900	-5.05e-02	-1.19e-01	8.30e-01	6.14e-01
GOBP METANEPHRIC NEPHRON DEVELOPMENT	40	3.83e-01	6.17e-01	0.12900	2.52e-02	1.27e-01	7.83e-01	1.66e-01
GOBP REGULATION OF NEUTROPHIL CHEMOTAXIS	31	4.16e-01	6.46e-01	0.12900	-2.56e-02	1.27e-01	8.05e-01	2.23e-01
GOBP FEMALE GAMETE GENERATION	162	1.21e-02	6.89e-02	0.12900	1.28e-01	-1.49e-02	4.88e-03	7.44e-01
GOBP TUBE FORMATION	148	4.85e-02	1.84e-01	0.12900	8.71e-02	9.52e-02	6.75e-02	4.57e-02
GOMF MANGANESE ION TRANSMEMBRANE TRANSPORTER ACTIVITY	9	8.19e-01	9.09e-01	0.12900	-1.19e-01	-4.95e-02	5.36e-01	7.97e-01
GOCC BASAL PART OF CELL	300	1.63e-03	1.50e-02	0.12900	-1.15e-01	-5.75e-02	5.81e-04	8.68e-02
Recycling pathway of L1	42	4.05e-01	6.38e-01	0.12900	6.00e-02	1.14e-01	5.01e-01	2.00e-01
GOMF PHOSPHORIC DIESTER HYDROLASE ACTIVITY	86	1.68e-01	3.90e-01	0.12900	-1.04e-01	-7.61e-02	9.52e-02	2.22e-01
GOBP OLFACTORY NERVE DEVELOPMENT	6	8.54e-01	9.27e-01	0.12900	1.19e-03	-1.29e-01	9.96e-01	5.84e-01
GOBP CAMP PKA SIGNAL TRANSDUCTION	5	8.84e-01	9.44e-01	0.12900	-1.28e-01	-1.59e-02	6.20e-01	9.51e-01
GOBP TERPENOID METABOLIC PROCESS	98	1.20e-01	3.22e-01	0.12900	-5.58e-02	-1.16e-01	3.39e-01	4.69e-02
GOBP NOSE DEVELOPMENT	16	7.20e-01	8.56e-01	0.12900	8.88e-02	9.34e-02	5.39e-01	5.18e-01
GOMF DEHYDROASCORBIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY	8	7.81e-01	8.90e-01	0.12900	-1.11e-01	6.49e-02	5.86e-01	7.51e-01
GOBP OSTEOCLAST PROLIFERATION	11	7.44e-01	8.69e-01	0.12900	-9.56e-03	1.28e-01	9.56e-01	4.61e-01
GOMF FIBRONECTIN BINDING	30	5.07e-01	7.15e-01	0.12900	1.22e-01	4.11e-02	2.47e-01	6.97e-01
PKA activation	18	6.64e-01	8.22e-01	0.12900	-1.22e-01	-4.07e-02	3.69e-01	7.65e-01
GOBP MYELOID LEUKOCYTE ACTIVATION	238	6.51e-04	7.49e-03	0.12900	-1.08e-01	7.06e-02	4.23e-03	6.06e-02
GOBP INTERLEUKIN 8 PRODUCTION	97	6.72e-02	2.26e-01	0.12900	-1.27e-01	2.24e-02	3.10e-02	7.03e-01
GOBP DETERMINATION OF ADULT LIFESPAN	35	4.89e-01	7.03e-01	0.12900	9.38e-02	8.81e-02	3.37e-01	3.67e-01
GOBP MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL	47	3.83e-01	6.17e-01	0.12900	-8.90e-02	-9.30e-02	2.91e-01	2.70e-01
GOBP ENDONUCLEOLYTIC CLEAVAGE IN 5 ETS OF TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA	7	8.47e-01	9.23e-01	0.12900	2.65e-02	1.26e-01	9.03e-01	5.64e-01
GOMF PRIMARY ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY	147	1.22e-02	6.92e-02	0.12900	1.18e-01	-5.20e-02	1.37e-02	2.77e-01
GOBP LAMELLIPODIUM ORGANIZATION	86	1.47e-01	3.61e-01	0.12900	1.20e-01	4.53e-02	5.35e-02	4.68e-01
GOBP PEPTIDYL METHIONINE MODIFICATION	11	7.62e-01	8.79e-01	0.12900	1.28e-01	1.46e-02	4.63e-01	9.33e-01
GOMF NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY	12	7.79e-01	8.89e-01	0.12900	7.17e-02	1.07e-01	6.67e-01	5.22e-01
Disease	1704	6.46e-15	6.44e-13	0.12800	1.06e-01	7.28e-02	3.48e-13	5.81e-07
GOBP APICAL JUNCTION ASSEMBLY	75	2.10e-01	4.42e-01	0.12800	-6.99e-02	-1.08e-01	2.96e-01	1.06e-01
GOBP DIGESTIVE SYSTEM DEVELOPMENT	140	4.85e-02	1.84e-01	0.12800	1.17e-01	5.28e-02	1.68e-02	2.81e-01
GOBP REGULATION OF OSTEOBLAST DIFFERENTIATION	151	4.28e-02	1.70e-01	0.12800	6.59e-02	1.10e-01	1.62e-01	1.95e-02
GOBP L GLUTAMATE IMPORT	39	3.89e-01	6.22e-01	0.12800	1.27e-01	1.86e-02	1.70e-01	8.41e-01
GOBP POSITIVE REGULATION OF DEFENSE RESPONSE TO BACTERIUM	14	6.48e-01	8.09e-01	0.12800	-7.60e-02	1.03e-01	6.22e-01	5.04e-01
GOBP ADAPTIVE IMMUNE RESPONSE	454	2.90e-06	7.47e-05	0.12800	-1.23e-01	3.48e-02	6.72e-06	2.04e-01
Triglyceride catabolism	23	4.95e-01	7.08e-01	0.12800	6.46e-02	-1.11e-01	5.92e-01	3.59e-01
Signaling by RNF43 mutants	8	7.85e-01	8.92e-01	0.12800	5.93e-02	-1.13e-01	7.71e-01	5.78e-01
GOBP POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION	25	5.48e-01	7.45e-01	0.12800	1.96e-02	1.27e-01	8.65e-01	2.74e-01
GOBP REGULATION OF PLATELET AGGREGATION	29	4.05e-01	6.38e-01	0.12800	-9.56e-02	8.51e-02	3.73e-01	4.28e-01
GOMF FRIZZLED BINDING	36	3.40e-01	5.78e-01	0.12800	-5.48e-02	1.16e-01	5.69e-01	2.30e-01
GOMF THYROID HORMONE TRANSMEMBRANE TRANSPORTER ACTIVITY	7	8.68e-01	9.35e-01	0.12800	-8.96e-02	-9.13e-02	6.81e-01	6.76e-01
GOBP AUTONOMIC NERVOUS SYSTEM DEVELOPMENT	45	3.94e-01	6.28e-01	0.12800	1.08e-01	6.86e-02	2.10e-01	4.26e-01
GOBP EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	110	7.97e-02	2.52e-01	0.12800	1.24e-01	3.11e-02	2.46e-02	5.73e-01
GOBP NEGATIVE REGULATION OF PLATELET AGGREGATION	11	7.62e-01	8.79e-01	0.12800	-1.27e-01	-1.16e-02	4.65e-01	9.47e-01
GOBP AMINOPHOSPHOLIPID TRANSPORT	8	8.39e-01	9.19e-01	0.12800	4.64e-02	1.19e-01	8.20e-01	5.60e-01
Serotonin Neurotransmitter Release Cycle	17	6.68e-01	8.25e-01	0.12800	-1.26e-01	-2.30e-02	3.70e-01	8.70e-01
GOCC PLATELET ALPHA GRANULE MEMBRANE	16	7.06e-01	8.48e-01	0.12800	-4.89e-02	-1.18e-01	7.35e-01	4.14e-01
GOBP REGULATION OF ACTIN FILAMENT ORGANIZATION	259	2.55e-03	2.13e-02	0.12800	1.25e-01	2.74e-02	5.48e-04	4.48e-01
GOCC NUCLEAR ENVELOPE	473	7.06e-05	1.16e-03	0.12800	1.08e-01	6.86e-02	6.00e-05	1.06e-02
GOBP PURINE NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS	6	8.81e-01	9.43e-01	0.12800	-5.85e-02	-1.13e-01	8.04e-01	6.30e-01
GOBP ENERGY RESERVE METABOLIC PROCESS	93	8.32e-02	2.59e-01	0.12800	1.27e-01	-1.48e-02	3.47e-02	8.05e-01
GOBP GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS	23	5.63e-01	7.55e-01	0.12800	1.27e-01	6.61e-03	2.90e-01	9.56e-01
GOBP L ALANINE TRANSPORT	10	8.13e-01	9.06e-01	0.12800	6.74e-02	1.08e-01	7.12e-01	5.53e-01
Regulated Necrosis	56	2.50e-01	4.89e-01	0.12800	9.19e-03	1.27e-01	9.05e-01	9.96e-02
GOBP D AMINO ACID TRANSPORT	6	8.71e-01	9.37e-01	0.12800	-3.03e-02	-1.24e-01	8.98e-01	5.99e-01
GOBP POSITIVE REGULATION OF VASCULAR PERMEABILITY	17	7.11e-01	8.51e-01	0.12800	-9.33e-02	-8.70e-02	5.05e-01	5.35e-01
GOBP RESPONSE TO RADIATION	414	8.87e-05	1.41e-03	0.12700	1.24e-01	3.08e-02	1.58e-05	2.82e-01
GOMF ACYLGLYCEROL LIPASE ACTIVITY	15	6.87e-01	8.37e-01	0.12700	-1.27e-01	-5.32e-03	3.93e-01	9.72e-01
GOBP SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND	67	2.55e-01	4.93e-01	0.12700	1.05e-01	7.15e-02	1.35e-01	3.12e-01
GOBP INTRACELLULAR PH ELEVATION	7	8.12e-01	9.05e-01	0.12700	5.53e-02	-1.15e-01	8.00e-01	5.99e-01
GOBP HEMOPOIESIS	928	5.86e-09	2.69e-07	0.12700	5.42e-02	1.15e-01	5.16e-03	2.58e-09
GOBP SENSORY SYSTEM DEVELOPMENT	395	9.00e-05	1.42e-03	0.12700	1.26e-01	1.77e-02	1.68e-05	5.46e-01
Acetylcholine regulates insulin secretion	10	8.18e-01	9.08e-01	0.12700	-9.74e-02	-8.21e-02	5.94e-01	6.53e-01
GOBP POSITIVE REGULATION OF PROTEIN IMPORT INTO NUCLEUS	39	3.99e-01	6.32e-01	0.12700	1.25e-01	2.29e-02	1.76e-01	8.04e-01
GOBP NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS	41	3.83e-01	6.17e-01	0.12700	-2.43e-02	-1.25e-01	7.88e-01	1.66e-01
Caspase activation via Dependence Receptors in the absence of ligand	9	7.86e-01	8.92e-01	0.12700	1.26e-01	-1.62e-02	5.12e-01	9.33e-01
Repression of WNT target genes	14	7.47e-01	8.70e-01	0.12700	6.13e-02	1.11e-01	6.91e-01	4.70e-01
GOBP HEART VALVE MORPHOGENESIS	61	2.82e-01	5.21e-01	0.12700	6.21e-02	1.11e-01	4.02e-01	1.34e-01
GOBP REGULATION OF POLYSACCHARIDE METABOLIC PROCESS	43	4.06e-01	6.39e-01	0.12700	5.82e-02	1.13e-01	5.09e-01	2.00e-01
GOBP EXTRACELLULAR EXOSOME ASSEMBLY	7	8.66e-01	9.35e-01	0.12700	6.79e-02	1.08e-01	7.56e-01	6.22e-01
GOMF PHOSPHATIDYLSERINE BINDING	66	2.50e-01	4.88e-01	0.12700	-1.14e-01	-5.61e-02	1.09e-01	4.31e-01
GOMF ESTROGEN RESPONSE ELEMENT BINDING	10	8.02e-01	9.01e-01	0.12700	1.20e-01	4.16e-02	5.11e-01	8.20e-01
GOBP ADAPTIVE THERMOGENESIS	166	3.42e-02	1.45e-01	0.12700	1.08e-01	6.74e-02	1.67e-02	1.34e-01
GOCC SCAR COMPLEX	12	7.37e-01	8.66e-01	0.12700	1.27e-01	-5.32e-04	4.46e-01	9.97e-01
GOBP NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS	15	6.53e-01	8.13e-01	0.12700	-3.79e-02	1.21e-01	8.00e-01	4.17e-01
GOBP LYMPHOCYTE COSTIMULATION	45	2.58e-01	4.96e-01	0.12700	-6.76e-02	1.07e-01	4.33e-01	2.13e-01
GOBP CYCLIC NUCLEOTIDE CATABOLIC PROCESS	14	7.46e-01	8.70e-01	0.12700	-1.14e-01	-5.64e-02	4.62e-01	7.15e-01
GOMF CADHERIN BINDING	329	8.55e-04	9.29e-03	0.12700	1.19e-01	4.33e-02	2.03e-04	1.77e-01
GOBP PROTEIN DEACETYLATION	38	3.49e-01	5.87e-01	0.12700	1.23e-01	-2.98e-02	1.89e-01	7.50e-01
GOBP POSITIVE REGULATION OF CELLULAR RESPIRATION	13	7.62e-01	8.79e-01	0.12700	5.77e-02	1.13e-01	7.19e-01	4.81e-01
GOBP POTASSIUM ION TRANSPORT	239	9.16e-03	5.62e-02	0.12700	-8.82e-02	-9.10e-02	1.88e-02	1.54e-02
GOBP PARTURITION	14	7.48e-01	8.71e-01	0.12700	-6.01e-02	-1.12e-01	6.97e-01	4.70e-01
GOBP EXTERNAL ENCAPSULATING STRUCTURE ORGANIZATION	324	3.14e-04	4.06e-03	0.12700	2.03e-04	-1.27e-01	9.95e-01	8.78e-05
GOBP NEGATIVE REGULATION OF AMINE TRANSPORT	27	5.10e-01	7.17e-01	0.12700	-1.27e-01	-2.99e-03	2.55e-01	9.79e-01
GOBP PURINE NUCLEOSIDE METABOLIC PROCESS	25	5.89e-01	7.72e-01	0.12700	1.16e-01	5.14e-02	3.16e-01	6.57e-01
Transcriptional Regulation by MECP2	60	2.96e-01	5.35e-01	0.12700	6.71e-02	1.07e-01	3.69e-01	1.50e-01
GOBP VIRAL GENOME REPLICATION	123	8.29e-02	2.59e-01	0.12700	1.07e-01	6.74e-02	3.99e-02	1.97e-01
Cell surface interactions at the vascular wall	129	2.16e-02	1.05e-01	0.12700	-6.37e-02	1.09e-01	2.11e-01	3.18e-02
GOCC CLATHRIN COATED VESICLE	208	1.68e-02	8.79e-02	0.12700	8.73e-02	9.18e-02	3.00e-02	2.25e-02
GOBP POSITIVE REGULATION OF PROTEIN KINASE A SIGNALING	12	7.88e-01	8.92e-01	0.12700	-9.70e-02	-8.14e-02	5.61e-01	6.25e-01
GOBP RESPONSE TO INSULIN	269	5.17e-03	3.63e-02	0.12700	8.80e-02	9.10e-02	1.29e-02	1.02e-02
GOCC PROTEIN COMPLEX INVOLVED IN CELL ADHESION	56	1.87e-01	4.14e-01	0.12700	6.63e-02	-1.08e-01	3.91e-01	1.63e-01
SARS-CoV-2 activates/modulates innate and adaptive immune responses	118	8.36e-02	2.59e-01	0.12700	1.16e-01	5.16e-02	3.02e-02	3.33e-01
GOBP POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS	17	6.30e-01	7.98e-01	0.12600	1.24e-01	-2.41e-02	3.75e-01	8.63e-01
GOBP NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION	13	6.75e-01	8.29e-01	0.12600	-7.30e-02	1.03e-01	6.49e-01	5.19e-01
GOBP NITROGEN COMPOUND TRANSPORT	1808	1.83e-15	1.90e-13	0.12600	1.09e-01	6.43e-02	1.49e-14	5.80e-06
GOBP GLAND MORPHOGENESIS	124	8.73e-02	2.67e-01	0.12600	8.54e-02	9.32e-02	1.00e-01	7.30e-02
GOBP NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY	14	7.54e-01	8.74e-01	0.12600	6.89e-02	1.06e-01	6.55e-01	4.92e-01
GOBP LYMPHOID PROGENITOR CELL DIFFERENTIATION	24	6.04e-01	7.82e-01	0.12600	1.15e-01	5.34e-02	3.31e-01	6.51e-01
GOBP REGULATION OF LYASE ACTIVITY	55	2.80e-01	5.19e-01	0.12600	-2.27e-02	-1.24e-01	7.71e-01	1.11e-01
GOBP POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION	22	5.53e-01	7.48e-01	0.12600	2.17e-02	-1.24e-01	8.60e-01	3.12e-01
GOBP PYRIMIDINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS	11	8.02e-01	9.00e-01	0.12600	7.08e-02	1.05e-01	6.84e-01	5.48e-01
GOBP RESPONSE TO CYCLOHEXIMIDE	5	9.04e-01	9.53e-01	0.12600	-6.91e-02	-1.06e-01	7.89e-01	6.82e-01
GOBP REGULATION OF IMMUNE EFFECTOR PROCESS	377	1.27e-05	2.66e-04	0.12600	-8.88e-02	8.97e-02	3.06e-03	2.78e-03
GOBP RESPONSE TO INTERLEUKIN 17	18	6.60e-01	8.18e-01	0.12600	2.28e-02	1.24e-01	8.67e-01	3.62e-01
GOMF L ARGININE TRANSMEMBRANE TRANSPORTER ACTIVITY	12	7.01e-01	8.44e-01	0.12600	1.09e-01	-6.28e-02	5.12e-01	7.06e-01
GOBP SKELETAL MUSCLE TISSUE GROWTH	10	7.40e-01	8.68e-01	0.12600	-1.03e-01	7.26e-02	5.72e-01	6.91e-01
GOBP RESPONSE TO INACTIVITY	12	7.25e-01	8.59e-01	0.12600	2.16e-02	-1.24e-01	8.97e-01	4.56e-01
GOBP NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS	53	3.13e-01	5.53e-01	0.12600	3.79e-02	1.20e-01	6.34e-01	1.30e-01
GOBP CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY	168	2.94e-02	1.30e-01	0.12600	-4.91e-02	-1.16e-01	2.72e-01	9.41e-03
GOBP REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS	12	7.88e-01	8.92e-01	0.12600	7.55e-02	1.01e-01	6.51e-01	5.45e-01
GOBP REGULATION OF MESENCHYMAL CELL PROLIFERATION	33	5.02e-01	7.12e-01	0.12600	5.17e-02	1.15e-01	6.07e-01	2.54e-01
GOCC AUTOPHAGOSOME MEMBRANE	52	2.86e-01	5.24e-01	0.12600	8.89e-03	1.26e-01	9.12e-01	1.17e-01
Glycogen breakdown (glycogenolysis)	11	7.19e-01	8.55e-01	0.12600	9.85e-02	-7.82e-02	5.72e-01	6.53e-01
GOCC KINOCILIUM	10	7.46e-01	8.70e-01	0.12600	5.95e-02	-1.11e-01	7.44e-01	5.44e-01
GOBP BILE ACID METABOLIC PROCESS	50	3.21e-01	5.59e-01	0.12600	-2.49e-02	-1.23e-01	7.61e-01	1.31e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS OXYGEN AS ACCEPTOR	10	7.43e-01	8.69e-01	0.12600	1.05e-01	-6.99e-02	5.67e-01	7.02e-01
GOBP REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS	357	8.83e-04	9.55e-03	0.12600	1.06e-01	6.79e-02	5.90e-04	2.76e-02
GOBP PROXIMAL DISTAL PATTERN FORMATION INVOLVED IN NEPHRON DEVELOPMENT	5	9.06e-01	9.54e-01	0.12600	1.03e-01	7.17e-02	6.89e-01	7.81e-01
GOBP RESPONSE TO CGMP	8	8.06e-01	9.02e-01	0.12600	2.64e-02	-1.23e-01	8.97e-01	5.47e-01
GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION	12	7.37e-01	8.66e-01	0.12600	-1.25e-01	7.93e-03	4.52e-01	9.62e-01
GOCC FILTRATION DIAPHRAGM	9	7.93e-01	8.95e-01	0.12600	-1.12e-02	1.25e-01	9.54e-01	5.16e-01
Co-stimulation by ICOS	10	7.49e-01	8.71e-01	0.12600	-1.13e-01	5.36e-02	5.34e-01	7.69e-01
GOBP GLYCOLIPID CATABOLIC PROCESS	25	4.75e-01	6.95e-01	0.12500	-1.01e-01	7.43e-02	3.82e-01	5.20e-01
GOBP NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY	55	3.44e-01	5.81e-01	0.12500	8.42e-02	9.30e-02	2.80e-01	2.33e-01
GOBP REGULATION OF RESPONSE TO TUMOR CELL	24	6.28e-01	7.96e-01	0.12500	-9.18e-02	-8.54e-02	4.36e-01	4.69e-01
GOCC SMOOTH ENDOPLASMIC RETICULUM	28	5.78e-01	7.66e-01	0.12500	7.52e-02	1.00e-01	4.91e-01	3.58e-01
GOBP MALE GENITALIA DEVELOPMENT	23	6.40e-01	8.04e-01	0.12500	-8.86e-02	-8.86e-02	4.62e-01	4.62e-01
GOBP FOLATE TRANSMEMBRANE TRANSPORT	5	8.63e-01	9.33e-01	0.12500	1.05e-01	-6.78e-02	6.84e-01	7.93e-01
GOBP ATTACHMENT OF GPI ANCHOR TO PROTEIN	6	8.36e-01	9.18e-01	0.12500	9.57e-02	-8.05e-02	6.85e-01	7.33e-01
GOBP NEGATIVE REGULATION OF STEROL TRANSPORT	30	4.88e-01	7.02e-01	0.12500	-7.51e-03	-1.25e-01	9.43e-01	2.37e-01
GOBP HEART VALVE DEVELOPMENT	73	2.20e-01	4.53e-01	0.12500	4.77e-02	1.15e-01	4.81e-01	8.80e-02
Metal ion SLC transporters	23	6.11e-01	7.86e-01	0.12500	3.87e-02	1.19e-01	7.48e-01	3.24e-01
GOBP ASTROCYTE DEVELOPMENT	43	4.36e-01	6.64e-01	0.12500	-8.13e-02	-9.48e-02	3.56e-01	2.82e-01
GOBP NEGATIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS	6	8.59e-01	9.30e-01	0.12500	-9.28e-03	1.24e-01	9.69e-01	5.97e-01
GOBP NEGATIVE REGULATION OF TUBULIN DEACETYLATION	5	9.08e-01	9.55e-01	0.12500	-9.41e-02	-8.20e-02	7.15e-01	7.51e-01
GOBP CRANIAL SKELETAL SYSTEM DEVELOPMENT	71	2.46e-01	4.84e-01	0.12500	1.07e-01	6.48e-02	1.20e-01	3.45e-01
AMPK inhibits chREBP transcriptional activation activity	8	8.54e-01	9.26e-01	0.12500	-1.05e-01	-6.67e-02	6.06e-01	7.44e-01
GOBP RAS PROTEIN SIGNAL TRANSDUCTION	116	8.88e-02	2.70e-01	0.12500	1.17e-01	4.40e-02	2.99e-02	4.13e-01
CS/DS degradation	12	7.19e-01	8.56e-01	0.12500	1.19e-01	-3.86e-02	4.77e-01	8.17e-01
GOBP REGULATION OF STRIATED MUSCLE CONTRACTION	93	1.68e-01	3.90e-01	0.12500	-8.07e-02	-9.49e-02	1.78e-01	1.14e-01
GOBP REGULATION OF MACROPHAGE ACTIVATION	60	1.87e-01	4.14e-01	0.12500	-1.16e-01	4.58e-02	1.21e-01	5.39e-01
GOBP REGULATION OF POLYSACCHARIDE BIOSYNTHETIC PROCESS	37	4.92e-01	7.05e-01	0.12500	8.95e-02	8.67e-02	3.46e-01	3.62e-01
GOBP POSITIVE REGULATION OF RECEPTOR CATABOLIC PROCESS	7	8.23e-01	9.11e-01	0.12500	-4.25e-02	1.17e-01	8.46e-01	5.92e-01
GOBP IMP BIOSYNTHETIC PROCESS	10	7.65e-01	8.81e-01	0.12500	2.95e-02	-1.21e-01	8.72e-01	5.07e-01
GOBP RESPONSE TO HYDROSTATIC PRESSURE	7	8.34e-01	9.17e-01	0.12500	-1.85e-02	1.23e-01	9.32e-01	5.73e-01
GOBP VITAMIN D3 METABOLIC PROCESS	7	8.44e-01	9.21e-01	0.12500	-1.47e-03	-1.25e-01	9.95e-01	5.68e-01
Apoptotic cleavage of cellular proteins	35	4.85e-01	6.99e-01	0.12500	1.15e-01	4.68e-02	2.38e-01	6.32e-01
GOBP INTEGRIN ACTIVATION	26	4.70e-01	6.92e-01	0.12500	-1.05e-01	6.63e-02	3.52e-01	5.58e-01
GOBP RHYTHMIC PROCESS	289	2.93e-03	2.36e-02	0.12400	1.13e-01	5.12e-02	9.01e-04	1.35e-01
GOBP ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE	99	1.50e-01	3.65e-01	0.12400	-7.96e-02	-9.57e-02	1.71e-01	1.00e-01
GOBP REPRODUCTIVE SYSTEM DEVELOPMENT	291	3.94e-03	2.96e-02	0.12400	9.74e-02	7.75e-02	4.24e-03	2.30e-02
GOMF SIGNALING RECEPTOR REGULATOR ACTIVITY	518	2.21e-05	4.30e-04	0.12400	-1.18e-01	-3.99e-02	4.36e-06	1.20e-01
Constitutive Signaling by NOTCH1 HD Domain Mutants	15	6.77e-01	8.30e-01	0.12400	1.23e-01	-2.07e-02	4.11e-01	8.90e-01
Signaling by NOTCH1 HD Domain Mutants in Cancer	15	6.77e-01	8.30e-01	0.12400	1.23e-01	-2.07e-02	4.11e-01	8.90e-01
GOBP L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT	68	2.40e-01	4.77e-01	0.12400	1.17e-01	4.17e-02	9.45e-02	5.52e-01
GOBP LIPID PHOSPHORYLATION	10	8.16e-01	9.07e-01	0.12400	-5.34e-02	-1.12e-01	7.70e-01	5.38e-01
GOMF ATP DEPENDENT DIACYLGLYCEROL KINASE ACTIVITY	10	8.16e-01	9.07e-01	0.12400	-5.34e-02	-1.12e-01	7.70e-01	5.38e-01
GOBP ORGANELLE INHERITANCE	15	7.45e-01	8.70e-01	0.12400	1.05e-01	6.71e-02	4.82e-01	6.53e-01
GOBP REGULATION OF GLYCOGEN METABOLIC PROCESS	35	4.92e-01	7.05e-01	0.12400	5.31e-02	1.12e-01	5.87e-01	2.49e-01
GOBP GAP JUNCTION ASSEMBLY	16	6.74e-01	8.28e-01	0.12400	-1.24e-01	4.62e-03	3.90e-01	9.74e-01
FRS-mediated FGFR4 signaling	21	6.57e-01	8.16e-01	0.12400	1.10e-01	5.73e-02	3.81e-01	6.49e-01
G2 Phase	5	8.76e-01	9.40e-01	0.12400	-2.66e-02	1.21e-01	9.18e-01	6.38e-01
GOBP NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY	32	5.43e-01	7.41e-01	0.12400	8.67e-02	8.91e-02	3.96e-01	3.83e-01
GOBP DETECTION OF CELL DENSITY	8	8.58e-01	9.30e-01	0.12400	8.73e-02	8.84e-02	6.69e-01	6.65e-01
GOBP CAVEOLIN MEDIATED ENDOCYTOSIS	11	7.78e-01	8.89e-01	0.12400	-1.79e-02	-1.23e-01	9.18e-01	4.80e-01
Translocation of ZAP-70 to Immunological synapse	17	6.21e-01	7.92e-01	0.12400	-1.14e-01	4.97e-02	4.16e-01	7.23e-01
GOMF SUMO LIGASE ACTIVITY	13	7.44e-01	8.70e-01	0.12400	1.87e-02	1.23e-01	9.07e-01	4.43e-01
GOMF DEATH DOMAIN BINDING	11	7.86e-01	8.92e-01	0.12400	1.21e-01	2.83e-02	4.87e-01	8.71e-01
GOBP REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION	94	1.45e-01	3.58e-01	0.12400	1.15e-01	4.67e-02	5.38e-02	4.34e-01
GOBP REGULATION OF LEUKOCYTE APOPTOTIC PROCESS	87	9.97e-02	2.89e-01	0.12400	-2.93e-02	1.21e-01	6.36e-01	5.18e-02
GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE	11	7.30e-01	8.62e-01	0.12400	1.09e-01	-6.03e-02	5.33e-01	7.29e-01
GOBP PERIPHERAL NERVOUS SYSTEM DEVELOPMENT	85	1.97e-01	4.27e-01	0.12400	9.79e-02	7.63e-02	1.19e-01	2.24e-01
GOBP POSITIVE REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY	6	8.80e-01	9.43e-01	0.12400	3.74e-02	1.18e-01	8.74e-01	6.16e-01
GOBP REGULATION OF PLASMA MEMBRANE ORGANIZATION	16	6.95e-01	8.42e-01	0.12400	1.76e-02	1.23e-01	9.03e-01	3.95e-01
GOMF L AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY	63	2.85e-01	5.23e-01	0.12400	1.11e-01	5.58e-02	1.29e-01	4.44e-01
GOBP RESPONSE TO FOLLICLE STIMULATING HORMONE	15	7.53e-01	8.73e-01	0.12400	8.40e-02	9.10e-02	5.73e-01	5.42e-01
GOBP RESPONSE TO RETINOIC ACID	105	1.26e-01	3.31e-01	0.12400	5.79e-02	1.09e-01	3.06e-01	5.28e-02
GOBP RESPONSE TO NUTRIENT LEVELS	476	1.33e-04	1.96e-03	0.12400	9.99e-02	7.29e-02	1.87e-04	6.42e-03
GOBP RENAL SODIUM EXCRETION	12	7.20e-01	8.56e-01	0.12400	4.43e-02	-1.15e-01	7.90e-01	4.89e-01
GOBP REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY SARCOPLASMIC RETICULUM	30	4.44e-01	6.71e-01	0.12400	1.17e-01	-3.96e-02	2.67e-01	7.07e-01
GOBP HYALURONAN METABOLIC PROCESS	33	3.90e-01	6.23e-01	0.12400	6.55e-02	-1.05e-01	5.15e-01	2.98e-01
GOBP CIRCADIAN SLEEP WAKE CYCLE SLEEP	16	7.39e-01	8.67e-01	0.12400	-9.38e-02	-8.03e-02	5.16e-01	5.78e-01
GOBP LIGAND GATED ION CHANNEL SIGNALING PATHWAY	30	5.18e-01	7.24e-01	0.12400	-1.21e-01	-2.49e-02	2.51e-01	8.13e-01
GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION	95	1.31e-01	3.40e-01	0.12300	1.19e-01	3.11e-02	4.41e-02	6.00e-01
GOMF HISTONE H3K9ME2 H3K9ME3 DEMETHYLASE ACTIVITY	5	8.68e-01	9.35e-01	0.12300	1.06e-01	-6.29e-02	6.81e-01	8.08e-01
GOBP NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS	368	1.06e-03	1.10e-02	0.12300	7.73e-02	9.62e-02	1.09e-02	1.53e-03
GPCR ligand binding	445	1.21e-04	1.81e-03	0.12300	-1.16e-01	-4.15e-02	2.64e-05	1.34e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN NAD P H AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN	38	4.79e-01	6.97e-01	0.12300	-1.06e-01	-6.39e-02	2.60e-01	4.96e-01
Chaperone Mediated Autophagy	20	5.63e-01	7.55e-01	0.12300	9.98e-02	-7.25e-02	4.40e-01	5.75e-01
GOBP POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION	35	4.37e-01	6.65e-01	0.12300	2.83e-03	1.23e-01	9.77e-01	2.07e-01
GOBP NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS	9	8.41e-01	9.20e-01	0.12300	-6.55e-02	-1.04e-01	7.34e-01	5.87e-01
GOMF MRNA 5 UTR BINDING	22	6.62e-01	8.20e-01	0.12300	8.38e-02	9.03e-02	4.96e-01	4.64e-01
GOBP NEGATIVE REGULATION OF JNK CASCADE	35	4.59e-01	6.83e-01	0.12300	1.22e-01	1.92e-02	2.13e-01	8.44e-01
Assembly and cell surface presentation of NMDA receptors	40	3.66e-01	6.03e-01	0.12300	-1.22e-01	1.60e-02	1.82e-01	8.61e-01
Semaphorin interactions	61	2.62e-01	5.01e-01	0.12300	1.21e-01	2.17e-02	1.02e-01	7.69e-01
GOMF METAL CATION MONOATOMIC CATION ANTIPORTER ACTIVITY	39	4.81e-01	6.97e-01	0.12300	-9.55e-02	-7.75e-02	3.02e-01	4.02e-01
GOBP IMMUNOGLOBULIN PRODUCTION	102	1.29e-01	3.37e-01	0.12300	4.75e-02	1.13e-01	4.07e-01	4.78e-02
GOBP LEUKOTRIENE D4 BIOSYNTHETIC PROCESS	6	8.65e-01	9.34e-01	0.12300	-1.23e-01	5.52e-03	6.02e-01	9.81e-01
GOBP NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE	22	5.66e-01	7.57e-01	0.12300	1.20e-01	-2.67e-02	3.30e-01	8.28e-01
GOBP REGULATION OF RELAXATION OF MUSCLE	14	7.64e-01	8.81e-01	0.12300	-1.05e-01	-6.42e-02	4.97e-01	6.78e-01
GOBP OOGENESIS	112	6.66e-02	2.25e-01	0.12300	1.23e-01	-7.45e-03	2.51e-02	8.92e-01
GOBP RESPONSE TO GROWTH FACTOR	752	7.59e-07	2.31e-05	0.12300	1.07e-01	5.94e-02	5.28e-07	5.58e-03
GOMF MONOCARBOXYLIC ACID BINDING	87	1.95e-01	4.24e-01	0.12300	-7.28e-02	-9.88e-02	2.40e-01	1.11e-01
GOBP REGULATION OF CARBOHYDRATE CATABOLIC PROCESS	60	2.75e-01	5.15e-01	0.12300	2.58e-02	1.20e-01	7.29e-01	1.08e-01
GOBP REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS	42	3.13e-01	5.53e-01	0.12300	5.48e-02	-1.10e-01	5.39e-01	2.19e-01
MAP2K and MAPK activation	38	4.01e-01	6.34e-01	0.12300	1.23e-01	-5.04e-03	1.91e-01	9.57e-01
GOBP L GLUTAMATE TRANSMEMBRANE TRANSPORT	29	5.49e-01	7.46e-01	0.12300	1.17e-01	3.74e-02	2.76e-01	7.27e-01
GOBP GENOMIC IMPRINTING	17	6.98e-01	8.43e-01	0.12300	1.19e-01	3.04e-02	3.97e-01	8.28e-01
GOBP RHO PROTEIN SIGNAL TRANSDUCTION	137	7.99e-02	2.52e-01	0.12200	9.19e-02	8.09e-02	6.34e-02	1.02e-01
GOBP REGULATION OF ACTIN FILAMENT BASED MOVEMENT	39	3.52e-01	5.90e-01	0.12200	4.21e-02	-1.15e-01	6.49e-01	2.14e-01
G-protein beta:gamma signalling	30	5.61e-01	7.54e-01	0.12200	1.07e-01	5.91e-02	3.10e-01	5.75e-01
GOBP CARDIOLIPIN BIOSYNTHETIC PROCESS	7	8.34e-01	9.17e-01	0.12200	1.19e-01	-2.91e-02	5.86e-01	8.94e-01
GOBP CARDIAC CHAMBER MORPHOGENESIS	128	7.22e-02	2.37e-01	0.12200	3.69e-02	1.17e-01	4.71e-01	2.26e-02
GOBP REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS	30	4.68e-01	6.90e-01	0.12200	-2.20e-02	1.20e-01	8.35e-01	2.54e-01
GOBP POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION	22	6.47e-01	8.09e-01	0.12200	-1.12e-01	-4.98e-02	3.64e-01	6.86e-01
GOBP ENDODERM DEVELOPMENT	84	1.79e-01	4.04e-01	0.12200	1.16e-01	3.79e-02	6.54e-02	5.48e-01
GOMF ADENOSINE RECEPTOR BINDING	8	7.97e-01	8.98e-01	0.12200	-9.77e-02	7.35e-02	6.32e-01	7.19e-01
GOBP REPRODUCTIVE BEHAVIOR	44	3.43e-01	5.81e-01	0.12200	-1.08e-02	1.22e-01	9.02e-01	1.62e-01
GOBP PULMONARY VALVE MORPHOGENESIS	20	5.97e-01	7.77e-01	0.12200	-1.19e-01	2.90e-02	3.58e-01	8.23e-01
GOBP REGULATION OF STORE OPERATED CALCIUM ENTRY	15	6.93e-01	8.40e-01	0.12200	-1.25e-02	1.22e-01	9.33e-01	4.15e-01
GOBP REGULATION OF RENAL SYSTEM PROCESS	21	6.77e-01	8.30e-01	0.12200	-7.46e-02	-9.67e-02	5.54e-01	4.43e-01
GOMF KINASE BINDING	749	1.61e-06	4.44e-05	0.12200	8.88e-02	8.38e-02	3.53e-05	9.37e-05
GOBP LIVER MORPHOGENESIS	25	4.94e-01	7.07e-01	0.12200	-9.78e-02	7.31e-02	3.97e-01	5.27e-01
GOBP NEGATIVE REGULATION OF PHAGOCYTOSIS	21	5.81e-01	7.67e-01	0.12200	-1.18e-01	3.13e-02	3.49e-01	8.04e-01
EGR2 and SOX10-mediated initiation of Schwann cell myelination	27	4.72e-01	6.94e-01	0.12200	6.26e-02	-1.05e-01	5.73e-01	3.46e-01
GOMF PROTEASOME BINDING	17	7.30e-01	8.62e-01	0.12200	-7.59e-02	-9.56e-02	5.88e-01	4.95e-01
GOBP ISOLEUCINE TRANSPORT	5	8.93e-01	9.48e-01	0.12200	9.34e-03	1.22e-01	9.71e-01	6.38e-01
GOBP TRANSMISSION OF NERVE IMPULSE	73	2.45e-01	4.84e-01	0.12200	-1.08e-01	-5.59e-02	1.09e-01	4.08e-01
RUNX2 regulates genes involved in cell migration	8	8.11e-01	9.05e-01	0.12200	-1.17e-01	3.51e-02	5.67e-01	8.63e-01
GOBP SULFATION	20	6.82e-01	8.33e-01	0.12200	1.07e-01	5.80e-02	4.06e-01	6.53e-01
GOBP REGULATION OF CILIUM BEAT FREQUENCY	17	6.41e-01	8.04e-01	0.12200	1.17e-01	-3.59e-02	4.06e-01	7.98e-01
GOBP CEREBRAL CORTEX CELL MIGRATION	45	4.20e-01	6.50e-01	0.12200	1.09e-01	5.52e-02	2.07e-01	5.22e-01
GOBP NEGATIVE REGULATION OF MACROPHAGE CYTOKINE PRODUCTION	12	7.33e-01	8.63e-01	0.12200	-3.29e-02	1.17e-01	8.44e-01	4.81e-01
GOMF STRUCTURAL CONSTITUENT OF SYNAPSE	23	6.32e-01	7.99e-01	0.12200	-4.39e-02	-1.14e-01	7.16e-01	3.45e-01
GOBP BIOGENIC AMINE METABOLIC PROCESS	86	1.02e-01	2.93e-01	0.12200	-4.40e-02	1.14e-01	4.80e-01	6.88e-02
GOBP ICOSANOID METABOLIC PROCESS	117	9.05e-02	2.73e-01	0.12200	-3.39e-02	-1.17e-01	5.27e-01	2.89e-02
GOBP EMBRYO IMPLANTATION	58	3.47e-01	5.85e-01	0.12200	8.56e-02	8.66e-02	2.60e-01	2.54e-01
GOBP ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL COMMUNICATION	17	7.30e-01	8.62e-01	0.12200	-9.86e-02	-7.13e-02	4.81e-01	6.11e-01
GOBP EPITHELIAL TUBE FORMATION	134	8.71e-02	2.67e-01	0.12200	9.17e-02	7.99e-02	6.69e-02	1.10e-01
GOCC ENDOSOME MEMBRANE	541	6.44e-05	1.07e-03	0.12200	8.87e-02	8.32e-02	4.14e-04	9.37e-04
GOBP REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS	21	6.38e-01	8.03e-01	0.12200	1.19e-01	2.29e-02	3.44e-01	8.56e-01
GOBP MONOCARBOXYLIC ACID TRANSPORT	179	3.75e-02	1.54e-01	0.12200	-9.82e-02	-7.16e-02	2.34e-02	9.84e-02
GOBP ACTIN POLYMERIZATION DEPENDENT CELL MOTILITY	7	8.76e-01	9.40e-01	0.12100	1.06e-01	5.93e-02	6.27e-01	7.86e-01
GOCC CYTOSOLIC REGION	19	7.08e-01	8.49e-01	0.12100	8.74e-02	8.43e-02	5.09e-01	5.25e-01
GOBP POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS	84	1.07e-01	3.02e-01	0.12100	4.73e-02	-1.12e-01	4.53e-01	7.65e-02
GOBP REGULATION OF AUTOPHAGY OF MITOCHONDRION	41	4.65e-01	6.87e-01	0.12100	1.03e-01	6.39e-02	2.53e-01	4.79e-01
GOBP MEMBRANE DOCKING	83	2.11e-01	4.43e-01	0.12100	6.22e-02	1.04e-01	3.27e-01	1.01e-01
GOBP INSEMINATION	13	7.79e-01	8.89e-01	0.12100	5.30e-02	1.09e-01	7.41e-01	4.96e-01
GOBP REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION	17	6.90e-01	8.39e-01	0.12100	-1.20e-01	-1.64e-02	3.91e-01	9.07e-01
GOBP POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION	157	1.55e-02	8.30e-02	0.12100	-1.12e-01	4.78e-02	1.59e-02	3.01e-01
GOBP REGULATION OF MITOCHONDRIAL MRNA STABILITY	7	8.75e-01	9.40e-01	0.12100	5.75e-02	1.07e-01	7.92e-01	6.24e-01
GOBP ADENYLATE CYCLASE INHIBITING DOPAMINE RECEPTOR SIGNALING PATHWAY	5	9.09e-01	9.55e-01	0.12100	-5.66e-02	-1.07e-01	8.26e-01	6.78e-01
GOBP POLYSACCHARIDE METABOLIC PROCESS	104	7.89e-02	2.51e-01	0.12100	1.20e-01	-1.74e-02	3.44e-02	7.59e-01
GOBP NEGATIVE REGULATION OF SKELETAL MUSCLE CELL PROLIFERATION	5	8.85e-01	9.45e-01	0.12100	1.20e-01	-1.77e-02	6.42e-01	9.45e-01
GOMF MOLYBDOPTERIN COFACTOR BINDING	6	8.50e-01	9.25e-01	0.12100	1.09e-01	-5.33e-02	6.44e-01	8.21e-01
GOBP MONOCYTE ACTIVATION	12	7.81e-01	8.90e-01	0.12100	-1.17e-01	-3.13e-02	4.82e-01	8.51e-01
GOCC GOLGI APPARATUS SUBCOMPARTMENT	354	1.76e-03	1.59e-02	0.12100	7.93e-02	9.17e-02	1.04e-02	3.03e-03
GOMF RETINOIC ACID BINDING	27	5.94e-01	7.75e-01	0.12100	-1.10e-01	-5.14e-02	3.24e-01	6.44e-01
GOBP REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY	33	4.49e-01	6.75e-01	0.12100	-1.20e-01	1.52e-02	2.32e-01	8.80e-01
GOBP CELL MIGRATION INVOLVED IN METANEPHROS DEVELOPMENT	5	8.85e-01	9.45e-01	0.12100	-1.20e-01	1.80e-02	6.43e-01	9.44e-01
GOBP REGULATION OF GLYCOGEN BIOSYNTHETIC PROCESS	29	5.91e-01	7.73e-01	0.12100	9.20e-02	7.87e-02	3.91e-01	4.63e-01
GOBP POSITIVE REGULATION OF AMINO ACID TRANSPORT	22	5.83e-01	7.69e-01	0.12100	-1.85e-02	1.20e-01	8.81e-01	3.31e-01
GOBP NEURON CELLULAR HOMEOSTASIS	60	3.00e-01	5.40e-01	0.12100	3.79e-02	1.15e-01	6.11e-01	1.23e-01
MAPK targets/ Nuclear events mediated by MAP kinases	29	5.91e-01	7.73e-01	0.12100	7.77e-02	9.28e-02	4.69e-01	3.87e-01
GOBP CAP DEPENDENT TRANSLATIONAL INITIATION	7	8.57e-01	9.29e-01	0.12100	1.20e-01	1.27e-02	5.81e-01	9.54e-01
GOBP NEGATIVE REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY	8	8.24e-01	9.11e-01	0.12100	1.53e-02	-1.20e-01	9.40e-01	5.57e-01
GOBP ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY	166	1.56e-02	8.35e-02	0.12100	-1.18e-01	2.83e-02	8.95e-03	5.29e-01
GOBP POSITIVE REGULATION OF LIPID STORAGE	27	6.12e-01	7.86e-01	0.12100	-9.57e-02	-7.39e-02	3.89e-01	5.06e-01
GOBP GOLGI LUMEN ACIDIFICATION	10	8.30e-01	9.15e-01	0.12100	6.22e-02	1.04e-01	7.33e-01	5.70e-01
GOBP POSITIVE REGULATION OF MRNA CATABOLIC PROCESS	193	8.41e-03	5.28e-02	0.12100	1.18e-01	-2.54e-02	4.64e-03	5.44e-01
TP53 Regulates Transcription of Caspase Activators and Caspases	12	7.99e-01	8.99e-01	0.12100	6.08e-02	1.04e-01	7.16e-01	5.31e-01
GOMF MHC CLASS I PROTEIN COMPLEX BINDING	6	8.72e-01	9.38e-01	0.12100	-1.21e-01	-1.02e-03	6.08e-01	9.97e-01
GOBP REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION	29	5.67e-01	7.58e-01	0.12100	-1.13e-01	-4.36e-02	2.94e-01	6.85e-01
GOBP SULFUR COMPOUND TRANSPORT	62	2.13e-01	4.46e-01	0.12100	-1.18e-01	2.67e-02	1.09e-01	7.16e-01
GOBP CYTOPLASMIC SEQUESTERING OF PROTEIN	13	7.14e-01	8.53e-01	0.12100	1.14e-01	-3.94e-02	4.77e-01	8.06e-01
G-protein activation	24	6.37e-01	8.02e-01	0.12100	1.07e-01	5.58e-02	3.65e-01	6.36e-01
GOBP REGULATION OF CELL DIVISION	180	3.35e-02	1.43e-01	0.12100	1.09e-01	5.24e-02	1.20e-02	2.25e-01
GOMF CYTIDYLYLTRANSFERASE ACTIVITY	9	8.00e-01	8.99e-01	0.12100	2.52e-02	-1.18e-01	8.96e-01	5.40e-01
GOMF MODIFIED AMINO ACID BINDING	95	1.70e-01	3.92e-01	0.12100	-1.06e-01	-5.79e-02	7.49e-02	3.30e-01
GOBP SKELETAL MUSCLE TISSUE REGENERATION	42	3.44e-01	5.81e-01	0.12100	1.16e-01	-3.35e-02	1.94e-01	7.07e-01
GOBP REGULATION OF ATP BIOSYNTHETIC PROCESS	14	7.42e-01	8.69e-01	0.12100	-1.19e-01	-1.84e-02	4.40e-01	9.05e-01
GOMF LIPID TRANSFER ACTIVITY	56	2.19e-01	4.52e-01	0.12000	1.03e-01	-6.33e-02	1.84e-01	4.13e-01
GOBP POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION	13	7.46e-01	8.70e-01	0.12000	3.18e-03	1.20e-01	9.84e-01	4.52e-01
GOBP RENAL SYSTEM VASCULATURE DEVELOPMENT	33	5.14e-01	7.21e-01	0.12000	1.16e-01	3.34e-02	2.50e-01	7.40e-01
GOBP POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY	126	3.29e-02	1.41e-01	0.12000	-6.55e-02	1.01e-01	2.04e-01	5.02e-02
GOBP NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION	685	4.43e-06	1.08e-04	0.12000	1.04e-01	5.99e-02	3.17e-06	7.51e-03
Glycerophospholipid catabolism	7	8.70e-01	9.37e-01	0.12000	-3.77e-02	-1.14e-01	8.63e-01	6.00e-01
GOBP NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION	41	4.51e-01	6.76e-01	0.12000	4.36e-02	1.12e-01	6.29e-01	2.14e-01
GOBP SKELETAL MUSCLE SATELLITE CELL PROLIFERATION	17	6.46e-01	8.08e-01	0.12000	1.14e-01	-3.82e-02	4.15e-01	7.85e-01
GOMF C4 DICARBOXYLATE TRANSMEMBRANE TRANSPORTER ACTIVITY	15	7.50e-01	8.71e-01	0.12000	1.11e-01	4.75e-02	4.58e-01	7.50e-01
GOBP CELLULAR RESPONSE TO CAFFEINE	11	8.16e-01	9.07e-01	0.12000	-6.19e-02	-1.03e-01	7.22e-01	5.54e-01
GOBP OSTEOBLAST DIFFERENTIATION	254	8.76e-03	5.45e-02	0.12000	5.34e-02	1.08e-01	1.43e-01	3.10e-03
GOBP METANEPHRIC RENAL VESICLE MORPHOGENESIS	14	7.43e-01	8.69e-01	0.12000	-1.19e-01	-1.90e-02	4.42e-01	9.02e-01
Uptake and actions of bacterial toxins	28	4.81e-01	6.97e-01	0.12000	-4.55e-02	1.11e-01	6.77e-01	3.08e-01
GOBP LIPID DROPLET FUSION	5	8.74e-01	9.39e-01	0.12000	6.26e-02	-1.03e-01	8.09e-01	6.91e-01
GOBP NEGATIVE REGULATION OF CELL ACTIVATION	210	3.51e-03	2.71e-02	0.12000	-6.59e-02	1.01e-01	9.96e-02	1.20e-02
GOBP EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS	30	5.85e-01	7.70e-01	0.12000	7.94e-02	9.02e-02	4.52e-01	3.92e-01
GOBP NEGATIVE REGULATION OF PROTEIN MATURATION	26	6.23e-01	7.93e-01	0.12000	6.68e-02	9.99e-02	5.55e-01	3.78e-01
GOBP STARTLE RESPONSE	27	6.18e-01	7.90e-01	0.12000	-8.65e-02	-8.34e-02	4.36e-01	4.53e-01
CD28 dependent PI3K/Akt signaling	27	6.11e-01	7.86e-01	0.12000	6.53e-02	1.01e-01	5.57e-01	3.64e-01
GOBP HEART MORPHOGENESIS	267	9.03e-03	5.56e-02	0.12000	8.77e-02	8.21e-02	1.36e-02	2.09e-02
GOBP RIBONUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS	10	7.66e-01	8.82e-01	0.12000	5.49e-02	-1.07e-01	7.64e-01	5.58e-01
GOBP NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY	15	6.71e-01	8.26e-01	0.12000	-5.51e-02	1.07e-01	7.12e-01	4.74e-01
GOCC GTPASE COMPLEX	38	4.72e-01	6.94e-01	0.12000	1.14e-01	3.72e-02	2.23e-01	6.92e-01
VEGFA-VEGFR2 Pathway	94	1.70e-01	3.92e-01	0.12000	1.09e-01	5.04e-02	6.79e-02	3.99e-01
GOBP BONE CELL DEVELOPMENT	18	6.60e-01	8.18e-01	0.12000	-1.20e-01	6.21e-03	3.79e-01	9.64e-01
GOBP CELLULAR RESPONSE TO OSMOTIC STRESS	53	3.85e-01	6.19e-01	0.12000	9.78e-02	6.96e-02	2.18e-01	3.81e-01
GOBP POSITIVE REGULATION OF FATTY ACID TRANSPORT	24	5.42e-01	7.40e-01	0.12000	-3.83e-02	1.14e-01	7.45e-01	3.35e-01
GABA receptor activation	57	2.22e-01	4.56e-01	0.12000	5.28e-02	-1.08e-01	4.91e-01	1.59e-01
GOBP LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS	18	6.18e-01	7.90e-01	0.12000	-1.05e-01	5.85e-02	4.42e-01	6.68e-01
GOBP REGULATION OF ENDOTHELIAL CELL DEVELOPMENT	18	7.15e-01	8.53e-01	0.12000	1.07e-01	5.50e-02	4.34e-01	6.86e-01
GOBP REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY	17	7.20e-01	8.56e-01	0.12000	-4.34e-02	-1.12e-01	7.57e-01	4.25e-01
GOBP NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION	151	3.78e-02	1.55e-01	0.12000	1.19e-01	9.23e-03	1.13e-02	8.45e-01
GOBP REGULATION OF MEMBRANE DEPOLARIZATION	46	4.07e-01	6.40e-01	0.12000	3.95e-02	1.13e-01	6.43e-01	1.84e-01
GOBP REGULATION OF MITOTIC NUCLEAR DIVISION	118	8.69e-02	2.66e-01	0.12000	1.18e-01	2.21e-02	2.71e-02	6.78e-01
GOMF ACID AMINO ACID LIGASE ACTIVITY	23	6.39e-01	8.03e-01	0.12000	-4.01e-02	-1.13e-01	7.39e-01	3.49e-01
Post-translational protein phosphorylation	100	9.69e-02	2.84e-01	0.12000	1.13e-02	-1.19e-01	8.46e-01	3.94e-02
GOBP INNERVATION	27	5.81e-01	7.68e-01	0.12000	1.16e-01	3.08e-02	2.98e-01	7.81e-01
GOBP CAMKK AMPK SIGNALING CASCADE	9	8.53e-01	9.26e-01	0.12000	8.04e-02	8.86e-02	6.76e-01	6.45e-01
GOBP NEGATIVE REGULATION OF OSSIFICATION	38	3.70e-01	6.06e-01	0.12000	-1.08e-01	5.13e-02	2.49e-01	5.84e-01
GOBP REGULATION OF BONE MINERALIZATION	77	2.15e-01	4.47e-01	0.12000	3.12e-02	1.15e-01	6.36e-01	7.99e-02
GOCC MEIOTIC SPINDLE	14	7.13e-01	8.52e-01	0.12000	-2.14e-02	1.18e-01	8.90e-01	4.46e-01
GOCC APICAL PART OF CELL	451	3.87e-04	4.83e-03	0.12000	-7.46e-02	-9.34e-02	6.62e-03	6.69e-04
GOBP GOLGI DISASSEMBLY	6	8.99e-01	9.51e-01	0.12000	7.76e-02	9.09e-02	7.42e-01	7.00e-01
GOBP ASTROCYTE CELL MIGRATION	9	8.26e-01	9.12e-01	0.12000	1.55e-02	1.19e-01	9.36e-01	5.38e-01
GOMF SIALYLTRANSFERASE ACTIVITY	21	6.44e-01	8.07e-01	0.12000	-1.18e-01	-1.84e-02	3.49e-01	8.84e-01
GOBP PHASIC SMOOTH MUSCLE CONTRACTION	24	5.21e-01	7.26e-01	0.11900	8.02e-02	-8.85e-02	4.96e-01	4.53e-01
GOBP INTRACELLULAR POTASSIUM ION HOMEOSTASIS	15	7.23e-01	8.58e-01	0.11900	-9.55e-03	-1.19e-01	9.49e-01	4.25e-01
GOBP FRUCTOSE METABOLIC PROCESS	13	7.29e-01	8.61e-01	0.11900	-1.17e-01	2.41e-02	4.65e-01	8.80e-01
GOBP ERBB SIGNALING PATHWAY	131	5.35e-02	1.96e-01	0.11900	1.19e-01	-7.99e-04	1.82e-02	9.87e-01
GOBP HISTAMINE SECRETION	12	7.67e-01	8.82e-01	0.11900	1.19e-01	3.18e-03	4.74e-01	9.85e-01
GOBP REGULATION OF PROTEOLYSIS	565	5.93e-05	1.01e-03	0.11900	7.65e-02	9.16e-02	1.87e-03	1.98e-04
GOBP LIPOPROTEIN BIOSYNTHETIC PROCESS	95	1.22e-01	3.26e-01	0.11900	1.19e-01	2.28e-03	4.44e-02	9.69e-01
GOBP DOPAMINE METABOLIC PROCESS	35	3.91e-01	6.25e-01	0.11900	-6.71e-02	9.87e-02	4.92e-01	3.12e-01
GOMF CARBON OXYGEN LYASE ACTIVITY	74	2.50e-01	4.89e-01	0.11900	1.09e-01	4.93e-02	1.06e-01	4.63e-01
GOBP REGULATION OF FIBROBLAST PROLIFERATION	89	2.10e-01	4.42e-01	0.11900	8.87e-02	7.98e-02	1.48e-01	1.93e-01
GOBP NEGATIVE REGULATION OF PHOSPHORYLATION	306	4.25e-03	3.14e-02	0.11900	6.23e-02	1.02e-01	6.11e-02	2.21e-03
GOBP NEGATIVE REGULATION OF CELL DEVELOPMENT	259	8.37e-03	5.26e-02	0.11900	5.03e-02	1.08e-01	1.64e-01	2.74e-03
GOMF LAMININ BINDING	29	4.83e-01	6.98e-01	0.11900	3.68e-02	-1.13e-01	7.32e-01	2.91e-01
GOBP COMMISSURAL NEURON AXON GUIDANCE	13	7.24e-01	8.59e-01	0.11900	1.14e-01	-3.30e-02	4.75e-01	8.37e-01
GOCC NEUROFILAMENT	10	8.05e-01	9.02e-01	0.11900	1.19e-01	6.94e-03	5.15e-01	9.70e-01
Signaling by BRAF and RAF1 fusions	63	2.38e-01	4.74e-01	0.11900	1.19e-01	-7.39e-03	1.03e-01	9.19e-01
GOBP PROTEIN DEPOLYMERIZATION	114	1.25e-01	3.29e-01	0.11900	1.06e-01	5.49e-02	5.15e-02	3.11e-01
GOMF HYDROLASE ACTIVITY ACTING ON ACID ANHYDRIDES	763	1.04e-06	3.02e-05	0.11900	1.09e-01	4.87e-02	3.33e-07	2.20e-02
GOMF TAT PROTEIN BINDING	10	7.91e-01	8.94e-01	0.11900	1.18e-01	-1.50e-02	5.18e-01	9.34e-01
GOBP CELL COMMUNICATION BY ELECTRICAL COUPLING	33	4.92e-01	7.05e-01	0.11900	1.19e-01	9.35e-03	2.38e-01	9.26e-01
Scavenging by Class A Receptors	19	6.18e-01	7.90e-01	0.11900	4.18e-02	-1.11e-01	7.52e-01	4.01e-01
GOBP NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS	19	6.50e-01	8.11e-01	0.11900	1.19e-01	-6.03e-03	3.70e-01	9.64e-01
GOBP REGULATION OF CELL SUBSTRATE ADHESION	214	1.90e-02	9.56e-02	0.11900	1.09e-01	4.81e-02	6.09e-03	2.26e-01
GOBP UTP METABOLIC PROCESS	12	7.67e-01	8.82e-01	0.11900	1.64e-03	1.19e-01	9.92e-01	4.76e-01
Pyroptosis	27	5.02e-01	7.12e-01	0.11900	-4.55e-02	1.10e-01	6.82e-01	3.23e-01
GOBP EPIDERMIS DEVELOPMENT	376	7.43e-04	8.39e-03	0.11900	-1.13e-01	-3.59e-02	1.60e-04	2.33e-01
GOBP POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION	18	6.16e-01	7.89e-01	0.11900	-8.65e-02	8.15e-02	5.25e-01	5.49e-01
GOBP NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT	31	5.81e-01	7.67e-01	0.11900	7.53e-02	9.20e-02	4.68e-01	3.75e-01
GOMF CYCLASE ACTIVITY	20	5.91e-01	7.73e-01	0.11900	-5.85e-02	1.04e-01	6.51e-01	4.23e-01
GOBP REGULATION OF PROTEIN IMPORT INTO NUCLEUS	57	2.84e-01	5.23e-01	0.11900	1.19e-01	7.92e-04	1.21e-01	9.92e-01
GOBP CELLULAR RESPONSE TO MURAMYL DIPEPTIDE	8	8.44e-01	9.21e-01	0.11900	1.18e-01	1.21e-02	5.63e-01	9.53e-01
GOBP PROTEIN CONTAINING COMPLEX REMODELING	37	4.27e-01	6.56e-01	0.11900	1.03e-02	-1.18e-01	9.13e-01	2.13e-01
GOMF ENZYME ACTIVATOR ACTIVITY	565	2.82e-05	5.37e-04	0.11900	1.11e-01	4.23e-02	6.43e-06	8.57e-02
GOBP L ARGININE TRANSMEMBRANE TRANSPORT	14	7.34e-01	8.65e-01	0.11900	1.19e-01	1.48e-03	4.42e-01	9.92e-01
GOBP MEMBRANE RAFT ORGANIZATION	26	5.77e-01	7.66e-01	0.11900	1.25e-02	1.18e-01	9.12e-01	2.97e-01
Receptor-type tyrosine-protein phosphatases	16	7.13e-01	8.52e-01	0.11900	-1.22e-02	-1.18e-01	9.32e-01	4.14e-01
GOBP REGULATION OF CELL DIFFERENTIATION	1553	1.24e-11	8.92e-10	0.11900	8.54e-02	8.23e-02	1.89e-08	6.11e-08
GOMF THREONINE TYPE ENDOPEPTIDASE ACTIVITY	9	8.53e-01	9.26e-01	0.11900	9.65e-02	6.89e-02	6.16e-01	7.20e-01
Activated NTRK2 signals through FYN	7	8.30e-01	9.15e-01	0.11900	7.30e-02	-9.35e-02	7.38e-01	6.68e-01
GOBP FEMALE SEX DIFFERENTIATION	118	7.31e-02	2.39e-01	0.11800	1.18e-01	-2.84e-03	2.62e-02	9.57e-01
GOCC ORGANELLE SUBCOMPARTMENT	1445	6.53e-11	4.36e-09	0.11800	8.75e-02	7.99e-02	2.60e-08	3.65e-07
GOBP POSITIVE REGULATION OF LIPID CATABOLIC PROCESS	26	6.12e-01	7.87e-01	0.11800	-4.25e-02	-1.11e-01	7.08e-01	3.29e-01
GOBP CD40 SIGNALING PATHWAY	15	7.16e-01	8.54e-01	0.11800	1.18e-01	-2.50e-03	4.27e-01	9.87e-01
GOBP LEFT RIGHT AXIS SPECIFICATION	13	7.38e-01	8.67e-01	0.11800	1.70e-02	-1.17e-01	9.15e-01	4.64e-01
Dopamine receptors	5	9.08e-01	9.55e-01	0.11800	3.70e-02	1.12e-01	8.86e-01	6.63e-01
GOMF DOPAMINE NEUROTRANSMITTER RECEPTOR ACTIVITY	5	9.08e-01	9.55e-01	0.11800	3.70e-02	1.12e-01	8.86e-01	6.63e-01
GOBP NEGATIVE REGULATION OF AMINO ACID TRANSPORT	15	6.95e-01	8.41e-01	0.11800	2.93e-02	-1.15e-01	8.44e-01	4.42e-01
GOBP CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS	20	6.06e-01	7.83e-01	0.11800	-4.14e-02	1.11e-01	7.49e-01	3.91e-01
GOMF DYNACTIN BINDING	12	8.13e-01	9.06e-01	0.11800	8.26e-02	8.48e-02	6.20e-01	6.11e-01
GOBP KERATINOCYTE PROLIFERATION	60	2.25e-01	4.59e-01	0.11800	-1.12e-01	3.90e-02	1.34e-01	6.01e-01
GOBP POSITIVE REGULATION OF RESPIRATORY BURST	7	8.86e-01	9.45e-01	0.11800	-8.09e-02	-8.64e-02	7.11e-01	6.92e-01
GOBP NON PROTEINOGENIC AMINO ACID METABOLIC PROCESS	71	2.00e-01	4.30e-01	0.11800	1.18e-01	-9.80e-03	8.59e-02	8.86e-01
GOMF MONOATOMIC ANION CHANNEL ACTIVITY	90	2.07e-01	4.38e-01	0.11800	-9.70e-02	-6.77e-02	1.12e-01	2.67e-01
GOBP FIBROBLAST PROLIFERATION	107	1.59e-01	3.77e-01	0.11800	8.56e-02	8.16e-02	1.26e-01	1.45e-01
GOMF STRUCTURAL MOLECULE ACTIVITY CONFERRING ELASTICITY	12	7.53e-01	8.73e-01	0.11800	1.16e-01	-2.15e-02	4.86e-01	8.97e-01
GOBP REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY	345	2.81e-03	2.29e-02	0.11800	7.85e-02	8.84e-02	1.22e-02	4.79e-03
GOBP NEGATIVE REGULATION OF BLOOD PRESSURE	48	2.79e-01	5.19e-01	0.11800	-7.88e-02	8.81e-02	3.45e-01	2.91e-01
Dopamine Neurotransmitter Release Cycle	21	6.82e-01	8.34e-01	0.11800	-1.06e-01	-5.22e-02	4.00e-01	6.79e-01
GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION	38	4.96e-01	7.08e-01	0.11800	4.75e-02	1.08e-01	6.12e-01	2.48e-01
GOBP GLYCEROLIPID CATABOLIC PROCESS	64	3.31e-01	5.70e-01	0.11800	-7.63e-02	-9.02e-02	2.91e-01	2.12e-01
C-type lectin receptors (CLRs)	126	1.09e-01	3.06e-01	0.11800	9.99e-02	6.31e-02	5.28e-02	2.21e-01
GOBP DIACYLGLYCEROL METABOLIC PROCESS	26	6.12e-01	7.87e-01	0.11800	-4.06e-02	-1.11e-01	7.20e-01	3.28e-01
GOBP REGULATION OF LEUKOCYTE PROLIFERATION	256	1.56e-03	1.45e-02	0.11800	-1.07e-01	5.06e-02	3.28e-03	1.64e-01
GOBP ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT	11	7.68e-01	8.83e-01	0.11800	2.69e-02	-1.15e-01	8.77e-01	5.09e-01
Sphingolipid metabolism	101	1.41e-01	3.54e-01	0.11800	3.16e-02	1.14e-01	5.83e-01	4.82e-02
GOBP REGULATION OF DIGESTIVE SYSTEM PROCESS	39	3.70e-01	6.06e-01	0.11800	1.06e-01	-5.09e-02	2.50e-01	5.82e-01
GOBP MODIFIED AMINO ACID TRANSPORT	40	4.59e-01	6.83e-01	0.11800	-1.14e-01	-3.13e-02	2.13e-01	7.32e-01
GOBP CELLULAR RESPONSE TO L GLUTAMATE	6	8.93e-01	9.48e-01	0.11800	-3.96e-02	-1.11e-01	8.67e-01	6.37e-01
GOBP AMINO SUGAR METABOLIC PROCESS	40	5.00e-01	7.11e-01	0.11800	7.29e-02	9.28e-02	4.25e-01	3.10e-01
GOBP MYELOID CELL DEVELOPMENT	84	1.27e-01	3.33e-01	0.11800	-3.71e-02	1.12e-01	5.57e-01	7.59e-02
GOMF NEUROPEPTIDE RECEPTOR BINDING	34	4.49e-01	6.75e-01	0.11800	-1.16e-01	2.22e-02	2.42e-01	8.23e-01
GOBP SECRETORY GRANULE ORGANIZATION	66	3.22e-01	5.60e-01	0.11800	8.87e-02	7.78e-02	2.13e-01	2.75e-01
GOBP NEGATIVE REGULATION OF MACROPHAGE DIFFERENTIATION	8	8.26e-01	9.12e-01	0.11800	-1.15e-01	2.62e-02	5.74e-01	8.98e-01
GOMF GROWTH HORMONE RECEPTOR BINDING	8	8.33e-01	9.17e-01	0.11800	-1.40e-02	1.17e-01	9.45e-01	5.67e-01
Class B/2 (Secretin family receptors)	93	1.03e-01	2.96e-01	0.11800	-1.12e-01	3.62e-02	6.19e-02	5.46e-01
GOBP REGULATION OF DENDRITIC SPINE MORPHOGENESIS	41	4.75e-01	6.95e-01	0.11800	-1.07e-01	-4.99e-02	2.37e-01	5.80e-01
GOBP REGULATION OF COLLAGEN FIBRIL ORGANIZATION	9	8.32e-01	9.16e-01	0.11800	-1.66e-02	-1.16e-01	9.31e-01	5.45e-01
Pregnenolone biosynthesis	12	8.14e-01	9.06e-01	0.11800	8.74e-02	7.87e-02	6.00e-01	6.37e-01
Diseases of Mismatch Repair (MMR)	5	8.88e-01	9.46e-01	0.11800	2.77e-02	-1.14e-01	9.15e-01	6.58e-01
GOBP MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS	48	2.87e-01	5.26e-01	0.11800	6.57e-02	-9.74e-02	4.31e-01	2.43e-01
GOBP PEPTIDYL THREONINE DEPHOSPHORYLATION	17	7.45e-01	8.70e-01	0.11800	9.62e-02	6.75e-02	4.92e-01	6.30e-01
GOMF MACROLIDE BINDING	12	7.58e-01	8.76e-01	0.11800	-1.16e-01	1.81e-02	4.86e-01	9.14e-01
GOBP LUNG MORPHOGENESIS	55	3.84e-01	6.18e-01	0.11700	9.81e-02	6.47e-02	2.08e-01	4.07e-01
GOBP NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE	17	7.34e-01	8.64e-01	0.11700	-1.07e-01	-4.84e-02	4.45e-01	7.30e-01
GOBP POSITIVE REGULATION OF ORGANIC ACID TRANSPORT	45	3.32e-01	5.71e-01	0.11700	-3.91e-02	1.11e-01	6.50e-01	1.99e-01
GOBP METANEPHRIC NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION	6	8.97e-01	9.50e-01	0.11700	-1.06e-01	-5.05e-02	6.53e-01	8.30e-01
GOBP REGULATION OF JUN KINASE ACTIVITY	40	4.53e-01	6.78e-01	0.11700	1.15e-01	2.33e-02	2.08e-01	7.99e-01
GOMF ISOMERASE ACTIVITY	165	4.56e-02	1.77e-01	0.11700	1.11e-01	3.71e-02	1.36e-02	4.11e-01
GOBP MAINTENANCE OF POSTSYNAPTIC SPECIALIZATION STRUCTURE	8	8.14e-01	9.06e-01	0.11700	1.01e-01	-5.94e-02	6.20e-01	7.71e-01
GOCC VACUOLAR PROTON TRANSPORTING V TYPE ATPASE V0 DOMAIN	9	8.51e-01	9.25e-01	0.11700	1.05e-01	5.25e-02	5.86e-01	7.85e-01
SHC-mediated cascade:FGFR4	19	7.24e-01	8.59e-01	0.11700	8.47e-02	8.11e-02	5.23e-01	5.41e-01
GOBP CYTOPLASM ORGANIZATION	15	7.71e-01	8.85e-01	0.11700	6.48e-02	9.77e-02	6.64e-01	5.13e-01
GOBP LYSINE METABOLIC PROCESS	8	8.61e-01	9.32e-01	0.11700	1.10e-01	3.91e-02	5.88e-01	8.48e-01
GOBP CELLULAR RESPONSE TO KETONE	101	1.78e-01	4.02e-01	0.11700	9.46e-02	6.92e-02	1.00e-01	2.30e-01
GOBP NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT	22	6.05e-01	7.82e-01	0.11700	-1.67e-02	1.16e-01	8.92e-01	3.47e-01
GOCC PRESYNAPTIC MEMBRANE	161	6.58e-02	2.23e-01	0.11700	-9.03e-02	-7.45e-02	4.79e-02	1.03e-01
GOBP UREA TRANSMEMBRANE TRANSPORT	9	7.95e-01	8.97e-01	0.11700	-5.68e-02	1.02e-01	7.68e-01	5.95e-01
GOBP METANEPHROS MORPHOGENESIS	30	5.65e-01	7.57e-01	0.11700	-1.12e-01	-3.26e-02	2.87e-01	7.57e-01
GOBP NEGATIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION	37	5.02e-01	7.12e-01	0.11700	1.11e-01	3.78e-02	2.44e-01	6.91e-01
GOMF LIPID TRANSPORTER ACTIVITY	164	5.29e-02	1.95e-01	0.11700	-4.80e-02	-1.07e-01	2.89e-01	1.85e-02
GOBP SYNAPSE MATURATION	33	5.71e-01	7.61e-01	0.11700	7.22e-02	9.19e-02	4.73e-01	3.61e-01
GOBP GLYCEROPHOSPHOLIPID METABOLIC PROCESS	295	5.23e-03	3.66e-02	0.11700	1.07e-01	4.77e-02	1.62e-03	1.59e-01
GOBP REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS	140	7.77e-02	2.48e-01	0.11700	4.19e-02	1.09e-01	3.92e-01	2.60e-02
GOBP REGULATION OF CYCLASE ACTIVITY	51	3.32e-01	5.71e-01	0.11700	3.10e-03	-1.17e-01	9.69e-01	1.49e-01
GOBP SEMI LUNAR VALVE DEVELOPMENT	48	3.59e-01	5.96e-01	0.11700	9.52e-05	1.17e-01	9.99e-01	1.62e-01
GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION	71	2.41e-01	4.79e-01	0.11700	-1.15e-01	-1.66e-02	9.25e-02	8.09e-01
GOBP DENDRITIC SPINE MORPHOGENESIS	54	3.78e-01	6.13e-01	0.11700	-1.07e-01	-4.58e-02	1.73e-01	5.61e-01
GOBP GLYCEROLIPID BIOSYNTHETIC PROCESS	239	1.53e-02	8.22e-02	0.11700	1.04e-01	5.29e-02	5.64e-03	1.59e-01
GOBP MONOCARBOXYLIC ACID CATABOLIC PROCESS	128	9.62e-02	2.83e-01	0.11700	4.05e-02	1.09e-01	4.29e-01	3.26e-02
GOCC EARLY PHAGOSOME	12	7.33e-01	8.63e-01	0.11700	-7.83e-02	8.64e-02	6.39e-01	6.04e-01
GOBP NEGATIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS	9	8.47e-01	9.23e-01	0.11600	3.82e-02	1.10e-01	8.43e-01	5.68e-01
GOBP ENTERIC NERVOUS SYSTEM DEVELOPMENT	12	7.90e-01	8.94e-01	0.11600	1.14e-01	2.21e-02	4.93e-01	8.95e-01
GOBP UDP N ACETYLGLUCOSAMINE TRANSMEMBRANE TRANSPORT	5	8.91e-01	9.47e-01	0.11600	1.14e-01	-2.42e-02	6.59e-01	9.25e-01
GOMF UDP N ACETYLGLUCOSAMINE TRANSMEMBRANE TRANSPORTER ACTIVITY	5	8.91e-01	9.47e-01	0.11600	1.14e-01	-2.42e-02	6.59e-01	9.25e-01
GOCC PLATELET ALPHA GRANULE	82	2.20e-01	4.54e-01	0.11600	-3.71e-02	-1.10e-01	5.61e-01	8.44e-02
GOBP RESPONSE TO FOOD	38	5.18e-01	7.24e-01	0.11600	5.75e-02	1.01e-01	5.40e-01	2.81e-01
GOBP PHOSPHATIDYLSERINE ACYL CHAIN REMODELING	9	8.31e-01	9.15e-01	0.11600	-8.33e-03	-1.16e-01	9.65e-01	5.47e-01
GOBP INNER EAR RECEPTOR CELL DEVELOPMENT	47	4.57e-01	6.82e-01	0.11600	-8.09e-02	-8.36e-02	3.37e-01	3.22e-01
Phospholipase C-mediated cascade: FGFR1	16	6.62e-01	8.20e-01	0.11600	7.69e-02	-8.72e-02	5.94e-01	5.46e-01
Neurotransmitter clearance	9	8.60e-01	9.31e-01	0.11600	-9.01e-02	-7.34e-02	6.40e-01	7.03e-01
GOBP POSITIVE REGULATION OF PEPTIDASE ACTIVITY	163	1.72e-02	8.91e-02	0.11600	-5.72e-02	1.01e-01	2.07e-01	2.59e-02
Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)	117	8.39e-02	2.60e-01	0.11600	8.68e-04	-1.16e-01	9.87e-01	2.99e-02
GOMF CYSTEINE TYPE PEPTIDASE ACTIVITY	154	7.40e-02	2.40e-01	0.11600	9.66e-02	6.45e-02	3.85e-02	1.67e-01
GOCC MRNA EDITING COMPLEX	6	8.67e-01	9.35e-01	0.11600	-1.11e-01	3.38e-02	6.37e-01	8.86e-01
GOBP REGULATION OF INFLAMMATORY RESPONSE	410	1.33e-04	1.95e-03	0.11600	-1.15e-01	1.26e-02	6.02e-05	6.62e-01
GOMF TRANSLATION REGULATOR ACTIVITY	380	1.51e-03	1.42e-02	0.11600	-5.54e-02	-1.02e-01	6.36e-02	6.35e-04
GOBP REGULATION OF AMINO ACID TRANSMEMBRANE TRANSPORT	14	7.67e-01	8.82e-01	0.11600	1.12e-01	2.97e-02	4.67e-01	8.48e-01
GOBP REGULATION OF MEIOTIC CELL CYCLE PHASE TRANSITION	11	7.70e-01	8.84e-01	0.11600	1.11e-01	-3.51e-02	5.25e-01	8.40e-01
GOBP TYPE I INTERFERON PRODUCTION	119	1.39e-01	3.51e-01	0.11600	7.69e-02	8.69e-02	1.47e-01	1.02e-01
GOMF EPINEPHRINE BINDING	6	9.01e-01	9.52e-01	0.11600	5.57e-02	1.02e-01	8.13e-01	6.66e-01
GOBP VESICLE UNCOATING	9	8.44e-01	9.21e-01	0.11600	1.12e-01	3.01e-02	5.61e-01	8.76e-01
GOBP METANEPHRIC EPITHELIUM DEVELOPMENT	28	6.28e-01	7.96e-01	0.11600	-8.75e-02	-7.61e-02	4.23e-01	4.86e-01
GOBP MORPHOGENESIS OF AN EPITHELIAL SHEET	64	3.17e-01	5.56e-01	0.11600	1.07e-01	4.35e-02	1.37e-01	5.47e-01
GOBP CALCIUM ACTIVATED PHOSPHOLIPID SCRAMBLING	5	8.98e-01	9.50e-01	0.11600	-1.16e-01	4.19e-03	6.54e-01	9.87e-01
GOMF 3 HYDROXYACYL COA DEHYDRATASE ACTIVITY	7	8.40e-01	9.20e-01	0.11600	-5.61e-02	1.01e-01	7.97e-01	6.42e-01
GOBP REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY	36	5.26e-01	7.30e-01	0.11600	4.45e-02	1.07e-01	6.44e-01	2.67e-01
GOBP MUSCLE CELL DIFFERENTIATION	417	1.71e-04	2.43e-03	0.11600	1.16e-01	-1.75e-03	5.02e-05	9.51e-01
GOBP NK T CELL ACTIVATION	14	7.21e-01	8.57e-01	0.11600	-3.06e-02	1.12e-01	8.43e-01	4.70e-01
GOCC MULTIVESICULAR BODY MEMBRANE	28	5.96e-01	7.76e-01	0.11600	3.44e-02	1.10e-01	7.53e-01	3.12e-01
GOMF PROTEIN HORMONE RECEPTOR ACTIVITY	20	6.90e-01	8.39e-01	0.11600	-3.28e-02	-1.11e-01	8.00e-01	3.91e-01
RHOF GTPase cycle	40	4.27e-01	6.56e-01	0.11600	1.16e-01	-3.48e-03	2.06e-01	9.70e-01
GOBP CELLULAR RESPONSE TO FRUCTOSE STIMULUS	5	9.12e-01	9.56e-01	0.11600	3.39e-02	1.11e-01	8.96e-01	6.69e-01
GOBP REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL	141	9.45e-02	2.80e-01	0.11600	-9.59e-02	-6.45e-02	4.92e-02	1.86e-01
GOBP RESPONSE TO VITAMIN	86	2.30e-01	4.65e-01	0.11600	1.01e-01	5.70e-02	1.07e-01	3.61e-01
GOBP NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION	60	2.51e-01	4.89e-01	0.11600	1.12e-01	-2.80e-02	1.33e-01	7.08e-01
GOBP POSITIVE REGULATION OF MHC CLASS II BIOSYNTHETIC PROCESS	14	7.54e-01	8.74e-01	0.11600	-1.15e-01	-1.00e-02	4.56e-01	9.48e-01
GOCC SHELTERIN COMPLEX	7	8.82e-01	9.43e-01	0.11500	1.08e-01	4.21e-02	6.22e-01	8.47e-01
GOMF DIACYLGLYCEROL BINDING	13	7.43e-01	8.69e-01	0.11500	-2.46e-02	1.13e-01	8.78e-01	4.81e-01
G alpha (i) signalling events	304	6.96e-03	4.56e-02	0.11500	-9.00e-02	-7.23e-02	6.95e-03	3.02e-02
GOBP GLIAL CELL FATE COMMITMENT	13	7.26e-01	8.60e-01	0.11500	1.02e-01	-5.36e-02	5.23e-01	7.38e-01
GOBP REGULATION OF PROTEIN EXPORT FROM NUCLEUS	32	5.88e-01	7.72e-01	0.11500	9.21e-02	6.95e-02	3.67e-01	4.96e-01
GOBP LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE	206	8.85e-03	5.49e-02	0.11500	-2.99e-02	1.11e-01	4.59e-01	5.84e-03
GOBP REGULATION OF LYMPHOCYTE DIFFERENTIATION	212	1.86e-02	9.45e-02	0.11500	2.53e-02	1.12e-01	5.25e-01	4.76e-03
GOBP SEX DIFFERENTIATION	268	1.24e-02	7.00e-02	0.11500	9.17e-02	6.99e-02	9.78e-03	4.89e-02
GOBP REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME	12	8.15e-01	9.07e-01	0.11500	5.73e-02	1.00e-01	7.31e-01	5.49e-01
GOBP RESPONSE TO CORTICOSTEROID	152	5.70e-02	2.03e-01	0.11500	2.50e-02	1.12e-01	5.95e-01	1.67e-02
GOBP REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE	37	5.44e-01	7.42e-01	0.11500	8.98e-02	7.21e-02	3.44e-01	4.48e-01
GOBP CELLULAR RESPONSE TO HEAT	63	2.09e-01	4.41e-01	0.11500	9.67e-02	-6.26e-02	1.85e-01	3.90e-01
GOBP REGULATION OF CELLULAR COMPONENT BIOGENESIS	965	1.93e-07	6.54e-06	0.11500	9.67e-02	6.24e-02	3.65e-07	1.03e-03
GOBP NEGATIVE REGULATION OF MEIOTIC CELL CYCLE	18	7.46e-01	8.70e-01	0.11500	8.04e-02	8.22e-02	5.55e-01	5.46e-01
Rap1 signalling	16	7.17e-01	8.54e-01	0.11500	1.15e-01	-7.99e-04	4.26e-01	9.96e-01
GOBP DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS	103	1.02e-01	2.93e-01	0.11500	1.13e-01	-2.01e-02	4.72e-02	7.24e-01
Glutamate binding, activation of AMPA receptors and synaptic plasticity	29	4.84e-01	6.99e-01	0.11500	8.97e-02	-7.18e-02	4.03e-01	5.04e-01
Trafficking of AMPA receptors	29	4.84e-01	6.99e-01	0.11500	8.97e-02	-7.18e-02	4.03e-01	5.04e-01
GOBP PYROPTOSIS	36	4.79e-01	6.96e-01	0.11500	-1.15e-01	-3.19e-03	2.33e-01	9.74e-01
GOBP REGULATION OF CELL DEVELOPMENT	812	2.39e-06	6.26e-05	0.11500	6.63e-02	9.37e-02	1.31e-03	5.60e-06
MET receptor recycling	10	8.14e-01	9.06e-01	0.11500	1.15e-01	2.25e-03	5.30e-01	9.90e-01
GOBP GLOMERULUS MORPHOGENESIS	9	8.44e-01	9.21e-01	0.11500	-1.12e-01	-2.44e-02	5.60e-01	8.99e-01
GOBP PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE	220	4.82e-03	3.44e-02	0.11500	-5.60e-02	1.00e-01	1.52e-01	1.04e-02
Neurexins and neuroligins	52	4.29e-01	6.58e-01	0.11500	-7.54e-02	-8.65e-02	3.47e-01	2.81e-01
GOBP REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS	85	1.25e-01	3.29e-01	0.11500	5.85e-02	-9.87e-02	3.51e-01	1.16e-01
GOBP CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN	226	1.38e-02	7.63e-02	0.11500	-1.13e-01	-2.04e-02	3.45e-03	5.97e-01
GOBP POSITIVE REGULATION OF LIPID LOCALIZATION	111	1.34e-01	3.43e-01	0.11500	-1.10e-01	-3.36e-02	4.59e-02	5.40e-01
GOBP HETEROCHROMATIN ORGANIZATION	13	7.22e-01	8.57e-01	0.11500	8.05e-02	-8.17e-02	6.15e-01	6.10e-01
GOBP REGULATION OF CORTICOSTEROID HORMONE SECRETION	16	7.37e-01	8.66e-01	0.11500	-2.08e-02	-1.13e-01	8.85e-01	4.35e-01
GOBP POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION	17	6.59e-01	8.17e-01	0.11500	-9.78e-02	5.97e-02	4.85e-01	6.70e-01
GOBP LYMPHOCYTE ACTIVATION	766	9.06e-08	3.31e-06	0.11500	-1.68e-02	1.13e-01	4.28e-01	9.34e-08
GOMF CAMP DEPENDENT PROTEIN KINASE REGULATOR ACTIVITY	12	7.45e-01	8.70e-01	0.11500	9.88e-02	-5.80e-02	5.53e-01	7.28e-01
GOCC MYELIN SHEATH ADAXONAL REGION	6	9.01e-01	9.52e-01	0.11500	1.04e-01	4.76e-02	6.58e-01	8.40e-01
Interleukin-20 family signaling	24	5.62e-01	7.54e-01	0.11500	-1.03e-01	4.97e-02	3.82e-01	6.73e-01
GOBP CYTIDINE TO URIDINE EDITING	12	7.82e-01	8.90e-01	0.11400	1.18e-03	1.14e-01	9.94e-01	4.92e-01
GOBP NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS	111	1.50e-01	3.64e-01	0.11400	1.04e-01	4.86e-02	5.92e-02	3.76e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON DIPHENOLS AND RELATED SUBSTANCES AS DONORS	8	8.66e-01	9.35e-01	0.11400	3.55e-02	1.09e-01	8.62e-01	5.94e-01
GOBP NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION	129	7.31e-02	2.39e-01	0.11400	1.88e-03	1.14e-01	9.71e-01	2.50e-02
GOBP MYELIN MAINTENANCE	17	7.60e-01	8.78e-01	0.11400	7.86e-02	8.30e-02	5.75e-01	5.53e-01
GOBP NEGATIVE REGULATION OF GLYCOGEN METABOLIC PROCESS	10	8.21e-01	9.09e-01	0.11400	1.14e-01	1.04e-02	5.33e-01	9.54e-01
GOBP FIBRINOLYSIS	27	5.53e-01	7.48e-01	0.11400	1.86e-02	-1.13e-01	8.67e-01	3.11e-01
GOBP POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS	32	4.61e-01	6.84e-01	0.11400	-1.00e-01	5.50e-02	3.27e-01	5.90e-01
GOBP DEFENSE RESPONSE TO VIRUS	297	8.26e-03	5.21e-02	0.11400	6.59e-02	9.33e-02	5.09e-02	5.67e-03
GOBP RRNA PSEUDOURIDINE SYNTHESIS	7	8.77e-01	9.41e-01	0.11400	1.12e-01	2.34e-02	6.09e-01	9.14e-01
GOBP REGULATORY NCRNA MEDIATED HETEROCHROMATIN FORMATION	19	6.24e-01	7.93e-01	0.11400	8.15e-02	-7.99e-02	5.39e-01	5.46e-01
GOBP EPITHELIAL CILIUM MOVEMENT INVOLVED IN DETERMINATION OF LEFT RIGHT ASYMMETRY	11	8.38e-01	9.18e-01	0.11400	-7.70e-02	-8.42e-02	6.58e-01	6.29e-01
GOCC PRESYNAPTIC ACTIVE ZONE	76	2.87e-01	5.25e-01	0.11400	-9.66e-02	-6.07e-02	1.46e-01	3.60e-01
Adrenaline,noradrenaline inhibits insulin secretion	28	5.65e-01	7.57e-01	0.11400	1.14e-01	1.96e-05	2.96e-01	1.00e+00
GOBP POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING	20	7.07e-01	8.49e-01	0.11400	-4.39e-02	-1.05e-01	7.34e-01	4.15e-01
GOMF CXCR CHEMOKINE RECEPTOR BINDING	18	7.09e-01	8.50e-01	0.11400	-1.67e-02	-1.13e-01	9.02e-01	4.07e-01
GOBP POSITIVE REGULATION OF ORGANELLE ASSEMBLY	87	2.49e-01	4.87e-01	0.11400	8.17e-02	7.94e-02	1.88e-01	2.00e-01
GOBP NEGATIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL	11	7.62e-01	8.79e-01	0.11400	7.34e-02	-8.71e-02	6.73e-01	6.17e-01
GOBP REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DEDIFFERENTIATION	5	8.85e-01	9.45e-01	0.11400	-6.11e-02	9.61e-02	8.13e-01	7.10e-01
GOBP CILIUM ORGANIZATION	421	6.37e-04	7.38e-03	0.11400	1.08e-01	3.50e-02	1.37e-04	2.19e-01
GOBP NADP METABOLIC PROCESS	42	4.80e-01	6.97e-01	0.11400	1.07e-01	3.91e-02	2.31e-01	6.61e-01
GOBP REGULATION OF CELLULAR COMPONENT SIZE	335	3.37e-03	2.63e-02	0.11400	1.05e-01	4.35e-02	9.45e-04	1.71e-01
GOBP CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS	310	6.76e-03	4.47e-02	0.11400	9.55e-02	6.16e-02	3.83e-03	6.20e-02
GOBP AMINE TRANSPORT	92	1.15e-01	3.14e-01	0.11400	-1.03e-01	4.81e-02	8.78e-02	4.26e-01
Post NMDA receptor activation events	75	1.64e-01	3.84e-01	0.11400	-6.04e-02	9.62e-02	3.66e-01	1.50e-01
GOBP POSITIVE REGULATION OF GLOMERULAR MESANGIAL CELL PROLIFERATION	7	8.68e-01	9.35e-01	0.11400	2.67e-04	1.14e-01	9.99e-01	6.03e-01
GOBP ADP BIOSYNTHETIC PROCESS	5	9.22e-01	9.63e-01	0.11400	-6.22e-02	-9.51e-02	8.10e-01	7.13e-01
GOCC NUCLEAR OUTER MEMBRANE ENDOPLASMIC RETICULUM MEMBRANE NETWORK	1170	2.11e-08	8.67e-07	0.11400	8.25e-02	7.80e-02	1.96e-06	6.81e-06
GOBP REGULATION OF NATURAL KILLER CELL ACTIVATION	38	4.60e-01	6.84e-01	0.11400	-2.39e-03	1.14e-01	9.80e-01	2.26e-01
GOBP POSITIVE REGULATION OF T CELL MIGRATION	33	5.43e-01	7.41e-01	0.11300	-2.28e-02	-1.11e-01	8.21e-01	2.69e-01
GOBP NEGATIVE REGULATION OF MAP KINASE ACTIVITY	45	4.76e-01	6.95e-01	0.11300	5.60e-02	9.87e-02	5.16e-01	2.52e-01
GOBP P38MAPK CASCADE	59	3.80e-01	6.14e-01	0.11300	5.74e-02	9.78e-02	4.46e-01	1.94e-01
GOBP VIRAL PROCESS	412	1.59e-03	1.48e-02	0.11300	7.38e-02	8.61e-02	1.02e-02	2.71e-03
GOBP MONOACYLGLYCEROL METABOLIC PROCESS	14	7.99e-01	8.99e-01	0.11300	-6.92e-02	-8.98e-02	6.54e-01	5.61e-01
GOBP GLOMERULAR MESANGIUM DEVELOPMENT	18	6.77e-01	8.30e-01	0.11300	1.12e-01	-2.00e-02	4.12e-01	8.83e-01
GOBP DEOXYRIBONUCLEOSIDE CATABOLIC PROCESS	6	8.63e-01	9.33e-01	0.11300	7.66e-02	-8.36e-02	7.45e-01	7.23e-01
GOBP NEGATIVE REGULATION OF COLLATERAL SPROUTING	10	8.53e-01	9.26e-01	0.11300	-8.59e-02	-7.39e-02	6.38e-01	6.86e-01
GOCC ACTIN FILAMENT	108	1.19e-01	3.20e-01	0.11300	4.64e-03	1.13e-01	9.34e-01	4.21e-02
GOBP MEMBRANE REPOLARIZATION	53	2.94e-01	5.33e-01	0.11300	4.25e-02	-1.05e-01	5.93e-01	1.86e-01
GOBP POSTSYNAPTIC MEMBRANE ORGANIZATION	38	4.66e-01	6.88e-01	0.11300	-2.14e-04	-1.13e-01	9.98e-01	2.27e-01
GOBP PROTEIN LOCALIZATION TO ENDOSOME	27	5.77e-01	7.66e-01	0.11300	1.13e-01	-3.28e-03	3.09e-01	9.76e-01
GOBP ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER	14	7.75e-01	8.87e-01	0.11300	2.58e-02	1.10e-01	8.67e-01	4.75e-01
GOCC CENTRIOLAR SATELLITE	116	1.40e-01	3.52e-01	0.11300	4.39e-02	1.04e-01	4.14e-01	5.23e-02
GOBP REGULATION OF TRANSFERASE ACTIVITY	606	6.67e-05	1.11e-03	0.11300	5.82e-02	9.70e-02	1.44e-02	4.53e-05
GOBP MATERNAL PROCESS INVOLVED IN PARTURITION	5	8.89e-01	9.46e-01	0.11300	1.01e-01	-5.13e-02	6.97e-01	8.42e-01
GOBP INTESTINE SMOOTH MUSCLE CONTRACTION	8	8.80e-01	9.43e-01	0.11300	6.94e-02	8.92e-02	7.34e-01	6.62e-01
GOBP REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION	46	4.24e-01	6.54e-01	0.11300	1.11e-01	1.89e-02	1.91e-01	8.24e-01
GOCC MITOTIC SPINDLE MIDZONE	13	8.14e-01	9.06e-01	0.11300	7.09e-02	8.81e-02	6.58e-01	5.82e-01
GOBP CAVEOLA ASSEMBLY	6	8.65e-01	9.34e-01	0.11300	6.71e-02	-9.10e-02	7.76e-01	7.00e-01
GOBP MELANOCYTE PROLIFERATION	5	8.89e-01	9.46e-01	0.11300	-9.96e-02	5.33e-02	7.00e-01	8.37e-01
GOBP PHAGOCYTOSIS ENGULFMENT	47	3.51e-01	5.89e-01	0.11300	-1.09e-01	3.10e-02	1.98e-01	7.13e-01
GOBP PROTEIN DEGLUTAMYLATION	6	9.07e-01	9.54e-01	0.11300	-9.79e-02	-5.64e-02	6.78e-01	8.11e-01
GOBP REGULATION OF MRNA CATABOLIC PROCESS	271	4.92e-03	3.49e-02	0.11300	1.13e-01	2.52e-03	1.38e-03	9.43e-01
GOMF LACTATE DEHYDROGENASE ACTIVITY	6	9.02e-01	9.52e-01	0.11300	-4.15e-02	-1.05e-01	8.60e-01	6.56e-01
GOBP CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS	30	6.06e-01	7.83e-01	0.11300	-1.02e-01	-4.77e-02	3.32e-01	6.51e-01
GOBP POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY	49	3.61e-01	5.98e-01	0.11300	-1.10e-02	1.12e-01	8.94e-01	1.74e-01
GOBP PEPTIDYL SERINE MODIFICATION	268	1.56e-02	8.33e-02	0.11300	8.15e-02	7.80e-02	2.16e-02	2.80e-02
GOMF LIPID PHOSPHATASE ACTIVITY	19	7.40e-01	8.68e-01	0.11300	-6.79e-02	-9.01e-02	6.08e-01	4.97e-01
GOBP NEGATIVE REGULATION OF INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY	8	8.33e-01	9.17e-01	0.11300	-3.94e-02	1.06e-01	8.47e-01	6.05e-01
GOBP REACTIVE OXYGEN SPECIES METABOLIC PROCESS	220	1.83e-02	9.32e-02	0.11300	2.15e-02	1.11e-01	5.83e-01	4.68e-03
GOBP DETECTION OF CALCIUM ION	13	7.86e-01	8.92e-01	0.11300	1.95e-02	1.11e-01	9.03e-01	4.88e-01
Cellular responses to mechanical stimuli	102	1.19e-01	3.21e-01	0.11300	1.12e-01	-1.35e-02	5.09e-02	8.14e-01
GOBP RESPONSE TO HORMONE	854	2.27e-06	6.00e-05	0.11300	9.00e-02	6.76e-02	7.87e-06	8.01e-04
GOBP GLYCOSYL COMPOUND METABOLIC PROCESS	81	2.61e-01	4.99e-01	0.11300	1.02e-01	4.74e-02	1.12e-01	4.61e-01
GOBP NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION	24	5.77e-01	7.66e-01	0.11300	-4.31e-02	1.04e-01	7.15e-01	3.78e-01
GOMF ORGANIC ACID SODIUM SYMPORTER ACTIVITY	32	5.46e-01	7.44e-01	0.11300	-1.12e-01	-1.27e-02	2.74e-01	9.01e-01
GOBP POSITIVE REGULATION OF MIRNA PROCESSING	5	8.87e-01	9.46e-01	0.11200	8.90e-02	-6.87e-02	7.30e-01	7.90e-01
GOBP NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY	43	4.67e-01	6.89e-01	0.11200	1.09e-01	2.92e-02	2.18e-01	7.40e-01
GOBP ATP METABOLIC PROCESS	205	3.40e-02	1.44e-01	0.11200	1.02e-01	4.63e-02	1.15e-02	2.53e-01
Blood group systems biosynthesis	22	7.04e-01	8.47e-01	0.11200	-9.41e-02	-6.12e-02	4.45e-01	6.19e-01
GOBP POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS	489	3.37e-04	4.31e-03	0.11200	1.03e-01	4.40e-02	9.30e-05	9.59e-02
GOMF ADP PHOSPHATASE ACTIVITY	6	9.05e-01	9.54e-01	0.11200	4.54e-02	1.02e-01	8.47e-01	6.64e-01
GOBP ACROSOME ASSEMBLY	30	5.05e-01	7.14e-01	0.11200	1.03e-01	-4.42e-02	3.29e-01	6.75e-01
GOMF INORGANIC MOLECULAR ENTITY TRANSMEMBRANE TRANSPORTER ACTIVITY	691	2.83e-05	5.37e-04	0.11200	-8.86e-02	-6.85e-02	7.12e-05	2.14e-03
GOCC GOLGI STACK	129	9.41e-02	2.79e-01	0.11200	1.74e-02	1.11e-01	7.33e-01	3.00e-02
GOBP PROTEIN LIPID COMPLEX ORGANIZATION	54	2.76e-01	5.16e-01	0.11200	7.54e-02	-8.28e-02	3.38e-01	2.93e-01
GOBP BONE RESORPTION	66	2.08e-01	4.40e-01	0.11200	-7.23e-02	8.55e-02	3.10e-01	2.30e-01
GOBP ACTIVATION OF PROTEIN KINASE B ACTIVITY	20	7.10e-01	8.50e-01	0.11200	3.53e-02	1.06e-01	7.85e-01	4.11e-01
Gastrin-CREB signalling pathway via PKC and MAPK	17	6.84e-01	8.35e-01	0.11200	1.05e-01	-3.77e-02	4.52e-01	7.88e-01
GOBP POSITIVE REGULATION OF GLYCOGEN BIOSYNTHETIC PROCESS	15	7.17e-01	8.55e-01	0.11200	1.06e-01	-3.47e-02	4.76e-01	8.16e-01
GOBP G1 TO G0 TRANSITION INVOLVED IN CELL DIFFERENTIATION	6	8.87e-01	9.45e-01	0.11200	1.12e-01	-5.51e-03	6.36e-01	9.81e-01
GOBP MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL	29	6.11e-01	7.86e-01	0.11200	-3.71e-02	-1.05e-01	7.30e-01	3.26e-01
GOBP NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL	22	6.20e-01	7.91e-01	0.11200	-2.91e-02	1.08e-01	8.13e-01	3.81e-01
GOBP SENSORY PERCEPTION OF LIGHT STIMULUS	207	1.22e-02	6.92e-02	0.11200	2.49e-02	-1.09e-01	5.36e-01	6.87e-03
GOBP POSITIVE REGULATION OF LIPID TRANSPORT	86	1.90e-01	4.17e-01	0.11200	-1.12e-01	-3.15e-03	7.32e-02	9.60e-01
GOBP REGULATION OF METALLOPEPTIDASE ACTIVITY	17	6.75e-01	8.29e-01	0.11200	-9.87e-02	5.24e-02	4.81e-01	7.08e-01
GOBP CELLULAR RESPONSE TO ALDEHYDE	16	6.85e-01	8.35e-01	0.11200	8.85e-02	-6.82e-02	5.40e-01	6.37e-01
GOBP REGULATION OF EXCRETION	11	7.93e-01	8.95e-01	0.11200	1.10e-01	-1.97e-02	5.28e-01	9.10e-01
GOBP NAIL DEVELOPMENT	11	8.00e-01	9.00e-01	0.11200	-8.67e-03	1.11e-01	9.60e-01	5.23e-01
GOBP RENAL FILTRATION	27	5.64e-01	7.56e-01	0.11200	2.24e-02	-1.09e-01	8.40e-01	3.25e-01
GOBP PROTEIN K63 LINKED DEUBIQUITINATION	26	6.18e-01	7.90e-01	0.11200	1.43e-02	1.11e-01	8.99e-01	3.28e-01
GOBP OSSIFICATION	434	1.40e-03	1.34e-02	0.11200	7.24e-02	8.49e-02	9.65e-03	2.41e-03
GOBP ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS	688	2.37e-05	4.58e-04	0.11200	9.69e-02	5.55e-02	1.48e-05	1.31e-02
Nephron development	13	7.95e-01	8.96e-01	0.11200	2.60e-02	1.09e-01	8.71e-01	4.98e-01
GOBP GROWTH	881	1.45e-06	4.05e-05	0.11200	9.57e-02	5.74e-02	1.41e-06	3.84e-03
GOBP ADENYLATE CYCLASE MODULATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY	255	6.36e-03	4.27e-02	0.11200	-1.11e-01	6.36e-03	2.18e-03	8.61e-01
GOBP NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS	120	6.96e-02	2.31e-01	0.11200	-1.05e-01	3.90e-02	4.79e-02	4.60e-01
GOBP CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS	177	6.67e-02	2.25e-01	0.11200	7.26e-02	8.47e-02	9.58e-02	5.18e-02
GOBP SKIN DEVELOPMENT	312	5.27e-03	3.68e-02	0.11200	-1.06e-01	-3.49e-02	1.30e-03	2.89e-01
GOBP NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS	940	9.52e-07	2.82e-05	0.11100	8.49e-02	7.22e-02	1.02e-05	1.77e-04
GOCC TRANSPORTER COMPLEX	439	1.32e-03	1.29e-02	0.11100	-8.53e-02	-7.17e-02	2.18e-03	1.00e-02
GOBP POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION	19	7.28e-01	8.61e-01	0.11100	3.95e-02	1.04e-01	7.65e-01	4.32e-01
GOBP SECRETION BY TISSUE	46	4.62e-01	6.86e-01	0.11100	-3.83e-02	-1.05e-01	6.53e-01	2.20e-01
GOBP INTRACELLULAR MRNA LOCALIZATION	15	7.12e-01	8.52e-01	0.11100	-4.67e-02	1.01e-01	7.54e-01	4.98e-01
GOBP CELL MATRIX ADHESION	234	5.39e-03	3.74e-02	0.11100	1.02e-01	-4.48e-02	7.24e-03	2.38e-01
GOBP POSITIVE REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY	19	7.07e-01	8.49e-01	0.11100	-1.10e-01	-1.60e-02	4.06e-01	9.04e-01
GOBP LYMPH VESSEL DEVELOPMENT	31	5.28e-01	7.32e-01	0.11100	-1.61e-02	1.10e-01	8.77e-01	2.89e-01
GOBP HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION	133	1.32e-01	3.40e-01	0.11100	7.04e-02	8.60e-02	1.61e-01	8.69e-02
GOMF CALCIUM DEPENDENT PROTEIN BINDING	76	1.78e-01	4.02e-01	0.11100	-5.15e-02	9.84e-02	4.38e-01	1.38e-01
GOBP MHC CLASS I BIOSYNTHETIC PROCESS	8	8.51e-01	9.25e-01	0.11100	-1.07e-02	1.11e-01	9.58e-01	5.88e-01
GOMF PHOSPHATIDYLGLYCEROL BINDING	15	7.85e-01	8.92e-01	0.11100	-4.84e-02	-1.00e-01	7.46e-01	5.03e-01
GOBP MEMBRANE LIPID BIOSYNTHETIC PROCESS	149	7.88e-02	2.50e-01	0.11100	3.09e-02	1.07e-01	5.15e-01	2.46e-02
GOBP REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE	49	4.07e-01	6.40e-01	0.11100	1.33e-02	1.10e-01	8.72e-01	1.82e-01
GOBP REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	35	5.35e-01	7.37e-01	0.11100	2.02e-02	1.09e-01	8.36e-01	2.64e-01
GOMF SPECTRIN BINDING	26	6.00e-01	7.78e-01	0.11100	4.70e-03	-1.11e-01	9.67e-01	3.28e-01
GOBP CYCLIC NUCLEOTIDE TRANSPORT	11	7.72e-01	8.85e-01	0.11100	-8.00e-02	7.68e-02	6.46e-01	6.59e-01
GOBP RESPONSE TO ANGIOTENSIN	41	4.59e-01	6.83e-01	0.11100	1.11e-01	4.55e-03	2.19e-01	9.60e-01
RET signaling	41	5.36e-01	7.37e-01	0.11100	7.35e-02	8.31e-02	4.16e-01	3.57e-01
GOBP REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION	42	3.79e-01	6.13e-01	0.11100	9.20e-02	-6.18e-02	3.02e-01	4.88e-01
GOBP FAT CELL PROLIFERATION	15	7.92e-01	8.95e-01	0.11100	6.10e-02	9.26e-02	6.83e-01	5.35e-01
GOBP PROTEIN K6 LINKED UBIQUITINATION	16	7.84e-01	8.92e-01	0.11100	8.00e-02	7.67e-02	5.79e-01	5.95e-01
Fatty acyl-CoA biosynthesis	36	4.73e-01	6.94e-01	0.11100	-1.09e-01	2.10e-02	2.58e-01	8.27e-01
GOBP CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE	76	3.10e-01	5.50e-01	0.11100	-6.15e-02	-9.21e-02	3.54e-01	1.65e-01
GOBP RESPONSE TO FRUCTOSE	10	8.00e-01	8.99e-01	0.11100	1.01e-01	-4.51e-02	5.80e-01	8.05e-01
GOBP POSITIVE REGULATION OF CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE	9	8.20e-01	9.09e-01	0.11100	-1.03e-01	3.99e-02	5.92e-01	8.36e-01
GOBP NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY	140	1.16e-01	3.16e-01	0.11100	9.30e-02	5.99e-02	5.75e-02	2.21e-01
Phospholipase C-mediated cascade; FGFR2	17	6.73e-01	8.27e-01	0.11100	8.07e-02	-7.56e-02	5.64e-01	5.90e-01
GOBP MICROVILLUS ORGANIZATION	28	6.51e-01	8.11e-01	0.11100	9.10e-02	6.28e-02	4.05e-01	5.65e-01
Downregulation of ERBB2 signaling	29	5.54e-01	7.49e-01	0.11100	1.09e-01	-1.61e-02	3.08e-01	8.81e-01
GOBP POSITIVE REGULATION OF DEVELOPMENTAL PROCESS	1331	5.42e-09	2.53e-07	0.11100	6.81e-02	8.71e-02	3.06e-05	9.60e-08
GOBP POSITIVE REGULATION OF NATURAL KILLER CELL PROLIFERATION	10	8.29e-01	9.14e-01	0.11100	-1.10e-01	-6.44e-03	5.46e-01	9.72e-01
GOBP ENDOPLASMIC RETICULUM PLASMA MEMBRANE TETHERING	6	9.13e-01	9.58e-01	0.11100	-8.02e-02	-7.60e-02	7.34e-01	7.47e-01
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO EARLY ENDOSOME	8	8.42e-01	9.21e-01	0.11000	-3.26e-02	1.06e-01	8.73e-01	6.05e-01
GOBP REGULATORY T CELL DIFFERENTIATION	39	4.76e-01	6.95e-01	0.11000	-1.10e-01	-1.01e-03	2.33e-01	9.91e-01
GOBP LYMPHATIC ENDOTHELIAL CELL DIFFERENTIATION	8	8.30e-01	9.15e-01	0.11000	-7.66e-02	7.95e-02	7.08e-01	6.97e-01
GOBP POSITIVE REGULATION OF CELL DIFFERENTIATION	872	2.63e-06	6.81e-05	0.11000	6.20e-02	9.13e-02	1.89e-03	4.71e-06
GOBP ACTIVATION OF GTPASE ACTIVITY	82	2.67e-01	5.06e-01	0.11000	-1.01e-01	-4.39e-02	1.13e-01	4.92e-01
GOBP KETONE BIOSYNTHETIC PROCESS	47	4.57e-01	6.82e-01	0.11000	-1.05e-01	-3.43e-02	2.14e-01	6.84e-01
GOBP COLLAGEN METABOLIC PROCESS	104	9.62e-02	2.83e-01	0.11000	5.46e-02	-9.58e-02	3.36e-01	9.15e-02
GOMF TRANSITION METAL ION BINDING	1051	1.38e-07	4.81e-06	0.11000	9.80e-02	5.04e-02	7.75e-08	5.75e-03
GOBP RESPONSE TO TUMOR CELL	44	4.86e-01	7.00e-01	0.11000	-1.03e-01	-3.84e-02	2.36e-01	6.59e-01
GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	60	4.08e-01	6.40e-01	0.11000	7.89e-02	7.68e-02	2.90e-01	3.03e-01
GOMF PROTEIN HOMODIMERIZATION ACTIVITY	684	4.79e-05	8.45e-04	0.11000	8.18e-02	7.37e-02	2.65e-04	1.01e-03
GOMF TETRAPYRROLE BINDING	144	7.23e-02	2.37e-01	0.11000	-1.10e-01	-9.47e-03	2.30e-02	8.44e-01
Dissolution of Fibrin Clot	13	8.20e-01	9.09e-01	0.11000	6.11e-02	9.16e-02	7.03e-01	5.67e-01
GOBP POSITIVE REGULATION OF AMYLOID BETA CLEARANCE	8	8.52e-01	9.26e-01	0.11000	1.39e-02	-1.09e-01	9.46e-01	5.93e-01
GOBP MORPHOGENESIS OF AN EPITHELIUM	489	7.79e-04	8.69e-03	0.11000	7.51e-02	8.04e-02	4.44e-03	2.32e-03
GOBP NEGATIVE REGULATION OF MEMBRANE DEPOLARIZATION	7	8.51e-01	9.25e-01	0.11000	-7.27e-02	8.25e-02	7.39e-01	7.05e-01
GOBP UNSATURATED FATTY ACID METABOLIC PROCESS	109	1.66e-01	3.88e-01	0.11000	-3.45e-02	-1.04e-01	5.34e-01	5.98e-02
Synthesis of PIPs at the ER membrane	5	8.93e-01	9.48e-01	0.11000	9.28e-02	-5.88e-02	7.19e-01	8.20e-01
GOBP NEGATIVE REGULATION OF PROTEIN SECRETION	72	3.07e-01	5.47e-01	0.11000	-1.04e-01	-3.54e-02	1.27e-01	6.03e-01
GOBP CELLULAR CATABOLIC PROCESS	1087	1.76e-07	6.01e-06	0.11000	8.81e-02	6.55e-02	9.43e-07	2.68e-04
GOBP LONG CHAIN FATTY ACYL COA METABOLIC PROCESS	24	5.80e-01	7.67e-01	0.11000	-9.01e-02	6.26e-02	4.45e-01	5.95e-01
GOBP MANGANESE ION TRANSPORT	11	8.09e-01	9.04e-01	0.11000	-1.10e-01	5.26e-03	5.29e-01	9.76e-01
GOBP CELLULAR RESPONSE TO XENOBIOTIC STIMULUS	190	2.30e-02	1.10e-01	0.11000	1.53e-02	-1.09e-01	7.16e-01	9.85e-03
GOBP COPPER ION TRANSPORT	15	7.25e-01	8.59e-01	0.11000	-1.03e-01	3.74e-02	4.90e-01	8.02e-01
GOBP RADIAL GLIAL CELL DIFFERENTIATION	14	7.48e-01	8.71e-01	0.11000	-2.63e-02	1.06e-01	8.65e-01	4.91e-01
GOBP RESPONSE TO IMMOBILIZATION STRESS	25	6.88e-01	8.38e-01	0.11000	6.82e-02	8.58e-02	5.55e-01	4.58e-01
Bile acid and bile salt metabolism	44	3.75e-01	6.10e-01	0.11000	5.46e-02	-9.50e-02	5.31e-01	2.75e-01
GOBP PANTOTHENATE METABOLIC PROCESS	7	8.95e-01	9.49e-01	0.11000	4.63e-02	9.93e-02	8.32e-01	6.49e-01
GOBP GTP BIOSYNTHETIC PROCESS	11	8.49e-01	9.24e-01	0.11000	6.91e-02	8.50e-02	6.92e-01	6.25e-01
GOBP METHIONINE BIOSYNTHETIC PROCESS	12	7.95e-01	8.97e-01	0.10900	1.09e-01	-3.51e-03	5.12e-01	9.83e-01
Late endosomal microautophagy	33	6.14e-01	7.87e-01	0.10900	8.04e-02	7.43e-02	4.24e-01	4.60e-01
GOCC CELL LEADING EDGE	412	1.54e-03	1.44e-02	0.10900	1.01e-01	4.11e-02	4.12e-04	1.53e-01
GOBP CALCIUM ION TRANSPORT	420	1.62e-03	1.49e-02	0.10900	-4.89e-02	-9.79e-02	8.54e-02	5.80e-04
GOCC MICROTUBULE ORGANIZING CENTER ATTACHMENT SITE	11	8.41e-01	9.20e-01	0.10900	-4.52e-02	-9.96e-02	7.95e-01	5.67e-01
GOBP NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC	6	9.15e-01	9.59e-01	0.10900	-7.62e-02	-7.83e-02	7.46e-01	7.40e-01
GOBP RESPONSE TO MERCURY ION	10	8.60e-01	9.31e-01	0.10900	5.99e-02	9.14e-02	7.43e-01	6.17e-01
GOBP NEUROPEPTIDE SIGNALING PATHWAY	101	1.22e-01	3.25e-01	0.10900	-3.06e-02	1.05e-01	5.95e-01	6.86e-02
GOCC MICROTUBULE	460	1.26e-03	1.25e-02	0.10900	8.45e-02	6.92e-02	1.90e-03	1.09e-02
GOCC GERM CELL NUCLEUS	68	3.48e-01	5.85e-01	0.10900	9.82e-02	4.78e-02	1.62e-01	4.95e-01
GOBP RESPONSE TO VIRUS	396	2.60e-03	2.16e-02	0.10900	5.37e-02	9.51e-02	6.67e-02	1.16e-03
GOBP REGULATION OF RAB PROTEIN SIGNAL TRANSDUCTION	7	8.54e-01	9.26e-01	0.10900	6.61e-02	-8.69e-02	7.62e-01	6.91e-01
GOMF ADP BINDING	36	5.88e-01	7.72e-01	0.10900	8.31e-02	7.07e-02	3.88e-01	4.63e-01
GOBP RESPONSE TO ENDOGENOUS STIMULUS	1659	1.14e-10	7.21e-09	0.10900	8.84e-02	6.40e-02	2.01e-09	1.41e-05
GOMF 1 PHOSPHATIDYLINOSITOL BINDING	15	7.99e-01	8.99e-01	0.10900	8.94e-02	6.26e-02	5.49e-01	6.75e-01
GOBP POSITIVE REGULATION OF CELLULAR CATABOLIC PROCESS	214	1.94e-02	9.75e-02	0.10900	1.09e-01	1.40e-03	5.95e-03	9.72e-01
GOMF LIGASE ACTIVITY FORMING CARBON NITROGEN BONDS	49	3.53e-01	5.90e-01	0.10900	3.79e-02	-1.02e-01	6.46e-01	2.16e-01
GOBP POSITIVE REGULATION OF DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION	7	8.84e-01	9.44e-01	0.10900	1.55e-02	1.08e-01	9.43e-01	6.21e-01
GOBP ALCOHOL BIOSYNTHETIC PROCESS	136	6.17e-02	2.14e-01	0.10900	-1.06e-01	2.70e-02	3.34e-02	5.86e-01
GOBP GLOMERULUS VASCULATURE MORPHOGENESIS	6	8.76e-01	9.40e-01	0.10900	-9.41e-02	5.51e-02	6.90e-01	8.15e-01
GOBP LIVER REGENERATION	30	5.08e-01	7.17e-01	0.10900	-6.91e-02	8.43e-02	5.13e-01	4.24e-01
GOBP PROTEIN LOCALIZATION TO AXON	9	8.63e-01	9.33e-01	0.10900	-1.04e-01	-3.19e-02	5.89e-01	8.69e-01
GOBP NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS	115	1.84e-01	4.09e-01	0.10900	6.54e-02	8.71e-02	2.26e-01	1.07e-01
Interleukin-12 signaling	43	4.51e-01	6.76e-01	0.10900	1.03e-03	1.09e-01	9.91e-01	2.17e-01
RSV-host interactions	88	2.52e-01	4.90e-01	0.10900	9.99e-02	4.32e-02	1.05e-01	4.84e-01
GOBP EYE PHOTORECEPTOR CELL DIFFERENTIATION	49	4.46e-01	6.72e-01	0.10900	-2.95e-02	-1.05e-01	7.21e-01	2.05e-01
GOBP REGULATION OF RECEPTOR CATABOLIC PROCESS	11	7.84e-01	8.92e-01	0.10900	-5.58e-02	9.34e-02	7.49e-01	5.92e-01
GOBP IMMUNE RESPONSE TO TUMOR CELL	28	6.52e-01	8.12e-01	0.10900	-9.61e-02	-5.07e-02	3.79e-01	6.42e-01
GOBP PURINE DEOXYRIBONUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS	6	8.78e-01	9.41e-01	0.10900	-4.83e-02	9.73e-02	8.38e-01	6.80e-01
GOBP POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION	62	3.09e-01	5.49e-01	0.10900	-6.34e-03	1.08e-01	9.31e-01	1.40e-01
GOBP LOW DENSITY LIPOPROTEIN PARTICLE REMODELING	16	7.56e-01	8.75e-01	0.10900	-1.39e-02	-1.08e-01	9.23e-01	4.56e-01
GOBP SYNAPTIC VESICLE TRANSPORT	42	5.04e-01	7.14e-01	0.10800	1.04e-01	3.07e-02	2.43e-01	7.31e-01
GOBP L AMINO ACID TRANSPORT	90	2.27e-01	4.61e-01	0.10800	1.05e-01	2.77e-02	8.56e-02	6.50e-01
GOBP EXECUTION PHASE OF APOPTOSIS	79	3.19e-01	5.58e-01	0.10800	7.66e-02	7.67e-02	2.39e-01	2.39e-01
GOBP RESPONSE TO THYROGLOBULIN TRIIODOTHYRONINE	5	9.29e-01	9.67e-01	0.10800	8.64e-02	6.54e-02	7.38e-01	8.00e-01
GOMF NAD DEPENDENT HISTONE DEACETYLASE ACTIVITY	5	9.05e-01	9.53e-01	0.10800	-2.19e-02	1.06e-01	9.32e-01	6.81e-01
GOMF TRANSFERASE ACTIVITY TRANSFERRING SULPHUR CONTAINING GROUPS	66	3.67e-01	6.04e-01	0.10800	-9.64e-02	-4.94e-02	1.76e-01	4.88e-01
GOBP RESPONSE TO COCAINE	54	4.05e-01	6.38e-01	0.10800	2.31e-02	1.06e-01	7.69e-01	1.79e-01
GOMF MYOSIN II BINDING	12	7.67e-01	8.82e-01	0.10800	8.83e-02	-6.25e-02	5.96e-01	7.08e-01
GOBP REGULATION OF PROTEIN MODIFICATION PROCESS	1175	9.19e-08	3.35e-06	0.10800	8.47e-02	6.74e-02	1.00e-06	9.99e-05
GOMF TYPE I TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING	11	8.52e-01	9.26e-01	0.10800	6.83e-02	8.38e-02	6.95e-01	6.30e-01
GOMF CHLORIDE ION BINDING	9	8.19e-01	9.09e-01	0.10800	6.75e-02	-8.44e-02	7.26e-01	6.61e-01
GOBP REGULATION OF BONE REMODELING	51	3.29e-01	5.68e-01	0.10800	-9.18e-02	5.70e-02	2.57e-01	4.81e-01
GOBP PROTEIN GERANYLGERANYLATION	6	9.10e-01	9.56e-01	0.10800	1.00e-01	3.95e-02	6.70e-01	8.67e-01
GOCC GABA ERGIC SYNAPSE	73	2.87e-01	5.26e-01	0.10800	-1.63e-02	-1.07e-01	8.09e-01	1.15e-01
GOBP MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION	29	6.45e-01	8.08e-01	0.10800	4.93e-02	9.60e-02	6.46e-01	3.71e-01
GOMF POLYOL TRANSMEMBRANE TRANSPORTER ACTIVITY	11	7.96e-01	8.97e-01	0.10800	-3.47e-02	1.02e-01	8.42e-01	5.57e-01
GOMF KINASE ACTIVATOR ACTIVITY	137	1.41e-01	3.53e-01	0.10800	8.01e-02	7.23e-02	1.05e-01	1.44e-01
MAPK family signaling cascades	299	1.16e-02	6.69e-02	0.10800	9.59e-02	4.94e-02	4.34e-03	1.42e-01
GOCC T CELL RECEPTOR COMPLEX	16	7.61e-01	8.79e-01	0.10800	-1.06e-01	-1.69e-02	4.61e-01	9.07e-01
GOBP SUBSTRATE ADHESION DEPENDENT CELL SPREADING	99	2.42e-01	4.79e-01	0.10800	8.24e-02	6.95e-02	1.57e-01	2.32e-01
GOBP NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS	13	8.23e-01	9.11e-01	0.10800	-9.45e-02	-5.18e-02	5.55e-01	7.46e-01
GOBP MESONEPHRIC TUBULE MORPHOGENESIS	65	2.72e-01	5.12e-01	0.10800	-2.61e-02	1.04e-01	7.16e-01	1.45e-01
GOBP RESPONSE TO REDOX STATE	14	7.56e-01	8.75e-01	0.10800	-2.55e-02	1.05e-01	8.69e-01	4.98e-01
GOBP PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS	29	5.77e-01	7.66e-01	0.10800	-1.02e-02	1.07e-01	9.25e-01	3.18e-01
GOBP CELLULAR RESPONSE TO ELECTRICAL STIMULUS	12	8.13e-01	9.06e-01	0.10800	1.34e-02	1.07e-01	9.36e-01	5.22e-01
GOBP RESPONSE TO UV A	13	8.30e-01	9.15e-01	0.10800	-8.00e-02	-7.20e-02	6.17e-01	6.53e-01
GOBP REGULATION OF SYNAPTIC VESICLE MEMBRANE ORGANIZATION	12	7.89e-01	8.93e-01	0.10800	-2.24e-02	1.05e-01	8.93e-01	5.28e-01
GOBP PROTEIN LOCALIZATION TO CELL SURFACE	65	2.45e-01	4.83e-01	0.10800	9.07e-02	-5.79e-02	2.06e-01	4.20e-01
GOBP REGULATION OF INTRACELLULAR PROTEIN TRANSPORT	140	1.32e-01	3.41e-01	0.10700	6.05e-02	8.89e-02	2.17e-01	6.95e-02
GOBP RESPONSE TO PEPTIDE HORMONE	427	2.37e-03	2.01e-02	0.10700	8.62e-02	6.42e-02	2.25e-03	2.30e-02
GOCC CYTOPLASMIC SIDE OF MEMBRANE	195	5.42e-02	1.98e-01	0.10700	9.65e-02	4.73e-02	2.01e-02	2.55e-01
GOBP SEROTONIN UPTAKE	12	7.72e-01	8.85e-01	0.10700	5.66e-02	-9.13e-02	7.34e-01	5.84e-01
GOBP MATING BEHAVIOR	36	4.98e-01	7.09e-01	0.10700	-1.74e-02	1.06e-01	8.57e-01	2.71e-01
GOBP URETERIC BUD ELONGATION	8	8.40e-01	9.19e-01	0.10700	6.46e-02	-8.58e-02	7.52e-01	6.74e-01
GOBP LYMPHOCYTE DIFFERENTIATION	418	6.83e-04	7.80e-03	0.10700	4.96e-03	1.07e-01	8.62e-01	1.68e-04
GOBP IRON ION TRANSPORT	52	3.31e-01	5.70e-01	0.10700	-4.94e-02	9.54e-02	5.38e-01	2.34e-01
Activation of NMDA receptors and postsynaptic events	86	1.53e-01	3.69e-01	0.10700	-8.39e-02	6.70e-02	1.79e-01	2.82e-01
GOBP ADHESION OF SYMBIONT TO HOST CELL	8	8.40e-01	9.20e-01	0.10700	-6.32e-02	8.68e-02	7.57e-01	6.71e-01
GOBP RESPONSE TO PROSTAGLANDIN D	5	9.04e-01	9.53e-01	0.10700	1.03e-01	-3.12e-02	6.91e-01	9.04e-01
GOCC RUFFLE MEMBRANE	99	2.42e-01	4.79e-01	0.10700	8.65e-02	6.36e-02	1.37e-01	2.74e-01
GOBP ARTERY MORPHOGENESIS	82	3.04e-01	5.44e-01	0.10700	9.01e-02	5.84e-02	1.59e-01	3.61e-01
Evasion by RSV of host interferon responses	31	5.30e-01	7.33e-01	0.10700	1.01e-01	-3.59e-02	3.30e-01	7.30e-01
GOBP RESPONSE TO SALT	22	7.29e-01	8.62e-01	0.10700	8.56e-02	6.47e-02	4.87e-01	5.99e-01
GOBP CHOLESTEROL EFFLUX	74	2.36e-01	4.73e-01	0.10700	2.08e-02	-1.05e-01	7.57e-01	1.17e-01
GOBP CARBOHYDRATE PHOSPHORYLATION	22	7.32e-01	8.63e-01	0.10700	7.33e-02	7.83e-02	5.51e-01	5.25e-01
GOBP REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS	17	7.23e-01	8.58e-01	0.10700	1.06e-01	-1.37e-02	4.48e-01	9.22e-01
GOBP T HELPER 1 CELL CYTOKINE PRODUCTION	8	8.93e-01	9.48e-01	0.10700	-7.83e-02	-7.31e-02	7.01e-01	7.20e-01
GOBP SLEEP	22	7.31e-01	8.63e-01	0.10700	-6.66e-02	-8.38e-02	5.88e-01	4.96e-01
GOBP POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS	35	5.74e-01	7.64e-01	0.10700	-3.10e-02	-1.02e-01	7.51e-01	2.94e-01
GOBP ACYL COA METABOLIC PROCESS	89	2.82e-01	5.21e-01	0.10700	6.49e-02	8.51e-02	2.90e-01	1.65e-01
GOCC INTERCELLULAR BRIDGE	90	2.29e-01	4.63e-01	0.10700	1.05e-01	2.17e-02	8.59e-02	7.23e-01
Chylomicron clearance	5	9.25e-01	9.64e-01	0.10700	-3.46e-02	-1.01e-01	8.93e-01	6.95e-01
GOBP POSITIVE REGULATION OF NUCLEOTIDE CATABOLIC PROCESS	21	6.33e-01	7.99e-01	0.10700	7.87e-02	-7.23e-02	5.32e-01	5.66e-01
Formation of the Editosome	8	8.63e-01	9.33e-01	0.10700	6.62e-03	-1.07e-01	9.74e-01	6.01e-01
mRNA Editing: C to U Conversion	8	8.63e-01	9.33e-01	0.10700	6.62e-03	-1.07e-01	9.74e-01	6.01e-01
GOBP REGULATION OF EXOCYTOSIS	159	3.72e-02	1.54e-01	0.10700	-4.47e-02	9.70e-02	3.31e-01	3.48e-02
GOMF INOSITOL 1 4 5 TRISPHOSPHATE BINDING	11	8.05e-01	9.02e-01	0.10700	-1.04e-01	2.59e-02	5.52e-01	8.82e-01
GOBP POSITIVE REGULATION OF MITOCHONDRIAL FISSION	21	6.80e-01	8.32e-01	0.10700	1.07e-01	-6.51e-03	3.98e-01	9.59e-01
GOBP POSITIVE REGULATION OF ENDOCYTOSIS	147	1.24e-01	3.28e-01	0.10700	-8.70e-02	-6.19e-02	6.86e-02	1.95e-01
GOBP NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT	146	9.76e-02	2.86e-01	0.10700	-2.70e-02	-1.03e-01	5.73e-01	3.12e-02
GPER1 signaling	45	4.63e-01	6.86e-01	0.10700	1.06e-01	1.09e-02	2.18e-01	8.99e-01
GOBP INTERLEUKIN 18 MEDIATED SIGNALING PATHWAY	10	8.47e-01	9.23e-01	0.10700	1.81e-02	1.05e-01	9.21e-01	5.65e-01
GOBP TYPE II INTERFERON MEDIATED SIGNALING PATHWAY	26	6.81e-01	8.33e-01	0.10700	4.88e-02	9.49e-02	6.67e-01	4.02e-01
GOBP NEGATIVE REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION	8	8.75e-01	9.40e-01	0.10700	-1.05e-01	-1.70e-02	6.06e-01	9.34e-01
GOBP LUNG EPITHELIUM DEVELOPMENT	45	4.73e-01	6.94e-01	0.10700	1.05e-01	1.74e-02	2.22e-01	8.40e-01
GOBP POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING	42	5.46e-01	7.44e-01	0.10700	5.70e-02	9.02e-02	5.23e-01	3.12e-01
GOBP REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY	13	8.33e-01	9.17e-01	0.10700	7.21e-02	7.86e-02	6.52e-01	6.24e-01
GOBP REGULATION OF RESPONSE TO OXIDATIVE STRESS	32	6.31e-01	7.99e-01	0.10700	5.81e-02	8.95e-02	5.69e-01	3.81e-01
GOBP REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION	33	5.73e-01	7.63e-01	0.10700	-1.06e-01	-1.32e-02	2.93e-01	8.95e-01
GOCC SEROTONIN RECEPTOR COMPLEX	5	8.97e-01	9.50e-01	0.10700	-7.70e-02	7.37e-02	7.66e-01	7.75e-01
GOMF SEROTONIN GATED MONOATOMIC CATION CHANNEL ACTIVITY	5	8.97e-01	9.50e-01	0.10700	-7.70e-02	7.37e-02	7.66e-01	7.75e-01
GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY	182	3.37e-02	1.43e-01	0.10700	-1.32e-02	1.06e-01	7.59e-01	1.39e-02
GOBP MUSCLE CELL DEVELOPMENT	199	2.16e-02	1.05e-01	0.10700	1.04e-01	-2.28e-02	1.14e-02	5.79e-01
GOBP REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY	45	5.29e-01	7.32e-01	0.10700	6.31e-02	8.59e-02	4.64e-01	3.19e-01
GOBP TRANSPOSITION	37	4.69e-01	6.91e-01	0.10700	9.86e-02	-4.03e-02	2.99e-01	6.71e-01
GOBP EPITHELIAL TUBE MORPHOGENESIS	326	1.10e-02	6.43e-02	0.10600	6.91e-02	8.10e-02	3.21e-02	1.19e-02
GOBP REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS	11	8.02e-01	9.01e-01	0.10600	-1.01e-01	3.32e-02	5.61e-01	8.49e-01
GOBP AXON CHOICE POINT RECOGNITION	7	8.93e-01	9.48e-01	0.10600	2.21e-02	1.04e-01	9.19e-01	6.33e-01
GOBP NEGATIVE REGULATION OF SIGNALING	1450	5.62e-09	2.59e-07	0.10600	6.78e-02	8.19e-02	1.57e-05	1.80e-07
GOBP REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY	28	6.35e-01	8.01e-01	0.10600	-2.15e-02	-1.04e-01	8.44e-01	3.41e-01
GOMF DICARBOXYLIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY	31	6.00e-01	7.78e-01	0.10600	-1.05e-01	-1.70e-02	3.12e-01	8.70e-01
GOBP DEOXYRIBONUCLEOSIDE METABOLIC PROCESS	11	8.24e-01	9.11e-01	0.10600	1.93e-03	1.06e-01	9.91e-01	5.42e-01
GOBP IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY	330	9.66e-04	1.02e-02	0.10600	-6.40e-02	8.46e-02	4.56e-02	8.21e-03
GOBP RESPONSE TO ABIOTIC STIMULUS	1086	1.86e-07	6.31e-06	0.10600	9.79e-02	4.09e-02	5.02e-08	2.29e-02
GOBP NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS	15	7.31e-01	8.63e-01	0.10600	9.29e-02	-5.12e-02	5.33e-01	7.32e-01
GOBP REGULATION OF MONOCYTE CHEMOTAXIS	26	5.83e-01	7.69e-01	0.10600	4.86e-02	-9.43e-02	6.68e-01	4.05e-01
Activation of G protein gated Potassium channels	29	5.43e-01	7.41e-01	0.10600	5.65e-02	-8.97e-02	5.98e-01	4.03e-01
G protein gated Potassium channels	29	5.43e-01	7.41e-01	0.10600	5.65e-02	-8.97e-02	5.98e-01	4.03e-01
Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits	29	5.43e-01	7.41e-01	0.10600	5.65e-02	-8.97e-02	5.98e-01	4.03e-01
GOBP METENCEPHALON DEVELOPMENT	107	2.23e-01	4.57e-01	0.10600	6.12e-02	8.65e-02	2.74e-01	1.22e-01
Integrin signaling	27	5.81e-01	7.68e-01	0.10600	9.89e-02	-3.77e-02	3.74e-01	7.34e-01
GOBP STEROID BIOSYNTHETIC PROCESS	178	7.63e-02	2.45e-01	0.10600	-9.44e-02	-4.79e-02	2.98e-02	2.70e-01
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY	71	2.73e-01	5.12e-01	0.10600	1.05e-01	-1.10e-02	1.25e-01	8.73e-01
GOBP SULFUR AMINO ACID METABOLIC PROCESS	31	5.28e-01	7.32e-01	0.10600	9.45e-02	-4.75e-02	3.63e-01	6.47e-01
GOBP REGULATION OF RESPIRATORY GASEOUS EXCHANGE	22	7.09e-01	8.50e-01	0.10600	2.81e-02	1.02e-01	8.20e-01	4.08e-01
GOBP NEGATIVE REGULATION OF PROTEIN POLYMERIZATION	74	2.75e-01	5.15e-01	0.10600	1.06e-01	9.80e-04	1.16e-01	9.88e-01
GOCC PHOTORECEPTOR RIBBON SYNAPSE	9	8.71e-01	9.37e-01	0.10600	-3.25e-02	-1.01e-01	8.66e-01	6.01e-01
GOBP REGULATION OF CELL GROWTH	383	5.34e-03	3.71e-02	0.10600	6.60e-02	8.26e-02	2.66e-02	5.52e-03
GOBP PARATHYROID GLAND DEVELOPMENT	7	8.87e-01	9.46e-01	0.10600	-1.06e-01	-6.72e-03	6.29e-01	9.75e-01
GOBP NEGATIVE ADAPTATION OF SIGNALING PATHWAY	16	8.00e-01	8.99e-01	0.10600	-6.17e-02	-8.57e-02	6.69e-01	5.53e-01
Glucagon-like Peptide-1 (GLP1) regulates insulin secretion	42	4.78e-01	6.96e-01	0.10600	1.06e-01	-1.03e-03	2.36e-01	9.91e-01
GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE	33	6.25e-01	7.94e-01	0.10600	-5.31e-02	-9.13e-02	5.98e-01	3.64e-01
Activation of PPARGC1A (PGC-1alpha) by phosphorylation	10	8.11e-01	9.05e-01	0.10600	8.78e-02	-5.86e-02	6.31e-01	7.48e-01
GOBP RESPONSE TO NUTRIENT	157	1.10e-01	3.06e-01	0.10600	9.00e-02	5.51e-02	5.16e-02	2.33e-01
GOCC EXTRINSIC COMPONENT OF POSTSYNAPTIC MEMBRANE	7	8.72e-01	9.38e-01	0.10600	1.01e-01	-3.09e-02	6.44e-01	8.87e-01
GOBP REGULATION OF PROTEIN AUTOUBIQUITINATION	5	9.05e-01	9.53e-01	0.10600	9.83e-02	-3.85e-02	7.04e-01	8.82e-01
GOBP CELLULAR LIPID BIOSYNTHETIC PROCESS	12	8.25e-01	9.12e-01	0.10600	-2.14e-02	-1.03e-01	8.98e-01	5.35e-01
GOBP REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY	66	3.98e-01	6.31e-01	0.10500	5.92e-02	8.73e-02	4.06e-01	2.20e-01
GOBP INCLUSION BODY ASSEMBLY	23	7.29e-01	8.61e-01	0.10500	7.21e-02	7.70e-02	5.49e-01	5.23e-01
GOBP IMMUNE EFFECTOR PROCESS	621	3.81e-06	9.52e-05	0.10500	-9.19e-02	5.17e-02	9.26e-05	2.78e-02
GOBP METANEPHROS DEVELOPMENT	89	2.96e-01	5.35e-01	0.10500	7.53e-02	7.37e-02	2.19e-01	2.29e-01
GOBP CELL JUNCTION DISASSEMBLY	27	6.91e-01	8.39e-01	0.10500	7.64e-02	7.26e-02	4.92e-01	5.14e-01
Sialic acid metabolism	33	5.30e-01	7.33e-01	0.10500	-1.02e-01	2.65e-02	3.11e-01	7.92e-01
GOBP POSITIVE REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY	8	8.51e-01	9.25e-01	0.10500	4.28e-02	-9.62e-02	8.34e-01	6.37e-01
GOBP CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION	32	6.42e-01	8.05e-01	0.10500	-8.51e-02	-6.21e-02	4.05e-01	5.43e-01
GOBP CELL PROJECTION ASSEMBLY	597	2.42e-04	3.25e-03	0.10500	9.30e-02	4.95e-02	1.04e-04	3.89e-02
Glycosphingolipid biosynthesis	19	6.83e-01	8.34e-01	0.10500	-4.08e-02	9.71e-02	7.58e-01	4.64e-01
GOMF MONOATOMIC ION TRANSMEMBRANE TRANSPORTER ACTIVITY	723	5.15e-05	8.90e-04	0.10500	-9.00e-02	-5.46e-02	3.74e-05	1.24e-02
GOBP RESPONSE TO GONADOTROPIN	27	5.73e-01	7.63e-01	0.10500	-5.25e-02	9.12e-02	6.37e-01	4.12e-01
GOBP MICROTUBULE BASED PROCESS	909	4.59e-06	1.11e-04	0.10500	9.00e-02	5.44e-02	4.13e-06	5.43e-03
GOMF TELOMERASE ACTIVITY	6	8.81e-01	9.43e-01	0.10500	7.15e-02	-7.71e-02	7.62e-01	7.44e-01
GOBP POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE	30	5.86e-01	7.71e-01	0.10500	-1.05e-01	6.43e-03	3.20e-01	9.51e-01
GOBP ORGANIC ACID CATABOLIC PROCESS	242	3.66e-02	1.52e-01	0.10500	6.24e-02	8.46e-02	9.47e-02	2.34e-02
GOMF ORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY	258	2.26e-02	1.09e-01	0.10500	-9.80e-02	-3.81e-02	6.73e-03	2.93e-01
GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL DEVELOPMENT	6	8.82e-01	9.43e-01	0.10500	-8.26e-02	6.50e-02	7.26e-01	7.83e-01
GOBP ASPARTATE TRANSMEMBRANE TRANSPORT	20	7.20e-01	8.56e-01	0.10500	1.31e-02	1.04e-01	9.19e-01	4.20e-01
GOCC ENDOCYTIC VESICLE LUMEN	23	6.69e-01	8.25e-01	0.10500	1.05e-01	-1.98e-03	3.83e-01	9.87e-01
GOBP REGULATION OF DENDRITIC CELL CHEMOTAXIS	9	8.37e-01	9.18e-01	0.10500	-9.82e-02	3.71e-02	6.10e-01	8.47e-01
GOMF ADRENERGIC RECEPTOR ACTIVITY	10	8.13e-01	9.06e-01	0.10500	-5.61e-02	8.88e-02	7.59e-01	6.27e-01
GOMF ORGANIC ACID BINDING	202	6.23e-02	2.15e-01	0.10500	-8.68e-02	-5.90e-02	3.34e-02	1.49e-01
GOBP CARDIAC VENTRICLE DEVELOPMENT	128	1.76e-01	4.00e-01	0.10500	6.96e-02	7.86e-02	1.74e-01	1.25e-01
GOBP POSITIVE REGULATION OF FIBROBLAST PROLIFERATION	54	4.72e-01	6.94e-01	0.10500	8.82e-02	5.69e-02	2.62e-01	4.69e-01
GOBP BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR SIGNALING PATHWAY	6	9.16e-01	9.59e-01	0.10500	3.96e-02	9.71e-02	8.67e-01	6.80e-01
GOBP CRANIAL NERVE DEVELOPMENT	62	4.13e-01	6.45e-01	0.10500	9.36e-02	4.72e-02	2.02e-01	5.21e-01
GOBP BASE CONVERSION OR SUBSTITUTION EDITING	18	6.96e-01	8.42e-01	0.10500	-4.59e-02	9.42e-02	7.36e-01	4.89e-01
GOBP DEPHOSPHORYLATION	272	1.66e-02	8.69e-02	0.10500	1.01e-01	2.95e-02	4.31e-03	4.03e-01
GOBP REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE	40	4.34e-01	6.62e-01	0.10500	6.70e-02	-8.06e-02	4.64e-01	3.78e-01
GOBP CEREBELLAR CORTEX DEVELOPMENT	50	4.97e-01	7.09e-01	0.10500	5.30e-02	9.03e-02	5.17e-01	2.69e-01
GOBP CELLULAR RESPONSE TO CGMP	7	8.95e-01	9.49e-01	0.10500	-1.03e-01	-2.05e-02	6.38e-01	9.25e-01
GOMF HORMONE RECEPTOR BINDING	31	5.26e-01	7.30e-01	0.10500	-8.34e-02	6.33e-02	4.22e-01	5.42e-01
GOMF PROTEIN SERINE THREONINE PHOSPHATASE ACTIVITY	94	2.76e-01	5.16e-01	0.10500	8.57e-02	6.01e-02	1.51e-01	3.14e-01
GOBP REGULATION OF LYMPHOCYTE ACTIVATION	491	1.61e-04	2.29e-03	0.10500	-1.41e-02	1.04e-01	5.94e-01	8.31e-05
GOBP PROTEIN REPAIR	7	8.65e-01	9.34e-01	0.10500	-8.49e-02	6.10e-02	6.97e-01	7.80e-01
GOBP PROTEIN POLYGLUTAMYLATION	12	7.86e-01	8.92e-01	0.10500	4.66e-02	-9.36e-02	7.80e-01	5.75e-01
GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY	6	9.22e-01	9.63e-01	0.10400	8.29e-02	6.36e-02	7.25e-01	7.87e-01
GOCC PLASMA MEMBRANE SIGNALING RECEPTOR COMPLEX	183	4.31e-02	1.70e-01	0.10400	-1.04e-01	2.42e-03	1.48e-02	9.55e-01
GOBP REGULATION OF NERVOUS SYSTEM PROCESS	115	2.14e-01	4.47e-01	0.10400	-7.45e-02	-7.32e-02	1.68e-01	1.75e-01
GOBP REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE	31	5.53e-01	7.48e-01	0.10400	-1.00e-01	3.00e-02	3.35e-01	7.73e-01
GOBP INTRACELLULAR AMINO ACID HOMEOSTASIS	9	8.69e-01	9.36e-01	0.10400	-1.02e-01	-2.21e-02	5.96e-01	9.08e-01
GOBP CGMP METABOLIC PROCESS	16	7.38e-01	8.67e-01	0.10400	-2.75e-02	1.01e-01	8.49e-01	4.86e-01
GOBP SMOOTH MUSCLE CELL APOPTOTIC PROCESS	38	5.90e-01	7.73e-01	0.10400	8.99e-02	5.29e-02	3.38e-01	5.72e-01
GOBP EXTRACELLULAR TRANSPORT	44	5.40e-01	7.39e-01	0.10400	-4.98e-02	-9.16e-02	5.67e-01	2.93e-01
GOBP REGULATION OF INTRACELLULAR TRANSPORT	252	3.36e-02	1.43e-01	0.10400	8.48e-02	6.07e-02	2.04e-02	9.73e-02
GOMF TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS	864	4.34e-06	1.06e-04	0.10400	9.88e-02	3.30e-02	8.12e-07	9.92e-02
GOBP RESPONSE TO LEUKEMIA INHIBITORY FACTOR	100	2.60e-01	4.99e-01	0.10400	6.39e-02	8.23e-02	2.70e-01	1.55e-01
G alpha (12/13) signalling events	74	2.33e-01	4.69e-01	0.10400	9.52e-02	-4.21e-02	1.57e-01	5.31e-01
GOBP MONOSACCHARIDE BIOSYNTHETIC PROCESS	90	2.44e-01	4.82e-01	0.10400	-1.90e-02	-1.02e-01	7.55e-01	9.32e-02
GOBP NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS	171	6.01e-02	2.11e-01	0.10400	6.69e-03	1.04e-01	8.80e-01	1.91e-02
GOBP RESPONSE TO ORGANIC CYCLIC COMPOUND	861	1.55e-05	3.15e-04	0.10400	7.48e-02	7.23e-02	1.94e-04	3.14e-04
GOBP TRANSITION METAL ION TRANSPORT	93	2.13e-01	4.45e-01	0.10400	4.47e-03	1.04e-01	9.41e-01	8.31e-02
GOBP REGULATION OF AEROBIC RESPIRATION	30	6.03e-01	7.81e-01	0.10400	1.67e-03	1.04e-01	9.87e-01	3.24e-01
GOCC PAR POLARITY COMPLEX	6	9.19e-01	9.62e-01	0.10400	4.83e-02	9.21e-02	8.38e-01	6.96e-01
EGFR interacts with phospholipase C-gamma	9	8.33e-01	9.17e-01	0.10400	8.66e-02	-5.74e-02	6.53e-01	7.66e-01
GOBP CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS	29	5.73e-01	7.63e-01	0.10400	-3.42e-02	9.80e-02	7.50e-01	3.61e-01
GOBP NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS	14	7.79e-01	8.89e-01	0.10400	1.28e-02	-1.03e-01	9.34e-01	5.04e-01
GOBP NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT	11	8.46e-01	9.22e-01	0.10400	-1.01e-01	-2.44e-02	5.63e-01	8.88e-01
GOBP MUCOPOLYSACCHARIDE METABOLIC PROCESS	88	2.16e-01	4.48e-01	0.10400	7.96e-03	-1.03e-01	8.97e-01	9.34e-02
GOBP POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS	9	8.34e-01	9.17e-01	0.10400	5.41e-02	-8.85e-02	7.79e-01	6.46e-01
GOBP PHOSPHOLIPID METABOLIC PROCESS	373	7.63e-03	4.90e-02	0.10400	7.63e-02	7.02e-02	1.14e-02	1.99e-02
GOBP MONONUCLEAR CELL MIGRATION	216	2.92e-02	1.29e-01	0.10400	-1.04e-01	-5.34e-03	8.72e-03	8.92e-01
GOBP LONG CHAIN FATTY ACID METABOLIC PROCESS	103	1.74e-01	3.97e-01	0.10400	2.40e-03	-1.04e-01	9.66e-01	6.91e-02
GOBP POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS	28	5.95e-01	7.75e-01	0.10400	-2.46e-02	1.01e-01	8.21e-01	3.56e-01
GOBP POSITIVE REGULATION OF NEUTROPHIL MIGRATION	30	5.42e-01	7.40e-01	0.10400	-6.87e-02	7.75e-02	5.15e-01	4.62e-01
GOBP TRANSFORMING GROWTH FACTOR BETA PRODUCTION	32	5.57e-01	7.51e-01	0.10400	1.01e-01	-2.17e-02	3.22e-01	8.31e-01
GOBP LOCALIZATION WITHIN MEMBRANE	653	6.86e-05	1.13e-03	0.10300	1.00e-01	2.53e-02	1.21e-05	2.71e-01
GOBP CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT	22	7.20e-01	8.56e-01	0.10300	2.76e-02	9.97e-02	8.22e-01	4.18e-01
GOBP ACTIN FILAMENT ORGANIZATION	442	2.40e-03	2.03e-02	0.10300	9.23e-02	4.67e-02	8.76e-04	9.21e-02
GOBP CELL GROWTH	460	2.59e-03	2.16e-02	0.10300	7.56e-02	7.06e-02	5.46e-03	9.46e-03
RA biosynthesis pathway	22	7.18e-01	8.55e-01	0.10300	2.58e-02	1.00e-01	8.34e-01	4.16e-01
GOBP CELL CELL JUNCTION ASSEMBLY	151	1.37e-01	3.48e-01	0.10300	-6.65e-02	-7.92e-02	1.58e-01	9.31e-02
PKA-mediated phosphorylation of CREB	19	7.65e-01	8.81e-01	0.10300	-9.43e-02	-4.24e-02	4.77e-01	7.49e-01
GOBP ACTIN CROSSLINK FORMATION	13	8.32e-01	9.16e-01	0.10300	9.45e-02	4.18e-02	5.55e-01	7.94e-01
CaM pathway	34	5.95e-01	7.75e-01	0.10300	-1.01e-01	-2.14e-02	3.08e-01	8.29e-01
Calmodulin induced events	34	5.95e-01	7.75e-01	0.10300	-1.01e-01	-2.14e-02	3.08e-01	8.29e-01
GOBP POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS	26	5.93e-01	7.74e-01	0.10300	-8.48e-02	5.88e-02	4.54e-01	6.04e-01
GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT	50	5.17e-01	7.22e-01	0.10300	8.07e-02	6.42e-02	3.23e-01	4.32e-01
GOMF 1 PHOSPHATIDYLINOSITOL 4 PHOSPHATE 3 KINASE ACTIVITY	7	8.68e-01	9.35e-01	0.10300	7.74e-02	-6.82e-02	7.23e-01	7.55e-01
GOMF DIPEPTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY	5	9.21e-01	9.62e-01	0.10300	3.20e-03	1.03e-01	9.90e-01	6.90e-01
Synthesis of PIPs at the plasma membrane	48	4.15e-01	6.46e-01	0.10300	1.00e-01	-2.48e-02	2.30e-01	7.67e-01
Ion transport by P-type ATPases	51	4.01e-01	6.34e-01	0.10300	1.82e-02	-1.01e-01	8.22e-01	2.10e-01
GOBP REGULATION OF GLUCOSE METABOLIC PROCESS	97	1.84e-01	4.10e-01	0.10300	1.02e-01	-1.23e-02	8.16e-02	8.35e-01
GOMF JUN KINASE BINDING	11	8.09e-01	9.04e-01	0.10300	9.46e-02	-4.09e-02	5.87e-01	8.14e-01
GOBP PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT	24	7.07e-01	8.49e-01	0.10300	-9.73e-02	-3.38e-02	4.10e-01	7.74e-01
GOBP POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY	21	6.73e-01	8.27e-01	0.10300	9.70e-02	-3.44e-02	4.41e-01	7.85e-01
GOBP TETRAPYRROLE METABOLIC PROCESS	59	4.24e-01	6.53e-01	0.10300	9.81e-02	3.12e-02	1.92e-01	6.79e-01
GOBP CHONDROITIN SULFATE METABOLIC PROCESS	25	7.18e-01	8.55e-01	0.10300	-5.93e-02	-8.41e-02	6.08e-01	4.67e-01
GOCC NUCLEAR MEMBRANE	299	2.03e-02	1.01e-01	0.10300	8.20e-02	6.21e-02	1.47e-02	6.47e-02
GOBP EXTRACELLULAR VESICLE BIOGENESIS	25	6.96e-01	8.42e-01	0.10300	9.77e-02	3.20e-02	3.98e-01	7.82e-01
GOBP MAMMARY GLAND DEVELOPMENT	131	1.82e-01	4.06e-01	0.10300	6.66e-02	7.83e-02	1.88e-01	1.22e-01
GOBP MITOCHONDRIAL FISSION	40	5.85e-01	7.70e-01	0.10300	5.41e-02	8.74e-02	5.54e-01	3.39e-01
GOBP FEAR RESPONSE	47	3.97e-01	6.30e-01	0.10300	-5.23e-02	8.85e-02	5.35e-01	2.94e-01
GOBP SEX CHROMOSOME DOSAGE COMPENSATION	15	8.22e-01	9.10e-01	0.10300	6.61e-02	7.87e-02	6.57e-01	5.98e-01
GOBP PROTEIN SIDE CHAIN DEGLUTAMYLATION	5	9.23e-01	9.63e-01	0.10300	-1.02e-01	-8.62e-03	6.92e-01	9.73e-01
Defective HLCS causes multiple carboxylase deficiency	7	8.99e-01	9.51e-01	0.10300	1.01e-01	2.09e-02	6.45e-01	9.24e-01
GOBP POSITIVE REGULATION OF P38MAPK CASCADE	30	6.68e-01	8.25e-01	0.10300	5.27e-02	8.82e-02	6.17e-01	4.03e-01
GOMF INTRAMEMBRANE LIPID TRANSPORTER ACTIVITY	41	4.98e-01	7.09e-01	0.10300	-1.02e-01	6.81e-03	2.56e-01	9.40e-01
GOBP STRIATED MUSCLE CELL DIFFERENTIATION	305	4.69e-03	3.38e-02	0.10300	1.01e-01	-1.84e-02	2.41e-03	5.81e-01
GOBP RESPONSE TO INORGANIC SUBSTANCE	492	1.70e-03	1.55e-02	0.10300	5.79e-02	8.48e-02	2.79e-02	1.28e-03
GOBP RESPONSE TO AMPHETAMINE	34	6.37e-01	8.02e-01	0.10300	5.72e-02	8.52e-02	5.64e-01	3.90e-01
GOBP SPHINGOID BIOSYNTHETIC PROCESS	14	8.24e-01	9.11e-01	0.10300	4.39e-02	9.27e-02	7.76e-01	5.48e-01
GOBP TRIGEMINAL NERVE DEVELOPMENT	12	8.43e-01	9.21e-01	0.10300	-3.48e-02	-9.65e-02	8.35e-01	5.63e-01
Cell death signalling via NRAGE, NRIF and NADE	69	3.42e-01	5.80e-01	0.10300	1.02e-01	1.34e-02	1.44e-01	8.47e-01
GOBP GLYCINE TRANSPORT	14	7.79e-01	8.89e-01	0.10200	1.01e-01	-1.97e-02	5.15e-01	8.99e-01
GOBP SENSORY PERCEPTION OF MECHANICAL STIMULUS	183	6.80e-02	2.27e-01	0.10200	-2.49e-02	-9.93e-02	5.60e-01	2.05e-02
GOMF PURINE NUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY	25	7.19e-01	8.56e-01	0.10200	5.76e-02	8.46e-02	6.18e-01	4.64e-01
GOBP DENDRITE ARBORIZATION	11	8.67e-01	9.35e-01	0.10200	7.97e-02	6.43e-02	6.47e-01	7.12e-01
GOBP MULTICELLULAR ORGANISMAL LEVEL CHEMICAL HOMEOSTASIS	76	2.69e-01	5.08e-01	0.10200	1.30e-02	-1.02e-01	8.45e-01	1.26e-01
Ion channel transport	172	1.00e-01	2.91e-01	0.10200	-4.95e-02	-8.96e-02	2.63e-01	4.27e-02
PTK6 Regulates Cell Cycle	6	9.24e-01	9.64e-01	0.10200	-8.29e-02	-6.00e-02	7.25e-01	7.99e-01
GOBP FORMATION OF PRIMARY GERM LAYER	129	1.90e-01	4.17e-01	0.10200	7.42e-02	7.05e-02	1.45e-01	1.67e-01
GOMF ORGANIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY	177	7.42e-02	2.41e-01	0.10200	-9.93e-02	-2.46e-02	2.27e-02	5.72e-01
GOBP REGULATION OF STEROID HORMONE SECRETION	22	6.94e-01	8.41e-01	0.10200	-1.02e-01	2.36e-03	4.07e-01	9.85e-01
GOBP HEPARIN BIOSYNTHETIC PROCESS	11	8.09e-01	9.04e-01	0.10200	4.71e-02	-9.07e-02	7.87e-01	6.03e-01
GOBP ADULT LOCOMOTORY BEHAVIOR	80	3.51e-01	5.88e-01	0.10200	8.45e-02	5.75e-02	1.91e-01	3.74e-01
GOBP REGULATION OF IMMUNOGLOBULIN PRODUCTION	70	3.32e-01	5.71e-01	0.10200	8.71e-03	1.02e-01	9.00e-01	1.41e-01
GOCC DENDRITIC SPINE MEMBRANE	13	8.42e-01	9.20e-01	0.10200	-8.74e-02	-5.29e-02	5.85e-01	7.41e-01
GOBP RECEPTOR CLUSTERING	57	3.53e-01	5.90e-01	0.10200	2.93e-02	-9.78e-02	7.02e-01	2.02e-01
GOBP NEGATIVE REGULATION OF GTPASE ACTIVITY	17	7.49e-01	8.71e-01	0.10200	-1.02e-01	9.57e-03	4.68e-01	9.46e-01
GOBP NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY	74	3.02e-01	5.42e-01	0.10200	2.28e-03	1.02e-01	9.73e-01	1.29e-01
GOBP MEMBRANE ORGANIZATION	768	6.22e-05	1.04e-03	0.10200	8.34e-02	5.88e-02	8.44e-05	5.54e-03
GOBP NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION	13	8.44e-01	9.22e-01	0.10200	6.05e-02	8.22e-02	7.06e-01	6.08e-01
GOBP REGULATION OF VIRAL GENOME REPLICATION	83	3.44e-01	5.81e-01	0.10200	7.85e-02	6.51e-02	2.16e-01	3.05e-01
GOMF THIOL OXIDASE ACTIVITY	6	8.95e-01	9.49e-01	0.10200	-3.18e-02	9.69e-02	8.93e-01	6.81e-01
GOBP CARDIAC CHAMBER DEVELOPMENT	169	1.11e-01	3.08e-01	0.10200	8.45e-02	5.71e-02	5.80e-02	2.00e-01
GOCC LATERAL PART OF CELL	5	9.08e-01	9.55e-01	0.10200	-5.19e-02	8.78e-02	8.41e-01	7.34e-01
GOBP NEGATIVE REGULATION OF RESPIRATORY BURST	6	8.91e-01	9.48e-01	0.10200	-9.10e-02	4.59e-02	6.99e-01	8.46e-01
Class A/1 (Rhodopsin-like receptors)	313	1.28e-02	7.17e-02	0.10200	-9.61e-02	-3.39e-02	3.46e-03	3.02e-01
Growth hormone receptor signaling	23	6.64e-01	8.22e-01	0.10200	-2.21e-02	9.95e-02	8.54e-01	4.09e-01
GOBP MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE	19	7.82e-01	8.90e-01	0.10200	-6.16e-02	-8.11e-02	6.42e-01	5.41e-01
GOBP NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION	24	6.23e-01	7.93e-01	0.10200	7.67e-02	-6.70e-02	5.16e-01	5.70e-01
GOBP ACTOMYOSIN STRUCTURE ORGANIZATION	212	1.95e-02	9.81e-02	0.10200	9.42e-02	-3.85e-02	1.80e-02	3.33e-01
GOBP PIGMENTATION	107	2.04e-01	4.34e-01	0.10200	9.98e-02	2.00e-02	7.44e-02	7.21e-01
GOBP BONE MINERALIZATION	120	2.13e-01	4.46e-01	0.10200	6.01e-02	8.21e-02	2.55e-01	1.20e-01
GOBP POSITIVE REGULATION OF ATP METABOLIC PROCESS	30	6.59e-01	8.18e-01	0.10200	-3.70e-02	-9.47e-02	7.26e-01	3.69e-01
GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS	19	6.92e-01	8.40e-01	0.10200	-5.56e-02	8.51e-02	6.75e-01	5.21e-01
GOMF CYSTEINE TYPE ENDOPEPTIDASE REGULATOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS	38	6.07e-01	7.83e-01	0.10200	5.23e-02	8.71e-02	5.77e-01	3.53e-01
GOBP NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS	40	5.99e-01	7.78e-01	0.10200	-6.27e-02	-7.98e-02	4.92e-01	3.82e-01
GOMF MONOATOMIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY	612	4.44e-04	5.45e-03	0.10100	-8.43e-02	-5.65e-02	3.71e-04	1.70e-02
GOBP PROTON TRANSMEMBRANE TRANSPORT	143	1.63e-01	3.83e-01	0.10100	7.76e-02	6.53e-02	1.09e-01	1.77e-01
Activated point mutants of FGFR2	16	7.31e-01	8.63e-01	0.10100	7.30e-02	-7.04e-02	6.13e-01	6.26e-01
GOBP GRANULOCYTE MIGRATION	144	1.62e-01	3.82e-01	0.10100	-7.55e-02	-6.77e-02	1.18e-01	1.61e-01
GOBP PLASMA MEMBRANE RAFT ASSEMBLY	8	8.55e-01	9.27e-01	0.10100	-6.44e-02	7.83e-02	7.52e-01	7.01e-01
GOBP NEGATIVE REGULATION OF CIRCADIAN RHYTHM	11	8.62e-01	9.32e-01	0.10100	9.22e-02	4.21e-02	5.96e-01	8.09e-01
GOBP NEURAL CREST CELL DIFFERENTIATION	92	2.30e-01	4.65e-01	0.10100	1.01e-01	1.24e-03	9.30e-02	9.84e-01
GOBP REGULATION OF GLYCOPROTEIN METABOLIC PROCESS	57	4.86e-01	7.00e-01	0.10100	-7.08e-02	-7.25e-02	3.55e-01	3.44e-01
RHOA GTPase cycle	140	8.52e-02	2.63e-01	0.10100	9.85e-02	-2.38e-02	4.43e-02	6.27e-01
GOBP MESONEPHROS DEVELOPMENT	101	1.94e-01	4.23e-01	0.10100	-3.05e-03	1.01e-01	9.58e-01	7.88e-02
GOBP REGULATION OF WOUND HEALING SPREADING OF EPIDERMAL CELLS	10	8.25e-01	9.12e-01	0.10100	8.62e-02	-5.31e-02	6.37e-01	7.71e-01
GOMF ACTIN MONOMER BINDING	24	6.44e-01	8.07e-01	0.10100	3.59e-02	-9.46e-02	7.61e-01	4.22e-01
GOCC MICROFIBRIL	13	8.21e-01	9.09e-01	0.10100	-1.00e-01	-1.32e-02	5.31e-01	9.34e-01
GOBP HEPATOCYTE APOPTOTIC PROCESS	20	7.77e-01	8.88e-01	0.10100	6.83e-02	7.47e-02	5.97e-01	5.63e-01
GOBP ACTIVATION OF PROTEIN KINASE ACTIVITY	76	3.74e-01	6.10e-01	0.10100	5.37e-02	8.57e-02	4.18e-01	1.96e-01
GOBP NEGATIVE REGULATION OF SECRETION	163	7.64e-02	2.45e-01	0.10100	-1.01e-01	-2.67e-03	2.59e-02	9.53e-01
GOBP ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS	303	3.81e-03	2.88e-02	0.10100	-9.22e-02	4.15e-02	5.78e-03	2.14e-01
GOCC TRANSPORT VESICLE	414	5.55e-03	3.83e-02	0.10100	5.92e-02	8.19e-02	3.88e-02	4.26e-03
GOBP POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS	100	2.51e-01	4.89e-01	0.10100	3.34e-02	9.53e-02	5.63e-01	9.96e-02
GOBP GLYCOLYTIC PROCESS THROUGH GLUCOSE 6 PHOSPHATE	19	7.45e-01	8.70e-01	0.10100	-1.01e-01	-7.43e-03	4.47e-01	9.55e-01
Sodium/Proton exchangers	7	9.10e-01	9.55e-01	0.10100	-4.03e-02	-9.26e-02	8.54e-01	6.71e-01
GOBP GLOMERULAR MESANGIAL CELL DEVELOPMENT	5	9.26e-01	9.65e-01	0.10100	1.04e-02	1.00e-01	9.68e-01	6.98e-01
GOBP FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY	31	6.51e-01	8.12e-01	0.10100	3.36e-02	9.51e-02	7.46e-01	3.59e-01
GOBP CAMP CATABOLIC PROCESS	9	8.59e-01	9.30e-01	0.10100	-9.99e-02	1.40e-02	6.04e-01	9.42e-01
GOBP POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY	14	8.06e-01	9.02e-01	0.10100	-8.26e-03	-1.01e-01	9.57e-01	5.15e-01
GOBP FC EPSILON RECEPTOR SIGNALING PATHWAY	24	6.65e-01	8.23e-01	0.10100	-1.49e-02	9.98e-02	9.00e-01	3.98e-01
GOBP DEVELOPMENTAL GROWTH	631	1.82e-04	2.54e-03	0.10100	9.63e-02	3.00e-02	3.64e-05	1.99e-01
GOBP CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS	264	1.55e-02	8.32e-02	0.10100	3.57e-04	1.01e-01	9.92e-01	4.79e-03
Early SARS-CoV-2 Infection Events	34	6.33e-01	7.99e-01	0.10100	4.04e-02	9.24e-02	6.84e-01	3.51e-01
GOBP GLUTAMATE SECRETION NEUROTRANSMISSION	8	8.74e-01	9.39e-01	0.10100	9.98e-02	-1.40e-02	6.25e-01	9.45e-01
Phase II - Conjugation of compounds	103	1.58e-01	3.76e-01	0.10100	3.13e-02	-9.58e-02	5.83e-01	9.31e-02
GOBP CORTICAL ACTIN CYTOSKELETON ORGANIZATION	43	5.76e-01	7.65e-01	0.10100	8.51e-02	5.40e-02	3.35e-01	5.40e-01
GOBP VITAMIN METABOLIC PROCESS	112	2.37e-01	4.74e-01	0.10100	5.25e-02	8.60e-02	3.37e-01	1.16e-01
GOBP PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS	86	3.12e-01	5.52e-01	0.10100	3.67e-02	9.37e-02	5.56e-01	1.33e-01
GOBP GLYCOLIPID BIOSYNTHETIC PROCESS	77	3.60e-01	5.97e-01	0.10100	4.20e-02	9.14e-02	5.24e-01	1.65e-01
GOBP CELLULAR COMPONENT MAINTENANCE	70	3.47e-01	5.85e-01	0.10100	-1.09e-02	-1.00e-01	8.75e-01	1.48e-01
GOBP POLYSACCHARIDE CATABOLIC PROCESS	27	6.39e-01	8.03e-01	0.10100	1.07e-02	-1.00e-01	9.23e-01	3.69e-01
GOBP CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT	82	3.59e-01	5.96e-01	0.10100	7.72e-02	6.44e-02	2.27e-01	3.14e-01
GOBP HORMONE METABOLIC PROCESS	231	5.55e-02	2.00e-01	0.10100	-8.12e-02	-5.93e-02	3.35e-02	1.21e-01
GOBP REGULATION OF FEAR RESPONSE	10	8.57e-01	9.29e-01	0.10000	-6.85e-03	-1.00e-01	9.70e-01	5.83e-01
GOMF CARBOXYPEPTIDASE ACTIVITY	45	5.18e-01	7.24e-01	0.10000	-1.81e-02	-9.88e-02	8.34e-01	2.52e-01
GOBP REGULATION OF ALPHA BETA T CELL ACTIVATION	109	1.43e-01	3.56e-01	0.10000	-3.27e-02	9.49e-02	5.55e-01	8.68e-02
GOBP RESPONSE TO LEPTIN	21	7.54e-01	8.74e-01	0.10000	9.27e-02	3.87e-02	4.62e-01	7.59e-01
GOBP POSITIVE REGULATION OF T CELL PROLIFERATION	98	1.55e-01	3.70e-01	0.10000	-7.92e-02	6.18e-02	1.76e-01	2.91e-01
GOMF PHOSPHATIDYLCHOLINE FLIPPASE ACTIVITY	5	9.38e-01	9.72e-01	0.10000	-5.06e-02	-8.67e-02	8.45e-01	7.37e-01
Nuclear signaling by ERBB4	32	6.07e-01	7.83e-01	0.10000	1.00e-01	2.92e-03	3.26e-01	9.77e-01
GOBP GANGLIOSIDE METABOLIC PROCESS	28	5.84e-01	7.69e-01	0.10000	-6.98e-02	7.22e-02	5.23e-01	5.09e-01
GOBP REGULATION OF PROTEIN OLIGOMERIZATION	5	9.20e-01	9.62e-01	0.10000	-1.13e-02	9.97e-02	9.65e-01	6.99e-01
GOCC CALYX OF HELD	18	7.53e-01	8.73e-01	0.10000	1.11e-03	1.00e-01	9.94e-01	4.61e-01
Death Receptor Signaling	144	1.33e-01	3.43e-01	0.10000	9.67e-02	2.71e-02	4.52e-02	5.75e-01
GOBP T CELL PROLIFERATION INVOLVED IN IMMUNE RESPONSE	5	9.22e-01	9.63e-01	0.10000	-6.98e-03	1.00e-01	9.78e-01	6.98e-01
GOBP REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL	82	2.73e-01	5.12e-01	0.10000	1.19e-03	-1.00e-01	9.85e-01	1.16e-01
GOBP NEGATIVE REGULATION OF T CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL	5	9.09e-01	9.55e-01	0.10000	-7.64e-02	6.51e-02	7.67e-01	8.01e-01
GOMF OXO ACID LYASE ACTIVITY	7	8.89e-01	9.46e-01	0.10000	-9.94e-02	1.38e-02	6.49e-01	9.49e-01
GOBP PHAGOCYTOSIS	231	1.76e-02	9.06e-02	0.10000	-9.60e-02	2.90e-02	1.19e-02	4.48e-01
GOBP TISSUE MORPHOGENESIS	604	6.63e-04	7.60e-03	0.10000	7.61e-02	6.53e-02	1.40e-03	6.14e-03
GOBP REGULATION OF LIPID LOCALIZATION	184	9.17e-02	2.75e-01	0.10000	-8.97e-02	-4.46e-02	3.58e-02	2.97e-01
GOBP STEM CELL DEVELOPMENT	86	2.42e-01	4.80e-01	0.10000	9.95e-02	-1.15e-02	1.11e-01	8.53e-01
GOBP ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY	998	6.04e-06	1.42e-04	0.10000	8.25e-02	5.68e-02	1.04e-05	2.39e-03
Plasma lipoprotein assembly, remodeling, and clearance	74	3.11e-01	5.51e-01	0.10000	1.00e-01	-1.12e-03	1.36e-01	9.87e-01
GOBP CORTICOSTEROID HORMONE SECRETION	19	7.78e-01	8.88e-01	0.10000	-4.09e-02	-9.14e-02	7.58e-01	4.90e-01
Cation-coupled Chloride cotransporters	7	8.81e-01	9.43e-01	0.10000	3.83e-02	-9.25e-02	8.61e-01	6.72e-01
GOCC CLATHRIN COATED VESICLE MEMBRANE	129	2.00e-01	4.30e-01	0.10000	8.15e-02	5.81e-02	1.10e-01	2.54e-01
GOBP MONONUCLEAR CELL DIFFERENTIATION	507	4.47e-04	5.47e-03	0.10000	2.43e-03	1.00e-01	9.25e-01	1.15e-04
Interleukin-3, Interleukin-5 and GM-CSF signaling	44	5.78e-01	7.66e-01	0.10000	7.91e-02	6.12e-02	3.64e-01	4.82e-01
GOBP T CELL DIFFERENTIATION	307	1.05e-02	6.19e-02	0.10000	9.79e-03	9.95e-02	7.68e-01	2.71e-03
GOBP GLYCOSYLCERAMIDE METABOLIC PROCESS	20	7.08e-01	8.49e-01	0.10000	-2.43e-02	9.70e-02	8.51e-01	4.53e-01
GOBP NEGATIVE REGULATION OF CELL CELL ADHESION	197	2.42e-02	1.14e-01	0.09990	-7.11e-02	7.03e-02	8.54e-02	8.90e-02
GOBP POLAR BODY EXTRUSION AFTER MEIOTIC DIVISIONS	5	9.40e-01	9.73e-01	0.09990	8.01e-02	5.97e-02	7.56e-01	8.17e-01
GOBP ANIMAL ORGAN MORPHOGENESIS	999	6.81e-06	1.57e-04	0.09990	8.00e-02	5.98e-02	1.86e-05	1.37e-03
GOBP ORGANOPHOSPHATE BIOSYNTHETIC PROCESS	557	1.25e-03	1.24e-02	0.09980	7.05e-02	7.07e-02	4.43e-03	4.35e-03
GOBP PROGRAMMED NECROTIC CELL DEATH	57	4.96e-01	7.08e-01	0.09980	6.51e-02	7.56e-02	3.96e-01	3.23e-01
Signaling by VEGF	102	2.45e-01	4.83e-01	0.09970	9.58e-02	2.74e-02	9.45e-02	6.32e-01
GOBP POSITIVE REGULATION OF GLIAL CELL MIGRATION	11	8.74e-01	9.39e-01	0.09970	-7.01e-02	-7.08e-02	6.87e-01	6.84e-01
GOBP POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION	84	2.32e-01	4.67e-01	0.09970	9.54e-02	-2.90e-02	1.31e-01	6.46e-01
GOBP CILIARY BASAL BODY ORGANIZATION	5	9.23e-01	9.63e-01	0.09960	-6.69e-03	9.94e-02	9.79e-01	7.00e-01
GOBP REGULATION OF CELLULAR RESPIRATION	45	4.68e-01	6.89e-01	0.09960	-2.02e-02	9.76e-02	8.15e-01	2.57e-01
GOBP POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS	52	3.88e-01	6.21e-01	0.09960	4.44e-02	-8.92e-02	5.80e-01	2.66e-01
GOBP GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY	27	6.29e-01	7.97e-01	0.09960	2.45e-02	-9.65e-02	8.26e-01	3.85e-01
GOBP HEAT GENERATION	18	7.22e-01	8.57e-01	0.09960	4.20e-02	-9.03e-02	7.58e-01	5.07e-01
GOBP REGULATION OF MAST CELL ACTIVATION	18	7.19e-01	8.56e-01	0.09960	-8.80e-02	4.66e-02	5.18e-01	7.32e-01
GOBP FOLIC ACID METABOLIC PROCESS	14	7.70e-01	8.84e-01	0.09950	-5.57e-02	8.25e-02	7.18e-01	5.93e-01
GOBP GLUCOSE CATABOLIC PROCESS	25	6.44e-01	8.07e-01	0.09950	-3.28e-02	9.40e-02	7.77e-01	4.16e-01
GOMF DNA METHYLTRANSFERASE ACTIVITY	7	9.09e-01	9.55e-01	0.09950	2.97e-02	9.50e-02	8.92e-01	6.64e-01
Peptide hormone biosynthesis	11	8.52e-01	9.26e-01	0.09950	-9.83e-02	-1.53e-02	5.73e-01	9.30e-01
GOCC MANCHETTE	21	6.82e-01	8.34e-01	0.09940	-8.86e-02	4.52e-02	4.82e-01	7.20e-01
GOBP HEPATOCYTE DIFFERENTIATION	14	7.72e-01	8.85e-01	0.09940	-8.45e-02	5.24e-02	5.84e-01	7.34e-01
GOBP TELOMERIC LOOP DISASSEMBLY	9	8.96e-01	9.49e-01	0.09930	6.23e-02	7.73e-02	7.46e-01	6.88e-01
GOBP POSITIVE REGULATION OF CELL ACTIVATION	368	2.98e-03	2.39e-02	0.09920	-8.81e-03	9.88e-02	7.72e-01	1.13e-03
GOBP PROTEIN AUTOPROCESSING	27	6.27e-01	7.96e-01	0.09920	-2.86e-02	9.50e-02	7.97e-01	3.93e-01
GOBP ENDOTHELIUM DEVELOPMENT	144	1.75e-01	3.97e-01	0.09920	6.42e-02	7.56e-02	1.83e-01	1.18e-01
GOCC POSTSYNAPTIC SPECIALIZATION INTRACELLULAR COMPONENT	19	7.67e-01	8.82e-01	0.09920	-2.28e-02	-9.65e-02	8.63e-01	4.67e-01
GOBP RESPONSE TO CARBOHYDRATE	233	6.08e-02	2.12e-01	0.09910	7.12e-02	6.90e-02	6.13e-02	6.95e-02
GOBP REGULATION OF MEMBRANE LIPID DISTRIBUTION	59	3.68e-01	6.05e-01	0.09910	-9.62e-02	2.39e-02	2.01e-01	7.51e-01
GOCC MOTILE CILIUM	266	2.20e-02	1.07e-01	0.09900	-1.36e-02	-9.81e-02	7.02e-01	5.89e-03
GOMF VOLTAGE GATED MONOATOMIC ION CHANNEL ACTIVITY INVOLVED IN REGULATION OF PRESYNAPTIC MEMBRANE POTENTIAL	11	8.24e-01	9.11e-01	0.09900	-9.23e-02	3.59e-02	5.96e-01	8.37e-01
GOBP ZINC ION TRANSPORT	29	6.99e-01	8.44e-01	0.09900	5.47e-02	8.25e-02	6.10e-01	4.42e-01
GOBP POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION	17	7.97e-01	8.97e-01	0.09900	9.36e-02	3.22e-02	5.04e-01	8.18e-01
GOBP T CELL RECEPTOR SIGNALING PATHWAY	136	1.85e-01	4.11e-01	0.09880	5.02e-02	8.52e-02	3.13e-01	8.64e-02
GOBP PURINE CONTAINING COMPOUND CATABOLIC PROCESS	144	1.34e-01	3.43e-01	0.09880	1.99e-02	9.68e-02	6.80e-01	4.49e-02
GOBP NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS	843	4.65e-05	8.23e-04	0.09880	8.19e-02	5.53e-02	5.38e-05	6.37e-03
GOBP REGULATION OF MITOPHAGY	35	6.00e-01	7.79e-01	0.09880	9.82e-02	1.08e-02	3.15e-01	9.12e-01
GOBP CELLULAR RESPONSE TO INTERFERON ALPHA	7	9.19e-01	9.61e-01	0.09870	7.72e-02	6.15e-02	7.23e-01	7.78e-01
GOBP REGULATION OF HOMOTYPIC CELL CELL ADHESION	36	5.31e-01	7.34e-01	0.09870	-3.73e-02	9.13e-02	6.98e-01	3.43e-01
GOBP POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS	77	3.76e-01	6.11e-01	0.09860	-4.22e-02	-8.91e-02	5.22e-01	1.76e-01
GOBP FOREBRAIN NEUROBLAST DIVISION	6	9.27e-01	9.66e-01	0.09860	8.70e-02	4.64e-02	7.12e-01	8.44e-01
GOBP REGULATION OF ADAPTIVE IMMUNE RESPONSE	204	2.39e-02	1.13e-01	0.09860	-7.68e-02	6.19e-02	5.88e-02	1.28e-01
GOBP POSITIVE REGULATION OF SYNAPTIC VESICLE RECYCLING	8	9.07e-01	9.55e-01	0.09850	-8.02e-02	-5.72e-02	6.94e-01	7.79e-01
GOBP POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE	21	7.18e-01	8.55e-01	0.09850	-7.81e-03	9.82e-02	9.51e-01	4.36e-01
GOBP NOTCH SIGNALING PATHWAY	176	6.59e-02	2.23e-01	0.09850	-4.96e-03	9.84e-02	9.10e-01	2.44e-02
Metabolism of nucleotides	92	2.63e-01	5.02e-01	0.09850	1.03e-02	9.80e-02	8.65e-01	1.04e-01
GOBP VASOCONSTRICTION	85	2.15e-01	4.47e-01	0.09850	5.15e-02	-8.39e-02	4.12e-01	1.81e-01
GOBP PEPTIDYL AMINO ACID MODIFICATION	801	4.16e-05	7.47e-04	0.09840	9.20e-02	3.50e-02	9.52e-06	9.22e-02
GOBP REGULATION OF CARDIOCYTE DIFFERENTIATION	32	6.32e-01	7.99e-01	0.09840	9.76e-02	1.31e-02	3.40e-01	8.98e-01
MECP2 regulates neuronal receptors and channels	17	8.09e-01	9.04e-01	0.09840	8.62e-02	4.75e-02	5.38e-01	7.35e-01
Passive transport by Aquaporins	13	8.40e-01	9.20e-01	0.09830	-9.40e-02	-2.87e-02	5.57e-01	8.58e-01
GOBP REGULATION OF FEEDING BEHAVIOR	27	6.09e-01	7.85e-01	0.09820	-6.43e-02	7.43e-02	5.63e-01	5.04e-01
GOBP PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS	30	6.12e-01	7.87e-01	0.09820	-1.86e-02	9.65e-02	8.60e-01	3.60e-01
GOBP REGULATION OF GROWTH	575	1.20e-03	1.21e-02	0.09820	6.10e-02	7.70e-02	1.24e-02	1.61e-03
GOBP ACETATE ESTER TRANSPORT	9	8.70e-01	9.37e-01	0.09820	4.17e-03	-9.81e-02	9.83e-01	6.10e-01
GOBP MESENCHYMAL CELL MIGRATION	59	3.39e-01	5.77e-01	0.09820	7.25e-02	-6.62e-02	3.35e-01	3.79e-01
GOBP NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION	45	4.67e-01	6.89e-01	0.09820	-9.40e-02	2.84e-02	2.75e-01	7.42e-01
GOMF CYTOKINE RECEPTOR ACTIVITY	88	2.64e-01	5.03e-01	0.09820	-9.82e-02	5.50e-04	1.11e-01	9.93e-01
GOCC PRC1 COMPLEX	18	7.67e-01	8.82e-01	0.09810	5.51e-03	9.80e-02	9.68e-01	4.72e-01
GOCC SIDE OF MEMBRANE	691	5.14e-05	8.90e-04	0.09810	-9.80e-02	-5.90e-03	1.13e-05	7.92e-01
GOBP REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION	83	3.11e-01	5.51e-01	0.09810	9.69e-02	1.54e-02	1.27e-01	8.08e-01
GOBP REGULATION OF PROTEIN K63 LINKED UBIQUITINATION	13	7.91e-01	8.94e-01	0.09810	-8.18e-02	5.41e-02	6.10e-01	7.36e-01
GOBP POSITIVE REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION	18	7.37e-01	8.66e-01	0.09810	2.93e-02	-9.36e-02	8.30e-01	4.92e-01
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE	101	1.60e-01	3.79e-01	0.09810	7.83e-02	-5.90e-02	1.74e-01	3.05e-01
GOBP ALPHA BETA T CELL ACTIVATION	172	5.65e-02	2.02e-01	0.09800	-2.72e-02	9.42e-02	5.39e-01	3.30e-02
GOBP SEBACEOUS GLAND DEVELOPMENT	10	8.53e-01	9.26e-01	0.09800	1.19e-02	-9.73e-02	9.48e-01	5.94e-01
GOMF GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY	217	4.47e-02	1.74e-01	0.09800	9.75e-02	9.61e-03	1.33e-02	8.07e-01
GOBP REGULATION OF NOTCH SIGNALING PATHWAY	95	2.19e-01	4.52e-01	0.09790	-1.54e-02	9.67e-02	7.95e-01	1.03e-01
GOBP NEGATIVE REGULATION OF ENDOCYTOSIS	75	3.18e-01	5.57e-01	0.09790	-3.83e-03	9.78e-02	9.54e-01	1.43e-01
GOBP T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE	121	1.17e-01	3.17e-01	0.09790	-4.89e-02	8.48e-02	3.52e-01	1.07e-01
GOBP CALMODULIN DEPENDENT KINASE SIGNALING PATHWAY	12	8.03e-01	9.02e-01	0.09790	7.41e-02	-6.39e-02	6.57e-01	7.02e-01
GOBP REGULATION OF THYROID HORMONE GENERATION	7	9.21e-01	9.62e-01	0.09780	-6.70e-02	-7.13e-02	7.59e-01	7.44e-01
GOMF RETINAL DEHYDROGENASE ACTIVITY	9	8.97e-01	9.50e-01	0.09770	-5.48e-02	-8.09e-02	7.76e-01	6.74e-01
GOBP POSTSYNAPSE ASSEMBLY	41	6.17e-01	7.90e-01	0.09760	-6.58e-02	-7.22e-02	4.66e-01	4.24e-01
GOMF CHEMOKINE BINDING	31	6.68e-01	8.25e-01	0.09760	-3.14e-02	-9.24e-02	7.62e-01	3.73e-01
GOBP POSITIVE REGULATION OF MAP KINASE ACTIVITY	78	3.69e-01	6.06e-01	0.09760	-3.51e-02	-9.11e-02	5.92e-01	1.64e-01
GOBP MAINTENANCE OF BLOOD BRAIN BARRIER	37	5.44e-01	7.42e-01	0.09750	-2.40e-02	9.46e-02	8.01e-01	3.20e-01
GOBP POTASSIUM ION HOMEOSTASIS	34	6.45e-01	8.07e-01	0.09750	-9.19e-02	-3.25e-02	3.53e-01	7.43e-01
GOBP REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN	11	8.69e-01	9.36e-01	0.09750	9.09e-02	3.53e-02	6.02e-01	8.39e-01
GOBP BIOLOGICAL PROCESS INVOLVED IN INTERACTION WITH HOST	198	9.74e-02	2.85e-01	0.09750	5.87e-02	7.78e-02	1.54e-01	5.90e-02
GOBP REGULATION OF VIRAL PROCESS	164	1.47e-01	3.59e-01	0.09750	6.22e-02	7.51e-02	1.69e-01	9.71e-02
GOMF ALPHA N ACETYLGALACTOSAMINIDE ALPHA 2 6 SIALYLTRANSFERASE ACTIVITY	6	9.22e-01	9.63e-01	0.09750	-9.50e-02	-2.20e-02	6.87e-01	9.26e-01
GOBP JNK CASCADE	163	1.41e-01	3.53e-01	0.09750	8.38e-02	4.97e-02	6.47e-02	2.74e-01
GOBP RESPONSE TO ETHANOL	120	1.35e-01	3.45e-01	0.09740	-2.93e-02	9.29e-02	5.79e-01	7.87e-02
GOBP EPITHELIAL CELL CELL ADHESION	15	7.87e-01	8.92e-01	0.09740	1.71e-02	-9.59e-02	9.09e-01	5.20e-01
GOBP SUBSTRATE DEPENDENT CELL MIGRATION	25	6.37e-01	8.02e-01	0.09740	6.57e-02	-7.19e-02	5.70e-01	5.34e-01
GOMF MONOSACCHARIDE BINDING	72	2.85e-01	5.24e-01	0.09730	8.64e-02	-4.47e-02	2.05e-01	5.12e-01
GOBP REGULATION OF EXECUTION PHASE OF APOPTOSIS	23	7.19e-01	8.56e-01	0.09720	9.69e-02	8.05e-03	4.21e-01	9.47e-01
GOBP PEPTIDE BIOSYNTHETIC PROCESS	25	6.37e-01	8.02e-01	0.09720	7.18e-02	-6.56e-02	5.35e-01	5.70e-01
GOBP NEURON PROJECTION REGENERATION	57	5.01e-01	7.11e-01	0.09720	-4.72e-02	-8.50e-02	5.38e-01	2.67e-01
GOBP PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS	29	6.41e-01	8.04e-01	0.09720	-8.20e-03	9.68e-02	9.39e-01	3.67e-01
GOCC POSTSYNAPTIC CYTOSOL	13	8.22e-01	9.10e-01	0.09710	9.71e-02	-3.91e-03	5.45e-01	9.81e-01
GOBP OVARIAN FOLLICLE DEVELOPMENT	55	4.92e-01	7.05e-01	0.09710	9.22e-02	3.07e-02	2.37e-01	6.94e-01
GOBP POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE	27	6.21e-01	7.92e-01	0.09710	5.06e-02	-8.29e-02	6.49e-01	4.56e-01
GOBP POSITIVE REGULATION OF CELL POPULATION PROLIFERATION	938	1.86e-05	3.72e-04	0.09710	4.74e-02	8.48e-02	1.40e-02	1.08e-05
GOBP PLATELET MORPHOGENESIS	25	6.40e-01	8.04e-01	0.09710	5.91e-02	-7.70e-02	6.09e-01	5.05e-01
GOBP DENDRITIC SPINE DEVELOPMENT	88	3.25e-01	5.63e-01	0.09700	-3.18e-02	-9.17e-02	6.06e-01	1.37e-01
GOBP RESPONSE TO CAMP	83	3.63e-01	6.00e-01	0.09700	8.68e-02	4.34e-02	1.72e-01	4.95e-01
GOBP POSITIVE REGULATION OF B CELL ACTIVATION	80	3.26e-01	5.64e-01	0.09700	1.10e-02	9.64e-02	8.65e-01	1.36e-01
GOBP REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS	53	3.89e-01	6.23e-01	0.09700	5.97e-02	-7.64e-02	4.52e-01	3.36e-01
GOBP GLYCEROL 3 PHOSPHATE METABOLIC PROCESS	7	8.82e-01	9.43e-01	0.09690	-7.00e-02	6.71e-02	7.49e-01	7.58e-01
GOBP REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS	18	7.44e-01	8.69e-01	0.09690	-2.69e-02	9.31e-02	8.43e-01	4.94e-01
GOBP POSITIVE REGULATION OF CIRCADIAN RHYTHM	18	7.88e-01	8.92e-01	0.09670	2.27e-02	9.40e-02	8.67e-01	4.90e-01
GOBP CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL	182	1.22e-01	3.26e-01	0.09670	-6.04e-02	-7.56e-02	1.60e-01	7.86e-02
GOBP CALCIUM ION TRANSMEMBRANE TRANSPORT	329	1.75e-02	9.05e-02	0.09670	-3.71e-02	-8.93e-02	2.48e-01	5.34e-03
GOBP POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS	43	5.39e-01	7.39e-01	0.09670	-4.20e-03	-9.66e-02	9.62e-01	2.73e-01
GOBP REGULATION OF LYMPHOCYTE MIGRATION	66	3.98e-01	6.31e-01	0.09670	-9.61e-02	-1.06e-02	1.77e-01	8.82e-01
GOCC PROTEIN COMPLEX INVOLVED IN CELL MATRIX ADHESION	17	7.68e-01	8.83e-01	0.09670	1.29e-02	-9.58e-02	9.27e-01	4.94e-01
GOMF GUANYL RIBONUCLEOTIDE BINDING	368	1.45e-02	7.86e-02	0.09660	5.63e-02	7.86e-02	6.38e-02	9.63e-03
GOBP VIRAL LIFE CYCLE	309	2.86e-02	1.28e-01	0.09660	7.76e-02	5.75e-02	1.89e-02	8.20e-02
GOBP PROTEIN TARGETING TO MEMBRANE	111	1.93e-01	4.22e-01	0.09660	9.66e-02	-3.11e-03	7.88e-02	9.55e-01
GOBP REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY	42	5.69e-01	7.59e-01	0.09660	1.87e-02	9.47e-02	8.34e-01	2.88e-01
CaMK IV-mediated phosphorylation of CREB	10	8.37e-01	9.18e-01	0.09650	-6.43e-02	7.20e-02	7.25e-01	6.94e-01
GOBP MULTICELLULAR ORGANISMAL RESPONSE TO STRESS	94	2.16e-01	4.48e-01	0.09650	-9.24e-02	2.78e-02	1.22e-01	6.41e-01
RHOG GTPase cycle	71	3.52e-01	5.90e-01	0.09650	9.64e-02	-1.96e-03	1.60e-01	9.77e-01
GOBP POSITIVE REGULATION OF CELL MATRIX ADHESION	56	5.04e-01	7.13e-01	0.09640	8.80e-02	3.96e-02	2.55e-01	6.08e-01
GOCC ACTIN CYTOSKELETON	503	3.08e-04	4.00e-03	0.09640	9.18e-02	-2.96e-02	4.23e-04	2.56e-01
Chondroitin sulfate biosynthesis	18	7.46e-01	8.70e-01	0.09640	-9.25e-02	2.74e-02	4.97e-01	8.41e-01
GOCC RECEPTOR COMPLEX	387	1.12e-02	6.51e-02	0.09640	-8.20e-02	-5.06e-02	5.59e-03	8.72e-02
FGFR2 ligand binding and activation	19	7.42e-01	8.69e-01	0.09640	9.47e-02	-1.77e-02	4.75e-01	8.94e-01
GOBP INTEGRIN MEDIATED SIGNALING PATHWAY	110	1.77e-01	4.01e-01	0.09630	9.44e-02	-1.92e-02	8.72e-02	7.29e-01
GOBP POSITIVE REGULATION OF INTRACELLULAR TRANSPORT	130	2.25e-01	4.59e-01	0.09630	7.56e-02	5.97e-02	1.37e-01	2.40e-01
GOBP REGULATION OF FATTY ACID TRANSPORT	33	5.78e-01	7.66e-01	0.09630	-3.38e-02	9.02e-02	7.37e-01	3.70e-01
GOBP REGULATION OF RESPONSE TO STRESS	1376	3.07e-07	1.01e-05	0.09620	5.54e-02	7.87e-02	5.66e-04	9.87e-07
GOBP ACTIVATION OF JANUS KINASE ACTIVITY	13	8.11e-01	9.05e-01	0.09620	2.47e-02	-9.30e-02	8.77e-01	5.62e-01
Neuronal System	389	6.03e-03	4.09e-02	0.09620	-9.44e-02	-1.84e-02	1.39e-03	5.34e-01
GOBP RESPONSE TO BACTERIUM	660	2.64e-04	3.52e-03	0.09610	-9.24e-02	-2.66e-02	5.16e-05	2.44e-01
GOCC NEURON PROJECTION MEMBRANE	56	5.14e-01	7.21e-01	0.09600	-8.49e-02	-4.48e-02	2.72e-01	5.62e-01
GOBP RESPONSE TO PLATELET DERIVED GROWTH FACTOR	21	6.92e-01	8.40e-01	0.09600	7.14e-02	-6.41e-02	5.71e-01	6.11e-01
GOBP NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY	21	7.60e-01	8.78e-01	0.09590	-9.34e-02	-2.16e-02	4.59e-01	8.64e-01
GOBP AMINO ACID CATABOLIC PROCESS	98	3.30e-01	5.69e-01	0.09590	6.62e-02	6.94e-02	2.57e-01	2.35e-01
GOBP GROOMING BEHAVIOR	18	7.33e-01	8.63e-01	0.09590	-5.19e-02	8.07e-02	7.03e-01	5.53e-01
GOCC RECYCLING ENDOSOME	198	1.08e-01	3.03e-01	0.09590	6.46e-02	7.09e-02	1.17e-01	8.56e-02
GOBP CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT	55	4.67e-01	6.89e-01	0.09580	9.54e-02	8.95e-03	2.21e-01	9.09e-01
GOBP NEUTROPHIL MEDIATED KILLING OF GRAM NEGATIVE BACTERIUM	7	8.91e-01	9.47e-01	0.09580	-3.56e-02	8.90e-02	8.70e-01	6.84e-01
GOMF FOLIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY	5	9.21e-01	9.62e-01	0.09580	-8.94e-02	3.44e-02	7.29e-01	8.94e-01
Transport of nucleotide sugars	8	8.70e-01	9.36e-01	0.09580	-6.26e-02	7.26e-02	7.59e-01	7.22e-01
GOMF PURINE NUCLEOTIDE BINDING	1884	1.19e-10	7.46e-09	0.09580	9.40e-02	1.85e-02	1.39e-11	1.84e-01
GOBP ENDOTHELIAL CELL CHEMOTAXIS	28	6.37e-01	8.02e-01	0.09580	2.78e-02	-9.17e-02	7.99e-01	4.01e-01
GOBP NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS	514	1.74e-04	2.46e-03	0.09580	-5.25e-02	8.01e-02	4.16e-02	1.89e-03
GOBP LEUKOCYTE DIFFERENTIATION	605	2.77e-04	3.67e-03	0.09570	7.51e-03	9.54e-02	7.53e-01	6.09e-05
GOBP RESPONSE TO INTERLEUKIN 6	43	6.15e-01	7.88e-01	0.09570	7.22e-02	6.28e-02	4.13e-01	4.76e-01
GOCC LIPID DROPLET	96	2.65e-01	5.04e-01	0.09550	9.53e-02	6.51e-03	1.07e-01	9.12e-01
GOMF CAMP DEPENDENT PROTEIN KINASE INHIBITOR ACTIVITY	10	8.48e-01	9.23e-01	0.09550	3.67e-02	-8.82e-02	8.41e-01	6.29e-01
GOBP RIBOSE PHOSPHATE METABOLIC PROCESS	446	7.27e-03	4.71e-02	0.09550	6.98e-02	6.52e-02	1.15e-02	1.83e-02
GOBP POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY	6	9.19e-01	9.61e-01	0.09540	-9.53e-02	-3.80e-03	6.86e-01	9.87e-01
GOMF PROTEIN KINASE ACTIVITY	551	9.20e-04	9.81e-03	0.09540	9.31e-02	2.07e-02	1.85e-04	4.05e-01
GOBP CELLULAR RESPONSE TO LEPTIN STIMULUS	17	8.15e-01	9.07e-01	0.09540	3.90e-02	8.70e-02	7.80e-01	5.34e-01
GOMF ADENYL NUCLEOTIDE BINDING	1565	1.03e-09	5.57e-08	0.09540	9.54e-02	1.22e-03	2.96e-10	9.36e-01
GOBP PYRIMIDINE RIBONUCLEOTIDE BIOSYNTHETIC PROCESS	22	7.81e-01	8.90e-01	0.09540	7.17e-02	6.29e-02	5.60e-01	6.10e-01
GOCC CTF18 RFC LIKE COMPLEX	8	9.02e-01	9.52e-01	0.09540	9.28e-02	2.20e-02	6.49e-01	9.14e-01
GOBP NEGATIVE REGULATION OF RESPONSE TO STIMULUS	1706	1.17e-08	5.04e-07	0.09540	4.89e-02	8.19e-02	7.75e-04	1.85e-08
GOBP KYNURENINE METABOLIC PROCESS	11	8.83e-01	9.44e-01	0.09540	-7.56e-02	-5.82e-02	6.64e-01	7.38e-01
GOBP RESPONSE TO SALT STRESS	24	7.64e-01	8.80e-01	0.09530	6.51e-02	6.96e-02	5.81e-01	5.55e-01
GOBP TOLL LIKE RECEPTOR SIGNALING PATHWAY	72	3.18e-01	5.56e-01	0.09530	-2.75e-02	9.12e-02	6.86e-01	1.81e-01
GOBP NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS	30	6.22e-01	7.93e-01	0.09530	-9.17e-02	2.58e-02	3.85e-01	8.07e-01
GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN CYCLIC AMIDES	15	8.30e-01	9.15e-01	0.09520	-3.01e-02	-9.04e-02	8.40e-01	5.45e-01
GOBP TIGHT JUNCTION ORGANIZATION	80	3.98e-01	6.31e-01	0.09520	-4.92e-02	-8.15e-02	4.47e-01	2.07e-01
GOBP RESPONSE TO TEMPERATURE STIMULUS	166	9.42e-02	2.79e-01	0.09520	9.52e-02	-1.47e-03	3.43e-02	9.74e-01
GOBP GASTRIC ACID SECRETION	13	8.52e-01	9.26e-01	0.09520	-8.98e-02	-3.14e-02	5.75e-01	8.44e-01
GOBP POSITIVE REGULATION OF GROWTH HORMONE SECRETION	9	8.77e-01	9.40e-01	0.09520	-9.50e-02	5.88e-03	6.22e-01	9.76e-01
GOBP NEGATIVE REGULATION OF FIBROBLAST MIGRATION	12	8.73e-01	9.39e-01	0.09510	5.76e-02	7.57e-02	7.30e-01	6.50e-01
GOCC EQUATORIAL MICROTUBULE ORGANIZING CENTER	5	9.45e-01	9.76e-01	0.09510	-5.79e-02	-7.54e-02	8.23e-01	7.70e-01
Transport of inorganic cations/anions and amino acids/oligopeptides	102	3.18e-01	5.56e-01	0.09510	-5.71e-02	-7.60e-02	3.19e-01	1.84e-01
GOBP REGULATION OF CELL ACTIVATION	615	7.35e-05	1.20e-03	0.09510	-2.80e-02	9.09e-02	2.37e-01	1.19e-04
GOCC ENDOSOME	1010	2.07e-05	4.08e-04	0.09500	7.19e-02	6.22e-02	1.12e-04	8.27e-04
Phase 3 - rapid repolarisation	8	8.90e-01	9.47e-01	0.09500	-9.48e-02	5.99e-03	6.42e-01	9.77e-01
GOBP MEMBRANE REPOLARIZATION DURING ATRIAL CARDIAC MUSCLE CELL ACTION POTENTIAL	6	9.35e-01	9.70e-01	0.09500	7.56e-02	5.75e-02	7.48e-01	8.07e-01
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE	59	3.72e-01	6.08e-01	0.09490	8.18e-02	-4.82e-02	2.77e-01	5.22e-01
GOBP REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY	102	3.14e-01	5.54e-01	0.09490	7.98e-02	5.13e-02	1.64e-01	3.70e-01
GOBP REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY	28	7.04e-01	8.47e-01	0.09490	-9.11e-02	-2.64e-02	4.04e-01	8.09e-01
GOBP MITOCHONDRIAL RNA MODIFICATION	8	9.14e-01	9.58e-01	0.09480	7.70e-02	5.54e-02	7.06e-01	7.86e-01
GOBP CALCIUM ION TRANSPORT INTO CYTOSOL	28	7.32e-01	8.63e-01	0.09480	7.22e-02	6.14e-02	5.08e-01	5.74e-01
Regulation of gene expression in beta cells	21	7.04e-01	8.47e-01	0.09480	4.77e-02	-8.19e-02	7.05e-01	5.16e-01
GOBP SPONTANEOUS SYNAPTIC TRANSMISSION	14	8.19e-01	9.09e-01	0.09480	-9.48e-02	1.98e-03	5.39e-01	9.90e-01
GOBP POSITIVE REGULATION OF PROTEOLYSIS	326	2.10e-02	1.03e-01	0.09470	3.49e-02	8.80e-02	2.78e-01	6.28e-03
GOBP REGULATION OF TISSUE REMODELING	88	2.28e-01	4.62e-01	0.09470	-5.23e-02	7.89e-02	3.96e-01	2.01e-01
GOBP LEUKOCYTE CELL CELL ADHESION	407	1.31e-03	1.28e-02	0.09470	-4.48e-02	8.34e-02	1.21e-01	3.89e-03
GOBP POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN	11	8.68e-01	9.35e-01	0.09470	1.87e-02	9.28e-02	9.14e-01	5.94e-01
GOBP REGULATION OF CELL POPULATION PROLIFERATION	1690	1.86e-08	7.67e-07	0.09470	4.94e-02	8.08e-02	7.30e-04	3.26e-08
GOMF PROTEIN CONTAINING COMPLEX DESTABILIZING ACTIVITY	15	7.89e-01	8.93e-01	0.09460	-2.81e-02	9.04e-02	8.51e-01	5.45e-01
Neurotransmitter release cycle	48	4.42e-01	6.69e-01	0.09460	-6.29e-02	7.07e-02	4.51e-01	3.97e-01
GOBP POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT	52	5.51e-01	7.46e-01	0.09450	8.27e-02	4.58e-02	3.02e-01	5.68e-01
GOBP PEPTIDYL THREONINE MODIFICATION	103	2.53e-01	4.91e-01	0.09450	9.40e-02	9.99e-03	9.93e-02	8.61e-01
GOBP NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS	11	8.63e-01	9.33e-01	0.09450	-9.39e-02	-1.02e-02	5.90e-01	9.53e-01
GOBP CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE	296	8.96e-03	5.54e-02	0.09450	-3.61e-02	8.73e-02	2.85e-01	9.78e-03
GOBP TRNA TRANSPORT	6	9.09e-01	9.55e-01	0.09440	8.89e-02	-3.17e-02	7.06e-01	8.93e-01
GOBP SERTOLI CELL DIFFERENTIATION	17	8.23e-01	9.11e-01	0.09440	8.27e-02	4.55e-02	5.55e-01	7.45e-01
Norepinephrine Neurotransmitter Release Cycle	17	8.28e-01	9.14e-01	0.09440	-7.45e-02	-5.80e-02	5.95e-01	6.79e-01
GOBP NUCLEAR MIGRATION ALONG MICROTUBULE	5	9.19e-01	9.62e-01	0.09440	-7.68e-02	5.49e-02	7.66e-01	8.32e-01
Biosynthesis of Lipoxins (LX)	6	9.12e-01	9.57e-01	0.09440	9.20e-02	-2.08e-02	6.96e-01	9.30e-01
GOMF STEROID HORMONE BINDING	6	9.04e-01	9.53e-01	0.09430	7.80e-02	-5.30e-02	7.41e-01	8.22e-01
GOBP POSITIVE REGULATION OF CATECHOLAMINE SECRETION	12	8.17e-01	9.08e-01	0.09430	-7.50e-02	5.73e-02	6.53e-01	7.31e-01
FGFR4 ligand binding and activation	13	8.24e-01	9.11e-01	0.09430	-9.30e-02	1.55e-02	5.62e-01	9.23e-01
GOBP VASODILATION	49	4.87e-01	7.02e-01	0.09430	9.35e-02	-1.17e-02	2.57e-01	8.88e-01
GOBP HYALURONAN BIOSYNTHETIC PROCESS	14	8.05e-01	9.02e-01	0.09420	9.08e-02	-2.51e-02	5.56e-01	8.71e-01
GOBP EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT	10	8.82e-01	9.43e-01	0.09420	2.20e-02	9.16e-02	9.04e-01	6.16e-01
GOBP RESPONSE TO ACIDIC PH	26	7.52e-01	8.73e-01	0.09420	-6.81e-02	-6.51e-02	5.48e-01	5.65e-01
GOBP SEMICIRCULAR CANAL DEVELOPMENT	9	8.95e-01	9.49e-01	0.09420	9.07e-02	2.55e-02	6.38e-01	8.95e-01
GOBP REGULATION OF T CELL PROLIFERATION	172	5.64e-02	2.02e-01	0.09420	-7.37e-02	5.86e-02	9.55e-02	1.85e-01
GOBP CEREBRAL CORTEX TANGENTIAL MIGRATION	5	9.45e-01	9.76e-01	0.09420	-4.93e-02	-8.02e-02	8.49e-01	7.56e-01
GOBP CELLULAR RESPONSE TO FLUID SHEAR STRESS	21	7.94e-01	8.95e-01	0.09410	5.93e-02	7.31e-02	6.38e-01	5.62e-01
GOBP EPITHELIAL CELL APOPTOTIC PROCESS	146	1.68e-01	3.90e-01	0.09410	9.02e-02	2.70e-02	6.00e-02	5.73e-01
GOMF EXOPEPTIDASE ACTIVITY	100	1.99e-01	4.29e-01	0.09410	4.05e-02	-8.49e-02	4.84e-01	1.42e-01
GOMF SH3 DOMAIN BINDING	114	2.19e-01	4.52e-01	0.09400	9.37e-02	7.83e-03	8.39e-02	8.85e-01
GOBP NEGATIVE REGULATION OF LIPOPROTEIN LIPASE ACTIVITY	7	8.94e-01	9.49e-01	0.09400	8.65e-02	-3.69e-02	6.92e-01	8.66e-01
Transport of fatty acids	8	8.84e-01	9.44e-01	0.09390	2.65e-02	-9.01e-02	8.97e-01	6.59e-01
GOBP CIRCADIAN RHYTHM	198	1.10e-01	3.06e-01	0.09380	8.11e-02	4.72e-02	4.91e-02	2.52e-01
GOBP DENSE CORE GRANULE TRANSPORT	10	8.74e-01	9.39e-01	0.09380	-9.37e-02	-5.13e-03	6.08e-01	9.78e-01
GOBP EPIDERMAL CELL FATE SPECIFICATION	5	9.47e-01	9.77e-01	0.09380	-5.85e-02	-7.33e-02	8.21e-01	7.77e-01
GOBP REGULATION OF CILIUM MOVEMENT	40	5.23e-01	7.27e-01	0.09370	4.28e-02	-8.34e-02	6.40e-01	3.61e-01
GOCC MICROTUBULE ASSOCIATED COMPLEX	149	1.09e-01	3.06e-01	0.09370	9.19e-02	-1.85e-02	5.28e-02	6.97e-01
GPCR downstream signalling	603	1.59e-03	1.48e-02	0.09370	-7.54e-02	-5.57e-02	1.57e-03	1.94e-02
GOBP RESPONSE TO LECTIN	21	7.91e-01	8.94e-01	0.09370	-4.95e-02	-7.96e-02	6.95e-01	5.28e-01
GOCC ASTER	10	8.97e-01	9.50e-01	0.09370	6.24e-02	6.99e-02	7.33e-01	7.02e-01
GOBP SENSORY ORGAN DEVELOPMENT	581	1.28e-03	1.26e-02	0.09360	8.72e-02	3.40e-02	3.27e-04	1.61e-01
GOBP THYROID HORMONE METABOLIC PROCESS	28	7.10e-01	8.50e-01	0.09360	-9.02e-02	-2.51e-02	4.09e-01	8.18e-01
GOBP OTIC VESICLE FORMATION	8	9.10e-01	9.55e-01	0.09360	8.78e-02	3.25e-02	6.67e-01	8.74e-01
GOBP REGULATION OF DEFENSE RESPONSE TO BACTERIUM	20	7.43e-01	8.69e-01	0.09360	-1.82e-02	9.18e-02	8.88e-01	4.77e-01
GOBP LOCOMOTOR RHYTHM	16	7.82e-01	8.90e-01	0.09350	2.79e-02	-8.93e-02	8.47e-01	5.36e-01
GOMF MICROTUBULE MOTOR ACTIVITY	67	4.61e-01	6.85e-01	0.09350	-3.74e-02	-8.57e-02	5.96e-01	2.25e-01
GOBP CELLULAR RESPONSE TO STEROL DEPLETION	16	7.78e-01	8.89e-01	0.09350	8.72e-02	-3.36e-02	5.46e-01	8.16e-01
GOBP NEUROMUSCULAR JUNCTION DEVELOPMENT	51	5.59e-01	7.52e-01	0.09350	-4.02e-02	-8.44e-02	6.20e-01	2.97e-01
GOBP EXTRACELLULAR MATRIX ASSEMBLY	51	4.78e-01	6.96e-01	0.09340	9.26e-02	-1.27e-02	2.53e-01	8.75e-01
GOBP NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION	144	9.26e-02	2.77e-01	0.09340	-6.19e-02	7.00e-02	2.00e-01	1.47e-01
GOBP MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON	11	8.34e-01	9.17e-01	0.09340	-7.45e-02	5.63e-02	6.69e-01	7.46e-01
GOBP PEPTIDOGLYCAN METABOLIC PROCESS	6	9.32e-01	9.68e-01	0.09340	-8.65e-02	-3.51e-02	7.14e-01	8.82e-01
GOMF STRUCTURAL CONSTITUENT OF CYTOSKELETON	104	2.11e-01	4.43e-01	0.09340	-9.08e-02	2.17e-02	1.10e-01	7.02e-01
GOBP RESPONSE TO NITRIC OXIDE	19	8.14e-01	9.06e-01	0.09330	5.73e-02	7.37e-02	6.66e-01	5.78e-01
GOBP NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS	27	6.43e-01	8.06e-01	0.09330	-5.03e-02	7.86e-02	6.51e-01	4.80e-01
GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION	34	6.21e-01	7.92e-01	0.09330	9.31e-02	-5.58e-03	3.47e-01	9.55e-01
GOBP RESPONSE TO LIGHT STIMULUS	304	1.97e-02	9.87e-02	0.09330	9.28e-02	9.34e-03	5.38e-03	7.79e-01
GOCC CAVEOLA	81	2.64e-01	5.04e-01	0.09330	5.62e-02	-7.44e-02	3.82e-01	2.47e-01
GOBP METANEPHRIC PROXIMAL TUBULE DEVELOPMENT	5	9.22e-01	9.63e-01	0.09320	5.05e-02	-7.84e-02	8.45e-01	7.62e-01
GOBP LYMPHOCYTE MIGRATION	99	2.50e-01	4.88e-01	0.09320	-9.30e-02	6.40e-03	1.10e-01	9.12e-01
GOMF TRIPEPTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY	9	9.02e-01	9.52e-01	0.09320	3.87e-02	8.48e-02	8.41e-01	6.60e-01
GOBP REGULATION OF CALCIUM ION EXPORT ACROSS PLASMA MEMBRANE	6	9.19e-01	9.61e-01	0.09320	9.29e-02	-7.06e-03	6.93e-01	9.76e-01
GOBP REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL	72	4.59e-01	6.83e-01	0.09320	5.61e-02	7.44e-02	4.11e-01	2.75e-01
GOMF HORMONE BINDING	89	3.04e-01	5.44e-01	0.09320	9.31e-02	3.30e-03	1.29e-01	9.57e-01
GOBP REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY	20	8.04e-01	9.02e-01	0.09320	5.28e-02	7.67e-02	6.82e-01	5.53e-01
Inwardly rectifying K+ channels	35	5.78e-01	7.66e-01	0.09310	3.56e-02	-8.61e-02	7.16e-01	3.78e-01
GOBP RENAL SYSTEM PROCESS	120	2.71e-01	5.11e-01	0.09310	-5.20e-02	-7.72e-02	3.25e-01	1.44e-01
GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION	207	1.09e-01	3.06e-01	0.09310	5.75e-02	7.32e-02	1.54e-01	6.94e-02
GOBP MICROTUBULE BASED PROTEIN TRANSPORT	14	8.32e-01	9.16e-01	0.09290	9.27e-02	6.60e-03	5.48e-01	9.66e-01
GOBP NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS	639	1.33e-03	1.29e-02	0.09290	6.70e-02	6.44e-02	3.85e-03	5.44e-03
Gap junction trafficking and regulation	48	4.74e-01	6.94e-01	0.09290	-8.62e-02	3.48e-02	3.02e-01	6.77e-01
GOBP HAIR CYCLE PHASE	9	9.08e-01	9.55e-01	0.09290	6.79e-02	6.34e-02	7.24e-01	7.42e-01
GOBP POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION	16	7.97e-01	8.97e-01	0.09290	9.24e-02	-9.96e-03	5.22e-01	9.45e-01
GOBP SPERM FLAGELLUM ASSEMBLY	47	6.02e-01	7.80e-01	0.09290	-5.33e-02	-7.61e-02	5.27e-01	3.67e-01
GOBP POSITIVE REGULATION OF PROTEIN K63 LINKED UBIQUITINATION	7	9.12e-01	9.56e-01	0.09290	-5.63e-03	-9.27e-02	9.79e-01	6.71e-01
GOBP POSITIVE REGULATION OF ERBB SIGNALING PATHWAY	31	6.50e-01	8.11e-01	0.09290	9.27e-02	-5.39e-03	3.72e-01	9.59e-01
GOBP ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS	240	3.34e-02	1.42e-01	0.09290	-9.21e-02	1.23e-02	1.40e-02	7.43e-01
GOBP REGULATION OF PROSTAGLANDIN SECRETION	14	8.21e-01	9.09e-01	0.09290	-9.26e-03	9.24e-02	9.52e-01	5.49e-01
GOBP CELLULAR RESPONSE TO NITROGEN COMPOUND	626	1.23e-03	1.23e-02	0.09280	8.04e-02	4.63e-02	5.96e-04	4.80e-02
Signaling by Receptor Tyrosine Kinases	514	4.08e-03	3.04e-02	0.09270	7.95e-02	4.77e-02	2.03e-03	6.43e-02
GOBP REGULATION OF MICROTUBULE BASED MOVEMENT	53	4.32e-01	6.59e-01	0.09270	4.36e-02	-8.18e-02	5.83e-01	3.03e-01
GOBP REGULATION OF COLLATERAL SPROUTING	19	7.33e-01	8.63e-01	0.09260	-6.55e-02	6.55e-02	6.21e-01	6.21e-01
Glycosaminoglycan metabolism	121	2.79e-01	5.19e-01	0.09260	-6.33e-02	-6.76e-02	2.29e-01	1.99e-01
GOBP SPHINGOLIPID BIOSYNTHETIC PROCESS	111	2.33e-01	4.68e-01	0.09260	4.55e-03	9.25e-02	9.34e-01	9.23e-02
Sema3A PAK dependent Axon repulsion	14	8.61e-01	9.31e-01	0.09260	5.58e-02	7.39e-02	7.18e-01	6.32e-01
GOBP EPITHELIAL CELL MORPHOGENESIS	30	7.27e-01	8.60e-01	0.09260	-7.14e-02	-5.89e-02	4.98e-01	5.77e-01
GOBP REGULATION OF RESPONSE TO WOUNDING	172	1.45e-01	3.58e-01	0.09250	-3.77e-02	-8.45e-02	3.94e-01	5.58e-02
GOMF DIPEPTIDASE ACTIVITY	16	8.11e-01	9.05e-01	0.09250	-5.60e-03	-9.24e-02	9.69e-01	5.22e-01
GOBP LEUKOCYTE PROLIFERATION	335	6.46e-03	4.32e-02	0.09250	-8.71e-02	3.12e-02	6.14e-03	3.27e-01
GOMF HORMONE ACTIVITY	122	1.86e-01	4.12e-01	0.09250	-9.22e-02	6.77e-03	7.84e-02	8.97e-01
GOBP REGULATION OF RESPONSE TO TYPE II INTERFERON	14	8.16e-01	9.07e-01	0.09250	-9.09e-02	1.72e-02	5.56e-01	9.11e-01
GOBP REGULATION OF TRANSMISSION OF NERVE IMPULSE	15	8.48e-01	9.23e-01	0.09240	8.12e-02	4.41e-02	5.86e-01	7.68e-01
GOBP NEGATIVE REGULATION OF AMIDE METABOLIC PROCESS	33	6.14e-01	7.88e-01	0.09240	-2.24e-02	8.97e-02	8.23e-01	3.73e-01
GOMF CATALYTIC ACTIVITY ACTING ON A GLYCOPROTEIN	22	7.86e-01	8.92e-01	0.09240	-8.04e-02	-4.56e-02	5.14e-01	7.11e-01
GOBP REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY	13	8.11e-01	9.05e-01	0.09240	7.46e-02	-5.46e-02	6.42e-01	7.33e-01
GOBP CELL MIGRATION INVOLVED IN KIDNEY DEVELOPMENT	6	9.19e-01	9.61e-01	0.09230	-9.15e-02	1.21e-02	6.98e-01	9.59e-01
GOMF THREONINE TYPE PEPTIDASE ACTIVITY	16	7.71e-01	8.85e-01	0.09230	6.12e-02	-6.92e-02	6.72e-01	6.32e-01
GOBP NEGATIVE REGULATION OF CELL MATURATION	8	8.92e-01	9.48e-01	0.09230	1.51e-02	-9.11e-02	9.41e-01	6.56e-01
GOBP SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION	471	7.17e-03	4.66e-02	0.09230	7.61e-02	5.22e-02	4.67e-03	5.21e-02
Activated NOTCH1 Transmits Signal to the Nucleus	30	7.15e-01	8.53e-01	0.09230	8.36e-02	3.91e-02	4.28e-01	7.11e-01
GOBP POSITIVE REGULATION OF SODIUM ION TRANSPORT	28	7.34e-01	8.64e-01	0.09230	4.21e-02	8.21e-02	7.00e-01	4.52e-01
GOMF GDP PHOSPHATASE ACTIVITY	10	8.50e-01	9.25e-01	0.09230	-6.22e-02	6.82e-02	7.33e-01	7.09e-01
GOBP POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION	269	2.23e-02	1.08e-01	0.09220	-1.52e-02	9.10e-02	6.68e-01	1.02e-02
GOBP POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT	50	5.40e-01	7.39e-01	0.09220	-9.07e-02	-1.66e-02	2.67e-01	8.39e-01
GOBP SYNAPTIC TRANSMISSION GABAERGIC	58	4.85e-01	7.00e-01	0.09220	-9.11e-02	-1.41e-02	2.30e-01	8.52e-01
GOMF ALDO KETO REDUCTASE NADPH ACTIVITY	30	6.88e-01	8.37e-01	0.09220	-9.11e-02	-1.40e-02	3.88e-01	8.95e-01
GOBP NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY	31	6.76e-01	8.30e-01	0.09220	1.16e-02	9.14e-02	9.11e-01	3.78e-01
GOBP POSITIVE REGULATION OF MELANOCYTE DIFFERENTIATION	5	9.47e-01	9.77e-01	0.09220	4.72e-02	7.91e-02	8.55e-01	7.59e-01
GOBP ACTIN FILAMENT BUNDLE ORGANIZATION	163	1.69e-01	3.90e-01	0.09210	8.17e-02	4.26e-02	7.19e-02	3.48e-01
GOMF NUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY	29	7.24e-01	8.59e-01	0.09210	3.90e-02	8.35e-02	7.16e-01	4.37e-01
GOBP CYCLIC NUCLEOTIDE METABOLIC PROCESS	40	5.46e-01	7.44e-01	0.09210	-8.68e-02	3.09e-02	3.42e-01	7.35e-01
GOBP AMINO ACID SALVAGE	7	9.29e-01	9.67e-01	0.09210	5.91e-02	7.05e-02	7.86e-01	7.47e-01
GOBP MYELOID LEUKOCYTE DIFFERENTIATION	231	4.50e-02	1.75e-01	0.09200	-4.13e-03	9.19e-02	9.14e-01	1.61e-02
GOCC PLASMA MEMBRANE REGION	1223	5.73e-06	1.35e-04	0.09200	-6.54e-02	-6.47e-02	1.19e-04	1.40e-04
GOBP LOCALIZATION OF CELL	6	9.12e-01	9.57e-01	0.09200	-8.42e-02	3.69e-02	7.21e-01	8.76e-01
GOBP NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION	23	7.13e-01	8.52e-01	0.09190	-2.39e-02	8.88e-02	8.43e-01	4.61e-01
Disorders of transmembrane transporters	158	9.15e-02	2.74e-01	0.09190	8.53e-02	-3.42e-02	6.41e-02	4.59e-01
GOBP REGULATION OF MITOCHONDRIAL FISSION	30	7.32e-01	8.63e-01	0.09190	6.52e-02	6.47e-02	5.36e-01	5.40e-01
GOMF PROTEIN MEMBRANE ADAPTOR ACTIVITY	40	6.52e-01	8.12e-01	0.09190	4.89e-02	7.78e-02	5.93e-01	3.95e-01
GOBP CYTOPLASMIC MICROTUBULE ORGANIZATION	58	4.98e-01	7.09e-01	0.09180	2.01e-02	8.96e-02	7.91e-01	2.38e-01
GOBP PROTEIN LOCALIZATION TO GOLGI MEMBRANE	5	9.23e-01	9.63e-01	0.09180	6.08e-02	-6.88e-02	8.14e-01	7.90e-01
GOCC CHOLINERGIC SYNAPSE	10	8.77e-01	9.40e-01	0.09180	-9.18e-02	-1.88e-03	6.15e-01	9.92e-01
GOMF STEROL TRANSFER ACTIVITY	24	6.80e-01	8.32e-01	0.09180	6.36e-02	-6.61e-02	5.89e-01	5.75e-01
GOCC COSTAMERE	16	7.85e-01	8.92e-01	0.09180	3.35e-02	-8.54e-02	8.16e-01	5.54e-01
Metabolism of amino acids and derivatives	330	3.31e-02	1.41e-01	0.09170	7.25e-02	5.62e-02	2.36e-02	7.91e-02
GOBP REGULATION OF T CELL MIGRATION	47	6.05e-01	7.82e-01	0.09170	-4.77e-02	-7.83e-02	5.72e-01	3.53e-01
Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation	10	8.53e-01	9.26e-01	0.09170	-7.25e-02	5.62e-02	6.91e-01	7.58e-01
GOBP RESPONSE TO MOLECULE OF BACTERIAL ORIGIN	350	9.01e-03	5.56e-02	0.09170	-9.14e-02	7.39e-03	3.30e-03	8.12e-01
GOBP GLYCINE METABOLIC PROCESS	13	8.70e-01	9.36e-01	0.09170	-4.58e-02	-7.94e-02	7.75e-01	6.20e-01
GOBP POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION	312	3.95e-02	1.61e-01	0.09170	7.37e-02	5.46e-02	2.52e-02	9.75e-02
GOBP UTERUS DEVELOPMENT	25	7.12e-01	8.52e-01	0.09170	9.14e-02	-6.78e-03	4.29e-01	9.53e-01
GOBP MORPHOGENESIS OF A BRANCHING STRUCTURE	200	9.73e-02	2.85e-01	0.09160	2.43e-02	8.84e-02	5.54e-01	3.12e-02
GOMF BETA GLUCOSIDASE ACTIVITY	6	9.09e-01	9.55e-01	0.09160	-6.02e-02	6.91e-02	7.98e-01	7.70e-01
GOBP VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT	62	5.20e-01	7.25e-01	0.09150	5.04e-02	7.64e-02	4.92e-01	2.98e-01
GOBP MONOATOMIC ION TRANSPORT	1183	8.84e-06	1.94e-04	0.09150	-7.03e-02	-5.86e-02	4.59e-05	6.92e-04
GOBP BIOLOGICAL PROCESS INVOLVED IN INTRASPECIES INTERACTION BETWEEN ORGANISMS	49	4.87e-01	7.02e-01	0.09150	-8.77e-02	2.62e-02	2.88e-01	7.51e-01
GOMF NUCLEOBASE CONTAINING COMPOUND KINASE ACTIVITY	41	5.85e-01	7.70e-01	0.09150	9.46e-04	9.15e-02	9.92e-01	3.11e-01
GOBP REGULATION OF PHOSPHOLIPID METABOLIC PROCESS	31	6.31e-01	7.99e-01	0.09150	8.67e-02	-2.91e-02	4.03e-01	7.79e-01
Adenylate cyclase inhibitory pathway	14	8.65e-01	9.34e-01	0.09150	-6.25e-02	-6.67e-02	6.85e-01	6.65e-01
GOBP RESPONSE TO AMINE	50	5.05e-01	7.14e-01	0.09140	-8.96e-03	9.10e-02	9.13e-01	2.66e-01
GOBP REGULATION OF ADENYLATE CYCLASE ACTIVITY	42	5.59e-01	7.52e-01	0.09140	1.22e-02	-9.06e-02	8.91e-01	3.10e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH GROUP OF DONORS NAD OR NADP AS ACCEPTOR	17	7.87e-01	8.92e-01	0.09140	-1.54e-02	9.01e-02	9.13e-01	5.20e-01
GOMF LYSOPHOSPHOLIPASE ACTIVITY	26	6.81e-01	8.33e-01	0.09140	-8.68e-02	2.86e-02	4.43e-01	8.01e-01
GOBP MACROPHAGE MIGRATION	61	4.53e-01	6.79e-01	0.09140	-1.94e-03	-9.14e-02	9.79e-01	2.17e-01
Phospholipid metabolism	200	1.02e-01	2.93e-01	0.09140	8.73e-02	2.70e-02	3.33e-02	5.10e-01
GOBP REGULATION OF LEUKOCYTE MIGRATION	220	3.80e-02	1.56e-01	0.09130	-8.51e-02	3.33e-02	2.97e-02	3.95e-01
GOBP REGULATION OF ICOSANOID SECRETION	21	7.33e-01	8.63e-01	0.09130	-8.65e-02	2.92e-02	4.93e-01	8.17e-01
GOBP REGULATION OF PROTEIN TARGETING TO MEMBRANE	31	6.18e-01	7.90e-01	0.09130	4.61e-02	-7.88e-02	6.57e-01	4.48e-01
GOBP PHENYLPROPANOID METABOLIC PROCESS	6	9.11e-01	9.56e-01	0.09120	-7.73e-02	4.85e-02	7.43e-01	8.37e-01
GOBP REGULATION OF WOUND HEALING	134	2.04e-01	4.34e-01	0.09120	-1.86e-02	-8.93e-02	7.11e-01	7.44e-02
GOBP NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE	43	5.83e-01	7.69e-01	0.09110	-9.08e-02	-7.77e-03	3.03e-01	9.30e-01
GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSPORT	67	3.92e-01	6.25e-01	0.09110	8.96e-02	-1.63e-02	2.04e-01	8.18e-01
GOBP INHIBITORY SYNAPSE ASSEMBLY	23	6.99e-01	8.44e-01	0.09110	7.63e-02	-4.97e-02	5.26e-01	6.80e-01
GOBP REGULATION OF LEUKOCYTE DIFFERENTIATION	322	2.31e-02	1.10e-01	0.09110	1.94e-02	8.90e-02	5.49e-01	6.05e-03
GOMF PROTEIN DISULFIDE ISOMERASE ACTIVITY	21	7.25e-01	8.59e-01	0.09110	-8.03e-02	4.30e-02	5.24e-01	7.33e-01
GOBP CELL SURFACE PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY	79	3.36e-01	5.75e-01	0.09100	-1.35e-02	9.00e-02	8.36e-01	1.66e-01
GOBP POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION	88	3.35e-01	5.74e-01	0.09100	-9.17e-03	-9.06e-02	8.82e-01	1.42e-01
GOBP REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION	73	4.30e-01	6.58e-01	0.09100	-2.38e-02	-8.78e-02	7.25e-01	1.94e-01
GOBP POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION	212	9.03e-02	2.73e-01	0.09100	2.66e-02	8.70e-02	5.04e-01	2.90e-02
GOBP REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS	17	7.65e-01	8.81e-01	0.09100	6.43e-02	-6.44e-02	6.46e-01	6.46e-01
GOMF VOLTAGE GATED CHLORIDE CHANNEL ACTIVITY	9	8.75e-01	9.40e-01	0.09100	3.08e-02	-8.56e-02	8.73e-01	6.57e-01
GOBP PROTEIN IMPORT INTO PEROXISOME MATRIX SUBSTRATE RELEASE	5	9.25e-01	9.64e-01	0.09090	7.16e-02	-5.59e-02	7.82e-01	8.28e-01
GOMF SYNTAXIN BINDING	59	5.02e-01	7.12e-01	0.09080	8.83e-02	2.13e-02	2.41e-01	7.77e-01
GOBP REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY	11	8.43e-01	9.21e-01	0.09080	-5.10e-02	7.52e-02	7.70e-01	6.66e-01
GOBP GLUTAMINE METABOLIC PROCESS	26	7.26e-01	8.60e-01	0.09080	1.03e-02	9.03e-02	9.27e-01	4.26e-01
GOBP MUSCLE ORGAN MORPHOGENESIS	82	4.34e-01	6.62e-01	0.09080	6.76e-02	6.06e-02	2.90e-01	3.43e-01
GOCC NEURON PROJECTION CYTOPLASM	83	4.30e-01	6.58e-01	0.09080	6.10e-02	6.73e-02	3.37e-01	2.89e-01
GOBP SENSORY PERCEPTION OF PAIN	79	3.30e-01	5.70e-01	0.09070	-8.87e-02	1.91e-02	1.73e-01	7.70e-01
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION	463	8.78e-03	5.46e-02	0.09070	7.68e-02	4.83e-02	4.61e-03	7.52e-02
GOBP FATTY ACID HOMEOSTASIS	16	8.01e-01	9.00e-01	0.09070	-8.93e-02	1.60e-02	5.36e-01	9.12e-01
GOBP BRAINSTEM DEVELOPMENT	7	9.18e-01	9.61e-01	0.09070	9.00e-02	1.11e-02	6.80e-01	9.59e-01
FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes	29	7.05e-01	8.47e-01	0.09070	1.40e-02	8.96e-02	8.96e-01	4.04e-01
GOBP ENDOCRINE HORMONE SECRETION	57	4.10e-01	6.42e-01	0.09070	6.22e-02	-6.60e-02	4.17e-01	3.89e-01
GOMF METAL CATION PROTON ANTIPORTER ACTIVITY	23	7.35e-01	8.65e-01	0.09070	-9.03e-02	8.25e-03	4.54e-01	9.45e-01
GOBP NATURAL KILLER CELL PROLIFERATION	14	8.48e-01	9.23e-01	0.09070	-1.96e-02	-8.85e-02	8.99e-01	5.66e-01
GOBP PROTEIN AUTOPHOSPHORYLATION	179	1.12e-01	3.11e-01	0.09060	9.01e-02	9.78e-03	3.76e-02	8.21e-01
GOMF TRANSPORTER ACTIVITY	1173	8.90e-06	1.95e-04	0.09060	-7.79e-02	-4.63e-02	6.99e-06	7.56e-03
GOBP POSITIVE REGULATION OF NUCLEAR DIVISION	61	4.96e-01	7.08e-01	0.09060	8.76e-02	2.29e-02	2.37e-01	7.57e-01
GOBP PROTEIN LOCALIZATION TO PLASMA MEMBRANE	275	6.31e-02	2.17e-01	0.09060	6.94e-02	5.82e-02	4.77e-02	9.67e-02
GOBP CERAMIDE METABOLIC PROCESS	109	2.39e-01	4.77e-01	0.09050	-4.90e-03	9.04e-02	9.30e-01	1.03e-01
GOBP ENDOPLASMIC RETICULUM LOCALIZATION	10	8.58e-01	9.30e-01	0.09040	7.72e-02	-4.71e-02	6.72e-01	7.97e-01
GOMF EXOGENOUS PROTEIN BINDING	79	3.29e-01	5.68e-01	0.09040	8.79e-02	-2.14e-02	1.77e-01	7.42e-01
GOBP REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY	130	2.51e-01	4.89e-01	0.09040	8.13e-02	3.95e-02	1.09e-01	4.37e-01
GOBP GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION	12	8.31e-01	9.15e-01	0.09040	-7.35e-02	5.26e-02	6.59e-01	7.52e-01
GOBP INTRACELLULAR TRANSPORT OF VIRUS	10	9.02e-01	9.52e-01	0.09040	7.52e-02	5.02e-02	6.81e-01	7.83e-01
GOBP MONOATOMIC ION TRANSMEMBRANE TRANSPORT	969	8.23e-05	1.32e-03	0.09040	-7.02e-02	-5.70e-02	2.16e-04	2.68e-03
GOCC PLASMA MEMBRANE PROTEIN COMPLEX	579	2.00e-03	1.75e-02	0.09030	-8.46e-02	-3.14e-02	4.99e-04	1.97e-01
GOBP DGMP METABOLIC PROCESS	6	9.41e-01	9.73e-01	0.09030	-5.45e-02	-7.20e-02	8.17e-01	7.60e-01
GOBP NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS	20	7.38e-01	8.67e-01	0.09020	-7.80e-02	4.53e-02	5.46e-01	7.26e-01
Platelet homeostasis	84	4.20e-01	6.51e-01	0.09020	7.70e-02	4.70e-02	2.22e-01	4.56e-01
Paradoxical activation of RAF signaling by kinase inactive BRAF	42	5.57e-01	7.51e-01	0.09020	8.80e-02	-1.97e-02	3.24e-01	8.25e-01
Signaling by RAS mutants	42	5.57e-01	7.51e-01	0.09020	8.80e-02	-1.97e-02	3.24e-01	8.25e-01
Signaling by moderate kinase activity BRAF mutants	42	5.57e-01	7.51e-01	0.09020	8.80e-02	-1.97e-02	3.24e-01	8.25e-01
Signaling downstream of RAS mutants	42	5.57e-01	7.51e-01	0.09020	8.80e-02	-1.97e-02	3.24e-01	8.25e-01
Negative regulation of TCF-dependent signaling by DVL-interacting proteins	5	9.51e-01	9.78e-01	0.09020	-6.56e-02	-6.19e-02	7.99e-01	8.11e-01
GOCC BRUSH BORDER MEMBRANE	57	5.54e-01	7.49e-01	0.09020	-4.61e-02	-7.75e-02	5.47e-01	3.12e-01
GOBP BONE DEVELOPMENT	205	1.21e-01	3.24e-01	0.09010	7.79e-02	4.53e-02	5.45e-02	2.63e-01
GOBP L LEUCINE TRANSPORT	10	9.02e-01	9.52e-01	0.09010	7.76e-02	4.57e-02	6.71e-01	8.02e-01
GOBP VITAMIN TRANSPORT	50	5.83e-01	7.69e-01	0.09010	-8.31e-02	-3.47e-02	3.09e-01	6.71e-01
GOBP REGULATION OF ACTIN FILAMENT BASED PROCESS	370	9.33e-03	5.69e-02	0.09010	9.01e-02	-1.51e-03	2.92e-03	9.60e-01
GOBP REGULATION OF DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION	10	8.87e-01	9.46e-01	0.09010	8.92e-02	1.29e-02	6.25e-01	9.44e-01
GOMF FAD BINDING	39	6.29e-01	7.96e-01	0.09000	-1.37e-02	-8.90e-02	8.82e-01	3.36e-01
GOBP POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS	12	8.81e-01	9.43e-01	0.09000	-4.07e-02	-8.03e-02	8.07e-01	6.30e-01
GOCC DOPAMINERGIC SYNAPSE	15	7.95e-01	8.97e-01	0.09000	-7.45e-02	5.06e-02	6.17e-01	7.34e-01
GOBP PURINE DEOXYRIBONUCLEOSIDE METABOLIC PROCESS	5	9.33e-01	9.68e-01	0.09000	-2.06e-02	8.76e-02	9.36e-01	7.34e-01
GOBP RENAL PROTEIN ABSORPTION	9	8.90e-01	9.46e-01	0.09000	8.99e-02	-4.56e-03	6.40e-01	9.81e-01
GOBP REGULATION OF EXCITATORY SYNAPSE ASSEMBLY	17	7.99e-01	8.99e-01	0.09000	-8.97e-02	8.06e-03	5.22e-01	9.54e-01
GOBP POSITIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION	17	7.81e-01	8.90e-01	0.09000	-3.26e-02	8.39e-02	8.16e-01	5.49e-01
GOBP POSITIVE REGULATION OF JUN KINASE ACTIVITY	28	7.55e-01	8.75e-01	0.09000	6.81e-02	5.88e-02	5.33e-01	5.90e-01
Protein-protein interactions at synapses	78	4.59e-01	6.83e-01	0.09000	-6.78e-02	-5.91e-02	3.00e-01	3.67e-01
GOBP ADHESION OF SYMBIONT TO HOST	12	8.40e-01	9.20e-01	0.08980	-8.38e-02	3.23e-02	6.15e-01	8.47e-01
NADE modulates death signalling	5	9.28e-01	9.67e-01	0.08980	-7.94e-02	4.19e-02	7.58e-01	8.71e-01
GOBP IMP METABOLIC PROCESS	17	7.80e-01	8.90e-01	0.08970	3.54e-02	-8.25e-02	8.01e-01	5.56e-01
Prolactin receptor signaling	14	8.11e-01	9.05e-01	0.08970	4.56e-02	-7.72e-02	7.68e-01	6.17e-01
GOBP REGULATION OF ANATOMICAL STRUCTURE SIZE	476	4.69e-03	3.38e-02	0.08960	8.76e-02	1.90e-02	1.06e-03	4.78e-01
GOBP TELENCEPHALON GLIAL CELL MIGRATION	26	7.47e-01	8.70e-01	0.08960	8.64e-02	2.37e-02	4.46e-01	8.34e-01
GOBP CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS	37	6.92e-01	8.40e-01	0.08960	5.71e-02	6.90e-02	5.47e-01	4.68e-01
GOBP NON CANONICAL WNT SIGNALING PATHWAY	69	4.85e-01	6.99e-01	0.08960	8.10e-02	3.84e-02	2.45e-01	5.81e-01
GOBP RENAL SYSTEM DEVELOPMENT	322	3.73e-02	1.54e-01	0.08960	7.89e-02	4.25e-02	1.50e-02	1.90e-01
GOBP POSITIVE REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY	5	9.49e-01	9.77e-01	0.08960	-8.14e-02	-3.74e-02	7.53e-01	8.85e-01
GOBP AMMONIUM TRANSMEMBRANE TRANSPORT	13	8.33e-01	9.17e-01	0.08940	-8.58e-02	2.54e-02	5.92e-01	8.74e-01
Cytokine Signaling in Immune system	723	4.07e-04	5.05e-03	0.08940	2.43e-02	8.61e-02	2.65e-01	8.09e-05
GOCC ENDOCYTIC VESICLE	329	4.06e-02	1.64e-01	0.08940	6.18e-02	6.46e-02	5.39e-02	4.39e-02
GOBP NEGATIVE REGULATION OF PLATELET ACTIVATION	18	7.89e-01	8.93e-01	0.08940	-8.89e-02	9.87e-03	5.14e-01	9.42e-01
Signaling by GPCR	674	1.09e-03	1.12e-02	0.08940	-8.04e-02	-3.92e-02	3.74e-04	8.30e-02
GOBP DIAPHRAGM DEVELOPMENT	9	9.13e-01	9.58e-01	0.08930	-7.42e-02	-4.98e-02	7.00e-01	7.96e-01
GOBP POSITIVE REGULATION OF T CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL	5	9.44e-01	9.75e-01	0.08930	-1.77e-02	-8.76e-02	9.45e-01	7.35e-01
GOBP NECROPTOTIC PROCESS	45	6.42e-01	8.05e-01	0.08930	6.56e-02	6.06e-02	4.46e-01	4.82e-01
GOCC PODOSOME	33	6.07e-01	7.83e-01	0.08920	6.74e-02	-5.85e-02	5.03e-01	5.61e-01
FGFR1 ligand binding and activation	17	7.83e-01	8.90e-01	0.08920	8.24e-02	-3.41e-02	5.56e-01	8.08e-01
GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION	106	2.45e-01	4.84e-01	0.08920	-1.36e-02	8.82e-02	8.09e-01	1.17e-01
Ca-dependent events	36	6.98e-01	8.43e-01	0.08920	-7.35e-02	-5.06e-02	4.45e-01	6.00e-01
GOBP REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS	115	2.40e-01	4.77e-01	0.08920	8.92e-02	2.16e-04	9.85e-02	9.97e-01
GOMF ALCOHOL DEHYDROGENASE NADPPLUS ACTIVITY	23	7.06e-01	8.48e-01	0.08910	-6.48e-02	6.11e-02	5.91e-01	6.12e-01
GOBP INTERFERON ALPHA PRODUCTION	27	7.28e-01	8.61e-01	0.08910	-8.83e-02	-1.20e-02	4.27e-01	9.14e-01
GOMF EXTRACELLULAR MATRIX BINDING	63	4.29e-01	6.58e-01	0.08910	1.69e-02	-8.74e-02	8.17e-01	2.30e-01
GOBP OTIC VESICLE MORPHOGENESIS	10	8.91e-01	9.47e-01	0.08900	8.77e-02	1.50e-02	6.31e-01	9.35e-01
GOBP RECEPTOR METABOLIC PROCESS	69	4.91e-01	7.04e-01	0.08900	7.97e-02	3.96e-02	2.52e-01	5.70e-01
GOBP POSITIVE REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT	8	8.91e-01	9.48e-01	0.08900	3.50e-02	-8.18e-02	8.64e-01	6.89e-01
GOBP EPITHELIAL CELL DEVELOPMENT	211	1.06e-01	3.00e-01	0.08900	2.98e-02	8.38e-02	4.56e-01	3.58e-02
GOBP LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE	52	4.58e-01	6.82e-01	0.08890	-5.84e-02	6.71e-02	4.66e-01	4.03e-01
GOCC TRANSPORT VESICLE MEMBRANE	232	8.50e-02	2.62e-01	0.08890	3.00e-02	8.37e-02	4.32e-01	2.80e-02
GOBP APOPTOTIC CELL CLEARANCE	47	5.91e-01	7.73e-01	0.08890	-8.64e-02	-2.10e-02	3.06e-01	8.03e-01
GOCC CATION TRANSPORTING ATPASE COMPLEX	18	7.91e-01	8.94e-01	0.08890	9.85e-03	-8.84e-02	9.42e-01	5.16e-01
GOBP FLOOR PLATE DEVELOPMENT	11	8.48e-01	9.23e-01	0.08890	7.00e-02	-5.47e-02	6.88e-01	7.53e-01
GOBP NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS	28	7.12e-01	8.52e-01	0.08880	-4.17e-03	-8.87e-02	9.70e-01	4.16e-01
GOBP AMELOBLAST DIFFERENTIATION	5	9.32e-01	9.68e-01	0.08880	-3.10e-02	8.32e-02	9.04e-01	7.47e-01
GOBP REGULATION OF CARTILAGE DEVELOPMENT	71	4.66e-01	6.88e-01	0.08880	8.42e-02	2.80e-02	2.20e-01	6.83e-01
GOBP NEGATIVE REGULATION OF COAGULATION	53	5.75e-01	7.65e-01	0.08880	-3.54e-02	-8.14e-02	6.56e-01	3.05e-01
GOBP REGULATION OF BLOOD VESSEL REMODELING	12	8.84e-01	9.44e-01	0.08880	-7.94e-02	-3.97e-02	6.34e-01	8.12e-01
GOMF QUATERNARY AMMONIUM GROUP BINDING	37	5.90e-01	7.73e-01	0.08880	8.18e-02	-3.44e-02	3.89e-01	7.17e-01
GOBP PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS	50	5.63e-01	7.55e-01	0.08870	8.75e-02	1.44e-02	2.84e-01	8.60e-01
GOBP NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION	170	1.80e-01	4.04e-01	0.08870	4.15e-02	7.84e-02	3.51e-01	7.78e-02
Leishmania infection	155	1.56e-01	3.73e-01	0.08870	5.02e-03	8.86e-02	9.14e-01	5.71e-02
Parasitic Infection Pathways	155	1.56e-01	3.73e-01	0.08870	5.02e-03	8.86e-02	9.14e-01	5.71e-02
GOBP POSITIVE REGULATION OF GLUCOSE IMPORT	35	6.92e-01	8.40e-01	0.08860	8.24e-02	3.26e-02	3.99e-01	7.39e-01
GOCC EXOCYST	16	7.93e-01	8.95e-01	0.08850	-4.22e-02	7.78e-02	7.70e-01	5.90e-01
GOBP MALE MEIOSIS I	28	6.60e-01	8.19e-01	0.08850	7.10e-02	-5.28e-02	5.16e-01	6.28e-01
GOMF PHOSPHATIDYLINOSITOL 4 PHOSPHATE BINDING	29	6.70e-01	8.25e-01	0.08850	2.69e-02	-8.43e-02	8.02e-01	4.32e-01
GOBP NEGATIVE REGULATION OF VIRAL LIFE CYCLE	27	6.76e-01	8.30e-01	0.08840	-4.21e-02	7.78e-02	7.05e-01	4.84e-01
GOBP REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND	44	6.53e-01	8.13e-01	0.08840	6.69e-02	5.79e-02	4.43e-01	5.07e-01
GOBP PROSTANOID METABOLIC PROCESS	50	5.27e-01	7.31e-01	0.08840	9.50e-03	-8.79e-02	9.07e-01	2.82e-01
GOBP POSITIVE REGULATION OF TRANSPORTER ACTIVITY	82	4.55e-01	6.80e-01	0.08840	6.20e-02	6.30e-02	3.32e-01	3.24e-01
GOCC TERMINAL BOUTON	44	6.00e-01	7.79e-01	0.08830	-1.08e-02	-8.77e-02	9.01e-01	3.14e-01
TNFs bind their physiological receptors	25	7.60e-01	8.78e-01	0.08830	-8.55e-02	-2.22e-02	4.59e-01	8.48e-01
GOBP NEGATIVE REGULATION OF LOW DENSITY LIPOPROTEIN RECEPTOR ACTIVITY	8	8.97e-01	9.50e-01	0.08830	-8.50e-02	2.37e-02	6.77e-01	9.07e-01
GOMF SNRNP BINDING	9	9.09e-01	9.55e-01	0.08820	8.36e-02	2.82e-02	6.64e-01	8.83e-01
GOMF PROTEIN TYROSINE KINASE ACTIVATOR ACTIVITY	31	7.23e-01	8.58e-01	0.08820	-3.18e-02	-8.23e-02	7.59e-01	4.28e-01
GOCC POSTSYNAPTIC SPECIALIZATION	335	3.00e-02	1.32e-01	0.08810	-2.78e-02	-8.36e-02	3.82e-01	8.56e-03
GOBP ALANINE TRANSPORT	16	8.03e-01	9.01e-01	0.08800	-2.77e-02	8.36e-02	8.48e-01	5.63e-01
GOMF OLIGOPEPTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY	14	8.16e-01	9.07e-01	0.08800	-4.66e-02	7.47e-02	7.63e-01	6.29e-01
GOBP PIGMENT BIOSYNTHETIC PROCESS	51	5.86e-01	7.71e-01	0.08800	3.02e-02	8.27e-02	7.09e-01	3.07e-01
GOMF ATPASE COUPLED MONOATOMIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY	52	4.74e-01	6.94e-01	0.08800	7.68e-02	-4.31e-02	3.38e-01	5.91e-01
GOCC VACUOLE	817	2.97e-04	3.88e-03	0.08800	3.38e-02	8.12e-02	1.00e-01	7.92e-05
GOMF SHORT CHAIN FATTY ACYL COA DEHYDROGENASE ACTIVITY	5	9.52e-01	9.79e-01	0.08800	4.80e-02	7.37e-02	8.53e-01	7.75e-01
GOBP NEGATIVE REGULATION OF CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY	51	5.46e-01	7.44e-01	0.08790	4.60e-03	8.78e-02	9.55e-01	2.78e-01
GOBP REGULATION OF T CELL ACTIVATION	374	7.42e-03	4.78e-02	0.08790	-2.06e-02	8.55e-02	4.93e-01	4.54e-03
GOBP NEGATIVE REGULATION OF VIRAL GENOME REPLICATION	54	5.59e-01	7.52e-01	0.08790	2.36e-02	8.47e-02	7.64e-01	2.82e-01
GOBP TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY	113	3.02e-01	5.41e-01	0.08790	2.63e-02	8.39e-02	6.29e-01	1.24e-01
GOCC NUCLEOLUS	1319	1.75e-06	4.77e-05	0.08790	8.40e-02	2.58e-02	2.96e-07	1.16e-01
GOBP REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION	101	3.76e-01	6.12e-01	0.08790	7.26e-02	4.95e-02	2.07e-01	3.90e-01
GOBP MOTOR NEURON MIGRATION	13	8.67e-01	9.35e-01	0.08790	2.01e-02	8.56e-02	9.00e-01	5.93e-01
GOBP REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE	104	3.30e-01	5.70e-01	0.08780	8.41e-02	2.51e-02	1.38e-01	6.59e-01
GOBP PHENOL CONTAINING COMPOUND METABOLIC PROCESS	106	2.12e-01	4.44e-01	0.08780	-6.56e-02	5.83e-02	2.43e-01	2.99e-01
GOBP NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT	133	2.82e-01	5.20e-01	0.08770	5.33e-02	6.96e-02	2.88e-01	1.66e-01
GOBP POSITIVE REGULATION OF VASOCONSTRICTION	31	7.45e-01	8.70e-01	0.08770	-5.72e-02	-6.65e-02	5.82e-01	5.22e-01
GOBP PROTEOLYSIS	1529	1.05e-06	3.05e-05	0.08760	7.28e-02	4.88e-02	2.00e-06	1.44e-03
GOBP CELL ADHESION MEDIATED BY INTEGRIN	87	3.19e-01	5.57e-01	0.08760	8.53e-02	-1.98e-02	1.69e-01	7.50e-01
GOBP REGULATION OF PRESYNAPSE ORGANIZATION	30	7.43e-01	8.69e-01	0.08750	7.77e-02	4.03e-02	4.61e-01	7.03e-01
GOBP REGULATION OF TYPE 2 IMMUNE RESPONSE	34	6.22e-01	7.93e-01	0.08750	-3.64e-02	7.96e-02	7.14e-01	4.22e-01
GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION	30	7.13e-01	8.52e-01	0.08740	1.23e-02	8.66e-02	9.07e-01	4.12e-01
GOBP VASCULOGENESIS INVOLVED IN CORONARY VASCULAR MORPHOGENESIS	5	9.53e-01	9.79e-01	0.08740	4.99e-02	7.18e-02	8.47e-01	7.81e-01
GOBP NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION	53	5.87e-01	7.71e-01	0.08730	3.58e-02	7.96e-02	6.52e-01	3.16e-01
GOBP POSITIVE REGULATION OF PROTEIN DEUBIQUITINATION	5	9.31e-01	9.68e-01	0.08730	4.91e-02	-7.22e-02	8.49e-01	7.80e-01
GOMF PHOSPHATIDYLINOSITOL BINDING	263	4.22e-02	1.68e-01	0.08730	8.72e-02	-3.52e-03	1.49e-02	9.22e-01
GOBP NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION	71	4.99e-01	7.09e-01	0.08720	-4.13e-02	-7.69e-02	5.48e-01	2.63e-01
GOBP LENS FIBER CELL DEVELOPMENT	14	8.39e-01	9.19e-01	0.08720	-8.66e-02	1.04e-02	5.75e-01	9.46e-01
GOBP POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY	207	1.38e-01	3.49e-01	0.08720	4.59e-02	7.41e-02	2.54e-01	6.61e-02
GOBP PROTEIN COMPLEX OLIGOMERIZATION	256	8.77e-02	2.68e-01	0.08720	7.34e-02	4.70e-02	4.32e-02	1.95e-01
GOBP NEUROMUSCULAR PROCESS	163	9.95e-02	2.89e-01	0.08710	4.77e-02	-7.29e-02	2.93e-01	1.08e-01
Hyaluronan biosynthesis and export	5	9.41e-01	9.73e-01	0.08700	4.17e-03	-8.69e-02	9.87e-01	7.36e-01
GOBP NEGATIVE REGULATION OF CHOLESTEROL METABOLIC PROCESS	10	8.98e-01	9.50e-01	0.08700	1.97e-02	8.48e-02	9.14e-01	6.42e-01
GOBP RESPONSE TO ORGANOPHOSPHORUS	123	3.03e-01	5.43e-01	0.08700	7.64e-02	4.18e-02	1.44e-01	4.24e-01
GOBP STEROID METABOLIC PROCESS	315	5.19e-02	1.92e-01	0.08700	-4.91e-02	-7.19e-02	1.34e-01	2.83e-02
GOBP NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY	23	7.18e-01	8.55e-01	0.08700	5.95e-02	-6.35e-02	6.21e-01	5.98e-01
GOBP INTRACELLULAR GLUCOSE HOMEOSTASIS	161	2.09e-01	4.41e-01	0.08690	7.71e-02	4.02e-02	9.13e-02	3.79e-01
GOBP T CELL ACTIVATION	551	1.09e-03	1.13e-02	0.08690	-1.40e-02	8.58e-02	5.75e-01	5.71e-04
Diseases of metabolism	250	9.49e-02	2.81e-01	0.08690	-4.83e-02	-7.23e-02	1.89e-01	4.90e-02
GOBP REGULATION OF MEMBRANE POTENTIAL	445	1.70e-02	8.83e-02	0.08690	-6.51e-02	-5.75e-02	1.85e-02	3.74e-02
GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS	24	7.88e-01	8.92e-01	0.08690	3.59e-02	7.91e-02	7.61e-01	5.02e-01
GOBP SUPEROXIDE METABOLIC PROCESS	64	4.17e-01	6.48e-01	0.08690	-3.40e-02	8.00e-02	6.38e-01	2.69e-01
GOBP SYNAPTIC VESICLE UNCOATING	7	9.07e-01	9.55e-01	0.08690	7.73e-02	-3.97e-02	7.23e-01	8.56e-01
GOBP PEPTIDYL L CYSTEINE S PALMITOYLATION	20	8.17e-01	9.08e-01	0.08680	-8.07e-02	-3.19e-02	5.32e-01	8.05e-01
GOBP RESPIRATORY SYSTEM DEVELOPMENT	217	9.41e-02	2.79e-01	0.08670	8.55e-02	1.44e-02	2.99e-02	7.14e-01
GOBP REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION	1767	2.74e-07	9.09e-06	0.08670	6.00e-02	6.27e-02	2.82e-05	1.22e-05
GOBP GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE	22	7.57e-01	8.76e-01	0.08670	-8.55e-02	1.48e-02	4.88e-01	9.04e-01
GOCC CILIARY PLASM	178	1.08e-01	3.04e-01	0.08660	8.55e-02	-1.41e-02	4.92e-02	7.46e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PEROXIDE AS ACCEPTOR	56	5.17e-01	7.22e-01	0.08660	-7.79e-04	8.66e-02	9.92e-01	2.63e-01
GOCC CAMP DEPENDENT PROTEIN KINASE COMPLEX	7	9.28e-01	9.67e-01	0.08660	8.44e-02	1.93e-02	6.99e-01	9.29e-01
Late SARS-CoV-2 Infection Events	67	4.96e-01	7.08e-01	0.08650	2.26e-02	8.35e-02	7.49e-01	2.37e-01
GOCC CLUSTER OF ACTIN BASED CELL PROJECTIONS	161	2.27e-01	4.61e-01	0.08650	-5.66e-02	-6.55e-02	2.16e-01	1.52e-01
GOMF CYTOSKELETON NUCLEAR MEMBRANE ANCHOR ACTIVITY	5	9.52e-01	9.79e-01	0.08650	7.87e-02	3.57e-02	7.60e-01	8.90e-01
GOBP POSITIVE REGULATION OF DEPHOSPHORYLATION	51	5.25e-01	7.29e-01	0.08650	8.50e-02	-1.56e-02	2.93e-01	8.47e-01
GOBP CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION	35	7.12e-01	8.52e-01	0.08640	7.69e-02	3.93e-02	4.31e-01	6.87e-01
GOBP THALAMUS DEVELOPMENT	11	8.81e-01	9.43e-01	0.08640	4.18e-03	8.63e-02	9.81e-01	6.20e-01
GOBP REGULATION OF CILIUM DEPENDENT CELL MOTILITY	29	6.99e-01	8.44e-01	0.08630	1.12e-02	-8.55e-02	9.17e-01	4.25e-01
Nicotinate metabolism	31	7.05e-01	8.48e-01	0.08630	-7.36e-03	-8.60e-02	9.43e-01	4.08e-01
GOBP REGULATION OF CELLULAR LOCALIZATION	947	1.26e-04	1.87e-03	0.08630	7.95e-02	3.34e-02	3.38e-05	8.12e-02
GOBP PLATELET AGGREGATION	74	3.87e-01	6.21e-01	0.08620	-2.09e-02	8.37e-02	7.56e-01	2.13e-01
GOBP RESPONSE TO NITROGEN COMPOUND	1055	9.92e-05	1.54e-03	0.08620	6.21e-02	5.97e-02	6.51e-04	1.04e-03
GOBP NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS	413	1.10e-02	6.44e-02	0.08610	-8.56e-02	-9.03e-03	2.84e-03	7.53e-01
GOBP REGULATION OF NEUROTRANSMITTER SECRETION	78	3.63e-01	6.00e-01	0.08610	-8.22e-02	2.55e-02	2.09e-01	6.97e-01
GOBP REGULATION OF RESPONSE TO CYTOKINE STIMULUS	186	1.84e-01	4.10e-01	0.08600	5.57e-02	6.55e-02	1.90e-01	1.23e-01
GOMF GAMMA CATENIN BINDING	12	8.50e-01	9.25e-01	0.08600	-7.73e-02	3.77e-02	6.43e-01	8.21e-01
GOBP MECHANORECEPTOR DIFFERENTIATION	70	4.32e-01	6.59e-01	0.08590	-8.56e-02	7.40e-03	2.15e-01	9.15e-01
GOBP PURINE NUCLEOBASE BIOSYNTHETIC PROCESS	8	9.11e-01	9.56e-01	0.08580	9.81e-04	-8.58e-02	9.96e-01	6.74e-01
GOBP PROTEIN LOCALIZATION TO CELL PERIPHERY	333	5.03e-02	1.89e-01	0.08580	6.43e-02	5.68e-02	4.36e-02	7.49e-02
GOMF LYASE ACTIVITY	191	1.72e-01	3.94e-01	0.08580	7.15e-02	4.74e-02	8.83e-02	2.59e-01
GOBP BILE ACID BIOSYNTHETIC PROCESS	37	6.35e-01	8.01e-01	0.08580	1.29e-02	-8.48e-02	8.92e-01	3.72e-01
GOBP REGULATION OF LONG TERM SYNAPTIC POTENTIATION	47	6.05e-01	7.82e-01	0.08580	-1.48e-02	-8.45e-02	8.61e-01	3.16e-01
GOBP POSITIVE REGULATION OF VASCULATURE DEVELOPMENT	188	1.22e-01	3.25e-01	0.08570	4.40e-03	8.56e-02	9.17e-01	4.30e-02
GOMF TRANSFERASE ACTIVITY TRANSFERRING NITROGENOUS GROUPS	27	6.86e-01	8.36e-01	0.08570	-6.22e-02	5.89e-02	5.76e-01	5.96e-01
GOBP REGULATION OF HEAT GENERATION	13	8.89e-01	9.46e-01	0.08560	-6.13e-02	-5.97e-02	7.02e-01	7.09e-01
GOBP ICOSANOID BIOSYNTHETIC PROCESS	55	5.82e-01	7.68e-01	0.08550	-3.01e-02	-8.01e-02	6.99e-01	3.04e-01
GOCC POSTSYNAPTIC ENDOSOME	13	8.34e-01	9.17e-01	0.08550	5.61e-02	-6.46e-02	7.26e-01	6.87e-01
GOBP NEGATIVE REGULATION OF LIPASE ACTIVITY	13	8.39e-01	9.19e-01	0.08550	7.56e-02	-4.00e-02	6.37e-01	8.03e-01
GOBP ECTODERMAL PLACODE DEVELOPMENT	13	8.84e-01	9.44e-01	0.08550	3.82e-02	7.65e-02	8.12e-01	6.33e-01
GOBP ENDOTHELIAL CELL DEVELOPMENT	65	5.23e-01	7.27e-01	0.08550	2.75e-02	8.10e-02	7.01e-01	2.59e-01
TP53 Regulates Transcription of Genes Involved in Cytochrome C Release	20	8.35e-01	9.17e-01	0.08550	6.31e-02	5.77e-02	6.25e-01	6.55e-01
GOBP REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL	28	7.43e-01	8.69e-01	0.08550	-1.54e-02	-8.41e-02	8.88e-01	4.41e-01
GOBP BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS	22	7.72e-01	8.85e-01	0.08550	5.44e-03	-8.53e-02	9.65e-01	4.89e-01
GOMF CYTOKINE RECEPTOR BINDING	254	6.73e-02	2.26e-01	0.08540	-8.45e-02	-1.28e-02	2.04e-02	7.26e-01
GOBP VERY LONG CHAIN FATTY ACID METABOLIC PROCESS	34	6.97e-01	8.42e-01	0.08540	-8.42e-02	-1.44e-02	3.96e-01	8.85e-01
GOBP EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT	47	5.31e-01	7.34e-01	0.08530	7.53e-02	-4.02e-02	3.72e-01	6.33e-01
GOBP NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS	66	4.05e-01	6.38e-01	0.08530	7.01e-02	-4.86e-02	3.25e-01	4.95e-01
GOBP RENAL WATER TRANSPORT	9	8.87e-01	9.46e-01	0.08530	-7.70e-02	3.68e-02	6.89e-01	8.48e-01
GOBP SMALL MOLECULE CATABOLIC PROCESS	364	3.52e-02	1.48e-01	0.08530	4.19e-02	7.43e-02	1.69e-01	1.49e-02
GOBP NEGATIVE REGULATION OF MONOATOMIC ION TRANSPORT	123	2.00e-01	4.30e-01	0.08530	7.87e-02	-3.29e-02	1.32e-01	5.29e-01
GOBP CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS	633	3.73e-03	2.84e-02	0.08530	5.04e-02	6.88e-02	3.05e-02	3.14e-03
GOCC FILOPODIUM TIP	18	8.43e-01	9.21e-01	0.08520	-7.69e-02	-3.67e-02	5.72e-01	7.87e-01
GOBP TISSUE REGENERATION	79	3.40e-01	5.78e-01	0.08520	4.89e-02	-6.98e-02	4.52e-01	2.84e-01
GOBP REGULATION OF POTASSIUM ION TRANSPORT	97	2.75e-01	5.15e-01	0.08520	3.79e-02	-7.63e-02	5.19e-01	1.94e-01
GOBP NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT	13	8.46e-01	9.22e-01	0.08520	-8.05e-02	2.79e-02	6.15e-01	8.62e-01
Immune System	1913	6.33e-10	3.48e-08	0.08510	-1.30e-02	8.41e-02	3.48e-01	1.13e-09
GOBP REGULATION OF KINASE ACTIVITY	503	9.44e-03	5.74e-02	0.08500	3.62e-02	7.69e-02	1.64e-01	3.15e-03
Signaling by high-kinase activity BRAF mutants	34	6.40e-01	8.04e-01	0.08500	7.79e-02	-3.39e-02	4.32e-01	7.32e-01
GOBP APICAL PROTEIN LOCALIZATION	14	8.56e-01	9.28e-01	0.08490	-4.01e-03	-8.49e-02	9.79e-01	5.83e-01
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE	20	8.15e-01	9.07e-01	0.08490	1.99e-02	8.26e-02	8.78e-01	5.23e-01
GOBP POSITIVE REGULATION OF PROTEIN TRANSPORT	241	1.15e-01	3.14e-01	0.08490	4.77e-02	7.03e-02	2.03e-01	6.01e-02
GOBP CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC	111	3.57e-01	5.94e-01	0.08490	-7.49e-02	-4.00e-02	1.73e-01	4.66e-01
GOBP SEMICIRCULAR CANAL MORPHOGENESIS	7	9.36e-01	9.71e-01	0.08490	7.59e-02	3.81e-02	7.28e-01	8.61e-01
GOMF CARBOHYDRATE KINASE ACTIVITY	20	8.22e-01	9.10e-01	0.08480	8.00e-02	2.81e-02	5.35e-01	8.28e-01
GOBP REGULATION OF EPITHELIAL CELL PROLIFERATION	396	2.48e-02	1.16e-01	0.08480	3.45e-02	7.75e-02	2.38e-01	8.15e-03
Gap junction trafficking	46	5.49e-01	7.45e-01	0.08470	-7.74e-02	3.44e-02	3.64e-01	6.87e-01
Inhibition of Signaling by Overexpressed EGFR	8	8.98e-01	9.50e-01	0.08470	7.19e-02	-4.47e-02	7.25e-01	8.27e-01
Signaling by Overexpressed Wild-Type EGFR in Cancer	8	8.98e-01	9.50e-01	0.08470	7.19e-02	-4.47e-02	7.25e-01	8.27e-01
Diseases associated with glycosylation precursor biosynthesis	15	8.20e-01	9.09e-01	0.08460	3.83e-02	-7.55e-02	7.97e-01	6.13e-01
GOBP POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY	30	7.47e-01	8.70e-01	0.08450	7.97e-02	2.82e-02	4.50e-01	7.89e-01
Peptide ligand-binding receptors	188	1.86e-01	4.12e-01	0.08450	-4.67e-02	-7.04e-02	2.69e-01	9.58e-02
GOCC ADHERENS JUNCTION	179	9.36e-02	2.78e-01	0.08450	4.31e-02	-7.27e-02	3.20e-01	9.34e-02
GOBP ATRIAL CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION	9	8.85e-01	9.45e-01	0.08450	6.78e-02	-5.04e-02	7.25e-01	7.93e-01
GOBP NEGATIVE REGULATION OF MOLECULAR FUNCTION	696	2.49e-03	2.10e-02	0.08440	5.12e-02	6.72e-02	2.14e-02	2.52e-03
Interleukin receptor SHC signaling	23	7.36e-01	8.65e-01	0.08440	-7.12e-02	4.53e-02	5.54e-01	7.07e-01
GOMF HEXOSAMINIDASE ACTIVITY	15	8.42e-01	9.20e-01	0.08440	8.42e-02	-5.55e-03	5.72e-01	9.70e-01
GOBP POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS	1179	5.35e-05	9.17e-04	0.08440	6.37e-02	5.53e-02	2.30e-04	1.37e-03
GOMF NUCLEOSIDE TRIPHOSPHATASE REGULATOR ACTIVITY	450	1.02e-02	6.09e-02	0.08430	8.32e-02	1.39e-02	2.50e-03	6.14e-01
GOBP GLYCEROLIPID METABOLIC PROCESS	381	2.00e-02	9.97e-02	0.08430	8.33e-02	1.29e-02	5.24e-03	6.64e-01
GOBP NEGATIVE REGULATION OF CATALYTIC ACTIVITY	420	2.59e-02	1.19e-01	0.08430	5.06e-02	6.74e-02	7.50e-02	1.78e-02
GOBP POSITIVE REGULATION OF MEIOTIC CELL CYCLE	28	7.41e-01	8.68e-01	0.08430	8.39e-02	7.66e-03	4.42e-01	9.44e-01
Activation of GABAB receptors	43	5.94e-01	7.75e-01	0.08420	1.78e-02	-8.23e-02	8.40e-01	3.51e-01
GABA B receptor activation	43	5.94e-01	7.75e-01	0.08420	1.78e-02	-8.23e-02	8.40e-01	3.51e-01
GOMF CCR3 CHEMOKINE RECEPTOR BINDING	5	9.44e-01	9.75e-01	0.08410	-8.38e-02	7.64e-03	7.46e-01	9.76e-01
GOBP NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION	14	8.47e-01	9.23e-01	0.08410	-1.36e-02	8.30e-02	9.30e-01	5.91e-01
GOBP POSITIVE REGULATION OF GENE EXPRESSION	1145	3.64e-05	6.71e-04	0.08410	3.25e-02	7.75e-02	6.35e-02	9.65e-06
GOBP REGULATION OF CARDIAC CONDUCTION	26	7.68e-01	8.83e-01	0.08410	-1.75e-02	-8.22e-02	8.77e-01	4.68e-01
GOBP AMIDE METABOLIC PROCESS	435	2.15e-02	1.05e-01	0.08400	4.32e-02	7.21e-02	1.22e-01	9.97e-03
GOMF NADP BINDING	51	5.80e-01	7.67e-01	0.08400	8.37e-02	6.86e-03	3.01e-01	9.32e-01
GOBP POSITIVE REGULATION OF CELL CELL ADHESION	318	2.05e-02	1.01e-01	0.08390	-2.48e-02	8.02e-02	4.47e-01	1.40e-02
GOBP LUNG ALVEOLUS DEVELOPMENT	52	4.98e-01	7.09e-01	0.08390	6.01e-02	-5.85e-02	4.54e-01	4.65e-01
GOBP HYDROGEN PEROXIDE METABOLIC PROCESS	50	5.60e-01	7.53e-01	0.08390	-8.32e-02	1.03e-02	3.09e-01	9.00e-01
PIWI-interacting RNA (piRNA) biogenesis	29	7.76e-01	8.87e-01	0.08380	5.14e-02	6.62e-02	6.32e-01	5.37e-01
GOCC AZUROPHIL GRANULE	149	1.39e-01	3.50e-01	0.08380	-6.60e-02	5.17e-02	1.65e-01	2.76e-01
GOMF SERINE TYPE EXOPEPTIDASE ACTIVITY	12	8.63e-01	9.33e-01	0.08380	2.29e-02	-8.06e-02	8.91e-01	6.29e-01
GOBP WALKING BEHAVIOR	35	6.54e-01	8.13e-01	0.08380	-2.04e-02	8.12e-02	8.35e-01	4.06e-01
GOMF SNARE BINDING	103	3.68e-01	6.05e-01	0.08380	8.03e-02	2.39e-02	1.59e-01	6.76e-01
GOBP CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS	9	9.03e-01	9.53e-01	0.08380	4.79e-03	-8.36e-02	9.80e-01	6.64e-01
GOCC MCM COMPLEX	11	8.82e-01	9.43e-01	0.08380	8.35e-02	-6.69e-03	6.32e-01	9.69e-01
VxPx cargo-targeting to cilium	20	7.67e-01	8.82e-01	0.08370	6.71e-02	-5.00e-02	6.03e-01	6.99e-01
GOBP ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY	79	4.51e-01	6.76e-01	0.08370	-8.21e-02	-1.60e-02	2.07e-01	8.06e-01
GOBP NEGATIVE REGULATION OF PHOSPHOLIPASE ACTIVITY	5	9.45e-01	9.76e-01	0.08370	8.34e-02	-6.09e-03	7.47e-01	9.81e-01
GOMF KINASE ACTIVITY	706	1.36e-03	1.32e-02	0.08360	7.98e-02	2.50e-02	3.02e-04	2.57e-01
GOMF 1 PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE 3 KINASE ACTIVITY	7	9.24e-01	9.64e-01	0.08360	-4.41e-03	8.35e-02	9.84e-01	7.02e-01
GOBP EPITHELIAL CELL PROLIFERATION INVOLVED IN SALIVARY GLAND MORPHOGENESIS	5	9.38e-01	9.72e-01	0.08360	7.64e-02	-3.40e-02	7.67e-01	8.95e-01
GOBP REGULATION OF THE FORCE OF HEART CONTRACTION BY CHEMICAL SIGNAL	6	9.48e-01	9.77e-01	0.08360	7.22e-02	4.22e-02	7.59e-01	8.58e-01
GOBP NEUROTRANSMITTER TRANSPORT	200	1.72e-01	3.94e-01	0.08360	-7.13e-02	-4.37e-02	8.23e-02	2.86e-01
GOBP GRANULOCYTE CHEMOTAXIS	121	3.38e-01	5.77e-01	0.08360	-3.98e-02	-7.35e-02	4.49e-01	1.63e-01
GOBP CALCIUM ION HOMEOSTASIS	318	6.44e-02	2.20e-01	0.08360	-4.89e-02	-6.78e-02	1.34e-01	3.77e-02
GOBP MEMORY	122	3.39e-01	5.77e-01	0.08360	-7.20e-02	-4.25e-02	1.70e-01	4.18e-01
GOBP REGULATION OF PROTEIN KINASE C SIGNALING	18	8.41e-01	9.20e-01	0.08360	-7.95e-02	-2.56e-02	5.59e-01	8.51e-01
Defective binding of VWF variant to GPIb:IX:V	7	9.41e-01	9.73e-01	0.08360	5.12e-02	6.60e-02	8.14e-01	7.62e-01
Enhanced binding of GP1BA variant to VWF multimer:collagen	7	9.41e-01	9.73e-01	0.08360	5.12e-02	6.60e-02	8.14e-01	7.62e-01
GOBP DIOL METABOLIC PROCESS	30	7.31e-01	8.63e-01	0.08350	9.01e-03	8.30e-02	9.32e-01	4.31e-01
GOCC PRESYNAPTIC ACTIVE ZONE MEMBRANE	31	6.76e-01	8.29e-01	0.08340	-7.64e-02	3.36e-02	4.62e-01	7.46e-01
GOBP ZYMOGEN ACTIVATION	56	5.86e-01	7.71e-01	0.08340	-7.93e-02	-2.59e-02	3.05e-01	7.38e-01
GOBP CELL SURFACE RECEPTOR SIGNALING PATHWAY VIA STAT	178	2.09e-01	4.41e-01	0.08340	-7.17e-02	-4.26e-02	9.91e-02	3.26e-01
GOMF LAMIN BINDING	16	8.28e-01	9.14e-01	0.08340	8.19e-02	-1.56e-02	5.71e-01	9.14e-01
GOBP B CELL MEDIATED IMMUNITY	130	2.02e-01	4.32e-01	0.08330	-7.87e-02	2.75e-02	1.21e-01	5.88e-01
GOMF PEPTIDE BINDING	243	1.17e-01	3.17e-01	0.08330	4.05e-02	7.28e-02	2.77e-01	5.05e-02
GOBP POSITIVE REGULATION OF WOUND HEALING	64	4.30e-01	6.58e-01	0.08330	5.45e-02	-6.31e-02	4.51e-01	3.83e-01
GOMF PEPTIDASE ACTIVITY	557	3.53e-03	2.72e-02	0.08330	-9.02e-03	-8.28e-02	7.16e-01	8.33e-04
GOBP REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY	10	8.94e-01	9.49e-01	0.08330	5.25e-03	-8.31e-02	9.77e-01	6.49e-01
GOBP MAINTENANCE OF PROTEIN LOCATION	83	3.84e-01	6.18e-01	0.08330	8.24e-02	-1.23e-02	1.95e-01	8.46e-01
GOBP ALPHA LINOLENIC ACID METABOLIC PROCESS	9	9.20e-01	9.62e-01	0.08330	3.14e-02	7.71e-02	8.70e-01	6.89e-01
GOBP CARNITINE TRANSMEMBRANE TRANSPORT	6	9.50e-01	9.78e-01	0.08330	-6.40e-02	-5.33e-02	7.86e-01	8.21e-01
GOCC FHF COMPLEX	5	9.57e-01	9.80e-01	0.08320	-6.88e-02	-4.69e-02	7.90e-01	8.56e-01
GOBP POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT	21	8.35e-01	9.17e-01	0.08320	6.29e-02	5.44e-02	6.18e-01	6.66e-01
GOBP REGULATION OF POSTSYNAPSE ASSEMBLY	6	9.46e-01	9.77e-01	0.08310	-3.31e-02	-7.63e-02	8.88e-01	7.46e-01
GOBP GLUCOSYLCERAMIDE CATABOLIC PROCESS	8	9.01e-01	9.52e-01	0.08310	-6.96e-02	4.53e-02	7.33e-01	8.24e-01
GOBP BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE	153	2.60e-01	4.98e-01	0.08310	4.04e-02	7.26e-02	3.88e-01	1.21e-01
GOMF DYNEIN LIGHT INTERMEDIATE CHAIN BINDING	28	7.17e-01	8.55e-01	0.08300	1.93e-02	-8.08e-02	8.59e-01	4.60e-01
GOBP CELL ADHESION INVOLVED IN HEART MORPHOGENESIS	8	9.29e-01	9.67e-01	0.08300	-7.63e-02	-3.27e-02	7.09e-01	8.73e-01
GOBP REGULATION OF SIGNALING RECEPTOR ACTIVITY	90	4.22e-01	6.52e-01	0.08300	-7.99e-02	-2.23e-02	1.90e-01	7.14e-01
GOBP POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY	28	6.93e-01	8.40e-01	0.08300	-5.75e-02	5.99e-02	5.99e-01	5.84e-01
GOBP EPITHELIAL CELL PROLIFERATION	471	1.41e-02	7.73e-02	0.08300	3.02e-02	7.73e-02	2.61e-01	4.06e-03
GOBP NEGATIVE REGULATION OF IMMUNE RESPONSE	192	9.26e-02	2.77e-01	0.08290	-7.61e-02	3.30e-02	6.90e-02	4.31e-01
GOBP POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION	151	2.80e-01	5.19e-01	0.08290	-6.02e-02	-5.70e-02	2.02e-01	2.26e-01
GOBP FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS	44	6.07e-01	7.83e-01	0.08280	-1.06e-02	8.22e-02	9.04e-01	3.46e-01
GOBP CELL ACTIVATION	1077	5.11e-06	1.22e-04	0.08280	-2.05e-02	8.02e-02	2.55e-01	8.67e-06
GOBP NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION	53	5.66e-01	7.57e-01	0.08270	-8.71e-05	8.27e-02	9.99e-01	2.97e-01
GOBP NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS	17	8.17e-01	9.08e-01	0.08270	8.00e-02	-2.13e-02	5.68e-01	8.79e-01
GOBP POSITIVE REGULATION OF URINE VOLUME	13	8.78e-01	9.41e-01	0.08270	8.15e-02	1.41e-02	6.11e-01	9.30e-01
GOBP ESTROGEN BIOSYNTHETIC PROCESS	11	9.08e-01	9.55e-01	0.08270	-4.14e-02	-7.15e-02	8.12e-01	6.81e-01
GOMF RNA CAP BINDING	19	8.34e-01	9.17e-01	0.08270	7.97e-02	2.20e-02	5.48e-01	8.68e-01
GOMF CALCIUM INDEPENDENT PHOSPHOLIPASE A2 ACTIVITY	9	8.96e-01	9.49e-01	0.08260	7.75e-02	-2.87e-02	6.87e-01	8.81e-01
GOBP LEUKOTRIENE BIOSYNTHETIC PROCESS	17	8.16e-01	9.07e-01	0.08260	7.92e-02	-2.36e-02	5.72e-01	8.66e-01
GOBP REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION	20	8.44e-01	9.21e-01	0.08260	6.55e-02	5.04e-02	6.12e-01	6.97e-01
GOBP POSITIVE REGULATION OF BLOOD VESSEL REMODELING	6	9.47e-01	9.77e-01	0.08260	3.20e-02	7.61e-02	8.92e-01	7.47e-01
GOBP SUBPALLIUM DEVELOPMENT	26	8.03e-01	9.01e-01	0.08260	6.40e-02	5.21e-02	5.72e-01	6.45e-01
GOBP POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION	70	4.44e-01	6.71e-01	0.08250	8.07e-02	-1.72e-02	2.43e-01	8.03e-01
GOMF HYDROLASE ACTIVITY HYDROLYZING O GLYCOSYL COMPOUNDS	89	4.72e-01	6.94e-01	0.08250	-6.41e-02	-5.19e-02	2.96e-01	3.97e-01
GOBP LIPOSACCHARIDE METABOLIC PROCESS	111	3.07e-01	5.47e-01	0.08250	-2.25e-04	8.25e-02	9.97e-01	1.33e-01
GOBP NEGATIVE REGULATION OF PROTEOLYSIS	206	1.79e-01	4.04e-01	0.08240	6.39e-02	5.20e-02	1.14e-01	1.99e-01
GOBP PHOTORECEPTOR CELL DIFFERENTIATION	65	5.22e-01	7.26e-01	0.08230	-1.16e-02	-8.15e-02	8.72e-01	2.56e-01
GOMF SODIUM ION BINDING	8	9.06e-01	9.54e-01	0.08230	7.47e-02	-3.46e-02	7.14e-01	8.66e-01
GOBP TEMPERATURE HOMEOSTASIS	182	2.20e-01	4.54e-01	0.08230	6.03e-02	5.60e-02	1.60e-01	1.93e-01
GOBP ENDOSOMAL LUMEN ACIDIFICATION	12	8.84e-01	9.44e-01	0.08230	6.06e-03	8.21e-02	9.71e-01	6.23e-01
GOBP GLYCOSPHINGOLIPID METABOLIC PROCESS	68	4.30e-01	6.58e-01	0.08230	-3.66e-02	7.37e-02	6.02e-01	2.93e-01
GOCC CYTOPLASMIC REGION	295	4.07e-02	1.64e-01	0.08230	8.20e-02	-6.49e-03	1.54e-02	8.48e-01
GOMF VITAMIN BINDING	143	2.41e-01	4.79e-01	0.08230	-1.17e-02	-8.14e-02	8.10e-01	9.27e-02
GOBP POSITIVE REGULATION OF INTERLEUKIN 5 PRODUCTION	10	8.94e-01	9.49e-01	0.08230	-8.16e-02	1.02e-02	6.55e-01	9.55e-01
GOBP SENSORY ORGAN MORPHOGENESIS	274	9.93e-02	2.89e-01	0.08220	6.87e-02	4.52e-02	5.04e-02	1.98e-01
Bacterial Infection Pathways	67	5.65e-01	7.57e-01	0.08210	4.40e-02	6.93e-02	5.33e-01	3.27e-01
GOBP T CELL SELECTION	57	4.87e-01	7.02e-01	0.08210	-6.92e-02	4.41e-02	3.66e-01	5.65e-01
GOBP IMMUNE RESPONSE REGULATING SIGNALING PATHWAY	515	1.63e-03	1.50e-02	0.08210	-4.95e-02	6.55e-02	5.47e-02	1.10e-02
GOBP VESICLE MEDIATED TRANSPORT	1476	8.30e-06	1.85e-04	0.08200	6.84e-02	4.54e-02	1.11e-05	3.55e-03
GOBP ESTABLISHMENT OF ENDOTHELIAL BARRIER	51	6.07e-01	7.83e-01	0.08200	1.39e-02	8.08e-02	8.64e-01	3.18e-01
GOBP NEGATIVE REGULATION OF MUSCLE CONTRACTION	23	7.50e-01	8.71e-01	0.08190	7.09e-02	-4.11e-02	5.56e-01	7.33e-01
GOBP APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT	41	6.00e-01	7.79e-01	0.08190	-4.02e-02	7.14e-02	6.56e-01	4.29e-01
GOMF STEROL BINDING	66	4.31e-01	6.59e-01	0.08180	5.94e-02	-5.63e-02	4.04e-01	4.29e-01
GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION	171	2.46e-01	4.84e-01	0.08180	-5.89e-02	-5.68e-02	1.84e-01	2.00e-01
GOBP POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION	76	4.62e-01	6.85e-01	0.08180	5.70e-03	8.16e-02	9.32e-01	2.19e-01
GOBP RENAL RESPONSE TO BLOOD FLOW INVOLVED IN CIRCULATORY RENIN ANGIOTENSIN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE	7	9.36e-01	9.70e-01	0.08170	-7.97e-02	-1.81e-02	7.15e-01	9.34e-01
GOCC GLIAL CELL PROJECTION	38	7.32e-01	8.63e-01	0.08160	-5.81e-02	-5.74e-02	5.36e-01	5.40e-01
GOBP RETINA MORPHOGENESIS IN CAMERA TYPE EYE	64	5.86e-01	7.71e-01	0.08160	-4.68e-02	-6.68e-02	5.17e-01	3.55e-01
GOBP REGULATION OF TRANSLATION AT POSTSYNAPSE	6	9.32e-01	9.68e-01	0.08160	7.84e-02	-2.28e-02	7.40e-01	9.23e-01
GOBP POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION	1079	1.32e-04	1.95e-03	0.08160	7.34e-02	3.55e-02	4.62e-05	4.86e-02
Innate Immune System	989	7.24e-06	1.64e-04	0.08150	-4.62e-02	6.72e-02	1.40e-02	3.50e-04
GOBP POSITIVE REGULATION OF CELL DEVELOPMENT	439	2.79e-02	1.26e-01	0.08150	4.75e-02	6.62e-02	8.81e-02	1.73e-02
GOBP REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	24	7.69e-01	8.83e-01	0.08150	-9.43e-03	8.09e-02	9.36e-01	4.93e-01
GOBP ORGANIC ANION TRANSPORT	439	2.64e-02	1.21e-01	0.08150	-6.94e-02	-4.26e-02	1.26e-02	1.26e-01
GOBP CELLULAR RESPONSE TO MAGNESIUM ION	7	9.41e-01	9.73e-01	0.08150	7.30e-02	3.61e-02	7.38e-01	8.68e-01
Signal Transduction	2475	5.05e-09	2.42e-07	0.08140	7.36e-02	3.48e-02	2.29e-09	4.77e-03
GOBP MUSCLE CONTRACTION	344	2.93e-02	1.30e-01	0.08140	1.65e-04	-8.14e-02	9.96e-01	9.47e-03
GOBP REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY	67	4.69e-01	6.91e-01	0.08140	7.95e-02	-1.73e-02	2.60e-01	8.07e-01
GOBP RESPONSE TO METAL ION	330	6.11e-02	2.13e-01	0.08140	3.69e-02	7.25e-02	2.49e-01	2.36e-02
GOMF CERAMIDE BINDING	19	7.88e-01	8.92e-01	0.08130	-4.98e-02	6.43e-02	7.07e-01	6.28e-01
GOMF HYALURONONGLUCOSAMINIDASE ACTIVITY	8	9.06e-01	9.54e-01	0.08120	7.01e-02	-4.10e-02	7.31e-01	8.41e-01
GOBP REGULATION OF VERY LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE	5	9.41e-01	9.73e-01	0.08120	-7.36e-02	3.43e-02	7.76e-01	8.94e-01
GOBP REGULATED EXOCYTOSIS	211	7.35e-02	2.40e-01	0.08120	-6.52e-02	4.84e-02	1.02e-01	2.26e-01
GOBP SMOOTH MUSCLE CONTRACTION	109	2.69e-01	5.08e-01	0.08120	7.29e-02	-3.57e-02	1.88e-01	5.20e-01
GOBP CARDIAC VASCULAR SMOOTH MUSCLE CELL DIFFERENTIATION	10	8.89e-01	9.46e-01	0.08110	-7.65e-02	2.71e-02	6.75e-01	8.82e-01
GOBP REGULATION OF VASOCONSTRICTION	65	4.86e-01	7.00e-01	0.08110	1.49e-02	-7.98e-02	8.36e-01	2.66e-01
GOBP NEURON PROJECTION ARBORIZATION	32	7.61e-01	8.78e-01	0.08110	7.24e-02	3.66e-02	4.79e-01	7.20e-01
GOBP SULFUR AMINO ACID TRANSPORT	12	8.60e-01	9.31e-01	0.08110	-5.80e-02	5.66e-02	7.28e-01	7.34e-01
GOBP ORGANOPHOSPHATE CATABOLIC PROCESS	229	8.63e-02	2.65e-01	0.08110	-8.77e-03	8.06e-02	8.19e-01	3.56e-02
GOBP REGULATION OF POSTSYNAPSE ORGANIZATION	100	4.36e-01	6.64e-01	0.08110	-4.35e-02	-6.84e-02	4.52e-01	2.37e-01
GOBP ORGANOPHOSPHATE METABOLIC PROCESS	981	4.89e-04	5.92e-03	0.08110	5.40e-02	6.04e-02	4.16e-03	1.36e-03
GOBP SYNAPTIC VESICLE RECYCLING	77	5.24e-01	7.28e-01	0.08100	3.97e-02	7.06e-02	5.47e-01	2.84e-01
GOBP REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT	1429	1.98e-05	3.92e-04	0.08100	5.72e-02	5.73e-02	2.94e-04	2.83e-04
GOBP GRANZYME MEDIATED PROGRAMMED CELL DEATH SIGNALING PATHWAY	8	9.26e-01	9.65e-01	0.08100	-7.98e-02	-1.36e-02	6.96e-01	9.47e-01
GOBP VASCULAR ENDOTHELIAL CELL PROLIFERATION	49	5.79e-01	7.67e-01	0.08090	-1.65e-02	7.92e-02	8.42e-01	3.37e-01
GOBP REGULATION OF SYNAPTIC VESICLE CLUSTERING	6	9.40e-01	9.73e-01	0.08090	8.09e-02	-9.73e-04	7.32e-01	9.97e-01
GOBP CORPUS CALLOSUM DEVELOPMENT	26	7.73e-01	8.85e-01	0.08080	8.06e-02	6.19e-03	4.77e-01	9.56e-01
High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells	69	4.40e-01	6.67e-01	0.08080	7.31e-02	-3.43e-02	2.94e-01	6.22e-01
GOBP THYROID HORMONE TRANSPORT	10	9.17e-01	9.61e-01	0.08080	-7.38e-02	-3.28e-02	6.86e-01	8.57e-01
GOMF POTASSIUM PROTON ANTIPORTER ACTIVITY	12	8.65e-01	9.34e-01	0.08070	3.97e-02	-7.03e-02	8.12e-01	6.73e-01
Interconversion of nucleotide di- and triphosphates	29	7.85e-01	8.92e-01	0.08070	3.99e-02	7.02e-02	7.10e-01	5.13e-01
GOMF TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY	81	4.84e-01	6.99e-01	0.08070	-2.44e-02	-7.70e-02	7.05e-01	2.31e-01
GOBP MONOATOMIC CATION TRANSMEMBRANE TRANSPORT	811	1.86e-03	1.67e-02	0.08070	-5.79e-02	-5.62e-02	5.05e-03	6.53e-03
GOCC AGGRESOME	33	7.61e-01	8.78e-01	0.08070	4.15e-02	6.92e-02	6.80e-01	4.92e-01
GOBP POSITIVE REGULATION OF MUSCLE CONTRACTION	49	5.48e-01	7.45e-01	0.08070	-6.56e-02	4.70e-02	4.27e-01	5.69e-01
GOBP PIGMENT CELL DIFFERENTIATION	35	6.75e-01	8.29e-01	0.08070	7.83e-02	-1.92e-02	4.23e-01	8.44e-01
GOBP OLIGOPEPTIDE TRANSPORT	19	7.93e-01	8.95e-01	0.08070	-4.45e-02	6.73e-02	7.37e-01	6.12e-01
Chylomicron assembly	10	8.87e-01	9.45e-01	0.08070	3.79e-02	-7.12e-02	8.36e-01	6.97e-01
GOBP POSITIVE REGULATION OF AMINE TRANSPORT	39	6.80e-01	8.32e-01	0.08060	5.84e-03	8.04e-02	9.50e-01	3.85e-01
GOMF RNA 7 METHYLGUANOSINE CAP BINDING	13	8.67e-01	9.35e-01	0.08060	-1.37e-02	7.95e-02	9.32e-01	6.20e-01
GOBP NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION	45	6.76e-01	8.30e-01	0.08060	7.49e-02	2.98e-02	3.85e-01	7.29e-01
GOCC NUCLEAR ENVELOPE LUMEN	11	9.07e-01	9.55e-01	0.08060	2.60e-02	7.63e-02	8.81e-01	6.61e-01
GOBP GALACTOSYLCERAMIDE BIOSYNTHETIC PROCESS	6	9.51e-01	9.78e-01	0.08060	-6.97e-02	-4.05e-02	7.68e-01	8.64e-01
GOBP CELLULAR RESPONSE TO PH	25	7.63e-01	8.80e-01	0.08060	1.13e-02	-7.98e-02	9.22e-01	4.90e-01
GOMF CALCIUM CHANNEL INHIBITOR ACTIVITY	13	8.81e-01	9.43e-01	0.08060	8.01e-02	9.18e-03	6.17e-01	9.54e-01
GOBP NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION	744	2.26e-03	1.93e-02	0.08050	3.51e-02	7.24e-02	1.03e-01	7.67e-04
GOBP CIRCULATORY SYSTEM DEVELOPMENT	1190	2.21e-05	4.30e-04	0.08040	7.95e-02	1.21e-02	3.81e-06	4.83e-01
GOBP POSTSYNAPSE TO NUCLEUS SIGNALING PATHWAY	6	9.52e-01	9.79e-01	0.08040	-4.32e-02	-6.78e-02	8.55e-01	7.74e-01
GOBP NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY	32	7.63e-01	8.80e-01	0.08040	-3.46e-02	-7.26e-02	7.35e-01	4.78e-01
GOBP POSITIVE REGULATION OF SYNAPSE ASSEMBLY	57	5.89e-01	7.72e-01	0.08020	-1.52e-02	-7.88e-02	8.43e-01	3.04e-01
GOCC MYELIN SHEATH ABAXONAL REGION	6	9.30e-01	9.67e-01	0.08020	6.45e-02	-4.76e-02	7.84e-01	8.40e-01
Ion homeostasis	52	5.96e-01	7.76e-01	0.08010	-2.16e-03	-8.01e-02	9.79e-01	3.18e-01
Diseases of carbohydrate metabolism	31	7.42e-01	8.69e-01	0.08010	-8.32e-03	-7.97e-02	9.36e-01	4.43e-01
GOBP ARTERY DEVELOPMENT	113	3.85e-01	6.19e-01	0.08010	7.32e-02	3.24e-02	1.79e-01	5.52e-01
GOBP CELLULAR RESPONSE TO CAMP	49	6.69e-01	8.25e-01	0.08010	6.95e-02	3.97e-02	4.00e-01	6.31e-01
GOBP ADENOHYPOPHYSIS DEVELOPMENT	16	8.65e-01	9.34e-01	0.08000	1.95e-02	7.76e-02	8.92e-01	5.91e-01
GOBP REGULATION OF NEURON PROJECTION REGENERATION	31	7.13e-01	8.52e-01	0.08000	-7.84e-02	1.61e-02	4.50e-01	8.77e-01
GOCC MYELIN SHEATH	43	6.71e-01	8.26e-01	0.08000	1.45e-02	7.87e-02	8.70e-01	3.72e-01
GOMF ZINC ION TRANSMEMBRANE TRANSPORTER ACTIVITY	24	8.26e-01	9.12e-01	0.08000	4.94e-02	6.29e-02	6.76e-01	5.94e-01
GOBP ARF PROTEIN SIGNAL TRANSDUCTION	21	8.12e-01	9.05e-01	0.07990	7.99e-02	1.72e-03	5.26e-01	9.89e-01
NFE2L2 regulating tumorigenic genes	11	9.08e-01	9.55e-01	0.07980	2.53e-02	7.57e-02	8.84e-01	6.64e-01
GOBP SEROTONIN METABOLIC PROCESS	10	8.86e-01	9.45e-01	0.07980	6.30e-02	-4.91e-02	7.30e-01	7.88e-01
GOBP PHOSPHORYLATION	1334	5.13e-05	8.90e-04	0.07980	5.93e-02	5.35e-02	2.80e-04	1.05e-03
GOCC NUCLEAR LAMINA	10	9.00e-01	9.51e-01	0.07980	7.92e-02	-9.88e-03	6.65e-01	9.57e-01
GOBP REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION	102	3.23e-01	5.62e-01	0.07980	-2.15e-02	7.68e-02	7.07e-01	1.80e-01
GOCC INTERSTITIAL MATRIX	11	8.89e-01	9.46e-01	0.07970	7.85e-02	-1.39e-02	6.52e-01	9.36e-01
GOBP POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS	69	5.08e-01	7.16e-01	0.07960	2.22e-03	7.96e-02	9.75e-01	2.53e-01
GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS	129	2.84e-01	5.22e-01	0.07960	7.95e-02	2.34e-03	1.19e-01	9.63e-01
GOBP REGULATION OF ERBB SIGNALING PATHWAY	72	5.50e-01	7.46e-01	0.07950	7.23e-02	3.31e-02	2.89e-01	6.28e-01
GOMF INTERLEUKIN 1 RECEPTOR ACTIVITY	6	9.54e-01	9.79e-01	0.07950	-4.65e-02	-6.45e-02	8.44e-01	7.84e-01
GOBP LONG CHAIN FATTY ACID IMPORT ACROSS PLASMA MEMBRANE	10	9.18e-01	9.61e-01	0.07950	-2.77e-02	-7.45e-02	8.79e-01	6.83e-01
GOBP MAINTENANCE OF SYNAPSE STRUCTURE	24	8.22e-01	9.10e-01	0.07940	-7.06e-02	-3.62e-02	5.49e-01	7.59e-01
GOBP ENUCLEATE ERYTHROCYTE DEVELOPMENT	6	9.31e-01	9.68e-01	0.07930	-4.73e-02	6.37e-02	8.41e-01	7.87e-01
GOBP MACROPHAGE ACTIVATION	110	2.69e-01	5.08e-01	0.07930	-5.71e-02	5.50e-02	3.01e-01	3.19e-01
GOBP LEUKOCYTE MIGRATION	382	1.71e-02	8.88e-02	0.07920	-7.70e-02	1.87e-02	9.76e-03	5.30e-01
p75 NTR receptor-mediated signalling	90	4.20e-01	6.51e-01	0.07920	7.91e-02	3.49e-03	1.95e-01	9.54e-01
GOBP POSITIVE REGULATION OF BLOOD PRESSURE	31	7.02e-01	8.45e-01	0.07920	-7.23e-02	3.23e-02	4.86e-01	7.56e-01
Response of EIF2AK1 (HRI) to heme deficiency	14	8.97e-01	9.50e-01	0.07900	5.21e-02	5.94e-02	7.36e-01	7.00e-01
GOBP AMINO SUGAR CATABOLIC PROCESS	14	8.65e-01	9.34e-01	0.07900	-1.08e-02	7.83e-02	9.44e-01	6.12e-01
GOBP NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE	87	3.69e-01	6.06e-01	0.07900	-7.06e-02	3.55e-02	2.55e-01	5.68e-01
GOBP POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY	18	8.69e-01	9.36e-01	0.07900	4.54e-02	6.46e-02	7.39e-01	6.35e-01
Vasopressin regulates renal water homeostasis via Aquaporins	42	7.21e-01	8.57e-01	0.07900	4.62e-02	6.40e-02	6.04e-01	4.73e-01
TNFR1-mediated ceramide production	6	9.53e-01	9.79e-01	0.07890	3.81e-02	6.92e-02	8.72e-01	7.69e-01
GOBP FEEDING BEHAVIOR	104	3.91e-01	6.25e-01	0.07890	1.39e-02	7.77e-02	8.07e-01	1.71e-01
OAS antiviral response	8	9.36e-01	9.70e-01	0.07890	-3.05e-02	-7.28e-02	8.81e-01	7.22e-01
Synthesis of IP3 and IP4 in the cytosol	25	8.01e-01	9.00e-01	0.07880	-1.66e-02	-7.71e-02	8.86e-01	5.05e-01
GOBP POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY	46	5.81e-01	7.68e-01	0.07880	-5.19e-02	5.93e-02	5.43e-01	4.86e-01
GOBP REGULATION OF KERATINOCYTE PROLIFERATION	48	5.79e-01	7.66e-01	0.07880	-7.03e-02	3.54e-02	3.99e-01	6.71e-01
GOBP EYE MORPHOGENESIS	160	2.53e-01	4.91e-01	0.07870	7.57e-02	2.15e-02	9.82e-02	6.39e-01
GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN LINEAR AMIDES	71	5.65e-01	7.57e-01	0.07870	3.57e-02	7.02e-02	6.03e-01	3.07e-01
GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION	13	9.04e-01	9.53e-01	0.07870	4.74e-02	6.28e-02	7.67e-01	6.95e-01
GOBP ACTIVATION OF PHOSPHOLIPASE C ACTIVITY	23	8.36e-01	9.18e-01	0.07870	-4.52e-02	-6.44e-02	7.08e-01	5.93e-01
GOBP NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS	268	1.30e-01	3.38e-01	0.07870	6.15e-02	4.91e-02	8.31e-02	1.67e-01
GOCC DENSE CORE GRANULE	38	7.10e-01	8.50e-01	0.07860	-7.75e-02	-1.31e-02	4.08e-01	8.89e-01
GOCC GROWTH CONE MEMBRANE	8	9.13e-01	9.57e-01	0.07860	3.63e-02	-6.97e-02	8.59e-01	7.33e-01
GOCC CHLORIDE CHANNEL COMPLEX	51	6.35e-01	8.01e-01	0.07860	-1.50e-02	-7.71e-02	8.53e-01	3.41e-01
GOBP CARBOHYDRATE HOMEOSTASIS	255	1.46e-01	3.59e-01	0.07860	5.73e-02	5.38e-02	1.15e-01	1.39e-01
GOBP GLUCOSE METABOLIC PROCESS	182	2.04e-01	4.34e-01	0.07860	7.67e-02	1.73e-02	7.45e-02	6.87e-01
GOBP T CELL MIGRATION	66	5.91e-01	7.73e-01	0.07860	-6.96e-02	-3.65e-02	3.28e-01	6.09e-01
GOBP POSITIVE REGULATION OF LYASE ACTIVITY	36	7.23e-01	8.58e-01	0.07860	-1.28e-02	-7.75e-02	8.94e-01	4.21e-01
GOBP REGULATION OF HEPATOCYTE PROLIFERATION	16	8.81e-01	9.43e-01	0.07850	-6.82e-02	-3.88e-02	6.37e-01	7.88e-01
GOBP AMINO ACID METABOLIC PROCESS	285	8.34e-02	2.59e-01	0.07840	7.67e-02	1.63e-02	2.58e-02	6.37e-01
GOBP RETINAL METABOLIC PROCESS	18	8.33e-01	9.17e-01	0.07840	7.77e-02	-1.01e-02	5.68e-01	9.41e-01
Zinc transporters	15	8.67e-01	9.35e-01	0.07840	2.86e-03	7.83e-02	9.85e-01	5.99e-01
GOBP RESPONSE TO FIBROBLAST GROWTH FACTOR	117	3.30e-01	5.70e-01	0.07840	7.83e-02	2.58e-03	1.43e-01	9.62e-01
GOBP CELLULAR RESPONSE TO OXYGEN RADICAL	22	8.07e-01	9.03e-01	0.07830	7.82e-02	-2.52e-03	5.25e-01	9.84e-01
GOBP GENERATION OF NEURONS	1444	3.59e-05	6.63e-04	0.07820	5.05e-02	5.97e-02	1.31e-03	1.46e-04
GOBP CAMERA TYPE EYE MORPHOGENESIS	131	3.74e-01	6.10e-01	0.07820	5.82e-02	5.22e-02	2.50e-01	3.02e-01
GOBP INFLAMMATORY RESPONSE	856	5.88e-04	6.87e-03	0.07820	-7.74e-02	-1.09e-02	1.20e-04	5.90e-01
GOBP RESPONSE TO TUMOR NECROSIS FACTOR	232	1.67e-01	3.88e-01	0.07820	3.99e-02	6.72e-02	2.96e-01	7.77e-02
GOBP REGULATION OF NEUROGENESIS	362	6.78e-02	2.27e-01	0.07820	5.23e-02	5.81e-02	8.75e-02	5.76e-02
GOBP REGULATION OF THE FORCE OF HEART CONTRACTION	26	8.19e-01	9.09e-01	0.07810	-6.46e-02	-4.39e-02	5.68e-01	6.99e-01
Signaling by RAF1 mutants	39	6.36e-01	8.01e-01	0.07810	5.56e-02	-5.48e-02	5.48e-01	5.53e-01
GOBP NEGATIVE REGULATION OF VASCULAR PERMEABILITY	18	8.37e-01	9.18e-01	0.07810	-7.79e-02	5.82e-03	5.67e-01	9.66e-01
GOBP CELLULAR RESPONSE TO GONADOTROPIN STIMULUS	17	8.36e-01	9.18e-01	0.07810	-1.85e-02	7.58e-02	8.95e-01	5.88e-01
GOCC GOLGI CISTERNA	98	3.91e-01	6.25e-01	0.07800	-1.12e-03	7.80e-02	9.85e-01	1.82e-01
GOMF MRNA 3 UTR BINDING	231	1.05e-01	3.00e-01	0.07790	5.71e-03	-7.77e-02	8.81e-01	4.19e-02
GOBP AXON EXTENSION	96	3.33e-01	5.71e-01	0.07780	5.99e-02	-4.96e-02	3.10e-01	4.01e-01
RUNX3 regulates WNT signaling	8	9.42e-01	9.74e-01	0.07780	5.34e-02	5.66e-02	7.94e-01	7.82e-01
Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA	8	9.37e-01	9.71e-01	0.07780	-7.26e-02	-2.79e-02	7.22e-01	8.91e-01
GOBP BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS	22	8.27e-01	9.13e-01	0.07780	1.71e-02	7.59e-02	8.89e-01	5.38e-01
GOBP SYMPATHETIC NEURON PROJECTION EXTENSION	5	9.60e-01	9.81e-01	0.07780	-2.77e-02	-7.27e-02	9.15e-01	7.78e-01
GOBP POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION	173	2.13e-01	4.46e-01	0.07770	7.72e-02	9.36e-03	8.00e-02	8.32e-01
GOBP CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY	160	3.06e-01	5.46e-01	0.07770	5.63e-02	5.35e-02	2.19e-01	2.43e-01
GOBP SPERM AXONEME ASSEMBLY	31	7.81e-01	8.90e-01	0.07760	-3.17e-02	-7.09e-02	7.60e-01	4.94e-01
GOBP METHIONINE METABOLIC PROCESS	15	8.74e-01	9.39e-01	0.07760	-8.96e-03	-7.71e-02	9.52e-01	6.05e-01
GOBP CARBOHYDRATE DERIVATIVE TRANSPORT	89	3.79e-01	6.13e-01	0.07760	-7.12e-02	3.09e-02	2.46e-01	6.15e-01
GOBP CELLULAR RESPONSE TO LIPID	592	1.10e-02	6.44e-02	0.07760	3.52e-02	6.92e-02	1.43e-01	4.04e-03
GOBP ADRENAL GLAND DEVELOPMENT	26	8.03e-01	9.01e-01	0.07760	7.50e-02	1.97e-02	5.08e-01	8.62e-01
GOBP MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT	22	8.48e-01	9.23e-01	0.07760	4.80e-02	6.10e-02	6.97e-01	6.21e-01
GOBP REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN TRANSCRIPTION OF P21 CLASS MEDIATOR	6	9.33e-01	9.69e-01	0.07760	-5.72e-02	5.24e-02	8.08e-01	8.24e-01
GOBP REGULATION OF POSTSYNAPTIC DENSITY ASSEMBLY	13	8.77e-01	9.40e-01	0.07760	-7.64e-02	1.33e-02	6.33e-01	9.34e-01
GOBP NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	13	8.63e-01	9.33e-01	0.07760	6.39e-02	-4.39e-02	6.90e-01	7.84e-01
GOBP CELLULAR RESPONSE TO BIOTIC STIMULUS	251	9.11e-02	2.74e-01	0.07760	-7.75e-02	3.83e-03	3.46e-02	9.17e-01
GOBP EOSINOPHIL DIFFERENTIATION	6	9.54e-01	9.79e-01	0.07760	-3.40e-02	-6.97e-02	8.85e-01	7.67e-01
GOBP RESPONSE TO OXYGEN CONTAINING COMPOUND	1609	9.99e-06	2.15e-04	0.07750	3.82e-02	6.75e-02	1.07e-02	6.32e-06
Transport of small molecules	693	4.74e-03	3.40e-02	0.07750	-3.08e-02	-7.11e-02	1.67e-01	1.41e-03
GOMF PHOSPHOLIPID TRANSFER ACTIVITY	25	8.27e-01	9.13e-01	0.07740	6.60e-02	4.03e-02	5.68e-01	7.27e-01
GOMF SIGNALING RECEPTOR COMPLEX ADAPTOR ACTIVITY	51	6.26e-01	7.95e-01	0.07740	7.73e-02	3.75e-03	3.40e-01	9.63e-01
GOMF GAP JUNCTION HEMI CHANNEL ACTIVITY	6	9.56e-01	9.80e-01	0.07730	-6.55e-02	-4.10e-02	7.81e-01	8.62e-01
GOMF ORGANOPHOSPHATE ESTER TRANSMEMBRANE TRANSPORTER ACTIVITY	35	6.86e-01	8.36e-01	0.07730	-2.89e-02	7.17e-02	7.68e-01	4.63e-01
GOBP POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS	137	3.66e-01	6.03e-01	0.07730	-5.56e-02	-5.37e-02	2.61e-01	2.78e-01
MAPK1/MAPK3 signaling	258	1.32e-01	3.40e-01	0.07730	7.12e-02	3.00e-02	4.89e-02	4.07e-01
GOBP LEUKOCYTE CHEMOTAXIS	226	9.67e-02	2.84e-01	0.07730	-7.43e-02	2.11e-02	5.42e-02	5.84e-01
GOBP NEUTROPHIL HOMEOSTASIS	19	8.36e-01	9.17e-01	0.07730	7.72e-02	-1.29e-03	5.60e-01	9.92e-01
GOCC EARLY ENDOSOME MEMBRANE	188	2.52e-01	4.90e-01	0.07720	5.84e-02	5.05e-02	1.67e-01	2.32e-01
Metabolism	2055	5.90e-07	1.82e-05	0.07720	6.79e-02	3.67e-02	3.77e-07	6.08e-03
GOBP RESPONSE TO ALKALOID	98	4.86e-01	7.00e-01	0.07720	5.96e-02	4.91e-02	3.08e-01	4.01e-01
GOBP REGULATION OF CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY	107	3.92e-01	6.25e-01	0.07710	1.08e-02	7.64e-02	8.48e-01	1.72e-01
GOBP REGULATION OF SECONDARY METABOLIC PROCESS	15	8.47e-01	9.23e-01	0.07710	-3.82e-02	6.70e-02	7.98e-01	6.53e-01
GOBP CELLULAR RESPONSE TO ANGIOTENSIN	34	7.15e-01	8.53e-01	0.07710	7.64e-02	-1.06e-02	4.41e-01	9.15e-01
GOCC CORTICAL ACTIN CYTOSKELETON	74	5.73e-01	7.63e-01	0.07700	6.59e-02	3.97e-02	3.27e-01	5.55e-01
Pre-NOTCH Processing in Golgi	18	8.75e-01	9.40e-01	0.07690	-4.53e-02	-6.22e-02	7.40e-01	6.48e-01
GOBP CELLULAR RESPONSE TO TYPE II INTERFERON	93	4.71e-01	6.93e-01	0.07690	2.37e-02	7.32e-02	6.92e-01	2.23e-01
GOCC STEREOCILIUM TIP	20	8.61e-01	9.31e-01	0.07690	-4.07e-02	-6.52e-02	7.53e-01	6.14e-01
GOBP SERTOLI CELL DEVELOPMENT	12	8.97e-01	9.50e-01	0.07680	7.67e-02	4.29e-03	6.45e-01	9.79e-01
GOMF CARNITINE TRANSMEMBRANE TRANSPORTER ACTIVITY	5	9.63e-01	9.83e-01	0.07680	-3.99e-02	-6.56e-02	8.77e-01	7.99e-01
GOBP FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	81	4.49e-01	6.75e-01	0.07680	7.57e-02	-1.30e-02	2.39e-01	8.40e-01
GOBP BEHAVIORAL RESPONSE TO ETHANOL	9	9.06e-01	9.54e-01	0.07670	-6.62e-02	3.88e-02	7.31e-01	8.40e-01
GOBP POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS	1633	2.41e-06	6.28e-05	0.07670	1.36e-02	7.55e-02	3.60e-01	3.70e-07
GOMF TUMOR NECROSIS FACTOR BINDING	7	9.49e-01	9.78e-01	0.07670	-6.40e-02	-4.22e-02	7.69e-01	8.47e-01
GOBP NEGATIVE REGULATION OF CALCIUM ION IMPORT	18	8.48e-01	9.23e-01	0.07660	-1.71e-03	-7.66e-02	9.90e-01	5.74e-01
GOBP REGULATION OF JNK CASCADE	134	3.34e-01	5.73e-01	0.07660	7.39e-02	2.00e-02	1.39e-01	6.90e-01
GOBP REGULATION OF DEFENSE RESPONSE TO FUNGUS	5	9.59e-01	9.81e-01	0.07660	-1.77e-02	-7.45e-02	9.45e-01	7.73e-01
GOBP CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND	1147	3.78e-04	4.75e-03	0.07650	5.13e-02	5.68e-02	3.37e-03	1.19e-03
GOBP GLUTATHIONE TRANSPORT	10	9.29e-01	9.67e-01	0.07650	4.19e-02	6.40e-02	8.18e-01	7.26e-01
GOMF LIM DOMAIN BINDING	5	9.50e-01	9.78e-01	0.07650	2.22e-02	-7.32e-02	9.31e-01	7.77e-01
GOBP GLUTAMATE SECRETION	28	8.17e-01	9.08e-01	0.07650	-5.19e-02	-5.62e-02	6.35e-01	6.07e-01
GOBP TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR	10	8.99e-01	9.51e-01	0.07650	6.95e-02	-3.20e-02	7.04e-01	8.61e-01
GOCC PLATELET ALPHA GRANULE LUMEN	60	5.69e-01	7.59e-01	0.07640	4.75e-03	-7.63e-02	9.49e-01	3.07e-01
GOMF AMINO ACID BINDING	47	6.69e-01	8.25e-01	0.07630	1.18e-02	7.54e-02	8.89e-01	3.71e-01
GOBP POSITIVE REGULATION OF RESPONSE TO WOUNDING	76	4.37e-01	6.64e-01	0.07630	4.14e-02	-6.41e-02	5.33e-01	3.34e-01
GOBP POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION	44	7.14e-01	8.53e-01	0.07630	6.94e-02	3.17e-02	4.26e-01	7.16e-01
GOBP PERISTALSIS	12	8.83e-01	9.44e-01	0.07630	2.57e-02	-7.18e-02	8.78e-01	6.67e-01
Molecules associated with elastic fibres	37	6.78e-01	8.31e-01	0.07620	7.03e-02	-2.93e-02	4.59e-01	7.58e-01
GOBP NEGATIVE REGULATION OF COMPLEMENT ACTIVATION	12	8.81e-01	9.43e-01	0.07610	6.92e-02	-3.18e-02	6.78e-01	8.49e-01
GOBP REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT	16	8.89e-01	9.46e-01	0.07610	3.95e-02	6.51e-02	7.84e-01	6.52e-01
Triglyceride metabolism	35	7.77e-01	8.88e-01	0.07610	-4.75e-02	-5.95e-02	6.27e-01	5.42e-01
GOBP REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	35	7.72e-01	8.85e-01	0.07600	3.76e-02	6.61e-02	7.00e-01	4.99e-01
GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION	511	2.67e-02	1.22e-01	0.07600	6.28e-02	4.28e-02	1.51e-02	9.80e-02
GOBP REGULATION OF CELL CELL ADHESION	486	6.31e-03	4.25e-02	0.07590	-3.52e-02	6.73e-02	1.84e-01	1.10e-02
GOBP SULFUR COMPOUND METABOLIC PROCESS	301	1.16e-01	3.16e-01	0.07590	6.28e-02	4.26e-02	6.08e-02	2.03e-01
GOBP POSITIVE REGULATION OF DEOXYRIBONUCLEASE ACTIVITY	5	9.48e-01	9.77e-01	0.07590	6.47e-02	-3.96e-02	8.02e-01	8.78e-01
GOMF NOTCH BINDING	23	8.41e-01	9.20e-01	0.07590	6.85e-02	3.26e-02	5.69e-01	7.87e-01
GOBP RESPONSE TO CALCIUM ION	125	4.03e-01	6.35e-01	0.07590	4.04e-02	6.43e-02	4.36e-01	2.14e-01
GOBP RETINA DEVELOPMENT IN CAMERA TYPE EYE	158	1.97e-01	4.27e-01	0.07590	7.09e-02	-2.71e-02	1.24e-01	5.57e-01
GOBP RESPONSE TO TYPE I INTERFERON	84	5.21e-01	7.26e-01	0.07580	7.13e-02	2.59e-02	2.59e-01	6.81e-01
GOMF POTASSIUM CHLORIDE SYMPORTER ACTIVITY	9	9.20e-01	9.62e-01	0.07580	-7.56e-02	4.64e-03	6.94e-01	9.81e-01
GOBP MONOATOMIC CATION TRANSPORT	990	1.22e-03	1.23e-02	0.07580	-5.50e-02	-5.21e-02	3.40e-03	5.53e-03
Negative regulation of NMDA receptor-mediated neuronal transmission	20	8.36e-01	9.17e-01	0.07570	-7.57e-02	-4.29e-04	5.58e-01	9.97e-01
GOBP POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION	52	6.24e-01	7.94e-01	0.07560	-1.89e-03	7.56e-02	9.81e-01	3.46e-01
GOBP NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION	65	6.04e-01	7.82e-01	0.07560	2.53e-02	7.12e-02	7.24e-01	3.21e-01
GOBP WOUND HEALING SPREADING OF EPIDERMAL CELLS	26	7.58e-01	8.76e-01	0.07550	4.00e-02	-6.41e-02	7.24e-01	5.72e-01
GOBP CYTOKINE PRODUCTION	841	1.56e-04	2.22e-03	0.07550	-4.73e-02	5.89e-02	1.98e-02	3.74e-03
GOBP LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY	55	5.63e-01	7.55e-01	0.07550	-6.78e-02	3.32e-02	3.84e-01	6.70e-01
GOCC RNA POLYMERASE TRANSCRIPTION FACTOR SL1 COMPLEX	5	9.48e-01	9.77e-01	0.07550	4.25e-02	-6.23e-02	8.69e-01	8.09e-01
GOBP NEURON PROJECTION ORGANIZATION	87	4.23e-01	6.53e-01	0.07550	2.01e-02	-7.27e-02	7.46e-01	2.41e-01
GOBP SECONDARY METABOLITE BIOSYNTHETIC PROCESS	24	7.82e-01	8.90e-01	0.07540	-7.01e-02	2.78e-02	5.52e-01	8.13e-01
GOMF MYOSIN PHOSPHATASE ACTIVITY	73	5.68e-01	7.58e-01	0.07540	2.42e-02	7.14e-02	7.20e-01	2.91e-01
GOMF CARBOXY LYASE ACTIVITY	33	7.92e-01	8.94e-01	0.07540	4.56e-02	6.00e-02	6.50e-01	5.51e-01
GOBP MAST CELL DIFFERENTIATION	6	9.37e-01	9.71e-01	0.07520	-5.65e-02	4.96e-02	8.10e-01	8.33e-01
Synthesis of substrates in N-glycan biosythesis	63	5.29e-01	7.32e-01	0.07510	-7.01e-02	2.71e-02	3.36e-01	7.10e-01
GOBP DEVELOPMENTAL MATURATION	326	9.54e-02	2.81e-01	0.07510	6.67e-02	3.44e-02	3.83e-02	2.85e-01
GOBP REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY	165	2.08e-01	4.40e-01	0.07510	-1.47e-02	7.36e-02	7.44e-01	1.03e-01
GOBP ENDOCARDIAL CUSHION FUSION	5	9.66e-01	9.84e-01	0.07510	-5.24e-02	-5.38e-02	8.39e-01	8.35e-01
GOCC NEURON TO NEURON SYNAPSE	349	6.16e-02	2.14e-01	0.07510	-1.50e-02	-7.35e-02	6.30e-01	1.82e-02
Regulation of RUNX1 Expression and Activity	25	7.86e-01	8.92e-01	0.07490	7.29e-02	-1.72e-02	5.28e-01	8.82e-01
GOBP CELLULAR RESPONSE TO PROGESTERONE STIMULUS	7	9.32e-01	9.68e-01	0.07490	7.08e-02	-2.45e-02	7.46e-01	9.11e-01
GOBP CELL CELL JUNCTION ORGANIZATION	208	2.39e-01	4.77e-01	0.07490	-5.51e-02	-5.07e-02	1.71e-01	2.07e-01
GOBP POSITIVE REGULATION OF CATION CHANNEL ACTIVITY	46	7.27e-01	8.60e-01	0.07490	5.77e-02	4.76e-02	4.98e-01	5.76e-01
FCGR activation	11	8.97e-01	9.50e-01	0.07480	-7.12e-02	2.29e-02	6.83e-01	8.95e-01
PDH complex synthesizes acetyl-CoA from PYR	5	9.66e-01	9.84e-01	0.07470	5.76e-02	4.76e-02	8.23e-01	8.54e-01
GOMF PYRUVATE DEHYDROGENASE ACTIVITY	5	9.66e-01	9.84e-01	0.07470	5.76e-02	4.76e-02	8.23e-01	8.54e-01
GOCC CEREBELLAR MOSSY FIBER	7	9.29e-01	9.67e-01	0.07470	4.01e-02	-6.30e-02	8.54e-01	7.73e-01
GOBP RENAL SYSTEM VASCULATURE MORPHOGENESIS	8	9.29e-01	9.67e-01	0.07470	-8.02e-03	7.42e-02	9.69e-01	7.16e-01
GOBP REGULATION OF HAIR CYCLE	29	7.71e-01	8.84e-01	0.07460	5.24e-03	-7.44e-02	9.61e-01	4.88e-01
GOBP NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION	74	5.99e-01	7.78e-01	0.07450	-4.44e-02	-5.99e-02	5.09e-01	3.73e-01
GOBP GANGLIOSIDE BIOSYNTHETIC PROCESS	17	8.37e-01	9.18e-01	0.07450	-6.23e-02	4.09e-02	6.56e-01	7.70e-01
GOBP POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY	13	8.72e-01	9.38e-01	0.07440	-5.07e-02	5.45e-02	7.52e-01	7.34e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS NAD P AS ACCEPTOR	11	9.17e-01	9.60e-01	0.07440	7.26e-02	1.63e-02	6.77e-01	9.25e-01
GOBP NEGATIVE REGULATION OF DEFENSE RESPONSE	280	8.46e-02	2.62e-01	0.07440	-7.42e-02	4.91e-03	3.26e-02	8.87e-01
GOCC VESICLE LUMEN	311	3.94e-02	1.60e-01	0.07430	-5.31e-02	5.20e-02	1.07e-01	1.15e-01
GOBP REGULATION OF OSTEOCLAST DIFFERENTIATION	70	4.97e-01	7.09e-01	0.07430	-6.84e-02	2.91e-02	3.22e-01	6.74e-01
PLC beta mediated events	48	7.21e-01	8.57e-01	0.07430	-5.59e-02	-4.90e-02	5.03e-01	5.57e-01
GOBP NEPHRON MORPHOGENESIS	78	4.75e-01	6.95e-01	0.07430	-1.82e-02	7.21e-02	7.81e-01	2.71e-01
GOBP REGULATION OF PHOSPHORYLATION	950	1.85e-03	1.66e-02	0.07430	4.29e-02	6.07e-02	2.52e-02	1.54e-03
GOMF APOLIPOPROTEIN RECEPTOR BINDING	7	9.29e-01	9.67e-01	0.07430	5.57e-02	-4.91e-02	7.99e-01	8.22e-01
GOBP NEUTROPHIL MIGRATION	100	3.68e-01	6.05e-01	0.07430	-6.80e-02	2.98e-02	2.40e-01	6.06e-01
Vitamin B2 (riboflavin) metabolism	7	9.40e-01	9.73e-01	0.07420	7.41e-02	-3.90e-03	7.34e-01	9.86e-01
GOBP REGULATION OF MORPHOGENESIS OF AN EPITHELIUM	63	6.04e-01	7.81e-01	0.07420	1.27e-02	7.31e-02	8.61e-01	3.15e-01
GOBP GLOMERULAR MESANGIAL CELL PROLIFERATION	13	8.78e-01	9.41e-01	0.07420	6.83e-02	-2.90e-02	6.70e-01	8.56e-01
GOMF ENZYME REGULATOR ACTIVITY	1239	9.59e-05	1.49e-03	0.07420	7.26e-02	1.51e-02	1.70e-05	3.71e-01
GOBP NEUROMUSCULAR PROCESS CONTROLLING BALANCE	52	5.85e-01	7.70e-01	0.07420	6.23e-02	-4.03e-02	4.37e-01	6.15e-01
GOBP PYRIDINE CONTAINING COMPOUND CATABOLIC PROCESS	96	5.01e-01	7.11e-01	0.07410	3.10e-02	6.73e-02	5.99e-01	2.54e-01
GOBP PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS	39	6.97e-01	8.42e-01	0.07410	-1.32e-02	7.30e-02	8.87e-01	4.30e-01
RAC1 GTPase cycle	171	1.98e-01	4.28e-01	0.07410	7.17e-02	-1.90e-02	1.06e-01	6.68e-01
GOBP MODULATION BY HOST OF VIRAL PROCESS	45	6.87e-01	8.37e-01	0.07410	5.51e-03	7.39e-02	9.49e-01	3.91e-01
GOBP NEUROGENESIS	1676	2.67e-05	5.10e-04	0.07410	4.79e-02	5.65e-02	1.09e-03	1.19e-04
GOBP PROTEIN LOCALIZATION TO PLASMA MEMBRANE RAFT	5	9.49e-01	9.77e-01	0.07400	-5.21e-02	5.26e-02	8.40e-01	8.39e-01
GOBP AMINOGLYCAN METABOLIC PROCESS	119	3.99e-01	6.32e-01	0.07390	-1.71e-02	-7.19e-02	7.48e-01	1.76e-01
GOBP RETINAL ROD CELL DIFFERENTIATION	16	8.92e-01	9.48e-01	0.07390	-6.70e-02	-3.12e-02	6.43e-01	8.29e-01
GOBP LEYDIG CELL DIFFERENTIATION	9	9.35e-01	9.70e-01	0.07380	7.05e-02	2.17e-02	7.14e-01	9.10e-01
GOBP RESPONSE TO CORTICOTROPIN RELEASING HORMONE	5	9.62e-01	9.82e-01	0.07370	-1.62e-02	-7.20e-02	9.50e-01	7.81e-01
GOBP CALCIUM MEDIATED SIGNALING	220	1.72e-01	3.94e-01	0.07370	-7.32e-02	-9.31e-03	6.15e-02	8.12e-01
GOBP NEGATIVE REGULATION OF VIRAL PROCESS	91	5.16e-01	7.22e-01	0.07370	2.72e-02	6.85e-02	6.54e-01	2.58e-01
GOBP ONE CARBON METABOLIC PROCESS	37	7.26e-01	8.60e-01	0.07370	-2.41e-03	7.36e-02	9.80e-01	4.38e-01
GOBP TRANSMEMBRANE TRANSPORT	1509	7.69e-05	1.25e-03	0.07360	-5.73e-02	-4.62e-02	1.96e-04	2.72e-03
GOBP L CYSTINE TRANSPORT	6	9.48e-01	9.77e-01	0.07360	9.17e-03	-7.30e-02	9.69e-01	7.57e-01
GOBP ENDODERM FORMATION	59	6.69e-01	8.25e-01	0.07360	6.16e-02	4.02e-02	4.13e-01	5.94e-01
GOBP PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE	103	5.01e-01	7.11e-01	0.07350	-5.88e-02	-4.41e-02	3.02e-01	4.40e-01
GOCC ACTIN BASED CELL PROJECTION	221	2.30e-01	4.64e-01	0.07350	-5.81e-02	-4.50e-02	1.37e-01	2.49e-01
Endogenous sterols	26	8.40e-01	9.19e-01	0.07350	-5.83e-02	-4.47e-02	6.07e-01	6.93e-01
GOBP POLYOL BIOSYNTHETIC PROCESS	59	5.47e-01	7.44e-01	0.07340	-5.65e-02	4.70e-02	4.53e-01	5.33e-01
GOMF ASPARTIC ENDOPEPTIDASE ACTIVITY INTRAMEMBRANE CLEAVING	8	9.24e-01	9.64e-01	0.07340	6.58e-02	-3.26e-02	7.47e-01	8.73e-01
GOMF THIOREDOXIN DEPENDENT PEROXIREDOXIN ACTIVITY	5	9.66e-01	9.84e-01	0.07330	6.29e-02	3.77e-02	8.08e-01	8.84e-01
GOBP POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT	42	7.17e-01	8.54e-01	0.07330	7.26e-02	1.03e-02	4.16e-01	9.08e-01
GOBP PHOSPHATE ION TRANSMEMBRANE TRANSPORT	14	9.00e-01	9.51e-01	0.07330	-7.07e-02	-1.91e-02	6.47e-01	9.01e-01
GOMF PROTEIN DISULFIDE REDUCTASE NAD P H ACTIVITY	8	9.30e-01	9.67e-01	0.07330	-1.28e-02	7.22e-02	9.50e-01	7.24e-01
GOBP KERATINOCYTE MIGRATION	20	8.76e-01	9.40e-01	0.07330	5.02e-02	5.34e-02	6.98e-01	6.79e-01
GOBP REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION	113	4.50e-01	6.75e-01	0.07330	2.95e-02	6.71e-02	5.88e-01	2.18e-01
Adherens junctions interactions	58	5.56e-01	7.50e-01	0.07320	5.90e-02	-4.34e-02	4.37e-01	5.68e-01
GOBP CELLULAR RESPONSE TO INSULIN LIKE GROWTH FACTOR STIMULUS	8	9.30e-01	9.67e-01	0.07320	7.19e-02	-1.37e-02	7.25e-01	9.46e-01
GOBP REGULATION OF MOLECULAR FUNCTION	1871	8.24e-06	1.84e-04	0.07320	3.74e-02	6.29e-02	7.36e-03	6.52e-06
GOBP INTERMEDIATE FILAMENT BUNDLE ASSEMBLY	8	9.26e-01	9.65e-01	0.07320	2.52e-02	-6.87e-02	9.02e-01	7.36e-01
GOBP SEROTONIN TRANSPORT	20	8.28e-01	9.13e-01	0.07320	-6.96e-02	2.26e-02	5.90e-01	8.61e-01
GOMF MYOSIN BINDING	72	4.85e-01	6.99e-01	0.07310	6.01e-02	-4.16e-02	3.78e-01	5.41e-01
Peptide hormone metabolism	81	5.62e-01	7.55e-01	0.07300	2.71e-02	6.77e-02	6.73e-01	2.92e-01
GOMF HYDROXYMETHYL FORMYL AND RELATED TRANSFERASE ACTIVITY	8	9.26e-01	9.65e-01	0.07290	-6.76e-02	2.75e-02	7.41e-01	8.93e-01
GOMF AMP BINDING	15	8.92e-01	9.48e-01	0.07290	-7.14e-02	-1.48e-02	6.32e-01	9.21e-01
GOBP AROMATIC AMINO ACID TRANSPORT	10	9.32e-01	9.68e-01	0.07290	3.06e-02	6.62e-02	8.67e-01	7.17e-01
Scavenging by Class F Receptors	6	9.53e-01	9.79e-01	0.07290	6.46e-03	7.26e-02	9.78e-01	7.58e-01
GOBP AXONEME ASSEMBLY	96	5.34e-01	7.36e-01	0.07290	-5.16e-02	-5.15e-02	3.83e-01	3.83e-01
GOBP ANATOMICAL STRUCTURE REGRESSION	15	8.89e-01	9.46e-01	0.07290	-1.09e-02	-7.20e-02	9.42e-01	6.29e-01
GOBP POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS	1044	1.41e-04	2.05e-03	0.07290	-1.18e-02	7.19e-02	5.20e-01	8.59e-05
Cobalamin (Cbl, vitamin B12) transport and metabolism	21	8.53e-01	9.26e-01	0.07280	7.11e-02	1.56e-02	5.73e-01	9.02e-01
GOBP NUCLEOTIDE TRANSPORT	44	6.80e-01	8.32e-01	0.07270	-9.40e-03	7.21e-02	9.14e-01	4.08e-01
GOBP GAMMA AMINOBUTYRIC ACID SECRETION	13	9.10e-01	9.56e-01	0.07270	6.92e-02	2.22e-02	6.66e-01	8.90e-01
GOBP REGULATION OF CELL SHAPE	132	3.95e-01	6.28e-01	0.07260	2.65e-02	6.76e-02	5.99e-01	1.80e-01
GOBP POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY	19	8.79e-01	9.41e-01	0.07250	6.44e-02	3.34e-02	6.27e-01	8.01e-01
GOBP POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE	19	8.84e-01	9.44e-01	0.07250	-4.76e-02	-5.47e-02	7.19e-01	6.80e-01
GOBP RESPONSE TO DISACCHARIDE	8	9.24e-01	9.64e-01	0.07250	3.77e-02	-6.19e-02	8.53e-01	7.62e-01
GOBP POSITIVE REGULATION OF MOLECULAR FUNCTION	1104	7.68e-04	8.61e-03	0.07250	3.26e-02	6.47e-02	6.74e-02	2.82e-04
GOMF TRANSLATION ACTIVATOR ACTIVITY	9	9.20e-01	9.62e-01	0.07250	2.19e-02	-6.91e-02	9.09e-01	7.20e-01
GOBP ESTABLISHMENT OF EPITHELIAL CELL POLARITY	33	8.05e-01	9.02e-01	0.07250	4.21e-02	5.90e-02	6.76e-01	5.57e-01
GOBP NEURON MIGRATION	173	2.98e-01	5.38e-01	0.07240	6.75e-02	2.64e-02	1.26e-01	5.49e-01
GOBP ASSOCIATIVE LEARNING	86	4.24e-01	6.53e-01	0.07240	-5.12e-02	5.12e-02	4.12e-01	4.12e-01
GOCC NEURON SPINE	167	3.27e-01	5.66e-01	0.07240	-3.54e-02	-6.32e-02	4.29e-01	1.59e-01
GOBP COLLATERAL SPROUTING	26	7.77e-01	8.88e-01	0.07240	-3.51e-02	6.34e-02	7.57e-01	5.76e-01
GOMF BETA CATENIN BINDING	101	5.03e-01	7.13e-01	0.07230	6.50e-02	3.16e-02	2.59e-01	5.83e-01
GOBP POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION	26	8.05e-01	9.02e-01	0.07230	2.87e-03	-7.23e-02	9.80e-01	5.24e-01
Signaling by PDGF	57	5.69e-01	7.59e-01	0.07230	5.76e-02	-4.37e-02	4.52e-01	5.68e-01
GOBP NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE	7	9.52e-01	9.78e-01	0.07230	6.81e-02	2.42e-02	7.55e-01	9.12e-01
GOBP ODONTOGENESIS	129	4.11e-01	6.43e-01	0.07230	2.86e-02	6.64e-02	5.75e-01	1.93e-01
GOBP DIACYLGLYCEROL BIOSYNTHETIC PROCESS	9	9.32e-01	9.68e-01	0.07230	6.76e-03	7.20e-02	9.72e-01	7.09e-01
GOBP POSITIVE REGULATION OF LIPID METABOLIC PROCESS	118	3.48e-01	5.85e-01	0.07230	1.67e-02	-7.03e-02	7.55e-01	1.87e-01
GOBP RAC PROTEIN SIGNAL TRANSDUCTION	48	7.26e-01	8.60e-01	0.07220	3.61e-02	6.25e-02	6.65e-01	4.54e-01
GOBP HYPOTHALAMUS GONADOTROPHIN RELEASING HORMONE NEURON DIFFERENTIATION	7	9.55e-01	9.80e-01	0.07220	-3.80e-02	-6.14e-02	8.62e-01	7.79e-01
GOBP AMEBOIDAL TYPE CELL MIGRATION	481	3.28e-02	1.41e-01	0.07220	6.94e-02	1.97e-02	9.11e-03	4.58e-01
GOBP PROTEASOME ASSEMBLY	12	9.21e-01	9.62e-01	0.07220	-6.56e-02	-3.01e-02	6.94e-01	8.57e-01
GOMF GROWTH FACTOR RECEPTOR BINDING	135	2.80e-01	5.19e-01	0.07210	-2.97e-02	6.57e-02	5.52e-01	1.87e-01
GOBP ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY	55	6.69e-01	8.25e-01	0.07200	6.98e-02	1.76e-02	3.70e-01	8.22e-01
GOBP POSITIVE REGULATION OF CELL GROWTH	152	2.91e-01	5.30e-01	0.07200	-6.43e-04	7.20e-02	9.89e-01	1.25e-01
GOBP TUBE DEVELOPMENT	1135	6.49e-04	7.49e-03	0.07200	6.54e-02	3.01e-02	2.03e-04	8.72e-02
GOBP HINDBRAIN MORPHOGENESIS	44	7.06e-01	8.48e-01	0.07190	4.00e-03	7.18e-02	9.63e-01	4.10e-01
GOBP POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION	46	6.42e-01	8.05e-01	0.07190	-6.13e-02	3.75e-02	4.72e-01	6.60e-01
GOBP PURINE CONTAINING COMPOUND METABOLIC PROCESS	532	3.54e-02	1.48e-01	0.07180	5.68e-02	4.39e-02	2.49e-02	8.29e-02
GOBP CELLULAR RESPONSE TO ORGANIC SUBSTANCE	1898	1.28e-05	2.67e-04	0.07180	4.04e-02	5.94e-02	3.58e-03	1.83e-05
Phospholipase C-mediated cascade; FGFR4	14	8.91e-01	9.47e-01	0.07180	-7.18e-02	3.02e-03	6.42e-01	9.84e-01
GOBP REGULATION OF RECEPTOR CLUSTERING	16	9.01e-01	9.52e-01	0.07180	3.97e-02	5.99e-02	7.83e-01	6.78e-01
GOBP RESPONSE TO LIPID	896	2.23e-03	1.91e-02	0.07180	2.15e-02	6.85e-02	2.74e-01	5.08e-04
GOBP RESPONSE TO LEAD ION	19	8.57e-01	9.29e-01	0.07170	7.17e-02	-2.62e-04	5.88e-01	9.98e-01
GOBP SPHINGOLIPID METABOLIC PROCESS	170	2.05e-01	4.36e-01	0.07170	-2.96e-02	6.53e-02	5.05e-01	1.42e-01
GOBP CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS	73	5.17e-01	7.23e-01	0.07170	6.84e-02	-2.14e-02	3.12e-01	7.52e-01
GOBP POSITIVE REGULATION OF DNA TEMPLATED DNA REPLICATION	13	9.18e-01	9.61e-01	0.07170	3.63e-02	6.18e-02	8.21e-01	7.00e-01
GOCC DENDRITIC SHAFT	40	6.79e-01	8.32e-01	0.07160	4.16e-02	-5.83e-02	6.49e-01	5.23e-01
GOBP HEART PROCESS	251	1.78e-01	4.02e-01	0.07150	-2.39e-02	-6.74e-02	5.14e-01	6.58e-02
Platelet Aggregation (Plug Formation)	39	7.46e-01	8.70e-01	0.07150	7.07e-02	1.06e-02	4.45e-01	9.08e-01
GOBP CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS	29	7.89e-01	8.93e-01	0.07150	-3.45e-03	7.14e-02	9.74e-01	5.06e-01
GOBP POSITIVE REGULATION OF RUFFLE ASSEMBLY	15	9.09e-01	9.55e-01	0.07150	-5.73e-02	-4.28e-02	7.01e-01	7.74e-01
GOBP PLATELET ACTIVATION	132	2.81e-01	5.20e-01	0.07150	-4.19e-02	5.79e-02	4.06e-01	2.51e-01
GOBP REGULATION OF GTPASE ACTIVITY	249	1.62e-01	3.82e-01	0.07150	-7.02e-02	-1.33e-02	5.64e-02	7.17e-01
GOBP CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS	42	7.53e-01	8.73e-01	0.07140	6.56e-02	2.82e-02	4.62e-01	7.52e-01
GOBP ANTIBACTERIAL HUMORAL RESPONSE	58	5.72e-01	7.62e-01	0.07140	-5.72e-02	4.27e-02	4.51e-01	5.74e-01
GOBP NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND	34	7.81e-01	8.90e-01	0.07140	6.97e-02	1.53e-02	4.82e-01	8.78e-01
GOBP MEMBRANE INVAGINATION	63	5.43e-01	7.41e-01	0.07130	-4.85e-02	5.23e-02	5.05e-01	4.73e-01
GOBP POSITIVE REGULATION OF FILOPODIUM ASSEMBLY	28	8.14e-01	9.06e-01	0.07120	7.00e-02	1.31e-02	5.21e-01	9.04e-01
GOBP REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION	23	8.65e-01	9.34e-01	0.07120	4.28e-02	5.69e-02	7.22e-01	6.36e-01
GOBP TAXIS	440	4.45e-02	1.74e-01	0.07120	-6.94e-02	-1.61e-02	1.26e-02	5.62e-01
GOBP AMP METABOLIC PROCESS	22	8.26e-01	9.12e-01	0.07120	1.61e-02	-6.93e-02	8.96e-01	5.74e-01
GOMF CALMODULIN BINDING	199	2.61e-01	4.99e-01	0.07110	-2.54e-02	-6.65e-02	5.37e-01	1.06e-01
RAF/MAP kinase cascade	252	1.71e-01	3.92e-01	0.07110	6.87e-02	1.85e-02	6.05e-02	6.13e-01
GOBP INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY	32	7.40e-01	8.68e-01	0.07110	-3.56e-02	6.16e-02	7.28e-01	5.47e-01
GOBP POSITIVE REGULATION OF CYCLASE ACTIVITY	35	7.60e-01	8.78e-01	0.07110	-1.82e-03	-7.11e-02	9.85e-01	4.67e-01
GOBP ZINC ION IMPORT INTO ORGANELLE	11	9.00e-01	9.51e-01	0.07110	-5.41e-02	4.61e-02	7.56e-01	7.91e-01
GOBP REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION	21	8.66e-01	9.35e-01	0.07100	-2.45e-02	-6.67e-02	8.46e-01	5.97e-01
GOMF CORECEPTOR ACTIVITY	55	6.82e-01	8.34e-01	0.07100	-2.08e-02	-6.79e-02	7.90e-01	3.84e-01
GOBP THIAMINE CONTAINING COMPOUND METABOLIC PROCESS	6	9.59e-01	9.81e-01	0.07090	-6.81e-02	-1.98e-02	7.73e-01	9.33e-01
GOBP REGULATION OF PHOSPHORUS METABOLIC PROCESS	1100	1.51e-03	1.41e-02	0.07090	4.70e-02	5.31e-02	8.50e-03	2.98e-03
GOMF MITOGEN ACTIVATED PROTEIN KINASE KINASE BINDING	10	9.10e-01	9.55e-01	0.07090	4.09e-02	-5.79e-02	8.23e-01	7.51e-01
GOBP L AMINO ACID BIOSYNTHETIC PROCESS	56	6.68e-01	8.25e-01	0.07090	1.43e-02	6.94e-02	8.53e-01	3.69e-01
GOBP REGULATION OF STEROL TRANSPORT	77	6.19e-01	7.90e-01	0.07080	-5.65e-02	-4.26e-02	3.91e-01	5.18e-01
GOBP REGULATION OF IMMUNE SYSTEM PROCESS	1511	5.69e-06	1.35e-04	0.07070	-1.55e-02	6.90e-02	3.13e-01	7.39e-06
GOBP IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN PHAGOCYTOSIS	22	8.41e-01	9.20e-01	0.07070	7.07e-02	-3.03e-04	5.66e-01	9.98e-01
GOBP REGULATION OF PROTEIN AUTOPHOSPHORYLATION	35	7.37e-01	8.66e-01	0.07060	6.78e-02	-1.95e-02	4.87e-01	8.42e-01
GOBP REGULATION OF NUCLEOTIDE CATABOLIC PROCESS	50	7.00e-01	8.44e-01	0.07060	1.44e-02	6.91e-02	8.60e-01	3.98e-01
GOMF ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY	428	7.53e-02	2.43e-01	0.07050	-4.63e-02	-5.32e-02	1.01e-01	5.89e-02
GOBP 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS	15	8.94e-01	9.49e-01	0.07050	7.00e-02	7.83e-03	6.39e-01	9.58e-01
GOBP REGULATION OF IMMUNE RESPONSE	900	2.84e-04	3.73e-03	0.07050	-4.61e-02	5.33e-02	1.91e-02	6.65e-03
Synthesis of PA	38	7.06e-01	8.49e-01	0.07040	3.22e-02	-6.26e-02	7.31e-01	5.04e-01
GOMF PHOSPHATASE ACTIVITY	259	2.01e-01	4.31e-01	0.07030	5.95e-02	3.75e-02	9.91e-02	2.99e-01
GOBP REPLACEMENT OSSIFICATION	29	8.36e-01	9.18e-01	0.07030	5.58e-02	4.27e-02	6.03e-01	6.90e-01
GOBP ENDOTHELIAL CELL PROLIFERATION	196	1.67e-01	3.88e-01	0.07030	-3.62e-02	6.02e-02	3.82e-01	1.46e-01
GOBP CELLULAR RESPONSE TO VIRUS	79	5.97e-01	7.77e-01	0.07020	-2.79e-02	-6.45e-02	6.68e-01	3.22e-01
GOBP MAINTENANCE OF PROTEIN LOCATION IN CELL	63	6.27e-01	7.96e-01	0.07010	6.98e-02	6.22e-03	3.38e-01	9.32e-01
GOCC GOLGI MEMBRANE	655	2.12e-02	1.04e-01	0.07000	5.13e-02	4.76e-02	2.50e-02	3.76e-02
GOBP REGULATION OF MUSCLE CONTRACTION	165	3.62e-01	5.99e-01	0.07000	-3.73e-02	-5.92e-02	4.08e-01	1.90e-01
GOBP RESPONSE TO ETHER	15	8.86e-01	9.45e-01	0.06990	-8.12e-03	6.94e-02	9.57e-01	6.41e-01
GOBP CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS	155	3.86e-01	6.20e-01	0.06990	5.88e-02	3.79e-02	2.07e-01	4.15e-01
GOBP POSTSYNAPTIC SPECIALIZATION ASSEMBLY	29	8.40e-01	9.19e-01	0.06990	-5.05e-02	-4.83e-02	6.38e-01	6.52e-01
GOBP REGULATION OF CALCIUM MEDIATED SIGNALING	95	4.17e-01	6.47e-01	0.06990	-5.57e-02	4.21e-02	3.48e-01	4.78e-01
GOBP CANONICAL NF KAPPAB SIGNAL TRANSDUCTION	299	1.69e-01	3.91e-01	0.06980	5.10e-02	4.77e-02	1.29e-01	1.56e-01
GOCC SECRETORY GRANULE	865	4.42e-04	5.43e-03	0.06980	-5.08e-02	4.79e-02	1.12e-02	1.69e-02
GOBP REGULATION OF CHONDROCYTE DIFFERENTIATION	52	7.29e-01	8.61e-01	0.06980	5.64e-02	4.11e-02	4.82e-01	6.08e-01
GOMF 1 PHOSPHATIDYLINOSITOL 4 PHOSPHATE 5 KINASE ACTIVITY	9	9.38e-01	9.72e-01	0.06980	6.88e-02	1.14e-02	7.21e-01	9.53e-01
GOBP REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY	13	8.94e-01	9.49e-01	0.06970	6.61e-02	-2.22e-02	6.80e-01	8.90e-01
GOBP NEUROTRANSMITTER SECRETION	141	4.15e-01	6.45e-01	0.06970	-6.16e-02	-3.27e-02	2.07e-01	5.02e-01
GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION	31	8.28e-01	9.13e-01	0.06970	5.73e-02	3.97e-02	5.81e-01	7.02e-01
GOBP POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE	128	3.22e-01	5.60e-01	0.06970	-3.02e-02	6.28e-02	5.55e-01	2.20e-01
GOBP NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT	121	4.24e-01	6.53e-01	0.06960	1.04e-02	6.88e-02	8.43e-01	1.91e-01
GOBP MULTI MULTICELLULAR ORGANISM PROCESS	199	2.74e-01	5.14e-01	0.06960	2.41e-02	6.53e-02	5.58e-01	1.12e-01
GOMF THIOREDOXIN DISULFIDE REDUCTASE NADPH ACTIVITY	7	9.54e-01	9.79e-01	0.06960	-6.69e-02	-1.91e-02	7.59e-01	9.30e-01
GOBP SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT	41	6.98e-01	8.43e-01	0.06950	2.78e-02	-6.37e-02	7.58e-01	4.80e-01
GOBP CELL SUBSTRATE ADHESION	346	5.99e-02	2.10e-01	0.06950	6.80e-02	-1.46e-02	2.98e-02	6.42e-01
GOBP CELL SURFACE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY	630	2.49e-02	1.17e-01	0.06950	5.57e-02	4.15e-02	1.70e-02	7.52e-02
ADORA2B mediated anti-inflammatory cytokines production	42	7.58e-01	8.76e-01	0.06950	6.60e-02	2.18e-02	4.60e-01	8.07e-01
GOBP RESPONSE TO ATP	31	8.32e-01	9.16e-01	0.06940	4.72e-02	5.09e-02	6.49e-01	6.24e-01
GOBP ATP TRANSPORT	19	8.60e-01	9.31e-01	0.06940	-7.78e-03	6.89e-02	9.53e-01	6.03e-01
GOBP SYNAPTIC VESICLE MEMBRANE ORGANIZATION	27	8.16e-01	9.07e-01	0.06940	6.94e-02	1.23e-04	5.33e-01	9.99e-01
GOCC ENDOCYTIC VESICLE MEMBRANE	189	3.22e-01	5.60e-01	0.06930	3.89e-02	5.74e-02	3.56e-01	1.74e-01
GOBP STEROL TRANSPORT	128	3.32e-01	5.71e-01	0.06930	2.59e-02	-6.43e-02	6.13e-01	2.09e-01
GOBP UTP BIOSYNTHETIC PROCESS	10	9.42e-01	9.74e-01	0.06930	4.48e-02	5.28e-02	8.06e-01	7.72e-01
GOCC PERINUCLEAR REGION OF CYTOPLASM	706	1.58e-02	8.41e-02	0.06930	5.81e-02	3.76e-02	8.48e-03	8.83e-02
GOMF GALACTOSYLTRANSFERASE ACTIVITY	32	7.98e-01	8.98e-01	0.06920	-6.84e-02	-1.04e-02	5.03e-01	9.19e-01
GOBP RESPONSE TO TYPE II INTERFERON	115	4.02e-01	6.35e-01	0.06920	-9.33e-03	6.86e-02	8.63e-01	2.04e-01
GOCC POSTSYNAPSE	626	8.22e-03	5.19e-02	0.06920	8.03e-03	-6.87e-02	7.32e-01	3.33e-03
GOBP ISOPRENOID METABOLIC PROCESS	134	3.93e-01	6.27e-01	0.06920	-1.13e-02	-6.83e-02	8.22e-01	1.72e-01
GOBP MEMBRANE LIPID METABOLIC PROCESS	217	1.90e-01	4.17e-01	0.06920	-4.51e-03	6.90e-02	9.09e-01	7.97e-02
GOMF L LACTATE DEHYDROGENASE ACTIVITY	5	9.71e-01	9.86e-01	0.06920	4.11e-02	5.56e-02	8.73e-01	8.30e-01
GOBP PYRIMIDINE NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS	6	9.56e-01	9.80e-01	0.06910	9.43e-04	6.91e-02	9.97e-01	7.69e-01
GOBP RESPONSE TO INTERLEUKIN 1	110	3.74e-01	6.10e-01	0.06910	-5.72e-02	3.88e-02	3.00e-01	4.82e-01
GOCC CILIUM	733	1.95e-03	1.72e-02	0.06890	6.07e-02	-3.27e-02	5.13e-03	1.32e-01
GOBP REGULATION OF CELL PROJECTION ORGANIZATION	649	2.08e-02	1.02e-01	0.06890	3.23e-02	6.09e-02	1.60e-01	8.14e-03
GOBP REGULATION OF NATURAL KILLER CELL PROLIFERATION	12	9.32e-01	9.68e-01	0.06890	-4.52e-02	-5.20e-02	7.86e-01	7.55e-01
GOCC MEMBRANE MICRODOMAIN	282	8.10e-02	2.54e-01	0.06890	-4.43e-02	5.27e-02	2.00e-01	1.28e-01
GOBP CARBOHYDRATE DERIVATIVE METABOLIC PROCESS	1051	2.47e-03	2.09e-02	0.06890	3.75e-02	5.78e-02	3.98e-02	1.55e-03
GOBP NEUROMUSCULAR PROCESS CONTROLLING POSTURE	18	8.50e-01	9.25e-01	0.06880	-4.91e-02	4.81e-02	7.18e-01	7.24e-01
GOBP REGULATION OF SKELETAL MUSCLE SATELLITE CELL PROLIFERATION	12	9.01e-01	9.52e-01	0.06880	6.19e-02	-2.99e-02	7.10e-01	8.58e-01
Disinhibition of SNARE formation	5	9.64e-01	9.83e-01	0.06880	2.91e-03	6.87e-02	9.91e-01	7.90e-01
GOBP AMINO ACID BIOSYNTHETIC PROCESS	72	6.48e-01	8.09e-01	0.06880	3.44e-02	5.96e-02	6.14e-01	3.82e-01
GOBP TRANSCYTOSIS	21	8.70e-01	9.36e-01	0.06870	1.69e-02	6.66e-02	8.93e-01	5.97e-01
GOBP ERBB2 SIGNALING PATHWAY	23	8.26e-01	9.12e-01	0.06870	2.07e-02	-6.55e-02	8.64e-01	5.87e-01
GOBP POSITIVE REGULATION OF GROWTH	240	2.27e-01	4.61e-01	0.06870	2.73e-02	6.30e-02	4.66e-01	9.27e-02
GOMF MELANOCORTIN RECEPTOR BINDING	5	9.56e-01	9.80e-01	0.06860	-4.89e-02	4.80e-02	8.50e-01	8.52e-01
GOBP LIPOPROTEIN LOCALIZATION	24	8.15e-01	9.07e-01	0.06850	-2.77e-02	6.26e-02	8.14e-01	5.95e-01
GOMF PROTEIN KINASE A CATALYTIC SUBUNIT BINDING	14	8.89e-01	9.46e-01	0.06850	-6.39e-02	2.47e-02	6.79e-01	8.73e-01
GOMF SCAFFOLD PROTEIN BINDING	66	6.84e-01	8.35e-01	0.06830	-4.57e-02	-5.08e-02	5.21e-01	4.75e-01
EPHA-mediated growth cone collapse	29	8.38e-01	9.19e-01	0.06820	2.96e-02	6.15e-02	7.83e-01	5.66e-01
GOBP SYNAPSE ORGANIZATION	459	5.54e-02	2.00e-01	0.06820	-2.00e-02	-6.52e-02	4.63e-01	1.66e-02
GOBP EPIDERMIS MORPHOGENESIS	36	7.47e-01	8.70e-01	0.06820	6.57e-02	-1.83e-02	4.95e-01	8.49e-01
GOMF KINESIN BINDING	42	7.62e-01	8.79e-01	0.06810	6.55e-02	1.87e-02	4.63e-01	8.34e-01
GOCC HAUS COMPLEX	7	9.45e-01	9.76e-01	0.06810	-1.79e-02	6.58e-02	9.35e-01	7.63e-01
GOBP GLUTAMATE METABOLIC PROCESS	33	7.63e-01	8.80e-01	0.06810	-2.09e-02	6.49e-02	8.36e-01	5.19e-01
GOBP MONOSACCHARIDE CATABOLIC PROCESS	48	6.67e-01	8.24e-01	0.06810	-6.23e-02	2.74e-02	4.55e-01	7.42e-01
GOBP RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS	31	8.30e-01	9.15e-01	0.06810	6.08e-02	3.07e-02	5.58e-01	7.68e-01
GOBP TETRAHYDROFOLATE BIOSYNTHETIC PROCESS	7	9.53e-01	9.79e-01	0.06810	6.75e-02	9.02e-03	7.57e-01	9.67e-01
GOBP T CELL PROLIFERATION	204	1.68e-01	3.90e-01	0.06810	-4.40e-02	5.20e-02	2.79e-01	2.01e-01
GOBP ENDOLYSOSOMAL TOLL LIKE RECEPTOR SIGNALING PATHWAY	45	7.23e-01	8.58e-01	0.06810	1.60e-03	6.80e-02	9.85e-01	4.30e-01
GOBP NEGATIVE REGULATION OF HORMONE SECRETION	66	6.32e-01	7.99e-01	0.06800	-6.77e-02	-6.11e-03	3.42e-01	9.32e-01
GOBP LACTATION	38	7.79e-01	8.89e-01	0.06800	1.52e-02	6.62e-02	8.71e-01	4.80e-01
GOBP ENDOTHELIAL CELL APOPTOTIC PROCESS	68	6.58e-01	8.17e-01	0.06790	-2.55e-02	-6.30e-02	7.16e-01	3.69e-01
GOMF ANTIPORTER ACTIVITY	128	4.41e-01	6.68e-01	0.06790	-6.53e-02	-1.86e-02	2.02e-01	7.17e-01
GOBP EAR MORPHOGENESIS	125	4.64e-01	6.86e-01	0.06790	2.50e-02	6.31e-02	6.29e-01	2.23e-01
GOBP REGULATION OF CIRCADIAN SLEEP WAKE CYCLE NON REM SLEEP	5	9.58e-01	9.80e-01	0.06780	-3.81e-02	5.61e-02	8.83e-01	8.28e-01
GOMF TITIN BINDING	13	9.20e-01	9.62e-01	0.06780	-1.82e-02	-6.53e-02	9.09e-01	6.84e-01
GOBP NADPH REGENERATION	21	8.47e-01	9.23e-01	0.06770	6.58e-02	-1.62e-02	6.02e-01	8.98e-01
GOBP NEGATIVE REGULATION OF KERATINOCYTE DIFFERENTIATION	8	9.37e-01	9.71e-01	0.06770	-6.34e-02	2.35e-02	7.56e-01	9.08e-01
GOBP IRON IMPORT INTO CELL	10	9.18e-01	9.61e-01	0.06760	-5.86e-02	3.37e-02	7.48e-01	8.54e-01
GOBP NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH	92	4.66e-01	6.88e-01	0.06760	6.14e-02	-2.82e-02	3.09e-01	6.40e-01
GOBP RHYTHMIC BEHAVIOR	46	7.65e-01	8.81e-01	0.06750	-5.81e-02	-3.45e-02	4.96e-01	6.85e-01
GOBP REGULATION OF NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION	7	9.44e-01	9.75e-01	0.06750	2.73e-02	-6.18e-02	9.01e-01	7.77e-01
Metabolism of porphyrins	27	8.10e-01	9.04e-01	0.06750	-1.49e-02	6.59e-02	8.93e-01	5.54e-01
GOBP CELLULAR RESPONSE TO ALKALOID	37	7.53e-01	8.73e-01	0.06750	6.66e-02	-1.14e-02	4.84e-01	9.05e-01
GOMF ADENYLATE CYCLASE REGULATOR ACTIVITY	8	9.53e-01	9.79e-01	0.06750	-6.21e-02	-2.65e-02	7.61e-01	8.97e-01
GOMF MICROTUBULE BINDING	267	2.27e-01	4.61e-01	0.06750	4.65e-02	4.90e-02	1.91e-01	1.69e-01
GOBP REGULATION OF HEART RATE	100	4.75e-01	6.95e-01	0.06750	7.07e-03	-6.71e-02	9.03e-01	2.46e-01
Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation	35	8.13e-01	9.06e-01	0.06740	2.95e-02	6.06e-02	7.63e-01	5.35e-01
GOBP ACTIN FILAMENT BASED PROCESS	797	2.20e-03	1.89e-02	0.06740	6.46e-02	-1.92e-02	1.94e-03	3.56e-01
GOCC NEURONAL DENSE CORE VESICLE	25	8.56e-01	9.28e-01	0.06730	-6.38e-02	-2.14e-02	5.81e-01	8.53e-01
GOBP POSITIVE REGULATION OF HAIR FOLLICLE DEVELOPMENT	12	9.30e-01	9.67e-01	0.06730	-6.22e-02	-2.57e-02	7.09e-01	8.78e-01
GOBP RESPONSE TO OSMOTIC STRESS	80	6.40e-01	8.03e-01	0.06730	4.39e-02	5.10e-02	4.98e-01	4.30e-01
GOMF GROWTH FACTOR ACTIVITY	152	2.79e-01	5.19e-01	0.06730	-5.76e-02	3.47e-02	2.20e-01	4.60e-01
GOMF SHORT CHAIN CARBOXYLESTERASE ACTIVITY	6	9.67e-01	9.84e-01	0.06720	4.87e-02	4.62e-02	8.36e-01	8.45e-01
GOBP MONOSACCHARIDE TRANSMEMBRANE TRANSPORT	121	5.09e-01	7.17e-01	0.06710	-4.10e-02	-5.31e-02	4.36e-01	3.13e-01
RAS processing	22	8.77e-01	9.41e-01	0.06710	6.12e-02	2.76e-02	6.19e-01	8.22e-01
GOBP REGULATION OF CALCIUM ION TRANSPORT	243	1.99e-01	4.29e-01	0.06710	-8.03e-03	-6.66e-02	8.29e-01	7.36e-02
GOBP MONOSACCHARIDE METABOLIC PROCESS	242	2.25e-01	4.59e-01	0.06710	6.42e-02	1.93e-02	8.53e-02	6.05e-01
EPH-ephrin mediated repulsion of cells	50	7.49e-01	8.71e-01	0.06710	3.17e-02	5.91e-02	6.98e-01	4.70e-01
GOBP T CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL	12	9.18e-01	9.61e-01	0.06700	-2.07e-03	6.69e-02	9.90e-01	6.88e-01
GOBP TRIPEPTIDE TRANSPORT	12	9.16e-01	9.60e-01	0.06690	6.67e-02	-5.58e-03	6.89e-01	9.73e-01
GOBP NEGATIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS	5	9.58e-01	9.81e-01	0.06680	-4.51e-02	4.93e-02	8.61e-01	8.49e-01
GOBP NATURAL KILLER CELL ACTIVATION	90	4.84e-01	6.99e-01	0.06670	-2.67e-02	6.11e-02	6.61e-01	3.16e-01
Uptake and function of diphtheria toxin	6	9.62e-01	9.82e-01	0.06670	1.12e-02	6.57e-02	9.62e-01	7.80e-01
GOBP NEGATIVE REGULATION OF MEMBRANE POTENTIAL	13	9.06e-01	9.54e-01	0.06670	-1.38e-02	6.52e-02	9.31e-01	6.84e-01
GOBP NEGATIVE REGULATION OF PEPTIDASE ACTIVITY	118	5.22e-01	7.26e-01	0.06670	-5.30e-02	-4.05e-02	3.20e-01	4.48e-01
GOBP MOLTING CYCLE PROCESS	95	5.95e-01	7.75e-01	0.06670	4.86e-02	4.56e-02	4.13e-01	4.42e-01
GOBP RESPONSE TO ESTROGEN	67	6.93e-01	8.40e-01	0.06660	5.00e-02	4.39e-02	4.79e-01	5.34e-01
Axon guidance	510	4.91e-02	1.86e-01	0.06650	6.30e-02	2.12e-02	1.49e-02	4.13e-01
GOBP POST EMBRYONIC ANIMAL MORPHOGENESIS	5	9.60e-01	9.81e-01	0.06650	-3.38e-02	5.72e-02	8.96e-01	8.25e-01
GOBP GLUCOSAMINE CONTAINING COMPOUND CATABOLIC PROCESS	9	9.30e-01	9.67e-01	0.06640	-5.94e-02	2.97e-02	7.57e-01	8.78e-01
GOBP NEURON INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS	21	8.43e-01	9.21e-01	0.06640	-3.06e-02	5.90e-02	8.09e-01	6.40e-01
GOBP SUPRAMOLECULAR FIBER ORGANIZATION	821	2.52e-03	2.11e-02	0.06640	6.47e-02	-1.48e-02	1.63e-03	4.71e-01
GOBP PROTEIN C LINKED GLYCOSYLATION	5	9.73e-01	9.87e-01	0.06630	-5.24e-02	-4.07e-02	8.39e-01	8.75e-01
GOBP CELLULAR RESPONSE TO FATTY ACID	33	8.30e-01	9.15e-01	0.06630	-5.80e-02	-3.22e-02	5.64e-01	7.49e-01
GOBP POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION	18	8.60e-01	9.31e-01	0.06630	4.64e-02	-4.73e-02	7.33e-01	7.28e-01
GOMF ACETYLGLUCOSAMINYLTRANSFERASE ACTIVITY	42	7.13e-01	8.52e-01	0.06630	-2.90e-02	5.96e-02	7.45e-01	5.04e-01
GOBP SYNAPSE ASSEMBLY	196	2.20e-01	4.54e-01	0.06630	2.09e-02	-6.29e-02	6.14e-01	1.29e-01
GOBP ADULT BEHAVIOR	143	4.61e-01	6.85e-01	0.06630	5.02e-02	4.33e-02	3.00e-01	3.72e-01
GOBP POST TRANSCRIPTIONAL REGULATION OF GENE EXPRESSION	976	5.14e-04	6.16e-03	0.06630	3.07e-02	-5.87e-02	1.04e-01	1.89e-03
GOBP RADIAL GLIA GUIDED PYRAMIDAL NEURON MIGRATION	6	9.51e-01	9.78e-01	0.06630	-4.99e-02	4.36e-02	8.32e-01	8.53e-01
GOBP PURINE NUCLEOTIDE TRANSPORT	38	7.72e-01	8.85e-01	0.06620	1.68e-03	6.62e-02	9.86e-01	4.80e-01
GOBP POSITIVE REGULATION OF SIGNALING	1747	1.66e-04	2.35e-03	0.06620	4.57e-02	4.79e-02	1.52e-03	8.76e-04
GOMF UREA TRANSMEMBRANE TRANSPORTER ACTIVITY	7	9.53e-01	9.79e-01	0.06610	6.61e-02	-2.93e-04	7.62e-01	9.99e-01
GOBP CELLULAR RESPONSE TO CALCIUM ION	69	6.79e-01	8.32e-01	0.06610	3.15e-02	5.81e-02	6.51e-01	4.04e-01
GOMF PROTEIN TYROSINE PHOSPHATASE ACTIVITY	97	4.98e-01	7.09e-01	0.06610	-6.56e-02	8.07e-03	2.64e-01	8.91e-01
GOMF ADENYLATE CYCLASE BINDING	12	9.21e-01	9.62e-01	0.06600	1.10e-03	-6.60e-02	9.95e-01	6.92e-01
GOBP REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY	44	7.44e-01	8.70e-01	0.06600	-6.59e-02	-2.76e-03	4.49e-01	9.75e-01
GOBP OLIGOPEPTIDE IMPORT ACROSS PLASMA MEMBRANE	5	9.73e-01	9.87e-01	0.06600	-4.05e-02	-5.21e-02	8.76e-01	8.40e-01
GOMF FMN BINDING	15	9.12e-01	9.57e-01	0.06600	-6.38e-02	-1.66e-02	6.69e-01	9.11e-01
GOBP REGULATION OF DENDRITE DEVELOPMENT	92	6.12e-01	7.86e-01	0.06590	-4.55e-02	-4.77e-02	4.51e-01	4.29e-01
GOBP POSTSYNAPSE ORGANIZATION	183	3.65e-01	6.01e-01	0.06590	-3.29e-02	-5.71e-02	4.42e-01	1.83e-01
PECAM1 interactions	12	9.33e-01	9.69e-01	0.06590	2.63e-02	6.04e-02	8.75e-01	7.17e-01
GOBP CYTOSKELETON ORGANIZATION	1456	3.03e-04	3.96e-03	0.06590	6.26e-02	2.04e-02	6.36e-05	1.92e-01
GOBP MUSCLE SYSTEM PROCESS	449	2.97e-02	1.31e-01	0.06590	2.99e-02	-5.87e-02	2.77e-01	3.31e-02
GOMF AROMATIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY	9	9.35e-01	9.70e-01	0.06570	-6.37e-02	1.63e-02	7.41e-01	9.32e-01
GOBP MYELOID PROGENITOR CELL DIFFERENTIATION	9	9.43e-01	9.74e-01	0.06570	-6.54e-02	-6.09e-03	7.34e-01	9.75e-01
GOBP PROTEIN LOCALIZATION TO PRESYNAPSE	11	9.19e-01	9.61e-01	0.06570	-6.20e-02	2.17e-02	7.22e-01	9.01e-01
GOCC MALE GERM CELL NUCLEUS	52	7.07e-01	8.49e-01	0.06570	6.57e-02	2.18e-03	4.13e-01	9.78e-01
Nervous system development	534	4.28e-02	1.70e-01	0.06570	6.34e-02	1.72e-02	1.22e-02	4.96e-01
GOBP REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS	91	5.36e-01	7.37e-01	0.06560	2.78e-03	-6.55e-02	9.63e-01	2.80e-01
GOBP CEREBRAL CORTEX GABAERGIC INTERNEURON DEVELOPMENT	5	9.70e-01	9.86e-01	0.06560	1.45e-02	6.40e-02	9.55e-01	8.04e-01
GOCC PERIKARYON	144	3.32e-01	5.71e-01	0.06560	-6.13e-02	2.32e-02	2.04e-01	6.31e-01
GOBP PROTEIN TRANSPORT WITHIN LIPID BILAYER	6	9.67e-01	9.84e-01	0.06560	3.07e-02	5.79e-02	8.96e-01	8.06e-01
FCGR3A-mediated IL10 synthesis	36	7.58e-01	8.76e-01	0.06550	-6.12e-02	2.34e-02	5.25e-01	8.08e-01
GOBP CRANIAL NERVE MORPHOGENESIS	30	7.96e-01	8.97e-01	0.06550	-6.20e-02	2.12e-02	5.57e-01	8.41e-01
GOBP REGULATION OF NADP METABOLIC PROCESS	8	9.51e-01	9.78e-01	0.06550	-9.72e-03	-6.48e-02	9.62e-01	7.51e-01
GOCC EARLY ENDOSOME	424	8.78e-02	2.68e-01	0.06550	6.19e-02	2.15e-02	2.88e-02	4.48e-01
GOMF SULFUR AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY	11	9.43e-01	9.74e-01	0.06550	5.07e-02	4.15e-02	7.71e-01	8.12e-01
GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO OXIDATIVE STRESS	5	9.60e-01	9.81e-01	0.06540	-3.94e-02	5.22e-02	8.79e-01	8.40e-01
GOBP POSITIVE REGULATION OF CELL SUBSTRATE ADHESION	122	5.22e-01	7.26e-01	0.06540	5.31e-02	3.82e-02	3.11e-01	4.66e-01
GOBP HOMOTYPIC CELL CELL ADHESION	96	4.76e-01	6.95e-01	0.06520	-2.72e-02	5.92e-02	6.45e-01	3.16e-01
GOMF PROTEIN BINDING INVOLVED IN HETEROTYPIC CELL CELL ADHESION	12	9.32e-01	9.68e-01	0.06520	-1.99e-02	-6.21e-02	9.05e-01	7.10e-01
GOMF TUBULIN BINDING	364	1.53e-01	3.69e-01	0.06520	4.66e-02	4.56e-02	1.27e-01	1.35e-01
GOBP MEMBRANE PROTEIN PROTEOLYSIS	59	6.21e-01	7.92e-01	0.06520	4.94e-02	-4.26e-02	5.12e-01	5.72e-01
GOBP ISOPRENOID BIOSYNTHETIC PROCESS	29	8.55e-01	9.27e-01	0.06520	5.56e-02	3.40e-02	6.04e-01	7.51e-01
GOBP REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY	52	7.09e-01	8.50e-01	0.06520	6.52e-02	8.28e-04	4.16e-01	9.92e-01
GOBP SULFUR COMPOUND CATABOLIC PROCESS	40	7.26e-01	8.60e-01	0.06510	5.35e-02	-3.72e-02	5.58e-01	6.84e-01
GOBP POSITIVE REGULATION OF INSULIN SECRETION	85	5.30e-01	7.33e-01	0.06510	-2.03e-02	6.18e-02	7.46e-01	3.25e-01
GOBP PHOSPHATIDYLCHOLINE CATABOLIC PROCESS	16	9.17e-01	9.60e-01	0.06500	-5.68e-02	-3.18e-02	6.94e-01	8.26e-01
GOBP REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE	171	3.12e-01	5.52e-01	0.06490	6.47e-02	-5.25e-03	1.44e-01	9.06e-01
GOBP SKIN EPIDERMIS DEVELOPMENT	128	4.09e-01	6.41e-01	0.06490	-9.00e-03	6.43e-02	8.60e-01	2.09e-01
GOMF PHOSPHATIDYLINOSITOL BISPHOSPHATE BINDING	103	4.45e-01	6.72e-01	0.06490	3.43e-02	-5.51e-02	5.47e-01	3.34e-01
GOBP NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORTER ACTIVITY	64	6.10e-01	7.85e-01	0.06490	5.81e-02	-2.89e-02	4.21e-01	6.90e-01
Transmission across Chemical Synapses	255	2.02e-01	4.32e-01	0.06480	-6.45e-02	-5.98e-03	7.60e-02	8.69e-01
GOCC DENDRITE CYTOPLASM	26	8.13e-01	9.06e-01	0.06480	5.05e-02	-4.06e-02	6.56e-01	7.20e-01
GOBP NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION	110	4.61e-01	6.84e-01	0.06480	1.11e-02	-6.38e-02	8.40e-01	2.47e-01
GOMF AMINE BINDING	12	9.20e-01	9.62e-01	0.06480	6.43e-02	-7.99e-03	7.00e-01	9.62e-01
GOBP REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION	286	1.21e-01	3.23e-01	0.06480	6.10e-02	-2.19e-02	7.61e-02	5.25e-01
GOMF VITAMIN B6 BINDING	53	6.87e-01	8.37e-01	0.06470	1.18e-02	-6.36e-02	8.82e-01	4.23e-01
GOMF CLATHRIN BINDING	55	7.45e-01	8.70e-01	0.06470	3.20e-02	5.62e-02	6.81e-01	4.71e-01
GOBP SYNAPTIC VESICLE LOCALIZATION	55	6.48e-01	8.09e-01	0.06470	5.26e-02	-3.76e-02	5.00e-01	6.30e-01
GOBP ENSHEATHMENT OF NEURONS	154	3.06e-01	5.46e-01	0.06460	5.68e-02	-3.07e-02	2.23e-01	5.10e-01
GOMF PHOSPHOLIPID TRANSPORTER ACTIVITY	63	6.11e-01	7.86e-01	0.06450	-5.39e-02	3.54e-02	4.59e-01	6.27e-01
GOCC CILIARY BASE	45	7.87e-01	8.92e-01	0.06440	5.61e-02	3.17e-02	5.15e-01	7.13e-01
GOMF G PROTEIN BETA GAMMA SUBUNIT COMPLEX BINDING	21	8.86e-01	9.45e-01	0.06440	-6.18e-02	-1.80e-02	6.24e-01	8.87e-01
GOBP POSITIVE REGULATION OF CELL ADHESION	473	5.44e-02	1.98e-01	0.06430	4.64e-03	6.41e-02	8.63e-01	1.69e-02
GOMF FATTY ACID BINDING	48	7.72e-01	8.85e-01	0.06420	-2.74e-02	-5.80e-02	7.42e-01	4.87e-01
GOCC NEURON PROJECTION TERMINUS	122	5.05e-01	7.14e-01	0.06410	2.03e-02	6.08e-02	6.98e-01	2.46e-01
CDC42 GTPase cycle	143	3.70e-01	6.06e-01	0.06410	6.28e-02	-1.28e-02	1.95e-01	7.91e-01
GOBP POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS	19	8.63e-01	9.33e-01	0.06410	5.18e-02	-3.77e-02	6.96e-01	7.76e-01
GOMF CERAMIDE 1 PHOSPHATE BINDING	7	9.61e-01	9.82e-01	0.06410	1.87e-02	6.13e-02	9.32e-01	7.79e-01
GOMF PHOSPHATIDYLCHOLINE TRANSPORTER ACTIVITY	18	9.12e-01	9.56e-01	0.06400	-5.21e-02	-3.73e-02	7.02e-01	7.84e-01
GOMF ARYLESTERASE ACTIVITY	6	9.54e-01	9.79e-01	0.06400	-4.80e-02	4.23e-02	8.39e-01	8.58e-01
Glucose metabolism	83	5.63e-01	7.56e-01	0.06390	6.28e-02	-1.21e-02	3.23e-01	8.48e-01
GOBP STEROL HOMEOSTASIS	101	4.88e-01	7.02e-01	0.06380	1.75e-02	-6.14e-02	7.61e-01	2.86e-01
GOBP LEUKOCYTE HOMEOSTASIS	103	5.78e-01	7.66e-01	0.06380	5.77e-02	2.72e-02	3.11e-01	6.33e-01
GOBP OLIGODENDROCYTE DEVELOPMENT	45	7.43e-01	8.69e-01	0.06380	6.36e-02	-5.25e-03	4.60e-01	9.51e-01
GOBP INNATE IMMUNE RESPONSE	906	1.23e-03	1.23e-02	0.06380	-5.10e-02	3.83e-02	9.25e-03	5.03e-02
GOBP SPERMATID NUCLEUS DIFFERENTIATION	27	8.13e-01	9.06e-01	0.06380	5.32e-02	-3.52e-02	6.32e-01	7.51e-01
GOBP BODY FLUID SECRETION	89	6.18e-01	7.90e-01	0.06380	-2.41e-02	-5.91e-02	6.95e-01	3.35e-01
GOBP RESPONSE TO PURINE CONTAINING COMPOUND	138	4.80e-01	6.97e-01	0.06370	5.79e-02	2.66e-02	2.40e-01	5.90e-01
GOMF HYDROLASE ACTIVITY ACTING ON ESTER BONDS	729	2.63e-02	1.21e-01	0.06370	5.42e-02	3.34e-02	1.26e-02	1.24e-01
Metabolism of lipids	722	2.77e-02	1.25e-01	0.06370	5.36e-02	3.44e-02	1.41e-02	1.16e-01
GOBP EMBRYONIC VISCEROCRANIUM MORPHOGENESIS	10	9.48e-01	9.77e-01	0.06370	5.73e-02	2.77e-02	7.54e-01	8.79e-01
RUNX1 regulates transcription of genes involved in BCR signaling	6	9.67e-01	9.84e-01	0.06360	1.75e-02	6.12e-02	9.41e-01	7.95e-01
GOBP NONASSOCIATIVE LEARNING	6	9.55e-01	9.80e-01	0.06350	4.87e-02	-4.09e-02	8.36e-01	8.62e-01
GOBP EPITHELIUM DEVELOPMENT	1194	2.79e-03	2.28e-02	0.06350	2.98e-02	5.60e-02	8.24e-02	1.11e-03
GOBP PRONEPHROS DEVELOPMENT	9	9.56e-01	9.80e-01	0.06350	-4.68e-02	-4.29e-02	8.08e-01	8.24e-01
GOMF COPPER ION BINDING	58	6.73e-01	8.28e-01	0.06330	-1.26e-02	6.21e-02	8.68e-01	4.14e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS	60	7.40e-01	8.68e-01	0.06330	5.21e-02	3.60e-02	4.85e-01	6.29e-01
GOBP NEGATIVE REGULATION OF AXONOGENESIS	45	7.98e-01	8.98e-01	0.06330	-3.65e-02	-5.17e-02	6.72e-01	5.48e-01
GOBP NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION	54	7.65e-01	8.81e-01	0.06330	4.02e-02	4.88e-02	6.09e-01	5.35e-01
GOBP MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE	43	8.06e-01	9.02e-01	0.06320	3.65e-02	5.17e-02	6.79e-01	5.58e-01
GOBP POLARIZED EPITHELIAL CELL DIFFERENTIATION	25	8.63e-01	9.33e-01	0.06320	6.25e-02	9.06e-03	5.88e-01	9.37e-01
GOBP DELAMINATION	7	9.62e-01	9.82e-01	0.06310	-6.10e-02	-1.61e-02	7.80e-01	9.41e-01
GOBP REGULATION OF LEUKOCYTE CHEMOTAXIS	117	4.14e-01	6.45e-01	0.06310	-4.01e-02	4.87e-02	4.53e-01	3.63e-01
GOBP COLLAGEN BIOSYNTHETIC PROCESS	46	7.26e-01	8.60e-01	0.06310	1.77e-02	-6.05e-02	8.35e-01	4.77e-01
GOBP REGULATION OF PROTEIN TRANSPORT	421	1.31e-01	3.40e-01	0.06310	4.24e-02	4.67e-02	1.36e-01	1.01e-01
GOBP PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS	167	4.16e-01	6.47e-01	0.06300	2.45e-02	5.81e-02	5.84e-01	1.95e-01
GOBP REGULATION OF CATALYTIC ACTIVITY	1302	1.37e-03	1.32e-02	0.06300	2.16e-02	5.92e-02	1.90e-01	3.32e-04
GOBP RETINA LAYER FORMATION	23	8.93e-01	9.49e-01	0.06300	-4.46e-02	-4.45e-02	7.11e-01	7.12e-01
GOBP POSITIVE REGULATION OF LYMPHOCYTE MIGRATION	40	8.22e-01	9.10e-01	0.06300	-4.79e-02	-4.10e-02	6.00e-01	6.54e-01
GOBP BEHAVIORAL RESPONSE TO COCAINE	16	9.24e-01	9.64e-01	0.06300	4.09e-02	4.79e-02	7.77e-01	7.40e-01
GOBP RENAL TUBULE DEVELOPMENT	100	5.84e-01	7.69e-01	0.06300	2.07e-02	5.95e-02	7.21e-01	3.04e-01
GOBP NERVE DEVELOPMENT	95	6.27e-01	7.96e-01	0.06300	4.91e-02	3.94e-02	4.08e-01	5.07e-01
GOBP ARGININE METABOLIC PROCESS	18	8.74e-01	9.39e-01	0.06280	3.61e-02	-5.14e-02	7.91e-01	7.06e-01
GOBP T HELPER 1 TYPE IMMUNE RESPONSE	48	7.52e-01	8.73e-01	0.06280	5.77e-03	6.25e-02	9.45e-01	4.54e-01
GOMF CARBOHYDRATE BINDING	264	1.92e-01	4.20e-01	0.06270	-6.26e-02	3.44e-03	7.97e-02	9.23e-01
GOBP REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING	25	8.75e-01	9.40e-01	0.06260	5.91e-02	2.06e-02	6.09e-01	8.58e-01
GOBP POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS	721	3.12e-02	1.35e-01	0.06260	5.31e-02	3.32e-02	1.52e-02	1.29e-01
GOBP POSITIVE REGULATION OF GTPASE ACTIVITY	187	3.94e-01	6.27e-01	0.06260	-5.45e-02	-3.08e-02	1.99e-01	4.68e-01
GOBP POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS	65	7.20e-01	8.56e-01	0.06250	2.89e-02	5.54e-02	6.87e-01	4.39e-01
GOBP PRESYNAPTIC ACTIVE ZONE ORGANIZATION	7	9.64e-01	9.83e-01	0.06240	2.10e-02	5.88e-02	9.24e-01	7.88e-01
GOBP HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING	17	9.02e-01	9.52e-01	0.06230	6.23e-02	9.05e-04	6.56e-01	9.95e-01
GOCC GOLGI APPARATUS	1550	9.47e-04	1.00e-02	0.06230	4.93e-02	3.81e-02	1.20e-03	1.23e-02
GOBP MONOCYTE CHEMOTAXIS	50	7.38e-01	8.67e-01	0.06230	-6.23e-02	-7.13e-05	4.46e-01	9.99e-01
L1CAM interactions	111	5.37e-01	7.38e-01	0.06220	-1.10e-02	-6.12e-02	8.42e-01	2.65e-01
GOBP FOREBRAIN CELL MIGRATION	62	7.25e-01	8.59e-01	0.06220	5.80e-02	2.25e-02	4.30e-01	7.59e-01
GOBP NEGATIVE REGULATION OF TYPE 2 IMMUNE RESPONSE	15	8.95e-01	9.49e-01	0.06220	4.57e-02	-4.22e-02	7.59e-01	7.77e-01
GOBP REGULATION OF OXIDATIVE PHOSPHORYLATION	21	8.70e-01	9.37e-01	0.06210	-1.38e-02	6.06e-02	9.13e-01	6.31e-01
GOBP GLIOGENESIS	338	2.05e-01	4.36e-01	0.06210	4.33e-02	4.45e-02	1.71e-01	1.60e-01
GOBP POSITIVE REGULATION OF DEVELOPMENTAL GROWTH	158	4.12e-01	6.44e-01	0.06200	9.50e-03	6.13e-02	8.37e-01	1.84e-01
GOBP CELLULAR RESPONSE TO EPINEPHRINE STIMULUS	11	9.35e-01	9.70e-01	0.06200	6.19e-02	-1.99e-03	7.22e-01	9.91e-01
GOBP ENDOCRINE PROCESS	87	5.83e-01	7.69e-01	0.06190	4.65e-03	-6.18e-02	9.40e-01	3.19e-01
GOMF G PROTEIN ALPHA SUBUNIT BINDING	29	8.16e-01	9.07e-01	0.06190	5.59e-02	-2.64e-02	6.02e-01	8.06e-01
GOBP RESPONSE TO INTERFERON BETA	33	8.53e-01	9.26e-01	0.06180	3.43e-02	5.15e-02	7.33e-01	6.09e-01
RHOBTB3 ATPase cycle	8	9.60e-01	9.81e-01	0.06180	-5.66e-02	-2.50e-02	7.82e-01	9.03e-01
GOBP REGULATION OF TUBE SIZE	148	3.49e-01	5.87e-01	0.06180	5.26e-02	-3.25e-02	2.70e-01	4.95e-01
PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling	112	5.66e-01	7.57e-01	0.06180	5.72e-02	2.33e-02	2.96e-01	6.70e-01
GOMF MRNA BINDING	576	1.70e-02	8.85e-02	0.06180	3.99e-02	-4.72e-02	1.02e-01	5.29e-02
GOBP DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION	14	9.05e-01	9.54e-01	0.06170	-5.28e-02	3.18e-02	7.32e-01	8.37e-01
GOBP GLIAL CELL ACTIVATION	58	6.75e-01	8.29e-01	0.06170	-5.80e-02	2.09e-02	4.45e-01	7.83e-01
GOBP PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING	6	9.69e-01	9.85e-01	0.06160	-5.93e-02	-1.65e-02	8.01e-01	9.44e-01
GOBP REGULATION OF NEUROTRANSMITTER TRANSPORT	94	5.75e-01	7.65e-01	0.06160	-6.15e-02	-1.23e-03	3.02e-01	9.84e-01
GOCC SYNAPTIC CLEFT	22	9.03e-01	9.52e-01	0.06130	-3.85e-02	-4.77e-02	7.55e-01	6.99e-01
GOBP BONE REMODELING	90	5.27e-01	7.31e-01	0.06130	-4.63e-02	4.02e-02	4.48e-01	5.10e-01
GOBP NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION	11	9.49e-01	9.77e-01	0.06120	-3.23e-02	-5.20e-02	8.53e-01	7.65e-01
GOBP POSITIVE REGULATION OF IMMUNE RESPONSE	723	8.16e-03	5.16e-02	0.06120	-2.65e-02	5.52e-02	2.26e-01	1.14e-02
GOBP NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE	69	6.89e-01	8.38e-01	0.06110	6.00e-02	1.13e-02	3.88e-01	8.71e-01
GOMF CARBOHYDRATE DERIVATIVE TRANSMEMBRANE TRANSPORTER ACTIVITY	54	7.41e-01	8.68e-01	0.06110	-6.07e-02	-7.10e-03	4.41e-01	9.28e-01
GOBP POSITIVE REGULATION OF TRANSFERASE ACTIVITY	353	1.99e-01	4.29e-01	0.06100	4.94e-02	3.57e-02	1.11e-01	2.49e-01
Opioid Signalling	89	5.99e-01	7.78e-01	0.06090	6.09e-02	1.24e-03	3.21e-01	9.84e-01
GOBP SPROUTING ANGIOGENESIS	190	2.80e-01	5.19e-01	0.06090	-5.56e-02	2.48e-02	1.86e-01	5.55e-01
GOBP PROTEIN HOMOTETRAMERIZATION	60	6.58e-01	8.17e-01	0.06090	3.48e-02	-5.00e-02	6.41e-01	5.03e-01
GOBP REGULATION OF FATTY ACID METABOLIC PROCESS	94	6.40e-01	8.03e-01	0.06090	5.35e-02	2.91e-02	3.70e-01	6.26e-01
GOCC VACUOLAR LUMEN	167	3.31e-01	5.70e-01	0.06080	-5.66e-02	2.24e-02	2.07e-01	6.18e-01
GOBP NEGATIVE REGULATION OF PLASMINOGEN ACTIVATION	8	9.46e-01	9.77e-01	0.06080	-5.31e-02	2.97e-02	7.95e-01	8.84e-01
GOBP NEGATIVE REGULATION OF CANONICAL NF KAPPAB SIGNAL TRANSDUCTION	63	6.82e-01	8.33e-01	0.06080	-7.17e-03	6.04e-02	9.22e-01	4.07e-01
GOBP ERYTHROCYTE DEVELOPMENT	40	8.34e-01	9.17e-01	0.06070	4.24e-02	4.34e-02	6.43e-01	6.34e-01
GOMF CALMODULIN DEPENDENT PROTEIN KINASE ACTIVITY	24	8.79e-01	9.41e-01	0.06060	5.98e-02	9.79e-03	6.12e-01	9.34e-01
GOBP PLASMA LIPOPROTEIN PARTICLE CLEARANCE	54	7.51e-01	8.72e-01	0.06060	-1.15e-02	-5.95e-02	8.84e-01	4.50e-01
GOBP REGULATION OF PEPTIDASE ACTIVITY	287	1.39e-01	3.51e-01	0.06060	-3.72e-02	4.78e-02	2.78e-01	1.64e-01
GOBP ACINAR CELL DIFFERENTIATION	5	9.74e-01	9.87e-01	0.06050	9.48e-03	5.97e-02	9.71e-01	8.17e-01
GOBP REGULATION OF B CELL MEDIATED IMMUNITY	58	6.86e-01	8.36e-01	0.06040	-2.05e-02	5.68e-02	7.87e-01	4.54e-01
GOBP POSITIVE REGULATION OF CANONICAL NF KAPPAB SIGNAL TRANSDUCTION	200	3.84e-01	6.18e-01	0.06040	5.53e-02	2.44e-02	1.78e-01	5.52e-01
GOCC FILOPODIUM	101	5.02e-01	7.12e-01	0.06040	5.05e-02	-3.30e-02	3.80e-01	5.66e-01
GOBP ORGANIC CATION TRANSPORT	110	5.00e-01	7.10e-01	0.06040	-1.56e-02	5.83e-02	7.77e-01	2.91e-01
GOBP POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION	1015	1.28e-02	7.19e-02	0.06030	4.30e-02	4.23e-02	2.05e-02	2.25e-02
GOBP COPULATION	19	8.78e-01	9.41e-01	0.06020	-3.60e-02	4.83e-02	7.86e-01	7.16e-01
GOBP POSITIVE REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT	142	3.89e-01	6.22e-01	0.06020	5.32e-02	-2.82e-02	2.74e-01	5.62e-01
GOBP REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION	125	4.63e-01	6.86e-01	0.06020	-1.28e-02	5.88e-02	8.05e-01	2.56e-01
GOBP G PROTEIN COUPLED RECEPTOR INTERNALIZATION	10	9.53e-01	9.79e-01	0.06020	-2.52e-02	-5.46e-02	8.90e-01	7.65e-01
GOBP POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION	340	2.23e-01	4.57e-01	0.06020	4.56e-02	3.93e-02	1.49e-01	2.13e-01
GOBP ACIDIC AMINO ACID TRANSPORT	66	6.54e-01	8.13e-01	0.06010	5.66e-02	-2.03e-02	4.26e-01	7.75e-01
HDL remodeling	10	9.51e-01	9.78e-01	0.06010	1.66e-02	5.78e-02	9.27e-01	7.52e-01
GOBP CELL DIFFERENTIATION INVOLVED IN PHENOTYPIC SWITCHING	5	9.69e-01	9.85e-01	0.06010	-5.82e-02	1.52e-02	8.22e-01	9.53e-01
GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE CONTRACTION	7	9.69e-01	9.85e-01	0.06010	-4.67e-02	-3.79e-02	8.31e-01	8.62e-01
GOBP VESICLE TRANSPORT ALONG ACTIN FILAMENT	8	9.64e-01	9.83e-01	0.06010	5.17e-02	3.07e-02	8.00e-01	8.81e-01
GOBP NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS	55	7.77e-01	8.88e-01	0.06010	3.05e-02	5.17e-02	6.95e-01	5.07e-01
GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION	59	7.18e-01	8.55e-01	0.06000	-5.37e-04	-6.00e-02	9.94e-01	4.25e-01
GOBP LEUKOTRIENE METABOLIC PROCESS	30	8.46e-01	9.23e-01	0.06000	-2.41e-03	-6.00e-02	9.82e-01	5.70e-01
GOMF AMYLOID BETA BINDING	80	6.97e-01	8.42e-01	0.05990	-3.34e-02	-4.98e-02	6.05e-01	4.42e-01
GOMF LIPID KINASE ACTIVITY	40	8.27e-01	9.13e-01	0.05990	5.48e-02	2.40e-02	5.48e-01	7.92e-01
GOBP LONG TERM SYNAPTIC POTENTIATION	105	6.20e-01	7.91e-01	0.05980	-3.03e-02	-5.16e-02	5.91e-01	3.61e-01
GOBP TUBE MORPHOGENESIS	928	1.66e-02	8.70e-02	0.05980	5.25e-02	2.87e-02	6.71e-03	1.39e-01
GOBP REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY	17	8.95e-01	9.49e-01	0.05980	-2.58e-02	5.40e-02	8.54e-01	7.00e-01
GOBP AMINE METABOLIC PROCESS	106	5.71e-01	7.61e-01	0.05980	7.58e-03	5.93e-02	8.93e-01	2.91e-01
GOBP POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY	36	7.88e-01	8.92e-01	0.05980	-5.27e-02	2.82e-02	5.84e-01	7.69e-01
GOBP POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY	119	5.53e-01	7.48e-01	0.05970	-1.54e-02	-5.77e-02	7.71e-01	2.77e-01
GOBP CELL CHEMOTAXIS	302	1.86e-01	4.12e-01	0.05970	-5.97e-02	1.07e-03	7.43e-02	9.74e-01
GOBP SHORT CHAIN FATTY ACID CATABOLIC PROCESS	7	9.69e-01	9.85e-01	0.05970	-3.61e-02	-4.75e-02	8.69e-01	8.28e-01
GOBP ORGANIC ACID TRANSPORT	340	2.26e-01	4.60e-01	0.05960	-4.77e-02	-3.58e-02	1.31e-01	2.57e-01
GOBP REGULATION OF FILOPODIUM ASSEMBLY	45	7.50e-01	8.71e-01	0.05960	2.17e-02	-5.55e-02	8.01e-01	5.19e-01
GOBP NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS	25	8.96e-01	9.49e-01	0.05960	-4.48e-02	-3.94e-02	6.98e-01	7.33e-01
GOMF POTASSIUM CHANNEL REGULATOR ACTIVITY	46	8.14e-01	9.06e-01	0.05960	3.34e-02	4.93e-02	6.95e-01	5.63e-01
GOBP RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM	37	7.94e-01	8.95e-01	0.05960	1.78e-02	-5.68e-02	8.52e-01	5.50e-01
GOBP PULMONARY VALVE DEVELOPMENT	24	8.50e-01	9.25e-01	0.05950	-4.23e-02	4.19e-02	7.20e-01	7.22e-01
RUNX3 Regulates Immune Response and Cell Migration	6	9.61e-01	9.82e-01	0.05950	-5.23e-02	2.83e-02	8.24e-01	9.04e-01
GOBP MYELOID LEUKOCYTE MIGRATION	228	3.13e-01	5.53e-01	0.05950	-5.85e-02	-1.05e-02	1.28e-01	7.84e-01
GOMF PLUS END DIRECTED MICROTUBULE MOTOR ACTIVITY	17	9.04e-01	9.53e-01	0.05940	5.86e-02	-9.93e-03	6.76e-01	9.43e-01
GOBP INOSITOL PHOSPHATE METABOLIC PROCESS	39	7.78e-01	8.89e-01	0.05940	-5.40e-02	2.47e-02	5.59e-01	7.90e-01
GOMF LIGASE ACTIVITY FORMING CARBON SULFUR BONDS	39	8.24e-01	9.11e-01	0.05940	5.75e-02	1.48e-02	5.34e-01	8.73e-01
GOBP LIPID IMPORT INTO CELL	21	9.12e-01	9.56e-01	0.05940	4.82e-02	3.46e-02	7.02e-01	7.84e-01
Elastic fibre formation	44	7.46e-01	8.70e-01	0.05930	4.79e-02	-3.51e-02	5.83e-01	6.87e-01
Glycogen storage diseases	15	9.04e-01	9.53e-01	0.05930	4.23e-02	-4.15e-02	7.77e-01	7.81e-01
GOBP NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS	38	7.96e-01	8.97e-01	0.05930	-1.27e-02	5.79e-02	8.92e-01	5.37e-01
GOBP ACTIN FILAMENT BASED TRANSPORT	10	9.54e-01	9.79e-01	0.05930	2.25e-02	5.48e-02	9.02e-01	7.64e-01
GOBP ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS	1235	1.99e-03	1.75e-02	0.05920	5.91e-02	4.46e-03	4.79e-04	7.92e-01
GOBP NEGATIVE REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT	96	5.94e-01	7.75e-01	0.05920	5.92e-02	1.68e-03	3.16e-01	9.77e-01
Ras activation upon Ca2+ influx through NMDA receptor	19	9.10e-01	9.56e-01	0.05920	-5.74e-02	-1.45e-02	6.65e-01	9.13e-01
GOCC EXTRINSIC COMPONENT OF PLASMA MEMBRANE	99	5.28e-01	7.31e-01	0.05910	2.89e-02	-5.15e-02	6.19e-01	3.76e-01
GOBP TETRAHYDROFOLATE METABOLIC PROCESS	18	8.87e-01	9.46e-01	0.05910	-3.79e-02	4.52e-02	7.80e-01	7.40e-01
GOBP INNATE IMMUNE RESPONSE ACTIVATING CELL SURFACE RECEPTOR SIGNALING PATHWAY	97	5.29e-01	7.32e-01	0.05900	-3.56e-02	4.70e-02	5.45e-01	4.23e-01
GOBP REGULATION OF TRANS SYNAPTIC SIGNALING	477	1.14e-01	3.13e-01	0.05890	-5.47e-02	-2.18e-02	4.06e-02	4.14e-01
GOBP POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT	197	3.46e-01	5.84e-01	0.05890	5.89e-02	5.21e-04	1.54e-01	9.90e-01
GOCC EXTRINSIC COMPONENT OF MEMBRANE	170	4.35e-01	6.63e-01	0.05880	5.74e-02	1.30e-02	1.97e-01	7.70e-01
GOBP REGULATION OF LIPASE ACTIVITY	65	6.53e-01	8.13e-01	0.05880	3.65e-02	-4.61e-02	6.11e-01	5.20e-01
GOBP LONG TERM MEMORY	37	8.15e-01	9.07e-01	0.05880	2.38e-03	-5.87e-02	9.80e-01	5.36e-01
GOCC SECRETORY VESICLE	1032	1.53e-03	1.43e-02	0.05880	-4.16e-02	4.16e-02	2.40e-02	2.40e-02
GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS	133	4.74e-01	6.94e-01	0.05880	-5.57e-03	5.85e-02	9.12e-01	2.44e-01
GOBP REGULATION OF EXOSOMAL SECRETION	19	9.02e-01	9.52e-01	0.05860	-6.49e-05	-5.86e-02	1.00e+00	6.58e-01
GOBP DEVELOPMENTAL PIGMENTATION	46	7.60e-01	8.78e-01	0.05860	5.66e-02	-1.53e-02	5.07e-01	8.57e-01
GOBP PROTEIN PALMITOYLATION	28	8.77e-01	9.40e-01	0.05860	-5.56e-02	-1.85e-02	6.11e-01	8.65e-01
GOMF EPIDERMAL GROWTH FACTOR RECEPTOR BINDING	34	8.62e-01	9.32e-01	0.05850	2.91e-02	5.07e-02	7.69e-01	6.09e-01
GOBP REGULATION OF MUSCLE SYSTEM PROCESS	244	2.14e-01	4.46e-01	0.05850	3.03e-02	-5.01e-02	4.15e-01	1.78e-01
GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION	359	1.25e-01	3.30e-01	0.05850	-5.70e-02	1.31e-02	6.35e-02	6.71e-01
GOCC ENDOPLASMIC RETICULUM LUMEN	295	1.53e-01	3.68e-01	0.05850	3.38e-02	-4.77e-02	3.18e-01	1.59e-01
GOBP CELLULAR RESPONSE TO INTERLEUKIN 1	84	6.85e-01	8.36e-01	0.05840	-5.35e-02	-2.35e-02	3.97e-01	7.09e-01
GOBP ERYTHROCYTE MATURATION	20	8.82e-01	9.43e-01	0.05840	2.54e-02	-5.26e-02	8.44e-01	6.84e-01
GOBP PURINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT	37	8.48e-01	9.23e-01	0.05840	-2.53e-02	-5.26e-02	7.90e-01	5.80e-01
Netrin-1 signaling	42	8.38e-01	9.19e-01	0.05830	-4.45e-02	-3.78e-02	6.18e-01	6.72e-01
GOBP ORGANIC HYDROXY COMPOUND TRANSPORT	280	2.85e-01	5.23e-01	0.05830	-5.39e-02	-2.22e-02	1.20e-01	5.23e-01
GOBP VESICLE FUSION TO PLASMA MEMBRANE	24	8.96e-01	9.49e-01	0.05820	1.97e-02	5.48e-02	8.67e-01	6.42e-01
GOMF OXIDOREDUCTASE ACTIVITY	682	5.06e-02	1.90e-01	0.05820	5.37e-02	2.25e-02	1.68e-02	3.17e-01
GOBP REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION	47	7.87e-01	8.92e-01	0.05820	5.79e-02	5.58e-03	4.92e-01	9.47e-01
GOCC CYTOPLASMIC SIDE OF PLASMA MEMBRANE	155	4.48e-01	6.74e-01	0.05820	5.81e-02	2.60e-03	2.12e-01	9.55e-01
GOBP REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS	55	7.02e-01	8.45e-01	0.05810	-4.06e-02	4.16e-02	6.02e-01	5.94e-01
Metabolism of folate and pterines	17	9.01e-01	9.52e-01	0.05810	-5.36e-02	2.23e-02	7.02e-01	8.74e-01
GOBP SODIUM ION EXPORT ACROSS PLASMA MEMBRANE	15	9.22e-01	9.63e-01	0.05810	5.80e-02	-3.65e-03	6.97e-01	9.80e-01
GOBP AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS	67	7.49e-01	8.71e-01	0.05810	5.06e-02	2.85e-02	4.74e-01	6.86e-01
GOMF CYTOSKELETAL ANCHOR ACTIVITY	23	8.87e-01	9.46e-01	0.05800	-5.80e-02	-1.80e-03	6.30e-01	9.88e-01
GOBP POSITIVE REGULATION OF SECRETION	307	1.81e-01	4.06e-01	0.05800	-9.32e-03	5.72e-02	7.79e-01	8.45e-02
GOCC CLATHRIN COATED ENDOCYTIC VESICLE MEMBRANE	69	7.20e-01	8.56e-01	0.05800	5.64e-02	1.32e-02	4.18e-01	8.49e-01
GOBP POSITIVE REGULATION OF FIBROBLAST APOPTOTIC PROCESS	10	9.50e-01	9.78e-01	0.05790	4.39e-03	5.77e-02	9.81e-01	7.52e-01
GOBP MYOTUBE DIFFERENTIATION	129	5.16e-01	7.22e-01	0.05790	5.78e-02	2.90e-03	2.57e-01	9.55e-01
GOBP GLYCOSYLATION	238	3.60e-01	5.97e-01	0.05790	2.69e-02	5.12e-02	4.74e-01	1.73e-01
GOBP CELL JUNCTION MAINTENANCE	44	8.34e-01	9.17e-01	0.05780	-4.22e-02	-3.94e-02	6.28e-01	6.51e-01
GOCC MEMBRANE PROTEIN COMPLEX	1214	6.79e-03	4.48e-02	0.05770	5.18e-02	2.55e-02	2.38e-03	1.34e-01
GOMF PHOSPHORYLATION DEPENDENT PROTEIN BINDING	9	9.48e-01	9.77e-01	0.05770	-1.82e-02	5.48e-02	9.25e-01	7.76e-01
GOBP REGULATION OF CHROMATIN BINDING	11	9.54e-01	9.79e-01	0.05770	2.78e-02	5.06e-02	8.73e-01	7.71e-01
GOBP RESPONSE TO OXYGEN RADICAL	26	8.82e-01	9.43e-01	0.05770	1.05e-02	5.67e-02	9.26e-01	6.17e-01
GOBP REGULATION OF CELL SIZE	163	4.04e-01	6.36e-01	0.05770	5.69e-02	-9.78e-03	2.10e-01	8.29e-01
GOMF CATECHOLAMINE BINDING	12	9.48e-01	9.77e-01	0.05770	-2.15e-02	-5.35e-02	8.97e-01	7.48e-01
GOCC MULTIVESICULAR BODY	65	7.09e-01	8.50e-01	0.05770	-2.35e-03	5.76e-02	9.74e-01	4.22e-01
GOBP CARDIAC MUSCLE MYOBLAST PROLIFERATION	7	9.60e-01	9.81e-01	0.05760	-5.53e-02	1.63e-02	8.00e-01	9.41e-01
GOBP DICARBOXYLIC ACID TRANSPORT	100	6.64e-01	8.21e-01	0.05760	-3.72e-02	-4.40e-02	5.20e-01	4.47e-01
GOBP FOLIC ACID CONTAINING COMPOUND BIOSYNTHETIC PROCESS	9	9.62e-01	9.82e-01	0.05760	2.80e-02	5.03e-02	8.84e-01	7.94e-01
GOBP POSITIVE REGULATION OF DEFENSE RESPONSE	494	5.05e-02	1.90e-01	0.05760	-2.89e-02	4.98e-02	2.71e-01	5.81e-02
GOBP SYMBIONT ENTRY INTO HOST	159	5.03e-01	7.13e-01	0.05760	5.22e-02	2.43e-02	2.56e-01	5.97e-01
GOBP RESPONSE TO FLUID SHEAR STRESS	35	8.53e-01	9.26e-01	0.05750	1.81e-02	5.46e-02	8.53e-01	5.76e-01
GOBP SMALL MOLECULE METABOLIC PROCESS	1746	1.27e-03	1.25e-02	0.05750	4.68e-02	3.35e-02	1.15e-03	2.02e-02
GOBP REGULATION OF NERVOUS SYSTEM DEVELOPMENT	436	1.74e-01	3.97e-01	0.05750	3.92e-02	4.21e-02	1.61e-01	1.31e-01
GOBP VISUAL BEHAVIOR	56	7.93e-01	8.95e-01	0.05750	-4.67e-02	-3.35e-02	5.45e-01	6.64e-01
GOBP PROSTATE GLAND GROWTH	10	9.41e-01	9.73e-01	0.05750	-2.64e-02	5.10e-02	8.85e-01	7.80e-01
GOBP CIRCADIAN SLEEP WAKE CYCLE NON REM SLEEP	6	9.71e-01	9.86e-01	0.05740	5.69e-02	7.88e-03	8.09e-01	9.73e-01
GOBP TISSUE MIGRATION	369	1.75e-01	3.97e-01	0.05740	5.66e-02	9.75e-03	6.19e-02	7.48e-01
DAG and IP3 signaling	40	8.33e-01	9.17e-01	0.05740	-5.51e-02	-1.63e-02	5.47e-01	8.59e-01
GOBP MAGNESIUM ION HOMEOSTASIS	11	9.55e-01	9.80e-01	0.05740	2.79e-02	5.01e-02	8.73e-01	7.73e-01
GOBP CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM	396	9.33e-02	2.78e-01	0.05730	5.00e-02	-2.79e-02	8.74e-02	3.41e-01
GOBP PROXIMAL TUBULE DEVELOPMENT	10	9.47e-01	9.77e-01	0.05730	-5.69e-02	6.65e-03	7.55e-01	9.71e-01
GOBP MESONEPHRIC TUBULE FORMATION	10	9.42e-01	9.74e-01	0.05730	-5.25e-02	2.29e-02	7.74e-01	9.00e-01
GOBP REGULATION OF MYOBLAST FUSION	20	9.05e-01	9.54e-01	0.05720	-5.71e-02	-4.33e-03	6.59e-01	9.73e-01
GOBP REGULATION OF BIOMINERAL TISSUE DEVELOPMENT	96	6.66e-01	8.23e-01	0.05720	2.54e-02	5.12e-02	6.67e-01	3.86e-01
GOMF FLAVIN ADENINE DINUCLEOTIDE BINDING	84	6.32e-01	7.99e-01	0.05710	9.62e-03	-5.62e-02	8.79e-01	3.73e-01
GOBP POSITIVE REGULATION OF GLIAL CELL PROLIFERATION	20	9.19e-01	9.62e-01	0.05700	2.67e-02	5.04e-02	8.36e-01	6.96e-01
GOBP ACTIVATION OF IMMUNE RESPONSE	530	4.48e-02	1.75e-01	0.05700	-2.62e-02	5.07e-02	3.02e-01	4.60e-02
GOBP GAMETE GENERATION	743	2.62e-02	1.20e-01	0.05700	5.70e-02	9.83e-04	8.16e-03	9.64e-01
GOBP PIGMENT METABOLIC PROCESS	74	6.33e-01	7.99e-01	0.05700	-4.09e-02	3.98e-02	5.43e-01	5.54e-01
GOBP NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY	14	9.27e-01	9.66e-01	0.05700	7.32e-03	-5.65e-02	9.62e-01	7.14e-01
GOBP GLIAL CELL DEVELOPMENT	131	4.47e-01	6.74e-01	0.05700	4.42e-02	-3.60e-02	3.83e-01	4.76e-01
GOBP ALDEHYDE CATABOLIC PROCESS	14	9.31e-01	9.68e-01	0.05690	5.87e-04	-5.69e-02	9.97e-01	7.12e-01
GOBP SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING	37	8.14e-01	9.06e-01	0.05690	1.34e-02	-5.53e-02	8.88e-01	5.60e-01
GOBP BIOLOGICAL PROCESS INVOLVED IN SYMBIOTIC INTERACTION	297	2.72e-01	5.12e-01	0.05690	1.77e-02	5.40e-02	6.00e-01	1.09e-01
GOBP CARBOHYDRATE TRANSPORT	137	5.59e-01	7.52e-01	0.05690	-5.20e-02	-2.30e-02	2.93e-01	6.42e-01
GOMF RETINOIC ACID 4 HYDROXYLASE ACTIVITY	10	9.60e-01	9.81e-01	0.05680	-4.84e-02	-2.96e-02	7.91e-01	8.71e-01
GOBP RESPONSE TO INTERLEUKIN 18	12	9.45e-01	9.76e-01	0.05680	5.61e-02	9.03e-03	7.37e-01	9.57e-01
GOBP CELLULAR RESPONSE TO TOXIC SUBSTANCE	129	5.93e-01	7.74e-01	0.05680	3.09e-02	4.76e-02	5.45e-01	3.50e-01
GOBP L AMINO ACID CATABOLIC PROCESS	64	7.73e-01	8.85e-01	0.05670	4.67e-02	3.22e-02	5.18e-01	6.56e-01
GOCC ACROSOMAL VESICLE	142	5.42e-01	7.40e-01	0.05670	-1.99e-02	-5.31e-02	6.83e-01	2.75e-01
GOBP STEROID HORMONE SECRETION	27	8.83e-01	9.44e-01	0.05670	-5.55e-02	-1.13e-02	6.17e-01	9.19e-01
Negative regulation of the PI3K/AKT network	119	5.95e-01	7.75e-01	0.05660	5.37e-02	1.81e-02	3.12e-01	7.33e-01
GOMF PROTEASE BINDING	136	5.12e-01	7.20e-01	0.05660	-2.24e-03	-5.65e-02	9.64e-01	2.55e-01
GOBP ALDITOL PHOSPHATE METABOLIC PROCESS	9	9.48e-01	9.77e-01	0.05660	-5.02e-02	2.61e-02	7.94e-01	8.92e-01
GOBP VASCULATURE DEVELOPMENT	811	2.53e-02	1.17e-01	0.05650	5.59e-02	8.39e-03	6.82e-03	6.85e-01
GOBP INTRACELLULAR PH REDUCTION	52	7.74e-01	8.86e-01	0.05650	2.13e-03	5.64e-02	9.79e-01	4.81e-01
GOBP INTRACELLULAR SIGNALING CASSETTE	1856	1.24e-03	1.23e-02	0.05640	3.77e-02	4.20e-02	7.09e-03	2.73e-03
Fatty acid metabolism	169	4.69e-01	6.91e-01	0.05640	5.49e-02	1.29e-02	2.18e-01	7.72e-01
GOBP PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS	20	9.23e-01	9.63e-01	0.05640	3.20e-02	4.64e-02	8.04e-01	7.19e-01
GOBP REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE	22	9.15e-01	9.59e-01	0.05640	2.86e-02	4.86e-02	8.17e-01	6.93e-01
GOBP REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY	147	4.25e-01	6.54e-01	0.05620	2.71e-02	-4.92e-02	5.71e-01	3.03e-01
GOMF GTPASE ACTIVATOR ACTIVITY	243	2.85e-01	5.23e-01	0.05620	5.57e-02	-7.05e-03	1.35e-01	8.50e-01
GOBP ACTIVATION OF ADENYLATE CYCLASE ACTIVITY	23	8.92e-01	9.48e-01	0.05620	7.92e-04	-5.62e-02	9.95e-01	6.41e-01
GOBP NEGATIVE REGULATION OF RESPIRATORY BURST INVOLVED IN INFLAMMATORY RESPONSE	5	9.75e-01	9.88e-01	0.05610	4.29e-04	-5.61e-02	9.99e-01	8.28e-01
Phospholipase C-mediated cascade; FGFR3	12	9.32e-01	9.68e-01	0.05610	4.75e-02	-2.99e-02	7.76e-01	8.57e-01
Synthesis of pyrophosphates in the cytosol	8	9.54e-01	9.79e-01	0.05600	4.75e-02	-2.97e-02	8.16e-01	8.84e-01
GOBP INTRACELLULAR STEROL TRANSPORT	37	8.47e-01	9.23e-01	0.05600	1.15e-02	5.48e-02	9.04e-01	5.64e-01
GOBP VASCULAR PROCESS IN CIRCULATORY SYSTEM	265	3.44e-01	5.81e-01	0.05600	-2.52e-02	-5.00e-02	4.80e-01	1.61e-01
GOMF CYTOSKELETAL PROTEIN BINDING	946	9.59e-03	5.81e-02	0.05600	5.57e-02	-5.59e-03	3.71e-03	7.71e-01
GOBP REGULATION OF CELL MORPHOGENESIS	231	3.59e-01	5.95e-01	0.05590	1.13e-02	5.47e-02	7.67e-01	1.52e-01
GOMF PHOSPHATIDYLINOSITOL PHOSPHATE BINDING	170	3.70e-01	6.07e-01	0.05570	4.40e-02	-3.42e-02	3.22e-01	4.42e-01
GOBP REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS	855	2.23e-02	1.08e-01	0.05570	6.62e-03	5.53e-02	7.43e-01	6.05e-03
GOBP KIDNEY EPITHELIUM DEVELOPMENT	148	5.41e-01	7.40e-01	0.05560	1.96e-02	5.21e-02	6.81e-01	2.74e-01
GOBP MICROTUBULE BASED MOVEMENT	417	1.04e-01	2.96e-01	0.05560	5.21e-02	-1.94e-02	6.80e-02	4.96e-01
GOMF HYDRO LYASE ACTIVITY	56	8.00e-01	8.99e-01	0.05550	4.95e-02	2.52e-02	5.22e-01	7.45e-01
GOBP EMBRYONIC AXIS SPECIFICATION	40	8.59e-01	9.30e-01	0.05550	3.81e-02	4.03e-02	6.77e-01	6.59e-01
GOBP CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION	57	8.05e-01	9.02e-01	0.05540	-4.37e-02	-3.41e-02	5.69e-01	6.56e-01
GOBP FATTY ACID BIOSYNTHETIC PROCESS	159	5.21e-01	7.26e-01	0.05530	-5.17e-02	-1.97e-02	2.61e-01	6.68e-01
G alpha (q) signalling events	207	4.30e-01	6.58e-01	0.05520	-1.97e-02	-5.16e-02	6.25e-01	2.01e-01
GOMF MODIFIED AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY	30	8.72e-01	9.38e-01	0.05520	-5.65e-03	-5.49e-02	9.57e-01	6.03e-01
GOBP STEROL BIOSYNTHETIC PROCESS	63	7.03e-01	8.47e-01	0.05520	-4.95e-02	2.44e-02	4.97e-01	7.38e-01
GOMF ALPHA TUBULIN BINDING	38	8.52e-01	9.26e-01	0.05520	1.54e-02	5.30e-02	8.70e-01	5.72e-01
GOBP SECONDARY METABOLIC PROCESS	54	8.08e-01	9.03e-01	0.05510	4.95e-02	2.43e-02	5.29e-01	7.57e-01
GOBP CELLULAR RESPONSE TO INTERFERON BETA	26	9.00e-01	9.51e-01	0.05500	5.12e-02	2.01e-02	6.51e-01	8.59e-01
GOBP RESPONSE TO AMMONIUM ION	6	9.73e-01	9.87e-01	0.05490	-5.47e-02	-5.32e-03	8.17e-01	9.82e-01
GOBP REGULATION OF DENDRITE MORPHOGENESIS	58	8.04e-01	9.02e-01	0.05490	-3.23e-02	-4.44e-02	6.71e-01	5.59e-01
GOCC ANCHORING JUNCTION	863	2.31e-02	1.10e-01	0.05490	5.46e-02	5.02e-03	6.45e-03	8.02e-01
GOBP EAR DEVELOPMENT	221	3.92e-01	6.26e-01	0.05470	1.18e-02	5.34e-02	7.62e-01	1.71e-01
GOBP POSITIVE REGULATION OF CALCIUM ION TRANSPORT	112	5.84e-01	7.69e-01	0.05470	3.50e-03	-5.46e-02	9.49e-01	3.18e-01
GOMF ACID THIOL LIGASE ACTIVITY	30	8.94e-01	9.49e-01	0.05460	-3.28e-02	-4.37e-02	7.56e-01	6.79e-01
GOBP NEGATIVE REGULATION OF CELL ADHESION	299	1.97e-01	4.27e-01	0.05450	-4.79e-02	2.60e-02	1.54e-01	4.40e-01
GOBP NEURON MATURATION	46	8.45e-01	9.22e-01	0.05440	3.90e-02	3.80e-02	6.47e-01	6.56e-01
GOBP RECEPTOR MEDIATED ENDOCYTOSIS	254	3.94e-01	6.28e-01	0.05440	4.39e-02	3.21e-02	2.28e-01	3.78e-01
PI3K/AKT activation	9	9.64e-01	9.83e-01	0.05440	5.18e-02	1.68e-02	7.88e-01	9.31e-01
Defects of platelet adhesion to exposed collagen	8	9.59e-01	9.81e-01	0.05440	1.80e-02	-5.13e-02	9.30e-01	8.01e-01
Depolymerization of the Nuclear Lamina	14	9.25e-01	9.64e-01	0.05440	-4.46e-02	3.11e-02	7.73e-01	8.40e-01
FGFR3 ligand binding and activation	12	9.57e-01	9.80e-01	0.05430	-3.32e-02	-4.29e-02	8.42e-01	7.97e-01
FGFR3c ligand binding and activation	12	9.57e-01	9.80e-01	0.05430	-3.32e-02	-4.29e-02	8.42e-01	7.97e-01
GOBP MEMBRANE DEPOLARIZATION	91	6.12e-01	7.87e-01	0.05430	-4.89e-02	2.37e-02	4.20e-01	6.96e-01
GOBP RESPONSE TO COPPER ION	34	8.78e-01	9.41e-01	0.05430	2.47e-02	4.84e-02	8.03e-01	6.26e-01
GOBP CELLULAR OXIDANT DETOXIFICATION	93	6.93e-01	8.40e-01	0.05430	1.94e-02	5.06e-02	7.46e-01	3.99e-01
Amino acid transport across the plasma membrane	30	8.96e-01	9.49e-01	0.05420	-4.39e-02	-3.19e-02	6.77e-01	7.62e-01
GOBP THYROID HORMONE GENERATION	22	8.97e-01	9.50e-01	0.05420	-5.36e-02	8.56e-03	6.64e-01	9.45e-01
GOBP CIRCULATORY SYSTEM PROCESS	588	9.86e-02	2.88e-01	0.05420	-1.64e-02	-5.17e-02	4.96e-01	3.23e-02
GOBP NEGATIVE REGULATION OF TRANSLATION	200	3.57e-01	5.94e-01	0.05420	5.16e-02	-1.66e-02	2.08e-01	6.86e-01
GOBP FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS	28	9.03e-01	9.53e-01	0.05420	-4.17e-02	-3.47e-02	7.03e-01	7.51e-01
GOBP SYNAPTIC VESICLE EXOCYTOSIS	91	6.02e-01	7.80e-01	0.05410	-3.90e-02	3.75e-02	5.20e-01	5.36e-01
GOMF UDP GLYCOSYLTRANSFERASE ACTIVITY	141	5.66e-01	7.57e-01	0.05410	-5.19e-02	-1.54e-02	2.87e-01	7.52e-01
GOBP RESPONSE TO ACTIVITY	77	6.51e-01	8.12e-01	0.05410	3.70e-02	-3.95e-02	5.74e-01	5.49e-01
GOBP CELL MATURATION	201	4.41e-01	6.69e-01	0.05410	5.22e-02	1.39e-02	2.02e-01	7.33e-01
GOBP RESPONSE TO DSRNA	53	7.74e-01	8.86e-01	0.05410	5.37e-02	-6.65e-03	4.99e-01	9.33e-01
GOBP CELL PROJECTION ORGANIZATION	1566	5.12e-03	3.60e-02	0.05400	4.18e-02	3.43e-02	5.80e-03	2.35e-02
Neurofascin interactions	6	9.68e-01	9.85e-01	0.05400	-4.90e-02	2.28e-02	8.35e-01	9.23e-01
GOMF CHOLESTEROL BINDING	52	7.50e-01	8.71e-01	0.05400	4.14e-02	-3.47e-02	6.05e-01	6.65e-01
GOBP REGULATION OF EPITHELIAL CELL MIGRATION	287	2.32e-01	4.67e-01	0.05390	5.12e-02	-1.71e-02	1.36e-01	6.18e-01
GOMF CARBOXYLIC ESTER HYDROLASE ACTIVITY	150	5.64e-01	7.56e-01	0.05390	-2.20e-02	-4.92e-02	6.43e-01	2.98e-01
GOBP REGULATION OF SYNAPTIC VESICLE RECYCLING	24	8.78e-01	9.41e-01	0.05390	-2.86e-02	4.57e-02	8.08e-01	6.98e-01
GOCC DISTAL AXON	258	3.64e-01	6.01e-01	0.05390	1.73e-02	5.10e-02	6.33e-01	1.58e-01
GOBP REGULATION OF LIPID TRANSPORT	153	5.76e-01	7.65e-01	0.05380	-4.39e-02	-3.11e-02	3.49e-01	5.06e-01
GOBP POSITIVE REGULATION OF LEUKOCYTE MIGRATION	143	5.82e-01	7.69e-01	0.05380	-4.89e-02	-2.25e-02	3.13e-01	6.43e-01
GOBP REGULATION OF DEVELOPMENTAL GROWTH	299	3.48e-01	5.86e-01	0.05380	3.66e-02	3.94e-02	2.77e-01	2.41e-01
GOBP POSITIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY	28	8.88e-01	9.46e-01	0.05380	-7.98e-03	-5.32e-02	9.42e-01	6.26e-01
GOBP MEMBRANE LIPID CATABOLIC PROCESS	52	7.87e-01	8.92e-01	0.05370	-5.36e-02	2.81e-03	5.04e-01	9.72e-01
GOBP TISSUE REMODELING	183	5.25e-01	7.29e-01	0.05360	3.93e-02	3.65e-02	3.59e-01	3.95e-01
GOBP REGULATION OF BODY FLUID LEVELS	357	2.61e-01	5.01e-01	0.05360	-4.93e-02	-2.09e-02	1.09e-01	4.98e-01
GOBP NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS	71	6.97e-01	8.42e-01	0.05360	-5.07e-02	1.75e-02	4.61e-01	7.99e-01
GOBP NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE	15	9.29e-01	9.67e-01	0.05360	1.18e-02	-5.22e-02	9.37e-01	7.26e-01
Cell junction organization	113	6.57e-01	8.16e-01	0.05340	-2.28e-02	-4.82e-02	6.75e-01	3.76e-01
GOMF CALCIUM CHANNEL REGULATOR ACTIVITY	49	8.26e-01	9.12e-01	0.05340	1.66e-02	5.07e-02	8.41e-01	5.39e-01
GOCC KATANIN COMPLEX	5	9.81e-01	9.91e-01	0.05340	-4.83e-02	-2.26e-02	8.52e-01	9.30e-01
GOBP POSITIVE REGULATION OF POST TRANSCRIPTIONAL GENE SILENCING	11	9.62e-01	9.82e-01	0.05330	3.34e-02	4.15e-02	8.48e-01	8.12e-01
GOBP REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY	255	4.13e-01	6.45e-01	0.05320	3.56e-02	3.96e-02	3.28e-01	2.76e-01
GOBP RESPONSE TO FATTY ACID	55	7.50e-01	8.71e-01	0.05320	-2.60e-02	4.64e-02	7.39e-01	5.52e-01
GOBP UREA CYCLE	10	9.66e-01	9.84e-01	0.05310	3.87e-02	3.63e-02	8.32e-01	8.42e-01
GOBP POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS	25	9.01e-01	9.52e-01	0.05300	7.07e-03	5.25e-02	9.51e-01	6.49e-01
Anti-inflammatory response favouring Leishmania parasite infection	73	7.49e-01	8.71e-01	0.05300	1.27e-02	5.14e-02	8.51e-01	4.47e-01
Leishmania parasite growth and survival	73	7.49e-01	8.71e-01	0.05300	1.27e-02	5.14e-02	8.51e-01	4.47e-01
GOMF STEROID BINDING	103	6.75e-01	8.29e-01	0.05290	-1.70e-02	-5.01e-02	7.66e-01	3.79e-01
GOBP RESPONSE TO CYTOKINE	918	1.41e-02	7.73e-02	0.05290	-1.30e-02	5.13e-02	5.05e-01	8.44e-03
GOBP NEGATIVE REGULATION OF GENE EXPRESSION	1518	2.05e-03	1.79e-02	0.05290	5.29e-02	4.33e-04	5.75e-04	9.77e-01
GOBP NEURON PROJECTION GUIDANCE	226	4.63e-01	6.86e-01	0.05280	-3.76e-02	-3.71e-02	3.31e-01	3.37e-01
GOBP REGULATION OF MONONUCLEAR CELL MIGRATION	137	5.76e-01	7.65e-01	0.05280	-5.19e-02	-9.27e-03	2.94e-01	8.51e-01
GOBP RESPONSE TO SODIUM PHOSPHATE	9	9.56e-01	9.80e-01	0.05280	4.93e-02	-1.89e-02	7.98e-01	9.22e-01
GOCC SUPRAMOLECULAR POLYMER	1007	2.92e-02	1.29e-01	0.05270	-2.14e-02	-4.82e-02	2.51e-01	9.63e-03
GOBP DEFENSE RESPONSE	1762	5.87e-04	6.87e-03	0.05270	-5.24e-02	6.17e-03	2.60e-04	6.67e-01
GOBP REGULATION OF MICROVILLUS ASSEMBLY	6	9.72e-01	9.87e-01	0.05270	1.02e-02	-5.17e-02	9.66e-01	8.26e-01
Metabolism of steroids	149	5.92e-01	7.73e-01	0.05270	2.66e-02	4.54e-02	5.75e-01	3.38e-01
GOMF NEUROTRANSMITTER TRANSMEMBRANE TRANSPORTER ACTIVITY	20	9.00e-01	9.51e-01	0.05260	-3.85e-02	3.59e-02	7.66e-01	7.81e-01
GOBP POLYAMINE TRANSPORT	16	9.42e-01	9.74e-01	0.05260	4.95e-02	1.78e-02	7.32e-01	9.02e-01
GOBP REGULATION OF GLIOGENESIS	108	6.92e-01	8.40e-01	0.05260	3.70e-02	3.74e-02	5.07e-01	5.02e-01
GOBP PROTEIN TETRAMERIZATION	92	6.32e-01	7.99e-01	0.05260	4.86e-02	-2.03e-02	4.21e-01	7.37e-01
GOBP OSTEOCLAST DIFFERENTIATION	106	5.73e-01	7.63e-01	0.05260	-3.91e-02	3.52e-02	4.86e-01	5.32e-01
GOBP BIOLOGICAL PROCESS INVOLVED IN INTERACTION WITH SYMBIONT	110	6.14e-01	7.88e-01	0.05260	-5.25e-02	2.96e-03	3.41e-01	9.57e-01
GOBP REGULATION OF SYSTEM PROCESS	552	9.64e-02	2.83e-01	0.05260	-6.65e-05	-5.26e-02	9.98e-01	3.46e-02
GOBP NEGATIVE REGULATION OF CELL DIVISION	17	9.43e-01	9.74e-01	0.05260	3.06e-02	4.28e-02	8.27e-01	7.60e-01
GOBP POSITIVE REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION	63	7.98e-01	8.98e-01	0.05260	2.42e-02	4.67e-02	7.40e-01	5.22e-01
GOBP DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION	938	3.97e-02	1.61e-01	0.05260	4.69e-02	2.38e-02	1.50e-02	2.17e-01
GOCC VESICLE MEMBRANE	1199	1.40e-02	7.70e-02	0.05260	1.73e-02	4.96e-02	3.14e-01	3.79e-03
GOBP POSITIVE REGULATION OF CILIUM MOVEMENT	13	9.56e-01	9.80e-01	0.05250	-2.97e-02	-4.32e-02	8.53e-01	7.87e-01
GOCC CLATHRIN COATED ENDOCYTIC VESICLE	87	7.40e-01	8.68e-01	0.05250	2.86e-02	4.40e-02	6.45e-01	4.78e-01
GOBP CELLULAR RESPONSE TO ALCOHOL	102	6.17e-01	7.90e-01	0.05240	1.25e-02	-5.09e-02	8.28e-01	3.74e-01
GOMF PEPTIDE HORMONE BINDING	48	8.09e-01	9.04e-01	0.05240	3.35e-03	-5.23e-02	9.68e-01	5.31e-01
PI3K/AKT Signaling in Cancer	111	6.66e-01	8.23e-01	0.05240	4.88e-02	1.92e-02	3.75e-01	7.27e-01
GOBP POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT	24	9.00e-01	9.51e-01	0.05240	-5.23e-02	2.10e-03	6.57e-01	9.86e-01
GOBP PROSTANOID BIOSYNTHETIC PROCESS	30	8.95e-01	9.49e-01	0.05240	-1.80e-02	-4.92e-02	8.64e-01	6.41e-01
GOBP REGULATION OF CATION CHANNEL ACTIVITY	106	6.46e-01	8.08e-01	0.05230	5.21e-02	4.74e-03	3.54e-01	9.33e-01
GOBP MOTILE CILIUM ASSEMBLY	70	7.19e-01	8.56e-01	0.05230	-5.09e-02	1.21e-02	4.61e-01	8.61e-01
GOBP MULTICELLULAR ORGANISMAL REPRODUCTIVE PROCESS	893	2.69e-02	1.22e-01	0.05230	5.23e-02	2.41e-03	8.06e-03	9.03e-01
GOBP POSITIVE REGULATION OF EXOCYTOSIS	72	6.99e-01	8.44e-01	0.05220	-2.20e-02	4.73e-02	7.47e-01	4.87e-01
GOBP TRIPEPTIDE TRANSMEMBRANE TRANSPORT	10	9.66e-01	9.84e-01	0.05210	2.63e-02	4.50e-02	8.86e-01	8.05e-01
GOBP REGULATION OF HEART CONTRACTION	201	5.10e-01	7.17e-01	0.05200	-3.07e-02	-4.20e-02	4.53e-01	3.05e-01
GOBP AMYLOID BETA METABOLIC PROCESS	64	8.06e-01	9.02e-01	0.05200	4.18e-02	3.09e-02	5.63e-01	6.69e-01
GOBP ALLANTOIN METABOLIC PROCESS	9	9.59e-01	9.81e-01	0.05200	-1.20e-02	5.06e-02	9.50e-01	7.93e-01
GOBP EXOCYTOSIS	330	1.88e-01	4.15e-01	0.05190	-3.93e-02	3.39e-02	2.20e-01	2.89e-01
Kinesins	59	7.49e-01	8.71e-01	0.05180	-4.69e-02	2.21e-02	5.33e-01	7.69e-01
GOMF INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY TRANSPOSING C C BONDS	15	9.41e-01	9.73e-01	0.05180	-5.16e-02	-4.65e-03	7.29e-01	9.75e-01
GOBP MULTICELLULAR ORGANISMAL LEVEL HOMEOSTASIS	785	7.92e-02	2.51e-01	0.05180	4.17e-02	3.06e-02	4.69e-02	1.44e-01
GOCC PERINUCLEOLAR COMPARTMENT	5	9.83e-01	9.91e-01	0.05180	-2.16e-02	-4.70e-02	9.33e-01	8.55e-01
GOBP ANATOMICAL STRUCTURE MATURATION	263	3.83e-01	6.17e-01	0.05160	4.94e-02	1.49e-02	1.67e-01	6.77e-01
GOBP MONOATOMIC ION HOMEOSTASIS	589	9.10e-02	2.74e-01	0.05160	-5.16e-02	-2.65e-04	3.23e-02	9.91e-01
GOBP REGULATION OF GRANULOCYTE CHEMOTAXIS	49	8.09e-01	9.04e-01	0.05160	4.37e-03	-5.14e-02	9.58e-01	5.34e-01
Lipophagy	9	9.58e-01	9.80e-01	0.05150	-1.75e-02	4.85e-02	9.28e-01	8.01e-01
GOCC POLYMERIC CYTOSKELETAL FIBER	762	5.49e-02	1.99e-01	0.05150	-5.11e-02	-6.70e-03	1.64e-02	7.53e-01
GOMF SIGNALING ADAPTOR ACTIVITY	111	6.71e-01	8.26e-01	0.05150	4.86e-02	1.68e-02	3.76e-01	7.59e-01
GOBP POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION	161	5.62e-01	7.54e-01	0.05140	1.67e-02	4.86e-02	7.14e-01	2.87e-01
GOBP REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY	28	9.05e-01	9.54e-01	0.05140	-1.86e-02	-4.79e-02	8.65e-01	6.61e-01
GOBP NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS	110	6.70e-01	8.25e-01	0.05130	-4.93e-02	-1.45e-02	3.72e-01	7.93e-01
GOCC PLASMA MEMBRANE RAFT	112	6.94e-01	8.41e-01	0.05130	-3.13e-02	-4.06e-02	5.67e-01	4.57e-01
GOMF HYALURONIC ACID BINDING	24	8.87e-01	9.46e-01	0.05120	3.40e-02	-3.83e-02	7.73e-01	7.45e-01
Transcriptional regulation of testis differentiation	12	9.60e-01	9.81e-01	0.05120	-2.51e-02	-4.46e-02	8.80e-01	7.89e-01
GOBP RESPONSE TO ISOQUINOLINE ALKALOID	13	9.59e-01	9.81e-01	0.05110	3.33e-02	3.88e-02	8.35e-01	8.09e-01
GOBP REGULATION OF T CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL	11	9.64e-01	9.83e-01	0.05100	4.49e-02	2.41e-02	7.96e-01	8.90e-01
GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION CHOLINERGIC	6	9.79e-01	9.90e-01	0.05090	-1.60e-02	-4.83e-02	9.46e-01	8.38e-01
GOBP ESTABLISHMENT OF TISSUE POLARITY	36	8.86e-01	9.45e-01	0.05090	2.23e-02	4.57e-02	8.17e-01	6.35e-01
GOBP REGULATION OF CELL ADHESION	781	4.65e-02	1.79e-01	0.05090	-1.83e-04	5.09e-02	9.93e-01	1.56e-02
GOBP REGULATION OF TRANSPORTER ACTIVITY	230	3.67e-01	6.03e-01	0.05080	1.03e-02	-4.98e-02	7.88e-01	1.93e-01
GOMF CELL ADHESION MOLECULE BINDING	545	1.04e-01	2.96e-01	0.05080	5.04e-02	-6.29e-03	4.43e-02	8.02e-01
GOBP NEGATIVE REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION	14	9.34e-01	9.69e-01	0.05070	3.32e-02	-3.84e-02	8.30e-01	8.04e-01
GOCC PLATELET DENSE TUBULAR NETWORK	11	9.48e-01	9.77e-01	0.05070	-2.90e-02	4.16e-02	8.68e-01	8.11e-01
GOBP AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS	93	6.71e-01	8.26e-01	0.05070	-7.82e-03	5.01e-02	8.96e-01	4.04e-01
GOMF ACTIN FILAMENT BINDING	203	4.90e-01	7.03e-01	0.05070	-1.50e-02	-4.84e-02	7.12e-01	2.34e-01
GOBP POSITIVE REGULATION OF JNK CASCADE	91	7.50e-01	8.71e-01	0.05070	3.44e-02	3.72e-02	5.70e-01	5.40e-01
GOBP WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY	48	8.53e-01	9.26e-01	0.05060	4.46e-02	2.38e-02	5.93e-01	7.75e-01
GOMF SPHINGOLIPID TRANSPORTER ACTIVITY	20	9.12e-01	9.57e-01	0.05060	-4.71e-02	1.85e-02	7.15e-01	8.86e-01
GOMF STRUCTURAL MOLECULE ACTIVITY	750	2.98e-02	1.31e-01	0.05050	3.12e-02	-3.98e-02	1.46e-01	6.38e-02
GOMF ANTIOXIDANT ACTIVITY	82	7.10e-01	8.51e-01	0.05050	-5.22e-03	5.02e-02	9.35e-01	4.32e-01
GOBP POSITIVE REGULATION OF CARTILAGE DEVELOPMENT	31	8.61e-01	9.32e-01	0.05040	3.95e-02	-3.13e-02	7.03e-01	7.63e-01
GOMF AMMONIUM TRANSMEMBRANE TRANSPORTER ACTIVITY	12	9.61e-01	9.81e-01	0.05040	-4.61e-02	-2.04e-02	7.82e-01	9.03e-01
Regulation of insulin secretion	77	7.86e-01	8.92e-01	0.05030	-3.65e-02	-3.47e-02	5.80e-01	5.99e-01
TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)	16	9.51e-01	9.78e-01	0.05030	3.95e-02	3.12e-02	7.85e-01	8.29e-01
GOBP FATTY ACID TRANSPORT	119	6.90e-01	8.39e-01	0.05030	-3.35e-02	-3.76e-02	5.28e-01	4.79e-01
GOBP BLOOD VESSEL MORPHOGENESIS	694	8.84e-02	2.70e-01	0.05030	4.91e-02	1.11e-02	2.76e-02	6.20e-01
GOBP REGULATION OF ATP METABOLIC PROCESS	68	7.26e-01	8.60e-01	0.05020	-2.60e-02	4.29e-02	7.10e-01	5.40e-01
GOBP CELL JUNCTION ASSEMBLY	433	1.43e-01	3.56e-01	0.05020	2.03e-02	-4.59e-02	4.70e-01	1.01e-01
GOBP DEFENSE RESPONSE TO OTHER ORGANISM	1162	7.38e-03	4.77e-02	0.05020	-4.76e-02	1.58e-02	6.22e-03	3.65e-01
GOBP RESPIRATORY SYSTEM PROCESS	42	8.78e-01	9.41e-01	0.05010	-3.31e-02	-3.77e-02	7.11e-01	6.72e-01
GOBP TRIGLYCERIDE METABOLIC PROCESS	104	6.55e-01	8.14e-01	0.05010	4.05e-03	-5.00e-02	9.43e-01	3.79e-01
GOBP REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS	50	8.56e-01	9.28e-01	0.05000	3.89e-02	3.14e-02	6.34e-01	7.01e-01
GOBP REGULATION OF AMINE METABOLIC PROCESS	29	8.99e-01	9.51e-01	0.05000	7.14e-03	4.95e-02	9.47e-01	6.45e-01
GOBP NADH METABOLIC PROCESS	32	8.97e-01	9.50e-01	0.05000	-4.69e-02	-1.72e-02	6.46e-01	8.66e-01
GOBP ENDOTHELIAL CELL MIGRATION	274	3.82e-01	6.16e-01	0.05000	4.87e-02	1.11e-02	1.65e-01	7.52e-01
GOBP NEGATIVE REGULATION OF CHEMOKINE PRODUCTION	29	9.09e-01	9.55e-01	0.05000	-4.57e-02	-2.03e-02	6.70e-01	8.50e-01
GOBP REGULATION OF DEFENSE RESPONSE	810	2.53e-02	1.17e-01	0.04980	-3.07e-02	3.92e-02	1.37e-01	5.79e-02
GOBP SOMATOTROPIN SECRETING CELL DIFFERENTIATION	5	9.81e-01	9.91e-01	0.04980	3.64e-03	4.97e-02	9.89e-01	8.47e-01
GOBP REGULATION OF CARDIAC MUSCLE CONTRACTION	73	7.91e-01	8.94e-01	0.04980	-4.42e-02	-2.29e-02	5.14e-01	7.35e-01
GOBP LONG CHAIN FATTY ACID TRANSPORT	66	8.17e-01	9.08e-01	0.04980	-3.16e-02	-3.84e-02	6.57e-01	5.89e-01
GOMF EFFLUX TRANSMEMBRANE TRANSPORTER ACTIVITY	15	9.53e-01	9.79e-01	0.04970	2.17e-02	4.47e-02	8.84e-01	7.64e-01
GOBP CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS	92	7.57e-01	8.76e-01	0.04960	3.50e-02	3.51e-02	5.61e-01	5.61e-01
Platelet activation, signaling and aggregation	249	4.58e-01	6.83e-01	0.04950	2.32e-02	4.37e-02	5.29e-01	2.35e-01
GOBP NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS	99	7.11e-01	8.51e-01	0.04940	4.80e-02	1.17e-02	4.09e-01	8.40e-01
GOBP REGULATION OF BLOOD CIRCULATION	252	4.48e-01	6.74e-01	0.04940	-2.05e-02	-4.50e-02	5.75e-01	2.19e-01
GOBP REGULATION OF NAD P H OXIDASE ACTIVITY	5	9.82e-01	9.91e-01	0.04940	7.27e-03	4.88e-02	9.78e-01	8.50e-01
GOBP REGULATION OF INNATE IMMUNE RESPONSE	430	1.79e-01	4.03e-01	0.04940	-7.67e-03	4.88e-02	7.85e-01	8.29e-02
NPAS4 regulates expression of target genes	20	9.33e-01	9.68e-01	0.04930	9.94e-03	4.83e-02	9.39e-01	7.09e-01
GOBP LYMPHOCYTE HOMEOSTASIS	73	8.04e-01	9.02e-01	0.04930	3.27e-02	3.68e-02	6.29e-01	5.86e-01
GOBP MAINTENANCE OF APICAL BASAL CELL POLARITY	10	9.57e-01	9.80e-01	0.04920	4.54e-02	-1.89e-02	8.04e-01	9.18e-01
GOBP POSITIVE REGULATION OF HYDROLASE ACTIVITY	430	1.43e-01	3.56e-01	0.04920	-3.64e-02	3.31e-02	1.95e-01	2.40e-01
GOBP POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT	80	6.95e-01	8.41e-01	0.04890	3.60e-02	-3.31e-02	5.78e-01	6.08e-01
GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL	40	8.47e-01	9.23e-01	0.04890	1.26e-02	-4.73e-02	8.90e-01	6.05e-01
GOBP HETEROTYPIC CELL CELL ADHESION	62	7.74e-01	8.86e-01	0.04870	-1.28e-02	4.70e-02	8.62e-01	5.22e-01
GOBP SEXUAL REPRODUCTION	1011	2.23e-02	1.08e-01	0.04870	4.82e-02	-6.78e-03	9.55e-03	7.16e-01
GOMF SIGNALING RECEPTOR INHIBITOR ACTIVITY	27	9.24e-01	9.64e-01	0.04860	-3.29e-02	-3.58e-02	7.68e-01	7.47e-01
GOMF HSP70 PROTEIN BINDING	50	8.63e-01	9.33e-01	0.04860	3.00e-02	3.83e-02	7.14e-01	6.40e-01
GOBP VENTRICULAR CARDIAC MUSCLE TISSUE MORPHOGENESIS	47	8.37e-01	9.18e-01	0.04860	-2.70e-03	4.85e-02	9.74e-01	5.65e-01
GOBP CELL JUNCTION ORGANIZATION	724	9.95e-02	2.89e-01	0.04850	-1.30e-02	-4.68e-02	5.53e-01	3.21e-02
Reduction of cytosolic Ca++ levels	11	9.61e-01	9.82e-01	0.04850	4.84e-02	2.29e-03	7.81e-01	9.90e-01
GOBP REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION	209	5.48e-01	7.45e-01	0.04850	-3.53e-02	-3.33e-02	3.79e-01	4.07e-01
GOMF GLUCOSE BINDING	10	9.58e-01	9.80e-01	0.04840	4.39e-02	-2.05e-02	8.10e-01	9.11e-01
Integration of energy metabolism	105	7.15e-01	8.53e-01	0.04840	-1.52e-02	-4.60e-02	7.88e-01	4.16e-01
Cell-cell junction organization	88	7.75e-01	8.87e-01	0.04840	-3.12e-02	-3.70e-02	6.13e-01	5.49e-01
GOBP REGULATION OF REPRODUCTIVE PROCESS	198	5.57e-01	7.51e-01	0.04840	4.15e-02	2.49e-02	3.14e-01	5.45e-01
GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION	129	6.86e-01	8.36e-01	0.04840	3.95e-02	2.80e-02	4.39e-01	5.83e-01
GOMF ACTIVE MONOATOMIC ION TRANSMEMBRANE TRANSPORTER ACTIVITY	265	3.54e-01	5.92e-01	0.04840	8.92e-03	-4.75e-02	8.03e-01	1.83e-01
GOBP REGULATION OF CALCIUM ION IMPORT	46	8.67e-01	9.35e-01	0.04840	-4.46e-02	-1.86e-02	6.00e-01	8.27e-01
GOBP TRIGLYCERIDE BIOSYNTHETIC PROCESS	41	8.81e-01	9.43e-01	0.04830	1.92e-02	4.44e-02	8.32e-01	6.23e-01
GOBP NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION	9	9.71e-01	9.86e-01	0.04830	1.44e-02	4.61e-02	9.40e-01	8.11e-01
GOBP NEUTRAL AMINO ACID TRANSPORT	54	7.96e-01	8.97e-01	0.04830	4.43e-02	-1.93e-02	5.73e-01	8.06e-01
GOBP REGULATION OF MONOATOMIC ION TRANSPORT	445	2.27e-01	4.61e-01	0.04830	-8.35e-03	-4.76e-02	7.63e-01	8.53e-02
GOBP NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY	60	8.40e-01	9.19e-01	0.04820	-2.77e-02	-3.95e-02	7.11e-01	5.97e-01
GOBP NEUTRAL LIPID METABOLIC PROCESS	130	6.12e-01	7.86e-01	0.04820	4.47e-03	-4.80e-02	9.30e-01	3.44e-01
GOBP REGULATION OF REMOVAL OF SUPEROXIDE RADICALS	6	9.83e-01	9.92e-01	0.04820	3.01e-02	3.77e-02	8.98e-01	8.73e-01
GOBP MACROPHAGE DIFFERENTIATION	62	8.05e-01	9.02e-01	0.04820	4.39e-03	4.80e-02	9.52e-01	5.13e-01
GOBP CELLULAR RESPONSE TO ETHANOL	12	9.66e-01	9.84e-01	0.04810	3.11e-02	3.68e-02	8.52e-01	8.25e-01
GOMF ARYL SULFOTRANSFERASE ACTIVITY	7	9.74e-01	9.87e-01	0.04800	6.45e-03	-4.75e-02	9.76e-01	8.28e-01
GOMF WNT PROTEIN BINDING	31	8.90e-01	9.46e-01	0.04790	-4.76e-02	5.37e-03	6.46e-01	9.59e-01
GOBP POSITIVE REGULATION OF MONOATOMIC ION TRANSPORT	196	4.30e-01	6.58e-01	0.04790	2.79e-02	-3.89e-02	5.00e-01	3.47e-01
GOBP POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS	383	2.53e-01	4.91e-01	0.04790	-1.36e-03	4.79e-02	9.64e-01	1.08e-01
GOBP MEDIUM CHAIN FATTY ACID BIOSYNTHETIC PROCESS	6	9.78e-01	9.89e-01	0.04780	-4.75e-02	5.86e-03	8.40e-01	9.80e-01
GOBP UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS	48	8.73e-01	9.38e-01	0.04780	-2.90e-02	-3.79e-02	7.28e-01	6.49e-01
GOCC LATERAL PLASMA MEMBRANE	64	7.81e-01	8.90e-01	0.04770	-9.24e-03	4.68e-02	8.98e-01	5.17e-01
GOBP POSITIVE REGULATION OF CATALYTIC ACTIVITY	802	7.43e-02	2.41e-01	0.04770	6.54e-03	4.72e-02	7.53e-01	2.30e-02
GOBP AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM	24	9.02e-01	9.52e-01	0.04770	2.98e-02	-3.72e-02	8.01e-01	7.52e-01
GOBP REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY	23	9.12e-01	9.57e-01	0.04760	1.39e-02	-4.56e-02	9.08e-01	7.05e-01
SLC transporter disorders	94	6.83e-01	8.34e-01	0.04760	1.74e-02	-4.43e-02	7.71e-01	4.58e-01
GOBP REGULATION OF PHOSPHOLIPASE ACTIVITY	48	8.13e-01	9.06e-01	0.04750	3.31e-02	-3.41e-02	6.91e-01	6.83e-01
GOCC SUPRAMOLECULAR COMPLEX	1357	7.99e-03	5.08e-02	0.04750	4.68e-02	-7.86e-03	3.80e-03	6.27e-01
GOCC GOLGI CISTERNA MEMBRANE	74	7.28e-01	8.61e-01	0.04750	-3.52e-02	3.18e-02	6.00e-01	6.36e-01
GOCC FILOPODIUM MEMBRANE	17	9.30e-01	9.67e-01	0.04750	-3.28e-02	3.43e-02	8.15e-01	8.06e-01
GOBP GLIAL CELL DIFFERENTIATION	256	4.94e-01	7.07e-01	0.04750	3.54e-02	3.17e-02	3.30e-01	3.83e-01
GOMF PHOSPHOLIPID BINDING	463	1.65e-01	3.86e-01	0.04750	4.52e-02	-1.45e-02	9.56e-02	5.94e-01
GOBP INTERFERON MEDIATED SIGNALING PATHWAY	100	7.58e-01	8.76e-01	0.04740	3.56e-02	3.14e-02	5.39e-01	5.88e-01
Glucagon-type ligand receptors	32	9.03e-01	9.52e-01	0.04730	-1.00e-02	-4.63e-02	9.22e-01	6.51e-01
GOBP REGULATION OF RESPONSE TO BIOTIC STIMULUS	515	2.05e-01	4.35e-01	0.04730	1.18e-02	4.58e-02	6.46e-01	7.51e-02
GOBP REGULATION OF OSTEOBLAST PROLIFERATION	30	9.03e-01	9.53e-01	0.04730	4.71e-02	3.93e-03	6.55e-01	9.70e-01
GOBP G PROTEIN COUPLED OPIOID RECEPTOR SIGNALING PATHWAY	11	9.55e-01	9.80e-01	0.04720	3.76e-02	-2.86e-02	8.29e-01	8.69e-01
GOBP PROTEIN LOCALIZATION TO CELL CELL JUNCTION	21	9.31e-01	9.68e-01	0.04700	-4.70e-02	-1.57e-03	7.09e-01	9.90e-01
GOBP POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH	31	9.19e-01	9.61e-01	0.04690	3.70e-02	2.88e-02	7.21e-01	7.81e-01
GOMF PHOSPHOTRANSFERASE ACTIVITY PHOSPHATE GROUP AS ACCEPTOR	35	9.05e-01	9.54e-01	0.04690	-4.16e-02	-2.15e-02	6.70e-01	8.26e-01
GOBP FAT SOLUBLE VITAMIN METABOLIC PROCESS	47	8.76e-01	9.40e-01	0.04680	4.13e-02	2.22e-02	6.25e-01	7.92e-01
GOBP RECEPTOR RECYCLING	45	8.42e-01	9.21e-01	0.04670	4.49e-02	-1.29e-02	6.02e-01	8.81e-01
GOBP REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS	76	7.94e-01	8.96e-01	0.04670	1.27e-02	4.49e-02	8.48e-01	4.98e-01
Signaling by Interleukins	421	2.45e-01	4.83e-01	0.04660	2.76e-04	4.66e-02	9.92e-01	1.01e-01
GOBP CELL CELL SIGNALING	1255	2.87e-02	1.28e-01	0.04650	-4.45e-02	-1.35e-02	7.96e-03	4.21e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON CH OH GROUP OF DONORS	130	6.50e-01	8.11e-01	0.04650	-2.09e-03	-4.65e-02	9.67e-01	3.60e-01
GOCC PROTEASE INHIBITOR COMPLEX	8	9.68e-01	9.85e-01	0.04640	-3.15e-02	3.41e-02	8.78e-01	8.67e-01
Glycerophospholipid biosynthesis	123	7.12e-01	8.52e-01	0.04640	4.06e-02	2.24e-02	4.36e-01	6.68e-01
GOMF SIRNA BINDING	9	9.68e-01	9.85e-01	0.04630	8.22e-03	-4.55e-02	9.66e-01	8.13e-01
GOCC APOLIPOPROTEIN B MRNA EDITING ENZYME COMPLEX	5	9.82e-01	9.91e-01	0.04620	-4.56e-02	7.38e-03	8.60e-01	9.77e-01
GOBP NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY	14	9.61e-01	9.82e-01	0.04610	1.86e-02	4.22e-02	9.04e-01	7.85e-01
GOBP REGULATION OF P38MAPK CASCADE	46	8.47e-01	9.23e-01	0.04610	-9.44e-03	4.51e-02	9.12e-01	5.97e-01
GOBP DEVELOPMENTAL CELL GROWTH	213	5.60e-01	7.53e-01	0.04600	4.08e-02	2.13e-02	3.05e-01	5.92e-01
GOBP REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT	168	5.15e-01	7.22e-01	0.04600	2.48e-02	-3.88e-02	5.79e-01	3.86e-01
GOBP SEQUESTERING OF CALCIUM ION	133	6.87e-01	8.37e-01	0.04600	-1.68e-02	-4.28e-02	7.37e-01	3.94e-01
GOBP LEARNING	149	5.66e-01	7.57e-01	0.04600	-4.21e-02	1.86e-02	3.75e-01	6.96e-01
GOBP NEGATIVE REGULATION OF TRANSMISSION OF NERVE IMPULSE	6	9.81e-01	9.91e-01	0.04600	4.59e-02	2.75e-03	8.46e-01	9.91e-01
GOBP RENAL ALBUMIN ABSORPTION	6	9.83e-01	9.92e-01	0.04590	-1.88e-02	-4.19e-02	9.36e-01	8.59e-01
GOBP CELLULAR LIPID METABOLIC PROCESS	990	6.11e-02	2.13e-01	0.04590	4.43e-02	1.19e-02	1.82e-02	5.27e-01
GOCC PHOSPHOLIPID TRANSLOCATING ATPASE COMPLEX	13	9.62e-01	9.82e-01	0.04590	-4.46e-02	-1.09e-02	7.81e-01	9.46e-01
GOMF CARBON CARBON LYASE ACTIVITY	51	8.63e-01	9.33e-01	0.04590	4.38e-02	1.38e-02	5.89e-01	8.65e-01
GOBP POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION	28	9.06e-01	9.54e-01	0.04590	4.53e-02	-6.89e-03	6.78e-01	9.50e-01
GOCC MITOTIC SPINDLE ASTRAL MICROTUBULE	7	9.81e-01	9.91e-01	0.04590	-3.90e-02	-2.42e-02	8.58e-01	9.12e-01
GOBP CELLULAR RESPONSE TO EXTERNAL STIMULUS	72	8.22e-01	9.10e-01	0.04580	2.03e-02	4.10e-02	7.65e-01	5.47e-01
GOMF PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE BINDING	80	7.46e-01	8.70e-01	0.04570	4.39e-02	-1.28e-02	4.97e-01	8.43e-01
GOBP REGULATION OF ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN	6	9.81e-01	9.91e-01	0.04570	3.57e-03	4.56e-02	9.88e-01	8.47e-01
GOBP MONOACYLGLYCEROL CATABOLIC PROCESS	7	9.73e-01	9.87e-01	0.04560	2.50e-02	-3.82e-02	9.09e-01	8.61e-01
Serotonin receptors	11	9.63e-01	9.83e-01	0.04550	-6.11e-03	4.51e-02	9.72e-01	7.96e-01
GOBP PROTEIN HOMOOLIGOMERIZATION	192	6.05e-01	7.83e-01	0.04540	3.92e-02	2.29e-02	3.49e-01	5.84e-01
GOBP PROTEIN LOCALIZATION TO CELL JUNCTION	102	7.26e-01	8.60e-01	0.04540	-2.83e-03	-4.53e-02	9.61e-01	4.29e-01
GOBP REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN	48	8.60e-01	9.31e-01	0.04540	2.69e-03	4.53e-02	9.74e-01	5.87e-01
Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein	77	7.99e-01	8.99e-01	0.04530	1.05e-02	4.41e-02	8.74e-01	5.04e-01
GOBP CARDIAC CONDUCTION	95	7.86e-01	8.92e-01	0.04530	-2.91e-02	-3.47e-02	6.24e-01	5.59e-01
GOBP AMINOGLYCAN BIOSYNTHETIC PROCESS	75	8.27e-01	9.13e-01	0.04530	-3.43e-02	-2.95e-02	6.07e-01	6.58e-01
GOBP CARBOHYDRATE BIOSYNTHETIC PROCESS	200	5.85e-01	7.70e-01	0.04530	-1.86e-02	-4.13e-02	6.50e-01	3.14e-01
GOCC DENDRITE MEMBRANE	36	8.95e-01	9.49e-01	0.04520	4.50e-02	4.16e-03	6.40e-01	9.66e-01
Neurotransmitter receptors and postsynaptic signal transmission	192	6.07e-01	7.83e-01	0.04520	-3.95e-02	-2.19e-02	3.45e-01	6.01e-01
GOCC SARCOPLASMIC RETICULUM MEMBRANE	42	8.74e-01	9.39e-01	0.04510	4.51e-02	-4.79e-04	6.13e-01	9.96e-01
GOMF INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY	52	8.35e-01	9.17e-01	0.04510	-4.40e-02	9.86e-03	5.83e-01	9.02e-01
GOMF ENZYME INHIBITOR ACTIVITY	379	3.04e-01	5.43e-01	0.04510	3.01e-04	-4.51e-02	9.92e-01	1.32e-01
GOBP POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY	101	6.98e-01	8.43e-01	0.04500	1.36e-02	-4.29e-02	8.13e-01	4.56e-01
GOBP PROTEIN PROCESSING	230	4.29e-01	6.58e-01	0.04500	4.03e-02	-2.00e-02	2.93e-01	6.02e-01
GOBP SHORT TERM MEMORY	10	9.62e-01	9.82e-01	0.04490	-3.26e-02	3.09e-02	8.58e-01	8.66e-01
GOBP MEMBRANE FUSION	177	6.35e-01	8.01e-01	0.04490	2.21e-02	3.90e-02	6.11e-01	3.70e-01
G-protein mediated events	53	8.76e-01	9.40e-01	0.04480	-2.69e-02	-3.59e-02	7.35e-01	6.51e-01
GOBP PROTEIN LOCALIZATION TO EXTRACELLULAR REGION	370	3.89e-01	6.23e-01	0.04480	3.95e-02	2.10e-02	1.92e-01	4.87e-01
GOBP NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT	139	6.17e-01	7.90e-01	0.04480	1.18e-02	-4.32e-02	8.10e-01	3.79e-01
GOBP POSITIVE REGULATION OF POTASSIUM ION TRANSPORT	41	8.96e-01	9.49e-01	0.04480	-1.65e-02	-4.16e-02	8.55e-01	6.45e-01
GOBP C4 DICARBOXYLATE TRANSPORT	28	9.32e-01	9.68e-01	0.04470	2.36e-02	3.79e-02	8.29e-01	7.28e-01
Hemostasis	577	1.43e-01	3.56e-01	0.04450	-1.20e-02	4.29e-02	6.23e-01	7.84e-02
GOBP PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE	15	9.54e-01	9.79e-01	0.04440	4.44e-02	-1.81e-03	7.66e-01	9.90e-01
GOMF ACTIN BINDING	412	2.19e-01	4.52e-01	0.04440	3.40e-02	-2.87e-02	2.37e-01	3.18e-01
GOBP NEUROMUSCULAR SYNAPTIC TRANSMISSION	28	9.23e-01	9.63e-01	0.04440	-4.37e-02	-7.63e-03	6.89e-01	9.44e-01
GOBP REGULATION OF ENTRY OF BACTERIUM INTO HOST CELL	7	9.74e-01	9.88e-01	0.04430	-2.94e-02	3.31e-02	8.93e-01	8.79e-01
GOBP ANIMAL ORGAN REGENERATION	62	7.96e-01	8.97e-01	0.04420	-3.60e-02	2.57e-02	6.24e-01	7.26e-01
GOBP NEUTROPHIL CHEMOTAXIS	81	7.46e-01	8.70e-01	0.04420	-2.18e-02	3.85e-02	7.35e-01	5.50e-01
GOBP REGULATION OF SYNAPSE ASSEMBLY	109	7.46e-01	8.70e-01	0.04420	-1.30e-02	-4.22e-02	8.15e-01	4.46e-01
GOBP NEGATIVE REGULATION BY HOST OF VIRAL PROCESS	14	9.65e-01	9.83e-01	0.04420	-4.03e-02	-1.80e-02	7.94e-01	9.07e-01
GOBP ODONTOGENESIS OF DENTIN CONTAINING TOOTH	91	7.20e-01	8.56e-01	0.04400	-3.74e-02	2.31e-02	5.37e-01	7.04e-01
GOMF G PROTEIN COUPLED RECEPTOR BINDING	274	5.19e-01	7.25e-01	0.04390	-2.55e-02	-3.58e-02	4.67e-01	3.08e-01
GOBP SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS	15	9.47e-01	9.77e-01	0.04390	-2.71e-02	3.45e-02	8.56e-01	8.17e-01
GOBP PHOSPHOLIPID CATABOLIC PROCESS	55	8.35e-01	9.17e-01	0.04390	-4.29e-02	9.37e-03	5.82e-01	9.04e-01
GOBP REGULATION OF NUCLEOTIDE METABOLIC PROCESS	86	7.39e-01	8.67e-01	0.04380	-3.93e-02	1.95e-02	5.29e-01	7.55e-01
GOMF SH2 DOMAIN BINDING	41	9.07e-01	9.55e-01	0.04380	3.32e-02	2.85e-02	7.13e-01	7.52e-01
GOBP STEROID CATABOLIC PROCESS	24	9.42e-01	9.74e-01	0.04370	-2.02e-02	-3.88e-02	8.64e-01	7.42e-01
GOBP REGULATION OF RECEPTOR INTERNALIZATION	62	8.01e-01	9.00e-01	0.04370	2.42e-02	-3.64e-02	7.42e-01	6.20e-01
GOCC NEUROMUSCULAR JUNCTION	72	7.72e-01	8.85e-01	0.04370	3.58e-02	-2.51e-02	6.00e-01	7.13e-01
GOCC CORTICAL CYTOSKELETON	105	7.81e-01	8.90e-01	0.04360	2.71e-02	3.41e-02	6.31e-01	5.46e-01
GOBP GLYCOPROTEIN METABOLIC PROCESS	373	3.20e-01	5.58e-01	0.04360	-4.34e-03	4.34e-02	8.86e-01	1.50e-01
Basigin interactions	24	9.23e-01	9.63e-01	0.04350	-1.37e-02	4.13e-02	9.08e-01	7.26e-01
GOBP REGULATION OF ASTROCYTE DIFFERENTIATION	31	8.97e-01	9.50e-01	0.04340	-3.73e-02	2.22e-02	7.19e-01	8.30e-01
GOBP POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE	198	5.94e-01	7.75e-01	0.04330	-4.20e-02	-1.06e-02	3.08e-01	7.98e-01
GOBP POSITIVE REGULATION OF TELOMERE CAPPING	17	9.57e-01	9.80e-01	0.04330	4.15e-02	1.23e-02	7.67e-01	9.30e-01
GOBP POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY	129	6.37e-01	8.02e-01	0.04330	-2.35e-02	3.64e-02	6.45e-01	4.76e-01
GOBP REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT	76	7.64e-01	8.80e-01	0.04330	2.71e-02	-3.37e-02	6.83e-01	6.11e-01
GOBP SPHINGOID METABOLIC PROCESS	22	9.34e-01	9.69e-01	0.04320	-6.44e-03	4.27e-02	9.58e-01	7.29e-01
GOBP REGULATION OF ANTIGEN PROCESSING AND PRESENTATION	18	9.58e-01	9.80e-01	0.04320	-2.22e-02	-3.71e-02	8.71e-01	7.85e-01
Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580 K2555) Translocation Mutant	7	9.77e-01	9.89e-01	0.04310	-3.99e-02	1.64e-02	8.55e-01	9.40e-01
Signaling by NOTCH1 t(7;9)(NOTCH1:M1580 K2555) Translocation Mutant	7	9.77e-01	9.89e-01	0.04310	-3.99e-02	1.64e-02	8.55e-01	9.40e-01
GOBP GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS	39	8.74e-01	9.39e-01	0.04310	-2.19e-02	3.71e-02	8.13e-01	6.88e-01
GOBP PROTEIN RETENTION IN ER LUMEN	8	9.79e-01	9.90e-01	0.04290	-4.19e-02	-9.27e-03	8.38e-01	9.64e-01
GOBP MESENCHYMAL TO EPITHELIAL TRANSITION	18	9.51e-01	9.78e-01	0.04280	-4.27e-02	-3.01e-03	7.54e-01	9.82e-01
GOBP GENITALIA DEVELOPMENT	46	8.91e-01	9.47e-01	0.04280	4.08e-02	1.29e-02	6.32e-01	8.80e-01
GOBP REGULATION OF HORMONE LEVELS	524	3.15e-01	5.54e-01	0.04270	-2.80e-02	-3.22e-02	2.73e-01	2.07e-01
CREB1 phosphorylation through the activation of Adenylate Cyclase	11	9.62e-01	9.82e-01	0.04270	-2.94e-02	3.09e-02	8.66e-01	8.59e-01
GOBP INNER EAR MORPHOGENESIS	105	6.98e-01	8.43e-01	0.04250	-3.33e-02	2.65e-02	5.56e-01	6.39e-01
Apoptotic cleavage of cell adhesion proteins	11	9.65e-01	9.84e-01	0.04250	1.56e-02	-3.95e-02	9.29e-01	8.20e-01
GOBP PROTEOGLYCAN METABOLIC PROCESS	85	8.07e-01	9.03e-01	0.04250	-1.08e-02	-4.11e-02	8.63e-01	5.13e-01
GOBP REGENERATION	192	5.75e-01	7.64e-01	0.04240	2.76e-03	-4.23e-02	9.47e-01	3.12e-01
GOBP REGULATION OF MAP KINASE ACTIVITY	128	7.11e-01	8.51e-01	0.04240	-5.34e-03	-4.21e-02	9.17e-01	4.11e-01
GOBP POSITIVE REGULATION OF RECEPTOR RECYCLING	13	9.66e-01	9.84e-01	0.04240	5.72e-03	4.20e-02	9.72e-01	7.93e-01
Metabolism of water-soluble vitamins and cofactors	125	7.58e-01	8.76e-01	0.04240	3.29e-02	2.68e-02	5.25e-01	6.05e-01
GOCC CATSPER COMPLEX	14	9.57e-01	9.80e-01	0.04230	1.06e-02	-4.10e-02	9.45e-01	7.91e-01
GOBP NEUROINFLAMMATORY RESPONSE	84	8.13e-01	9.06e-01	0.04230	-1.24e-02	-4.04e-02	8.44e-01	5.22e-01
GOMF ALCOHOL BINDING	88	8.23e-01	9.11e-01	0.04230	-2.76e-02	-3.21e-02	6.55e-01	6.03e-01
GOBP NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS	1189	8.00e-02	2.52e-01	0.04200	2.21e-02	3.58e-02	1.99e-01	3.78e-02
GOBP CELLULAR LIPID CATABOLIC PROCESS	234	5.89e-01	7.73e-01	0.04200	1.95e-02	3.72e-02	6.07e-01	3.27e-01
GOMF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY	168	6.41e-01	8.04e-01	0.04200	4.18e-02	3.39e-03	3.50e-01	9.40e-01
Developmental Biology	1331	6.61e-02	2.24e-01	0.04190	2.91e-02	3.02e-02	7.48e-02	6.44e-02
GOBP REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS	15	9.64e-01	9.83e-01	0.04190	4.01e-02	1.22e-02	7.88e-01	9.35e-01
ARMS-mediated activation	7	9.77e-01	9.89e-01	0.04190	2.59e-02	-3.29e-02	9.06e-01	8.80e-01
Cytosolic iron-sulfur cluster assembly	12	9.70e-01	9.86e-01	0.04190	8.25e-03	4.10e-02	9.61e-01	8.06e-01
GOBP REGULATION OF SECRETION	588	1.48e-01	3.61e-01	0.04180	-3.02e-02	2.89e-02	2.10e-01	2.31e-01
GOBP REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY	16	9.56e-01	9.80e-01	0.04180	4.18e-02	-1.47e-03	7.72e-01	9.92e-01
GOBP NUCLEOSIDE DIPHOSPHATE CATABOLIC PROCESS	100	7.81e-01	8.90e-01	0.04180	9.53e-03	4.07e-02	8.69e-01	4.82e-01
GOBP LIPID EXPORT FROM CELL	50	8.48e-01	9.23e-01	0.04170	-3.27e-02	2.59e-02	6.89e-01	7.51e-01
GOBP SPERMATID DIFFERENTIATION	215	5.16e-01	7.22e-01	0.04170	1.44e-02	-3.91e-02	7.17e-01	3.23e-01
GOBP REGULATION OF COAGULATION	74	8.29e-01	9.14e-01	0.04160	-6.43e-03	-4.11e-02	9.24e-01	5.41e-01
GOBP PHENOTYPIC SWITCHING	16	9.58e-01	9.80e-01	0.04160	4.16e-02	1.83e-03	7.73e-01	9.90e-01
GOBP NEUTROPHIL APOPTOTIC PROCESS	7	9.79e-01	9.90e-01	0.04160	4.03e-02	-1.06e-02	8.54e-01	9.61e-01
GOCC SITE OF POLARIZED GROWTH	159	7.05e-01	8.48e-01	0.04150	2.03e-02	3.62e-02	6.58e-01	4.31e-01
GOBP GLYCOPROTEIN BIOSYNTHETIC PROCESS	315	4.18e-01	6.49e-01	0.04150	-3.84e-03	4.13e-02	9.07e-01	2.08e-01
GOBP PHOSPHATIDYLCHOLINE METABOLIC PROCESS	74	8.01e-01	9.00e-01	0.04140	3.98e-02	-1.17e-02	5.54e-01	8.62e-01
GOBP RELAXATION OF MUSCLE	33	9.25e-01	9.65e-01	0.04140	-3.93e-02	-1.30e-02	6.96e-01	8.97e-01
GOBP REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS	98	7.66e-01	8.81e-01	0.04140	1.58e-03	-4.14e-02	9.78e-01	4.79e-01
GOMF L ALANINE TRANSMEMBRANE TRANSPORTER ACTIVITY	9	9.81e-01	9.91e-01	0.04140	2.31e-02	3.44e-02	9.05e-01	8.58e-01
GOBP NEURON REMODELING	15	9.68e-01	9.85e-01	0.04140	-3.44e-02	-2.30e-02	8.18e-01	8.77e-01
GOBP EPIBOLY	42	8.92e-01	9.48e-01	0.04130	4.13e-02	-1.76e-03	6.43e-01	9.84e-01
GOBP POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY	40	8.84e-01	9.44e-01	0.04130	1.55e-02	-3.83e-02	8.66e-01	6.75e-01
GOBP INORGANIC ION HOMEOSTASIS	515	2.74e-01	5.13e-01	0.04130	-4.11e-02	-3.71e-03	1.10e-01	8.86e-01
GOBP L GLUTAMATE IMPORT ACROSS PLASMA MEMBRANE	17	9.57e-01	9.80e-01	0.04130	-4.11e-03	-4.11e-02	9.77e-01	7.69e-01
GOBP PROLINE TRANSPORT	11	9.71e-01	9.86e-01	0.04120	-4.12e-02	1.71e-03	8.13e-01	9.92e-01
GOMF TRANSMEMBRANE TRANSPORTER BINDING	128	7.42e-01	8.69e-01	0.04120	-3.94e-02	-1.21e-02	4.42e-01	8.13e-01
GOBP CYTOKINE MEDIATED SIGNALING PATHWAY	501	2.24e-01	4.58e-01	0.04100	-3.77e-02	1.61e-02	1.48e-01	5.37e-01
GOMF STRUCTURAL CONSTITUENT OF POSTSYNAPSE	18	9.45e-01	9.76e-01	0.04100	2.24e-02	-3.43e-02	8.69e-01	8.01e-01
GOBP LIPID BIOSYNTHETIC PROCESS	709	2.15e-01	4.47e-01	0.04090	1.55e-02	3.79e-02	4.83e-01	8.54e-02
GOBP POSITIVE REGULATION OF NEUROGENESIS	231	5.74e-01	7.64e-01	0.04090	4.02e-02	7.56e-03	2.92e-01	8.43e-01
GOBP CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY	23	9.52e-01	9.79e-01	0.04090	1.95e-02	3.59e-02	8.71e-01	7.65e-01
GOCC RNA POLYMERASE I TRANSCRIPTION REGULATOR COMPLEX	6	9.88e-01	9.95e-01	0.04040	-2.92e-02	-2.79e-02	9.01e-01	9.06e-01
GOBP REGULATION OF INSULIN SECRETION	164	6.10e-01	7.85e-01	0.04040	-2.00e-02	3.51e-02	6.58e-01	4.38e-01
GOBP VESICLE DOCKING INVOLVED IN EXOCYTOSIS	35	9.08e-01	9.55e-01	0.04030	3.97e-02	-7.20e-03	6.85e-01	9.41e-01
GOBP BIOLOGICAL PROCESS INVOLVED IN INTERSPECIES INTERACTION BETWEEN ORGANISMS	1628	9.47e-03	5.75e-02	0.04030	-2.96e-02	2.73e-02	4.65e-02	6.66e-02
GOBP REPRODUCTIVE PROCESS	1435	5.55e-02	2.00e-01	0.04020	3.71e-02	1.56e-02	1.86e-02	3.22e-01
GOBP MALE MEIOTIC NUCLEAR DIVISION	54	8.48e-01	9.23e-01	0.04020	2.41e-02	-3.22e-02	7.60e-01	6.82e-01
GOBP TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE CLEARANCE	7	9.85e-01	9.93e-01	0.04020	3.69e-02	1.58e-02	8.66e-01	9.42e-01
GOMF ENDODEOXYRIBONUCLEASE ACTIVITY PRODUCING 5 PHOSPHOMONOESTERS	11	9.72e-01	9.87e-01	0.04010	4.01e-02	-1.19e-03	8.18e-01	9.95e-01
GOCC CELL CORTEX	305	5.12e-01	7.20e-01	0.04000	3.84e-02	1.14e-02	2.49e-01	7.33e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN	171	6.56e-01	8.15e-01	0.04000	-1.04e-03	-3.99e-02	9.81e-01	3.67e-01
GOBP REGULATION OF MACROPHAGE MIGRATION	45	9.00e-01	9.51e-01	0.03990	-5.80e-03	-3.95e-02	9.46e-01	6.47e-01
GOBP REGULATION OF CELL JUNCTION ASSEMBLY	205	5.83e-01	7.69e-01	0.03990	3.95e-02	-5.73e-03	3.30e-01	8.88e-01
GOBP REGULATION OF BEHAVIOR	73	8.56e-01	9.28e-01	0.03990	-3.70e-02	-1.49e-02	5.85e-01	8.25e-01
GOBP REGULATION OF RENAL SODIUM EXCRETION	8	9.78e-01	9.89e-01	0.03970	3.84e-02	-1.04e-02	8.51e-01	9.59e-01
GOBP PROTEIN LOCALIZATION TO SYNAPSE	73	8.32e-01	9.16e-01	0.03970	1.59e-03	-3.97e-02	9.81e-01	5.58e-01
GOBP REGULATION OF ENDODEOXYRIBONUCLEASE ACTIVITY	8	9.77e-01	9.89e-01	0.03950	3.50e-02	-1.82e-02	8.64e-01	9.29e-01
GOBP REGULATION OF CHOLESTEROL EFFLUX	54	8.91e-01	9.48e-01	0.03940	-1.19e-02	-3.75e-02	8.80e-01	6.33e-01
GOBP KIDNEY MORPHOGENESIS	95	8.13e-01	9.06e-01	0.03930	9.03e-03	3.82e-02	8.79e-01	5.20e-01
GOCC CELL CELL JUNCTION	487	3.43e-01	5.80e-01	0.03930	-6.66e-03	-3.87e-02	8.01e-01	1.44e-01
GOMF PROTEIN TYROSINE KINASE BINDING	120	7.89e-01	8.93e-01	0.03920	1.87e-02	3.45e-02	7.24e-01	5.14e-01
GOMF LYSOPHOSPHATIDIC ACID PHOSPHATASE ACTIVITY	7	9.84e-01	9.92e-01	0.03920	6.34e-03	3.87e-02	9.77e-01	8.59e-01
GOBP RESPONSE TO PH	40	9.26e-01	9.65e-01	0.03920	-3.21e-02	-2.26e-02	7.26e-01	8.05e-01
GOBP RESPONSE TO LAMINAR FLUID SHEAR STRESS	15	9.57e-01	9.80e-01	0.03920	3.25e-02	-2.20e-02	8.28e-01	8.83e-01
GOCC AZUROPHIL GRANULE MEMBRANE	56	8.87e-01	9.46e-01	0.03920	-1.08e-02	-3.77e-02	8.89e-01	6.26e-01
GOBP MOLTING CYCLE	115	8.05e-01	9.02e-01	0.03920	2.96e-02	2.57e-02	5.84e-01	6.34e-01
GOMF AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY	93	8.20e-01	9.09e-01	0.03910	-3.78e-02	-1.02e-02	5.29e-01	8.65e-01
GOBP REGULATION OF FAT CELL PROLIFERATION	10	9.71e-01	9.86e-01	0.03910	-2.87e-02	2.65e-02	8.75e-01	8.85e-01
GOBP CARDIAC MUSCLE TISSUE MORPHOGENESIS	61	8.86e-01	9.45e-01	0.03890	1.62e-02	3.53e-02	8.26e-01	6.33e-01
GOBP GLUCOSE 6 PHOSPHATE METABOLIC PROCESS	27	9.48e-01	9.77e-01	0.03880	-3.56e-02	-1.54e-02	7.49e-01	8.90e-01
GOBP POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION	82	8.55e-01	9.27e-01	0.03870	-3.36e-02	-1.92e-02	5.99e-01	7.64e-01
GOBP FOAM CELL DIFFERENTIATION	41	8.92e-01	9.48e-01	0.03860	-3.18e-02	2.18e-02	7.25e-01	8.09e-01
GOBP ENDOCARDIUM DEVELOPMENT	12	9.68e-01	9.85e-01	0.03850	-1.61e-02	3.50e-02	9.23e-01	8.34e-01
GOCC SARCOPLASMIC RETICULUM	74	8.55e-01	9.27e-01	0.03850	3.77e-02	7.77e-03	5.75e-01	9.08e-01
GOBP CELLULAR RESPONSE TO COCAINE	10	9.81e-01	9.91e-01	0.03850	3.33e-02	1.93e-02	8.56e-01	9.16e-01
GOBP RENAL ABSORPTION	34	9.38e-01	9.72e-01	0.03850	-2.02e-02	-3.28e-02	8.39e-01	7.41e-01
GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS	13	9.76e-01	9.89e-01	0.03850	-2.33e-02	-3.06e-02	8.84e-01	8.48e-01
GOBP ACETYLCHOLINE SECRETION	5	9.88e-01	9.95e-01	0.03840	-2.38e-03	3.84e-02	9.93e-01	8.82e-01
GOBP REGULATION OF ENDOCRINE PROCESS	40	9.03e-01	9.53e-01	0.03830	-9.88e-03	3.70e-02	9.14e-01	6.86e-01
GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN EXECUTION PHASE OF APOPTOSIS	5	9.89e-01	9.95e-01	0.03820	-3.81e-02	-2.71e-03	8.83e-01	9.92e-01
GOBP ORGANIC ACID METABOLIC PROCESS	901	1.95e-01	4.24e-01	0.03820	3.40e-02	1.74e-02	8.37e-02	3.75e-01
GOBP REGULATION OF ENDOTHELIAL CELL MIGRATION	225	5.53e-01	7.48e-01	0.03810	3.46e-02	-1.60e-02	3.71e-01	6.80e-01
GOBP POSITIVE REGULATION OF GAMMA DELTA T CELL DIFFERENTIATION	7	9.87e-01	9.94e-01	0.03800	3.51e-02	1.46e-02	8.72e-01	9.47e-01
GOBP PROTEOGLYCAN BIOSYNTHETIC PROCESS	63	8.94e-01	9.49e-01	0.03800	-2.76e-02	-2.61e-02	7.05e-01	7.20e-01
GOBP LIPID LOCALIZATION	497	3.68e-01	6.05e-01	0.03790	-8.28e-03	-3.70e-02	7.52e-01	1.58e-01
FGFR3 mutant receptor activation	11	9.71e-01	9.86e-01	0.03790	3.33e-02	-1.82e-02	8.48e-01	9.17e-01
Signaling by activated point mutants of FGFR3	11	9.71e-01	9.86e-01	0.03790	3.33e-02	-1.82e-02	8.48e-01	9.17e-01
GOBP MUSCLE CELL CELLULAR HOMEOSTASIS	23	9.41e-01	9.73e-01	0.03780	1.74e-02	-3.36e-02	8.85e-01	7.81e-01
GOBP POSITIVE REGULATION OF PROTEIN SECRETION	145	7.46e-01	8.70e-01	0.03780	8.24e-03	3.69e-02	8.64e-01	4.44e-01
GOBP L AMINO ACID METABOLIC PROCESS	171	6.69e-01	8.25e-01	0.03770	3.74e-02	-5.00e-03	3.99e-01	9.10e-01
NRAGE signals death through JNK	53	8.68e-01	9.35e-01	0.03770	2.16e-02	-3.09e-02	7.86e-01	6.97e-01
GOBP CELL MORPHOGENESIS	930	1.66e-01	3.87e-01	0.03770	8.64e-03	3.67e-02	6.55e-01	5.80e-02
GOMF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY INVOLVED IN CARDIAC MUSCLE CELL ACTION POTENTIAL REPOLARIZATION	14	9.68e-01	9.85e-01	0.03760	2.83e-03	-3.75e-02	9.85e-01	8.08e-01
GOBP REGULATION OF RESPIRATORY SYSTEM PROCESS	14	9.74e-01	9.87e-01	0.03740	-3.54e-02	-1.21e-02	8.19e-01	9.37e-01
GOBP L KYNURENINE METABOLIC PROCESS	7	9.82e-01	9.91e-01	0.03740	-1.45e-02	3.45e-02	9.47e-01	8.75e-01
GOBP GLIAL CELL MIGRATION	58	8.85e-01	9.45e-01	0.03740	3.72e-02	3.50e-03	6.24e-01	9.63e-01
Metabolism of vitamins and cofactors	194	6.00e-01	7.79e-01	0.03730	2.84e-02	-2.43e-02	4.96e-01	5.60e-01
GOBP MYELIN ASSEMBLY	24	9.55e-01	9.80e-01	0.03730	-1.10e-02	-3.57e-02	9.26e-01	7.62e-01
GOBP AMINO ACID TRANSMEMBRANE TRANSPORT	96	8.44e-01	9.21e-01	0.03730	1.89e-02	3.21e-02	7.49e-01	5.86e-01
GOBP RESPONSE TO MECHANICAL STIMULUS	216	5.68e-01	7.58e-01	0.03730	2.49e-02	-2.77e-02	5.28e-01	4.83e-01
GOBP TRIPARTITE REGIONAL SUBDIVISION	20	9.52e-01	9.79e-01	0.03720	-1.19e-02	3.53e-02	9.26e-01	7.85e-01
GOBP AMINE CATABOLIC PROCESS	16	9.59e-01	9.81e-01	0.03720	-3.12e-02	2.03e-02	8.29e-01	8.88e-01
GOBP MICROTUBULE BUNDLE FORMATION	125	8.08e-01	9.03e-01	0.03720	-2.39e-02	-2.85e-02	6.44e-01	5.82e-01
GOBP REGULATION OF PHOSPHOLIPASE C ACTIVITY	34	9.27e-01	9.65e-01	0.03720	3.71e-02	-2.67e-03	7.08e-01	9.78e-01
GOBP NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION	15	9.65e-01	9.83e-01	0.03720	9.85e-03	-3.58e-02	9.47e-01	8.10e-01
GOBP LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE	34	9.33e-01	9.69e-01	0.03710	-3.68e-02	-5.02e-03	7.11e-01	9.60e-01
GOBP ACTIVATION OF INNATE IMMUNE RESPONSE	291	5.66e-01	7.57e-01	0.03710	7.22e-03	3.64e-02	8.32e-01	2.86e-01
GOBP REGULATION OF URINE VOLUME	21	9.47e-01	9.77e-01	0.03700	-2.82e-02	2.39e-02	8.23e-01	8.50e-01
Mechanical load activates signaling by PIEZO1 and integrins in osteocytes	17	9.58e-01	9.80e-01	0.03690	3.21e-02	-1.82e-02	8.19e-01	8.96e-01
GOBP REGULATION OF AXON EXTENSION	71	8.34e-01	9.17e-01	0.03690	3.10e-02	-2.01e-02	6.52e-01	7.69e-01
Vitamin B5 (pantothenate) metabolism	19	9.68e-01	9.85e-01	0.03680	3.05e-02	2.07e-02	8.18e-01	8.76e-01
GOBP POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION	34	9.39e-01	9.72e-01	0.03680	3.50e-02	1.13e-02	7.24e-01	9.09e-01
GOBP POSITIVE REGULATION OF NEURON PROJECTION REGENERATION	10	9.76e-01	9.89e-01	0.03670	-3.48e-02	1.17e-02	8.49e-01	9.49e-01
GOBP CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS	10	9.75e-01	9.88e-01	0.03670	2.76e-02	-2.42e-02	8.80e-01	8.94e-01
GOBP POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS	25	9.58e-01	9.81e-01	0.03670	3.07e-02	2.00e-02	7.90e-01	8.62e-01
GOBP NEURON DEVELOPMENT	1106	1.75e-01	3.98e-01	0.03660	2.58e-02	2.60e-02	1.48e-01	1.44e-01
GOBP POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION	21	9.63e-01	9.83e-01	0.03660	3.35e-02	1.46e-02	7.90e-01	9.08e-01
GOBP REGULATION OF RESPONSE TO EXTERNAL STIMULUS	1073	7.97e-02	2.52e-01	0.03660	-3.23e-02	1.72e-02	7.41e-02	3.41e-01
GOBP REGULATION OF GLIAL CELL DIFFERENTIATION	78	8.21e-01	9.09e-01	0.03660	-2.33e-02	2.82e-02	7.22e-01	6.67e-01
Drug-mediated inhibition of CDK4/CDK6 activity	5	9.91e-01	9.96e-01	0.03650	8.35e-03	3.56e-02	9.74e-01	8.90e-01
GOCC KINESIN COMPLEX	47	8.99e-01	9.51e-01	0.03650	7.35e-03	-3.57e-02	9.31e-01	6.72e-01
GOBP NEGATIVE REGULATION OF LOCOMOTION	387	5.35e-01	7.37e-01	0.03640	2.74e-02	2.41e-02	3.55e-01	4.16e-01
GOCC BRUSH BORDER	103	8.46e-01	9.23e-01	0.03630	-2.43e-02	-2.70e-02	6.70e-01	6.36e-01
GOBP RESPONSE TO AXON INJURY	81	8.37e-01	9.18e-01	0.03630	-5.81e-03	3.58e-02	9.28e-01	5.78e-01
GOBP REGULATION OF CELLULAR RESPONSE TO OXIDATIVE STRESS	20	9.51e-01	9.78e-01	0.03620	-2.65e-02	2.47e-02	8.37e-01	8.49e-01
GOBP BLOOD VESSEL ENDOTHELIAL CELL MIGRATION	174	7.28e-01	8.61e-01	0.03610	9.07e-03	3.50e-02	8.36e-01	4.26e-01
GOMF GROWTH FACTOR BINDING	130	7.25e-01	8.59e-01	0.03610	2.63e-02	-2.48e-02	6.05e-01	6.26e-01
GOBP HORMONE CATABOLIC PROCESS	12	9.76e-01	9.88e-01	0.03610	3.61e-02	-3.12e-04	8.29e-01	9.99e-01
GOBP BEHAVIOR	636	2.85e-01	5.23e-01	0.03600	-3.00e-05	3.60e-02	9.99e-01	1.22e-01
GOBP REGULATION OF GLUTAMATE RECEPTOR CLUSTERING	6	9.89e-01	9.95e-01	0.03600	7.57e-03	3.52e-02	9.74e-01	8.81e-01
GOBP REGULATION OF HYDROLASE ACTIVITY	673	2.01e-01	4.31e-01	0.03590	-2.34e-02	2.73e-02	3.01e-01	2.28e-01
GOMF CONNEXIN BINDING	5	9.90e-01	9.96e-01	0.03580	-3.58e-02	-1.36e-03	8.90e-01	9.96e-01
GOBP ALPHA AMINO ACID METABOLIC PROCESS	205	6.67e-01	8.24e-01	0.03580	3.58e-02	7.41e-04	3.77e-01	9.85e-01
GOMF HYDROLASE ACTIVITY ACTING ON GLYCOSYL BONDS	127	7.44e-01	8.69e-01	0.03570	-3.19e-02	1.60e-02	5.35e-01	7.55e-01
Interleukin-37 signaling	20	9.57e-01	9.80e-01	0.03560	3.42e-02	-9.92e-03	7.91e-01	9.39e-01
GOBP REGULATION OF AMIDE METABOLIC PROCESS	79	8.72e-01	9.38e-01	0.03560	1.08e-02	3.39e-02	8.68e-01	6.02e-01
GOBP MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS	11	9.81e-01	9.91e-01	0.03550	-3.42e-02	-9.56e-03	8.44e-01	9.56e-01
GOBP REGULATION OF MACROPHAGE DIFFERENTIATION	25	9.44e-01	9.75e-01	0.03550	3.25e-02	-1.43e-02	7.79e-01	9.02e-01
GOBP NEGATIVE REGULATION OF MAPK CASCADE	159	7.83e-01	8.90e-01	0.03540	2.58e-02	2.43e-02	5.75e-01	5.97e-01
GOMF CHEMOATTRACTANT ACTIVITY	34	9.49e-01	9.77e-01	0.03530	-2.55e-02	-2.44e-02	7.97e-01	8.06e-01
GOBP NEPHRON EPITHELIUM DEVELOPMENT	118	8.26e-01	9.12e-01	0.03530	1.54e-02	3.18e-02	7.73e-01	5.51e-01
GOBP REGULATION OF RECEPTOR RECYCLING	24	9.55e-01	9.80e-01	0.03530	-2.17e-03	-3.52e-02	9.85e-01	7.65e-01
Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects	17	9.74e-01	9.88e-01	0.03530	2.77e-02	2.18e-02	8.43e-01	8.76e-01
Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)	17	9.74e-01	9.88e-01	0.03530	2.77e-02	2.18e-02	8.43e-01	8.76e-01
GOBP DENDRITE DEVELOPMENT	223	6.12e-01	7.87e-01	0.03510	1.31e-02	-3.25e-02	7.35e-01	4.03e-01
GOBP NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION	161	7.52e-01	8.73e-01	0.03510	6.28e-03	3.45e-02	8.91e-01	4.50e-01
GOBP POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY	40	9.12e-01	9.56e-01	0.03510	2.87e-02	-2.02e-02	7.54e-01	8.25e-01
GOCC APICAL JUNCTION COMPLEX	138	7.25e-01	8.59e-01	0.03500	2.36e-02	-2.59e-02	6.32e-01	5.99e-01
PTK6 promotes HIF1A stabilization	7	9.84e-01	9.92e-01	0.03500	-1.63e-02	3.10e-02	9.41e-01	8.87e-01
GOBP CARBOHYDRATE METABOLIC PROCESS	542	4.49e-01	6.75e-01	0.03500	2.57e-02	2.38e-02	3.07e-01	3.43e-01
GOBP REGULATION OF ORGANIC ACID TRANSPORT	76	8.39e-01	9.19e-01	0.03500	-2.11e-02	2.79e-02	7.51e-01	6.74e-01
GOBP FOLIC ACID CONTAINING COMPOUND CATABOLIC PROCESS	5	9.89e-01	9.95e-01	0.03480	1.16e-02	-3.28e-02	9.64e-01	8.99e-01
GOBP NEUTRAL LIPID BIOSYNTHETIC PROCESS	49	9.29e-01	9.67e-01	0.03480	2.12e-02	2.76e-02	7.98e-01	7.38e-01
GOBP REGULATION OF CHOLESTEROL METABOLIC PROCESS	40	9.41e-01	9.73e-01	0.03480	-2.92e-02	-1.89e-02	7.49e-01	8.36e-01
GOBP REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT	332	5.26e-01	7.30e-01	0.03470	3.10e-03	-3.45e-02	9.23e-01	2.79e-01
Cell-Cell communication	148	7.85e-01	8.92e-01	0.03470	-3.28e-02	-1.11e-02	4.90e-01	8.15e-01
GOCC LEADING EDGE MEMBRANE	174	7.63e-01	8.79e-01	0.03460	1.50e-02	3.12e-02	7.32e-01	4.78e-01
GOBP NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL	10	9.84e-01	9.92e-01	0.03460	-1.24e-02	-3.23e-02	9.46e-01	8.60e-01
GOBP NEGATIVE REGULATION OF OSTEOBLAST PROLIFERATION	15	9.66e-01	9.84e-01	0.03460	-2.56e-02	2.33e-02	8.64e-01	8.76e-01
GOMF TRANSPORTER REGULATOR ACTIVITY	145	7.89e-01	8.93e-01	0.03460	1.07e-02	3.29e-02	8.24e-01	4.94e-01
GOBP GAMMA AMINOBUTYRIC ACID TRANSPORT	20	9.71e-01	9.86e-01	0.03460	2.10e-02	2.74e-02	8.71e-01	8.32e-01
GOBP REGULATION OF TRANSMEMBRANE TRANSPORT	465	4.60e-01	6.84e-01	0.03440	-7.07e-03	-3.37e-02	7.94e-01	2.13e-01
GOBP POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT	154	7.73e-01	8.85e-01	0.03440	3.35e-02	8.12e-03	4.74e-01	8.62e-01
Negative regulation of TCF-dependent signaling by WNT ligand antagonists	15	9.67e-01	9.84e-01	0.03430	-2.29e-02	2.55e-02	8.78e-01	8.64e-01
Z-decay: degradation of maternal mRNAs by zygotically expressed factors	10	9.83e-01	9.92e-01	0.03420	-3.38e-02	-4.71e-03	8.53e-01	9.79e-01
GOBP VESICLE MEDIATED TRANSPORT IN SYNAPSE	213	7.12e-01	8.52e-01	0.03400	3.26e-02	9.40e-03	4.11e-01	8.13e-01
GOBP REGULATION OF SMOOTH MUSCLE CONTRACTION	61	9.16e-01	9.60e-01	0.03390	2.77e-02	1.95e-02	7.08e-01	7.92e-01
GOBP BLASTODERM SEGMENTATION	25	9.55e-01	9.80e-01	0.03390	-3.39e-02	1.49e-03	7.70e-01	9.90e-01
GOBP NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT	49	9.33e-01	9.69e-01	0.03380	2.62e-02	2.13e-02	7.51e-01	7.97e-01
GOBP PERIPHERAL NERVOUS SYSTEM MYELIN MAINTENANCE	9	9.85e-01	9.92e-01	0.03370	2.19e-03	3.36e-02	9.91e-01	8.61e-01
GOBP POSITIVE REGULATION OF LIPASE ACTIVITY	50	9.02e-01	9.52e-01	0.03370	1.44e-02	-3.04e-02	8.60e-01	7.10e-01
GOBP COGNITION	305	5.35e-01	7.37e-01	0.03360	-3.01e-02	1.50e-02	3.66e-01	6.53e-01
GOBP BIOLOGICAL PHASE	11	9.77e-01	9.89e-01	0.03360	-2.41e-02	2.34e-02	8.90e-01	8.93e-01
GOBP EMBRYONIC PATTERN SPECIFICATION	69	9.08e-01	9.55e-01	0.03360	2.58e-02	2.16e-02	7.11e-01	7.57e-01
GOBP CELL CELL JUNCTION MAINTENANCE	18	9.72e-01	9.87e-01	0.03360	-9.38e-03	-3.22e-02	9.45e-01	8.13e-01
GOBP PEPTIDYL GLUTAMIC ACID MODIFICATION	26	9.59e-01	9.81e-01	0.03310	3.27e-02	5.04e-03	7.73e-01	9.64e-01
GOBP SECRETION	937	2.02e-01	4.32e-01	0.03310	-3.30e-02	2.84e-03	8.72e-02	8.83e-01
GOBP POSITIVE REGULATION OF AXON EXTENSION	33	9.48e-01	9.77e-01	0.03300	-4.33e-03	-3.28e-02	9.66e-01	7.45e-01
GOBP SYNAPTIC SIGNALING	756	3.64e-01	6.01e-01	0.03300	-2.80e-02	-1.76e-02	1.91e-01	4.10e-01
GOCC CELL PROJECTION MEMBRANE	340	5.03e-01	7.13e-01	0.03290	1.99e-02	-2.62e-02	5.29e-01	4.06e-01
GOBP REGULATION OF CARBOHYDRATE METABOLIC PROCESS	176	7.91e-01	8.94e-01	0.03280	2.58e-02	2.03e-02	5.55e-01	6.42e-01
GOBP POLYOL METABOLIC PROCESS	101	8.26e-01	9.12e-01	0.03280	-3.13e-02	9.89e-03	5.87e-01	8.64e-01
GOBP POSTSYNAPTIC DENSITY PROTEIN 95 CLUSTERING	10	9.80e-01	9.91e-01	0.03270	1.88e-02	-2.68e-02	9.18e-01	8.83e-01
GOBP DETOXIFICATION	157	7.69e-01	8.83e-01	0.03270	-3.27e-02	3.87e-04	4.80e-01	9.93e-01
GOBP POSITIVE REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION	10	9.81e-01	9.91e-01	0.03260	3.01e-02	-1.25e-02	8.69e-01	9.46e-01
GOMF AMIDE BINDING	236	7.37e-01	8.66e-01	0.03260	-2.27e-02	-2.33e-02	5.48e-01	5.37e-01
GOBP FILOPODIUM ASSEMBLY	64	8.85e-01	9.45e-01	0.03250	1.26e-02	-2.99e-02	8.62e-01	6.79e-01
GOBP ADHERENS JUNCTION ORGANIZATION	57	9.28e-01	9.67e-01	0.03240	-2.58e-02	-1.95e-02	7.36e-01	7.98e-01
GOBP GLYCERALDEHYDE 3 PHOSPHATE METABOLIC PROCESS	12	9.84e-01	9.92e-01	0.03240	-1.99e-02	-2.55e-02	9.05e-01	8.78e-01
GOCC GLUTAMATERGIC SYNAPSE	401	5.75e-01	7.65e-01	0.03240	-1.20e-02	-3.01e-02	6.81e-01	3.01e-01
GOBP NEGATIVE REGULATION OF PEPTIDE SECRETION	45	9.22e-01	9.63e-01	0.03230	-3.13e-02	7.76e-03	7.16e-01	9.28e-01
Aquaporin-mediated transport	51	9.35e-01	9.70e-01	0.03210	2.72e-02	1.72e-02	7.37e-01	8.32e-01
GOBP DICARBOXYLIC ACID BIOSYNTHETIC PROCESS	12	9.77e-01	9.89e-01	0.03210	-2.42e-02	2.12e-02	8.85e-01	8.99e-01
GOBP RECEPTOR INTERNALIZATION	125	7.85e-01	8.92e-01	0.03210	1.84e-02	-2.63e-02	7.22e-01	6.11e-01
GOBP MAPK CASCADE	736	4.02e-01	6.35e-01	0.03210	2.03e-02	2.49e-02	3.48e-01	2.51e-01
GOBP REGULATION OF OXIDOREDUCTASE ACTIVITY	62	9.23e-01	9.63e-01	0.03210	1.73e-02	2.70e-02	8.13e-01	7.13e-01
GOBP REGULATION OF AXONOGENESIS	129	8.48e-01	9.23e-01	0.03200	-2.64e-02	-1.81e-02	6.05e-01	7.22e-01
GOBP L ASPARTATE IMPORT ACROSS PLASMA MEMBRANE	6	9.92e-01	9.96e-01	0.03200	-2.52e-02	-1.97e-02	9.15e-01	9.33e-01
GOBP POSTSYNAPTIC SPECIALIZATION ORGANIZATION	45	9.40e-01	9.73e-01	0.03200	-1.20e-02	-2.97e-02	8.90e-01	7.31e-01
GOBP LIPID STORAGE	93	8.47e-01	9.23e-01	0.03200	8.77e-03	-3.07e-02	8.84e-01	6.08e-01
GOBP POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY	239	7.38e-01	8.67e-01	0.03190	1.77e-02	2.65e-02	6.37e-01	4.80e-01
GOBP CELL ADHESION	1475	1.30e-01	3.37e-01	0.03190	-5.44e-03	-3.14e-02	7.27e-01	4.34e-02
GOBP REGULATION OF SODIUM ION TRANSPORT	79	9.06e-01	9.54e-01	0.03190	2.34e-02	2.16e-02	7.19e-01	7.40e-01
GOBP INSULIN SECRETION	195	7.32e-01	8.63e-01	0.03180	-1.39e-03	3.17e-02	9.73e-01	4.45e-01
GOBP CALCINEURIN MEDIATED SIGNALING	47	9.15e-01	9.59e-01	0.03160	-2.64e-02	1.75e-02	7.55e-01	8.36e-01
GOBP DICARBOXYLIC ACID METABOLIC PROCESS	93	8.44e-01	9.21e-01	0.03160	2.84e-02	-1.38e-02	6.36e-01	8.18e-01
GOMF AMIDE TRANSMEMBRANE TRANSPORTER ACTIVITY	34	9.39e-01	9.72e-01	0.03160	1.51e-02	-2.78e-02	8.79e-01	7.79e-01
GOBP MODULATION BY HOST OF SYMBIONT PROCESS	81	8.92e-01	9.48e-01	0.03160	7.29e-03	3.07e-02	9.10e-01	6.33e-01
GOMF MOLECULAR FUNCTION INHIBITOR ACTIVITY	489	4.56e-01	6.81e-01	0.03140	3.11e-02	-4.51e-03	2.40e-01	8.64e-01
GOBP EPITHELIAL CELL DIFFERENTIATION	724	2.75e-01	5.15e-01	0.03140	-1.69e-02	2.64e-02	4.39e-01	2.26e-01
GOCC PORE COMPLEX	24	9.56e-01	9.80e-01	0.03120	2.19e-02	-2.23e-02	8.53e-01	8.50e-01
GOBP CORNEA DEVELOPMENT IN CAMERA TYPE EYE	12	9.81e-01	9.91e-01	0.03120	3.12e-02	-1.92e-03	8.52e-01	9.91e-01
GOBP REGULATION OF SYNAPTIC PLASTICITY	210	7.49e-01	8.71e-01	0.03120	-6.77e-03	-3.04e-02	8.66e-01	4.47e-01
GOBP GAMMA AMINOBUTYRIC ACID IMPORT	6	9.91e-01	9.96e-01	0.03110	2.92e-03	-3.10e-02	9.90e-01	8.95e-01
GOBP POSITIVE REGULATION OF GLIOGENESIS	70	8.83e-01	9.44e-01	0.03110	-2.77e-02	1.41e-02	6.88e-01	8.38e-01
GOBP MALE GAMETE GENERATION	590	3.48e-01	5.85e-01	0.03110	2.15e-02	-2.24e-02	3.72e-01	3.53e-01
GOBP HEMOSTASIS	223	6.85e-01	8.36e-01	0.03100	-2.92e-02	1.03e-02	4.52e-01	7.90e-01
GOBP POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS	621	3.42e-01	5.80e-01	0.03090	-1.51e-02	2.70e-02	5.19e-01	2.51e-01
GOMF CYTOKINE BINDING	134	7.93e-01	8.95e-01	0.03080	2.78e-02	-1.33e-02	5.78e-01	7.90e-01
CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling	25	9.56e-01	9.80e-01	0.03070	-1.82e-02	2.47e-02	8.75e-01	8.30e-01
Metabolism of carbohydrates	276	6.51e-01	8.12e-01	0.03070	4.79e-03	-3.03e-02	8.91e-01	3.87e-01
GOBP N TERMINAL PROTEIN LIPIDATION	6	9.90e-01	9.96e-01	0.03070	2.95e-02	-8.47e-03	9.01e-01	9.71e-01
GOBP GLOMERULUS DEVELOPMENT	71	8.88e-01	9.46e-01	0.03070	2.89e-02	-1.01e-02	6.73e-01	8.83e-01
GOBP CARBOHYDRATE CATABOLIC PROCESS	162	8.05e-01	9.02e-01	0.03060	6.13e-03	3.00e-02	8.93e-01	5.10e-01
GOBP ENDOCYTOSIS	675	4.20e-01	6.50e-01	0.03060	7.38e-03	2.97e-02	7.44e-01	1.88e-01
GOBP NEGATIVE REGULATION OF LIPID METABOLIC PROCESS	108	8.33e-01	9.17e-01	0.03050	-2.78e-02	1.26e-02	6.18e-01	8.20e-01
Signalling to p38 via RIT and RIN	5	9.94e-01	9.97e-01	0.03050	-2.71e-02	-1.39e-02	9.16e-01	9.57e-01
GOBP RESPONSE TO ALCOHOL	253	6.47e-01	8.08e-01	0.03050	-1.64e-02	2.57e-02	6.54e-01	4.81e-01
GOBP NEURON PROJECTION EXTENSION	153	7.87e-01	8.92e-01	0.03040	6.08e-03	-2.98e-02	8.97e-01	5.24e-01
GOBP NEGATIVE REGULATION OF SODIUM ION TRANSPORT	17	9.71e-01	9.86e-01	0.03040	1.73e-02	-2.50e-02	9.01e-01	8.58e-01
FGFR2c ligand binding and activation	12	9.82e-01	9.91e-01	0.03040	-3.51e-03	3.02e-02	9.83e-01	8.56e-01
GOBP MAMMARY GLAND DUCT MORPHOGENESIS	31	9.65e-01	9.84e-01	0.03040	2.35e-02	1.93e-02	8.21e-01	8.53e-01
GOBP REGULATION OF CHEMOTAXIS	200	7.10e-01	8.50e-01	0.03040	-2.56e-02	1.64e-02	5.33e-01	6.89e-01
GOBP ANGIOTENSIN ACTIVATED SIGNALING PATHWAY	19	9.77e-01	9.89e-01	0.03040	-2.82e-02	-1.12e-02	8.31e-01	9.33e-01
GOBP POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS	13	9.85e-01	9.93e-01	0.03030	1.64e-02	2.55e-02	9.18e-01	8.74e-01
GOMF SULFURIC ESTER HYDROLASE ACTIVITY	11	9.81e-01	9.91e-01	0.03030	-2.02e-02	2.26e-02	9.08e-01	8.97e-01
GOMF CADHERIN BINDING INVOLVED IN CELL CELL ADHESION	18	9.72e-01	9.87e-01	0.03020	-7.40e-03	2.92e-02	9.57e-01	8.30e-01
GOBP SIGNAL RELEASE	472	5.83e-01	7.69e-01	0.03000	-2.66e-02	-1.40e-02	3.22e-01	6.03e-01
GOBP ORGANIC ACID TRANSMEMBRANE TRANSPORT	141	8.50e-01	9.25e-01	0.03000	1.47e-02	2.62e-02	7.64e-01	5.91e-01
GOBP OTIC VESICLE DEVELOPMENT	15	9.78e-01	9.89e-01	0.03000	-2.99e-02	2.62e-03	8.41e-01	9.86e-01
Regulation of localization of FOXO transcription factors	11	9.86e-01	9.93e-01	0.03000	2.94e-02	6.04e-03	8.66e-01	9.72e-01
GOBP MODULATION BY SYMBIONT OF ENTRY INTO HOST	55	9.32e-01	9.68e-01	0.02990	-5.72e-03	-2.93e-02	9.42e-01	7.07e-01
GOBP CALCIUM ION EXPORT ACROSS PLASMA MEMBRANE	10	9.86e-01	9.93e-01	0.02980	-2.16e-03	2.97e-02	9.91e-01	8.71e-01
GOBP INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS	64	9.15e-01	9.59e-01	0.02970	-5.28e-04	2.97e-02	9.94e-01	6.81e-01
GOBP POSITIVE REGULATION OF PHOSPHORYLATION	590	5.31e-01	7.34e-01	0.02960	1.67e-02	2.44e-02	4.89e-01	3.11e-01
GOBP POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS	40	9.50e-01	9.78e-01	0.02950	-3.98e-03	-2.92e-02	9.65e-01	7.49e-01
GOBP LIPID METABOLIC PROCESS	1350	2.19e-01	4.52e-01	0.02940	2.82e-02	8.13e-03	8.21e-02	6.16e-01
GOBP PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS	40	9.49e-01	9.78e-01	0.02930	2.92e-02	2.48e-03	7.49e-01	9.78e-01
GOBP REGULATION OF VESICLE MEDIATED TRANSPORT	490	4.98e-01	7.09e-01	0.02930	-5.65e-03	2.87e-02	8.30e-01	2.77e-01
GOBP REGULATION OF HAIR FOLLICLE DEVELOPMENT	20	9.79e-01	9.90e-01	0.02920	-1.79e-02	-2.31e-02	8.90e-01	8.58e-01
GOCC AXONEMAL OUTER DOUBLET	37	9.47e-01	9.77e-01	0.02910	2.82e-02	-7.42e-03	7.67e-01	9.38e-01
GOBP POSITIVE REGULATION OF TRANSPORT	806	4.28e-01	6.57e-01	0.02910	1.41e-02	2.55e-02	4.98e-01	2.18e-01
GOCC GLYCINERGIC SYNAPSE	7	9.91e-01	9.96e-01	0.02900	2.86e-02	4.19e-03	8.96e-01	9.85e-01
GOBP POSITIVE REGULATION OF AMYLOID BETA FORMATION	20	9.69e-01	9.85e-01	0.02890	2.33e-02	-1.71e-02	8.57e-01	8.94e-01
GOBP FATTY ACID METABOLIC PROCESS	387	5.54e-01	7.49e-01	0.02890	2.52e-02	-1.41e-02	3.95e-01	6.33e-01
GOBP T CELL HOMEOSTASIS	45	9.34e-01	9.69e-01	0.02890	-1.10e-02	2.67e-02	8.99e-01	7.56e-01
GOBP STEROL METABOLIC PROCESS	152	8.34e-01	9.17e-01	0.02880	2.83e-02	5.35e-03	5.47e-01	9.09e-01
GOCC AXON	623	3.86e-01	6.20e-01	0.02880	-1.75e-02	2.29e-02	4.57e-01	3.29e-01
GOBP TISSUE HOMEOSTASIS	254	7.03e-01	8.47e-01	0.02870	-2.81e-02	5.82e-03	4.41e-01	8.73e-01
GOBP PHOSPHATE ION TRANSPORT	27	9.60e-01	9.81e-01	0.02860	1.30e-02	-2.55e-02	9.07e-01	8.19e-01
Role of phospholipids in phagocytosis	24	9.76e-01	9.88e-01	0.02860	-2.38e-02	-1.59e-02	8.40e-01	8.93e-01
GOBP MAINTENANCE OF LOCATION	329	6.12e-01	7.86e-01	0.02850	1.42e-02	-2.47e-02	6.57e-01	4.41e-01
GOCC NUCLEAR OUTER MEMBRANE	28	9.71e-01	9.86e-01	0.02840	-1.27e-02	-2.54e-02	9.07e-01	8.16e-01
GOBP HOMEOSTATIC PROCESS	1676	2.12e-01	4.44e-01	0.02840	1.76e-02	2.22e-02	2.29e-01	1.30e-01
GOBP IMPORT INTO CELL	887	3.21e-01	5.60e-01	0.02830	-2.80e-02	3.92e-03	1.57e-01	8.43e-01
GOBP NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION	128	8.42e-01	9.21e-01	0.02820	-5.39e-03	2.77e-02	9.16e-01	5.88e-01
GOBP PLASMA MEMBRANE ORGANIZATION	161	8.17e-01	9.08e-01	0.02810	-2.81e-02	1.13e-03	5.38e-01	9.80e-01
GOBP GLUCOSE IMPORT	77	8.94e-01	9.49e-01	0.02810	1.32e-02	-2.48e-02	8.42e-01	7.07e-01
GOBP PEPTIDYL TYROSINE MODIFICATION	257	7.69e-01	8.83e-01	0.02800	-1.17e-02	-2.54e-02	7.46e-01	4.83e-01
GOBP MORPHOGENESIS OF A POLARIZED EPITHELIUM	60	9.39e-01	9.72e-01	0.02800	1.02e-02	2.61e-02	8.91e-01	7.27e-01
GOBP ORGANOPHOSPHATE ESTER TRANSPORT	151	8.19e-01	9.09e-01	0.02800	-2.74e-02	5.66e-03	5.61e-01	9.04e-01
GOBP LIPID HOMEOSTASIS	175	7.72e-01	8.85e-01	0.02800	2.11e-02	-1.83e-02	6.30e-01	6.76e-01
GOCC EXOCYTIC VESICLE	227	8.04e-01	9.02e-01	0.02790	2.21e-02	1.71e-02	5.66e-01	6.58e-01
GOBP CHOLINE TRANSPORT	9	9.88e-01	9.95e-01	0.02790	-2.74e-02	5.11e-03	8.87e-01	9.79e-01
GOBP RESPONSE TO BLUE LIGHT	6	9.94e-01	9.97e-01	0.02780	2.28e-02	1.59e-02	9.23e-01	9.46e-01
GOBP PYRUVATE METABOLIC PROCESS	114	8.97e-01	9.50e-01	0.02780	1.93e-02	2.00e-02	7.22e-01	7.12e-01
GOBP POSITIVE REGULATION OF HORMONE SECRETION	142	8.74e-01	9.39e-01	0.02770	2.01e-02	1.91e-02	6.79e-01	6.94e-01
GOBP MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS	217	8.12e-01	9.05e-01	0.02770	-2.32e-02	-1.52e-02	5.56e-01	7.00e-01
GOBP PROTEIN AUTO ADP RIBOSYLATION	11	9.89e-01	9.95e-01	0.02770	2.40e-02	1.38e-02	8.90e-01	9.37e-01
GOMF NEUTRAL L AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY	40	9.55e-01	9.80e-01	0.02760	-2.81e-03	-2.74e-02	9.75e-01	7.64e-01
GOMF S ACYLTRANSFERASE ACTIVITY	27	9.62e-01	9.82e-01	0.02750	1.70e-02	-2.17e-02	8.79e-01	8.45e-01
Signaling by MAPK mutants	6	9.91e-01	9.96e-01	0.02750	1.66e-02	-2.19e-02	9.44e-01	9.26e-01
GOBP REGULATION OF NEURON MIGRATION	44	9.56e-01	9.80e-01	0.02720	-2.60e-02	-8.02e-03	7.66e-01	9.27e-01
GOBP GLYCEROPHOSPHOLIPID CATABOLIC PROCESS	34	9.69e-01	9.85e-01	0.02720	-1.39e-02	-2.34e-02	8.89e-01	8.14e-01
Factors involved in megakaryocyte development and platelet production	148	8.19e-01	9.09e-01	0.02690	-2.25e-02	1.47e-02	6.36e-01	7.58e-01
GOBP REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT	54	9.29e-01	9.67e-01	0.02680	-2.08e-02	1.70e-02	7.91e-01	8.29e-01
GOBP T CELL DIFFERENTIATION IN THYMUS	85	9.23e-01	9.63e-01	0.02680	-2.43e-02	-1.14e-02	6.99e-01	8.56e-01
GOBP POSITIVE REGULATION OF PEPTIDE SECRETION	112	8.59e-01	9.30e-01	0.02680	-2.08e-02	1.69e-02	7.03e-01	7.58e-01
GOBP ANTEROGRADE AXONAL TRANSPORT OF MITOCHONDRION	6	9.93e-01	9.96e-01	0.02660	2.74e-03	-2.64e-02	9.91e-01	9.11e-01
GOBP KETONE CATABOLIC PROCESS	15	9.83e-01	9.92e-01	0.02620	2.59e-02	-3.50e-03	8.62e-01	9.81e-01
GOBP ERK1 AND ERK2 CASCADE	314	6.90e-01	8.39e-01	0.02620	-2.52e-02	7.17e-03	4.43e-01	8.27e-01
GOBP POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT	34	9.69e-01	9.85e-01	0.02620	-8.41e-03	-2.48e-02	9.32e-01	8.03e-01
GOBP NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS	123	8.75e-01	9.40e-01	0.02610	-1.20e-03	2.61e-02	9.82e-01	6.18e-01
GOBP REGULATION OF PH	97	9.00e-01	9.51e-01	0.02600	-2.60e-02	1.68e-03	6.58e-01	9.77e-01
GOBP REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS	117	8.74e-01	9.39e-01	0.02590	2.52e-02	-6.04e-03	6.38e-01	9.10e-01
GOBP POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS	21	9.75e-01	9.88e-01	0.02580	2.34e-02	-1.09e-02	8.53e-01	9.31e-01
GOBP NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION	14	9.88e-01	9.95e-01	0.02580	1.12e-02	2.32e-02	9.42e-01	8.80e-01
GOBP POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT	276	7.43e-01	8.69e-01	0.02560	2.54e-02	-3.56e-03	4.68e-01	9.19e-01
GOBP CRANIAL SUTURE MORPHOGENESIS	9	9.89e-01	9.95e-01	0.02550	-1.43e-02	2.12e-02	9.41e-01	9.12e-01
GOBP POSITIVE REGULATION OF AMIDE METABOLIC PROCESS	30	9.76e-01	9.89e-01	0.02530	1.98e-02	1.58e-02	8.51e-01	8.81e-01
GOMF WNT RECEPTOR ACTIVITY	17	9.79e-01	9.90e-01	0.02530	-1.90e-02	1.67e-02	8.92e-01	9.05e-01
GOCC PLATELET DENSE GRANULE	20	9.84e-01	9.92e-01	0.02490	2.29e-02	9.94e-03	8.59e-01	9.39e-01
GOBP PRESYNAPSE ORGANIZATION	48	9.58e-01	9.80e-01	0.02480	2.44e-02	4.26e-03	7.70e-01	9.59e-01
Glucagon signaling in metabolic regulation	32	9.75e-01	9.88e-01	0.02480	-2.16e-02	-1.21e-02	8.32e-01	9.06e-01
GOBP REGULATION OF PEPTIDE TRANSPORT	196	7.99e-01	8.99e-01	0.02460	-1.77e-02	1.72e-02	6.70e-01	6.79e-01
GOBP POSITIVE REGULATION OF LOCOMOTION	608	5.67e-01	7.58e-01	0.02460	2.46e-02	-6.93e-04	3.01e-01	9.77e-01
GOMF PHOSPHATIDYLETHANOLAMINE BINDING	17	9.82e-01	9.91e-01	0.02450	8.81e-03	-2.29e-02	9.50e-01	8.70e-01
GOBP REACTIVE NITROGEN SPECIES METABOLIC PROCESS	84	9.37e-01	9.71e-01	0.02420	9.52e-03	2.22e-02	8.80e-01	7.25e-01
GOBP EXPORT FROM CELL	881	4.39e-01	6.66e-01	0.02410	-2.38e-02	3.68e-03	2.30e-01	8.53e-01
GOBP POSITIVE REGULATION OF REPRODUCTIVE PROCESS	88	9.37e-01	9.71e-01	0.02410	1.17e-02	2.10e-02	8.49e-01	7.33e-01
GOBP SMALL MOLECULE BIOSYNTHETIC PROCESS	576	5.40e-01	7.39e-01	0.02410	-1.93e-02	1.44e-02	4.30e-01	5.54e-01
GOMF MONOAMINE TRANSMEMBRANE TRANSPORTER ACTIVITY	12	9.90e-01	9.95e-01	0.02400	-2.92e-03	-2.38e-02	9.86e-01	8.86e-01
GOBP CELLULAR ALDEHYDE METABOLIC PROCESS	76	9.23e-01	9.63e-01	0.02390	-2.09e-02	1.16e-02	7.53e-01	8.61e-01
GOBP INTERLEUKIN 17 MEDIATED SIGNALING PATHWAY	12	9.88e-01	9.95e-01	0.02370	-1.20e-02	2.04e-02	9.42e-01	9.03e-01
GOBP REGULATION OF ATRIAL CARDIAC MUSCLE CELL MEMBRANE DEPOLARIZATION	10	9.90e-01	9.95e-01	0.02370	1.16e-02	-2.06e-02	9.49e-01	9.10e-01
Carboxyterminal post-translational modifications of tubulin	43	9.65e-01	9.84e-01	0.02370	-2.34e-02	-3.22e-03	7.90e-01	9.71e-01
GOBP REGULATION OF PROTEIN MATURATION	65	9.34e-01	9.69e-01	0.02370	-1.23e-02	2.02e-02	8.64e-01	7.78e-01
GOBP OPTIC NERVE DEVELOPMENT	20	9.85e-01	9.93e-01	0.02360	2.17e-02	9.47e-03	8.67e-01	9.42e-01
GOBP INNER DYNEIN ARM ASSEMBLY	15	9.88e-01	9.95e-01	0.02330	-2.32e-02	-1.98e-03	8.76e-01	9.89e-01
GOBP REGULATION OF NEURON PROJECTION DEVELOPMENT	422	7.17e-01	8.55e-01	0.02320	2.72e-03	2.30e-02	9.24e-01	4.17e-01
GOBP MAINTENANCE OF LOCATION IN CELL	220	8.11e-01	9.05e-01	0.02320	2.17e-02	-8.12e-03	5.79e-01	8.36e-01
GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE	86	9.40e-01	9.73e-01	0.02300	-7.48e-03	-2.18e-02	9.05e-01	7.27e-01
GOBP CELL PROJECTION MORPHOGENESIS	636	6.14e-01	7.88e-01	0.02300	2.87e-03	2.28e-02	9.02e-01	3.26e-01
Uptake and function of anthrax toxins	11	9.92e-01	9.96e-01	0.02250	-2.19e-02	-5.31e-03	9.00e-01	9.76e-01
GOMF G PROTEIN COUPLED GLUTAMATE RECEPTOR BINDING	10	9.94e-01	9.97e-01	0.02250	1.52e-02	1.65e-02	9.33e-01	9.28e-01
GOBP REGULATION OF LIPID BIOSYNTHETIC PROCESS	179	8.96e-01	9.49e-01	0.02230	-1.75e-02	-1.38e-02	6.86e-01	7.51e-01
GOBP REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY	237	8.26e-01	9.12e-01	0.02220	2.53e-03	-2.21e-02	9.46e-01	5.58e-01
GOMF ORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY	76	9.41e-01	9.73e-01	0.02220	-1.65e-03	2.22e-02	9.80e-01	7.38e-01
GOBP POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS	663	6.76e-01	8.29e-01	0.02210	1.38e-02	1.73e-02	5.44e-01	4.47e-01
GOMF SIGNALING RECEPTOR BINDING	1409	2.99e-01	5.39e-01	0.02200	-1.33e-02	1.75e-02	4.05e-01	2.70e-01
GOBP GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS	71	9.58e-01	9.80e-01	0.02180	1.88e-02	1.10e-02	7.84e-01	8.72e-01
GOCC CELL BODY	530	6.76e-01	8.29e-01	0.02170	-2.16e-02	1.41e-03	3.94e-01	9.56e-01
GOMF PHOSPHORIC ESTER HYDROLASE ACTIVITY	346	8.21e-01	9.09e-01	0.02160	1.69e-02	1.34e-02	5.89e-01	6.67e-01
Platelet degranulation	117	9.35e-01	9.70e-01	0.02140	-1.29e-02	-1.71e-02	8.10e-01	7.49e-01
GOBP REGULATION OF ENDOCYTOSIS	285	7.87e-01	8.92e-01	0.02140	-1.87e-02	1.04e-02	5.87e-01	7.62e-01
GOMF PDZ DOMAIN BINDING	85	9.44e-01	9.75e-01	0.02130	-2.22e-03	-2.12e-02	9.72e-01	7.36e-01
GOMF SINGLE STRANDED DNA EXODEOXYRIBONUCLEASE ACTIVITY	10	9.92e-01	9.96e-01	0.02130	-1.92e-02	9.17e-03	9.16e-01	9.60e-01
GOBP NEPHRON DEVELOPMENT	156	9.05e-01	9.53e-01	0.02110	2.08e-02	4.05e-03	6.55e-01	9.30e-01
GOBP REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS	54	9.57e-01	9.80e-01	0.02100	-9.68e-03	1.86e-02	9.02e-01	8.13e-01
GOCC SYNAPSE	1414	3.40e-01	5.78e-01	0.02080	1.22e-02	-1.68e-02	4.40e-01	2.91e-01
GOBP NEURAL RETINA DEVELOPMENT	80	9.51e-01	9.78e-01	0.02070	2.99e-03	2.05e-02	9.63e-01	7.52e-01
GOBP POSITIVE REGULATION OF CHEMOTAXIS	137	9.23e-01	9.63e-01	0.02070	-5.87e-03	-1.98e-02	9.06e-01	6.89e-01
GOBP NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY	30	9.77e-01	9.89e-01	0.02060	8.93e-03	-1.86e-02	9.33e-01	8.60e-01
GOCC TIGHT JUNCTION	121	9.38e-01	9.72e-01	0.02060	1.68e-02	1.20e-02	7.50e-01	8.20e-01
GOBP PLASMA MEMBRANE RAFT ORGANIZATION	12	9.94e-01	9.97e-01	0.02040	1.42e-02	1.47e-02	9.32e-01	9.30e-01
GOBP REGULATION OF CALCINEURIN MEDIATED SIGNALING	40	9.70e-01	9.85e-01	0.02030	-1.07e-02	1.73e-02	9.06e-01	8.50e-01
GOBP CDC42 PROTEIN SIGNAL TRANSDUCTION	16	9.88e-01	9.95e-01	0.02030	1.93e-02	-6.24e-03	8.94e-01	9.66e-01
GOMF LONG CHAIN FATTY ACID COA LIGASE ACTIVITY	14	9.92e-01	9.96e-01	0.02030	-1.83e-02	-8.67e-03	9.06e-01	9.55e-01
GOBP POSITIVE REGULATION OF IMMATURE T CELL PROLIFERATION	5	9.97e-01	9.99e-01	0.02020	-1.74e-02	-1.03e-02	9.46e-01	9.68e-01
GOMF IRON ION BINDING	146	9.08e-01	9.55e-01	0.02020	1.78e-03	-2.01e-02	9.70e-01	6.75e-01
GOBP POSITIVE REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION	6	9.96e-01	9.98e-01	0.02010	-2.51e-03	-1.99e-02	9.92e-01	9.33e-01
GOCC SCHAFFER COLLATERAL CA1 SYNAPSE	89	9.39e-01	9.72e-01	0.01970	-8.61e-03	1.77e-02	8.88e-01	7.73e-01
GOBP ASTROCYTE DIFFERENTIATION	85	9.48e-01	9.77e-01	0.01960	1.95e-02	-2.16e-03	7.56e-01	9.73e-01
GOBP HISTAMINE TRANSPORT	15	9.92e-01	9.96e-01	0.01960	-4.66e-03	-1.90e-02	9.75e-01	8.99e-01
GOMF PHOSPHOFRUCTOKINASE ACTIVITY	6	9.97e-01	9.99e-01	0.01950	1.01e-02	1.67e-02	9.66e-01	9.43e-01
GOBP POSITIVE REGULATION OF KINASE ACTIVITY	285	8.77e-01	9.40e-01	0.01940	1.45e-02	1.29e-02	6.74e-01	7.07e-01
GOMF SODIUM CHANNEL REGULATOR ACTIVITY	38	9.74e-01	9.88e-01	0.01940	-8.09e-03	1.76e-02	9.31e-01	8.51e-01
GOBP REGULATION OF NITRIC OXIDE METABOLIC PROCESS	63	9.67e-01	9.84e-01	0.01940	-1.89e-02	-4.15e-03	7.95e-01	9.55e-01
GOBP DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS	219	9.03e-01	9.53e-01	0.01940	1.13e-02	1.57e-02	7.74e-01	6.88e-01
GOMF MOLECULAR FUNCTION ACTIVATOR ACTIVITY	1073	6.13e-01	7.87e-01	0.01930	1.70e-02	9.09e-03	3.47e-01	6.15e-01
GOBP REGULATION OF LOCOMOTION	1106	5.95e-01	7.76e-01	0.01920	1.78e-02	7.24e-03	3.18e-01	6.85e-01
GOBP PHOSPHATIDIC ACID METABOLIC PROCESS	36	9.83e-01	9.92e-01	0.01920	-1.65e-02	-9.72e-03	8.64e-01	9.20e-01
GOBP REGULATION OF NEURONAL SYNAPTIC PLASTICITY	54	9.73e-01	9.87e-01	0.01920	-1.80e-02	-6.48e-03	8.19e-01	9.34e-01
GOBP RECEPTOR LOCALIZATION TO SYNAPSE	57	9.74e-01	9.88e-01	0.01910	-1.07e-02	-1.58e-02	8.88e-01	8.36e-01
GOBP COCHLEA DEVELOPMENT	49	9.67e-01	9.84e-01	0.01910	-1.57e-02	1.09e-02	8.50e-01	8.95e-01
GOBP REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE	35	9.77e-01	9.89e-01	0.01910	1.77e-02	-7.22e-03	8.56e-01	9.41e-01
GOBP EPHRIN RECEPTOR SIGNALING PATHWAY	49	9.76e-01	9.89e-01	0.01880	4.79e-03	1.82e-02	9.54e-01	8.25e-01
GOBP PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS	34	9.84e-01	9.92e-01	0.01870	-1.75e-02	-6.80e-03	8.60e-01	9.45e-01
GOBP PEPTIDE TRANSPORT	253	8.56e-01	9.28e-01	0.01870	5.90e-03	-1.78e-02	8.72e-01	6.26e-01
GOMF GLYCOSYLTRANSFERASE ACTIVITY	266	8.81e-01	9.43e-01	0.01870	5.49e-03	1.79e-02	8.78e-01	6.16e-01
GOBP REGULATION OF COLLAGEN METABOLIC PROCESS	41	9.82e-01	9.91e-01	0.01860	-9.14e-03	-1.62e-02	9.19e-01	8.58e-01
GOBP PROTEIN DEUBIQUITINATION INVOLVED IN UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS	5	9.98e-01	9.99e-01	0.01840	-1.66e-02	-7.93e-03	9.49e-01	9.76e-01
Inositol phosphate metabolism	45	9.80e-01	9.91e-01	0.01830	1.65e-02	7.97e-03	8.48e-01	9.26e-01
Response to elevated platelet cytosolic Ca2+	122	9.51e-01	9.78e-01	0.01830	-1.22e-02	-1.36e-02	8.16e-01	7.95e-01
GOBP NEGATIVE REGULATION OF BLOOD CIRCULATION	24	9.89e-01	9.95e-01	0.01830	1.75e-02	5.16e-03	8.82e-01	9.65e-01
GOMF INTEGRIN BINDING	154	9.10e-01	9.56e-01	0.01820	8.52e-03	-1.61e-02	8.55e-01	7.30e-01
GOBP LIPID CATABOLIC PROCESS	342	8.36e-01	9.18e-01	0.01820	-1.82e-02	7.66e-04	5.63e-01	9.81e-01
GOBP REGULATION OF LONG CHAIN FATTY ACID IMPORT ACROSS PLASMA MEMBRANE	6	9.97e-01	9.99e-01	0.01820	1.66e-03	1.81e-02	9.94e-01	9.39e-01
Ephrin signaling	17	9.90e-01	9.95e-01	0.01790	-9.56e-03	1.52e-02	9.46e-01	9.14e-01
GOBP REGULATION OF EXTENT OF CELL GROWTH	87	9.48e-01	9.77e-01	0.01790	1.33e-02	-1.20e-02	8.30e-01	8.46e-01
GOBP SULFUR COMPOUND BIOSYNTHETIC PROCESS	160	9.39e-01	9.72e-01	0.01790	1.43e-02	1.07e-02	7.54e-01	8.16e-01
GOBP PROTEIN DE ADP RIBOSYLATION	5	9.98e-01	9.99e-01	0.01780	4.77e-03	1.71e-02	9.85e-01	9.47e-01
GOBP DENDRITE MORPHOGENESIS	133	9.45e-01	9.76e-01	0.01770	-5.87e-03	-1.67e-02	9.07e-01	7.39e-01
G alpha (z) signalling events	48	9.73e-01	9.87e-01	0.01770	6.61e-03	-1.64e-02	9.37e-01	8.44e-01
GOBP REGULATION OF OLIGODENDROCYTE DIFFERENTIATION	46	9.73e-01	9.87e-01	0.01770	-1.48e-02	9.70e-03	8.62e-01	9.09e-01
GOCC SARCOPLASM	94	9.64e-01	9.83e-01	0.01770	1.44e-02	1.02e-02	8.09e-01	8.64e-01
GOBP PROTEIN LOCALIZATION TO PERINUCLEAR REGION OF CYTOPLASM	9	9.96e-01	9.98e-01	0.01770	3.02e-03	1.74e-02	9.87e-01	9.28e-01
GOBP SHORT CHAIN FATTY ACID METABOLIC PROCESS	16	9.91e-01	9.96e-01	0.01760	1.07e-02	-1.40e-02	9.41e-01	9.23e-01
GOBP REGULATION OF GLIAL CELL MIGRATION	19	9.89e-01	9.95e-01	0.01750	-1.03e-02	1.42e-02	9.38e-01	9.15e-01
GOBP NEGATIVE REGULATION OF HYDROLASE ACTIVITY	182	9.16e-01	9.60e-01	0.01750	8.64e-05	-1.75e-02	9.98e-01	6.83e-01
GOBP POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION	15	9.93e-01	9.97e-01	0.01750	3.10e-03	1.72e-02	9.83e-01	9.08e-01
GOMF HEXOSYLTRANSFERASE ACTIVITY	193	9.19e-01	9.61e-01	0.01740	-2.98e-03	-1.72e-02	9.43e-01	6.81e-01
GOBP SIRNA MEDIATED RETROTRANSPOSON SILENCING BY HETEROCHROMATIN FORMATION	10	9.96e-01	9.98e-01	0.01720	1.65e-02	5.10e-03	9.28e-01	9.78e-01
GOBP AXON DEVELOPMENT	489	8.10e-01	9.04e-01	0.01710	1.68e-03	1.70e-02	9.49e-01	5.19e-01
GOBP CRANIAL NERVE FORMATION	10	9.96e-01	9.98e-01	0.01710	5.94e-03	1.60e-02	9.74e-01	9.30e-01
GOBP POSITIVE REGULATION OF MAPK CASCADE	458	8.19e-01	9.09e-01	0.01680	-1.68e-02	-4.47e-05	5.37e-01	9.99e-01
GOBP PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION	305	8.63e-01	9.33e-01	0.01680	1.63e-02	-4.03e-03	6.24e-01	9.04e-01
mRNA Editing	10	9.95e-01	9.97e-01	0.01680	1.26e-02	-1.11e-02	9.45e-01	9.52e-01
GOBP PROSTAGLANDIN SECRETION	18	9.93e-01	9.96e-01	0.01670	1.65e-02	2.49e-03	9.04e-01	9.85e-01
GOBP OLIGODENDROCYTE DIFFERENTIATION	105	9.63e-01	9.83e-01	0.01660	7.37e-03	1.48e-02	8.96e-01	7.93e-01
GOBP HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS	32	9.88e-01	9.95e-01	0.01650	-5.73e-03	-1.55e-02	9.55e-01	8.79e-01
GOMF PROTEIN TYROSINE KINASE ACTIVITY	140	9.48e-01	9.77e-01	0.01640	-4.12e-03	-1.59e-02	9.33e-01	7.45e-01
GOBP POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION	52	9.81e-01	9.91e-01	0.01630	1.55e-02	5.06e-03	8.47e-01	9.50e-01
GOBP RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS	54	9.81e-01	9.91e-01	0.01610	1.56e-02	4.27e-03	8.43e-01	9.57e-01
GOBP RESPONSE TO CAFFEINE	15	9.93e-01	9.96e-01	0.01610	-1.54e-02	4.86e-03	9.18e-01	9.74e-01
GOBP REGULATION OF VASCULATURE DEVELOPMENT	349	8.44e-01	9.22e-01	0.01610	-1.14e-02	1.13e-02	7.14e-01	7.17e-01
GOBP CELL CELL ADHESION	937	7.17e-01	8.55e-01	0.01590	-2.49e-03	-1.57e-02	8.97e-01	4.16e-01
GOCC LYSOSOMAL LUMEN	91	9.66e-01	9.84e-01	0.01560	4.51e-04	-1.56e-02	9.94e-01	7.97e-01
GOCC PAM COMPLEX TIM23 ASSOCIATED IMPORT MOTOR	5	9.98e-01	9.99e-01	0.01550	-1.52e-02	3.26e-03	9.53e-01	9.90e-01
GOBP CELL MOTILITY	1764	6.26e-01	7.95e-01	0.01530	1.17e-02	9.85e-03	4.16e-01	4.92e-01
GOMF TPR DOMAIN BINDING	7	9.97e-01	9.99e-01	0.01510	1.28e-03	-1.51e-02	9.95e-01	9.45e-01
GOCC MICROTUBULE BUNDLE	6	9.98e-01	9.99e-01	0.01510	-5.86e-03	-1.39e-02	9.80e-01	9.53e-01
GOBP POSITIVE REGULATION OF AXONOGENESIS	71	9.75e-01	9.88e-01	0.01510	-1.51e-02	-5.09e-05	8.26e-01	9.99e-01
GOBP LOCOMOTORY BEHAVIOR	200	9.38e-01	9.72e-01	0.01500	3.13e-03	1.47e-02	9.39e-01	7.21e-01
GOCC SOMATODENDRITIC COMPARTMENT	802	7.81e-01	8.90e-01	0.01490	-1.46e-02	-2.81e-03	4.82e-01	8.92e-01
GOBP MITOCHONDRION DISTRIBUTION	17	9.93e-01	9.96e-01	0.01490	-1.32e-02	6.94e-03	9.25e-01	9.61e-01
GOBP NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT	34	9.91e-01	9.96e-01	0.01480	8.86e-03	1.18e-02	9.29e-01	9.05e-01
GOMF NUCLEOBASE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY	52	9.83e-01	9.92e-01	0.01480	1.47e-02	8.95e-04	8.54e-01	9.91e-01
GOBP REGULATION OF SMALL MOLECULE METABOLIC PROCESS	319	8.89e-01	9.46e-01	0.01470	-3.78e-03	1.42e-02	9.08e-01	6.63e-01
GOBP REGULATION OF BLOOD PRESSURE	175	9.55e-01	9.80e-01	0.01460	1.01e-02	1.05e-02	8.17e-01	8.10e-01
GOBP RESPONSE TO WOUNDING	552	8.66e-01	9.35e-01	0.01460	8.40e-03	1.19e-02	7.36e-01	6.32e-01
Constitutive Signaling by Aberrant PI3K in Cancer	85	9.67e-01	9.85e-01	0.01440	-7.88e-03	1.21e-02	9.00e-01	8.48e-01
GOBP REGULATION OF GLUCOSE IMPORT	58	9.78e-01	9.89e-01	0.01430	1.08e-02	-9.39e-03	8.87e-01	9.02e-01
GOBP POSITIVE REGULATION OF EXOSOMAL SECRETION	15	9.96e-01	9.98e-01	0.01420	1.39e-02	3.06e-03	9.26e-01	9.84e-01
GOCC DENDRITIC TREE	590	8.65e-01	9.34e-01	0.01410	-7.88e-03	-1.17e-02	7.44e-01	6.26e-01
GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY	81	9.72e-01	9.87e-01	0.01390	4.64e-03	-1.31e-02	9.42e-01	8.38e-01
GOBP POSTSYNAPTIC DENSITY ASSEMBLY	24	9.92e-01	9.96e-01	0.01390	1.79e-03	-1.38e-02	9.88e-01	9.07e-01
GOBP REGULATION OF LIPID METABOLIC PROCESS	314	8.99e-01	9.51e-01	0.01360	6.72e-03	-1.18e-02	8.38e-01	7.19e-01
GOMF MAP KINASE ACTIVITY	16	9.95e-01	9.97e-01	0.01350	-1.08e-02	8.03e-03	9.40e-01	9.56e-01
GOBP NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY	25	9.92e-01	9.96e-01	0.01340	-1.27e-02	4.17e-03	9.12e-01	9.71e-01
GOBP EXOCYTIC PROCESS	77	9.83e-01	9.92e-01	0.01340	8.92e-03	1.00e-02	8.92e-01	8.79e-01
GOCC NEURON PROJECTION	1260	7.78e-01	8.88e-01	0.01300	-8.07e-03	-1.02e-02	6.30e-01	5.41e-01
GOBP EXCITATORY SYNAPSE ASSEMBLY	34	9.90e-01	9.96e-01	0.01280	3.73e-03	-1.23e-02	9.70e-01	9.02e-01
GOBP RESPONSE TO XENOBIOTIC STIMULUS	435	8.96e-01	9.49e-01	0.01270	5.69e-04	-1.27e-02	9.84e-01	6.50e-01
Other interleukin signaling	24	9.93e-01	9.96e-01	0.01260	-9.28e-03	8.54e-03	9.37e-01	9.42e-01
GOBP BIOMINERAL TISSUE DEVELOPMENT	170	9.66e-01	9.84e-01	0.01230	1.17e-02	3.81e-03	7.92e-01	9.32e-01
GOBP REGULATION OF AMINO ACID TRANSPORT	40	9.91e-01	9.96e-01	0.01230	-2.03e-03	-1.21e-02	9.82e-01	8.95e-01
GOBP REGULATION OF HORMONE SECRETION	252	9.33e-01	9.69e-01	0.01210	-9.60e-03	7.41e-03	7.93e-01	8.40e-01
GOBP RETINAL GANGLION CELL AXON GUIDANCE	22	9.94e-01	9.97e-01	0.01190	-1.01e-02	6.26e-03	9.35e-01	9.59e-01
GOBP AMIDE TRANSPORT	308	9.33e-01	9.69e-01	0.01190	-1.19e-02	7.07e-04	7.21e-01	9.83e-01
GOBP ALCOHOL METABOLIC PROCESS	354	9.23e-01	9.63e-01	0.01180	1.35e-03	-1.18e-02	9.65e-01	7.04e-01
GOBP CEREBELLAR CORTEX MORPHOGENESIS	35	9.91e-01	9.96e-01	0.01170	6.72e-03	-9.53e-03	9.45e-01	9.22e-01
GOBP REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION	25	9.94e-01	9.97e-01	0.01150	1.07e-02	-4.31e-03	9.26e-01	9.70e-01
Nuclear events stimulated by ALK signaling in cancer	34	9.94e-01	9.97e-01	0.01150	1.10e-02	3.18e-03	9.11e-01	9.74e-01
GOBP REGULATION OF BIOLOGICAL PROCESS INVOLVED IN SYMBIOTIC INTERACTION	64	9.88e-01	9.95e-01	0.01140	3.14e-03	1.10e-02	9.65e-01	8.79e-01
GOBP CELLULAR HOMEOSTASIS	799	8.41e-01	9.20e-01	0.01140	-2.78e-03	1.11e-02	8.94e-01	5.95e-01
GOBP AMINO ACID IMPORT ACROSS PLASMA MEMBRANE	45	9.93e-01	9.96e-01	0.01140	-6.07e-03	-9.60e-03	9.44e-01	9.11e-01
GOMF NUCLEOSIDE DIPHOSPHATE KINASE ACTIVITY	18	9.97e-01	9.99e-01	0.01040	-1.04e-02	-4.46e-04	9.39e-01	9.97e-01
GOBP HORMONE TRANSPORT	315	9.53e-01	9.79e-01	0.01030	-1.87e-03	-1.02e-02	9.54e-01	7.56e-01
GOBP NEGATIVE REGULATION OF TRANSPORT	438	9.32e-01	9.68e-01	0.01030	-3.31e-04	-1.03e-02	9.91e-01	7.12e-01
GOBP BONE MINERALIZATION INVOLVED IN BONE MATURATION	13	9.98e-01	9.99e-01	0.01010	-8.68e-03	5.16e-03	9.57e-01	9.74e-01
GOBP REGULATION OF LIPID CATABOLIC PROCESS	65	9.88e-01	9.95e-01	0.00997	4.13e-03	-9.08e-03	9.54e-01	8.99e-01
GOBP PROTEIN O LINKED GLYCOSYLATION	99	9.85e-01	9.92e-01	0.00970	1.34e-03	-9.61e-03	9.82e-01	8.69e-01
GOBP NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT	32	9.94e-01	9.97e-01	0.00969	-5.25e-03	8.15e-03	9.59e-01	9.36e-01
GOBP NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT	14	9.98e-01	9.99e-01	0.00964	-1.66e-03	9.50e-03	9.91e-01	9.51e-01
GOBP REGULATION OF TRANSPORT	1559	7.82e-01	8.90e-01	0.00962	-4.13e-03	8.68e-03	7.85e-01	5.67e-01
GOMF SULFURTRANSFERASE ACTIVITY	11	9.99e-01	9.99e-01	0.00949	8.24e-03	4.70e-03	9.62e-01	9.78e-01
GOBP CHEMICAL HOMEOSTASIS	1016	8.48e-01	9.23e-01	0.00947	-7.30e-03	6.03e-03	6.94e-01	7.45e-01
GOBP PROTEIN LOCALIZATION TO POSTSYNAPSE	40	9.95e-01	9.98e-01	0.00943	-4.71e-03	-8.16e-03	9.59e-01	9.29e-01
GOBP POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION	183	9.77e-01	9.89e-01	0.00918	3.42e-04	9.18e-03	9.94e-01	8.30e-01
GOBP MONOCARBOXYLIC ACID METABOLIC PROCESS	616	9.14e-01	9.58e-01	0.00890	6.85e-03	-5.68e-03	7.72e-01	8.10e-01
GOMF LIPID BINDING	826	9.12e-01	9.56e-01	0.00888	-1.26e-03	-8.79e-03	9.51e-01	6.68e-01
GOBP RETINAL ROD CELL DEVELOPMENT	10	9.99e-01	9.99e-01	0.00882	-5.52e-03	-6.88e-03	9.76e-01	9.70e-01
GOBP PHOSPHOLIPID TRANSPORT	101	9.91e-01	9.96e-01	0.00836	-6.84e-03	-4.80e-03	9.05e-01	9.34e-01
GOBP NEGATIVE REGULATION OF REPRODUCTIVE PROCESS	71	9.93e-01	9.96e-01	0.00820	9.35e-04	8.14e-03	9.89e-01	9.06e-01
GOBP RESPONSE TO TOXIC SUBSTANCE	255	9.77e-01	9.89e-01	0.00805	-1.81e-03	-7.84e-03	9.60e-01	8.29e-01
GOBP LOCOMOTION	1278	9.11e-01	9.56e-01	0.00777	3.80e-03	6.78e-03	8.19e-01	6.84e-01
GOBP POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS	90	9.92e-01	9.96e-01	0.00771	-2.24e-05	-7.71e-03	1.00e+00	8.99e-01
GOCC PRESYNAPSE	547	9.48e-01	9.77e-01	0.00730	-3.65e-03	6.32e-03	8.84e-01	8.00e-01
GOMF DIACYLGLYCEROL DEPENDENT SERINE THREONINE KINASE ACTIVITY	16	9.99e-01	9.99e-01	0.00728	-5.93e-03	-4.23e-03	9.67e-01	9.77e-01
GOBP PROTEIN TRIMERIZATION	17	9.99e-01	9.99e-01	0.00679	3.77e-03	-5.65e-03	9.79e-01	9.68e-01
GOBP REGULATION OF CELLULAR KETONE METABOLIC PROCESS	138	9.90e-01	9.96e-01	0.00667	-4.76e-04	6.65e-03	9.92e-01	8.93e-01
GOBP WOUND HEALING	416	9.73e-01	9.87e-01	0.00621	5.99e-03	-1.62e-03	8.34e-01	9.55e-01
GOBP RAB PROTEIN SIGNAL TRANSDUCTION	17	9.99e-01	1.00e+00	0.00599	-2.46e-03	-5.46e-03	9.86e-01	9.69e-01
GOBP ORGANIC HYDROXY COMPOUND METABOLIC PROCESS	540	9.72e-01	9.87e-01	0.00554	-5.26e-03	1.74e-03	8.34e-01	9.45e-01
GOBP RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM	75	9.97e-01	9.98e-01	0.00487	3.54e-03	-3.35e-03	9.58e-01	9.60e-01
GOBP CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION	555	9.79e-01	9.90e-01	0.00473	-1.21e-03	4.57e-03	9.61e-01	8.54e-01
GOBP CELLULAR KETONE METABOLIC PROCESS	219	9.92e-01	9.96e-01	0.00460	4.81e-04	-4.58e-03	9.90e-01	9.07e-01
GOMF MYOSIN V BINDING	16	1.00e+00	1.00e+00	0.00440	-4.37e-03	-5.42e-04	9.76e-01	9.97e-01
GOBP AMINO ACID TRANSPORT	150	9.96e-01	9.98e-01	0.00426	-3.83e-03	-1.86e-03	9.36e-01	9.69e-01
GOBP NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION	33	1.00e+00	1.00e+00	0.00250	-1.06e-03	-2.26e-03	9.92e-01	9.82e-01
GOBP REGULATION OF PROTEIN SECRETION	261	9.98e-01	9.99e-01	0.00231	1.81e-03	1.43e-03	9.60e-01	9.68e-01
GOBP NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS	120	9.99e-01	1.00e+00	0.00195	6.56e-04	1.84e-03	9.90e-01	9.72e-01
GOBP ORGANIC ACID BIOSYNTHETIC PROCESS	319	9.99e-01	9.99e-01	0.00169	-1.46e-03	-8.43e-04	9.64e-01	9.79e-01
GOCC SYNAPTIC VESICLE MEMBRANE	130	1.00e+00	1.00e+00	0.00164	1.55e-03	5.38e-04	9.76e-01	9.92e-01

---

Detailed Gene set reports

GOMF CCR6 CHEMOKINE RECEPTOR BINDING

GOMF CCR6 CHEMOKINE RECEPTOR BINDING

metric	value
setSize	5
pMANOVA	0.00132
p.adjustMANOVA	0.0129
s.dist	1.03
s.cancer	-0.794
s.incidence	-0.662
p.cancer	0.00211
p.incidence	0.0103

Top 20 genes

Gene	cancer	incidence
DEFB114	-8829	-10241
DEFB110	-8728	-10024
DEFB133	-8549	-5434
CCL20	-595	-7550
DEFB1	-6644	-566

Click HERE to show all gene set members

All member genes

	cancer	incidence
CCL20	-595	-7550
DEFB1	-6644	-566
DEFB110	-8728	-10024
DEFB114	-8829	-10241
DEFB133	-8549	-5434

---

---

GOMF INHIBITORY MHC CLASS I RECEPTOR ACTIVITY

GOMF INHIBITORY MHC CLASS I RECEPTOR ACTIVITY

metric	value
setSize	9
pMANOVA	8.64e-06
p.adjustMANOVA	0.00019
s.dist	0.998
s.cancer	-0.89
s.incidence	-0.451
p.cancer	3.74e-06
p.incidence	0.019

Top 20 genes

Gene	cancer	incidence
LILRA1	-8905	-9834
LILRB2	-8245	-9071
LILRB1	-8370	-8782
LILRA2	-8822	-7421
LILRA5	-7163	-7106
LILRA4	-7837	-3476
KIR3DL1	-8325	-989

Click HERE to show all gene set members

All member genes

	cancer	incidence
KIR3DL1	-8325	-989
LILRA1	-8905	-9834
LILRA2	-8822	-7421
LILRA3	-3148	5947
LILRA4	-7837	-3476
LILRA5	-7163	-7106
LILRB1	-8370	-8782
LILRB2	-8245	-9071
LILRB4	-8676	672

---

---

GOMF ODORANT BINDING

GOMF ODORANT BINDING

metric	value
setSize	99
pMANOVA	2.31e-54
p.adjustMANOVA	1.29e-51
s.dist	0.962
s.cancer	-0.898
s.incidence	-0.345
p.cancer	4.68e-54
p.incidence	2.81e-09

Top 20 genes

Gene	cancer	incidence
OR10J3	-8913	-10402
OR5AC2	-8794	-10384
OR10Z1	-8846	-10322
OR10K2	-8756	-10278
OR8H3	-8915	-9992
OR5A1	-8850	-9972
OR8G2P	-8443	-10227
OR8D2	-8615	-9930
OR5F1	-8710	-9540
OR5T1	-8552	-9672
OR8J3	-8742	-9170
OR10V1	-8188	-9597
OR9Q2	-7687	-10121
OR5K1	-7935	-9797
OR12D2	-8849	-8693
OR8A1	-7596	-10041
OR5M9	-8652	-8807
OR5D16	-8193	-9261
OR8B12	-8838	-8500
OR5P3	-7960	-9224

Click HERE to show all gene set members

All member genes

	cancer	incidence
GPR148	-5358	-4843
OBP2A	-7360	-9458
OBP2B	-1280	-8072
OR10J1	-8874	-7751
OR10J3	-8913	-10402
OR10K1	-7467	-9101
OR10K2	-8756	-10278
OR10Q1	-8271	-4562
OR10T2	-8533	10603
OR10V1	-8188	-9597
OR10W1	-8406	10427
OR10Z1	-8846	-10322
OR11L1	-8363	1925
OR12D2	-8849	-8693
OR12D3	-7860	-9340
OR13A1	-5572	-9481
OR13G1	-7645	10248
OR14A16	-6409	2820
OR14C36	-8782	-8133
OR14I1	-8740	-7443
OR14J1	-8737	-8113
OR1K1	-2878	-2441
OR2C1	3265	-5317
OR4E2	-7896	-8794
OR5A1	-8850	-9972
OR5A2	-8392	-8107
OR5AC2	-8794	-10384
OR5AK2	-8404	7338
OR5AN1	-8490	1830
OR5AP2	-8700	-7595
OR5AR1	-8911	-7168
OR5AS1	-8860	-8172
OR5AU1	-1164	8558
OR5B12	-8702	-111
OR5B17	-7781	2218
OR5B2	-7893	-3718
OR5B21	-7572	-217
OR5B3	-8411	4139
OR5C1	110	10713
OR5D13	-8255	10278
OR5D14	-8719	-3423
OR5D16	-8193	-9261
OR5D18	-8746	1560
OR5F1	-8710	-9540
OR5H15	-8607	-8387
OR5H2	-7083	3502
OR5H6	-8916	3949
OR5I1	-8777	1024
OR5J2	-8907	-644
OR5K1	-7935	-9797
OR5K2	-7997	-7840
OR5K3	-7376	709
OR5K4	-8108	-3495
OR5L1	-8896	-6365
OR5L2	-8484	-8465
OR5M1	-8817	-5980
OR5M10	-7002	10258
OR5M11	-8851	-6869
OR5M3	-8892	6320
OR5M8	-8202	6633
OR5M9	-8652	-8807
OR5P2	-8229	9202
OR5P3	-7960	-9224
OR5T1	-8552	-9672
OR5T2	-8868	-8111
OR5W2	-8835	190
OR6B2	-3920	-3238
OR6B3	-2940	-2345
OR6K2	-8767	-6575
OR6K3	-8529	350
OR6K6	-8446	-7680
OR6N2	-8251	-582
OR8A1	-7596	-10041
OR8B12	-8838	-8500
OR8B2	-7565	3496
OR8B4	-8779	-7684
OR8B8	-8605	-6828
OR8D1	-8738	3524
OR8D2	-8615	-9930
OR8D4	-3371	-7348
OR8G1	-8679	-4815
OR8G2P	-8443	-10227
OR8G5	-8771	-511
OR8H1	-8618	2535
OR8H3	-8915	-9992
OR8I2	-8063	-3055
OR8J1	-8875	-7150
OR8J3	-8742	-9170
OR8K1	-7782	-8075
OR8K3	-8787	-107
OR8K5	-8444	-5584
OR8U1	-8883	2452
OR8U3	-8828	-5561
OR8U8	-8799	2138
OR9G4	-8861	-7382
OR9I1	-8609	582
OR9K2	-7491	9051
OR9Q1	-6502	3161
OR9Q2	-7687	-10121

---

---

GOMF HEMOGLOBIN ALPHA BINDING

GOMF HEMOGLOBIN ALPHA BINDING

metric	value
setSize	5
pMANOVA	0.00166
p.adjustMANOVA	0.0152
s.dist	0.955
s.cancer	-0.922
s.incidence	-0.249
p.cancer	0.000355
p.incidence	0.334

Top 20 genes

Gene	cancer	incidence
HBG1	-8249	-8342
HBE1	-8054	-7497
HBG2	-8655	-5692

Click HERE to show all gene set members

All member genes

	cancer	incidence
HBB	-8451	1032
HBD	-6965	9310
HBE1	-8054	-7497
HBG1	-8249	-8342
HBG2	-8655	-5692

---

---

GOBP REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY

GOBP REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY

metric	value
setSize	6
pMANOVA	0.0011
p.adjustMANOVA	0.0113
s.dist	0.951
s.cancer	0.777
s.incidence	0.548
p.cancer	0.000973
p.incidence	0.0201

Top 20 genes

Gene	cancer	incidence
TP53	11321	7975
PSMC6	10576	8152
WNT10B	9690	8897
HMGB1	12597	4633
CAND1	6470	6724
THRA	12651	2624

Click HERE to show all gene set members

All member genes

	cancer	incidence
CAND1	6470	6724
HMGB1	12597	4633
PSMC6	10576	8152
THRA	12651	2624
TP53	11321	7975
WNT10B	9690	8897

---

---

GOBP MATURE CONVENTIONAL DENDRITIC CELL DIFFERENTIATION

GOBP MATURE CONVENTIONAL DENDRITIC CELL DIFFERENTIATION

metric	value
setSize	5
pMANOVA	0.000205
p.adjustMANOVA	0.00282
s.dist	0.944
s.cancer	-0.683
s.incidence	0.651
p.cancer	0.00814
p.incidence	0.0117

Top 20 genes

Gene	cancer	incidence
F2RL1	-5898	10837
LGALS9	-5035	9929
CCR7	-3930	9368
CCL19	-5246	5248
PRTN3	-7176	2742

Click HERE to show all gene set members

All member genes

	cancer	incidence
CCL19	-5246	5248
CCR7	-3930	9368
F2RL1	-5898	10837
LGALS9	-5035	9929
PRTN3	-7176	2742

---

---

Organic anion transport

Organic anion transport

metric	value
setSize	5
pMANOVA	0.00319
p.adjustMANOVA	0.0252
s.dist	0.923
s.cancer	-0.324
s.incidence	-0.864
p.cancer	0.21
p.incidence	0.000822

Top 20 genes

Gene	cancer	incidence
SLC22A6	-7387	-8689
SLC22A12	-6618	-8306
SLC22A8	-5043	-8218

Click HERE to show all gene set members

All member genes

	cancer	incidence
SLC22A11	2495	-9730
SLC22A12	-6618	-8306
SLC22A6	-7387	-8689
SLC22A7	8954	-9912
SLC22A8	-5043	-8218

---

---

GOBP ANTIGEN PROCESSING AND PRESENTATION ENDOGENOUS LIPID ANTIGEN VIA MHC CLASS IB

GOBP ANTIGEN PROCESSING AND PRESENTATION ENDOGENOUS LIPID ANTIGEN VIA MHC CLASS IB

metric	value
setSize	5
pMANOVA	0.00196
p.adjustMANOVA	0.0173
s.dist	0.906
s.cancer	-0.903
s.incidence	-0.0709
p.cancer	0.000469
p.incidence	0.784

Top 20 genes

Gene	cancer	incidence
CD1E	-8511	-6703
CD1A	-7501	-6428
CD1C	-8294	-3575

Click HERE to show all gene set members

All member genes

	cancer	incidence
CD1A	-7501	-6428
CD1B	-8480	6144
CD1C	-8294	-3575
CD1D	-6544	9151
CD1E	-8511	-6703

---

---

GOMF LIPID ANTIGEN BINDING

GOMF LIPID ANTIGEN BINDING

metric	value
setSize	5
pMANOVA	0.00196
p.adjustMANOVA	0.0173
s.dist	0.906
s.cancer	-0.903
s.incidence	-0.0709
p.cancer	0.000469
p.incidence	0.784

Top 20 genes

Gene	cancer	incidence
CD1E	-8511	-6703
CD1A	-7501	-6428
CD1C	-8294	-3575

Click HERE to show all gene set members

All member genes

	cancer	incidence
CD1A	-7501	-6428
CD1B	-8480	6144
CD1C	-8294	-3575
CD1D	-6544	9151
CD1E	-8511	-6703

---

---

GOBP CARDIAC SEPTUM CELL DIFFERENTIATION

GOBP CARDIAC SEPTUM CELL DIFFERENTIATION

metric	value
setSize	5
pMANOVA	0.00484
p.adjustMANOVA	0.0344
s.dist	0.891
s.cancer	0.829
s.incidence	0.327
p.cancer	0.00132
p.incidence	0.205

Top 20 genes

Gene	cancer	incidence
NKX2-5	12016	8834
TBX5	10674	7011
BMPR1A	11582	6178

Click HERE to show all gene set members

All member genes

	cancer	incidence
BMPR1A	11582	6178
KCNJ8	12506	-57
MAML1	8803	-1550
NKX2-5	12016	8834
TBX5	10674	7011

---

---

GOMF PROTEIN ARGININE DEIMINASE ACTIVITY

GOMF PROTEIN ARGININE DEIMINASE ACTIVITY

metric	value
setSize	5
pMANOVA	0.00682
p.adjustMANOVA	0.0449
s.dist	0.889
s.cancer	-0.488
s.incidence	-0.743
p.cancer	0.0587
p.incidence	0.00402

Top 20 genes

Gene	cancer	incidence
PADI3	-5551	-9689
PADI1	-3241	-9276
PADI4	-2575	-6148
PADI2	-4697	-3298
PADI6	-524	-9814

Click HERE to show all gene set members

All member genes

	cancer	incidence
PADI1	-3241	-9276
PADI2	-4697	-3298
PADI3	-5551	-9689
PADI4	-2575	-6148
PADI6	-524	-9814

---

---

GOMF OLFACTORY RECEPTOR ACTIVITY

GOMF OLFACTORY RECEPTOR ACTIVITY

metric	value
setSize	338
pMANOVA	1.17e-148
p.adjustMANOVA	1.43e-144
s.dist	0.875
s.cancer	-0.796
s.incidence	-0.363
p.cancer	1.8e-141
p.incidence	1.53e-30

Top 20 genes

Gene	cancer	incidence
OR10J3	-8913	-10402
OR51A7	-8920	-10383
OR5AC2	-8794	-10384
OR10Z1	-8846	-10322
OR10K2	-8756	-10278
OR51G2	-8910	-10087
OR56B1	-8757	-10234
OR52L1	-8606	-10358
OR8H3	-8915	-9992
OR5A1	-8850	-9972
OR51F1	-8865	-9809
OR1G1	-8539	-10149
OR8G2P	-8443	-10227
OR13C2	-8434	-10224
OR10C1	-8852	-9684
OR8D2	-8615	-9930
OR2D3	-8376	-10189
OR4D11	-8900	-9585
OR6C65	-8727	-9768
OR52E4	-8457	-10066

Click HERE to show all gene set members

All member genes

	cancer	incidence
GPR148	-5358.0	-4843.0
OR10A2	-7787.0	-6844.0
OR10A3	-8278.0	-10283.0
OR10A4	-8573.0	-7006.0
OR10A5	-7881.0	-3145.5
OR10A6	-6953.0	4168.0
OR10A7	-8430.0	-9179.0
OR10AD1	7665.0	-2498.0
OR10AG1	-8863.0	6412.0
OR10C1	-8852.0	-9684.0
OR10G2	-8071.0	-7664.0
OR10G3	12510.0	7224.0
OR10G4	-8902.0	3049.0
OR10G7	-8466.0	-8682.0
OR10G8	-8667.0	-9735.0
OR10G9	-7568.0	-4730.0
OR10H1	-7788.0	-7869.0
OR10H2	-8754.0	-4755.0
OR10H3	-5196.0	-6901.0
OR10H4	-8046.0	-10154.0
OR10H5	-8257.0	6410.0
OR10J1	-8874.0	-7751.0
OR10J3	-8913.0	-10402.0
OR10J5	-8826.0	-7423.0
OR10K1	-7467.0	-9101.0
OR10K2	-8756.0	-10278.0
OR10P1	-7238.0	-10349.0
OR10Q1	-8271.0	-4562.0
OR10S1	-8816.0	-9650.0
OR10T2	-8533.0	10603.0
OR10V1	-8188.0	-9597.0
OR10W1	-8406.0	10427.0
OR10X1	-8893.0	-6701.0
OR10Z1	-8846.0	-10322.0
OR11A1	-8601.0	-8876.0
OR11G2	-4694.0	-5081.0
OR11H4	-3616.0	-6905.0
OR11H6	1508.0	-9002.0
OR11L1	-8363.0	1925.0
OR12D2	-8849.0	-8693.0
OR12D3	-7860.0	-9340.0
OR13A1	-5572.0	-9481.0
OR13C2	-8434.0	-10224.0
OR13C3	-5340.0	-3089.0
OR13C4	-1482.0	-8407.0
OR13C8	-5365.0	-10016.0
OR13C9	4794.0	-3843.0
OR13D1	-6091.0	7322.0
OR13F1	-5594.0	-7134.0
OR13G1	-7645.0	10248.0
OR13J1	-1469.0	1462.0
OR14A16	-6409.0	2820.0
OR14C36	-8782.0	-8133.0
OR14I1	-8740.0	-7443.0
OR14J1	-8737.0	-8113.0
OR1A1	-8187.0	-9136.0
OR1A2	-7024.0	-7703.0
OR1B1	-4473.0	-6957.0
OR1C1	-7900.0	-8088.0
OR1D2	-5998.0	2104.0
OR1E1	-7021.0	-9685.0
OR1E2	-7975.0	-6968.0
OR1F1	-3776.0	-4566.0
OR1F2P	-5316.0	5759.0
OR1G1	-8539.0	-10149.0
OR1I1	-7108.0	-1606.0
OR1J1	6716.0	11383.0
OR1J2	10792.0	9030.0
OR1J4	9362.0	10497.0
OR1K1	-2878.0	-2441.0
OR1L1	-2354.0	-6342.0
OR1L3	1433.0	1513.0
OR1L4	364.0	-2983.0
OR1L6	-1611.0	-5802.0
OR1L8	3611.0	7885.0
OR1M1	-7517.0	-8662.0
OR1N1	2130.0	10537.0
OR1N2	6772.0	11101.0
OR1Q1	5303.0	-1992.0
OR1S1	-7946.0	-9292.0
OR1S2	-8118.0	-5196.0
OR2A12	-7621.0	7647.0
OR2A14	-6850.0	-7449.0
OR2A2	-8346.0	-7960.0
OR2A5	-6433.0	-9812.0
OR2AE1	-4280.0	3758.0
OR2AG1	-8515.0	-6440.0
OR2AG2	-8309.0	-1022.0
OR2AK2	-5701.0	-9060.0
OR2AP1	-8766.0	-6978.0
OR2AT4	-5943.0	-5589.0
OR2B11	-8548.0	-6622.0
OR2B2	12144.0	-8249.0
OR2B3	-7988.0	-8083.0
OR2B6	1129.0	8845.0
OR2C1	3265.0	-5317.0
OR2C3	-1253.0	-7183.0
OR2D2	-8724.0	-5136.0
OR2D3	-8376.0	-10189.0
OR2F1	-8527.0	-977.0
OR2F2	-8689.0	-4563.0
OR2G2	-8764.0	-9649.0
OR2G3	-8563.0	1861.0
OR2G6	-8429.0	-8663.0
OR2H1	-8461.0	-9048.0
OR2H2	3122.0	-7030.0
OR2J2	-6213.0	7779.0
OR2K2	-5397.0	-7566.0
OR2L13	-7474.0	-751.0
OR2L2	-6903.0	-8023.0
OR2L3	-6858.0	-6162.0
OR2L5	-8901.0	6885.0
OR2L8	-6728.0	8876.0
OR2M2	-7793.0	-4401.0
OR2M3	-8395.0	-5578.0
OR2M4	-8711.0	-6883.0
OR2M5	-8683.0	-8650.0
OR2M7	-8726.0	-2246.0
OR2S2	7657.0	-8282.0
OR2T1	-8157.0	-6879.0
OR2T11	-8582.0	3006.0
OR2T12	-7940.0	-9826.0
OR2T27	-7020.0	-2813.0
OR2T3	-8191.0	-10339.0
OR2T33	-8441.0	5685.0
OR2T4	-7350.0	4014.0
OR2T6	-8745.0	2119.0
OR2T8	-7137.0	-9270.0
OR2V1	-4956.0	-10441.0
OR2V2	-662.0	482.0
OR2W1	-8059.0	1286.0
OR2W3	-7056.0	-8717.0
OR2W5P	-7557.0	-9742.0
OR2Y1	-6479.0	-2580.0
OR2Z1	-8323.0	5961.0
OR3A1	-7575.0	-8216.0
OR3A2	-8329.0	10096.0
OR3A3	-7316.0	-8600.0
OR4A15	-6950.0	-3278.0
OR4A16	-7844.0	6147.0
OR4A47	-7399.0	-2644.0
OR4A5	-749.0	6622.0
OR4B1	-8352.0	9928.0
OR4C12	-8651.0	6962.0
OR4C15	-8485.0	-884.0
OR4C16	-7992.0	-1614.0
OR4C3	-5070.0	7640.0
OR4C45	-2202.0	3791.0
OR4C46	-8881.0	10922.0
OR4C6	-8617.0	-2250.0
OR4D1	-8367.0	-5164.0
OR4D10	576.0	-9386.0
OR4D11	-8900.0	-9585.0
OR4D2	-8230.0	5666.0
OR4D5	-8821.0	-2479.0
OR4D6	-8068.0	-10318.0
OR4D9	-8415.0	-5700.0
OR4E2	-7896.0	-8794.0
OR4F15	-8731.0	5223.0
OR4F6	-8707.0	3991.0
OR4K1	-2489.0	-1923.0
OR4K13	-7182.0	-1003.0
OR4K14	-1026.0	-489.0
OR4K15	-4948.0	-8389.0
OR4K17	-5205.0	2118.0
OR4K2	10125.0	-6222.0
OR4K5	-8409.0	-9447.0
OR4L1	-2709.0	-8508.0
OR4M1	-5722.0	-10074.0
OR4N2	8511.0	-6761.0
OR4N5	5148.0	-5237.0
OR4S1	-7921.0	2903.0
OR4X1	-7029.0	9130.0
OR51A2	-8685.0	-7196.0
OR51A7	-8920.0	-10383.0
OR51B2	-8841.0	-8606.0
OR51B4	-8805.0	-7312.0
OR51B5	-8775.0	-8338.0
OR51B6	-8917.0	3724.0
OR51D1	-7739.0	-10341.0
OR51E1	-6194.0	-735.0
OR51E2	-5475.0	-8919.0
OR51F1	-8865.0	-9809.0
OR51F2	-8591.0	-7420.0
OR51G1	-8531.0	-9910.0
OR51G2	-8910.0	-10087.0
OR51I1	-8886.0	-8594.0
OR51I2	-8580.0	-5564.0
OR51L1	-8789.0	-9671.0
OR51M1	-8876.0	6499.0
OR51Q1	-7204.0	-6608.0
OR51S1	-8813.0	-9468.0
OR51T1	-8643.0	-4924.0
OR51V1	-8878.0	-9517.0
OR52A1	-7603.0	-9024.0
OR52A4P	-8909.0	-2936.0
OR52A5	-8845.0	-7485.0
OR52B2	-6912.0	-8527.0
OR52B4	-8668.0	-4941.0
OR52B6	-6138.0	2054.0
OR52D1	-8623.0	8882.0
OR52E2	-8871.0	3861.0
OR52E4	-8457.0	-10066.0
OR52E6	-8468.0	2573.0
OR52E8	-7394.0	-1223.0
OR52H1	-8102.0	-8601.0
OR52I1	-7589.0	-9979.0
OR52I2	-7995.0	-9404.0
OR52J3	-7624.0	-7597.0
OR52K1	-8280.0	3766.0
OR52K2	-4066.0	-7724.0
OR52L1	-8606.0	-10358.0
OR52M1	-4343.0	-8014.0
OR52N1	-7558.0	-8745.0
OR52N2	-8123.0	-10347.0
OR52R1	-8784.0	-4011.0
OR52W1	587.0	-5968.0
OR56A1	-8128.0	-4054.0
OR56A3	-8086.0	-8542.0
OR56A4	-7996.0	-7540.0
OR56A5	-6703.0	11038.0
OR56B1	-8757.0	-10234.0
OR56B4	-7993.0	-10289.0
OR5A1	-8850.0	-9972.0
OR5A2	-8392.0	-8107.0
OR5AC2	-8794.0	-10384.0
OR5AK2	-8404.0	7338.0
OR5AN1	-8490.0	1830.0
OR5AP2	-8700.0	-7595.0
OR5AR1	-8911.0	-7168.0
OR5AS1	-8860.0	-8172.0
OR5AU1	-1164.0	8558.0
OR5B12	-8702.0	-111.0
OR5B17	-7781.0	2218.0
OR5B2	-7893.0	-3718.0
OR5B21	-7572.0	-217.0
OR5B3	-8411.0	4139.0
OR5C1	110.0	10713.0
OR5D13	-8255.0	10278.0
OR5D14	-8719.0	-3423.0
OR5D16	-8193.0	-9261.0
OR5D18	-8746.0	1560.0
OR5F1	-8710.0	-9540.0
OR5H15	-8607.0	-8387.0
OR5H2	-7083.0	3502.0
OR5H6	-8916.0	3949.0
OR5I1	-8777.0	1024.0
OR5J2	-8907.0	-644.0
OR5K1	-7935.0	-9797.0
OR5K2	-7997.0	-7840.0
OR5K3	-7376.0	709.0
OR5K4	-8108.0	-3495.0
OR5L1	-8896.0	-6365.0
OR5L2	-8484.0	-8465.0
OR5M1	-8817.0	-5980.0
OR5M10	-7002.0	10258.0
OR5M11	-8851.0	-6869.0
OR5M3	-8892.0	6320.0
OR5M8	-8202.0	6633.0
OR5M9	-8652.0	-8807.0
OR5P2	-8229.0	9202.0
OR5P3	-7960.0	-9224.0
OR5T1	-8552.0	-9672.0
OR5T2	-8868.0	-8111.0
OR5V1	-8433.0	-8947.0
OR5W2	-8835.0	190.0
OR6A2	-7547.0	4389.0
OR6B1	-8333.0	-8565.0
OR6B2	-3920.0	-3238.0
OR6B3	-2940.0	-2345.0
OR6C1	-8355.0	-1839.0
OR6C2	-8734.0	-9189.0
OR6C3	-7287.0	9079.0
OR6C4	-7898.0	307.0
OR6C6	-8598.0	-9568.0
OR6C65	-8727.0	-9768.0
OR6C68	-8360.0	1509.0
OR6C70	-6899.0	-5260.0
OR6C74	-8094.0	6249.0
OR6C75	-8479.0	-8904.0
OR6C76	-8583.0	-5198.0
OR6F1	-8192.0	-7574.0
OR6K2	-8767.0	-6575.0
OR6K3	-8529.0	350.0
OR6K6	-8446.0	-7680.0
OR6M1	-7104.0	-1351.0
OR6N1	-8709.0	3763.0
OR6N2	-8251.0	-582.0
OR6P1	-7847.0	-790.0
OR6Q1	5223.0	11409.0
OR6S1	256.0	-8969.0
OR6T1	-8736.0	-9448.0
OR6V1	-4309.0	-1428.0
OR6X1	-7171.0	-5161.0
OR6Y1	-6846.0	-6126.0
OR7A10	-3281.0	10552.0
OR7A17	-8171.0	-7929.0
OR7A5	-8470.0	-1738.0
OR7C1	-7248.0	-4989.0
OR7C2	-8185.0	5937.0
OR7D2	-7628.0	-5028.0
OR7D4	-8301.0	-9848.0
OR7E24	-5138.0	5675.0
OR7G1	-1215.0	1186.0
OR7G2	630.0	-5976.0
OR7G3	-8366.0	8430.0
OR8A1	-7596.0	-10041.0
OR8B12	-8838.0	-8500.0
OR8B2	-7565.0	3496.0
OR8B4	-8779.0	-7684.0
OR8B8	-8605.0	-6828.0
OR8D1	-8738.0	3524.0
OR8D2	-8615.0	-9930.0
OR8D4	-3371.0	-7348.0
OR8G1	-8679.0	-4815.0
OR8G2P	-8443.0	-10227.0
OR8G5	-8771.0	-511.0
OR8H1	-8618.0	2535.0
OR8H3	-8915.0	-9992.0
OR8I2	-8063.0	-3055.0
OR8J1	-8875.0	-7150.0
OR8J3	-8742.0	-9170.0
OR8K1	-7782.0	-8075.0
OR8K3	-8787.0	-107.0
OR8K5	-8444.0	-5584.0
OR8S1	1566.0	-6033.0
OR8U1	-8883.0	2452.0
OR8U3	-8828.0	-5561.0
OR8U8	-8799.0	2138.0
OR9A2	-7956.0	-2581.0
OR9A4	-8469.0	-7752.0
OR9G1	-8692.5	-9740.5
OR9G4	-8861.0	-7382.0
OR9G9	-8692.5	-9740.5
OR9I1	-8609.0	582.0
OR9K2	-7491.0	9051.0
OR9Q1	-6502.0	3161.0
OR9Q2	-7687.0	-10121.0

---

---

Expression and translocation of olfactory receptors

Expression and translocation of olfactory receptors

metric	value
setSize	339
pMANOVA	4.07e-143
p.adjustMANOVA	2.5e-139
s.dist	0.857
s.cancer	-0.78
s.incidence	-0.356
p.cancer	3.21e-136
p.incidence	1.6e-29

Top 20 genes

Gene	cancer	incidence
OR10J3	-8913	-10402
OR51A7	-8920	-10383
OR5AC2	-8794	-10384
OR10Z1	-8846	-10322
OR10K2	-8756	-10278
OR51G2	-8910	-10087
OR56B1	-8757	-10234
OR52L1	-8606	-10358
OR8H3	-8915	-9992
OR5A1	-8850	-9972
OR51F1	-8865	-9809
OR1G1	-8539	-10149
OR13C2	-8434	-10224
OR10C1	-8852	-9684
OR8D2	-8615	-9930
OR2D3	-8376	-10189
OR4D11	-8900	-9585
OR6C65	-8727	-9768
OR52E4	-8457	-10066
OR10A3	-8278	-10283

Click HERE to show all gene set members

All member genes

	cancer	incidence
EBF1	2028.0	-80.0
LDB1	11687.0	9276.0
LHX2	10204.0	8960.0
OR10A2	-7787.0	-6844.0
OR10A3	-8278.0	-10283.0
OR10A4	-8573.0	-7006.0
OR10A5	-7881.0	-3145.5
OR10A6	-6953.0	4168.0
OR10A7	-8430.0	-9179.0
OR10AD1	7665.0	-2498.0
OR10AG1	-8863.0	6412.0
OR10C1	-8852.0	-9684.0
OR10G2	-8071.0	-7664.0
OR10G3	12510.0	7224.0
OR10G4	-8902.0	3049.0
OR10G7	-8466.0	-8682.0
OR10G8	-8667.0	-9735.0
OR10G9	-7568.0	-4730.0
OR10H1	-7788.0	-7869.0
OR10H2	-8754.0	-4755.0
OR10H3	-5196.0	-6901.0
OR10H4	-8046.0	-10154.0
OR10H5	-8257.0	6410.0
OR10J1	-8874.0	-7751.0
OR10J3	-8913.0	-10402.0
OR10J5	-8826.0	-7423.0
OR10K1	-7467.0	-9101.0
OR10K2	-8756.0	-10278.0
OR10P1	-7238.0	-10349.0
OR10Q1	-8271.0	-4562.0
OR10S1	-8816.0	-9650.0
OR10T2	-8533.0	10603.0
OR10V1	-8188.0	-9597.0
OR10W1	-8406.0	10427.0
OR10X1	-8893.0	-6701.0
OR10Z1	-8846.0	-10322.0
OR11A1	-8601.0	-8876.0
OR11G2	-4694.0	-5081.0
OR11H4	-3616.0	-6905.0
OR11H6	1508.0	-9002.0
OR11L1	-8363.0	1925.0
OR12D2	-8849.0	-8693.0
OR12D3	-7860.0	-9340.0
OR13A1	-5572.0	-9481.0
OR13C2	-8434.0	-10224.0
OR13C3	-5340.0	-3089.0
OR13C4	-1482.0	-8407.0
OR13C8	-5365.0	-10016.0
OR13C9	4794.0	-3843.0
OR13D1	-6091.0	7322.0
OR13F1	-5594.0	-7134.0
OR13G1	-7645.0	10248.0
OR13J1	-1469.0	1462.0
OR14A16	-6409.0	2820.0
OR14C36	-8782.0	-8133.0
OR14I1	-8740.0	-7443.0
OR14J1	-8737.0	-8113.0
OR1A1	-8187.0	-9136.0
OR1A2	-7024.0	-7703.0
OR1B1	-4473.0	-6957.0
OR1C1	-7900.0	-8088.0
OR1D2	-5998.0	2104.0
OR1E1	-7021.0	-9685.0
OR1E2	-7975.0	-6968.0
OR1F1	-3776.0	-4566.0
OR1G1	-8539.0	-10149.0
OR1I1	-7108.0	-1606.0
OR1J1	6716.0	11383.0
OR1J2	10792.0	9030.0
OR1J4	9362.0	10497.0
OR1K1	-2878.0	-2441.0
OR1L1	-2354.0	-6342.0
OR1L3	1433.0	1513.0
OR1L4	364.0	-2983.0
OR1L6	-1611.0	-5802.0
OR1L8	3611.0	7885.0
OR1M1	-7517.0	-8662.0
OR1N1	2130.0	10537.0
OR1N2	6772.0	11101.0
OR1Q1	5303.0	-1992.0
OR1S1	-7946.0	-9292.0
OR1S2	-8118.0	-5196.0
OR2A12	-7621.0	7647.0
OR2A14	-6850.0	-7449.0
OR2A2	-8346.0	-7960.0
OR2A5	-6433.0	-9812.0
OR2AE1	-4280.0	3758.0
OR2AG1	-8515.0	-6440.0
OR2AG2	-8309.0	-1022.0
OR2AK2	-5701.0	-9060.0
OR2AP1	-8766.0	-6978.0
OR2AT4	-5943.0	-5589.0
OR2B11	-8548.0	-6622.0
OR2B2	12144.0	-8249.0
OR2B3	-7988.0	-8083.0
OR2B6	1129.0	8845.0
OR2C1	3265.0	-5317.0
OR2C3	-1253.0	-7183.0
OR2D2	-8724.0	-5136.0
OR2D3	-8376.0	-10189.0
OR2F1	-8527.0	-977.0
OR2F2	-8689.0	-4563.0
OR2G2	-8764.0	-9649.0
OR2G3	-8563.0	1861.0
OR2G6	-8429.0	-8663.0
OR2H1	-8461.0	-9048.0
OR2H2	3122.0	-7030.0
OR2J2	-6213.0	7779.0
OR2K2	-5397.0	-7566.0
OR2L13	-7474.0	-751.0
OR2L2	-6903.0	-8023.0
OR2L3	-6858.0	-6162.0
OR2L5	-8901.0	6885.0
OR2L8	-6728.0	8876.0
OR2M2	-7793.0	-4401.0
OR2M3	-8395.0	-5578.0
OR2M4	-8711.0	-6883.0
OR2M5	-8683.0	-8650.0
OR2M7	-8726.0	-2246.0
OR2S2	7657.0	-8282.0
OR2T1	-8157.0	-6879.0
OR2T11	-8582.0	3006.0
OR2T12	-7940.0	-9826.0
OR2T27	-7020.0	-2813.0
OR2T3	-8191.0	-10339.0
OR2T33	-8441.0	5685.0
OR2T4	-7350.0	4014.0
OR2T6	-8745.0	2119.0
OR2T8	-7137.0	-9270.0
OR2V1	-4956.0	-10441.0
OR2V2	-662.0	482.0
OR2W1	-8059.0	1286.0
OR2W3	-7056.0	-8717.0
OR2Y1	-6479.0	-2580.0
OR2Z1	-8323.0	5961.0
OR3A1	-7575.0	-8216.0
OR3A2	-8329.0	10096.0
OR3A3	-7316.0	-8600.0
OR4A15	-6950.0	-3278.0
OR4A16	-7844.0	6147.0
OR4A47	-7399.0	-2644.0
OR4A5	-749.0	6622.0
OR4B1	-8352.0	9928.0
OR4C12	-8651.0	6962.0
OR4C15	-8485.0	-884.0
OR4C16	-7992.0	-1614.0
OR4C3	-5070.0	7640.0
OR4C45	-2202.0	3791.0
OR4C46	-8881.0	10922.0
OR4C6	-8617.0	-2250.0
OR4D1	-8367.0	-5164.0
OR4D10	576.0	-9386.0
OR4D11	-8900.0	-9585.0
OR4D2	-8230.0	5666.0
OR4D5	-8821.0	-2479.0
OR4D6	-8068.0	-10318.0
OR4D9	-8415.0	-5700.0
OR4E2	-7896.0	-8794.0
OR4F15	-8731.0	5223.0
OR4F6	-8707.0	3991.0
OR4K1	-2489.0	-1923.0
OR4K13	-7182.0	-1003.0
OR4K14	-1026.0	-489.0
OR4K15	-4948.0	-8389.0
OR4K17	-5205.0	2118.0
OR4K2	10125.0	-6222.0
OR4K5	-8409.0	-9447.0
OR4L1	-2709.0	-8508.0
OR4M1	-5722.0	-10074.0
OR4N2	8511.0	-6761.0
OR4N5	5148.0	-5237.0
OR4S1	-7921.0	2903.0
OR4X1	-7029.0	9130.0
OR51A2	-8685.0	-7196.0
OR51A7	-8920.0	-10383.0
OR51B2	-8841.0	-8606.0
OR51B4	-8805.0	-7312.0
OR51B5	-8775.0	-8338.0
OR51B6	-8917.0	3724.0
OR51D1	-7739.0	-10341.0
OR51E1	-6194.0	-735.0
OR51E2	-5475.0	-8919.0
OR51F1	-8865.0	-9809.0
OR51F2	-8591.0	-7420.0
OR51G1	-8531.0	-9910.0
OR51G2	-8910.0	-10087.0
OR51I1	-8886.0	-8594.0
OR51I2	-8580.0	-5564.0
OR51L1	-8789.0	-9671.0
OR51M1	-8876.0	6499.0
OR51Q1	-7204.0	-6608.0
OR51S1	-8813.0	-9468.0
OR51T1	-8643.0	-4924.0
OR51V1	-8878.0	-9517.0
OR52A1	-7603.0	-9024.0
OR52A4P	-8909.0	-2936.0
OR52A5	-8845.0	-7485.0
OR52B2	-6912.0	-8527.0
OR52B6	-6138.0	2054.0
OR52D1	-8623.0	8882.0
OR52E2	-8871.0	3861.0
OR52E4	-8457.0	-10066.0
OR52E6	-8468.0	2573.0
OR52E8	-7394.0	-1223.0
OR52H1	-8102.0	-8601.0
OR52I1	-7589.0	-9979.0
OR52I2	-7995.0	-9404.0
OR52J3	-7624.0	-7597.0
OR52K1	-8280.0	3766.0
OR52K2	-4066.0	-7724.0
OR52L1	-8606.0	-10358.0
OR52M1	-4343.0	-8014.0
OR52N1	-7558.0	-8745.0
OR52N2	-8123.0	-10347.0
OR52R1	-8784.0	-4011.0
OR52W1	587.0	-5968.0
OR56A1	-8128.0	-4054.0
OR56A3	-8086.0	-8542.0
OR56A4	-7996.0	-7540.0
OR56A5	-6703.0	11038.0
OR56B1	-8757.0	-10234.0
OR56B4	-7993.0	-10289.0
OR5A1	-8850.0	-9972.0
OR5A2	-8392.0	-8107.0
OR5AC2	-8794.0	-10384.0
OR5AK2	-8404.0	7338.0
OR5AN1	-8490.0	1830.0
OR5AP2	-8700.0	-7595.0
OR5AR1	-8911.0	-7168.0
OR5AS1	-8860.0	-8172.0
OR5AU1	-1164.0	8558.0
OR5B12	-8702.0	-111.0
OR5B17	-7781.0	2218.0
OR5B2	-7893.0	-3718.0
OR5B21	-7572.0	-217.0
OR5B3	-8411.0	4139.0
OR5C1	110.0	10713.0
OR5D13	-8255.0	10278.0
OR5D14	-8719.0	-3423.0
OR5D16	-8193.0	-9261.0
OR5D18	-8746.0	1560.0
OR5F1	-8710.0	-9540.0
OR5H15	-8607.0	-8387.0
OR5H2	-7083.0	3502.0
OR5H6	-8916.0	3949.0
OR5I1	-8777.0	1024.0
OR5J2	-8907.0	-644.0
OR5K1	-7935.0	-9797.0
OR5K2	-7997.0	-7840.0
OR5K3	-7376.0	709.0
OR5K4	-8108.0	-3495.0
OR5L1	-8896.0	-6365.0
OR5L2	-8484.0	-8465.0
OR5M1	-8817.0	-5980.0
OR5M10	-7002.0	10258.0
OR5M11	-8851.0	-6869.0
OR5M3	-8892.0	6320.0
OR5M8	-8202.0	6633.0
OR5M9	-8652.0	-8807.0
OR5P2	-8229.0	9202.0
OR5P3	-7960.0	-9224.0
OR5T1	-8552.0	-9672.0
OR5T2	-8868.0	-8111.0
OR5V1	-8433.0	-8947.0
OR5W2	-8835.0	190.0
OR6A2	-7547.0	4389.0
OR6B1	-8333.0	-8565.0
OR6B2	-3920.0	-3238.0
OR6B3	-2940.0	-2345.0
OR6C1	-8355.0	-1839.0
OR6C2	-8734.0	-9189.0
OR6C3	-7287.0	9079.0
OR6C4	-7898.0	307.0
OR6C6	-8598.0	-9568.0
OR6C65	-8727.0	-9768.0
OR6C68	-8360.0	1509.0
OR6C70	-6899.0	-5260.0
OR6C74	-8094.0	6249.0
OR6C75	-8479.0	-8904.0
OR6C76	-8583.0	-5198.0
OR6F1	-8192.0	-7574.0
OR6K2	-8767.0	-6575.0
OR6K3	-8529.0	350.0
OR6K6	-8446.0	-7680.0
OR6M1	-7104.0	-1351.0
OR6N1	-8709.0	3763.0
OR6N2	-8251.0	-582.0
OR6P1	-7847.0	-790.0
OR6Q1	5223.0	11409.0
OR6S1	256.0	-8969.0
OR6T1	-8736.0	-9448.0
OR6V1	-4309.0	-1428.0
OR6X1	-7171.0	-5161.0
OR6Y1	-6846.0	-6126.0
OR7A10	-3281.0	10552.0
OR7A17	-8171.0	-7929.0
OR7A5	-8470.0	-1738.0
OR7C1	-7248.0	-4989.0
OR7C2	-8185.0	5937.0
OR7D2	-7628.0	-5028.0
OR7D4	-8301.0	-9848.0
OR7E24	-5138.0	5675.0
OR7G1	-1215.0	1186.0
OR7G2	630.0	-5976.0
OR7G3	-8366.0	8430.0
OR8A1	-7596.0	-10041.0
OR8B12	-8838.0	-8500.0
OR8B2	-7565.0	3496.0
OR8B4	-8779.0	-7684.0
OR8B8	-8605.0	-6828.0
OR8D1	-8738.0	3524.0
OR8D2	-8615.0	-9930.0
OR8D4	-3371.0	-7348.0
OR8G1	-8679.0	-4815.0
OR8G5	-8771.0	-511.0
OR8H1	-8618.0	2535.0
OR8H3	-8915.0	-9992.0
OR8I2	-8063.0	-3055.0
OR8J1	-8875.0	-7150.0
OR8J3	-8742.0	-9170.0
OR8K1	-7782.0	-8075.0
OR8K3	-8787.0	-107.0
OR8K5	-8444.0	-5584.0
OR8S1	1566.0	-6033.0
OR8U1	-8883.0	2452.0
OR8U3	-8828.0	-5561.0
OR8U8	-8799.0	2138.0
OR9A2	-7956.0	-2581.0
OR9A4	-8469.0	-7752.0
OR9G1	-8692.5	-9740.5
OR9G4	-8861.0	-7382.0
OR9G9	-8692.5	-9740.5
OR9I1	-8609.0	582.0
OR9K2	-7491.0	9051.0
OR9Q1	-6502.0	3161.0
OR9Q2	-7687.0	-10121.0
REEP1	4877.0	-6606.0
RTP1	-4321.0	-4768.0
RTP2	-7549.0	-8666.0

---

---

Olfactory Signaling Pathway

Olfactory Signaling Pathway

metric	value
setSize	346
pMANOVA	3.22e-141
p.adjustMANOVA	1.32e-137
s.dist	0.844
s.cancer	-0.765
s.incidence	-0.356
p.cancer	6.68e-134
p.incidence	4.93e-30

Top 20 genes

Gene	cancer	incidence
OR10J3	-8913	-10402
OR51A7	-8920	-10383
OR5AC2	-8794	-10384
OR10Z1	-8846	-10322
OR10K2	-8756	-10278
OR51G2	-8910	-10087
OR56B1	-8757	-10234
OR52L1	-8606	-10358
OR8H3	-8915	-9992
OR5A1	-8850	-9972
OR51F1	-8865	-9809
OR1G1	-8539	-10149
OR13C2	-8434	-10224
OR10C1	-8852	-9684
OR8D2	-8615	-9930
OR2D3	-8376	-10189
OR4D11	-8900	-9585
OR6C65	-8727	-9768
OR52E4	-8457	-10066
OR10A3	-8278	-10283

Click HERE to show all gene set members

All member genes

	cancer	incidence
ADCY3	3889.0	-7058.0
ANO2	-6159.0	-4179.0
CNGA4	-5719.0	-9424.0
CNGB1	5936.0	-8858.0
EBF1	2028.0	-80.0
GNAL	-1291.0	-589.0
GNB1	10183.0	-351.0
GNG13	3196.0	8748.0
LDB1	11687.0	9276.0
LHX2	10204.0	8960.0
OR10A2	-7787.0	-6844.0
OR10A3	-8278.0	-10283.0
OR10A4	-8573.0	-7006.0
OR10A5	-7881.0	-3145.5
OR10A6	-6953.0	4168.0
OR10A7	-8430.0	-9179.0
OR10AD1	7665.0	-2498.0
OR10AG1	-8863.0	6412.0
OR10C1	-8852.0	-9684.0
OR10G2	-8071.0	-7664.0
OR10G3	12510.0	7224.0
OR10G4	-8902.0	3049.0
OR10G7	-8466.0	-8682.0
OR10G8	-8667.0	-9735.0
OR10G9	-7568.0	-4730.0
OR10H1	-7788.0	-7869.0
OR10H2	-8754.0	-4755.0
OR10H3	-5196.0	-6901.0
OR10H4	-8046.0	-10154.0
OR10H5	-8257.0	6410.0
OR10J1	-8874.0	-7751.0
OR10J3	-8913.0	-10402.0
OR10J5	-8826.0	-7423.0
OR10K1	-7467.0	-9101.0
OR10K2	-8756.0	-10278.0
OR10P1	-7238.0	-10349.0
OR10Q1	-8271.0	-4562.0
OR10S1	-8816.0	-9650.0
OR10T2	-8533.0	10603.0
OR10V1	-8188.0	-9597.0
OR10W1	-8406.0	10427.0
OR10X1	-8893.0	-6701.0
OR10Z1	-8846.0	-10322.0
OR11A1	-8601.0	-8876.0
OR11G2	-4694.0	-5081.0
OR11H4	-3616.0	-6905.0
OR11H6	1508.0	-9002.0
OR11L1	-8363.0	1925.0
OR12D2	-8849.0	-8693.0
OR12D3	-7860.0	-9340.0
OR13A1	-5572.0	-9481.0
OR13C2	-8434.0	-10224.0
OR13C3	-5340.0	-3089.0
OR13C4	-1482.0	-8407.0
OR13C8	-5365.0	-10016.0
OR13C9	4794.0	-3843.0
OR13D1	-6091.0	7322.0
OR13F1	-5594.0	-7134.0
OR13G1	-7645.0	10248.0
OR13J1	-1469.0	1462.0
OR14A16	-6409.0	2820.0
OR14C36	-8782.0	-8133.0
OR14I1	-8740.0	-7443.0
OR14J1	-8737.0	-8113.0
OR1A1	-8187.0	-9136.0
OR1A2	-7024.0	-7703.0
OR1B1	-4473.0	-6957.0
OR1C1	-7900.0	-8088.0
OR1D2	-5998.0	2104.0
OR1E1	-7021.0	-9685.0
OR1E2	-7975.0	-6968.0
OR1F1	-3776.0	-4566.0
OR1G1	-8539.0	-10149.0
OR1I1	-7108.0	-1606.0
OR1J1	6716.0	11383.0
OR1J2	10792.0	9030.0
OR1J4	9362.0	10497.0
OR1K1	-2878.0	-2441.0
OR1L1	-2354.0	-6342.0
OR1L3	1433.0	1513.0
OR1L4	364.0	-2983.0
OR1L6	-1611.0	-5802.0
OR1L8	3611.0	7885.0
OR1M1	-7517.0	-8662.0
OR1N1	2130.0	10537.0
OR1N2	6772.0	11101.0
OR1Q1	5303.0	-1992.0
OR1S1	-7946.0	-9292.0
OR1S2	-8118.0	-5196.0
OR2A12	-7621.0	7647.0
OR2A14	-6850.0	-7449.0
OR2A2	-8346.0	-7960.0
OR2A5	-6433.0	-9812.0
OR2AE1	-4280.0	3758.0
OR2AG1	-8515.0	-6440.0
OR2AG2	-8309.0	-1022.0
OR2AK2	-5701.0	-9060.0
OR2AP1	-8766.0	-6978.0
OR2AT4	-5943.0	-5589.0
OR2B11	-8548.0	-6622.0
OR2B2	12144.0	-8249.0
OR2B3	-7988.0	-8083.0
OR2B6	1129.0	8845.0
OR2C1	3265.0	-5317.0
OR2C3	-1253.0	-7183.0
OR2D2	-8724.0	-5136.0
OR2D3	-8376.0	-10189.0
OR2F1	-8527.0	-977.0
OR2F2	-8689.0	-4563.0
OR2G2	-8764.0	-9649.0
OR2G3	-8563.0	1861.0
OR2G6	-8429.0	-8663.0
OR2H1	-8461.0	-9048.0
OR2H2	3122.0	-7030.0
OR2J2	-6213.0	7779.0
OR2K2	-5397.0	-7566.0
OR2L13	-7474.0	-751.0
OR2L2	-6903.0	-8023.0
OR2L3	-6858.0	-6162.0
OR2L5	-8901.0	6885.0
OR2L8	-6728.0	8876.0
OR2M2	-7793.0	-4401.0
OR2M3	-8395.0	-5578.0
OR2M4	-8711.0	-6883.0
OR2M5	-8683.0	-8650.0
OR2M7	-8726.0	-2246.0
OR2S2	7657.0	-8282.0
OR2T1	-8157.0	-6879.0
OR2T11	-8582.0	3006.0
OR2T12	-7940.0	-9826.0
OR2T27	-7020.0	-2813.0
OR2T3	-8191.0	-10339.0
OR2T33	-8441.0	5685.0
OR2T4	-7350.0	4014.0
OR2T6	-8745.0	2119.0
OR2T8	-7137.0	-9270.0
OR2V1	-4956.0	-10441.0
OR2V2	-662.0	482.0
OR2W1	-8059.0	1286.0
OR2W3	-7056.0	-8717.0
OR2Y1	-6479.0	-2580.0
OR2Z1	-8323.0	5961.0
OR3A1	-7575.0	-8216.0
OR3A2	-8329.0	10096.0
OR3A3	-7316.0	-8600.0
OR4A15	-6950.0	-3278.0
OR4A16	-7844.0	6147.0
OR4A47	-7399.0	-2644.0
OR4A5	-749.0	6622.0
OR4B1	-8352.0	9928.0
OR4C12	-8651.0	6962.0
OR4C15	-8485.0	-884.0
OR4C16	-7992.0	-1614.0
OR4C3	-5070.0	7640.0
OR4C45	-2202.0	3791.0
OR4C46	-8881.0	10922.0
OR4C6	-8617.0	-2250.0
OR4D1	-8367.0	-5164.0
OR4D10	576.0	-9386.0
OR4D11	-8900.0	-9585.0
OR4D2	-8230.0	5666.0
OR4D5	-8821.0	-2479.0
OR4D6	-8068.0	-10318.0
OR4D9	-8415.0	-5700.0
OR4E2	-7896.0	-8794.0
OR4F15	-8731.0	5223.0
OR4F6	-8707.0	3991.0
OR4K1	-2489.0	-1923.0
OR4K13	-7182.0	-1003.0
OR4K14	-1026.0	-489.0
OR4K15	-4948.0	-8389.0
OR4K17	-5205.0	2118.0
OR4K2	10125.0	-6222.0
OR4K5	-8409.0	-9447.0
OR4L1	-2709.0	-8508.0
OR4M1	-5722.0	-10074.0
OR4N2	8511.0	-6761.0
OR4N5	5148.0	-5237.0
OR4S1	-7921.0	2903.0
OR4X1	-7029.0	9130.0
OR51A2	-8685.0	-7196.0
OR51A7	-8920.0	-10383.0
OR51B2	-8841.0	-8606.0
OR51B4	-8805.0	-7312.0
OR51B5	-8775.0	-8338.0
OR51B6	-8917.0	3724.0
OR51D1	-7739.0	-10341.0
OR51E1	-6194.0	-735.0
OR51E2	-5475.0	-8919.0
OR51F1	-8865.0	-9809.0
OR51F2	-8591.0	-7420.0
OR51G1	-8531.0	-9910.0
OR51G2	-8910.0	-10087.0
OR51I1	-8886.0	-8594.0
OR51I2	-8580.0	-5564.0
OR51L1	-8789.0	-9671.0
OR51M1	-8876.0	6499.0
OR51Q1	-7204.0	-6608.0
OR51S1	-8813.0	-9468.0
OR51T1	-8643.0	-4924.0
OR51V1	-8878.0	-9517.0
OR52A1	-7603.0	-9024.0
OR52A4P	-8909.0	-2936.0
OR52A5	-8845.0	-7485.0
OR52B2	-6912.0	-8527.0
OR52B6	-6138.0	2054.0
OR52D1	-8623.0	8882.0
OR52E2	-8871.0	3861.0
OR52E4	-8457.0	-10066.0
OR52E6	-8468.0	2573.0
OR52E8	-7394.0	-1223.0
OR52H1	-8102.0	-8601.0
OR52I1	-7589.0	-9979.0
OR52I2	-7995.0	-9404.0
OR52J3	-7624.0	-7597.0
OR52K1	-8280.0	3766.0
OR52K2	-4066.0	-7724.0
OR52L1	-8606.0	-10358.0
OR52M1	-4343.0	-8014.0
OR52N1	-7558.0	-8745.0
OR52N2	-8123.0	-10347.0
OR52R1	-8784.0	-4011.0
OR52W1	587.0	-5968.0
OR56A1	-8128.0	-4054.0
OR56A3	-8086.0	-8542.0
OR56A4	-7996.0	-7540.0
OR56A5	-6703.0	11038.0
OR56B1	-8757.0	-10234.0
OR56B4	-7993.0	-10289.0
OR5A1	-8850.0	-9972.0
OR5A2	-8392.0	-8107.0
OR5AC2	-8794.0	-10384.0
OR5AK2	-8404.0	7338.0
OR5AN1	-8490.0	1830.0
OR5AP2	-8700.0	-7595.0
OR5AR1	-8911.0	-7168.0
OR5AS1	-8860.0	-8172.0
OR5AU1	-1164.0	8558.0
OR5B12	-8702.0	-111.0
OR5B17	-7781.0	2218.0
OR5B2	-7893.0	-3718.0
OR5B21	-7572.0	-217.0
OR5B3	-8411.0	4139.0
OR5C1	110.0	10713.0
OR5D13	-8255.0	10278.0
OR5D14	-8719.0	-3423.0
OR5D16	-8193.0	-9261.0
OR5D18	-8746.0	1560.0
OR5F1	-8710.0	-9540.0
OR5H15	-8607.0	-8387.0
OR5H2	-7083.0	3502.0
OR5H6	-8916.0	3949.0
OR5I1	-8777.0	1024.0
OR5J2	-8907.0	-644.0
OR5K1	-7935.0	-9797.0
OR5K2	-7997.0	-7840.0
OR5K3	-7376.0	709.0
OR5K4	-8108.0	-3495.0
OR5L1	-8896.0	-6365.0
OR5L2	-8484.0	-8465.0
OR5M1	-8817.0	-5980.0
OR5M10	-7002.0	10258.0
OR5M11	-8851.0	-6869.0
OR5M3	-8892.0	6320.0
OR5M8	-8202.0	6633.0
OR5M9	-8652.0	-8807.0
OR5P2	-8229.0	9202.0
OR5P3	-7960.0	-9224.0
OR5T1	-8552.0	-9672.0
OR5T2	-8868.0	-8111.0
OR5V1	-8433.0	-8947.0
OR5W2	-8835.0	190.0
OR6A2	-7547.0	4389.0
OR6B1	-8333.0	-8565.0
OR6B2	-3920.0	-3238.0
OR6B3	-2940.0	-2345.0
OR6C1	-8355.0	-1839.0
OR6C2	-8734.0	-9189.0
OR6C3	-7287.0	9079.0
OR6C4	-7898.0	307.0
OR6C6	-8598.0	-9568.0
OR6C65	-8727.0	-9768.0
OR6C68	-8360.0	1509.0
OR6C70	-6899.0	-5260.0
OR6C74	-8094.0	6249.0
OR6C75	-8479.0	-8904.0
OR6C76	-8583.0	-5198.0
OR6F1	-8192.0	-7574.0
OR6K2	-8767.0	-6575.0
OR6K3	-8529.0	350.0
OR6K6	-8446.0	-7680.0
OR6M1	-7104.0	-1351.0
OR6N1	-8709.0	3763.0
OR6N2	-8251.0	-582.0
OR6P1	-7847.0	-790.0
OR6Q1	5223.0	11409.0
OR6S1	256.0	-8969.0
OR6T1	-8736.0	-9448.0
OR6V1	-4309.0	-1428.0
OR6X1	-7171.0	-5161.0
OR6Y1	-6846.0	-6126.0
OR7A10	-3281.0	10552.0
OR7A17	-8171.0	-7929.0
OR7A5	-8470.0	-1738.0
OR7C1	-7248.0	-4989.0
OR7C2	-8185.0	5937.0
OR7D2	-7628.0	-5028.0
OR7D4	-8301.0	-9848.0
OR7E24	-5138.0	5675.0
OR7G1	-1215.0	1186.0
OR7G2	630.0	-5976.0
OR7G3	-8366.0	8430.0
OR8A1	-7596.0	-10041.0
OR8B12	-8838.0	-8500.0
OR8B2	-7565.0	3496.0
OR8B4	-8779.0	-7684.0
OR8B8	-8605.0	-6828.0
OR8D1	-8738.0	3524.0
OR8D2	-8615.0	-9930.0
OR8D4	-3371.0	-7348.0
OR8G1	-8679.0	-4815.0
OR8G5	-8771.0	-511.0
OR8H1	-8618.0	2535.0
OR8H3	-8915.0	-9992.0
OR8I2	-8063.0	-3055.0
OR8J1	-8875.0	-7150.0
OR8J3	-8742.0	-9170.0
OR8K1	-7782.0	-8075.0
OR8K3	-8787.0	-107.0
OR8K5	-8444.0	-5584.0
OR8S1	1566.0	-6033.0
OR8U1	-8883.0	2452.0
OR8U3	-8828.0	-5561.0
OR8U8	-8799.0	2138.0
OR9A2	-7956.0	-2581.0
OR9A4	-8469.0	-7752.0
OR9G1	-8692.5	-9740.5
OR9G4	-8861.0	-7382.0
OR9G9	-8692.5	-9740.5
OR9I1	-8609.0	582.0
OR9K2	-7491.0	9051.0
OR9Q1	-6502.0	3161.0
OR9Q2	-7687.0	-10121.0
REEP1	4877.0	-6606.0
RTP1	-4321.0	-4768.0
RTP2	-7549.0	-8666.0

---

---

NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake

NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake

metric	value
setSize	5
pMANOVA	0.0129
p.adjustMANOVA	0.072
s.dist	0.839
s.cancer	0.575
s.incidence	0.611
p.cancer	0.0259
p.incidence	0.0179

Top 20 genes

Gene	cancer	incidence
NR1H2	9751	10491
NR1H3	9392	7653
MYLIP	6405	10147
RXRA	5852	7091
RXRB	10278	583

Click HERE to show all gene set members

All member genes

	cancer	incidence
MYLIP	6405	10147
NR1H2	9751	10491
NR1H3	9392	7653
RXRA	5852	7091
RXRB	10278	583

---

---

H139Hfs13* PPM1K causes a mild variant of MSUD

H139Hfs13* PPM1K causes a mild variant of MSUD

metric	value
setSize	5
pMANOVA	0.011
p.adjustMANOVA	0.0643
s.dist	0.837
s.cancer	0.735
s.incidence	0.4
p.cancer	0.00444
p.incidence	0.121

Top 20 genes

Gene	cancer	incidence
DLD	10107	10169
BCKDHA	10116	6326
BCKDHB	10440	3463
PPM1K	7138	4399
DBT	12608	56

Click HERE to show all gene set members

All member genes

	cancer	incidence
BCKDHA	10116	6326
BCKDHB	10440	3463
DBT	12608	56
DLD	10107	10169
PPM1K	7138	4399

---

---

Maple Syrup Urine Disease

Maple Syrup Urine Disease

metric	value
setSize	5
pMANOVA	0.011
p.adjustMANOVA	0.0643
s.dist	0.837
s.cancer	0.735
s.incidence	0.4
p.cancer	0.00444
p.incidence	0.121

Top 20 genes

Gene	cancer	incidence
DLD	10107	10169
BCKDHA	10116	6326
BCKDHB	10440	3463
PPM1K	7138	4399
DBT	12608	56

Click HERE to show all gene set members

All member genes

	cancer	incidence
BCKDHA	10116	6326
BCKDHB	10440	3463
DBT	12608	56
DLD	10107	10169
PPM1K	7138	4399

---

---

GOBP REGULATION OF AMACRINE CELL DIFFERENTIATION

GOBP REGULATION OF AMACRINE CELL DIFFERENTIATION

metric	value
setSize	6
pMANOVA	0.00137
p.adjustMANOVA	0.0132
s.dist	0.833
s.cancer	-0.0163
s.incidence	0.833
p.cancer	0.945
p.incidence	0.000412

Top 20 genes

Gene	cancer	incidence
DLX2	-8080	11028
TGIF2	-8143	8624
DLX1	-4243	9873

Click HERE to show all gene set members

All member genes

	cancer	incidence
DLX1	-4243	9873
DLX2	-8080	11028
GDF11	10090	10189
HES1	8759	7625
POU4F2	12732	10375
TGIF2	-8143	8624

---

---

Conjugation of salicylate with glycine

Conjugation of salicylate with glycine

metric	value
setSize	8
pMANOVA	0.00108
p.adjustMANOVA	0.0112
s.dist	0.824
s.cancer	-0.678
s.incidence	-0.469
p.cancer	9e-04
p.incidence	0.0216

Top 20 genes

Gene	cancer	incidence
GLYATL2	-8384	-8156
ACSM4	-6444	-9155
GLYAT	-6505	-8095
ACSM5	-6715	-5904
GLYATL1	-1089	-8222

Click HERE to show all gene set members

All member genes

	cancer	incidence
ACSM2A	-7827	11261
ACSM2B	-6214	206
ACSM4	-6444	-9155
ACSM5	-6715	-5904
GLYAT	-6505	-8095
GLYATL1	-1089	-8222
GLYATL2	-8384	-8156
GLYATL3	19	-9099

---

---

GOBP SENSORY PERCEPTION OF SMELL

GOBP SENSORY PERCEPTION OF SMELL

metric	value
setSize	364
pMANOVA	7.14e-141
p.adjustMANOVA	2.19e-137
s.dist	0.823
s.cancer	-0.745
s.incidence	-0.35
p.cancer	2.89e-133
p.incidence	1.79e-30

Top 20 genes

Gene	cancer	incidence
OR10J3	-8913	-10402
OR51A7	-8920	-10383
OR5AC2	-8794	-10384
OR10Z1	-8846	-10322
OR10K2	-8756	-10278
OR51G2	-8910	-10087
OR56B1	-8757	-10234
OR52L1	-8606	-10358
OR8H3	-8915	-9992
OR5A1	-8850	-9972
OR51F1	-8865	-9809
OR1G1	-8539	-10149
OR8G2P	-8443	-10227
OR13C2	-8434	-10224
OR10C1	-8852	-9684
OR8D2	-8615	-9930
OR2D3	-8376	-10189
OR4D11	-8900	-9585
OR6C65	-8727	-9768
OR52E4	-8457	-10066

Click HERE to show all gene set members

All member genes

	cancer	incidence
ADCY3	3889.0	-7058.0
B2M	368.0	9278.0
B3GNT2	-1957.0	4996.0
BBS1	11310.0	-1405.0
BBS4	4379.0	5714.0
BEST2	-5487.0	4784.0
CFAP69	4592.0	2695.0
CNGA4	-5719.0	-9424.0
CNGB1	5936.0	-8858.0
DRD2	509.0	-4571.0
FZD2	9952.0	4923.0
GFY	9918.0	6472.0
GJB4	-6697.0	-10045.0
GPR148	-5358.0	-4843.0
MKKS	7844.0	-4747.0
NAV2	-1676.0	-1618.0
NXNL2	2329.0	2787.0
OBP2A	-7360.0	-9458.0
OBP2B	-1280.0	-8072.0
OMP	-6907.0	-7622.0
OR10A2	-7787.0	-6844.0
OR10A3	-8278.0	-10283.0
OR10A4	-8573.0	-7006.0
OR10A5	-7881.0	-3145.5
OR10A6	-6953.0	4168.0
OR10A7	-8430.0	-9179.0
OR10AD1	7665.0	-2498.0
OR10AG1	-8863.0	6412.0
OR10C1	-8852.0	-9684.0
OR10G2	-8071.0	-7664.0
OR10G3	12510.0	7224.0
OR10G4	-8902.0	3049.0
OR10G7	-8466.0	-8682.0
OR10G8	-8667.0	-9735.0
OR10G9	-7568.0	-4730.0
OR10H1	-7788.0	-7869.0
OR10H2	-8754.0	-4755.0
OR10H3	-5196.0	-6901.0
OR10H4	-8046.0	-10154.0
OR10H5	-8257.0	6410.0
OR10J1	-8874.0	-7751.0
OR10J3	-8913.0	-10402.0
OR10J5	-8826.0	-7423.0
OR10K1	-7467.0	-9101.0
OR10K2	-8756.0	-10278.0
OR10P1	-7238.0	-10349.0
OR10Q1	-8271.0	-4562.0
OR10S1	-8816.0	-9650.0
OR10T2	-8533.0	10603.0
OR10V1	-8188.0	-9597.0
OR10W1	-8406.0	10427.0
OR10X1	-8893.0	-6701.0
OR10Z1	-8846.0	-10322.0
OR11A1	-8601.0	-8876.0
OR11G2	-4694.0	-5081.0
OR11H4	-3616.0	-6905.0
OR11H6	1508.0	-9002.0
OR11L1	-8363.0	1925.0
OR12D2	-8849.0	-8693.0
OR12D3	-7860.0	-9340.0
OR13A1	-5572.0	-9481.0
OR13C2	-8434.0	-10224.0
OR13C3	-5340.0	-3089.0
OR13C4	-1482.0	-8407.0
OR13C8	-5365.0	-10016.0
OR13C9	4794.0	-3843.0
OR13D1	-6091.0	7322.0
OR13F1	-5594.0	-7134.0
OR13G1	-7645.0	10248.0
OR13J1	-1469.0	1462.0
OR14A16	-6409.0	2820.0
OR14C36	-8782.0	-8133.0
OR14I1	-8740.0	-7443.0
OR14J1	-8737.0	-8113.0
OR1A1	-8187.0	-9136.0
OR1A2	-7024.0	-7703.0
OR1B1	-4473.0	-6957.0
OR1C1	-7900.0	-8088.0
OR1D2	-5998.0	2104.0
OR1E1	-7021.0	-9685.0
OR1E2	-7975.0	-6968.0
OR1F1	-3776.0	-4566.0
OR1F2P	-5316.0	5759.0
OR1G1	-8539.0	-10149.0
OR1I1	-7108.0	-1606.0
OR1J1	6716.0	11383.0
OR1J2	10792.0	9030.0
OR1J4	9362.0	10497.0
OR1K1	-2878.0	-2441.0
OR1L1	-2354.0	-6342.0
OR1L3	1433.0	1513.0
OR1L4	364.0	-2983.0
OR1L6	-1611.0	-5802.0
OR1L8	3611.0	7885.0
OR1M1	-7517.0	-8662.0
OR1N1	2130.0	10537.0
OR1N2	6772.0	11101.0
OR1Q1	5303.0	-1992.0
OR1S1	-7946.0	-9292.0
OR1S2	-8118.0	-5196.0
OR2A12	-7621.0	7647.0
OR2A14	-6850.0	-7449.0
OR2A2	-8346.0	-7960.0
OR2A5	-6433.0	-9812.0
OR2AE1	-4280.0	3758.0
OR2AG1	-8515.0	-6440.0
OR2AG2	-8309.0	-1022.0
OR2AK2	-5701.0	-9060.0
OR2AP1	-8766.0	-6978.0
OR2AT4	-5943.0	-5589.0
OR2B11	-8548.0	-6622.0
OR2B2	12144.0	-8249.0
OR2B3	-7988.0	-8083.0
OR2B6	1129.0	8845.0
OR2C1	3265.0	-5317.0
OR2C3	-1253.0	-7183.0
OR2D2	-8724.0	-5136.0
OR2D3	-8376.0	-10189.0
OR2F1	-8527.0	-977.0
OR2F2	-8689.0	-4563.0
OR2G2	-8764.0	-9649.0
OR2G3	-8563.0	1861.0
OR2G6	-8429.0	-8663.0
OR2H1	-8461.0	-9048.0
OR2H2	3122.0	-7030.0
OR2J2	-6213.0	7779.0
OR2K2	-5397.0	-7566.0
OR2L13	-7474.0	-751.0
OR2L2	-6903.0	-8023.0
OR2L3	-6858.0	-6162.0
OR2L5	-8901.0	6885.0
OR2L8	-6728.0	8876.0
OR2M2	-7793.0	-4401.0
OR2M3	-8395.0	-5578.0
OR2M4	-8711.0	-6883.0
OR2M5	-8683.0	-8650.0
OR2M7	-8726.0	-2246.0
OR2S2	7657.0	-8282.0
OR2T1	-8157.0	-6879.0
OR2T11	-8582.0	3006.0
OR2T12	-7940.0	-9826.0
OR2T27	-7020.0	-2813.0
OR2T3	-8191.0	-10339.0
OR2T33	-8441.0	5685.0
OR2T4	-7350.0	4014.0
OR2T6	-8745.0	2119.0
OR2T8	-7137.0	-9270.0
OR2V1	-4956.0	-10441.0
OR2V2	-662.0	482.0
OR2W1	-8059.0	1286.0
OR2W3	-7056.0	-8717.0
OR2W5P	-7557.0	-9742.0
OR2Y1	-6479.0	-2580.0
OR2Z1	-8323.0	5961.0
OR3A1	-7575.0	-8216.0
OR3A2	-8329.0	10096.0
OR3A3	-7316.0	-8600.0
OR4A15	-6950.0	-3278.0
OR4A16	-7844.0	6147.0
OR4A47	-7399.0	-2644.0
OR4A5	-749.0	6622.0
OR4B1	-8352.0	9928.0
OR4C12	-8651.0	6962.0
OR4C15	-8485.0	-884.0
OR4C16	-7992.0	-1614.0
OR4C3	-5070.0	7640.0
OR4C45	-2202.0	3791.0
OR4C46	-8881.0	10922.0
OR4C6	-8617.0	-2250.0
OR4D1	-8367.0	-5164.0
OR4D10	576.0	-9386.0
OR4D11	-8900.0	-9585.0
OR4D2	-8230.0	5666.0
OR4D5	-8821.0	-2479.0
OR4D6	-8068.0	-10318.0
OR4D9	-8415.0	-5700.0
OR4E2	-7896.0	-8794.0
OR4F15	-8731.0	5223.0
OR4F6	-8707.0	3991.0
OR4K1	-2489.0	-1923.0
OR4K13	-7182.0	-1003.0
OR4K14	-1026.0	-489.0
OR4K15	-4948.0	-8389.0
OR4K17	-5205.0	2118.0
OR4K2	10125.0	-6222.0
OR4K5	-8409.0	-9447.0
OR4L1	-2709.0	-8508.0
OR4M1	-5722.0	-10074.0
OR4N2	8511.0	-6761.0
OR4N5	5148.0	-5237.0
OR4S1	-7921.0	2903.0
OR4X1	-7029.0	9130.0
OR51A2	-8685.0	-7196.0
OR51A7	-8920.0	-10383.0
OR51B2	-8841.0	-8606.0
OR51B4	-8805.0	-7312.0
OR51B5	-8775.0	-8338.0
OR51B6	-8917.0	3724.0
OR51D1	-7739.0	-10341.0
OR51E1	-6194.0	-735.0
OR51E2	-5475.0	-8919.0
OR51F1	-8865.0	-9809.0
OR51F2	-8591.0	-7420.0
OR51G1	-8531.0	-9910.0
OR51G2	-8910.0	-10087.0
OR51I1	-8886.0	-8594.0
OR51I2	-8580.0	-5564.0
OR51L1	-8789.0	-9671.0
OR51M1	-8876.0	6499.0
OR51Q1	-7204.0	-6608.0
OR51S1	-8813.0	-9468.0
OR51T1	-8643.0	-4924.0
OR51V1	-8878.0	-9517.0
OR52A1	-7603.0	-9024.0
OR52A4P	-8909.0	-2936.0
OR52A5	-8845.0	-7485.0
OR52B2	-6912.0	-8527.0
OR52B4	-8668.0	-4941.0
OR52B6	-6138.0	2054.0
OR52D1	-8623.0	8882.0
OR52E2	-8871.0	3861.0
OR52E4	-8457.0	-10066.0
OR52E6	-8468.0	2573.0
OR52E8	-7394.0	-1223.0
OR52H1	-8102.0	-8601.0
OR52I1	-7589.0	-9979.0
OR52I2	-7995.0	-9404.0
OR52J3	-7624.0	-7597.0
OR52K1	-8280.0	3766.0
OR52K2	-4066.0	-7724.0
OR52L1	-8606.0	-10358.0
OR52M1	-4343.0	-8014.0
OR52N1	-7558.0	-8745.0
OR52N2	-8123.0	-10347.0
OR52R1	-8784.0	-4011.0
OR52W1	587.0	-5968.0
OR56A1	-8128.0	-4054.0
OR56A3	-8086.0	-8542.0
OR56A4	-7996.0	-7540.0
OR56A5	-6703.0	11038.0
OR56B1	-8757.0	-10234.0
OR56B4	-7993.0	-10289.0
OR5A1	-8850.0	-9972.0
OR5A2	-8392.0	-8107.0
OR5AC2	-8794.0	-10384.0
OR5AK2	-8404.0	7338.0
OR5AN1	-8490.0	1830.0
OR5AP2	-8700.0	-7595.0
OR5AR1	-8911.0	-7168.0
OR5AS1	-8860.0	-8172.0
OR5AU1	-1164.0	8558.0
OR5B12	-8702.0	-111.0
OR5B17	-7781.0	2218.0
OR5B2	-7893.0	-3718.0
OR5B21	-7572.0	-217.0
OR5B3	-8411.0	4139.0
OR5C1	110.0	10713.0
OR5D13	-8255.0	10278.0
OR5D14	-8719.0	-3423.0
OR5D16	-8193.0	-9261.0
OR5D18	-8746.0	1560.0
OR5F1	-8710.0	-9540.0
OR5H15	-8607.0	-8387.0
OR5H2	-7083.0	3502.0
OR5H6	-8916.0	3949.0
OR5I1	-8777.0	1024.0
OR5J2	-8907.0	-644.0
OR5K1	-7935.0	-9797.0
OR5K2	-7997.0	-7840.0
OR5K3	-7376.0	709.0
OR5K4	-8108.0	-3495.0
OR5L1	-8896.0	-6365.0
OR5L2	-8484.0	-8465.0
OR5M1	-8817.0	-5980.0
OR5M10	-7002.0	10258.0
OR5M11	-8851.0	-6869.0
OR5M3	-8892.0	6320.0
OR5M8	-8202.0	6633.0
OR5M9	-8652.0	-8807.0
OR5P2	-8229.0	9202.0
OR5P3	-7960.0	-9224.0
OR5T1	-8552.0	-9672.0
OR5T2	-8868.0	-8111.0
OR5V1	-8433.0	-8947.0
OR5W2	-8835.0	190.0
OR6A2	-7547.0	4389.0
OR6B1	-8333.0	-8565.0
OR6B2	-3920.0	-3238.0
OR6B3	-2940.0	-2345.0
OR6C1	-8355.0	-1839.0
OR6C2	-8734.0	-9189.0
OR6C3	-7287.0	9079.0
OR6C4	-7898.0	307.0
OR6C6	-8598.0	-9568.0
OR6C65	-8727.0	-9768.0
OR6C68	-8360.0	1509.0
OR6C70	-6899.0	-5260.0
OR6C74	-8094.0	6249.0
OR6C75	-8479.0	-8904.0
OR6C76	-8583.0	-5198.0
OR6F1	-8192.0	-7574.0
OR6K2	-8767.0	-6575.0
OR6K3	-8529.0	350.0
OR6K6	-8446.0	-7680.0
OR6M1	-7104.0	-1351.0
OR6N1	-8709.0	3763.0
OR6N2	-8251.0	-582.0
OR6P1	-7847.0	-790.0
OR6Q1	5223.0	11409.0
OR6S1	256.0	-8969.0
OR6T1	-8736.0	-9448.0
OR6V1	-4309.0	-1428.0
OR6X1	-7171.0	-5161.0
OR6Y1	-6846.0	-6126.0
OR7A10	-3281.0	10552.0
OR7A17	-8171.0	-7929.0
OR7A5	-8470.0	-1738.0
OR7C1	-7248.0	-4989.0
OR7C2	-8185.0	5937.0
OR7D2	-7628.0	-5028.0
OR7D4	-8301.0	-9848.0
OR7E24	-5138.0	5675.0
OR7G1	-1215.0	1186.0
OR7G2	630.0	-5976.0
OR7G3	-8366.0	8430.0
OR8A1	-7596.0	-10041.0
OR8B12	-8838.0	-8500.0
OR8B2	-7565.0	3496.0
OR8B4	-8779.0	-7684.0
OR8B8	-8605.0	-6828.0
OR8D1	-8738.0	3524.0
OR8D2	-8615.0	-9930.0
OR8D4	-3371.0	-7348.0
OR8G1	-8679.0	-4815.0
OR8G2P	-8443.0	-10227.0
OR8G5	-8771.0	-511.0
OR8H1	-8618.0	2535.0
OR8H3	-8915.0	-9992.0
OR8I2	-8063.0	-3055.0
OR8J1	-8875.0	-7150.0
OR8J3	-8742.0	-9170.0
OR8K1	-7782.0	-8075.0
OR8K3	-8787.0	-107.0
OR8K5	-8444.0	-5584.0
OR8S1	1566.0	-6033.0
OR8U1	-8883.0	2452.0
OR8U3	-8828.0	-5561.0
OR8U8	-8799.0	2138.0
OR9A2	-7956.0	-2581.0
OR9A4	-8469.0	-7752.0
OR9G1	-8692.5	-9740.5
OR9G4	-8861.0	-7382.0
OR9G9	-8692.5	-9740.5
OR9I1	-8609.0	582.0
OR9K2	-7491.0	9051.0
OR9Q1	-6502.0	3161.0
OR9Q2	-7687.0	-10121.0
PDE4A	-151.0	6287.0
SLC24A4	3970.0	-915.0
SLC6A3	-6420.0	-6362.0
SYT10	8633.0	5963.0
TTC8	6694.0	1411.0
UBR3	5153.0	-2464.0
UGT2A1	-8116.0	-7417.0

---

---

Digestion of dietary carbohydrate

Digestion of dietary carbohydrate

metric	value
setSize	6
pMANOVA	0.0065
p.adjustMANOVA	0.0434
s.dist	0.821
s.cancer	-0.644
s.incidence	-0.51
p.cancer	0.00632
p.incidence	0.0305

Top 20 genes

Gene	cancer	incidence
MGAM	-7737	-8706
CHIT1	-6066	-7930
AMY2B	-3932	-7126
TREH	-2740	-7925

Click HERE to show all gene set members

All member genes

	cancer	incidence
AMY2B	-3932	-7126
CHIA	-4908	1093
CHIT1	-6066	-7930
LCT	-4753	18
MGAM	-7737	-8706
TREH	-2740	-7925

---

---

GOBP PROTEIN POLYUFMYLATION

GOBP PROTEIN POLYUFMYLATION

metric	value
setSize	5
pMANOVA	0.0157
p.adjustMANOVA	0.0837
s.dist	0.812
s.cancer	0.673
s.incidence	0.455
p.cancer	0.0092
p.incidence	0.0778

Top 20 genes

Gene	cancer	incidence
UFL1	11885	10930
UFM1	11438	9367
UFC1	11764	6891
UBA5	9062	7166

Click HERE to show all gene set members

All member genes

	cancer	incidence
DDRGK1	2859	-6924
UBA5	9062	7166
UFC1	11764	6891
UFL1	11885	10930
UFM1	11438	9367

---

---

GOBP MESENCHYME MIGRATION

GOBP MESENCHYME MIGRATION

metric	value
setSize	5
pMANOVA	0.00636
p.adjustMANOVA	0.0427
s.dist	0.811
s.cancer	0.81
s.incidence	0.0418
p.cancer	0.00171
p.incidence	0.872

Top 20 genes

Gene	cancer	incidence
ACTA1	11462	4411
FOXF1	6882	6774
ACTC1	10948	2481

Click HERE to show all gene set members

All member genes

	cancer	incidence
ACTA1	11462	4411
ACTA2	12309	-897
ACTC1	10948	2481
ACTG2	12942	-8008
FOXF1	6882	6774

---

---

Branched-chain ketoacid dehydrogenase kinase deficiency

Branched-chain ketoacid dehydrogenase kinase deficiency

metric	value
setSize	5
pMANOVA	0.0161
p.adjustMANOVA	0.0851
s.dist	0.811
s.cancer	0.665
s.incidence	0.464
p.cancer	0.01
p.incidence	0.0723

Top 20 genes

Gene	cancer	incidence
DLD	10107	10169
BCKDHA	10116	6326
BCKDHB	10440	3463
BCKDK	3317	7887
DBT	12608	56

Click HERE to show all gene set members

All member genes

	cancer	incidence
BCKDHA	10116	6326
BCKDHB	10440	3463
BCKDK	3317	7887
DBT	12608	56
DLD	10107	10169

---

---

GOMF TRACE AMINE RECEPTOR ACTIVITY

GOMF TRACE AMINE RECEPTOR ACTIVITY

metric	value
setSize	7
pMANOVA	0.00274
p.adjustMANOVA	0.0225
s.dist	0.805
s.cancer	-0.719
s.incidence	-0.362
p.cancer	0.000988
p.incidence	0.0975

Top 20 genes

Gene	cancer	incidence
TAAR9	-8197	-9212
TAAR8	-7398	-9198
TAAR5	-7833	-4938
TAAR6	-692	-7654

Click HERE to show all gene set members

All member genes

	cancer	incidence
TAAR1	-6786	4462
TAAR2	-2825	1796
TAAR3P	-7186	468
TAAR5	-7833	-4938
TAAR6	-692	-7654
TAAR8	-7398	-9198
TAAR9	-8197	-9212

---

---

GOBP NEGATIVE REGULATION OF INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY

GOBP NEGATIVE REGULATION OF INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY

metric	value
setSize	8
pMANOVA	5.93e-05
p.adjustMANOVA	0.00101
s.dist	0.803
s.cancer	0.66
s.incidence	-0.457
p.cancer	0.00122
p.incidence	0.0251

Top 20 genes

Gene	cancer	incidence
MIR125A	12915	-9761
MIRLET7E	12897	-8625
MIR99A	9938	-8735
MIRLET7A1	12793	-6471
MIRLET7C	2132	-9263
MIR26A1	9678	-584
PTPN2	1017	-1241

Click HERE to show all gene set members

All member genes

	cancer	incidence
MIR125A	12915	-9761
MIR125B1	12750	8564
MIR26A1	9678	-584
MIR99A	9938	-8735
MIRLET7A1	12793	-6471
MIRLET7C	2132	-9263
MIRLET7E	12897	-8625
PTPN2	1017	-1241

---

---

Prostanoid ligand receptors

Prostanoid ligand receptors

metric	value
setSize	9
pMANOVA	0.000344
p.adjustMANOVA	0.00438
s.dist	0.803
s.cancer	0.246
s.incidence	0.764
p.cancer	0.201
p.incidence	7.21e-05

Top 20 genes

Gene	cancer	incidence
PTGDR2	11766	9877
PTGDR	10373	10273
PTGER1	7598	9722
PTGIR	6595	10969
PTGER2	5967	9473
PTGFR	3983	7118
PTGER4	3826	6322

Click HERE to show all gene set members

All member genes

	cancer	incidence
PTGDR	10373	10273
PTGDR2	11766	9877
PTGER1	7598	9722
PTGER2	5967	9473
PTGER3	-6289	6301
PTGER4	3826	6322
PTGFR	3983	7118
PTGIR	6595	10969
TBXA2R	-1278	9728

---

---

GOBP REGULATION OF BINDING OF SPERM TO ZONA PELLUCIDA

GOBP REGULATION OF BINDING OF SPERM TO ZONA PELLUCIDA

metric	value
setSize	5
pMANOVA	0.0122
p.adjustMANOVA	0.0689
s.dist	0.797
s.cancer	-0.226
s.incidence	-0.764
p.cancer	0.38
p.incidence	0.00308

Top 20 genes

Gene	cancer	incidence
ZP4	-6747	-9747
PAEP	-5987	-8576
ZP3	-5467	-5937

Click HERE to show all gene set members

All member genes

	cancer	incidence
ASTL	2998	-7731
OVGP1	12951	-7406
PAEP	-5987	-8576
ZP3	-5467	-5937
ZP4	-6747	-9747

---

---

GOMF ESTROGEN 2 HYDROXYLASE ACTIVITY

GOMF ESTROGEN 2 HYDROXYLASE ACTIVITY

metric	value
setSize	5
pMANOVA	0.00266
p.adjustMANOVA	0.022
s.dist	0.795
s.cancer	0.421
s.incidence	-0.675
p.cancer	0.103
p.incidence	0.00898

Top 20 genes

Gene	cancer	incidence
CYP3A7	9026	-8529
CYP1A2	8365	-8488
CYP1A1	9519	-5386
CYP3A4	3764	-5822
CYP2B6	2569	-6273

Click HERE to show all gene set members

All member genes

	cancer	incidence
CYP1A1	9519	-5386
CYP1A2	8365	-8488
CYP2B6	2569	-6273
CYP3A4	3764	-5822
CYP3A7	9026	-8529

---

---

GOCC INTRACELLULAR CYCLIC NUCLEOTIDE ACTIVATED CATION CHANNEL COMPLEX

GOCC INTRACELLULAR CYCLIC NUCLEOTIDE ACTIVATED CATION CHANNEL COMPLEX

metric	value
setSize	5
pMANOVA	0.0163
p.adjustMANOVA	0.086
s.dist	0.786
s.cancer	-0.302
s.incidence	-0.726
p.cancer	0.243
p.incidence	0.00496

Top 20 genes

Gene	cancer	incidence
CNGA4	-5719	-9424
CNGB3	-2769	-6046
CNGA1	-2678	-3950
CNGA3	-1143	-9005

Click HERE to show all gene set members

All member genes

	cancer	incidence
CNGA1	-2678	-3950
CNGA3	-1143	-9005
CNGA4	-5719	-9424
CNGB1	5936	-8858
CNGB3	-2769	-6046

---

---

GOBP NEGATIVE REGULATION OF MHC CLASS II BIOSYNTHETIC PROCESS

GOBP NEGATIVE REGULATION OF MHC CLASS II BIOSYNTHETIC PROCESS

metric	value
setSize	5
pMANOVA	0.00408
p.adjustMANOVA	0.0304
s.dist	0.785
s.cancer	-0.262
s.incidence	0.741
p.cancer	0.311
p.incidence	0.00413

Top 20 genes

Gene	cancer	incidence
IL10	-6702	11177
PF4	-7158	10143
TAF7	-1887	11370

Click HERE to show all gene set members

All member genes

	cancer	incidence
HDAC2	7839	5829
IL10	-6702	11177
NFX1	3718	4530
PF4	-7158	10143
TAF7	-1887	11370

---

---

GOBP XENOBIOTIC GLUCURONIDATION

GOBP XENOBIOTIC GLUCURONIDATION

metric	value
setSize	6
pMANOVA	0.00947
p.adjustMANOVA	0.0575
s.dist	0.785
s.cancer	-0.441
s.incidence	-0.65
p.cancer	0.0611
p.incidence	0.00585

Top 20 genes

Gene	cancer	incidence
UGT2B11	-8176	-8354
UGT1A3	-2344	-6282
UGT1A8	-2222	-5791
UGT1A9	-1445	-6750
UGT1A7	-1267	-6818
UGT1A1	-1379	-5753

Click HERE to show all gene set members

All member genes

	cancer	incidence
UGT1A1	-1379	-5753
UGT1A3	-2344	-6282
UGT1A7	-1267	-6818
UGT1A8	-2222	-5791
UGT1A9	-1445	-6750
UGT2B11	-8176	-8354

---

---

GOBP CARDIAC PACEMAKER CELL DEVELOPMENT

GOBP CARDIAC PACEMAKER CELL DEVELOPMENT

metric	value
setSize	8
pMANOVA	0.00208
p.adjustMANOVA	0.0182
s.dist	0.779
s.cancer	0.663
s.incidence	0.409
p.cancer	0.00116
p.incidence	0.045

Top 20 genes

Gene	cancer	incidence
NKX2-5	12016	8834
ISL1	10774	8357
TBX5	10674	7011
BMPR1A	11582	6178
TBX18	7534	6807
SHOX2	2051	9187

Click HERE to show all gene set members

All member genes

	cancer	incidence
BMPR1A	11582	6178
ISL1	10774	8357
MAML1	8803	-1550
NKX2-5	12016	8834
SHOX2	2051	9187
TBX18	7534	6807
TBX3	10944	-4988
TBX5	10674	7011

---

---

Activation of C3 and C5

Activation of C3 and C5

metric	value
setSize	6
pMANOVA	0.0103
p.adjustMANOVA	0.061
s.dist	0.773
s.cancer	-0.393
s.incidence	-0.666
p.cancer	0.0954
p.incidence	0.00475

Top 20 genes

Gene	cancer	incidence
CFB	-5305	-8832.0
C4B	-6042	-4862.5
C4A	-5631	-4862.5
C3	-372	-4660.0

Click HERE to show all gene set members

All member genes

	cancer	incidence
C2	2923	-8020.0
C3	-372	-4660.0
C4A	-5631	-4862.5
C4B	-6042	-4862.5
C5	769	-9560.0
CFB	-5305	-8832.0

---

---

Ficolins bind to repetitive carbohydrate structures on the target cell surface

Ficolins bind to repetitive carbohydrate structures on the target cell surface

metric	value
setSize	5
pMANOVA	0.0266
p.adjustMANOVA	0.122
s.dist	0.766
s.cancer	-0.551
s.incidence	-0.532
p.cancer	0.0327
p.incidence	0.0394

Top 20 genes

Gene	cancer	incidence
FCN1	-8061	-9854
FCN3	-4880	-5679
MASP1	-139	-8026

Click HERE to show all gene set members

All member genes

	cancer	incidence
FCN1	-8061	-9854
FCN2	-7311	4340
FCN3	-4880	-5679
MASP1	-139	-8026
MASP2	334	-7450

---

---

GOBP POSITIVE REGULATION OF KERATINOCYTE APOPTOTIC PROCESS

GOBP POSITIVE REGULATION OF KERATINOCYTE APOPTOTIC PROCESS

metric	value
setSize	5
pMANOVA	0.0269
p.adjustMANOVA	0.122
s.dist	0.765
s.cancer	0.534
s.incidence	0.548
p.cancer	0.0387
p.incidence	0.0339

Top 20 genes

Gene	cancer	incidence
SFRP4	11772	8392
SAV1	11390	6408
PIAS4	9164	5420
GSN	11791	2212

Click HERE to show all gene set members

All member genes

	cancer	incidence
GSN	11791	2212
MIR4516	-4702	10052
PIAS4	9164	5420
SAV1	11390	6408
SFRP4	11772	8392

---

---

GOBP SPERM MITOCHONDRIAL SHEATH ASSEMBLY

GOBP SPERM MITOCHONDRIAL SHEATH ASSEMBLY

metric	value
setSize	6
pMANOVA	0.0132
p.adjustMANOVA	0.0735
s.dist	0.764
s.cancer	-0.551
s.incidence	-0.529
p.cancer	0.0193
p.incidence	0.0249

Top 20 genes

Gene	cancer	incidence
GK2	-8452	-9683
CFAP58	-7303	-6526
TBC1D21	-4062	-7211
KLC3	-4452	-1104

Click HERE to show all gene set members

All member genes

	cancer	incidence
ARMC12	427	-7573
CFAP58	-7303	-6526
GK2	-8452	-9683
KLC3	-4452	-1104
TBC1D21	-4062	-7211
VDAC3	-221	292

---

---

GOCC RADIAL SPOKE HEAD

GOCC RADIAL SPOKE HEAD

metric	value
setSize	5
pMANOVA	0.0103
p.adjustMANOVA	0.0611
s.dist	0.764
s.cancer	0.00255
s.incidence	0.764
p.cancer	0.992
p.incidence	0.0031

Top 20 genes

Gene	cancer	incidence
RSPH4A	12770	6496
RSPH1	1019	6838
RSPH6A	186	10919

Click HERE to show all gene set members

All member genes

	cancer	incidence
RSPH1	1019	6838
RSPH3	-53	9196
RSPH4A	12770	6496
RSPH6A	186	10919
RSPH9	-3625	10868

---

---

Conjugation of benzoate with glycine

Conjugation of benzoate with glycine

metric	value
setSize	6
pMANOVA	0.0137
p.adjustMANOVA	0.0757
s.dist	0.752
s.cancer	-0.406
s.incidence	-0.633
p.cancer	0.0849
p.incidence	0.00729

Top 20 genes

Gene	cancer	incidence
GLYATL2	-8384	-8156
GLYAT	-6505	-8095
GLYATL1	-1089	-8222

Click HERE to show all gene set members

All member genes

	cancer	incidence
ACSM1	7658	-5256
ACSM2B	-6214	206
GLYAT	-6505	-8095
GLYATL1	-1089	-8222
GLYATL2	-8384	-8156
GLYATL3	19	-9099

---

---

Regulation of gene expression in early pancreatic precursor cells

Regulation of gene expression in early pancreatic precursor cells

metric	value
setSize	8
pMANOVA	0.00319
p.adjustMANOVA	0.0252
s.dist	0.749
s.cancer	0.648
s.incidence	0.376
p.cancer	0.0015
p.incidence	0.0653

Top 20 genes

Gene	cancer	incidence
PTF1A	12466	9112
PDX1	10909	8625
ONECUT1	9924	8263
NKX6-1	5978	10061
NR5A2	4165	7799
ONECUT3	8725	3356

Click HERE to show all gene set members

All member genes

	cancer	incidence
FGF10	11444	-2410
HNF1B	9442	-7864
NKX6-1	5978	10061
NR5A2	4165	7799
ONECUT1	9924	8263
ONECUT3	8725	3356
PDX1	10909	8625
PTF1A	12466	9112

---

---

Sensory perception of salty taste

Sensory perception of salty taste

metric	value
setSize	6
pMANOVA	0.0157
p.adjustMANOVA	0.0838
s.dist	0.748
s.cancer	-0.563
s.incidence	-0.492
p.cancer	0.0169
p.incidence	0.037

Top 20 genes

Gene	cancer	incidence
SCNN1D	-5156	-9526
CALHM3	-3822	-8390
SCNN1A	-5735	-4971
SCNN1G	-6298	-4203
CALHM1	-6339	-495

Click HERE to show all gene set members

All member genes

	cancer	incidence
CALHM1	-6339	-495
CALHM3	-3822	-8390
SCNN1A	-5735	-4971
SCNN1B	2503	-1768
SCNN1D	-5156	-9526
SCNN1G	-6298	-4203

---

---

GOBP FC RECEPTOR MEDIATED INHIBITORY SIGNALING PATHWAY

GOBP FC RECEPTOR MEDIATED INHIBITORY SIGNALING PATHWAY

metric	value
setSize	5
pMANOVA	0.03
p.adjustMANOVA	0.132
s.dist	0.746
s.cancer	-0.62
s.incidence	-0.415
p.cancer	0.0164
p.incidence	0.108

Top 20 genes

Gene	cancer	incidence
LILRB2	-8245	-9071
LILRB1	-8370	-8782
PSG9	-2868	-9567

Click HERE to show all gene set members

All member genes

	cancer	incidence
LILRB1	-8370	-8782
LILRB2	-8245	-9071
LILRB4	-8676	672
LYN	4358	6491
PSG9	-2868	-9567

---

---

GOMF MHC CLASS IB RECEPTOR ACTIVITY

GOMF MHC CLASS IB RECEPTOR ACTIVITY

metric	value
setSize	7
pMANOVA	0.00251
p.adjustMANOVA	0.0211
s.dist	0.742
s.cancer	-0.741
s.incidence	-0.0185
p.cancer	0.000681
p.incidence	0.932

Top 20 genes

Gene	cancer	incidence
KLRC1	-8574	-10062
LILRB1	-8370	-8782
CD160	-947	-861

Click HERE to show all gene set members

All member genes

	cancer	incidence
CD160	-947	-861
KIR2DL4	-8765	10832
KLRC1	-8574	-10062
KLRC4-KLRK1	-6439	42
KLRD1	-2995	1282
KLRK1	-6554	9589
LILRB1	-8370	-8782

---

---

GOMF COENZYME A DIPHOSPHATASE ACTIVITY

GOMF COENZYME A DIPHOSPHATASE ACTIVITY

metric	value
setSize	5
pMANOVA	0.00676
p.adjustMANOVA	0.0447
s.dist	0.736
s.cancer	-0.336
s.incidence	0.655
p.cancer	0.194
p.incidence	0.0112

Top 20 genes

Gene	cancer	incidence
FITM1	-4361	11037
NUDT8	-3114	10139
FITM2	-3646	5938

Click HERE to show all gene set members

All member genes

	cancer	incidence
FITM1	-4361	11037
FITM2	-3646	5938
NUDT19	1394	9557
NUDT7	1500	1694
NUDT8	-3114	10139

---

---

GOBP NEGATIVE REGULATION OF MIRNA PROCESSING

GOBP NEGATIVE REGULATION OF MIRNA PROCESSING

metric	value
setSize	9
pMANOVA	0.00251
p.adjustMANOVA	0.0211
s.dist	0.733
s.cancer	0.493
s.incidence	0.543
p.cancer	0.0104
p.incidence	0.00477

Top 20 genes

Gene	cancer	incidence
LIN28A	11237	9624
LIN28B	9861	10642
ZC3H10	10205	9874
TP53	11321	7975
HOXB-AS3	8169	9628
STAT3	7049	6114

Click HERE to show all gene set members

All member genes

	cancer	incidence
BCDIN3D	3036	-2762
HOXB-AS3	8169	9628
IL6	-5178	7742
LIN28A	11237	9624
LIN28B	9861	10642
STAT3	7049	6114
TP53	11321	7975
ZC3H10	10205	9874
ZMPSTE24	11187	-826

---

---

GOBP SENSORY PERCEPTION OF CHEMICAL STIMULUS

GOBP SENSORY PERCEPTION OF CHEMICAL STIMULUS

metric	value
setSize	439
pMANOVA	2.12e-133
p.adjustMANOVA	5.21e-130
s.dist	0.733
s.cancer	-0.656
s.incidence	-0.328
p.cancer	3.38e-124
p.incidence	3.1e-32

Top 20 genes

Gene	cancer	incidence
OR10J3	-8913	-10402
OR51A7	-8920	-10383
OR5AC2	-8794	-10384
OR10Z1	-8846	-10322
OR10K2	-8756	-10278
OR51G2	-8910	-10087
OR56B1	-8757	-10234
OR52L1	-8606	-10358
OR8H3	-8915	-9992
OR5A1	-8850	-9972
OR51F1	-8865	-9809
OR1G1	-8539	-10149
OR8G2P	-8443	-10227
OR13C2	-8434	-10224
OR10C1	-8852	-9684
OR8D2	-8615	-9930
OR2D3	-8376	-10189
OR4D11	-8900	-9585
OR6C65	-8727	-9768
OR52E4	-8457	-10066

Click HERE to show all gene set members

All member genes

	cancer	incidence
ADCY3	3889.0	-7058.0
ASIC1	-4470.0	-2864.0
ASIC2	-5076.0	-4545.0
ASIC3	942.0	1219.0
AZGP1	-3387.0	9085.0
B2M	368.0	9278.0
B3GNT2	-1957.0	4996.0
BBS1	11310.0	-1405.0
BBS4	4379.0	5714.0
BEST2	-5487.0	4784.0
C5AR1	-7884.0	5852.0
CA6	-5270.0	10328.0
CALHM1	-6339.0	-495.0
CALHM3	-3822.0	-8390.0
CD36	3681.0	-9031.0
CFAP69	4592.0	2695.0
CNGA4	-5719.0	-9424.0
CNGB1	5936.0	-8858.0
CST1	5466.0	-6705.0
CST2	-7746.0	-8065.0
DRD2	509.0	-4571.0
FFAR4	11745.0	-5472.0
FZD2	9952.0	4923.0
GFY	9918.0	6472.0
GJB4	-6697.0	-10045.0
GNAS	-1514.0	1352.0
GNAT1	-4968.0	-1395.0
GNAT2	6572.0	-7529.0
GNAT3	-753.0	-5183.0
GNB1	10183.0	-351.0
GNG13	3196.0	8748.0
GPR148	-5358.0	-4843.0
ITPR3	-700.0	-263.0
LCN1	12950.0	-6085.0
LEF1	1070.0	10605.0
LPO	-1197.0	8412.0
MKKS	7844.0	-4747.0
NAV2	-1676.0	-1618.0
NXNL2	2329.0	2787.0
OBP2A	-7360.0	-9458.0
OBP2B	-1280.0	-8072.0
OMP	-6907.0	-7622.0
OR10A2	-7787.0	-6844.0
OR10A3	-8278.0	-10283.0
OR10A4	-8573.0	-7006.0
OR10A5	-7881.0	-3145.5
OR10A6	-6953.0	4168.0
OR10A7	-8430.0	-9179.0
OR10AD1	7665.0	-2498.0
OR10AG1	-8863.0	6412.0
OR10C1	-8852.0	-9684.0
OR10G2	-8071.0	-7664.0
OR10G3	12510.0	7224.0
OR10G4	-8902.0	3049.0
OR10G7	-8466.0	-8682.0
OR10G8	-8667.0	-9735.0
OR10G9	-7568.0	-4730.0
OR10H1	-7788.0	-7869.0
OR10H2	-8754.0	-4755.0
OR10H3	-5196.0	-6901.0
OR10H4	-8046.0	-10154.0
OR10H5	-8257.0	6410.0
OR10J1	-8874.0	-7751.0
OR10J3	-8913.0	-10402.0
OR10J5	-8826.0	-7423.0
OR10K1	-7467.0	-9101.0
OR10K2	-8756.0	-10278.0
OR10P1	-7238.0	-10349.0
OR10Q1	-8271.0	-4562.0
OR10S1	-8816.0	-9650.0
OR10T2	-8533.0	10603.0
OR10V1	-8188.0	-9597.0
OR10W1	-8406.0	10427.0
OR10X1	-8893.0	-6701.0
OR10Z1	-8846.0	-10322.0
OR11A1	-8601.0	-8876.0
OR11G2	-4694.0	-5081.0
OR11H4	-3616.0	-6905.0
OR11H6	1508.0	-9002.0
OR11L1	-8363.0	1925.0
OR12D2	-8849.0	-8693.0
OR12D3	-7860.0	-9340.0
OR13A1	-5572.0	-9481.0
OR13C2	-8434.0	-10224.0
OR13C3	-5340.0	-3089.0
OR13C4	-1482.0	-8407.0
OR13C8	-5365.0	-10016.0
OR13C9	4794.0	-3843.0
OR13D1	-6091.0	7322.0
OR13F1	-5594.0	-7134.0
OR13G1	-7645.0	10248.0
OR13J1	-1469.0	1462.0
OR14A16	-6409.0	2820.0
OR14C36	-8782.0	-8133.0
OR14I1	-8740.0	-7443.0
OR14J1	-8737.0	-8113.0
OR1A1	-8187.0	-9136.0
OR1A2	-7024.0	-7703.0
OR1B1	-4473.0	-6957.0
OR1C1	-7900.0	-8088.0
OR1D2	-5998.0	2104.0
OR1E1	-7021.0	-9685.0
OR1E2	-7975.0	-6968.0
OR1F1	-3776.0	-4566.0
OR1F2P	-5316.0	5759.0
OR1G1	-8539.0	-10149.0
OR1I1	-7108.0	-1606.0
OR1J1	6716.0	11383.0
OR1J2	10792.0	9030.0
OR1J4	9362.0	10497.0
OR1K1	-2878.0	-2441.0
OR1L1	-2354.0	-6342.0
OR1L3	1433.0	1513.0
OR1L4	364.0	-2983.0
OR1L6	-1611.0	-5802.0
OR1L8	3611.0	7885.0
OR1M1	-7517.0	-8662.0
OR1N1	2130.0	10537.0
OR1N2	6772.0	11101.0
OR1Q1	5303.0	-1992.0
OR1S1	-7946.0	-9292.0
OR1S2	-8118.0	-5196.0
OR2A12	-7621.0	7647.0
OR2A14	-6850.0	-7449.0
OR2A2	-8346.0	-7960.0
OR2A5	-6433.0	-9812.0
OR2AE1	-4280.0	3758.0
OR2AG1	-8515.0	-6440.0
OR2AG2	-8309.0	-1022.0
OR2AK2	-5701.0	-9060.0
OR2AP1	-8766.0	-6978.0
OR2AT4	-5943.0	-5589.0
OR2B11	-8548.0	-6622.0
OR2B2	12144.0	-8249.0
OR2B3	-7988.0	-8083.0
OR2B6	1129.0	8845.0
OR2C1	3265.0	-5317.0
OR2C3	-1253.0	-7183.0
OR2D2	-8724.0	-5136.0
OR2D3	-8376.0	-10189.0
OR2F1	-8527.0	-977.0
OR2F2	-8689.0	-4563.0
OR2G2	-8764.0	-9649.0
OR2G3	-8563.0	1861.0
OR2G6	-8429.0	-8663.0
OR2H1	-8461.0	-9048.0
OR2H2	3122.0	-7030.0
OR2J2	-6213.0	7779.0
OR2K2	-5397.0	-7566.0
OR2L13	-7474.0	-751.0
OR2L2	-6903.0	-8023.0
OR2L3	-6858.0	-6162.0
OR2L5	-8901.0	6885.0
OR2L8	-6728.0	8876.0
OR2M2	-7793.0	-4401.0
OR2M3	-8395.0	-5578.0
OR2M4	-8711.0	-6883.0
OR2M5	-8683.0	-8650.0
OR2M7	-8726.0	-2246.0
OR2S2	7657.0	-8282.0
OR2T1	-8157.0	-6879.0
OR2T11	-8582.0	3006.0
OR2T12	-7940.0	-9826.0
OR2T27	-7020.0	-2813.0
OR2T3	-8191.0	-10339.0
OR2T33	-8441.0	5685.0
OR2T4	-7350.0	4014.0
OR2T6	-8745.0	2119.0
OR2T8	-7137.0	-9270.0
OR2V1	-4956.0	-10441.0
OR2V2	-662.0	482.0
OR2W1	-8059.0	1286.0
OR2W3	-7056.0	-8717.0
OR2W5P	-7557.0	-9742.0
OR2Y1	-6479.0	-2580.0
OR2Z1	-8323.0	5961.0
OR3A1	-7575.0	-8216.0
OR3A2	-8329.0	10096.0
OR3A3	-7316.0	-8600.0
OR4A15	-6950.0	-3278.0
OR4A16	-7844.0	6147.0
OR4A47	-7399.0	-2644.0
OR4A5	-749.0	6622.0
OR4B1	-8352.0	9928.0
OR4C12	-8651.0	6962.0
OR4C15	-8485.0	-884.0
OR4C16	-7992.0	-1614.0
OR4C3	-5070.0	7640.0
OR4C45	-2202.0	3791.0
OR4C46	-8881.0	10922.0
OR4C6	-8617.0	-2250.0
OR4D1	-8367.0	-5164.0
OR4D10	576.0	-9386.0
OR4D11	-8900.0	-9585.0
OR4D2	-8230.0	5666.0
OR4D5	-8821.0	-2479.0
OR4D6	-8068.0	-10318.0
OR4D9	-8415.0	-5700.0
OR4E2	-7896.0	-8794.0
OR4F15	-8731.0	5223.0
OR4F6	-8707.0	3991.0
OR4K1	-2489.0	-1923.0
OR4K13	-7182.0	-1003.0
OR4K14	-1026.0	-489.0
OR4K15	-4948.0	-8389.0
OR4K17	-5205.0	2118.0
OR4K2	10125.0	-6222.0
OR4K5	-8409.0	-9447.0
OR4L1	-2709.0	-8508.0
OR4M1	-5722.0	-10074.0
OR4N2	8511.0	-6761.0
OR4N5	5148.0	-5237.0
OR4S1	-7921.0	2903.0
OR4X1	-7029.0	9130.0
OR51A2	-8685.0	-7196.0
OR51A7	-8920.0	-10383.0
OR51B2	-8841.0	-8606.0
OR51B4	-8805.0	-7312.0
OR51B5	-8775.0	-8338.0
OR51B6	-8917.0	3724.0
OR51D1	-7739.0	-10341.0
OR51E1	-6194.0	-735.0
OR51E2	-5475.0	-8919.0
OR51F1	-8865.0	-9809.0
OR51F2	-8591.0	-7420.0
OR51G1	-8531.0	-9910.0
OR51G2	-8910.0	-10087.0
OR51I1	-8886.0	-8594.0
OR51I2	-8580.0	-5564.0
OR51L1	-8789.0	-9671.0
OR51M1	-8876.0	6499.0
OR51Q1	-7204.0	-6608.0
OR51S1	-8813.0	-9468.0
OR51T1	-8643.0	-4924.0
OR51V1	-8878.0	-9517.0
OR52A1	-7603.0	-9024.0
OR52A4P	-8909.0	-2936.0
OR52A5	-8845.0	-7485.0
OR52B2	-6912.0	-8527.0
OR52B4	-8668.0	-4941.0
OR52B6	-6138.0	2054.0
OR52D1	-8623.0	8882.0
OR52E2	-8871.0	3861.0
OR52E4	-8457.0	-10066.0
OR52E6	-8468.0	2573.0
OR52E8	-7394.0	-1223.0
OR52H1	-8102.0	-8601.0
OR52I1	-7589.0	-9979.0
OR52I2	-7995.0	-9404.0
OR52J3	-7624.0	-7597.0
OR52K1	-8280.0	3766.0
OR52K2	-4066.0	-7724.0
OR52L1	-8606.0	-10358.0
OR52M1	-4343.0	-8014.0
OR52N1	-7558.0	-8745.0
OR52N2	-8123.0	-10347.0
OR52R1	-8784.0	-4011.0
OR52W1	587.0	-5968.0
OR56A1	-8128.0	-4054.0
OR56A3	-8086.0	-8542.0
OR56A4	-7996.0	-7540.0
OR56A5	-6703.0	11038.0
OR56B1	-8757.0	-10234.0
OR56B4	-7993.0	-10289.0
OR5A1	-8850.0	-9972.0
OR5A2	-8392.0	-8107.0
OR5AC2	-8794.0	-10384.0
OR5AK2	-8404.0	7338.0
OR5AN1	-8490.0	1830.0
OR5AP2	-8700.0	-7595.0
OR5AR1	-8911.0	-7168.0
OR5AS1	-8860.0	-8172.0
OR5AU1	-1164.0	8558.0
OR5B12	-8702.0	-111.0
OR5B17	-7781.0	2218.0
OR5B2	-7893.0	-3718.0
OR5B21	-7572.0	-217.0
OR5B3	-8411.0	4139.0
OR5C1	110.0	10713.0
OR5D13	-8255.0	10278.0
OR5D14	-8719.0	-3423.0
OR5D16	-8193.0	-9261.0
OR5D18	-8746.0	1560.0
OR5F1	-8710.0	-9540.0
OR5H15	-8607.0	-8387.0
OR5H2	-7083.0	3502.0
OR5H6	-8916.0	3949.0
OR5I1	-8777.0	1024.0
OR5J2	-8907.0	-644.0
OR5K1	-7935.0	-9797.0
OR5K2	-7997.0	-7840.0
OR5K3	-7376.0	709.0
OR5K4	-8108.0	-3495.0
OR5L1	-8896.0	-6365.0
OR5L2	-8484.0	-8465.0
OR5M1	-8817.0	-5980.0
OR5M10	-7002.0	10258.0
OR5M11	-8851.0	-6869.0
OR5M3	-8892.0	6320.0
OR5M8	-8202.0	6633.0
OR5M9	-8652.0	-8807.0
OR5P2	-8229.0	9202.0
OR5P3	-7960.0	-9224.0
OR5T1	-8552.0	-9672.0
OR5T2	-8868.0	-8111.0
OR5V1	-8433.0	-8947.0
OR5W2	-8835.0	190.0
OR6A2	-7547.0	4389.0
OR6B1	-8333.0	-8565.0
OR6B2	-3920.0	-3238.0
OR6B3	-2940.0	-2345.0
OR6C1	-8355.0	-1839.0
OR6C2	-8734.0	-9189.0
OR6C3	-7287.0	9079.0
OR6C4	-7898.0	307.0
OR6C6	-8598.0	-9568.0
OR6C65	-8727.0	-9768.0
OR6C68	-8360.0	1509.0
OR6C70	-6899.0	-5260.0
OR6C74	-8094.0	6249.0
OR6C75	-8479.0	-8904.0
OR6C76	-8583.0	-5198.0
OR6F1	-8192.0	-7574.0
OR6K2	-8767.0	-6575.0
OR6K3	-8529.0	350.0
OR6K6	-8446.0	-7680.0
OR6M1	-7104.0	-1351.0
OR6N1	-8709.0	3763.0
OR6N2	-8251.0	-582.0
OR6P1	-7847.0	-790.0
OR6Q1	5223.0	11409.0
OR6S1	256.0	-8969.0
OR6T1	-8736.0	-9448.0
OR6V1	-4309.0	-1428.0
OR6X1	-7171.0	-5161.0
OR6Y1	-6846.0	-6126.0
OR7A10	-3281.0	10552.0
OR7A17	-8171.0	-7929.0
OR7A5	-8470.0	-1738.0
OR7C1	-7248.0	-4989.0
OR7C2	-8185.0	5937.0
OR7D2	-7628.0	-5028.0
OR7D4	-8301.0	-9848.0
OR7E24	-5138.0	5675.0
OR7G1	-1215.0	1186.0
OR7G2	630.0	-5976.0
OR7G3	-8366.0	8430.0
OR8A1	-7596.0	-10041.0
OR8B12	-8838.0	-8500.0
OR8B2	-7565.0	3496.0
OR8B4	-8779.0	-7684.0
OR8B8	-8605.0	-6828.0
OR8D1	-8738.0	3524.0
OR8D2	-8615.0	-9930.0
OR8D4	-3371.0	-7348.0
OR8G1	-8679.0	-4815.0
OR8G2P	-8443.0	-10227.0
OR8G5	-8771.0	-511.0
OR8H1	-8618.0	2535.0
OR8H3	-8915.0	-9992.0
OR8I2	-8063.0	-3055.0
OR8J1	-8875.0	-7150.0
OR8J3	-8742.0	-9170.0
OR8K1	-7782.0	-8075.0
OR8K3	-8787.0	-107.0
OR8K5	-8444.0	-5584.0
OR8S1	1566.0	-6033.0
OR8U1	-8883.0	2452.0
OR8U3	-8828.0	-5561.0
OR8U8	-8799.0	2138.0
OR9A2	-7956.0	-2581.0
OR9A4	-8469.0	-7752.0
OR9G1	-8692.5	-9740.5
OR9G4	-8861.0	-7382.0
OR9G9	-8692.5	-9740.5
OR9I1	-8609.0	582.0
OR9K2	-7491.0	9051.0
OR9Q1	-6502.0	3161.0
OR9Q2	-7687.0	-10121.0
P2RX2	-533.0	553.0
P2RX3	9277.0	-5338.0
PDE4A	-151.0	6287.0
PIGR	-3039.0	-8727.0
PIP	-3982.0	-2434.0
PKD1L3	11183.0	2767.0
PKD2L1	4949.0	-3685.0
PLCB2	-1310.0	1078.0
REEP2	11283.0	-1263.0
RGS21	-6050.0	-923.0
RTP1	-4321.0	-4768.0
RTP2	-7549.0	-8666.0
RTP3	4486.0	7542.0
RTP4	11116.0	-6263.0
RTP5	-7531.0	6745.0
SCNN1A	-5735.0	-4971.0
SCNN1B	2503.0	-1768.0
SCNN1D	-5156.0	-9526.0
SCNN1G	-6298.0	-4203.0
SLC24A4	3970.0	-915.0
SLC6A3	-6420.0	-6362.0
SYT10	8633.0	5963.0
TAAR3P	-7186.0	468.0
TAAR5	-7833.0	-4938.0
TAS1R1	-1881.0	5906.0
TAS1R2	-7734.0	-4943.0
TAS1R3	-8267.0	-5306.0
TAS2R1	-8379.0	-4614.0
TAS2R10	-2499.0	-9539.0
TAS2R13	5640.0	-3080.0
TAS2R14	-6360.0	5969.0
TAS2R16	-8089.0	7470.0
TAS2R19	12447.0	4766.0
TAS2R20	-2939.0	1364.0
TAS2R3	2661.0	-8961.0
TAS2R30	9022.0	10829.0
TAS2R31	8597.0	-4350.0
TAS2R38	-6885.0	9611.0
TAS2R39	-7497.0	-8855.0
TAS2R4	5342.0	-2437.0
TAS2R40	-6928.0	-7774.0
TAS2R41	-7455.0	-9875.0
TAS2R42	7274.0	1478.0
TAS2R43	11807.0	-9773.0
TAS2R46	10818.0	-7639.0
TAS2R5	803.0	2429.0
TAS2R50	5891.0	-6430.0
TAS2R60	-7443.0	-8007.0
TAS2R7	9218.0	-2844.0
TAS2R8	-5032.0	1687.0
TAS2R9	-6812.0	-10330.0
TRPA1	-5829.0	3759.0
TRPV1	7947.0	-8004.0
TTC8	6694.0	1411.0
UBR3	5153.0	-2464.0
UGT2A1	-8116.0	-7417.0
VN1R1	126.0	-9022.0
VN1R2	-7852.0	-8333.0
VN1R4	-8148.0	-5114.0
WNT10B	9690.0	8897.0

---

---

GOBP ASCENDING AORTA DEVELOPMENT

GOBP ASCENDING AORTA DEVELOPMENT

metric	value
setSize	5
pMANOVA	0.0368
p.adjustMANOVA	0.152
s.dist	0.73
s.cancer	0.471
s.incidence	0.558
p.cancer	0.0681
p.incidence	0.0308

Top 20 genes

Gene	cancer	incidence
SOX4	10104	9926
HES1	8759	7625
TGFB2	8196	4949
LOX	10088	3494

Click HERE to show all gene set members

All member genes

	cancer	incidence
HES1	8759	7625
HEY2	-1176	7028
LOX	10088	3494
SOX4	10104	9926
TGFB2	8196	4949

---

---

GOBP POSITIVE REGULATION OF ENAMEL MINERALIZATION

GOBP POSITIVE REGULATION OF ENAMEL MINERALIZATION

metric	value
setSize	5
pMANOVA	0.0153
p.adjustMANOVA	0.0821
s.dist	0.73
s.cancer	-0.00052
s.incidence	-0.73
p.cancer	0.998
p.incidence	0.00472

Top 20 genes

Gene	cancer	incidence
AMTN	-8238	-8376
ODAPH	-6037	-4993

Click HERE to show all gene set members

All member genes

	cancer	incidence
AMTN	-8238	-8376
CFTR	10064	-8943
ENAM	10540	-9114
ODAPH	-6037	-4993
SLC4A2	3800	-6080

---

---

GOBP EMBRYONIC HEART TUBE LEFT RIGHT PATTERN FORMATION

GOBP EMBRYONIC HEART TUBE LEFT RIGHT PATTERN FORMATION

metric	value
setSize	6
pMANOVA	0.018
p.adjustMANOVA	0.092
s.dist	0.729
s.cancer	0.604
s.incidence	0.408
p.cancer	0.0104
p.incidence	0.0834

Top 20 genes

Gene	cancer	incidence
PITX2	12073	9710
CIMAP3	11149	9951
NKX2-5	12016	8834
CITED2	6911	7445
IFT122	6057	1181

Click HERE to show all gene set members

All member genes

	cancer	incidence
CIMAP3	11149	9951
CITED2	6911	7445
IFT122	6057	1181
MEGF8	3720	-7319
NKX2-5	12016	8834
PITX2	12073	9710

---

---

GOBP NEGATIVE REGULATION OF CERAMIDE BIOSYNTHETIC PROCESS

GOBP NEGATIVE REGULATION OF CERAMIDE BIOSYNTHETIC PROCESS

metric	value
setSize	5
pMANOVA	0.0361
p.adjustMANOVA	0.15
s.dist	0.727
s.cancer	0.416
s.incidence	0.597
p.cancer	0.107
p.incidence	0.0208

Top 20 genes

Gene	cancer	incidence
ORMDL3	9129	9507
ORMDL2	12269	6987
PRKAA1	8412	9244
ORMDL1	5710	6649

Click HERE to show all gene set members

All member genes

	cancer	incidence
ORMDL1	5710	6649
ORMDL2	12269	6987
ORMDL3	9129	9507
PRKAA1	8412	9244
SPHK1	-2577	2780

---

---

Here is the session info with all the versions of packages used.

sessionInfo()

## R version 4.4.1 (2024-06-14)
## Platform: x86_64-pc-linux-gnu
## Running under: Ubuntu 22.04.5 LTS
## 
## Matrix products: default
## BLAS:   /usr/lib/x86_64-linux-gnu/blas/libblas.so.3.10.0 
## LAPACK: /usr/lib/x86_64-linux-gnu/lapack/liblapack.so.3.10.0
## 
## locale:
##  [1] LC_CTYPE=en_US.UTF-8       LC_NUMERIC=C              
##  [3] LC_TIME=en_US.UTF-8        LC_COLLATE=en_US.UTF-8    
##  [5] LC_MONETARY=en_US.UTF-8    LC_MESSAGES=en_US.UTF-8   
##  [7] LC_PAPER=en_US.UTF-8       LC_NAME=C                 
##  [9] LC_ADDRESS=C               LC_TELEPHONE=C            
## [11] LC_MEASUREMENT=en_US.UTF-8 LC_IDENTIFICATION=C       
## 
## time zone: Australia/Melbourne
## tzcode source: system (glibc)
## 
## attached base packages:
## [1] parallel  stats4    stats     graphics  grDevices utils     datasets 
## [8] methods   base     
## 
## other attached packages:
##  [1] pkgload_1.4.0                                      
##  [2] GGally_2.2.1                                       
##  [3] ggplot2_3.5.1                                      
##  [4] reshape2_1.4.4                                     
##  [5] gtools_3.9.5                                       
##  [6] tibble_3.2.1                                       
##  [7] dplyr_1.1.4                                        
##  [8] echarts4r_0.4.5                                    
##  [9] gplots_3.2.0                                       
## [10] eulerr_7.0.2                                       
## [11] RhpcBLASctl_0.23-42                                
## [12] beeswarm_0.4.0                                     
## [13] vioplot_0.5.0                                      
## [14] zoo_1.8-12                                         
## [15] sm_2.2-6.0                                         
## [16] kableExtra_1.4.0                                   
## [17] IlluminaHumanMethylationEPICanno.ilm10b4.hg19_0.6.0
## [18] IlluminaHumanMethylation450kanno.ilmn12.hg19_0.6.1 
## [19] minfi_1.50.0                                       
## [20] bumphunter_1.46.0                                  
## [21] locfit_1.5-9.10                                    
## [22] iterators_1.0.14                                   
## [23] foreach_1.5.2                                      
## [24] Biostrings_2.72.1                                  
## [25] XVector_0.44.0                                     
## [26] SummarizedExperiment_1.34.0                        
## [27] Biobase_2.64.0                                     
## [28] MatrixGenerics_1.16.0                              
## [29] matrixStats_1.4.1                                  
## [30] GenomicRanges_1.56.2                               
## [31] GenomeInfoDb_1.40.1                                
## [32] IRanges_2.38.1                                     
## [33] S4Vectors_0.42.1                                   
## [34] BiocGenerics_0.50.0                                
## [35] HGNChelper_0.8.15                                  
## [36] mitch_1.19.3                                       
## 
## loaded via a namespace (and not attached):
##   [1] splines_4.4.1             later_1.4.0              
##   [3] BiocIO_1.14.0             bitops_1.0-9             
##   [5] polyclip_1.10-7           preprocessCore_1.66.0    
##   [7] XML_3.99-0.17             lifecycle_1.0.4          
##   [9] lattice_0.22-6            MASS_7.3-61              
##  [11] base64_2.0.2              scrime_1.3.5             
##  [13] magrittr_2.0.3            limma_3.60.6             
##  [15] sass_0.4.9                rmarkdown_2.29           
##  [17] jquerylib_0.1.4           yaml_2.3.10              
##  [19] httpuv_1.6.15             doRNG_1.8.6              
##  [21] askpass_1.2.1             DBI_1.2.3                
##  [23] RColorBrewer_1.1-3        abind_1.4-8              
##  [25] zlibbioc_1.50.0           quadprog_1.5-8           
##  [27] purrr_1.0.2               RCurl_1.98-1.16          
##  [29] GenomeInfoDbData_1.2.12   genefilter_1.86.0        
##  [31] annotate_1.82.0           svglite_2.1.3            
##  [33] DelayedMatrixStats_1.26.0 codetools_0.2-20         
##  [35] DelayedArray_0.30.1       xml2_1.3.6               
##  [37] tidyselect_1.2.1          farver_2.1.2             
##  [39] UCSC.utils_1.0.0          beanplot_1.3.1           
##  [41] illuminaio_0.46.0         GenomicAlignments_1.40.0 
##  [43] jsonlite_1.8.9            multtest_2.60.0          
##  [45] survival_3.7-0            systemfonts_1.1.0        
##  [47] polylabelr_0.3.0          tools_4.4.1              
##  [49] Rcpp_1.0.13-1             glue_1.8.0               
##  [51] gridExtra_2.3             SparseArray_1.4.8        
##  [53] xfun_0.49                 HDF5Array_1.32.1         
##  [55] withr_3.0.2               fastmap_1.2.0            
##  [57] rhdf5filters_1.16.0       fansi_1.0.6              
##  [59] openssl_2.2.2             caTools_1.18.3           
##  [61] digest_0.6.37             R6_2.5.1                 
##  [63] mime_0.12                 colorspace_2.1-1         
##  [65] RSQLite_2.3.8             utf8_1.2.4               
##  [67] tidyr_1.3.1               generics_0.1.3           
##  [69] data.table_1.16.2         rtracklayer_1.64.0       
##  [71] httr_1.4.7                htmlwidgets_1.6.4        
##  [73] S4Arrays_1.4.1            ggstats_0.7.0            
##  [75] pkgconfig_2.0.3           gtable_0.3.6             
##  [77] blob_1.2.4                siggenes_1.78.0          
##  [79] htmltools_0.5.8.1         scales_1.3.0             
##  [81] png_0.1-8                 knitr_1.49               
##  [83] rstudioapi_0.17.1         tzdb_0.4.0               
##  [85] rjson_0.2.23              nlme_3.1-166             
##  [87] curl_6.0.1                cachem_1.1.0             
##  [89] rhdf5_2.48.0              stringr_1.5.1            
##  [91] KernSmooth_2.23-24        AnnotationDbi_1.66.0     
##  [93] restfulr_0.0.15           GEOquery_2.72.0          
##  [95] pillar_1.9.0              grid_4.4.1               
##  [97] reshape_0.8.9             vctrs_0.6.5              
##  [99] promises_1.3.1            xtable_1.8-4             
## [101] evaluate_1.0.1            readr_2.1.5              
## [103] GenomicFeatures_1.56.0    cli_3.6.3                
## [105] compiler_4.4.1            Rsamtools_2.20.0         
## [107] rlang_1.1.4               crayon_1.5.3             
## [109] rngtools_1.5.2            labeling_0.4.3           
## [111] nor1mix_1.3-3             mclust_6.1.1             
## [113] plyr_1.8.9                stringi_1.8.4            
## [115] viridisLite_0.4.2         BiocParallel_1.38.0      
## [117] munsell_0.5.1             Matrix_1.7-1             
## [119] hms_1.1.3                 sparseMatrixStats_1.16.0 
## [121] bit64_4.5.2               Rhdf5lib_1.26.0          
## [123] KEGGREST_1.44.1           statmod_1.5.0            
## [125] shiny_1.9.1               memoise_2.0.1.9000       
## [127] bslib_0.8.0               bit_4.5.0                
## [129] splitstackshape_1.4.8

END of report